GOMF IGE BINDING
|
5
|
4.16e-04
|
2.73e-02
|
1.07000
|
-5.75e-01
|
9.04e-01
|
2.60e-02
|
4.60e-04
|
GOCC ALPHA BETA T CELL RECEPTOR COMPLEX
|
5
|
8.01e-05
|
7.81e-03
|
1.05000
|
7.04e-01
|
7.81e-01
|
6.40e-03
|
2.48e-03
|
GOCC BOX H ACA RNP COMPLEX
|
7
|
3.36e-05
|
4.09e-03
|
1.05000
|
6.60e-01
|
-8.13e-01
|
2.49e-03
|
1.95e-04
|
GOCC B CELL RECEPTOR COMPLEX
|
5
|
4.22e-04
|
2.75e-02
|
0.95400
|
6.65e-01
|
6.84e-01
|
9.98e-03
|
8.06e-03
|
GOMF IGG BINDING
|
7
|
6.98e-05
|
6.94e-03
|
0.90900
|
-8.35e-01
|
-3.58e-01
|
1.30e-04
|
1.01e-01
|
GOBP POSITIVE REGULATION OF PROTEOGLYCAN BIOSYNTHETIC PROCESS
|
5
|
1.16e-02
|
2.31e-01
|
0.81400
|
-5.02e-01
|
6.42e-01
|
5.20e-02
|
1.30e-02
|
GOCC MICROTUBULE BUNDLE
|
6
|
5.03e-03
|
1.46e-01
|
0.81200
|
-5.81e-01
|
5.67e-01
|
1.37e-02
|
1.61e-02
|
GOBP POSITIVE REGULATION OF COMPLEMENT ACTIVATION
|
7
|
8.52e-04
|
4.64e-02
|
0.80600
|
-7.19e-02
|
-8.03e-01
|
7.42e-01
|
2.35e-04
|
GOCC T CELL RECEPTOR COMPLEX
|
13
|
7.62e-07
|
2.44e-04
|
0.79700
|
5.56e-01
|
5.71e-01
|
5.20e-04
|
3.63e-04
|
GOBP POSITIVE REGULATION OF I KAPPAB PHOSPHORYLATION
|
6
|
7.31e-03
|
1.78e-01
|
0.77800
|
-6.51e-01
|
4.27e-01
|
5.76e-03
|
7.02e-02
|
GOBP POSITIVE REGULATION OF GAP JUNCTION ASSEMBLY
|
6
|
7.45e-03
|
1.80e-01
|
0.77400
|
3.89e-01
|
-6.69e-01
|
9.87e-02
|
4.52e-03
|
GOCC INTERPHOTORECEPTOR MATRIX
|
6
|
8.56e-03
|
1.95e-01
|
0.76800
|
6.13e-01
|
-4.62e-01
|
9.27e-03
|
4.98e-02
|
GOBP GROWTH PLATE CARTILAGE CHONDROCYTE DEVELOPMENT
|
5
|
8.14e-03
|
1.88e-01
|
0.76100
|
3.11e-01
|
6.95e-01
|
2.29e-01
|
7.11e-03
|
GOBP REGULATION OF I KAPPAB PHOSPHORYLATION
|
8
|
2.57e-03
|
9.91e-02
|
0.74600
|
-5.73e-01
|
4.77e-01
|
4.98e-03
|
1.96e-02
|
GOBP LIPID HYDROXYLATION
|
7
|
1.75e-03
|
7.68e-02
|
0.73900
|
6.72e-01
|
3.06e-01
|
2.06e-03
|
1.61e-01
|
GOBP THORAX AND ANTERIOR ABDOMEN DETERMINATION
|
5
|
1.48e-02
|
2.62e-01
|
0.73800
|
5.09e-02
|
7.36e-01
|
8.44e-01
|
4.36e-03
|
GOBP POSITIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS
|
5
|
2.65e-02
|
3.40e-01
|
0.73600
|
-4.67e-01
|
5.69e-01
|
7.07e-02
|
2.76e-02
|
GOBP POSITIVE REGULATION OF FERTILIZATION
|
5
|
2.77e-02
|
3.46e-01
|
0.72800
|
4.02e-01
|
-6.07e-01
|
1.20e-01
|
1.87e-02
|
GOBP POSITIVE REGULATION OF MIRNA PROCESSING
|
5
|
2.72e-02
|
3.43e-01
|
0.72600
|
-6.40e-01
|
3.43e-01
|
1.32e-02
|
1.84e-01
|
GOBP PH REDUCTION
|
6
|
1.71e-02
|
2.78e-01
|
0.71200
|
-4.70e-01
|
5.35e-01
|
4.64e-02
|
2.33e-02
|
GOMF HAPTOGLOBIN BINDING
|
10
|
1.89e-04
|
1.47e-02
|
0.71100
|
5.73e-01
|
4.20e-01
|
1.69e-03
|
2.14e-02
|
GOBP POSITIVE REGULATION OF DNA LIGATION
|
5
|
1.87e-02
|
2.92e-01
|
0.70300
|
-1.76e-01
|
-6.80e-01
|
4.95e-01
|
8.45e-03
|
GOBP EPOXIDE METABOLIC PROCESS
|
5
|
2.56e-02
|
3.32e-01
|
0.70000
|
-4.79e-02
|
6.98e-01
|
8.53e-01
|
6.85e-03
|
GOCC PHAGOCYTIC VESICLE LUMEN
|
5
|
2.30e-02
|
3.21e-01
|
0.69600
|
-6.93e-01
|
-6.68e-02
|
7.31e-03
|
7.96e-01
|
GOBP CELLULAR RESPONSE TO AMMONIUM ION
|
5
|
3.18e-02
|
3.65e-01
|
0.69000
|
6.75e-01
|
-1.44e-01
|
8.94e-03
|
5.77e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CHROMATIN
|
6
|
2.08e-02
|
3.05e-01
|
0.69000
|
-5.86e-01
|
3.63e-01
|
1.29e-02
|
1.24e-01
|
GOCC ENDOPLASMIC RETICULUM PALMITOYLTRANSFERASE COMPLEX
|
8
|
4.55e-03
|
1.38e-01
|
0.68900
|
2.02e-01
|
-6.59e-01
|
3.23e-01
|
1.24e-03
|
GOBP GTP BIOSYNTHETIC PROCESS
|
11
|
1.58e-04
|
1.31e-02
|
0.68900
|
-3.27e-01
|
-6.07e-01
|
6.06e-02
|
4.93e-04
|
GOBP CILIARY BODY MORPHOGENESIS
|
5
|
1.93e-02
|
2.98e-01
|
0.68700
|
3.16e-01
|
6.10e-01
|
2.22e-01
|
1.81e-02
|
GOBP SEQUESTERING OF BMP IN EXTRACELLULAR MATRIX
|
5
|
4.25e-02
|
4.24e-01
|
0.68500
|
5.49e-01
|
-4.11e-01
|
3.36e-02
|
1.12e-01
|
GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS
|
6
|
8.90e-03
|
1.97e-01
|
0.68000
|
5.15e-01
|
4.43e-01
|
2.88e-02
|
6.02e-02
|
GOMF TAP BINDING
|
7
|
1.04e-02
|
2.18e-01
|
0.67500
|
1.70e-01
|
-6.53e-01
|
4.36e-01
|
2.76e-03
|
GOBP POSITIVE REGULATION OF CHEMOKINE C X C MOTIF LIGAND 1 PRODUCTION
|
5
|
3.68e-02
|
3.91e-01
|
0.67200
|
-6.63e-01
|
1.09e-01
|
1.02e-02
|
6.74e-01
|
GOBP REGULATION OF RAB PROTEIN SIGNAL TRANSDUCTION
|
7
|
1.50e-02
|
2.62e-01
|
0.67000
|
-4.65e-01
|
4.82e-01
|
3.32e-02
|
2.71e-02
|
GOBP REGULATION OF PHENOTYPIC SWITCHING
|
6
|
2.68e-02
|
3.41e-01
|
0.66700
|
-5.67e-01
|
3.52e-01
|
1.62e-02
|
1.36e-01
|
GOBP REGULATION OF LUNG BLOOD PRESSURE
|
5
|
5.15e-02
|
4.48e-01
|
0.66600
|
-4.72e-01
|
4.70e-01
|
6.78e-02
|
6.87e-02
|
GOBP REGULATION OF DNA LIGATION
|
6
|
1.36e-02
|
2.52e-01
|
0.66400
|
-1.90e-01
|
-6.37e-01
|
4.21e-01
|
6.91e-03
|
GOCC MHC CLASS I PEPTIDE LOADING COMPLEX
|
8
|
7.97e-03
|
1.87e-01
|
0.66400
|
3.07e-01
|
-5.89e-01
|
1.33e-01
|
3.94e-03
|
GOBP AMP CATABOLIC PROCESS
|
5
|
2.99e-02
|
3.61e-01
|
0.66200
|
1.44e-01
|
6.46e-01
|
5.77e-01
|
1.23e-02
|
GOBP TYPE III INTERFERON PRODUCTION
|
5
|
3.38e-02
|
3.75e-01
|
0.66100
|
-5.01e-02
|
-6.59e-01
|
8.46e-01
|
1.07e-02
|
GOCC CHAPERONIN CONTAINING T COMPLEX
|
10
|
2.97e-03
|
1.06e-01
|
0.65800
|
3.89e-01
|
-5.30e-01
|
3.32e-02
|
3.69e-03
|
GOBP CORPUS CALLOSUM MORPHOGENESIS
|
6
|
1.95e-02
|
3.00e-01
|
0.65700
|
-1.18e-03
|
6.57e-01
|
9.96e-01
|
5.34e-03
|
GOBP BASOLATERAL PROTEIN SECRETION
|
5
|
3.18e-02
|
3.65e-01
|
0.65600
|
1.46e-01
|
6.40e-01
|
5.72e-01
|
1.32e-02
|
GOMF CORTICOTROPIN RELEASING HORMONE RECEPTOR BINDING
|
5
|
4.31e-02
|
4.26e-01
|
0.65500
|
-1.02e-01
|
6.47e-01
|
6.92e-01
|
1.22e-02
|
GOMF RNA POLYMERASE I GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY
|
5
|
3.62e-02
|
3.88e-01
|
0.65500
|
-6.53e-01
|
-4.65e-02
|
1.14e-02
|
8.57e-01
|
GOBP TRACHEA FORMATION
|
7
|
1.87e-02
|
2.92e-01
|
0.65200
|
-4.28e-01
|
4.92e-01
|
5.00e-02
|
2.43e-02
|
GOBP RETINAL CELL PROGRAMMED CELL DEATH
|
6
|
1.58e-02
|
2.65e-01
|
0.65000
|
2.18e-01
|
6.12e-01
|
3.56e-01
|
9.42e-03
|
GOBP REGULATION OF PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS
|
5
|
6.18e-02
|
4.82e-01
|
0.64500
|
-4.57e-01
|
4.55e-01
|
7.67e-02
|
7.80e-02
|
GOMF MORPHOGEN ACTIVITY
|
8
|
1.04e-02
|
2.18e-01
|
0.64500
|
5.74e-01
|
-2.94e-01
|
4.95e-03
|
1.50e-01
|
GOBP PROTEIN SIALYLATION
|
5
|
5.38e-02
|
4.58e-01
|
0.64400
|
-6.09e-01
|
2.09e-01
|
1.83e-02
|
4.19e-01
|
GOMF G PROTEIN COUPLED RECEPTOR KINASE ACTIVITY
|
7
|
2.06e-02
|
3.05e-01
|
0.64200
|
-5.12e-01
|
3.88e-01
|
1.91e-02
|
7.54e-02
|
GOBP UTP METABOLIC PROCESS
|
12
|
2.32e-04
|
1.67e-02
|
0.64200
|
-3.54e-01
|
-5.36e-01
|
3.37e-02
|
1.31e-03
|
GOMF THIOL OXIDASE ACTIVITY
|
6
|
3.73e-02
|
3.93e-01
|
0.64000
|
-4.89e-01
|
4.12e-01
|
3.79e-02
|
8.07e-02
|
GOBP NEGATIVE REGULATION OF CERAMIDE BIOSYNTHETIC PROCESS
|
5
|
6.32e-02
|
4.84e-01
|
0.63500
|
3.02e-01
|
-5.59e-01
|
2.43e-01
|
3.04e-02
|
GOMF C PALMITOYLTRANSFERASE ACTIVITY
|
5
|
5.49e-02
|
4.62e-01
|
0.63400
|
1.41e-01
|
-6.19e-01
|
5.85e-01
|
1.66e-02
|
GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 2B COMPLEX
|
5
|
7.07e-02
|
5.07e-01
|
0.62900
|
4.59e-01
|
-4.31e-01
|
7.57e-02
|
9.52e-02
|
GOBP NEGATIVE REGULATION OF PEPTIDYL CYSTEINE S NITROSYLATION
|
7
|
2.44e-02
|
3.31e-01
|
0.62700
|
-5.14e-01
|
3.59e-01
|
1.85e-02
|
9.99e-02
|
GOMF VERY LONG CHAIN FATTY ACID COA LIGASE ACTIVITY
|
9
|
8.76e-03
|
1.97e-01
|
0.62500
|
-5.02e-01
|
3.73e-01
|
9.07e-03
|
5.28e-02
|
GOCC INNER ACROSOMAL MEMBRANE
|
5
|
7.31e-02
|
5.13e-01
|
0.62500
|
4.48e-01
|
-4.37e-01
|
8.31e-02
|
9.07e-02
|
GOMF NAADP SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY
|
5
|
6.22e-02
|
4.82e-01
|
0.62500
|
-1.76e-01
|
6.00e-01
|
4.96e-01
|
2.02e-02
|
GOCC U7 SNRNP
|
7
|
2.56e-02
|
3.32e-01
|
0.62200
|
3.31e-01
|
-5.26e-01
|
1.29e-01
|
1.60e-02
|
GOBP PHOTORECEPTOR CELL MORPHOGENESIS
|
5
|
3.75e-02
|
3.94e-01
|
0.62100
|
-4.75e-01
|
-4.00e-01
|
6.59e-02
|
1.22e-01
|
GOMF HISTONE H3K4 MONOMETHYLTRANSFERASE ACTIVITY
|
8
|
1.47e-02
|
2.59e-01
|
0.62100
|
-2.90e-01
|
5.49e-01
|
1.56e-01
|
7.15e-03
|
GOBP NEGATIVE REGULATION OF TROPHOBLAST CELL MIGRATION
|
7
|
1.21e-02
|
2.36e-01
|
0.61900
|
5.78e-01
|
2.22e-01
|
8.08e-03
|
3.09e-01
|
GOBP MYELOID DENDRITIC CELL CHEMOTAXIS
|
5
|
4.88e-02
|
4.41e-01
|
0.61900
|
9.07e-02
|
6.13e-01
|
7.25e-01
|
1.77e-02
|
GOCC HEMOGLOBIN COMPLEX
|
12
|
4.03e-04
|
2.69e-02
|
0.61900
|
4.83e-01
|
3.87e-01
|
3.79e-03
|
2.02e-02
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OR CH2 GROUPS DISULFIDE AS ACCEPTOR
|
5
|
7.72e-02
|
5.23e-01
|
0.61800
|
-4.09e-01
|
4.64e-01
|
1.13e-01
|
7.26e-02
|
GOBP POSITIVE REGULATION OF LAMELLIPODIUM MORPHOGENESIS
|
7
|
2.51e-02
|
3.31e-01
|
0.61800
|
-2.72e-01
|
5.56e-01
|
2.13e-01
|
1.09e-02
|
GOMF G PROTEIN COUPLED ADENOSINE RECEPTOR ACTIVITY
|
5
|
5.34e-02
|
4.57e-01
|
0.61800
|
2.07e-02
|
6.18e-01
|
9.36e-01
|
1.68e-02
|
GOBP REGULATION OF LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE
|
6
|
4.55e-02
|
4.32e-01
|
0.61800
|
-3.55e-01
|
5.06e-01
|
1.33e-01
|
3.18e-02
|
GOBP AXONEMAL CENTRAL APPARATUS ASSEMBLY
|
6
|
4.58e-02
|
4.33e-01
|
0.61700
|
5.10e-01
|
-3.47e-01
|
3.05e-02
|
1.41e-01
|
GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY
|
8
|
1.66e-02
|
2.74e-01
|
0.61600
|
-5.12e-01
|
3.42e-01
|
1.22e-02
|
9.37e-02
|
GOCC KNL1 SPC105 COMPLEX
|
6
|
4.01e-02
|
4.12e-01
|
0.61500
|
1.87e-01
|
-5.86e-01
|
4.28e-01
|
1.29e-02
|
GOBP NEGATIVE REGULATION OF PROTEIN K63 LINKED UBIQUITINATION
|
5
|
7.97e-02
|
5.27e-01
|
0.61500
|
4.47e-01
|
-4.22e-01
|
8.33e-02
|
1.02e-01
|
GOMF PROTEIN CYSTEINE S STEAROYLTRANSFERASE ACTIVITY
|
6
|
4.76e-02
|
4.38e-01
|
0.61400
|
-3.55e-01
|
5.00e-01
|
1.32e-01
|
3.39e-02
|
GOBP UTP BIOSYNTHETIC PROCESS
|
10
|
1.83e-03
|
7.94e-02
|
0.61200
|
-3.11e-01
|
-5.27e-01
|
8.81e-02
|
3.92e-03
|
GOMF ARACHIDONIC ACID MONOOXYGENASE ACTIVITY
|
17
|
1.37e-04
|
1.20e-02
|
0.61000
|
5.75e-01
|
-2.04e-01
|
4.02e-05
|
1.46e-01
|
GOBP FOREBRAIN NEUROBLAST DIVISION
|
5
|
7.56e-02
|
5.19e-01
|
0.60900
|
5.63e-01
|
-2.34e-01
|
2.94e-02
|
3.66e-01
|
GOBP REDUCTION OF FOOD INTAKE IN RESPONSE TO DIETARY EXCESS
|
5
|
8.17e-02
|
5.33e-01
|
0.60800
|
5.17e-01
|
-3.19e-01
|
4.52e-02
|
2.17e-01
|
GOBP ZYGOTIC DETERMINATION OF ANTERIOR POSTERIOR AXIS EMBRYO
|
6
|
2.96e-02
|
3.59e-01
|
0.60700
|
1.14e-01
|
5.96e-01
|
6.27e-01
|
1.14e-02
|
GOMF OXYGEN CARRIER ACTIVITY
|
14
|
1.70e-04
|
1.38e-02
|
0.60700
|
5.19e-01
|
3.14e-01
|
7.69e-04
|
4.20e-02
|
GOBP G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY
|
10
|
7.35e-03
|
1.78e-01
|
0.60600
|
-4.00e-01
|
4.55e-01
|
2.84e-02
|
1.28e-02
|
GOMF G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR ACTIVITY
|
10
|
7.35e-03
|
1.78e-01
|
0.60600
|
-4.00e-01
|
4.55e-01
|
2.84e-02
|
1.28e-02
|
GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS
|
5
|
5.85e-02
|
4.71e-01
|
0.60600
|
-6.04e-01
|
-4.26e-02
|
1.93e-02
|
8.69e-01
|
GOBP POSITIVE REGULATION OF HEPATIC STELLATE CELL ACTIVATION
|
5
|
4.46e-02
|
4.29e-01
|
0.60600
|
-3.51e-01
|
-4.94e-01
|
1.74e-01
|
5.59e-02
|
GOMF UNMETHYLATED CPG BINDING
|
9
|
1.06e-02
|
2.20e-01
|
0.60500
|
-2.61e-01
|
5.46e-01
|
1.75e-01
|
4.56e-03
|
GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX CATALYTIC CORE F 1
|
7
|
2.86e-02
|
3.52e-01
|
0.60400
|
2.26e-01
|
-5.60e-01
|
3.00e-01
|
1.03e-02
|
GOBP POSITIVE REGULATION OF MICROGLIAL CELL ACTIVATION
|
10
|
7.68e-03
|
1.83e-01
|
0.60200
|
4.78e-01
|
-3.65e-01
|
8.80e-03
|
4.55e-02
|
GOBP POSITIVE REGULATION OF RECEPTOR CLUSTERING
|
6
|
4.85e-02
|
4.41e-01
|
0.60100
|
-5.59e-01
|
2.20e-01
|
1.77e-02
|
3.50e-01
|
GOBP NEGATIVE REGULATION OF MATRIX METALLOPEPTIDASE SECRETION
|
6
|
2.52e-02
|
3.31e-01
|
0.60000
|
-3.80e-01
|
-4.65e-01
|
1.07e-01
|
4.87e-02
|
GOMF MITOCHONDRION TARGETING SEQUENCE BINDING
|
5
|
8.76e-02
|
5.47e-01
|
0.59500
|
5.35e-01
|
-2.59e-01
|
3.82e-02
|
3.17e-01
|
GOBP NEGATIVE REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS
|
6
|
4.49e-02
|
4.30e-01
|
0.59400
|
9.42e-02
|
-5.87e-01
|
6.89e-01
|
1.28e-02
|
GOBP PHENYLPROPANOID METABOLIC PROCESS
|
6
|
2.81e-02
|
3.48e-01
|
0.59200
|
4.83e-01
|
3.43e-01
|
4.04e-02
|
1.46e-01
|
GOCC HIPPOCAMPAL MOSSY FIBER
|
5
|
7.89e-02
|
5.27e-01
|
0.59200
|
-1.23e-01
|
5.80e-01
|
6.34e-01
|
2.48e-02
|
GOBP INTRACELLULAR SPHINGOLIPID HOMEOSTASIS
|
5
|
6.06e-02
|
4.78e-01
|
0.59200
|
-1.28e-01
|
-5.78e-01
|
6.20e-01
|
2.52e-02
|
GOBP FLAVONOID METABOLIC PROCESS
|
11
|
4.95e-03
|
1.45e-01
|
0.59200
|
5.33e-01
|
-2.57e-01
|
2.20e-03
|
1.40e-01
|
GOBP NEGATIVE REGULATION OF ATP METABOLIC PROCESS
|
7
|
3.79e-02
|
3.97e-01
|
0.59100
|
-4.06e-01
|
4.30e-01
|
6.29e-02
|
4.90e-02
|
GOMF DNA TOPOISOMERASE ACTIVITY
|
7
|
3.51e-02
|
3.82e-01
|
0.59100
|
-2.74e-01
|
5.23e-01
|
2.09e-01
|
1.65e-02
|
GOMF CCR1 CHEMOKINE RECEPTOR BINDING
|
5
|
7.34e-02
|
5.13e-01
|
0.59100
|
-5.89e-01
|
4.12e-02
|
2.25e-02
|
8.73e-01
|
GOCC EPSILON DNA POLYMERASE COMPLEX
|
5
|
9.04e-02
|
5.51e-01
|
0.59100
|
-5.32e-01
|
2.57e-01
|
3.95e-02
|
3.19e-01
|
GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE
|
7
|
3.76e-02
|
3.95e-01
|
0.59000
|
-4.70e-01
|
3.57e-01
|
3.13e-02
|
1.02e-01
|
GOBP INTERLEUKIN 21 PRODUCTION
|
5
|
6.90e-02
|
5.01e-01
|
0.58900
|
2.71e-02
|
5.89e-01
|
9.17e-01
|
2.26e-02
|
GOMF LIPOPOLYSACCHARIDE IMMUNE RECEPTOR ACTIVITY
|
6
|
5.04e-02
|
4.45e-01
|
0.58900
|
-5.71e-01
|
1.45e-01
|
1.54e-02
|
5.38e-01
|
GOBP MAINTENANCE OF PROTEIN LOCATION IN MITOCHONDRION
|
5
|
9.60e-02
|
5.61e-01
|
0.58900
|
-4.88e-01
|
3.31e-01
|
5.90e-02
|
2.00e-01
|
GOCC FC RECEPTOR COMPLEX
|
5
|
9.37e-02
|
5.56e-01
|
0.58600
|
-2.47e-01
|
5.31e-01
|
3.39e-01
|
3.98e-02
|
GOBP REGULATION OF COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY
|
5
|
6.60e-02
|
4.96e-01
|
0.58500
|
-1.07e-01
|
-5.75e-01
|
6.78e-01
|
2.59e-02
|
GOCC WEIBEL PALADE BODY
|
5
|
1.01e-01
|
5.69e-01
|
0.58400
|
-4.70e-01
|
3.46e-01
|
6.85e-02
|
1.80e-01
|
GOBP R LOOP PROCESSING
|
6
|
3.05e-02
|
3.61e-01
|
0.58400
|
-4.05e-01
|
-4.21e-01
|
8.61e-02
|
7.40e-02
|
GOBP OXYGEN TRANSPORT
|
15
|
1.92e-04
|
1.48e-02
|
0.58300
|
5.08e-01
|
2.85e-01
|
6.50e-04
|
5.58e-02
|
GOMF OXYGEN SENSOR ACTIVITY
|
5
|
5.70e-02
|
4.68e-01
|
0.58300
|
3.10e-01
|
4.93e-01
|
2.30e-01
|
5.62e-02
|
GOBP REGULATION OF MICROVILLUS LENGTH
|
7
|
4.17e-02
|
4.21e-01
|
0.58200
|
-3.81e-01
|
4.40e-01
|
8.09e-02
|
4.38e-02
|
GOCC BOX C D RNP COMPLEX
|
6
|
3.43e-02
|
3.78e-01
|
0.58000
|
-5.20e-01
|
-2.57e-01
|
2.73e-02
|
2.75e-01
|
GOBP XENOBIOTIC GLUCURONIDATION
|
6
|
4.26e-02
|
4.25e-01
|
0.58000
|
5.77e-01
|
6.35e-02
|
1.44e-02
|
7.88e-01
|
GOBP FC RECEPTOR MEDIATED INHIBITORY SIGNALING PATHWAY
|
5
|
7.62e-02
|
5.19e-01
|
0.57900
|
-5.79e-01
|
-1.87e-02
|
2.49e-02
|
9.42e-01
|
GOBP CELLULAR RESPONSE TO GONADOTROPIN RELEASING HORMONE
|
5
|
8.76e-02
|
5.47e-01
|
0.57900
|
1.11e-01
|
-5.68e-01
|
6.69e-01
|
2.77e-02
|
GOBP NEGATIVE REGULATION OF T CELL MIGRATION
|
6
|
4.42e-02
|
4.29e-01
|
0.57800
|
5.25e-02
|
5.76e-01
|
8.24e-01
|
1.46e-02
|
GOBP ALKALOID METABOLIC PROCESS
|
7
|
2.25e-02
|
3.17e-01
|
0.57700
|
5.52e-01
|
1.70e-01
|
1.15e-02
|
4.35e-01
|
GOBP TOOTH ERUPTION
|
5
|
1.04e-01
|
5.75e-01
|
0.57700
|
-4.90e-01
|
3.06e-01
|
5.79e-02
|
2.37e-01
|
GOMF N N DIMETHYLANILINE MONOOXYGENASE ACTIVITY
|
5
|
9.56e-02
|
5.61e-01
|
0.57400
|
5.52e-01
|
-1.58e-01
|
3.26e-02
|
5.39e-01
|
GOBP POST TRANSLATIONAL PROTEIN TARGETING TO MEMBRANE TRANSLOCATION
|
8
|
2.66e-02
|
3.41e-01
|
0.57400
|
2.50e-01
|
-5.17e-01
|
2.21e-01
|
1.14e-02
|
GOMF IMMUNOGLOBULIN RECEPTOR ACTIVITY
|
6
|
6.94e-02
|
5.02e-01
|
0.57300
|
-4.79e-01
|
3.16e-01
|
4.24e-02
|
1.80e-01
|
GOBP NEGATIVE REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION
|
5
|
1.11e-01
|
5.89e-01
|
0.57300
|
3.80e-01
|
-4.29e-01
|
1.41e-01
|
9.68e-02
|
GOBP POSITIVE REGULATION OF IMMATURE T CELL PROLIFERATION
|
5
|
1.12e-01
|
5.91e-01
|
0.57200
|
4.33e-01
|
-3.73e-01
|
9.34e-02
|
1.49e-01
|
GOBP CHOLINE METABOLIC PROCESS
|
6
|
4.54e-02
|
4.31e-01
|
0.57100
|
5.64e-01
|
8.95e-02
|
1.67e-02
|
7.04e-01
|
GOMF TRACE AMINE RECEPTOR ACTIVITY
|
7
|
3.32e-02
|
3.71e-01
|
0.56800
|
-2.56e-02
|
5.68e-01
|
9.07e-01
|
9.27e-03
|
GOBP RESPONSE TO AMMONIUM ION
|
6
|
6.24e-02
|
4.82e-01
|
0.56800
|
5.50e-01
|
-1.39e-01
|
1.95e-02
|
5.54e-01
|
GOCC PERINEURONAL NET
|
10
|
1.09e-02
|
2.23e-01
|
0.56800
|
5.32e-01
|
-1.97e-01
|
3.55e-03
|
2.81e-01
|
GOBP REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION
|
6
|
7.07e-02
|
5.07e-01
|
0.56700
|
-2.53e-01
|
5.07e-01
|
2.84e-01
|
3.14e-02
|
GOMF INOSITOL 1 3 4 5 TETRAKISPHOSPHATE BINDING
|
5
|
1.17e-01
|
5.97e-01
|
0.56600
|
-4.28e-01
|
3.71e-01
|
9.71e-02
|
1.51e-01
|
GOBP GLOMERULAR MESANGIAL CELL DEVELOPMENT
|
5
|
1.09e-01
|
5.84e-01
|
0.56400
|
-5.21e-01
|
2.16e-01
|
4.36e-02
|
4.03e-01
|
GOBP RENAL VESICLE FORMATION
|
8
|
2.89e-02
|
3.54e-01
|
0.56400
|
-2.11e-01
|
5.23e-01
|
3.01e-01
|
1.05e-02
|
GOBP MICROGLIAL CELL MEDIATED CYTOTOXICITY
|
5
|
1.09e-01
|
5.84e-01
|
0.56300
|
-5.26e-01
|
2.01e-01
|
4.17e-02
|
4.35e-01
|
GOBP NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR PRODUCTION
|
5
|
8.92e-02
|
5.50e-01
|
0.56300
|
5.63e-01
|
8.09e-03
|
2.94e-02
|
9.75e-01
|
GOMF MELANOCORTIN RECEPTOR ACTIVITY
|
6
|
7.34e-02
|
5.13e-01
|
0.56200
|
2.45e-01
|
-5.06e-01
|
2.99e-01
|
3.18e-02
|
GOBP SPERM MITOCHONDRIAL SHEATH ASSEMBLY
|
6
|
4.17e-02
|
4.21e-01
|
0.56100
|
2.77e-01
|
4.88e-01
|
2.40e-01
|
3.83e-02
|
GOCC SYNAPSE ASSOCIATED EXTRACELLULAR MATRIX
|
12
|
4.89e-03
|
1.44e-01
|
0.56100
|
5.32e-01
|
-1.78e-01
|
1.43e-03
|
2.86e-01
|
GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS
|
8
|
2.51e-02
|
3.31e-01
|
0.56000
|
-5.54e-01
|
8.49e-02
|
6.66e-03
|
6.78e-01
|
GOMF XMP 5 NUCLEOSIDASE ACTIVITY
|
6
|
4.35e-02
|
4.28e-01
|
0.56000
|
2.42e-01
|
5.05e-01
|
3.05e-01
|
3.21e-02
|
GOBP POSITIVE REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS
|
6
|
7.99e-02
|
5.28e-01
|
0.56000
|
-4.45e-01
|
3.39e-01
|
5.89e-02
|
1.50e-01
|
GOMF CXCR3 CHEMOKINE RECEPTOR BINDING
|
5
|
1.22e-01
|
6.03e-01
|
0.55900
|
4.61e-01
|
-3.16e-01
|
7.44e-02
|
2.21e-01
|
GOMF INOSITOL TRISPHOSPHATE PHOSPHATASE ACTIVITY
|
11
|
9.66e-03
|
2.08e-01
|
0.55800
|
-4.71e-01
|
2.98e-01
|
6.78e-03
|
8.67e-02
|
GOBP NEGATIVE REGULATION OF MONOCYTE CHEMOTAXIS
|
6
|
6.56e-02
|
4.95e-01
|
0.55700
|
9.26e-02
|
-5.50e-01
|
6.95e-01
|
1.97e-02
|
GOCC MHC CLASS I PROTEIN COMPLEX
|
10
|
1.55e-02
|
2.64e-01
|
0.55600
|
3.30e-01
|
-4.48e-01
|
7.07e-02
|
1.42e-02
|
GOMF PHOSPHATIDYL PHOSPHOLIPASE B ACTIVITY
|
11
|
1.05e-02
|
2.19e-01
|
0.55600
|
-4.34e-01
|
3.47e-01
|
1.27e-02
|
4.65e-02
|
GOBP SUCCINATE METABOLIC PROCESS
|
5
|
8.40e-02
|
5.37e-01
|
0.55500
|
-1.31e-01
|
-5.40e-01
|
6.11e-01
|
3.67e-02
|
GOMF INOSITOL POLYPHOSPHATE 5 PHOSPHATASE ACTIVITY
|
6
|
7.34e-02
|
5.13e-01
|
0.55500
|
-5.28e-01
|
1.72e-01
|
2.52e-02
|
4.65e-01
|
GOBP REGULATION OF DOSAGE COMPENSATION BY INACTIVATION OF X CHROMOSOME
|
9
|
1.29e-02
|
2.46e-01
|
0.55400
|
-5.48e-01
|
-8.21e-02
|
4.44e-03
|
6.70e-01
|
GOBP FLAVONOID GLUCURONIDATION
|
5
|
1.04e-01
|
5.75e-01
|
0.55400
|
5.49e-01
|
-7.19e-02
|
3.35e-02
|
7.81e-01
|
GOBP DETERMINATION OF LIVER LEFT RIGHT ASYMMETRY
|
5
|
1.22e-01
|
6.03e-01
|
0.55200
|
-2.35e-01
|
4.99e-01
|
3.62e-01
|
5.31e-02
|
GOCC CBM COMPLEX
|
5
|
1.25e-01
|
6.06e-01
|
0.55200
|
-2.63e-01
|
4.85e-01
|
3.08e-01
|
6.04e-02
|
GOMF CCR6 CHEMOKINE RECEPTOR BINDING
|
5
|
9.39e-02
|
5.57e-01
|
0.55000
|
6.25e-02
|
5.46e-01
|
8.09e-01
|
3.43e-02
|
GOMF PROTEIN SERINE THREONINE KINASE BINDING
|
6
|
8.60e-02
|
5.45e-01
|
0.55000
|
3.03e-01
|
-4.59e-01
|
1.98e-01
|
5.17e-02
|
GOBP RHOMBOMERE DEVELOPMENT
|
8
|
1.81e-02
|
2.87e-01
|
0.55000
|
-5.01e-01
|
-2.26e-01
|
1.41e-02
|
2.68e-01
|
GOCC PICLN SM PROTEIN COMPLEX
|
6
|
8.85e-02
|
5.50e-01
|
0.55000
|
3.99e-01
|
-3.78e-01
|
9.06e-02
|
1.09e-01
|
GOMF KERATIN FILAMENT BINDING
|
6
|
6.04e-02
|
4.78e-01
|
0.54900
|
4.09e-02
|
5.48e-01
|
8.62e-01
|
2.01e-02
|
GOBP CELL DIFFERENTIATION INVOLVED IN PHENOTYPIC SWITCHING
|
5
|
8.38e-02
|
5.37e-01
|
0.54900
|
-5.14e-01
|
-1.95e-01
|
4.67e-02
|
4.51e-01
|
GOMF NAD DEPENDENT HISTONE DEACETYLASE ACTIVITY
|
5
|
8.00e-02
|
5.28e-01
|
0.54800
|
-4.73e-01
|
-2.77e-01
|
6.70e-02
|
2.84e-01
|
GOMF ALPHA 2A ADRENERGIC RECEPTOR BINDING
|
5
|
1.16e-01
|
5.94e-01
|
0.54700
|
-1.22e-01
|
5.33e-01
|
6.36e-01
|
3.89e-02
|
GOBP NEGATIVE REGULATION OF NEUTROPHIL ACTIVATION
|
5
|
1.07e-01
|
5.80e-01
|
0.54700
|
-5.45e-01
|
4.17e-02
|
3.47e-02
|
8.72e-01
|
GOBP CHONDROCYTE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS
|
8
|
2.08e-02
|
3.05e-01
|
0.54700
|
1.53e-01
|
5.25e-01
|
4.55e-01
|
1.01e-02
|
GOMF TORC2 COMPLEX BINDING
|
5
|
1.05e-01
|
5.77e-01
|
0.54600
|
1.76e-02
|
-5.46e-01
|
9.46e-01
|
3.45e-02
|
GOCC PALMITOYLTRANSFERASE COMPLEX
|
10
|
1.51e-02
|
2.62e-01
|
0.54600
|
1.83e-01
|
-5.15e-01
|
3.17e-01
|
4.83e-03
|
GOCC ATP BINDING CASSETTE ABC TRANSPORTER COMPLEX
|
6
|
5.64e-02
|
4.67e-01
|
0.54500
|
-5.28e-01
|
-1.35e-01
|
2.50e-02
|
5.66e-01
|
GOBP POSITIVE REGULATION OF CARDIAC MUSCLE CONTRACTION
|
8
|
2.46e-02
|
3.31e-01
|
0.54500
|
5.43e-01
|
5.15e-02
|
7.82e-03
|
8.01e-01
|
GOCC H3 HISTONE ACETYLTRANSFERASE COMPLEX
|
8
|
3.53e-02
|
3.82e-01
|
0.54500
|
-1.81e-01
|
5.14e-01
|
3.76e-01
|
1.18e-02
|
GOBP REGULATION OF LONG CHAIN FATTY ACID IMPORT INTO CELL
|
8
|
4.15e-02
|
4.20e-01
|
0.54500
|
-3.57e-01
|
4.12e-01
|
8.05e-02
|
4.36e-02
|
GOMF UBIQUITIN LIGASE COMPLEX SCAFFOLD ACTIVITY
|
6
|
5.59e-02
|
4.65e-01
|
0.54400
|
-5.22e-01
|
-1.54e-01
|
2.67e-02
|
5.14e-01
|
GOBP REGULATION OF PROTEIN LOCALIZATION TO CHROMATIN
|
10
|
1.77e-02
|
2.83e-01
|
0.54400
|
-4.70e-01
|
2.75e-01
|
1.01e-02
|
1.32e-01
|
GOCC GATOR2 COMPLEX
|
5
|
9.47e-02
|
5.59e-01
|
0.54400
|
-1.10e-01
|
-5.32e-01
|
6.69e-01
|
3.93e-02
|
GOBP BLOOD COAGULATION INTRINSIC PATHWAY
|
6
|
8.90e-02
|
5.50e-01
|
0.54300
|
4.77e-01
|
-2.60e-01
|
4.31e-02
|
2.70e-01
|
GOCC HAPTOGLOBIN HEMOGLOBIN COMPLEX
|
11
|
4.06e-03
|
1.31e-01
|
0.54300
|
4.37e-01
|
3.23e-01
|
1.21e-02
|
6.39e-02
|
GOMF HISTONE H3K14 ACETYLTRANSFERASE ACTIVITY
|
9
|
2.76e-02
|
3.45e-01
|
0.54300
|
-2.94e-01
|
4.56e-01
|
1.26e-01
|
1.78e-02
|
GOBP GALACTOSE CATABOLIC PROCESS
|
5
|
1.30e-01
|
6.09e-01
|
0.54100
|
-4.99e-01
|
2.09e-01
|
5.31e-02
|
4.18e-01
|
GOBP EMBRYONIC CLEAVAGE
|
8
|
4.35e-02
|
4.28e-01
|
0.54100
|
-3.81e-01
|
3.85e-01
|
6.23e-02
|
5.95e-02
|
GOMF CHONDROITIN SULFOTRANSFERASE ACTIVITY
|
5
|
1.32e-01
|
6.13e-01
|
0.54000
|
-2.10e-01
|
4.97e-01
|
4.16e-01
|
5.43e-02
|
GOBP NEGATIVE REGULATION OF RUFFLE ASSEMBLY
|
7
|
3.11e-02
|
3.62e-01
|
0.53900
|
3.71e-01
|
3.92e-01
|
8.95e-02
|
7.28e-02
|
GOBP REGULATION OF NEUTROPHIL DEGRANULATION
|
8
|
4.44e-02
|
4.29e-01
|
0.53900
|
-4.13e-01
|
3.46e-01
|
4.31e-02
|
8.98e-02
|
GOCC TORC1 COMPLEX
|
6
|
9.60e-02
|
5.61e-01
|
0.53900
|
-4.31e-01
|
3.24e-01
|
6.75e-02
|
1.70e-01
|
GOMF LARGE RIBOSOMAL SUBUNIT RRNA BINDING
|
5
|
1.39e-01
|
6.23e-01
|
0.53900
|
2.78e-01
|
-4.61e-01
|
2.81e-01
|
7.41e-02
|
GOBP POSITIVE REGULATION OF SODIUM PROTON ANTIPORTER ACTIVITY
|
5
|
9.04e-02
|
5.51e-01
|
0.53900
|
2.15e-01
|
4.94e-01
|
4.04e-01
|
5.59e-02
|
GOMF INOSITOL BISPHOSPHATE PHOSPHATASE ACTIVITY
|
5
|
1.44e-01
|
6.28e-01
|
0.53700
|
-4.27e-01
|
3.26e-01
|
9.81e-02
|
2.07e-01
|
GOBP POSITIVE REGULATION OF PODOSOME ASSEMBLY
|
10
|
1.27e-02
|
2.44e-01
|
0.53500
|
-5.35e-01
|
-6.11e-03
|
3.39e-03
|
9.73e-01
|
GOMF N ACETYLGALACTOSAMINE 4 O SULFOTRANSFERASE ACTIVITY
|
5
|
1.46e-01
|
6.31e-01
|
0.53500
|
-4.24e-01
|
3.27e-01
|
1.01e-01
|
2.06e-01
|
GOMF FATTY ACYL COA SYNTHASE ACTIVITY
|
7
|
6.05e-02
|
4.78e-01
|
0.53500
|
1.86e-01
|
-5.01e-01
|
3.93e-01
|
2.17e-02
|
GOBP REGULATION OF RELAXATION OF CARDIAC MUSCLE
|
6
|
5.55e-02
|
4.63e-01
|
0.53400
|
4.47e-01
|
2.93e-01
|
5.82e-02
|
2.15e-01
|
GOBP OMEGA HYDROXYLASE P450 PATHWAY
|
11
|
1.38e-02
|
2.54e-01
|
0.53400
|
4.69e-01
|
-2.55e-01
|
7.05e-03
|
1.44e-01
|
GOMF RETINYL PALMITATE ESTERASE ACTIVITY
|
6
|
8.19e-02
|
5.33e-01
|
0.53300
|
-5.27e-01
|
7.88e-02
|
2.54e-02
|
7.38e-01
|
GOBP RESPONSE TO ZINC ION STARVATION
|
9
|
1.72e-02
|
2.79e-01
|
0.53200
|
1.03e-01
|
5.22e-01
|
5.92e-01
|
6.65e-03
|
GOBP INTERLEUKIN 17 MEDIATED SIGNALING PATHWAY
|
11
|
1.54e-02
|
2.64e-01
|
0.53200
|
-4.11e-01
|
3.37e-01
|
1.81e-02
|
5.28e-02
|
GOCC PERICHROMATIN FIBRILS
|
5
|
1.50e-01
|
6.38e-01
|
0.53200
|
4.02e-01
|
-3.48e-01
|
1.19e-01
|
1.78e-01
|
GOBP PERICYTE CELL DIFFERENTIATION
|
11
|
1.53e-02
|
2.63e-01
|
0.53000
|
-4.45e-01
|
2.88e-01
|
1.06e-02
|
9.84e-02
|
GOBP NEGATIVE REGULATION OF ATP BIOSYNTHETIC PROCESS
|
5
|
1.54e-01
|
6.41e-01
|
0.52900
|
-3.88e-01
|
3.60e-01
|
1.33e-01
|
1.63e-01
|
GOMF COPPER CHAPERONE ACTIVITY
|
6
|
6.38e-02
|
4.87e-01
|
0.52900
|
-1.77e-01
|
-4.98e-01
|
4.52e-01
|
3.45e-02
|
GOBP NEGATIVE REGULATION OF LAMELLIPODIUM ORGANIZATION
|
7
|
3.66e-02
|
3.90e-01
|
0.52900
|
2.87e-01
|
4.45e-01
|
1.89e-01
|
4.17e-02
|
GOCC NSL COMPLEX
|
9
|
2.54e-02
|
3.31e-01
|
0.52800
|
-5.21e-01
|
8.44e-02
|
6.77e-03
|
6.61e-01
|
GOBP POSITIVE REGULATION OF DNA TEMPLATED DNA REPLICATION
|
12
|
3.46e-03
|
1.19e-01
|
0.52700
|
-4.22e-01
|
-3.16e-01
|
1.13e-02
|
5.83e-02
|
GOBP REGULATION OF PROTEIN LOCALIZATION TO LYSOSOME
|
5
|
1.56e-01
|
6.43e-01
|
0.52700
|
-3.45e-01
|
3.97e-01
|
1.81e-01
|
1.24e-01
|
GOBP POSITIVE REGULATION OF INTERLEUKIN 23 PRODUCTION
|
7
|
6.52e-02
|
4.93e-01
|
0.52600
|
-4.97e-01
|
1.73e-01
|
2.27e-02
|
4.28e-01
|
GOBP POSITIVE REGULATION OF NATURAL KILLER CELL CHEMOTAXIS
|
5
|
1.43e-01
|
6.28e-01
|
0.52500
|
-4.96e-01
|
1.74e-01
|
5.49e-02
|
4.99e-01
|
GOMF RETINAL DEHYDROGENASE ACTIVITY
|
8
|
4.95e-02
|
4.42e-01
|
0.52500
|
4.54e-01
|
-2.64e-01
|
2.61e-02
|
1.97e-01
|
GOBP REGULATION OF T CELL COSTIMULATION
|
5
|
1.59e-01
|
6.48e-01
|
0.52400
|
-3.65e-01
|
3.76e-01
|
1.58e-01
|
1.45e-01
|
GOMF SYNDECAN BINDING
|
5
|
1.58e-01
|
6.47e-01
|
0.52400
|
4.10e-01
|
-3.26e-01
|
1.12e-01
|
2.07e-01
|
GOCC PHAGOLYSOSOME
|
5
|
1.55e-01
|
6.42e-01
|
0.52400
|
-4.48e-01
|
2.71e-01
|
8.27e-02
|
2.94e-01
|
GOMF PORIN ACTIVITY
|
6
|
1.01e-01
|
5.69e-01
|
0.52300
|
1.89e-01
|
-4.88e-01
|
4.22e-01
|
3.85e-02
|
GOBP EPOXYGENASE P450 PATHWAY
|
17
|
1.72e-03
|
7.57e-02
|
0.52300
|
4.62e-01
|
-2.45e-01
|
9.73e-04
|
7.99e-02
|
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL DEVELOPMENT
|
6
|
1.12e-01
|
5.91e-01
|
0.52200
|
-3.93e-01
|
3.44e-01
|
9.57e-02
|
1.45e-01
|
GOBP COPI COATED VESICLE BUDDING
|
6
|
7.60e-02
|
5.19e-01
|
0.52200
|
-5.16e-01
|
-8.01e-02
|
2.87e-02
|
7.34e-01
|
GOBP ATRIOVENTRICULAR VALVE FORMATION
|
8
|
4.61e-02
|
4.34e-01
|
0.52100
|
-4.97e-01
|
1.58e-01
|
1.50e-02
|
4.38e-01
|
GOBP REGULATION OF PEPTIDYL CYSTEINE S NITROSYLATION
|
10
|
2.51e-02
|
3.31e-01
|
0.52100
|
-4.42e-01
|
2.77e-01
|
1.55e-02
|
1.30e-01
|
GOBP REPLICATION BORN DOUBLE STRAND BREAK REPAIR VIA SISTER CHROMATID EXCHANGE
|
6
|
6.43e-02
|
4.89e-01
|
0.52100
|
-4.48e-01
|
-2.66e-01
|
5.73e-02
|
2.59e-01
|
GOBP NUCLEAR MIGRATION ALONG MICROTUBULE
|
5
|
1.51e-01
|
6.38e-01
|
0.52100
|
-4.81e-01
|
2.01e-01
|
6.27e-02
|
4.36e-01
|
GOMF 1 ACYLGLYCEROPHOSPHOCHOLINE O ACYLTRANSFERASE ACTIVITY
|
7
|
6.05e-02
|
4.78e-01
|
0.52100
|
-5.17e-01
|
6.29e-02
|
1.78e-02
|
7.73e-01
|
GOBP CYTOLYSIS BY HOST OF SYMBIONT CELLS
|
6
|
6.24e-02
|
4.82e-01
|
0.52100
|
-3.65e-01
|
-3.71e-01
|
1.22e-01
|
1.15e-01
|
GOBP FLAVONE METABOLIC PROCESS
|
6
|
8.47e-02
|
5.39e-01
|
0.51900
|
5.19e-01
|
6.85e-03
|
2.77e-02
|
9.77e-01
|
GOBP DETECTION OF VIRUS
|
6
|
1.15e-01
|
5.94e-01
|
0.51900
|
3.43e-01
|
-3.89e-01
|
1.46e-01
|
9.85e-02
|
GOBP REGULATION OF GROWTH RATE
|
5
|
1.40e-01
|
6.24e-01
|
0.51900
|
-8.68e-02
|
5.11e-01
|
7.37e-01
|
4.77e-02
|
GOBP BRADYKININ CATABOLIC PROCESS
|
7
|
7.35e-02
|
5.13e-01
|
0.51900
|
-2.09e-01
|
4.75e-01
|
3.37e-01
|
2.97e-02
|
GOBP POSITIVE THYMIC T CELL SELECTION
|
14
|
1.87e-03
|
8.02e-02
|
0.51800
|
2.32e-01
|
4.64e-01
|
1.33e-01
|
2.66e-03
|
GOBP PYRIMIDINE NUCLEOBASE CATABOLIC PROCESS
|
8
|
4.56e-02
|
4.32e-01
|
0.51700
|
-1.10e-01
|
5.05e-01
|
5.89e-01
|
1.34e-02
|
GOBP NEGATIVE REGULATION OF PROTEIN POLYUBIQUITINATION
|
8
|
5.76e-02
|
4.68e-01
|
0.51600
|
3.57e-01
|
-3.73e-01
|
8.01e-02
|
6.77e-02
|
GOBP REGULATION OF GASTRIC ACID SECRETION
|
6
|
9.97e-02
|
5.68e-01
|
0.51500
|
-1.07e-01
|
5.04e-01
|
6.48e-01
|
3.25e-02
|
GOMF NUCLEOTIDE RECEPTOR ACTIVITY
|
17
|
2.31e-03
|
9.17e-02
|
0.51500
|
-4.13e-01
|
3.08e-01
|
3.21e-03
|
2.77e-02
|
GOMF GDP DISSOCIATION INHIBITOR ACTIVITY
|
14
|
1.80e-03
|
7.83e-02
|
0.51500
|
3.37e-01
|
3.89e-01
|
2.90e-02
|
1.17e-02
|
GOMF T CELL RECEPTOR BINDING
|
11
|
7.47e-03
|
1.80e-01
|
0.51400
|
4.38e-01
|
2.69e-01
|
1.19e-02
|
1.22e-01
|
GOBP DOLICHYL DIPHOSPHATE METABOLIC PROCESS
|
5
|
1.31e-01
|
6.11e-01
|
0.51300
|
-5.13e-01
|
-2.85e-02
|
4.71e-02
|
9.12e-01
|
GOBP HISTIDINE CATABOLIC PROCESS
|
8
|
3.53e-02
|
3.82e-01
|
0.51300
|
-5.05e-01
|
-9.19e-02
|
1.34e-02
|
6.53e-01
|
GOBP POSITIVE REGULATION OF THYROID HORMONE GENERATION
|
5
|
1.58e-01
|
6.46e-01
|
0.51100
|
1.51e-01
|
-4.88e-01
|
5.58e-01
|
5.90e-02
|
GOMF ESTROGEN 2 HYDROXYLASE ACTIVITY
|
5
|
1.60e-01
|
6.48e-01
|
0.51000
|
4.81e-01
|
-1.68e-01
|
6.23e-02
|
5.15e-01
|
GOBP INTESTINAL EPITHELIAL CELL MATURATION
|
6
|
1.24e-01
|
6.06e-01
|
0.51000
|
3.60e-01
|
-3.61e-01
|
1.26e-01
|
1.26e-01
|
GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE I PROMOTER
|
11
|
1.34e-02
|
2.51e-01
|
0.51000
|
-5.09e-01
|
1.67e-02
|
3.43e-03
|
9.24e-01
|
GOBP FATTY ACID OMEGA OXIDATION
|
5
|
1.10e-01
|
5.85e-01
|
0.50900
|
-3.51e-01
|
-3.69e-01
|
1.74e-01
|
1.53e-01
|
GOBP POSITIVE REGULATION OF PSEUDOPODIUM ASSEMBLY
|
12
|
5.28e-03
|
1.52e-01
|
0.50600
|
3.35e-01
|
3.79e-01
|
4.43e-02
|
2.29e-02
|
GOBP HEAT ACCLIMATION
|
5
|
1.21e-01
|
6.03e-01
|
0.50600
|
4.68e-01
|
1.92e-01
|
7.01e-02
|
4.58e-01
|
GOBP IMP CATABOLIC PROCESS
|
5
|
1.20e-01
|
6.00e-01
|
0.50500
|
2.12e-01
|
4.58e-01
|
4.11e-01
|
7.59e-02
|
GOMF SHORT CHAIN CARBOXYLESTERASE ACTIVITY
|
6
|
1.10e-01
|
5.86e-01
|
0.50500
|
-4.92e-01
|
1.13e-01
|
3.67e-02
|
6.33e-01
|
GOMF HISTONE H3K9ME2 H3K9ME3 DEMETHYLASE ACTIVITY
|
5
|
1.62e-01
|
6.48e-01
|
0.50400
|
-4.88e-01
|
1.26e-01
|
5.87e-02
|
6.25e-01
|
GOBP DIADENOSINE POLYPHOSPHATE METABOLIC PROCESS
|
6
|
1.25e-01
|
6.06e-01
|
0.50300
|
2.42e-01
|
-4.41e-01
|
3.05e-01
|
6.11e-02
|
GOBP PROTEIN K27 LINKED UBIQUITINATION
|
7
|
8.10e-02
|
5.31e-01
|
0.50300
|
1.49e-01
|
-4.81e-01
|
4.95e-01
|
2.76e-02
|
GOBP GANGLIOSIDE BIOSYNTHETIC PROCESS VIA LACTOSYLCERAMIDE
|
6
|
1.19e-01
|
6.00e-01
|
0.50300
|
-4.74e-01
|
1.68e-01
|
4.44e-02
|
4.77e-01
|
GOMF LONG CHAIN FATTY ACID COA LIGASE ACTIVITY
|
14
|
8.26e-03
|
1.90e-01
|
0.50200
|
-2.64e-01
|
4.27e-01
|
8.69e-02
|
5.62e-03
|
GOBP NEGATIVE REGULATION OF MEIOTIC CELL CYCLE PHASE TRANSITION
|
5
|
1.39e-01
|
6.22e-01
|
0.50200
|
6.66e-02
|
4.97e-01
|
7.96e-01
|
5.42e-02
|
GOCC ACTIVIN RECEPTOR COMPLEX
|
6
|
9.60e-02
|
5.61e-01
|
0.50100
|
4.43e-02
|
4.99e-01
|
8.51e-01
|
3.41e-02
|
GOBP FORMATION OF TRANSLATION PREINITIATION COMPLEX
|
7
|
7.91e-02
|
5.27e-01
|
0.50100
|
1.06e-01
|
-4.89e-01
|
6.27e-01
|
2.49e-02
|
GOBP CELL CELL JUNCTION DISASSEMBLY
|
5
|
1.24e-01
|
6.06e-01
|
0.50100
|
2.20e-01
|
4.50e-01
|
3.93e-01
|
8.17e-02
|
GOBP TOLL LIKE RECEPTOR 7 SIGNALING PATHWAY
|
9
|
4.89e-02
|
4.41e-01
|
0.50100
|
-3.64e-01
|
3.43e-01
|
5.84e-02
|
7.44e-02
|
GOBP GEPHYRIN CLUSTERING INVOLVED IN POSTSYNAPTIC DENSITY ASSEMBLY
|
5
|
1.35e-01
|
6.16e-01
|
0.50100
|
-1.05e-01
|
-4.90e-01
|
6.85e-01
|
5.80e-02
|
GOCC EQUATORIAL MICROTUBULE ORGANIZING CENTER
|
5
|
1.87e-01
|
6.79e-01
|
0.50000
|
-3.65e-01
|
3.42e-01
|
1.57e-01
|
1.85e-01
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS OXYGEN AS ACCEPTOR
|
11
|
2.52e-02
|
3.31e-01
|
0.50000
|
-3.62e-01
|
3.45e-01
|
3.78e-02
|
4.72e-02
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN REDUCED ASCORBATE AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN
|
5
|
1.19e-01
|
6.00e-01
|
0.49900
|
3.39e-01
|
3.67e-01
|
1.89e-01
|
1.55e-01
|
GOBP NEGATIVE REGULATION OF TRANSMISSION OF NERVE IMPULSE
|
6
|
1.01e-01
|
5.70e-01
|
0.49900
|
-4.99e-01
|
-1.59e-02
|
3.43e-02
|
9.46e-01
|
GOBP REGULATION OF MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL
|
5
|
1.20e-01
|
6.00e-01
|
0.49900
|
3.75e-01
|
3.29e-01
|
1.47e-01
|
2.02e-01
|
GOBP PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS
|
17
|
7.39e-04
|
4.27e-02
|
0.49900
|
-3.57e-01
|
-3.48e-01
|
1.07e-02
|
1.31e-02
|
GOBP NEGATIVE REGULATION OF RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE
|
5
|
1.34e-01
|
6.16e-01
|
0.49900
|
-1.35e-01
|
-4.80e-01
|
6.00e-01
|
6.31e-02
|
GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY
|
5
|
1.84e-01
|
6.73e-01
|
0.49900
|
4.33e-01
|
-2.48e-01
|
9.38e-02
|
3.37e-01
|
GOBP GOLGI VESICLE BUDDING
|
10
|
1.84e-02
|
2.90e-01
|
0.49800
|
-4.83e-01
|
-1.22e-01
|
8.16e-03
|
5.04e-01
|
GOBP L PROLINE BIOSYNTHETIC PROCESS
|
6
|
8.50e-02
|
5.41e-01
|
0.49800
|
-4.58e-01
|
-1.97e-01
|
5.23e-02
|
4.03e-01
|
GOBP TRANSFERRIN TRANSPORT
|
10
|
3.63e-02
|
3.88e-01
|
0.49800
|
-3.50e-01
|
3.54e-01
|
5.56e-02
|
5.23e-02
|
GOBP ADHERENS JUNCTION MAINTENANCE
|
7
|
9.84e-02
|
5.65e-01
|
0.49700
|
-3.24e-01
|
3.77e-01
|
1.37e-01
|
8.43e-02
|
GOMF GUANINE NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
5
|
1.59e-01
|
6.48e-01
|
0.49700
|
-4.95e-01
|
4.84e-02
|
5.53e-02
|
8.51e-01
|
GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE 5 PHOSPHATASE ACTIVITY
|
9
|
3.24e-02
|
3.68e-01
|
0.49700
|
-4.96e-01
|
-2.77e-02
|
9.93e-03
|
8.86e-01
|
GOBP DIACYLGLYCEROL CATABOLIC PROCESS
|
5
|
1.78e-01
|
6.67e-01
|
0.49600
|
-4.64e-01
|
1.75e-01
|
7.22e-02
|
4.97e-01
|
GOBP NEGATIVE REGULATION OF SYNAPSE ASSEMBLY
|
8
|
6.78e-02
|
4.99e-01
|
0.49600
|
-4.35e-01
|
2.38e-01
|
3.30e-02
|
2.44e-01
|
GOCC BASAL CORTEX
|
5
|
1.80e-01
|
6.70e-01
|
0.49500
|
-4.63e-01
|
1.75e-01
|
7.29e-02
|
4.98e-01
|
GOBP CARBON DIOXIDE TRANSPORT
|
15
|
1.94e-03
|
8.09e-02
|
0.49500
|
3.86e-01
|
3.10e-01
|
9.67e-03
|
3.78e-02
|
GOMF HISTONE H3K27 METHYLTRANSFERASE ACTIVITY
|
6
|
1.29e-01
|
6.09e-01
|
0.49400
|
-4.61e-01
|
1.79e-01
|
5.06e-02
|
4.48e-01
|
GOBP MUCOCILIARY CLEARANCE
|
8
|
6.68e-02
|
4.98e-01
|
0.49400
|
2.01e-01
|
-4.51e-01
|
3.24e-01
|
2.70e-02
|
GOBP PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS
|
23
|
6.98e-05
|
6.94e-03
|
0.49400
|
-3.73e-01
|
-3.24e-01
|
1.96e-03
|
7.07e-03
|
GOCC MYELIN SHEATH ABAXONAL REGION
|
6
|
1.22e-01
|
6.03e-01
|
0.49400
|
-4.80e-01
|
1.14e-01
|
4.16e-02
|
6.29e-01
|
GOBP ALPHA LINOLENIC ACID METABOLIC PROCESS
|
9
|
3.63e-02
|
3.88e-01
|
0.49300
|
-4.93e-01
|
8.74e-03
|
1.04e-02
|
9.64e-01
|
GOMF LIGAND GATED CALCIUM CHANNEL ACTIVITY
|
27
|
1.47e-04
|
1.27e-02
|
0.49300
|
-2.83e-01
|
4.03e-01
|
1.08e-02
|
2.90e-04
|
GOBP ACETYLCHOLINE SECRETION
|
5
|
1.29e-01
|
6.09e-01
|
0.49200
|
4.12e-01
|
2.69e-01
|
1.10e-01
|
2.98e-01
|
GOBP PEPTIDYL LYSINE OXIDATION
|
5
|
1.98e-01
|
6.88e-01
|
0.49200
|
-3.68e-01
|
3.26e-01
|
1.54e-01
|
2.06e-01
|
GOMF PROTEIN LYSINE 6 OXIDASE ACTIVITY
|
5
|
1.98e-01
|
6.88e-01
|
0.49200
|
-3.68e-01
|
3.26e-01
|
1.54e-01
|
2.06e-01
|
GOMF INTERFERON RECEPTOR ACTIVITY
|
5
|
1.37e-01
|
6.20e-01
|
0.49200
|
1.73e-01
|
4.60e-01
|
5.03e-01
|
7.46e-02
|
GOBP PURINE RIBONUCLEOSIDE SALVAGE
|
6
|
1.22e-01
|
6.03e-01
|
0.49200
|
9.79e-02
|
-4.82e-01
|
6.78e-01
|
4.10e-02
|
GOBP NEGATIVE REGULATION OF FATTY ACID BETA OXIDATION
|
6
|
1.41e-01
|
6.25e-01
|
0.49100
|
-2.72e-01
|
4.09e-01
|
2.49e-01
|
8.25e-02
|
GOMF BETA GALACTOSIDE CMP ALPHA 2 3 SIALYLTRANSFERASE ACTIVITY
|
7
|
8.70e-02
|
5.46e-01
|
0.49100
|
-4.80e-01
|
1.04e-01
|
2.78e-02
|
6.35e-01
|
GOBP POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL
|
7
|
1.03e-01
|
5.75e-01
|
0.49100
|
3.97e-01
|
-2.88e-01
|
6.89e-02
|
1.86e-01
|
GOBP INTERMEDIATE FILAMENT BUNDLE ASSEMBLY
|
8
|
4.72e-02
|
4.38e-01
|
0.49000
|
9.31e-02
|
4.81e-01
|
6.48e-01
|
1.85e-02
|
GOCC INNER DYNEIN ARM
|
5
|
1.56e-01
|
6.43e-01
|
0.49000
|
3.38e-02
|
4.89e-01
|
8.96e-01
|
5.85e-02
|
GOBP TELOMERIC LOOP DISASSEMBLY
|
9
|
5.42e-02
|
4.60e-01
|
0.49000
|
-4.05e-01
|
2.75e-01
|
3.53e-02
|
1.53e-01
|
GOMF THIOESTERASE BINDING
|
9
|
4.41e-02
|
4.29e-01
|
0.49000
|
-1.02e-01
|
4.79e-01
|
5.97e-01
|
1.28e-02
|
GOBP RESPONSE TO BACTERIAL LIPOPROTEIN
|
10
|
1.86e-02
|
2.92e-01
|
0.48900
|
-2.09e-01
|
-4.42e-01
|
2.52e-01
|
1.54e-02
|
GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS
|
6
|
8.86e-02
|
5.50e-01
|
0.48900
|
-4.16e-01
|
-2.58e-01
|
7.78e-02
|
2.74e-01
|
GOBP ACETATE ESTER TRANSPORT
|
9
|
2.61e-02
|
3.36e-01
|
0.48800
|
3.89e-01
|
2.95e-01
|
4.32e-02
|
1.25e-01
|
GOBP REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY
|
6
|
1.03e-01
|
5.75e-01
|
0.48800
|
-4.80e-01
|
-9.01e-02
|
4.18e-02
|
7.02e-01
|
GOMF C ACYLTRANSFERASE ACTIVITY
|
20
|
9.04e-04
|
4.87e-02
|
0.48800
|
6.64e-02
|
-4.83e-01
|
6.07e-01
|
1.81e-04
|
GOCC POSTSYNAPTIC ENDOCYTIC ZONE
|
5
|
1.34e-01
|
6.16e-01
|
0.48800
|
-4.11e-01
|
-2.62e-01
|
1.11e-01
|
3.11e-01
|
GOCC VACUOLAR PROTON TRANSPORTING V TYPE ATPASE V0 DOMAIN
|
9
|
5.69e-02
|
4.68e-01
|
0.48700
|
-3.83e-01
|
3.02e-01
|
4.69e-02
|
1.17e-01
|
GOBP NEGATIVE REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT
|
6
|
1.45e-01
|
6.29e-01
|
0.48700
|
-2.52e-01
|
4.16e-01
|
2.85e-01
|
7.73e-02
|
GOMF PROFILIN BINDING
|
10
|
1.86e-02
|
2.92e-01
|
0.48700
|
2.45e-01
|
4.20e-01
|
1.79e-01
|
2.14e-02
|
GOBP PROTEIN LOCALIZATION TO CELL LEADING EDGE
|
5
|
1.39e-01
|
6.22e-01
|
0.48600
|
4.29e-01
|
2.28e-01
|
9.65e-02
|
3.78e-01
|
GOBP GAS TRANSPORT
|
22
|
1.52e-04
|
1.29e-02
|
0.48600
|
3.95e-01
|
2.83e-01
|
1.34e-03
|
2.18e-02
|
GOCC EGG COAT
|
5
|
2.04e-01
|
6.94e-01
|
0.48500
|
3.94e-01
|
-2.84e-01
|
1.27e-01
|
2.71e-01
|
GOBP PYRIMIDINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS
|
6
|
9.17e-02
|
5.52e-01
|
0.48500
|
-4.06e-01
|
-2.66e-01
|
8.48e-02
|
2.60e-01
|
GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION CHOLINERGIC
|
6
|
1.51e-01
|
6.38e-01
|
0.48500
|
3.70e-01
|
-3.14e-01
|
1.16e-01
|
1.83e-01
|
GOBP POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT
|
6
|
9.72e-02
|
5.61e-01
|
0.48500
|
-1.83e-01
|
-4.49e-01
|
4.37e-01
|
5.67e-02
|
GOBP REGULATION OF 3 UTR MEDIATED MRNA STABILIZATION
|
6
|
1.50e-01
|
6.37e-01
|
0.48400
|
-3.90e-01
|
2.87e-01
|
9.77e-02
|
2.24e-01
|
GOBP POSITIVE REGULATION OF AMYLOID BETA CLEARANCE
|
8
|
7.30e-02
|
5.13e-01
|
0.48300
|
-1.71e-01
|
4.52e-01
|
4.03e-01
|
2.68e-02
|
GOMF GLUTAMATE GATED CALCIUM ION CHANNEL ACTIVITY
|
5
|
2.04e-01
|
6.94e-01
|
0.48300
|
-2.41e-01
|
4.18e-01
|
3.50e-01
|
1.05e-01
|
GOBP CARBOHYDRATE MEDIATED SIGNALING
|
11
|
3.06e-02
|
3.61e-01
|
0.48300
|
-2.49e-01
|
4.14e-01
|
1.52e-01
|
1.75e-02
|
GOCC ER MEMBRANE INSERTION COMPLEX
|
10
|
4.29e-02
|
4.26e-01
|
0.48300
|
-2.69e-01
|
4.01e-01
|
1.41e-01
|
2.82e-02
|
GOMF HEMOGLOBIN ALPHA BINDING
|
5
|
1.55e-01
|
6.42e-01
|
0.48200
|
4.67e-01
|
1.18e-01
|
7.07e-02
|
6.47e-01
|
GOBP ESTABLISHMENT OF GOLGI LOCALIZATION
|
8
|
5.68e-02
|
4.68e-01
|
0.48100
|
-4.79e-01
|
-4.00e-02
|
1.90e-02
|
8.45e-01
|
GOBP MONOTERPENOID METABOLIC PROCESS
|
6
|
1.51e-01
|
6.38e-01
|
0.48100
|
4.20e-01
|
-2.34e-01
|
7.49e-02
|
3.21e-01
|
GOBP OLIGOPEPTIDE IMPORT ACROSS PLASMA MEMBRANE
|
5
|
1.40e-01
|
6.23e-01
|
0.48000
|
3.34e-01
|
3.46e-01
|
1.96e-01
|
1.81e-01
|
GOBP REGULATION OF MICROVILLUS ASSEMBLY
|
6
|
1.06e-01
|
5.77e-01
|
0.48000
|
-4.60e-01
|
-1.40e-01
|
5.13e-02
|
5.53e-01
|
GOBP NEGATIVE REGULATION OF LAMELLIPODIUM ASSEMBLY
|
5
|
1.41e-01
|
6.25e-01
|
0.48000
|
2.98e-01
|
3.77e-01
|
2.48e-01
|
1.45e-01
|
GOMF C ACETYLTRANSFERASE ACTIVITY
|
7
|
7.61e-02
|
5.19e-01
|
0.48000
|
-1.01e-01
|
-4.69e-01
|
6.42e-01
|
3.16e-02
|
GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE 5 PHOSPHATASE ACTIVITY
|
6
|
1.25e-01
|
6.06e-01
|
0.48000
|
-4.79e-01
|
2.31e-02
|
4.21e-02
|
9.22e-01
|
GOBP RESPONSE TO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR
|
9
|
6.27e-02
|
4.83e-01
|
0.47900
|
-3.15e-01
|
3.61e-01
|
1.02e-01
|
6.05e-02
|
GOBP HYPOXIA INDUCIBLE FACTOR 1ALPHA SIGNALING PATHWAY
|
5
|
1.66e-01
|
6.50e-01
|
0.47900
|
4.75e-01
|
6.18e-02
|
6.59e-02
|
8.11e-01
|
GOCC SIGNAL PEPTIDASE COMPLEX
|
5
|
1.77e-01
|
6.67e-01
|
0.47900
|
1.61e-02
|
-4.78e-01
|
9.50e-01
|
6.39e-02
|
GOBP ANDROGEN CATABOLIC PROCESS
|
5
|
1.56e-01
|
6.43e-01
|
0.47800
|
-1.41e-01
|
-4.57e-01
|
5.85e-01
|
7.70e-02
|
GOBP SYNAPTIC VESICLE COATING
|
5
|
1.44e-01
|
6.29e-01
|
0.47700
|
-3.82e-01
|
-2.87e-01
|
1.40e-01
|
2.67e-01
|
GOBP NEURON GLIAL CELL SIGNALING
|
5
|
1.54e-01
|
6.41e-01
|
0.47700
|
4.47e-01
|
1.68e-01
|
8.36e-02
|
5.16e-01
|
GOBP FLOOR PLATE DEVELOPMENT
|
11
|
3.51e-02
|
3.82e-01
|
0.47700
|
3.45e-01
|
-3.29e-01
|
4.73e-02
|
5.88e-02
|
GOBP REGULATION OF FOREBRAIN NEURON DIFFERENTIATION
|
5
|
1.90e-01
|
6.83e-01
|
0.47700
|
4.71e-01
|
-7.73e-02
|
6.84e-02
|
7.65e-01
|
GOMF CAMP RESPONSE ELEMENT BINDING PROTEIN BINDING
|
8
|
7.36e-02
|
5.13e-01
|
0.47600
|
-4.63e-01
|
1.13e-01
|
2.34e-02
|
5.79e-01
|
GOBP NEGATIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION
|
12
|
2.51e-02
|
3.31e-01
|
0.47600
|
-4.02e-01
|
2.54e-01
|
1.58e-02
|
1.27e-01
|
GOBP NEGATIVE REGULATION OF FATTY ACID TRANSPORT
|
7
|
1.15e-01
|
5.93e-01
|
0.47500
|
-4.21e-01
|
2.19e-01
|
5.36e-02
|
3.15e-01
|
GOBP LIPID GLYCOSYLATION
|
12
|
2.21e-02
|
3.15e-01
|
0.47500
|
-4.49e-01
|
1.54e-01
|
7.07e-03
|
3.54e-01
|
GOMF CALCIUM RELEASE CHANNEL ACTIVITY
|
18
|
4.30e-03
|
1.34e-01
|
0.47500
|
-2.90e-01
|
3.76e-01
|
3.31e-02
|
5.77e-03
|
GOMF PROLINE SODIUM SYMPORTER ACTIVITY
|
5
|
1.47e-01
|
6.34e-01
|
0.47400
|
3.30e-01
|
3.40e-01
|
2.01e-01
|
1.88e-01
|
GOBP CARDIAC FIBROBLAST CELL DIFFERENTIATION
|
5
|
1.54e-01
|
6.41e-01
|
0.47400
|
2.04e-01
|
4.28e-01
|
4.30e-01
|
9.77e-02
|
GOBP NEGATIVE REGULATION OF LIPOPROTEIN LIPASE ACTIVITY
|
8
|
9.07e-02
|
5.51e-01
|
0.47400
|
3.32e-01
|
-3.38e-01
|
1.04e-01
|
9.79e-02
|
GOBP GAMMA DELTA T CELL DIFFERENTIATION
|
13
|
7.54e-03
|
1.81e-01
|
0.47400
|
2.26e-01
|
4.16e-01
|
1.58e-01
|
9.35e-03
|
GOBP MEMBRANE RAFT LOCALIZATION
|
8
|
5.05e-02
|
4.46e-01
|
0.47400
|
2.01e-01
|
4.29e-01
|
3.24e-01
|
3.57e-02
|
GOBP INDOLE CONTAINING COMPOUND BIOSYNTHETIC PROCESS
|
5
|
2.23e-01
|
7.12e-01
|
0.47300
|
3.27e-01
|
-3.43e-01
|
2.06e-01
|
1.84e-01
|
GOBP UDP GLUCOSE METABOLIC PROCESS
|
6
|
1.36e-01
|
6.18e-01
|
0.47300
|
5.11e-02
|
-4.71e-01
|
8.28e-01
|
4.59e-02
|
GOBP SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION
|
10
|
2.20e-02
|
3.13e-01
|
0.47300
|
-3.07e-01
|
-3.61e-01
|
9.32e-02
|
4.83e-02
|
GOBP INTERLEUKIN 23 PRODUCTION
|
9
|
6.23e-02
|
4.82e-01
|
0.47300
|
-4.26e-01
|
2.07e-01
|
2.71e-02
|
2.82e-01
|
GOBP HISTONE H4 K16 ACETYLATION
|
6
|
1.03e-01
|
5.74e-01
|
0.47300
|
-3.79e-01
|
-2.83e-01
|
1.08e-01
|
2.31e-01
|
GOBP IMMUNOLOGICAL SYNAPSE FORMATION
|
15
|
3.64e-03
|
1.23e-01
|
0.47300
|
2.23e-01
|
4.17e-01
|
1.34e-01
|
5.20e-03
|
GOBP GDP MANNOSE METABOLIC PROCESS
|
7
|
8.63e-02
|
5.45e-01
|
0.47200
|
-4.69e-01
|
-5.98e-02
|
3.18e-02
|
7.84e-01
|
GOMF MYOSIN II BINDING
|
12
|
2.61e-02
|
3.36e-01
|
0.47200
|
-2.27e-01
|
4.13e-01
|
1.73e-01
|
1.32e-02
|
GOMF THIAMINE PYROPHOSPHATE BINDING
|
7
|
1.04e-01
|
5.75e-01
|
0.47200
|
8.42e-02
|
-4.64e-01
|
7.00e-01
|
3.35e-02
|
GOBP CRANIAL SUTURE MORPHOGENESIS
|
8
|
9.27e-02
|
5.54e-01
|
0.47100
|
-3.14e-01
|
3.52e-01
|
1.25e-01
|
8.49e-02
|
GOBP D ASPARTATE IMPORT ACROSS PLASMA MEMBRANE
|
5
|
1.72e-01
|
6.61e-01
|
0.47100
|
8.45e-02
|
4.63e-01
|
7.44e-01
|
7.29e-02
|
GOBP POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE
|
18
|
4.15e-03
|
1.32e-01
|
0.47000
|
2.05e-01
|
-4.23e-01
|
1.32e-01
|
1.87e-03
|
GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE PHOSPHATASE ACTIVITY
|
11
|
1.89e-02
|
2.94e-01
|
0.47000
|
-4.45e-01
|
-1.51e-01
|
1.06e-02
|
3.86e-01
|
GOMF OLFACTORY RECEPTOR BINDING
|
6
|
1.30e-01
|
6.09e-01
|
0.46900
|
3.00e-02
|
4.68e-01
|
8.99e-01
|
4.72e-02
|
GOBP FUNGIFORM PAPILLA MORPHOGENESIS
|
5
|
2.09e-01
|
6.97e-01
|
0.46900
|
-1.27e-01
|
4.51e-01
|
6.23e-01
|
8.06e-02
|
GOBP INTERLEUKIN 3 MEDIATED SIGNALING PATHWAY
|
6
|
1.53e-01
|
6.41e-01
|
0.46800
|
-4.51e-01
|
1.23e-01
|
5.55e-02
|
6.01e-01
|
GOBP NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY
|
13
|
1.96e-02
|
3.00e-01
|
0.46800
|
-4.25e-01
|
1.96e-01
|
7.98e-03
|
2.22e-01
|
GOBP RADIAL GLIA GUIDED PYRAMIDAL NEURON MIGRATION
|
6
|
1.51e-01
|
6.38e-01
|
0.46800
|
-1.06e-01
|
4.56e-01
|
6.54e-01
|
5.33e-02
|
GOBP METANEPHRIC TUBULE FORMATION
|
6
|
1.71e-01
|
6.59e-01
|
0.46700
|
-3.83e-01
|
2.68e-01
|
1.04e-01
|
2.56e-01
|
GOMF INSULIN BINDING
|
5
|
2.13e-01
|
7.02e-01
|
0.46700
|
-1.36e-01
|
4.46e-01
|
5.97e-01
|
8.39e-02
|
GOMF N ACETYLLACTOSAMINIDE BETA 1 3 N ACETYLGLUCOSAMINYLTRANSFERASE ACTIVITY
|
5
|
2.33e-01
|
7.20e-01
|
0.46700
|
-3.39e-01
|
3.20e-01
|
1.89e-01
|
2.15e-01
|
GOMF METAL ION SENSOR ACTIVITY
|
5
|
2.31e-01
|
7.18e-01
|
0.46600
|
-2.67e-01
|
3.82e-01
|
3.01e-01
|
1.39e-01
|
GOBP DENTINOGENESIS
|
6
|
1.73e-01
|
6.61e-01
|
0.46600
|
-2.68e-01
|
3.81e-01
|
2.56e-01
|
1.06e-01
|
GOBP FORMATE METABOLIC PROCESS
|
6
|
1.57e-01
|
6.45e-01
|
0.46500
|
-4.47e-01
|
1.31e-01
|
5.81e-02
|
5.80e-01
|
GOBP POSITIVE REGULATION OF PINOCYTOSIS
|
7
|
1.27e-01
|
6.07e-01
|
0.46500
|
-2.39e-01
|
3.99e-01
|
2.73e-01
|
6.74e-02
|
GOCC DENTATE GYRUS MOSSY FIBER
|
6
|
1.62e-01
|
6.48e-01
|
0.46500
|
-1.59e-01
|
4.37e-01
|
4.99e-01
|
6.37e-02
|
GOBP POSITIVE REGULATION OF NEUTROPHIL ACTIVATION
|
6
|
1.27e-01
|
6.07e-01
|
0.46500
|
-4.56e-01
|
-8.84e-02
|
5.29e-02
|
7.08e-01
|
GOCC GLYCINERGIC SYNAPSE
|
7
|
8.16e-02
|
5.33e-01
|
0.46500
|
-1.90e-01
|
-4.24e-01
|
3.84e-01
|
5.21e-02
|
GOMF EXTRACELLULAR MATRIX PROTEIN BINDING
|
6
|
1.13e-01
|
5.91e-01
|
0.46400
|
2.36e-01
|
4.00e-01
|
3.17e-01
|
8.98e-02
|
GOCC MICROTUBULE MINUS END
|
7
|
1.23e-01
|
6.04e-01
|
0.46400
|
-1.73e-01
|
4.30e-01
|
4.27e-01
|
4.88e-02
|
GOCC POSTSYNAPTIC ACTIN CYTOSKELETON
|
5
|
2.08e-01
|
6.97e-01
|
0.46300
|
4.57e-01
|
-7.67e-02
|
7.68e-02
|
7.67e-01
|
GOBP SPHINGOMYELIN CATABOLIC PROCESS
|
8
|
9.01e-02
|
5.51e-01
|
0.46300
|
-1.58e-01
|
4.35e-01
|
4.40e-01
|
3.30e-02
|
GOBP REGULATION OF FEAR RESPONSE
|
9
|
3.79e-02
|
3.97e-01
|
0.46300
|
3.67e-01
|
2.82e-01
|
5.67e-02
|
1.43e-01
|
GOBP PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS
|
14
|
6.10e-03
|
1.62e-01
|
0.46300
|
-2.98e-01
|
-3.54e-01
|
5.38e-02
|
2.18e-02
|
GOMF CUPROUS ION BINDING
|
8
|
6.58e-02
|
4.95e-01
|
0.46200
|
-8.90e-02
|
-4.54e-01
|
6.63e-01
|
2.63e-02
|
GOMF DIHYDROPYRIMIDINASE ACTIVITY
|
6
|
1.48e-01
|
6.35e-01
|
0.46200
|
-3.57e-02
|
4.61e-01
|
8.80e-01
|
5.08e-02
|
GOBP SIALYLATION
|
8
|
8.84e-02
|
5.50e-01
|
0.46200
|
-4.43e-01
|
1.30e-01
|
3.00e-02
|
5.23e-01
|
GOBP POSITIVE REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION
|
6
|
1.76e-01
|
6.65e-01
|
0.46200
|
2.35e-01
|
-3.97e-01
|
3.19e-01
|
9.18e-02
|
GOBP REGULATION OF TRANSLATION AT SYNAPSE
|
6
|
1.13e-01
|
5.91e-01
|
0.46200
|
-3.51e-01
|
-2.99e-01
|
1.36e-01
|
2.04e-01
|
GOMF INTERMEDIATE FILAMENT BINDING
|
10
|
3.15e-02
|
3.64e-01
|
0.46200
|
1.33e-01
|
4.42e-01
|
4.67e-01
|
1.55e-02
|
GOMF GLUCOSE SODIUM SYMPORTER ACTIVITY
|
7
|
1.22e-01
|
6.03e-01
|
0.46100
|
-1.37e-01
|
4.40e-01
|
5.29e-01
|
4.38e-02
|
GOMF AMINOACYL TRNA HYDROLASE ACTIVITY
|
5
|
1.92e-01
|
6.85e-01
|
0.46000
|
-4.65e-02
|
-4.58e-01
|
8.57e-01
|
7.63e-02
|
GOBP REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS INVOLVED IN CHOLESTEROL TRANSPORT
|
6
|
1.50e-01
|
6.36e-01
|
0.46000
|
-4.59e-01
|
3.02e-02
|
5.17e-02
|
8.98e-01
|
GOBP REGULATION OF GAP JUNCTION ASSEMBLY
|
9
|
7.13e-02
|
5.09e-01
|
0.45900
|
1.77e-01
|
-4.24e-01
|
3.59e-01
|
2.76e-02
|
GOCC MITOCHONDRIAL INTERMEMBRANE SPACE PROTEIN TRANSPORTER COMPLEX
|
5
|
2.42e-01
|
7.25e-01
|
0.45900
|
3.76e-01
|
-2.64e-01
|
1.46e-01
|
3.07e-01
|
GOBP MEDIUM CHAIN FATTY ACYL COA METABOLIC PROCESS
|
6
|
1.84e-01
|
6.73e-01
|
0.45900
|
2.87e-01
|
-3.58e-01
|
2.24e-01
|
1.29e-01
|
GOBP REGULATION OF SNRNA TRANSCRIPTION BY RNA POLYMERASE II
|
5
|
1.91e-01
|
6.85e-01
|
0.45900
|
-6.44e-02
|
-4.54e-01
|
8.03e-01
|
7.87e-02
|
GOBP LONG CHAIN FATTY ACYL COA METABOLIC PROCESS
|
24
|
1.01e-03
|
5.10e-02
|
0.45900
|
-4.04e-01
|
2.17e-01
|
6.11e-04
|
6.60e-02
|
GOBP LIPOXIN METABOLIC PROCESS
|
5
|
2.13e-01
|
7.02e-01
|
0.45800
|
-6.49e-02
|
4.54e-01
|
8.02e-01
|
7.89e-02
|
GOBP REGULATION OF CELL CHEMOTAXIS TO FIBROBLAST GROWTH FACTOR
|
9
|
4.03e-02
|
4.12e-01
|
0.45800
|
3.61e-01
|
2.82e-01
|
6.09e-02
|
1.42e-01
|
GOCC FLOTILLIN COMPLEX
|
9
|
6.67e-02
|
4.98e-01
|
0.45800
|
-1.12e-01
|
4.44e-01
|
5.60e-01
|
2.11e-02
|
GOBP POSITIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT
|
6
|
1.86e-01
|
6.77e-01
|
0.45800
|
-3.39e-01
|
3.08e-01
|
1.51e-01
|
1.91e-01
|
GOMF NADPLUS PROTEIN ARGININE ADP RIBOSYLTRANSFERASE ACTIVITY
|
6
|
1.18e-01
|
6.00e-01
|
0.45800
|
-3.73e-01
|
-2.66e-01
|
1.14e-01
|
2.59e-01
|
GOMF P TYPE CALCIUM TRANSPORTER ACTIVITY
|
8
|
1.05e-01
|
5.77e-01
|
0.45800
|
-3.62e-01
|
2.80e-01
|
7.61e-02
|
1.70e-01
|
GOMF VINCULIN BINDING
|
11
|
4.11e-02
|
4.18e-01
|
0.45800
|
-1.85e-01
|
4.18e-01
|
2.87e-01
|
1.63e-02
|
GOBP RESPONSE TO SYMBIONT
|
6
|
1.30e-01
|
6.09e-01
|
0.45700
|
-4.37e-01
|
-1.36e-01
|
6.38e-02
|
5.65e-01
|
GOBP PLASMA CELL DIFFERENTIATION
|
8
|
5.80e-02
|
4.69e-01
|
0.45700
|
-3.54e-01
|
-2.89e-01
|
8.28e-02
|
1.57e-01
|
GOMF ARYL SULFOTRANSFERASE ACTIVITY
|
7
|
1.41e-01
|
6.25e-01
|
0.45700
|
2.97e-01
|
-3.48e-01
|
1.74e-01
|
1.11e-01
|
GOMF O ACETYLTRANSFERASE ACTIVITY
|
8
|
9.11e-02
|
5.51e-01
|
0.45600
|
-4.44e-01
|
1.01e-01
|
2.95e-02
|
6.20e-01
|
GOCC PLATELET DENSE TUBULAR NETWORK MEMBRANE
|
9
|
7.27e-02
|
5.13e-01
|
0.45500
|
-4.29e-01
|
1.52e-01
|
2.58e-02
|
4.31e-01
|
GOCC TRANSLOCON COMPLEX
|
5
|
2.33e-01
|
7.20e-01
|
0.45500
|
1.47e-01
|
-4.31e-01
|
5.70e-01
|
9.55e-02
|
GOBP MODULATION BY VIRUS OF HOST PROCESS
|
7
|
1.42e-01
|
6.26e-01
|
0.45500
|
-2.54e-01
|
3.77e-01
|
2.44e-01
|
8.41e-02
|
GOBP HISTIDINE METABOLIC PROCESS
|
10
|
3.42e-02
|
3.78e-01
|
0.45400
|
-4.31e-01
|
-1.46e-01
|
1.84e-02
|
4.25e-01
|
GOCC SPERMATOPROTEASOME COMPLEX
|
5
|
1.96e-01
|
6.88e-01
|
0.45400
|
-7.28e-02
|
-4.49e-01
|
7.78e-01
|
8.24e-02
|
GOMF CALCIUM SENSITIVE GUANYLATE CYCLASE ACTIVATOR ACTIVITY
|
5
|
2.41e-01
|
7.25e-01
|
0.45400
|
4.08e-01
|
-1.99e-01
|
1.14e-01
|
4.40e-01
|
GOMF THIOREDOXIN DEPENDENT PEROXIREDOXIN ACTIVITY
|
5
|
1.79e-01
|
6.69e-01
|
0.45400
|
-1.98e-01
|
-4.09e-01
|
4.42e-01
|
1.14e-01
|
GOMF OXYGEN BINDING
|
37
|
4.51e-06
|
8.51e-04
|
0.45400
|
4.38e-01
|
1.20e-01
|
4.06e-06
|
2.05e-01
|
GOMF METAL ION SEQUESTERING ACTIVITY
|
5
|
2.33e-01
|
7.20e-01
|
0.45400
|
1.37e-01
|
-4.32e-01
|
5.94e-01
|
9.40e-02
|
GOBP MULTI PASS TRANSMEMBRANE PROTEIN INSERTION INTO ER MEMBRANE
|
6
|
1.91e-01
|
6.85e-01
|
0.45400
|
-2.90e-01
|
3.49e-01
|
2.19e-01
|
1.39e-01
|
GOCC MULTI PASS TRANSLOCON COMPLEX
|
6
|
1.91e-01
|
6.85e-01
|
0.45400
|
-2.90e-01
|
3.49e-01
|
2.19e-01
|
1.39e-01
|
GOBP LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE
|
10
|
6.40e-02
|
4.87e-01
|
0.45300
|
-2.87e-01
|
3.50e-01
|
1.16e-01
|
5.53e-02
|
GOBP POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
12
|
2.42e-02
|
3.30e-01
|
0.45300
|
-9.24e-03
|
4.53e-01
|
9.56e-01
|
6.63e-03
|
GOBP REGULATION OF NODAL SIGNALING PATHWAY
|
8
|
6.37e-02
|
4.87e-01
|
0.45200
|
2.26e-01
|
3.92e-01
|
2.68e-01
|
5.49e-02
|
GOBP POSITIVE REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION
|
9
|
7.90e-02
|
5.27e-01
|
0.45200
|
-1.95e-01
|
4.08e-01
|
3.12e-01
|
3.39e-02
|
GOBP NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY
|
9
|
6.20e-02
|
4.82e-01
|
0.45200
|
-4.52e-01
|
1.16e-02
|
1.89e-02
|
9.52e-01
|
GOMF LIGASE ACTIVITY FORMING PHOSPHORIC ESTER BONDS
|
5
|
1.76e-01
|
6.65e-01
|
0.45200
|
-2.86e-01
|
-3.50e-01
|
2.68e-01
|
1.76e-01
|
GOCC RIPOPTOSOME
|
6
|
1.77e-01
|
6.67e-01
|
0.45200
|
-4.31e-01
|
1.36e-01
|
6.77e-02
|
5.64e-01
|
GOBP MATERNAL PROCESS INVOLVED IN PARTURITION
|
5
|
1.83e-01
|
6.73e-01
|
0.45200
|
1.94e-01
|
4.08e-01
|
4.53e-01
|
1.14e-01
|
GOBP REGULATION OF MICROVILLUS ORGANIZATION
|
13
|
2.50e-02
|
3.31e-01
|
0.45200
|
-4.17e-01
|
1.72e-01
|
9.17e-03
|
2.82e-01
|
GOMF COMPLEMENT COMPONENT C3B BINDING
|
8
|
6.55e-02
|
4.94e-01
|
0.45100
|
-2.07e-01
|
-4.01e-01
|
3.10e-01
|
4.94e-02
|
GOMF MANGANESE ION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
9
|
8.58e-02
|
5.44e-01
|
0.45100
|
-2.96e-01
|
3.40e-01
|
1.24e-01
|
7.70e-02
|
GOMF STEROL ESTERASE ACTIVITY
|
7
|
9.70e-02
|
5.61e-01
|
0.45100
|
-4.24e-01
|
-1.53e-01
|
5.20e-02
|
4.83e-01
|
GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS IB
|
18
|
6.88e-03
|
1.74e-01
|
0.45100
|
2.26e-01
|
-3.90e-01
|
9.64e-02
|
4.19e-03
|
GOBP LUNG GROWTH
|
6
|
1.54e-01
|
6.41e-01
|
0.45100
|
-4.50e-01
|
-1.60e-02
|
5.61e-02
|
9.46e-01
|
GOBP MYCOTOXIN METABOLIC PROCESS
|
6
|
1.59e-01
|
6.48e-01
|
0.45100
|
4.50e-01
|
-1.59e-02
|
5.61e-02
|
9.46e-01
|
GOBP ANTEROGRADE DENDRITIC TRANSPORT OF NEUROTRANSMITTER RECEPTOR COMPLEX
|
5
|
2.57e-01
|
7.35e-01
|
0.45000
|
-3.33e-01
|
3.03e-01
|
1.97e-01
|
2.41e-01
|
GOBP REGULATION OF LAMELLIPODIUM MORPHOGENESIS
|
11
|
3.27e-02
|
3.70e-01
|
0.45000
|
1.44e-02
|
4.50e-01
|
9.34e-01
|
9.75e-03
|
GOBP NEGATIVE REGULATION OF INTERLEUKIN 4 PRODUCTION
|
7
|
1.18e-01
|
5.98e-01
|
0.45000
|
-1.52e-02
|
4.50e-01
|
9.45e-01
|
3.93e-02
|
GOBP GALACTOSE METABOLIC PROCESS
|
8
|
1.05e-01
|
5.77e-01
|
0.45000
|
-4.13e-01
|
1.78e-01
|
4.29e-02
|
3.82e-01
|
GOBP POSITIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION
|
5
|
2.54e-01
|
7.33e-01
|
0.45000
|
-3.74e-01
|
2.51e-01
|
1.48e-01
|
3.31e-01
|
GOMF THYROID HORMONE BINDING
|
6
|
1.45e-01
|
6.29e-01
|
0.45000
|
4.43e-01
|
8.19e-02
|
6.04e-02
|
7.28e-01
|
GOMF ACETYLESTERASE ACTIVITY
|
5
|
2.36e-01
|
7.24e-01
|
0.45000
|
-4.33e-01
|
1.21e-01
|
9.35e-02
|
6.40e-01
|
GOBP DEOXYRIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS
|
5
|
2.55e-01
|
7.34e-01
|
0.45000
|
-3.76e-01
|
2.47e-01
|
1.46e-01
|
3.39e-01
|
GOBP MANGANESE ION TRANSPORT
|
11
|
5.11e-02
|
4.47e-01
|
0.45000
|
-3.05e-01
|
3.30e-01
|
7.95e-02
|
5.81e-02
|
GOBP B CELL LINEAGE COMMITMENT
|
6
|
1.98e-01
|
6.88e-01
|
0.45000
|
-3.16e-01
|
3.20e-01
|
1.81e-01
|
1.74e-01
|
GOBP RESPONSE TO SORBITOL
|
6
|
1.59e-01
|
6.48e-01
|
0.45000
|
-8.56e-03
|
4.49e-01
|
9.71e-01
|
5.66e-02
|
GOBP ANTEROGRADE DENDRITIC TRANSPORT
|
9
|
8.21e-02
|
5.33e-01
|
0.44900
|
-4.03e-01
|
1.99e-01
|
3.62e-02
|
3.02e-01
|
GOCC SARCOPLASMIC RETICULUM LUMEN
|
9
|
8.77e-02
|
5.47e-01
|
0.44900
|
2.88e-01
|
-3.45e-01
|
1.35e-01
|
7.33e-02
|
GOBP NEGATIVE REGULATION OF B CELL PROLIFERATION
|
15
|
1.75e-02
|
2.82e-01
|
0.44900
|
-3.34e-01
|
3.00e-01
|
2.53e-02
|
4.40e-02
|
GOBP NEGATIVE REGULATION OF RELAXATION OF MUSCLE
|
7
|
1.13e-01
|
5.91e-01
|
0.44900
|
2.85e-02
|
4.48e-01
|
8.96e-01
|
4.01e-02
|
GOBP SUGAR MEDIATED SIGNALING PATHWAY
|
9
|
7.70e-02
|
5.23e-01
|
0.44900
|
-1.36e-01
|
4.28e-01
|
4.80e-01
|
2.63e-02
|
GOMF AP 1 ADAPTOR COMPLEX BINDING
|
5
|
2.59e-01
|
7.36e-01
|
0.44900
|
-2.71e-01
|
3.58e-01
|
2.95e-01
|
1.66e-01
|
GOBP POSITIVE REGULATION OF BASEMENT MEMBRANE ASSEMBLY INVOLVED IN EMBRYONIC BODY MORPHOGENESIS
|
5
|
2.20e-01
|
7.09e-01
|
0.44800
|
-4.48e-01
|
2.03e-02
|
8.28e-02
|
9.37e-01
|
GOMF ARACHIDONATE COA LIGASE ACTIVITY
|
10
|
6.30e-02
|
4.84e-01
|
0.44800
|
-1.99e-01
|
4.02e-01
|
2.75e-01
|
2.78e-02
|
GOBP HIS PURKINJE SYSTEM DEVELOPMENT
|
7
|
1.27e-01
|
6.07e-01
|
0.44800
|
6.56e-02
|
-4.43e-01
|
7.64e-01
|
4.23e-02
|
GOMF NADPLUS PROTEIN LYSINE ADP RIBOSYLTRANSFERASE ACTIVITY
|
5
|
1.85e-01
|
6.75e-01
|
0.44800
|
-2.26e-01
|
-3.87e-01
|
3.81e-01
|
1.34e-01
|
GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL
|
5
|
2.49e-01
|
7.27e-01
|
0.44800
|
-4.13e-01
|
1.74e-01
|
1.10e-01
|
5.02e-01
|
GOBP MESANGIAL CELL DIFFERENTIATION
|
7
|
1.42e-01
|
6.26e-01
|
0.44700
|
-4.16e-01
|
1.65e-01
|
5.69e-02
|
4.49e-01
|
GOBP PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS
|
18
|
2.16e-03
|
8.79e-02
|
0.44700
|
-3.24e-01
|
-3.08e-01
|
1.73e-02
|
2.35e-02
|
GOBP SPHINGOMYELIN BIOSYNTHETIC PROCESS
|
11
|
2.58e-02
|
3.34e-01
|
0.44700
|
-1.88e-01
|
-4.06e-01
|
2.79e-01
|
1.99e-02
|
GOMF HISTONE H3K36 DEMETHYLASE ACTIVITY
|
9
|
8.71e-02
|
5.46e-01
|
0.44700
|
-3.81e-01
|
2.34e-01
|
4.78e-02
|
2.25e-01
|
GOBP POSITIVE REGULATION OF VASCULOGENESIS
|
12
|
1.83e-02
|
2.90e-01
|
0.44700
|
4.00e-01
|
1.99e-01
|
1.63e-02
|
2.33e-01
|
GOBP REGULATION OF RELAXATION OF MUSCLE
|
14
|
8.65e-03
|
1.95e-01
|
0.44700
|
2.70e-01
|
3.56e-01
|
8.05e-02
|
2.10e-02
|
GOMF MICROFIBRIL BINDING
|
5
|
2.63e-01
|
7.40e-01
|
0.44700
|
-3.28e-01
|
3.03e-01
|
2.04e-01
|
2.40e-01
|
GOBP CITRATE METABOLIC PROCESS
|
5
|
2.14e-01
|
7.03e-01
|
0.44700
|
-4.46e-01
|
-2.61e-02
|
8.41e-02
|
9.19e-01
|
GOBP POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY
|
16
|
1.10e-02
|
2.23e-01
|
0.44700
|
-1.39e-01
|
4.25e-01
|
3.37e-01
|
3.27e-03
|
GOBP HEMIDESMOSOME ASSEMBLY
|
6
|
1.37e-01
|
6.20e-01
|
0.44600
|
1.89e-01
|
4.04e-01
|
4.22e-01
|
8.64e-02
|
GOCC BASAL DENDRITE
|
6
|
1.38e-01
|
6.22e-01
|
0.44600
|
4.08e-01
|
1.82e-01
|
8.39e-02
|
4.41e-01
|
GOBP KETONE BODY BIOSYNTHETIC PROCESS
|
6
|
1.73e-01
|
6.61e-01
|
0.44600
|
-4.41e-01
|
6.32e-02
|
6.11e-02
|
7.89e-01
|
GOCC INSULIN RESPONSIVE COMPARTMENT
|
7
|
9.94e-02
|
5.68e-01
|
0.44600
|
-1.82e-01
|
-4.07e-01
|
4.04e-01
|
6.22e-02
|
GOMF 4 GALACTOSYL N ACETYLGLUCOSAMINIDE 3 ALPHA L FUCOSYLTRANSFERASE ACTIVITY
|
6
|
1.63e-01
|
6.48e-01
|
0.44600
|
7.27e-04
|
-4.46e-01
|
9.98e-01
|
5.86e-02
|
GOBP REGULATION OF RESPONSE TO OSMOTIC STRESS
|
16
|
1.18e-02
|
2.32e-01
|
0.44500
|
-4.17e-01
|
1.57e-01
|
3.90e-03
|
2.77e-01
|
GOBP PEPTIDYL L CYSTEINE S PALMITOYLATION
|
20
|
4.54e-03
|
1.38e-01
|
0.44500
|
-2.25e-01
|
3.84e-01
|
8.21e-02
|
2.91e-03
|
GOBP PRIMARY AMINO COMPOUND BIOSYNTHETIC PROCESS
|
6
|
2.00e-01
|
6.89e-01
|
0.44500
|
3.79e-01
|
-2.32e-01
|
1.08e-01
|
3.24e-01
|
GOBP RESPONSE TO TYPE III INTERFERON
|
11
|
4.95e-02
|
4.42e-01
|
0.44400
|
-4.05e-01
|
1.82e-01
|
2.00e-02
|
2.95e-01
|
GOBP SCHWANN CELL PROLIFERATION
|
9
|
9.29e-02
|
5.54e-01
|
0.44400
|
-3.27e-01
|
3.01e-01
|
8.98e-02
|
1.18e-01
|
GOBP CILIUM DISASSEMBLY
|
5
|
2.47e-01
|
7.26e-01
|
0.44400
|
1.29e-01
|
-4.25e-01
|
6.17e-01
|
9.99e-02
|
GOMF NUCLEOSIDE DIPHOSPHATE KINASE ACTIVITY
|
18
|
2.60e-03
|
9.94e-02
|
0.44400
|
-2.21e-01
|
-3.85e-01
|
1.05e-01
|
4.72e-03
|
GOMF CHROMATIN PROTEIN ADAPTOR ACTIVITY
|
14
|
2.49e-02
|
3.31e-01
|
0.44400
|
-3.41e-01
|
2.83e-01
|
2.71e-02
|
6.63e-02
|
GOMF CYSTEINE TYPE EXOPEPTIDASE ACTIVITY
|
7
|
9.57e-02
|
5.61e-01
|
0.44300
|
-3.13e-01
|
-3.14e-01
|
1.52e-01
|
1.50e-01
|
GOBP REGULATION OF PRE MIRNA PROCESSING
|
6
|
1.34e-01
|
6.16e-01
|
0.44300
|
-3.05e-01
|
-3.21e-01
|
1.95e-01
|
1.73e-01
|
GOBP REGULATION OF PROTEIN MONOUBIQUITINATION
|
6
|
2.03e-01
|
6.92e-01
|
0.44300
|
3.73e-01
|
-2.39e-01
|
1.13e-01
|
3.11e-01
|
GOBP REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION
|
12
|
3.93e-02
|
4.06e-01
|
0.44300
|
-1.99e-01
|
3.96e-01
|
2.33e-01
|
1.75e-02
|
GOCC SNO S RNA CONTAINING RIBONUCLEOPROTEIN COMPLEX
|
27
|
6.85e-04
|
4.00e-02
|
0.44300
|
1.91e-01
|
-3.99e-01
|
8.55e-02
|
3.29e-04
|
GOMF MOLYBDOPTERIN COFACTOR BINDING
|
6
|
1.61e-01
|
6.48e-01
|
0.44300
|
3.93e-02
|
4.41e-01
|
8.68e-01
|
6.15e-02
|
GOMF ADP D RIBOSE MODIFICATION DEPENDENT PROTEIN BINDING
|
6
|
1.36e-01
|
6.17e-01
|
0.44200
|
-2.78e-01
|
-3.44e-01
|
2.39e-01
|
1.44e-01
|
GOBP POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY
|
14
|
2.46e-02
|
3.31e-01
|
0.44200
|
2.42e-01
|
-3.70e-01
|
1.17e-01
|
1.65e-02
|
GOBP ALLANTOIN METABOLIC PROCESS
|
9
|
5.26e-02
|
4.51e-01
|
0.44200
|
2.08e-01
|
3.90e-01
|
2.79e-01
|
4.28e-02
|
GOBP TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE PHOSPHATASE SIGNALING PATHWAY
|
6
|
1.39e-01
|
6.23e-01
|
0.44200
|
2.19e-01
|
3.84e-01
|
3.53e-01
|
1.03e-01
|
GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY
|
14
|
2.50e-02
|
3.31e-01
|
0.44200
|
-3.64e-01
|
2.50e-01
|
1.83e-02
|
1.05e-01
|
GOCC TORC2 COMPLEX
|
9
|
9.13e-02
|
5.51e-01
|
0.44200
|
-3.83e-01
|
2.21e-01
|
4.67e-02
|
2.52e-01
|
GOMF EXTRACELLULARLY ATP GATED MONOATOMIC CATION CHANNEL ACTIVITY
|
7
|
1.40e-01
|
6.23e-01
|
0.44200
|
-4.30e-01
|
9.91e-02
|
4.86e-02
|
6.50e-01
|
GOBP REGULATION OF ODONTOBLAST DIFFERENTIATION
|
5
|
2.70e-01
|
7.45e-01
|
0.44100
|
-3.49e-01
|
2.70e-01
|
1.76e-01
|
2.95e-01
|
GOBP REGULATION OF IRON ION TRANSPORT
|
7
|
1.14e-01
|
5.91e-01
|
0.44100
|
4.31e-01
|
9.23e-02
|
4.83e-02
|
6.72e-01
|
GOMF ANGIOTENSIN RECEPTOR BINDING
|
9
|
7.51e-02
|
5.17e-01
|
0.44100
|
-4.38e-01
|
4.90e-02
|
2.29e-02
|
7.99e-01
|
GOMF CCR3 CHEMOKINE RECEPTOR BINDING
|
5
|
2.40e-01
|
7.25e-01
|
0.44100
|
6.26e-02
|
-4.36e-01
|
8.09e-01
|
9.12e-02
|
GOMF GALACTOSYLCERAMIDASE ACTIVITY
|
5
|
2.12e-01
|
7.01e-01
|
0.43900
|
-1.01e-01
|
-4.28e-01
|
6.95e-01
|
9.77e-02
|
GOBP NEGATIVE REGULATION OF IMMATURE T CELL PROLIFERATION
|
5
|
2.74e-01
|
7.49e-01
|
0.43900
|
-3.38e-01
|
2.81e-01
|
1.91e-01
|
2.76e-01
|
GOMF KETOSTEROID MONOOXYGENASE ACTIVITY
|
5
|
2.26e-01
|
7.14e-01
|
0.43900
|
4.39e-01
|
2.25e-02
|
8.93e-02
|
9.30e-01
|
GOBP FATTY ACID ELONGATION SATURATED FATTY ACID
|
7
|
1.24e-01
|
6.06e-01
|
0.43900
|
-4.38e-01
|
-2.66e-02
|
4.46e-02
|
9.03e-01
|
GOMF FATTY ACID ELONGASE ACTIVITY
|
7
|
1.24e-01
|
6.06e-01
|
0.43900
|
-4.38e-01
|
-2.66e-02
|
4.46e-02
|
9.03e-01
|
GOMF DOUBLE STRANDED RNA ADENOSINE DEAMINASE ACTIVITY
|
6
|
2.08e-01
|
6.97e-01
|
0.43800
|
-2.19e-01
|
3.80e-01
|
3.53e-01
|
1.07e-01
|
GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING TO IGG ISOTYPES
|
11
|
3.07e-02
|
3.61e-01
|
0.43800
|
4.05e-01
|
1.66e-01
|
1.99e-02
|
3.41e-01
|
GOBP POSITIVE REGULATION OF FEEDING BEHAVIOR
|
10
|
4.38e-02
|
4.29e-01
|
0.43800
|
-1.38e-01
|
-4.15e-01
|
4.48e-01
|
2.30e-02
|
GOBP REGULATION OF MITOCHONDRIAL DNA METABOLIC PROCESS
|
8
|
7.39e-02
|
5.14e-01
|
0.43800
|
-3.43e-01
|
-2.71e-01
|
9.26e-02
|
1.84e-01
|
GOBP PROSTATE GLANDULAR ACINUS MORPHOGENESIS
|
6
|
2.16e-01
|
7.06e-01
|
0.43700
|
3.22e-01
|
-2.96e-01
|
1.72e-01
|
2.10e-01
|
GOBP NEURONAL SIGNAL TRANSDUCTION
|
7
|
1.20e-01
|
6.01e-01
|
0.43700
|
-4.30e-01
|
-7.86e-02
|
4.90e-02
|
7.19e-01
|
GOCC SYNAPTOBREVIN 2 SNAP 25 SYNTAXIN 1A COMPLEX
|
5
|
2.60e-01
|
7.37e-01
|
0.43600
|
4.16e-01
|
-1.31e-01
|
1.07e-01
|
6.11e-01
|
GOMF N ACETYLLACTOSAMINE SYNTHASE ACTIVITY
|
5
|
1.99e-01
|
6.89e-01
|
0.43600
|
-3.52e-01
|
-2.56e-01
|
1.72e-01
|
3.21e-01
|
GOBP POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL
|
10
|
6.78e-02
|
4.99e-01
|
0.43600
|
-1.30e-01
|
4.16e-01
|
4.75e-01
|
2.28e-02
|
GOBP REGULATION OF SOMITOGENESIS
|
6
|
2.12e-01
|
7.01e-01
|
0.43600
|
-3.77e-01
|
2.18e-01
|
1.10e-01
|
3.54e-01
|
GOMF NAD DEPENDENT PROTEIN DEACETYLASE ACTIVITY
|
7
|
1.07e-01
|
5.80e-01
|
0.43600
|
-3.77e-01
|
-2.18e-01
|
8.38e-02
|
3.19e-01
|
GOBP REGULATION OF GAMMA DELTA T CELL DIFFERENTIATION
|
9
|
5.94e-02
|
4.75e-01
|
0.43600
|
1.69e-01
|
4.02e-01
|
3.81e-01
|
3.70e-02
|
GOBP RRNA 5 END PROCESSING
|
5
|
2.75e-01
|
7.49e-01
|
0.43600
|
-3.74e-01
|
2.23e-01
|
1.48e-01
|
3.87e-01
|
GOBP CELLULAR RESPONSE TO ATP
|
16
|
1.60e-02
|
2.67e-01
|
0.43500
|
-3.81e-01
|
2.10e-01
|
8.32e-03
|
1.46e-01
|
GOBP DNA LIGATION
|
16
|
7.74e-03
|
1.83e-01
|
0.43500
|
-1.01e-01
|
-4.23e-01
|
4.82e-01
|
3.39e-03
|
GOBP IMMUNOGLOBULIN V D J RECOMBINATION
|
8
|
1.04e-01
|
5.75e-01
|
0.43500
|
-4.34e-01
|
3.04e-02
|
3.35e-02
|
8.82e-01
|
GOCC CRD MEDIATED MRNA STABILITY COMPLEX
|
6
|
1.83e-01
|
6.72e-01
|
0.43500
|
2.55e-02
|
-4.34e-01
|
9.14e-01
|
6.57e-02
|
GOBP REGULATION OF XENOPHAGY
|
9
|
5.54e-02
|
4.63e-01
|
0.43500
|
-3.34e-01
|
-2.77e-01
|
8.23e-02
|
1.50e-01
|
GOBP OPTIC NERVE MORPHOGENESIS
|
6
|
1.71e-01
|
6.59e-01
|
0.43400
|
4.32e-01
|
4.48e-02
|
6.68e-02
|
8.49e-01
|
GOBP NEGATIVE REGULATION OF DENDRITIC CELL APOPTOTIC PROCESS
|
8
|
8.16e-02
|
5.33e-01
|
0.43400
|
3.96e-01
|
1.79e-01
|
5.24e-02
|
3.82e-01
|
GOBP NEGATIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY
|
8
|
1.21e-01
|
6.03e-01
|
0.43400
|
-1.53e-01
|
4.06e-01
|
4.53e-01
|
4.67e-02
|
GOCC PLATELET DENSE TUBULAR NETWORK
|
11
|
5.45e-02
|
4.61e-01
|
0.43400
|
-4.09e-01
|
1.47e-01
|
1.90e-02
|
4.00e-01
|
GOMF HISTONE READER ACTIVITY
|
12
|
4.87e-02
|
4.41e-01
|
0.43400
|
-2.92e-01
|
3.21e-01
|
8.01e-02
|
5.41e-02
|
GOBP GENITALIA MORPHOGENESIS
|
11
|
6.27e-02
|
4.83e-01
|
0.43400
|
-3.23e-01
|
2.89e-01
|
6.37e-02
|
9.64e-02
|
GOBP POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY
|
12
|
3.22e-02
|
3.67e-01
|
0.43300
|
4.33e-01
|
4.05e-03
|
9.34e-03
|
9.81e-01
|
GOMF TOLL LIKE RECEPTOR 4 BINDING
|
5
|
2.64e-01
|
7.41e-01
|
0.43300
|
-4.14e-01
|
1.28e-01
|
1.09e-01
|
6.21e-01
|
GOBP REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY
|
8
|
1.25e-01
|
6.06e-01
|
0.43300
|
-1.67e-01
|
3.99e-01
|
4.12e-01
|
5.07e-02
|
GOMF NMDA GLUTAMATE RECEPTOR ACTIVITY
|
8
|
1.14e-01
|
5.91e-01
|
0.43200
|
-8.26e-02
|
4.24e-01
|
6.86e-01
|
3.76e-02
|
GOBP PROTEIN IMPORT INTO PEROXISOME MEMBRANE
|
6
|
2.06e-01
|
6.95e-01
|
0.43200
|
1.41e-01
|
-4.09e-01
|
5.51e-01
|
8.28e-02
|
GOBP ANAGEN
|
5
|
2.39e-01
|
7.25e-01
|
0.43200
|
4.32e-01
|
1.07e-02
|
9.43e-02
|
9.67e-01
|
GOCC RNA POLYMERASE III TRANSCRIPTION REGULATOR COMPLEX
|
9
|
5.77e-02
|
4.68e-01
|
0.43200
|
-3.49e-01
|
-2.55e-01
|
6.97e-02
|
1.86e-01
|
GOBP REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS
|
13
|
2.88e-02
|
3.53e-01
|
0.43200
|
-4.26e-01
|
7.10e-02
|
7.80e-03
|
6.58e-01
|
GOBP SENSORY PERCEPTION OF SWEET TASTE
|
7
|
1.73e-01
|
6.61e-01
|
0.43200
|
-3.43e-01
|
2.63e-01
|
1.17e-01
|
2.28e-01
|
GOBP ANGIOGENESIS INVOLVED IN CORONARY VASCULAR MORPHOGENESIS
|
5
|
2.22e-01
|
7.12e-01
|
0.43200
|
1.12e-01
|
4.17e-01
|
6.64e-01
|
1.06e-01
|
GOBP REGULATION OF BILE ACID SECRETION
|
6
|
1.50e-01
|
6.36e-01
|
0.43200
|
-2.60e-01
|
-3.44e-01
|
2.70e-01
|
1.44e-01
|
GOMF PYRUVATE DEHYDROGENASE ACTIVITY
|
5
|
2.50e-01
|
7.28e-01
|
0.43100
|
4.04e-02
|
-4.30e-01
|
8.76e-01
|
9.62e-02
|
GOBP METAPHASE ANAPHASE TRANSITION OF MEIOTIC CELL CYCLE
|
5
|
2.05e-01
|
6.95e-01
|
0.43100
|
3.09e-01
|
3.01e-01
|
2.32e-01
|
2.44e-01
|
GOBP REGULATION OF FC GAMMA RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS
|
5
|
2.25e-01
|
7.13e-01
|
0.43100
|
1.00e-01
|
4.19e-01
|
6.97e-01
|
1.04e-01
|
GOBP NEGATIVE REGULATION OF HIPPO SIGNALING
|
12
|
5.02e-02
|
4.44e-01
|
0.43100
|
-3.36e-01
|
2.71e-01
|
4.42e-02
|
1.04e-01
|
GOBP PROTEIN TARGETING TO VACUOLE INVOLVED IN AUTOPHAGY
|
5
|
2.08e-01
|
6.97e-01
|
0.43100
|
-3.62e-01
|
-2.34e-01
|
1.61e-01
|
3.64e-01
|
GOMF GAP JUNCTION HEMI CHANNEL ACTIVITY
|
6
|
2.12e-01
|
7.01e-01
|
0.43100
|
3.99e-01
|
-1.63e-01
|
9.06e-02
|
4.90e-01
|
GOBP RIGHTING REFLEX
|
8
|
1.10e-01
|
5.86e-01
|
0.43100
|
4.00e-02
|
-4.29e-01
|
8.45e-01
|
3.57e-02
|
GOBP GLYCERALDEHYDE 3 PHOSPHATE METABOLIC PROCESS
|
6
|
1.53e-01
|
6.41e-01
|
0.43100
|
-3.64e-01
|
-2.30e-01
|
1.23e-01
|
3.29e-01
|
GOBP LUTEOLYSIS
|
6
|
1.84e-01
|
6.74e-01
|
0.43100
|
-4.31e-01
|
2.80e-03
|
6.77e-02
|
9.91e-01
|
GOCC PSEUDOPODIUM
|
16
|
1.72e-02
|
2.78e-01
|
0.43000
|
-3.83e-01
|
1.95e-01
|
7.93e-03
|
1.76e-01
|
GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY
|
12
|
4.69e-02
|
4.37e-01
|
0.43000
|
-1.85e-01
|
3.88e-01
|
2.68e-01
|
1.98e-02
|
GOBP REGULATION OF NODAL SIGNALING PATHWAY INVOLVED IN DETERMINATION OF LEFT RIGHT ASYMMETRY
|
5
|
2.08e-01
|
6.97e-01
|
0.42900
|
3.31e-01
|
2.73e-01
|
1.99e-01
|
2.91e-01
|
GOBP TRNA TRANSCRIPTION
|
11
|
5.70e-02
|
4.68e-01
|
0.42900
|
-4.09e-01
|
1.31e-01
|
1.90e-02
|
4.51e-01
|
GOBP IRON COORDINATION ENTITY TRANSPORT
|
12
|
5.25e-02
|
4.51e-01
|
0.42800
|
2.95e-01
|
-3.11e-01
|
7.69e-02
|
6.22e-02
|
GOCC MITOCHONDRIAL PERMEABILITY TRANSITION PORE COMPLEX
|
6
|
2.16e-01
|
7.07e-01
|
0.42800
|
-3.95e-01
|
1.65e-01
|
9.36e-02
|
4.84e-01
|
GOBP PROTEIN K29 LINKED UBIQUITINATION
|
7
|
1.73e-01
|
6.62e-01
|
0.42800
|
2.10e-01
|
-3.73e-01
|
3.35e-01
|
8.74e-02
|
GOMF MICROTUBULE MINUS END BINDING
|
13
|
4.04e-02
|
4.13e-01
|
0.42800
|
-2.46e-01
|
3.50e-01
|
1.25e-01
|
2.87e-02
|
GOBP DTTP METABOLIC PROCESS
|
5
|
2.24e-01
|
7.12e-01
|
0.42800
|
-4.03e-01
|
-1.43e-01
|
1.19e-01
|
5.79e-01
|
GOBP EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT
|
10
|
8.59e-02
|
5.45e-01
|
0.42800
|
-2.64e-01
|
3.37e-01
|
1.49e-01
|
6.53e-02
|
GOBP POSITIVE REGULATION OF CENTRIOLE ELONGATION
|
5
|
2.78e-01
|
7.51e-01
|
0.42700
|
1.48e-01
|
-4.01e-01
|
5.66e-01
|
1.20e-01
|
GOMF 11 CIS RETINAL BINDING
|
7
|
1.41e-01
|
6.26e-01
|
0.42700
|
1.03e-02
|
4.27e-01
|
9.62e-01
|
5.03e-02
|
GOBP REGULATION OF ANGIOTENSIN LEVELS IN BLOOD
|
8
|
1.37e-01
|
6.21e-01
|
0.42700
|
-3.67e-01
|
2.19e-01
|
7.23e-02
|
2.84e-01
|
GOCC RIBONUCLEASE MRP COMPLEX
|
10
|
8.21e-02
|
5.33e-01
|
0.42700
|
3.80e-01
|
-1.93e-01
|
3.73e-02
|
2.89e-01
|
GOMF C X C CHEMOKINE RECEPTOR ACTIVITY
|
7
|
1.58e-01
|
6.47e-01
|
0.42600
|
-8.88e-02
|
4.17e-01
|
6.84e-01
|
5.60e-02
|
GOBP POSITIVE REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY
|
5
|
2.12e-01
|
7.01e-01
|
0.42600
|
3.10e-01
|
2.92e-01
|
2.29e-01
|
2.57e-01
|
GOBP PRESYNAPTIC ACTIVE ZONE ORGANIZATION
|
8
|
1.26e-01
|
6.06e-01
|
0.42600
|
-1.16e-01
|
4.10e-01
|
5.69e-01
|
4.45e-02
|
GOMF NEUROTROPHIN TRK RECEPTOR BINDING
|
6
|
1.67e-01
|
6.53e-01
|
0.42600
|
4.00e-01
|
1.48e-01
|
8.99e-02
|
5.31e-01
|
GOMF NUCLEOSIDE TRIPHOSPHATE DIPHOSPHATASE ACTIVITY
|
9
|
6.21e-02
|
4.82e-01
|
0.42600
|
-3.34e-01
|
-2.65e-01
|
8.28e-02
|
1.69e-01
|
GOBP ESTABLISHMENT OF LYMPHOCYTE POLARITY
|
16
|
9.50e-03
|
2.07e-01
|
0.42600
|
9.79e-02
|
4.15e-01
|
4.98e-01
|
4.08e-03
|
GOCC GBAF COMPLEX
|
14
|
3.32e-02
|
3.70e-01
|
0.42600
|
-3.34e-01
|
2.64e-01
|
3.06e-02
|
8.68e-02
|
GOCC HISTONE PRE MRNA 3 END PROCESSING COMPLEX
|
6
|
2.06e-01
|
6.95e-01
|
0.42600
|
7.97e-02
|
-4.18e-01
|
7.35e-01
|
7.62e-02
|
GOBP RNA POLYMERASE I PREINITIATION COMPLEX ASSEMBLY
|
8
|
1.14e-01
|
5.92e-01
|
0.42500
|
-4.24e-01
|
2.18e-02
|
3.77e-02
|
9.15e-01
|
GOMF CARBOHYDRATE MONOATOMIC CATION SYMPORTER ACTIVITY
|
16
|
2.08e-02
|
3.05e-01
|
0.42500
|
-2.62e-01
|
3.34e-01
|
6.93e-02
|
2.07e-02
|
GOBP RESPONSE TO VASOPRESSIN
|
8
|
1.32e-01
|
6.13e-01
|
0.42400
|
-4.00e-01
|
1.41e-01
|
5.00e-02
|
4.89e-01
|
GOMF SPHINGOMYELIN PHOSPHODIESTERASE ACTIVITY
|
7
|
1.62e-01
|
6.48e-01
|
0.42400
|
-9.24e-02
|
4.14e-01
|
6.72e-01
|
5.78e-02
|
GOBP PROTEIN DNA COVALENT CROSS LINKING REPAIR
|
6
|
2.24e-01
|
7.13e-01
|
0.42400
|
-3.89e-01
|
1.69e-01
|
9.89e-02
|
4.74e-01
|
GOBP ASTRAL MICROTUBULE ORGANIZATION
|
10
|
4.94e-02
|
4.42e-01
|
0.42400
|
-3.73e-01
|
-2.02e-01
|
4.13e-02
|
2.69e-01
|
GOMF ATPASE INHIBITOR ACTIVITY
|
5
|
2.45e-01
|
7.26e-01
|
0.42400
|
5.25e-02
|
4.20e-01
|
8.39e-01
|
1.04e-01
|
GOBP POSITIVE REGULATION OF ENDOCYTIC RECYCLING
|
8
|
1.37e-01
|
6.20e-01
|
0.42400
|
-1.71e-01
|
3.88e-01
|
4.03e-01
|
5.76e-02
|
GOBP REGULATION OF THYROID HORMONE GENERATION
|
7
|
1.81e-01
|
6.70e-01
|
0.42300
|
2.09e-01
|
-3.68e-01
|
3.38e-01
|
9.16e-02
|
GOBP GLYCINE METABOLIC PROCESS
|
15
|
2.16e-02
|
3.12e-01
|
0.42300
|
1.13e-01
|
-4.08e-01
|
4.50e-01
|
6.21e-03
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN REDUCED PTERIDINE AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN
|
7
|
1.87e-01
|
6.78e-01
|
0.42300
|
3.18e-01
|
-2.79e-01
|
1.45e-01
|
2.01e-01
|
GOBP VERY LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE
|
7
|
1.37e-01
|
6.20e-01
|
0.42300
|
4.17e-01
|
7.28e-02
|
5.61e-02
|
7.39e-01
|
GOBP NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION
|
15
|
1.22e-02
|
2.37e-01
|
0.42300
|
1.47e-01
|
3.97e-01
|
3.23e-01
|
7.82e-03
|
GOBP CELLULAR RESPONSE TO UV C
|
5
|
3.02e-01
|
7.68e-01
|
0.42300
|
-2.81e-01
|
3.16e-01
|
2.77e-01
|
2.21e-01
|
GOCC PINOSOME
|
7
|
1.83e-01
|
6.72e-01
|
0.42200
|
-2.13e-01
|
3.65e-01
|
3.29e-01
|
9.48e-02
|
GOBP PROTEIN DEPALMITOYLATION
|
8
|
1.05e-01
|
5.75e-01
|
0.42200
|
-4.16e-01
|
-7.14e-02
|
4.15e-02
|
7.27e-01
|
GOMF ER RETENTION SEQUENCE BINDING
|
5
|
3.03e-01
|
7.68e-01
|
0.42200
|
2.68e-01
|
-3.27e-01
|
3.00e-01
|
2.06e-01
|
GOBP TERMINAL BUTTON ORGANIZATION
|
6
|
1.66e-01
|
6.50e-01
|
0.42200
|
-2.08e-01
|
-3.67e-01
|
3.78e-01
|
1.19e-01
|
GOBP BLOOD COAGULATION FIBRIN CLOT FORMATION
|
14
|
2.76e-02
|
3.45e-01
|
0.42200
|
4.11e-01
|
-9.54e-02
|
7.75e-03
|
5.36e-01
|
GOBP PROLINE TRANSMEMBRANE TRANSPORT
|
9
|
7.78e-02
|
5.25e-01
|
0.42200
|
4.13e-01
|
8.63e-02
|
3.20e-02
|
6.54e-01
|
GOBP REGULATION OF GERM CELL PROLIFERATION
|
7
|
1.34e-01
|
6.16e-01
|
0.42200
|
-4.07e-01
|
-1.10e-01
|
6.21e-02
|
6.16e-01
|
GOBP NEGATIVE REGULATION OF NEUTROPHIL MIGRATION
|
5
|
2.39e-01
|
7.25e-01
|
0.42200
|
-1.01e-01
|
-4.09e-01
|
6.96e-01
|
1.13e-01
|
GOBP REGULATION OF FOCAL ADHESION DISASSEMBLY
|
6
|
2.36e-01
|
7.24e-01
|
0.42200
|
-3.51e-01
|
2.33e-01
|
1.36e-01
|
3.22e-01
|
GOMF PROTEIN ARGININE OMEGA N ASYMMETRIC METHYLTRANSFERASE ACTIVITY
|
7
|
1.39e-01
|
6.22e-01
|
0.42100
|
-4.13e-01
|
-8.29e-02
|
5.86e-02
|
7.04e-01
|
GOBP POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN
|
6
|
1.96e-01
|
6.88e-01
|
0.42100
|
1.27e-02
|
4.21e-01
|
9.57e-01
|
7.43e-02
|
GOMF ALCOHOL DEHYDROGENASE ACTIVITY ZINC DEPENDENT
|
7
|
1.90e-01
|
6.85e-01
|
0.42100
|
3.15e-01
|
-2.79e-01
|
1.49e-01
|
2.01e-01
|
GOBP REGULATION OF EXTRACELLULAR MATRIX CONSTITUENT SECRETION
|
9
|
1.07e-01
|
5.80e-01
|
0.42100
|
-1.47e-01
|
3.94e-01
|
4.46e-01
|
4.05e-02
|
GOCC NUCLEOLAR RIBONUCLEASE P COMPLEX
|
7
|
1.58e-01
|
6.46e-01
|
0.42000
|
4.19e-01
|
-3.37e-02
|
5.48e-02
|
8.77e-01
|
GOMF RIBOSOMAL PROTEIN S6 KINASE ACTIVITY
|
5
|
2.56e-01
|
7.35e-01
|
0.42000
|
2.62e-02
|
4.19e-01
|
9.19e-01
|
1.04e-01
|
GOBP STEM CELL FATE SPECIFICATION
|
6
|
1.95e-01
|
6.88e-01
|
0.42000
|
-4.19e-01
|
-2.48e-02
|
7.54e-02
|
9.16e-01
|
GOBP NEGATIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS
|
9
|
1.10e-01
|
5.87e-01
|
0.42000
|
-1.65e-01
|
3.86e-01
|
3.92e-01
|
4.48e-02
|
GOMF SUPEROXIDE GENERATING NAD P H OXIDASE ACTIVITY
|
7
|
1.30e-01
|
6.09e-01
|
0.42000
|
1.63e-01
|
3.87e-01
|
4.54e-01
|
7.64e-02
|
GOBP REGULATION OF MESODERM DEVELOPMENT
|
6
|
1.97e-01
|
6.88e-01
|
0.42000
|
4.19e-01
|
1.87e-02
|
7.53e-02
|
9.37e-01
|
GOCC TUBULAR ENDOSOME
|
5
|
3.07e-01
|
7.71e-01
|
0.41900
|
2.55e-01
|
-3.33e-01
|
3.23e-01
|
1.97e-01
|
GOMF SPHINGOSINE N ACYLTRANSFERASE ACTIVITY
|
7
|
1.64e-01
|
6.49e-01
|
0.41900
|
-4.15e-01
|
6.03e-02
|
5.74e-02
|
7.82e-01
|
GOBP NEGATIVE REGULATION OF PLATELET AGGREGATION
|
10
|
8.38e-02
|
5.37e-01
|
0.41900
|
-1.32e-01
|
3.98e-01
|
4.71e-01
|
2.93e-02
|
GOMF LIGASE ACTIVITY FORMING CARBON CARBON BONDS
|
7
|
1.26e-01
|
6.06e-01
|
0.41900
|
-3.60e-01
|
-2.15e-01
|
9.92e-02
|
3.25e-01
|
GOBP NEGATIVE REGULATION OF SEQUESTERING OF TRIGLYCERIDE
|
6
|
1.83e-01
|
6.72e-01
|
0.41900
|
-1.09e-01
|
-4.05e-01
|
6.44e-01
|
8.61e-02
|
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS
|
10
|
7.23e-02
|
5.13e-01
|
0.41900
|
-4.18e-01
|
2.82e-02
|
2.21e-02
|
8.77e-01
|
GOBP PYRUVATE FAMILY AMINO ACID METABOLIC PROCESS
|
5
|
2.46e-01
|
7.26e-01
|
0.41900
|
-8.73e-02
|
-4.10e-01
|
7.35e-01
|
1.13e-01
|
GOBP GERM CELL MIGRATION
|
8
|
1.16e-01
|
5.94e-01
|
0.41900
|
4.18e-01
|
2.00e-02
|
4.06e-02
|
9.22e-01
|
GOBP POSITIVE REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS
|
6
|
2.45e-01
|
7.26e-01
|
0.41800
|
-2.72e-01
|
3.18e-01
|
2.49e-01
|
1.77e-01
|
GOCC CANONICAL INFLAMMASOME COMPLEX
|
16
|
1.09e-02
|
2.23e-01
|
0.41800
|
-1.11e-01
|
-4.03e-01
|
4.43e-01
|
5.23e-03
|
GOBP NEGATIVE REGULATION OF THYMOCYTE APOPTOTIC PROCESS
|
10
|
5.08e-02
|
4.46e-01
|
0.41800
|
2.78e-01
|
3.12e-01
|
1.27e-01
|
8.75e-02
|
GOBP NEGATIVE REGULATION OF PHOTORECEPTOR CELL DIFFERENTIATION
|
6
|
2.46e-01
|
7.26e-01
|
0.41800
|
-2.81e-01
|
3.09e-01
|
2.33e-01
|
1.89e-01
|
GOBP ACTIVATION OF MEIOSIS
|
6
|
2.37e-01
|
7.24e-01
|
0.41800
|
-1.82e-01
|
3.76e-01
|
4.39e-01
|
1.11e-01
|
GOMF GLUTAMATE SODIUM SYMPORTER ACTIVITY
|
5
|
2.27e-01
|
7.14e-01
|
0.41700
|
2.74e-01
|
3.15e-01
|
2.89e-01
|
2.23e-01
|
GOBP POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS
|
5
|
3.10e-01
|
7.73e-01
|
0.41700
|
-2.44e-01
|
3.38e-01
|
3.45e-01
|
1.90e-01
|
GOBP PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS
|
5
|
2.88e-01
|
7.59e-01
|
0.41700
|
-4.04e-01
|
1.04e-01
|
1.18e-01
|
6.87e-01
|
GOBP PEPTIDE MODIFICATION
|
5
|
2.50e-01
|
7.28e-01
|
0.41700
|
8.45e-02
|
4.08e-01
|
7.43e-01
|
1.14e-01
|
GOBP PROTECTION FROM NATURAL KILLER CELL MEDIATED CYTOTOXICITY
|
6
|
2.28e-01
|
7.15e-01
|
0.41700
|
1.21e-01
|
-3.99e-01
|
6.07e-01
|
9.09e-02
|
GOMF CYTOSKELETON NUCLEAR MEMBRANE ANCHOR ACTIVITY
|
5
|
3.03e-01
|
7.68e-01
|
0.41700
|
-3.75e-01
|
1.81e-01
|
1.46e-01
|
4.84e-01
|
GOMF TOXIN TRANSMEMBRANE TRANSPORTER ACTIVITY
|
9
|
7.20e-02
|
5.12e-01
|
0.41600
|
2.17e-01
|
3.55e-01
|
2.60e-01
|
6.48e-02
|
GOMF ALPHA 1 3 FUCOSYLTRANSFERASE ACTIVITY
|
8
|
1.22e-01
|
6.03e-01
|
0.41600
|
6.01e-03
|
-4.16e-01
|
9.77e-01
|
4.14e-02
|
GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR ACTIVITY
|
7
|
1.91e-01
|
6.85e-01
|
0.41600
|
1.99e-01
|
-3.65e-01
|
3.61e-01
|
9.42e-02
|
GOCC AP 1 ADAPTOR COMPLEX
|
11
|
7.27e-02
|
5.13e-01
|
0.41600
|
-1.83e-01
|
3.74e-01
|
2.94e-01
|
3.18e-02
|
GOMF CALCIUM DEPENDENT PROTEIN SERINE THREONINE PHOSPHATASE REGULATOR ACTIVITY
|
5
|
2.31e-01
|
7.18e-01
|
0.41600
|
2.35e-01
|
3.43e-01
|
3.63e-01
|
1.84e-01
|
GOBP CLATHRIN COATED VESICLE CARGO LOADING
|
7
|
1.27e-01
|
6.07e-01
|
0.41600
|
-2.60e-01
|
-3.24e-01
|
2.33e-01
|
1.37e-01
|
GOCC PTW PP1 PHOSPHATASE COMPLEX
|
7
|
1.62e-01
|
6.48e-01
|
0.41600
|
-1.92e-02
|
4.15e-01
|
9.30e-01
|
5.70e-02
|
GOMF HISTONE H3 ACETYLTRANSFERASE ACTIVITY
|
14
|
3.74e-02
|
3.93e-01
|
0.41600
|
-3.56e-01
|
2.15e-01
|
2.11e-02
|
1.64e-01
|
GOBP PROTOPORPHYRINOGEN IX BIOSYNTHETIC PROCESS
|
8
|
1.03e-01
|
5.75e-01
|
0.41500
|
-1.47e-01
|
-3.89e-01
|
4.72e-01
|
5.69e-02
|
GOBP NAIL DEVELOPMENT
|
11
|
6.83e-02
|
5.00e-01
|
0.41500
|
-1.26e-01
|
3.96e-01
|
4.70e-01
|
2.31e-02
|
GOCC PRE SNORNP COMPLEX
|
7
|
1.97e-01
|
6.88e-01
|
0.41500
|
2.41e-01
|
-3.38e-01
|
2.70e-01
|
1.21e-01
|
GOBP POSITIVE REGULATION OF PLASMINOGEN ACTIVATION
|
8
|
1.30e-01
|
6.09e-01
|
0.41500
|
4.55e-02
|
-4.13e-01
|
8.24e-01
|
4.33e-02
|
GOBP REGULATION OF PHOSPHATIDYLCHOLINE METABOLIC PROCESS
|
10
|
9.91e-02
|
5.68e-01
|
0.41500
|
-3.25e-01
|
2.58e-01
|
7.54e-02
|
1.57e-01
|
GOBP PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING
|
9
|
1.22e-01
|
6.03e-01
|
0.41500
|
-2.20e-01
|
3.52e-01
|
2.54e-01
|
6.75e-02
|
GOBP FUSED ANTRUM STAGE
|
6
|
2.29e-01
|
7.18e-01
|
0.41400
|
-4.00e-01
|
1.10e-01
|
8.99e-02
|
6.42e-01
|
GOBP NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION
|
15
|
1.47e-02
|
2.59e-01
|
0.41400
|
-3.88e-01
|
-1.46e-01
|
9.36e-03
|
3.29e-01
|
GOBP DGMP METABOLIC PROCESS
|
5
|
2.55e-01
|
7.34e-01
|
0.41400
|
8.50e-02
|
4.05e-01
|
7.42e-01
|
1.17e-01
|
GOMF CARNITINE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
5
|
2.48e-01
|
7.26e-01
|
0.41400
|
1.27e-01
|
3.94e-01
|
6.23e-01
|
1.27e-01
|
GOBP POSITIVE REGULATION OF HEART RATE BY EPINEPHRINE NOREPINEPHRINE
|
5
|
2.44e-01
|
7.25e-01
|
0.41400
|
1.56e-01
|
3.83e-01
|
5.45e-01
|
1.38e-01
|
GOBP REGULATION OF CAVEOLIN MEDIATED ENDOCYTOSIS
|
6
|
2.46e-01
|
7.26e-01
|
0.41300
|
-3.64e-01
|
1.96e-01
|
1.23e-01
|
4.05e-01
|
GOBP CHEMOKINE C X C MOTIF LIGAND 1 PRODUCTION
|
6
|
2.09e-01
|
6.97e-01
|
0.41300
|
-4.13e-01
|
-6.89e-03
|
7.96e-02
|
9.77e-01
|
GOBP CAVEOLIN MEDIATED ENDOCYTOSIS
|
11
|
7.44e-02
|
5.15e-01
|
0.41300
|
-3.77e-01
|
1.69e-01
|
3.04e-02
|
3.32e-01
|
GOBP PURINE NUCLEOBASE BIOSYNTHETIC PROCESS
|
9
|
8.38e-02
|
5.37e-01
|
0.41300
|
-1.10e-01
|
-3.98e-01
|
5.66e-01
|
3.88e-02
|
GOBP INTRACELLULAR GLUTAMATE HOMEOSTASIS
|
5
|
2.64e-01
|
7.41e-01
|
0.41200
|
4.98e-02
|
4.09e-01
|
8.47e-01
|
1.13e-01
|
GOBP RESPIRATORY CHAIN COMPLEX III ASSEMBLY
|
12
|
4.58e-02
|
4.33e-01
|
0.41200
|
-4.12e-01
|
1.10e-02
|
1.34e-02
|
9.48e-01
|
GOBP PROTEIN LOCALIZATION TO CYTOPLASMIC STRESS GRANULE
|
7
|
1.66e-01
|
6.50e-01
|
0.41200
|
1.24e-02
|
-4.12e-01
|
9.55e-01
|
5.91e-02
|
GOBP REGULATION OF PODOSOME ASSEMBLY
|
13
|
3.50e-02
|
3.81e-01
|
0.41200
|
-4.12e-01
|
3.28e-03
|
1.01e-02
|
9.84e-01
|
GOMF GLUTATHIONE HYDROLASE ACTIVITY
|
5
|
3.17e-01
|
7.77e-01
|
0.41200
|
-3.45e-01
|
2.26e-01
|
1.82e-01
|
3.82e-01
|
GOBP OXALOACETATE METABOLIC PROCESS
|
9
|
1.05e-01
|
5.75e-01
|
0.41200
|
4.82e-02
|
-4.09e-01
|
8.02e-01
|
3.36e-02
|
GOBP VENTRICULAR COMPACT MYOCARDIUM MORPHOGENESIS
|
8
|
9.97e-02
|
5.68e-01
|
0.41200
|
3.25e-01
|
2.53e-01
|
1.12e-01
|
2.15e-01
|
GOMF POTASSIUM CHLORIDE SYMPORTER ACTIVITY
|
9
|
1.29e-01
|
6.09e-01
|
0.41200
|
-3.18e-01
|
2.62e-01
|
9.88e-02
|
1.74e-01
|
GOBP CENTRAL NERVOUS SYSTEM MATURATION
|
6
|
2.45e-01
|
7.26e-01
|
0.41200
|
-3.76e-01
|
1.67e-01
|
1.10e-01
|
4.79e-01
|
GOBP NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING
|
7
|
1.33e-01
|
6.14e-01
|
0.41200
|
-3.21e-01
|
-2.58e-01
|
1.42e-01
|
2.37e-01
|
GOMF RIBOSOMAL SMALL SUBUNIT BINDING
|
16
|
2.05e-02
|
3.05e-01
|
0.41200
|
1.01e-01
|
-3.99e-01
|
4.84e-01
|
5.72e-03
|
GOBP REGULATION OF PROTEIN K48 LINKED UBIQUITINATION
|
6
|
2.53e-01
|
7.32e-01
|
0.41100
|
2.23e-01
|
-3.46e-01
|
3.44e-01
|
1.43e-01
|
GOBP POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS
|
6
|
1.80e-01
|
6.70e-01
|
0.41100
|
3.47e-01
|
2.20e-01
|
1.41e-01
|
3.50e-01
|
GOBP NEGATIVE REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE
|
8
|
1.07e-01
|
5.79e-01
|
0.41100
|
3.78e-01
|
1.61e-01
|
6.38e-02
|
4.31e-01
|
GOMF ESTROGEN 16 ALPHA HYDROXYLASE ACTIVITY
|
8
|
1.21e-01
|
6.02e-01
|
0.41100
|
4.08e-01
|
4.74e-02
|
4.55e-02
|
8.17e-01
|
GOMF TRANSCRIPTION REGULATOR ACTIVATOR ACTIVITY
|
5
|
3.18e-01
|
7.78e-01
|
0.41100
|
-2.16e-01
|
3.49e-01
|
4.02e-01
|
1.76e-01
|
GOBP ENDONUCLEOLYTIC CLEAVAGE IN 5 ETS OF TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA
|
8
|
1.43e-01
|
6.28e-01
|
0.41100
|
-4.00e-01
|
9.39e-02
|
5.01e-02
|
6.45e-01
|
GOMF LYSOPHOSPHOLIPASE ACTIVITY
|
26
|
2.75e-03
|
1.02e-01
|
0.41100
|
-2.48e-01
|
3.27e-01
|
2.85e-02
|
3.86e-03
|
GOMF PROTEIN ARGININE DEIMINASE ACTIVITY
|
5
|
3.20e-01
|
7.78e-01
|
0.41100
|
-2.36e-01
|
3.36e-01
|
3.61e-01
|
1.93e-01
|
GOBP TRICUSPID VALVE MORPHOGENESIS
|
5
|
3.22e-01
|
7.79e-01
|
0.41100
|
-2.56e-01
|
3.21e-01
|
3.22e-01
|
2.13e-01
|
GOBP POSITIVE REGULATION OF VITAMIN D RECEPTOR SIGNALING PATHWAY
|
6
|
2.56e-01
|
7.35e-01
|
0.41100
|
-2.37e-01
|
3.35e-01
|
3.15e-01
|
1.55e-01
|
GOBP VOLUNTARY MUSCULOSKELETAL MOVEMENT
|
7
|
2.03e-01
|
6.93e-01
|
0.41100
|
-3.38e-01
|
2.33e-01
|
1.21e-01
|
2.87e-01
|
GOBP CELLULAR RESPONSE TO ALDOSTERONE
|
7
|
2.00e-01
|
6.90e-01
|
0.41000
|
-3.57e-01
|
2.02e-01
|
1.02e-01
|
3.55e-01
|
GOBP REGULATION OF GLUTAMATE RECEPTOR CLUSTERING
|
6
|
2.50e-01
|
7.28e-01
|
0.41000
|
-1.84e-01
|
3.66e-01
|
4.35e-01
|
1.20e-01
|
GOBP POSTSYNAPSE TO NUCLEUS SIGNALING PATHWAY
|
6
|
1.88e-01
|
6.80e-01
|
0.41000
|
-1.69e-01
|
-3.73e-01
|
4.72e-01
|
1.14e-01
|
GOBP IMMUNE RESPONSE INHIBITING CELL SURFACE RECEPTOR SIGNALING PATHWAY
|
9
|
8.72e-02
|
5.46e-01
|
0.40900
|
-3.94e-01
|
-1.10e-01
|
4.05e-02
|
5.67e-01
|
GOBP DNA METHYLATION ON CYTOSINE
|
6
|
2.02e-01
|
6.92e-01
|
0.40900
|
-4.01e-01
|
-8.14e-02
|
8.91e-02
|
7.30e-01
|
GOBP POSITIVE REGULATION OF MESENCHYMAL STEM CELL PROLIFERATION
|
6
|
2.43e-01
|
7.25e-01
|
0.40900
|
-1.29e-01
|
3.88e-01
|
5.84e-01
|
9.98e-02
|
GOBP NITRIC OXIDE TRANSPORT
|
5
|
2.40e-01
|
7.25e-01
|
0.40900
|
2.83e-01
|
2.95e-01
|
2.72e-01
|
2.54e-01
|
GOBP EPITHELIAL CELL PROLIFERATION INVOLVED IN SALIVARY GLAND MORPHOGENESIS
|
5
|
2.47e-01
|
7.26e-01
|
0.40900
|
-1.93e-01
|
-3.61e-01
|
4.56e-01
|
1.63e-01
|
GOBP REGULATION OF NEUTROPHIL ACTIVATION
|
14
|
3.06e-02
|
3.61e-01
|
0.40800
|
-4.07e-01
|
3.06e-02
|
8.35e-03
|
8.43e-01
|
GOMF INOSITOL 1 4 5 TRISPHOSPHATE 5 PHOSPHATASE ACTIVITY
|
6
|
2.49e-01
|
7.27e-01
|
0.40800
|
-3.75e-01
|
1.60e-01
|
1.11e-01
|
4.97e-01
|
GOBP POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS
|
11
|
4.53e-02
|
4.31e-01
|
0.40800
|
3.44e-01
|
2.20e-01
|
4.85e-02
|
2.06e-01
|
GOBP REGULATION OF EATING BEHAVIOR
|
7
|
1.37e-01
|
6.20e-01
|
0.40800
|
-2.90e-01
|
-2.87e-01
|
1.83e-01
|
1.89e-01
|
GOBP AXON MIDLINE CHOICE POINT RECOGNITION
|
5
|
2.59e-01
|
7.36e-01
|
0.40800
|
-1.19e-01
|
-3.90e-01
|
6.46e-01
|
1.31e-01
|
GOMF NATURAL KILLER CELL LECTIN LIKE RECEPTOR BINDING
|
8
|
1.69e-01
|
6.55e-01
|
0.40800
|
2.88e-01
|
-2.88e-01
|
1.58e-01
|
1.58e-01
|
GOBP NEGATIVE REGULATION OF INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY
|
8
|
1.04e-01
|
5.75e-01
|
0.40800
|
3.12e-01
|
2.62e-01
|
1.26e-01
|
1.99e-01
|
GOMF PEROXIREDOXIN ACTIVITY
|
7
|
1.47e-01
|
6.34e-01
|
0.40800
|
-1.50e-01
|
-3.79e-01
|
4.93e-01
|
8.24e-02
|
GOMF RETROMER COMPLEX BINDING
|
9
|
9.33e-02
|
5.55e-01
|
0.40700
|
7.62e-02
|
4.00e-01
|
6.92e-01
|
3.77e-02
|
GOMF EPOXIDE HYDROLASE ACTIVITY
|
6
|
2.64e-01
|
7.41e-01
|
0.40700
|
-2.64e-01
|
3.10e-01
|
2.63e-01
|
1.89e-01
|
GOCC SERINE TYPE ENDOPEPTIDASE COMPLEX
|
11
|
8.20e-02
|
5.33e-01
|
0.40700
|
1.85e-01
|
-3.62e-01
|
2.87e-01
|
3.74e-02
|
GOMF OLEATE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
6
|
2.47e-01
|
7.26e-01
|
0.40700
|
-3.84e-01
|
1.34e-01
|
1.03e-01
|
5.69e-01
|
GOBP ESTROGEN BIOSYNTHETIC PROCESS
|
11
|
7.38e-02
|
5.14e-01
|
0.40700
|
1.04e-01
|
-3.93e-01
|
5.51e-01
|
2.38e-02
|
GOBP POSITIVE REGULATION OF TRANSCRIPTION BY GLUCOSE
|
6
|
2.00e-01
|
6.89e-01
|
0.40700
|
-3.89e-01
|
-1.19e-01
|
9.89e-02
|
6.15e-01
|
GOBP REGULATION OF NON MOTILE CILIUM ASSEMBLY
|
11
|
8.40e-02
|
5.37e-01
|
0.40700
|
2.03e-01
|
-3.52e-01
|
2.43e-01
|
4.31e-02
|
GOBP CARDIOLIPIN BIOSYNTHETIC PROCESS
|
7
|
1.39e-01
|
6.23e-01
|
0.40700
|
-3.13e-01
|
-2.59e-01
|
1.51e-01
|
2.35e-01
|
GOBP ACTOMYOSIN CONTRACTILE RING ORGANIZATION
|
10
|
9.05e-02
|
5.51e-01
|
0.40700
|
-3.99e-01
|
7.64e-02
|
2.88e-02
|
6.76e-01
|
GOBP ISG15 PROTEIN CONJUGATION
|
6
|
2.14e-01
|
7.03e-01
|
0.40600
|
-3.59e-02
|
-4.05e-01
|
8.79e-01
|
8.59e-02
|
GOBP POSITIVE REGULATION OF T HELPER 2 CELL DIFFERENTIATION
|
7
|
1.40e-01
|
6.24e-01
|
0.40600
|
-3.20e-01
|
-2.51e-01
|
1.43e-01
|
2.51e-01
|
GOCC PEPTIDASE INHIBITOR COMPLEX
|
11
|
5.70e-02
|
4.68e-01
|
0.40600
|
-4.01e-01
|
-6.24e-02
|
2.11e-02
|
7.20e-01
|
GOMF ACTIVIN RECEPTOR ACTIVITY TYPE I
|
5
|
2.93e-01
|
7.63e-01
|
0.40600
|
-3.68e-02
|
4.04e-01
|
8.87e-01
|
1.17e-01
|
GOBP PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY
|
8
|
1.51e-01
|
6.38e-01
|
0.40600
|
-3.94e-01
|
9.55e-02
|
5.35e-02
|
6.40e-01
|
GOCC LEWY BODY
|
8
|
1.40e-01
|
6.23e-01
|
0.40600
|
2.84e-02
|
-4.05e-01
|
8.89e-01
|
4.75e-02
|
GOMF ALKANE 1 MONOOXYGENASE ACTIVITY
|
5
|
3.29e-01
|
7.84e-01
|
0.40500
|
3.36e-01
|
-2.27e-01
|
1.93e-01
|
3.79e-01
|
GOBP KERATAN SULFATE METABOLIC PROCESS
|
18
|
1.52e-02
|
2.62e-01
|
0.40500
|
-3.86e-01
|
1.23e-01
|
4.54e-03
|
3.66e-01
|
GOBP D AMINO ACID TRANSPORT
|
6
|
1.90e-01
|
6.83e-01
|
0.40500
|
2.17e-01
|
3.42e-01
|
3.57e-01
|
1.47e-01
|
GOCC DENSE CORE GRANULE MEMBRANE
|
7
|
1.58e-01
|
6.46e-01
|
0.40500
|
-3.93e-01
|
-9.71e-02
|
7.17e-02
|
6.56e-01
|
GOMF HISTONE H4K5 ACETYLTRANSFERASE ACTIVITY
|
11
|
8.88e-02
|
5.50e-01
|
0.40500
|
-2.47e-01
|
3.21e-01
|
1.56e-01
|
6.55e-02
|
GOBP LEUKOTRIENE D4 BIOSYNTHETIC PROCESS
|
6
|
2.38e-01
|
7.25e-01
|
0.40400
|
-3.99e-01
|
6.55e-02
|
9.05e-02
|
7.81e-01
|
GOMF ACTIVIN RECEPTOR ACTIVITY
|
9
|
1.21e-01
|
6.01e-01
|
0.40400
|
-9.56e-02
|
3.93e-01
|
6.20e-01
|
4.12e-02
|
GOBP MICROTUBULE SEVERING
|
8
|
1.73e-01
|
6.61e-01
|
0.40400
|
2.45e-01
|
-3.22e-01
|
2.30e-01
|
1.15e-01
|
GOMF CUPRIC ION BINDING
|
5
|
2.64e-01
|
7.41e-01
|
0.40400
|
-3.83e-01
|
-1.27e-01
|
1.38e-01
|
6.22e-01
|
GOBP KERATINOCYTE APOPTOTIC PROCESS
|
7
|
1.91e-01
|
6.85e-01
|
0.40400
|
-8.13e-02
|
3.96e-01
|
7.10e-01
|
6.99e-02
|
GOMF ESTRADIOL 17 BETA DEHYDROGENASE NAD P ACTIVITY
|
18
|
1.41e-02
|
2.57e-01
|
0.40400
|
7.70e-02
|
-3.96e-01
|
5.72e-01
|
3.60e-03
|
GOBP CHEMOKINE C X C MOTIF LIGAND 12 SIGNALING PATHWAY
|
7
|
2.06e-01
|
6.95e-01
|
0.40400
|
3.68e-01
|
-1.66e-01
|
9.20e-02
|
4.46e-01
|
GOBP G QUADRUPLEX DNA UNWINDING
|
7
|
2.16e-01
|
7.07e-01
|
0.40400
|
2.49e-01
|
-3.17e-01
|
2.53e-01
|
1.46e-01
|
GOCC SMN SM PROTEIN COMPLEX
|
16
|
2.78e-02
|
3.46e-01
|
0.40300
|
1.79e-01
|
-3.62e-01
|
2.16e-01
|
1.22e-02
|
GOMF DEUBIQUITINASE ACTIVATOR ACTIVITY
|
5
|
2.79e-01
|
7.52e-01
|
0.40300
|
-4.00e-01
|
-5.02e-02
|
1.21e-01
|
8.46e-01
|
GOCC TRAPPII PROTEIN COMPLEX
|
11
|
8.95e-02
|
5.51e-01
|
0.40300
|
-3.30e-01
|
2.32e-01
|
5.80e-02
|
1.83e-01
|
GOCC ELASTIC FIBER
|
5
|
2.51e-01
|
7.29e-01
|
0.40300
|
2.45e-01
|
3.21e-01
|
3.44e-01
|
2.14e-01
|
GOBP THYMIC T CELL SELECTION
|
23
|
1.96e-03
|
8.17e-02
|
0.40300
|
1.78e-01
|
3.62e-01
|
1.40e-01
|
2.67e-03
|
GOMF EPINEPHRINE BINDING
|
6
|
1.89e-01
|
6.83e-01
|
0.40300
|
2.92e-01
|
2.78e-01
|
2.16e-01
|
2.38e-01
|
GOMF CARBOHYDRATE PROTON SYMPORTER ACTIVITY
|
7
|
2.19e-01
|
7.07e-01
|
0.40300
|
-2.83e-01
|
2.87e-01
|
1.95e-01
|
1.89e-01
|
GOBP MEIOTIC CHROMOSOME CONDENSATION
|
6
|
1.91e-01
|
6.85e-01
|
0.40300
|
-2.37e-01
|
-3.26e-01
|
3.15e-01
|
1.67e-01
|
GOBP RESPONSE TO CORTICOTROPIN RELEASING HORMONE
|
5
|
3.08e-01
|
7.72e-01
|
0.40300
|
7.65e-02
|
-3.95e-01
|
7.67e-01
|
1.26e-01
|
GOBP REACTIVE GLIOSIS
|
6
|
1.92e-01
|
6.85e-01
|
0.40300
|
-3.27e-01
|
-2.35e-01
|
1.65e-01
|
3.20e-01
|
GOBP DE NOVO CENTRIOLE ASSEMBLY
|
6
|
2.72e-01
|
7.47e-01
|
0.40300
|
2.91e-01
|
-2.78e-01
|
2.17e-01
|
2.38e-01
|
GOMF L PROLINE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
7
|
1.98e-01
|
6.88e-01
|
0.40200
|
3.88e-01
|
-1.05e-01
|
7.53e-02
|
6.29e-01
|
GOBP NEGATIVE REGULATION OF OSTEOCLAST DEVELOPMENT
|
5
|
3.14e-01
|
7.76e-01
|
0.40200
|
1.03e-01
|
-3.89e-01
|
6.90e-01
|
1.32e-01
|
GOMF BUTYRATE COA LIGASE ACTIVITY
|
9
|
1.27e-01
|
6.07e-01
|
0.40200
|
1.22e-01
|
-3.83e-01
|
5.26e-01
|
4.64e-02
|
GOBP POSITIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY
|
8
|
1.57e-01
|
6.44e-01
|
0.40200
|
-1.01e-01
|
3.89e-01
|
6.22e-01
|
5.65e-02
|
GOCC CATALYTIC STEP 1 SPLICEOSOME
|
12
|
3.92e-02
|
4.05e-01
|
0.40200
|
-1.87e-01
|
-3.56e-01
|
2.62e-01
|
3.29e-02
|
GOBP REGULATION OF BRANCHING INVOLVED IN LUNG MORPHOGENESIS
|
6
|
2.65e-01
|
7.41e-01
|
0.40200
|
-1.86e-01
|
3.56e-01
|
4.30e-01
|
1.31e-01
|
GOBP NEGATIVE REGULATION OF MAST CELL DEGRANULATION
|
5
|
2.55e-01
|
7.34e-01
|
0.40200
|
-3.32e-01
|
-2.26e-01
|
1.98e-01
|
3.82e-01
|
GOBP NEGATIVE REGULATION OF NUCLEASE ACTIVITY
|
7
|
1.49e-01
|
6.35e-01
|
0.40200
|
3.40e-01
|
2.14e-01
|
1.19e-01
|
3.27e-01
|
GOBP TRANSCRIPTION ELONGATION COUPLED CHROMATIN REMODELING
|
7
|
2.18e-01
|
7.07e-01
|
0.40200
|
-2.34e-01
|
3.26e-01
|
2.83e-01
|
1.35e-01
|
GOBP EPIDERMAL CELL FATE SPECIFICATION
|
5
|
3.26e-01
|
7.82e-01
|
0.40200
|
-1.57e-01
|
3.70e-01
|
5.43e-01
|
1.52e-01
|
GOBP REGULATION OF GOLGI ORGANIZATION
|
17
|
2.51e-02
|
3.31e-01
|
0.40100
|
-3.24e-01
|
2.37e-01
|
2.07e-02
|
9.12e-02
|
GOBP CYCLIC GMP AMP TRANSMEMBRANE IMPORT ACROSS PLASMA MEMBRANE
|
6
|
2.21e-01
|
7.11e-01
|
0.40100
|
-3.99e-01
|
-4.26e-02
|
9.06e-02
|
8.57e-01
|
GOBP REGULATION OF OSTEOCLAST PROLIFERATION
|
6
|
2.42e-01
|
7.25e-01
|
0.40100
|
5.90e-02
|
-3.97e-01
|
8.03e-01
|
9.23e-02
|
GOCC PROXIMAL DENDRITE
|
6
|
2.39e-01
|
7.25e-01
|
0.40100
|
3.99e-01
|
-4.31e-02
|
9.08e-02
|
8.55e-01
|
GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT POSTSYNAPTIC ENDOSOME TO LYSOSOME
|
7
|
1.88e-01
|
6.79e-01
|
0.40100
|
-3.99e-01
|
3.71e-02
|
6.74e-02
|
8.65e-01
|
GOMF NADPLUS PROTEIN ASPARTATE ADP RIBOSYLTRANSFERASE ACTIVITY
|
5
|
3.42e-01
|
7.93e-01
|
0.40100
|
-2.88e-01
|
2.79e-01
|
2.65e-01
|
2.81e-01
|
GOBP COMPLEMENT ACTIVATION LECTIN PATHWAY
|
11
|
6.95e-02
|
5.02e-01
|
0.40000
|
4.00e-01
|
-1.00e-02
|
2.15e-02
|
9.54e-01
|
GOBP POSITIVE REGULATION OF SUPEROXIDE ANION GENERATION
|
16
|
2.32e-02
|
3.22e-01
|
0.40000
|
-3.96e-01
|
5.82e-02
|
6.10e-03
|
6.87e-01
|
GOBP NEGATIVE T CELL SELECTION
|
13
|
3.43e-02
|
3.78e-01
|
0.40000
|
3.83e-01
|
1.16e-01
|
1.69e-02
|
4.70e-01
|
GOCC PROCENTRIOLE REPLICATION COMPLEX
|
6
|
2.29e-01
|
7.18e-01
|
0.40000
|
-1.53e-02
|
-3.99e-01
|
9.48e-01
|
9.02e-02
|
GOBP DE NOVO CENTRIOLE ASSEMBLY INVOLVED IN MULTI CILIATED EPITHELIAL CELL DIFFERENTIATION
|
5
|
3.41e-01
|
7.91e-01
|
0.40000
|
2.30e-01
|
-3.27e-01
|
3.73e-01
|
2.06e-01
|
GOBP POSITIVE REGULATION OF MITOPHAGY
|
7
|
2.21e-01
|
7.11e-01
|
0.40000
|
-3.29e-01
|
2.27e-01
|
1.32e-01
|
2.99e-01
|
GOBP IMMATURE B CELL DIFFERENTIATION
|
12
|
7.09e-02
|
5.07e-01
|
0.40000
|
-1.68e-01
|
3.63e-01
|
3.13e-01
|
2.96e-02
|
GOBP NEGATIVE REGULATION OF CELL CYCLE CHECKPOINT
|
6
|
2.05e-01
|
6.95e-01
|
0.39900
|
3.67e-01
|
1.57e-01
|
1.19e-01
|
5.04e-01
|
GOCC TIM22 MITOCHONDRIAL IMPORT INNER MEMBRANE INSERTION COMPLEX
|
7
|
1.92e-01
|
6.85e-01
|
0.39900
|
4.56e-02
|
-3.97e-01
|
8.35e-01
|
6.92e-02
|
GOBP TRIPARTITE REGIONAL SUBDIVISION
|
19
|
1.24e-02
|
2.40e-01
|
0.39900
|
-8.01e-02
|
3.91e-01
|
5.46e-01
|
3.16e-03
|
GOMF DEATH RECEPTOR ACTIVITY
|
11
|
9.57e-02
|
5.61e-01
|
0.39900
|
-2.64e-01
|
3.00e-01
|
1.30e-01
|
8.52e-02
|
GOBP HARD PALATE DEVELOPMENT
|
8
|
1.75e-01
|
6.64e-01
|
0.39900
|
-1.85e-01
|
3.54e-01
|
3.65e-01
|
8.33e-02
|
GOCC NMDA SELECTIVE GLUTAMATE RECEPTOR COMPLEX
|
9
|
1.16e-01
|
5.96e-01
|
0.39800
|
-1.52e-02
|
3.98e-01
|
9.37e-01
|
3.87e-02
|
GOBP REGULATION OF PLASMA CELL DIFFERENTIATION
|
5
|
2.64e-01
|
7.41e-01
|
0.39800
|
-3.45e-01
|
-1.98e-01
|
1.81e-01
|
4.43e-01
|
GOBP REGULATION OF ESTABLISHMENT OF T CELL POLARITY
|
6
|
2.68e-01
|
7.43e-01
|
0.39800
|
-1.59e-01
|
3.65e-01
|
5.01e-01
|
1.22e-01
|
GOMF THREONINE TYPE ENDOPEPTIDASE ACTIVITY
|
9
|
1.05e-01
|
5.75e-01
|
0.39800
|
-6.99e-02
|
-3.92e-01
|
7.17e-01
|
4.19e-02
|
GOBP NEGATIVE REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE
|
12
|
4.25e-02
|
4.24e-01
|
0.39800
|
1.70e-01
|
3.59e-01
|
3.07e-01
|
3.11e-02
|
GOBP PROTEIN SULFATION
|
6
|
1.99e-01
|
6.89e-01
|
0.39700
|
-2.61e-01
|
-3.00e-01
|
2.69e-01
|
2.03e-01
|
GOBP WYBUTOSINE METABOLIC PROCESS
|
6
|
2.41e-01
|
7.25e-01
|
0.39700
|
1.56e-02
|
-3.97e-01
|
9.47e-01
|
9.25e-02
|
GOBP CHORION DEVELOPMENT
|
10
|
7.33e-02
|
5.13e-01
|
0.39700
|
-3.61e-01
|
-1.65e-01
|
4.82e-02
|
3.67e-01
|
GOBP NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION
|
11
|
6.68e-02
|
4.98e-01
|
0.39700
|
-3.94e-01
|
-4.66e-02
|
2.37e-02
|
7.89e-01
|
GOBP CDP CHOLINE PATHWAY
|
6
|
2.83e-01
|
7.56e-01
|
0.39700
|
-2.59e-01
|
3.00e-01
|
2.72e-01
|
2.03e-01
|
GOMF PYRIMIDINE NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY
|
9
|
1.15e-01
|
5.93e-01
|
0.39600
|
-1.67e-02
|
-3.95e-01
|
9.31e-01
|
4.00e-02
|
GOCC NUCLEOTIDE EXCISION REPAIR COMPLEX
|
10
|
6.99e-02
|
5.03e-01
|
0.39600
|
-3.12e-01
|
-2.43e-01
|
8.78e-02
|
1.83e-01
|
GOBP POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE
|
13
|
5.68e-02
|
4.68e-01
|
0.39500
|
-1.23e-01
|
3.76e-01
|
4.42e-01
|
1.90e-02
|
GOBP GLYCEROL 3 PHOSPHATE METABOLIC PROCESS
|
7
|
2.27e-01
|
7.14e-01
|
0.39500
|
-2.06e-01
|
3.37e-01
|
3.45e-01
|
1.23e-01
|
GOBP REGULATION OF MAST CELL CHEMOTAXIS
|
7
|
2.19e-01
|
7.08e-01
|
0.39500
|
-1.50e-01
|
3.65e-01
|
4.92e-01
|
9.43e-02
|
GOBP NUCLEOBASE CATABOLIC PROCESS
|
10
|
1.02e-01
|
5.72e-01
|
0.39500
|
-6.14e-02
|
3.90e-01
|
7.37e-01
|
3.27e-02
|
GOBP NEGATIVE REGULATION OF CYTOKINESIS
|
7
|
1.56e-01
|
6.43e-01
|
0.39400
|
-2.64e-01
|
-2.93e-01
|
2.27e-01
|
1.79e-01
|
GOCC SERINE TYPE PEPTIDASE COMPLEX
|
13
|
6.69e-02
|
4.98e-01
|
0.39400
|
2.71e-01
|
-2.87e-01
|
9.11e-02
|
7.34e-02
|
GOBP MELANOCYTE PROLIFERATION
|
5
|
3.50e-01
|
7.96e-01
|
0.39400
|
3.25e-01
|
-2.22e-01
|
2.08e-01
|
3.89e-01
|
GOBP POSITIVE REGULATION OF HORMONE BIOSYNTHETIC PROCESS
|
9
|
9.84e-02
|
5.65e-01
|
0.39400
|
1.59e-01
|
3.61e-01
|
4.08e-01
|
6.11e-02
|
GOBP RESPONSE TO WATER DEPRIVATION
|
5
|
3.28e-01
|
7.83e-01
|
0.39400
|
3.82e-01
|
-9.50e-02
|
1.39e-01
|
7.13e-01
|
GOCC MANNOSYLTRANSFERASE COMPLEX
|
5
|
2.67e-01
|
7.43e-01
|
0.39400
|
-2.44e-01
|
-3.09e-01
|
3.45e-01
|
2.31e-01
|
GOBP REGULATION OF LYMPHANGIOGENESIS
|
6
|
2.83e-01
|
7.56e-01
|
0.39400
|
3.38e-01
|
-2.03e-01
|
1.52e-01
|
3.90e-01
|
GOMF INTERLEUKIN 1 RECEPTOR ACTIVITY
|
6
|
2.09e-01
|
6.97e-01
|
0.39400
|
2.03e-01
|
3.37e-01
|
3.88e-01
|
1.53e-01
|
GOCC FASCIA ADHERENS
|
8
|
1.25e-01
|
6.06e-01
|
0.39300
|
3.45e-01
|
1.90e-01
|
9.13e-02
|
3.53e-01
|
GOBP 7 METHYLGUANOSINE CAP HYPERMETHYLATION
|
8
|
1.76e-01
|
6.65e-01
|
0.39300
|
1.31e-01
|
-3.71e-01
|
5.22e-01
|
6.93e-02
|
GOBP MANNOSE METABOLIC PROCESS
|
9
|
1.34e-01
|
6.16e-01
|
0.39300
|
-3.84e-01
|
8.59e-02
|
4.62e-02
|
6.55e-01
|
GOBP TOXIN METABOLIC PROCESS
|
14
|
4.35e-02
|
4.28e-01
|
0.39300
|
3.85e-01
|
-7.97e-02
|
1.26e-02
|
6.06e-01
|
GOBP POLE PLASM ASSEMBLY
|
6
|
2.83e-01
|
7.56e-01
|
0.39300
|
-1.93e-01
|
3.42e-01
|
4.12e-01
|
1.47e-01
|
GOCC TRANSCRIPTION FACTOR TFIIH HOLO COMPLEX
|
10
|
8.24e-02
|
5.34e-01
|
0.39300
|
-1.06e-01
|
-3.78e-01
|
5.60e-01
|
3.84e-02
|
GOBP UREA METABOLIC PROCESS
|
12
|
8.10e-02
|
5.31e-01
|
0.39300
|
2.05e-01
|
-3.35e-01
|
2.19e-01
|
4.44e-02
|
GOBP PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY
|
29
|
2.49e-03
|
9.67e-02
|
0.39300
|
-2.43e-01
|
3.08e-01
|
2.35e-02
|
4.04e-03
|
GOBP NEGATIVE REGULATION OF CELLULAR SENESCENCE
|
25
|
2.34e-03
|
9.23e-02
|
0.39200
|
-5.74e-02
|
-3.88e-01
|
6.19e-01
|
7.80e-04
|
GOBP CELLULAR RESPONSE TO L GLUTAMATE
|
5
|
2.90e-01
|
7.61e-01
|
0.39200
|
9.64e-02
|
3.80e-01
|
7.09e-01
|
1.41e-01
|
GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING
|
14
|
5.61e-02
|
4.65e-01
|
0.39200
|
-2.90e-01
|
2.64e-01
|
6.02e-02
|
8.72e-02
|
GOCC PROTEASOME CORE COMPLEX BETA SUBUNIT COMPLEX
|
11
|
9.76e-02
|
5.62e-01
|
0.39200
|
1.68e-01
|
-3.54e-01
|
3.34e-01
|
4.22e-02
|
GOBP SMOOTHENED SIGNALING PATHWAY INVOLVED IN VENTRAL SPINAL CORD PATTERNING
|
8
|
1.49e-01
|
6.35e-01
|
0.39200
|
3.47e-02
|
3.90e-01
|
8.65e-01
|
5.60e-02
|
GOBP NEGATIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS
|
6
|
2.79e-01
|
7.52e-01
|
0.39200
|
-3.60e-01
|
1.53e-01
|
1.26e-01
|
5.15e-01
|
GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY
|
6
|
2.17e-01
|
7.07e-01
|
0.39100
|
-3.53e-01
|
-1.68e-01
|
1.34e-01
|
4.75e-01
|
GOBP NEGATIVE REGULATION OF SKELETAL MUSCLE CELL PROLIFERATION
|
5
|
3.60e-01
|
8.01e-01
|
0.39100
|
2.86e-01
|
-2.66e-01
|
2.68e-01
|
3.02e-01
|
GOBP POSTSYNAPTIC DENSITY PROTEIN 95 CLUSTERING
|
9
|
9.96e-02
|
5.68e-01
|
0.39100
|
-1.88e-01
|
-3.42e-01
|
3.28e-01
|
7.52e-02
|
GOBP PRIMARY ALCOHOL CATABOLIC PROCESS
|
13
|
6.83e-02
|
5.00e-01
|
0.39100
|
2.16e-01
|
-3.26e-01
|
1.78e-01
|
4.19e-02
|
GOBP CAP DEPENDENT TRANSLATIONAL INITIATION
|
7
|
1.62e-01
|
6.48e-01
|
0.39000
|
-2.98e-01
|
-2.52e-01
|
1.72e-01
|
2.48e-01
|
GOMF PHOSPHATIDYLINOSITOL PHOSPHATE 5 PHOSPHATASE ACTIVITY
|
12
|
6.04e-02
|
4.78e-01
|
0.39000
|
-3.90e-01
|
-1.49e-02
|
1.93e-02
|
9.29e-01
|
GOBP PURINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS
|
6
|
2.74e-01
|
7.49e-01
|
0.39000
|
-3.72e-01
|
1.18e-01
|
1.15e-01
|
6.17e-01
|
GOBP REGULATION OF HEART RATE BY CHEMICAL SIGNAL
|
7
|
1.80e-01
|
6.70e-01
|
0.39000
|
9.85e-02
|
3.77e-01
|
6.52e-01
|
8.38e-02
|
GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY
|
5
|
3.32e-01
|
7.85e-01
|
0.39000
|
-3.83e-01
|
7.60e-02
|
1.39e-01
|
7.69e-01
|
GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE
|
9
|
1.60e-01
|
6.48e-01
|
0.39000
|
2.49e-01
|
-3.00e-01
|
1.96e-01
|
1.19e-01
|
GOBP NEGATIVE REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS
|
6
|
2.49e-01
|
7.27e-01
|
0.39000
|
3.90e-01
|
8.79e-04
|
9.81e-02
|
9.97e-01
|
GOCC NASCENT POLYPEPTIDE ASSOCIATED COMPLEX
|
5
|
3.62e-01
|
8.03e-01
|
0.39000
|
2.89e-01
|
-2.62e-01
|
2.64e-01
|
3.10e-01
|
GOBP MESANGIAL CELL DEVELOPMENT
|
6
|
2.61e-01
|
7.39e-01
|
0.39000
|
-3.86e-01
|
5.29e-02
|
1.01e-01
|
8.22e-01
|
GOBP POSITIVE REGULATION OF NECROPTOTIC PROCESS
|
7
|
1.78e-01
|
6.67e-01
|
0.38900
|
1.15e-01
|
3.72e-01
|
6.00e-01
|
8.81e-02
|
GOBP HISTONE H4 ACETYLATION
|
11
|
6.97e-02
|
5.03e-01
|
0.38900
|
-3.81e-01
|
-8.14e-02
|
2.87e-02
|
6.40e-01
|
GOBP ADP BIOSYNTHETIC PROCESS
|
5
|
3.15e-01
|
7.76e-01
|
0.38900
|
-3.89e-01
|
-3.53e-03
|
1.32e-01
|
9.89e-01
|
GOBP EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS
|
10
|
1.30e-01
|
6.09e-01
|
0.38900
|
-2.22e-01
|
3.20e-01
|
2.24e-01
|
7.99e-02
|
GOBP RESPONSE TO ISOQUINOLINE ALKALOID
|
11
|
5.97e-02
|
4.77e-01
|
0.38900
|
3.17e-01
|
2.25e-01
|
6.85e-02
|
1.97e-01
|
GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS ENZYMATIC MODIFICATION
|
11
|
1.04e-01
|
5.75e-01
|
0.38900
|
-3.37e-01
|
1.94e-01
|
5.31e-02
|
2.65e-01
|
GOMF DOUBLE STRANDED TELOMERIC DNA BINDING
|
9
|
1.61e-01
|
6.48e-01
|
0.38900
|
2.39e-01
|
-3.07e-01
|
2.15e-01
|
1.11e-01
|
GOBP REGULATION OF HISTONE H3 K4 METHYLATION
|
11
|
9.38e-02
|
5.56e-01
|
0.38800
|
-3.74e-01
|
1.05e-01
|
3.17e-02
|
5.47e-01
|
GOBP POST FERTILIZATION EPIGENETIC REGULATION OF GENE EXPRESSION
|
13
|
5.20e-02
|
4.49e-01
|
0.38800
|
-3.88e-01
|
1.33e-02
|
1.54e-02
|
9.34e-01
|
GOBP COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY
|
8
|
1.30e-01
|
6.09e-01
|
0.38800
|
3.19e-01
|
2.22e-01
|
1.19e-01
|
2.78e-01
|
GOCC NADPH OXIDASE COMPLEX
|
13
|
5.12e-02
|
4.47e-01
|
0.38800
|
-2.20e-03
|
3.88e-01
|
9.89e-01
|
1.54e-02
|
GOBP MELANOSOME ASSEMBLY
|
18
|
2.37e-02
|
3.26e-01
|
0.38800
|
-3.53e-01
|
1.62e-01
|
9.59e-03
|
2.35e-01
|
GOBP NEGATIVE REGULATION OF LENS FIBER CELL DIFFERENTIATION
|
6
|
2.22e-01
|
7.11e-01
|
0.38800
|
1.71e-01
|
3.48e-01
|
4.68e-01
|
1.40e-01
|
GOBP REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE
|
28
|
3.52e-03
|
1.21e-01
|
0.38800
|
-2.41e-01
|
3.04e-01
|
2.75e-02
|
5.36e-03
|
GOBP REGULATION OF RECEPTOR CLUSTERING
|
13
|
7.24e-02
|
5.13e-01
|
0.38800
|
-3.09e-01
|
2.33e-01
|
5.34e-02
|
1.45e-01
|
GOMF DENEDDYLASE ACTIVITY
|
6
|
2.28e-01
|
7.15e-01
|
0.38800
|
-1.34e-01
|
-3.64e-01
|
5.71e-01
|
1.23e-01
|
GOBP XENOPHAGY
|
14
|
3.48e-02
|
3.81e-01
|
0.38700
|
-3.78e-01
|
-8.46e-02
|
1.44e-02
|
5.84e-01
|
GOBP CELLULAR GLUCURONIDATION
|
19
|
1.52e-02
|
2.62e-01
|
0.38700
|
3.83e-01
|
-5.28e-02
|
3.80e-03
|
6.90e-01
|
GOBP RESPONSE TO FRUCTOSE
|
8
|
1.48e-01
|
6.35e-01
|
0.38700
|
-3.79e-01
|
-7.66e-02
|
6.32e-02
|
7.08e-01
|
GOMF FRUCTOSE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
9
|
1.45e-01
|
6.29e-01
|
0.38700
|
-3.75e-01
|
9.49e-02
|
5.13e-02
|
6.22e-01
|
GOBP NEGATIVE REGULATION OF GLUCOCORTICOID METABOLIC PROCESS
|
5
|
3.51e-01
|
7.96e-01
|
0.38700
|
3.62e-01
|
-1.37e-01
|
1.61e-01
|
5.94e-01
|
GOMF LNCRNA BINDING
|
18
|
1.06e-02
|
2.20e-01
|
0.38700
|
-2.07e-01
|
-3.27e-01
|
1.28e-01
|
1.64e-02
|
GOCC POSTSYNAPTIC RECYCLING ENDOSOME
|
7
|
2.17e-01
|
7.07e-01
|
0.38700
|
-3.81e-01
|
6.78e-02
|
8.11e-02
|
7.56e-01
|
GOBP POSITIVE REGULATION OF AMINE METABOLIC PROCESS
|
6
|
2.66e-01
|
7.42e-01
|
0.38700
|
3.84e-01
|
-4.83e-02
|
1.04e-01
|
8.38e-01
|
GOMF CYTOCHROME B5 REDUCTASE ACTIVITY ACTING ON NAD P H
|
6
|
2.17e-01
|
7.07e-01
|
0.38600
|
-2.75e-01
|
-2.71e-01
|
2.43e-01
|
2.50e-01
|
GOBP REGULATION OF LIPID TRANSPORTER ACTIVITY
|
6
|
2.18e-01
|
7.07e-01
|
0.38600
|
-2.95e-01
|
-2.49e-01
|
2.11e-01
|
2.90e-01
|
GOCC SERINE PROTEASE INHIBITOR COMPLEX
|
6
|
2.47e-01
|
7.26e-01
|
0.38600
|
-3.83e-01
|
-4.50e-02
|
1.04e-01
|
8.49e-01
|
GOMF THIOREDOXIN DISULFIDE REDUCTASE NADP ACTIVITY
|
7
|
1.88e-01
|
6.80e-01
|
0.38600
|
-3.75e-01
|
-9.04e-02
|
8.59e-02
|
6.79e-01
|
GOBP REGULATION OF MITOTIC CENTROSOME SEPARATION
|
9
|
1.05e-01
|
5.77e-01
|
0.38500
|
-3.31e-01
|
-1.97e-01
|
8.51e-02
|
3.07e-01
|
GOMF FERROUS IRON TRANSMEMBRANE TRANSPORTER ACTIVITY
|
5
|
3.50e-01
|
7.96e-01
|
0.38500
|
-3.66e-01
|
1.20e-01
|
1.56e-01
|
6.41e-01
|
GOBP C 5 METHYLATION OF CYTOSINE
|
5
|
3.08e-01
|
7.72e-01
|
0.38500
|
-3.78e-01
|
-7.19e-02
|
1.43e-01
|
7.81e-01
|
GOMF VASOPRESSIN RECEPTOR ACTIVITY
|
6
|
2.97e-01
|
7.66e-01
|
0.38500
|
1.87e-01
|
-3.37e-01
|
4.28e-01
|
1.53e-01
|
GOBP PROTEIN DENEDDYLATION
|
11
|
6.52e-02
|
4.93e-01
|
0.38500
|
-3.40e-01
|
-1.80e-01
|
5.06e-02
|
3.01e-01
|
GOBP SUCCINYL COA CATABOLIC PROCESS
|
6
|
3.01e-01
|
7.67e-01
|
0.38500
|
2.17e-01
|
-3.18e-01
|
3.56e-01
|
1.78e-01
|
GOBP FOREBRAIN RADIAL GLIAL CELL DIFFERENTIATION
|
7
|
1.92e-01
|
6.85e-01
|
0.38500
|
3.78e-01
|
7.16e-02
|
8.31e-02
|
7.43e-01
|
GOCC SMN COMPLEX
|
9
|
1.61e-01
|
6.48e-01
|
0.38500
|
1.79e-01
|
-3.41e-01
|
3.54e-01
|
7.65e-02
|
GOBP CYTOPLASMIC SEQUESTERING OF NF KAPPAB
|
5
|
3.54e-01
|
7.97e-01
|
0.38500
|
1.34e-01
|
-3.61e-01
|
6.03e-01
|
1.63e-01
|
GOBP SKELETAL MUSCLE SATELLITE CELL ACTIVATION
|
8
|
1.64e-01
|
6.49e-01
|
0.38500
|
-2.49e-03
|
-3.85e-01
|
9.90e-01
|
5.95e-02
|
GOBP TETRAHYDROFOLATE BIOSYNTHETIC PROCESS
|
5
|
3.11e-01
|
7.75e-01
|
0.38500
|
-5.82e-02
|
-3.80e-01
|
8.22e-01
|
1.41e-01
|
GOBP REGULATION OF NK T CELL DIFFERENTIATION
|
6
|
3.04e-01
|
7.68e-01
|
0.38500
|
-3.01e-01
|
2.39e-01
|
2.01e-01
|
3.11e-01
|
GOCC TRAMP COMPLEX
|
5
|
3.67e-01
|
8.07e-01
|
0.38400
|
-2.06e-01
|
3.25e-01
|
4.26e-01
|
2.09e-01
|
GOCC SEH1 ASSOCIATED COMPLEX
|
8
|
1.35e-01
|
6.16e-01
|
0.38400
|
-3.11e-01
|
-2.26e-01
|
1.28e-01
|
2.69e-01
|
GOBP PROTEIN LOCALIZATION TO NUCLEAR BODY
|
11
|
1.12e-01
|
5.91e-01
|
0.38400
|
2.27e-01
|
-3.10e-01
|
1.93e-01
|
7.47e-02
|
GOBP REGULATION OF LIGASE ACTIVITY
|
7
|
1.89e-01
|
6.82e-01
|
0.38400
|
-9.94e-02
|
-3.71e-01
|
6.49e-01
|
8.92e-02
|
GOMF PHOSPHATIDYLETHANOLAMINE FLIPPASE ACTIVITY
|
5
|
3.51e-01
|
7.96e-01
|
0.38400
|
-1.09e-01
|
3.68e-01
|
6.72e-01
|
1.54e-01
|
GOMF AROMATASE ACTIVITY
|
26
|
5.34e-03
|
1.52e-01
|
0.38400
|
3.37e-01
|
-1.85e-01
|
2.97e-03
|
1.03e-01
|
GOBP NEGATIVE REGULATION OF CHEMOKINE PRODUCTION
|
29
|
7.67e-04
|
4.34e-02
|
0.38400
|
-3.32e-01
|
-1.92e-01
|
1.95e-03
|
7.39e-02
|
GOBP LYMPHOCYTE ANERGY
|
7
|
1.78e-01
|
6.67e-01
|
0.38300
|
3.34e-01
|
1.88e-01
|
1.26e-01
|
3.90e-01
|
GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO OXIDATIVE STRESS
|
8
|
2.06e-01
|
6.95e-01
|
0.38300
|
-2.37e-01
|
3.01e-01
|
2.45e-01
|
1.40e-01
|
GOMF FOLIC ACID BINDING
|
13
|
4.05e-02
|
4.13e-01
|
0.38300
|
-3.31e-01
|
-1.93e-01
|
3.87e-02
|
2.29e-01
|
GOMF RETINOIC ACID 4 HYDROXYLASE ACTIVITY
|
10
|
9.47e-02
|
5.59e-01
|
0.38300
|
3.72e-01
|
9.05e-02
|
4.15e-02
|
6.20e-01
|
GOMF HYALURONIC ACID BINDING
|
24
|
6.94e-03
|
1.74e-01
|
0.38300
|
3.65e-01
|
-1.16e-01
|
1.99e-03
|
3.25e-01
|
GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY
|
12
|
5.16e-02
|
4.48e-01
|
0.38300
|
-2.02e-01
|
-3.25e-01
|
2.25e-01
|
5.14e-02
|
GOBP LAMELLIPODIUM MORPHOGENESIS
|
18
|
1.77e-02
|
2.83e-01
|
0.38300
|
1.17e-02
|
3.82e-01
|
9.32e-01
|
4.97e-03
|
GOBP REGULATION OF RIBONUCLEASE ACTIVITY
|
9
|
1.71e-01
|
6.60e-01
|
0.38200
|
2.48e-01
|
-2.91e-01
|
1.98e-01
|
1.30e-01
|
GOCC STEREOCILIUM BASE
|
5
|
3.72e-01
|
8.09e-01
|
0.38200
|
-3.22e-01
|
2.07e-01
|
2.13e-01
|
4.23e-01
|
GOMF NEDD8 TRANSFERASE ACTIVITY
|
7
|
2.18e-01
|
7.07e-01
|
0.38200
|
-3.31e-02
|
3.81e-01
|
8.80e-01
|
8.09e-02
|
GOBP SKELETAL MUSCLE ATROPHY
|
5
|
3.73e-01
|
8.10e-01
|
0.38200
|
3.12e-01
|
-2.21e-01
|
2.27e-01
|
3.92e-01
|
GOBP PHENOL CONTAINING COMPOUND CATABOLIC PROCESS
|
7
|
1.93e-01
|
6.85e-01
|
0.38200
|
8.96e-02
|
3.72e-01
|
6.82e-01
|
8.86e-02
|
GOBP PIGMENT GRANULE MATURATION
|
10
|
1.17e-01
|
5.98e-01
|
0.38200
|
-3.78e-01
|
5.45e-02
|
3.84e-02
|
7.65e-01
|
GOMF GLUTATHIONE DISULFIDE OXIDOREDUCTASE ACTIVITY
|
5
|
3.16e-01
|
7.76e-01
|
0.38200
|
6.36e-02
|
3.76e-01
|
8.05e-01
|
1.45e-01
|
GOBP ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY
|
6
|
2.26e-01
|
7.14e-01
|
0.38200
|
2.44e-01
|
2.94e-01
|
3.01e-01
|
2.13e-01
|
GOBP NEURAL PLATE REGIONALIZATION
|
6
|
2.48e-01
|
7.26e-01
|
0.38100
|
8.47e-02
|
3.72e-01
|
7.19e-01
|
1.15e-01
|
GOBP NEGATIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS
|
8
|
2.09e-01
|
6.97e-01
|
0.38100
|
-2.17e-01
|
3.13e-01
|
2.87e-01
|
1.26e-01
|
GOBP NEGATIVE REGULATION OF ADIPOSE TISSUE DEVELOPMENT
|
5
|
3.57e-01
|
7.98e-01
|
0.38100
|
-1.07e-01
|
3.65e-01
|
6.79e-01
|
1.57e-01
|
GOMF ADENYLATE CYCLASE BINDING
|
12
|
8.03e-02
|
5.29e-01
|
0.38100
|
3.73e-01
|
-7.55e-02
|
2.52e-02
|
6.51e-01
|
GOBP REGULATION OF GUANYLATE CYCLASE ACTIVITY
|
6
|
2.83e-01
|
7.56e-01
|
0.38100
|
7.02e-02
|
-3.74e-01
|
7.66e-01
|
1.13e-01
|
GOCC DEUTEROSOME
|
6
|
3.13e-01
|
7.76e-01
|
0.38000
|
2.45e-01
|
-2.90e-01
|
2.98e-01
|
2.18e-01
|
GOBP DORSAL AORTA MORPHOGENESIS
|
8
|
1.55e-01
|
6.42e-01
|
0.38000
|
-3.66e-01
|
-1.02e-01
|
7.32e-02
|
6.17e-01
|
GOBP INTRACELLULAR TRIGLYCERIDE HOMEOSTASIS
|
7
|
1.91e-01
|
6.85e-01
|
0.38000
|
-3.56e-01
|
-1.32e-01
|
1.03e-01
|
5.44e-01
|
GOBP VESTIBULOCOCHLEAR NERVE FORMATION
|
5
|
3.51e-01
|
7.96e-01
|
0.38000
|
-7.34e-02
|
3.73e-01
|
7.76e-01
|
1.49e-01
|
GOBP GAP JUNCTION ASSEMBLY
|
16
|
4.47e-02
|
4.29e-01
|
0.38000
|
2.18e-01
|
-3.11e-01
|
1.31e-01
|
3.15e-02
|
GOBP REGULATION OF APOPTOTIC PROCESS IN BONE MARROW CELL
|
5
|
3.81e-01
|
8.16e-01
|
0.38000
|
2.48e-01
|
-2.87e-01
|
3.37e-01
|
2.66e-01
|
GOMF TUMOR NECROSIS FACTOR RECEPTOR ACTIVITY
|
8
|
2.00e-01
|
6.90e-01
|
0.38000
|
-3.53e-01
|
1.38e-01
|
8.34e-02
|
4.98e-01
|
GOMF S ACYLTRANSFERASE ACTIVITY
|
27
|
5.16e-03
|
1.49e-01
|
0.38000
|
-2.02e-01
|
3.21e-01
|
6.89e-02
|
3.87e-03
|
GOMF PHOSPHATIDYLINOSITOL 3 KINASE REGULATORY SUBUNIT BINDING
|
10
|
1.44e-01
|
6.28e-01
|
0.37900
|
-2.22e-01
|
3.08e-01
|
2.24e-01
|
9.22e-02
|
GOCC IMMUNOLOGICAL SYNAPSE
|
45
|
2.65e-05
|
3.52e-03
|
0.37900
|
1.20e-01
|
3.59e-01
|
1.62e-01
|
3.03e-05
|
GOBP NODAL SIGNALING PATHWAY
|
15
|
2.75e-02
|
3.45e-01
|
0.37900
|
1.70e-01
|
3.39e-01
|
2.55e-01
|
2.31e-02
|
GOCC GLYCOSYLPHOSPHATIDYLINOSITOL N ACETYLGLUCOSAMINYLTRANSFERASE GPI GNT COMPLEX
|
6
|
2.58e-01
|
7.35e-01
|
0.37900
|
-3.75e-01
|
-5.45e-02
|
1.12e-01
|
8.17e-01
|
GOCC ANKYRIN 1 COMPLEX
|
7
|
2.56e-01
|
7.35e-01
|
0.37900
|
1.96e-01
|
-3.24e-01
|
3.68e-01
|
1.38e-01
|
GOBP SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION
|
12
|
9.81e-02
|
5.63e-01
|
0.37800
|
2.09e-01
|
-3.15e-01
|
2.09e-01
|
5.87e-02
|
GOBP INTRACELLULAR AMINO ACID HOMEOSTASIS
|
8
|
1.86e-01
|
6.78e-01
|
0.37800
|
-5.57e-02
|
3.74e-01
|
7.85e-01
|
6.69e-02
|
GOBP POSITIVE REGULATION OF 3 UTR MEDIATED MRNA STABILIZATION
|
5
|
3.82e-01
|
8.16e-01
|
0.37800
|
-3.05e-01
|
2.23e-01
|
2.37e-01
|
3.88e-01
|
GOMF FATTY ACID OMEGA HYDROXYLASE ACTIVITY
|
7
|
2.60e-01
|
7.38e-01
|
0.37800
|
3.04e-01
|
-2.25e-01
|
1.64e-01
|
3.03e-01
|
GOBP POSITIVE REGULATION OF NATURAL KILLER CELL DIFFERENTIATION
|
7
|
2.04e-01
|
6.94e-01
|
0.37800
|
3.71e-01
|
7.22e-02
|
8.91e-02
|
7.41e-01
|
GOCC TOR COMPLEX
|
11
|
1.20e-01
|
6.00e-01
|
0.37700
|
-3.19e-01
|
2.02e-01
|
6.70e-02
|
2.46e-01
|
GOBP CELL CELL ADHESION INVOLVED IN GASTRULATION
|
11
|
1.02e-01
|
5.72e-01
|
0.37700
|
-3.72e-01
|
6.62e-02
|
3.28e-02
|
7.04e-01
|
GOBP TRNA 5 LEADER REMOVAL
|
13
|
7.76e-02
|
5.24e-01
|
0.37700
|
3.42e-01
|
-1.59e-01
|
3.26e-02
|
3.20e-01
|
GOBP ERK5 CASCADE
|
5
|
3.05e-01
|
7.69e-01
|
0.37700
|
3.36e-01
|
1.71e-01
|
1.93e-01
|
5.08e-01
|
GOBP CELLULAR RESPONSE TO EPINEPHRINE STIMULUS
|
11
|
9.25e-02
|
5.54e-01
|
0.37700
|
-3.77e-01
|
-5.04e-04
|
3.03e-02
|
9.98e-01
|
GOBP CELL SUBSTRATE JUNCTION DISASSEMBLY
|
8
|
2.17e-01
|
7.07e-01
|
0.37700
|
-2.97e-01
|
2.32e-01
|
1.45e-01
|
2.56e-01
|
GOBP G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY
|
21
|
1.85e-02
|
2.92e-01
|
0.37700
|
-2.61e-01
|
2.72e-01
|
3.81e-02
|
3.12e-02
|
GOBP CORPUS CALLOSUM DEVELOPMENT
|
26
|
4.85e-03
|
1.44e-01
|
0.37700
|
-8.04e-02
|
3.68e-01
|
4.78e-01
|
1.16e-03
|
GOBP NEUROBLAST DIFFERENTIATION
|
8
|
1.98e-01
|
6.88e-01
|
0.37700
|
1.02e-01
|
-3.62e-01
|
6.17e-01
|
7.58e-02
|
GOMF MUTSALPHA COMPLEX BINDING
|
7
|
2.01e-01
|
6.91e-01
|
0.37700
|
-9.84e-02
|
-3.63e-01
|
6.52e-01
|
9.58e-02
|
GOMF SEQUENCE SPECIFIC MRNA BINDING
|
12
|
8.66e-02
|
5.46e-01
|
0.37600
|
8.61e-02
|
-3.66e-01
|
6.06e-01
|
2.80e-02
|
GOBP RESPONSE TO GRAM POSITIVE BACTERIUM
|
5
|
3.64e-01
|
8.05e-01
|
0.37600
|
-3.63e-01
|
9.96e-02
|
1.60e-01
|
7.00e-01
|
GOBP POSITIVE REGULATION OF INTERLEUKIN 18 PRODUCTION
|
8
|
2.11e-01
|
7.00e-01
|
0.37600
|
1.67e-01
|
-3.37e-01
|
4.13e-01
|
9.88e-02
|
GOMF VITAMIN D BINDING
|
6
|
3.19e-01
|
7.78e-01
|
0.37600
|
2.21e-01
|
-3.04e-01
|
3.49e-01
|
1.97e-01
|
GOBP REGULATION OF MATRIX METALLOPEPTIDASE SECRETION
|
10
|
9.14e-02
|
5.51e-01
|
0.37600
|
-2.10e-01
|
-3.12e-01
|
2.49e-01
|
8.80e-02
|
GOMF HEXOKINASE ACTIVITY
|
5
|
3.74e-01
|
8.11e-01
|
0.37600
|
-1.41e-01
|
3.48e-01
|
5.85e-01
|
1.78e-01
|
GOBP ER TO GOLGI CERAMIDE TRANSPORT
|
5
|
3.69e-01
|
8.09e-01
|
0.37600
|
-1.16e-01
|
3.57e-01
|
6.53e-01
|
1.66e-01
|
GOBP NEGATIVE REGULATION OF RESPIRATORY BURST
|
6
|
2.40e-01
|
7.25e-01
|
0.37600
|
-1.95e-01
|
-3.21e-01
|
4.09e-01
|
1.73e-01
|
GOBP ANTIBACTERIAL PEPTIDE PRODUCTION
|
9
|
1.25e-01
|
6.06e-01
|
0.37600
|
-1.26e-01
|
-3.54e-01
|
5.11e-01
|
6.62e-02
|
GOBP MEMBRANOUS SEPTUM MORPHOGENESIS
|
8
|
1.99e-01
|
6.89e-01
|
0.37500
|
-9.57e-02
|
3.63e-01
|
6.39e-01
|
7.53e-02
|
GOCC RADIAL SPOKE
|
5
|
3.49e-01
|
7.96e-01
|
0.37500
|
3.74e-01
|
-2.83e-02
|
1.47e-01
|
9.13e-01
|
GOBP REGULATION OF PROTEIN KINASE C ACTIVITY
|
5
|
3.09e-01
|
7.72e-01
|
0.37500
|
-1.67e-01
|
-3.36e-01
|
5.18e-01
|
1.93e-01
|
GOMF POTASSIUM CHANNEL INHIBITOR ACTIVITY
|
5
|
3.64e-01
|
8.05e-01
|
0.37500
|
3.64e-01
|
-9.36e-02
|
1.59e-01
|
7.17e-01
|
GOMF HISTONE H3K9 DEMETHYLASE ACTIVITY
|
12
|
9.53e-02
|
5.61e-01
|
0.37500
|
-3.47e-01
|
1.44e-01
|
3.76e-02
|
3.88e-01
|
GOBP CELLULAR RESPONSE TO INTERFERON ALPHA
|
7
|
2.61e-01
|
7.38e-01
|
0.37500
|
3.27e-01
|
-1.84e-01
|
1.34e-01
|
4.00e-01
|
GOMF NUCLEAR LOCALIZATION SEQUENCE BINDING
|
24
|
4.33e-03
|
1.34e-01
|
0.37500
|
-9.43e-02
|
-3.63e-01
|
4.24e-01
|
2.07e-03
|
GOBP REGULATION OF STRESS GRANULE ASSEMBLY
|
8
|
2.11e-01
|
7.00e-01
|
0.37500
|
1.56e-01
|
-3.41e-01
|
4.45e-01
|
9.48e-02
|
GOMF NEUREGULIN BINDING
|
5
|
3.16e-01
|
7.76e-01
|
0.37500
|
1.29e-01
|
3.52e-01
|
6.16e-01
|
1.73e-01
|
GOCC AP 3 ADAPTOR COMPLEX
|
9
|
1.20e-01
|
6.00e-01
|
0.37500
|
-1.80e-01
|
-3.29e-01
|
3.49e-01
|
8.77e-02
|
GOBP CMP METABOLIC PROCESS
|
8
|
1.68e-01
|
6.54e-01
|
0.37500
|
-3.69e-01
|
-6.77e-02
|
7.11e-02
|
7.40e-01
|
GOBP TRNA AMINOACYLATION FOR MITOCHONDRIAL PROTEIN TRANSLATION
|
8
|
2.22e-01
|
7.11e-01
|
0.37500
|
2.93e-01
|
-2.34e-01
|
1.52e-01
|
2.52e-01
|
GOBP FERMENTATION
|
5
|
3.91e-01
|
8.21e-01
|
0.37500
|
2.44e-01
|
-2.84e-01
|
3.44e-01
|
2.72e-01
|
GOCC CYTOLYTIC GRANULE
|
13
|
5.94e-02
|
4.75e-01
|
0.37500
|
-3.74e-01
|
-2.66e-02
|
1.96e-02
|
8.68e-01
|
GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING
|
26
|
6.04e-03
|
1.62e-01
|
0.37400
|
-3.52e-01
|
1.28e-01
|
1.91e-03
|
2.57e-01
|
GOBP NEURAL PLATE ANTERIOR POSTERIOR REGIONALIZATION
|
5
|
3.38e-01
|
7.90e-01
|
0.37400
|
2.52e-02
|
3.73e-01
|
9.22e-01
|
1.48e-01
|
GOBP REGULATION OF GROWTH HORMONE RECEPTOR SIGNALING PATHWAY
|
6
|
3.10e-01
|
7.73e-01
|
0.37400
|
-3.47e-01
|
1.40e-01
|
1.41e-01
|
5.52e-01
|
GOBP ENDOCARDIAL CUSHION TO MESENCHYMAL TRANSITION
|
6
|
2.44e-01
|
7.26e-01
|
0.37400
|
-3.28e-01
|
-1.80e-01
|
1.64e-01
|
4.45e-01
|
GOMF RNA POLYMERASE III TYPE 3 PROMOTER SEQUENCE SPECIFIC DNA BINDING
|
7
|
2.10e-01
|
6.99e-01
|
0.37400
|
-3.66e-01
|
-7.55e-02
|
9.32e-02
|
7.30e-01
|
GOBP POSITIVE REGULATION OF RESPONSE TO TYPE II INTERFERON
|
6
|
2.96e-01
|
7.65e-01
|
0.37400
|
-7.36e-02
|
3.67e-01
|
7.55e-01
|
1.20e-01
|
GOBP REGULATION OF FAT CELL PROLIFERATION
|
10
|
1.35e-01
|
6.16e-01
|
0.37400
|
-3.62e-01
|
9.20e-02
|
4.72e-02
|
6.14e-01
|
GOBP 4FE 4S CLUSTER ASSEMBLY
|
5
|
3.14e-01
|
7.76e-01
|
0.37400
|
-3.43e-01
|
-1.50e-01
|
1.85e-01
|
5.62e-01
|
GOBP AUTOCRINE SIGNALING
|
7
|
2.70e-01
|
7.45e-01
|
0.37400
|
-2.81e-01
|
2.47e-01
|
1.98e-01
|
2.58e-01
|
GOBP MONOACYLGLYCEROL BIOSYNTHETIC PROCESS
|
5
|
3.93e-01
|
8.22e-01
|
0.37400
|
-2.70e-01
|
2.59e-01
|
2.96e-01
|
3.17e-01
|
GOMF PHOSPHOFRUCTOKINASE ACTIVITY
|
6
|
3.13e-01
|
7.76e-01
|
0.37400
|
-1.50e-01
|
3.42e-01
|
5.23e-01
|
1.47e-01
|
GOBP REGULATION OF LIPOPROTEIN LIPASE ACTIVITY
|
16
|
4.72e-02
|
4.38e-01
|
0.37400
|
1.79e-01
|
-3.28e-01
|
2.14e-01
|
2.32e-02
|
GOBP MAINTENANCE OF PRESYNAPTIC ACTIVE ZONE STRUCTURE
|
6
|
2.61e-01
|
7.39e-01
|
0.37400
|
8.45e-02
|
3.64e-01
|
7.20e-01
|
1.23e-01
|
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY BARORECEPTOR FEEDBACK
|
5
|
3.51e-01
|
7.96e-01
|
0.37400
|
3.73e-01
|
-2.00e-02
|
1.49e-01
|
9.38e-01
|
GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE ADAPTATION
|
8
|
2.20e-01
|
7.09e-01
|
0.37400
|
-1.99e-01
|
3.16e-01
|
3.30e-01
|
1.21e-01
|
GOMF DIACYLGLYCEROL O ACYLTRANSFERASE ACTIVITY
|
5
|
3.91e-01
|
8.21e-01
|
0.37300
|
-2.12e-01
|
3.07e-01
|
4.12e-01
|
2.34e-01
|
GOBP DOUBLE STRAND BREAK REPAIR VIA SYNTHESIS DEPENDENT STRAND ANNEALING
|
8
|
1.63e-01
|
6.48e-01
|
0.37300
|
-1.11e-01
|
-3.56e-01
|
5.88e-01
|
8.09e-02
|
GOBP DETOXIFICATION OF COPPER ION
|
15
|
4.11e-02
|
4.18e-01
|
0.37300
|
3.73e-01
|
7.46e-03
|
1.24e-02
|
9.60e-01
|
GOBP REGULATION OF LEUKOCYTE DEGRANULATION
|
41
|
4.69e-04
|
2.98e-02
|
0.37300
|
-2.99e-01
|
2.24e-01
|
9.38e-04
|
1.32e-02
|
GOBP ADENYLATE CYCLASE INHIBITING DOPAMINE RECEPTOR SIGNALING PATHWAY
|
5
|
3.07e-01
|
7.71e-01
|
0.37300
|
2.16e-01
|
3.04e-01
|
4.02e-01
|
2.39e-01
|
GOMF RNA POLYMERASE I TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING
|
8
|
2.06e-01
|
6.95e-01
|
0.37300
|
-3.57e-01
|
1.06e-01
|
8.00e-02
|
6.05e-01
|
GOBP TELOMERE MAINTENANCE VIA RECOMBINATION
|
14
|
3.65e-02
|
3.89e-01
|
0.37300
|
-2.40e-01
|
-2.85e-01
|
1.20e-01
|
6.47e-02
|
GOBP INDUCTION OF BACTERIAL AGGLUTINATION
|
6
|
2.94e-01
|
7.63e-01
|
0.37300
|
-3.69e-01
|
5.18e-02
|
1.18e-01
|
8.26e-01
|
GOMF INOSITOL TETRAKISPHOSPHATE PHOSPHATASE ACTIVITY
|
7
|
2.44e-01
|
7.26e-01
|
0.37300
|
-3.65e-01
|
7.32e-02
|
9.42e-02
|
7.37e-01
|
GOBP REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS
|
8
|
2.25e-01
|
7.13e-01
|
0.37300
|
-2.96e-01
|
2.27e-01
|
1.47e-01
|
2.67e-01
|
GOBP POSITIVE REGULATION OF SARCOMERE ORGANIZATION
|
6
|
2.60e-01
|
7.38e-01
|
0.37200
|
1.02e-01
|
3.58e-01
|
6.67e-01
|
1.28e-01
|
GOBP GLYCINE TRANSPORT
|
14
|
5.07e-02
|
4.46e-01
|
0.37200
|
3.72e-01
|
1.47e-02
|
1.59e-02
|
9.24e-01
|
GOBP TELOMERIC D LOOP DISASSEMBLY
|
7
|
2.69e-01
|
7.44e-01
|
0.37200
|
-3.13e-01
|
2.01e-01
|
1.51e-01
|
3.56e-01
|
GOMF ACETYL COA C ACYLTRANSFERASE ACTIVITY
|
7
|
1.94e-01
|
6.86e-01
|
0.37200
|
-2.04e-01
|
-3.11e-01
|
3.49e-01
|
1.54e-01
|
GOBP MAMMARY GLAND BRANCHING INVOLVED IN PREGNANCY
|
6
|
3.23e-01
|
7.79e-01
|
0.37200
|
-3.22e-01
|
1.86e-01
|
1.72e-01
|
4.29e-01
|
GOBP SYMPATHETIC NEURON PROJECTION EXTENSION
|
5
|
3.14e-01
|
7.76e-01
|
0.37200
|
3.28e-01
|
1.76e-01
|
2.04e-01
|
4.96e-01
|
GOBP THIAMINE DIPHOSPHATE METABOLIC PROCESS
|
5
|
3.33e-01
|
7.86e-01
|
0.37200
|
-7.01e-02
|
-3.65e-01
|
7.86e-01
|
1.57e-01
|
GOBP PRIMITIVE HEMOPOIESIS
|
8
|
1.57e-01
|
6.44e-01
|
0.37200
|
-1.80e-01
|
-3.25e-01
|
3.77e-01
|
1.12e-01
|
GOBP REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I
|
15
|
5.90e-02
|
4.73e-01
|
0.37200
|
-3.26e-01
|
1.79e-01
|
2.89e-02
|
2.31e-01
|
GOBP LEUCINE TRANSPORT
|
10
|
1.44e-01
|
6.28e-01
|
0.37100
|
-1.20e-01
|
3.51e-01
|
5.13e-01
|
5.44e-02
|
GOBP AMINO ACID BETAINE BIOSYNTHETIC PROCESS
|
5
|
3.48e-01
|
7.96e-01
|
0.37100
|
3.71e-01
|
1.17e-02
|
1.51e-01
|
9.64e-01
|
GOBP NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 1 SIGNALING PATHWAY
|
7
|
2.25e-01
|
7.13e-01
|
0.37100
|
-2.90e-02
|
-3.70e-01
|
8.94e-01
|
9.02e-02
|
GOMF INOSITOL TETRAKISPHOSPHATE KINASE ACTIVITY
|
5
|
3.98e-01
|
8.25e-01
|
0.37100
|
-2.38e-01
|
2.84e-01
|
3.57e-01
|
2.71e-01
|
GOBP L LYSINE TRANSPORT
|
7
|
2.40e-01
|
7.25e-01
|
0.37100
|
-3.69e-01
|
3.80e-02
|
9.12e-02
|
8.62e-01
|
GOMF L LYSINE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
7
|
2.40e-01
|
7.25e-01
|
0.37100
|
-3.69e-01
|
3.80e-02
|
9.12e-02
|
8.62e-01
|
GOBP POSITIVE REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION
|
5
|
3.17e-01
|
7.77e-01
|
0.37100
|
-1.75e-01
|
-3.27e-01
|
4.99e-01
|
2.06e-01
|
GOBP EOSINOPHIL ACTIVATION
|
8
|
1.54e-01
|
6.41e-01
|
0.37100
|
-2.31e-01
|
-2.90e-01
|
2.58e-01
|
1.56e-01
|
GOBP ENTRY OF BACTERIUM INTO HOST CELL
|
9
|
1.89e-01
|
6.81e-01
|
0.37000
|
-3.07e-01
|
2.07e-01
|
1.11e-01
|
2.82e-01
|
GOCC LAMIN FILAMENT
|
5
|
3.99e-01
|
8.25e-01
|
0.37000
|
-2.57e-01
|
2.66e-01
|
3.19e-01
|
3.02e-01
|
GOBP GLUTATHIONE CATABOLIC PROCESS
|
7
|
2.20e-01
|
7.09e-01
|
0.37000
|
-3.66e-01
|
-5.59e-02
|
9.34e-02
|
7.98e-01
|
GOCC G PROTEIN COUPLED RECEPTOR DIMERIC COMPLEX
|
7
|
2.49e-01
|
7.27e-01
|
0.37000
|
3.62e-01
|
-7.64e-02
|
9.70e-02
|
7.26e-01
|
GOBP ONCOGENE INDUCED CELL SENESCENCE
|
6
|
2.63e-01
|
7.40e-01
|
0.37000
|
-3.55e-01
|
-1.06e-01
|
1.33e-01
|
6.53e-01
|
GOBP FRUCTOSE TRANSMEMBRANE TRANSPORT
|
10
|
1.44e-01
|
6.28e-01
|
0.37000
|
-3.53e-01
|
1.11e-01
|
5.32e-02
|
5.44e-01
|
GOBP POSITIVE REGULATION OF DENDRITIC CELL CYTOKINE PRODUCTION
|
13
|
8.99e-02
|
5.51e-01
|
0.37000
|
-3.13e-01
|
1.97e-01
|
5.08e-02
|
2.18e-01
|
GOMF ALPHA ADRENERGIC RECEPTOR ACTIVITY
|
6
|
2.48e-01
|
7.26e-01
|
0.37000
|
2.84e-01
|
2.37e-01
|
2.29e-01
|
3.15e-01
|
GOBP POSITIVE REGULATION OF NEURON PROJECTION REGENERATION
|
10
|
1.57e-01
|
6.44e-01
|
0.37000
|
-1.95e-01
|
3.14e-01
|
2.84e-01
|
8.60e-02
|
GOBP CALCITONIN FAMILY RECEPTOR SIGNALING PATHWAY
|
8
|
2.19e-01
|
7.07e-01
|
0.36900
|
1.39e-01
|
-3.42e-01
|
4.95e-01
|
9.39e-02
|
GOBP REGULATION OF SARCOMERE ORGANIZATION
|
9
|
1.52e-01
|
6.41e-01
|
0.36900
|
1.05e-02
|
3.69e-01
|
9.56e-01
|
5.51e-02
|
GOBP NEGATIVE REGULATION OF SCHWANN CELL PROLIFERATION
|
8
|
2.32e-01
|
7.19e-01
|
0.36900
|
-2.62e-01
|
2.60e-01
|
2.00e-01
|
2.02e-01
|
GOBP PSEUDOPODIUM ORGANIZATION
|
15
|
3.15e-02
|
3.64e-01
|
0.36900
|
2.03e-01
|
3.08e-01
|
1.73e-01
|
3.86e-02
|
GOMF MEMBRANE INSERTASE ACTIVITY
|
16
|
4.55e-02
|
4.32e-01
|
0.36900
|
1.11e-01
|
-3.52e-01
|
4.44e-01
|
1.47e-02
|
GOMF LRR DOMAIN BINDING
|
16
|
3.46e-02
|
3.80e-01
|
0.36900
|
-3.68e-01
|
-2.18e-02
|
1.07e-02
|
8.80e-01
|
GOMF SODIUM BICARBONATE SYMPORTER ACTIVITY
|
6
|
2.89e-01
|
7.60e-01
|
0.36900
|
-1.53e-03
|
3.69e-01
|
9.95e-01
|
1.18e-01
|
GOBP EXTRACELLULAR MATRIX CONSTITUENT SECRETION
|
13
|
7.53e-02
|
5.18e-01
|
0.36900
|
-5.71e-02
|
3.64e-01
|
7.22e-01
|
2.30e-02
|
GOMF ICOSANOID BINDING
|
8
|
2.33e-01
|
7.20e-01
|
0.36800
|
-2.84e-01
|
2.35e-01
|
1.65e-01
|
2.49e-01
|
GOBP DTMP METABOLIC PROCESS
|
6
|
2.56e-01
|
7.35e-01
|
0.36800
|
-1.72e-01
|
-3.26e-01
|
4.67e-01
|
1.67e-01
|
GOCC PERINUCLEOLAR COMPARTMENT
|
5
|
3.98e-01
|
8.25e-01
|
0.36800
|
-3.14e-01
|
1.92e-01
|
2.24e-01
|
4.57e-01
|
GOMF AP 2 ADAPTOR COMPLEX BINDING
|
10
|
1.60e-01
|
6.48e-01
|
0.36800
|
-2.05e-01
|
3.06e-01
|
2.62e-01
|
9.42e-02
|
GOBP SUPPRESSION OF VIRAL RELEASE BY HOST
|
15
|
3.71e-02
|
3.92e-01
|
0.36800
|
-3.52e-01
|
-1.06e-01
|
1.82e-02
|
4.76e-01
|
GOBP EXCITATORY CHEMICAL SYNAPTIC TRANSMISSION
|
10
|
1.63e-01
|
6.48e-01
|
0.36700
|
-2.21e-01
|
2.94e-01
|
2.27e-01
|
1.08e-01
|
GOCC PWP2P CONTAINING SUBCOMPLEX OF 90S PRERIBOSOME
|
5
|
3.38e-01
|
7.90e-01
|
0.36700
|
-8.87e-02
|
-3.56e-01
|
7.31e-01
|
1.68e-01
|
GOCC LATE ENDOSOME LUMEN
|
8
|
2.32e-01
|
7.18e-01
|
0.36700
|
1.94e-01
|
-3.12e-01
|
3.43e-01
|
1.27e-01
|
GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 SIGNALING PATHWAY
|
6
|
2.61e-01
|
7.38e-01
|
0.36700
|
-1.54e-01
|
-3.33e-01
|
5.13e-01
|
1.58e-01
|
GOMF SINGLE STRANDED DNA 3 5 DNA EXONUCLEASE ACTIVITY
|
5
|
3.29e-01
|
7.84e-01
|
0.36700
|
1.39e-01
|
3.40e-01
|
5.91e-01
|
1.89e-01
|
GOMF DOUBLE STRANDED METHYLATED DNA BINDING
|
5
|
4.06e-01
|
8.26e-01
|
0.36700
|
-2.40e-01
|
2.78e-01
|
3.53e-01
|
2.82e-01
|
GOBP DNA PROTECTION
|
5
|
3.41e-01
|
7.93e-01
|
0.36700
|
-7.82e-02
|
-3.58e-01
|
7.62e-01
|
1.65e-01
|
GOCC PI BODY
|
10
|
1.28e-01
|
6.08e-01
|
0.36700
|
7.17e-03
|
3.67e-01
|
9.69e-01
|
4.47e-02
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H HEME PROTEIN AS ACCEPTOR
|
10
|
1.04e-01
|
5.75e-01
|
0.36700
|
-3.10e-01
|
-1.95e-01
|
8.95e-02
|
2.84e-01
|
GOBP REGULATION OF CELLULAR PH REDUCTION
|
7
|
2.74e-01
|
7.49e-01
|
0.36600
|
-1.62e-01
|
3.29e-01
|
4.58e-01
|
1.32e-01
|
GOBP COBALAMIN TRANSPORT
|
8
|
2.36e-01
|
7.24e-01
|
0.36600
|
-2.94e-01
|
2.18e-01
|
1.49e-01
|
2.85e-01
|
GOBP COMPARTMENT PATTERN SPECIFICATION
|
5
|
4.07e-01
|
8.26e-01
|
0.36600
|
-2.75e-01
|
2.42e-01
|
2.87e-01
|
3.49e-01
|
GOBP POSITIVE REGULATION OF PROTEIN NEDDYLATION
|
5
|
3.98e-01
|
8.25e-01
|
0.36600
|
-3.28e-01
|
1.63e-01
|
2.04e-01
|
5.27e-01
|
GOBP CELL MIGRATION INVOLVED IN METANEPHROS DEVELOPMENT
|
5
|
3.24e-01
|
7.80e-01
|
0.36600
|
-1.78e-01
|
-3.20e-01
|
4.90e-01
|
2.15e-01
|
GOBP U2 TYPE PRESPLICEOSOME ASSEMBLY
|
22
|
1.33e-02
|
2.51e-01
|
0.36600
|
5.50e-02
|
-3.62e-01
|
6.55e-01
|
3.31e-03
|
GOBP POSITIVE REGULATION OF RNA BINDING
|
5
|
3.23e-01
|
7.79e-01
|
0.36600
|
-1.96e-01
|
-3.09e-01
|
4.47e-01
|
2.32e-01
|
GOBP CELL MOTILITY INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION
|
7
|
2.70e-01
|
7.45e-01
|
0.36500
|
-3.43e-01
|
1.23e-01
|
1.16e-01
|
5.72e-01
|
GOMF TRANSFERRIN RECEPTOR BINDING
|
10
|
1.29e-01
|
6.09e-01
|
0.36500
|
1.69e-02
|
3.64e-01
|
9.26e-01
|
4.61e-02
|
GOCC IMMUNOGLOBULIN COMPLEX
|
10
|
1.04e-01
|
5.75e-01
|
0.36400
|
2.76e-01
|
2.38e-01
|
1.31e-01
|
1.92e-01
|
GOBP RIBOSOME DISASSEMBLY
|
12
|
6.78e-02
|
4.99e-01
|
0.36400
|
-1.96e-01
|
-3.07e-01
|
2.40e-01
|
6.53e-02
|
GOBP NEGATIVE REGULATION OF GLYCOGEN METABOLIC PROCESS
|
10
|
1.40e-01
|
6.23e-01
|
0.36400
|
3.49e-02
|
-3.62e-01
|
8.49e-01
|
4.73e-02
|
GOBP NEGATIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS
|
7
|
2.12e-01
|
7.01e-01
|
0.36400
|
-3.22e-01
|
-1.69e-01
|
1.40e-01
|
4.39e-01
|
GOBP NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING
|
6
|
2.94e-01
|
7.63e-01
|
0.36400
|
-3.63e-01
|
-2.37e-02
|
1.24e-01
|
9.20e-01
|
GOBP PARKIN MEDIATED STIMULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION
|
5
|
3.36e-01
|
7.88e-01
|
0.36300
|
-1.41e-01
|
-3.35e-01
|
5.86e-01
|
1.95e-01
|
GOBP IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION
|
10
|
1.12e-01
|
5.91e-01
|
0.36300
|
-3.30e-01
|
-1.52e-01
|
7.08e-02
|
4.06e-01
|
GOBP HEME TRANSPORT
|
9
|
2.02e-01
|
6.92e-01
|
0.36300
|
2.99e-01
|
-2.07e-01
|
1.21e-01
|
2.83e-01
|
GOMF MONOATOMIC CATION BICARBONATE SYMPORTER ACTIVITY
|
13
|
7.93e-02
|
5.27e-01
|
0.36300
|
-4.11e-02
|
3.61e-01
|
7.98e-01
|
2.44e-02
|
GOCC CYTOSOLIC LARGE RIBOSOMAL SUBUNIT
|
54
|
6.20e-05
|
6.54e-03
|
0.36300
|
1.73e-01
|
-3.19e-01
|
2.78e-02
|
5.11e-05
|
GOMF FERRIC IRON BINDING
|
9
|
1.61e-01
|
6.48e-01
|
0.36300
|
1.98e-02
|
3.62e-01
|
9.18e-01
|
6.00e-02
|
GOMF TYPE 1 ANGIOTENSIN RECEPTOR BINDING
|
6
|
3.00e-01
|
7.67e-01
|
0.36200
|
-3.62e-01
|
-7.03e-03
|
1.24e-01
|
9.76e-01
|
GOBP NEGATIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION
|
9
|
2.04e-01
|
6.94e-01
|
0.36100
|
1.98e-01
|
-3.02e-01
|
3.03e-01
|
1.17e-01
|
GOBP MITOCHONDRION ENDOPLASMIC RETICULUM MEMBRANE TETHERING
|
7
|
2.11e-01
|
7.00e-01
|
0.36100
|
-2.37e-01
|
-2.73e-01
|
2.77e-01
|
2.11e-01
|
GOCC VOLTAGE GATED SODIUM CHANNEL COMPLEX
|
14
|
8.13e-02
|
5.32e-01
|
0.36100
|
3.25e-01
|
-1.58e-01
|
3.55e-02
|
3.06e-01
|
GOBP MAST CELL CHEMOTAXIS
|
10
|
1.30e-01
|
6.09e-01
|
0.36100
|
4.73e-02
|
3.58e-01
|
7.96e-01
|
5.01e-02
|
GOBP MICROGLIAL CELL MIGRATION
|
8
|
2.04e-01
|
6.94e-01
|
0.36100
|
-3.61e-01
|
-3.74e-03
|
7.72e-02
|
9.85e-01
|
GOBP OOCYTE CONSTRUCTION
|
8
|
2.30e-01
|
7.18e-01
|
0.36100
|
-1.16e-01
|
3.42e-01
|
5.71e-01
|
9.41e-02
|
GOBP POSITIVE REGULATION OF POST TRANSCRIPTIONAL GENE SILENCING
|
14
|
8.73e-02
|
5.46e-01
|
0.36100
|
-2.36e-01
|
2.73e-01
|
1.27e-01
|
7.69e-02
|
GOBP POSITIVE REGULATION OF CHROMOSOME CONDENSATION
|
8
|
1.81e-01
|
6.71e-01
|
0.36100
|
-1.26e-01
|
-3.38e-01
|
5.36e-01
|
9.80e-02
|
GOCC CONDENSIN COMPLEX
|
8
|
1.81e-01
|
6.71e-01
|
0.36100
|
-1.26e-01
|
-3.38e-01
|
5.36e-01
|
9.80e-02
|
GOBP BERGMANN GLIAL CELL DIFFERENTIATION
|
11
|
1.24e-01
|
6.06e-01
|
0.36100
|
-3.55e-01
|
6.40e-02
|
4.16e-02
|
7.13e-01
|
GOMF STRUCTURAL CONSTITUENT OF PRESYNAPTIC ACTIVE ZONE
|
5
|
3.49e-01
|
7.96e-01
|
0.36100
|
9.73e-02
|
3.47e-01
|
7.06e-01
|
1.79e-01
|
GOMF ADRENERGIC RECEPTOR ACTIVITY
|
9
|
1.37e-01
|
6.20e-01
|
0.36000
|
2.30e-01
|
2.77e-01
|
2.31e-01
|
1.50e-01
|
GOBP REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE DEPOLARIZATION
|
7
|
2.18e-01
|
7.07e-01
|
0.36000
|
3.15e-01
|
1.75e-01
|
1.49e-01
|
4.24e-01
|
GOBP POSITIVE REGULATION OF MUCUS SECRETION
|
5
|
3.71e-01
|
8.09e-01
|
0.36000
|
-3.60e-01
|
-7.85e-03
|
1.63e-01
|
9.76e-01
|
GOBP VIRAL TRANSLATIONAL TERMINATION REINITIATION
|
5
|
3.31e-01
|
7.85e-01
|
0.36000
|
-2.41e-01
|
-2.68e-01
|
3.50e-01
|
3.00e-01
|
GOBP REGULATION OF SYNAPTIC VESICLE CLUSTERING
|
6
|
3.22e-01
|
7.79e-01
|
0.36000
|
-3.54e-01
|
6.37e-02
|
1.33e-01
|
7.87e-01
|
GOBP MULTI CILIATED EPITHELIAL CELL DIFFERENTIATION
|
9
|
1.98e-01
|
6.88e-01
|
0.36000
|
1.45e-01
|
-3.30e-01
|
4.51e-01
|
8.68e-02
|
GOBP CENTROSOME SEPARATION
|
15
|
3.81e-02
|
3.98e-01
|
0.35900
|
-3.06e-01
|
-1.88e-01
|
4.00e-02
|
2.07e-01
|
GOBP POSITIVE REGULATION OF PROTEIN DEUBIQUITINATION
|
5
|
4.12e-01
|
8.28e-01
|
0.35900
|
-3.22e-01
|
1.61e-01
|
2.13e-01
|
5.34e-01
|
GOMF UBIQUITIN LIGASE INHIBITOR ACTIVITY
|
8
|
2.44e-01
|
7.25e-01
|
0.35900
|
1.70e-01
|
-3.16e-01
|
4.05e-01
|
1.21e-01
|
GOBP RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE
|
15
|
4.62e-02
|
4.35e-01
|
0.35900
|
-6.73e-02
|
-3.53e-01
|
6.52e-01
|
1.80e-02
|
GOBP 5S CLASS RRNA TRANSCRIPTION BY RNA POLYMERASE III
|
6
|
2.79e-01
|
7.52e-01
|
0.35900
|
-3.31e-01
|
-1.40e-01
|
1.61e-01
|
5.54e-01
|
GOCC TRANSCRIPTION FACTOR TFIIIC COMPLEX
|
6
|
2.79e-01
|
7.52e-01
|
0.35900
|
-3.31e-01
|
-1.40e-01
|
1.61e-01
|
5.54e-01
|
GOBP REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY
|
10
|
1.29e-01
|
6.09e-01
|
0.35900
|
-3.53e-01
|
-6.62e-02
|
5.35e-02
|
7.17e-01
|
GOBP LUNG ASSOCIATED MESENCHYME DEVELOPMENT
|
8
|
2.27e-01
|
7.14e-01
|
0.35800
|
3.50e-01
|
-7.78e-02
|
8.66e-02
|
7.03e-01
|
GOBP NEGATIVE REGULATION OF GRANULOCYTE DIFFERENTIATION
|
8
|
2.43e-01
|
7.25e-01
|
0.35800
|
-3.23e-01
|
1.55e-01
|
1.14e-01
|
4.48e-01
|
GOBP CELLULAR RESPONSE TO LAMINAR FLUID SHEAR STRESS
|
8
|
2.41e-01
|
7.25e-01
|
0.35800
|
-1.44e-01
|
3.28e-01
|
4.80e-01
|
1.08e-01
|
GOMF ARGININE BINDING
|
8
|
2.53e-01
|
7.32e-01
|
0.35800
|
2.71e-01
|
-2.34e-01
|
1.84e-01
|
2.52e-01
|
GOBP MITOCHONDRIAL ATP TRANSMEMBRANE TRANSPORT
|
6
|
3.56e-01
|
7.98e-01
|
0.35800
|
-2.83e-01
|
2.19e-01
|
2.30e-01
|
3.52e-01
|
GOBP POSITIVE REGULATION OF RESPONSE TO TUMOR CELL
|
15
|
7.25e-02
|
5.13e-01
|
0.35800
|
3.14e-01
|
-1.71e-01
|
3.51e-02
|
2.51e-01
|
GOMF ALKANESULFONATE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
5
|
3.71e-01
|
8.09e-01
|
0.35800
|
3.57e-01
|
2.82e-02
|
1.67e-01
|
9.13e-01
|
GOBP CELLULAR RESPONSE TO STEROL DEPLETION
|
16
|
4.88e-02
|
4.41e-01
|
0.35800
|
-3.55e-01
|
4.39e-02
|
1.40e-02
|
7.61e-01
|
GOBP REGULATION OF HISTONE DEACETYLATION
|
5
|
4.25e-01
|
8.36e-01
|
0.35700
|
2.49e-01
|
-2.57e-01
|
3.36e-01
|
3.20e-01
|
GOMF PIRNA BINDING
|
5
|
3.59e-01
|
8.01e-01
|
0.35700
|
-3.48e-01
|
-8.02e-02
|
1.77e-01
|
7.56e-01
|
GOBP POSITIVE REGULATION OF TRANSLATION IN RESPONSE TO STRESS
|
6
|
3.08e-01
|
7.72e-01
|
0.35700
|
-3.57e-01
|
-1.57e-02
|
1.30e-01
|
9.47e-01
|
GOBP REGULATION OF ARTERY MORPHOGENESIS
|
11
|
1.52e-01
|
6.39e-01
|
0.35700
|
-2.79e-01
|
2.23e-01
|
1.09e-01
|
2.01e-01
|
GOBP MITOCHONDRIAL RNA CATABOLIC PROCESS
|
6
|
2.80e-01
|
7.53e-01
|
0.35700
|
-1.50e-01
|
-3.24e-01
|
5.25e-01
|
1.69e-01
|
GOBP TRYPTOPHAN CATABOLIC PROCESS TO KYNURENINE
|
5
|
3.89e-01
|
8.20e-01
|
0.35700
|
3.55e-01
|
-4.02e-02
|
1.69e-01
|
8.76e-01
|
GOBP MONOACYLGLYCEROL METABOLIC PROCESS
|
12
|
1.27e-01
|
6.07e-01
|
0.35700
|
-2.03e-01
|
2.93e-01
|
2.23e-01
|
7.86e-02
|
GOCC CONTRACTILE RING
|
10
|
1.77e-01
|
6.67e-01
|
0.35700
|
-3.10e-01
|
1.77e-01
|
9.00e-02
|
3.32e-01
|
GOBP NEGATIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN
|
9
|
1.62e-01
|
6.48e-01
|
0.35700
|
6.88e-02
|
3.50e-01
|
7.21e-01
|
6.90e-02
|
GOBP AUTOPHAGOSOME LYSOSOME FUSION
|
9
|
2.16e-01
|
7.07e-01
|
0.35700
|
-2.41e-01
|
2.63e-01
|
2.11e-01
|
1.71e-01
|
GOCC APICAL CORTEX
|
8
|
1.86e-01
|
6.77e-01
|
0.35600
|
3.26e-01
|
1.43e-01
|
1.10e-01
|
4.83e-01
|
GOBP POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY
|
7
|
2.23e-01
|
7.12e-01
|
0.35600
|
-1.91e-01
|
-3.01e-01
|
3.81e-01
|
1.68e-01
|
GOBP POSITIVE REGULATION OF TRANSMISSION OF NERVE IMPULSE
|
7
|
2.20e-01
|
7.09e-01
|
0.35600
|
-2.55e-01
|
-2.49e-01
|
2.43e-01
|
2.54e-01
|
GOBP REGULATION OF NEUTROPHIL EXTRAVASATION
|
5
|
3.58e-01
|
8.00e-01
|
0.35600
|
-3.43e-01
|
-9.74e-02
|
1.85e-01
|
7.06e-01
|
GOBP REGULATION OF ENDOTHELIAL TUBE MORPHOGENESIS
|
6
|
2.79e-01
|
7.52e-01
|
0.35600
|
3.13e-01
|
1.70e-01
|
1.84e-01
|
4.72e-01
|
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE
|
6
|
3.46e-01
|
7.96e-01
|
0.35600
|
-3.30e-01
|
1.33e-01
|
1.61e-01
|
5.73e-01
|
GOMF INOSITOL PHOSPHATE PHOSPHATASE ACTIVITY
|
17
|
4.96e-02
|
4.42e-01
|
0.35600
|
-3.30e-01
|
1.33e-01
|
1.84e-02
|
3.43e-01
|
GOBP LEUKOTRIENE D4 METABOLIC PROCESS
|
8
|
2.37e-01
|
7.24e-01
|
0.35600
|
-3.41e-01
|
1.01e-01
|
9.47e-02
|
6.20e-01
|
GOBP GAMMA DELTA T CELL ACTIVATION
|
23
|
7.05e-03
|
1.76e-01
|
0.35600
|
2.26e-01
|
2.75e-01
|
6.07e-02
|
2.25e-02
|
GOBP PROTEIN LOCALIZATION TO SITE OF DOUBLE STRAND BREAK
|
6
|
3.39e-01
|
7.91e-01
|
0.35500
|
9.56e-02
|
-3.42e-01
|
6.85e-01
|
1.46e-01
|
GOMF PHOSPHATIDYLINOSITOL PHOSPHATE 4 PHOSPHATASE ACTIVITY
|
8
|
2.27e-01
|
7.15e-01
|
0.35500
|
-3.51e-01
|
5.47e-02
|
8.54e-02
|
7.89e-01
|
GOBP REGULATION OF MALE GONAD DEVELOPMENT
|
8
|
2.08e-01
|
6.97e-01
|
0.35500
|
3.42e-02
|
3.53e-01
|
8.67e-01
|
8.34e-02
|
GOBP VACUOLE FUSION
|
12
|
1.20e-01
|
6.00e-01
|
0.35500
|
-3.34e-01
|
1.19e-01
|
4.50e-02
|
4.74e-01
|
GOBP BUNDLE OF HIS CELL TO PURKINJE MYOCYTE SIGNALING
|
7
|
2.75e-01
|
7.49e-01
|
0.35500
|
3.51e-01
|
-5.57e-02
|
1.08e-01
|
7.99e-01
|
GOMF GANGLIOSIDE BINDING
|
5
|
3.98e-01
|
8.25e-01
|
0.35500
|
-5.94e-02
|
3.50e-01
|
8.18e-01
|
1.75e-01
|
GOBP DITERPENOID BIOSYNTHETIC PROCESS
|
10
|
1.83e-01
|
6.73e-01
|
0.35500
|
2.07e-01
|
-2.88e-01
|
2.56e-01
|
1.15e-01
|
GOMF COBALAMIN BINDING
|
9
|
1.98e-01
|
6.88e-01
|
0.35500
|
-3.43e-01
|
9.06e-02
|
7.47e-02
|
6.38e-01
|
GOBP POSITIVE REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION
|
7
|
2.28e-01
|
7.15e-01
|
0.35500
|
1.76e-01
|
3.08e-01
|
4.21e-01
|
1.58e-01
|
GOMF I SMAD BINDING
|
16
|
6.72e-02
|
4.98e-01
|
0.35500
|
-2.23e-01
|
2.76e-01
|
1.23e-01
|
5.60e-02
|
GOBP GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT
|
10
|
1.62e-01
|
6.48e-01
|
0.35500
|
-3.47e-01
|
7.14e-02
|
5.71e-02
|
6.96e-01
|
GOMF 2 ACYLGLYCEROL 3 PHOSPHATE O ACYLTRANSFERASE ACTIVITY
|
9
|
2.20e-01
|
7.09e-01
|
0.35400
|
-2.67e-01
|
2.33e-01
|
1.66e-01
|
2.26e-01
|
GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS
|
14
|
9.03e-02
|
5.51e-01
|
0.35400
|
1.66e-01
|
-3.13e-01
|
2.82e-01
|
4.27e-02
|
GOMF TESTOSTERONE DEHYDROGENASE NADPLUS ACTIVITY
|
7
|
2.58e-01
|
7.35e-01
|
0.35400
|
-1.91e-02
|
-3.54e-01
|
9.30e-01
|
1.05e-01
|
GOMF PRE MRNA 5 SPLICE SITE BINDING
|
6
|
3.64e-01
|
8.05e-01
|
0.35400
|
2.76e-01
|
-2.21e-01
|
2.41e-01
|
3.48e-01
|
GOBP CELLULAR RESPONSE TO UV A
|
10
|
1.47e-01
|
6.34e-01
|
0.35400
|
3.54e-01
|
8.81e-03
|
5.27e-02
|
9.62e-01
|
GOBP MONOACYLGLYCEROL CATABOLIC PROCESS
|
7
|
2.99e-01
|
7.67e-01
|
0.35400
|
-1.55e-01
|
3.18e-01
|
4.76e-01
|
1.45e-01
|
GOBP OUTER MITOCHONDRIAL MEMBRANE ORGANIZATION
|
15
|
6.99e-02
|
5.03e-01
|
0.35400
|
1.03e-01
|
-3.38e-01
|
4.88e-01
|
2.33e-02
|
GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY
|
14
|
9.47e-02
|
5.59e-01
|
0.35400
|
2.88e-01
|
-2.05e-01
|
6.19e-02
|
1.85e-01
|
GOBP PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE
|
15
|
7.58e-02
|
5.19e-01
|
0.35300
|
-3.18e-01
|
1.54e-01
|
3.30e-02
|
3.01e-01
|
GOBP AUTOPHAGOSOME MEMBRANE DOCKING
|
7
|
2.31e-01
|
7.18e-01
|
0.35300
|
-1.67e-01
|
-3.12e-01
|
4.45e-01
|
1.53e-01
|
GOBP REGULATION OF ACROSOME REACTION
|
17
|
4.88e-02
|
4.41e-01
|
0.35300
|
9.81e-02
|
-3.39e-01
|
4.84e-01
|
1.54e-02
|
GOBP TOXIN TRANSPORT
|
11
|
9.64e-02
|
5.61e-01
|
0.35300
|
2.54e-01
|
2.45e-01
|
1.45e-01
|
1.59e-01
|
GOBP NEGATIVE REGULATION OF HAIR FOLLICLE DEVELOPMENT
|
5
|
3.63e-01
|
8.05e-01
|
0.35300
|
1.03e-01
|
3.38e-01
|
6.90e-01
|
1.91e-01
|
GOBP VITAMIN D3 METABOLIC PROCESS
|
6
|
3.67e-01
|
8.07e-01
|
0.35300
|
2.76e-01
|
-2.20e-01
|
2.41e-01
|
3.51e-01
|
GOBP PARAXIAL MESODERM FORMATION
|
7
|
2.38e-01
|
7.25e-01
|
0.35300
|
3.29e-01
|
1.28e-01
|
1.32e-01
|
5.57e-01
|
GOBP SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING
|
10
|
1.54e-01
|
6.41e-01
|
0.35300
|
-3.52e-01
|
1.36e-02
|
5.37e-02
|
9.41e-01
|
GOBP NEGATIVE REGULATION OF KERATINOCYTE DIFFERENTIATION
|
9
|
1.48e-01
|
6.35e-01
|
0.35300
|
-2.52e-01
|
-2.46e-01
|
1.90e-01
|
2.01e-01
|
GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE SIGNAL SEQUENCE RECOGNITION
|
6
|
3.41e-01
|
7.93e-01
|
0.35300
|
3.43e-01
|
-7.96e-02
|
1.45e-01
|
7.36e-01
|
GOBP REGULATION OF MITOCHONDRIAL ATP SYNTHESIS COUPLED ELECTRON TRANSPORT
|
7
|
3.07e-01
|
7.71e-01
|
0.35200
|
1.82e-01
|
-3.01e-01
|
4.04e-01
|
1.67e-01
|
GOBP POSITIVE REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS
|
9
|
2.13e-01
|
7.02e-01
|
0.35200
|
-1.40e-01
|
3.23e-01
|
4.66e-01
|
9.34e-02
|
GOBP ATRIAL CARDIAC MUSCLE TISSUE MORPHOGENESIS
|
6
|
3.03e-01
|
7.68e-01
|
0.35200
|
8.17e-02
|
3.42e-01
|
7.29e-01
|
1.46e-01
|
GOBP SIGNAL COMPLEX ASSEMBLY
|
8
|
2.38e-01
|
7.25e-01
|
0.35200
|
-6.97e-02
|
3.45e-01
|
7.33e-01
|
9.11e-02
|
GOMF ACTIVIN BINDING
|
11
|
1.62e-01
|
6.48e-01
|
0.35200
|
-2.34e-01
|
2.63e-01
|
1.80e-01
|
1.31e-01
|
GOBP CHROMOSOME MOVEMENT TOWARDS SPINDLE POLE
|
7
|
2.62e-01
|
7.39e-01
|
0.35200
|
-2.42e-02
|
-3.51e-01
|
9.12e-01
|
1.08e-01
|
GOBP POSITIVE REGULATION OF GAMMA DELTA T CELL DIFFERENTIATION
|
7
|
2.34e-01
|
7.22e-01
|
0.35200
|
1.67e-01
|
3.10e-01
|
4.45e-01
|
1.56e-01
|
GOBP REGULATION OF SUPEROXIDE ANION GENERATION
|
19
|
3.42e-02
|
3.78e-01
|
0.35200
|
-3.42e-01
|
8.41e-02
|
9.95e-03
|
5.25e-01
|
GOCC NUCLEAR STRESS GRANULE
|
6
|
3.29e-01
|
7.83e-01
|
0.35200
|
2.13e-02
|
-3.51e-01
|
9.28e-01
|
1.36e-01
|
GOBP OLFACTORY NERVE DEVELOPMENT
|
6
|
3.46e-01
|
7.96e-01
|
0.35200
|
-9.03e-02
|
3.40e-01
|
7.02e-01
|
1.49e-01
|
GOMF RIBONUCLEASE P ACTIVITY
|
12
|
1.30e-01
|
6.09e-01
|
0.35200
|
3.14e-01
|
-1.58e-01
|
5.94e-02
|
3.44e-01
|
GOCC EUKARYOTIC 48S PREINITIATION COMPLEX
|
14
|
6.80e-02
|
5.00e-01
|
0.35200
|
-3.02e-02
|
-3.50e-01
|
8.45e-01
|
2.32e-02
|
GOMF G QUADRUPLEX RNA BINDING
|
5
|
3.56e-01
|
7.98e-01
|
0.35200
|
-3.13e-01
|
-1.59e-01
|
2.25e-01
|
5.37e-01
|
GOBP POSITIVE REGULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION
|
8
|
2.03e-01
|
6.93e-01
|
0.35100
|
-9.13e-02
|
-3.39e-01
|
6.55e-01
|
9.65e-02
|
GOMF UBIQUITIN LIKE PROTEIN SPECIFIC ENDOPEPTIDASE ACTIVITY
|
5
|
3.79e-01
|
8.14e-01
|
0.35100
|
-4.95e-02
|
-3.48e-01
|
8.48e-01
|
1.78e-01
|
GOMF FLAP ENDONUCLEASE ACTIVITY
|
6
|
3.68e-01
|
8.08e-01
|
0.35100
|
2.04e-01
|
-2.86e-01
|
3.86e-01
|
2.25e-01
|
GOBP PEPTIDYL LYSINE MONOMETHYLATION
|
9
|
2.18e-01
|
7.07e-01
|
0.35100
|
-3.11e-01
|
1.64e-01
|
1.06e-01
|
3.94e-01
|
GOCC PARANODAL JUNCTION
|
8
|
2.08e-01
|
6.97e-01
|
0.35100
|
3.45e-01
|
6.77e-02
|
9.14e-02
|
7.40e-01
|
GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS
|
5
|
3.60e-01
|
8.03e-01
|
0.35100
|
-1.39e-01
|
-3.23e-01
|
5.91e-01
|
2.12e-01
|
GOBP NEGATIVE REGULATION OF CELL MATURATION
|
8
|
2.12e-01
|
7.00e-01
|
0.35100
|
-3.46e-01
|
-5.50e-02
|
8.98e-02
|
7.88e-01
|
GOMF SUMO LIGASE ACTIVITY
|
13
|
1.14e-01
|
5.91e-01
|
0.35100
|
-1.78e-01
|
3.02e-01
|
2.67e-01
|
5.92e-02
|
GOBP ACINAR CELL DIFFERENTIATION
|
5
|
3.95e-01
|
8.24e-01
|
0.35100
|
-8.22e-03
|
3.51e-01
|
9.75e-01
|
1.75e-01
|
GOMF PHOSPHOLIPASE D ACTIVITY
|
6
|
3.06e-01
|
7.70e-01
|
0.35100
|
-3.40e-01
|
-8.47e-02
|
1.49e-01
|
7.19e-01
|
GOMF TUMOR NECROSIS FACTOR BINDING
|
7
|
2.85e-01
|
7.57e-01
|
0.35000
|
-5.85e-02
|
3.46e-01
|
7.89e-01
|
1.13e-01
|
GOCC BBAF COMPLEX
|
10
|
1.93e-01
|
6.85e-01
|
0.35000
|
-2.41e-01
|
2.54e-01
|
1.86e-01
|
1.64e-01
|
GOBP NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY
|
24
|
1.50e-02
|
2.62e-01
|
0.35000
|
-9.51e-02
|
3.37e-01
|
4.20e-01
|
4.24e-03
|
GOBP TRIGEMINAL NERVE DEVELOPMENT
|
10
|
1.51e-01
|
6.38e-01
|
0.35000
|
2.04e-02
|
3.50e-01
|
9.11e-01
|
5.56e-02
|
GOBP PROTEIN ACTIVATION CASCADE
|
17
|
4.76e-02
|
4.38e-01
|
0.35000
|
3.45e-01
|
-5.80e-02
|
1.37e-02
|
6.79e-01
|
GOBP RESPONSE TO 2 3 7 8 TETRACHLORODIBENZODIOXINE
|
5
|
4.18e-01
|
8.32e-01
|
0.35000
|
3.36e-01
|
-9.94e-02
|
1.94e-01
|
7.00e-01
|
GOBP TELOMERASE HOLOENZYME COMPLEX ASSEMBLY
|
6
|
3.67e-01
|
8.07e-01
|
0.35000
|
1.72e-01
|
-3.05e-01
|
4.66e-01
|
1.96e-01
|
GOBP POSITIVE REGULATION OF PROTEIN MONOUBIQUITINATION
|
5
|
4.18e-01
|
8.32e-01
|
0.35000
|
3.36e-01
|
-9.84e-02
|
1.93e-01
|
7.03e-01
|
GOBP THYROID HORMONE MEDIATED SIGNALING PATHWAY
|
8
|
2.21e-01
|
7.11e-01
|
0.35000
|
1.69e-02
|
3.50e-01
|
9.34e-01
|
8.69e-02
|
GOBP RESPONSE TO SELENIUM ION
|
8
|
1.91e-01
|
6.85e-01
|
0.35000
|
-1.90e-01
|
-2.94e-01
|
3.52e-01
|
1.50e-01
|
GOBP UREA CYCLE
|
10
|
1.78e-01
|
6.67e-01
|
0.35000
|
1.11e-01
|
-3.32e-01
|
5.43e-01
|
6.93e-02
|
GOBP TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR
|
10
|
1.58e-01
|
6.46e-01
|
0.35000
|
-3.50e-01
|
1.22e-02
|
5.56e-02
|
9.47e-01
|
GOMF HEME TRANSMEMBRANE TRANSPORTER ACTIVITY
|
8
|
2.69e-01
|
7.45e-01
|
0.35000
|
2.26e-01
|
-2.67e-01
|
2.68e-01
|
1.91e-01
|
GOBP POSITIVE REGULATION OF ACROSOME REACTION
|
11
|
1.34e-01
|
6.16e-01
|
0.35000
|
2.77e-02
|
-3.48e-01
|
8.73e-01
|
4.53e-02
|
GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX EIF3M
|
7
|
2.35e-01
|
7.23e-01
|
0.35000
|
-2.89e-01
|
-1.97e-01
|
1.86e-01
|
3.68e-01
|
GOCC TRANSLATION PREINITIATION COMPLEX
|
16
|
4.81e-02
|
4.40e-01
|
0.34900
|
-3.22e-02
|
-3.48e-01
|
8.24e-01
|
1.60e-02
|
GOCC EARLY ENDOSOME LUMEN
|
5
|
4.19e-01
|
8.33e-01
|
0.34900
|
-9.43e-02
|
3.36e-01
|
7.15e-01
|
1.93e-01
|
GOBP UV DAMAGE EXCISION REPAIR
|
12
|
8.40e-02
|
5.37e-01
|
0.34900
|
-2.89e-01
|
-1.96e-01
|
8.27e-02
|
2.41e-01
|
GOBP PHAGOSOME LYSOSOME FUSION
|
13
|
1.20e-01
|
6.00e-01
|
0.34900
|
2.57e-01
|
-2.37e-01
|
1.09e-01
|
1.40e-01
|
GOBP VENOUS BLOOD VESSEL DEVELOPMENT
|
16
|
6.92e-02
|
5.01e-01
|
0.34900
|
-3.10e-01
|
1.61e-01
|
3.19e-02
|
2.66e-01
|
GOBP REGULATION OF GLYCOGEN STARCH SYNTHASE ACTIVITY
|
5
|
3.84e-01
|
8.17e-01
|
0.34900
|
-4.78e-02
|
-3.46e-01
|
8.53e-01
|
1.81e-01
|
GOMF PROCOLLAGEN PROLINE 4 DIOXYGENASE ACTIVITY
|
5
|
3.92e-01
|
8.22e-01
|
0.34900
|
1.75e-02
|
3.48e-01
|
9.46e-01
|
1.77e-01
|
GOBP NEGATIVE REGULATION OF MYOSIN LIGHT CHAIN PHOSPHATASE ACTIVITY
|
5
|
4.09e-01
|
8.27e-01
|
0.34900
|
-3.45e-01
|
5.17e-02
|
1.82e-01
|
8.41e-01
|
GOBP CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS
|
15
|
4.46e-02
|
4.29e-01
|
0.34900
|
-2.34e-01
|
-2.58e-01
|
1.16e-01
|
8.34e-02
|
GOMF ABC TYPE GLUTATHIONE S CONJUGATE TRANSPORTER ACTIVITY
|
8
|
2.11e-01
|
7.00e-01
|
0.34900
|
-3.41e-01
|
-7.34e-02
|
9.49e-02
|
7.19e-01
|
GOBP SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION
|
11
|
1.48e-01
|
6.35e-01
|
0.34900
|
3.36e-01
|
-9.29e-02
|
5.36e-02
|
5.94e-01
|
GOBP POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION
|
13
|
7.18e-02
|
5.12e-01
|
0.34900
|
3.13e-01
|
1.53e-01
|
5.06e-02
|
3.39e-01
|
GOCC PROTEASE INHIBITOR COMPLEX
|
8
|
1.91e-01
|
6.85e-01
|
0.34900
|
-2.52e-01
|
-2.41e-01
|
2.17e-01
|
2.39e-01
|
GOMF THYROID HORMONE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
7
|
2.39e-01
|
7.25e-01
|
0.34800
|
1.81e-01
|
2.98e-01
|
4.07e-01
|
1.72e-01
|
GOBP REGULATION OF GLUCAGON SECRETION
|
8
|
1.94e-01
|
6.85e-01
|
0.34800
|
-1.97e-01
|
-2.87e-01
|
3.34e-01
|
1.60e-01
|
GOBP ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS
|
9
|
1.82e-01
|
6.72e-01
|
0.34800
|
3.96e-02
|
3.46e-01
|
8.37e-01
|
7.24e-02
|
GOBP TRNA THREONYLCARBAMOYLADENOSINE MODIFICATION
|
5
|
4.20e-01
|
8.33e-01
|
0.34800
|
3.37e-01
|
-8.77e-02
|
1.92e-01
|
7.34e-01
|
GOBP REGULATION OF CORE PROMOTER BINDING
|
5
|
4.38e-01
|
8.40e-01
|
0.34800
|
1.70e-01
|
-3.03e-01
|
5.10e-01
|
2.40e-01
|
GOBP FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS
|
11
|
1.67e-01
|
6.53e-01
|
0.34800
|
-2.10e-01
|
2.77e-01
|
2.28e-01
|
1.11e-01
|
GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION
|
6
|
3.78e-01
|
8.14e-01
|
0.34800
|
-2.25e-01
|
2.65e-01
|
3.40e-01
|
2.61e-01
|
GOBP METANEPHRIC TUBULE MORPHOGENESIS
|
11
|
1.68e-01
|
6.54e-01
|
0.34800
|
-2.12e-01
|
2.76e-01
|
2.24e-01
|
1.14e-01
|
GOBP CYCLIC NUCLEOTIDE TRANSPORT
|
9
|
1.87e-01
|
6.78e-01
|
0.34700
|
-3.47e-01
|
-2.21e-02
|
7.16e-02
|
9.09e-01
|
GOBP REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS
|
18
|
4.96e-02
|
4.42e-01
|
0.34700
|
-3.16e-01
|
1.44e-01
|
2.01e-02
|
2.91e-01
|
GOBP REFLEX
|
21
|
3.31e-02
|
3.70e-01
|
0.34700
|
2.78e-01
|
-2.08e-01
|
2.73e-02
|
9.88e-02
|
GOBP REGULATION OF MYELOID DENDRITIC CELL ACTIVATION
|
5
|
4.46e-01
|
8.40e-01
|
0.34700
|
2.56e-01
|
-2.35e-01
|
3.22e-01
|
3.62e-01
|
GOMF CALCIUM DEPENDENT PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY
|
7
|
3.18e-01
|
7.77e-01
|
0.34700
|
-2.96e-01
|
1.82e-01
|
1.75e-01
|
4.05e-01
|
GOBP AIM2 INFLAMMASOME COMPLEX ASSEMBLY
|
5
|
4.06e-01
|
8.26e-01
|
0.34700
|
2.48e-02
|
-3.46e-01
|
9.24e-01
|
1.80e-01
|
GOBP MITOCHONDRIAL DNA REPLICATION
|
14
|
5.74e-02
|
4.68e-01
|
0.34700
|
-2.86e-01
|
-1.96e-01
|
6.35e-02
|
2.03e-01
|
GOBP ACTIVATION INDUCED CELL DEATH OF T CELLS
|
8
|
1.93e-01
|
6.85e-01
|
0.34700
|
-2.45e-01
|
-2.46e-01
|
2.31e-01
|
2.28e-01
|
GOBP G1 TO G0 TRANSITION INVOLVED IN CELL DIFFERENTIATION
|
6
|
3.79e-01
|
8.14e-01
|
0.34700
|
-2.20e-01
|
2.69e-01
|
3.51e-01
|
2.54e-01
|
GOBP GTP METABOLIC PROCESS
|
24
|
7.55e-03
|
1.81e-01
|
0.34700
|
-1.90e-01
|
-2.90e-01
|
1.07e-01
|
1.38e-02
|
GOBP PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE
|
8
|
2.00e-01
|
6.90e-01
|
0.34700
|
-1.56e-01
|
-3.10e-01
|
4.46e-01
|
1.29e-01
|
GOBP SYNAPTIC VESICLE ENDOSOMAL PROCESSING
|
8
|
2.31e-01
|
7.18e-01
|
0.34700
|
-1.67e-03
|
3.47e-01
|
9.93e-01
|
8.92e-02
|
GOMF C X3 C CHEMOKINE BINDING
|
5
|
4.39e-01
|
8.40e-01
|
0.34700
|
-1.60e-01
|
3.07e-01
|
5.35e-01
|
2.34e-01
|
GOBP DIACYLGLYCEROL BIOSYNTHETIC PROCESS
|
9
|
2.35e-01
|
7.23e-01
|
0.34600
|
-2.61e-01
|
2.28e-01
|
1.75e-01
|
2.37e-01
|
GOMF MAP KINASE SCAFFOLD ACTIVITY
|
11
|
1.63e-01
|
6.48e-01
|
0.34600
|
-3.10e-01
|
1.54e-01
|
7.47e-02
|
3.76e-01
|
GOMF PYRUVATE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
5
|
3.85e-01
|
8.18e-01
|
0.34600
|
-3.40e-01
|
-6.57e-02
|
1.88e-01
|
7.99e-01
|
GOBP MRNA 3 END PROCESSING BY STEM LOOP BINDING AND CLEAVAGE
|
6
|
3.77e-01
|
8.13e-01
|
0.34600
|
2.91e-01
|
-1.87e-01
|
2.16e-01
|
4.28e-01
|
GOBP REGULATION OF ADHERENS JUNCTION ORGANIZATION
|
5
|
4.40e-01
|
8.40e-01
|
0.34600
|
-3.05e-01
|
1.63e-01
|
2.37e-01
|
5.27e-01
|
GOBP PROTEIN LOCALIZATION TO ADHERENS JUNCTION
|
6
|
3.34e-01
|
7.87e-01
|
0.34600
|
4.44e-03
|
3.46e-01
|
9.85e-01
|
1.42e-01
|
GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN EXECUTION PHASE OF APOPTOSIS
|
5
|
3.99e-01
|
8.25e-01
|
0.34600
|
1.10e-02
|
3.46e-01
|
9.66e-01
|
1.80e-01
|
GOCC INTERSTITIAL MATRIX
|
11
|
1.65e-01
|
6.49e-01
|
0.34600
|
3.06e-01
|
-1.61e-01
|
7.84e-02
|
3.56e-01
|
GOBP CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS
|
31
|
5.97e-03
|
1.62e-01
|
0.34600
|
-3.15e-01
|
1.42e-01
|
2.38e-03
|
1.72e-01
|
GOBP NEGATIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY
|
6
|
3.08e-01
|
7.72e-01
|
0.34600
|
-3.24e-01
|
-1.19e-01
|
1.69e-01
|
6.13e-01
|
GOMF METALLODIPEPTIDASE ACTIVITY
|
8
|
2.72e-01
|
7.47e-01
|
0.34600
|
-1.72e-01
|
2.99e-01
|
3.98e-01
|
1.42e-01
|
GOMF SMALL PROTEIN ACTIVATING ENZYME BINDING
|
5
|
3.73e-01
|
8.10e-01
|
0.34600
|
1.32e-01
|
3.19e-01
|
6.09e-01
|
2.16e-01
|
GOBP SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR
|
11
|
1.70e-01
|
6.57e-01
|
0.34500
|
1.96e-01
|
-2.85e-01
|
2.61e-01
|
1.02e-01
|
GOBP OTOLITH MORPHOGENESIS
|
5
|
3.84e-01
|
8.17e-01
|
0.34500
|
7.85e-02
|
3.36e-01
|
7.61e-01
|
1.93e-01
|
GOBP POSITIVE REGULATION OF METALLOENDOPEPTIDASE ACTIVITY
|
7
|
2.93e-01
|
7.63e-01
|
0.34500
|
4.86e-02
|
-3.42e-01
|
8.24e-01
|
1.17e-01
|
GOBP NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY
|
20
|
2.04e-02
|
3.04e-01
|
0.34500
|
1.13e-01
|
3.26e-01
|
3.83e-01
|
1.15e-02
|
GOBP GOLGI LUMEN ACIDIFICATION
|
10
|
1.94e-01
|
6.85e-01
|
0.34500
|
-3.12e-01
|
1.48e-01
|
8.80e-02
|
4.16e-01
|
GOMF ACYL COA OXIDASE ACTIVITY
|
7
|
3.05e-01
|
7.69e-01
|
0.34500
|
-3.32e-01
|
9.39e-02
|
1.28e-01
|
6.67e-01
|
GOBP REGULATION OF ISOMERASE ACTIVITY
|
8
|
2.37e-01
|
7.24e-01
|
0.34500
|
-3.45e-01
|
8.18e-03
|
9.11e-02
|
9.68e-01
|
GOBP ENUCLEATE ERYTHROCYTE DIFFERENTIATION
|
10
|
1.70e-01
|
6.57e-01
|
0.34500
|
-3.43e-01
|
3.30e-02
|
6.00e-02
|
8.57e-01
|
GOMF TPR DOMAIN BINDING
|
7
|
2.62e-01
|
7.39e-01
|
0.34500
|
-8.19e-02
|
-3.35e-01
|
7.08e-01
|
1.25e-01
|
GOMF ARYL HYDROCARBON RECEPTOR BINDING
|
8
|
2.09e-01
|
6.97e-01
|
0.34500
|
1.25e-01
|
3.22e-01
|
5.42e-01
|
1.15e-01
|
GOBP POSITIVE REGULATION OF OPSONIZATION
|
8
|
2.75e-01
|
7.49e-01
|
0.34500
|
2.93e-01
|
-1.81e-01
|
1.51e-01
|
3.75e-01
|
GOMF 7SK SNRNA BINDING
|
9
|
1.62e-01
|
6.48e-01
|
0.34500
|
-2.19e-01
|
-2.66e-01
|
2.56e-01
|
1.66e-01
|
GOBP MEIOTIC CHROMOSOME SEPARATION
|
8
|
2.22e-01
|
7.12e-01
|
0.34400
|
5.93e-02
|
3.39e-01
|
7.72e-01
|
9.66e-02
|
GOBP NEGATIVE REGULATION OF CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION
|
5
|
3.71e-01
|
8.09e-01
|
0.34400
|
-1.58e-01
|
-3.06e-01
|
5.40e-01
|
2.36e-01
|
GOBP PROTOPORPHYRINOGEN IX METABOLIC PROCESS
|
10
|
1.48e-01
|
6.35e-01
|
0.34400
|
-8.67e-02
|
-3.33e-01
|
6.35e-01
|
6.81e-02
|
GOBP REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT
|
10
|
1.85e-01
|
6.75e-01
|
0.34400
|
9.29e-02
|
-3.31e-01
|
6.11e-01
|
6.96e-02
|
GOBP REGULATION OF PLASMA MEMBRANE ORGANIZATION
|
16
|
6.95e-02
|
5.02e-01
|
0.34400
|
-1.11e-01
|
3.26e-01
|
4.41e-01
|
2.42e-02
|
GOMF CASPASE BINDING
|
13
|
1.14e-01
|
5.91e-01
|
0.34400
|
1.05e-01
|
-3.27e-01
|
5.13e-01
|
4.09e-02
|
GOBP 7 METHYLGUANOSINE RNA CAPPING
|
8
|
2.22e-01
|
7.12e-01
|
0.34400
|
-6.49e-02
|
-3.38e-01
|
7.50e-01
|
9.82e-02
|
GOBP DISTAL TUBULE DEVELOPMENT
|
12
|
1.30e-01
|
6.09e-01
|
0.34400
|
-3.35e-01
|
7.74e-02
|
4.46e-02
|
6.42e-01
|
GOBP I KAPPAB PHOSPHORYLATION
|
15
|
9.29e-02
|
5.54e-01
|
0.34400
|
-2.67e-01
|
2.17e-01
|
7.38e-02
|
1.46e-01
|
GOBP ORNITHINE METABOLIC PROCESS
|
9
|
1.72e-01
|
6.61e-01
|
0.34400
|
-1.34e-01
|
-3.17e-01
|
4.88e-01
|
1.00e-01
|
GOBP REGULATION BY VIRUS OF VIRAL PROTEIN LEVELS IN HOST CELL
|
7
|
2.47e-01
|
7.26e-01
|
0.34400
|
-2.89e-01
|
-1.86e-01
|
1.86e-01
|
3.93e-01
|
GOBP ACTIVATION OF PROTEIN KINASE C ACTIVITY
|
5
|
4.41e-01
|
8.40e-01
|
0.34400
|
1.38e-01
|
-3.15e-01
|
5.94e-01
|
2.23e-01
|
GOBP INTERLEUKIN 17A MEDIATED SIGNALING PATHWAY
|
6
|
3.28e-01
|
7.83e-01
|
0.34300
|
-3.40e-01
|
-4.89e-02
|
1.49e-01
|
8.36e-01
|
GOBP ENDOCARDIAL CUSHION FUSION
|
5
|
3.83e-01
|
8.16e-01
|
0.34300
|
1.04e-01
|
3.27e-01
|
6.86e-01
|
2.05e-01
|
GOBP INTESTINAL HEXOSE ABSORPTION
|
5
|
4.52e-01
|
8.45e-01
|
0.34300
|
-2.02e-01
|
2.78e-01
|
4.34e-01
|
2.82e-01
|
GOCC U12 TYPE SPLICEOSOMAL COMPLEX
|
25
|
1.17e-02
|
2.31e-01
|
0.34300
|
1.03e-02
|
-3.43e-01
|
9.29e-01
|
2.98e-03
|
GOBP IP 10 PRODUCTION
|
5
|
3.71e-01
|
8.09e-01
|
0.34300
|
-1.76e-01
|
-2.95e-01
|
4.96e-01
|
2.54e-01
|
GOBP NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY
|
14
|
8.41e-02
|
5.37e-01
|
0.34300
|
-1.83e-02
|
3.43e-01
|
9.06e-01
|
2.64e-02
|
GOBP ADENOSINE METABOLIC PROCESS
|
10
|
1.35e-01
|
6.16e-01
|
0.34300
|
2.50e-01
|
2.35e-01
|
1.71e-01
|
1.99e-01
|
GOBP ENDOSOME TO LYSOSOME TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY
|
17
|
5.16e-02
|
4.48e-01
|
0.34300
|
-3.41e-01
|
3.34e-02
|
1.49e-02
|
8.12e-01
|
GOBP POSITIVE REGULATION OF MITOTIC CYTOKINESIS
|
8
|
2.85e-01
|
7.57e-01
|
0.34300
|
-2.53e-01
|
2.30e-01
|
2.14e-01
|
2.59e-01
|
GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE 5 PHOSPHATASE ACTIVITY
|
5
|
3.72e-01
|
8.09e-01
|
0.34300
|
-2.92e-01
|
-1.80e-01
|
2.59e-01
|
4.86e-01
|
GOBP URONIC ACID METABOLIC PROCESS
|
24
|
1.71e-02
|
2.78e-01
|
0.34200
|
3.35e-01
|
-7.05e-02
|
4.50e-03
|
5.50e-01
|
GOBP NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION
|
14
|
1.03e-01
|
5.74e-01
|
0.34200
|
-1.35e-01
|
3.14e-01
|
3.80e-01
|
4.17e-02
|
GOBP PODOSOME ASSEMBLY
|
19
|
4.31e-02
|
4.26e-01
|
0.34200
|
-3.26e-01
|
1.06e-01
|
1.40e-02
|
4.25e-01
|
GOBP POSITIVE REGULATION OF CENTRIOLE REPLICATION
|
9
|
2.08e-01
|
6.97e-01
|
0.34200
|
2.92e-02
|
-3.41e-01
|
8.80e-01
|
7.65e-02
|
GOBP MEDIUM CHAIN FATTY ACID BIOSYNTHETIC PROCESS
|
6
|
3.76e-01
|
8.11e-01
|
0.34200
|
-1.29e-01
|
3.17e-01
|
5.85e-01
|
1.79e-01
|
GOCC MCM COMPLEX
|
8
|
2.08e-01
|
6.97e-01
|
0.34200
|
-1.71e-01
|
-2.96e-01
|
4.03e-01
|
1.47e-01
|
GOBP HOST MEDIATED REGULATION OF INTESTINAL MICROBIOTA COMPOSITION
|
9
|
1.83e-01
|
6.72e-01
|
0.34200
|
-3.29e-01
|
-9.34e-02
|
8.77e-02
|
6.27e-01
|
GOBP RETINOIC ACID METABOLIC PROCESS
|
33
|
4.07e-03
|
1.31e-01
|
0.34100
|
3.31e-01
|
-8.54e-02
|
1.01e-03
|
3.96e-01
|
GOBP NEGATIVE REGULATION OF INTERLEUKIN 5 PRODUCTION
|
7
|
3.20e-01
|
7.78e-01
|
0.34100
|
-3.18e-01
|
1.25e-01
|
1.46e-01
|
5.66e-01
|
GOBP GLYCINE BIOSYNTHETIC PROCESS
|
7
|
2.71e-01
|
7.47e-01
|
0.34100
|
-7.45e-02
|
-3.33e-01
|
7.33e-01
|
1.27e-01
|
GOBP CGMP CATABOLIC PROCESS
|
5
|
4.59e-01
|
8.48e-01
|
0.34100
|
2.59e-01
|
-2.22e-01
|
3.17e-01
|
3.89e-01
|
GOBP DETECTION OF TEMPERATURE STIMULUS INVOLVED IN THERMOCEPTION
|
5
|
4.40e-01
|
8.40e-01
|
0.34100
|
-3.25e-01
|
1.04e-01
|
2.09e-01
|
6.87e-01
|
GOBP PARTURITION
|
14
|
1.09e-01
|
5.84e-01
|
0.34100
|
-1.69e-01
|
2.96e-01
|
2.73e-01
|
5.53e-02
|
GOBP NEGATIVE REGULATION OF FEEDING BEHAVIOR
|
6
|
3.69e-01
|
8.09e-01
|
0.34100
|
8.85e-02
|
-3.29e-01
|
7.07e-01
|
1.63e-01
|
GOCC CHECKPOINT CLAMP COMPLEX
|
5
|
3.81e-01
|
8.15e-01
|
0.34100
|
-3.07e-01
|
-1.47e-01
|
2.34e-01
|
5.69e-01
|
GOBP REGULATION OF ARACHIDONIC ACID SECRETION
|
7
|
2.93e-01
|
7.63e-01
|
0.34100
|
3.40e-01
|
-1.10e-02
|
1.19e-01
|
9.60e-01
|
GOMF LEUCINE ZIPPER DOMAIN BINDING
|
11
|
1.28e-01
|
6.08e-01
|
0.34000
|
-3.29e-01
|
-8.74e-02
|
5.88e-02
|
6.16e-01
|
GOBP ISOTYPE SWITCHING TO IGG ISOTYPES
|
15
|
5.21e-02
|
4.49e-01
|
0.34000
|
2.67e-01
|
2.11e-01
|
7.34e-02
|
1.57e-01
|
GOMF PHOSPHOSERINE RESIDUE BINDING
|
10
|
1.54e-01
|
6.41e-01
|
0.34000
|
-3.26e-01
|
-9.64e-02
|
7.43e-02
|
5.98e-01
|
GOBP RESPONSE TO STEROL DEPLETION
|
18
|
4.49e-02
|
4.30e-01
|
0.34000
|
-3.39e-01
|
2.58e-02
|
1.28e-02
|
8.50e-01
|
GOBP ERROR FREE TRANSLESION SYNTHESIS
|
5
|
4.58e-01
|
8.48e-01
|
0.34000
|
-2.85e-01
|
1.86e-01
|
2.71e-01
|
4.72e-01
|
GOCC INTERCELLULAR CANALICULUS
|
6
|
3.90e-01
|
8.21e-01
|
0.34000
|
2.92e-01
|
-1.74e-01
|
2.16e-01
|
4.61e-01
|
GOBP REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION
|
15
|
8.05e-02
|
5.30e-01
|
0.33900
|
-5.98e-02
|
3.34e-01
|
6.88e-01
|
2.50e-02
|
GOBP CELL MIGRATION INVOLVED IN KIDNEY DEVELOPMENT
|
6
|
3.13e-01
|
7.76e-01
|
0.33900
|
-2.92e-01
|
-1.73e-01
|
2.15e-01
|
4.64e-01
|
GOBP ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM
|
16
|
6.73e-02
|
4.98e-01
|
0.33900
|
-5.23e-02
|
3.35e-01
|
7.17e-01
|
2.03e-02
|
GOBP GOLGI LOCALIZATION
|
14
|
8.40e-02
|
5.37e-01
|
0.33900
|
-3.39e-01
|
-1.58e-02
|
2.82e-02
|
9.19e-01
|
GOBP HYPOTHALAMUS CELL MIGRATION
|
6
|
3.16e-01
|
7.77e-01
|
0.33900
|
-1.52e-01
|
-3.03e-01
|
5.18e-01
|
1.99e-01
|
GOBP CRANIAL NERVE FORMATION
|
10
|
1.96e-01
|
6.88e-01
|
0.33900
|
-9.92e-02
|
3.24e-01
|
5.87e-01
|
7.60e-02
|
GOBP LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS
|
18
|
5.54e-02
|
4.63e-01
|
0.33900
|
-3.17e-01
|
1.20e-01
|
1.98e-02
|
3.80e-01
|
GOBP REGULATION OF T CIRCLE FORMATION
|
5
|
4.58e-01
|
8.48e-01
|
0.33900
|
-2.91e-01
|
1.74e-01
|
2.60e-01
|
5.00e-01
|
GOCC PROTEASOME CORE COMPLEX ALPHA SUBUNIT COMPLEX
|
8
|
2.18e-01
|
7.07e-01
|
0.33900
|
3.08e-01
|
1.40e-01
|
1.31e-01
|
4.93e-01
|
GOBP WATER SOLUBLE VITAMIN BIOSYNTHETIC PROCESS
|
11
|
1.41e-01
|
6.25e-01
|
0.33900
|
-3.04e-02
|
-3.37e-01
|
8.62e-01
|
5.28e-02
|
GOCC CORTICAL GRANULE
|
6
|
3.86e-01
|
8.19e-01
|
0.33800
|
-3.09e-01
|
1.37e-01
|
1.90e-01
|
5.61e-01
|
GOBP POSITIVE REGULATION OF GLUTAMATE SECRETION
|
11
|
1.66e-01
|
6.50e-01
|
0.33800
|
-8.65e-02
|
3.27e-01
|
6.19e-01
|
6.05e-02
|
GOBP INOSITOL TRISPHOSPHATE METABOLIC PROCESS
|
12
|
1.49e-01
|
6.36e-01
|
0.33800
|
-1.30e-01
|
3.12e-01
|
4.36e-01
|
6.15e-02
|
GOBP RRNA PSEUDOURIDINE SYNTHESIS
|
7
|
2.79e-01
|
7.52e-01
|
0.33800
|
-7.48e-02
|
-3.29e-01
|
7.32e-01
|
1.31e-01
|
GOBP RESPONSE TO IRON II ION
|
6
|
3.16e-01
|
7.76e-01
|
0.33800
|
-2.87e-01
|
-1.78e-01
|
2.24e-01
|
4.50e-01
|
GOCC KATANIN COMPLEX
|
5
|
4.61e-01
|
8.48e-01
|
0.33800
|
2.90e-01
|
-1.72e-01
|
2.61e-01
|
5.04e-01
|
GOMF ACYLGLYCEROL O ACYLTRANSFERASE ACTIVITY
|
26
|
1.91e-02
|
2.95e-01
|
0.33800
|
-2.38e-01
|
2.40e-01
|
3.59e-02
|
3.44e-02
|
GOBP PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS
|
10
|
2.05e-01
|
6.95e-01
|
0.33700
|
1.29e-01
|
-3.12e-01
|
4.78e-01
|
8.79e-02
|
GOBP EQUILIBRIOCEPTION
|
7
|
2.59e-01
|
7.37e-01
|
0.33700
|
1.92e-01
|
2.78e-01
|
3.80e-01
|
2.03e-01
|
GOBP NEGATIVE REGULATION OF RECEPTOR RECYCLING
|
5
|
4.67e-01
|
8.51e-01
|
0.33700
|
2.38e-01
|
-2.39e-01
|
3.56e-01
|
3.55e-01
|
GOBP REGULATION OF FEMALE RECEPTIVITY
|
7
|
2.94e-01
|
7.64e-01
|
0.33700
|
1.32e-02
|
3.37e-01
|
9.52e-01
|
1.23e-01
|
GOBP SPERM EJACULATION
|
5
|
4.07e-01
|
8.26e-01
|
0.33700
|
3.33e-01
|
5.55e-02
|
1.98e-01
|
8.30e-01
|
GOBP CATECHOL CONTAINING COMPOUND CATABOLIC PROCESS
|
5
|
4.06e-01
|
8.26e-01
|
0.33700
|
5.73e-02
|
3.32e-01
|
8.24e-01
|
1.98e-01
|
GOCC WNT SIGNALOSOME
|
13
|
1.28e-01
|
6.07e-01
|
0.33700
|
-1.27e-01
|
3.12e-01
|
4.28e-01
|
5.12e-02
|
GOBP TRACHEA DEVELOPMENT
|
18
|
6.03e-02
|
4.78e-01
|
0.33700
|
-1.53e-01
|
3.00e-01
|
2.61e-01
|
2.73e-02
|
GOBP AMACRINE CELL DIFFERENTIATION
|
12
|
1.47e-01
|
6.34e-01
|
0.33700
|
1.12e-01
|
-3.18e-01
|
5.00e-01
|
5.68e-02
|
GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY
|
19
|
2.53e-02
|
3.31e-01
|
0.33700
|
-2.48e-01
|
-2.28e-01
|
6.17e-02
|
8.47e-02
|
GOBP REGULATION OF VERY LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE
|
5
|
4.06e-01
|
8.26e-01
|
0.33700
|
3.31e-01
|
6.14e-02
|
2.00e-01
|
8.12e-01
|
GOBP RESPONSE TO MISFOLDED PROTEIN
|
23
|
1.43e-02
|
2.59e-01
|
0.33700
|
-1.05e-01
|
-3.20e-01
|
3.82e-01
|
7.95e-03
|
GOBP DIET INDUCED THERMOGENESIS
|
13
|
1.34e-01
|
6.16e-01
|
0.33600
|
-1.63e-01
|
2.94e-01
|
3.07e-01
|
6.66e-02
|
GOBP DEFENSE RESPONSE TO TUMOR CELL
|
13
|
1.18e-01
|
5.99e-01
|
0.33600
|
-6.07e-02
|
3.31e-01
|
7.05e-01
|
3.90e-02
|
GOBP SYNAPTIC TRANSMISSION GLYCINERGIC
|
5
|
4.14e-01
|
8.29e-01
|
0.33600
|
-3.72e-02
|
-3.34e-01
|
8.85e-01
|
1.96e-01
|
GOMF MITOGEN ACTIVATED PROTEIN KINASE KINASE BINDING
|
9
|
2.50e-01
|
7.28e-01
|
0.33600
|
-2.92e-01
|
1.66e-01
|
1.29e-01
|
3.89e-01
|
GOBP DIACYLGLYCEROL METABOLIC PROCESS
|
26
|
1.97e-02
|
3.00e-01
|
0.33600
|
-2.24e-01
|
2.50e-01
|
4.81e-02
|
2.71e-02
|
GOMF LYSINE N ACETYLTRANSFERASE ACTIVITY ACTING ON ACETYL PHOSPHATE AS DONOR
|
6
|
3.29e-01
|
7.83e-01
|
0.33600
|
-3.14e-01
|
-1.20e-01
|
1.83e-01
|
6.12e-01
|
GOCC TRNA SPLICING LIGASE COMPLEX
|
8
|
2.32e-01
|
7.18e-01
|
0.33600
|
-9.48e-02
|
-3.22e-01
|
6.42e-01
|
1.15e-01
|
GOBP SECONDARY PALATE DEVELOPMENT
|
26
|
1.03e-02
|
2.18e-01
|
0.33600
|
3.74e-02
|
3.34e-01
|
7.41e-01
|
3.23e-03
|
GOBP NEGATIVE REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY
|
9
|
1.87e-01
|
6.78e-01
|
0.33600
|
-3.09e-01
|
-1.32e-01
|
1.09e-01
|
4.92e-01
|
GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY
|
13
|
9.93e-02
|
5.68e-01
|
0.33600
|
-3.32e-01
|
-5.18e-02
|
3.84e-02
|
7.46e-01
|
GOCC HEMIDESMOSOME
|
8
|
2.84e-01
|
7.57e-01
|
0.33600
|
-1.21e-01
|
3.13e-01
|
5.52e-01
|
1.25e-01
|
GOBP REGULATION OF HISTONE METHYLATION
|
16
|
7.47e-02
|
5.16e-01
|
0.33500
|
-3.27e-01
|
7.37e-02
|
2.35e-02
|
6.10e-01
|
GOBP FOREGUT MORPHOGENESIS
|
10
|
2.21e-01
|
7.11e-01
|
0.33500
|
-2.11e-01
|
2.61e-01
|
2.48e-01
|
1.54e-01
|
GOCC SIGNAL RECOGNITION PARTICLE
|
8
|
2.98e-01
|
7.67e-01
|
0.33500
|
2.71e-01
|
-1.98e-01
|
1.85e-01
|
3.33e-01
|
GOBP MONOCYTE AGGREGATION
|
5
|
4.61e-01
|
8.48e-01
|
0.33500
|
3.04e-01
|
-1.42e-01
|
2.40e-01
|
5.83e-01
|
GOBP MOTOR LEARNING
|
7
|
3.03e-01
|
7.68e-01
|
0.33500
|
-3.35e-01
|
8.96e-04
|
1.25e-01
|
9.97e-01
|
GOBP PROTEIN TRANSPORT TO VACUOLE INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY
|
15
|
8.42e-02
|
5.37e-01
|
0.33500
|
-3.32e-01
|
4.64e-02
|
2.61e-02
|
7.56e-01
|
GOBP MITOTIC CYTOKINETIC PROCESS
|
26
|
1.34e-02
|
2.51e-01
|
0.33500
|
-3.33e-01
|
3.70e-02
|
3.31e-03
|
7.44e-01
|
GOBP NEGATIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT
|
26
|
2.03e-02
|
3.03e-01
|
0.33500
|
-2.55e-01
|
2.16e-01
|
2.43e-02
|
5.60e-02
|
GOMF ACYLTRANSFERASE ACTIVITY ACYL GROUPS CONVERTED INTO ALKYL ON TRANSFER
|
5
|
4.62e-01
|
8.48e-01
|
0.33500
|
-3.04e-01
|
1.40e-01
|
2.40e-01
|
5.87e-01
|
GOBP REGULATION OF LYSOSOMAL PROTEIN CATABOLIC PROCESS
|
11
|
1.25e-01
|
6.06e-01
|
0.33500
|
-2.78e-01
|
-1.86e-01
|
1.10e-01
|
2.85e-01
|
GOBP BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS
|
13
|
1.38e-01
|
6.22e-01
|
0.33500
|
1.69e-01
|
-2.89e-01
|
2.92e-01
|
7.14e-02
|
GOBP PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS
|
29
|
3.99e-03
|
1.30e-01
|
0.33400
|
-2.32e-01
|
-2.41e-01
|
3.05e-02
|
2.49e-02
|
GOMF PROTEIN TRANSMEMBRANE TRANSPORTER ACTIVITY
|
26
|
1.29e-02
|
2.45e-01
|
0.33400
|
2.01e-02
|
-3.34e-01
|
8.59e-01
|
3.22e-03
|
GOMF CILIARY NEUROTROPHIC FACTOR RECEPTOR BINDING
|
6
|
4.08e-01
|
8.27e-01
|
0.33400
|
2.59e-01
|
-2.11e-01
|
2.73e-01
|
3.70e-01
|
GOCC CD95 DEATH INDUCING SIGNALING COMPLEX
|
6
|
3.20e-01
|
7.78e-01
|
0.33400
|
-2.43e-01
|
-2.29e-01
|
3.02e-01
|
3.32e-01
|
GOBP ORNITHINE TRANSPORT
|
6
|
3.49e-01
|
7.96e-01
|
0.33400
|
-3.30e-01
|
-4.90e-02
|
1.62e-01
|
8.35e-01
|
GOCC RIBONUCLEASE P COMPLEX
|
13
|
1.43e-01
|
6.28e-01
|
0.33300
|
2.69e-01
|
-1.97e-01
|
9.26e-02
|
2.20e-01
|
GOBP POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION
|
16
|
6.14e-02
|
4.80e-01
|
0.33300
|
-4.44e-02
|
-3.30e-01
|
7.58e-01
|
2.22e-02
|
GOBP DIAPEDESIS
|
6
|
3.28e-01
|
7.83e-01
|
0.33300
|
2.94e-01
|
1.57e-01
|
2.13e-01
|
5.05e-01
|
GOBP FATTY ACYL COA CATABOLIC PROCESS
|
5
|
4.40e-01
|
8.40e-01
|
0.33300
|
3.95e-02
|
-3.31e-01
|
8.79e-01
|
2.00e-01
|
GOCC ESCRT COMPLEX
|
27
|
1.29e-02
|
2.45e-01
|
0.33300
|
-3.27e-01
|
6.04e-02
|
3.23e-03
|
5.87e-01
|
GOBP CADMIUM ION TRANSMEMBRANE TRANSPORT
|
6
|
4.00e-01
|
8.25e-01
|
0.33300
|
-1.41e-01
|
3.01e-01
|
5.51e-01
|
2.01e-01
|
GOBP RNA GUANINE N7 METHYLATION
|
6
|
4.10e-01
|
8.27e-01
|
0.33300
|
2.58e-01
|
-2.10e-01
|
2.74e-01
|
3.72e-01
|
GOCC SORTING ENDOSOME
|
6
|
3.59e-01
|
8.01e-01
|
0.33200
|
2.01e-02
|
3.32e-01
|
9.32e-01
|
1.59e-01
|
GOBP MAINTENANCE OF POSTSYNAPTIC SPECIALIZATION STRUCTURE
|
7
|
3.01e-01
|
7.67e-01
|
0.33200
|
-3.31e-01
|
-2.73e-02
|
1.29e-01
|
9.01e-01
|
GOBP DETERMINATION OF LEFT RIGHT ASYMMETRY IN LATERAL MESODERM
|
8
|
2.22e-01
|
7.11e-01
|
0.33200
|
2.19e-01
|
2.50e-01
|
2.83e-01
|
2.22e-01
|
GOBP MEMBRANE DEPOLARIZATION DURING AV NODE CELL ACTION POTENTIAL
|
6
|
3.55e-01
|
7.97e-01
|
0.33200
|
3.91e-02
|
3.30e-01
|
8.68e-01
|
1.62e-01
|
GOMF ALDITOL NADPPLUS 1 OXIDOREDUCTASE ACTIVITY
|
12
|
1.69e-01
|
6.55e-01
|
0.33200
|
2.62e-01
|
-2.04e-01
|
1.16e-01
|
2.22e-01
|
GOMF G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR ACTIVITY
|
7
|
3.25e-01
|
7.80e-01
|
0.33200
|
-3.27e-01
|
5.89e-02
|
1.34e-01
|
7.87e-01
|
GOCC SPERM HEAD PLASMA MEMBRANE
|
6
|
4.08e-01
|
8.27e-01
|
0.33200
|
1.80e-01
|
-2.79e-01
|
4.46e-01
|
2.36e-01
|
GOMF METALLOAMINOPEPTIDASE ACTIVITY
|
24
|
2.70e-02
|
3.42e-01
|
0.33200
|
-2.91e-01
|
1.59e-01
|
1.35e-02
|
1.78e-01
|
GOMF PROTEIN LYSINE DEACETYLASE ACTIVITY
|
21
|
3.99e-02
|
4.10e-01
|
0.33200
|
-3.08e-01
|
1.23e-01
|
1.46e-02
|
3.28e-01
|
GOBP REGULATION OF PROTEIN ADP RIBOSYLATION
|
8
|
2.37e-01
|
7.25e-01
|
0.33200
|
-1.08e-01
|
-3.14e-01
|
5.98e-01
|
1.25e-01
|
GOMF BMP RECEPTOR BINDING
|
11
|
1.76e-01
|
6.65e-01
|
0.33200
|
-7.89e-02
|
3.22e-01
|
6.50e-01
|
6.43e-02
|
GOBP PROTEIN RETENTION IN GOLGI APPARATUS
|
5
|
4.05e-01
|
8.26e-01
|
0.33100
|
-3.09e-01
|
-1.21e-01
|
2.32e-01
|
6.40e-01
|
GOBP CENTRIOLE ELONGATION
|
8
|
2.88e-01
|
7.59e-01
|
0.33100
|
1.00e-01
|
-3.16e-01
|
6.24e-01
|
1.22e-01
|
GOBP NEGATIVE REGULATION OF MYOFIBROBLAST DIFFERENTIATION
|
6
|
3.26e-01
|
7.82e-01
|
0.33100
|
2.18e-01
|
2.49e-01
|
3.55e-01
|
2.91e-01
|
GOBP REGULATION OF INTESTINAL LIPID ABSORPTION
|
10
|
1.55e-01
|
6.42e-01
|
0.33100
|
-2.15e-01
|
-2.52e-01
|
2.40e-01
|
1.68e-01
|
GOBP BRAINSTEM DEVELOPMENT
|
7
|
3.23e-01
|
7.79e-01
|
0.33100
|
4.17e-02
|
-3.28e-01
|
8.49e-01
|
1.33e-01
|
GOMF AMINO ACID PROTON SYMPORTER ACTIVITY
|
6
|
4.06e-01
|
8.26e-01
|
0.33100
|
2.94e-01
|
-1.52e-01
|
2.12e-01
|
5.19e-01
|
GOMF NETRIN RECEPTOR ACTIVITY
|
5
|
4.09e-01
|
8.27e-01
|
0.33100
|
-3.13e-01
|
-1.06e-01
|
2.25e-01
|
6.81e-01
|
GOBP CARNITINE TRANSMEMBRANE TRANSPORT
|
6
|
3.26e-01
|
7.82e-01
|
0.33100
|
2.25e-01
|
2.42e-01
|
3.39e-01
|
3.04e-01
|
GOBP ATRIOVENTRICULAR NODE DEVELOPMENT
|
9
|
2.62e-01
|
7.39e-01
|
0.33100
|
-1.67e-01
|
2.85e-01
|
3.85e-01
|
1.39e-01
|
GOBP POSITIVE REGULATION OF CILIUM MOVEMENT
|
11
|
1.31e-01
|
6.13e-01
|
0.33000
|
-1.79e-01
|
-2.78e-01
|
3.04e-01
|
1.10e-01
|
GOBP PRONEPHROS DEVELOPMENT
|
9
|
2.09e-01
|
6.97e-01
|
0.33000
|
-6.55e-02
|
-3.24e-01
|
7.34e-01
|
9.24e-02
|
GOMF DEOXYRIBONUCLEOTIDE BINDING
|
5
|
3.99e-01
|
8.25e-01
|
0.33000
|
-2.84e-01
|
-1.69e-01
|
2.72e-01
|
5.13e-01
|
GOMF AMINOPEPTIDASE ACTIVITY
|
38
|
3.80e-03
|
1.25e-01
|
0.33000
|
-2.66e-01
|
1.96e-01
|
4.51e-03
|
3.70e-02
|
GOMF HYDROLASE ACTIVITY ACTING ON ETHER BONDS
|
9
|
2.66e-01
|
7.42e-01
|
0.33000
|
-1.91e-01
|
2.69e-01
|
3.21e-01
|
1.62e-01
|
GOMF NEUROTROPHIN RECEPTOR BINDING
|
11
|
1.31e-01
|
6.12e-01
|
0.33000
|
2.71e-01
|
1.88e-01
|
1.19e-01
|
2.80e-01
|
GOBP NOREPINEPHRINE BIOSYNTHETIC PROCESS
|
8
|
2.70e-01
|
7.45e-01
|
0.33000
|
3.30e-01
|
-1.61e-02
|
1.06e-01
|
9.37e-01
|
GOMF PYRIMIDINE NUCLEOTIDE BINDING
|
6
|
3.36e-01
|
7.88e-01
|
0.33000
|
-2.94e-01
|
-1.49e-01
|
2.12e-01
|
5.26e-01
|
GOCC CASPASE COMPLEX
|
10
|
1.97e-01
|
6.88e-01
|
0.33000
|
-3.29e-01
|
2.58e-02
|
7.18e-02
|
8.88e-01
|
GOCC RAGULATOR COMPLEX
|
5
|
4.40e-01
|
8.40e-01
|
0.33000
|
3.30e-01
|
-9.27e-03
|
2.02e-01
|
9.71e-01
|
GOBP NATURAL KILLER CELL DEGRANULATION
|
10
|
1.91e-01
|
6.85e-01
|
0.33000
|
-3.30e-01
|
2.82e-04
|
7.10e-02
|
9.99e-01
|
GOBP XMP METABOLIC PROCESS
|
7
|
3.01e-01
|
7.67e-01
|
0.33000
|
-5.24e-02
|
-3.26e-01
|
8.10e-01
|
1.36e-01
|
GOMF WD40 REPEAT DOMAIN BINDING
|
5
|
4.67e-01
|
8.51e-01
|
0.33000
|
1.15e-01
|
-3.09e-01
|
6.57e-01
|
2.31e-01
|
GOBP ANTRAL OVARIAN FOLLICLE GROWTH
|
11
|
1.99e-01
|
6.89e-01
|
0.33000
|
-2.74e-01
|
1.82e-01
|
1.15e-01
|
2.95e-01
|
GOBP AXONAL TRANSPORT OF MITOCHONDRION
|
16
|
5.18e-02
|
4.48e-01
|
0.32900
|
2.41e-01
|
2.25e-01
|
9.51e-02
|
1.20e-01
|
GOMF GLUCOSIDASE ACTIVITY
|
13
|
9.16e-02
|
5.51e-01
|
0.32900
|
-2.68e-01
|
-1.91e-01
|
9.37e-02
|
2.34e-01
|
GOMF O PALMITOYLTRANSFERASE ACTIVITY
|
5
|
4.72e-01
|
8.52e-01
|
0.32900
|
-3.01e-01
|
1.32e-01
|
2.43e-01
|
6.08e-01
|
GOBP RIBOFLAVIN TRANSPORT
|
6
|
4.01e-01
|
8.26e-01
|
0.32900
|
3.11e-01
|
-1.09e-01
|
1.88e-01
|
6.45e-01
|
GOMF RIBOFLAVIN TRANSMEMBRANE TRANSPORTER ACTIVITY
|
6
|
4.01e-01
|
8.26e-01
|
0.32900
|
3.11e-01
|
-1.09e-01
|
1.88e-01
|
6.45e-01
|
GOBP NEGATIVE REGULATION OF DENDRITE DEVELOPMENT
|
8
|
2.31e-01
|
7.18e-01
|
0.32900
|
-2.75e-01
|
-1.81e-01
|
1.78e-01
|
3.76e-01
|
GOMF HYDROPEROXY ICOSATETRAENOATE DEHYDRATASE ACTIVITY
|
7
|
3.61e-01
|
8.03e-01
|
0.32900
|
2.62e-01
|
-1.99e-01
|
2.31e-01
|
3.61e-01
|
GOMF EUKARYOTIC INITIATION FACTOR 4E BINDING
|
9
|
2.10e-01
|
7.00e-01
|
0.32900
|
-3.20e-01
|
-7.68e-02
|
9.69e-02
|
6.90e-01
|
GOBP FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS
|
44
|
1.28e-03
|
6.06e-02
|
0.32900
|
-3.09e-01
|
1.11e-01
|
3.84e-04
|
2.04e-01
|
GOBP POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION
|
29
|
1.45e-02
|
2.59e-01
|
0.32800
|
-1.75e-01
|
2.78e-01
|
1.02e-01
|
9.62e-03
|
GOCC KAINATE SELECTIVE GLUTAMATE RECEPTOR COMPLEX
|
5
|
4.74e-01
|
8.53e-01
|
0.32800
|
1.32e-01
|
-3.01e-01
|
6.09e-01
|
2.44e-01
|
GOMF KAINATE SELECTIVE GLUTAMATE RECEPTOR ACTIVITY
|
5
|
4.74e-01
|
8.53e-01
|
0.32800
|
1.32e-01
|
-3.01e-01
|
6.09e-01
|
2.44e-01
|
GOBP REGULATION OF THYMOCYTE APOPTOTIC PROCESS
|
14
|
8.69e-02
|
5.46e-01
|
0.32800
|
9.01e-02
|
3.16e-01
|
5.59e-01
|
4.08e-02
|
GOBP LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY
|
26
|
2.19e-02
|
3.13e-01
|
0.32800
|
-2.86e-01
|
1.62e-01
|
1.16e-02
|
1.54e-01
|
GOBP FUCOSE CATABOLIC PROCESS
|
9
|
2.33e-01
|
7.20e-01
|
0.32800
|
1.93e-02
|
-3.28e-01
|
9.20e-01
|
8.87e-02
|
GOBP DETERMINATION OF DORSAL VENTRAL ASYMMETRY
|
11
|
2.02e-01
|
6.92e-01
|
0.32800
|
1.86e-01
|
-2.70e-01
|
2.85e-01
|
1.21e-01
|
GOCC MICOS COMPLEX
|
6
|
3.42e-01
|
7.93e-01
|
0.32800
|
-2.97e-01
|
-1.39e-01
|
2.08e-01
|
5.55e-01
|
GOCC BETA CATENIN TCF COMPLEX
|
13
|
1.13e-01
|
5.91e-01
|
0.32800
|
3.18e-02
|
3.26e-01
|
8.43e-01
|
4.16e-02
|
GOMF DNA DNA ANNEALING ACTIVITY
|
7
|
2.96e-01
|
7.65e-01
|
0.32800
|
-3.15e-01
|
-9.06e-02
|
1.49e-01
|
6.78e-01
|
GOCC ELONGATOR HOLOENZYME COMPLEX
|
6
|
3.40e-01
|
7.91e-01
|
0.32800
|
-1.52e-01
|
-2.91e-01
|
5.20e-01
|
2.17e-01
|
GOBP LOBAR BRONCHUS EPITHELIUM DEVELOPMENT
|
5
|
4.13e-01
|
8.29e-01
|
0.32800
|
3.05e-01
|
1.19e-01
|
2.37e-01
|
6.44e-01
|
GOBP MYOBLAST FATE COMMITMENT
|
6
|
4.11e-01
|
8.28e-01
|
0.32800
|
-1.41e-01
|
2.96e-01
|
5.49e-01
|
2.10e-01
|
GOBP MAST CELL PROLIFERATION
|
7
|
3.21e-01
|
7.79e-01
|
0.32800
|
-9.18e-03
|
3.28e-01
|
9.66e-01
|
1.33e-01
|
GOBP SENSORY PERCEPTION OF UMAMI TASTE
|
7
|
3.66e-01
|
8.06e-01
|
0.32800
|
-2.36e-01
|
2.27e-01
|
2.79e-01
|
2.98e-01
|
GOBP NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT
|
11
|
1.38e-01
|
6.22e-01
|
0.32800
|
-1.56e-01
|
-2.88e-01
|
3.70e-01
|
9.81e-02
|
GOBP NEGATIVE REGULATION OF HEPATOCYTE APOPTOTIC PROCESS
|
7
|
3.05e-01
|
7.69e-01
|
0.32700
|
-5.42e-02
|
-3.23e-01
|
8.04e-01
|
1.39e-01
|
GOBP ROUNDABOUT SIGNALING PATHWAY
|
5
|
4.10e-01
|
8.27e-01
|
0.32700
|
-2.96e-01
|
-1.40e-01
|
2.51e-01
|
5.89e-01
|
GOMF STEROID HYDROXYLASE ACTIVITY
|
26
|
1.45e-02
|
2.59e-01
|
0.32700
|
3.27e-01
|
-3.92e-04
|
3.87e-03
|
9.97e-01
|
GOBP POSITIVE REGULATION OF LONG TERM SYNAPTIC DEPRESSION
|
6
|
4.22e-01
|
8.34e-01
|
0.32700
|
-2.03e-01
|
2.56e-01
|
3.88e-01
|
2.77e-01
|
GOBP COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY
|
16
|
6.19e-02
|
4.82e-01
|
0.32700
|
-9.67e-02
|
-3.12e-01
|
5.03e-01
|
3.05e-02
|
GOBP REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN
|
11
|
1.62e-01
|
6.48e-01
|
0.32700
|
2.13e-02
|
3.26e-01
|
9.03e-01
|
6.10e-02
|
GOBP REGULATION OF LYSOSOME ORGANIZATION
|
12
|
1.20e-01
|
6.00e-01
|
0.32700
|
-3.01e-01
|
-1.27e-01
|
7.09e-02
|
4.45e-01
|
GOBP PEPTIDYL SERINE AUTOPHOSPHORYLATION
|
8
|
2.96e-01
|
7.66e-01
|
0.32700
|
-3.14e-01
|
9.18e-02
|
1.24e-01
|
6.53e-01
|
GOBP SIRNA MEDIATED RETROTRANSPOSON SILENCING BY HETEROCHROMATIN FORMATION
|
11
|
1.48e-01
|
6.34e-01
|
0.32700
|
1.01e-01
|
3.11e-01
|
5.61e-01
|
7.44e-02
|
GOMF PHOSPHATIDYLINOSITOL 5 PHOSPHATE BINDING
|
20
|
2.76e-02
|
3.45e-01
|
0.32700
|
1.67e-01
|
2.81e-01
|
1.97e-01
|
2.96e-02
|
GOBP NON LYTIC VIRAL RELEASE
|
14
|
1.19e-01
|
6.00e-01
|
0.32700
|
-3.15e-01
|
8.68e-02
|
4.14e-02
|
5.74e-01
|
GOBP POSITIVE REGULATION OF CELLULAR PH REDUCTION
|
5
|
4.70e-01
|
8.51e-01
|
0.32600
|
-9.70e-02
|
3.12e-01
|
7.07e-01
|
2.28e-01
|
GOBP RESPONSE TO GONADOTROPIN RELEASING HORMONE
|
7
|
3.32e-01
|
7.85e-01
|
0.32600
|
3.55e-02
|
-3.24e-01
|
8.71e-01
|
1.37e-01
|
GOMF PROTEINASE ACTIVATED RECEPTOR ACTIVITY
|
5
|
4.30e-01
|
8.36e-01
|
0.32600
|
-6.08e-02
|
-3.20e-01
|
8.14e-01
|
2.15e-01
|
GOMF DNA DEMETHYLASE ACTIVITY
|
5
|
4.91e-01
|
8.58e-01
|
0.32600
|
-2.39e-01
|
2.22e-01
|
3.56e-01
|
3.89e-01
|
GOBP CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS
|
23
|
3.69e-02
|
3.91e-01
|
0.32600
|
-2.69e-01
|
1.83e-01
|
2.53e-02
|
1.28e-01
|
GOBP AUTOPHAGIC CELL DEATH
|
9
|
2.42e-01
|
7.25e-01
|
0.32600
|
3.24e-01
|
-3.43e-02
|
9.22e-02
|
8.58e-01
|
GOCC LSM1 7 PAT1 COMPLEX
|
5
|
4.15e-01
|
8.30e-01
|
0.32600
|
-1.31e-01
|
-2.98e-01
|
6.11e-01
|
2.48e-01
|
GOBP RESPONSE TO EPINEPHRINE
|
14
|
1.05e-01
|
5.75e-01
|
0.32600
|
-3.26e-01
|
2.67e-03
|
3.47e-02
|
9.86e-01
|
GOBP REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS
|
10
|
1.66e-01
|
6.51e-01
|
0.32600
|
-1.77e-01
|
-2.74e-01
|
3.32e-01
|
1.34e-01
|
GOBP POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION
|
6
|
4.03e-01
|
8.26e-01
|
0.32600
|
3.14e-01
|
-8.61e-02
|
1.83e-01
|
7.15e-01
|
GOBP REGULATION OF ASTROCYTE ACTIVATION
|
8
|
3.18e-01
|
7.78e-01
|
0.32600
|
1.84e-01
|
-2.69e-01
|
3.67e-01
|
1.88e-01
|
GOBP T FOLLICULAR HELPER CELL DIFFERENTIATION
|
7
|
3.02e-01
|
7.67e-01
|
0.32600
|
8.55e-02
|
3.14e-01
|
6.95e-01
|
1.50e-01
|
GOMF PROCOLLAGEN PROLINE DIOXYGENASE ACTIVITY
|
8
|
2.63e-01
|
7.40e-01
|
0.32600
|
4.82e-02
|
3.22e-01
|
8.13e-01
|
1.15e-01
|
GOCC ENDOLYSOSOME LUMEN
|
5
|
4.90e-01
|
8.57e-01
|
0.32600
|
-2.60e-01
|
1.96e-01
|
3.14e-01
|
4.47e-01
|
GOBP NEGATIVE REGULATION OF MEMBRANE DEPOLARIZATION
|
7
|
3.50e-01
|
7.96e-01
|
0.32600
|
-1.01e-01
|
3.10e-01
|
6.45e-01
|
1.56e-01
|
GOBP GOLGI VESICLE FUSION TO TARGET MEMBRANE
|
5
|
4.52e-01
|
8.45e-01
|
0.32500
|
3.25e-01
|
-1.84e-02
|
2.08e-01
|
9.43e-01
|
GOMF SMALL RIBOSOMAL SUBUNIT RRNA BINDING
|
8
|
3.22e-01
|
7.79e-01
|
0.32500
|
2.13e-01
|
-2.46e-01
|
2.96e-01
|
2.29e-01
|
GOBP INTERLEUKIN 18 PRODUCTION
|
14
|
1.33e-01
|
6.13e-01
|
0.32500
|
1.60e-01
|
-2.83e-01
|
3.00e-01
|
6.64e-02
|
GOMF C X C CHEMOKINE BINDING
|
5
|
4.93e-01
|
8.58e-01
|
0.32500
|
-2.37e-01
|
2.22e-01
|
3.58e-01
|
3.89e-01
|
GOMF PHOSPHOLIPASE A2 INHIBITOR ACTIVITY
|
6
|
3.95e-01
|
8.24e-01
|
0.32500
|
-3.21e-01
|
5.34e-02
|
1.74e-01
|
8.21e-01
|
GOBP FARNESYL DIPHOSPHATE METABOLIC PROCESS
|
6
|
3.61e-01
|
8.03e-01
|
0.32500
|
-3.16e-01
|
-7.74e-02
|
1.80e-01
|
7.43e-01
|
GOMF ALL TRANS RETINAL BINDING
|
5
|
4.31e-01
|
8.37e-01
|
0.32500
|
6.45e-02
|
3.19e-01
|
8.03e-01
|
2.17e-01
|
GOBP LEUKOTRIENE TRANSPORT
|
7
|
3.21e-01
|
7.78e-01
|
0.32500
|
-3.25e-01
|
-1.42e-02
|
1.37e-01
|
9.48e-01
|
GOBP POSITIVE REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I
|
10
|
2.40e-01
|
7.25e-01
|
0.32500
|
-2.69e-01
|
1.83e-01
|
1.41e-01
|
3.17e-01
|
GOBP PROTEIN NITROSYLATION
|
15
|
1.07e-01
|
5.79e-01
|
0.32500
|
-3.09e-01
|
1.01e-01
|
3.84e-02
|
4.97e-01
|
GOCC ZYMOGEN GRANULE
|
14
|
1.00e-01
|
5.69e-01
|
0.32500
|
-2.94e-02
|
-3.24e-01
|
8.49e-01
|
3.60e-02
|
GOBP REGULATION OF ANTIBACTERIAL PEPTIDE PRODUCTION
|
7
|
3.20e-01
|
7.78e-01
|
0.32500
|
-1.91e-02
|
-3.24e-01
|
9.30e-01
|
1.37e-01
|
GOMF INHIBITORY EXTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY
|
11
|
1.46e-01
|
6.33e-01
|
0.32500
|
-1.27e-01
|
-2.99e-01
|
4.66e-01
|
8.59e-02
|
GOBP AORTA SMOOTH MUSCLE TISSUE MORPHOGENESIS
|
6
|
3.52e-01
|
7.96e-01
|
0.32500
|
1.22e-01
|
3.01e-01
|
6.05e-01
|
2.01e-01
|
GOBP ORGANELLE INHERITANCE
|
15
|
9.53e-02
|
5.61e-01
|
0.32500
|
-3.23e-01
|
3.23e-02
|
3.02e-02
|
8.28e-01
|
GOMF STRUCTURAL CONSTITUENT OF SKIN EPIDERMIS
|
35
|
1.98e-03
|
8.19e-02
|
0.32500
|
1.72e-01
|
2.75e-01
|
7.74e-02
|
4.82e-03
|
GOMF FUCOSYLTRANSFERASE ACTIVITY
|
13
|
1.22e-01
|
6.03e-01
|
0.32500
|
-1.20e-02
|
-3.25e-01
|
9.40e-01
|
4.27e-02
|
GOBP POST ANAL TAIL MORPHOGENESIS
|
18
|
7.85e-02
|
5.26e-01
|
0.32500
|
-2.49e-01
|
2.09e-01
|
6.74e-02
|
1.25e-01
|
GOBP POLY N ACETYLLACTOSAMINE METABOLIC PROCESS
|
7
|
3.50e-01
|
7.96e-01
|
0.32500
|
-3.11e-01
|
9.20e-02
|
1.54e-01
|
6.73e-01
|
GOMF PROTEIN CARBOXYL O METHYLTRANSFERASE ACTIVITY
|
6
|
4.28e-01
|
8.36e-01
|
0.32500
|
-2.51e-01
|
2.06e-01
|
2.86e-01
|
3.83e-01
|
GOMF GPI LINKED EPHRIN RECEPTOR ACTIVITY
|
6
|
3.45e-01
|
7.96e-01
|
0.32500
|
-1.62e-01
|
-2.82e-01
|
4.93e-01
|
2.32e-01
|
GOMF TRANSLATION INITIATION FACTOR ACTIVITY
|
44
|
1.30e-03
|
6.12e-02
|
0.32500
|
7.83e-02
|
-3.15e-01
|
3.69e-01
|
2.99e-04
|
GOBP REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS
|
13
|
1.40e-01
|
6.23e-01
|
0.32400
|
3.16e-01
|
-7.58e-02
|
4.89e-02
|
6.36e-01
|
GOBP REGULATION OF PROTEIN FOLDING
|
8
|
2.93e-01
|
7.63e-01
|
0.32400
|
5.62e-02
|
-3.19e-01
|
7.83e-01
|
1.18e-01
|
GOBP EMBRYONIC VISCEROCRANIUM MORPHOGENESIS
|
10
|
2.33e-01
|
7.20e-01
|
0.32400
|
-2.95e-01
|
1.34e-01
|
1.06e-01
|
4.63e-01
|
GOBP NEUROBLAST MIGRATION
|
6
|
3.81e-01
|
8.16e-01
|
0.32400
|
-6.70e-03
|
-3.24e-01
|
9.77e-01
|
1.69e-01
|
GOCC MICROTUBULE ORGANIZING CENTER ATTACHMENT SITE
|
11
|
1.77e-01
|
6.67e-01
|
0.32400
|
-3.24e-01
|
2.22e-02
|
6.31e-02
|
8.99e-01
|
GOBP REGULATION OF ENDOSOME ORGANIZATION
|
5
|
4.94e-01
|
8.58e-01
|
0.32400
|
2.12e-01
|
-2.46e-01
|
4.13e-01
|
3.41e-01
|
GOCC PARASPECKLES
|
7
|
3.24e-01
|
7.80e-01
|
0.32400
|
-8.61e-03
|
-3.24e-01
|
9.69e-01
|
1.38e-01
|
GOBP REGULATION OF VITAMIN D RECEPTOR SIGNALING PATHWAY
|
10
|
2.25e-01
|
7.13e-01
|
0.32400
|
-9.32e-02
|
3.10e-01
|
6.10e-01
|
8.92e-02
|
GOBP POSITIVE REGULATION OF CGMP MEDIATED SIGNALING
|
5
|
4.31e-01
|
8.37e-01
|
0.32400
|
7.27e-02
|
3.16e-01
|
7.78e-01
|
2.21e-01
|
GOBP ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE
|
13
|
1.45e-01
|
6.29e-01
|
0.32400
|
-9.72e-02
|
3.09e-01
|
5.44e-01
|
5.39e-02
|
GOBP BLASTODERM SEGMENTATION
|
24
|
2.39e-02
|
3.28e-01
|
0.32400
|
-3.18e-02
|
3.22e-01
|
7.87e-01
|
6.30e-03
|
GOMF OXO ACID LYASE ACTIVITY
|
7
|
2.86e-01
|
7.59e-01
|
0.32400
|
-2.30e-01
|
-2.28e-01
|
2.92e-01
|
2.97e-01
|
GOBP NEGATIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS
|
7
|
2.95e-01
|
7.64e-01
|
0.32300
|
-1.45e-01
|
-2.89e-01
|
5.07e-01
|
1.85e-01
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN ANOTHER COMPOUND AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN
|
6
|
4.31e-01
|
8.37e-01
|
0.32300
|
2.08e-01
|
-2.48e-01
|
3.78e-01
|
2.93e-01
|
GOBP REGULATION OF COMPLEMENT ACTIVATION
|
22
|
4.31e-02
|
4.26e-01
|
0.32300
|
1.54e-01
|
-2.84e-01
|
2.11e-01
|
2.09e-02
|
GOBP G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY
|
12
|
1.44e-01
|
6.28e-01
|
0.32300
|
2.31e-02
|
3.22e-01
|
8.90e-01
|
5.32e-02
|
GOBP REGULATION OF ENAMEL MINERALIZATION
|
7
|
2.98e-01
|
7.67e-01
|
0.32300
|
2.95e-01
|
1.32e-01
|
1.77e-01
|
5.46e-01
|
GOMF MEDIUM CHAIN FATTY ACID COA LIGASE ACTIVITY
|
9
|
2.69e-01
|
7.45e-01
|
0.32300
|
1.16e-01
|
-3.01e-01
|
5.45e-01
|
1.18e-01
|
GOMF L LACTATE DEHYDROGENASE ACTIVITY
|
5
|
4.93e-01
|
8.58e-01
|
0.32300
|
1.70e-01
|
-2.74e-01
|
5.10e-01
|
2.88e-01
|
GOBP NOREPINEPHRINE METABOLIC PROCESS
|
12
|
1.61e-01
|
6.48e-01
|
0.32300
|
3.18e-01
|
-5.23e-02
|
5.61e-02
|
7.54e-01
|
GOBP SEPTUM PRIMUM DEVELOPMENT
|
5
|
4.81e-01
|
8.54e-01
|
0.32300
|
-1.09e-01
|
3.04e-01
|
6.74e-01
|
2.39e-01
|
GOBP DETERMINATION OF DIGESTIVE TRACT LEFT RIGHT ASYMMETRY
|
6
|
4.00e-01
|
8.25e-01
|
0.32300
|
-4.81e-02
|
3.19e-01
|
8.38e-01
|
1.76e-01
|
GOBP GROWTH INVOLVED IN HEART MORPHOGENESIS
|
5
|
4.27e-01
|
8.36e-01
|
0.32300
|
-3.05e-01
|
-1.05e-01
|
2.38e-01
|
6.83e-01
|
GOBP TOLERANCE INDUCTION DEPENDENT UPON IMMUNE RESPONSE
|
5
|
4.50e-01
|
8.43e-01
|
0.32300
|
-1.16e-02
|
-3.22e-01
|
9.64e-01
|
2.12e-01
|
GOBP POSITIVE REGULATION OF ENAMEL MINERALIZATION
|
5
|
4.94e-01
|
8.58e-01
|
0.32300
|
2.74e-01
|
-1.71e-01
|
2.90e-01
|
5.08e-01
|
GOMF HISTONE H3K4 METHYLTRANSFERASE ACTIVITY
|
19
|
7.11e-02
|
5.08e-01
|
0.32300
|
-2.16e-01
|
2.40e-01
|
1.03e-01
|
7.07e-02
|
GOBP NEGATIVE REGULATION OF LIPASE ACTIVITY
|
15
|
1.23e-01
|
6.06e-01
|
0.32200
|
1.95e-01
|
-2.57e-01
|
1.91e-01
|
8.53e-02
|
GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE TRANSLOCATION
|
8
|
2.85e-01
|
7.57e-01
|
0.32200
|
7.92e-03
|
-3.22e-01
|
9.69e-01
|
1.15e-01
|
GOCC U2 SNRNP
|
24
|
2.80e-02
|
3.48e-01
|
0.32200
|
7.58e-02
|
-3.13e-01
|
5.21e-01
|
7.95e-03
|
GOBP N ACYLETHANOLAMINE METABOLIC PROCESS
|
5
|
4.90e-01
|
8.57e-01
|
0.32200
|
-2.88e-01
|
1.44e-01
|
2.65e-01
|
5.78e-01
|
GOBP TRNA 5 END PROCESSING
|
15
|
1.21e-01
|
6.03e-01
|
0.32200
|
2.73e-01
|
-1.70e-01
|
6.70e-02
|
2.53e-01
|
GOMF RAGE RECEPTOR BINDING
|
10
|
2.41e-01
|
7.25e-01
|
0.32200
|
2.88e-01
|
-1.44e-01
|
1.15e-01
|
4.32e-01
|
GOBP AMPA GLUTAMATE RECEPTOR CLUSTERING
|
10
|
2.33e-01
|
7.20e-01
|
0.32200
|
-1.05e-01
|
3.04e-01
|
5.66e-01
|
9.56e-02
|
GOMF INHIBITORY MHC CLASS I RECEPTOR ACTIVITY
|
9
|
2.04e-01
|
6.94e-01
|
0.32200
|
2.31e-01
|
2.24e-01
|
2.31e-01
|
2.44e-01
|
GOBP POSITIVE REGULATION OF NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION
|
5
|
4.99e-01
|
8.61e-01
|
0.32200
|
1.96e-01
|
-2.55e-01
|
4.47e-01
|
3.24e-01
|
GOBP POSITIVE REGULATION OF MHC CLASS I BIOSYNTHETIC PROCESS
|
6
|
3.62e-01
|
8.03e-01
|
0.32200
|
-1.05e-01
|
-3.04e-01
|
6.56e-01
|
1.97e-01
|
GOBP COMMON BILE DUCT DEVELOPMENT
|
5
|
4.19e-01
|
8.32e-01
|
0.32200
|
1.64e-01
|
2.77e-01
|
5.26e-01
|
2.84e-01
|
GOBP AMYLIN RECEPTOR SIGNALING PATHWAY
|
6
|
3.83e-01
|
8.16e-01
|
0.32200
|
-2.32e-02
|
-3.21e-01
|
9.22e-01
|
1.74e-01
|
GOBP OVIDUCT DEVELOPMENT
|
5
|
4.14e-01
|
8.29e-01
|
0.32100
|
-2.29e-01
|
-2.26e-01
|
3.75e-01
|
3.82e-01
|
GOBP COMPLEMENT ACTIVATION CLASSICAL PATHWAY
|
34
|
8.61e-03
|
1.95e-01
|
0.32100
|
1.70e-01
|
-2.72e-01
|
8.57e-02
|
5.97e-03
|
GOBP ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN
|
25
|
3.01e-02
|
3.61e-01
|
0.32100
|
1.65e-01
|
-2.75e-01
|
1.52e-01
|
1.71e-02
|
GOBP VOLUNTARY SKELETAL MUSCLE CONTRACTION
|
5
|
4.28e-01
|
8.36e-01
|
0.32100
|
-3.00e-01
|
-1.15e-01
|
2.45e-01
|
6.57e-01
|
GOCC CHROMAFFIN GRANULE MEMBRANE
|
9
|
2.38e-01
|
7.25e-01
|
0.32100
|
2.09e-02
|
3.21e-01
|
9.13e-01
|
9.59e-02
|
GOBP NEGATIVE REGULATION OF MITOCHONDRIAL FUSION
|
7
|
3.44e-01
|
7.95e-01
|
0.32100
|
3.68e-02
|
-3.19e-01
|
8.66e-01
|
1.44e-01
|
GOMF IMPORTIN ALPHA FAMILY PROTEIN BINDING
|
9
|
2.35e-01
|
7.24e-01
|
0.32100
|
-3.36e-02
|
-3.19e-01
|
8.61e-01
|
9.73e-02
|
GOBP EMBRYONIC PROCESS INVOLVED IN FEMALE PREGNANCY
|
6
|
3.86e-01
|
8.19e-01
|
0.32100
|
3.20e-01
|
1.82e-02
|
1.74e-01
|
9.39e-01
|
GOBP NEGATIVE REGULATION OF FIBROBLAST MIGRATION
|
10
|
1.88e-01
|
6.81e-01
|
0.32100
|
9.22e-02
|
3.07e-01
|
6.14e-01
|
9.25e-02
|
GOMF IRON ION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
8
|
3.19e-01
|
7.78e-01
|
0.32100
|
-1.26e-01
|
2.95e-01
|
5.36e-01
|
1.49e-01
|
GOBP VENOUS BLOOD VESSEL MORPHOGENESIS
|
9
|
2.89e-01
|
7.60e-01
|
0.32100
|
-2.49e-01
|
2.02e-01
|
1.96e-01
|
2.93e-01
|
GOCC OUTER KINETOCHORE
|
20
|
5.29e-02
|
4.54e-01
|
0.32100
|
8.29e-02
|
-3.10e-01
|
5.21e-01
|
1.65e-02
|
GOBP PEXOPHAGY
|
6
|
3.71e-01
|
8.09e-01
|
0.32100
|
-7.80e-02
|
-3.11e-01
|
7.41e-01
|
1.87e-01
|
GOBP MOTOR NEURON MIGRATION
|
13
|
1.55e-01
|
6.42e-01
|
0.32000
|
2.99e-01
|
-1.16e-01
|
6.22e-02
|
4.69e-01
|
GOMF SIGNAL RECOGNITION PARTICLE BINDING
|
7
|
2.97e-01
|
7.66e-01
|
0.32000
|
-1.74e-01
|
-2.69e-01
|
4.27e-01
|
2.17e-01
|
GOBP POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS
|
12
|
1.44e-01
|
6.28e-01
|
0.32000
|
4.62e-02
|
3.17e-01
|
7.82e-01
|
5.72e-02
|
GOCC ESC E Z COMPLEX
|
9
|
2.83e-01
|
7.56e-01
|
0.32000
|
-2.82e-01
|
1.51e-01
|
1.42e-01
|
4.33e-01
|
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN
|
14
|
1.23e-01
|
6.05e-01
|
0.32000
|
-3.16e-01
|
5.46e-02
|
4.09e-02
|
7.23e-01
|
GOCC MICROFIBRIL
|
13
|
1.29e-01
|
6.09e-01
|
0.32000
|
1.09e-02
|
3.20e-01
|
9.46e-01
|
4.57e-02
|
GOMF UBIQUITIN LIGASE ACTIVATOR ACTIVITY
|
7
|
3.83e-01
|
8.16e-01
|
0.32000
|
2.19e-01
|
-2.33e-01
|
3.15e-01
|
2.85e-01
|
GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION INDEPENDENT DECAY
|
7
|
3.65e-01
|
8.06e-01
|
0.32000
|
-3.02e-01
|
1.06e-01
|
1.67e-01
|
6.26e-01
|
GOBP VESICLE MEDIATED CHOLESTEROL TRANSPORT
|
9
|
2.13e-01
|
7.02e-01
|
0.32000
|
-2.81e-01
|
-1.53e-01
|
1.45e-01
|
4.26e-01
|
GOBP PROPIONATE METABOLIC PROCESS
|
5
|
4.70e-01
|
8.51e-01
|
0.32000
|
-3.17e-01
|
4.12e-02
|
2.19e-01
|
8.73e-01
|
GOBP HEART VALVE FORMATION
|
15
|
9.65e-02
|
5.61e-01
|
0.32000
|
-3.20e-01
|
-1.49e-03
|
3.19e-02
|
9.92e-01
|
GOBP NEGATIVE REGULATION OF P38MAPK CASCADE
|
8
|
2.87e-01
|
7.59e-01
|
0.32000
|
-4.36e-03
|
-3.20e-01
|
9.83e-01
|
1.17e-01
|
GOBP POSITIVE REGULATION OF GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION
|
5
|
5.05e-01
|
8.65e-01
|
0.32000
|
-2.14e-01
|
2.38e-01
|
4.08e-01
|
3.57e-01
|
GOBP GASTRIC ACID SECRETION
|
13
|
1.46e-01
|
6.30e-01
|
0.32000
|
-6.33e-02
|
3.13e-01
|
6.93e-01
|
5.04e-02
|
GOCC INTEGRIN COMPLEX
|
30
|
1.56e-02
|
2.64e-01
|
0.32000
|
-1.63e-01
|
2.75e-01
|
1.23e-01
|
9.11e-03
|
GOCC ENDOPLASMIC RETICULUM PLASMA MEMBRANE CONTACT SITE
|
12
|
1.89e-01
|
6.83e-01
|
0.32000
|
-1.64e-01
|
2.74e-01
|
3.24e-01
|
1.00e-01
|
GOMF PHOSPHOTRANSFERASE ACTIVITY PHOSPHATE GROUP AS ACCEPTOR
|
34
|
2.70e-03
|
1.01e-01
|
0.31900
|
-2.20e-01
|
-2.32e-01
|
2.64e-02
|
1.94e-02
|
GOBP CARDIAC NEURAL CREST CELL MIGRATION INVOLVED IN OUTFLOW TRACT MORPHOGENESIS
|
11
|
1.80e-01
|
6.69e-01
|
0.31900
|
-3.19e-01
|
-6.81e-03
|
6.66e-02
|
9.69e-01
|
GOBP TYROSINE CATABOLIC PROCESS
|
6
|
4.40e-01
|
8.40e-01
|
0.31900
|
-2.02e-01
|
2.47e-01
|
3.91e-01
|
2.95e-01
|
GOBP POSITIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION
|
10
|
1.76e-01
|
6.65e-01
|
0.31900
|
-2.19e-01
|
-2.32e-01
|
2.30e-01
|
2.04e-01
|
GOMF ACYLGLYCEROL LIPASE ACTIVITY
|
15
|
1.29e-01
|
6.09e-01
|
0.31900
|
-2.03e-01
|
2.46e-01
|
1.73e-01
|
9.88e-02
|
GOBP GLYCOSYLCERAMIDE CATABOLIC PROCESS
|
6
|
3.54e-01
|
7.97e-01
|
0.31900
|
-1.87e-01
|
-2.59e-01
|
4.29e-01
|
2.72e-01
|
GOCC MHC PROTEIN COMPLEX
|
24
|
3.75e-02
|
3.94e-01
|
0.31900
|
1.97e-01
|
-2.52e-01
|
9.54e-02
|
3.29e-02
|
GOBP WOUND HEALING SPREADING OF EPIDERMAL CELLS
|
21
|
4.18e-02
|
4.21e-01
|
0.31900
|
-3.18e-01
|
3.13e-02
|
1.17e-02
|
8.04e-01
|
GOMF PROTEIN DEMETHYLASE ACTIVITY
|
25
|
3.16e-02
|
3.64e-01
|
0.31900
|
-2.73e-01
|
1.66e-01
|
1.83e-02
|
1.51e-01
|
GOMF GROWTH HORMONE RECEPTOR BINDING
|
9
|
2.11e-01
|
7.00e-01
|
0.31900
|
-2.58e-01
|
-1.88e-01
|
1.80e-01
|
3.29e-01
|
GOBP DENSE CORE GRANULE LOCALIZATION
|
10
|
2.56e-01
|
7.35e-01
|
0.31900
|
-2.11e-01
|
2.39e-01
|
2.48e-01
|
1.90e-01
|
GOBP REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS
|
7
|
3.73e-01
|
8.10e-01
|
0.31900
|
-1.31e-01
|
2.91e-01
|
5.48e-01
|
1.83e-01
|
GOBP PARAXIAL MESODERM MORPHOGENESIS
|
10
|
1.78e-01
|
6.67e-01
|
0.31900
|
1.86e-01
|
2.59e-01
|
3.09e-01
|
1.56e-01
|
GOBP NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY
|
21
|
5.06e-02
|
4.46e-01
|
0.31900
|
-2.98e-01
|
1.15e-01
|
1.83e-02
|
3.63e-01
|
GOBP REGULATION OF SULFUR METABOLIC PROCESS
|
12
|
1.53e-01
|
6.41e-01
|
0.31900
|
1.68e-02
|
3.18e-01
|
9.20e-01
|
5.62e-02
|
GOMF PROTEIN PRENYLTRANSFERASE ACTIVITY
|
6
|
3.55e-01
|
7.97e-01
|
0.31900
|
-2.56e-01
|
-1.90e-01
|
2.77e-01
|
4.21e-01
|
GOMF 1 PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE 3 KINASE ACTIVITY
|
7
|
3.35e-01
|
7.88e-01
|
0.31900
|
1.19e-02
|
3.19e-01
|
9.57e-01
|
1.44e-01
|
GOMF MITOGEN ACTIVATED PROTEIN KINASE P38 BINDING
|
7
|
3.48e-01
|
7.96e-01
|
0.31900
|
-3.17e-01
|
3.15e-02
|
1.46e-01
|
8.85e-01
|
GOBP RESPONSE TO GRAVITY
|
9
|
2.23e-01
|
7.12e-01
|
0.31900
|
2.99e-01
|
1.09e-01
|
1.20e-01
|
5.71e-01
|
GOBP NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS
|
11
|
2.24e-01
|
7.13e-01
|
0.31900
|
-2.11e-01
|
2.39e-01
|
2.25e-01
|
1.71e-01
|
GOMF 7S RNA BINDING
|
7
|
3.81e-01
|
8.16e-01
|
0.31900
|
1.64e-01
|
-2.73e-01
|
4.53e-01
|
2.11e-01
|
GOCC GEMINI OF COILED BODIES
|
11
|
2.25e-01
|
7.13e-01
|
0.31800
|
2.11e-01
|
-2.38e-01
|
2.25e-01
|
1.72e-01
|
GOBP NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION
|
8
|
2.63e-01
|
7.40e-01
|
0.31800
|
-2.96e-01
|
-1.16e-01
|
1.47e-01
|
5.68e-01
|
GOBP NEUTROPHIL MEDIATED KILLING OF GRAM NEGATIVE BACTERIUM
|
6
|
3.69e-01
|
8.09e-01
|
0.31800
|
-1.09e-01
|
-2.99e-01
|
6.45e-01
|
2.05e-01
|
GOMF POLYSOME BINDING
|
6
|
4.24e-01
|
8.35e-01
|
0.31800
|
9.67e-02
|
-3.03e-01
|
6.82e-01
|
1.99e-01
|
GOMF BIOTIN BINDING
|
5
|
4.72e-01
|
8.53e-01
|
0.31800
|
-3.16e-01
|
3.37e-02
|
2.21e-01
|
8.96e-01
|
GOBP POSITIVE REGULATION OF T HELPER 1 CELL DIFFERENTIATION
|
6
|
4.40e-01
|
8.40e-01
|
0.31800
|
2.67e-01
|
-1.72e-01
|
2.57e-01
|
4.65e-01
|
GOCC CHOLINERGIC SYNAPSE
|
11
|
1.77e-01
|
6.67e-01
|
0.31800
|
-3.16e-01
|
-3.02e-02
|
6.91e-02
|
8.62e-01
|
GOBP COPPER ION IMPORT
|
6
|
3.89e-01
|
8.21e-01
|
0.31800
|
-3.17e-01
|
-2.93e-02
|
1.79e-01
|
9.01e-01
|
GOMF UREA TRANSMEMBRANE TRANSPORTER ACTIVITY
|
7
|
3.87e-01
|
8.19e-01
|
0.31800
|
-2.52e-01
|
1.94e-01
|
2.48e-01
|
3.74e-01
|
GOMF CALCIUM ACTIVATED POTASSIUM CHANNEL ACTIVITY
|
13
|
1.56e-01
|
6.43e-01
|
0.31800
|
3.02e-01
|
-9.76e-02
|
5.90e-02
|
5.42e-01
|
GOBP CHROMOSOME ATTACHMENT TO THE NUCLEAR ENVELOPE
|
7
|
3.26e-01
|
7.82e-01
|
0.31800
|
5.59e-02
|
3.13e-01
|
7.98e-01
|
1.52e-01
|
GOBP ALDITOL PHOSPHATE METABOLIC PROCESS
|
10
|
2.58e-01
|
7.35e-01
|
0.31800
|
-2.52e-01
|
1.94e-01
|
1.68e-01
|
2.89e-01
|
GOBP PROTEIN LOCALIZATION TO NUCLEOPLASM
|
13
|
1.64e-01
|
6.48e-01
|
0.31800
|
1.36e-01
|
-2.87e-01
|
3.97e-01
|
7.29e-02
|
GOBP POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS
|
16
|
8.14e-02
|
5.32e-01
|
0.31800
|
-3.16e-01
|
-2.81e-02
|
2.84e-02
|
8.45e-01
|
GOBP MICROGLIAL CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE
|
5
|
4.23e-01
|
8.34e-01
|
0.31800
|
-2.42e-01
|
-2.05e-01
|
3.48e-01
|
4.27e-01
|
GOBP PANCREATIC JUICE SECRETION
|
11
|
2.24e-01
|
7.13e-01
|
0.31800
|
-2.57e-01
|
1.87e-01
|
1.40e-01
|
2.84e-01
|
GOBP PROTEIN LOCALIZATION TO CELL CELL JUNCTION
|
21
|
4.65e-02
|
4.37e-01
|
0.31800
|
-6.30e-02
|
3.11e-01
|
6.17e-01
|
1.35e-02
|
GOBP POSITIVE REGULATION OF AXON GUIDANCE
|
5
|
5.10e-01
|
8.66e-01
|
0.31800
|
2.22e-01
|
-2.27e-01
|
3.90e-01
|
3.79e-01
|
GOBP NEUTROPHIL MEDIATED KILLING OF SYMBIONT CELL
|
12
|
1.34e-01
|
6.16e-01
|
0.31800
|
-1.36e-01
|
-2.87e-01
|
4.13e-01
|
8.55e-02
|
GOMF SULFURTRANSFERASE ACTIVITY
|
11
|
2.27e-01
|
7.15e-01
|
0.31700
|
-2.26e-01
|
2.23e-01
|
1.95e-01
|
2.00e-01
|
GOBP REGULATION OF RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE
|
6
|
3.83e-01
|
8.16e-01
|
0.31700
|
-6.11e-02
|
-3.11e-01
|
7.96e-01
|
1.87e-01
|
GOBP POSITIVE REGULATION OF LOW DENSITY LIPOPROTEIN RECEPTOR ACTIVITY
|
5
|
5.04e-01
|
8.65e-01
|
0.31700
|
1.57e-01
|
-2.75e-01
|
5.42e-01
|
2.87e-01
|
GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY
|
7
|
3.50e-01
|
7.96e-01
|
0.31700
|
2.56e-02
|
-3.16e-01
|
9.06e-01
|
1.48e-01
|
GOBP POLYOL CATABOLIC PROCESS
|
9
|
2.98e-01
|
7.67e-01
|
0.31700
|
-2.31e-01
|
2.17e-01
|
2.31e-01
|
2.59e-01
|
GOBP REGULATION OF BINDING OF SPERM TO ZONA PELLUCIDA
|
5
|
5.09e-01
|
8.66e-01
|
0.31700
|
1.80e-01
|
-2.60e-01
|
4.86e-01
|
3.13e-01
|
GOMF C C CHEMOKINE BINDING
|
23
|
1.97e-02
|
3.00e-01
|
0.31600
|
2.17e-01
|
2.30e-01
|
7.11e-02
|
5.63e-02
|
GOBP CELLULAR RESPONSE TO IRON ION
|
8
|
2.99e-01
|
7.67e-01
|
0.31600
|
-1.28e-02
|
3.16e-01
|
9.50e-01
|
1.22e-01
|
GOMF GLYCEROL CHANNEL ACTIVITY
|
5
|
5.06e-01
|
8.65e-01
|
0.31600
|
-1.56e-01
|
2.75e-01
|
5.46e-01
|
2.87e-01
|
GOMF GLYCINE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
9
|
2.45e-01
|
7.26e-01
|
0.31600
|
3.14e-01
|
3.45e-02
|
1.02e-01
|
8.58e-01
|
GOMF LEUKOTRIENE C4 SYNTHASE ACTIVITY
|
5
|
5.09e-01
|
8.66e-01
|
0.31600
|
-1.76e-01
|
2.63e-01
|
4.96e-01
|
3.09e-01
|
GOBP REGULATION OF VASCULOGENESIS
|
16
|
6.77e-02
|
4.99e-01
|
0.31600
|
2.71e-01
|
1.63e-01
|
6.08e-02
|
2.58e-01
|
GOBP AROMATIC AMINO ACID TRANSPORT
|
9
|
3.01e-01
|
7.67e-01
|
0.31600
|
-2.31e-01
|
2.16e-01
|
2.30e-01
|
2.63e-01
|
GOBP DNA REPLICATION DEPENDENT CHROMATIN ASSEMBLY
|
6
|
3.99e-01
|
8.25e-01
|
0.31600
|
-1.25e-02
|
-3.15e-01
|
9.58e-01
|
1.81e-01
|
GOBP NEGATIVE REGULATION OF JUN KINASE ACTIVITY
|
14
|
1.38e-01
|
6.21e-01
|
0.31600
|
9.04e-02
|
-3.02e-01
|
5.58e-01
|
5.00e-02
|
GOMF HISTONE H4K12 ACETYLTRANSFERASE ACTIVITY
|
12
|
2.02e-01
|
6.92e-01
|
0.31600
|
-2.10e-01
|
2.36e-01
|
2.08e-01
|
1.58e-01
|
GOBP POSITIVE REGULATION OF SEQUESTERING OF TRIGLYCERIDE
|
9
|
2.78e-01
|
7.51e-01
|
0.31600
|
-3.05e-01
|
8.27e-02
|
1.14e-01
|
6.68e-01
|
GOBP APOPTOTIC PROCESS IN BONE MARROW CELL
|
6
|
4.47e-01
|
8.41e-01
|
0.31600
|
1.85e-01
|
-2.55e-01
|
4.31e-01
|
2.79e-01
|
GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING
|
15
|
1.34e-01
|
6.16e-01
|
0.31500
|
-1.80e-01
|
2.59e-01
|
2.27e-01
|
8.24e-02
|
GOMF RNA POLYMERASE III TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING
|
9
|
2.39e-01
|
7.25e-01
|
0.31500
|
-3.08e-01
|
-6.75e-02
|
1.10e-01
|
7.26e-01
|
GOBP REGULATION OF ENDOTHELIAL CELL DEVELOPMENT
|
18
|
8.97e-02
|
5.51e-01
|
0.31500
|
-2.59e-01
|
1.79e-01
|
5.69e-02
|
1.88e-01
|
GOBP POSITIVE REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY
|
7
|
3.87e-01
|
8.19e-01
|
0.31500
|
-1.53e-01
|
2.75e-01
|
4.83e-01
|
2.07e-01
|
GOBP POSITIVE REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY
|
5
|
4.29e-01
|
8.36e-01
|
0.31500
|
2.30e-01
|
2.15e-01
|
3.73e-01
|
4.04e-01
|
GOBP PHOSPHATIDYLSERINE EXPOSURE ON APOPTOTIC CELL SURFACE
|
8
|
2.61e-01
|
7.39e-01
|
0.31500
|
2.64e-01
|
1.72e-01
|
1.96e-01
|
4.00e-01
|
GOBP RESPONSE TO REDOX STATE
|
14
|
9.72e-02
|
5.61e-01
|
0.31500
|
1.54e-01
|
2.75e-01
|
3.20e-01
|
7.48e-02
|
GOCC MITOCHONDRIAL CRISTA
|
8
|
3.46e-01
|
7.96e-01
|
0.31500
|
-2.28e-01
|
2.17e-01
|
2.65e-01
|
2.87e-01
|
GOMF MOLECULAR TAG ACTIVITY
|
13
|
1.78e-01
|
6.67e-01
|
0.31500
|
2.29e-01
|
-2.16e-01
|
1.52e-01
|
1.78e-01
|
GOBP REGULATION OF WNT PROTEIN SECRETION
|
5
|
4.72e-01
|
8.52e-01
|
0.31500
|
3.15e-01
|
-6.05e-03
|
2.23e-01
|
9.81e-01
|
GOBP WNT PROTEIN SECRETION
|
5
|
4.72e-01
|
8.52e-01
|
0.31500
|
3.15e-01
|
-6.05e-03
|
2.23e-01
|
9.81e-01
|
GOBP RESPONSE TO PROSTAGLANDIN D
|
5
|
5.15e-01
|
8.68e-01
|
0.31500
|
2.02e-01
|
-2.42e-01
|
4.34e-01
|
3.50e-01
|
GOBP MACROMOLECULE DEPALMITOYLATION
|
11
|
2.06e-01
|
6.95e-01
|
0.31500
|
-3.08e-01
|
6.33e-02
|
7.66e-02
|
7.16e-01
|
GOMF PALMITOYL HYDROLASE ACTIVITY
|
11
|
2.06e-01
|
6.95e-01
|
0.31500
|
-3.08e-01
|
6.33e-02
|
7.66e-02
|
7.16e-01
|
GOBP SMOOTH MUSCLE CELL MATRIX ADHESION
|
6
|
4.07e-01
|
8.26e-01
|
0.31500
|
-6.48e-03
|
3.15e-01
|
9.78e-01
|
1.82e-01
|
GOBP NEGATIVE REGULATION OF RESPONSE TO TYPE II INTERFERON
|
7
|
3.94e-01
|
8.23e-01
|
0.31500
|
1.90e-01
|
-2.51e-01
|
3.84e-01
|
2.50e-01
|
GOBP TRACHEA MORPHOGENESIS
|
11
|
2.33e-01
|
7.20e-01
|
0.31400
|
-2.27e-01
|
2.18e-01
|
1.92e-01
|
2.11e-01
|
GOBP ESTABLISHMENT OF LEFT RIGHT ASYMMETRY
|
6
|
3.68e-01
|
8.08e-01
|
0.31400
|
-2.67e-01
|
-1.65e-01
|
2.57e-01
|
4.83e-01
|
GOBP POSITIVE REGULATION OF MACROPHAGE MIGRATION
|
26
|
3.09e-02
|
3.61e-01
|
0.31400
|
-2.66e-01
|
1.67e-01
|
1.87e-02
|
1.42e-01
|
GOBP CELLULAR RESPONSE TO X RAY
|
11
|
2.02e-01
|
6.92e-01
|
0.31400
|
3.92e-02
|
-3.12e-01
|
8.22e-01
|
7.35e-02
|
GOMF ARRESTIN FAMILY PROTEIN BINDING
|
9
|
3.00e-01
|
7.67e-01
|
0.31400
|
-2.66e-01
|
1.67e-01
|
1.67e-01
|
3.87e-01
|
GOBP POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT
|
16
|
8.39e-02
|
5.37e-01
|
0.31400
|
4.24e-02
|
3.11e-01
|
7.69e-01
|
3.12e-02
|
GOBP ABSCISSION
|
6
|
3.68e-01
|
8.08e-01
|
0.31400
|
-2.64e-01
|
-1.70e-01
|
2.62e-01
|
4.72e-01
|
GOBP REGULATION OF MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE
|
6
|
4.49e-01
|
8.43e-01
|
0.31400
|
2.62e-01
|
-1.73e-01
|
2.66e-01
|
4.63e-01
|
GOBP CELLULAR RESPONSE TO ETHER
|
6
|
4.02e-01
|
8.26e-01
|
0.31400
|
-3.14e-01
|
-1.55e-02
|
1.83e-01
|
9.48e-01
|
GOBP BOX C D SNORNP ASSEMBLY
|
10
|
2.60e-01
|
7.38e-01
|
0.31400
|
1.53e-01
|
-2.74e-01
|
4.01e-01
|
1.33e-01
|
GOBP ATP TRANSPORT
|
17
|
1.04e-01
|
5.75e-01
|
0.31400
|
-2.60e-01
|
1.75e-01
|
6.31e-02
|
2.10e-01
|
GOMF ALPHA GLUCOSIDASE ACTIVITY
|
5
|
4.60e-01
|
8.48e-01
|
0.31400
|
-3.11e-01
|
-4.56e-02
|
2.29e-01
|
8.60e-01
|
GOBP REGULATION OF INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY
|
11
|
1.62e-01
|
6.48e-01
|
0.31400
|
1.56e-01
|
2.72e-01
|
3.69e-01
|
1.18e-01
|
GOBP CELLULAR RESPONSE TO UV B
|
12
|
2.06e-01
|
6.95e-01
|
0.31400
|
-2.19e-01
|
2.25e-01
|
1.89e-01
|
1.78e-01
|
GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE BINDING
|
35
|
9.39e-03
|
2.06e-01
|
0.31400
|
-1.66e-01
|
2.66e-01
|
8.89e-02
|
6.43e-03
|
GOMF RNA POLYMERASE II C TERMINAL DOMAIN BINDING
|
10
|
2.47e-01
|
7.26e-01
|
0.31400
|
-3.01e-01
|
8.64e-02
|
9.88e-02
|
6.36e-01
|
GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED EIF2 ALPHA PHOSPHORYLATION
|
5
|
4.34e-01
|
8.38e-01
|
0.31300
|
-1.90e-01
|
-2.49e-01
|
4.61e-01
|
3.35e-01
|
GOBP PYRIMIDINE RIBONUCLEOTIDE BIOSYNTHETIC PROCESS
|
22
|
2.54e-02
|
3.31e-01
|
0.31300
|
-1.97e-01
|
-2.44e-01
|
1.10e-01
|
4.77e-02
|
GOBP PROTEIN REPAIR
|
7
|
3.84e-01
|
8.17e-01
|
0.31300
|
-1.20e-01
|
2.89e-01
|
5.81e-01
|
1.85e-01
|
GOCC CONE PHOTORECEPTOR OUTER SEGMENT
|
8
|
2.97e-01
|
7.66e-01
|
0.31300
|
-3.12e-01
|
-2.12e-02
|
1.26e-01
|
9.17e-01
|
GOBP THYMOCYTE MIGRATION
|
7
|
4.00e-01
|
8.25e-01
|
0.31300
|
-2.19e-01
|
2.23e-01
|
3.15e-01
|
3.06e-01
|
GOBP NEUROTRANSMITTER LOADING INTO SYNAPTIC VESICLE
|
7
|
3.63e-01
|
8.04e-01
|
0.31300
|
3.11e-01
|
-3.59e-02
|
1.54e-01
|
8.69e-01
|
GOMF ACROSIN BINDING
|
5
|
5.10e-01
|
8.66e-01
|
0.31300
|
2.82e-01
|
-1.36e-01
|
2.75e-01
|
6.00e-01
|
GOBP OTOLITH DEVELOPMENT
|
10
|
1.89e-01
|
6.81e-01
|
0.31300
|
2.10e-01
|
2.32e-01
|
2.51e-01
|
2.04e-01
|
GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN EXECUTION PHASE OF APOPTOSIS
|
7
|
3.74e-01
|
8.11e-01
|
0.31300
|
-3.04e-01
|
7.40e-02
|
1.64e-01
|
7.35e-01
|
GOCC PLATELET DENSE GRANULE MEMBRANE
|
5
|
4.34e-01
|
8.38e-01
|
0.31300
|
-2.32e-01
|
-2.09e-01
|
3.68e-01
|
4.17e-01
|
GOBP GLYCOLYTIC PROCESS THROUGH GLUCOSE 6 PHOSPHATE
|
19
|
7.59e-02
|
5.19e-01
|
0.31300
|
-2.87e-01
|
1.24e-01
|
3.02e-02
|
3.51e-01
|
GOBP MRNA ALTERNATIVE POLYADENYLATION
|
5
|
4.44e-01
|
8.40e-01
|
0.31300
|
2.85e-01
|
1.29e-01
|
2.70e-01
|
6.17e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN KINASE ACTIVITY BY REGULATION OF PROTEIN PHOSPHORYLATION
|
6
|
4.14e-01
|
8.29e-01
|
0.31300
|
-3.12e-01
|
1.58e-02
|
1.85e-01
|
9.47e-01
|
GOBP REGULATION OF METANEPHROS DEVELOPMENT
|
5
|
5.13e-01
|
8.67e-01
|
0.31300
|
-2.75e-01
|
1.49e-01
|
2.87e-01
|
5.65e-01
|
GOBP LEUKOTRIENE BIOSYNTHETIC PROCESS
|
17
|
1.07e-01
|
5.79e-01
|
0.31300
|
-2.57e-01
|
1.79e-01
|
6.71e-02
|
2.03e-01
|
GOBP POLY A PLUS MRNA EXPORT FROM NUCLEUS
|
18
|
7.86e-02
|
5.26e-01
|
0.31200
|
-3.06e-01
|
6.44e-02
|
2.47e-02
|
6.36e-01
|
GOMF SNRNP BINDING
|
9
|
3.09e-01
|
7.72e-01
|
0.31200
|
2.27e-01
|
-2.15e-01
|
2.38e-01
|
2.65e-01
|
GOCC MCRD MEDIATED MRNA STABILITY COMPLEX
|
5
|
5.12e-01
|
8.67e-01
|
0.31200
|
1.44e-01
|
-2.78e-01
|
5.78e-01
|
2.83e-01
|
GOMF DINUCLEOTIDE PHOSPHATASE ACTIVITY
|
8
|
3.05e-01
|
7.69e-01
|
0.31200
|
-9.55e-04
|
-3.12e-01
|
9.96e-01
|
1.26e-01
|
GOBP MYOSIN FILAMENT ORGANIZATION
|
6
|
4.14e-01
|
8.29e-01
|
0.31200
|
-3.12e-01
|
9.59e-03
|
1.86e-01
|
9.68e-01
|
GOBP POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS
|
13
|
1.23e-01
|
6.04e-01
|
0.31200
|
-2.86e-01
|
-1.26e-01
|
7.47e-02
|
4.31e-01
|
GOBP REGULATION OF RNA BINDING
|
7
|
3.19e-01
|
7.78e-01
|
0.31200
|
-1.52e-01
|
-2.73e-01
|
4.87e-01
|
2.11e-01
|
GOBP PRE MIRNA PROCESSING
|
17
|
6.29e-02
|
4.83e-01
|
0.31200
|
-2.78e-01
|
-1.43e-01
|
4.76e-02
|
3.08e-01
|
GOCC PRONUCLEUS
|
14
|
1.14e-01
|
5.91e-01
|
0.31200
|
-6.21e-02
|
-3.06e-01
|
6.87e-01
|
4.76e-02
|
GOBP NEUTROPHIL APOPTOTIC PROCESS
|
8
|
2.69e-01
|
7.45e-01
|
0.31200
|
1.59e-01
|
2.68e-01
|
4.35e-01
|
1.89e-01
|
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS BY VEGF ACTIVATED VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY
|
5
|
4.36e-01
|
8.39e-01
|
0.31200
|
2.15e-01
|
2.26e-01
|
4.05e-01
|
3.82e-01
|
GOBP SPHINGOSINE BIOSYNTHETIC PROCESS
|
14
|
1.03e-01
|
5.74e-01
|
0.31200
|
-1.41e-01
|
-2.78e-01
|
3.60e-01
|
7.16e-02
|
GOBP REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY
|
53
|
9.31e-04
|
4.91e-02
|
0.31200
|
-2.64e-01
|
1.66e-01
|
8.72e-04
|
3.69e-02
|
GOBP LEUCINE CATABOLIC PROCESS
|
6
|
4.24e-01
|
8.35e-01
|
0.31200
|
-3.09e-01
|
4.51e-02
|
1.91e-01
|
8.48e-01
|
GOBP 3 UTR MEDIATED MRNA DESTABILIZATION
|
19
|
4.30e-02
|
4.26e-01
|
0.31200
|
2.03e-01
|
2.37e-01
|
1.26e-01
|
7.36e-02
|
GOBP CARNITINE TRANSPORT
|
8
|
2.67e-01
|
7.43e-01
|
0.31200
|
2.51e-01
|
1.85e-01
|
2.19e-01
|
3.66e-01
|
GOBP NEGATIVE REGULATION OF BONE MINERALIZATION
|
18
|
9.64e-02
|
5.61e-01
|
0.31200
|
-2.27e-01
|
2.13e-01
|
9.49e-02
|
1.17e-01
|
GOMF RNA ENDONUCLEASE ACTIVITY PRODUCING 3 PHOSPHOMONOESTERS
|
7
|
3.28e-01
|
7.83e-01
|
0.31200
|
1.05e-01
|
2.93e-01
|
6.30e-01
|
1.79e-01
|
GOMF NEUROPEPTIDE Y RECEPTOR ACTIVITY
|
9
|
2.84e-01
|
7.57e-01
|
0.31200
|
-3.04e-01
|
7.01e-02
|
1.15e-01
|
7.16e-01
|
GOMF U1 SNRNP BINDING
|
6
|
4.58e-01
|
8.48e-01
|
0.31100
|
1.93e-01
|
-2.45e-01
|
4.14e-01
|
2.99e-01
|
GOBP SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION
|
10
|
2.33e-01
|
7.20e-01
|
0.31100
|
-1.47e-02
|
3.11e-01
|
9.36e-01
|
8.86e-02
|
GOBP NEGATIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION
|
5
|
5.15e-01
|
8.68e-01
|
0.31100
|
1.43e-01
|
-2.77e-01
|
5.80e-01
|
2.84e-01
|
GOBP POSITIVE REGULATION OF DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION
|
7
|
3.15e-01
|
7.76e-01
|
0.31100
|
2.42e-01
|
1.96e-01
|
2.68e-01
|
3.69e-01
|
GOBP RESOLUTION OF RECOMBINATION INTERMEDIATES
|
6
|
3.92e-01
|
8.22e-01
|
0.31100
|
-3.01e-01
|
-7.85e-02
|
2.01e-01
|
7.39e-01
|
GOBP RESPONSE TO HEPARIN
|
7
|
3.15e-01
|
7.76e-01
|
0.31100
|
-2.34e-01
|
-2.05e-01
|
2.84e-01
|
3.47e-01
|
GOBP NEUTROPHIL DIFFERENTIATION
|
11
|
2.41e-01
|
7.25e-01
|
0.31100
|
-2.20e-01
|
2.19e-01
|
2.06e-01
|
2.08e-01
|
GOBP PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS
|
28
|
2.69e-02
|
3.41e-01
|
0.31100
|
-2.25e-01
|
2.15e-01
|
3.96e-02
|
4.91e-02
|
GOCC GROWTH FACTOR COMPLEX
|
8
|
2.74e-01
|
7.48e-01
|
0.31100
|
-2.73e-01
|
-1.48e-01
|
1.81e-01
|
4.69e-01
|
GOBP GROWTH PLATE CARTILAGE CHONDROCYTE DIFFERENTIATION
|
10
|
2.01e-01
|
6.90e-01
|
0.31100
|
1.33e-01
|
2.81e-01
|
4.68e-01
|
1.24e-01
|
GOBP OVULATION FROM OVARIAN FOLLICLE
|
8
|
2.71e-01
|
7.47e-01
|
0.31100
|
-1.71e-01
|
-2.59e-01
|
4.03e-01
|
2.04e-01
|
GOBP DENDRITIC TRANSPORT OF RIBONUCLEOPROTEIN COMPLEX
|
5
|
4.41e-01
|
8.40e-01
|
0.31100
|
-1.81e-01
|
-2.52e-01
|
4.83e-01
|
3.28e-01
|
GOBP CRD MEDIATED MRNA STABILIZATION
|
11
|
2.39e-01
|
7.25e-01
|
0.31100
|
1.74e-01
|
-2.58e-01
|
3.19e-01
|
1.39e-01
|
GOBP REGULATION OF MITOCHONDRIAL RNA CATABOLIC PROCESS
|
5
|
4.47e-01
|
8.41e-01
|
0.31100
|
-1.38e-01
|
-2.78e-01
|
5.94e-01
|
2.81e-01
|
GOBP REGULATION OF OXIDATIVE PHOSPHORYLATION
|
21
|
3.18e-02
|
3.65e-01
|
0.31100
|
-2.37e-01
|
-2.01e-01
|
6.00e-02
|
1.12e-01
|
GOBP MULTIVESICULAR BODY SORTING PATHWAY
|
46
|
1.68e-03
|
7.45e-02
|
0.31000
|
-3.03e-01
|
6.78e-02
|
3.78e-04
|
4.26e-01
|
GOBP SPERMIDINE TRANSPORT
|
5
|
4.75e-01
|
8.54e-01
|
0.31000
|
2.07e-02
|
3.10e-01
|
9.36e-01
|
2.30e-01
|
GOBP NEUTROPHIL CLEARANCE
|
6
|
4.59e-01
|
8.48e-01
|
0.31000
|
1.76e-01
|
-2.56e-01
|
4.56e-01
|
2.78e-01
|
GOBP CARDIAC SEPTUM CELL DIFFERENTIATION
|
5
|
5.16e-01
|
8.69e-01
|
0.31000
|
-2.77e-01
|
1.39e-01
|
2.83e-01
|
5.90e-01
|
GOCC NEURONAL DENSE CORE VESICLE MEMBRANE
|
5
|
4.63e-01
|
8.48e-01
|
0.31000
|
-3.03e-01
|
-6.73e-02
|
2.41e-01
|
7.94e-01
|
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS
|
23
|
2.53e-02
|
3.31e-01
|
0.31000
|
1.32e-01
|
2.81e-01
|
2.75e-01
|
1.97e-02
|
GOMF OPSONIN RECEPTOR ACTIVITY
|
5
|
4.50e-01
|
8.43e-01
|
0.31000
|
-2.81e-01
|
-1.32e-01
|
2.77e-01
|
6.10e-01
|
GOMF CHEMOKINE BINDING
|
31
|
6.39e-03
|
1.66e-01
|
0.31000
|
2.40e-01
|
1.95e-01
|
2.07e-02
|
5.96e-02
|
GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION
|
14
|
1.53e-01
|
6.41e-01
|
0.30900
|
1.10e-01
|
-2.89e-01
|
4.74e-01
|
6.11e-02
|
GOMF CAMP DEPENDENT PROTEIN KINASE INHIBITOR ACTIVITY
|
10
|
2.56e-01
|
7.35e-01
|
0.30900
|
-2.98e-01
|
8.30e-02
|
1.03e-01
|
6.50e-01
|
GOMF ATP DEPENDENT PROTEIN FOLDING CHAPERONE
|
35
|
9.57e-03
|
2.08e-01
|
0.30900
|
1.19e-01
|
-2.85e-01
|
2.23e-01
|
3.48e-03
|
GOBP NEUTROPHIL ACTIVATION INVOLVED IN IMMUNE RESPONSE
|
20
|
7.75e-02
|
5.24e-01
|
0.30900
|
-2.06e-01
|
2.31e-01
|
1.11e-01
|
7.43e-02
|
GOBP POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION
|
8
|
2.73e-01
|
7.47e-01
|
0.30900
|
-2.48e-01
|
-1.84e-01
|
2.24e-01
|
3.67e-01
|
GOBP SKELETAL MUSCLE THIN FILAMENT ASSEMBLY
|
7
|
3.67e-01
|
8.07e-01
|
0.30900
|
-2.04e-02
|
3.08e-01
|
9.25e-01
|
1.58e-01
|
GOMF AROMATIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY
|
8
|
3.44e-01
|
7.95e-01
|
0.30900
|
-2.88e-01
|
1.11e-01
|
1.58e-01
|
5.88e-01
|
GOMF CXCR CHEMOKINE RECEPTOR BINDING
|
18
|
6.20e-02
|
4.82e-01
|
0.30900
|
2.97e-01
|
8.49e-02
|
2.91e-02
|
5.33e-01
|
GOMF MRNA 5 PHOSPHATASE ACTIVITY
|
11
|
1.74e-01
|
6.63e-01
|
0.30900
|
-1.35e-01
|
-2.78e-01
|
4.37e-01
|
1.11e-01
|
GOBP RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE
|
8
|
2.74e-01
|
7.49e-01
|
0.30900
|
-1.80e-01
|
-2.51e-01
|
3.78e-01
|
2.19e-01
|
GOBP PHOTOTRANSDUCTION VISIBLE LIGHT
|
18
|
9.38e-02
|
5.56e-01
|
0.30900
|
-2.79e-01
|
1.32e-01
|
4.03e-02
|
3.33e-01
|
GOBP MITOCHONDRIAL RIBOSOME ASSEMBLY
|
10
|
1.97e-01
|
6.88e-01
|
0.30900
|
-2.14e-01
|
-2.23e-01
|
2.42e-01
|
2.23e-01
|
GOCC FEMALE PRONUCLEUS
|
10
|
2.05e-01
|
6.95e-01
|
0.30900
|
-1.35e-01
|
-2.77e-01
|
4.60e-01
|
1.29e-01
|
GOBP MITOCHONDRIAL RNA MODIFICATION
|
9
|
2.56e-01
|
7.35e-01
|
0.30800
|
-6.03e-02
|
-3.02e-01
|
7.54e-01
|
1.16e-01
|
GOBP CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR
|
11
|
2.37e-01
|
7.24e-01
|
0.30800
|
-2.79e-01
|
1.32e-01
|
1.10e-01
|
4.48e-01
|
GOBP SOFT PALATE DEVELOPMENT
|
5
|
4.87e-01
|
8.56e-01
|
0.30800
|
-7.13e-03
|
3.08e-01
|
9.78e-01
|
2.33e-01
|
GOCC BBSOME
|
8
|
3.15e-01
|
7.76e-01
|
0.30800
|
1.05e-03
|
-3.08e-01
|
9.96e-01
|
1.31e-01
|
GOBP SERTOLI CELL DEVELOPMENT
|
12
|
1.44e-01
|
6.28e-01
|
0.30800
|
1.93e-01
|
2.40e-01
|
2.46e-01
|
1.50e-01
|
GOBP PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS
|
30
|
7.86e-03
|
1.84e-01
|
0.30800
|
-2.37e-01
|
-1.96e-01
|
2.44e-02
|
6.26e-02
|
GOBP DCMP CATABOLIC PROCESS
|
6
|
4.46e-01
|
8.40e-01
|
0.30800
|
-2.95e-01
|
8.95e-02
|
2.11e-01
|
7.04e-01
|
GOBP REGULATION OF MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL
|
6
|
3.84e-01
|
8.17e-01
|
0.30800
|
2.68e-01
|
1.52e-01
|
2.56e-01
|
5.19e-01
|
GOMF UDP XYLOSYLTRANSFERASE ACTIVITY
|
11
|
1.77e-01
|
6.67e-01
|
0.30800
|
-2.81e-01
|
-1.26e-01
|
1.07e-01
|
4.68e-01
|
GOBP POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION
|
14
|
1.61e-01
|
6.48e-01
|
0.30800
|
-1.35e-01
|
2.77e-01
|
3.83e-01
|
7.29e-02
|
GOBP UV PROTECTION
|
12
|
1.56e-01
|
6.43e-01
|
0.30800
|
-9.84e-02
|
-2.92e-01
|
5.55e-01
|
8.01e-02
|
GOBP MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION
|
7
|
3.29e-01
|
7.83e-01
|
0.30800
|
2.70e-01
|
1.48e-01
|
2.16e-01
|
4.98e-01
|
GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION
|
10
|
2.11e-01
|
7.00e-01
|
0.30800
|
1.05e-01
|
2.89e-01
|
5.66e-01
|
1.13e-01
|
GOMF OXYSTEROL BINDING
|
8
|
3.12e-01
|
7.75e-01
|
0.30800
|
1.54e-02
|
3.07e-01
|
9.40e-01
|
1.32e-01
|
GOMF MISMATCHED DNA BINDING
|
14
|
1.53e-01
|
6.41e-01
|
0.30800
|
9.19e-02
|
-2.94e-01
|
5.51e-01
|
5.72e-02
|
GOBP LATE ENDOSOME TO VACUOLE TRANSPORT
|
36
|
7.69e-03
|
1.83e-01
|
0.30800
|
-2.97e-01
|
7.86e-02
|
2.01e-03
|
4.15e-01
|
GOBP RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME
|
13
|
1.93e-01
|
6.85e-01
|
0.30800
|
2.05e-01
|
-2.30e-01
|
2.01e-01
|
1.52e-01
|
GOBP BRONCHUS DEVELOPMENT
|
11
|
2.01e-01
|
6.92e-01
|
0.30800
|
1.55e-02
|
3.07e-01
|
9.29e-01
|
7.77e-02
|
GOBP NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION
|
16
|
1.32e-01
|
6.13e-01
|
0.30700
|
-2.03e-01
|
2.31e-01
|
1.59e-01
|
1.10e-01
|
GOMF TRANSFORMING GROWTH FACTOR BETA BINDING
|
23
|
3.89e-02
|
4.04e-01
|
0.30700
|
-2.11e-02
|
3.07e-01
|
8.61e-01
|
1.09e-02
|
GOBP PHOSPHOLIPID HOMEOSTASIS
|
16
|
7.82e-02
|
5.26e-01
|
0.30700
|
1.64e-01
|
2.60e-01
|
2.56e-01
|
7.21e-02
|
GOMF HISTONE H3K9ME2 METHYLTRANSFERASE ACTIVITY
|
7
|
3.76e-01
|
8.11e-01
|
0.30700
|
-3.05e-01
|
3.31e-02
|
1.62e-01
|
8.80e-01
|
GOCC SEROTONIN ACTIVATED CATION SELECTIVE CHANNEL COMPLEX
|
5
|
5.09e-01
|
8.66e-01
|
0.30700
|
2.98e-01
|
-7.57e-02
|
2.49e-01
|
7.69e-01
|
GOMF SEROTONIN GATED MONOATOMIC CATION SELECTIVE CHANNEL ACTIVITY
|
5
|
5.09e-01
|
8.66e-01
|
0.30700
|
2.98e-01
|
-7.57e-02
|
2.49e-01
|
7.69e-01
|
GOBP POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN WOUND HEALING
|
10
|
2.04e-01
|
6.94e-01
|
0.30700
|
-1.60e-01
|
-2.62e-01
|
3.80e-01
|
1.52e-01
|
GOBP ROSTROCAUDAL NEURAL TUBE PATTERNING
|
10
|
2.26e-01
|
7.14e-01
|
0.30700
|
-5.17e-02
|
-3.02e-01
|
7.77e-01
|
9.79e-02
|
GOMF K48 LINKED POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING
|
10
|
2.57e-01
|
7.35e-01
|
0.30700
|
-3.00e-01
|
6.53e-02
|
1.01e-01
|
7.21e-01
|
GOBP RESPONSE TO OZONE
|
5
|
5.14e-01
|
8.67e-01
|
0.30700
|
-9.21e-02
|
2.92e-01
|
7.21e-01
|
2.57e-01
|
GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS
|
18
|
5.60e-02
|
4.65e-01
|
0.30700
|
2.00e-01
|
2.32e-01
|
1.41e-01
|
8.82e-02
|
GOBP NEGATIVE REGULATION OF GLUTAMATE SECRETION
|
6
|
4.32e-01
|
8.37e-01
|
0.30700
|
3.05e-01
|
-2.90e-02
|
1.95e-01
|
9.02e-01
|
GOBP TYPE I PNEUMOCYTE DIFFERENTIATION
|
8
|
3.40e-01
|
7.91e-01
|
0.30600
|
-7.50e-02
|
2.97e-01
|
7.13e-01
|
1.46e-01
|
GOBP POSITIVE REGULATION OF GASTRULATION
|
6
|
4.39e-01
|
8.40e-01
|
0.30600
|
5.12e-02
|
-3.02e-01
|
8.28e-01
|
2.00e-01
|
GOBP NEGATIVE REGULATION OF CENTRIOLE REPLICATION
|
7
|
3.30e-01
|
7.85e-01
|
0.30600
|
-1.66e-01
|
-2.57e-01
|
4.46e-01
|
2.39e-01
|
GOBP REGULATION OF T HELPER 2 CELL DIFFERENTIATION
|
12
|
1.47e-01
|
6.33e-01
|
0.30600
|
-2.12e-01
|
-2.21e-01
|
2.03e-01
|
1.85e-01
|
GOMF ASPARTIC TYPE PEPTIDASE ACTIVITY
|
26
|
3.59e-02
|
3.87e-01
|
0.30600
|
-2.68e-01
|
1.48e-01
|
1.79e-02
|
1.92e-01
|
GOMF 1 4 ALPHA OLIGOGLUCAN PHOSPHORYLASE ACTIVITY
|
5
|
4.91e-01
|
8.58e-01
|
0.30600
|
-3.06e-01
|
2.80e-03
|
2.36e-01
|
9.91e-01
|
GOMF HISTONE H3 KINASE ACTIVITY
|
11
|
2.52e-01
|
7.31e-01
|
0.30600
|
-2.22e-01
|
2.10e-01
|
2.02e-01
|
2.27e-01
|
GOBP FATTY ACYL COA BIOSYNTHETIC PROCESS
|
25
|
3.09e-02
|
3.61e-01
|
0.30600
|
-3.05e-01
|
2.96e-02
|
8.38e-03
|
7.98e-01
|
GOBP POSITIVE REGULATION OF PROTEIN KINASE A SIGNALING
|
12
|
1.62e-01
|
6.48e-01
|
0.30600
|
-8.80e-02
|
-2.93e-01
|
5.97e-01
|
7.88e-02
|
GOMF PROTEIN ARGININE N METHYLTRANSFERASE ACTIVITY
|
12
|
1.55e-01
|
6.42e-01
|
0.30600
|
-2.79e-01
|
-1.25e-01
|
9.38e-02
|
4.55e-01
|
GOCC FIBRILLAR COLLAGEN TRIMER
|
12
|
2.00e-01
|
6.90e-01
|
0.30600
|
2.97e-01
|
-7.50e-02
|
7.53e-02
|
6.53e-01
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN REDUCED FLAVIN OR FLAVOPROTEIN AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN
|
42
|
4.12e-03
|
1.32e-01
|
0.30600
|
2.86e-01
|
-1.08e-01
|
1.33e-03
|
2.26e-01
|
GOBP CELLULAR RESPONSE TO EXOGENOUS DSRNA
|
16
|
1.04e-01
|
5.75e-01
|
0.30600
|
4.63e-03
|
-3.06e-01
|
9.74e-01
|
3.42e-02
|
GOMF RNA POLYMERASE II INTRONIC TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING
|
8
|
2.83e-01
|
7.56e-01
|
0.30600
|
-2.57e-01
|
-1.66e-01
|
2.09e-01
|
4.15e-01
|
GOBP KETONE BODY METABOLIC PROCESS
|
9
|
2.92e-01
|
7.63e-01
|
0.30600
|
-3.02e-01
|
5.01e-02
|
1.17e-01
|
7.95e-01
|
GOBP CDP DIACYLGLYCEROL BIOSYNTHETIC PROCESS
|
12
|
1.98e-01
|
6.88e-01
|
0.30600
|
-6.64e-02
|
2.98e-01
|
6.90e-01
|
7.35e-02
|
GOMF PROTEASOME ACTIVATING ACTIVITY
|
6
|
4.54e-01
|
8.46e-01
|
0.30600
|
2.89e-01
|
-1.01e-01
|
2.21e-01
|
6.70e-01
|
GOBP OLFACTORY BEHAVIOR
|
10
|
2.22e-01
|
7.11e-01
|
0.30500
|
-2.95e-01
|
-8.02e-02
|
1.07e-01
|
6.60e-01
|
GOMF DNA METHYLTRANSFERASE ACTIVITY
|
7
|
3.36e-01
|
7.88e-01
|
0.30500
|
-2.73e-01
|
-1.37e-01
|
2.12e-01
|
5.29e-01
|
GOBP DNA LIGATION INVOLVED IN DNA REPAIR
|
5
|
4.53e-01
|
8.45e-01
|
0.30500
|
-2.39e-01
|
-1.90e-01
|
3.55e-01
|
4.62e-01
|
GOCC CARBOXY TERMINAL DOMAIN PROTEIN KINASE COMPLEX
|
16
|
8.81e-02
|
5.48e-01
|
0.30500
|
-9.54e-02
|
-2.90e-01
|
5.09e-01
|
4.47e-02
|
GOBP PHENOTYPIC SWITCHING
|
16
|
1.20e-01
|
6.00e-01
|
0.30500
|
-2.93e-01
|
8.52e-02
|
4.24e-02
|
5.55e-01
|
GOCC CYTOPLASMIC SIDE OF ENDOSOME MEMBRANE
|
6
|
3.90e-01
|
8.21e-01
|
0.30500
|
2.60e-01
|
1.60e-01
|
2.71e-01
|
4.97e-01
|
GOBP POSITIVE REGULATION OF HEPATOCYTE PROLIFERATION
|
10
|
2.47e-01
|
7.26e-01
|
0.30500
|
1.54e-02
|
-3.05e-01
|
9.33e-01
|
9.52e-02
|
GOBP NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS
|
14
|
1.53e-01
|
6.41e-01
|
0.30500
|
-6.90e-02
|
2.97e-01
|
6.55e-01
|
5.43e-02
|
GOBP REGULATION OF GLOMERULUS DEVELOPMENT
|
5
|
5.36e-01
|
8.77e-01
|
0.30500
|
-2.34e-01
|
1.95e-01
|
3.64e-01
|
4.50e-01
|
GOMF ACETYLGLUCOSAMINYLTRANSFERASE ACTIVITY
|
42
|
5.42e-03
|
1.53e-01
|
0.30500
|
-1.93e-01
|
2.35e-01
|
3.02e-02
|
8.29e-03
|
GOBP PLANAR CELL POLARITY PATHWAY INVOLVED IN NEURAL TUBE CLOSURE
|
11
|
2.43e-01
|
7.25e-01
|
0.30500
|
-1.24e-01
|
2.78e-01
|
4.77e-01
|
1.10e-01
|
GOBP CHONDROITIN SULFATE METABOLIC PROCESS
|
26
|
3.22e-02
|
3.67e-01
|
0.30500
|
-2.93e-01
|
8.23e-02
|
9.65e-03
|
4.68e-01
|
GOBP POSITIVE REGULATION OF MEMBRANE POTENTIAL
|
15
|
1.22e-01
|
6.03e-01
|
0.30500
|
-8.32e-03
|
3.04e-01
|
9.56e-01
|
4.12e-02
|
GOBP URETER MORPHOGENESIS
|
7
|
3.78e-01
|
8.14e-01
|
0.30500
|
-3.04e-01
|
1.87e-02
|
1.64e-01
|
9.32e-01
|
GOBP AXIAL MESODERM DEVELOPMENT
|
8
|
2.99e-01
|
7.67e-01
|
0.30400
|
9.28e-02
|
2.90e-01
|
6.50e-01
|
1.56e-01
|
GOMF NITRIC OXIDE SYNTHASE BINDING
|
10
|
2.13e-01
|
7.02e-01
|
0.30400
|
2.72e-01
|
1.36e-01
|
1.36e-01
|
4.56e-01
|
GOCC AMPHISOME MEMBRANE
|
11
|
2.41e-01
|
7.25e-01
|
0.30400
|
-2.84e-01
|
1.11e-01
|
1.03e-01
|
5.25e-01
|
GOCC FANCONI ANAEMIA NUCLEAR COMPLEX
|
11
|
1.79e-01
|
6.69e-01
|
0.30400
|
-1.61e-01
|
-2.58e-01
|
3.55e-01
|
1.38e-01
|
GOBP TELOMERASE RNA LOCALIZATION
|
18
|
1.06e-01
|
5.79e-01
|
0.30400
|
2.45e-01
|
-1.80e-01
|
7.18e-02
|
1.85e-01
|
GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX
|
13
|
1.29e-01
|
6.09e-01
|
0.30400
|
-1.93e-01
|
-2.35e-01
|
2.29e-01
|
1.42e-01
|
GOMF MHC CLASS I RECEPTOR ACTIVITY
|
13
|
1.32e-01
|
6.13e-01
|
0.30400
|
1.57e-01
|
2.60e-01
|
3.26e-01
|
1.04e-01
|
GOMF C3HC4 TYPE RING FINGER DOMAIN BINDING
|
6
|
4.70e-01
|
8.51e-01
|
0.30400
|
1.52e-01
|
-2.63e-01
|
5.19e-01
|
2.64e-01
|
GOBP DEHYDROASCORBIC ACID TRANSPORT
|
9
|
2.42e-01
|
7.25e-01
|
0.30400
|
-2.19e-01
|
-2.10e-01
|
2.54e-01
|
2.74e-01
|
GOBP REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION
|
13
|
1.66e-01
|
6.50e-01
|
0.30400
|
2.17e-02
|
-3.03e-01
|
8.92e-01
|
5.84e-02
|
GOBP DETECTION OF MUSCLE STRETCH
|
7
|
3.47e-01
|
7.96e-01
|
0.30400
|
9.95e-02
|
2.87e-01
|
6.48e-01
|
1.88e-01
|
GOBP EMBRYONIC NEUROCRANIUM MORPHOGENESIS
|
8
|
3.70e-01
|
8.09e-01
|
0.30400
|
-1.82e-01
|
2.43e-01
|
3.72e-01
|
2.34e-01
|
GOBP EPIGENETIC PROGRAMMING IN THE ZYGOTIC PRONUCLEI
|
8
|
3.11e-01
|
7.74e-01
|
0.30400
|
-3.00e-01
|
-5.04e-02
|
1.42e-01
|
8.05e-01
|
GOBP REGULATION OF RESPIRATORY SYSTEM PROCESS
|
13
|
1.30e-01
|
6.09e-01
|
0.30400
|
-2.42e-01
|
-1.84e-01
|
1.31e-01
|
2.50e-01
|
GOBP CELLULAR RESPONSE TO MINERALOCORTICOID STIMULUS
|
11
|
2.41e-01
|
7.25e-01
|
0.30400
|
-2.85e-01
|
1.03e-01
|
1.01e-01
|
5.53e-01
|
GOMF NEUROLIGIN FAMILY PROTEIN BINDING
|
5
|
5.10e-01
|
8.66e-01
|
0.30300
|
2.99e-01
|
-5.01e-02
|
2.46e-01
|
8.46e-01
|
GOBP REGULATION OF MITOPHAGY
|
15
|
1.49e-01
|
6.36e-01
|
0.30300
|
-2.74e-01
|
1.31e-01
|
6.66e-02
|
3.78e-01
|
GOBP INTESTINAL STEM CELL HOMEOSTASIS
|
6
|
3.96e-01
|
8.24e-01
|
0.30300
|
-1.48e-01
|
-2.65e-01
|
5.30e-01
|
2.61e-01
|
GOBP POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION
|
22
|
6.72e-02
|
4.98e-01
|
0.30300
|
-2.16e-01
|
2.12e-01
|
7.92e-02
|
8.47e-02
|
GOBP CORTISOL SECRETION
|
5
|
4.64e-01
|
8.48e-01
|
0.30300
|
-1.45e-01
|
-2.66e-01
|
5.74e-01
|
3.03e-01
|
GOBP STRESS GRANULE DISASSEMBLY
|
5
|
5.42e-01
|
8.78e-01
|
0.30300
|
-2.23e-01
|
2.05e-01
|
3.88e-01
|
4.27e-01
|
GOBP POSITIVE REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS
|
8
|
3.75e-01
|
8.11e-01
|
0.30300
|
2.01e-01
|
-2.26e-01
|
3.24e-01
|
2.69e-01
|
GOMF HISTONE H4K16 ACETYLTRANSFERASE ACTIVITY
|
8
|
3.56e-01
|
7.97e-01
|
0.30300
|
-2.87e-01
|
9.57e-02
|
1.60e-01
|
6.39e-01
|
GOBP RECEPTOR MEDIATED ENDOCYTOSIS INVOLVED IN CHOLESTEROL TRANSPORT
|
8
|
3.23e-01
|
7.79e-01
|
0.30200
|
-3.02e-01
|
-1.96e-02
|
1.39e-01
|
9.24e-01
|
GOBP CARDIAC VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION
|
10
|
2.62e-01
|
7.39e-01
|
0.30200
|
-2.99e-01
|
4.63e-02
|
1.02e-01
|
8.00e-01
|
GOBP REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS
|
20
|
4.86e-02
|
4.41e-01
|
0.30200
|
-2.77e-01
|
-1.21e-01
|
3.21e-02
|
3.49e-01
|
GOBP REGULATION OF RRNA PROCESSING
|
16
|
8.37e-02
|
5.37e-01
|
0.30200
|
-1.88e-01
|
-2.36e-01
|
1.92e-01
|
1.02e-01
|
GOBP ZINC ION IMPORT ACROSS PLASMA MEMBRANE
|
9
|
3.18e-01
|
7.78e-01
|
0.30200
|
-1.11e-01
|
2.81e-01
|
5.65e-01
|
1.45e-01
|
GOBP POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION
|
15
|
1.12e-01
|
5.91e-01
|
0.30200
|
-2.94e-01
|
-6.77e-02
|
4.87e-02
|
6.50e-01
|
GOCC NUCLEOTIDE ACTIVATED PROTEIN KINASE COMPLEX
|
15
|
1.60e-01
|
6.48e-01
|
0.30200
|
-2.42e-01
|
1.80e-01
|
1.05e-01
|
2.27e-01
|
GOBP MEDIUM CHAIN FATTY ACID CATABOLIC PROCESS
|
5
|
5.44e-01
|
8.78e-01
|
0.30200
|
-2.10e-01
|
2.16e-01
|
4.15e-01
|
4.03e-01
|
GOBP RESPONSE TO HYDROSTATIC PRESSURE
|
7
|
4.19e-01
|
8.32e-01
|
0.30200
|
-1.43e-01
|
2.66e-01
|
5.13e-01
|
2.23e-01
|
GOBP RESPONSE TO NEMATODE
|
7
|
3.98e-01
|
8.25e-01
|
0.30200
|
6.27e-02
|
-2.95e-01
|
7.74e-01
|
1.77e-01
|
GOBP TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY
|
17
|
7.17e-02
|
5.12e-01
|
0.30100
|
-2.14e-01
|
-2.12e-01
|
1.26e-01
|
1.30e-01
|
GOMF OLIGOSACCHARIDE BINDING
|
15
|
1.01e-01
|
5.70e-01
|
0.30100
|
-1.55e-01
|
-2.59e-01
|
2.99e-01
|
8.29e-02
|
GOBP POSITIVE REGULATION OF NON MOTILE CILIUM ASSEMBLY
|
8
|
3.70e-01
|
8.09e-01
|
0.30100
|
1.39e-01
|
-2.67e-01
|
4.97e-01
|
1.90e-01
|
GOMF LYSOPHOSPHOLIPID ACYLTRANSFERASE ACTIVITY
|
20
|
8.72e-02
|
5.46e-01
|
0.30100
|
-1.80e-01
|
2.41e-01
|
1.62e-01
|
6.18e-02
|
GOBP NEURAL PLATE PATTERN SPECIFICATION
|
8
|
2.93e-01
|
7.63e-01
|
0.30100
|
1.70e-01
|
2.48e-01
|
4.04e-01
|
2.24e-01
|
GOBP HYPOTONIC RESPONSE
|
13
|
2.07e-01
|
6.97e-01
|
0.30100
|
-2.12e-01
|
2.13e-01
|
1.85e-01
|
1.83e-01
|
GOCC RSC TYPE COMPLEX
|
15
|
1.51e-01
|
6.38e-01
|
0.30100
|
-2.79e-01
|
1.13e-01
|
6.17e-02
|
4.47e-01
|
GOBP REGULATION OF SERINE TYPE PEPTIDASE ACTIVITY
|
6
|
4.76e-01
|
8.54e-01
|
0.30100
|
2.66e-01
|
-1.41e-01
|
2.60e-01
|
5.51e-01
|
GOBP CHIASMA ASSEMBLY
|
6
|
4.33e-01
|
8.37e-01
|
0.30100
|
3.00e-01
|
1.74e-02
|
2.03e-01
|
9.41e-01
|
GOBP REGULATION OF MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION
|
5
|
5.11e-01
|
8.66e-01
|
0.30100
|
-2.99e-01
|
2.96e-02
|
2.47e-01
|
9.09e-01
|
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL MATRIX ADHESION VIA FIBRONECTIN
|
5
|
5.42e-01
|
8.78e-01
|
0.30100
|
2.54e-01
|
-1.61e-01
|
3.26e-01
|
5.33e-01
|
GOBP UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY
|
35
|
1.10e-02
|
2.23e-01
|
0.30100
|
-2.90e-01
|
7.99e-02
|
3.00e-03
|
4.14e-01
|
GOBP POSITIVE REGULATION OF ANOIKIS
|
5
|
4.64e-01
|
8.48e-01
|
0.30100
|
-1.85e-01
|
-2.37e-01
|
4.73e-01
|
3.59e-01
|
GOBP REGULATION OF THE FORCE OF HEART CONTRACTION BY CHEMICAL SIGNAL
|
6
|
4.56e-01
|
8.47e-01
|
0.30100
|
-6.02e-02
|
2.95e-01
|
7.98e-01
|
2.12e-01
|
GOBP NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION
|
17
|
1.26e-01
|
6.06e-01
|
0.30100
|
-2.45e-01
|
1.74e-01
|
8.02e-02
|
2.14e-01
|
GOBP INNER CELL MASS CELL DIFFERENTIATION
|
8
|
2.94e-01
|
7.63e-01
|
0.30000
|
-1.79e-01
|
-2.41e-01
|
3.80e-01
|
2.38e-01
|
GOBP REGULATION OF PLASMA MEMBRANE REPAIR
|
6
|
4.39e-01
|
8.40e-01
|
0.30000
|
-2.50e-03
|
3.00e-01
|
9.92e-01
|
2.03e-01
|
GOBP CYTOPLASM ORGANIZATION
|
15
|
1.64e-01
|
6.48e-01
|
0.30000
|
-2.19e-01
|
2.05e-01
|
1.41e-01
|
1.69e-01
|
GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE TO BACTERIUM
|
5
|
5.47e-01
|
8.78e-01
|
0.30000
|
2.29e-01
|
-1.94e-01
|
3.75e-01
|
4.52e-01
|
GOMF CLASS I DNA APURINIC OR APYRIMIDINIC SITE ENDONUCLEASE ACTIVITY
|
8
|
2.94e-01
|
7.64e-01
|
0.30000
|
2.45e-01
|
1.73e-01
|
2.29e-01
|
3.97e-01
|
GOBP LYSOSOMAL MICROAUTOPHAGY
|
13
|
1.75e-01
|
6.65e-01
|
0.30000
|
-2.99e-01
|
2.90e-02
|
6.21e-02
|
8.56e-01
|
GOBP C X C CHEMOKINE RECEPTOR CXCR4 SIGNALING PATHWAY
|
5
|
5.38e-01
|
8.78e-01
|
0.30000
|
2.69e-01
|
-1.33e-01
|
2.97e-01
|
6.07e-01
|
GOBP ADIPONECTIN ACTIVATED SIGNALING PATHWAY
|
7
|
4.20e-01
|
8.33e-01
|
0.30000
|
-2.69e-01
|
1.33e-01
|
2.18e-01
|
5.42e-01
|
GOMF GLUCOSYLTRANSFERASE ACTIVITY
|
19
|
5.41e-02
|
4.60e-01
|
0.30000
|
-2.21e-01
|
-2.03e-01
|
9.51e-02
|
1.26e-01
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H OXYGEN AS ACCEPTOR
|
12
|
1.79e-01
|
6.69e-01
|
0.30000
|
5.81e-02
|
2.94e-01
|
7.28e-01
|
7.74e-02
|
GOMF TESTOSTERONE 17 BETA DEHYDROGENASE NADPPLUS ACTIVITY
|
9
|
3.31e-01
|
7.85e-01
|
0.30000
|
1.44e-01
|
-2.63e-01
|
4.54e-01
|
1.72e-01
|
GOBP REGULATION OF EXCRETION
|
11
|
2.42e-01
|
7.25e-01
|
0.30000
|
7.31e-02
|
-2.91e-01
|
6.74e-01
|
9.48e-02
|
GOBP POSITIVE REGULATION OF CHONDROCYTE PROLIFERATION
|
8
|
3.75e-01
|
8.11e-01
|
0.30000
|
-1.47e-01
|
2.61e-01
|
4.72e-01
|
2.00e-01
|
GOBP REGULATION OF COMPLEMENT ACTIVATION CLASSICAL PATHWAY
|
9
|
3.38e-01
|
7.90e-01
|
0.30000
|
1.98e-01
|
-2.25e-01
|
3.03e-01
|
2.42e-01
|
GOBP REGULATION OF BLOOD VESSEL REMODELING
|
12
|
2.16e-01
|
7.07e-01
|
0.30000
|
-2.87e-01
|
8.58e-02
|
8.50e-02
|
6.07e-01
|
GOBP RESPONSE TO MERCURY ION
|
10
|
2.18e-01
|
7.07e-01
|
0.30000
|
1.78e-01
|
2.41e-01
|
3.31e-01
|
1.86e-01
|
GOMF CARGO ADAPTOR ACTIVITY
|
18
|
1.16e-01
|
5.94e-01
|
0.29900
|
-2.05e-01
|
2.18e-01
|
1.33e-01
|
1.09e-01
|
GOBP REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME
|
12
|
2.01e-01
|
6.90e-01
|
0.29900
|
-2.98e-01
|
2.34e-02
|
7.34e-02
|
8.88e-01
|
GOBP NOSE DEVELOPMENT
|
16
|
9.69e-02
|
5.61e-01
|
0.29900
|
2.85e-01
|
9.19e-02
|
4.85e-02
|
5.25e-01
|
GOBP EYELID DEVELOPMENT IN CAMERA TYPE EYE
|
13
|
2.07e-01
|
6.96e-01
|
0.29900
|
-1.62e-01
|
2.52e-01
|
3.11e-01
|
1.16e-01
|
GOBP GASTRIC MOTILITY
|
5
|
5.41e-01
|
8.78e-01
|
0.29900
|
-2.66e-01
|
1.38e-01
|
3.04e-01
|
5.94e-01
|
GOBP REGULATION OF SUPEROXIDE DISMUTASE ACTIVITY
|
7
|
4.29e-01
|
8.36e-01
|
0.29900
|
-1.67e-01
|
2.48e-01
|
4.44e-01
|
2.56e-01
|
GOMF SUMO TRANSFERASE ACTIVITY
|
25
|
5.01e-02
|
4.44e-01
|
0.29900
|
-1.90e-01
|
2.31e-01
|
9.97e-02
|
4.59e-02
|
GOMF HISTONE H3K4 TRIMETHYLTRANSFERASE ACTIVITY
|
10
|
2.97e-01
|
7.66e-01
|
0.29900
|
-1.56e-01
|
2.55e-01
|
3.94e-01
|
1.62e-01
|
GOBP RECEPTOR MEDIATED ENDOCYTOSIS OF VIRUS BY HOST CELL
|
10
|
2.75e-01
|
7.49e-01
|
0.29900
|
6.52e-02
|
-2.92e-01
|
7.21e-01
|
1.10e-01
|
GOBP NEURON FATE DETERMINATION
|
10
|
2.42e-01
|
7.25e-01
|
0.29900
|
-2.93e-01
|
-5.74e-02
|
1.08e-01
|
7.53e-01
|
GOMF LYSINE ACETYLATED HISTONE BINDING
|
24
|
5.71e-02
|
4.68e-01
|
0.29900
|
-2.25e-01
|
1.97e-01
|
5.67e-02
|
9.55e-02
|
GOMF CD4 RECEPTOR BINDING
|
8
|
3.02e-01
|
7.68e-01
|
0.29800
|
2.59e-01
|
1.49e-01
|
2.05e-01
|
4.67e-01
|
GOBP TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING
|
12
|
2.39e-01
|
7.25e-01
|
0.29800
|
-2.27e-01
|
1.93e-01
|
1.73e-01
|
2.47e-01
|
GOBP PURINE NUCLEOTIDE SALVAGE
|
10
|
3.03e-01
|
7.68e-01
|
0.29800
|
-1.88e-01
|
2.32e-01
|
3.05e-01
|
2.04e-01
|
GOBP NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I
|
21
|
7.34e-02
|
5.13e-01
|
0.29800
|
-2.79e-01
|
1.05e-01
|
2.69e-02
|
4.06e-01
|
GOBP REGULATION OF MEIOTIC CELL CYCLE PHASE TRANSITION
|
9
|
2.66e-01
|
7.42e-01
|
0.29800
|
1.20e-01
|
2.73e-01
|
5.34e-01
|
1.56e-01
|
GOCC MALE PRONUCLEUS
|
8
|
3.01e-01
|
7.67e-01
|
0.29800
|
-1.61e-01
|
-2.50e-01
|
4.29e-01
|
2.20e-01
|
GOMF SINGLE STRANDED DNA HELICASE ACTIVITY
|
23
|
4.76e-02
|
4.38e-01
|
0.29800
|
2.32e-02
|
-2.97e-01
|
8.47e-01
|
1.37e-02
|
GOMF TESTOSTERONE DEHYDROGENASE NAD P ACTIVITY
|
10
|
2.93e-01
|
7.63e-01
|
0.29800
|
1.21e-01
|
-2.72e-01
|
5.06e-01
|
1.37e-01
|
GOBP PURINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS
|
6
|
4.04e-01
|
8.26e-01
|
0.29800
|
2.03e-01
|
2.17e-01
|
3.89e-01
|
3.56e-01
|
GOBP RESPONSE TO COBALT ION
|
9
|
2.69e-01
|
7.44e-01
|
0.29700
|
-2.76e-01
|
-1.12e-01
|
1.52e-01
|
5.60e-01
|
GOBP POLYKETIDE METABOLIC PROCESS
|
10
|
3.04e-01
|
7.68e-01
|
0.29700
|
1.74e-01
|
-2.41e-01
|
3.42e-01
|
1.86e-01
|
GOCC SPERM HEAD
|
17
|
9.96e-02
|
5.68e-01
|
0.29700
|
-1.06e-02
|
-2.97e-01
|
9.39e-01
|
3.39e-02
|
GOBP HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION
|
8
|
3.01e-01
|
7.67e-01
|
0.29700
|
1.76e-01
|
2.39e-01
|
3.88e-01
|
2.41e-01
|
GOCC GROWTH CONE MEMBRANE
|
8
|
3.88e-01
|
8.20e-01
|
0.29700
|
-2.17e-01
|
2.03e-01
|
2.88e-01
|
3.19e-01
|
GOBP SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY
|
12
|
2.23e-01
|
7.12e-01
|
0.29700
|
8.92e-02
|
-2.83e-01
|
5.93e-01
|
8.91e-02
|
GOBP GLYCOSPHINGOLIPID CATABOLIC PROCESS
|
13
|
1.42e-01
|
6.26e-01
|
0.29700
|
-2.25e-01
|
-1.94e-01
|
1.60e-01
|
2.27e-01
|
GOBP REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION
|
12
|
2.26e-01
|
7.14e-01
|
0.29700
|
9.98e-02
|
-2.80e-01
|
5.49e-01
|
9.35e-02
|
GOBP CYTOPLASMIC SEQUESTERING OF PROTEIN
|
18
|
1.16e-01
|
5.94e-01
|
0.29700
|
-2.56e-01
|
1.50e-01
|
5.97e-02
|
2.72e-01
|
GOBP POSITIVE REGULATION OF CELL MIGRATION BY VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY
|
8
|
3.06e-01
|
7.70e-01
|
0.29700
|
1.46e-01
|
2.59e-01
|
4.75e-01
|
2.05e-01
|
GOBP POSITIVE REGULATION OF MYELINATION
|
17
|
1.35e-01
|
6.16e-01
|
0.29700
|
-2.01e-01
|
2.19e-01
|
1.52e-01
|
1.19e-01
|
GOBP ENDOTHELIAL CELL CHEMOTAXIS
|
27
|
1.74e-02
|
2.82e-01
|
0.29700
|
1.95e-01
|
2.24e-01
|
7.97e-02
|
4.41e-02
|
GOBP POSITIVE REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY
|
8
|
3.28e-01
|
7.83e-01
|
0.29700
|
-2.92e-01
|
-4.95e-02
|
1.52e-01
|
8.08e-01
|
GOBP REGULATION OF PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION
|
5
|
5.18e-01
|
8.69e-01
|
0.29700
|
-1.98e-02
|
2.96e-01
|
9.39e-01
|
2.52e-01
|
GOBP DUCTUS ARTERIOSUS CLOSURE
|
5
|
5.56e-01
|
8.81e-01
|
0.29600
|
-2.17e-01
|
2.02e-01
|
4.00e-01
|
4.35e-01
|
GOBP EPITHELIAL MESENCHYMAL CELL SIGNALING
|
6
|
4.76e-01
|
8.54e-01
|
0.29600
|
-2.80e-01
|
9.71e-02
|
2.35e-01
|
6.81e-01
|
GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME
|
11
|
2.72e-01
|
7.47e-01
|
0.29600
|
1.72e-01
|
-2.41e-01
|
3.24e-01
|
1.65e-01
|
GOBP RENAL RESPONSE TO BLOOD FLOW INVOLVED IN CIRCULATORY RENIN ANGIOTENSIN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE
|
6
|
4.10e-01
|
8.27e-01
|
0.29600
|
-2.47e-01
|
-1.64e-01
|
2.95e-01
|
4.86e-01
|
GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CONTRACTION
|
9
|
3.02e-01
|
7.68e-01
|
0.29600
|
-6.31e-03
|
2.96e-01
|
9.74e-01
|
1.24e-01
|
GOMF NUCLEOBASE CONTAINING COMPOUND KINASE ACTIVITY
|
41
|
2.18e-03
|
8.83e-02
|
0.29600
|
-2.23e-01
|
-1.95e-01
|
1.34e-02
|
3.07e-02
|
GOBP CARDIAC MUSCLE MYOBLAST PROLIFERATION
|
7
|
3.91e-01
|
8.21e-01
|
0.29600
|
2.96e-01
|
5.57e-03
|
1.75e-01
|
9.80e-01
|
GOBP DENDRITIC TRANSPORT
|
12
|
2.17e-01
|
7.07e-01
|
0.29600
|
-2.91e-01
|
5.58e-02
|
8.10e-02
|
7.38e-01
|
GOBP POSITIVE REGULATION OF HELICASE ACTIVITY
|
6
|
4.68e-01
|
8.51e-01
|
0.29600
|
-2.89e-01
|
6.61e-02
|
2.21e-01
|
7.79e-01
|
GOBP NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY
|
38
|
5.68e-03
|
1.58e-01
|
0.29600
|
-2.95e-01
|
-2.56e-02
|
1.64e-03
|
7.85e-01
|
GOBP PROGESTERONE BIOSYNTHETIC PROCESS
|
6
|
4.38e-01
|
8.40e-01
|
0.29600
|
-3.93e-02
|
-2.94e-01
|
8.68e-01
|
2.13e-01
|
GOBP LUNG LOBE DEVELOPMENT
|
7
|
3.51e-01
|
7.96e-01
|
0.29600
|
-2.23e-01
|
-1.95e-01
|
3.07e-01
|
3.72e-01
|
GOMF INTERLEUKIN 1 RECEPTOR BINDING
|
17
|
7.94e-02
|
5.27e-01
|
0.29600
|
2.33e-01
|
1.82e-01
|
9.57e-02
|
1.93e-01
|
GOBP POSITIVE REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY
|
5
|
5.00e-01
|
8.62e-01
|
0.29600
|
5.12e-02
|
2.91e-01
|
8.43e-01
|
2.59e-01
|
GOMF PRIMARY MIRNA BINDING
|
9
|
2.72e-01
|
7.47e-01
|
0.29600
|
-1.14e-01
|
-2.73e-01
|
5.53e-01
|
1.56e-01
|
GOBP RETINAL ROD CELL DEVELOPMENT
|
8
|
3.60e-01
|
8.02e-01
|
0.29600
|
5.06e-02
|
-2.92e-01
|
8.04e-01
|
1.53e-01
|
GOBP CRANIOFACIAL SUTURE MORPHOGENESIS
|
18
|
1.22e-01
|
6.03e-01
|
0.29600
|
-2.04e-01
|
2.15e-01
|
1.35e-01
|
1.15e-01
|
GOBP MITOTIC RECOMBINATION
|
25
|
2.66e-02
|
3.41e-01
|
0.29600
|
-1.20e-01
|
-2.70e-01
|
2.98e-01
|
1.93e-02
|
GOMF BMP RECEPTOR ACTIVITY
|
7
|
3.78e-01
|
8.14e-01
|
0.29600
|
-2.91e-01
|
-5.54e-02
|
1.83e-01
|
8.00e-01
|
GOBP PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING
|
14
|
1.94e-01
|
6.86e-01
|
0.29600
|
-1.94e-01
|
2.23e-01
|
2.09e-01
|
1.48e-01
|
GOBP NEGATIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE
|
8
|
3.46e-01
|
7.96e-01
|
0.29600
|
-2.96e-01
|
4.65e-03
|
1.48e-01
|
9.82e-01
|
GOBP SPLICEOSOMAL CONFORMATIONAL CHANGES TO GENERATE CATALYTIC CONFORMATION
|
5
|
5.54e-01
|
8.81e-01
|
0.29600
|
-2.47e-01
|
1.63e-01
|
3.39e-01
|
5.29e-01
|
GOMF 1 PHOSPHATIDYLINOSITOL 4 PHOSPHATE 5 KINASE ACTIVITY
|
9
|
2.82e-01
|
7.54e-01
|
0.29500
|
7.65e-02
|
2.85e-01
|
6.91e-01
|
1.38e-01
|
GOBP HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY
|
13
|
2.20e-01
|
7.09e-01
|
0.29500
|
-2.11e-01
|
2.07e-01
|
1.89e-01
|
1.96e-01
|
GOBP POSITIVE REGULATION OF HISTONE METHYLATION
|
14
|
1.72e-01
|
6.60e-01
|
0.29500
|
-2.88e-01
|
6.39e-02
|
6.18e-02
|
6.79e-01
|
GOBP SPINDLE ASSEMBLY INVOLVED IN FEMALE MEIOSIS
|
9
|
3.46e-01
|
7.96e-01
|
0.29500
|
1.62e-01
|
-2.47e-01
|
4.01e-01
|
1.99e-01
|
GOBP RESPONSE TO SODIUM PHOSPHATE
|
7
|
3.81e-01
|
8.16e-01
|
0.29500
|
4.76e-02
|
2.91e-01
|
8.27e-01
|
1.82e-01
|
GOBP REGULATION OF RIBOSOME BIOGENESIS
|
9
|
2.74e-01
|
7.48e-01
|
0.29500
|
-1.13e-01
|
-2.73e-01
|
5.57e-01
|
1.57e-01
|
GOBP BRUSH BORDER ASSEMBLY
|
7
|
3.54e-01
|
7.97e-01
|
0.29500
|
1.94e-01
|
2.22e-01
|
3.73e-01
|
3.09e-01
|
GOBP LOBAR BRONCHUS DEVELOPMENT
|
6
|
4.43e-01
|
8.40e-01
|
0.29500
|
2.94e-01
|
2.76e-02
|
2.13e-01
|
9.07e-01
|
GOBP MODULATION OF PROCESS OF ANOTHER ORGANISM
|
19
|
1.06e-01
|
5.79e-01
|
0.29500
|
-2.48e-01
|
1.59e-01
|
6.09e-02
|
2.29e-01
|
GOBP NEGATIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY
|
8
|
3.94e-01
|
8.23e-01
|
0.29500
|
1.91e-01
|
-2.25e-01
|
3.49e-01
|
2.71e-01
|
GOMF INTRONIC TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING
|
11
|
2.00e-01
|
6.89e-01
|
0.29500
|
-2.51e-01
|
-1.54e-01
|
1.49e-01
|
3.77e-01
|
GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND
|
10
|
2.60e-01
|
7.38e-01
|
0.29500
|
2.22e-02
|
2.94e-01
|
9.03e-01
|
1.08e-01
|
GOBP NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS
|
5
|
4.93e-01
|
8.58e-01
|
0.29500
|
-2.81e-01
|
-8.90e-02
|
2.77e-01
|
7.30e-01
|
GOBP CARBON CATABOLITE REGULATION OF TRANSCRIPTION
|
7
|
3.75e-01
|
8.11e-01
|
0.29500
|
-2.84e-01
|
-7.70e-02
|
1.93e-01
|
7.24e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE
|
5
|
4.80e-01
|
8.54e-01
|
0.29500
|
-1.63e-01
|
-2.46e-01
|
5.29e-01
|
3.42e-01
|
GOBP FC EPSILON RECEPTOR SIGNALING PATHWAY
|
24
|
4.29e-02
|
4.26e-01
|
0.29400
|
-4.70e-03
|
2.94e-01
|
9.68e-01
|
1.26e-02
|
GOBP POSITIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS
|
14
|
1.32e-01
|
6.13e-01
|
0.29400
|
-1.32e-01
|
-2.63e-01
|
3.92e-01
|
8.85e-02
|
GOBP RESPONSE TO CORTICOSTERONE
|
12
|
2.20e-01
|
7.09e-01
|
0.29400
|
2.90e-01
|
-5.27e-02
|
8.25e-02
|
7.52e-01
|
GOBP REGULATION OF T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL
|
6
|
4.35e-01
|
8.38e-01
|
0.29400
|
-2.87e-01
|
-6.60e-02
|
2.24e-01
|
7.79e-01
|
GOBP HEPARAN SULFATE PROTEOGLYCAN CATABOLIC PROCESS
|
8
|
3.89e-01
|
8.21e-01
|
0.29400
|
-1.46e-01
|
2.55e-01
|
4.75e-01
|
2.11e-01
|
GOBP PROTEIN IMPORT
|
7
|
4.29e-01
|
8.36e-01
|
0.29400
|
-1.05e-01
|
2.75e-01
|
6.29e-01
|
2.08e-01
|
GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING
|
26
|
4.96e-02
|
4.42e-01
|
0.29400
|
-2.02e-01
|
2.14e-01
|
7.46e-02
|
5.93e-02
|
GOBP TRICUSPID VALVE DEVELOPMENT
|
6
|
5.00e-01
|
8.62e-01
|
0.29400
|
-2.05e-01
|
2.11e-01
|
3.85e-01
|
3.71e-01
|
GOCC LARGE RIBOSOMAL SUBUNIT
|
111
|
2.06e-06
|
5.14e-04
|
0.29400
|
1.36e-01
|
-2.61e-01
|
1.35e-02
|
2.07e-06
|
GOBP FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX
|
14
|
1.53e-01
|
6.41e-01
|
0.29400
|
-2.46e-02
|
-2.93e-01
|
8.73e-01
|
5.77e-02
|
GOMF DEHYDROASCORBIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY
|
8
|
3.16e-01
|
7.76e-01
|
0.29400
|
-2.63e-01
|
-1.31e-01
|
1.97e-01
|
5.22e-01
|
GOMF CALCIUM DEPENDENT CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY
|
16
|
1.53e-01
|
6.41e-01
|
0.29400
|
-1.54e-01
|
2.50e-01
|
2.86e-01
|
8.30e-02
|
GOBP RESPONSE TO HEPATOCYTE GROWTH FACTOR
|
17
|
1.40e-01
|
6.24e-01
|
0.29400
|
-2.23e-01
|
1.92e-01
|
1.12e-01
|
1.72e-01
|
GOBP ERBB4 ERBB4 SIGNALING PATHWAY
|
6
|
4.90e-01
|
8.57e-01
|
0.29400
|
1.26e-01
|
-2.65e-01
|
5.92e-01
|
2.61e-01
|
GOMF CHOLINE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
7
|
4.38e-01
|
8.40e-01
|
0.29400
|
2.58e-01
|
-1.40e-01
|
2.37e-01
|
5.21e-01
|
GOBP EXTRACELLULAR VESICLE BIOGENESIS
|
25
|
4.34e-02
|
4.28e-01
|
0.29400
|
-2.89e-01
|
5.41e-02
|
1.25e-02
|
6.40e-01
|
GOCC CD40 RECEPTOR COMPLEX
|
11
|
2.70e-01
|
7.45e-01
|
0.29400
|
-1.23e-01
|
2.67e-01
|
4.79e-01
|
1.26e-01
|
GOBP RESPONSE TO PEPTIDOGLYCAN
|
13
|
1.54e-01
|
6.41e-01
|
0.29400
|
-2.64e-01
|
-1.29e-01
|
9.99e-02
|
4.19e-01
|
GOBP TNFSF11 MEDIATED SIGNALING PATHWAY
|
5
|
4.80e-01
|
8.54e-01
|
0.29400
|
2.08e-01
|
2.07e-01
|
4.21e-01
|
4.22e-01
|
GOMF AMINE BINDING
|
11
|
2.11e-01
|
7.00e-01
|
0.29400
|
1.04e-01
|
2.75e-01
|
5.52e-01
|
1.15e-01
|
GOBP NEGATIVE REGULATION OF MUSCLE ORGAN DEVELOPMENT
|
9
|
2.86e-01
|
7.58e-01
|
0.29300
|
7.79e-02
|
2.83e-01
|
6.86e-01
|
1.42e-01
|
GOBP NEGATIVE REGULATION OF ACTIN NUCLEATION
|
9
|
2.67e-01
|
7.43e-01
|
0.29300
|
2.21e-01
|
1.92e-01
|
2.50e-01
|
3.18e-01
|
GOBP NEGATIVE REGULATION OF RIG I SIGNALING PATHWAY
|
8
|
3.89e-01
|
8.20e-01
|
0.29300
|
-2.62e-01
|
1.32e-01
|
2.00e-01
|
5.18e-01
|
GOBP POSITIVE REGULATION OF DNA DAMAGE CHECKPOINT
|
5
|
5.60e-01
|
8.83e-01
|
0.29300
|
-1.72e-01
|
2.38e-01
|
5.06e-01
|
3.57e-01
|
GOMF HISTONE DEACETYLASE REGULATOR ACTIVITY
|
6
|
4.53e-01
|
8.45e-01
|
0.29300
|
1.16e-02
|
2.93e-01
|
9.61e-01
|
2.14e-01
|
GOBP GRANULOCYTE ACTIVATION
|
48
|
3.11e-03
|
1.09e-01
|
0.29300
|
-2.75e-01
|
1.00e-01
|
9.64e-04
|
2.30e-01
|
GOBP ETHANOL CATABOLIC PROCESS
|
10
|
3.09e-01
|
7.72e-01
|
0.29300
|
1.39e-01
|
-2.58e-01
|
4.48e-01
|
1.58e-01
|
GOBP REGULATION OF REGULATORY NCRNA PROCESSING
|
16
|
1.11e-01
|
5.87e-01
|
0.29300
|
-2.85e-01
|
-6.78e-02
|
4.85e-02
|
6.39e-01
|
GOBP REGULATION OF FERTILIZATION
|
17
|
1.20e-01
|
6.00e-01
|
0.29300
|
5.27e-02
|
-2.88e-01
|
7.07e-01
|
3.98e-02
|
GOBP KERATINIZATION
|
78
|
4.43e-05
|
4.98e-03
|
0.29300
|
2.92e-01
|
-1.25e-02
|
8.04e-06
|
8.48e-01
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH OXIDATION OF A PAIR OF DONORS RESULTING IN THE REDUCTION OF MOLECULAR OXYGEN TO TWO MOLECULES OF WATER
|
10
|
2.33e-01
|
7.20e-01
|
0.29300
|
-2.24e-01
|
-1.88e-01
|
2.20e-01
|
3.03e-01
|
GOBP REGULATION OF MICROTUBULE BINDING
|
7
|
3.97e-01
|
8.25e-01
|
0.29200
|
-2.92e-01
|
-1.74e-02
|
1.81e-01
|
9.36e-01
|
GOMF INTRACELLULAR CYCLIC NUCLEOTIDE ACTIVATED MONOATOMIC CATION CHANNEL ACTIVITY
|
10
|
2.50e-01
|
7.27e-01
|
0.29200
|
2.80e-01
|
8.49e-02
|
1.25e-01
|
6.42e-01
|
GOBP MUSCULAR SEPTUM MORPHOGENESIS
|
5
|
5.46e-01
|
8.78e-01
|
0.29200
|
-8.67e-02
|
2.79e-01
|
7.37e-01
|
2.80e-01
|
GOBP INTERLEUKIN 4 PRODUCTION
|
32
|
1.33e-02
|
2.51e-01
|
0.29200
|
4.82e-02
|
2.88e-01
|
6.37e-01
|
4.76e-03
|
GOBP REGULATION OF CHAPERONE MEDIATED AUTOPHAGY
|
8
|
3.95e-01
|
8.24e-01
|
0.29200
|
-2.50e-01
|
1.51e-01
|
2.21e-01
|
4.58e-01
|
GOBP GANGLIOSIDE CATABOLIC PROCESS
|
7
|
3.67e-01
|
8.07e-01
|
0.29200
|
-2.58e-01
|
-1.37e-01
|
2.37e-01
|
5.29e-01
|
GOBP POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST
|
14
|
1.60e-01
|
6.48e-01
|
0.29200
|
-2.92e-01
|
-7.92e-03
|
5.84e-02
|
9.59e-01
|
GOMF ESTROGEN RESPONSE ELEMENT BINDING
|
10
|
2.69e-01
|
7.44e-01
|
0.29200
|
-1.47e-02
|
-2.92e-01
|
9.36e-01
|
1.10e-01
|
GOBP REGULATION OF NAD P H OXIDASE ACTIVITY
|
7
|
4.23e-01
|
8.34e-01
|
0.29200
|
6.75e-02
|
-2.84e-01
|
7.57e-01
|
1.93e-01
|
GOMF NADPH BINDING
|
15
|
1.26e-01
|
6.06e-01
|
0.29200
|
-2.81e-01
|
-8.09e-02
|
5.98e-02
|
5.87e-01
|
GOBP RESPONSE TO FLUID SHEAR STRESS
|
34
|
1.98e-02
|
3.00e-01
|
0.29200
|
-2.45e-01
|
1.59e-01
|
1.35e-02
|
1.08e-01
|
GOMF CADMIUM ION BINDING
|
5
|
5.60e-01
|
8.83e-01
|
0.29200
|
1.48e-01
|
-2.52e-01
|
5.66e-01
|
3.30e-01
|
GOMF HEPARAN SULFATE GLUCOSAMINE 3 SULFOTRANSFERASE 1 ACTIVITY
|
7
|
3.62e-01
|
8.03e-01
|
0.29200
|
-1.80e-01
|
-2.30e-01
|
4.09e-01
|
2.92e-01
|
GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION
|
10
|
2.42e-01
|
7.25e-01
|
0.29200
|
1.24e-01
|
2.65e-01
|
4.99e-01
|
1.47e-01
|
GOBP POSITIVE REGULATION OF BLOOD PRESSURE BY EPINEPHRINE NOREPINEPHRINE
|
6
|
4.65e-01
|
8.49e-01
|
0.29200
|
-1.85e-02
|
2.91e-01
|
9.37e-01
|
2.17e-01
|
GOBP POSITIVE REGULATION OF HEMATOPOIETIC STEM CELL PROLIFERATION
|
9
|
3.28e-01
|
7.83e-01
|
0.29200
|
2.87e-01
|
-5.35e-02
|
1.36e-01
|
7.81e-01
|
GOBP NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION
|
6
|
4.99e-01
|
8.61e-01
|
0.29200
|
1.46e-01
|
-2.53e-01
|
5.36e-01
|
2.84e-01
|
GOBP LEYDIG CELL DIFFERENTIATION
|
9
|
3.58e-01
|
7.99e-01
|
0.29200
|
-2.29e-01
|
1.81e-01
|
2.35e-01
|
3.46e-01
|
GOMF ARYLESTERASE ACTIVITY
|
6
|
4.22e-01
|
8.34e-01
|
0.29200
|
2.45e-01
|
1.58e-01
|
2.99e-01
|
5.02e-01
|
GOBP ERBB2 ERBB4 SIGNALING PATHWAY
|
5
|
5.62e-01
|
8.84e-01
|
0.29200
|
-1.58e-01
|
2.45e-01
|
5.41e-01
|
3.42e-01
|
GOBP UMP CATABOLIC PROCESS
|
5
|
5.43e-01
|
8.78e-01
|
0.29100
|
-2.83e-01
|
6.96e-02
|
2.73e-01
|
7.87e-01
|
GOBP SATELLITE CELL ACTIVATION INVOLVED IN SKELETAL MUSCLE REGENERATION
|
5
|
4.88e-01
|
8.56e-01
|
0.29100
|
-1.60e-01
|
-2.43e-01
|
5.34e-01
|
3.46e-01
|
GOCC MIB COMPLEX
|
11
|
2.04e-01
|
6.94e-01
|
0.29100
|
-2.24e-01
|
-1.86e-01
|
1.97e-01
|
2.86e-01
|
GOMF GAP JUNCTION CHANNEL ACTIVITY INVOLVED IN CARDIAC CONDUCTION ELECTRICAL COUPLING
|
5
|
5.40e-01
|
8.78e-01
|
0.29100
|
2.86e-01
|
-5.70e-02
|
2.69e-01
|
8.25e-01
|
GOBP REGULATION OF TERMINATION OF DNA TEMPLATED TRANSCRIPTION
|
5
|
5.54e-01
|
8.81e-01
|
0.29100
|
-1.10e-01
|
2.70e-01
|
6.70e-01
|
2.96e-01
|
GOBP CALCIUM ACTIVATED PHOSPHOLIPID SCRAMBLING
|
5
|
5.65e-01
|
8.85e-01
|
0.29100
|
2.32e-01
|
-1.77e-01
|
3.70e-01
|
4.93e-01
|
GOBP REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY
|
20
|
1.02e-01
|
5.72e-01
|
0.29100
|
-1.74e-01
|
2.33e-01
|
1.77e-01
|
7.09e-02
|
GOBP POSITIVE REGULATION OF DNA CATABOLIC PROCESS
|
5
|
5.49e-01
|
8.80e-01
|
0.29100
|
-2.77e-01
|
8.98e-02
|
2.83e-01
|
7.28e-01
|
GOMF UBIQUITIN PROTEIN TRANSFERASE ACTIVATOR ACTIVITY
|
13
|
2.03e-01
|
6.93e-01
|
0.29100
|
6.12e-02
|
-2.85e-01
|
7.02e-01
|
7.56e-02
|
GOBP ELASTIN CATABOLIC PROCESS
|
5
|
5.18e-01
|
8.69e-01
|
0.29100
|
-2.90e-01
|
-2.47e-02
|
2.61e-01
|
9.24e-01
|
GOCC JUNCTIONAL SARCOPLASMIC RETICULUM MEMBRANE
|
9
|
3.55e-01
|
7.97e-01
|
0.29100
|
2.50e-01
|
-1.50e-01
|
1.95e-01
|
4.37e-01
|
GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY
|
13
|
1.94e-01
|
6.86e-01
|
0.29100
|
2.47e-02
|
-2.90e-01
|
8.77e-01
|
7.03e-02
|
GOBP NEGATIVE REGULATION BY HOST OF VIRAL PROCESS
|
14
|
1.97e-01
|
6.88e-01
|
0.29100
|
1.32e-01
|
-2.59e-01
|
3.91e-01
|
9.33e-02
|
GOBP GLYCOSIDE TRANSPORT
|
5
|
5.43e-01
|
8.78e-01
|
0.29100
|
-2.84e-01
|
6.36e-02
|
2.72e-01
|
8.06e-01
|
GOCC TELOMERASE HOLOENZYME COMPLEX
|
20
|
7.92e-02
|
5.27e-01
|
0.29100
|
1.73e-02
|
-2.90e-01
|
8.93e-01
|
2.46e-02
|
GOBP REGULATION OF FATTY ACID BETA OXIDATION
|
19
|
1.16e-01
|
5.95e-01
|
0.29100
|
-1.79e-01
|
2.29e-01
|
1.76e-01
|
8.41e-02
|
GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION
|
10
|
3.19e-01
|
7.78e-01
|
0.29100
|
-1.61e-01
|
2.42e-01
|
3.78e-01
|
1.85e-01
|
GOMF OLFACTORY RECEPTOR ACTIVITY
|
341
|
1.94e-18
|
1.98e-14
|
0.29100
|
2.82e-01
|
-6.93e-02
|
3.21e-19
|
2.78e-02
|
GOBP LIPID IMPORT INTO CELL
|
20
|
1.03e-01
|
5.74e-01
|
0.29000
|
-1.63e-01
|
2.41e-01
|
2.08e-01
|
6.24e-02
|
GOBP RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION
|
14
|
1.34e-01
|
6.16e-01
|
0.29000
|
-2.25e-01
|
-1.84e-01
|
1.45e-01
|
2.34e-01
|
GOBP REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS
|
21
|
4.92e-02
|
4.42e-01
|
0.29000
|
1.85e-01
|
2.24e-01
|
1.42e-01
|
7.58e-02
|
GOMF UDP GALACTOSE BETA N ACETYLGLUCOSAMINE BETA 1 3 GALACTOSYLTRANSFERASE ACTIVITY
|
12
|
2.57e-01
|
7.35e-01
|
0.29000
|
-2.31e-01
|
1.75e-01
|
1.65e-01
|
2.94e-01
|
GOMF G PROTEIN COUPLED CHEMOATTRACTANT RECEPTOR ACTIVITY
|
25
|
2.95e-02
|
3.58e-01
|
0.29000
|
1.37e-01
|
2.56e-01
|
2.37e-01
|
2.67e-02
|
GOBP CELL ADHESION INVOLVED IN HEART MORPHOGENESIS
|
6
|
4.64e-01
|
8.48e-01
|
0.29000
|
-1.35e-03
|
2.90e-01
|
9.95e-01
|
2.18e-01
|
GOBP REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE
|
12
|
1.85e-01
|
6.77e-01
|
0.29000
|
-2.59e-01
|
-1.30e-01
|
1.20e-01
|
4.36e-01
|
GOBP CELLULAR RESPONSE TO NITROGEN STARVATION
|
12
|
1.79e-01
|
6.69e-01
|
0.29000
|
-2.16e-01
|
-1.94e-01
|
1.95e-01
|
2.46e-01
|
GOMF CAMP DEPENDENT PROTEIN KINASE ACTIVITY
|
5
|
5.44e-01
|
8.78e-01
|
0.29000
|
2.84e-01
|
-5.98e-02
|
2.72e-01
|
8.17e-01
|
GOBP HEPOXILIN METABOLIC PROCESS
|
9
|
2.87e-01
|
7.59e-01
|
0.29000
|
-2.68e-01
|
-1.10e-01
|
1.64e-01
|
5.68e-01
|
GOBP NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING
|
14
|
1.61e-01
|
6.48e-01
|
0.29000
|
2.60e-02
|
2.89e-01
|
8.66e-01
|
6.16e-02
|
GOBP POSITIVE REGULATION OF PROTEIN SUMOYLATION
|
12
|
2.54e-01
|
7.33e-01
|
0.29000
|
-1.47e-01
|
2.50e-01
|
3.78e-01
|
1.34e-01
|
GOBP CELL CELL JUNCTION MAINTENANCE
|
18
|
1.24e-01
|
6.06e-01
|
0.29000
|
-2.63e-01
|
1.21e-01
|
5.34e-02
|
3.73e-01
|
GOMF PHOSPHATIDIC ACID TRANSFER ACTIVITY
|
7
|
4.26e-01
|
8.36e-01
|
0.29000
|
5.59e-02
|
-2.84e-01
|
7.98e-01
|
1.93e-01
|
GOBP REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY
|
12
|
1.87e-01
|
6.78e-01
|
0.28900
|
-1.33e-01
|
-2.57e-01
|
4.25e-01
|
1.24e-01
|
GOBP NUCLEOTIDE SALVAGE
|
17
|
1.49e-01
|
6.35e-01
|
0.28900
|
-2.27e-01
|
1.79e-01
|
1.05e-01
|
2.01e-01
|
GOBP MITOCHONDRIAL PROTON TRANSPORTING ATP SYNTHASE COMPLEX ASSEMBLY
|
8
|
3.97e-01
|
8.25e-01
|
0.28900
|
1.20e-01
|
-2.63e-01
|
5.58e-01
|
1.98e-01
|
GOBP LEUKOTRIENE METABOLIC PROCESS
|
30
|
3.07e-02
|
3.61e-01
|
0.28900
|
-2.67e-01
|
1.09e-01
|
1.12e-02
|
3.01e-01
|
GOBP ANTIGEN PROCESSING AND PRESENTATION ENDOGENOUS LIPID ANTIGEN VIA MHC CLASS IB
|
5
|
4.93e-01
|
8.58e-01
|
0.28900
|
2.31e-01
|
1.73e-01
|
3.70e-01
|
5.04e-01
|
GOMF LIPID ANTIGEN BINDING
|
5
|
4.93e-01
|
8.58e-01
|
0.28900
|
2.31e-01
|
1.73e-01
|
3.70e-01
|
5.04e-01
|
GOBP INHIBITORY POSTSYNAPTIC POTENTIAL
|
16
|
1.04e-01
|
5.75e-01
|
0.28900
|
2.28e-01
|
1.78e-01
|
1.15e-01
|
2.19e-01
|
GOBP INTRACELLULAR TRANSPORT OF VIRUS
|
10
|
2.93e-01
|
7.63e-01
|
0.28900
|
3.80e-02
|
-2.86e-01
|
8.35e-01
|
1.17e-01
|
GOCC NONHOMOLOGOUS END JOINING COMPLEX
|
9
|
3.47e-01
|
7.96e-01
|
0.28900
|
9.07e-02
|
-2.74e-01
|
6.37e-01
|
1.55e-01
|
GOBP EARLY ENDOSOME TO GOLGI TRANSPORT
|
13
|
2.16e-01
|
7.07e-01
|
0.28800
|
-2.75e-01
|
8.60e-02
|
8.56e-02
|
5.91e-01
|
GOCC CUL5 RING UBIQUITIN LIGASE COMPLEX
|
9
|
3.02e-01
|
7.68e-01
|
0.28800
|
6.23e-02
|
2.82e-01
|
7.46e-01
|
1.44e-01
|
GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II
|
5
|
5.66e-01
|
8.85e-01
|
0.28800
|
1.35e-01
|
-2.54e-01
|
6.00e-01
|
3.24e-01
|
GOBP CELLULAR RESPONSE TO DSRNA
|
22
|
7.47e-02
|
5.16e-01
|
0.28800
|
8.18e-02
|
-2.76e-01
|
5.07e-01
|
2.49e-02
|
GOBP PYRIMIDINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS
|
6
|
4.93e-01
|
8.58e-01
|
0.28800
|
-2.76e-01
|
8.22e-02
|
2.42e-01
|
7.27e-01
|
GOBP MICTURITION
|
8
|
4.07e-01
|
8.26e-01
|
0.28800
|
1.53e-01
|
-2.44e-01
|
4.53e-01
|
2.33e-01
|
GOMF RNA POLYMERASE III GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY
|
12
|
1.84e-01
|
6.74e-01
|
0.28800
|
-1.79e-01
|
-2.25e-01
|
2.83e-01
|
1.76e-01
|
GOMF COLLAGEN BINDING INVOLVED IN CELL MATRIX ADHESION
|
5
|
5.00e-01
|
8.62e-01
|
0.28800
|
-2.54e-01
|
-1.36e-01
|
3.26e-01
|
5.98e-01
|
GOBP GLYCOLIPID TRANSPORT
|
8
|
3.71e-01
|
8.09e-01
|
0.28800
|
-1.98e-02
|
2.87e-01
|
9.23e-01
|
1.60e-01
|
GOMF NERVE GROWTH FACTOR BINDING
|
6
|
4.35e-01
|
8.38e-01
|
0.28800
|
1.36e-01
|
2.54e-01
|
5.65e-01
|
2.82e-01
|
GOBP REGULATION OF LONG TERM SYNAPTIC DEPRESSION
|
12
|
2.63e-01
|
7.40e-01
|
0.28800
|
-1.76e-01
|
2.28e-01
|
2.91e-01
|
1.72e-01
|
GOBP NEGATIVE REGULATION OF MUSCLE ADAPTATION
|
10
|
3.22e-01
|
7.79e-01
|
0.28800
|
-1.33e-01
|
2.55e-01
|
4.67e-01
|
1.62e-01
|
GOBP PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS
|
39
|
4.17e-03
|
1.32e-01
|
0.28700
|
-1.88e-01
|
-2.18e-01
|
4.24e-02
|
1.87e-02
|
GOBP PERIPHERAL NERVOUS SYSTEM MYELIN MAINTENANCE
|
9
|
3.70e-01
|
8.09e-01
|
0.28700
|
-1.97e-01
|
2.09e-01
|
3.06e-01
|
2.77e-01
|
GOMF PROTEIN CARRIER CHAPERONE
|
33
|
2.00e-02
|
3.00e-01
|
0.28700
|
6.72e-02
|
-2.79e-01
|
5.04e-01
|
5.49e-03
|
GOBP PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS
|
10
|
3.07e-01
|
7.71e-01
|
0.28700
|
-2.78e-01
|
7.07e-02
|
1.27e-01
|
6.99e-01
|
GOBP REGULATION OF GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS
|
8
|
3.25e-01
|
7.80e-01
|
0.28700
|
2.09e-01
|
1.97e-01
|
3.07e-01
|
3.34e-01
|
GOBP NEGATIVE REGULATION OF HYPOXIA INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY
|
6
|
4.35e-01
|
8.38e-01
|
0.28700
|
-2.46e-01
|
-1.48e-01
|
2.96e-01
|
5.31e-01
|
GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY
|
12
|
2.42e-01
|
7.25e-01
|
0.28700
|
6.87e-02
|
-2.79e-01
|
6.80e-01
|
9.46e-02
|
GOBP REGULATION OF BONE DEVELOPMENT
|
9
|
3.34e-01
|
7.87e-01
|
0.28700
|
-3.25e-02
|
2.85e-01
|
8.66e-01
|
1.38e-01
|
GOCC METHYLOSOME
|
13
|
2.14e-01
|
7.03e-01
|
0.28700
|
6.60e-02
|
-2.79e-01
|
6.80e-01
|
8.12e-02
|
GOBP MALE SEX DETERMINATION
|
11
|
2.20e-01
|
7.09e-01
|
0.28700
|
1.31e-01
|
2.55e-01
|
4.53e-01
|
1.42e-01
|
GOBP ATRIAL CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION
|
9
|
2.87e-01
|
7.59e-01
|
0.28700
|
2.44e-01
|
1.51e-01
|
2.05e-01
|
4.34e-01
|
GOBP ESTROGEN METABOLIC PROCESS
|
37
|
1.33e-02
|
2.51e-01
|
0.28700
|
2.75e-01
|
-8.25e-02
|
3.83e-03
|
3.85e-01
|
GOBP COENZYME A METABOLIC PROCESS
|
19
|
9.24e-02
|
5.54e-01
|
0.28700
|
-2.46e-03
|
-2.87e-01
|
9.85e-01
|
3.04e-02
|
GOBP REGULATION OF SYNAPTIC VESICLE CYCLE
|
12
|
2.46e-01
|
7.26e-01
|
0.28700
|
-7.89e-02
|
2.76e-01
|
6.36e-01
|
9.83e-02
|
GOBP DENSE CORE GRANULE EXOCYTOSIS
|
10
|
2.76e-01
|
7.50e-01
|
0.28700
|
3.53e-02
|
2.84e-01
|
8.47e-01
|
1.19e-01
|
GOMF HYDROXYMETHYL FORMYL AND RELATED TRANSFERASE ACTIVITY
|
8
|
3.27e-01
|
7.82e-01
|
0.28600
|
-1.83e-01
|
-2.21e-01
|
3.70e-01
|
2.80e-01
|
GOBP MAINTENANCE OF PROTEIN LOCATION IN EXTRACELLULAR REGION
|
8
|
4.05e-01
|
8.26e-01
|
0.28600
|
2.58e-01
|
-1.24e-01
|
2.06e-01
|
5.43e-01
|
GOBP REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY
|
15
|
1.78e-01
|
6.67e-01
|
0.28600
|
2.69e-01
|
-9.88e-02
|
7.14e-02
|
5.08e-01
|
GOBP NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE
|
21
|
9.35e-02
|
5.56e-01
|
0.28600
|
1.25e-01
|
-2.57e-01
|
3.20e-01
|
4.11e-02
|
GOBP TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY
|
17
|
1.55e-01
|
6.42e-01
|
0.28600
|
-1.80e-01
|
2.23e-01
|
2.00e-01
|
1.12e-01
|
GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION
|
16
|
1.74e-01
|
6.63e-01
|
0.28600
|
-1.93e-01
|
2.11e-01
|
1.81e-01
|
1.45e-01
|
GOMF SH2 DOMAIN BINDING
|
40
|
4.26e-03
|
1.34e-01
|
0.28600
|
1.31e-01
|
2.54e-01
|
1.52e-01
|
5.39e-03
|
GOBP SERTOLI CELL DIFFERENTIATION
|
17
|
1.01e-01
|
5.69e-01
|
0.28600
|
1.13e-01
|
2.63e-01
|
4.21e-01
|
6.08e-02
|
GOBP POSITIVE REGULATION OF TRIGLYCERIDE LIPASE ACTIVITY
|
9
|
3.49e-01
|
7.96e-01
|
0.28600
|
7.15e-02
|
-2.77e-01
|
7.10e-01
|
1.51e-01
|
GOBP L METHIONINE SALVAGE FROM METHYLTHIOADENOSINE
|
5
|
5.13e-01
|
8.67e-01
|
0.28600
|
-2.71e-01
|
-9.06e-02
|
2.94e-01
|
7.26e-01
|
GOBP PROGESTERONE RECEPTOR SIGNALING PATHWAY
|
11
|
3.00e-01
|
7.67e-01
|
0.28600
|
-2.25e-01
|
1.76e-01
|
1.96e-01
|
3.12e-01
|
GOCC GID COMPLEX
|
5
|
5.76e-01
|
8.89e-01
|
0.28600
|
-1.57e-01
|
2.38e-01
|
5.43e-01
|
3.56e-01
|
GOMF TRANSLATION TERMINATION FACTOR ACTIVITY
|
6
|
5.18e-01
|
8.69e-01
|
0.28500
|
1.66e-01
|
-2.32e-01
|
4.81e-01
|
3.25e-01
|
GOMF UBIQUITIN UBIQUITIN LIGASE ACTIVITY
|
14
|
2.13e-01
|
7.02e-01
|
0.28500
|
-2.42e-01
|
1.50e-01
|
1.16e-01
|
3.30e-01
|
GOBP VIRAL BUDDING
|
25
|
4.96e-02
|
4.42e-01
|
0.28500
|
-2.83e-01
|
3.44e-02
|
1.42e-02
|
7.66e-01
|
GOCC CYTOSOLIC RIBOSOME
|
107
|
6.27e-06
|
1.07e-03
|
0.28500
|
1.19e-01
|
-2.59e-01
|
3.27e-02
|
3.65e-06
|
GOBP REGULATION OF NUCLEOTIDE EXCISION REPAIR
|
28
|
4.74e-02
|
4.38e-01
|
0.28500
|
-2.17e-01
|
1.85e-01
|
4.69e-02
|
8.98e-02
|
GOMF INTERLEUKIN 6 RECEPTOR BINDING
|
7
|
4.34e-01
|
8.38e-01
|
0.28500
|
-4.27e-02
|
2.82e-01
|
8.45e-01
|
1.96e-01
|
GOBP DENDRITE SELF AVOIDANCE
|
14
|
2.19e-01
|
7.07e-01
|
0.28500
|
1.95e-01
|
-2.07e-01
|
2.06e-01
|
1.79e-01
|
GOBP GLUTAMATE REUPTAKE
|
6
|
5.20e-01
|
8.69e-01
|
0.28500
|
-1.77e-01
|
2.23e-01
|
4.54e-01
|
3.43e-01
|
GOBP PROTEIN O LINKED MANNOSYLATION
|
17
|
1.26e-01
|
6.06e-01
|
0.28500
|
-2.84e-01
|
1.26e-02
|
4.23e-02
|
9.28e-01
|
GOBP AMINO ACID BETAINE TRANSPORT
|
13
|
1.72e-01
|
6.60e-01
|
0.28500
|
2.53e-01
|
1.30e-01
|
1.14e-01
|
4.16e-01
|
GOBP NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION
|
12
|
2.45e-01
|
7.26e-01
|
0.28500
|
-5.87e-02
|
2.79e-01
|
7.25e-01
|
9.47e-02
|
GOMF ATP DEPENDENT PEPTIDASE ACTIVITY
|
7
|
4.61e-01
|
8.48e-01
|
0.28500
|
-2.50e-01
|
1.37e-01
|
2.53e-01
|
5.30e-01
|
GOMF NUCLEOTIDASE ACTIVITY
|
14
|
1.82e-01
|
6.72e-01
|
0.28500
|
-1.30e-02
|
2.84e-01
|
9.33e-01
|
6.55e-02
|
GOCC MULTIVESICULAR BODY MEMBRANE
|
28
|
4.78e-02
|
4.38e-01
|
0.28500
|
-2.24e-01
|
1.75e-01
|
4.00e-02
|
1.09e-01
|
GOCC PROTON TRANSPORTING V TYPE ATPASE V0 DOMAIN
|
11
|
3.04e-01
|
7.68e-01
|
0.28400
|
-2.12e-01
|
1.90e-01
|
2.23e-01
|
2.76e-01
|
GOBP MITRAL VALVE DEVELOPMENT
|
13
|
2.30e-01
|
7.18e-01
|
0.28400
|
-1.04e-01
|
2.65e-01
|
5.17e-01
|
9.84e-02
|
GOBP MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE
|
19
|
1.08e-01
|
5.81e-01
|
0.28400
|
-2.79e-01
|
5.51e-02
|
3.53e-02
|
6.78e-01
|
GOBP REGULATION OF HELICASE ACTIVITY
|
10
|
2.80e-01
|
7.53e-01
|
0.28400
|
-2.81e-01
|
-4.03e-02
|
1.23e-01
|
8.25e-01
|
GOMF TYPE 2 FIBROBLAST GROWTH FACTOR RECEPTOR BINDING
|
5
|
5.46e-01
|
8.78e-01
|
0.28400
|
1.75e-02
|
-2.84e-01
|
9.46e-01
|
2.72e-01
|
GOBP DISACCHARIDE METABOLIC PROCESS
|
11
|
2.54e-01
|
7.32e-01
|
0.28400
|
-1.70e-02
|
-2.84e-01
|
9.22e-01
|
1.03e-01
|
GOBP THIOESTER BIOSYNTHETIC PROCESS
|
43
|
4.62e-03
|
1.39e-01
|
0.28400
|
-2.83e-01
|
-2.26e-02
|
1.31e-03
|
7.98e-01
|
GOBP TAURINE METABOLIC PROCESS
|
9
|
3.58e-01
|
8.00e-01
|
0.28400
|
8.77e-02
|
-2.70e-01
|
6.49e-01
|
1.61e-01
|
GOMF CROSSOVER JUNCTION DNA ENDONUCLEASE ACTIVITY
|
7
|
3.82e-01
|
8.16e-01
|
0.28400
|
-1.89e-01
|
-2.12e-01
|
3.86e-01
|
3.32e-01
|
GOMF CYCLOHYDROLASE ACTIVITY
|
5
|
5.28e-01
|
8.72e-01
|
0.28400
|
-4.94e-02
|
-2.80e-01
|
8.48e-01
|
2.79e-01
|
GOBP ENDOCARDIAL CELL DIFFERENTIATION
|
6
|
5.19e-01
|
8.69e-01
|
0.28400
|
-1.52e-01
|
2.40e-01
|
5.20e-01
|
3.09e-01
|
GOBP REGULATION OF SKELETAL MUSCLE TISSUE GROWTH
|
6
|
4.75e-01
|
8.54e-01
|
0.28400
|
2.83e-01
|
1.44e-02
|
2.29e-01
|
9.51e-01
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN NAD P H AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN
|
38
|
1.33e-02
|
2.51e-01
|
0.28400
|
2.70e-01
|
-8.77e-02
|
3.98e-03
|
3.49e-01
|
GOMF DOUBLE STRANDED DNA EXODEOXYRIBONUCLEASE ACTIVITY
|
6
|
4.39e-01
|
8.40e-01
|
0.28400
|
-2.10e-01
|
-1.91e-01
|
3.73e-01
|
4.18e-01
|
GOMF N6 METHYLADENOSINE CONTAINING RNA BINDING
|
10
|
3.26e-01
|
7.82e-01
|
0.28400
|
2.63e-01
|
-1.06e-01
|
1.49e-01
|
5.63e-01
|
GOBP CHOLINE TRANSPORT
|
9
|
3.72e-01
|
8.09e-01
|
0.28400
|
2.48e-01
|
-1.38e-01
|
1.98e-01
|
4.72e-01
|
GOBP NEGATIVE REGULATION OF INTERLEUKIN 18 PRODUCTION
|
5
|
5.78e-01
|
8.89e-01
|
0.28400
|
2.48e-01
|
-1.38e-01
|
3.37e-01
|
5.93e-01
|
GOMF 14 3 3 PROTEIN BINDING
|
31
|
3.19e-02
|
3.66e-01
|
0.28400
|
-2.58e-01
|
1.17e-01
|
1.28e-02
|
2.61e-01
|
GOBP DIPEPTIDE TRANSMEMBRANE TRANSPORT
|
7
|
3.87e-01
|
8.19e-01
|
0.28300
|
1.54e-01
|
2.38e-01
|
4.80e-01
|
2.76e-01
|
GOBP CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS
|
20
|
6.87e-02
|
5.00e-01
|
0.28300
|
-1.25e-01
|
-2.54e-01
|
3.32e-01
|
4.91e-02
|
GOBP MITOTIC SPINDLE ELONGATION
|
11
|
2.94e-01
|
7.64e-01
|
0.28300
|
-2.60e-01
|
1.12e-01
|
1.35e-01
|
5.19e-01
|
GOBP AMINOPHOSPHOLIPID TRANSLOCATION
|
6
|
4.46e-01
|
8.40e-01
|
0.28300
|
-1.39e-01
|
-2.46e-01
|
5.54e-01
|
2.96e-01
|
GOMF AMINOPHOSPHOLIPID FLIPPASE ACTIVITY
|
6
|
4.46e-01
|
8.40e-01
|
0.28300
|
-1.39e-01
|
-2.46e-01
|
5.54e-01
|
2.96e-01
|
GOBP RESPONSE TO ACETYLCHOLINE
|
36
|
2.09e-02
|
3.05e-01
|
0.28300
|
-1.73e-01
|
2.24e-01
|
7.28e-02
|
1.99e-02
|
GOBP RHODOPSIN MEDIATED SIGNALING PATHWAY
|
12
|
2.64e-01
|
7.41e-01
|
0.28300
|
-2.59e-01
|
1.14e-01
|
1.20e-01
|
4.94e-01
|
GOBP NEGATIVE REGULATION OF MIRNA METABOLIC PROCESS
|
26
|
5.38e-02
|
4.58e-01
|
0.28300
|
-2.66e-01
|
9.58e-02
|
1.87e-02
|
3.98e-01
|
GOBP REGULATION OF SKELETAL MUSCLE FIBER DEVELOPMENT
|
11
|
2.36e-01
|
7.24e-01
|
0.28300
|
2.66e-01
|
9.65e-02
|
1.27e-01
|
5.79e-01
|
GOBP HEMOGLOBIN BIOSYNTHETIC PROCESS
|
13
|
2.48e-01
|
7.26e-01
|
0.28300
|
-2.16e-01
|
1.82e-01
|
1.77e-01
|
2.55e-01
|
GOBP REGULATION OF GAMMA DELTA T CELL ACTIVATION
|
11
|
2.47e-01
|
7.26e-01
|
0.28300
|
5.11e-02
|
2.78e-01
|
7.69e-01
|
1.10e-01
|
GOBP DORSAL AORTA DEVELOPMENT
|
10
|
2.99e-01
|
7.67e-01
|
0.28300
|
-2.83e-01
|
1.02e-02
|
1.22e-01
|
9.56e-01
|
GOCC ELONGIN COMPLEX
|
5
|
5.14e-01
|
8.67e-01
|
0.28300
|
1.23e-01
|
2.54e-01
|
6.33e-01
|
3.24e-01
|
GOBP GLANDULAR EPITHELIAL CELL MATURATION
|
9
|
3.20e-01
|
7.78e-01
|
0.28300
|
-2.78e-01
|
-5.01e-02
|
1.48e-01
|
7.95e-01
|
GOMF G PROTEIN COUPLED AMINE RECEPTOR ACTIVITY
|
38
|
1.04e-02
|
2.18e-01
|
0.28300
|
-1.27e-02
|
2.82e-01
|
8.92e-01
|
2.59e-03
|
GOBP ETHANOL METABOLIC PROCESS
|
19
|
1.25e-01
|
6.06e-01
|
0.28300
|
1.27e-01
|
-2.52e-01
|
3.38e-01
|
5.68e-02
|
GOBP METANEPHRIC DISTAL TUBULE DEVELOPMENT
|
7
|
4.41e-01
|
8.40e-01
|
0.28300
|
-2.79e-01
|
4.35e-02
|
2.01e-01
|
8.42e-01
|
GOBP POSITIVE REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY
|
6
|
5.06e-01
|
8.65e-01
|
0.28200
|
-7.72e-02
|
2.72e-01
|
7.43e-01
|
2.49e-01
|
GOCC NUCLEAR OUTER MEMBRANE
|
28
|
3.70e-02
|
3.91e-01
|
0.28200
|
-2.80e-01
|
3.33e-02
|
1.02e-02
|
7.60e-01
|
GOBP REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT
|
17
|
1.59e-01
|
6.48e-01
|
0.28200
|
-2.40e-01
|
1.48e-01
|
8.64e-02
|
2.90e-01
|
GOBP NERVE GROWTH FACTOR SIGNALING PATHWAY
|
13
|
1.81e-01
|
6.70e-01
|
0.28200
|
2.60e-01
|
1.09e-01
|
1.04e-01
|
4.96e-01
|
GOBP TONGUE MORPHOGENESIS
|
10
|
2.86e-01
|
7.59e-01
|
0.28200
|
3.76e-02
|
2.80e-01
|
8.37e-01
|
1.26e-01
|
GOBP VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS
|
14
|
2.18e-01
|
7.07e-01
|
0.28200
|
-1.38e-01
|
2.46e-01
|
3.73e-01
|
1.10e-01
|
GOBP SEX DETERMINATION
|
18
|
9.33e-02
|
5.55e-01
|
0.28200
|
1.12e-01
|
2.59e-01
|
4.11e-01
|
5.71e-02
|
GOBP PROLACTIN SECRETION
|
5
|
5.18e-01
|
8.69e-01
|
0.28200
|
-1.07e-01
|
-2.61e-01
|
6.78e-01
|
3.12e-01
|
GOBP PROTEIN LOCALIZATION TO CENP A CONTAINING CHROMATIN
|
16
|
1.51e-01
|
6.38e-01
|
0.28200
|
2.81e-01
|
-2.99e-02
|
5.20e-02
|
8.36e-01
|
GOBP FOREBRAIN DORSAL VENTRAL PATTERN FORMATION
|
7
|
3.87e-01
|
8.19e-01
|
0.28200
|
-2.00e-01
|
-1.99e-01
|
3.60e-01
|
3.61e-01
|
GOBP REGULATION OF SUPEROXIDE METABOLIC PROCESS
|
30
|
3.97e-02
|
4.09e-01
|
0.28200
|
-2.36e-01
|
1.54e-01
|
2.50e-02
|
1.45e-01
|
GOMF ALCOHOL TRANSMEMBRANE TRANSPORTER ACTIVITY
|
6
|
4.97e-01
|
8.61e-01
|
0.28200
|
2.78e-01
|
-4.53e-02
|
2.38e-01
|
8.48e-01
|
GOBP TRANSITION BETWEEN FAST AND SLOW FIBER
|
9
|
3.37e-01
|
7.89e-01
|
0.28200
|
1.06e-03
|
-2.82e-01
|
9.96e-01
|
1.43e-01
|
GOMF ANNEALING ACTIVITY
|
8
|
3.41e-01
|
7.93e-01
|
0.28200
|
-2.37e-01
|
-1.53e-01
|
2.46e-01
|
4.54e-01
|
GOBP TETRAHYDROBIOPTERIN METABOLIC PROCESS
|
8
|
3.49e-01
|
7.96e-01
|
0.28200
|
-1.11e-01
|
-2.59e-01
|
5.87e-01
|
2.04e-01
|
GOBP ERBB2 EGFR SIGNALING PATHWAY
|
8
|
3.40e-01
|
7.91e-01
|
0.28200
|
-2.24e-01
|
-1.71e-01
|
2.73e-01
|
4.02e-01
|
GOCC L TYPE VOLTAGE GATED CALCIUM CHANNEL COMPLEX
|
12
|
2.50e-01
|
7.28e-01
|
0.28200
|
-5.07e-02
|
2.77e-01
|
7.61e-01
|
9.64e-02
|
GOMF MACROMOLECULE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
31
|
2.44e-02
|
3.31e-01
|
0.28200
|
9.22e-03
|
-2.82e-01
|
9.29e-01
|
6.65e-03
|
GOBP CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE
|
17
|
1.26e-01
|
6.06e-01
|
0.28200
|
1.19e-02
|
2.81e-01
|
9.32e-01
|
4.45e-02
|
GOBP PROTEIN SIDE CHAIN DEGLUTAMYLATION
|
5
|
5.66e-01
|
8.85e-01
|
0.28200
|
6.79e-02
|
-2.73e-01
|
7.93e-01
|
2.90e-01
|
GOCC MULTIMERIC RIBONUCLEASE P COMPLEX
|
10
|
3.18e-01
|
7.78e-01
|
0.28200
|
2.75e-01
|
-6.09e-02
|
1.32e-01
|
7.39e-01
|
GOMF RIBONUCLEASE P RNA BINDING
|
10
|
3.18e-01
|
7.78e-01
|
0.28200
|
2.75e-01
|
-6.09e-02
|
1.32e-01
|
7.39e-01
|
GOMF BETA GLUCOSIDASE ACTIVITY
|
6
|
4.62e-01
|
8.48e-01
|
0.28200
|
-8.13e-02
|
-2.70e-01
|
7.30e-01
|
2.53e-01
|
GOBP CELLULAR RESPONSE TO TEMPERATURE STIMULUS
|
5
|
5.45e-01
|
8.78e-01
|
0.28200
|
-2.81e-01
|
-6.73e-03
|
2.76e-01
|
9.79e-01
|
GOBP TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS
|
15
|
1.94e-01
|
6.86e-01
|
0.28200
|
1.21e-01
|
-2.54e-01
|
4.18e-01
|
8.81e-02
|
GOBP PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION
|
23
|
6.80e-02
|
5.00e-01
|
0.28100
|
-2.79e-01
|
3.49e-02
|
2.04e-02
|
7.72e-01
|
GOBP ADENYLATE CYCLASE INHIBITING SEROTONIN RECEPTOR SIGNALING PATHWAY
|
7
|
4.62e-01
|
8.48e-01
|
0.28100
|
-1.06e-01
|
2.61e-01
|
6.28e-01
|
2.32e-01
|
GOBP RESPONSE TO UV C
|
14
|
2.06e-01
|
6.95e-01
|
0.28100
|
-2.71e-01
|
7.40e-02
|
7.87e-02
|
6.32e-01
|
GOCC PRC1 COMPLEX
|
16
|
1.16e-01
|
5.96e-01
|
0.28100
|
-1.72e-01
|
-2.22e-01
|
2.33e-01
|
1.23e-01
|
GOBP DETECTION OF CELL DENSITY
|
9
|
3.82e-01
|
8.16e-01
|
0.28100
|
-2.36e-01
|
1.53e-01
|
2.21e-01
|
4.25e-01
|
GOCC POSTSYNAPTIC ENDOSOME
|
13
|
2.03e-01
|
6.93e-01
|
0.28100
|
-2.80e-01
|
-2.23e-02
|
8.01e-02
|
8.89e-01
|
GOBP ENDOCARDIUM MORPHOGENESIS
|
6
|
5.20e-01
|
8.69e-01
|
0.28100
|
-1.23e-01
|
2.53e-01
|
6.03e-01
|
2.83e-01
|
GOMF G PROTEIN COUPLED NEUROTRANSMITTER RECEPTOR ACTIVITY
|
11
|
3.04e-01
|
7.68e-01
|
0.28100
|
-2.51e-01
|
1.26e-01
|
1.50e-01
|
4.68e-01
|
GOMF CYCLASE ACTIVITY
|
21
|
1.08e-01
|
5.82e-01
|
0.28100
|
-2.25e-01
|
1.68e-01
|
7.44e-02
|
1.82e-01
|
GOBP NEGATIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION
|
8
|
4.04e-01
|
8.26e-01
|
0.28100
|
2.73e-01
|
-6.70e-02
|
1.82e-01
|
7.43e-01
|
GOBP REGULATION OF SREBP SIGNALING PATHWAY
|
8
|
3.92e-01
|
8.22e-01
|
0.28100
|
-2.79e-01
|
2.75e-02
|
1.71e-01
|
8.93e-01
|
GOBP GLOMERULAR MESANGIUM DEVELOPMENT
|
18
|
1.42e-01
|
6.26e-01
|
0.28100
|
-1.22e-01
|
2.53e-01
|
3.71e-01
|
6.34e-02
|
GOBP PYRIMIDINE CONTAINING COMPOUND SALVAGE
|
7
|
4.71e-01
|
8.51e-01
|
0.28000
|
-2.48e-01
|
1.32e-01
|
2.57e-01
|
5.46e-01
|
GOBP EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION
|
18
|
1.50e-01
|
6.36e-01
|
0.28000
|
-1.73e-01
|
2.21e-01
|
2.05e-01
|
1.05e-01
|
GOCC CUL4B RING E3 UBIQUITIN LIGASE COMPLEX
|
5
|
5.77e-01
|
8.89e-01
|
0.28000
|
-9.69e-02
|
2.63e-01
|
7.07e-01
|
3.09e-01
|
GOBP POSITIVE REGULATION OF SYNAPTIC PLASTICITY
|
10
|
2.77e-01
|
7.51e-01
|
0.28000
|
9.08e-02
|
2.65e-01
|
6.19e-01
|
1.47e-01
|
GOMF PHOSPHATIDYLSERINE FLOPPASE ACTIVITY
|
8
|
4.31e-01
|
8.37e-01
|
0.28000
|
-2.14e-01
|
1.81e-01
|
2.95e-01
|
3.76e-01
|
GOBP RESPONSE TO INTERLEUKIN 2
|
9
|
3.84e-01
|
8.17e-01
|
0.28000
|
-1.51e-01
|
2.36e-01
|
4.34e-01
|
2.20e-01
|
GOBP POSITIVE REGULATION OF AMINO ACID TRANSPORT
|
22
|
7.21e-02
|
5.12e-01
|
0.28000
|
2.27e-03
|
2.80e-01
|
9.85e-01
|
2.29e-02
|
GOBP REGULATION OF ATRIAL CARDIAC MUSCLE CELL MEMBRANE DEPOLARIZATION
|
9
|
3.89e-01
|
8.20e-01
|
0.28000
|
1.89e-01
|
-2.07e-01
|
3.27e-01
|
2.82e-01
|
GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC PROTEIN COMPLEX
|
18
|
1.49e-01
|
6.35e-01
|
0.28000
|
1.59e-01
|
-2.31e-01
|
2.43e-01
|
9.03e-02
|
GOBP CYTOPLASMIC TRANSLATIONAL INITIATION
|
34
|
1.35e-02
|
2.52e-01
|
0.28000
|
-7.31e-02
|
-2.70e-01
|
4.60e-01
|
6.36e-03
|
GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX
|
20
|
1.14e-01
|
5.91e-01
|
0.28000
|
1.13e-01
|
-2.56e-01
|
3.80e-01
|
4.74e-02
|
GOBP PEPTIDYL CYSTEINE MODIFICATION
|
41
|
1.36e-02
|
2.52e-01
|
0.28000
|
-2.11e-01
|
1.84e-01
|
1.94e-02
|
4.13e-02
|
GOBP REGULATION OF PROTEIN AUTOUBIQUITINATION
|
5
|
5.91e-01
|
8.93e-01
|
0.28000
|
-1.77e-01
|
2.17e-01
|
4.92e-01
|
4.02e-01
|
GOBP POSITIVE T CELL SELECTION
|
39
|
6.28e-03
|
1.64e-01
|
0.28000
|
1.18e-01
|
2.54e-01
|
2.01e-01
|
6.14e-03
|
GOBP PEPTIDOGLYCAN METABOLIC PROCESS
|
6
|
4.51e-01
|
8.44e-01
|
0.28000
|
2.25e-01
|
1.66e-01
|
3.39e-01
|
4.82e-01
|
GOBP SUBTELOMERIC HETEROCHROMATIN FORMATION
|
8
|
3.44e-01
|
7.95e-01
|
0.28000
|
-2.00e-01
|
-1.96e-01
|
3.28e-01
|
3.37e-01
|
GOMF TYPE II TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING
|
11
|
3.17e-01
|
7.77e-01
|
0.28000
|
-1.97e-01
|
1.98e-01
|
2.58e-01
|
2.55e-01
|
GOBP OUTER EAR MORPHOGENESIS
|
7
|
4.22e-01
|
8.34e-01
|
0.27900
|
-2.76e-01
|
-4.50e-02
|
2.06e-01
|
8.37e-01
|
GOCC POSTSYNAPTIC SPECIALIZATION INTRACELLULAR COMPONENT
|
17
|
1.48e-01
|
6.35e-01
|
0.27900
|
-2.72e-01
|
6.29e-02
|
5.20e-02
|
6.53e-01
|
GOBP GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE
|
22
|
8.22e-02
|
5.33e-01
|
0.27900
|
-2.75e-01
|
5.00e-02
|
2.56e-02
|
6.85e-01
|
GOMF HISTONE H3 METHYLTRANSFERASE ACTIVITY
|
42
|
1.13e-02
|
2.27e-01
|
0.27900
|
-2.47e-01
|
1.31e-01
|
5.67e-03
|
1.42e-01
|
GOBP PROTEIN MATURATION BY 4FE 4S CLUSTER TRANSFER
|
7
|
4.00e-01
|
8.25e-01
|
0.27900
|
2.43e-01
|
1.37e-01
|
2.65e-01
|
5.30e-01
|
GOBP ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS
|
17
|
1.14e-01
|
5.92e-01
|
0.27900
|
2.64e-01
|
9.18e-02
|
5.98e-02
|
5.12e-01
|
GOBP CELLULAR RESPONSE TO PROGESTERONE STIMULUS
|
7
|
4.15e-01
|
8.30e-01
|
0.27900
|
7.03e-02
|
2.70e-01
|
7.47e-01
|
2.16e-01
|
GOBP ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS
|
12
|
2.35e-01
|
7.23e-01
|
0.27900
|
-2.15e-02
|
-2.78e-01
|
8.97e-01
|
9.51e-02
|
GOBP LIPID DROPLET FORMATION
|
13
|
2.01e-01
|
6.90e-01
|
0.27900
|
-2.75e-01
|
-4.99e-02
|
8.65e-02
|
7.55e-01
|
GOCC MULTIVESICULAR BODY LUMEN
|
6
|
5.23e-01
|
8.70e-01
|
0.27900
|
1.10e-01
|
-2.56e-01
|
6.41e-01
|
2.77e-01
|
GOBP ISOPENTENYL DIPHOSPHATE BIOSYNTHETIC PROCESS
|
5
|
5.26e-01
|
8.71e-01
|
0.27900
|
-2.58e-01
|
-1.05e-01
|
3.17e-01
|
6.84e-01
|
GOCC COMPLEX OF COLLAGEN TRIMERS
|
19
|
1.27e-01
|
6.07e-01
|
0.27900
|
2.59e-01
|
-1.03e-01
|
5.05e-02
|
4.38e-01
|
GOBP XENOBIOTIC CATABOLIC PROCESS
|
24
|
5.17e-02
|
4.48e-01
|
0.27900
|
2.74e-01
|
5.28e-02
|
2.03e-02
|
6.54e-01
|
GOMF LEUCINE BINDING
|
6
|
4.93e-01
|
8.58e-01
|
0.27900
|
-2.92e-03
|
2.79e-01
|
9.90e-01
|
2.37e-01
|
GOBP UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY
|
5
|
5.17e-01
|
8.69e-01
|
0.27900
|
-1.71e-01
|
-2.20e-01
|
5.07e-01
|
3.95e-01
|
GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY INTERCONVERTING ALDOSES AND KETOSES
|
6
|
4.94e-01
|
8.58e-01
|
0.27900
|
-2.79e-01
|
3.95e-03
|
2.37e-01
|
9.87e-01
|
GOBP UREA TRANSMEMBRANE TRANSPORT
|
9
|
3.83e-01
|
8.16e-01
|
0.27900
|
-2.50e-01
|
1.23e-01
|
1.94e-01
|
5.23e-01
|
GOBP CHONDROBLAST DIFFERENTIATION
|
5
|
5.43e-01
|
8.78e-01
|
0.27800
|
4.15e-02
|
2.75e-01
|
8.72e-01
|
2.86e-01
|
GOBP GLUTAMATE CATABOLIC PROCESS
|
7
|
4.13e-01
|
8.29e-01
|
0.27800
|
-8.65e-02
|
-2.64e-01
|
6.92e-01
|
2.26e-01
|
GOCC WASH COMPLEX
|
10
|
2.96e-01
|
7.65e-01
|
0.27800
|
4.02e-02
|
2.75e-01
|
8.26e-01
|
1.32e-01
|
GOBP MAST CELL MIGRATION
|
13
|
2.06e-01
|
6.95e-01
|
0.27800
|
3.86e-02
|
2.75e-01
|
8.10e-01
|
8.56e-02
|
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY NOREPINEPHRINE EPINEPHRINE
|
8
|
3.56e-01
|
7.97e-01
|
0.27800
|
1.29e-01
|
2.46e-01
|
5.26e-01
|
2.28e-01
|
GOBP METANEPHRIC NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION
|
6
|
5.12e-01
|
8.66e-01
|
0.27800
|
5.79e-02
|
-2.72e-01
|
8.06e-01
|
2.49e-01
|
GOBP COMPLEMENT ACTIVATION
|
56
|
2.89e-03
|
1.04e-01
|
0.27800
|
1.50e-01
|
-2.34e-01
|
5.29e-02
|
2.43e-03
|
GOCC SWI SNF COMPLEX
|
30
|
4.39e-02
|
4.29e-01
|
0.27800
|
-2.31e-01
|
1.54e-01
|
2.85e-02
|
1.44e-01
|
GOBP ANTIMICROBIAL PEPTIDE PRODUCTION
|
11
|
2.36e-01
|
7.24e-01
|
0.27800
|
-2.14e-01
|
-1.77e-01
|
2.18e-01
|
3.11e-01
|
GOBP NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT
|
8
|
4.24e-01
|
8.35e-01
|
0.27800
|
1.06e-01
|
-2.57e-01
|
6.04e-01
|
2.09e-01
|
GOMF PROTON TRANSPORTING ATP SYNTHASE ACTIVITY ROTATIONAL MECHANISM
|
16
|
1.81e-01
|
6.71e-01
|
0.27800
|
1.11e-01
|
-2.54e-01
|
4.41e-01
|
7.81e-02
|
GOBP NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION
|
27
|
6.16e-02
|
4.81e-01
|
0.27800
|
1.77e-01
|
-2.14e-01
|
1.11e-01
|
5.45e-02
|
GOBP NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY
|
13
|
2.37e-01
|
7.24e-01
|
0.27700
|
-6.36e-02
|
2.70e-01
|
6.91e-01
|
9.19e-02
|
GOMF STRUCTURAL CONSTITUENT OF RIBOSOME
|
155
|
8.96e-08
|
5.93e-05
|
0.27700
|
1.29e-01
|
-2.46e-01
|
5.72e-03
|
1.30e-07
|
GOBP REGULATION OF MICROGLIAL CELL ACTIVATION
|
20
|
1.25e-01
|
6.06e-01
|
0.27700
|
1.44e-01
|
-2.37e-01
|
2.65e-01
|
6.69e-02
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH GROUP OF DONORS NAD OR NADP AS ACCEPTOR
|
17
|
1.19e-01
|
6.00e-01
|
0.27700
|
-2.62e-01
|
-9.02e-02
|
6.16e-02
|
5.20e-01
|
GOBP INTERLEUKIN 4 MEDIATED SIGNALING PATHWAY
|
9
|
3.92e-01
|
8.22e-01
|
0.27700
|
-2.36e-01
|
1.44e-01
|
2.20e-01
|
4.54e-01
|
GOCC EMC COMPLEX
|
9
|
3.69e-01
|
8.08e-01
|
0.27700
|
5.58e-02
|
-2.71e-01
|
7.72e-01
|
1.59e-01
|
GOBP NEGATIVE REGULATION OF VASOCONSTRICTION
|
8
|
3.99e-01
|
8.25e-01
|
0.27700
|
1.66e-02
|
-2.76e-01
|
9.35e-01
|
1.76e-01
|
GOBP ISOPRENOID TRANSPORT
|
5
|
5.81e-01
|
8.90e-01
|
0.27700
|
-8.03e-02
|
2.65e-01
|
7.56e-01
|
3.06e-01
|
GOBP RESPONSE TO INTERLEUKIN 3
|
6
|
5.07e-01
|
8.65e-01
|
0.27600
|
3.13e-02
|
-2.75e-01
|
8.95e-01
|
2.44e-01
|
GOMF STRUCTURAL CONSTITUENT OF POSTSYNAPTIC ACTIN CYTOSKELETON
|
7
|
4.80e-01
|
8.54e-01
|
0.27600
|
1.24e-01
|
-2.47e-01
|
5.70e-01
|
2.58e-01
|
GOBP MESENCHYMAL STEM CELL PROLIFERATION
|
10
|
3.60e-01
|
8.02e-01
|
0.27600
|
-1.93e-01
|
1.97e-01
|
2.90e-01
|
2.80e-01
|
GOBP OLIGOSACCHARIDE BIOSYNTHETIC PROCESS
|
29
|
3.29e-02
|
3.70e-01
|
0.27600
|
-1.65e-02
|
-2.76e-01
|
8.77e-01
|
1.01e-02
|
GOBP DIOL BIOSYNTHETIC PROCESS
|
21
|
6.91e-02
|
5.01e-01
|
0.27600
|
-1.22e-01
|
-2.48e-01
|
3.34e-01
|
4.91e-02
|
GOBP GOLGI DISASSEMBLY
|
6
|
5.28e-01
|
8.72e-01
|
0.27600
|
-2.57e-01
|
1.01e-01
|
2.76e-01
|
6.68e-01
|
GOMF INTERLEUKIN 1 BINDING
|
9
|
3.72e-01
|
8.09e-01
|
0.27600
|
-5.96e-02
|
2.70e-01
|
7.57e-01
|
1.61e-01
|
GOBP CYTOPLASMIC TRANSLATION
|
140
|
2.77e-07
|
1.17e-04
|
0.27600
|
7.64e-02
|
-2.65e-01
|
1.18e-01
|
6.00e-08
|
GOBP REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION
|
21
|
1.14e-01
|
5.91e-01
|
0.27600
|
-1.43e-01
|
2.36e-01
|
2.56e-01
|
6.12e-02
|
GOBP NEGATIVE REGULATION OF GONADOTROPIN SECRETION
|
7
|
4.57e-01
|
8.48e-01
|
0.27600
|
3.92e-02
|
-2.73e-01
|
8.58e-01
|
2.11e-01
|
GOBP HISTAMINE METABOLIC PROCESS
|
6
|
4.77e-01
|
8.54e-01
|
0.27600
|
-2.65e-01
|
-7.82e-02
|
2.62e-01
|
7.40e-01
|
GOBP ERROR PRONE TRANSLESION SYNTHESIS
|
11
|
2.45e-01
|
7.26e-01
|
0.27600
|
-2.38e-01
|
-1.40e-01
|
1.72e-01
|
4.22e-01
|
GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I
|
7
|
4.89e-01
|
8.56e-01
|
0.27600
|
-1.65e-01
|
2.21e-01
|
4.49e-01
|
3.12e-01
|
GOBP THERMOCEPTION
|
8
|
4.43e-01
|
8.40e-01
|
0.27600
|
-2.03e-01
|
1.86e-01
|
3.19e-01
|
3.61e-01
|
GOBP NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS
|
14
|
2.08e-01
|
6.97e-01
|
0.27600
|
-3.55e-02
|
2.73e-01
|
8.18e-01
|
7.64e-02
|
GOMF GLYCEROPHOSPHOLIPID FLIPPASE ACTIVITY
|
12
|
2.75e-01
|
7.49e-01
|
0.27600
|
-8.38e-02
|
2.63e-01
|
6.15e-01
|
1.15e-01
|
GOBP ECTODERMAL PLACODE DEVELOPMENT
|
13
|
1.97e-01
|
6.88e-01
|
0.27600
|
9.84e-02
|
2.58e-01
|
5.39e-01
|
1.08e-01
|
GOMF HEMOGLOBIN BINDING
|
9
|
3.46e-01
|
7.96e-01
|
0.27600
|
2.75e-01
|
2.30e-02
|
1.54e-01
|
9.05e-01
|
GOMF NEUROTRANSMITTER BINDING
|
17
|
1.41e-01
|
6.25e-01
|
0.27600
|
-2.02e-03
|
2.76e-01
|
9.88e-01
|
4.91e-02
|
GOCC NURF COMPLEX
|
5
|
5.54e-01
|
8.81e-01
|
0.27600
|
-2.33e-02
|
-2.75e-01
|
9.28e-01
|
2.88e-01
|
GOBP NEGATIVE REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS
|
5
|
5.34e-01
|
8.76e-01
|
0.27600
|
-2.53e-01
|
-1.08e-01
|
3.27e-01
|
6.74e-01
|
GOCC BRISC COMPLEX
|
5
|
5.53e-01
|
8.80e-01
|
0.27600
|
2.99e-02
|
2.74e-01
|
9.08e-01
|
2.89e-01
|
GOBP PRENYLATION
|
11
|
2.44e-01
|
7.25e-01
|
0.27500
|
-1.54e-01
|
-2.29e-01
|
3.77e-01
|
1.89e-01
|
GOMF CYCLIC NUCLEOTIDE DEPENDENT PROTEIN KINASE ACTIVITY
|
7
|
4.91e-01
|
8.58e-01
|
0.27500
|
1.86e-01
|
-2.03e-01
|
3.94e-01
|
3.52e-01
|
GOBP HINDBRAIN MATURATION
|
5
|
5.85e-01
|
8.90e-01
|
0.27500
|
-2.62e-01
|
8.35e-02
|
3.10e-01
|
7.46e-01
|
GOBP SYMPATHETIC GANGLION DEVELOPMENT
|
9
|
3.53e-01
|
7.97e-01
|
0.27500
|
2.75e-01
|
4.32e-03
|
1.53e-01
|
9.82e-01
|
GOBP NEGATIVE REGULATION OF RESPONSE TO TUMOR CELL
|
5
|
5.98e-01
|
8.95e-01
|
0.27500
|
-1.45e-01
|
2.34e-01
|
5.74e-01
|
3.65e-01
|
GOBP PARAXIAL MESODERM DEVELOPMENT
|
17
|
1.13e-01
|
5.91e-01
|
0.27500
|
1.58e-01
|
2.25e-01
|
2.59e-01
|
1.08e-01
|
GOBP METANEPHRIC GLOMERULAR MESANGIUM DEVELOPMENT
|
5
|
5.91e-01
|
8.93e-01
|
0.27500
|
-1.09e-01
|
2.53e-01
|
6.72e-01
|
3.28e-01
|
GOMF URIDYLYLTRANSFERASE ACTIVITY
|
7
|
4.08e-01
|
8.27e-01
|
0.27500
|
-2.30e-01
|
-1.50e-01
|
2.91e-01
|
4.91e-01
|
GOBP POSITIVE REGULATION OF VIRAL LIFE CYCLE
|
23
|
6.54e-02
|
4.94e-01
|
0.27500
|
-2.73e-01
|
-3.58e-02
|
2.36e-02
|
7.67e-01
|
GOBP CLEARANCE OF FOREIGN INTRACELLULAR NUCLEIC ACIDS
|
6
|
5.17e-01
|
8.69e-01
|
0.27500
|
-5.09e-02
|
2.70e-01
|
8.29e-01
|
2.52e-01
|
GOBP RIBONUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS
|
9
|
3.61e-01
|
8.03e-01
|
0.27500
|
-2.74e-01
|
1.77e-02
|
1.54e-01
|
9.27e-01
|
GOBP POSITIVE REGULATION OF NEUROTRANSMITTER UPTAKE
|
6
|
4.64e-01
|
8.48e-01
|
0.27500
|
1.57e-01
|
2.26e-01
|
5.05e-01
|
3.39e-01
|
GOBP DAMP METABOLIC PROCESS
|
7
|
4.09e-01
|
8.27e-01
|
0.27500
|
2.27e-01
|
1.55e-01
|
2.99e-01
|
4.78e-01
|
GOBP ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB
|
25
|
7.89e-02
|
5.27e-01
|
0.27500
|
1.58e-01
|
-2.24e-01
|
1.71e-01
|
5.21e-02
|
GOBP PURINE NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS
|
10
|
3.04e-01
|
7.69e-01
|
0.27500
|
4.29e-02
|
2.71e-01
|
8.14e-01
|
1.38e-01
|
GOBP CERAMIDE CATABOLIC PROCESS
|
20
|
7.94e-02
|
5.27e-01
|
0.27400
|
-2.37e-01
|
-1.39e-01
|
6.70e-02
|
2.82e-01
|
GOBP NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY
|
12
|
2.73e-01
|
7.47e-01
|
0.27400
|
-2.67e-01
|
6.32e-02
|
1.09e-01
|
7.05e-01
|
GOBP REGULATION OF CENTROMERE COMPLEX ASSEMBLY
|
6
|
5.11e-01
|
8.66e-01
|
0.27400
|
-2.73e-01
|
2.60e-02
|
2.47e-01
|
9.12e-01
|
GOMF GLUTAMATE BINDING
|
8
|
3.80e-01
|
8.15e-01
|
0.27400
|
6.61e-02
|
2.66e-01
|
7.46e-01
|
1.93e-01
|
GOBP REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY
|
29
|
2.72e-02
|
3.43e-01
|
0.27400
|
-1.09e-01
|
-2.52e-01
|
3.11e-01
|
1.90e-02
|
GOBP POSITIVE REGULATION OF HAIR FOLLICLE DEVELOPMENT
|
12
|
2.61e-01
|
7.39e-01
|
0.27400
|
-2.73e-01
|
2.36e-02
|
1.02e-01
|
8.87e-01
|
GOBP RRNA TRANSPORT
|
5
|
5.59e-01
|
8.82e-01
|
0.27400
|
-2.17e-02
|
-2.73e-01
|
9.33e-01
|
2.90e-01
|
GOBP PURINE NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS
|
5
|
5.50e-01
|
8.80e-01
|
0.27400
|
-2.68e-01
|
-5.48e-02
|
2.99e-01
|
8.32e-01
|
GOCC LATERAL ELEMENT
|
14
|
1.92e-01
|
6.85e-01
|
0.27400
|
-2.71e-01
|
-3.74e-02
|
7.87e-02
|
8.08e-01
|
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN
|
20
|
9.35e-02
|
5.56e-01
|
0.27400
|
-2.70e-01
|
-4.40e-02
|
3.63e-02
|
7.34e-01
|
GOCC HFE TRANSFERRIN RECEPTOR COMPLEX
|
8
|
3.61e-01
|
8.03e-01
|
0.27400
|
1.67e-01
|
2.17e-01
|
4.15e-01
|
2.87e-01
|
GOBP GUANINE NUCLEOTIDE TRANSPORT
|
9
|
3.35e-01
|
7.88e-01
|
0.27400
|
-2.63e-01
|
-7.76e-02
|
1.73e-01
|
6.87e-01
|
GOMF ADP PHOSPHATASE ACTIVITY
|
5
|
5.84e-01
|
8.90e-01
|
0.27400
|
-6.52e-02
|
2.66e-01
|
8.01e-01
|
3.03e-01
|
GOBP NEUTROPHIL DEGRANULATION
|
13
|
2.72e-01
|
7.47e-01
|
0.27400
|
-1.98e-01
|
1.89e-01
|
2.17e-01
|
2.37e-01
|
GOBP GLUCOSE IMPORT IN RESPONSE TO INSULIN STIMULUS
|
6
|
5.05e-01
|
8.65e-01
|
0.27400
|
-2.74e-01
|
2.73e-04
|
2.46e-01
|
9.99e-01
|
GOCC PROTEIN PHOSPHATASE 4 COMPLEX
|
5
|
5.44e-01
|
8.78e-01
|
0.27400
|
-8.25e-02
|
-2.61e-01
|
7.49e-01
|
3.12e-01
|
GOBP LIPID PHOSPHORYLATION
|
10
|
2.81e-01
|
7.53e-01
|
0.27400
|
1.61e-01
|
2.21e-01
|
3.78e-01
|
2.26e-01
|
GOMF ATP DEPENDENT DIACYLGLYCEROL KINASE ACTIVITY
|
10
|
2.81e-01
|
7.53e-01
|
0.27400
|
1.61e-01
|
2.21e-01
|
3.78e-01
|
2.26e-01
|
GOBP NEUTROPHIL MEDIATED IMMUNITY
|
36
|
2.23e-02
|
3.16e-01
|
0.27400
|
-2.60e-01
|
8.56e-02
|
6.97e-03
|
3.74e-01
|
GOBP CELLULAR RESPONSE TO HEPARIN
|
5
|
5.28e-01
|
8.72e-01
|
0.27400
|
-2.02e-01
|
-1.84e-01
|
4.34e-01
|
4.75e-01
|
GOBP BRANCHED CHAIN AMINO ACID TRANSPORT
|
13
|
2.62e-01
|
7.39e-01
|
0.27300
|
-1.17e-01
|
2.47e-01
|
4.66e-01
|
1.23e-01
|
GOMF MYRISTOYLTRANSFERASE ACTIVITY
|
10
|
3.67e-01
|
8.07e-01
|
0.27300
|
-2.09e-01
|
1.76e-01
|
2.53e-01
|
3.34e-01
|
GOMF SINGLE STRANDED DNA ENDODEOXYRIBONUCLEASE ACTIVITY
|
10
|
2.80e-01
|
7.53e-01
|
0.27300
|
-1.73e-01
|
-2.11e-01
|
3.43e-01
|
2.47e-01
|
GOBP BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION
|
15
|
2.12e-01
|
7.00e-01
|
0.27300
|
2.50e-01
|
-1.10e-01
|
9.32e-02
|
4.62e-01
|
GOBP PEPTIDYL ARGININE METHYLATION
|
7
|
4.17e-01
|
8.32e-01
|
0.27300
|
-2.43e-01
|
-1.25e-01
|
2.66e-01
|
5.66e-01
|
GOBP MESENDODERM DEVELOPMENT
|
9
|
3.46e-01
|
7.96e-01
|
0.27300
|
2.70e-01
|
4.47e-02
|
1.61e-01
|
8.16e-01
|
GOBP POSITIVE REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION
|
5
|
6.05e-01
|
8.96e-01
|
0.27300
|
-1.57e-01
|
2.24e-01
|
5.43e-01
|
3.87e-01
|
GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS
|
14
|
1.72e-01
|
6.60e-01
|
0.27300
|
-2.32e-01
|
-1.45e-01
|
1.34e-01
|
3.48e-01
|
GOBP LABYRINTHINE LAYER MORPHOGENESIS
|
22
|
1.05e-01
|
5.77e-01
|
0.27300
|
2.43e-01
|
-1.25e-01
|
4.85e-02
|
3.11e-01
|
GOBP COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE
|
24
|
8.19e-02
|
5.33e-01
|
0.27300
|
9.66e-02
|
-2.55e-01
|
4.12e-01
|
3.03e-02
|
GOBP NEGATIVE REGULATION OF MUSCLE HYPERTROPHY
|
36
|
2.78e-02
|
3.46e-01
|
0.27300
|
-1.87e-01
|
1.99e-01
|
5.20e-02
|
3.92e-02
|
GOBP PLATELET MORPHOGENESIS
|
22
|
9.70e-02
|
5.61e-01
|
0.27300
|
-2.63e-01
|
7.38e-02
|
3.30e-02
|
5.49e-01
|
GOCC GLYCOGEN GRANULE
|
7
|
4.98e-01
|
8.61e-01
|
0.27300
|
-1.77e-01
|
2.08e-01
|
4.18e-01
|
3.42e-01
|
GOMF MRNA REGULATORY ELEMENT BINDING TRANSLATION REPRESSOR ACTIVITY
|
15
|
2.11e-01
|
7.00e-01
|
0.27300
|
9.98e-02
|
-2.54e-01
|
5.03e-01
|
8.88e-02
|
GOCC LAMININ COMPLEX
|
9
|
3.21e-01
|
7.78e-01
|
0.27200
|
1.76e-01
|
2.08e-01
|
3.61e-01
|
2.80e-01
|
GOBP NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY
|
6
|
5.51e-01
|
8.80e-01
|
0.27200
|
-2.00e-01
|
1.85e-01
|
3.97e-01
|
4.32e-01
|
GOBP POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION
|
14
|
2.04e-01
|
6.94e-01
|
0.27200
|
-6.35e-03
|
-2.72e-01
|
9.67e-01
|
7.78e-02
|
GOBP POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS
|
9
|
3.45e-01
|
7.96e-01
|
0.27200
|
5.40e-02
|
2.67e-01
|
7.79e-01
|
1.66e-01
|
GOBP CHORIO ALLANTOIC FUSION
|
7
|
4.50e-01
|
8.43e-01
|
0.27200
|
2.72e-01
|
1.36e-02
|
2.13e-01
|
9.50e-01
|
GOMF DOLICHYL PHOSPHATE MANNOSE PROTEIN MANNOSYLTRANSFERASE ACTIVITY
|
8
|
4.52e-01
|
8.45e-01
|
0.27200
|
-1.83e-01
|
2.02e-01
|
3.70e-01
|
3.24e-01
|
GOBP REGULATION OF CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION
|
8
|
4.46e-01
|
8.40e-01
|
0.27200
|
-1.34e-01
|
2.37e-01
|
5.11e-01
|
2.46e-01
|
GOCC JUNCTIONAL MEMBRANE COMPLEX
|
6
|
5.51e-01
|
8.80e-01
|
0.27200
|
2.14e-01
|
-1.68e-01
|
3.65e-01
|
4.75e-01
|
GOBP ATRIAL SEPTUM MORPHOGENESIS
|
15
|
2.25e-01
|
7.14e-01
|
0.27200
|
-1.65e-01
|
2.16e-01
|
2.69e-01
|
1.47e-01
|
GOBP ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN
|
32
|
4.23e-02
|
4.24e-01
|
0.27200
|
1.76e-01
|
-2.07e-01
|
8.57e-02
|
4.22e-02
|
GOBP NADPH REGENERATION
|
21
|
1.18e-01
|
6.00e-01
|
0.27200
|
-2.45e-01
|
1.18e-01
|
5.20e-02
|
3.51e-01
|
GOBP REGULATION OF SYNAPTIC TRANSMISSION CHOLINERGIC
|
8
|
4.47e-01
|
8.41e-01
|
0.27200
|
2.36e-01
|
-1.34e-01
|
2.47e-01
|
5.12e-01
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A HEME GROUP OF DONORS
|
11
|
2.51e-01
|
7.28e-01
|
0.27200
|
-1.83e-01
|
-2.01e-01
|
2.93e-01
|
2.49e-01
|
GOCC BRCA1 A COMPLEX
|
7
|
4.58e-01
|
8.48e-01
|
0.27200
|
-6.32e-03
|
2.72e-01
|
9.77e-01
|
2.13e-01
|
GOBP REGULATION OF PLASMINOGEN ACTIVATION
|
18
|
1.15e-01
|
5.94e-01
|
0.27200
|
-8.29e-02
|
-2.59e-01
|
5.43e-01
|
5.75e-02
|
GOBP RNA SECONDARY STRUCTURE UNWINDING
|
8
|
4.55e-01
|
8.46e-01
|
0.27100
|
-1.97e-01
|
1.87e-01
|
3.35e-01
|
3.60e-01
|
GOBP CAMP BIOSYNTHETIC PROCESS
|
10
|
3.73e-01
|
8.10e-01
|
0.27100
|
-1.82e-01
|
2.02e-01
|
3.20e-01
|
2.70e-01
|
GOCC LUMENAL SIDE OF ENDOPLASMIC RETICULUM MEMBRANE
|
26
|
7.32e-02
|
5.13e-01
|
0.27100
|
1.30e-01
|
-2.38e-01
|
2.52e-01
|
3.54e-02
|
GOBP POSITIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION
|
9
|
3.33e-01
|
7.86e-01
|
0.27100
|
2.47e-01
|
1.12e-01
|
1.99e-01
|
5.61e-01
|
GOMF IONOTROPIC GLUTAMATE RECEPTOR BINDING
|
21
|
1.01e-01
|
5.70e-01
|
0.27100
|
-2.70e-01
|
2.85e-02
|
3.23e-02
|
8.21e-01
|
GOBP TRNA WOBBLE BASE MODIFICATION
|
20
|
9.10e-02
|
5.51e-01
|
0.27100
|
-8.42e-02
|
-2.58e-01
|
5.15e-01
|
4.59e-02
|
GOBP REGULATION OF TRANSMISSION OF NERVE IMPULSE
|
15
|
1.59e-01
|
6.48e-01
|
0.27100
|
-2.42e-01
|
-1.21e-01
|
1.04e-01
|
4.15e-01
|
GOBP REGULATION OF SKELETAL MUSCLE TISSUE REGENERATION
|
8
|
4.00e-01
|
8.25e-01
|
0.27100
|
-2.66e-02
|
-2.70e-01
|
8.96e-01
|
1.86e-01
|
GOBP POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN
|
22
|
1.08e-01
|
5.84e-01
|
0.27100
|
-1.21e-01
|
2.43e-01
|
3.25e-01
|
4.89e-02
|
GOBP MINERALOCORTICOID SECRETION
|
7
|
4.92e-01
|
8.58e-01
|
0.27100
|
-1.16e-01
|
2.45e-01
|
5.96e-01
|
2.61e-01
|
GOBP ETHANOL OXIDATION
|
9
|
4.01e-01
|
8.26e-01
|
0.27100
|
1.14e-01
|
-2.46e-01
|
5.54e-01
|
2.01e-01
|
GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN CYCLIC AMIDES
|
15
|
1.70e-01
|
6.57e-01
|
0.27100
|
6.77e-02
|
2.62e-01
|
6.50e-01
|
7.84e-02
|
GOBP CELLULAR RESPONSE TO ACIDIC PH
|
16
|
2.03e-01
|
6.93e-01
|
0.27100
|
-1.44e-01
|
2.30e-01
|
3.19e-01
|
1.12e-01
|
GOBP ASYMMETRIC NEUROBLAST DIVISION
|
5
|
6.03e-01
|
8.96e-01
|
0.27100
|
-2.44e-01
|
1.18e-01
|
3.45e-01
|
6.47e-01
|
GOMF RNA DNA HYBRID RIBONUCLEASE ACTIVITY
|
6
|
5.51e-01
|
8.80e-01
|
0.27100
|
2.26e-01
|
-1.50e-01
|
3.38e-01
|
5.25e-01
|
GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT ENDOSOME TO POSTSYNAPTIC MEMBRANE
|
10
|
3.44e-01
|
7.95e-01
|
0.27100
|
5.12e-02
|
-2.66e-01
|
7.79e-01
|
1.45e-01
|
GOBP CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES
|
16
|
1.41e-01
|
6.25e-01
|
0.27100
|
-1.23e-01
|
-2.41e-01
|
3.95e-01
|
9.46e-02
|
GOBP REGULATION OF MYOFIBROBLAST DIFFERENTIATION
|
9
|
3.29e-01
|
7.83e-01
|
0.27100
|
2.31e-01
|
1.42e-01
|
2.31e-01
|
4.61e-01
|
GOBP T CELL SELECTION
|
52
|
1.92e-03
|
8.07e-02
|
0.27100
|
9.64e-02
|
2.53e-01
|
2.29e-01
|
1.60e-03
|
GOMF DNA DIRECTED DNA POLYMERASE ACTIVITY
|
23
|
9.57e-02
|
5.61e-01
|
0.27100
|
-2.51e-01
|
1.01e-01
|
3.72e-02
|
4.01e-01
|
GOBP CITRULLINE METABOLIC PROCESS
|
7
|
4.55e-01
|
8.46e-01
|
0.27100
|
2.70e-01
|
1.22e-02
|
2.16e-01
|
9.55e-01
|
GOBP ADENOSINE TO INOSINE EDITING
|
7
|
5.03e-01
|
8.64e-01
|
0.27000
|
-2.10e-01
|
1.70e-01
|
3.35e-01
|
4.36e-01
|
GOBP REGULATION OF CHROMOSOME CONDENSATION
|
13
|
2.12e-01
|
7.00e-01
|
0.27000
|
-8.70e-02
|
-2.56e-01
|
5.87e-01
|
1.10e-01
|
GOBP NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS
|
24
|
5.63e-02
|
4.66e-01
|
0.27000
|
9.51e-02
|
2.53e-01
|
4.20e-01
|
3.19e-02
|
GOCC CALCIUM AND CALMODULIN DEPENDENT PROTEIN KINASE COMPLEX
|
5
|
5.40e-01
|
8.78e-01
|
0.27000
|
2.29e-01
|
1.44e-01
|
3.76e-01
|
5.77e-01
|
GOBP PURINE NUCLEOSIDE CATABOLIC PROCESS
|
8
|
4.36e-01
|
8.39e-01
|
0.27000
|
7.46e-02
|
-2.60e-01
|
7.15e-01
|
2.03e-01
|
GOBP REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN REGULATION OF CONTRACTION
|
7
|
5.02e-01
|
8.63e-01
|
0.27000
|
1.55e-01
|
-2.22e-01
|
4.79e-01
|
3.10e-01
|
GOBP CHOLESTEROL CATABOLIC PROCESS
|
9
|
3.32e-01
|
7.85e-01
|
0.27000
|
2.34e-01
|
1.35e-01
|
2.25e-01
|
4.83e-01
|
GOBP EOSINOPHIL DIFFERENTIATION
|
6
|
5.09e-01
|
8.66e-01
|
0.27000
|
-1.78e-02
|
-2.69e-01
|
9.40e-01
|
2.53e-01
|
GOMF ENDOPEPTIDASE ACTIVATOR ACTIVITY
|
15
|
1.75e-01
|
6.65e-01
|
0.27000
|
-5.64e-02
|
-2.64e-01
|
7.05e-01
|
7.68e-02
|
GOBP POSITIVE REGULATION OF MONOCYTE EXTRAVASATION
|
5
|
5.71e-01
|
8.87e-01
|
0.27000
|
1.19e-02
|
2.70e-01
|
9.63e-01
|
2.96e-01
|
GOMF STEROID DEHYDROGENASE ACTIVITY ACTING ON THE CH OH GROUP OF DONORS NAD OR NADP AS ACCEPTOR
|
29
|
4.46e-02
|
4.29e-01
|
0.27000
|
3.51e-02
|
-2.68e-01
|
7.43e-01
|
1.26e-02
|
GOBP DIAPHRAGM DEVELOPMENT
|
8
|
3.72e-01
|
8.09e-01
|
0.27000
|
2.16e-01
|
1.62e-01
|
2.90e-01
|
4.29e-01
|
GOMF SEMAPHORIN RECEPTOR ACTIVITY
|
10
|
3.23e-01
|
7.79e-01
|
0.27000
|
2.14e-02
|
2.69e-01
|
9.07e-01
|
1.41e-01
|
GOBP NUCLEOPHAGY
|
18
|
1.64e-01
|
6.48e-01
|
0.27000
|
-2.45e-01
|
1.12e-01
|
7.15e-02
|
4.11e-01
|
GOBP SENSORY PERCEPTION OF SMELL
|
367
|
3.93e-17
|
2.01e-13
|
0.27000
|
2.62e-01
|
-6.43e-02
|
6.44e-18
|
3.45e-02
|
GOBP PIGMENT ACCUMULATION
|
11
|
3.08e-01
|
7.72e-01
|
0.27000
|
-2.67e-01
|
3.76e-02
|
1.25e-01
|
8.29e-01
|
GOBP POSITIVE REGULATION OF GRANULOCYTE DIFFERENTIATION
|
9
|
3.30e-01
|
7.85e-01
|
0.27000
|
1.52e-01
|
2.23e-01
|
4.30e-01
|
2.47e-01
|
GOBP T HELPER 17 CELL LINEAGE COMMITMENT
|
16
|
1.38e-01
|
6.21e-01
|
0.26900
|
1.88e-01
|
1.93e-01
|
1.92e-01
|
1.82e-01
|
GOBP RESPONSE TO ACIDIC PH
|
28
|
6.13e-02
|
4.80e-01
|
0.26900
|
-1.20e-01
|
2.41e-01
|
2.72e-01
|
2.71e-02
|
GOBP SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT
|
18
|
1.19e-01
|
6.00e-01
|
0.26900
|
-8.33e-02
|
-2.56e-01
|
5.40e-01
|
5.98e-02
|
GOBP MAST CELL CYTOKINE PRODUCTION
|
6
|
4.83e-01
|
8.54e-01
|
0.26900
|
2.41e-01
|
1.21e-01
|
3.07e-01
|
6.07e-01
|
GOMF MANNOSIDASE ACTIVITY
|
15
|
2.23e-01
|
7.12e-01
|
0.26900
|
-1.16e-01
|
2.43e-01
|
4.35e-01
|
1.03e-01
|
GOBP REGULATION OF CD40 SIGNALING PATHWAY
|
6
|
5.58e-01
|
8.82e-01
|
0.26900
|
1.99e-01
|
-1.82e-01
|
3.99e-01
|
4.41e-01
|
GOBP CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS
|
21
|
7.46e-02
|
5.16e-01
|
0.26900
|
1.83e-01
|
1.97e-01
|
1.46e-01
|
1.17e-01
|
GOBP REGULATION OF PRIMARY MIRNA PROCESSING
|
5
|
5.70e-01
|
8.86e-01
|
0.26900
|
-2.68e-01
|
-2.27e-02
|
2.99e-01
|
9.30e-01
|
GOBP LENS MORPHOGENESIS IN CAMERA TYPE EYE
|
21
|
1.30e-01
|
6.09e-01
|
0.26900
|
-2.11e-01
|
1.67e-01
|
9.43e-02
|
1.85e-01
|
GOBP NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS
|
11
|
3.44e-01
|
7.95e-01
|
0.26900
|
-2.10e-01
|
1.68e-01
|
2.29e-01
|
3.33e-01
|
GOBP ENDOTHELIAL CELL FATE COMMITMENT
|
8
|
3.94e-01
|
8.23e-01
|
0.26900
|
2.60e-01
|
6.77e-02
|
2.02e-01
|
7.40e-01
|
GOBP RRNA TRANSCRIPTION
|
37
|
2.39e-02
|
3.28e-01
|
0.26900
|
-2.51e-01
|
9.59e-02
|
8.20e-03
|
3.13e-01
|
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY ENDOTHELIN
|
6
|
5.35e-01
|
8.76e-01
|
0.26900
|
-2.63e-01
|
5.78e-02
|
2.65e-01
|
8.06e-01
|
GOMF TRNA CYTOSINE METHYLTRANSFERASE ACTIVITY
|
8
|
3.79e-01
|
8.14e-01
|
0.26900
|
-2.34e-01
|
-1.31e-01
|
2.51e-01
|
5.20e-01
|
GOBP ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY
|
17
|
1.94e-01
|
6.86e-01
|
0.26900
|
-1.90e-01
|
1.90e-01
|
1.76e-01
|
1.75e-01
|
GOBP OSTEOCLAST PROLIFERATION
|
11
|
3.14e-01
|
7.76e-01
|
0.26900
|
4.62e-02
|
-2.65e-01
|
7.91e-01
|
1.29e-01
|
GOBP CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT
|
16
|
1.66e-01
|
6.50e-01
|
0.26800
|
-2.67e-01
|
-2.68e-02
|
6.43e-02
|
8.53e-01
|
GOBP REGULATION OF PROTEIN K63 LINKED UBIQUITINATION
|
13
|
2.84e-01
|
7.57e-01
|
0.26800
|
2.16e-01
|
-1.59e-01
|
1.77e-01
|
3.21e-01
|
GOMF NEUROTROPHIN BINDING
|
10
|
2.93e-01
|
7.63e-01
|
0.26800
|
1.94e-01
|
1.85e-01
|
2.88e-01
|
3.11e-01
|
GOBP MYELOID PROGENITOR CELL DIFFERENTIATION
|
9
|
3.65e-01
|
8.06e-01
|
0.26800
|
2.56e-02
|
2.67e-01
|
8.94e-01
|
1.66e-01
|
GOMF GUANYLATE CYCLASE REGULATOR ACTIVITY
|
8
|
4.61e-01
|
8.48e-01
|
0.26800
|
1.61e-01
|
-2.15e-01
|
4.31e-01
|
2.93e-01
|
GOBP CALCIUM ION EXPORT ACROSS PLASMA MEMBRANE
|
9
|
3.83e-01
|
8.16e-01
|
0.26800
|
-2.76e-02
|
2.67e-01
|
8.86e-01
|
1.66e-01
|
GOBP POSITIVE REGULATION OF DENDRITIC CELL DIFFERENTIATION
|
6
|
5.19e-01
|
8.69e-01
|
0.26800
|
-2.68e-01
|
1.17e-03
|
2.56e-01
|
9.96e-01
|
GOBP HEMATOPOIETIC STEM CELL MIGRATION
|
8
|
4.04e-01
|
8.26e-01
|
0.26800
|
2.64e-01
|
4.35e-02
|
1.96e-01
|
8.31e-01
|
GOBP BINDING OF SPERM TO ZONA PELLUCIDA
|
38
|
1.99e-02
|
3.00e-01
|
0.26800
|
6.05e-02
|
-2.61e-01
|
5.19e-01
|
5.40e-03
|
GOBP NEGATIVE REGULATION OF RECEPTOR BINDING
|
12
|
3.17e-01
|
7.77e-01
|
0.26800
|
-2.01e-01
|
1.77e-01
|
2.28e-01
|
2.89e-01
|
GOBP ODONTOBLAST DIFFERENTIATION
|
11
|
3.48e-01
|
7.96e-01
|
0.26800
|
-2.06e-01
|
1.71e-01
|
2.37e-01
|
3.26e-01
|
GOBP SALIVA SECRETION
|
13
|
2.75e-01
|
7.49e-01
|
0.26800
|
-2.45e-01
|
1.07e-01
|
1.26e-01
|
5.06e-01
|
GOBP RELAXATION OF CARDIAC MUSCLE
|
17
|
1.28e-01
|
6.07e-01
|
0.26700
|
1.51e-01
|
2.21e-01
|
2.80e-01
|
1.15e-01
|
GOBP REGULATION OF GLUTAMATE SECRETION NEUROTRANSMISSION
|
5
|
5.65e-01
|
8.85e-01
|
0.26700
|
5.59e-02
|
2.61e-01
|
8.29e-01
|
3.11e-01
|
GOMF SNORNA BINDING
|
31
|
3.04e-02
|
3.61e-01
|
0.26700
|
-4.11e-02
|
-2.64e-01
|
6.92e-01
|
1.09e-02
|
GOBP MARGINAL ZONE B CELL DIFFERENTIATION
|
8
|
4.44e-01
|
8.40e-01
|
0.26700
|
-7.40e-02
|
2.56e-01
|
7.17e-01
|
2.09e-01
|
GOMF ADENYLATE CYCLASE ACTIVITY
|
15
|
2.37e-01
|
7.24e-01
|
0.26700
|
-2.19e-01
|
1.53e-01
|
1.42e-01
|
3.06e-01
|
GOMF CELL MATRIX ADHESION MEDIATOR ACTIVITY
|
7
|
4.79e-01
|
8.54e-01
|
0.26700
|
-2.65e-01
|
3.36e-02
|
2.25e-01
|
8.78e-01
|
GOBP HISTONE H3 K4 METHYLATION
|
18
|
1.78e-01
|
6.67e-01
|
0.26700
|
-2.14e-01
|
1.59e-01
|
1.16e-01
|
2.43e-01
|
GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS
|
17
|
1.27e-01
|
6.07e-01
|
0.26700
|
-2.02e-01
|
-1.74e-01
|
1.49e-01
|
2.14e-01
|
GOBP KINETOCHORE ORGANIZATION
|
20
|
1.01e-01
|
5.69e-01
|
0.26700
|
-6.98e-02
|
-2.58e-01
|
5.89e-01
|
4.62e-02
|
GOBP URINARY BLADDER SMOOTH MUSCLE CONTRACTION
|
7
|
4.30e-01
|
8.36e-01
|
0.26700
|
-2.17e-01
|
-1.56e-01
|
3.21e-01
|
4.76e-01
|
GOBP MODULATION BY HOST OF VIRAL GENOME REPLICATION
|
23
|
8.27e-02
|
5.35e-01
|
0.26700
|
-1.86e-03
|
-2.67e-01
|
9.88e-01
|
2.68e-02
|
GOBP PROTEIN PALMITOYLATION
|
28
|
6.82e-02
|
5.00e-01
|
0.26700
|
-1.53e-01
|
2.19e-01
|
1.62e-01
|
4.52e-02
|
GOBP SOMATIC MOTOR NEURON DIFFERENTIATION
|
5
|
5.98e-01
|
8.95e-01
|
0.26700
|
-5.61e-02
|
2.61e-01
|
8.28e-01
|
3.13e-01
|
GOCC IKAPPAB KINASE COMPLEX
|
6
|
5.37e-01
|
8.78e-01
|
0.26700
|
-4.63e-02
|
2.62e-01
|
8.44e-01
|
2.66e-01
|
GOMF PHOSPHOLIPASE BINDING
|
20
|
9.60e-02
|
5.61e-01
|
0.26700
|
1.00e-01
|
2.47e-01
|
4.37e-01
|
5.59e-02
|
GOBP LEUKOTRIENE B4 METABOLIC PROCESS
|
5
|
6.13e-01
|
8.98e-01
|
0.26600
|
1.14e-01
|
-2.41e-01
|
6.58e-01
|
3.51e-01
|
GOBP CYTOKINETIC PROCESS
|
42
|
1.56e-02
|
2.64e-01
|
0.26600
|
-2.48e-01
|
9.72e-02
|
5.40e-03
|
2.76e-01
|
GOBP CHORIONIC TROPHOBLAST CELL DIFFERENTIATION
|
7
|
4.34e-01
|
8.38e-01
|
0.26600
|
-2.33e-01
|
-1.29e-01
|
2.86e-01
|
5.53e-01
|
GOBP SYNAPTIC VESICLE UNCOATING
|
6
|
5.64e-01
|
8.85e-01
|
0.26600
|
-2.14e-01
|
1.58e-01
|
3.63e-01
|
5.03e-01
|
GOMF UBIQUITIN PROTEIN TRANSFERASE INHIBITOR ACTIVITY
|
11
|
3.20e-01
|
7.78e-01
|
0.26600
|
4.43e-02
|
-2.63e-01
|
7.99e-01
|
1.32e-01
|
GOBP B CELL RECEPTOR SIGNALING PATHWAY
|
60
|
8.04e-04
|
4.47e-02
|
0.26600
|
1.30e-01
|
2.32e-01
|
8.05e-02
|
1.87e-03
|
GOBP REGULATION OF TOOTH MINERALIZATION
|
10
|
2.99e-01
|
7.67e-01
|
0.26600
|
1.94e-01
|
1.82e-01
|
2.88e-01
|
3.18e-01
|
GOBP REGULATION OF SPONTANEOUS SYNAPTIC TRANSMISSION
|
6
|
5.57e-01
|
8.81e-01
|
0.26600
|
-2.40e-01
|
1.15e-01
|
3.09e-01
|
6.25e-01
|
GOBP NEURON PROJECTION MAINTENANCE
|
11
|
3.36e-01
|
7.88e-01
|
0.26600
|
9.46e-02
|
-2.49e-01
|
5.87e-01
|
1.53e-01
|
GOBP NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN
|
12
|
2.58e-01
|
7.35e-01
|
0.26600
|
-5.47e-02
|
-2.60e-01
|
7.43e-01
|
1.18e-01
|
GOBP REGULATION OF TRANSCRIPTION BY GLUCOSE
|
8
|
3.83e-01
|
8.16e-01
|
0.26600
|
-2.20e-01
|
-1.50e-01
|
2.81e-01
|
4.64e-01
|
GOBP ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE
|
38
|
2.29e-02
|
3.21e-01
|
0.26600
|
-2.51e-01
|
8.96e-02
|
7.52e-03
|
3.39e-01
|
GOBP REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY
|
11
|
2.66e-01
|
7.42e-01
|
0.26600
|
1.64e-01
|
2.09e-01
|
3.45e-01
|
2.29e-01
|
GOBP NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT
|
6
|
5.67e-01
|
8.85e-01
|
0.26600
|
-1.89e-01
|
1.88e-01
|
4.24e-01
|
4.26e-01
|
GOCC DNA POLYMERASE COMPLEX
|
18
|
1.81e-01
|
6.70e-01
|
0.26600
|
-2.12e-01
|
1.61e-01
|
1.19e-01
|
2.38e-01
|
GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS
|
8
|
3.84e-01
|
8.17e-01
|
0.26600
|
-1.50e-01
|
-2.20e-01
|
4.63e-01
|
2.82e-01
|
GOBP RELAXATION OF MUSCLE
|
33
|
2.91e-02
|
3.54e-01
|
0.26600
|
-1.88e-03
|
2.66e-01
|
9.85e-01
|
8.22e-03
|
GOCC CYTOSOLIC SMALL RIBOSOMAL SUBUNIT
|
36
|
2.94e-02
|
3.57e-01
|
0.26600
|
1.04e-01
|
-2.44e-01
|
2.78e-01
|
1.12e-02
|
GOBP POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS
|
13
|
2.46e-01
|
7.26e-01
|
0.26600
|
-2.66e-01
|
-6.46e-03
|
9.73e-02
|
9.68e-01
|
GOBP REGULATION OF PINOCYTOSIS
|
12
|
3.20e-01
|
7.78e-01
|
0.26600
|
-2.16e-01
|
1.55e-01
|
1.96e-01
|
3.52e-01
|
GOBP POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION
|
11
|
3.40e-01
|
7.91e-01
|
0.26600
|
-1.04e-01
|
2.44e-01
|
5.50e-01
|
1.60e-01
|
GOBP POSITIVE REGULATION OF PROGRAMMED NECROTIC CELL DEATH
|
10
|
3.23e-01
|
7.79e-01
|
0.26600
|
6.02e-02
|
2.59e-01
|
7.42e-01
|
1.57e-01
|
GOMF FIBROBLAST GROWTH FACTOR RECEPTOR BINDING
|
24
|
5.96e-02
|
4.76e-01
|
0.26500
|
1.18e-01
|
2.38e-01
|
3.15e-01
|
4.39e-02
|
GOBP RESPONSE TO GLYCOPROTEIN
|
11
|
2.67e-01
|
7.43e-01
|
0.26500
|
1.78e-01
|
1.96e-01
|
3.05e-01
|
2.59e-01
|
GOBP CARDIAC NEURAL CREST CELL DEVELOPMENT INVOLVED IN OUTFLOW TRACT MORPHOGENESIS
|
13
|
2.30e-01
|
7.18e-01
|
0.26500
|
-2.58e-01
|
-6.25e-02
|
1.07e-01
|
6.97e-01
|
GOBP KERATINOCYTE DEVELOPMENT
|
13
|
2.95e-01
|
7.64e-01
|
0.26500
|
1.88e-01
|
-1.87e-01
|
2.40e-01
|
2.43e-01
|
GOBP NEGATIVE REGULATION OF MEGAKARYOCYTE DIFFERENTIATION
|
18
|
1.62e-01
|
6.48e-01
|
0.26500
|
2.58e-01
|
-5.92e-02
|
5.77e-02
|
6.63e-01
|
GOBP INTERLEUKIN 2 MEDIATED SIGNALING PATHWAY
|
8
|
4.70e-01
|
8.51e-01
|
0.26500
|
-1.63e-01
|
2.09e-01
|
4.25e-01
|
3.06e-01
|
GOMF CARBONYL REDUCTASE NADPH ACTIVITY
|
9
|
4.29e-01
|
8.36e-01
|
0.26500
|
1.67e-01
|
-2.06e-01
|
3.86e-01
|
2.85e-01
|
GOBP LYMPHOCYTE COSTIMULATION
|
46
|
5.32e-03
|
1.52e-01
|
0.26500
|
7.82e-02
|
2.53e-01
|
3.59e-01
|
2.98e-03
|
GOCC NUCLEAR PORE OUTER RING
|
9
|
4.30e-01
|
8.37e-01
|
0.26500
|
1.96e-01
|
-1.78e-01
|
3.08e-01
|
3.56e-01
|
GOBP RESPONSE TO PHEROMONE
|
7
|
4.61e-01
|
8.48e-01
|
0.26500
|
4.24e-02
|
2.61e-01
|
8.46e-01
|
2.31e-01
|
GOBP REGULATION OF MYOSIN LIGHT CHAIN PHOSPHATASE ACTIVITY
|
7
|
4.60e-01
|
8.48e-01
|
0.26500
|
-2.61e-01
|
-4.59e-02
|
2.32e-01
|
8.33e-01
|
GOBP REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE
|
18
|
1.29e-01
|
6.09e-01
|
0.26500
|
-2.53e-01
|
-7.91e-02
|
6.36e-02
|
5.61e-01
|
GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS
|
32
|
4.41e-02
|
4.29e-01
|
0.26500
|
-2.45e-01
|
9.92e-02
|
1.63e-02
|
3.32e-01
|
GOBP POSITIVE REGULATION OF CHOLESTEROL STORAGE
|
8
|
4.56e-01
|
8.48e-01
|
0.26500
|
-9.24e-02
|
2.48e-01
|
6.51e-01
|
2.25e-01
|
GOMF PROTEIN HORMONE RECEPTOR ACTIVITY
|
20
|
1.41e-01
|
6.26e-01
|
0.26500
|
9.42e-02
|
-2.47e-01
|
4.66e-01
|
5.56e-02
|
GOBP PROLINE TRANSPORT
|
11
|
2.70e-01
|
7.45e-01
|
0.26400
|
2.04e-01
|
1.68e-01
|
2.40e-01
|
3.35e-01
|
GOCC HOST CELLULAR COMPONENT
|
9
|
3.91e-01
|
8.21e-01
|
0.26400
|
1.97e-02
|
-2.64e-01
|
9.19e-01
|
1.71e-01
|
GOMF KINETOCHORE BINDING
|
6
|
5.59e-01
|
8.82e-01
|
0.26400
|
-2.43e-01
|
1.04e-01
|
3.03e-01
|
6.58e-01
|
GOBP PROTEIN LOCALIZATION TO CILIARY TRANSITION ZONE
|
8
|
4.11e-01
|
8.27e-01
|
0.26400
|
2.59e-01
|
5.23e-02
|
2.05e-01
|
7.98e-01
|
GOBP REGULATION OF OVARIAN FOLLICLE DEVELOPMENT
|
6
|
5.61e-01
|
8.84e-01
|
0.26400
|
-1.13e-01
|
2.39e-01
|
6.32e-01
|
3.11e-01
|
GOCC MITOCHONDRIAL PYRUVATE DEHYDROGENASE COMPLEX
|
7
|
4.72e-01
|
8.52e-01
|
0.26400
|
-1.06e-02
|
-2.64e-01
|
9.61e-01
|
2.27e-01
|
GOBP ENAMEL MINERALIZATION
|
19
|
1.63e-01
|
6.48e-01
|
0.26400
|
-1.22e-01
|
2.34e-01
|
3.58e-01
|
7.72e-02
|
GOBP PROTEIN HETEROOLIGOMERIZATION
|
28
|
6.91e-02
|
5.01e-01
|
0.26400
|
-2.36e-01
|
1.17e-01
|
3.07e-02
|
2.82e-01
|
GOCC NLS DEPENDENT PROTEIN NUCLEAR IMPORT COMPLEX
|
10
|
3.08e-01
|
7.72e-01
|
0.26400
|
-2.14e-01
|
-1.53e-01
|
2.40e-01
|
4.02e-01
|
GOBP HEMOGLOBIN METABOLIC PROCESS
|
17
|
1.92e-01
|
6.85e-01
|
0.26300
|
-9.18e-02
|
2.47e-01
|
5.12e-01
|
7.79e-02
|
GOBP REGULATION OF METALLOENDOPEPTIDASE ACTIVITY
|
15
|
2.16e-01
|
7.06e-01
|
0.26300
|
3.42e-02
|
-2.61e-01
|
8.18e-01
|
7.99e-02
|
GOBP NEGATIVE REGULATION OF CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION
|
5
|
5.81e-01
|
8.90e-01
|
0.26300
|
-3.04e-02
|
-2.62e-01
|
9.06e-01
|
3.11e-01
|
GOMF ANKYRIN BINDING
|
19
|
1.07e-01
|
5.79e-01
|
0.26300
|
1.60e-01
|
2.09e-01
|
2.26e-01
|
1.15e-01
|
GOMF K63 LINKED DEUBIQUITINASE ACTIVITY
|
11
|
3.44e-01
|
7.95e-01
|
0.26300
|
2.47e-01
|
-9.21e-02
|
1.57e-01
|
5.97e-01
|
GOBP DUMP CATABOLIC PROCESS
|
6
|
5.73e-01
|
8.88e-01
|
0.26300
|
-2.01e-01
|
1.69e-01
|
3.93e-01
|
4.72e-01
|
GOMF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY INVOLVED IN CARDIAC MUSCLE CELL ACTION POTENTIAL
|
5
|
5.65e-01
|
8.85e-01
|
0.26300
|
2.43e-01
|
1.01e-01
|
3.47e-01
|
6.96e-01
|
GOMF PHOSPHATIDYLINOSITOL TRANSFER ACTIVITY
|
10
|
3.86e-01
|
8.19e-01
|
0.26300
|
-1.16e-01
|
2.36e-01
|
5.24e-01
|
1.97e-01
|
GOBP GLYCOPROTEIN CATABOLIC PROCESS
|
33
|
3.59e-02
|
3.87e-01
|
0.26300
|
-4.48e-02
|
2.59e-01
|
6.56e-01
|
1.00e-02
|
GOBP ARF PROTEIN SIGNAL TRANSDUCTION
|
21
|
1.33e-01
|
6.14e-01
|
0.26300
|
-1.01e-01
|
2.43e-01
|
4.21e-01
|
5.43e-02
|
GOBP POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION
|
11
|
3.54e-01
|
7.97e-01
|
0.26300
|
-1.27e-01
|
2.30e-01
|
4.67e-01
|
1.86e-01
|
GOBP GMP BIOSYNTHETIC PROCESS
|
13
|
2.43e-01
|
7.25e-01
|
0.26300
|
-3.88e-02
|
-2.60e-01
|
8.09e-01
|
1.05e-01
|
GOBP POSITIVE REGULATION OF MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION
|
15
|
1.74e-01
|
6.64e-01
|
0.26300
|
-2.24e-01
|
-1.38e-01
|
1.34e-01
|
3.55e-01
|
GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX CLASS I
|
9
|
4.17e-01
|
8.32e-01
|
0.26300
|
-8.69e-02
|
2.48e-01
|
6.52e-01
|
1.98e-01
|
GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS
|
10
|
3.98e-01
|
8.25e-01
|
0.26300
|
-1.79e-01
|
1.92e-01
|
3.26e-01
|
2.94e-01
|
GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE METABOLIC PROCESS
|
5
|
6.13e-01
|
8.98e-01
|
0.26300
|
-2.52e-01
|
7.44e-02
|
3.30e-01
|
7.73e-01
|
GOBP COPPER ION TRANSPORT
|
15
|
1.73e-01
|
6.61e-01
|
0.26300
|
-2.09e-01
|
-1.59e-01
|
1.62e-01
|
2.85e-01
|
GOBP POSITIVE REGULATION OF MYOBLAST PROLIFERATION
|
14
|
2.05e-01
|
6.95e-01
|
0.26200
|
9.13e-02
|
2.46e-01
|
5.54e-01
|
1.11e-01
|
GOMF APOLIPOPROTEIN BINDING
|
17
|
1.93e-01
|
6.85e-01
|
0.26200
|
-8.78e-02
|
2.47e-01
|
5.31e-01
|
7.76e-02
|
GOCC PRESYNAPTIC ENDOCYTIC ZONE
|
9
|
4.19e-01
|
8.33e-01
|
0.26200
|
-2.47e-01
|
8.72e-02
|
1.99e-01
|
6.51e-01
|
GOBP PROTEIN LOCALIZATION TO BASOLATERAL PLASMA MEMBRANE
|
7
|
4.83e-01
|
8.54e-01
|
0.26200
|
3.38e-03
|
-2.62e-01
|
9.88e-01
|
2.30e-01
|
GOBP RIBOSOMAL SMALL SUBUNIT EXPORT FROM NUCLEUS
|
8
|
4.24e-01
|
8.35e-01
|
0.26200
|
2.60e-01
|
3.04e-02
|
2.03e-01
|
8.82e-01
|
GOBP ACETYL COA BIOSYNTHETIC PROCESS
|
16
|
1.59e-01
|
6.48e-01
|
0.26200
|
-2.30e-01
|
-1.25e-01
|
1.11e-01
|
3.88e-01
|
GOBP SYNAPTIC VESICLE BUDDING
|
10
|
3.11e-01
|
7.74e-01
|
0.26200
|
-1.80e-01
|
-1.90e-01
|
3.24e-01
|
2.99e-01
|
GOBP POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN
|
7
|
4.53e-01
|
8.46e-01
|
0.26200
|
9.86e-02
|
2.42e-01
|
6.51e-01
|
2.67e-01
|
GOMF U4 SNRNA BINDING
|
6
|
5.68e-01
|
8.86e-01
|
0.26200
|
-2.35e-01
|
1.14e-01
|
3.18e-01
|
6.29e-01
|
GOBP POSITIVE REGULATION OF BLOOD BRAIN BARRIER PERMEABILITY
|
5
|
6.02e-01
|
8.96e-01
|
0.26200
|
-2.87e-02
|
2.60e-01
|
9.12e-01
|
3.14e-01
|
GOBP VESICLE UNCOATING
|
8
|
4.59e-01
|
8.48e-01
|
0.26100
|
-2.51e-01
|
7.20e-02
|
2.18e-01
|
7.24e-01
|
GOBP GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT
|
11
|
2.89e-01
|
7.60e-01
|
0.26100
|
1.01e-01
|
2.41e-01
|
5.61e-01
|
1.66e-01
|
GOBP STEM CELL FATE COMMITMENT
|
10
|
3.35e-01
|
7.88e-01
|
0.26100
|
-2.55e-01
|
-5.64e-02
|
1.62e-01
|
7.58e-01
|
GOMF PHOSPHATIDYLINOSITOL TRISPHOSPHATE PHOSPHATASE ACTIVITY
|
9
|
3.77e-01
|
8.13e-01
|
0.26100
|
-2.57e-01
|
-4.63e-02
|
1.81e-01
|
8.10e-01
|
GOMF OXIDIZED DNA BINDING
|
11
|
3.56e-01
|
7.97e-01
|
0.26100
|
-2.34e-01
|
1.16e-01
|
1.78e-01
|
5.06e-01
|
GOMF GABA GATED CHLORIDE ION CHANNEL ACTIVITY
|
11
|
2.99e-01
|
7.67e-01
|
0.26100
|
-6.39e-02
|
-2.53e-01
|
7.14e-01
|
1.46e-01
|
GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION
|
11
|
3.57e-01
|
7.99e-01
|
0.26100
|
-2.32e-01
|
1.20e-01
|
1.83e-01
|
4.91e-01
|
GOMF OLIGOSACCHARYL TRANSFERASE ACTIVITY
|
6
|
5.66e-01
|
8.85e-01
|
0.26100
|
-1.02e-01
|
2.40e-01
|
6.66e-01
|
3.08e-01
|
GOBP GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION
|
18
|
1.26e-01
|
6.06e-01
|
0.26100
|
2.22e-01
|
1.37e-01
|
1.03e-01
|
3.13e-01
|
GOBP NEGATIVE REGULATION OF LOW DENSITY LIPOPROTEIN RECEPTOR ACTIVITY
|
10
|
3.36e-01
|
7.88e-01
|
0.26100
|
-5.72e-02
|
-2.55e-01
|
7.54e-01
|
1.63e-01
|
GOBP REGULATION OF LUTEINIZING HORMONE SECRETION
|
6
|
5.56e-01
|
8.81e-01
|
0.26100
|
6.49e-02
|
-2.53e-01
|
7.83e-01
|
2.83e-01
|
GOBP HEPATOCYTE APOPTOTIC PROCESS
|
21
|
1.26e-01
|
6.06e-01
|
0.26100
|
-2.56e-01
|
5.18e-02
|
4.24e-02
|
6.81e-01
|
GOCC RIBOSOMAL SUBUNIT
|
177
|
6.02e-08
|
4.40e-05
|
0.26100
|
1.02e-01
|
-2.40e-01
|
1.91e-02
|
3.53e-08
|
GOBP POSITIVE REGULATION OF CYTOKINESIS
|
43
|
1.97e-02
|
3.00e-01
|
0.26100
|
-1.60e-01
|
2.06e-01
|
7.01e-02
|
1.92e-02
|
GOBP NUCLEOSIDE TRANSPORT
|
10
|
3.15e-01
|
7.76e-01
|
0.26100
|
2.08e-01
|
1.58e-01
|
2.56e-01
|
3.87e-01
|
GOBP POSITIVE REGULATION OF CELL FATE COMMITMENT
|
13
|
2.30e-01
|
7.18e-01
|
0.26100
|
2.36e-01
|
1.11e-01
|
1.40e-01
|
4.90e-01
|
GOBP SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL SIGNALING
|
9
|
3.86e-01
|
8.19e-01
|
0.26100
|
2.60e-01
|
2.43e-02
|
1.77e-01
|
9.00e-01
|
GOBP NEURAL FOLD FORMATION
|
7
|
4.59e-01
|
8.48e-01
|
0.26100
|
2.46e-01
|
8.54e-02
|
2.59e-01
|
6.96e-01
|
GOBP SEQUESTERING OF TRIGLYCERIDE
|
18
|
1.25e-01
|
6.06e-01
|
0.26100
|
-1.98e-01
|
-1.70e-01
|
1.46e-01
|
2.13e-01
|
GOBP REGULATION OF PROTEIN POLYUBIQUITINATION
|
26
|
9.42e-02
|
5.58e-01
|
0.26100
|
1.74e-01
|
-1.94e-01
|
1.24e-01
|
8.70e-02
|
GOCC TRANSCRIPTION FACTOR TFIIA COMPLEX
|
5
|
5.91e-01
|
8.92e-01
|
0.26100
|
-2.09e-02
|
-2.60e-01
|
9.36e-01
|
3.14e-01
|
GOCC SECONDARY LYSOSOME
|
16
|
2.05e-01
|
6.95e-01
|
0.26100
|
-2.57e-01
|
4.45e-02
|
7.54e-02
|
7.58e-01
|
GOBP NEGATIVE REGULATION OF PINOCYTOSIS
|
5
|
5.61e-01
|
8.83e-01
|
0.26100
|
-1.82e-01
|
-1.86e-01
|
4.81e-01
|
4.71e-01
|
GOBP PROTEIN INSERTION INTO MITOCHONDRIAL INNER MEMBRANE
|
12
|
3.07e-01
|
7.71e-01
|
0.26000
|
5.21e-02
|
-2.55e-01
|
7.55e-01
|
1.26e-01
|
GOBP ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE
|
8
|
4.68e-01
|
8.51e-01
|
0.26000
|
-2.43e-01
|
9.29e-02
|
2.33e-01
|
6.49e-01
|
GOCC TRANSCRIPTION FACTOR AP 1 COMPLEX
|
5
|
5.90e-01
|
8.92e-01
|
0.26000
|
-2.31e-02
|
-2.59e-01
|
9.29e-01
|
3.15e-01
|
GOMF MITOGEN ACTIVATED PROTEIN KINASE BINDING
|
29
|
6.06e-02
|
4.78e-01
|
0.26000
|
-2.51e-01
|
6.80e-02
|
1.92e-02
|
5.26e-01
|
GOBP POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL
|
31
|
5.53e-02
|
4.63e-01
|
0.26000
|
-2.36e-01
|
1.10e-01
|
2.30e-02
|
2.90e-01
|
GOMF PEPTIDE ALPHA N ACETYLTRANSFERASE ACTIVITY
|
7
|
4.78e-01
|
8.54e-01
|
0.26000
|
-2.42e-02
|
-2.59e-01
|
9.12e-01
|
2.35e-01
|
GOBP LYMPH NODE DEVELOPMENT
|
18
|
1.26e-01
|
6.06e-01
|
0.26000
|
1.58e-01
|
2.07e-01
|
2.46e-01
|
1.29e-01
|
GOBP VITAMIN D RECEPTOR SIGNALING PATHWAY
|
12
|
3.15e-01
|
7.76e-01
|
0.26000
|
-7.33e-02
|
2.50e-01
|
6.60e-01
|
1.34e-01
|
GOBP INTRACELLULAR DISTRIBUTION OF MITOCHONDRIA
|
7
|
5.24e-01
|
8.70e-01
|
0.26000
|
-1.28e-01
|
2.26e-01
|
5.58e-01
|
3.00e-01
|
GOCC ENDOPLASMIC RETICULUM CHAPERONE COMPLEX
|
11
|
2.85e-01
|
7.57e-01
|
0.26000
|
-2.21e-01
|
-1.38e-01
|
2.05e-01
|
4.30e-01
|
GOMF INTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY
|
29
|
5.89e-02
|
4.72e-01
|
0.26000
|
-5.54e-02
|
2.54e-01
|
6.06e-01
|
1.79e-02
|
GOBP PROTEOGLYCAN BIOSYNTHETIC PROCESS
|
63
|
3.27e-03
|
1.14e-01
|
0.26000
|
-2.10e-01
|
1.53e-01
|
3.93e-03
|
3.53e-02
|
GOBP NOREPINEPHRINE UPTAKE
|
8
|
4.07e-01
|
8.26e-01
|
0.26000
|
1.08e-01
|
2.36e-01
|
5.96e-01
|
2.47e-01
|
GOBP MANNOSYLATION
|
22
|
1.08e-01
|
5.83e-01
|
0.26000
|
-2.59e-01
|
1.86e-02
|
3.52e-02
|
8.80e-01
|
GOBP NLS BEARING PROTEIN IMPORT INTO NUCLEUS
|
19
|
1.76e-01
|
6.65e-01
|
0.26000
|
2.19e-01
|
-1.39e-01
|
9.79e-02
|
2.93e-01
|
GOBP POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS
|
21
|
9.61e-02
|
5.61e-01
|
0.26000
|
-2.40e-01
|
-1.01e-01
|
5.73e-02
|
4.25e-01
|
GOBP REGULATION OF FEMALE GONAD DEVELOPMENT
|
7
|
4.52e-01
|
8.45e-01
|
0.26000
|
-2.27e-01
|
-1.26e-01
|
2.98e-01
|
5.62e-01
|
GOBP ANTIBACTERIAL INNATE IMMUNE RESPONSE
|
6
|
5.80e-01
|
8.90e-01
|
0.26000
|
-1.55e-01
|
2.08e-01
|
5.10e-01
|
3.77e-01
|
GOBP AXONOGENESIS INVOLVED IN INNERVATION
|
9
|
3.67e-01
|
8.07e-01
|
0.26000
|
9.84e-02
|
2.40e-01
|
6.09e-01
|
2.12e-01
|
GOBP T HELPER 17 CELL DIFFERENTIATION
|
32
|
2.54e-02
|
3.31e-01
|
0.26000
|
1.95e-01
|
1.72e-01
|
5.67e-02
|
9.24e-02
|
GOBP POSITIVE REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT
|
5
|
6.26e-01
|
9.01e-01
|
0.26000
|
-1.03e-01
|
2.38e-01
|
6.89e-01
|
3.56e-01
|
GOBP LATE NUCLEOPHAGY
|
8
|
4.65e-01
|
8.49e-01
|
0.26000
|
-2.49e-01
|
7.38e-02
|
2.23e-01
|
7.18e-01
|
GOBP POSITIVE REGULATION OF RECEPTOR BINDING
|
6
|
5.28e-01
|
8.72e-01
|
0.25900
|
2.56e-01
|
4.13e-02
|
2.77e-01
|
8.61e-01
|
GOBP ACTIN CROSSLINK FORMATION
|
12
|
3.20e-01
|
7.78e-01
|
0.25900
|
-8.23e-02
|
2.46e-01
|
6.22e-01
|
1.40e-01
|
GOBP NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION
|
44
|
9.79e-03
|
2.10e-01
|
0.25900
|
-2.57e-01
|
-3.12e-02
|
3.13e-03
|
7.21e-01
|
GOCC BLEB
|
9
|
4.29e-01
|
8.36e-01
|
0.25900
|
-2.43e-01
|
9.08e-02
|
2.07e-01
|
6.37e-01
|
GOBP REGULATION OF HISTAMINE SECRETION BY MAST CELL
|
6
|
5.46e-01
|
8.78e-01
|
0.25900
|
2.59e-01
|
-1.27e-02
|
2.72e-01
|
9.57e-01
|
GOBP NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT
|
11
|
3.63e-01
|
8.05e-01
|
0.25900
|
-2.30e-01
|
1.19e-01
|
1.86e-01
|
4.96e-01
|
GOBP POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY
|
7
|
4.99e-01
|
8.61e-01
|
0.25900
|
2.88e-02
|
-2.57e-01
|
8.95e-01
|
2.38e-01
|
GOBP PROTEIN DEGLUTAMYLATION
|
6
|
5.65e-01
|
8.85e-01
|
0.25900
|
7.68e-02
|
-2.47e-01
|
7.45e-01
|
2.94e-01
|
GOMF CARNITINE O ACYLTRANSFERASE ACTIVITY
|
6
|
5.70e-01
|
8.86e-01
|
0.25900
|
-2.41e-01
|
9.32e-02
|
3.06e-01
|
6.93e-01
|
GOBP PROTEIN O LINKED GLYCOSYLATION VIA SERINE
|
10
|
3.24e-01
|
7.80e-01
|
0.25900
|
-2.24e-01
|
-1.29e-01
|
2.19e-01
|
4.81e-01
|
GOBP OPTIC CUP MORPHOGENESIS INVOLVED IN CAMERA TYPE EYE DEVELOPMENT
|
7
|
4.68e-01
|
8.51e-01
|
0.25900
|
-7.28e-02
|
-2.48e-01
|
7.39e-01
|
2.55e-01
|
GOCC NURD COMPLEX
|
15
|
2.31e-01
|
7.18e-01
|
0.25900
|
-2.55e-01
|
4.32e-02
|
8.71e-02
|
7.72e-01
|
GOBP INTRACELLULAR SODIUM ION HOMEOSTASIS
|
22
|
1.34e-01
|
6.16e-01
|
0.25900
|
-1.25e-01
|
2.27e-01
|
3.10e-01
|
6.58e-02
|
GOBP NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS
|
13
|
2.87e-01
|
7.59e-01
|
0.25900
|
-2.51e-01
|
6.21e-02
|
1.17e-01
|
6.98e-01
|
GOCC TIM23 MITOCHONDRIAL IMPORT INNER MEMBRANE TRANSLOCASE COMPLEX
|
14
|
2.29e-01
|
7.16e-01
|
0.25900
|
-2.56e-01
|
-3.95e-02
|
9.78e-02
|
7.98e-01
|
GOBP GLOMERULUS VASCULATURE MORPHOGENESIS
|
6
|
5.20e-01
|
8.69e-01
|
0.25900
|
8.18e-02
|
2.45e-01
|
7.28e-01
|
2.98e-01
|
GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS
|
10
|
3.56e-01
|
7.97e-01
|
0.25800
|
1.81e-02
|
2.58e-01
|
9.21e-01
|
1.58e-01
|
GOBP NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION
|
17
|
2.07e-01
|
6.97e-01
|
0.25800
|
-2.37e-01
|
1.04e-01
|
9.12e-02
|
4.58e-01
|
GOCC CLATHRIN SCULPTED MONOAMINE TRANSPORT VESICLE
|
5
|
6.04e-01
|
8.96e-01
|
0.25800
|
2.58e-01
|
-9.31e-03
|
3.17e-01
|
9.71e-01
|
GOCC TRANS GOLGI NETWORK TRANSPORT VESICLE MEMBRANE
|
19
|
1.80e-01
|
6.70e-01
|
0.25800
|
-1.43e-01
|
2.15e-01
|
2.80e-01
|
1.05e-01
|
GOBP ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS
|
21
|
1.00e-01
|
5.69e-01
|
0.25800
|
-9.09e-02
|
-2.42e-01
|
4.71e-01
|
5.51e-02
|
GOBP PONS DEVELOPMENT
|
11
|
3.50e-01
|
7.96e-01
|
0.25800
|
-6.63e-02
|
2.50e-01
|
7.03e-01
|
1.52e-01
|
GOBP CORNIFIED ENVELOPE ASSEMBLY
|
6
|
5.73e-01
|
8.88e-01
|
0.25800
|
-9.96e-02
|
2.38e-01
|
6.73e-01
|
3.12e-01
|
GOBP ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY
|
26
|
6.31e-02
|
4.84e-01
|
0.25800
|
5.45e-02
|
2.52e-01
|
6.31e-01
|
2.60e-02
|
GOBP POSITIVE REGULATION OF ANTIBACTERIAL PEPTIDE PRODUCTION
|
5
|
5.87e-01
|
8.91e-01
|
0.25800
|
-5.69e-02
|
-2.52e-01
|
8.26e-01
|
3.30e-01
|
GOBP ESTABLISHMENT OF CENTROSOME LOCALIZATION
|
10
|
4.05e-01
|
8.26e-01
|
0.25800
|
2.20e-01
|
-1.35e-01
|
2.28e-01
|
4.61e-01
|
GOBP RESPONSE TO SODIUM ARSENITE
|
6
|
5.18e-01
|
8.69e-01
|
0.25800
|
9.42e-02
|
2.40e-01
|
6.90e-01
|
3.09e-01
|
GOBP PROTEIN LOCALIZATION TO NUCLEAR ENVELOPE
|
13
|
3.04e-01
|
7.68e-01
|
0.25800
|
1.10e-01
|
-2.33e-01
|
4.92e-01
|
1.46e-01
|
GOBP VITAMIN BIOSYNTHETIC PROCESS
|
24
|
1.00e-01
|
5.69e-01
|
0.25800
|
5.57e-02
|
-2.52e-01
|
6.37e-01
|
3.28e-02
|
GOBP MEIOTIC ATTACHMENT OF TELOMERE TO NUCLEAR ENVELOPE
|
5
|
6.02e-01
|
8.96e-01
|
0.25800
|
4.07e-03
|
2.58e-01
|
9.87e-01
|
3.18e-01
|
GOBP POSITIVE REGULATION OF AMYLOID FIBRIL FORMATION
|
5
|
6.39e-01
|
9.06e-01
|
0.25800
|
2.09e-01
|
-1.50e-01
|
4.17e-01
|
5.61e-01
|
GOBP UBIQUITIN DEPENDENT GLYCOPROTEIN ERAD PATHWAY
|
7
|
4.77e-01
|
8.54e-01
|
0.25800
|
4.99e-02
|
2.53e-01
|
8.19e-01
|
2.47e-01
|
GOMF MANNOSYL OLIGOSACCHARIDE 1 2 ALPHA MANNOSIDASE ACTIVITY
|
7
|
4.77e-01
|
8.54e-01
|
0.25800
|
4.99e-02
|
2.53e-01
|
8.19e-01
|
2.47e-01
|
GOBP PUTRESCINE BIOSYNTHETIC PROCESS
|
5
|
6.38e-01
|
9.06e-01
|
0.25800
|
2.15e-01
|
-1.42e-01
|
4.05e-01
|
5.83e-01
|
GOBP URATE METABOLIC PROCESS
|
12
|
2.74e-01
|
7.48e-01
|
0.25700
|
2.45e-01
|
7.86e-02
|
1.41e-01
|
6.37e-01
|
GOBP MITOCHONDRIAL TRNA PROCESSING
|
13
|
2.72e-01
|
7.47e-01
|
0.25700
|
8.14e-03
|
-2.57e-01
|
9.59e-01
|
1.08e-01
|
GOBP PROTEIN LOCALIZATION TO GOLGI APPARATUS
|
29
|
5.08e-02
|
4.46e-01
|
0.25700
|
-2.56e-01
|
-2.17e-02
|
1.68e-02
|
8.40e-01
|
GOBP REGULATION OF WOUND HEALING SPREADING OF EPIDERMAL CELLS
|
8
|
4.80e-01
|
8.54e-01
|
0.25700
|
-2.34e-01
|
1.06e-01
|
2.51e-01
|
6.03e-01
|
GOBP NEGATIVE REGULATION OF TELOMERASE ACTIVITY
|
10
|
4.05e-01
|
8.26e-01
|
0.25700
|
-2.26e-01
|
1.24e-01
|
2.16e-01
|
4.99e-01
|
GOBP TRANS SYNAPTIC SIGNALING BY TRANS SYNAPTIC COMPLEX
|
6
|
5.09e-01
|
8.66e-01
|
0.25700
|
1.55e-01
|
2.06e-01
|
5.12e-01
|
3.83e-01
|
GOMF ATP DEPENDENT PROTEIN BINDING
|
6
|
5.85e-01
|
8.90e-01
|
0.25700
|
-1.44e-01
|
2.13e-01
|
5.40e-01
|
3.67e-01
|
GOBP LEUCINE METABOLIC PROCESS
|
8
|
4.20e-01
|
8.33e-01
|
0.25700
|
-2.43e-01
|
-8.56e-02
|
2.35e-01
|
6.75e-01
|
GOMF MACROLIDE BINDING
|
12
|
3.45e-01
|
7.96e-01
|
0.25700
|
1.64e-01
|
-1.98e-01
|
3.25e-01
|
2.35e-01
|
GOCC TRAPP COMPLEX
|
16
|
2.42e-01
|
7.25e-01
|
0.25700
|
-2.04e-01
|
1.56e-01
|
1.57e-01
|
2.80e-01
|
GOBP REGULATION OF ISOTYPE SWITCHING TO IGE ISOTYPES
|
6
|
5.14e-01
|
8.67e-01
|
0.25700
|
-1.32e-01
|
-2.21e-01
|
5.77e-01
|
3.50e-01
|
GOBP NEUTROPHIL MEDIATED CYTOTOXICITY
|
14
|
2.08e-01
|
6.97e-01
|
0.25700
|
-1.95e-01
|
-1.67e-01
|
2.06e-01
|
2.80e-01
|
GOBP LYSOSOMAL PROTEIN CATABOLIC PROCESS
|
19
|
1.29e-01
|
6.09e-01
|
0.25700
|
-2.43e-01
|
-8.23e-02
|
6.64e-02
|
5.35e-01
|
GOBP NEGATIVE REGULATION OF MACROPHAGE CHEMOTAXIS
|
7
|
4.68e-01
|
8.51e-01
|
0.25700
|
-9.37e-02
|
-2.39e-01
|
6.68e-01
|
2.74e-01
|
GOBP REGULATION OF STORE OPERATED CALCIUM CHANNEL ACTIVITY
|
6
|
5.70e-01
|
8.86e-01
|
0.25700
|
-6.98e-02
|
2.47e-01
|
7.67e-01
|
2.95e-01
|
GOBP NEGATIVE REGULATION OF EXOCYTOSIS
|
31
|
5.22e-02
|
4.49e-01
|
0.25600
|
-2.51e-01
|
5.14e-02
|
1.54e-02
|
6.20e-01
|
GOBP NECROPTOTIC SIGNALING PATHWAY
|
8
|
4.13e-01
|
8.29e-01
|
0.25600
|
-2.22e-01
|
-1.29e-01
|
2.77e-01
|
5.29e-01
|
GOBP L CYSTINE TRANSPORT
|
6
|
5.10e-01
|
8.66e-01
|
0.25600
|
1.70e-01
|
1.92e-01
|
4.71e-01
|
4.15e-01
|
GOBP VITAMIN E METABOLIC PROCESS
|
6
|
5.30e-01
|
8.74e-01
|
0.25600
|
-2.49e-01
|
-6.18e-02
|
2.91e-01
|
7.93e-01
|
GOMF GLYCOSPHINGOLIPID BINDING
|
10
|
3.52e-01
|
7.96e-01
|
0.25600
|
4.76e-02
|
2.52e-01
|
7.94e-01
|
1.68e-01
|
GOBP REGULATION OF MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS
|
7
|
4.67e-01
|
8.51e-01
|
0.25600
|
-2.35e-01
|
-1.03e-01
|
2.82e-01
|
6.38e-01
|
GOBP MITOCHONDRIAL TRANSCRIPTION
|
19
|
1.28e-01
|
6.07e-01
|
0.25600
|
-9.76e-02
|
-2.37e-01
|
4.62e-01
|
7.38e-02
|
GOCC CORVET COMPLEX
|
7
|
4.58e-01
|
8.48e-01
|
0.25600
|
-2.01e-01
|
-1.59e-01
|
3.57e-01
|
4.67e-01
|
GOBP REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION
|
14
|
2.45e-01
|
7.26e-01
|
0.25600
|
-2.56e-01
|
-6.87e-03
|
9.73e-02
|
9.65e-01
|
GOBP REGULATION OF BROWN FAT CELL DIFFERENTIATION
|
24
|
7.31e-02
|
5.13e-01
|
0.25600
|
-2.32e-01
|
-1.09e-01
|
4.93e-02
|
3.57e-01
|
GOBP RESPONSE TO YEAST
|
7
|
4.60e-01
|
8.48e-01
|
0.25600
|
-1.42e-01
|
-2.13e-01
|
5.14e-01
|
3.30e-01
|
GOBP RESPONSE TO LIGHT INTENSITY
|
16
|
2.44e-01
|
7.26e-01
|
0.25600
|
-2.04e-01
|
1.54e-01
|
1.57e-01
|
2.86e-01
|
GOMF TRAIL BINDING
|
5
|
6.43e-01
|
9.07e-01
|
0.25600
|
-2.12e-01
|
1.44e-01
|
4.13e-01
|
5.77e-01
|
GOBP GDP METABOLIC PROCESS
|
9
|
4.05e-01
|
8.26e-01
|
0.25600
|
-2.56e-01
|
-1.02e-02
|
1.84e-01
|
9.58e-01
|
GOBP RESPONSE TO MURAMYL DIPEPTIDE
|
20
|
1.19e-01
|
6.00e-01
|
0.25600
|
-2.43e-01
|
-7.95e-02
|
5.98e-02
|
5.38e-01
|
GOBP DRINKING BEHAVIOR
|
8
|
4.75e-01
|
8.54e-01
|
0.25600
|
-2.46e-01
|
7.18e-02
|
2.29e-01
|
7.25e-01
|
GOCC NETWORK FORMING COLLAGEN TRIMER
|
6
|
5.91e-01
|
8.93e-01
|
0.25600
|
1.96e-01
|
-1.64e-01
|
4.06e-01
|
4.87e-01
|
GOBP POSITIVE REGULATION OF CHROMATIN ORGANIZATION
|
14
|
2.31e-01
|
7.18e-01
|
0.25500
|
-5.82e-02
|
-2.49e-01
|
7.06e-01
|
1.07e-01
|
GOBP POSITIVE REGULATION OF GLIAL CELL MIGRATION
|
11
|
3.00e-01
|
7.67e-01
|
0.25500
|
-2.23e-01
|
-1.25e-01
|
2.01e-01
|
4.73e-01
|
GOBP LYSOSOMAL LUMEN ACIDIFICATION
|
20
|
1.36e-01
|
6.18e-01
|
0.25500
|
-2.55e-01
|
-6.22e-03
|
4.81e-02
|
9.62e-01
|
GOBP PROTEIN OXIDATION
|
13
|
2.71e-01
|
7.46e-01
|
0.25500
|
-2.55e-01
|
-1.38e-02
|
1.11e-01
|
9.31e-01
|
GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS
|
14
|
2.85e-01
|
7.57e-01
|
0.25500
|
2.29e-01
|
-1.13e-01
|
1.38e-01
|
4.65e-01
|
GOBP REGULATION OF PROTEIN SUMOYLATION
|
21
|
1.56e-01
|
6.43e-01
|
0.25500
|
-1.34e-01
|
2.17e-01
|
2.87e-01
|
8.50e-02
|
GOBP REGULATION OF PANCREATIC JUICE SECRETION
|
7
|
5.43e-01
|
8.78e-01
|
0.25500
|
-1.67e-01
|
1.93e-01
|
4.44e-01
|
3.76e-01
|
GOBP GLOSSOPHARYNGEAL NERVE DEVELOPMENT
|
5
|
6.45e-01
|
9.07e-01
|
0.25500
|
2.03e-01
|
-1.55e-01
|
4.32e-01
|
5.48e-01
|
GOBP REGULATION OF SYNAPTIC ASSEMBLY AT NEUROMUSCULAR JUNCTION
|
6
|
5.38e-01
|
8.78e-01
|
0.25500
|
4.53e-02
|
2.51e-01
|
8.48e-01
|
2.87e-01
|
GOBP BONE MARROW DEVELOPMENT
|
9
|
3.72e-01
|
8.09e-01
|
0.25500
|
2.16e-01
|
1.36e-01
|
2.62e-01
|
4.79e-01
|
GOBP SPINDLE MIDZONE ASSEMBLY
|
13
|
2.83e-01
|
7.56e-01
|
0.25500
|
-2.54e-01
|
2.10e-02
|
1.12e-01
|
8.96e-01
|
GOBP REGULATION OF PROTEIN NEDDYLATION
|
19
|
1.65e-01
|
6.49e-01
|
0.25500
|
-2.51e-01
|
4.35e-02
|
5.78e-02
|
7.43e-01
|
GOBP VITAMIN CATABOLIC PROCESS
|
14
|
2.20e-01
|
7.09e-01
|
0.25500
|
2.31e-01
|
1.08e-01
|
1.34e-01
|
4.85e-01
|
GOBP PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT
|
24
|
7.86e-02
|
5.26e-01
|
0.25500
|
7.92e-02
|
2.42e-01
|
5.02e-01
|
3.98e-02
|
GOBP PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION
|
13
|
2.46e-01
|
7.26e-01
|
0.25500
|
-2.33e-01
|
-1.03e-01
|
1.45e-01
|
5.22e-01
|
GOMF SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY
|
30
|
7.38e-02
|
5.13e-01
|
0.25500
|
-1.80e-01
|
1.81e-01
|
8.86e-02
|
8.61e-02
|
GOBP TONGUE DEVELOPMENT
|
20
|
1.14e-01
|
5.91e-01
|
0.25500
|
2.24e-01
|
1.21e-01
|
8.27e-02
|
3.48e-01
|
GOBP NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE
|
15
|
2.62e-01
|
7.39e-01
|
0.25500
|
2.29e-01
|
-1.11e-01
|
1.24e-01
|
4.58e-01
|
GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CONTRACTION
|
7
|
4.74e-01
|
8.53e-01
|
0.25500
|
9.12e-02
|
2.38e-01
|
6.76e-01
|
2.76e-01
|
GOBP RELAXATION OF SMOOTH MUSCLE
|
9
|
4.55e-01
|
8.46e-01
|
0.25500
|
-2.11e-01
|
1.42e-01
|
2.73e-01
|
4.60e-01
|
GOBP ARTICULAR CARTILAGE DEVELOPMENT
|
5
|
6.47e-01
|
9.07e-01
|
0.25500
|
2.03e-01
|
-1.53e-01
|
4.31e-01
|
5.53e-01
|
GOBP GLUTAMATE SECRETION NEUROTRANSMISSION
|
8
|
4.40e-01
|
8.40e-01
|
0.25500
|
4.23e-02
|
2.51e-01
|
8.36e-01
|
2.19e-01
|
GOBP PHOSPHOLIPASE C ACTIVATING DOPAMINE RECEPTOR SIGNALING PATHWAY
|
9
|
4.33e-01
|
8.37e-01
|
0.25400
|
-2.47e-01
|
6.10e-02
|
1.99e-01
|
7.51e-01
|
GOCC U1 SNRNP
|
19
|
1.92e-01
|
6.85e-01
|
0.25400
|
1.54e-01
|
-2.02e-01
|
2.45e-01
|
1.26e-01
|
GOCC GOLGI TRANS CISTERNA
|
9
|
4.13e-01
|
8.29e-01
|
0.25400
|
-2.54e-01
|
2.99e-03
|
1.86e-01
|
9.88e-01
|
GOCC LATERAL PLASMA MEMBRANE
|
64
|
2.43e-03
|
9.50e-02
|
0.25400
|
-4.59e-02
|
2.50e-01
|
5.26e-01
|
5.35e-04
|
GOBP NEGATIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE
|
5
|
5.77e-01
|
8.89e-01
|
0.25400
|
-2.01e-01
|
-1.56e-01
|
4.36e-01
|
5.46e-01
|
GOCC STEREOCILIUM MEMBRANE
|
6
|
5.25e-01
|
8.71e-01
|
0.25400
|
1.05e-01
|
2.32e-01
|
6.57e-01
|
3.25e-01
|
GOCC GINS COMPLEX
|
5
|
6.46e-01
|
9.07e-01
|
0.25400
|
-1.40e-01
|
2.12e-01
|
5.88e-01
|
4.11e-01
|
GOBP POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS
|
20
|
1.24e-01
|
6.06e-01
|
0.25400
|
-2.46e-01
|
-6.62e-02
|
5.73e-02
|
6.08e-01
|
GOBP REGULATION OF TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY
|
10
|
4.20e-01
|
8.33e-01
|
0.25400
|
-1.59e-01
|
1.99e-01
|
3.85e-01
|
2.77e-01
|
GOBP DETOXIFICATION OF INORGANIC COMPOUND
|
21
|
1.25e-01
|
6.06e-01
|
0.25400
|
2.54e-01
|
7.42e-03
|
4.38e-02
|
9.53e-01
|
GOBP REGULATION OF NADP METABOLIC PROCESS
|
9
|
4.34e-01
|
8.38e-01
|
0.25400
|
-2.47e-01
|
6.14e-02
|
2.00e-01
|
7.50e-01
|
GOBP MULTIVESICULAR BODY ORGANIZATION
|
32
|
4.31e-02
|
4.26e-01
|
0.25400
|
-2.54e-01
|
-5.20e-04
|
1.28e-02
|
9.96e-01
|
GOBP ACYLGLYCEROL TRANSPORT
|
8
|
4.21e-01
|
8.33e-01
|
0.25400
|
2.25e-01
|
1.19e-01
|
2.71e-01
|
5.61e-01
|
GOBP NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION
|
13
|
2.39e-01
|
7.25e-01
|
0.25400
|
-1.90e-01
|
-1.69e-01
|
2.35e-01
|
2.93e-01
|
GOBP PROTEIN MATURATION BY PROTEIN FOLDING
|
7
|
5.34e-01
|
8.76e-01
|
0.25400
|
1.00e-01
|
-2.33e-01
|
6.46e-01
|
2.85e-01
|
GOBP NEGATIVE REGULATION OF METALLOPEPTIDASE ACTIVITY
|
12
|
3.00e-01
|
7.67e-01
|
0.25400
|
-2.53e-01
|
-2.27e-02
|
1.29e-01
|
8.92e-01
|
GOMF INWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY
|
27
|
5.82e-02
|
4.70e-01
|
0.25400
|
8.18e-02
|
2.40e-01
|
4.62e-01
|
3.06e-02
|
GOBP CELLULAR RESPONSE TO MAGNESIUM ION
|
7
|
5.35e-01
|
8.76e-01
|
0.25400
|
-1.03e-01
|
2.32e-01
|
6.36e-01
|
2.88e-01
|
GOMF SULFUR AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY
|
11
|
3.22e-01
|
7.79e-01
|
0.25400
|
5.36e-02
|
2.48e-01
|
7.58e-01
|
1.54e-01
|
GOCC AXOLEMMA
|
15
|
1.93e-01
|
6.85e-01
|
0.25400
|
1.94e-01
|
1.64e-01
|
1.93e-01
|
2.72e-01
|
GOCC DEATH INDUCING SIGNALING COMPLEX
|
9
|
4.06e-01
|
8.26e-01
|
0.25400
|
-2.53e-01
|
-2.10e-02
|
1.89e-01
|
9.13e-01
|
GOMF ACETYLCHOLINE RECEPTOR BINDING
|
11
|
3.42e-01
|
7.93e-01
|
0.25400
|
-2.54e-01
|
4.33e-03
|
1.45e-01
|
9.80e-01
|
GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS POLYSACCHARIDE CHAIN BIOSYNTHETIC PROCESS
|
8
|
4.81e-01
|
8.54e-01
|
0.25400
|
-7.21e-02
|
2.43e-01
|
7.24e-01
|
2.33e-01
|
GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY
|
24
|
1.26e-01
|
6.06e-01
|
0.25400
|
-1.97e-01
|
1.60e-01
|
9.53e-02
|
1.74e-01
|
GOBP REGULATION OF XENOBIOTIC DETOXIFICATION BY TRANSMEMBRANE EXPORT ACROSS THE PLASMA MEMBRANE
|
12
|
2.78e-01
|
7.51e-01
|
0.25400
|
2.31e-01
|
1.04e-01
|
1.65e-01
|
5.32e-01
|
GOBP PEPTIDYL LYSINE HYDROXYLATION
|
8
|
4.81e-01
|
8.54e-01
|
0.25400
|
2.43e-01
|
-7.36e-02
|
2.34e-01
|
7.18e-01
|
GOBP NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION
|
13
|
2.43e-01
|
7.25e-01
|
0.25400
|
1.39e-01
|
2.12e-01
|
3.86e-01
|
1.85e-01
|
GOMF NF KAPPAB INDUCING KINASE ACTIVITY
|
5
|
6.46e-01
|
9.07e-01
|
0.25400
|
-1.30e-01
|
2.18e-01
|
6.15e-01
|
3.99e-01
|
GOMF ACYL COA BINDING
|
19
|
1.42e-01
|
6.26e-01
|
0.25300
|
-5.49e-02
|
-2.47e-01
|
6.79e-01
|
6.19e-02
|
GOBP NEURON NEURON SYNAPTIC TRANSMISSION
|
6
|
5.33e-01
|
8.76e-01
|
0.25300
|
-7.94e-02
|
-2.41e-01
|
7.36e-01
|
3.07e-01
|
GOBP PLASMA MEMBRANE TO ENDOSOME TRANSPORT
|
8
|
4.78e-01
|
8.54e-01
|
0.25300
|
-2.46e-01
|
5.90e-02
|
2.28e-01
|
7.73e-01
|
GOBP XYLULOSE 5 PHOSPHATE METABOLIC PROCESS
|
6
|
5.61e-01
|
8.83e-01
|
0.25300
|
1.36e-02
|
-2.53e-01
|
9.54e-01
|
2.83e-01
|
GOBP POSITIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY
|
10
|
4.22e-01
|
8.34e-01
|
0.25300
|
-1.52e-01
|
2.02e-01
|
4.04e-01
|
2.68e-01
|
GOCC SCHMIDT LANTERMAN INCISURE
|
11
|
3.05e-01
|
7.69e-01
|
0.25300
|
1.31e-01
|
2.17e-01
|
4.52e-01
|
2.13e-01
|
GOBP INTRACELLULAR WATER HOMEOSTASIS
|
6
|
5.47e-01
|
8.78e-01
|
0.25300
|
2.51e-01
|
3.21e-02
|
2.87e-01
|
8.92e-01
|
GOBP GOLGI TO LYSOSOME TRANSPORT
|
12
|
2.99e-01
|
7.67e-01
|
0.25300
|
3.39e-02
|
2.51e-01
|
8.39e-01
|
1.32e-01
|
GOMF PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ACTIVITY
|
9
|
4.26e-01
|
8.36e-01
|
0.25300
|
-2.84e-02
|
2.51e-01
|
8.83e-01
|
1.92e-01
|
GOBP GENERAL ADAPTATION SYNDROME
|
6
|
5.85e-01
|
8.90e-01
|
0.25300
|
9.23e-02
|
-2.35e-01
|
6.96e-01
|
3.18e-01
|
GOBP TROPHOBLAST CELL MIGRATION
|
17
|
1.59e-01
|
6.48e-01
|
0.25300
|
1.42e-01
|
2.09e-01
|
3.10e-01
|
1.36e-01
|
GOBP VESICLE COATING
|
38
|
2.80e-02
|
3.48e-01
|
0.25300
|
-2.51e-01
|
3.23e-02
|
7.50e-03
|
7.31e-01
|
GOBP REGULATION OF SEQUESTERING OF TRIGLYCERIDE
|
15
|
2.02e-01
|
6.92e-01
|
0.25300
|
-2.26e-01
|
-1.12e-01
|
1.29e-01
|
4.51e-01
|
GOMF BILE ACID BINDING
|
10
|
3.42e-01
|
7.93e-01
|
0.25300
|
2.19e-01
|
1.26e-01
|
2.31e-01
|
4.90e-01
|
GOBP REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY
|
43
|
1.67e-02
|
2.74e-01
|
0.25200
|
-1.88e-02
|
2.52e-01
|
8.31e-01
|
4.27e-03
|
GOCC CUTICULAR PLATE
|
8
|
4.38e-01
|
8.40e-01
|
0.25200
|
7.04e-02
|
2.42e-01
|
7.30e-01
|
2.35e-01
|
GOBP INTRA GOLGI VESICLE MEDIATED TRANSPORT
|
32
|
3.13e-02
|
3.63e-01
|
0.25200
|
-1.57e-01
|
-1.97e-01
|
1.23e-01
|
5.34e-02
|
GOBP FATTY ACYL COA METABOLIC PROCESS
|
37
|
3.01e-02
|
3.61e-01
|
0.25200
|
-2.51e-01
|
2.34e-02
|
8.16e-03
|
8.05e-01
|
GOBP REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY
|
18
|
1.84e-01
|
6.74e-01
|
0.25200
|
-3.11e-02
|
2.50e-01
|
8.19e-01
|
6.58e-02
|
GOMF CCR5 CHEMOKINE RECEPTOR BINDING
|
7
|
5.51e-01
|
8.80e-01
|
0.25200
|
-1.88e-01
|
1.69e-01
|
3.90e-01
|
4.39e-01
|
GOBP BASIC AMINO ACID TRANSPORT
|
21
|
1.67e-01
|
6.53e-01
|
0.25200
|
-1.85e-01
|
1.72e-01
|
1.43e-01
|
1.73e-01
|
GOMF CERAMIDE 1 PHOSPHATE BINDING
|
7
|
5.28e-01
|
8.72e-01
|
0.25200
|
-6.36e-02
|
2.44e-01
|
7.71e-01
|
2.63e-01
|
GOBP NUCLEAR MIGRATION
|
25
|
1.13e-01
|
5.91e-01
|
0.25200
|
-2.23e-01
|
1.17e-01
|
5.33e-02
|
3.10e-01
|
GOBP DETOXIFICATION OF NITROGEN COMPOUND
|
5
|
6.52e-01
|
9.08e-01
|
0.25200
|
-2.05e-01
|
1.47e-01
|
4.28e-01
|
5.68e-01
|
GOBP NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION
|
24
|
9.10e-02
|
5.51e-01
|
0.25200
|
-2.50e-01
|
-3.47e-02
|
3.42e-02
|
7.69e-01
|
GOCC CUL4A RING E3 UBIQUITIN LIGASE COMPLEX
|
12
|
2.95e-01
|
7.65e-01
|
0.25200
|
-2.46e-01
|
-5.51e-02
|
1.40e-01
|
7.41e-01
|
GOBP PLATELET DENSE GRANULE ORGANIZATION
|
24
|
1.07e-01
|
5.79e-01
|
0.25200
|
-2.49e-01
|
3.66e-02
|
3.44e-02
|
7.56e-01
|
GOBP MICROVILLUS ORGANIZATION
|
28
|
9.27e-02
|
5.54e-01
|
0.25200
|
-1.81e-01
|
1.76e-01
|
9.78e-02
|
1.07e-01
|
GOMF PROTEIN GLUTAMIC ACID LIGASE ACTIVITY
|
10
|
3.38e-01
|
7.90e-01
|
0.25200
|
-1.74e-01
|
-1.82e-01
|
3.41e-01
|
3.18e-01
|
GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR
|
8
|
5.05e-01
|
8.65e-01
|
0.25200
|
1.99e-01
|
-1.54e-01
|
3.29e-01
|
4.50e-01
|
GOBP POSITIVE REGULATION OF RRNA PROCESSING
|
10
|
3.59e-01
|
8.01e-01
|
0.25200
|
-6.57e-02
|
-2.43e-01
|
7.19e-01
|
1.83e-01
|
GOBP PULMONARY ARTERY MORPHOGENESIS
|
6
|
6.01e-01
|
8.96e-01
|
0.25200
|
1.66e-01
|
-1.89e-01
|
4.81e-01
|
4.22e-01
|
GOBP REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION
|
13
|
2.48e-01
|
7.27e-01
|
0.25200
|
-1.38e-01
|
-2.11e-01
|
3.89e-01
|
1.89e-01
|
GOMF ADP RIBOSE DIPHOSPHATASE ACTIVITY
|
6
|
5.65e-01
|
8.85e-01
|
0.25200
|
-2.51e-01
|
1.48e-02
|
2.86e-01
|
9.50e-01
|
GOCC AUTOPHAGOSOME MEMBRANE
|
50
|
1.06e-02
|
2.20e-01
|
0.25200
|
-2.45e-01
|
5.82e-02
|
2.73e-03
|
4.76e-01
|
GOCC ROUGH ENDOPLASMIC RETICULUM
|
55
|
2.67e-03
|
1.01e-01
|
0.25200
|
-1.67e-01
|
-1.88e-01
|
3.19e-02
|
1.58e-02
|
GOBP REGULATION OF GAMMA AMINOBUTYRIC ACID SECRETION
|
8
|
4.75e-01
|
8.54e-01
|
0.25200
|
-3.50e-02
|
2.49e-01
|
8.64e-01
|
2.22e-01
|
GOCC EXTRINSIC COMPONENT OF MITOCHONDRIAL INNER MEMBRANE
|
7
|
5.09e-01
|
8.66e-01
|
0.25200
|
-2.25e-03
|
-2.52e-01
|
9.92e-01
|
2.49e-01
|
GOBP NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION
|
13
|
3.32e-01
|
7.85e-01
|
0.25200
|
-1.93e-01
|
1.61e-01
|
2.28e-01
|
3.15e-01
|
GOBP ANDROGEN BIOSYNTHETIC PROCESS
|
10
|
3.78e-01
|
8.14e-01
|
0.25200
|
-2.51e-01
|
-9.62e-03
|
1.69e-01
|
9.58e-01
|
GOBP POSITIVE REGULATION OF FEAR RESPONSE
|
6
|
5.41e-01
|
8.78e-01
|
0.25100
|
2.42e-01
|
6.87e-02
|
3.05e-01
|
7.71e-01
|
GOMF CORECEPTOR ACTIVITY
|
47
|
6.34e-03
|
1.65e-01
|
0.25100
|
1.79e-01
|
1.77e-01
|
3.37e-02
|
3.62e-02
|
GOBP CELLULAR RESPONSE TO FLUID SHEAR STRESS
|
21
|
1.70e-01
|
6.57e-01
|
0.25100
|
-1.80e-01
|
1.76e-01
|
1.54e-01
|
1.63e-01
|
GOBP ANTERIOR COMMISSURE MORPHOGENESIS
|
7
|
5.46e-01
|
8.78e-01
|
0.25100
|
2.21e-01
|
-1.20e-01
|
3.12e-01
|
5.81e-01
|
GOBP BASEMENT MEMBRANE ASSEMBLY
|
9
|
3.86e-01
|
8.19e-01
|
0.25100
|
-2.21e-01
|
-1.19e-01
|
2.50e-01
|
5.36e-01
|
GOBP POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS
|
15
|
2.31e-01
|
7.18e-01
|
0.25100
|
1.59e-02
|
2.51e-01
|
9.15e-01
|
9.26e-02
|
GOBP DE NOVO AMP BIOSYNTHETIC PROCESS
|
8
|
4.23e-01
|
8.34e-01
|
0.25100
|
-1.90e-01
|
-1.64e-01
|
3.51e-01
|
4.22e-01
|
GOMF UDP GLUCOSYLTRANSFERASE ACTIVITY
|
10
|
3.55e-01
|
7.97e-01
|
0.25100
|
-8.76e-02
|
-2.35e-01
|
6.32e-01
|
1.97e-01
|
GOBP EMBRYONIC HEART TUBE LEFT RIGHT PATTERN FORMATION
|
5
|
6.43e-01
|
9.07e-01
|
0.25100
|
8.79e-02
|
-2.35e-01
|
7.34e-01
|
3.62e-01
|
GOBP NEGATIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL
|
11
|
3.09e-01
|
7.72e-01
|
0.25100
|
1.38e-01
|
2.10e-01
|
4.29e-01
|
2.28e-01
|
GOBP TRANSCYTOSIS
|
20
|
1.60e-01
|
6.48e-01
|
0.25100
|
-2.47e-01
|
4.80e-02
|
5.63e-02
|
7.10e-01
|
GOBP FAT SOLUBLE VITAMIN CATABOLIC PROCESS
|
11
|
3.21e-01
|
7.79e-01
|
0.25100
|
2.37e-01
|
8.35e-02
|
1.74e-01
|
6.32e-01
|
GOBP EXOCYST LOCALIZATION
|
5
|
6.56e-01
|
9.09e-01
|
0.25100
|
-1.76e-01
|
1.79e-01
|
4.95e-01
|
4.89e-01
|
GOBP RISC COMPLEX ASSEMBLY
|
10
|
3.49e-01
|
7.96e-01
|
0.25100
|
-2.22e-01
|
-1.17e-01
|
2.25e-01
|
5.20e-01
|
GOBP POLARIZED EPITHELIAL CELL DIFFERENTIATION
|
25
|
1.20e-01
|
6.00e-01
|
0.25100
|
-2.06e-01
|
1.43e-01
|
7.43e-02
|
2.17e-01
|
GOBP GPI ANCHOR METABOLIC PROCESS
|
31
|
3.62e-02
|
3.88e-01
|
0.25100
|
-1.81e-01
|
-1.73e-01
|
8.11e-02
|
9.47e-02
|
GOBP L ALANINE TRANSPORT
|
10
|
4.31e-01
|
8.37e-01
|
0.25100
|
1.85e-01
|
-1.70e-01
|
3.12e-01
|
3.53e-01
|
GOBP RENAL SYSTEM VASCULATURE MORPHOGENESIS
|
8
|
4.72e-01
|
8.52e-01
|
0.25100
|
-1.73e-02
|
2.50e-01
|
9.33e-01
|
2.21e-01
|
GOBP ESTABLISHMENT OF BLOOD BRAIN BARRIER
|
14
|
2.96e-01
|
7.66e-01
|
0.25100
|
-1.02e-01
|
2.29e-01
|
5.09e-01
|
1.38e-01
|
GOBP EPITHELIAL FLUID TRANSPORT
|
11
|
3.08e-01
|
7.72e-01
|
0.25100
|
-1.73e-01
|
-1.81e-01
|
3.19e-01
|
2.99e-01
|
GOMF UBIQUITINATION LIKE MODIFICATION DEPENDENT PROTEIN BINDING
|
20
|
1.79e-01
|
6.69e-01
|
0.25100
|
-2.22e-01
|
1.16e-01
|
8.57e-02
|
3.68e-01
|
GOCC SPECTRIN ASSOCIATED CYTOSKELETON
|
9
|
3.89e-01
|
8.20e-01
|
0.25100
|
1.15e-01
|
2.23e-01
|
5.52e-01
|
2.47e-01
|
GOBP SIGNAL PEPTIDE PROCESSING
|
13
|
2.52e-01
|
7.31e-01
|
0.25100
|
-1.37e-01
|
-2.10e-01
|
3.94e-01
|
1.90e-01
|
GOBP REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC
|
9
|
3.93e-01
|
8.23e-01
|
0.25000
|
-2.31e-01
|
-9.68e-02
|
2.30e-01
|
6.15e-01
|
GOBP CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES
|
47
|
1.59e-02
|
2.67e-01
|
0.25000
|
2.36e-01
|
-8.27e-02
|
5.05e-03
|
3.27e-01
|
GOCC DYSTROPHIN ASSOCIATED GLYCOPROTEIN COMPLEX
|
17
|
2.28e-01
|
7.15e-01
|
0.25000
|
-9.92e-02
|
2.30e-01
|
4.79e-01
|
1.01e-01
|
GOBP CORTICOSTERONE SECRETION
|
5
|
6.48e-01
|
9.07e-01
|
0.25000
|
-2.28e-01
|
1.03e-01
|
3.77e-01
|
6.91e-01
|
GOBP CHONDROITIN SULFATE BIOSYNTHETIC PROCESS
|
18
|
2.12e-01
|
7.01e-01
|
0.25000
|
-2.25e-01
|
1.09e-01
|
9.83e-02
|
4.22e-01
|
GOBP POSITIVE REGULATION OF CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS
|
5
|
5.90e-01
|
8.92e-01
|
0.25000
|
-2.13e-01
|
-1.31e-01
|
4.09e-01
|
6.13e-01
|
GOMF PROTEIN SERINE THREONINE PHOSPHATASE INHIBITOR ACTIVITY
|
11
|
3.57e-01
|
7.99e-01
|
0.25000
|
1.62e-02
|
-2.50e-01
|
9.26e-01
|
1.52e-01
|
GOCC EARLY PHAGOSOME
|
12
|
2.81e-01
|
7.54e-01
|
0.25000
|
1.38e-01
|
2.09e-01
|
4.09e-01
|
2.11e-01
|
GOBP NEGATIVE REGULATION OF CGMP MEDIATED SIGNALING
|
6
|
6.04e-01
|
8.96e-01
|
0.25000
|
1.54e-01
|
-1.97e-01
|
5.14e-01
|
4.03e-01
|
GOBP RESPONSE TO L PHENYLALANINE DERIVATIVE
|
6
|
5.43e-01
|
8.78e-01
|
0.25000
|
2.38e-01
|
7.65e-02
|
3.13e-01
|
7.45e-01
|
GOMF MAP KINASE KINASE KINASE KINASE ACTIVITY
|
5
|
6.56e-01
|
9.09e-01
|
0.25000
|
-2.06e-01
|
1.42e-01
|
4.26e-01
|
5.82e-01
|
GOBP FUNGIFORM PAPILLA DEVELOPMENT
|
6
|
5.72e-01
|
8.88e-01
|
0.25000
|
-2.11e-02
|
2.49e-01
|
9.29e-01
|
2.91e-01
|
GOBP BLOOD VESSEL MATURATION
|
8
|
4.77e-01
|
8.54e-01
|
0.25000
|
-2.48e-01
|
2.77e-02
|
2.24e-01
|
8.92e-01
|
GOBP REGULATION OF ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE
|
8
|
4.45e-01
|
8.40e-01
|
0.25000
|
-2.39e-01
|
-7.13e-02
|
2.41e-01
|
7.27e-01
|
GOBP CARBOHYDRATE PHOSPHORYLATION
|
22
|
1.54e-01
|
6.41e-01
|
0.25000
|
-1.25e-01
|
2.16e-01
|
3.10e-01
|
7.91e-02
|
GOBP POSITIVE REGULATION OF CELL MORPHOGENESIS
|
31
|
7.43e-02
|
5.15e-01
|
0.25000
|
-1.48e-01
|
2.01e-01
|
1.55e-01
|
5.23e-02
|
GOBP POSITIVE REGULATION OF T CELL TOLERANCE INDUCTION
|
8
|
4.30e-01
|
8.37e-01
|
0.25000
|
1.39e-01
|
2.08e-01
|
4.97e-01
|
3.09e-01
|
GOBP NEURONAL DENSE CORE VESICLE EXOCYTOSIS
|
7
|
5.20e-01
|
8.69e-01
|
0.25000
|
-1.59e-02
|
2.49e-01
|
9.42e-01
|
2.54e-01
|
GOCC MANCHETTE
|
16
|
1.97e-01
|
6.88e-01
|
0.25000
|
2.38e-01
|
7.57e-02
|
9.94e-02
|
6.00e-01
|
GOMF GUANYLYLTRANSFERASE ACTIVITY
|
7
|
4.81e-01
|
8.54e-01
|
0.25000
|
-2.18e-01
|
-1.21e-01
|
3.17e-01
|
5.78e-01
|
GOMF SIGNAL SEQUENCE BINDING
|
46
|
1.41e-02
|
2.57e-01
|
0.25000
|
2.28e-02
|
-2.49e-01
|
7.89e-01
|
3.53e-03
|
GOBP POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS
|
27
|
6.85e-02
|
5.00e-01
|
0.25000
|
5.06e-02
|
2.44e-01
|
6.49e-01
|
2.79e-02
|
GOBP LEUKOCYTE AGGREGATION
|
12
|
3.40e-01
|
7.91e-01
|
0.25000
|
-5.40e-02
|
2.44e-01
|
7.46e-01
|
1.44e-01
|
GOBP NEGATIVE REGULATION OF BEHAVIOR
|
12
|
3.18e-01
|
7.77e-01
|
0.24900
|
-1.06e-02
|
-2.49e-01
|
9.49e-01
|
1.35e-01
|
GOBP GALACTOSE TRANSMEMBRANE TRANSPORT
|
5
|
6.52e-01
|
9.08e-01
|
0.24900
|
1.07e-01
|
-2.25e-01
|
6.78e-01
|
3.84e-01
|
GOBP REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY
|
7
|
5.57e-01
|
8.82e-01
|
0.24900
|
1.49e-01
|
-2.00e-01
|
4.94e-01
|
3.61e-01
|
GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR ACTIVITY TYPE I
|
5
|
6.18e-01
|
9.00e-01
|
0.24900
|
1.80e-02
|
2.48e-01
|
9.44e-01
|
3.36e-01
|
GOBP CELLULAR RESPONSE TO LUTEINIZING HORMONE STIMULUS
|
5
|
6.59e-01
|
9.09e-01
|
0.24900
|
1.47e-01
|
-2.01e-01
|
5.69e-01
|
4.37e-01
|
GOBP CENP A CONTAINING CHROMATIN ASSEMBLY
|
9
|
4.08e-01
|
8.27e-01
|
0.24900
|
-6.17e-02
|
-2.41e-01
|
7.48e-01
|
2.10e-01
|
GOBP POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION
|
15
|
2.11e-01
|
7.00e-01
|
0.24900
|
-1.20e-01
|
-2.18e-01
|
4.20e-01
|
1.44e-01
|
GOBP DEPYRIMIDINATION
|
8
|
4.93e-01
|
8.58e-01
|
0.24900
|
2.40e-01
|
-6.35e-02
|
2.39e-01
|
7.56e-01
|
GOBP FOLIC ACID TRANSPORT
|
10
|
4.05e-01
|
8.26e-01
|
0.24900
|
3.94e-02
|
-2.45e-01
|
8.29e-01
|
1.79e-01
|
GOMF PROTEIN TRANSPORTER ACTIVITY
|
38
|
3.04e-02
|
3.61e-01
|
0.24900
|
2.15e-02
|
-2.48e-01
|
8.19e-01
|
8.25e-03
|
GOBP SODIUM ION IMPORT ACROSS PLASMA MEMBRANE
|
23
|
1.49e-01
|
6.36e-01
|
0.24900
|
-1.58e-01
|
1.92e-01
|
1.90e-01
|
1.11e-01
|
GOMF ADENOSINE RECEPTOR BINDING
|
7
|
4.79e-01
|
8.54e-01
|
0.24800
|
-1.57e-01
|
-1.93e-01
|
4.72e-01
|
3.78e-01
|
GOBP MAMMARY GLAND ALVEOLUS DEVELOPMENT
|
19
|
2.07e-01
|
6.95e-01
|
0.24800
|
1.46e-01
|
-2.01e-01
|
2.71e-01
|
1.29e-01
|
GOBP CHORIONIC TROPHOBLAST CELL PROLIFERATION
|
5
|
6.00e-01
|
8.95e-01
|
0.24800
|
1.00e-01
|
2.27e-01
|
6.97e-01
|
3.79e-01
|
GOBP RESPONSE TO LIPOTEICHOIC ACID
|
10
|
3.70e-01
|
8.09e-01
|
0.24800
|
-6.40e-02
|
-2.40e-01
|
7.26e-01
|
1.89e-01
|
GOBP ENDOTHELIAL CELL MATRIX ADHESION
|
8
|
5.17e-01
|
8.69e-01
|
0.24800
|
1.71e-01
|
-1.80e-01
|
4.01e-01
|
3.79e-01
|
GOBP CELLULAR RESPONSE TO GLUCAGON STIMULUS
|
11
|
3.15e-01
|
7.76e-01
|
0.24800
|
1.80e-01
|
1.70e-01
|
3.00e-01
|
3.28e-01
|
GOBP REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION
|
18
|
2.10e-01
|
7.00e-01
|
0.24800
|
8.12e-02
|
-2.35e-01
|
5.51e-01
|
8.49e-02
|
GOMF HISTONE METHYLTRANSFERASE ACTIVITY
|
67
|
2.58e-03
|
9.91e-02
|
0.24800
|
-2.43e-01
|
5.07e-02
|
5.83e-04
|
4.73e-01
|
GOBP S ADENOSYLMETHIONINE CYCLE
|
7
|
4.87e-01
|
8.56e-01
|
0.24800
|
-1.09e-01
|
-2.23e-01
|
6.18e-01
|
3.07e-01
|
GOBP MEMBRANE REPOLARIZATION DURING ATRIAL CARDIAC MUSCLE CELL ACTION POTENTIAL
|
6
|
5.50e-01
|
8.80e-01
|
0.24800
|
6.98e-02
|
2.38e-01
|
7.67e-01
|
3.13e-01
|
GOCC AZUROPHIL GRANULE LUMEN
|
86
|
1.56e-04
|
1.31e-02
|
0.24800
|
-2.25e-01
|
-1.04e-01
|
3.02e-04
|
9.67e-02
|
GOBP NEGATIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION
|
7
|
5.11e-01
|
8.66e-01
|
0.24800
|
2.57e-02
|
2.47e-01
|
9.06e-01
|
2.58e-01
|
GOBP CEREBRAL CORTEX TANGENTIAL MIGRATION
|
5
|
6.24e-01
|
9.01e-01
|
0.24800
|
-8.84e-03
|
-2.48e-01
|
9.73e-01
|
3.37e-01
|
GOBP OXYGEN METABOLIC PROCESS
|
5
|
6.59e-01
|
9.09e-01
|
0.24800
|
2.12e-01
|
-1.29e-01
|
4.12e-01
|
6.18e-01
|
GOMF AMP BINDING
|
15
|
2.92e-01
|
7.63e-01
|
0.24800
|
-1.73e-01
|
1.77e-01
|
2.46e-01
|
2.34e-01
|
GOBP NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY
|
33
|
4.00e-02
|
4.11e-01
|
0.24800
|
-4.68e-02
|
-2.43e-01
|
6.41e-01
|
1.55e-02
|
GOBP POSITIVE REGULATION OF DENDRITIC CELL CHEMOTAXIS
|
9
|
4.29e-01
|
8.36e-01
|
0.24800
|
2.48e-01
|
5.41e-03
|
1.98e-01
|
9.78e-01
|
GOBP MAINTENANCE OF DNA REPEAT ELEMENTS
|
7
|
5.44e-01
|
8.78e-01
|
0.24800
|
-7.57e-02
|
2.36e-01
|
7.29e-01
|
2.80e-01
|
GOBP B CELL CHEMOTAXIS
|
7
|
4.82e-01
|
8.54e-01
|
0.24800
|
1.96e-01
|
1.51e-01
|
3.69e-01
|
4.88e-01
|
GOBP MITOCHONDRIAL DNA METABOLIC PROCESS
|
23
|
9.97e-02
|
5.68e-01
|
0.24800
|
-2.34e-01
|
-8.09e-02
|
5.20e-02
|
5.02e-01
|
GOBP TELENCEPHALON GLIAL CELL MIGRATION
|
26
|
1.17e-01
|
5.98e-01
|
0.24800
|
-1.51e-01
|
1.96e-01
|
1.83e-01
|
8.30e-02
|
GOMF CALMODULIN DEPENDENT PROTEIN PHOSPHATASE ACTIVITY
|
5
|
6.43e-01
|
9.07e-01
|
0.24800
|
-2.42e-01
|
5.43e-02
|
3.50e-01
|
8.34e-01
|
GOMF MEMBRANE POTENTIAL DRIVEN UNIPORTER ACTIVITY
|
5
|
6.47e-01
|
9.07e-01
|
0.24800
|
2.37e-01
|
-7.32e-02
|
3.60e-01
|
7.77e-01
|
GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS
|
33
|
3.57e-02
|
3.86e-01
|
0.24800
|
-2.30e-01
|
-9.24e-02
|
2.24e-02
|
3.58e-01
|
GOBP CEREBRAL CORTEX REGIONALIZATION
|
7
|
4.93e-01
|
8.58e-01
|
0.24800
|
-2.29e-01
|
-9.44e-02
|
2.94e-01
|
6.65e-01
|
GOBP ANGIOGENESIS INVOLVED IN WOUND HEALING
|
31
|
5.25e-02
|
4.51e-01
|
0.24800
|
-2.47e-01
|
-2.13e-02
|
1.75e-02
|
8.38e-01
|
GOBP CHAPERONE MEDIATED AUTOPHAGY
|
14
|
2.61e-01
|
7.39e-01
|
0.24700
|
-2.46e-01
|
-2.94e-02
|
1.11e-01
|
8.49e-01
|
GOBP MODULATION OF INHIBITORY POSTSYNAPTIC POTENTIAL
|
7
|
5.03e-01
|
8.64e-01
|
0.24700
|
5.68e-02
|
2.41e-01
|
7.95e-01
|
2.70e-01
|
GOMF VIRION BINDING
|
13
|
3.30e-01
|
7.85e-01
|
0.24700
|
-2.29e-01
|
9.39e-02
|
1.53e-01
|
5.58e-01
|
GOMF DEACETYLASE ACTIVITY
|
36
|
4.78e-02
|
4.38e-01
|
0.24700
|
-2.25e-01
|
1.03e-01
|
1.96e-02
|
2.84e-01
|
GOBP POSITIVE REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY
|
5
|
5.98e-01
|
8.95e-01
|
0.24700
|
-1.21e-01
|
-2.16e-01
|
6.39e-01
|
4.03e-01
|
GOBP INTESTINAL CHOLESTEROL ABSORPTION
|
18
|
1.53e-01
|
6.41e-01
|
0.24700
|
-1.66e-01
|
-1.83e-01
|
2.22e-01
|
1.79e-01
|
GOBP POSITIVE REGULATION OF P38MAPK CASCADE
|
30
|
4.44e-02
|
4.29e-01
|
0.24700
|
-1.94e-01
|
-1.53e-01
|
6.61e-02
|
1.46e-01
|
GOMF MYOSIN HEAVY CHAIN BINDING
|
12
|
3.00e-01
|
7.67e-01
|
0.24700
|
8.60e-02
|
2.32e-01
|
6.06e-01
|
1.65e-01
|
GOCC NUCLEAR LAMINA
|
10
|
4.42e-01
|
8.40e-01
|
0.24700
|
-1.84e-01
|
1.64e-01
|
3.13e-01
|
3.68e-01
|
GOBP SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY
|
15
|
2.82e-01
|
7.56e-01
|
0.24700
|
-2.25e-01
|
1.01e-01
|
1.31e-01
|
5.00e-01
|
GOMF NAD P H DEHYDROGENASE QUINONE ACTIVITY
|
37
|
2.57e-02
|
3.33e-01
|
0.24700
|
-7.37e-02
|
-2.35e-01
|
4.38e-01
|
1.32e-02
|
GOBP REGULATION OF MEMBRANE TUBULATION
|
5
|
6.46e-01
|
9.07e-01
|
0.24700
|
-2.40e-01
|
5.79e-02
|
3.53e-01
|
8.23e-01
|
GOBP PROTEIN HEXAMERIZATION
|
9
|
3.97e-01
|
8.25e-01
|
0.24700
|
-2.10e-01
|
-1.30e-01
|
2.76e-01
|
5.00e-01
|
GOMF GTPASE ACTIVATING PROTEIN BINDING
|
12
|
2.89e-01
|
7.60e-01
|
0.24700
|
1.51e-01
|
1.95e-01
|
3.65e-01
|
2.42e-01
|
GOBP INDOLALKYLAMINE METABOLIC PROCESS
|
11
|
4.08e-01
|
8.27e-01
|
0.24700
|
1.61e-01
|
-1.87e-01
|
3.56e-01
|
2.83e-01
|
GOBP NEGATIVE REGULATION OF INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY
|
7
|
5.62e-01
|
8.84e-01
|
0.24700
|
2.09e-01
|
-1.31e-01
|
3.39e-01
|
5.48e-01
|
GOBP DENDRITIC CELL CYTOKINE PRODUCTION
|
19
|
1.82e-01
|
6.72e-01
|
0.24700
|
-2.45e-01
|
2.96e-02
|
6.47e-02
|
8.23e-01
|
GOBP PEPTIDYL LYSINE DEACETYLATION
|
6
|
6.08e-01
|
8.97e-01
|
0.24700
|
-1.23e-01
|
2.14e-01
|
6.02e-01
|
3.65e-01
|
GOMF NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY
|
11
|
3.46e-01
|
7.96e-01
|
0.24600
|
-4.61e-02
|
-2.42e-01
|
7.91e-01
|
1.64e-01
|
GOMF GUANYLATE CYCLASE ACTIVITY
|
7
|
5.40e-01
|
8.78e-01
|
0.24600
|
-2.41e-01
|
4.94e-02
|
2.69e-01
|
8.21e-01
|
GOBP REGULATION OF T HELPER 17 CELL LINEAGE COMMITMENT
|
7
|
4.91e-01
|
8.58e-01
|
0.24600
|
1.15e-01
|
2.18e-01
|
6.00e-01
|
3.18e-01
|
GOBP CAVEOLA ASSEMBLY
|
5
|
5.96e-01
|
8.95e-01
|
0.24600
|
1.64e-01
|
1.84e-01
|
5.27e-01
|
4.76e-01
|
GOBP FATTY ACID DERIVATIVE METABOLIC PROCESS
|
68
|
3.35e-03
|
1.16e-01
|
0.24600
|
-2.26e-01
|
9.88e-02
|
1.30e-03
|
1.59e-01
|
GOBP POSITIVE REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY
|
8
|
5.00e-01
|
8.62e-01
|
0.24600
|
-2.38e-01
|
6.44e-02
|
2.45e-01
|
7.52e-01
|
GOBP SEQUESTERING OF IRON ION
|
6
|
5.55e-01
|
8.81e-01
|
0.24600
|
2.37e-01
|
6.73e-02
|
3.15e-01
|
7.75e-01
|
GOBP MITOCHONDRIAL PROTEIN CATABOLIC PROCESS
|
6
|
5.73e-01
|
8.88e-01
|
0.24600
|
6.94e-03
|
2.46e-01
|
9.77e-01
|
2.97e-01
|
GOBP REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE
|
16
|
1.95e-01
|
6.87e-01
|
0.24600
|
1.34e-01
|
2.06e-01
|
3.54e-01
|
1.53e-01
|
GOBP VASCULAR WOUND HEALING
|
22
|
1.32e-01
|
6.13e-01
|
0.24600
|
-2.46e-01
|
-3.14e-03
|
4.59e-02
|
9.80e-01
|
GOBP THREONINE METABOLIC PROCESS
|
5
|
6.58e-01
|
9.09e-01
|
0.24600
|
2.24e-01
|
-1.01e-01
|
3.85e-01
|
6.97e-01
|
GOBP ADRENERGIC RECEPTOR SIGNALING PATHWAY
|
32
|
3.89e-02
|
4.04e-01
|
0.24600
|
1.24e-01
|
2.12e-01
|
2.26e-01
|
3.76e-02
|
GOCC AMPHISOME
|
13
|
3.33e-01
|
7.86e-01
|
0.24600
|
-2.30e-01
|
8.55e-02
|
1.50e-01
|
5.94e-01
|
GOBP CONVERGENT EXTENSION INVOLVED IN GASTRULATION
|
9
|
4.01e-01
|
8.26e-01
|
0.24600
|
1.23e-01
|
2.13e-01
|
5.24e-01
|
2.69e-01
|
GOCC MITOTIC SPINDLE ASTRAL MICROTUBULE
|
7
|
4.95e-01
|
8.58e-01
|
0.24600
|
-1.08e-01
|
-2.20e-01
|
6.20e-01
|
3.13e-01
|
GOBP CEREBELLAR PURKINJE CELL GRANULE CELL PRECURSOR CELL SIGNALING INVOLVED IN REGULATION OF GRANULE CELL PRECURSOR CELL PROLIFERATION
|
5
|
6.68e-01
|
9.11e-01
|
0.24600
|
1.70e-01
|
-1.77e-01
|
5.10e-01
|
4.93e-01
|
GOBP NEGATIVE REGULATION OF MONOCYTE DIFFERENTIATION
|
8
|
5.16e-01
|
8.69e-01
|
0.24500
|
1.11e-01
|
-2.19e-01
|
5.86e-01
|
2.84e-01
|
GOMF GLUTATHIONE PEROXIDASE ACTIVITY
|
20
|
1.68e-01
|
6.54e-01
|
0.24500
|
-2.44e-01
|
2.69e-02
|
5.89e-02
|
8.35e-01
|
GOBP REGULATION OF CELLULAR RESPONSE TO OXIDATIVE STRESS
|
22
|
1.67e-01
|
6.52e-01
|
0.24500
|
-1.34e-01
|
2.05e-01
|
2.76e-01
|
9.53e-02
|
GOBP NEGATIVE REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY
|
7
|
5.54e-01
|
8.81e-01
|
0.24500
|
8.72e-02
|
-2.29e-01
|
6.90e-01
|
2.93e-01
|
GOBP HINDBRAIN TANGENTIAL CELL MIGRATION
|
5
|
6.68e-01
|
9.11e-01
|
0.24500
|
1.87e-01
|
-1.59e-01
|
4.70e-01
|
5.37e-01
|
GOCC ER UBIQUITIN LIGASE COMPLEX
|
9
|
4.77e-01
|
8.54e-01
|
0.24500
|
-2.15e-01
|
1.19e-01
|
2.64e-01
|
5.38e-01
|
GOBP TRNA THIO MODIFICATION
|
5
|
6.19e-01
|
9.00e-01
|
0.24500
|
-2.40e-01
|
-5.10e-02
|
3.53e-01
|
8.43e-01
|
GOCC COPI COATED VESICLE MEMBRANE
|
18
|
1.62e-01
|
6.48e-01
|
0.24500
|
-1.22e-01
|
-2.13e-01
|
3.70e-01
|
1.18e-01
|
GOBP NEGATIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY
|
9
|
4.84e-01
|
8.54e-01
|
0.24500
|
1.91e-01
|
-1.53e-01
|
3.21e-01
|
4.25e-01
|
GOBP RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM
|
50
|
7.03e-03
|
1.75e-01
|
0.24500
|
-2.26e-01
|
-9.52e-02
|
5.73e-03
|
2.44e-01
|
GOCC MYELIN SHEATH
|
42
|
3.16e-02
|
3.64e-01
|
0.24500
|
-1.12e-01
|
2.18e-01
|
2.09e-01
|
1.46e-02
|
GOBP INTRACELLULAR STEROL TRANSPORT
|
35
|
4.08e-02
|
4.15e-01
|
0.24500
|
-2.45e-01
|
-2.20e-03
|
1.21e-02
|
9.82e-01
|
GOBP REGULATION OF MITOTIC RECOMBINATION
|
7
|
5.48e-01
|
8.79e-01
|
0.24500
|
6.19e-02
|
-2.37e-01
|
7.77e-01
|
2.78e-01
|
GOBP INTRACELLULAR OXYGEN HOMEOSTASIS
|
7
|
5.33e-01
|
8.76e-01
|
0.24500
|
1.47e-02
|
-2.44e-01
|
9.46e-01
|
2.63e-01
|
GOBP NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC
|
8
|
5.19e-01
|
8.69e-01
|
0.24500
|
2.16e-01
|
-1.15e-01
|
2.91e-01
|
5.72e-01
|
GOBP REGULATION OF SECONDARY METABOLIC PROCESS
|
15
|
2.88e-01
|
7.59e-01
|
0.24500
|
-9.66e-02
|
2.25e-01
|
5.17e-01
|
1.32e-01
|
GOBP POSITIVE REGULATION OF DNA BINDING
|
41
|
2.36e-02
|
3.25e-01
|
0.24500
|
-4.62e-03
|
-2.45e-01
|
9.59e-01
|
6.71e-03
|
GOMF MISFOLDED PROTEIN BINDING
|
19
|
1.46e-01
|
6.30e-01
|
0.24500
|
-2.00e-01
|
-1.41e-01
|
1.32e-01
|
2.86e-01
|
GOBP TRNA SURVEILLANCE
|
8
|
4.43e-01
|
8.40e-01
|
0.24500
|
1.91e-01
|
1.53e-01
|
3.49e-01
|
4.55e-01
|
GOBP BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS
|
21
|
1.79e-01
|
6.68e-01
|
0.24500
|
-1.12e-01
|
2.18e-01
|
3.76e-01
|
8.43e-02
|
GOBP TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION
|
10
|
4.28e-01
|
8.36e-01
|
0.24500
|
-7.01e-02
|
2.34e-01
|
7.01e-01
|
1.99e-01
|
GOBP LIMB BUD FORMATION
|
9
|
4.82e-01
|
8.54e-01
|
0.24500
|
-1.32e-01
|
2.06e-01
|
4.92e-01
|
2.85e-01
|
GOBP NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT
|
14
|
2.40e-01
|
7.25e-01
|
0.24400
|
-1.78e-01
|
-1.68e-01
|
2.50e-01
|
2.76e-01
|
GOMF INTRACELLULAR CGMP ACTIVATED CATION CHANNEL ACTIVITY
|
6
|
5.64e-01
|
8.85e-01
|
0.24400
|
2.39e-01
|
5.16e-02
|
3.11e-01
|
8.27e-01
|
GOMF FMN BINDING
|
15
|
2.18e-01
|
7.07e-01
|
0.24400
|
-1.51e-01
|
-1.92e-01
|
3.12e-01
|
1.97e-01
|
GOCC SYMMETRIC SYNAPSE
|
8
|
5.21e-01
|
8.69e-01
|
0.24400
|
-2.13e-01
|
1.19e-01
|
2.96e-01
|
5.60e-01
|
GOMF STEROID DEHYDROGENASE ACTIVITY
|
35
|
4.49e-02
|
4.30e-01
|
0.24400
|
2.15e-02
|
-2.43e-01
|
8.26e-01
|
1.28e-02
|
GOMF FUCOSE BINDING
|
8
|
5.29e-01
|
8.72e-01
|
0.24400
|
-1.68e-01
|
1.77e-01
|
4.11e-01
|
3.85e-01
|
GOBP BILE ACID SECRETION
|
12
|
2.97e-01
|
7.66e-01
|
0.24400
|
-1.93e-01
|
-1.50e-01
|
2.48e-01
|
3.70e-01
|
GOBP POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET
|
7
|
5.63e-01
|
8.84e-01
|
0.24400
|
-1.06e-01
|
2.20e-01
|
6.28e-01
|
3.14e-01
|
GOBP PROTEIN POLY ADP RIBOSYLATION
|
10
|
4.14e-01
|
8.29e-01
|
0.24400
|
2.42e-01
|
-2.62e-02
|
1.84e-01
|
8.86e-01
|
GOBP URINARY TRACT SMOOTH MUSCLE CONTRACTION
|
9
|
4.04e-01
|
8.26e-01
|
0.24400
|
-1.38e-01
|
-2.01e-01
|
4.72e-01
|
2.97e-01
|
GOCC ROUGH ENDOPLASMIC RETICULUM MEMBRANE
|
22
|
1.63e-01
|
6.48e-01
|
0.24400
|
9.76e-02
|
-2.23e-01
|
4.28e-01
|
6.96e-02
|
GOBP VAGINA DEVELOPMENT
|
10
|
4.43e-01
|
8.40e-01
|
0.24400
|
1.15e-01
|
-2.15e-01
|
5.27e-01
|
2.40e-01
|
GOBP HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY
|
12
|
3.01e-01
|
7.67e-01
|
0.24400
|
1.26e-01
|
2.09e-01
|
4.49e-01
|
2.11e-01
|
GOMF LAMININ 1 BINDING
|
7
|
5.12e-01
|
8.66e-01
|
0.24400
|
-6.14e-02
|
-2.36e-01
|
7.78e-01
|
2.80e-01
|
GOCC LIPOPOLYSACCHARIDE RECEPTOR COMPLEX
|
5
|
6.50e-01
|
9.07e-01
|
0.24400
|
-2.39e-01
|
4.78e-02
|
3.55e-01
|
8.53e-01
|
GOBP POST EMBRYONIC CAMERA TYPE EYE DEVELOPMENT
|
8
|
5.16e-01
|
8.69e-01
|
0.24400
|
9.29e-02
|
-2.25e-01
|
6.49e-01
|
2.70e-01
|
GOCC ENDOLYSOSOME
|
26
|
1.25e-01
|
6.06e-01
|
0.24400
|
-1.45e-01
|
1.96e-01
|
2.02e-01
|
8.35e-02
|
GOMF BETA 2 ADRENERGIC RECEPTOR BINDING
|
6
|
6.20e-01
|
9.00e-01
|
0.24400
|
-1.88e-01
|
1.55e-01
|
4.26e-01
|
5.10e-01
|
GOMF SYNTAXIN 1 BINDING
|
19
|
1.48e-01
|
6.35e-01
|
0.24400
|
2.00e-01
|
1.38e-01
|
1.30e-01
|
2.96e-01
|
GOBP WOUND HEALING INVOLVED IN INFLAMMATORY RESPONSE
|
8
|
5.29e-01
|
8.73e-01
|
0.24300
|
-1.88e-01
|
1.54e-01
|
3.56e-01
|
4.50e-01
|
GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR
|
16
|
2.80e-01
|
7.53e-01
|
0.24300
|
1.89e-01
|
-1.54e-01
|
1.92e-01
|
2.86e-01
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS NAD P AS ACCEPTOR
|
11
|
3.30e-01
|
7.85e-01
|
0.24300
|
-1.49e-01
|
-1.92e-01
|
3.91e-01
|
2.70e-01
|
GOMF UBIQUITIN MODIFICATION DEPENDENT HISTONE BINDING
|
6
|
5.87e-01
|
8.91e-01
|
0.24300
|
-2.43e-01
|
1.63e-02
|
3.03e-01
|
9.45e-01
|
GOMF DOLICHYL DIPHOSPHOOLIGOSACCHARIDE PROTEIN GLYCOTRANSFERASE ACTIVITY
|
5
|
6.58e-01
|
9.09e-01
|
0.24300
|
-7.30e-02
|
2.32e-01
|
7.77e-01
|
3.69e-01
|
GOBP POSITIVE REGULATION OF SPINDLE ASSEMBLY
|
8
|
5.09e-01
|
8.66e-01
|
0.24300
|
6.39e-02
|
-2.35e-01
|
7.54e-01
|
2.50e-01
|
GOBP ERYTHROCYTE MATURATION
|
17
|
1.83e-01
|
6.73e-01
|
0.24300
|
-2.05e-01
|
-1.31e-01
|
1.44e-01
|
3.50e-01
|
GOBP POSITIVE REGULATION OF LEUKOCYTE TETHERING OR ROLLING
|
13
|
2.71e-01
|
7.46e-01
|
0.24300
|
-1.54e-01
|
-1.88e-01
|
3.37e-01
|
2.40e-01
|
GOMF CHROMO SHADOW DOMAIN BINDING
|
5
|
6.68e-01
|
9.11e-01
|
0.24300
|
-2.12e-01
|
1.18e-01
|
4.11e-01
|
6.47e-01
|
GOMF 4 IRON 4 SULFUR CLUSTER BINDING
|
43
|
1.80e-02
|
2.86e-01
|
0.24300
|
-2.39e-01
|
-4.34e-02
|
6.69e-03
|
6.22e-01
|
GOBP FACIAL NERVE MORPHOGENESIS
|
9
|
4.62e-01
|
8.48e-01
|
0.24300
|
-2.39e-01
|
4.41e-02
|
2.15e-01
|
8.19e-01
|
GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY
|
20
|
1.59e-01
|
6.48e-01
|
0.24300
|
-2.42e-01
|
-2.44e-02
|
6.14e-02
|
8.50e-01
|
GOMF NADPLUS NUCLEOSIDASE ACTIVITY
|
14
|
2.99e-01
|
7.67e-01
|
0.24300
|
-3.77e-02
|
2.40e-01
|
8.07e-01
|
1.20e-01
|
GOBP DUMP METABOLIC PROCESS
|
7
|
5.43e-01
|
8.78e-01
|
0.24300
|
-2.41e-01
|
2.64e-02
|
2.69e-01
|
9.04e-01
|
GOMF PROLINE RICH REGION BINDING
|
17
|
1.82e-01
|
6.72e-01
|
0.24300
|
1.90e-01
|
1.51e-01
|
1.76e-01
|
2.80e-01
|
GOBP BONE MINERALIZATION INVOLVED IN BONE MATURATION
|
13
|
2.82e-01
|
7.54e-01
|
0.24300
|
-9.73e-02
|
-2.22e-01
|
5.44e-01
|
1.65e-01
|
GOBP NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION
|
24
|
1.24e-01
|
6.06e-01
|
0.24300
|
-2.97e-02
|
2.41e-01
|
8.01e-01
|
4.12e-02
|
GOBP COPPER ION TRANSMEMBRANE TRANSPORT
|
7
|
5.31e-01
|
8.74e-01
|
0.24300
|
-2.42e-01
|
-1.10e-02
|
2.67e-01
|
9.60e-01
|
GOMF LONG CHAIN FATTY ACID BINDING
|
17
|
2.27e-01
|
7.15e-01
|
0.24200
|
-2.55e-02
|
2.41e-01
|
8.56e-01
|
8.52e-02
|
GOBP GLUCOCORTICOID SECRETION
|
12
|
3.07e-01
|
7.71e-01
|
0.24200
|
-2.14e-01
|
-1.14e-01
|
1.99e-01
|
4.94e-01
|
GOBP CANONICAL WNT SIGNALING PATHWAY INVOLVED IN REGULATION OF CELL PROLIFERATION
|
6
|
5.82e-01
|
8.90e-01
|
0.24200
|
2.42e-01
|
8.91e-03
|
3.04e-01
|
9.70e-01
|
GOBP NEGATIVE REGULATION OF INTERLEUKIN 1 ALPHA PRODUCTION
|
5
|
6.33e-01
|
9.03e-01
|
0.24200
|
-2.41e-01
|
-2.34e-02
|
3.50e-01
|
9.28e-01
|
GOMF ARMADILLO REPEAT DOMAIN BINDING
|
8
|
5.22e-01
|
8.70e-01
|
0.24200
|
-1.00e-01
|
2.21e-01
|
6.24e-01
|
2.80e-01
|
GOBP POSITIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION
|
61
|
2.61e-03
|
9.94e-02
|
0.24200
|
-2.19e-01
|
-1.04e-01
|
3.11e-03
|
1.60e-01
|
GOBP EXTRAEMBRYONIC MEMBRANE DEVELOPMENT
|
13
|
2.75e-01
|
7.49e-01
|
0.24200
|
-2.02e-01
|
-1.34e-01
|
2.07e-01
|
4.04e-01
|
GOBP CELLULAR RESPONSE TO LEUCINE
|
12
|
3.86e-01
|
8.19e-01
|
0.24200
|
-1.36e-01
|
2.00e-01
|
4.15e-01
|
2.29e-01
|
GOBP G PROTEIN COUPLED OPIOID RECEPTOR SIGNALING PATHWAY
|
10
|
3.84e-01
|
8.17e-01
|
0.24200
|
2.31e-01
|
7.44e-02
|
2.07e-01
|
6.84e-01
|
GOBP NATURAL KILLER CELL DIFFERENTIATION
|
24
|
9.11e-02
|
5.51e-01
|
0.24200
|
1.85e-01
|
1.57e-01
|
1.18e-01
|
1.84e-01
|
GOCC ARP2 3 PROTEIN COMPLEX
|
9
|
4.09e-01
|
8.27e-01
|
0.24200
|
-1.98e-01
|
-1.39e-01
|
3.03e-01
|
4.70e-01
|
GOCC PROTEASOME CORE COMPLEX
|
20
|
2.05e-01
|
6.95e-01
|
0.24200
|
2.04e-01
|
-1.31e-01
|
1.14e-01
|
3.12e-01
|
GOBP MITOCHONDRIAL RNA 3 END PROCESSING
|
5
|
6.70e-01
|
9.11e-01
|
0.24200
|
1.18e-01
|
-2.11e-01
|
6.48e-01
|
4.13e-01
|
GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX SUBSTRATE RELEASE
|
5
|
6.08e-01
|
8.97e-01
|
0.24200
|
-1.91e-01
|
-1.48e-01
|
4.59e-01
|
5.67e-01
|
GOBP PROSTHETIC GROUP METABOLIC PROCESS
|
6
|
6.16e-01
|
8.99e-01
|
0.24200
|
-9.89e-02
|
2.21e-01
|
6.75e-01
|
3.49e-01
|
GOBP POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY
|
16
|
2.05e-01
|
6.95e-01
|
0.24200
|
1.37e-01
|
1.99e-01
|
3.42e-01
|
1.68e-01
|
GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
21
|
1.32e-01
|
6.13e-01
|
0.24200
|
2.23e-01
|
9.27e-02
|
7.67e-02
|
4.62e-01
|
GOBP KILLING BY HOST OF SYMBIONT CELLS
|
23
|
1.25e-01
|
6.06e-01
|
0.24200
|
-1.83e-02
|
-2.41e-01
|
8.79e-01
|
4.55e-02
|
GOBP REGULATION OF METAPHASE PLATE CONGRESSION
|
13
|
3.13e-01
|
7.76e-01
|
0.24200
|
-2.41e-01
|
-5.76e-03
|
1.32e-01
|
9.71e-01
|
GOBP NEGATIVE REGULATION OF ASTROCYTE ACTIVATION
|
5
|
6.71e-01
|
9.11e-01
|
0.24100
|
1.10e-01
|
-2.15e-01
|
6.69e-01
|
4.06e-01
|
GOBP THYMOCYTE APOPTOTIC PROCESS
|
20
|
1.38e-01
|
6.22e-01
|
0.24100
|
1.46e-01
|
1.92e-01
|
2.57e-01
|
1.37e-01
|
GOBP REVERSIBLE DIFFERENTIATION
|
11
|
3.72e-01
|
8.09e-01
|
0.24100
|
-2.41e-01
|
-1.36e-02
|
1.67e-01
|
9.38e-01
|
GOMF NUCLEOSIDE KINASE ACTIVITY
|
9
|
4.29e-01
|
8.36e-01
|
0.24100
|
-2.32e-01
|
-6.56e-02
|
2.28e-01
|
7.33e-01
|
GOMF R SMAD BINDING
|
25
|
1.43e-01
|
6.28e-01
|
0.24100
|
-1.78e-01
|
1.63e-01
|
1.24e-01
|
1.59e-01
|
GOBP TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE CLEARANCE
|
7
|
5.23e-01
|
8.70e-01
|
0.24100
|
4.88e-02
|
2.36e-01
|
8.23e-01
|
2.79e-01
|
GOBP POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION
|
24
|
1.05e-01
|
5.77e-01
|
0.24100
|
6.24e-02
|
2.33e-01
|
5.97e-01
|
4.82e-02
|
GOBP REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING
|
16
|
2.79e-01
|
7.52e-01
|
0.24100
|
2.16e-01
|
-1.07e-01
|
1.35e-01
|
4.57e-01
|
GOMF CONNEXIN BINDING
|
5
|
6.14e-01
|
8.99e-01
|
0.24100
|
2.11e-01
|
1.17e-01
|
4.15e-01
|
6.51e-01
|
GOMF TRNA GUANINE METHYLTRANSFERASE ACTIVITY
|
11
|
4.09e-01
|
8.27e-01
|
0.24100
|
-8.52e-02
|
2.25e-01
|
6.25e-01
|
1.96e-01
|
GOMF NUCLEOSIDE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
10
|
3.83e-01
|
8.16e-01
|
0.24100
|
9.58e-02
|
2.21e-01
|
6.00e-01
|
2.27e-01
|
GOMF LIPOTEICHOIC ACID BINDING
|
5
|
6.79e-01
|
9.14e-01
|
0.24100
|
1.73e-01
|
-1.67e-01
|
5.02e-01
|
5.18e-01
|
GOBP POSITIVE REGULATION OF EPITHELIAL TUBE FORMATION
|
8
|
4.82e-01
|
8.54e-01
|
0.24100
|
2.38e-01
|
3.40e-02
|
2.43e-01
|
8.68e-01
|
GOCC PLATELET DENSE GRANULE
|
20
|
1.77e-01
|
6.67e-01
|
0.24100
|
-2.40e-01
|
1.67e-02
|
6.31e-02
|
8.97e-01
|
GOBP SPERM DNA CONDENSATION
|
17
|
2.21e-01
|
7.10e-01
|
0.24100
|
-2.40e-01
|
-9.36e-03
|
8.61e-02
|
9.47e-01
|
GOCC CENTRAL ELEMENT
|
7
|
5.71e-01
|
8.86e-01
|
0.24100
|
-9.73e-02
|
2.20e-01
|
6.56e-01
|
3.13e-01
|
GOBP NEGATIVE REGULATION OF VIRAL TRANSCRIPTION
|
14
|
3.32e-01
|
7.85e-01
|
0.24000
|
-2.10e-01
|
1.17e-01
|
1.74e-01
|
4.49e-01
|
GOBP SNRNA MODIFICATION
|
6
|
6.16e-01
|
8.99e-01
|
0.24000
|
8.50e-02
|
-2.25e-01
|
7.18e-01
|
3.40e-01
|
GOBP REGULATION OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY
|
8
|
5.32e-01
|
8.76e-01
|
0.24000
|
-2.10e-01
|
1.18e-01
|
3.05e-01
|
5.64e-01
|
GOBP FAT CELL PROLIFERATION
|
14
|
3.21e-01
|
7.79e-01
|
0.24000
|
-2.26e-01
|
8.07e-02
|
1.42e-01
|
6.01e-01
|
GOBP RESPONSE TO UV A
|
13
|
3.18e-01
|
7.78e-01
|
0.24000
|
2.40e-01
|
2.80e-03
|
1.34e-01
|
9.86e-01
|
GOBP MAMMARY GLAND INVOLUTION
|
8
|
5.36e-01
|
8.76e-01
|
0.24000
|
1.31e-01
|
-2.01e-01
|
5.21e-01
|
3.24e-01
|
GOBP CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION
|
19
|
1.56e-01
|
6.43e-01
|
0.24000
|
1.43e-01
|
1.93e-01
|
2.82e-01
|
1.45e-01
|
GOBP DORSAL SPINAL CORD DEVELOPMENT
|
20
|
2.13e-01
|
7.02e-01
|
0.24000
|
1.83e-01
|
-1.55e-01
|
1.56e-01
|
2.29e-01
|
GOBP PROTON MOTIVE FORCE DRIVEN ATP SYNTHESIS
|
65
|
3.26e-03
|
1.14e-01
|
0.24000
|
-5.89e-03
|
-2.40e-01
|
9.35e-01
|
8.14e-04
|
GOMF POLY A RNA POLYMERASE ACTIVITY
|
11
|
3.40e-01
|
7.91e-01
|
0.24000
|
-1.51e-01
|
-1.87e-01
|
3.87e-01
|
2.83e-01
|
GOMF DESUMOYLASE ACTIVITY
|
7
|
5.83e-01
|
8.90e-01
|
0.24000
|
1.82e-01
|
-1.57e-01
|
4.05e-01
|
4.72e-01
|
GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS
|
11
|
3.55e-01
|
7.97e-01
|
0.24000
|
-2.27e-01
|
-7.86e-02
|
1.93e-01
|
6.52e-01
|
GOBP REGULATION OF AMACRINE CELL DIFFERENTIATION
|
6
|
5.88e-01
|
8.91e-01
|
0.24000
|
-1.01e-02
|
-2.40e-01
|
9.66e-01
|
3.09e-01
|
GOBP REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY
|
10
|
3.76e-01
|
8.11e-01
|
0.24000
|
1.48e-01
|
1.89e-01
|
4.18e-01
|
3.01e-01
|
GOBP NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY
|
32
|
8.13e-02
|
5.32e-01
|
0.24000
|
-2.09e-01
|
1.17e-01
|
4.05e-02
|
2.51e-01
|
GOBP DERMATAN SULFATE METABOLIC PROCESS
|
8
|
4.57e-01
|
8.48e-01
|
0.24000
|
-1.56e-01
|
-1.82e-01
|
4.45e-01
|
3.72e-01
|
GOBP POSITIVE REGULATION OF PHOSPHOLIPID TRANSLOCATION
|
5
|
6.76e-01
|
9.13e-01
|
0.24000
|
2.09e-01
|
-1.18e-01
|
4.19e-01
|
6.49e-01
|
GOBP REGULATION OF RECEPTOR INTERNALIZATION
|
60
|
9.96e-03
|
2.12e-01
|
0.24000
|
-1.85e-01
|
1.52e-01
|
1.32e-02
|
4.13e-02
|
GOBP NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION
|
21
|
1.54e-01
|
6.41e-01
|
0.24000
|
-1.94e-02
|
-2.39e-01
|
8.78e-01
|
5.81e-02
|
GOBP UTERUS MORPHOGENESIS
|
6
|
6.31e-01
|
9.03e-01
|
0.24000
|
-1.73e-01
|
1.66e-01
|
4.64e-01
|
4.81e-01
|
GOBP INTESTINAL EPITHELIAL CELL DEVELOPMENT
|
17
|
2.68e-01
|
7.43e-01
|
0.24000
|
1.34e-01
|
-1.98e-01
|
3.38e-01
|
1.57e-01
|
GOBP REGULATION OF DEFENSE RESPONSE TO BACTERIUM
|
20
|
2.03e-01
|
6.92e-01
|
0.24000
|
9.12e-02
|
-2.22e-01
|
4.80e-01
|
8.63e-02
|
GOCC MITOCHONDRIAL ALPHA KETOGLUTARATE DEHYDROGENASE COMPLEX
|
5
|
6.64e-01
|
9.10e-01
|
0.24000
|
2.31e-01
|
-6.48e-02
|
3.72e-01
|
8.02e-01
|
GOBP L KYNURENINE METABOLIC PROCESS
|
7
|
5.40e-01
|
8.78e-01
|
0.23900
|
-8.83e-03
|
-2.39e-01
|
9.68e-01
|
2.73e-01
|
GOCC XY BODY
|
15
|
2.54e-01
|
7.32e-01
|
0.23900
|
5.00e-02
|
2.34e-01
|
7.37e-01
|
1.17e-01
|
GOCC PROTEIN COMPLEX INVOLVED IN CELL CELL ADHESION
|
5
|
6.78e-01
|
9.14e-01
|
0.23900
|
1.23e-01
|
-2.05e-01
|
6.33e-01
|
4.27e-01
|
GOBP REGULATION OF CIRCADIAN SLEEP WAKE CYCLE NON REM SLEEP
|
5
|
6.19e-01
|
9.00e-01
|
0.23900
|
2.11e-01
|
1.13e-01
|
4.14e-01
|
6.63e-01
|
GOBP NEGATIVE REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE
|
15
|
3.01e-01
|
7.67e-01
|
0.23900
|
-8.43e-02
|
2.24e-01
|
5.72e-01
|
1.33e-01
|
GOBP APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS
|
27
|
1.17e-01
|
5.98e-01
|
0.23900
|
-9.38e-02
|
2.20e-01
|
3.99e-01
|
4.78e-02
|
GOBP TRNA TRANSPORT
|
6
|
6.26e-01
|
9.01e-01
|
0.23900
|
1.15e-01
|
-2.10e-01
|
6.26e-01
|
3.74e-01
|
GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE 3 PHOSPHATASE ACTIVITY
|
5
|
6.37e-01
|
9.06e-01
|
0.23900
|
-2.36e-01
|
-3.71e-02
|
3.60e-01
|
8.86e-01
|
GOMF TOLL LIKE RECEPTOR BINDING
|
14
|
3.26e-01
|
7.82e-01
|
0.23900
|
-2.24e-01
|
8.25e-02
|
1.46e-01
|
5.93e-01
|
GOBP MEIOTIC CYTOKINESIS
|
8
|
4.60e-01
|
8.48e-01
|
0.23900
|
-1.93e-01
|
-1.41e-01
|
3.45e-01
|
4.89e-01
|
GOBP GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS
|
21
|
1.53e-01
|
6.41e-01
|
0.23900
|
-3.01e-02
|
-2.37e-01
|
8.11e-01
|
6.00e-02
|
GOBP REGULATION OF RESTING MEMBRANE POTENTIAL
|
10
|
4.55e-01
|
8.46e-01
|
0.23900
|
1.02e-01
|
-2.16e-01
|
5.77e-01
|
2.37e-01
|
GOBP REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY
|
21
|
1.99e-01
|
6.89e-01
|
0.23900
|
-1.40e-01
|
1.94e-01
|
2.68e-01
|
1.24e-01
|
GOBP RESPONSE TO ATP
|
31
|
7.98e-02
|
5.28e-01
|
0.23900
|
-2.31e-01
|
6.12e-02
|
2.61e-02
|
5.55e-01
|
GOBP MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS
|
11
|
3.82e-01
|
8.16e-01
|
0.23900
|
-2.39e-01
|
-7.36e-03
|
1.70e-01
|
9.66e-01
|
GOBP HYDROGEN SULFIDE METABOLIC PROCESS
|
5
|
6.22e-01
|
9.01e-01
|
0.23900
|
1.01e-01
|
2.16e-01
|
6.95e-01
|
4.02e-01
|
GOBP FATTY ACID ELONGATION
|
12
|
3.33e-01
|
7.86e-01
|
0.23900
|
-2.31e-01
|
-5.92e-02
|
1.65e-01
|
7.23e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE
|
33
|
8.01e-02
|
5.28e-01
|
0.23900
|
-1.44e-01
|
1.91e-01
|
1.53e-01
|
5.81e-02
|
GOBP ZYMOGEN INHIBITION
|
7
|
5.07e-01
|
8.65e-01
|
0.23900
|
-1.70e-01
|
-1.68e-01
|
4.36e-01
|
4.43e-01
|
GOBP REGULATION OF T HELPER 17 CELL DIFFERENTIATION
|
21
|
1.30e-01
|
6.09e-01
|
0.23900
|
1.70e-01
|
1.68e-01
|
1.79e-01
|
1.83e-01
|
GOBP POSITIVE REGULATION OF DNA DEMETHYLATION
|
8
|
5.43e-01
|
8.78e-01
|
0.23900
|
1.58e-01
|
-1.79e-01
|
4.39e-01
|
3.81e-01
|
GOMF CARBOHYDRATE PHOSPHATASE ACTIVITY
|
9
|
4.23e-01
|
8.34e-01
|
0.23900
|
2.08e-01
|
1.17e-01
|
2.80e-01
|
5.43e-01
|
GOBP NEGATIVE REGULATION OF SYNAPSE ORGANIZATION
|
11
|
4.33e-01
|
8.37e-01
|
0.23900
|
-1.65e-01
|
1.72e-01
|
3.42e-01
|
3.23e-01
|
GOBP CELLULAR RESPONSE TO PEPTIDOGLYCAN
|
6
|
5.66e-01
|
8.85e-01
|
0.23900
|
-1.05e-01
|
-2.14e-01
|
6.57e-01
|
3.63e-01
|
GOBP PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS
|
15
|
2.84e-01
|
7.57e-01
|
0.23900
|
-2.37e-01
|
3.00e-02
|
1.13e-01
|
8.41e-01
|
GOBP REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY
|
10
|
4.44e-01
|
8.40e-01
|
0.23800
|
6.29e-02
|
-2.30e-01
|
7.30e-01
|
2.08e-01
|
GOMF PHOSPHORUS OXYGEN LYASE ACTIVITY
|
22
|
1.86e-01
|
6.78e-01
|
0.23800
|
-1.42e-01
|
1.91e-01
|
2.48e-01
|
1.20e-01
|
GOMF PRIMARY AMINE OXIDASE ACTIVITY
|
7
|
5.20e-01
|
8.69e-01
|
0.23800
|
-8.46e-02
|
-2.23e-01
|
6.98e-01
|
3.08e-01
|
GOBP RESPONSE TO LAMINAR FLUID SHEAR STRESS
|
14
|
3.45e-01
|
7.96e-01
|
0.23800
|
-1.61e-01
|
1.76e-01
|
2.97e-01
|
2.55e-01
|
GOBP DEFINITIVE HEMOPOIESIS
|
19
|
1.62e-01
|
6.48e-01
|
0.23800
|
-1.98e-01
|
-1.33e-01
|
1.36e-01
|
3.17e-01
|
GOBP POSITIVE REGULATION OF DEFENSE RESPONSE TO BACTERIUM
|
14
|
3.26e-01
|
7.82e-01
|
0.23800
|
7.16e-02
|
-2.27e-01
|
6.43e-01
|
1.42e-01
|
GOBP ELASTIC FIBER ASSEMBLY
|
9
|
4.26e-01
|
8.36e-01
|
0.23800
|
1.15e-01
|
2.08e-01
|
5.50e-01
|
2.80e-01
|
GOBP REGULATION OF GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY
|
7
|
5.09e-01
|
8.66e-01
|
0.23800
|
1.77e-01
|
1.58e-01
|
4.17e-01
|
4.68e-01
|
GOMF 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE BINDING
|
9
|
4.95e-01
|
8.58e-01
|
0.23800
|
2.17e-01
|
-9.73e-02
|
2.60e-01
|
6.13e-01
|
GOBP SYNAPTIC SIGNALING VIA NEUROPEPTIDE
|
6
|
6.28e-01
|
9.02e-01
|
0.23800
|
-1.07e-01
|
2.12e-01
|
6.49e-01
|
3.68e-01
|
GOBP CARDIAC VENTRICLE FORMATION
|
8
|
4.65e-01
|
8.49e-01
|
0.23800
|
-1.92e-01
|
-1.40e-01
|
3.47e-01
|
4.93e-01
|
GOBP RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE
|
22
|
1.65e-01
|
6.50e-01
|
0.23800
|
4.69e-02
|
-2.33e-01
|
7.03e-01
|
5.87e-02
|
GOMF RACEMASE AND EPIMERASE ACTIVITY ACTING ON CARBOHYDRATES AND DERIVATIVES
|
10
|
4.07e-01
|
8.26e-01
|
0.23700
|
4.87e-02
|
2.32e-01
|
7.90e-01
|
2.03e-01
|
GOCC MYOFILAMENT
|
26
|
1.39e-01
|
6.22e-01
|
0.23700
|
-1.34e-01
|
1.96e-01
|
2.37e-01
|
8.38e-02
|
GOBP REGULATION OF POTASSIUM ION IMPORT
|
5
|
6.45e-01
|
9.07e-01
|
0.23700
|
2.36e-01
|
2.34e-02
|
3.60e-01
|
9.28e-01
|
GOBP CD4 POSITIVE CD25 POSITIVE ALPHA BETA REGULATORY T CELL DIFFERENTIATION
|
8
|
4.64e-01
|
8.48e-01
|
0.23700
|
-1.61e-01
|
-1.74e-01
|
4.29e-01
|
3.94e-01
|
GOBP INNER DYNEIN ARM ASSEMBLY
|
16
|
2.77e-01
|
7.51e-01
|
0.23700
|
-6.36e-02
|
2.29e-01
|
6.60e-01
|
1.14e-01
|
GOBP NEGATIVE REGULATION OF GLYCOLYTIC PROCESS
|
17
|
1.96e-01
|
6.88e-01
|
0.23700
|
-1.59e-01
|
-1.76e-01
|
2.57e-01
|
2.09e-01
|
GOBP PLASMA MEMBRANE FUSION
|
30
|
7.55e-02
|
5.19e-01
|
0.23700
|
-2.37e-01
|
-8.26e-03
|
2.47e-02
|
9.38e-01
|
GOBP ION CHANNEL MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY
|
8
|
5.48e-01
|
8.79e-01
|
0.23700
|
-1.60e-01
|
1.74e-01
|
4.32e-01
|
3.93e-01
|
GOBP COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY
|
12
|
4.02e-01
|
8.26e-01
|
0.23700
|
1.32e-01
|
-1.97e-01
|
4.30e-01
|
2.37e-01
|
GOMF BMP BINDING
|
19
|
2.32e-01
|
7.18e-01
|
0.23700
|
1.09e-01
|
-2.10e-01
|
4.11e-01
|
1.12e-01
|
GOBP MACROPHAGE INFLAMMATORY PROTEIN 1 ALPHA PRODUCTION
|
6
|
5.80e-01
|
8.90e-01
|
0.23700
|
-2.28e-01
|
-6.27e-02
|
3.33e-01
|
7.90e-01
|
GOBP MEMBRANE RAFT ORGANIZATION
|
26
|
1.07e-01
|
5.80e-01
|
0.23700
|
7.65e-03
|
2.37e-01
|
9.46e-01
|
3.67e-02
|
GOBP NEGATIVE REGULATION OF CELLULAR RESPIRATION
|
10
|
3.94e-01
|
8.23e-01
|
0.23700
|
-2.15e-01
|
-9.87e-02
|
2.38e-01
|
5.89e-01
|
GOBP SOMATOSTATIN RECEPTOR SIGNALING PATHWAY
|
5
|
6.55e-01
|
9.09e-01
|
0.23700
|
-7.82e-03
|
2.37e-01
|
9.76e-01
|
3.59e-01
|
GOMF SOMATOSTATIN RECEPTOR ACTIVITY
|
5
|
6.55e-01
|
9.09e-01
|
0.23700
|
-7.82e-03
|
2.37e-01
|
9.76e-01
|
3.59e-01
|
GOMF MHC CLASS I PROTEIN BINDING
|
18
|
2.56e-01
|
7.35e-01
|
0.23700
|
1.98e-01
|
-1.30e-01
|
1.46e-01
|
3.39e-01
|
GOBP LENS FIBER CELL MORPHOGENESIS
|
6
|
5.77e-01
|
8.89e-01
|
0.23700
|
-7.86e-02
|
-2.23e-01
|
7.39e-01
|
3.43e-01
|
GOBP DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS
|
14
|
3.00e-01
|
7.67e-01
|
0.23700
|
-2.37e-01
|
-8.70e-03
|
1.25e-01
|
9.55e-01
|
GOBP LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE
|
19
|
2.39e-01
|
7.25e-01
|
0.23700
|
-1.92e-01
|
1.38e-01
|
1.46e-01
|
2.99e-01
|
GOCC PAM COMPLEX TIM23 ASSOCIATED IMPORT MOTOR
|
5
|
6.44e-01
|
9.07e-01
|
0.23700
|
3.41e-02
|
2.34e-01
|
8.95e-01
|
3.65e-01
|
GOBP VIRAL RELEASE FROM HOST CELL
|
28
|
8.44e-02
|
5.38e-01
|
0.23700
|
-2.34e-01
|
-3.71e-02
|
3.23e-02
|
7.34e-01
|
GOBP TACHYKININ RECEPTOR SIGNALING PATHWAY
|
8
|
4.70e-01
|
8.51e-01
|
0.23600
|
-2.01e-01
|
-1.25e-01
|
3.25e-01
|
5.41e-01
|
GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN CELL CYCLE ARREST
|
18
|
2.46e-01
|
7.26e-01
|
0.23600
|
8.87e-02
|
-2.19e-01
|
5.15e-01
|
1.07e-01
|
GOBP CELLULAR HYPOTONIC RESPONSE
|
11
|
4.40e-01
|
8.40e-01
|
0.23600
|
-1.65e-01
|
1.70e-01
|
3.44e-01
|
3.30e-01
|
GOBP POSITIVE REGULATION OF INOSITOL TRISPHOSPHATE BIOSYNTHETIC PROCESS
|
5
|
6.58e-01
|
9.09e-01
|
0.23600
|
2.36e-01
|
-1.55e-02
|
3.61e-01
|
9.52e-01
|
GOBP MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL
|
22
|
1.25e-01
|
6.06e-01
|
0.23600
|
1.40e-01
|
1.90e-01
|
2.56e-01
|
1.22e-01
|
GOCC ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT MEMBRANE
|
76
|
8.26e-04
|
4.55e-02
|
0.23600
|
-2.06e-01
|
-1.16e-01
|
1.94e-03
|
7.99e-02
|
GOBP NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVITY
|
24
|
1.14e-01
|
5.92e-01
|
0.23600
|
-6.69e-02
|
-2.27e-01
|
5.71e-01
|
5.48e-02
|
GOCC MEMBRANE ATTACK COMPLEX
|
7
|
5.66e-01
|
8.85e-01
|
0.23600
|
4.09e-02
|
-2.33e-01
|
8.51e-01
|
2.87e-01
|
GOBP VACUOLAR PROTON TRANSPORTING V TYPE ATPASE COMPLEX ASSEMBLY
|
5
|
6.89e-01
|
9.19e-01
|
0.23600
|
-1.56e-01
|
1.77e-01
|
5.46e-01
|
4.93e-01
|
GOBP NADH OXIDATION
|
6
|
6.17e-01
|
9.00e-01
|
0.23600
|
-2.31e-01
|
5.03e-02
|
3.28e-01
|
8.31e-01
|
GOBP RESPONSE TO ARSENIC CONTAINING SUBSTANCE
|
31
|
7.84e-02
|
5.26e-01
|
0.23600
|
-2.92e-02
|
2.34e-01
|
7.78e-01
|
2.40e-02
|
GOBP SIRNA PROCESSING
|
9
|
4.26e-01
|
8.36e-01
|
0.23600
|
-1.72e-01
|
-1.62e-01
|
3.72e-01
|
4.01e-01
|
GOMF ODORANT BINDING
|
101
|
4.86e-04
|
3.03e-02
|
0.23600
|
2.06e-01
|
-1.15e-01
|
3.48e-04
|
4.66e-02
|
GOCC OTHER ORGANISM PART
|
5
|
6.74e-01
|
9.13e-01
|
0.23600
|
6.90e-02
|
-2.25e-01
|
7.89e-01
|
3.83e-01
|
GOMF DNA APURINIC OR APYRIMIDINIC SITE ENDONUCLEASE ACTIVITY
|
12
|
3.62e-01
|
8.03e-01
|
0.23600
|
2.36e-01
|
3.22e-03
|
1.58e-01
|
9.85e-01
|
GOMF PROTEIN DISULFIDE REDUCTASE ACTIVITY
|
27
|
8.81e-02
|
5.48e-01
|
0.23500
|
-2.25e-01
|
-6.87e-02
|
4.28e-02
|
5.36e-01
|
GOMF PHOSPHODIESTERASE I ACTIVITY
|
5
|
6.55e-01
|
9.09e-01
|
0.23500
|
4.36e-03
|
2.35e-01
|
9.87e-01
|
3.62e-01
|
GOBP CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS
|
14
|
3.47e-01
|
7.96e-01
|
0.23500
|
1.15e-01
|
-2.05e-01
|
4.54e-01
|
1.84e-01
|
GOMF PHOSPHATIDYLINOSITOL 3 PHOSPHATE BINDING
|
43
|
2.87e-02
|
3.52e-01
|
0.23500
|
-1.74e-02
|
2.35e-01
|
8.44e-01
|
7.77e-03
|
GOMF K63 LINKED POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING
|
24
|
1.65e-01
|
6.49e-01
|
0.23500
|
-2.02e-01
|
1.20e-01
|
8.60e-02
|
3.11e-01
|
GOMF GLUCOSE BINDING
|
10
|
4.58e-01
|
8.48e-01
|
0.23500
|
-7.11e-02
|
2.24e-01
|
6.97e-01
|
2.20e-01
|
GOBP HISTONE UBIQUITINATION
|
8
|
4.75e-01
|
8.54e-01
|
0.23500
|
-2.02e-01
|
-1.20e-01
|
3.23e-01
|
5.55e-01
|
GOBP G1 TO G0 TRANSITION
|
19
|
2.41e-01
|
7.25e-01
|
0.23500
|
-2.00e-01
|
1.23e-01
|
1.31e-01
|
3.52e-01
|
GOMF IODIDE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
5
|
6.26e-01
|
9.01e-01
|
0.23500
|
-1.38e-01
|
-1.90e-01
|
5.94e-01
|
4.61e-01
|
GOBP RAB PROTEIN SIGNAL TRANSDUCTION
|
16
|
3.06e-01
|
7.70e-01
|
0.23500
|
-1.45e-01
|
1.85e-01
|
3.17e-01
|
2.00e-01
|
GOBP NEGATIVE REGULATION OF B CELL DIFFERENTIATION
|
6
|
5.80e-01
|
8.90e-01
|
0.23500
|
-8.45e-02
|
-2.19e-01
|
7.20e-01
|
3.52e-01
|
GOMF POTASSIUM ION BINDING
|
13
|
3.31e-01
|
7.85e-01
|
0.23500
|
-2.35e-01
|
-1.31e-02
|
1.43e-01
|
9.35e-01
|
GOMF STRUCTURAL CONSTITUENT OF MYELIN SHEATH
|
9
|
4.46e-01
|
8.40e-01
|
0.23500
|
7.07e-02
|
2.24e-01
|
7.14e-01
|
2.44e-01
|
GOBP REGULATION OF ENTRY OF BACTERIUM INTO HOST CELL
|
7
|
5.72e-01
|
8.88e-01
|
0.23500
|
-2.30e-01
|
5.01e-02
|
2.93e-01
|
8.18e-01
|
GOBP REGULATION OF MONOCYTE CHEMOTAXIS
|
27
|
7.94e-02
|
5.27e-01
|
0.23500
|
-1.82e-01
|
-1.48e-01
|
1.01e-01
|
1.83e-01
|
GOBP TELENCEPHALON REGIONALIZATION
|
13
|
2.96e-01
|
7.65e-01
|
0.23500
|
-1.86e-01
|
-1.44e-01
|
2.47e-01
|
3.69e-01
|
GOBP POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION
|
17
|
2.02e-01
|
6.92e-01
|
0.23500
|
1.69e-01
|
1.63e-01
|
2.27e-01
|
2.45e-01
|
GOBP PROTEIN TRANSPORT WITHIN LIPID BILAYER
|
6
|
6.27e-01
|
9.02e-01
|
0.23500
|
-7.48e-02
|
2.22e-01
|
7.51e-01
|
3.45e-01
|
GOCC HRD1P UBIQUITIN LIGASE ERAD L COMPLEX
|
6
|
6.15e-01
|
8.99e-01
|
0.23500
|
-2.33e-01
|
3.19e-02
|
3.24e-01
|
8.92e-01
|
GOBP RENAL WATER ABSORPTION
|
6
|
6.20e-01
|
9.00e-01
|
0.23500
|
-4.80e-02
|
2.30e-01
|
8.39e-01
|
3.30e-01
|
GOBP LIPOPHAGY
|
7
|
5.97e-01
|
8.95e-01
|
0.23500
|
1.53e-01
|
-1.78e-01
|
4.83e-01
|
4.15e-01
|
GOBP ANATOMICAL STRUCTURE REGRESSION
|
16
|
2.24e-01
|
7.13e-01
|
0.23500
|
1.38e-01
|
1.89e-01
|
3.38e-01
|
1.90e-01
|
GOMF DNA REPLICATION ORIGIN BINDING
|
15
|
3.00e-01
|
7.67e-01
|
0.23500
|
4.18e-02
|
-2.31e-01
|
7.79e-01
|
1.22e-01
|
GOCC SPECIFIC GRANULE LUMEN
|
60
|
3.74e-03
|
1.24e-01
|
0.23500
|
-1.89e-01
|
-1.38e-01
|
1.11e-02
|
6.40e-02
|
GOBP POSITIVE REGULATION OF T HELPER 2 CELL CYTOKINE PRODUCTION
|
9
|
4.94e-01
|
8.58e-01
|
0.23500
|
-2.25e-01
|
6.50e-02
|
2.42e-01
|
7.36e-01
|
GOBP RESPONSE TO PHORBOL 13 ACETATE 12 MYRISTATE
|
10
|
4.69e-01
|
8.51e-01
|
0.23400
|
-1.01e-01
|
2.11e-01
|
5.79e-01
|
2.47e-01
|
GOBP REGULATION OF MITOCHONDRIAL TRANSLATION
|
25
|
1.02e-01
|
5.73e-01
|
0.23400
|
-9.66e-02
|
-2.14e-01
|
4.03e-01
|
6.45e-02
|
GOBP GLYCOSIDE CATABOLIC PROCESS
|
8
|
5.17e-01
|
8.69e-01
|
0.23400
|
-2.34e-01
|
1.17e-02
|
2.52e-01
|
9.54e-01
|
GOCC SEPTIN CYTOSKELETON
|
14
|
2.83e-01
|
7.56e-01
|
0.23400
|
2.20e-01
|
8.11e-02
|
1.54e-01
|
6.00e-01
|
GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT PHOSPHATASE ACTIVITY
|
7
|
5.66e-01
|
8.85e-01
|
0.23400
|
2.70e-02
|
-2.33e-01
|
9.02e-01
|
2.86e-01
|
GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 4F COMPLEX
|
12
|
4.06e-01
|
8.26e-01
|
0.23400
|
1.09e-01
|
-2.07e-01
|
5.13e-01
|
2.13e-01
|
GOBP TRANSCRIPTION INITIATION COUPLED CHROMATIN REMODELING
|
38
|
5.78e-02
|
4.69e-01
|
0.23400
|
-2.07e-01
|
1.10e-01
|
2.72e-02
|
2.42e-01
|
GOBP POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION
|
21
|
1.61e-01
|
6.48e-01
|
0.23400
|
-4.21e-02
|
-2.30e-01
|
7.39e-01
|
6.75e-02
|
GOBP DOSAGE COMPENSATION
|
27
|
1.20e-01
|
6.00e-01
|
0.23400
|
-2.27e-01
|
5.78e-02
|
4.12e-02
|
6.03e-01
|
GOBP NEGATIVE REGULATION OF PLATELET ACTIVATION
|
17
|
2.85e-01
|
7.57e-01
|
0.23400
|
-1.35e-01
|
1.91e-01
|
3.33e-01
|
1.73e-01
|
GOMF DEMETHYLASE ACTIVITY
|
35
|
6.76e-02
|
4.99e-01
|
0.23400
|
-2.21e-01
|
7.83e-02
|
2.39e-02
|
4.23e-01
|
GOBP REGULATION OF PROTON TRANSPORT
|
16
|
2.87e-01
|
7.59e-01
|
0.23400
|
-6.54e-02
|
2.25e-01
|
6.51e-01
|
1.19e-01
|
GOMF PRE MIRNA BINDING
|
9
|
4.83e-01
|
8.54e-01
|
0.23400
|
-2.32e-01
|
3.03e-02
|
2.28e-01
|
8.75e-01
|
GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS
|
12
|
4.04e-01
|
8.26e-01
|
0.23400
|
-2.12e-01
|
9.93e-02
|
2.04e-01
|
5.51e-01
|
GOBP SUCCINATE TRANSMEMBRANE TRANSPORT
|
6
|
6.13e-01
|
8.98e-01
|
0.23400
|
-2.08e-02
|
2.33e-01
|
9.30e-01
|
3.23e-01
|
GOMF SUCCINATE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
6
|
6.13e-01
|
8.98e-01
|
0.23400
|
-2.08e-02
|
2.33e-01
|
9.30e-01
|
3.23e-01
|
GOCC SMALL RIBOSOMAL SUBUNIT
|
70
|
4.45e-03
|
1.36e-01
|
0.23400
|
6.90e-02
|
-2.23e-01
|
3.18e-01
|
1.22e-03
|
GOBP REGULATION OF RHODOPSIN MEDIATED SIGNALING PATHWAY
|
9
|
4.59e-01
|
8.48e-01
|
0.23400
|
-2.31e-01
|
-3.90e-02
|
2.31e-01
|
8.40e-01
|
GOBP NEGATIVE REGULATION OF VITAMIN METABOLIC PROCESS
|
7
|
5.87e-01
|
8.91e-01
|
0.23400
|
8.87e-02
|
-2.16e-01
|
6.84e-01
|
3.22e-01
|
GOBP REGULATION OF CELLULAR RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR STIMULUS
|
6
|
6.32e-01
|
9.03e-01
|
0.23400
|
8.41e-02
|
-2.18e-01
|
7.21e-01
|
3.55e-01
|
GOBP REGULATION OF NEUROINFLAMMATORY RESPONSE
|
41
|
4.49e-02
|
4.30e-01
|
0.23400
|
9.26e-02
|
-2.15e-01
|
3.05e-01
|
1.74e-02
|
GOBP NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL
|
10
|
4.14e-01
|
8.29e-01
|
0.23400
|
-2.25e-01
|
-6.25e-02
|
2.18e-01
|
7.32e-01
|
GOBP QUATERNARY AMMONIUM GROUP TRANSPORT
|
29
|
8.29e-02
|
5.35e-01
|
0.23400
|
2.31e-01
|
3.44e-02
|
3.13e-02
|
7.49e-01
|
GOBP REGULATION OF BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS
|
8
|
5.54e-01
|
8.81e-01
|
0.23400
|
-1.28e-01
|
1.96e-01
|
5.31e-01
|
3.38e-01
|
GOBP VESICLE CARGO LOADING
|
29
|
6.82e-02
|
5.00e-01
|
0.23400
|
-1.41e-01
|
-1.86e-01
|
1.88e-01
|
8.28e-02
|
GOBP LATERAL VENTRICLE DEVELOPMENT
|
12
|
3.55e-01
|
7.97e-01
|
0.23400
|
2.30e-01
|
3.99e-02
|
1.68e-01
|
8.11e-01
|
GOBP PROTEIN K6 LINKED UBIQUITINATION
|
11
|
3.98e-01
|
8.25e-01
|
0.23300
|
-1.23e-02
|
-2.33e-01
|
9.44e-01
|
1.81e-01
|
GOCC ESCRT I COMPLEX
|
11
|
3.96e-01
|
8.25e-01
|
0.23300
|
-2.33e-01
|
-1.62e-02
|
1.81e-01
|
9.26e-01
|
GOBP POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY
|
26
|
9.07e-02
|
5.51e-01
|
0.23300
|
1.41e-01
|
1.86e-01
|
2.15e-01
|
1.00e-01
|
GOBP POSITIVE REGULATION OF SKELETAL MUSCLE FIBER DEVELOPMENT
|
9
|
4.41e-01
|
8.40e-01
|
0.23300
|
2.07e-01
|
1.08e-01
|
2.83e-01
|
5.76e-01
|
GOBP REGULATION OF CHONDROCYTE DEVELOPMENT
|
6
|
6.37e-01
|
9.06e-01
|
0.23300
|
-9.55e-02
|
2.13e-01
|
6.86e-01
|
3.67e-01
|
GOCC STEREOCILIA COUPLING LINK
|
7
|
5.23e-01
|
8.70e-01
|
0.23300
|
1.54e-01
|
1.75e-01
|
4.81e-01
|
4.22e-01
|
GOBP RETINAL PIGMENT EPITHELIUM DEVELOPMENT
|
6
|
5.74e-01
|
8.88e-01
|
0.23300
|
-1.51e-01
|
-1.77e-01
|
5.21e-01
|
4.52e-01
|
GOBP NEGATIVE REGULATION OF BLOOD CIRCULATION
|
24
|
1.14e-01
|
5.91e-01
|
0.23300
|
1.04e-01
|
2.09e-01
|
3.78e-01
|
7.68e-02
|
GOBP AMELOGENESIS
|
24
|
1.70e-01
|
6.57e-01
|
0.23300
|
-1.20e-01
|
2.00e-01
|
3.10e-01
|
8.98e-02
|
GOBP POSITIVE REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT
|
9
|
5.18e-01
|
8.69e-01
|
0.23300
|
1.34e-01
|
-1.90e-01
|
4.86e-01
|
3.23e-01
|
GOBP GANGLIOSIDE BIOSYNTHETIC PROCESS
|
17
|
2.90e-01
|
7.61e-01
|
0.23300
|
-1.85e-01
|
1.41e-01
|
1.86e-01
|
3.14e-01
|
GOMF O ACYLTRANSFERASE ACTIVITY
|
49
|
2.48e-02
|
3.31e-01
|
0.23300
|
-2.16e-01
|
8.62e-02
|
8.83e-03
|
2.96e-01
|
GOBP REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION
|
12
|
3.95e-01
|
8.24e-01
|
0.23300
|
2.25e-01
|
-6.08e-02
|
1.78e-01
|
7.15e-01
|
GOBP NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS
|
113
|
3.72e-05
|
4.29e-03
|
0.23300
|
-1.09e-01
|
-2.06e-01
|
4.55e-02
|
1.59e-04
|
GOMF GALACTOSYLTRANSFERASE ACTIVITY
|
31
|
8.30e-02
|
5.35e-01
|
0.23300
|
-2.31e-01
|
2.38e-02
|
2.57e-02
|
8.19e-01
|
GOBP INTRACELLULAR POTASSIUM ION HOMEOSTASIS
|
15
|
2.99e-01
|
7.67e-01
|
0.23300
|
-2.22e-02
|
2.32e-01
|
8.82e-01
|
1.20e-01
|
GOBP PYRIMIDINE NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS
|
9
|
4.75e-01
|
8.54e-01
|
0.23300
|
-2.33e-01
|
-2.57e-03
|
2.27e-01
|
9.89e-01
|
GOBP REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL
|
10
|
4.60e-01
|
8.48e-01
|
0.23300
|
2.26e-01
|
-5.56e-02
|
2.16e-01
|
7.61e-01
|
GOMF NAD RETINOL DEHYDROGENASE ACTIVITY
|
21
|
1.65e-01
|
6.49e-01
|
0.23300
|
-4.31e-02
|
-2.29e-01
|
7.33e-01
|
6.98e-02
|
GOMF PROTEIN ANTIGEN BINDING
|
7
|
5.67e-01
|
8.85e-01
|
0.23300
|
-1.41e-02
|
2.32e-01
|
9.49e-01
|
2.88e-01
|
GOCC LSM2 8 COMPLEX
|
7
|
5.45e-01
|
8.78e-01
|
0.23300
|
-5.39e-02
|
-2.26e-01
|
8.05e-01
|
3.00e-01
|
GOBP PYRIMIDINE RIBONUCLEOTIDE CATABOLIC PROCESS
|
8
|
5.10e-01
|
8.66e-01
|
0.23300
|
-2.32e-01
|
-2.10e-02
|
2.57e-01
|
9.18e-01
|
GOMF G PROTEIN COUPLED GLUTAMATE RECEPTOR BINDING
|
10
|
4.59e-01
|
8.48e-01
|
0.23200
|
-2.26e-01
|
5.30e-02
|
2.15e-01
|
7.71e-01
|
GOBP REGULATION OF MACROPHAGE MIGRATION
|
45
|
3.85e-02
|
4.02e-01
|
0.23200
|
-1.82e-01
|
1.45e-01
|
3.51e-02
|
9.24e-02
|
GOMF DNA N GLYCOSYLASE ACTIVITY
|
14
|
3.57e-01
|
7.99e-01
|
0.23200
|
2.01e-01
|
-1.16e-01
|
1.92e-01
|
4.54e-01
|
GOMF TRNA SPECIFIC RIBONUCLEASE ACTIVITY
|
16
|
3.09e-01
|
7.72e-01
|
0.23200
|
2.01e-01
|
-1.17e-01
|
1.64e-01
|
4.19e-01
|
GOBP NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION
|
32
|
5.57e-02
|
4.63e-01
|
0.23200
|
-1.11e-01
|
-2.04e-01
|
2.79e-01
|
4.56e-02
|
GOBP REGULATION OF AMYLOID BETA CLEARANCE
|
20
|
2.36e-01
|
7.24e-01
|
0.23200
|
-1.76e-01
|
1.52e-01
|
1.74e-01
|
2.40e-01
|
GOBP POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE
|
5
|
6.96e-01
|
9.21e-01
|
0.23200
|
-1.89e-01
|
1.35e-01
|
4.65e-01
|
6.00e-01
|
GOBP REGULATION OF OPSONIZATION
|
10
|
4.86e-01
|
8.56e-01
|
0.23200
|
1.74e-01
|
-1.54e-01
|
3.41e-01
|
4.00e-01
|
GOBP REGULATION OF RENAL SODIUM EXCRETION
|
8
|
5.59e-01
|
8.82e-01
|
0.23200
|
1.30e-01
|
-1.93e-01
|
5.26e-01
|
3.46e-01
|
GOBP GOLGI TO ENDOSOME TRANSPORT
|
17
|
2.10e-01
|
7.00e-01
|
0.23200
|
-1.69e-01
|
-1.59e-01
|
2.28e-01
|
2.56e-01
|
GOBP LOW DENSITY LIPOPROTEIN PARTICLE REMODELING
|
16
|
2.98e-01
|
7.67e-01
|
0.23200
|
2.19e-01
|
-7.61e-02
|
1.29e-01
|
5.98e-01
|
GOMF CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS
|
17
|
2.11e-01
|
7.00e-01
|
0.23200
|
-1.82e-01
|
-1.43e-01
|
1.93e-01
|
3.07e-01
|
GOBP REGULATION OF GENE SILENCING BY REGULATORY NCRNA
|
29
|
1.15e-01
|
5.93e-01
|
0.23200
|
-2.14e-01
|
8.91e-02
|
4.61e-02
|
4.06e-01
|
GOBP HEXOSE PHOSPHATE TRANSPORT
|
7
|
5.28e-01
|
8.72e-01
|
0.23200
|
-1.42e-01
|
-1.83e-01
|
5.15e-01
|
4.02e-01
|
GOCC AXON INITIAL SEGMENT
|
21
|
1.93e-01
|
6.85e-01
|
0.23200
|
2.28e-01
|
-4.06e-02
|
7.04e-02
|
7.47e-01
|
GOBP POSITIVE REGULATION OF STORE OPERATED CALCIUM CHANNEL ACTIVITY
|
5
|
6.93e-01
|
9.21e-01
|
0.23200
|
-1.10e-01
|
2.04e-01
|
6.69e-01
|
4.30e-01
|
GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I
|
32
|
8.96e-02
|
5.51e-01
|
0.23200
|
-2.18e-01
|
7.69e-02
|
3.24e-02
|
4.51e-01
|
GOMF PHOSPHATE ION BINDING
|
11
|
4.38e-01
|
8.40e-01
|
0.23200
|
8.20e-02
|
-2.17e-01
|
6.38e-01
|
2.14e-01
|
GOMF PHOSPHATIDYLINOSITOL 3 KINASE BINDING
|
24
|
1.34e-01
|
6.16e-01
|
0.23200
|
2.80e-02
|
2.30e-01
|
8.12e-01
|
5.13e-02
|
GOBP REGULATION OF TRANSFORMING GROWTH FACTOR BETA ACTIVATION
|
10
|
4.01e-01
|
8.26e-01
|
0.23200
|
1.56e-01
|
1.71e-01
|
3.94e-01
|
3.48e-01
|
GOBP CELLULAR RESPONSE TO WATER STIMULUS
|
6
|
5.90e-01
|
8.92e-01
|
0.23100
|
2.17e-01
|
8.08e-02
|
3.58e-01
|
7.32e-01
|
GOBP MACROPINOCYTOSIS
|
10
|
4.80e-01
|
8.54e-01
|
0.23100
|
-2.06e-01
|
1.05e-01
|
2.59e-01
|
5.67e-01
|
GOMF PRERIBOSOME BINDING
|
6
|
5.80e-01
|
8.90e-01
|
0.23100
|
-1.84e-01
|
-1.40e-01
|
4.35e-01
|
5.52e-01
|
GOMF BENZODIAZEPINE RECEPTOR ACTIVITY
|
9
|
4.58e-01
|
8.48e-01
|
0.23100
|
-6.62e-02
|
-2.22e-01
|
7.31e-01
|
2.50e-01
|
GOBP PROTEIN DEMETHYLATION
|
9
|
5.21e-01
|
8.69e-01
|
0.23100
|
-1.24e-01
|
1.95e-01
|
5.18e-01
|
3.11e-01
|
GOBP DISTAL CONVOLUTED TUBULE DEVELOPMENT
|
5
|
6.46e-01
|
9.07e-01
|
0.23100
|
-7.42e-02
|
-2.19e-01
|
7.74e-01
|
3.97e-01
|
GOBP LYMPHATIC ENDOTHELIAL CELL DIFFERENTIATION
|
8
|
5.52e-01
|
8.80e-01
|
0.23100
|
-8.79e-02
|
2.14e-01
|
6.67e-01
|
2.95e-01
|
GOMF HISTONE CHAPERONE ACTIVITY
|
12
|
4.03e-01
|
8.26e-01
|
0.23100
|
6.88e-02
|
-2.21e-01
|
6.80e-01
|
1.86e-01
|
GOBP REGULATION OF SECONDARY HEART FIELD CARDIOBLAST PROLIFERATION
|
9
|
5.05e-01
|
8.65e-01
|
0.23100
|
-2.22e-01
|
6.30e-02
|
2.49e-01
|
7.44e-01
|
GOBP FEMALE MEIOSIS I
|
13
|
3.82e-01
|
8.16e-01
|
0.23100
|
2.13e-01
|
-8.84e-02
|
1.83e-01
|
5.81e-01
|
GOBP AMMONIUM HOMEOSTASIS
|
5
|
7.00e-01
|
9.22e-01
|
0.23100
|
1.57e-01
|
-1.69e-01
|
5.42e-01
|
5.14e-01
|
GOMF TRANSFERASE ACTIVITY TRANSFERRING NITROGENOUS GROUPS
|
26
|
1.17e-01
|
5.98e-01
|
0.23100
|
-1.79e-02
|
-2.30e-01
|
8.75e-01
|
4.23e-02
|
GOBP PYRUVATE TRANSPORT
|
7
|
5.46e-01
|
8.78e-01
|
0.23100
|
-2.20e-01
|
-6.82e-02
|
3.13e-01
|
7.55e-01
|
GOBP DEDIFFERENTIATION
|
11
|
3.79e-01
|
8.14e-01
|
0.23100
|
-2.11e-01
|
-9.38e-02
|
2.26e-01
|
5.90e-01
|
GOBP POSTSYNAPTIC SIGNAL TRANSDUCTION
|
38
|
6.23e-02
|
4.82e-01
|
0.23100
|
-2.07e-01
|
1.02e-01
|
2.73e-02
|
2.78e-01
|
GOBP CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE
|
20
|
2.14e-01
|
7.03e-01
|
0.23000
|
-2.26e-01
|
4.42e-02
|
7.99e-02
|
7.32e-01
|
GOBP MITOTIC DNA REPLICATION
|
15
|
2.59e-01
|
7.36e-01
|
0.23000
|
-1.39e-01
|
-1.84e-01
|
3.52e-01
|
2.18e-01
|
GOBP RIBOSOMAL LARGE SUBUNIT EXPORT FROM NUCLEUS
|
7
|
6.02e-01
|
8.96e-01
|
0.23000
|
1.10e-01
|
-2.02e-01
|
6.14e-01
|
3.54e-01
|
GOBP ELASTIN METABOLIC PROCESS
|
8
|
5.48e-01
|
8.79e-01
|
0.23000
|
-2.20e-01
|
6.74e-02
|
2.81e-01
|
7.41e-01
|
GOBP SPHINGOMYELIN METABOLIC PROCESS
|
20
|
1.74e-01
|
6.64e-01
|
0.23000
|
-2.14e-01
|
-8.52e-02
|
9.77e-02
|
5.09e-01
|
GOBP NEGATIVE REGULATION OF FAT CELL PROLIFERATION
|
5
|
6.96e-01
|
9.21e-01
|
0.23000
|
-1.08e-01
|
2.03e-01
|
6.76e-01
|
4.31e-01
|
GOBP CELL PROLIFERATION IN BONE MARROW
|
10
|
4.51e-01
|
8.44e-01
|
0.23000
|
-2.30e-01
|
1.15e-02
|
2.08e-01
|
9.50e-01
|
GOBP MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL
|
47
|
2.43e-02
|
3.30e-01
|
0.23000
|
-2.30e-01
|
1.61e-02
|
6.46e-03
|
8.48e-01
|
GOBP INOSINE METABOLIC PROCESS
|
5
|
7.02e-01
|
9.22e-01
|
0.23000
|
1.65e-01
|
-1.61e-01
|
5.23e-01
|
5.34e-01
|
GOCC ARYL HYDROCARBON RECEPTOR COMPLEX
|
8
|
4.89e-01
|
8.56e-01
|
0.23000
|
1.29e-01
|
1.91e-01
|
5.29e-01
|
3.50e-01
|
GOMF LIPASE BINDING
|
7
|
6.09e-01
|
8.97e-01
|
0.23000
|
-1.80e-01
|
1.43e-01
|
4.10e-01
|
5.12e-01
|
GOCC CENTRIOLAR SUBDISTAL APPENDAGE
|
9
|
5.27e-01
|
8.72e-01
|
0.23000
|
-1.33e-01
|
1.87e-01
|
4.89e-01
|
3.31e-01
|
GOBP REGULATION OF GLUTAMATE SECRETION
|
20
|
1.92e-01
|
6.85e-01
|
0.23000
|
2.53e-02
|
2.28e-01
|
8.45e-01
|
7.70e-02
|
GOBP MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE
|
29
|
1.27e-01
|
6.07e-01
|
0.23000
|
-1.32e-01
|
1.88e-01
|
2.18e-01
|
7.98e-02
|
GOBP PROTEIN POLYGLUTAMYLATION
|
12
|
3.42e-01
|
7.93e-01
|
0.23000
|
-1.33e-01
|
-1.87e-01
|
4.26e-01
|
2.61e-01
|
GOBP PROTEIN TRIMERIZATION
|
17
|
3.02e-01
|
7.67e-01
|
0.23000
|
1.68e-01
|
-1.56e-01
|
2.29e-01
|
2.65e-01
|
GOBP C TERMINAL PROTEIN LIPIDATION
|
5
|
6.44e-01
|
9.07e-01
|
0.23000
|
-2.05e-01
|
-1.03e-01
|
4.26e-01
|
6.91e-01
|
GOBP PROLINE METABOLIC PROCESS
|
10
|
4.07e-01
|
8.26e-01
|
0.22900
|
-1.68e-01
|
-1.56e-01
|
3.58e-01
|
3.92e-01
|
GOBP SNRNA TRANSPORT
|
6
|
6.09e-01
|
8.97e-01
|
0.22900
|
3.16e-02
|
2.27e-01
|
8.94e-01
|
3.35e-01
|
GOBP POSITIVE REGULATION OF BLOOD VESSEL REMODELING
|
6
|
6.37e-01
|
9.06e-01
|
0.22900
|
-2.21e-01
|
6.12e-02
|
3.48e-01
|
7.95e-01
|
GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE
|
19
|
2.46e-01
|
7.26e-01
|
0.22900
|
7.90e-02
|
-2.15e-01
|
5.51e-01
|
1.04e-01
|
GOBP VESICLE FUSION WITH GOLGI APPARATUS
|
9
|
4.55e-01
|
8.46e-01
|
0.22900
|
-9.95e-02
|
-2.07e-01
|
6.05e-01
|
2.83e-01
|
GOBP B 1 B CELL DIFFERENTIATION
|
5
|
6.62e-01
|
9.10e-01
|
0.22900
|
2.77e-02
|
2.28e-01
|
9.15e-01
|
3.78e-01
|
GOBP REGULATION OF GLUCOCORTICOID SECRETION
|
10
|
4.10e-01
|
8.27e-01
|
0.22900
|
-1.85e-01
|
-1.35e-01
|
3.11e-01
|
4.58e-01
|
GOBP ADHERENS JUNCTION ASSEMBLY
|
13
|
3.80e-01
|
8.15e-01
|
0.22900
|
-6.96e-02
|
2.18e-01
|
6.64e-01
|
1.73e-01
|
GOBP CILIARY BASAL BODY ORGANIZATION
|
5
|
6.74e-01
|
9.13e-01
|
0.22900
|
2.29e-01
|
-1.31e-02
|
3.76e-01
|
9.59e-01
|
GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
31
|
7.37e-02
|
5.13e-01
|
0.22900
|
5.24e-02
|
2.23e-01
|
6.14e-01
|
3.16e-02
|
GOBP PROTEIN REFOLDING
|
26
|
1.44e-01
|
6.28e-01
|
0.22900
|
2.20e-01
|
-6.50e-02
|
5.25e-02
|
5.66e-01
|
GOBP HISTONE H3 K9 METHYLATION
|
5
|
6.59e-01
|
9.09e-01
|
0.22900
|
-4.19e-02
|
-2.25e-01
|
8.71e-01
|
3.83e-01
|
GOBP CARDIAC ATRIUM MORPHOGENESIS
|
29
|
1.26e-01
|
6.06e-01
|
0.22900
|
-1.12e-01
|
2.00e-01
|
2.96e-01
|
6.27e-02
|
GOBP CERAMIDE 1 PHOSPHATE TRANSPORT
|
7
|
5.74e-01
|
8.88e-01
|
0.22900
|
-4.30e-03
|
2.29e-01
|
9.84e-01
|
2.94e-01
|
GOMF CERAMIDE 1 PHOSPHATE TRANSFER ACTIVITY
|
7
|
5.74e-01
|
8.88e-01
|
0.22900
|
-4.30e-03
|
2.29e-01
|
9.84e-01
|
2.94e-01
|
GOBP REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE
|
17
|
2.95e-01
|
7.65e-01
|
0.22900
|
-2.03e-01
|
1.06e-01
|
1.48e-01
|
4.50e-01
|
GOBP INTERLEUKIN 33 MEDIATED SIGNALING PATHWAY
|
7
|
6.04e-01
|
8.96e-01
|
0.22900
|
2.05e-01
|
-1.03e-01
|
3.49e-01
|
6.38e-01
|
GOBP CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS
|
15
|
2.65e-01
|
7.41e-01
|
0.22900
|
1.29e-01
|
1.89e-01
|
3.86e-01
|
2.06e-01
|
GOCC MYOSIN FILAMENT
|
24
|
1.28e-01
|
6.08e-01
|
0.22900
|
7.62e-02
|
2.16e-01
|
5.18e-01
|
6.73e-02
|
GOBP RADIAL GLIAL CELL DIFFERENTIATION
|
14
|
3.19e-01
|
7.78e-01
|
0.22900
|
2.27e-01
|
2.43e-02
|
1.41e-01
|
8.75e-01
|
GOBP PIECEMEAL MICROAUTOPHAGY OF THE NUCLEUS
|
10
|
4.79e-01
|
8.54e-01
|
0.22900
|
-2.16e-01
|
7.41e-02
|
2.36e-01
|
6.85e-01
|
GOBP NEGATIVE REGULATION OF CHOLESTEROL STORAGE
|
11
|
4.34e-01
|
8.38e-01
|
0.22900
|
4.41e-02
|
-2.24e-01
|
8.00e-01
|
1.98e-01
|
GOBP MESENCHYMAL TO EPITHELIAL TRANSITION
|
18
|
2.82e-01
|
7.56e-01
|
0.22900
|
-1.83e-01
|
1.37e-01
|
1.79e-01
|
3.14e-01
|
GOBP REGULATION OF LYSOSOMAL LUMEN PH
|
27
|
1.21e-01
|
6.01e-01
|
0.22800
|
-2.28e-01
|
9.16e-03
|
4.03e-02
|
9.34e-01
|
GOBP MAINTENANCE OF CENTROSOME LOCATION
|
6
|
5.99e-01
|
8.95e-01
|
0.22800
|
2.13e-01
|
8.04e-02
|
3.65e-01
|
7.33e-01
|
GOCC TRAPPIII PROTEIN COMPLEX
|
11
|
4.52e-01
|
8.45e-01
|
0.22800
|
-2.10e-01
|
8.98e-02
|
2.29e-01
|
6.06e-01
|
GOBP REGULATION OF NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE
|
8
|
5.05e-01
|
8.65e-01
|
0.22800
|
-2.13e-01
|
-8.11e-02
|
2.96e-01
|
6.91e-01
|
GOMF INTERLEUKIN 12 RECEPTOR BINDING
|
5
|
7.05e-01
|
9.24e-01
|
0.22800
|
1.38e-01
|
-1.81e-01
|
5.92e-01
|
4.83e-01
|
GOBP CARBOHYDRATE IMPORT ACROSS PLASMA MEMBRANE
|
6
|
6.45e-01
|
9.07e-01
|
0.22800
|
-7.52e-02
|
2.15e-01
|
7.50e-01
|
3.61e-01
|
GOBP PHOSPHATIDYLSERINE ACYL CHAIN REMODELING
|
9
|
5.35e-01
|
8.76e-01
|
0.22800
|
-1.52e-01
|
1.70e-01
|
4.30e-01
|
3.77e-01
|
GOBP VESICLE TETHERING TO GOLGI
|
5
|
6.50e-01
|
9.07e-01
|
0.22800
|
2.09e-01
|
9.00e-02
|
4.17e-01
|
7.27e-01
|
GOBP TRANSPORT OF VIRUS
|
21
|
2.11e-01
|
7.00e-01
|
0.22800
|
5.97e-02
|
-2.20e-01
|
6.36e-01
|
8.10e-02
|
GOBP NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING
|
16
|
3.29e-01
|
7.84e-01
|
0.22800
|
-1.56e-01
|
1.66e-01
|
2.80e-01
|
2.50e-01
|
GOBP NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY
|
15
|
3.14e-01
|
7.76e-01
|
0.22800
|
-2.01e-02
|
2.27e-01
|
8.93e-01
|
1.28e-01
|
GOBP POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING
|
41
|
5.50e-02
|
4.63e-01
|
0.22800
|
-1.11e-01
|
1.99e-01
|
2.17e-01
|
2.76e-02
|
GOBP REGULATION OF RESPONSE TO OXIDATIVE STRESS
|
31
|
1.13e-01
|
5.91e-01
|
0.22800
|
-1.22e-01
|
1.92e-01
|
2.39e-01
|
6.38e-02
|
GOBP NEGATIVE REGULATION OF RIBOSOME BIOGENESIS
|
7
|
5.50e-01
|
8.80e-01
|
0.22800
|
-8.16e-02
|
-2.13e-01
|
7.08e-01
|
3.30e-01
|
GOBP POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT
|
19
|
2.32e-01
|
7.18e-01
|
0.22800
|
2.27e-01
|
-2.40e-02
|
8.73e-02
|
8.56e-01
|
GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT
|
35
|
4.78e-02
|
4.38e-01
|
0.22800
|
2.00e-01
|
1.10e-01
|
4.09e-02
|
2.62e-01
|
GOMF PHOSPHATIDYLINOSITOL PHOSPHATE PHOSPHATASE ACTIVITY
|
26
|
1.19e-01
|
6.00e-01
|
0.22800
|
-2.25e-01
|
-3.56e-02
|
4.71e-02
|
7.54e-01
|
GOMF NON MEMBRANE SPANNING PROTEIN TYROSINE PHOSPHATASE ACTIVITY
|
12
|
4.27e-01
|
8.36e-01
|
0.22800
|
-2.02e-01
|
1.05e-01
|
2.26e-01
|
5.28e-01
|
GOMF DOPAMINE NEUROTRANSMITTER RECEPTOR ACTIVITY
|
5
|
6.98e-01
|
9.21e-01
|
0.22800
|
-8.90e-02
|
2.10e-01
|
7.30e-01
|
4.17e-01
|
GOBP REGULATION OF NEUTROPHIL CHEMOTAXIS
|
31
|
7.90e-02
|
5.27e-01
|
0.22800
|
3.82e-02
|
2.24e-01
|
7.13e-01
|
3.06e-02
|
GOBP RESPONSE TO MAGNESIUM ION
|
20
|
2.19e-01
|
7.08e-01
|
0.22800
|
-3.43e-02
|
2.25e-01
|
7.91e-01
|
8.16e-02
|
GOMF SERINE TYPE EXOPEPTIDASE ACTIVITY
|
12
|
3.86e-01
|
8.19e-01
|
0.22800
|
5.54e-03
|
2.27e-01
|
9.73e-01
|
1.72e-01
|
GOBP FC GAMMA RECEPTOR SIGNALING PATHWAY
|
31
|
1.13e-01
|
5.91e-01
|
0.22800
|
-1.19e-01
|
1.94e-01
|
2.53e-01
|
6.14e-02
|
GOBP MESENCHYMAL CELL PROLIFERATION INVOLVED IN LUNG DEVELOPMENT
|
6
|
6.55e-01
|
9.09e-01
|
0.22700
|
1.98e-01
|
-1.11e-01
|
4.00e-01
|
6.36e-01
|
GOBP PROTEIN DNA COMPLEX DISASSEMBLY
|
21
|
1.62e-01
|
6.48e-01
|
0.22700
|
-2.00e-01
|
-1.08e-01
|
1.12e-01
|
3.91e-01
|
GOBP POSITIVE REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY
|
11
|
4.65e-01
|
8.49e-01
|
0.22700
|
-1.35e-01
|
1.83e-01
|
4.40e-01
|
2.92e-01
|
GOBP ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY
|
177
|
1.99e-07
|
1.02e-04
|
0.22700
|
1.35e-01
|
1.83e-01
|
1.98e-03
|
2.61e-05
|
GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE REGULATOR ACTIVITY
|
47
|
2.68e-02
|
3.41e-01
|
0.22700
|
1.84e-02
|
-2.27e-01
|
8.27e-01
|
7.17e-03
|
GOBP POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVITY
|
14
|
3.52e-01
|
7.97e-01
|
0.22700
|
-5.06e-02
|
2.22e-01
|
7.43e-01
|
1.51e-01
|
GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY
|
9
|
5.34e-01
|
8.76e-01
|
0.22700
|
1.30e-01
|
-1.87e-01
|
5.01e-01
|
3.32e-01
|
GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS
|
18
|
2.09e-01
|
6.97e-01
|
0.22700
|
1.18e-01
|
1.94e-01
|
3.88e-01
|
1.53e-01
|
GOBP SEROTONIN UPTAKE
|
12
|
3.53e-01
|
7.97e-01
|
0.22700
|
1.96e-01
|
1.15e-01
|
2.40e-01
|
4.89e-01
|
GOCC SMC5 SMC6 COMPLEX
|
9
|
5.37e-01
|
8.77e-01
|
0.22700
|
1.49e-01
|
-1.72e-01
|
4.40e-01
|
3.72e-01
|
GOBP PROTEIN LOCALIZATION TO GOLGI MEMBRANE
|
5
|
6.98e-01
|
9.21e-01
|
0.22700
|
-8.56e-02
|
2.10e-01
|
7.40e-01
|
4.15e-01
|
GOBP N TERMINAL PROTEIN AMINO ACID ACETYLATION
|
15
|
2.75e-01
|
7.49e-01
|
0.22700
|
-2.04e-01
|
-9.92e-02
|
1.71e-01
|
5.06e-01
|
GOBP MIDBRAIN HINDBRAIN BOUNDARY DEVELOPMENT
|
7
|
5.40e-01
|
8.78e-01
|
0.22700
|
-1.55e-01
|
-1.66e-01
|
4.76e-01
|
4.48e-01
|
GOBP POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE
|
46
|
3.29e-02
|
3.70e-01
|
0.22700
|
-5.07e-02
|
2.21e-01
|
5.52e-01
|
9.39e-03
|
GOBP REGULATION OF PENTOSE PHOSPHATE SHUNT
|
7
|
6.02e-01
|
8.96e-01
|
0.22700
|
-2.14e-01
|
7.68e-02
|
3.28e-01
|
7.25e-01
|
GOBP TOOTH MINERALIZATION
|
28
|
1.17e-01
|
5.97e-01
|
0.22700
|
-1.98e-02
|
2.26e-01
|
8.56e-01
|
3.83e-02
|
GOBP REGULATION OF NEURONAL SYNAPTIC PLASTICITY
|
53
|
1.39e-02
|
2.56e-01
|
0.22700
|
2.94e-02
|
2.25e-01
|
7.12e-01
|
4.60e-03
|
GOBP NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS
|
12
|
3.49e-01
|
7.96e-01
|
0.22700
|
1.47e-01
|
1.73e-01
|
3.79e-01
|
2.99e-01
|
GOBP CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION
|
27
|
1.02e-01
|
5.72e-01
|
0.22700
|
2.11e-01
|
8.27e-02
|
5.74e-02
|
4.57e-01
|
GOBP POSITIVE REGULATION OF G0 TO G1 TRANSITION
|
5
|
6.97e-01
|
9.21e-01
|
0.22700
|
-2.13e-01
|
7.91e-02
|
4.10e-01
|
7.59e-01
|
GOBP POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS
|
41
|
4.49e-02
|
4.30e-01
|
0.22700
|
-2.87e-02
|
2.25e-01
|
7.51e-01
|
1.27e-02
|
GOMF L LEUCINE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
6
|
6.61e-01
|
9.09e-01
|
0.22700
|
-1.81e-01
|
1.37e-01
|
4.43e-01
|
5.62e-01
|
GOBP GLUCOSE 6 PHOSPHATE METABOLIC PROCESS
|
27
|
1.50e-01
|
6.36e-01
|
0.22700
|
-2.02e-01
|
1.03e-01
|
6.97e-02
|
3.53e-01
|
GOBP POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS
|
19
|
2.68e-01
|
7.44e-01
|
0.22700
|
-1.29e-01
|
1.87e-01
|
3.32e-01
|
1.59e-01
|
GOBP ATRIAL SEPTUM DEVELOPMENT
|
23
|
1.62e-01
|
6.48e-01
|
0.22600
|
1.38e-02
|
2.26e-01
|
9.09e-01
|
6.06e-02
|
GOMF FATTY ACID TRANSMEMBRANE TRANSPORTER ACTIVITY
|
10
|
4.76e-01
|
8.54e-01
|
0.22600
|
-2.22e-01
|
4.67e-02
|
2.25e-01
|
7.98e-01
|
GOBP REGULATION OF SNARE COMPLEX ASSEMBLY
|
14
|
2.96e-01
|
7.65e-01
|
0.22600
|
-1.82e-01
|
-1.34e-01
|
2.38e-01
|
3.85e-01
|
GOMF ASPARTIC TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY
|
7
|
5.58e-01
|
8.82e-01
|
0.22600
|
-6.87e-02
|
-2.16e-01
|
7.53e-01
|
3.23e-01
|
GOBP LEUCINE IMPORT ACROSS PLASMA MEMBRANE
|
5
|
7.10e-01
|
9.26e-01
|
0.22600
|
-1.70e-01
|
1.50e-01
|
5.11e-01
|
5.62e-01
|
GOBP CHITIN METABOLIC PROCESS
|
6
|
5.93e-01
|
8.94e-01
|
0.22600
|
1.39e-01
|
1.78e-01
|
5.55e-01
|
4.49e-01
|
GOMF CHITINASE ACTIVITY
|
6
|
5.93e-01
|
8.94e-01
|
0.22600
|
1.39e-01
|
1.78e-01
|
5.55e-01
|
4.49e-01
|
GOCC OUTER MITOCHONDRIAL MEMBRANE PROTEIN COMPLEX
|
21
|
2.12e-01
|
7.00e-01
|
0.22600
|
4.70e-02
|
-2.21e-01
|
7.09e-01
|
7.93e-02
|
GOBP POSITIVE REGULATION OF BMP SIGNALING PATHWAY
|
40
|
6.14e-02
|
4.80e-01
|
0.22600
|
-1.08e-01
|
1.99e-01
|
2.38e-01
|
2.97e-02
|
GOMF GALACTOSIDASE ACTIVITY
|
6
|
6.24e-01
|
9.01e-01
|
0.22600
|
-1.23e-02
|
-2.26e-01
|
9.59e-01
|
3.39e-01
|
GOBP DORSAL VENTRAL AXIS SPECIFICATION
|
12
|
4.38e-01
|
8.40e-01
|
0.22600
|
-1.84e-01
|
1.31e-01
|
2.69e-01
|
4.33e-01
|
GOBP REGULATION OF MITOCHONDRIAL GENE EXPRESSION
|
30
|
7.90e-02
|
5.27e-01
|
0.22600
|
-9.31e-02
|
-2.06e-01
|
3.77e-01
|
5.11e-02
|
GOBP SKELETAL MUSCLE FIBER DIFFERENTIATION
|
8
|
5.04e-01
|
8.65e-01
|
0.22600
|
1.98e-01
|
1.09e-01
|
3.32e-01
|
5.94e-01
|
GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY
|
15
|
3.38e-01
|
7.90e-01
|
0.22600
|
6.61e-02
|
-2.16e-01
|
6.57e-01
|
1.48e-01
|
GOBP REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION
|
172
|
6.55e-06
|
1.10e-03
|
0.22600
|
-1.04e-01
|
2.00e-01
|
1.85e-02
|
5.79e-06
|
GOBP RESPONSE TO NITROSATIVE STRESS
|
10
|
4.28e-01
|
8.36e-01
|
0.22600
|
-2.04e-01
|
-9.63e-02
|
2.64e-01
|
5.98e-01
|
GOCC SEMAPHORIN RECEPTOR COMPLEX
|
9
|
5.10e-01
|
8.66e-01
|
0.22600
|
-3.24e-02
|
2.23e-01
|
8.66e-01
|
2.46e-01
|
GOBP PLASMA MEMBRANE RAFT ORGANIZATION
|
11
|
4.30e-01
|
8.37e-01
|
0.22600
|
-9.34e-03
|
2.25e-01
|
9.57e-01
|
1.95e-01
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS WITH A FLAVIN AS ACCEPTOR
|
12
|
3.55e-01
|
7.97e-01
|
0.22600
|
-1.81e-01
|
-1.34e-01
|
2.77e-01
|
4.21e-01
|
GOBP DIOL METABOLIC PROCESS
|
30
|
8.67e-02
|
5.46e-01
|
0.22500
|
-5.25e-02
|
-2.19e-01
|
6.18e-01
|
3.77e-02
|
GOMF SERINE TYPE CARBOXYPEPTIDASE ACTIVITY
|
5
|
6.48e-01
|
9.07e-01
|
0.22500
|
1.54e-01
|
1.64e-01
|
5.51e-01
|
5.24e-01
|
GOBP EMBRYONIC SKELETAL JOINT MORPHOGENESIS
|
11
|
4.54e-01
|
8.46e-01
|
0.22500
|
-7.01e-02
|
2.14e-01
|
6.87e-01
|
2.19e-01
|
GOBP LAYER FORMATION IN CEREBRAL CORTEX
|
14
|
3.22e-01
|
7.79e-01
|
0.22500
|
4.46e-02
|
2.21e-01
|
7.72e-01
|
1.52e-01
|
GOBP REGULATION OF MYOBLAST PROLIFERATION
|
25
|
1.19e-01
|
6.00e-01
|
0.22500
|
1.13e-01
|
1.95e-01
|
3.29e-01
|
9.14e-02
|
GOBP REGULATION OF LIPOPHAGY
|
5
|
7.10e-01
|
9.26e-01
|
0.22500
|
1.86e-01
|
-1.28e-01
|
4.72e-01
|
6.21e-01
|
GOBP GENERAL ADAPTATION SYNDROME BEHAVIORAL PROCESS
|
5
|
7.11e-01
|
9.27e-01
|
0.22500
|
1.76e-01
|
-1.40e-01
|
4.95e-01
|
5.87e-01
|
GOCC N TERMINAL PROTEIN ACETYLTRANSFERASE COMPLEX
|
9
|
5.41e-01
|
8.78e-01
|
0.22500
|
1.33e-01
|
-1.82e-01
|
4.90e-01
|
3.45e-01
|
GOBP ACROSOMAL VESICLE EXOCYTOSIS
|
9
|
5.33e-01
|
8.76e-01
|
0.22500
|
2.03e-01
|
-9.80e-02
|
2.92e-01
|
6.11e-01
|
GOBP DECIDUALIZATION
|
24
|
1.85e-01
|
6.76e-01
|
0.22500
|
-2.07e-01
|
8.97e-02
|
7.99e-02
|
4.47e-01
|
GOBP TENDON DEVELOPMENT
|
5
|
6.58e-01
|
9.09e-01
|
0.22500
|
-2.08e-01
|
-8.57e-02
|
4.20e-01
|
7.40e-01
|
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMATIN
|
9
|
5.43e-01
|
8.78e-01
|
0.22500
|
-1.64e-01
|
1.54e-01
|
3.94e-01
|
4.23e-01
|
GOBP SINGLE STRAND BREAK REPAIR
|
11
|
4.59e-01
|
8.48e-01
|
0.22500
|
8.20e-02
|
-2.10e-01
|
6.38e-01
|
2.29e-01
|
GOBP DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT
|
8
|
5.58e-01
|
8.82e-01
|
0.22500
|
-2.19e-01
|
5.26e-02
|
2.84e-01
|
7.97e-01
|
GOMF METHYLATION DEPENDENT PROTEIN BINDING
|
69
|
4.63e-03
|
1.39e-01
|
0.22500
|
-2.25e-01
|
-1.24e-02
|
1.25e-03
|
8.58e-01
|
GOBP NUCLEUS LOCALIZATION
|
33
|
1.05e-01
|
5.77e-01
|
0.22500
|
-1.86e-01
|
1.27e-01
|
6.48e-02
|
2.07e-01
|
GOBP DISRUPTION OF CELLULAR ANATOMICAL STRUCTURE IN ANOTHER ORGANISM
|
7
|
6.18e-01
|
9.00e-01
|
0.22500
|
1.93e-01
|
-1.15e-01
|
3.76e-01
|
5.98e-01
|
GOBP PULMONARY VALVE DEVELOPMENT
|
23
|
2.01e-01
|
6.90e-01
|
0.22500
|
-2.04e-01
|
9.45e-02
|
9.03e-02
|
4.33e-01
|
GOBP NEGATIVE REGULATION OF CELL ADHESION MOLECULE PRODUCTION
|
10
|
5.09e-01
|
8.66e-01
|
0.22500
|
-1.60e-01
|
1.58e-01
|
3.82e-01
|
3.86e-01
|
GOBP NEGATIVE REGULATION OF PHOSPHOLIPASE ACTIVITY
|
6
|
6.67e-01
|
9.11e-01
|
0.22500
|
1.48e-01
|
-1.69e-01
|
5.30e-01
|
4.74e-01
|
GOBP RIBOSOME ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS
|
7
|
5.51e-01
|
8.80e-01
|
0.22500
|
-1.22e-01
|
-1.88e-01
|
5.75e-01
|
3.88e-01
|
GOBP REGULATION OF NATURAL KILLER CELL DIFFERENTIATION
|
12
|
3.70e-01
|
8.09e-01
|
0.22500
|
2.10e-01
|
7.88e-02
|
2.07e-01
|
6.37e-01
|
GOBP PROTEIN LOCALIZATION TO NON MOTILE CILIUM
|
12
|
4.23e-01
|
8.34e-01
|
0.22500
|
6.35e-02
|
-2.15e-01
|
7.03e-01
|
1.96e-01
|
GOBP RESPONSE TO ACTINOMYCIN D
|
5
|
6.55e-01
|
9.09e-01
|
0.22400
|
1.11e-01
|
1.95e-01
|
6.68e-01
|
4.50e-01
|
GOCC DERLIN 1 RETROTRANSLOCATION COMPLEX
|
8
|
5.57e-01
|
8.82e-01
|
0.22400
|
-2.20e-01
|
4.39e-02
|
2.81e-01
|
8.30e-01
|
GOBP HEPARIN BIOSYNTHETIC PROCESS
|
11
|
4.51e-01
|
8.44e-01
|
0.22400
|
-5.20e-02
|
2.18e-01
|
7.65e-01
|
2.10e-01
|
GOBP RESPONSE TO MANGANESE ION
|
17
|
2.45e-01
|
7.26e-01
|
0.22400
|
-7.97e-02
|
-2.10e-01
|
5.69e-01
|
1.34e-01
|
GOBP N GLYCAN PROCESSING
|
17
|
3.06e-01
|
7.70e-01
|
0.22400
|
-8.98e-02
|
2.06e-01
|
5.21e-01
|
1.42e-01
|
GOCC NUCLEOID
|
43
|
2.52e-02
|
3.31e-01
|
0.22400
|
-1.55e-01
|
-1.62e-01
|
7.80e-02
|
6.66e-02
|
GOBP REGULATION OF ER ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS
|
7
|
6.25e-01
|
9.01e-01
|
0.22400
|
1.59e-01
|
-1.58e-01
|
4.65e-01
|
4.70e-01
|
GOBP NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS
|
54
|
1.46e-02
|
2.59e-01
|
0.22400
|
-2.23e-01
|
-2.37e-02
|
4.60e-03
|
7.63e-01
|
GOMF MANNOSE BINDING
|
24
|
1.47e-01
|
6.33e-01
|
0.22400
|
-2.20e-01
|
-4.46e-02
|
6.25e-02
|
7.05e-01
|
GOMF FILAMIN BINDING
|
14
|
3.38e-01
|
7.90e-01
|
0.22400
|
1.20e-02
|
2.24e-01
|
9.38e-01
|
1.47e-01
|
GOBP SULFATION
|
20
|
2.19e-01
|
7.08e-01
|
0.22400
|
5.93e-03
|
-2.24e-01
|
9.63e-01
|
8.29e-02
|
GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL MATURATION
|
13
|
3.50e-01
|
7.96e-01
|
0.22400
|
-5.62e-02
|
-2.17e-01
|
7.26e-01
|
1.76e-01
|
GOBP CRISTAE FORMATION
|
15
|
2.78e-01
|
7.51e-01
|
0.22400
|
-1.71e-01
|
-1.45e-01
|
2.52e-01
|
3.32e-01
|
GOBP POSITIVE REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE
|
11
|
4.15e-01
|
8.30e-01
|
0.22400
|
4.70e-02
|
2.19e-01
|
7.87e-01
|
2.09e-01
|
GOBP PROTEOGLYCAN CATABOLIC PROCESS
|
9
|
5.17e-01
|
8.69e-01
|
0.22400
|
-3.62e-02
|
2.21e-01
|
8.51e-01
|
2.51e-01
|
GOBP NEGATIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION
|
7
|
6.20e-01
|
9.00e-01
|
0.22400
|
-1.95e-01
|
1.09e-01
|
3.71e-01
|
6.17e-01
|
GOBP NEGATIVE REGULATION OF LIPID STORAGE
|
22
|
1.76e-01
|
6.65e-01
|
0.22400
|
-3.55e-02
|
-2.21e-01
|
7.73e-01
|
7.29e-02
|
GOBP NK T CELL PROLIFERATION
|
8
|
5.41e-01
|
8.78e-01
|
0.22400
|
2.23e-01
|
8.94e-03
|
2.74e-01
|
9.65e-01
|
GOBP LEPTIN MEDIATED SIGNALING PATHWAY
|
10
|
4.73e-01
|
8.53e-01
|
0.22400
|
1.56e-02
|
-2.23e-01
|
9.32e-01
|
2.22e-01
|
GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS
|
7
|
6.16e-01
|
9.00e-01
|
0.22400
|
9.25e-02
|
-2.04e-01
|
6.72e-01
|
3.51e-01
|
GOBP PROTEIN LOCALIZATION TO MEMBRANE RAFT
|
9
|
5.09e-01
|
8.66e-01
|
0.22400
|
-1.24e-02
|
2.23e-01
|
9.49e-01
|
2.46e-01
|
GOCC PARANODE REGION OF AXON
|
12
|
4.25e-01
|
8.36e-01
|
0.22400
|
-5.89e-02
|
2.16e-01
|
7.24e-01
|
1.96e-01
|
GOBP PURINE RIBONUCLEOTIDE SALVAGE
|
7
|
6.24e-01
|
9.01e-01
|
0.22300
|
-1.27e-01
|
1.84e-01
|
5.62e-01
|
3.99e-01
|
GOMF NUCLEAR IMPORT SIGNAL RECEPTOR ACTIVITY
|
20
|
1.83e-01
|
6.72e-01
|
0.22300
|
-1.44e-01
|
-1.71e-01
|
2.66e-01
|
1.85e-01
|
GOBP POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL
|
25
|
1.22e-01
|
6.03e-01
|
0.22300
|
-1.90e-01
|
-1.17e-01
|
9.95e-02
|
3.11e-01
|
GOMF ALCOHOL DEHYDROGENASE NAD P PLUS ACTIVITY
|
10
|
4.74e-01
|
8.54e-01
|
0.22300
|
1.65e-02
|
-2.23e-01
|
9.28e-01
|
2.22e-01
|
GOBP AMINE CATABOLIC PROCESS
|
15
|
2.80e-01
|
7.52e-01
|
0.22300
|
1.46e-01
|
1.69e-01
|
3.27e-01
|
2.57e-01
|
GOBP POSITIVE REGULATION OF EXOSOMAL SECRETION
|
15
|
3.39e-01
|
7.90e-01
|
0.22300
|
-2.19e-01
|
4.58e-02
|
1.43e-01
|
7.59e-01
|
GOBP CELLULAR RESPONSE TO INSULIN LIKE GROWTH FACTOR STIMULUS
|
7
|
5.52e-01
|
8.80e-01
|
0.22300
|
-1.76e-01
|
-1.38e-01
|
4.20e-01
|
5.29e-01
|
GOBP GRANULOCYTE COLONY STIMULATING FACTOR PRODUCTION
|
5
|
6.63e-01
|
9.10e-01
|
0.22300
|
2.08e-01
|
8.11e-02
|
4.21e-01
|
7.54e-01
|
GOBP REGULATION OF RESPONSE TO TUMOR CELL
|
22
|
2.18e-01
|
7.07e-01
|
0.22300
|
2.05e-01
|
-8.75e-02
|
9.54e-02
|
4.77e-01
|
GOMF QUINONE BINDING
|
15
|
3.65e-01
|
8.05e-01
|
0.22300
|
-1.85e-01
|
1.25e-01
|
2.14e-01
|
4.03e-01
|
GOBP CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS
|
18
|
2.30e-01
|
7.18e-01
|
0.22300
|
-7.51e-02
|
-2.10e-01
|
5.81e-01
|
1.23e-01
|
GOBP REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY
|
34
|
6.66e-02
|
4.98e-01
|
0.22300
|
5.01e-02
|
2.17e-01
|
6.13e-01
|
2.82e-02
|
GOBP POSITIVE REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE
|
11
|
4.42e-01
|
8.40e-01
|
0.22300
|
-2.22e-01
|
1.90e-02
|
2.02e-01
|
9.13e-01
|
GOMF DNA DAMAGE SENSOR ACTIVITY
|
23
|
1.43e-01
|
6.28e-01
|
0.22300
|
-1.74e-01
|
-1.39e-01
|
1.48e-01
|
2.47e-01
|
GOMF P TYPE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
21
|
2.47e-01
|
7.26e-01
|
0.22300
|
-1.63e-01
|
1.52e-01
|
1.95e-01
|
2.29e-01
|
GOBP ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA
|
10
|
4.80e-01
|
8.54e-01
|
0.22300
|
-2.21e-01
|
2.75e-02
|
2.26e-01
|
8.80e-01
|
GOBP IMMUNE RESPONSE INHIBITING SIGNAL TRANSDUCTION
|
11
|
4.64e-01
|
8.48e-01
|
0.22300
|
-2.10e-01
|
7.47e-02
|
2.28e-01
|
6.68e-01
|
GOBP REGULATION OF PLATELET AGGREGATION
|
27
|
1.34e-01
|
6.16e-01
|
0.22300
|
-1.31e-02
|
2.22e-01
|
9.06e-01
|
4.54e-02
|
GOMF ADENYLATE KINASE ACTIVITY
|
9
|
4.69e-01
|
8.51e-01
|
0.22300
|
-1.25e-01
|
-1.84e-01
|
5.15e-01
|
3.39e-01
|
GOBP ERBB2 SIGNALING PATHWAY
|
18
|
2.18e-01
|
7.07e-01
|
0.22300
|
-1.47e-01
|
-1.67e-01
|
2.79e-01
|
2.19e-01
|
GOBP PML BODY ORGANIZATION
|
7
|
6.26e-01
|
9.01e-01
|
0.22300
|
-1.82e-01
|
1.28e-01
|
4.03e-01
|
5.58e-01
|
GOBP VESICLE TETHERING
|
31
|
1.27e-01
|
6.07e-01
|
0.22300
|
-1.32e-01
|
1.79e-01
|
2.02e-01
|
8.45e-02
|
GOBP CARDIAC ATRIUM DEVELOPMENT
|
37
|
6.33e-02
|
4.84e-01
|
0.22300
|
-8.26e-03
|
2.22e-01
|
9.31e-01
|
1.92e-02
|
GOMF 5 3 DNA EXONUCLEASE ACTIVITY
|
9
|
5.51e-01
|
8.80e-01
|
0.22200
|
1.62e-01
|
-1.53e-01
|
4.01e-01
|
4.28e-01
|
GOBP NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS
|
9
|
4.69e-01
|
8.51e-01
|
0.22200
|
1.47e-01
|
1.67e-01
|
4.45e-01
|
3.86e-01
|
GOBP OSMOSENSORY SIGNALING PATHWAY
|
5
|
6.56e-01
|
9.09e-01
|
0.22200
|
-1.50e-01
|
-1.64e-01
|
5.60e-01
|
5.26e-01
|
GOBP MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS
|
13
|
3.35e-01
|
7.88e-01
|
0.22200
|
-1.45e-01
|
-1.68e-01
|
3.64e-01
|
2.94e-01
|
GOBP MATURE B CELL DIFFERENTIATION
|
34
|
1.01e-01
|
5.71e-01
|
0.22200
|
-1.09e-01
|
1.94e-01
|
2.73e-01
|
5.04e-02
|
GOBP FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA
|
13
|
3.76e-01
|
8.11e-01
|
0.22200
|
-2.22e-01
|
-2.61e-03
|
1.65e-01
|
9.87e-01
|
GOBP NUCLEOSIDE BISPHOSPHATE CATABOLIC PROCESS
|
11
|
4.31e-01
|
8.37e-01
|
0.22200
|
-1.65e-02
|
-2.22e-01
|
9.24e-01
|
2.03e-01
|
GOMF TRNA SPECIFIC ADENOSINE DEAMINASE ACTIVITY
|
8
|
5.87e-01
|
8.91e-01
|
0.22200
|
-1.23e-01
|
1.85e-01
|
5.46e-01
|
3.66e-01
|
GOBP AMINOPHOSPHOLIPID TRANSPORT
|
8
|
5.15e-01
|
8.68e-01
|
0.22200
|
-1.12e-01
|
-1.92e-01
|
5.84e-01
|
3.48e-01
|
GOBP NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION
|
14
|
3.96e-01
|
8.25e-01
|
0.22200
|
-1.40e-01
|
1.72e-01
|
3.65e-01
|
2.64e-01
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS OXYGEN AS ACCEPTOR
|
10
|
4.67e-01
|
8.51e-01
|
0.22200
|
-2.22e-01
|
-1.36e-02
|
2.25e-01
|
9.41e-01
|
GOBP NEPHRIC DUCT FORMATION
|
5
|
6.99e-01
|
9.21e-01
|
0.22200
|
-2.18e-01
|
4.08e-02
|
3.98e-01
|
8.74e-01
|
GOCC RISC LOADING COMPLEX
|
8
|
5.67e-01
|
8.85e-01
|
0.22200
|
-2.16e-01
|
4.91e-02
|
2.89e-01
|
8.10e-01
|
GOBP RRNA BASE METHYLATION
|
8
|
5.25e-01
|
8.71e-01
|
0.22200
|
2.10e-01
|
7.20e-02
|
3.04e-01
|
7.24e-01
|
GOCC MITOCHONDRIAL LARGE RIBOSOMAL SUBUNIT
|
56
|
2.23e-02
|
3.16e-01
|
0.22200
|
9.19e-02
|
-2.02e-01
|
2.34e-01
|
8.94e-03
|
GOBP NEGATIVE REGULATION OF PLASMINOGEN ACTIVATION
|
8
|
5.21e-01
|
8.69e-01
|
0.22200
|
-2.04e-01
|
-8.78e-02
|
3.18e-01
|
6.67e-01
|
GOBP ADENYLATE CYCLASE ACTIVATING DOPAMINE RECEPTOR SIGNALING PATHWAY
|
9
|
5.51e-01
|
8.80e-01
|
0.22200
|
-1.81e-01
|
1.28e-01
|
3.46e-01
|
5.08e-01
|
GOBP CEREBELLAR PURKINJE CELL LAYER FORMATION
|
14
|
3.12e-01
|
7.75e-01
|
0.22200
|
-1.25e-01
|
-1.83e-01
|
4.19e-01
|
2.35e-01
|
GOBP REGULATION OF TORC2 SIGNALING
|
6
|
6.05e-01
|
8.96e-01
|
0.22200
|
-1.68e-01
|
-1.44e-01
|
4.75e-01
|
5.41e-01
|
GOBP VACUOLAR ACIDIFICATION
|
32
|
9.67e-02
|
5.61e-01
|
0.22200
|
-2.21e-01
|
2.07e-02
|
3.07e-02
|
8.39e-01
|
GOBP LEUKOCYTE CHEMOTAXIS INVOLVED IN INFLAMMATORY RESPONSE
|
8
|
5.21e-01
|
8.69e-01
|
0.22200
|
9.03e-02
|
2.02e-01
|
6.58e-01
|
3.22e-01
|
GOBP 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS
|
15
|
3.52e-01
|
7.96e-01
|
0.22200
|
6.44e-02
|
-2.12e-01
|
6.66e-01
|
1.55e-01
|
GOBP CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION
|
15
|
2.85e-01
|
7.57e-01
|
0.22200
|
1.50e-01
|
1.63e-01
|
3.16e-01
|
2.73e-01
|
GOMF OPSONIN BINDING
|
18
|
2.56e-01
|
7.35e-01
|
0.22200
|
-1.15e-02
|
-2.21e-01
|
9.33e-01
|
1.04e-01
|
GOMF METALLOCHAPERONE ACTIVITY
|
12
|
4.04e-01
|
8.26e-01
|
0.22200
|
-1.04e-02
|
-2.21e-01
|
9.50e-01
|
1.84e-01
|
GOBP METANEPHRIC NEPHRON MORPHOGENESIS
|
24
|
2.02e-01
|
6.92e-01
|
0.22200
|
-1.15e-01
|
1.89e-01
|
3.28e-01
|
1.09e-01
|
GOMF CARBON NITROGEN LYASE ACTIVITY
|
13
|
3.62e-01
|
8.03e-01
|
0.22100
|
-2.17e-01
|
-4.39e-02
|
1.75e-01
|
7.84e-01
|
GOMF MRF BINDING
|
5
|
6.75e-01
|
9.13e-01
|
0.22100
|
-5.14e-02
|
-2.15e-01
|
8.42e-01
|
4.04e-01
|
GOBP STORE OPERATED CALCIUM ENTRY
|
21
|
1.84e-01
|
6.74e-01
|
0.22100
|
7.91e-02
|
2.07e-01
|
5.30e-01
|
1.01e-01
|
GOBP PEPTIDE CATABOLIC PROCESS
|
22
|
2.34e-01
|
7.22e-01
|
0.22100
|
-1.30e-01
|
1.79e-01
|
2.92e-01
|
1.45e-01
|
GOBP MYOFIBROBLAST DIFFERENTIATION
|
14
|
3.16e-01
|
7.77e-01
|
0.22100
|
1.07e-01
|
1.94e-01
|
4.87e-01
|
2.10e-01
|
GOBP POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION
|
13
|
3.65e-01
|
8.06e-01
|
0.22100
|
-3.61e-02
|
-2.18e-01
|
8.22e-01
|
1.73e-01
|
GOCC POSTSYNAPTIC CYTOSKELETON
|
10
|
4.73e-01
|
8.53e-01
|
0.22100
|
2.21e-01
|
3.45e-03
|
2.26e-01
|
9.85e-01
|
GOBP CELLULAR RESPONSE TO MANGANESE ION
|
10
|
5.02e-01
|
8.63e-01
|
0.22100
|
7.29e-02
|
-2.09e-01
|
6.90e-01
|
2.53e-01
|
GOBP POSITIVE REGULATION OF CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION
|
11
|
4.04e-01
|
8.26e-01
|
0.22100
|
-1.16e-01
|
-1.89e-01
|
5.07e-01
|
2.79e-01
|
GOCC NBAF COMPLEX
|
16
|
3.50e-01
|
7.96e-01
|
0.22100
|
-1.42e-01
|
1.70e-01
|
3.26e-01
|
2.40e-01
|
GOBP REGULATION OF INCLUSION BODY ASSEMBLY
|
17
|
2.73e-01
|
7.47e-01
|
0.22100
|
-2.20e-01
|
-2.59e-02
|
1.17e-01
|
8.53e-01
|
GOCC AXON HILLOCK
|
7
|
5.72e-01
|
8.87e-01
|
0.22100
|
-2.09e-01
|
-7.08e-02
|
3.37e-01
|
7.46e-01
|
GOBP AMINOGLYCOSIDE ANTIBIOTIC METABOLIC PROCESS
|
10
|
5.06e-01
|
8.65e-01
|
0.22100
|
2.05e-01
|
-8.23e-02
|
2.61e-01
|
6.52e-01
|
GOMF FIBROBLAST GROWTH FACTOR RECEPTOR ACTIVITY
|
5
|
6.70e-01
|
9.11e-01
|
0.22100
|
-2.07e-01
|
-7.67e-02
|
4.22e-01
|
7.66e-01
|
GOCC ZONA PELLUCIDA RECEPTOR COMPLEX
|
8
|
5.85e-01
|
8.90e-01
|
0.22100
|
1.97e-01
|
-1.01e-01
|
3.35e-01
|
6.22e-01
|
GOBP CELL CELL ADHESION MEDIATED BY INTEGRIN
|
17
|
2.76e-01
|
7.49e-01
|
0.22100
|
1.86e-02
|
2.20e-01
|
8.94e-01
|
1.16e-01
|
GOCC CHROMOSOME CENTROMERIC CORE DOMAIN
|
17
|
2.76e-01
|
7.50e-01
|
0.22100
|
2.20e-01
|
1.71e-02
|
1.16e-01
|
9.03e-01
|
GOBP STEROL BIOSYNTHETIC PROCESS
|
63
|
6.02e-03
|
1.62e-01
|
0.22100
|
-1.98e-01
|
-9.71e-02
|
6.45e-03
|
1.83e-01
|
GOMF MALATE DEHYDROGENASE ACTIVITY
|
8
|
5.22e-01
|
8.70e-01
|
0.22100
|
-9.74e-02
|
-1.98e-01
|
6.33e-01
|
3.32e-01
|
GOBP SNRNA TRANSCRIPTION
|
19
|
2.54e-01
|
7.33e-01
|
0.22100
|
2.55e-02
|
-2.19e-01
|
8.48e-01
|
9.78e-02
|
GOBP ESTABLISHMENT OF EPITHELIAL CELL POLARITY
|
33
|
1.16e-01
|
5.96e-01
|
0.22100
|
-1.64e-01
|
1.48e-01
|
1.03e-01
|
1.41e-01
|
GOBP NEGATIVE REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT
|
12
|
4.16e-01
|
8.30e-01
|
0.22100
|
-2.20e-01
|
1.33e-02
|
1.86e-01
|
9.36e-01
|
GOCC AP 2 ADAPTOR COMPLEX
|
10
|
5.01e-01
|
8.62e-01
|
0.22100
|
6.43e-02
|
-2.11e-01
|
7.25e-01
|
2.47e-01
|
GOBP EARLY ENDOSOME TO RECYCLING ENDOSOME TRANSPORT
|
6
|
6.73e-01
|
9.13e-01
|
0.22100
|
-1.17e-01
|
1.87e-01
|
6.20e-01
|
4.27e-01
|
GOBP PHAGOLYSOSOME ASSEMBLY
|
17
|
3.27e-01
|
7.83e-01
|
0.22100
|
1.80e-01
|
-1.27e-01
|
1.98e-01
|
3.63e-01
|
GOBP POSITIVE REGULATION OF FIBROBLAST PROLIFERATION
|
52
|
2.32e-02
|
3.22e-01
|
0.22100
|
1.92e-02
|
-2.20e-01
|
8.10e-01
|
6.10e-03
|
GOBP CELL JUNCTION MAINTENANCE
|
45
|
4.94e-02
|
4.42e-01
|
0.22100
|
-1.98e-01
|
9.82e-02
|
2.18e-02
|
2.54e-01
|
GOCC NUCLEAR CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX
|
14
|
3.47e-01
|
7.96e-01
|
0.22100
|
-1.92e-02
|
-2.20e-01
|
9.01e-01
|
1.55e-01
|
GOBP REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING
|
60
|
1.44e-02
|
2.59e-01
|
0.22100
|
-3.96e-02
|
2.17e-01
|
5.96e-01
|
3.65e-03
|
GOBP CELLULAR RESPONSE TO SODIUM ARSENITE
|
5
|
6.61e-01
|
9.09e-01
|
0.22000
|
1.70e-01
|
1.40e-01
|
5.09e-01
|
5.88e-01
|
GOBP POSITIVE REGULATION OF ACTIN NUCLEATION
|
14
|
3.17e-01
|
7.77e-01
|
0.22000
|
-1.84e-01
|
-1.22e-01
|
2.34e-01
|
4.30e-01
|
GOBP NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING
|
11
|
4.39e-01
|
8.40e-01
|
0.22000
|
1.08e-02
|
2.20e-01
|
9.50e-01
|
2.06e-01
|
GOBP FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS
|
13
|
4.27e-01
|
8.36e-01
|
0.22000
|
1.28e-01
|
-1.79e-01
|
4.23e-01
|
2.64e-01
|
GOBP LONG TERM SYNAPTIC DEPRESSION
|
30
|
1.35e-01
|
6.16e-01
|
0.22000
|
-1.98e-01
|
9.68e-02
|
6.07e-02
|
3.59e-01
|
GOBP SPINDLE ELONGATION
|
13
|
3.91e-01
|
8.21e-01
|
0.22000
|
-2.19e-01
|
1.94e-02
|
1.71e-01
|
9.04e-01
|
GOCC HAUS COMPLEX
|
7
|
6.00e-01
|
8.96e-01
|
0.22000
|
1.16e-02
|
-2.20e-01
|
9.58e-01
|
3.14e-01
|
GOBP RESPONSE TO INTERLEUKIN 15
|
11
|
4.86e-01
|
8.56e-01
|
0.22000
|
-1.84e-01
|
1.21e-01
|
2.91e-01
|
4.86e-01
|
GOBP POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION
|
61
|
1.70e-02
|
2.77e-01
|
0.22000
|
-9.27e-02
|
2.00e-01
|
2.10e-01
|
6.99e-03
|
GOBP REGULATION OF CELL MATURATION
|
20
|
2.57e-01
|
7.35e-01
|
0.22000
|
-2.06e-01
|
7.63e-02
|
1.10e-01
|
5.55e-01
|
GOMF ROUNDABOUT BINDING
|
8
|
5.43e-01
|
8.78e-01
|
0.22000
|
3.26e-02
|
2.18e-01
|
8.73e-01
|
2.86e-01
|
GOBP CYTOPLASMIC TRANSLATIONAL ELONGATION
|
5
|
7.00e-01
|
9.22e-01
|
0.22000
|
-2.18e-01
|
3.05e-02
|
3.99e-01
|
9.06e-01
|
GOCC BLOC 1 COMPLEX
|
9
|
5.25e-01
|
8.71e-01
|
0.22000
|
2.43e-02
|
-2.19e-01
|
9.00e-01
|
2.56e-01
|
GOBP FLAVIN CONTAINING COMPOUND METABOLIC PROCESS
|
6
|
6.40e-01
|
9.06e-01
|
0.22000
|
-2.20e-01
|
-1.02e-02
|
3.51e-01
|
9.65e-01
|
GOCC BLOC COMPLEX
|
14
|
3.24e-01
|
7.80e-01
|
0.22000
|
-1.99e-01
|
-9.40e-02
|
1.98e-01
|
5.43e-01
|
GOBP MEMBRANE FISSION
|
42
|
4.80e-02
|
4.39e-01
|
0.22000
|
-2.19e-01
|
1.36e-02
|
1.39e-02
|
8.78e-01
|
GOBP PODOCYTE CELL MIGRATION
|
7
|
5.96e-01
|
8.95e-01
|
0.22000
|
6.00e-03
|
2.20e-01
|
9.78e-01
|
3.14e-01
|
GOCC BASEMENT MEMBRANE COLLAGEN TRIMER
|
6
|
6.40e-01
|
9.06e-01
|
0.22000
|
2.20e-01
|
1.04e-02
|
3.52e-01
|
9.65e-01
|
GOBP NEGATIVE REGULATION OF VASCULAR WOUND HEALING
|
7
|
5.91e-01
|
8.93e-01
|
0.22000
|
-2.19e-01
|
-2.02e-02
|
3.16e-01
|
9.26e-01
|
GOBP EMBRYONIC HINDLIMB MORPHOGENESIS
|
27
|
1.63e-01
|
6.48e-01
|
0.22000
|
-8.21e-02
|
2.04e-01
|
4.60e-01
|
6.69e-02
|
GOBP RESPONSE TO AMPHETAMINE
|
29
|
9.75e-02
|
5.62e-01
|
0.22000
|
1.98e-01
|
9.50e-02
|
6.49e-02
|
3.76e-01
|
GOBP VITAMIN B6 METABOLIC PROCESS
|
5
|
7.14e-01
|
9.27e-01
|
0.22000
|
7.85e-02
|
-2.05e-01
|
7.61e-01
|
4.27e-01
|
GOBP INNER MITOCHONDRIAL MEMBRANE ORGANIZATION
|
36
|
5.86e-02
|
4.71e-01
|
0.21900
|
-7.32e-02
|
-2.07e-01
|
4.47e-01
|
3.17e-02
|
GOMF CHANNEL ACTIVATOR ACTIVITY
|
6
|
6.71e-01
|
9.11e-01
|
0.21900
|
-2.00e-01
|
8.96e-02
|
3.96e-01
|
7.04e-01
|
GOBP SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE
|
14
|
3.73e-01
|
8.09e-01
|
0.21900
|
-3.30e-02
|
2.17e-01
|
8.31e-01
|
1.60e-01
|
GOBP REGULATION OF ESTABLISHMENT OF PLANAR POLARITY
|
51
|
3.53e-02
|
3.82e-01
|
0.21900
|
-1.06e-01
|
1.92e-01
|
1.92e-01
|
1.76e-02
|
GOBP ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY
|
8
|
5.94e-01
|
8.94e-01
|
0.21900
|
-1.86e-01
|
1.16e-01
|
3.62e-01
|
5.70e-01
|
GOBP PROTEIN LIPOYLATION
|
5
|
7.19e-01
|
9.29e-01
|
0.21900
|
9.72e-02
|
-1.96e-01
|
7.07e-01
|
4.47e-01
|
GOMF OXIDOREDUCTION DRIVEN ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
53
|
1.54e-02
|
2.64e-01
|
0.21900
|
-7.59e-02
|
-2.06e-01
|
3.39e-01
|
9.59e-03
|
GOBP NADH DEHYDROGENASE COMPLEX ASSEMBLY
|
52
|
2.12e-02
|
3.08e-01
|
0.21900
|
-1.40e-02
|
-2.19e-01
|
8.62e-01
|
6.35e-03
|
GOMF COMPLEMENT RECEPTOR ACTIVITY
|
11
|
4.93e-01
|
8.58e-01
|
0.21900
|
1.62e-01
|
-1.48e-01
|
3.53e-01
|
3.96e-01
|
GOBP REGULATION OF GLUCOCORTICOID RECEPTOR SIGNALING PATHWAY
|
7
|
5.64e-01
|
8.85e-01
|
0.21900
|
-1.39e-01
|
-1.69e-01
|
5.23e-01
|
4.39e-01
|
GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS
|
20
|
2.15e-01
|
7.06e-01
|
0.21900
|
-2.14e-01
|
-4.76e-02
|
9.78e-02
|
7.12e-01
|
GOMF PLATELET DERIVED GROWTH FACTOR RECEPTOR BINDING
|
13
|
4.05e-01
|
8.26e-01
|
0.21900
|
-2.15e-01
|
4.21e-02
|
1.80e-01
|
7.93e-01
|
GOCC CHROMAFFIN GRANULE
|
13
|
4.11e-01
|
8.28e-01
|
0.21900
|
-5.78e-02
|
2.11e-01
|
7.18e-01
|
1.87e-01
|
GOCC RIBOSOME
|
224
|
3.10e-07
|
1.17e-04
|
0.21900
|
7.01e-02
|
-2.07e-01
|
7.04e-02
|
8.88e-08
|
GOBP INTERLEUKIN 5 MEDIATED SIGNALING PATHWAY
|
6
|
6.12e-01
|
8.98e-01
|
0.21900
|
-1.56e-01
|
-1.53e-01
|
5.07e-01
|
5.16e-01
|
GOMF LIPID KINASE ACTIVITY
|
40
|
4.96e-02
|
4.42e-01
|
0.21900
|
2.94e-02
|
2.17e-01
|
7.48e-01
|
1.76e-02
|
GOBP ETHER BIOSYNTHETIC PROCESS
|
12
|
4.64e-01
|
8.48e-01
|
0.21900
|
-1.60e-01
|
1.49e-01
|
3.37e-01
|
3.71e-01
|
GOBP RESPONSE TO X RAY
|
28
|
1.28e-01
|
6.08e-01
|
0.21900
|
-9.16e-03
|
-2.18e-01
|
9.33e-01
|
4.55e-02
|
GOBP PROTEIN GERANYLGERANYLATION
|
6
|
6.13e-01
|
8.98e-01
|
0.21900
|
1.59e-01
|
1.50e-01
|
5.00e-01
|
5.24e-01
|
GOBP OVULATION
|
15
|
3.11e-01
|
7.75e-01
|
0.21800
|
-2.08e-01
|
-6.76e-02
|
1.64e-01
|
6.50e-01
|
GOMF PHOSPHATIDYLCHOLINE STEROL O ACYLTRANSFERASE ACTIVATOR ACTIVITY
|
6
|
6.23e-01
|
9.01e-01
|
0.21800
|
-8.62e-02
|
-2.01e-01
|
7.15e-01
|
3.95e-01
|
GOBP POSITIVE REGULATION OF KIDNEY DEVELOPMENT
|
9
|
5.59e-01
|
8.82e-01
|
0.21800
|
-1.14e-01
|
1.86e-01
|
5.52e-01
|
3.34e-01
|
GOBP REGULATION OF CELLULAR RESPONSE TO HEAT
|
16
|
2.87e-01
|
7.59e-01
|
0.21800
|
-2.06e-01
|
-7.20e-02
|
1.54e-01
|
6.18e-01
|
GOBP MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE
|
43
|
4.87e-02
|
4.41e-01
|
0.21800
|
2.62e-02
|
-2.17e-01
|
7.66e-01
|
1.40e-02
|
GOBP CORTICOSTEROID RECEPTOR SIGNALING PATHWAY
|
14
|
3.23e-01
|
7.79e-01
|
0.21800
|
-1.27e-01
|
-1.78e-01
|
4.12e-01
|
2.50e-01
|
GOBP PENTOSE PHOSPHATE SHUNT NON OXIDATIVE BRANCH
|
6
|
6.45e-01
|
9.07e-01
|
0.21800
|
-2.18e-01
|
-9.47e-03
|
3.55e-01
|
9.68e-01
|
GOCC SODIUM POTASSIUM EXCHANGING ATPASE COMPLEX
|
11
|
4.82e-01
|
8.54e-01
|
0.21800
|
-8.13e-02
|
2.02e-01
|
6.40e-01
|
2.45e-01
|
GOBP REGULATION OF WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT
|
9
|
5.42e-01
|
8.78e-01
|
0.21800
|
5.45e-02
|
-2.11e-01
|
7.77e-01
|
2.73e-01
|
GOBP POSITIVE REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION
|
5
|
6.68e-01
|
9.11e-01
|
0.21800
|
-1.75e-01
|
-1.31e-01
|
4.99e-01
|
6.13e-01
|
GOBP POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION
|
18
|
3.15e-01
|
7.76e-01
|
0.21800
|
-1.80e-01
|
1.22e-01
|
1.85e-01
|
3.69e-01
|
GOMF CHLORIDE CHANNEL REGULATOR ACTIVITY
|
13
|
4.04e-01
|
8.26e-01
|
0.21800
|
-2.15e-01
|
3.33e-02
|
1.79e-01
|
8.35e-01
|
GOBP TOLL SIGNALING PATHWAY
|
10
|
5.11e-01
|
8.66e-01
|
0.21800
|
-2.07e-01
|
6.64e-02
|
2.56e-01
|
7.16e-01
|
GOBP SEROTONIN SECRETION
|
9
|
4.94e-01
|
8.58e-01
|
0.21800
|
8.17e-02
|
2.02e-01
|
6.71e-01
|
2.94e-01
|
GOBP POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION
|
17
|
3.40e-01
|
7.91e-01
|
0.21800
|
-1.63e-01
|
1.45e-01
|
2.46e-01
|
3.01e-01
|
GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE
|
34
|
8.77e-02
|
5.47e-01
|
0.21800
|
-2.18e-01
|
6.19e-03
|
2.81e-02
|
9.50e-01
|
GOBP AORTIC VALVE MORPHOGENESIS
|
38
|
6.86e-02
|
5.00e-01
|
0.21800
|
-2.17e-01
|
1.87e-02
|
2.07e-02
|
8.42e-01
|
GOBP RESPIRATORY SYSTEM PROCESS
|
37
|
5.14e-02
|
4.48e-01
|
0.21800
|
-1.26e-01
|
-1.77e-01
|
1.84e-01
|
6.18e-02
|
GOBP NEGATIVE REGULATION OF CHROMATIN ORGANIZATION
|
5
|
6.75e-01
|
9.13e-01
|
0.21800
|
-8.96e-02
|
-1.98e-01
|
7.29e-01
|
4.43e-01
|
GOBP REGULATION OF MDA 5 SIGNALING PATHWAY
|
6
|
6.79e-01
|
9.14e-01
|
0.21800
|
-1.08e-01
|
1.89e-01
|
6.46e-01
|
4.23e-01
|
GOMF WIDE PORE CHANNEL ACTIVITY
|
32
|
1.26e-01
|
6.06e-01
|
0.21800
|
1.92e-01
|
-1.02e-01
|
6.03e-02
|
3.16e-01
|
GOBP COMMA SHAPED BODY MORPHOGENESIS
|
5
|
7.13e-01
|
9.27e-01
|
0.21800
|
2.11e-01
|
-5.44e-02
|
4.15e-01
|
8.33e-01
|
GOBP REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION
|
77
|
6.94e-03
|
1.74e-01
|
0.21700
|
-1.02e-01
|
1.92e-01
|
1.21e-01
|
3.57e-03
|
GOMF UBIQUITIN LIKE MODIFIER ACTIVATING ENZYME ACTIVITY
|
9
|
5.56e-01
|
8.81e-01
|
0.21700
|
-1.96e-01
|
9.40e-02
|
3.08e-01
|
6.25e-01
|
GOBP PLASMA MEMBRANE RAFT ASSEMBLY
|
7
|
5.78e-01
|
8.89e-01
|
0.21700
|
1.99e-01
|
8.78e-02
|
3.62e-01
|
6.88e-01
|
GOMF LYSOZYME ACTIVITY
|
9
|
5.04e-01
|
8.64e-01
|
0.21700
|
-5.65e-02
|
-2.10e-01
|
7.69e-01
|
2.76e-01
|
GOBP G0 TO G1 TRANSITION
|
36
|
9.97e-02
|
5.68e-01
|
0.21700
|
-1.86e-01
|
1.13e-01
|
5.39e-02
|
2.41e-01
|
GOBP VASCULOGENESIS INVOLVED IN CORONARY VASCULAR MORPHOGENESIS
|
5
|
6.89e-01
|
9.19e-01
|
0.21700
|
3.46e-02
|
2.14e-01
|
8.93e-01
|
4.06e-01
|
GOCC TETRASPANIN ENRICHED MICRODOMAIN
|
10
|
4.74e-01
|
8.53e-01
|
0.21700
|
2.14e-01
|
3.73e-02
|
2.41e-01
|
8.38e-01
|
GOBP AMP BIOSYNTHETIC PROCESS
|
12
|
3.90e-01
|
8.21e-01
|
0.21700
|
-9.15e-02
|
-1.97e-01
|
5.83e-01
|
2.37e-01
|
GOBP HISTONE METHYLATION
|
35
|
9.24e-02
|
5.54e-01
|
0.21700
|
-2.12e-01
|
4.68e-02
|
2.99e-02
|
6.32e-01
|
GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH
|
27
|
1.79e-01
|
6.69e-01
|
0.21700
|
-1.81e-01
|
1.20e-01
|
1.03e-01
|
2.81e-01
|
GOBP TRACHEA CARTILAGE DEVELOPMENT
|
7
|
5.89e-01
|
8.92e-01
|
0.21700
|
4.96e-02
|
2.11e-01
|
8.20e-01
|
3.33e-01
|
GOBP SULFUR COMPOUND BIOSYNTHETIC PROCESS
|
149
|
3.73e-05
|
4.29e-03
|
0.21700
|
-2.14e-01
|
3.70e-02
|
6.49e-06
|
4.36e-01
|
GOBP PEPTIDYL LYSINE DIMETHYLATION
|
11
|
5.00e-01
|
8.62e-01
|
0.21700
|
-1.53e-01
|
1.54e-01
|
3.78e-01
|
3.77e-01
|
GOBP THYROID GLAND DEVELOPMENT
|
31
|
1.38e-01
|
6.21e-01
|
0.21700
|
-1.85e-01
|
1.14e-01
|
7.47e-02
|
2.73e-01
|
GOMF CALCIUM SODIUM ANTIPORTER ACTIVITY
|
10
|
4.64e-01
|
8.48e-01
|
0.21700
|
-2.07e-01
|
-6.61e-02
|
2.57e-01
|
7.17e-01
|
GOBP GLIAL CELL DERIVED NEUROTROPHIC FACTOR RECEPTOR SIGNALING PATHWAY
|
9
|
5.62e-01
|
8.84e-01
|
0.21700
|
1.86e-01
|
-1.13e-01
|
3.35e-01
|
5.59e-01
|
GOBP POSITIVE REGULATION OF VASCULAR WOUND HEALING
|
5
|
7.07e-01
|
9.25e-01
|
0.21700
|
-2.15e-01
|
2.94e-02
|
4.05e-01
|
9.09e-01
|
GOBP CHEMOREPULSION OF AXON
|
6
|
6.19e-01
|
9.00e-01
|
0.21700
|
1.24e-01
|
1.78e-01
|
5.99e-01
|
4.50e-01
|
GOBP POSITIVE REGULATION OF MEIOTIC CELL CYCLE
|
27
|
1.16e-01
|
5.94e-01
|
0.21700
|
1.29e-01
|
1.74e-01
|
2.45e-01
|
1.17e-01
|
GOBP REGULATION OF NUCLEASE ACTIVITY
|
22
|
2.41e-01
|
7.25e-01
|
0.21700
|
1.94e-01
|
-9.66e-02
|
1.15e-01
|
4.33e-01
|
GOBP MITOTIC DNA REPLICATION CHECKPOINT SIGNALING
|
10
|
4.69e-01
|
8.51e-01
|
0.21700
|
-5.48e-02
|
-2.10e-01
|
7.64e-01
|
2.51e-01
|
GOBP NEGATIVE REGULATION OF MIRNA PROCESSING
|
9
|
5.14e-01
|
8.67e-01
|
0.21700
|
-3.15e-02
|
-2.15e-01
|
8.70e-01
|
2.65e-01
|
GOBP PYROPTOSIS
|
36
|
8.27e-02
|
5.35e-01
|
0.21700
|
2.81e-02
|
-2.15e-01
|
7.71e-01
|
2.56e-02
|
GOBP ASCENDING AORTA DEVELOPMENT
|
5
|
7.04e-01
|
9.23e-01
|
0.21700
|
-2.16e-01
|
1.61e-02
|
4.02e-01
|
9.50e-01
|
GOBP AMINOGLYCAN BIOSYNTHETIC PROCESS
|
73
|
8.84e-03
|
1.97e-01
|
0.21700
|
-1.97e-01
|
9.00e-02
|
3.57e-03
|
1.84e-01
|
GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I
|
36
|
8.88e-02
|
5.50e-01
|
0.21700
|
5.35e-02
|
-2.10e-01
|
5.79e-01
|
2.92e-02
|
GOCC BRAHMA COMPLEX
|
14
|
4.15e-01
|
8.30e-01
|
0.21700
|
-1.58e-01
|
1.48e-01
|
3.05e-01
|
3.38e-01
|
GOBP REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT
|
13
|
4.42e-01
|
8.40e-01
|
0.21700
|
-1.59e-01
|
1.48e-01
|
3.22e-01
|
3.57e-01
|
GOBP CELLULAR RESPONSE TO PH
|
26
|
1.67e-01
|
6.53e-01
|
0.21700
|
-3.34e-02
|
2.14e-01
|
7.68e-01
|
5.88e-02
|
GOCC THO COMPLEX
|
5
|
6.72e-01
|
9.12e-01
|
0.21700
|
-1.26e-01
|
-1.76e-01
|
6.26e-01
|
4.95e-01
|
GOMF PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY
|
37
|
6.23e-02
|
4.82e-01
|
0.21700
|
-2.11e-01
|
-4.78e-02
|
2.61e-02
|
6.15e-01
|
GOCC GRANULAR COMPONENT
|
7
|
5.77e-01
|
8.89e-01
|
0.21700
|
-1.91e-01
|
-1.01e-01
|
3.80e-01
|
6.42e-01
|
GOCC INHIBITORY SYNAPSE
|
14
|
3.26e-01
|
7.82e-01
|
0.21700
|
-1.55e-01
|
-1.51e-01
|
3.14e-01
|
3.28e-01
|
GOBP L PHENYLALANINE METABOLIC PROCESS
|
8
|
5.95e-01
|
8.95e-01
|
0.21700
|
-1.98e-01
|
8.76e-02
|
3.32e-01
|
6.68e-01
|
GOMF PALMITOYLTRANSFERASE ACTIVITY
|
34
|
1.19e-01
|
6.00e-01
|
0.21700
|
-1.46e-01
|
1.60e-01
|
1.40e-01
|
1.07e-01
|
GOBP SEQUESTERING OF ACTIN MONOMERS
|
6
|
6.43e-01
|
9.07e-01
|
0.21700
|
-2.15e-01
|
-2.88e-02
|
3.63e-01
|
9.03e-01
|
GOBP REVERSE CHOLESTEROL TRANSPORT
|
20
|
2.86e-01
|
7.58e-01
|
0.21600
|
-1.52e-01
|
1.54e-01
|
2.39e-01
|
2.33e-01
|
GOBP POSITIVE REGULATION OF CONNECTIVE TISSUE REPLACEMENT
|
12
|
4.71e-01
|
8.51e-01
|
0.21600
|
-1.36e-01
|
1.68e-01
|
4.14e-01
|
3.14e-01
|
GOBP MEIOTIC SPINDLE ASSEMBLY
|
12
|
4.61e-01
|
8.48e-01
|
0.21600
|
9.19e-02
|
-1.96e-01
|
5.81e-01
|
2.40e-01
|
GOMF INTERLEUKIN 17 RECEPTOR ACTIVITY
|
8
|
5.38e-01
|
8.78e-01
|
0.21600
|
-8.51e-02
|
-1.99e-01
|
6.77e-01
|
3.30e-01
|
GOBP NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY
|
31
|
1.26e-01
|
6.06e-01
|
0.21600
|
-5.39e-02
|
2.09e-01
|
6.03e-01
|
4.37e-02
|
GOMF PHOSPHATIDYLINOSITOL 3 4 BISPHOSPHATE BINDING
|
26
|
1.97e-01
|
6.88e-01
|
0.21600
|
-1.40e-01
|
1.64e-01
|
2.16e-01
|
1.47e-01
|
GOBP VESICLE TETHERING INVOLVED IN EXOCYTOSIS
|
9
|
5.70e-01
|
8.86e-01
|
0.21600
|
-1.62e-01
|
1.43e-01
|
4.00e-01
|
4.58e-01
|
GOBP NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING
|
11
|
4.99e-01
|
8.61e-01
|
0.21600
|
-1.84e-01
|
1.13e-01
|
2.91e-01
|
5.16e-01
|
GOBP PANCREATIC A CELL DIFFERENTIATION
|
11
|
4.90e-01
|
8.57e-01
|
0.21600
|
8.26e-02
|
-2.00e-01
|
6.35e-01
|
2.52e-01
|
GOMF MONOATOMIC ANION MONOATOMIC CATION SYMPORTER ACTIVITY
|
24
|
2.18e-01
|
7.07e-01
|
0.21600
|
-1.07e-01
|
1.88e-01
|
3.66e-01
|
1.11e-01
|
GOCC VCP NPL4 UFD1 AAA ATPASE COMPLEX
|
8
|
5.66e-01
|
8.85e-01
|
0.21600
|
-2.16e-01
|
-3.97e-03
|
2.91e-01
|
9.85e-01
|
GOBP MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION
|
21
|
1.95e-01
|
6.86e-01
|
0.21600
|
-1.90e-01
|
-1.02e-01
|
1.32e-01
|
4.16e-01
|
GOMF CARBOHYDRATE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
41
|
7.52e-02
|
5.18e-01
|
0.21600
|
-1.12e-01
|
1.84e-01
|
2.14e-01
|
4.12e-02
|
GOBP NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION
|
13
|
4.45e-01
|
8.40e-01
|
0.21600
|
-1.41e-01
|
1.63e-01
|
3.79e-01
|
3.08e-01
|
GOBP NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY
|
30
|
1.50e-01
|
6.36e-01
|
0.21600
|
-1.86e-01
|
1.09e-01
|
7.75e-02
|
3.02e-01
|
GOBP POLYADENYLATION DEPENDENT SNORNA 3 END PROCESSING
|
8
|
6.08e-01
|
8.97e-01
|
0.21600
|
1.56e-01
|
-1.49e-01
|
4.46e-01
|
4.65e-01
|
GOBP REGULATION OF TAU PROTEIN KINASE ACTIVITY
|
13
|
3.58e-01
|
8.00e-01
|
0.21600
|
-1.70e-01
|
-1.33e-01
|
2.90e-01
|
4.06e-01
|
GOBP RESPONSE TO NITRIC OXIDE
|
19
|
2.65e-01
|
7.41e-01
|
0.21600
|
8.62e-03
|
-2.15e-01
|
9.48e-01
|
1.04e-01
|
GOBP EOSINOPHIL MEDIATED IMMUNITY
|
8
|
5.35e-01
|
8.76e-01
|
0.21600
|
-1.87e-01
|
-1.08e-01
|
3.61e-01
|
5.97e-01
|
GOBP FC RECEPTOR SIGNALING PATHWAY
|
52
|
2.93e-02
|
3.57e-01
|
0.21600
|
-3.42e-02
|
2.13e-01
|
6.69e-01
|
7.94e-03
|
GOBP MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY
|
92
|
9.11e-04
|
4.87e-02
|
0.21500
|
-7.69e-02
|
-2.01e-01
|
2.02e-01
|
8.45e-04
|
GOCC STEREOCILIUM TIP
|
20
|
2.79e-01
|
7.52e-01
|
0.21500
|
1.93e-01
|
-9.59e-02
|
1.35e-01
|
4.58e-01
|
GOCC SWI SNF SUPERFAMILY TYPE COMPLEX
|
90
|
2.51e-03
|
9.72e-02
|
0.21500
|
-2.10e-01
|
5.04e-02
|
5.91e-04
|
4.09e-01
|
GOBP PURINE RIBONUCLEOSIDE CATABOLIC PROCESS
|
6
|
6.82e-01
|
9.16e-01
|
0.21500
|
1.93e-01
|
-9.54e-02
|
4.12e-01
|
6.86e-01
|
GOBP RETROTRANSPOSON SILENCING BY HETEROCHROMATIN FORMATION
|
15
|
3.13e-01
|
7.76e-01
|
0.21500
|
9.59e-02
|
1.93e-01
|
5.20e-01
|
1.96e-01
|
GOBP POSITIVE REGULATION OF TROPHOBLAST CELL MIGRATION
|
7
|
6.45e-01
|
9.07e-01
|
0.21500
|
-1.24e-01
|
1.76e-01
|
5.71e-01
|
4.19e-01
|
GOBP VESICLE BUDDING FROM MEMBRANE
|
81
|
3.96e-03
|
1.30e-01
|
0.21500
|
-2.14e-01
|
2.58e-02
|
8.80e-04
|
6.89e-01
|
GOCC CORTICAL ENDOPLASMIC RETICULUM
|
5
|
6.90e-01
|
9.19e-01
|
0.21500
|
4.99e-02
|
2.09e-01
|
8.47e-01
|
4.17e-01
|
GOBP REGULATION OF HIPPOCAMPAL NEURON APOPTOTIC PROCESS
|
5
|
7.16e-01
|
9.28e-01
|
0.21500
|
-4.89e-02
|
2.10e-01
|
8.50e-01
|
4.17e-01
|
GOBP XENOBIOTIC METABOLIC PROCESS
|
121
|
2.07e-04
|
1.55e-02
|
0.21500
|
2.15e-01
|
-2.93e-04
|
4.33e-05
|
9.96e-01
|
GOBP NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS
|
21
|
2.73e-01
|
7.47e-01
|
0.21500
|
1.54e-01
|
-1.50e-01
|
2.21e-01
|
2.34e-01
|
GOBP FAT PAD DEVELOPMENT
|
8
|
6.02e-01
|
8.96e-01
|
0.21500
|
1.91e-01
|
-9.94e-02
|
3.50e-01
|
6.26e-01
|
GOBP REGULATION OF RESPIRATORY GASEOUS EXCHANGE
|
21
|
1.93e-01
|
6.85e-01
|
0.21500
|
-1.78e-01
|
-1.20e-01
|
1.58e-01
|
3.39e-01
|
GOBP REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I
|
44
|
5.74e-02
|
4.68e-01
|
0.21500
|
-2.03e-01
|
7.06e-02
|
1.98e-02
|
4.18e-01
|
GOBP TESTOSTERONE BIOSYNTHETIC PROCESS
|
11
|
4.60e-01
|
8.48e-01
|
0.21500
|
-2.92e-03
|
-2.15e-01
|
9.87e-01
|
2.17e-01
|
GOBP COBALT ION TRANSPORT
|
6
|
6.68e-01
|
9.11e-01
|
0.21500
|
-2.11e-01
|
3.83e-02
|
3.70e-01
|
8.71e-01
|
GOBP INTERLEUKIN 12 MEDIATED SIGNALING PATHWAY
|
9
|
5.73e-01
|
8.88e-01
|
0.21500
|
-1.42e-01
|
1.61e-01
|
4.61e-01
|
4.02e-01
|
GOBP MAMMARY GLAND FORMATION
|
7
|
6.21e-01
|
9.00e-01
|
0.21500
|
2.72e-02
|
-2.13e-01
|
9.01e-01
|
3.29e-01
|
GOBP SNRNA TRANSCRIPTION BY RNA POLYMERASE II
|
16
|
3.29e-01
|
7.84e-01
|
0.21500
|
1.01e-02
|
-2.15e-01
|
9.44e-01
|
1.37e-01
|
GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT CONFERRING TENSILE STRENGTH
|
42
|
3.90e-02
|
4.04e-01
|
0.21500
|
1.88e-01
|
1.04e-01
|
3.51e-02
|
2.44e-01
|
GOMF P TYPE POTASSIUM TRANSMEMBRANE TRANSPORTER ACTIVITY
|
7
|
6.50e-01
|
9.07e-01
|
0.21500
|
-1.52e-01
|
1.52e-01
|
4.86e-01
|
4.87e-01
|
GOBP REGULATION OF AEROBIC RESPIRATION
|
30
|
1.07e-01
|
5.80e-01
|
0.21500
|
-2.07e-01
|
-5.76e-02
|
5.00e-02
|
5.85e-01
|
GOBP DNA DEALKYLATION INVOLVED IN DNA REPAIR
|
9
|
5.47e-01
|
8.78e-01
|
0.21500
|
-2.11e-01
|
3.86e-02
|
2.73e-01
|
8.41e-01
|
GOBP MONOATOMIC ANION HOMEOSTASIS
|
20
|
2.86e-01
|
7.58e-01
|
0.21500
|
-1.09e-01
|
1.85e-01
|
4.01e-01
|
1.52e-01
|
GOBP REGULATION OF SYNAPSE STRUCTURAL PLASTICITY
|
7
|
6.41e-01
|
9.07e-01
|
0.21500
|
-1.94e-01
|
9.21e-02
|
3.75e-01
|
6.73e-01
|
GOBP SPLICEOSOMAL SNRNP ASSEMBLY
|
43
|
5.43e-02
|
4.61e-01
|
0.21500
|
2.78e-02
|
-2.13e-01
|
7.52e-01
|
1.58e-02
|
GOBP T CELL RECEPTOR SIGNALING PATHWAY
|
132
|
3.52e-05
|
4.24e-03
|
0.21400
|
1.27e-01
|
1.73e-01
|
1.17e-02
|
6.05e-04
|
GOMF NAD P H OXIDASE H2O2 FORMING ACTIVITY
|
8
|
5.42e-01
|
8.78e-01
|
0.21400
|
9.04e-02
|
1.94e-01
|
6.58e-01
|
3.41e-01
|
GOBP PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS
|
29
|
1.06e-01
|
5.79e-01
|
0.21400
|
-1.11e-01
|
-1.83e-01
|
3.00e-01
|
8.74e-02
|
GOBP NEGATIVE REGULATION OF DENDRITIC CELL DIFFERENTIATION
|
5
|
7.32e-01
|
9.33e-01
|
0.21400
|
1.10e-01
|
-1.84e-01
|
6.70e-01
|
4.76e-01
|
GOBP CYSTEINE METABOLIC PROCESS
|
10
|
5.14e-01
|
8.67e-01
|
0.21400
|
-2.10e-01
|
4.37e-02
|
2.50e-01
|
8.11e-01
|
GOCC LAMELLIPODIUM MEMBRANE
|
22
|
1.93e-01
|
6.85e-01
|
0.21400
|
2.03e-01
|
6.69e-02
|
9.85e-02
|
5.87e-01
|
GOBP SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION
|
13
|
4.27e-01
|
8.36e-01
|
0.21400
|
5.84e-02
|
-2.06e-01
|
7.16e-01
|
1.98e-01
|
GOMF TRANSLATION FACTOR ACTIVITY RNA BINDING
|
76
|
5.85e-03
|
1.60e-01
|
0.21400
|
2.51e-02
|
-2.13e-01
|
7.06e-01
|
1.34e-03
|
GOCC EXON EXON JUNCTION COMPLEX
|
10
|
4.62e-01
|
8.48e-01
|
0.21400
|
-1.12e-01
|
-1.83e-01
|
5.40e-01
|
3.17e-01
|
GOMF INITIATOR METHIONYL AMINOPEPTIDASE ACTIVITY
|
5
|
6.78e-01
|
9.14e-01
|
0.21400
|
-1.75e-01
|
-1.24e-01
|
4.99e-01
|
6.31e-01
|
GOCC FILAMENTOUS ACTIN
|
28
|
1.72e-01
|
6.61e-01
|
0.21400
|
-9.91e-02
|
1.90e-01
|
3.64e-01
|
8.21e-02
|
GOMF APOLIPOPROTEIN A I BINDING
|
5
|
7.33e-01
|
9.33e-01
|
0.21400
|
-1.81e-01
|
1.15e-01
|
4.84e-01
|
6.56e-01
|
GOMF TRANSLATION INITIATION FACTOR BINDING
|
29
|
1.04e-01
|
5.75e-01
|
0.21400
|
-1.37e-01
|
-1.64e-01
|
2.00e-01
|
1.26e-01
|
GOBP METANEPHRIC LOOP OF HENLE DEVELOPMENT
|
6
|
6.77e-01
|
9.14e-01
|
0.21400
|
-2.04e-01
|
6.43e-02
|
3.86e-01
|
7.85e-01
|
GOMF MHC CLASS II PROTEIN BINDING
|
7
|
6.48e-01
|
9.07e-01
|
0.21400
|
-1.19e-01
|
1.78e-01
|
5.87e-01
|
4.14e-01
|
GOBP WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION
|
12
|
4.69e-01
|
8.51e-01
|
0.21400
|
-9.19e-02
|
1.93e-01
|
5.81e-01
|
2.46e-01
|
GOBP CAMP CATABOLIC PROCESS
|
9
|
5.15e-01
|
8.68e-01
|
0.21400
|
2.07e-01
|
5.55e-02
|
2.83e-01
|
7.73e-01
|
GOBP MEIOTIC CELL CYCLE PHASE TRANSITION
|
12
|
3.93e-01
|
8.23e-01
|
0.21400
|
1.34e-01
|
1.66e-01
|
4.20e-01
|
3.18e-01
|
GOBP DETECTION OF OTHER ORGANISM
|
19
|
2.44e-01
|
7.26e-01
|
0.21400
|
-6.20e-02
|
-2.05e-01
|
6.40e-01
|
1.23e-01
|
GOBP DETECTION OF MOLECULE OF BACTERIAL ORIGIN
|
13
|
3.98e-01
|
8.25e-01
|
0.21400
|
-2.13e-01
|
-1.61e-02
|
1.83e-01
|
9.20e-01
|
GOBP DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION
|
456
|
1.57e-13
|
5.34e-10
|
0.21400
|
2.08e-01
|
-4.73e-02
|
2.24e-14
|
8.34e-02
|
GOBP POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY
|
40
|
8.28e-02
|
5.35e-01
|
0.21400
|
1.87e-01
|
-1.04e-01
|
4.09e-02
|
2.56e-01
|
GOCC PHOTORECEPTOR DISC MEMBRANE
|
19
|
3.05e-01
|
7.70e-01
|
0.21400
|
-1.88e-01
|
1.01e-01
|
1.56e-01
|
4.45e-01
|
GOBP REGULATION OF MONOATOMIC ANION TRANSPORT
|
16
|
3.23e-01
|
7.79e-01
|
0.21400
|
-1.49e-02
|
-2.13e-01
|
9.18e-01
|
1.40e-01
|
GOBP RNA CAPPING
|
35
|
1.09e-01
|
5.84e-01
|
0.21400
|
8.45e-02
|
-1.96e-01
|
3.87e-01
|
4.45e-02
|
GOBP NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION
|
11
|
4.27e-01
|
8.36e-01
|
0.21400
|
-1.73e-01
|
-1.26e-01
|
3.21e-01
|
4.71e-01
|
GOBP ICOSANOID CATABOLIC PROCESS
|
9
|
5.67e-01
|
8.85e-01
|
0.21400
|
-1.95e-01
|
8.71e-02
|
3.11e-01
|
6.51e-01
|
GOBP MHC CLASS I BIOSYNTHETIC PROCESS
|
8
|
5.46e-01
|
8.78e-01
|
0.21400
|
-8.69e-02
|
-1.95e-01
|
6.70e-01
|
3.39e-01
|
GOBP REGULATION OF FEEDING BEHAVIOR
|
27
|
1.45e-01
|
6.29e-01
|
0.21300
|
-3.01e-02
|
-2.11e-01
|
7.86e-01
|
5.75e-02
|
GOBP POSITIVE REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING SIGNALING PATHWAY
|
7
|
5.99e-01
|
8.95e-01
|
0.21300
|
-5.42e-02
|
-2.06e-01
|
8.04e-01
|
3.45e-01
|
GOBP NEGATIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS
|
7
|
5.97e-01
|
8.95e-01
|
0.21300
|
-5.88e-02
|
-2.05e-01
|
7.88e-01
|
3.48e-01
|
GOMF OXALATE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
10
|
4.66e-01
|
8.50e-01
|
0.21300
|
1.08e-01
|
1.84e-01
|
5.54e-01
|
3.15e-01
|
GOCC SUPER ELONGATION COMPLEX
|
5
|
6.96e-01
|
9.21e-01
|
0.21300
|
-4.44e-02
|
-2.08e-01
|
8.64e-01
|
4.20e-01
|
GOBP TRANSEPITHELIAL CHLORIDE TRANSPORT
|
8
|
5.63e-01
|
8.84e-01
|
0.21300
|
3.64e-02
|
2.10e-01
|
8.58e-01
|
3.04e-01
|
GOMF PROTEIN METHYLTRANSFERASE ACTIVITY
|
92
|
1.91e-03
|
8.07e-02
|
0.21300
|
-2.13e-01
|
9.68e-03
|
4.18e-04
|
8.73e-01
|
GOBP COCHLEA MORPHOGENESIS
|
23
|
1.70e-01
|
6.57e-01
|
0.21300
|
1.31e-01
|
1.68e-01
|
2.76e-01
|
1.64e-01
|
GOCC BRCA1 C COMPLEX
|
6
|
6.31e-01
|
9.03e-01
|
0.21300
|
-1.79e-01
|
-1.16e-01
|
4.48e-01
|
6.23e-01
|
GOBP GOLGI ORGANIZATION
|
138
|
1.86e-04
|
1.46e-02
|
0.21300
|
-1.93e-01
|
9.05e-02
|
9.21e-05
|
6.63e-02
|
GOBP REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT
|
14
|
3.80e-01
|
8.15e-01
|
0.21300
|
-2.30e-03
|
-2.13e-01
|
9.88e-01
|
1.68e-01
|
GOBP POSITIVE REGULATION OF BONE RESORPTION
|
18
|
3.30e-01
|
7.85e-01
|
0.21300
|
-1.09e-01
|
1.83e-01
|
4.23e-01
|
1.79e-01
|
GOMF TRANSMEMBRANE RECEPTOR PROTEIN PHOSPHATASE ACTIVITY
|
17
|
2.72e-01
|
7.47e-01
|
0.21300
|
1.79e-01
|
1.16e-01
|
2.03e-01
|
4.08e-01
|
GOBP DENTATE GYRUS DEVELOPMENT
|
23
|
2.07e-01
|
6.96e-01
|
0.21300
|
4.88e-03
|
-2.13e-01
|
9.68e-01
|
7.73e-02
|
GOCC PHOTORECEPTOR OUTER SEGMENT MEMBRANE
|
16
|
3.75e-01
|
8.11e-01
|
0.21300
|
-1.79e-01
|
1.14e-01
|
2.14e-01
|
4.28e-01
|
GOBP ESTABLISHMENT OF MITOCHONDRION LOCALIZATION
|
27
|
1.27e-01
|
6.07e-01
|
0.21300
|
1.78e-01
|
1.16e-01
|
1.09e-01
|
2.97e-01
|
GOCC NUCLEOLAR EXOSOME RNASE COMPLEX
|
10
|
5.45e-01
|
8.78e-01
|
0.21300
|
1.62e-01
|
-1.38e-01
|
3.76e-01
|
4.48e-01
|
GOBP POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT
|
23
|
2.25e-01
|
7.13e-01
|
0.21300
|
2.06e-01
|
-5.22e-02
|
8.69e-02
|
6.65e-01
|
GOBP CENTROMERIC SISTER CHROMATID COHESION
|
10
|
4.68e-01
|
8.51e-01
|
0.21300
|
1.05e-01
|
1.85e-01
|
5.66e-01
|
3.11e-01
|
GOBP BUD ELONGATION INVOLVED IN LUNG BRANCHING
|
7
|
6.25e-01
|
9.01e-01
|
0.21300
|
-2.12e-01
|
2.08e-02
|
3.32e-01
|
9.24e-01
|
GOBP FATTY ACID ALPHA OXIDATION
|
8
|
6.13e-01
|
8.98e-01
|
0.21300
|
1.79e-01
|
-1.15e-01
|
3.81e-01
|
5.72e-01
|
GOBP REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY
|
18
|
3.35e-01
|
7.88e-01
|
0.21300
|
1.67e-01
|
-1.31e-01
|
2.19e-01
|
3.34e-01
|
GOBP SERTOLI CELL PROLIFERATION
|
5
|
7.39e-01
|
9.35e-01
|
0.21300
|
-1.55e-01
|
1.46e-01
|
5.48e-01
|
5.73e-01
|
GOBP REGULATION OF ATRIAL CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION
|
6
|
6.48e-01
|
9.07e-01
|
0.21300
|
2.07e-01
|
4.72e-02
|
3.79e-01
|
8.41e-01
|
GOMF PHOSPHOLIPASE C ACTIVITY
|
29
|
1.25e-01
|
6.06e-01
|
0.21300
|
4.10e-02
|
2.09e-01
|
7.02e-01
|
5.19e-02
|
GOMF TYPE 1 FIBROBLAST GROWTH FACTOR RECEPTOR BINDING
|
5
|
6.98e-01
|
9.21e-01
|
0.21300
|
2.08e-01
|
4.13e-02
|
4.20e-01
|
8.73e-01
|
GOBP RESPONSE TO MITOCHONDRIAL DEPOLARISATION
|
19
|
2.36e-01
|
7.24e-01
|
0.21200
|
-1.08e-01
|
-1.83e-01
|
4.14e-01
|
1.68e-01
|
GOBP NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION
|
7
|
6.15e-01
|
8.99e-01
|
0.21200
|
-8.58e-03
|
-2.12e-01
|
9.69e-01
|
3.31e-01
|
GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION
|
39
|
9.02e-02
|
5.51e-01
|
0.21200
|
-1.88e-01
|
9.95e-02
|
4.25e-02
|
2.82e-01
|
GOBP IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS
|
25
|
2.17e-01
|
7.07e-01
|
0.21200
|
-1.15e-01
|
1.79e-01
|
3.21e-01
|
1.22e-01
|
GOBP GLYCOLIPID CATABOLIC PROCESS
|
16
|
2.98e-01
|
7.67e-01
|
0.21200
|
-1.04e-01
|
-1.85e-01
|
4.70e-01
|
2.00e-01
|
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE
|
37
|
9.06e-02
|
5.51e-01
|
0.21200
|
4.79e-02
|
-2.07e-01
|
6.14e-01
|
2.94e-02
|
GOBP GLOMERULUS MORPHOGENESIS
|
9
|
5.02e-01
|
8.63e-01
|
0.21200
|
1.25e-01
|
1.71e-01
|
5.15e-01
|
3.73e-01
|
GOCC ISWI TYPE COMPLEX
|
12
|
4.01e-01
|
8.26e-01
|
0.21200
|
-1.79e-01
|
-1.14e-01
|
2.83e-01
|
4.94e-01
|
GOMF PHOSPHOTRANSFERASE ACTIVITY FOR OTHER SUBSTITUTED PHOSPHATE GROUPS
|
22
|
2.23e-01
|
7.12e-01
|
0.21200
|
-2.12e-01
|
3.39e-03
|
8.48e-02
|
9.78e-01
|
GOBP NEGATIVE REGULATION OF HORMONE BIOSYNTHETIC PROCESS
|
10
|
4.95e-01
|
8.59e-01
|
0.21200
|
2.11e-01
|
2.23e-02
|
2.48e-01
|
9.03e-01
|
GOBP REGULATION OF CELLULAR SENESCENCE
|
52
|
2.41e-02
|
3.30e-01
|
0.21200
|
-4.17e-02
|
-2.08e-01
|
6.03e-01
|
9.43e-03
|
GOBP NEGATIVE REGULATION OF HEART RATE
|
11
|
4.52e-01
|
8.45e-01
|
0.21200
|
2.07e-01
|
4.77e-02
|
2.35e-01
|
7.84e-01
|
GOBP CONNECTIVE TISSUE REPLACEMENT
|
20
|
2.98e-01
|
7.67e-01
|
0.21200
|
-1.28e-01
|
1.69e-01
|
3.21e-01
|
1.91e-01
|
GOBP NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY
|
18
|
2.63e-01
|
7.40e-01
|
0.21200
|
-8.06e-02
|
-1.96e-01
|
5.54e-01
|
1.50e-01
|
GOBP PARATHYROID GLAND DEVELOPMENT
|
7
|
6.09e-01
|
8.97e-01
|
0.21200
|
2.10e-01
|
3.25e-02
|
3.37e-01
|
8.82e-01
|
GOBP REGULATION OF HOMOTYPIC CELL CELL ADHESION
|
34
|
1.03e-01
|
5.75e-01
|
0.21200
|
-2.02e-02
|
2.11e-01
|
8.39e-01
|
3.31e-02
|
GOCC UBIQUINONE BIOSYNTHESIS COMPLEX
|
6
|
6.64e-01
|
9.10e-01
|
0.21200
|
1.02e-03
|
-2.12e-01
|
9.97e-01
|
3.69e-01
|
GOCC NADH DEHYDROGENASE COMPLEX
|
40
|
5.13e-02
|
4.48e-01
|
0.21200
|
-8.48e-02
|
-1.94e-01
|
3.53e-01
|
3.36e-02
|
GOBP PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS
|
50
|
2.19e-02
|
3.13e-01
|
0.21200
|
-1.55e-01
|
-1.44e-01
|
5.80e-02
|
7.71e-02
|
GOBP CHROMOSOME CONDENSATION
|
46
|
3.01e-02
|
3.61e-01
|
0.21200
|
-1.68e-01
|
-1.29e-01
|
4.86e-02
|
1.30e-01
|
GOMF NEUROTROPHIN RECEPTOR ACTIVITY
|
5
|
7.23e-01
|
9.30e-01
|
0.21200
|
2.07e-01
|
-4.35e-02
|
4.22e-01
|
8.66e-01
|
GOCC PROTON TRANSPORTING V TYPE ATPASE COMPLEX
|
25
|
2.21e-01
|
7.10e-01
|
0.21200
|
-1.74e-01
|
1.20e-01
|
1.31e-01
|
2.98e-01
|
GOBP MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER
|
5
|
6.89e-01
|
9.19e-01
|
0.21200
|
9.04e-02
|
1.91e-01
|
7.26e-01
|
4.59e-01
|
GOMF POLY PYRIMIDINE TRACT BINDING
|
26
|
1.64e-01
|
6.48e-01
|
0.21200
|
-2.11e-01
|
-1.98e-02
|
6.29e-02
|
8.62e-01
|
GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN
|
6
|
6.94e-01
|
9.21e-01
|
0.21200
|
1.81e-01
|
-1.10e-01
|
4.44e-01
|
6.40e-01
|
GOBP NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY
|
12
|
4.83e-01
|
8.54e-01
|
0.21200
|
1.78e-01
|
-1.15e-01
|
2.86e-01
|
4.91e-01
|
GOBP INNATE IMMUNE RESPONSE IN MUCOSA
|
23
|
2.46e-01
|
7.26e-01
|
0.21200
|
-1.84e-01
|
1.05e-01
|
1.27e-01
|
3.83e-01
|
GOMF BRANCHED CHAIN AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY
|
9
|
5.77e-01
|
8.89e-01
|
0.21100
|
-1.86e-01
|
1.01e-01
|
3.34e-01
|
6.00e-01
|
GOBP NON CANONICAL WNT SIGNALING PATHWAY
|
66
|
1.95e-02
|
3.00e-01
|
0.21100
|
-1.46e-01
|
1.53e-01
|
3.98e-02
|
3.20e-02
|
GOBP REGULATION OF CONNECTIVE TISSUE REPLACEMENT
|
15
|
4.07e-01
|
8.26e-01
|
0.21100
|
-1.62e-01
|
1.36e-01
|
2.77e-01
|
3.63e-01
|
GOMF GAMMA TUBULIN BINDING
|
30
|
1.47e-01
|
6.34e-01
|
0.21100
|
-2.04e-01
|
5.39e-02
|
5.26e-02
|
6.10e-01
|
GOBP SUPEROXIDE ANION GENERATION
|
36
|
1.14e-01
|
5.91e-01
|
0.21100
|
-1.77e-01
|
1.16e-01
|
6.67e-02
|
2.27e-01
|
GOBP MAMMALIAN OOGENESIS STAGE
|
12
|
4.77e-01
|
8.54e-01
|
0.21100
|
-1.91e-01
|
9.07e-02
|
2.52e-01
|
5.86e-01
|
GOBP NEGATIVE REGULATION OF MICROGLIAL CELL ACTIVATION
|
8
|
5.44e-01
|
8.78e-01
|
0.21100
|
-1.36e-01
|
-1.62e-01
|
5.05e-01
|
4.28e-01
|
GOMF RRNA BINDING
|
62
|
1.90e-02
|
2.94e-01
|
0.21100
|
5.17e-02
|
-2.05e-01
|
4.81e-01
|
5.25e-03
|
GOBP CITRATE TRANSPORT
|
5
|
7.42e-01
|
9.37e-01
|
0.21100
|
-1.59e-01
|
1.39e-01
|
5.39e-01
|
5.89e-01
|
GOCC INNER MITOCHONDRIAL MEMBRANE PROTEIN COMPLEX
|
135
|
5.59e-05
|
6.02e-03
|
0.21100
|
-6.75e-02
|
-2.00e-01
|
1.76e-01
|
5.87e-05
|
GOBP GRANULOCYTE DIFFERENTIATION
|
40
|
8.52e-02
|
5.41e-01
|
0.21100
|
-1.92e-01
|
8.90e-02
|
3.60e-02
|
3.30e-01
|
GOBP ZINC ION IMPORT INTO ORGANELLE
|
9
|
5.07e-01
|
8.65e-01
|
0.21100
|
1.74e-01
|
1.19e-01
|
3.65e-01
|
5.36e-01
|
GOBP PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE
|
7
|
6.10e-01
|
8.98e-01
|
0.21100
|
-3.62e-02
|
-2.08e-01
|
8.68e-01
|
3.40e-01
|
GOBP VIRAL TRANSLATION
|
20
|
2.37e-01
|
7.24e-01
|
0.21100
|
-5.74e-02
|
-2.03e-01
|
6.57e-01
|
1.16e-01
|
GOMF NUCLEOSIDE MONOPHOSPHATE KINASE ACTIVITY
|
19
|
2.39e-01
|
7.25e-01
|
0.21100
|
-1.76e-01
|
-1.17e-01
|
1.85e-01
|
3.76e-01
|
GOBP NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION
|
26
|
2.00e-01
|
6.89e-01
|
0.21100
|
-1.95e-01
|
8.07e-02
|
8.51e-02
|
4.76e-01
|
GOBP POSITIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS
|
10
|
5.42e-01
|
8.78e-01
|
0.21100
|
1.89e-01
|
-9.48e-02
|
3.02e-01
|
6.04e-01
|
GOBP NETRIN ACTIVATED SIGNALING PATHWAY
|
9
|
5.72e-01
|
8.87e-01
|
0.21100
|
7.83e-02
|
-1.96e-01
|
6.84e-01
|
3.09e-01
|
GOBP POSITIVE REGULATION OF PROSTAGLANDIN BIOSYNTHETIC PROCESS
|
7
|
6.56e-01
|
9.09e-01
|
0.21100
|
1.16e-01
|
-1.76e-01
|
5.95e-01
|
4.19e-01
|
GOBP NEPHRIC DUCT MORPHOGENESIS
|
10
|
4.68e-01
|
8.51e-01
|
0.21100
|
-1.61e-01
|
-1.36e-01
|
3.77e-01
|
4.56e-01
|
GOMF CARD DOMAIN BINDING
|
16
|
3.38e-01
|
7.90e-01
|
0.21100
|
-2.11e-01
|
-3.67e-04
|
1.44e-01
|
9.98e-01
|
GOBP REGULATION OF T CELL DIFFERENTIATION IN THYMUS
|
26
|
2.02e-01
|
6.92e-01
|
0.21100
|
-8.65e-02
|
1.92e-01
|
4.45e-01
|
8.96e-02
|
GOMF AMP ACTIVATED PROTEIN KINASE ACTIVITY
|
8
|
5.76e-01
|
8.89e-01
|
0.21100
|
2.10e-01
|
1.66e-02
|
3.03e-01
|
9.35e-01
|
GOBP RESPONSE TO FORSKOLIN
|
14
|
3.92e-01
|
8.22e-01
|
0.21100
|
2.11e-01
|
-8.16e-03
|
1.72e-01
|
9.58e-01
|
GOBP REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY
|
36
|
1.18e-01
|
6.00e-01
|
0.21100
|
1.55e-01
|
-1.43e-01
|
1.07e-01
|
1.39e-01
|
GOBP CELLULAR RESPONSE TO OXYGEN GLUCOSE DEPRIVATION
|
5
|
7.42e-01
|
9.37e-01
|
0.21100
|
-1.66e-01
|
1.30e-01
|
5.20e-01
|
6.16e-01
|
GOBP NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS
|
15
|
3.49e-01
|
7.96e-01
|
0.21100
|
-2.08e-01
|
-3.45e-02
|
1.64e-01
|
8.17e-01
|
GOBP RESPONSE TO HYDROXYUREA
|
11
|
4.88e-01
|
8.56e-01
|
0.21100
|
-2.09e-01
|
2.96e-02
|
2.31e-01
|
8.65e-01
|
GOBP NEGATIVE REGULATION OF LIPOPROTEIN METABOLIC PROCESS
|
5
|
6.86e-01
|
9.18e-01
|
0.21100
|
1.31e-01
|
1.65e-01
|
6.11e-01
|
5.24e-01
|
GOBP REGULATION OF MUCUS SECRETION
|
8
|
5.63e-01
|
8.84e-01
|
0.21100
|
-2.02e-01
|
-5.92e-02
|
3.22e-01
|
7.72e-01
|
GOBP REGULATION OF MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON
|
5
|
7.07e-01
|
9.25e-01
|
0.21100
|
-2.09e-01
|
-2.57e-02
|
4.18e-01
|
9.21e-01
|
GOBP PHAGOSOME ACIDIFICATION
|
7
|
6.60e-01
|
9.09e-01
|
0.21100
|
-1.36e-01
|
1.61e-01
|
5.33e-01
|
4.62e-01
|
GOMF PHOSPHATIDYLCHOLINE FLIPPASE ACTIVITY
|
5
|
6.99e-01
|
9.21e-01
|
0.21000
|
5.59e-02
|
2.03e-01
|
8.29e-01
|
4.32e-01
|
GOBP RELAXATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE
|
6
|
6.81e-01
|
9.16e-01
|
0.21000
|
-2.06e-01
|
4.36e-02
|
3.83e-01
|
8.53e-01
|
GOMF FOLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY
|
5
|
7.44e-01
|
9.38e-01
|
0.21000
|
1.40e-01
|
-1.57e-01
|
5.88e-01
|
5.43e-01
|
GOBP NEGATIVE REGULATION OF FATTY ACID OXIDATION
|
14
|
4.15e-01
|
8.30e-01
|
0.21000
|
-5.98e-02
|
2.02e-01
|
6.98e-01
|
1.92e-01
|
GOBP PLUS END DIRECTED ORGANELLE TRANSPORT ALONG MICROTUBULE
|
7
|
6.46e-01
|
9.07e-01
|
0.21000
|
1.99e-01
|
-6.69e-02
|
3.61e-01
|
7.59e-01
|
GOBP ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION
|
40
|
9.13e-02
|
5.51e-01
|
0.21000
|
-1.78e-01
|
1.11e-01
|
5.08e-02
|
2.24e-01
|
GOCC GOLGI MEDIAL CISTERNA
|
11
|
4.57e-01
|
8.48e-01
|
0.21000
|
-2.03e-01
|
-5.34e-02
|
2.43e-01
|
7.59e-01
|
GOCC CYTOPLASMIC UBIQUITIN LIGASE COMPLEX
|
13
|
4.64e-01
|
8.48e-01
|
0.21000
|
-1.49e-01
|
1.48e-01
|
3.52e-01
|
3.55e-01
|
GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION
|
71
|
6.63e-03
|
1.69e-01
|
0.21000
|
2.04e-01
|
4.86e-02
|
2.90e-03
|
4.78e-01
|
GOCC TROPONIN COMPLEX
|
9
|
5.85e-01
|
8.90e-01
|
0.21000
|
-1.75e-01
|
1.16e-01
|
3.63e-01
|
5.46e-01
|
GOBP REGULATION OF TETRAPYRROLE METABOLIC PROCESS
|
8
|
5.95e-01
|
8.95e-01
|
0.21000
|
2.08e-01
|
-2.89e-02
|
3.08e-01
|
8.87e-01
|
GOBP LEUKOCYTE TETHERING OR ROLLING
|
34
|
7.82e-02
|
5.26e-01
|
0.21000
|
-1.64e-01
|
-1.31e-01
|
9.77e-02
|
1.86e-01
|
GOBP T HELPER 2 CELL CYTOKINE PRODUCTION
|
13
|
4.37e-01
|
8.39e-01
|
0.21000
|
-2.05e-01
|
4.48e-02
|
2.00e-01
|
7.80e-01
|
GOCC DNA RECOMBINASE MEDIATOR COMPLEX
|
7
|
6.18e-01
|
9.00e-01
|
0.21000
|
-2.09e-01
|
-2.17e-02
|
3.39e-01
|
9.21e-01
|
GOBP POSITIVE REGULATION OF MAST CELL ACTIVATION
|
18
|
2.80e-01
|
7.52e-01
|
0.21000
|
4.98e-02
|
2.04e-01
|
7.15e-01
|
1.34e-01
|
GOBP POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING
|
22
|
2.06e-01
|
6.95e-01
|
0.21000
|
-6.57e-02
|
-1.99e-01
|
5.94e-01
|
1.06e-01
|
GOBP MITOCHONDRIAL RNA METABOLIC PROCESS
|
51
|
3.28e-02
|
3.70e-01
|
0.21000
|
-1.65e-03
|
-2.10e-01
|
9.84e-01
|
9.52e-03
|
GOMF PHOSPHATIDIC ACID BINDING
|
23
|
2.46e-01
|
7.26e-01
|
0.21000
|
-8.27e-02
|
1.93e-01
|
4.93e-01
|
1.09e-01
|
GOBP EMBRYONIC BODY MORPHOGENESIS
|
11
|
4.42e-01
|
8.40e-01
|
0.21000
|
-1.14e-01
|
-1.76e-01
|
5.14e-01
|
3.11e-01
|
GOMF CALCIUM INDUCED CALCIUM RELEASE ACTIVITY
|
6
|
6.55e-01
|
9.09e-01
|
0.21000
|
4.81e-02
|
2.04e-01
|
8.38e-01
|
3.87e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN SUMOYLATION
|
8
|
6.09e-01
|
8.97e-01
|
0.21000
|
-6.71e-02
|
1.99e-01
|
7.42e-01
|
3.31e-01
|
GOCC APICAL DENDRITE
|
15
|
3.26e-01
|
7.82e-01
|
0.21000
|
1.60e-01
|
1.35e-01
|
2.83e-01
|
3.65e-01
|
GOBP REGULATION OF ANTIMICROBIAL HUMORAL RESPONSE
|
12
|
4.62e-01
|
8.48e-01
|
0.21000
|
3.32e-02
|
-2.07e-01
|
8.42e-01
|
2.14e-01
|
GOMF BETA 2 MICROGLOBULIN BINDING
|
9
|
5.11e-01
|
8.66e-01
|
0.21000
|
-1.27e-01
|
-1.66e-01
|
5.09e-01
|
3.87e-01
|
GOMF MODIFICATION DEPENDENT PROTEIN BINDING
|
165
|
2.80e-05
|
3.54e-03
|
0.20900
|
-2.06e-01
|
3.67e-02
|
4.85e-06
|
4.15e-01
|
GOBP APOPTOTIC CHROMOSOME CONDENSATION
|
6
|
6.45e-01
|
9.07e-01
|
0.20900
|
-1.88e-01
|
-9.19e-02
|
4.25e-01
|
6.97e-01
|
GOBP PROTEOGLYCAN METABOLIC PROCESS
|
86
|
6.42e-03
|
1.66e-01
|
0.20900
|
-1.66e-01
|
1.28e-01
|
7.77e-03
|
4.09e-02
|
GOBP PROTEIN LOCALIZATION TO ENDOSOME
|
26
|
1.93e-01
|
6.85e-01
|
0.20900
|
-2.05e-01
|
4.44e-02
|
7.09e-02
|
6.95e-01
|
GOBP NEGATIVE REGULATION OF AUTOPHAGOSOME MATURATION
|
5
|
6.91e-01
|
9.20e-01
|
0.20900
|
1.12e-01
|
1.77e-01
|
6.66e-01
|
4.93e-01
|
GOCC INTRACELLULAR CYCLIC NUCLEOTIDE ACTIVATED CATION CHANNEL COMPLEX
|
5
|
6.89e-01
|
9.19e-01
|
0.20900
|
1.65e-01
|
1.28e-01
|
5.22e-01
|
6.19e-01
|
GOBP NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS
|
22
|
1.97e-01
|
6.88e-01
|
0.20900
|
1.77e-01
|
1.12e-01
|
1.51e-01
|
3.64e-01
|
GOBP VESICLE TARGETING TO FROM OR WITHIN GOLGI
|
32
|
1.26e-01
|
6.06e-01
|
0.20900
|
-2.08e-01
|
2.32e-02
|
4.17e-02
|
8.20e-01
|
GOBP NEGATIVE REGULATION OF AMYLOID BETA CLEARANCE
|
11
|
4.69e-01
|
8.51e-01
|
0.20900
|
-2.07e-01
|
-2.78e-02
|
2.34e-01
|
8.73e-01
|
GOBP REGULATION OF DNA TEMPLATED DNA REPLICATION INITIATION
|
15
|
3.28e-01
|
7.83e-01
|
0.20900
|
-1.67e-01
|
-1.26e-01
|
2.62e-01
|
3.99e-01
|
GOCC RNA POLYMERASE I COMPLEX
|
13
|
4.62e-01
|
8.48e-01
|
0.20900
|
1.10e-01
|
-1.78e-01
|
4.92e-01
|
2.67e-01
|
GOBP SECRETORY GRANULE LOCALIZATION
|
13
|
4.63e-01
|
8.48e-01
|
0.20900
|
-1.15e-01
|
1.75e-01
|
4.72e-01
|
2.76e-01
|
GOBP ARTERIAL ENDOTHELIAL CELL DIFFERENTIATION
|
6
|
6.42e-01
|
9.07e-01
|
0.20900
|
-1.09e-01
|
-1.78e-01
|
6.43e-01
|
4.49e-01
|
GOBP ENDOCYTOSIS INVOLVED IN VIRAL ENTRY INTO HOST CELL
|
12
|
4.50e-01
|
8.43e-01
|
0.20900
|
-8.56e-04
|
-2.09e-01
|
9.96e-01
|
2.10e-01
|
GOBP POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS
|
21
|
2.31e-01
|
7.18e-01
|
0.20900
|
-4.48e-02
|
-2.04e-01
|
7.22e-01
|
1.05e-01
|
GOBP PROTEIN CATABOLIC PROCESS IN THE VACUOLE
|
22
|
2.22e-01
|
7.12e-01
|
0.20900
|
-2.07e-01
|
-2.55e-02
|
9.22e-02
|
8.36e-01
|
GOBP NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS
|
38
|
6.04e-02
|
4.78e-01
|
0.20900
|
-1.72e-01
|
-1.19e-01
|
6.72e-02
|
2.03e-01
|
GOBP INTERFERON BETA PRODUCTION
|
56
|
1.59e-02
|
2.67e-01
|
0.20900
|
-1.24e-01
|
-1.68e-01
|
1.09e-01
|
2.94e-02
|
GOBP NEGATIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION
|
22
|
2.65e-01
|
7.41e-01
|
0.20900
|
8.60e-02
|
-1.90e-01
|
4.85e-01
|
1.22e-01
|
GOBP RESPONSE TO INTERLEUKIN 17
|
17
|
3.53e-01
|
7.97e-01
|
0.20900
|
-1.97e-01
|
7.02e-02
|
1.60e-01
|
6.16e-01
|
GOBP TRICARBOXYLIC ACID CYCLE
|
29
|
1.34e-01
|
6.16e-01
|
0.20900
|
-3.96e-02
|
-2.05e-01
|
7.12e-01
|
5.59e-02
|
GOBP BONE TRABECULA MORPHOGENESIS
|
13
|
4.68e-01
|
8.51e-01
|
0.20900
|
-1.32e-01
|
1.62e-01
|
4.10e-01
|
3.13e-01
|
GOBP NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION
|
19
|
3.16e-01
|
7.76e-01
|
0.20900
|
-7.76e-02
|
1.94e-01
|
5.58e-01
|
1.44e-01
|
GOMF MONOAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
12
|
4.12e-01
|
8.28e-01
|
0.20900
|
1.25e-01
|
1.67e-01
|
4.54e-01
|
3.16e-01
|
GOBP NUCLEAR MEMBRANE REASSEMBLY
|
25
|
2.23e-01
|
7.12e-01
|
0.20900
|
-1.89e-01
|
8.82e-02
|
1.02e-01
|
4.45e-01
|
GOBP SELF PROTEOLYSIS
|
12
|
4.95e-01
|
8.59e-01
|
0.20900
|
-1.68e-01
|
1.24e-01
|
3.14e-01
|
4.58e-01
|
GOBP DNA TOPOLOGICAL CHANGE
|
9
|
5.88e-01
|
8.91e-01
|
0.20900
|
-1.77e-01
|
1.10e-01
|
3.57e-01
|
5.68e-01
|
GOMF MECHANOSENSITIVE MONOATOMIC ION CHANNEL ACTIVITY
|
16
|
3.16e-01
|
7.77e-01
|
0.20900
|
8.19e-02
|
1.92e-01
|
5.71e-01
|
1.84e-01
|
GOBP REGULATION OF SYNAPTIC VESICLE MEMBRANE ORGANIZATION
|
12
|
4.75e-01
|
8.54e-01
|
0.20900
|
-5.43e-02
|
2.01e-01
|
7.45e-01
|
2.27e-01
|
GOMF TYPE I INTERFERON RECEPTOR BINDING
|
14
|
4.43e-01
|
8.40e-01
|
0.20900
|
1.35e-01
|
-1.59e-01
|
3.82e-01
|
3.03e-01
|
GOBP PARALLEL ACTIN FILAMENT BUNDLE ASSEMBLY
|
7
|
6.42e-01
|
9.07e-01
|
0.20800
|
-2.05e-01
|
3.73e-02
|
3.47e-01
|
8.64e-01
|
GOBP TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY
|
11
|
5.21e-01
|
8.69e-01
|
0.20800
|
-1.82e-01
|
1.01e-01
|
2.95e-01
|
5.61e-01
|
GOBP RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS
|
31
|
1.03e-01
|
5.75e-01
|
0.20800
|
-1.76e-01
|
-1.12e-01
|
9.05e-02
|
2.81e-01
|
GOBP CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION
|
10
|
4.77e-01
|
8.54e-01
|
0.20800
|
-1.41e-01
|
-1.54e-01
|
4.42e-01
|
4.00e-01
|
GOBP KINETOCHORE ASSEMBLY
|
16
|
3.35e-01
|
7.88e-01
|
0.20800
|
-3.28e-02
|
-2.06e-01
|
8.20e-01
|
1.54e-01
|
GOBP LYSINE METABOLIC PROCESS
|
8
|
5.94e-01
|
8.94e-01
|
0.20800
|
2.08e-01
|
-1.21e-02
|
3.09e-01
|
9.53e-01
|
GOCC CIS GOLGI NETWORK MEMBRANE
|
10
|
5.09e-01
|
8.66e-01
|
0.20800
|
-2.12e-02
|
-2.07e-01
|
9.08e-01
|
2.57e-01
|
GOBP L ASCORBIC ACID METABOLIC PROCESS
|
9
|
5.15e-01
|
8.68e-01
|
0.20800
|
1.50e-01
|
1.44e-01
|
4.37e-01
|
4.53e-01
|
GOBP CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION
|
19
|
2.63e-01
|
7.40e-01
|
0.20800
|
-6.08e-02
|
-1.99e-01
|
6.46e-01
|
1.33e-01
|
GOCC POSTSYNAPTIC DENSITY INTRACELLULAR COMPONENT
|
13
|
4.52e-01
|
8.45e-01
|
0.20800
|
-1.97e-01
|
6.57e-02
|
2.18e-01
|
6.82e-01
|
GOBP GLUCOSE CATABOLIC PROCESS
|
25
|
2.30e-01
|
7.18e-01
|
0.20800
|
-1.78e-01
|
1.07e-01
|
1.23e-01
|
3.54e-01
|
GOBP POSITIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY
|
15
|
3.47e-01
|
7.96e-01
|
0.20800
|
6.74e-02
|
1.97e-01
|
6.51e-01
|
1.87e-01
|
GOMF 2 ACYLGLYCEROL O ACYLTRANSFERASE ACTIVITY
|
6
|
7.05e-01
|
9.24e-01
|
0.20800
|
-1.18e-01
|
1.71e-01
|
6.15e-01
|
4.69e-01
|
GOBP PURINE NUCLEOSIDE TRANSMEMBRANE TRANSPORT
|
5
|
6.98e-01
|
9.21e-01
|
0.20800
|
9.02e-02
|
1.87e-01
|
7.27e-01
|
4.68e-01
|
GOBP REGULATION OF GENE EXPRESSION BY GENOMIC IMPRINTING
|
10
|
4.81e-01
|
8.54e-01
|
0.20800
|
1.19e-01
|
1.71e-01
|
5.16e-01
|
3.50e-01
|
GOBP MESENCHYME MIGRATION
|
5
|
7.43e-01
|
9.38e-01
|
0.20800
|
-1.86e-01
|
9.36e-02
|
4.72e-01
|
7.17e-01
|
GOCC ATG1 ULK1 KINASE COMPLEX
|
6
|
6.65e-01
|
9.10e-01
|
0.20800
|
3.14e-02
|
2.05e-01
|
8.94e-01
|
3.84e-01
|
GOBP TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY
|
26
|
2.23e-01
|
7.12e-01
|
0.20800
|
-1.57e-01
|
1.36e-01
|
1.66e-01
|
2.30e-01
|
GOMF PROTEIN DISULFIDE ISOMERASE ACTIVITY
|
20
|
3.03e-01
|
7.68e-01
|
0.20800
|
-1.90e-01
|
8.50e-02
|
1.42e-01
|
5.10e-01
|
GOBP SYNAPTIC ASSEMBLY AT NEUROMUSCULAR JUNCTION
|
10
|
5.39e-01
|
8.78e-01
|
0.20800
|
-4.97e-02
|
2.02e-01
|
7.85e-01
|
2.70e-01
|
GOBP REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM
|
29
|
1.19e-01
|
6.00e-01
|
0.20800
|
1.54e-01
|
1.39e-01
|
1.52e-01
|
1.94e-01
|
GOBP CEREBELLAR GRANULAR LAYER FORMATION
|
6
|
6.89e-01
|
9.19e-01
|
0.20800
|
-2.02e-01
|
4.75e-02
|
3.91e-01
|
8.40e-01
|
GOBP ANTERIOR POSTERIOR AXON GUIDANCE
|
7
|
6.40e-01
|
9.06e-01
|
0.20800
|
2.27e-02
|
-2.06e-01
|
9.17e-01
|
3.45e-01
|
GOBP RIBOSOMAL LARGE SUBUNIT ASSEMBLY
|
24
|
1.80e-01
|
6.70e-01
|
0.20800
|
-8.60e-02
|
-1.89e-01
|
4.66e-01
|
1.09e-01
|
GOBP MALONYL COA METABOLIC PROCESS
|
6
|
6.70e-01
|
9.11e-01
|
0.20800
|
-1.67e-02
|
-2.07e-01
|
9.44e-01
|
3.80e-01
|
GOBP NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN
|
10
|
5.59e-01
|
8.82e-01
|
0.20700
|
1.73e-01
|
-1.15e-01
|
3.44e-01
|
5.30e-01
|
GOMF RETINAL BINDING
|
19
|
2.69e-01
|
7.45e-01
|
0.20700
|
2.01e-01
|
4.96e-02
|
1.29e-01
|
7.08e-01
|
GOBP POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS
|
25
|
1.70e-01
|
6.57e-01
|
0.20700
|
-1.92e-01
|
-7.79e-02
|
9.64e-02
|
5.00e-01
|
GOBP NEGATIVE REGULATION OF BLOOD PRESSURE
|
46
|
7.11e-02
|
5.08e-01
|
0.20700
|
1.57e-01
|
-1.35e-01
|
6.53e-02
|
1.12e-01
|
GOBP POSITIVE REGULATION OF UTERINE SMOOTH MUSCLE CONTRACTION
|
7
|
6.59e-01
|
9.09e-01
|
0.20700
|
8.19e-02
|
-1.90e-01
|
7.07e-01
|
3.83e-01
|
GOBP NK T CELL ACTIVATION
|
12
|
4.97e-01
|
8.61e-01
|
0.20700
|
1.08e-01
|
-1.77e-01
|
5.16e-01
|
2.90e-01
|
GOBP REGULATION OF MACROPHAGE FUSION
|
5
|
7.47e-01
|
9.39e-01
|
0.20700
|
1.79e-01
|
-1.04e-01
|
4.88e-01
|
6.88e-01
|
GOBP RESPONSE TO ISCHEMIA
|
62
|
2.12e-02
|
3.08e-01
|
0.20700
|
-2.03e-01
|
3.89e-02
|
5.62e-03
|
5.96e-01
|
GOBP SMOOTH MUSCLE TISSUE DEVELOPMENT
|
27
|
2.13e-01
|
7.01e-01
|
0.20700
|
-1.33e-01
|
1.59e-01
|
2.32e-01
|
1.54e-01
|
GOBP DETECTION OF CALCIUM ION
|
13
|
4.48e-01
|
8.42e-01
|
0.20700
|
2.02e-01
|
-4.55e-02
|
2.08e-01
|
7.77e-01
|
GOBP REGULATION OF MYELINATION
|
45
|
7.25e-02
|
5.13e-01
|
0.20700
|
-1.02e-01
|
1.80e-01
|
2.38e-01
|
3.64e-02
|
GOBP INTRACELLULAR PH REDUCTION
|
51
|
5.21e-02
|
4.49e-01
|
0.20700
|
-1.75e-01
|
1.10e-01
|
3.05e-02
|
1.74e-01
|
GOBP REGULATION OF POLYAMINE TRANSMEMBRANE TRANSPORT
|
5
|
7.51e-01
|
9.40e-01
|
0.20700
|
-1.42e-01
|
1.51e-01
|
5.84e-01
|
5.59e-01
|
GOMF ORNITHINE DECARBOXYLASE REGULATOR ACTIVITY
|
5
|
7.51e-01
|
9.40e-01
|
0.20700
|
-1.42e-01
|
1.51e-01
|
5.84e-01
|
5.59e-01
|
GOBP HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS
|
14
|
4.47e-01
|
8.41e-01
|
0.20700
|
1.65e-01
|
-1.25e-01
|
2.86e-01
|
4.18e-01
|
GOMF 2 OXOGLUTARATE DEPENDENT DIOXYGENASE ACTIVITY
|
54
|
4.53e-02
|
4.31e-01
|
0.20700
|
-1.63e-01
|
1.28e-01
|
3.87e-02
|
1.04e-01
|
GOMF DNA BINDING BENDING
|
16
|
3.97e-01
|
8.25e-01
|
0.20700
|
1.71e-01
|
-1.16e-01
|
2.35e-01
|
4.23e-01
|
GOMF MHC CLASS IB RECEPTOR ACTIVITY
|
7
|
6.54e-01
|
9.09e-01
|
0.20700
|
-5.92e-02
|
1.98e-01
|
7.86e-01
|
3.64e-01
|
GOBP MACROPHAGE MIGRATION
|
61
|
3.03e-02
|
3.61e-01
|
0.20700
|
-1.66e-01
|
1.24e-01
|
2.53e-02
|
9.47e-02
|
GOCC CELL POLE
|
7
|
6.63e-01
|
9.10e-01
|
0.20700
|
9.35e-02
|
-1.84e-01
|
6.68e-01
|
3.98e-01
|
GOBP NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION
|
10
|
5.59e-01
|
8.82e-01
|
0.20700
|
1.80e-01
|
-1.02e-01
|
3.25e-01
|
5.76e-01
|
GOBP REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH
|
12
|
4.36e-01
|
8.39e-01
|
0.20700
|
1.98e-01
|
5.85e-02
|
2.35e-01
|
7.26e-01
|
GOMF RNA STEM LOOP BINDING
|
14
|
3.69e-01
|
8.09e-01
|
0.20700
|
-1.85e-01
|
-9.18e-02
|
2.31e-01
|
5.52e-01
|
GOBP POSITIVE REGULATION OF INTERFERON BETA PRODUCTION
|
37
|
9.55e-02
|
5.61e-01
|
0.20700
|
1.79e-02
|
-2.06e-01
|
8.51e-01
|
3.03e-02
|
GOBP GERMINAL CENTER B CELL DIFFERENTIATION
|
9
|
5.23e-01
|
8.70e-01
|
0.20700
|
1.12e-01
|
1.74e-01
|
5.62e-01
|
3.67e-01
|
GOBP RESPONSE TO INTERLEUKIN 6
|
41
|
7.92e-02
|
5.27e-01
|
0.20600
|
-3.86e-02
|
2.03e-01
|
6.69e-01
|
2.47e-02
|
GOMF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY
|
27
|
1.44e-01
|
6.28e-01
|
0.20600
|
-1.12e-01
|
-1.73e-01
|
3.13e-01
|
1.19e-01
|
GOBP FOREBRAIN VENTRICULAR ZONE PROGENITOR CELL DIVISION
|
5
|
7.09e-01
|
9.25e-01
|
0.20600
|
-5.72e-02
|
-1.98e-01
|
8.25e-01
|
4.43e-01
|
GOCC ER TO GOLGI TRANSPORT VESICLE MEMBRANE
|
60
|
1.83e-02
|
2.90e-01
|
0.20600
|
-2.89e-02
|
-2.04e-01
|
6.98e-01
|
6.24e-03
|
GOMF PHOSPHATIDYLINOSITOL KINASE ACTIVITY
|
26
|
1.88e-01
|
6.80e-01
|
0.20600
|
-3.39e-03
|
2.06e-01
|
9.76e-01
|
6.89e-02
|
GOMF CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING
|
39
|
1.04e-01
|
5.75e-01
|
0.20600
|
-1.81e-01
|
9.88e-02
|
5.05e-02
|
2.86e-01
|
GOBP POSITIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY
|
8
|
6.32e-01
|
9.03e-01
|
0.20600
|
-1.18e-01
|
1.69e-01
|
5.65e-01
|
4.07e-01
|
GOBP PHOTOPERIODISM
|
27
|
1.92e-01
|
6.85e-01
|
0.20600
|
-2.00e-01
|
4.79e-02
|
7.14e-02
|
6.66e-01
|
GOMF ORGANOPHOSPHATE ESTER TRANSMEMBRANE TRANSPORTER ACTIVITY
|
34
|
1.04e-01
|
5.75e-01
|
0.20600
|
-2.05e-01
|
-2.48e-02
|
3.89e-02
|
8.03e-01
|
GOBP POSITIVE REGULATION OF PLATELET ACTIVATION
|
9
|
5.81e-01
|
8.90e-01
|
0.20600
|
1.98e-01
|
-5.78e-02
|
3.04e-01
|
7.64e-01
|
GOBP POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS
|
21
|
2.89e-01
|
7.60e-01
|
0.20600
|
-7.69e-02
|
1.91e-01
|
5.42e-01
|
1.29e-01
|
GOBP PROTEIN TO MEMBRANE DOCKING
|
5
|
7.42e-01
|
9.37e-01
|
0.20600
|
1.94e-01
|
-6.99e-02
|
4.53e-01
|
7.87e-01
|
GOCC TRNA METHYLTRANSFERASE COMPLEX
|
6
|
6.65e-01
|
9.10e-01
|
0.20600
|
-4.85e-02
|
-2.00e-01
|
8.37e-01
|
3.96e-01
|
GOCC CYTOSKELETON OF PRESYNAPTIC ACTIVE ZONE
|
8
|
5.65e-01
|
8.85e-01
|
0.20600
|
1.75e-01
|
1.08e-01
|
3.91e-01
|
5.96e-01
|
GOCC PRESPLICEOSOME
|
16
|
3.81e-01
|
8.16e-01
|
0.20600
|
5.75e-02
|
-1.98e-01
|
6.90e-01
|
1.71e-01
|
GOBP GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS
|
15
|
3.87e-01
|
8.19e-01
|
0.20600
|
-2.05e-01
|
1.42e-02
|
1.69e-01
|
9.24e-01
|
GOBP SODIUM INDEPENDENT ORGANIC ANION TRANSPORT
|
15
|
4.21e-01
|
8.33e-01
|
0.20600
|
1.78e-01
|
-1.03e-01
|
2.33e-01
|
4.88e-01
|
GOMF MAGNESIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
14
|
4.44e-01
|
8.40e-01
|
0.20600
|
9.48e-02
|
-1.83e-01
|
5.39e-01
|
2.37e-01
|
GOBP POSITIVE REGULATION OF STEROID METABOLIC PROCESS
|
27
|
1.83e-01
|
6.72e-01
|
0.20600
|
-1.82e-02
|
2.05e-01
|
8.70e-01
|
6.53e-02
|
GOMF MELANOCORTIN RECEPTOR BINDING
|
5
|
6.98e-01
|
9.21e-01
|
0.20600
|
1.26e-01
|
1.63e-01
|
6.27e-01
|
5.28e-01
|
GOBP NEGATIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE
|
8
|
6.27e-01
|
9.02e-01
|
0.20600
|
-1.85e-01
|
8.94e-02
|
3.64e-01
|
6.61e-01
|
GOMF MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE BINDING
|
15
|
4.26e-01
|
8.36e-01
|
0.20600
|
-1.64e-01
|
1.24e-01
|
2.71e-01
|
4.05e-01
|
GOCC DIHYDROLIPOYL DEHYDROGENASE COMPLEX
|
8
|
6.36e-01
|
9.06e-01
|
0.20600
|
1.42e-01
|
-1.49e-01
|
4.88e-01
|
4.65e-01
|
GOMF PHOSPHOLIPASE A1 ACTIVITY
|
18
|
3.49e-01
|
7.96e-01
|
0.20600
|
-8.42e-02
|
1.88e-01
|
5.36e-01
|
1.68e-01
|
GOBP POSITIVE REGULATION OF RNA EXPORT FROM NUCLEUS
|
5
|
7.51e-01
|
9.40e-01
|
0.20600
|
-1.13e-01
|
1.72e-01
|
6.61e-01
|
5.06e-01
|
GOBP REGULATION OF HUMORAL IMMUNE RESPONSE
|
46
|
7.34e-02
|
5.13e-01
|
0.20600
|
1.64e-01
|
-1.23e-01
|
5.36e-02
|
1.47e-01
|
GOBP POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION
|
15
|
3.45e-01
|
7.95e-01
|
0.20600
|
1.78e-01
|
1.02e-01
|
2.31e-01
|
4.94e-01
|
GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSPORT
|
41
|
5.75e-02
|
4.68e-01
|
0.20600
|
1.91e-01
|
7.70e-02
|
3.46e-02
|
3.93e-01
|
GOBP REGULATION OF PROTEIN GLYCOSYLATION
|
12
|
4.86e-01
|
8.56e-01
|
0.20600
|
-1.97e-01
|
5.76e-02
|
2.37e-01
|
7.30e-01
|
GOBP APOLIPOPROTEIN A I MEDIATED SIGNALING PATHWAY
|
7
|
6.45e-01
|
9.07e-01
|
0.20600
|
-2.04e-01
|
2.20e-02
|
3.49e-01
|
9.20e-01
|
GOMF CARBONATE DEHYDRATASE ACTIVITY
|
14
|
4.02e-01
|
8.26e-01
|
0.20600
|
2.05e-01
|
1.16e-02
|
1.84e-01
|
9.40e-01
|
GOBP REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY
|
63
|
1.51e-02
|
2.62e-01
|
0.20600
|
3.23e-02
|
2.03e-01
|
6.57e-01
|
5.33e-03
|
GOMF HISTONE DEUBIQUITINASE ACTIVITY
|
5
|
7.01e-01
|
9.22e-01
|
0.20600
|
-1.01e-01
|
-1.79e-01
|
6.97e-01
|
4.88e-01
|
GOMF CAMP DEPENDENT PROTEIN KINASE REGULATOR ACTIVITY
|
12
|
4.86e-01
|
8.56e-01
|
0.20500
|
-1.98e-01
|
5.53e-02
|
2.35e-01
|
7.40e-01
|
GOMF ADRENERGIC RECEPTOR BINDING
|
18
|
2.84e-01
|
7.57e-01
|
0.20500
|
8.19e-02
|
1.88e-01
|
5.47e-01
|
1.66e-01
|
GOBP VESTIBULOCOCHLEAR NERVE DEVELOPMENT
|
11
|
4.67e-01
|
8.51e-01
|
0.20500
|
7.01e-02
|
1.93e-01
|
6.87e-01
|
2.68e-01
|
GOMF INSULIN LIKE GROWTH FACTOR II BINDING
|
8
|
5.81e-01
|
8.90e-01
|
0.20500
|
-5.01e-02
|
-1.99e-01
|
8.06e-01
|
3.29e-01
|
GOCC INSULIN LIKE GROWTH FACTOR BINDING PROTEIN COMPLEX
|
5
|
7.20e-01
|
9.30e-01
|
0.20500
|
-2.04e-01
|
-1.93e-02
|
4.29e-01
|
9.40e-01
|
GOBP TETRAHYDROFOLATE METABOLIC PROCESS
|
15
|
3.41e-01
|
7.93e-01
|
0.20500
|
-1.28e-01
|
-1.61e-01
|
3.91e-01
|
2.82e-01
|
GOBP FOLLICLE STIMULATING HORMONE SECRETION
|
8
|
5.99e-01
|
8.95e-01
|
0.20500
|
-2.05e-01
|
2.05e-04
|
3.15e-01
|
9.99e-01
|
GOCC SMAD PROTEIN COMPLEX
|
9
|
5.70e-01
|
8.86e-01
|
0.20500
|
-2.04e-01
|
1.98e-02
|
2.89e-01
|
9.18e-01
|
GOBP PROTEIN HETEROTETRAMERIZATION
|
15
|
4.28e-01
|
8.36e-01
|
0.20500
|
-1.63e-01
|
1.24e-01
|
2.74e-01
|
4.04e-01
|
GOBP CELL DIFFERENTIATION IN HINDBRAIN
|
21
|
2.25e-01
|
7.13e-01
|
0.20500
|
-1.11e-01
|
-1.73e-01
|
3.79e-01
|
1.71e-01
|
GOBP REGULATION OF CENTROSOME CYCLE
|
54
|
2.26e-02
|
3.18e-01
|
0.20500
|
-9.40e-02
|
-1.82e-01
|
2.32e-01
|
2.05e-02
|
GOMF HSP70 PROTEIN BINDING
|
50
|
2.85e-02
|
3.51e-01
|
0.20500
|
-1.65e-01
|
-1.22e-01
|
4.37e-02
|
1.36e-01
|
GOCC CELL TRAILING EDGE
|
13
|
4.81e-01
|
8.54e-01
|
0.20500
|
-1.61e-01
|
1.27e-01
|
3.16e-01
|
4.28e-01
|
GOCC INNER KINETOCHORE
|
17
|
3.72e-01
|
8.09e-01
|
0.20500
|
8.03e-02
|
-1.88e-01
|
5.67e-01
|
1.79e-01
|
GOBP DETECTION OF BACTERIUM
|
16
|
3.31e-01
|
7.85e-01
|
0.20500
|
-7.58e-02
|
-1.90e-01
|
5.99e-01
|
1.88e-01
|
GOBP POSITIVE REGULATION OF CARDIAC MUSCLE ADAPTATION
|
9
|
5.75e-01
|
8.89e-01
|
0.20500
|
-3.11e-02
|
2.02e-01
|
8.72e-01
|
2.93e-01
|
GOBP HEPATOCYTE DIFFERENTIATION
|
15
|
4.22e-01
|
8.34e-01
|
0.20500
|
1.83e-01
|
-9.25e-02
|
2.21e-01
|
5.35e-01
|
GOBP SCHWANN CELL MIGRATION
|
5
|
7.43e-01
|
9.38e-01
|
0.20500
|
1.96e-01
|
-5.98e-02
|
4.48e-01
|
8.17e-01
|
GOBP CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT
|
9
|
5.36e-01
|
8.77e-01
|
0.20500
|
1.89e-01
|
7.96e-02
|
3.27e-01
|
6.79e-01
|
GOBP CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING
|
32
|
1.35e-01
|
6.16e-01
|
0.20500
|
1.44e-02
|
-2.04e-01
|
8.88e-01
|
4.57e-02
|
GOBP ENDOSOMAL VESICLE FUSION
|
12
|
4.33e-01
|
8.37e-01
|
0.20500
|
-1.83e-01
|
-9.07e-02
|
2.71e-01
|
5.87e-01
|
GOBP MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL
|
28
|
1.42e-01
|
6.26e-01
|
0.20500
|
1.83e-01
|
9.19e-02
|
9.43e-02
|
4.00e-01
|
GOBP REGULATION OF EXOSOMAL SECRETION
|
19
|
3.23e-01
|
7.79e-01
|
0.20400
|
-1.96e-01
|
5.77e-02
|
1.39e-01
|
6.63e-01
|
GOBP INOSITOL TRISPHOSPHATE BIOSYNTHETIC PROCESS
|
8
|
6.14e-01
|
8.98e-01
|
0.20400
|
-3.43e-02
|
2.02e-01
|
8.66e-01
|
3.23e-01
|
GOBP HISTAMINE TRANSPORT
|
15
|
4.12e-01
|
8.28e-01
|
0.20400
|
-6.21e-02
|
1.95e-01
|
6.77e-01
|
1.92e-01
|
GOBP CEREBELLAR CORTEX FORMATION
|
24
|
1.83e-01
|
6.73e-01
|
0.20400
|
-1.18e-01
|
-1.67e-01
|
3.17e-01
|
1.57e-01
|
GOBP SECRETION BY TISSUE
|
44
|
7.66e-02
|
5.22e-01
|
0.20400
|
-1.91e-01
|
7.14e-02
|
2.80e-02
|
4.13e-01
|
GOCC CONNEXIN COMPLEX
|
19
|
3.01e-01
|
7.67e-01
|
0.20400
|
2.04e-01
|
-2.74e-03
|
1.23e-01
|
9.83e-01
|
GOBP REGULATION OF ERAD PATHWAY
|
19
|
2.84e-01
|
7.57e-01
|
0.20400
|
-3.91e-02
|
-2.00e-01
|
7.68e-01
|
1.31e-01
|
GOBP PURINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS
|
5
|
7.08e-01
|
9.25e-01
|
0.20400
|
8.03e-02
|
1.88e-01
|
7.56e-01
|
4.67e-01
|
GOBP REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR
|
6
|
6.81e-01
|
9.16e-01
|
0.20400
|
-2.04e-01
|
-8.21e-03
|
3.87e-01
|
9.72e-01
|
GOBP GOLGI TO VACUOLE TRANSPORT
|
20
|
3.27e-01
|
7.83e-01
|
0.20400
|
-1.61e-01
|
1.25e-01
|
2.11e-01
|
3.35e-01
|
GOCC LUMENAL SIDE OF MEMBRANE
|
35
|
1.35e-01
|
6.16e-01
|
0.20400
|
8.69e-02
|
-1.84e-01
|
3.74e-01
|
5.90e-02
|
GOBP NEGATIVE REGULATION OF PROGRAMMED NECROTIC CELL DEATH
|
21
|
3.06e-01
|
7.70e-01
|
0.20400
|
-1.06e-01
|
1.74e-01
|
4.00e-01
|
1.67e-01
|
GOMF BASIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY
|
17
|
3.88e-01
|
8.20e-01
|
0.20400
|
-1.53e-01
|
1.35e-01
|
2.75e-01
|
3.35e-01
|
GOCC ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT
|
128
|
2.42e-04
|
1.73e-02
|
0.20400
|
-2.02e-01
|
-2.90e-02
|
8.06e-05
|
5.71e-01
|
GOMF GLYCOGEN BINDING
|
7
|
6.09e-01
|
8.97e-01
|
0.20400
|
-1.56e-01
|
-1.31e-01
|
4.74e-01
|
5.48e-01
|
GOMF ALPHA KETOGLUTARATE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
6
|
7.08e-01
|
9.25e-01
|
0.20400
|
1.86e-01
|
-8.40e-02
|
4.31e-01
|
7.22e-01
|
GOBP MICROTUBULE ANCHORING
|
23
|
1.98e-01
|
6.88e-01
|
0.20400
|
-1.65e-01
|
-1.19e-01
|
1.70e-01
|
3.23e-01
|
GOBP ENDOCARDIUM DEVELOPMENT
|
12
|
4.56e-01
|
8.47e-01
|
0.20400
|
3.14e-02
|
2.01e-01
|
8.50e-01
|
2.27e-01
|
GOBP GLUCURONATE CATABOLIC PROCESS TO XYLULOSE 5 PHOSPHATE
|
5
|
7.57e-01
|
9.43e-01
|
0.20400
|
1.50e-01
|
-1.37e-01
|
5.60e-01
|
5.94e-01
|
GOBP POSITIVE REGULATION OF TRANSLATIONAL INITIATION
|
24
|
2.64e-01
|
7.41e-01
|
0.20400
|
-1.40e-01
|
1.48e-01
|
2.35e-01
|
2.09e-01
|
GOBP MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY
|
25
|
1.75e-01
|
6.65e-01
|
0.20400
|
-1.05e-01
|
-1.75e-01
|
3.66e-01
|
1.30e-01
|
GOBP REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION
|
277
|
1.41e-07
|
8.02e-05
|
0.20400
|
-7.96e-02
|
1.87e-01
|
2.26e-02
|
7.82e-08
|
GOBP NEGATIVE REGULATION OF RESPONSE TO FOOD
|
10
|
5.70e-01
|
8.86e-01
|
0.20400
|
1.08e-01
|
-1.73e-01
|
5.56e-01
|
3.44e-01
|
GOBP NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY
|
10
|
5.18e-01
|
8.69e-01
|
0.20400
|
2.00e-01
|
3.77e-02
|
2.73e-01
|
8.36e-01
|
GOCC PRP19 COMPLEX
|
12
|
4.79e-01
|
8.54e-01
|
0.20400
|
2.30e-02
|
-2.02e-01
|
8.90e-01
|
2.25e-01
|
GOMF PHOSPHORYLATION DEPENDENT PROTEIN BINDING
|
6
|
6.95e-01
|
9.21e-01
|
0.20400
|
-3.22e-02
|
2.01e-01
|
8.91e-01
|
3.94e-01
|
GOMF 1 PHOSPHATIDYLINOSITOL 4 PHOSPHATE 3 KINASE ACTIVITY
|
7
|
6.18e-01
|
9.00e-01
|
0.20400
|
1.86e-01
|
8.25e-02
|
3.94e-01
|
7.06e-01
|
GOBP CELLULAR RESPONSE TO ETHANOL
|
11
|
4.82e-01
|
8.54e-01
|
0.20400
|
-1.98e-01
|
-4.60e-02
|
2.55e-01
|
7.92e-01
|
GOCC FILTRATION DIAPHRAGM
|
8
|
6.31e-01
|
9.03e-01
|
0.20300
|
-7.97e-02
|
1.87e-01
|
6.96e-01
|
3.59e-01
|
GOBP POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR
|
30
|
1.90e-01
|
6.84e-01
|
0.20300
|
1.52e-01
|
-1.35e-01
|
1.48e-01
|
2.01e-01
|
GOBP REGULATION OF HAIR FOLLICLE DEVELOPMENT
|
19
|
3.42e-01
|
7.93e-01
|
0.20300
|
-1.78e-01
|
9.79e-02
|
1.78e-01
|
4.60e-01
|
GOBP ANTIVIRAL INNATE IMMUNE RESPONSE
|
48
|
3.40e-02
|
3.76e-01
|
0.20300
|
-1.42e-01
|
-1.45e-01
|
8.83e-02
|
8.13e-02
|
GOBP REGULATION OF EOSINOPHIL MIGRATION
|
6
|
6.55e-01
|
9.09e-01
|
0.20300
|
-1.37e-01
|
-1.50e-01
|
5.60e-01
|
5.25e-01
|
GOBP REGULATION OF RESPONSE TO FOOD
|
14
|
4.42e-01
|
8.40e-01
|
0.20300
|
6.45e-02
|
-1.93e-01
|
6.76e-01
|
2.12e-01
|
GOMF COPPER ION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
6
|
6.64e-01
|
9.10e-01
|
0.20300
|
-1.88e-01
|
-7.83e-02
|
4.26e-01
|
7.40e-01
|
GOBP ENDOTHELIAL CELL ACTIVATION
|
11
|
4.80e-01
|
8.54e-01
|
0.20300
|
-5.27e-02
|
-1.96e-01
|
7.62e-01
|
2.60e-01
|
GOBP RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM
|
70
|
7.36e-03
|
1.79e-01
|
0.20300
|
-1.56e-01
|
-1.30e-01
|
2.40e-02
|
5.94e-02
|
GOMF GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY
|
215
|
2.70e-06
|
6.13e-04
|
0.20300
|
-3.62e-02
|
2.00e-01
|
3.60e-01
|
4.30e-07
|
GOBP DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS
|
11
|
4.85e-01
|
8.56e-01
|
0.20300
|
-1.99e-01
|
-4.00e-02
|
2.53e-01
|
8.18e-01
|
GOBP CELLULAR RESPONSE TO NICOTINE
|
8
|
6.11e-01
|
8.98e-01
|
0.20300
|
2.02e-01
|
-1.64e-02
|
3.21e-01
|
9.36e-01
|
GOBP NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION
|
7
|
6.50e-01
|
9.07e-01
|
0.20300
|
-2.02e-01
|
1.74e-02
|
3.54e-01
|
9.37e-01
|
GOMF OLIGOPEPTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
6
|
6.67e-01
|
9.11e-01
|
0.20300
|
1.92e-01
|
6.69e-02
|
4.16e-01
|
7.77e-01
|
GOBP RESPONSE TO CELL CYCLE CHECKPOINT SIGNALING
|
7
|
6.53e-01
|
9.08e-01
|
0.20300
|
-2.47e-02
|
2.02e-01
|
9.10e-01
|
3.56e-01
|
GOBP KYNURENINE METABOLIC PROCESS
|
11
|
5.43e-01
|
8.78e-01
|
0.20300
|
1.20e-01
|
-1.63e-01
|
4.89e-01
|
3.48e-01
|
GOMF SUMO POLYMER BINDING
|
5
|
7.13e-01
|
9.27e-01
|
0.20300
|
7.09e-02
|
1.90e-01
|
7.84e-01
|
4.62e-01
|
GOBP RESPONSE TO PH
|
41
|
9.57e-02
|
5.61e-01
|
0.20300
|
-7.64e-02
|
1.88e-01
|
3.97e-01
|
3.74e-02
|
GOBP REGULATION OF NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION
|
10
|
5.77e-01
|
8.89e-01
|
0.20300
|
1.46e-01
|
-1.40e-01
|
4.23e-01
|
4.42e-01
|
GOBP SHORT CHAIN FATTY ACID CATABOLIC PROCESS
|
7
|
6.12e-01
|
8.98e-01
|
0.20300
|
-1.55e-01
|
-1.31e-01
|
4.77e-01
|
5.50e-01
|
GOBP EPIBOLY
|
37
|
1.12e-01
|
5.91e-01
|
0.20300
|
-1.97e-01
|
4.70e-02
|
3.78e-02
|
6.21e-01
|
GOBP SPHINGOLIPID TRANSLOCATION
|
5
|
7.36e-01
|
9.35e-01
|
0.20300
|
-2.02e-01
|
1.81e-02
|
4.34e-01
|
9.44e-01
|
GOBP NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING
|
7
|
6.16e-01
|
8.99e-01
|
0.20300
|
-1.74e-01
|
-1.04e-01
|
4.25e-01
|
6.33e-01
|
GOBP REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS
|
13
|
4.81e-01
|
8.54e-01
|
0.20300
|
9.45e-02
|
-1.79e-01
|
5.55e-01
|
2.63e-01
|
GOMF G PROTEIN COUPLED SEROTONIN RECEPTOR ACTIVITY
|
21
|
3.11e-01
|
7.74e-01
|
0.20300
|
-1.08e-01
|
1.72e-01
|
3.93e-01
|
1.73e-01
|
GOMF WNT RECEPTOR ACTIVITY
|
17
|
3.71e-01
|
8.09e-01
|
0.20300
|
-5.70e-02
|
1.94e-01
|
6.84e-01
|
1.65e-01
|
GOBP CENTROMERE COMPLEX ASSEMBLY
|
28
|
1.68e-01
|
6.54e-01
|
0.20300
|
-1.63e-02
|
-2.02e-01
|
8.81e-01
|
6.43e-02
|
GOBP REGULATION OF MIRNA CATABOLIC PROCESS
|
9
|
5.33e-01
|
8.76e-01
|
0.20300
|
-1.48e-01
|
-1.38e-01
|
4.42e-01
|
4.73e-01
|
GOBP REGULATION OF GRANULOCYTE CHEMOTAXIS
|
50
|
5.12e-02
|
4.47e-01
|
0.20300
|
-3.97e-02
|
1.99e-01
|
6.27e-01
|
1.51e-02
|
GOBP POSITIVE REGULATION OF SISTER CHROMATID COHESION
|
9
|
5.99e-01
|
8.95e-01
|
0.20300
|
8.05e-02
|
-1.86e-01
|
6.76e-01
|
3.34e-01
|
GOBP DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS
|
8
|
6.07e-01
|
8.97e-01
|
0.20200
|
-2.02e-01
|
-1.32e-03
|
3.21e-01
|
9.95e-01
|
GOBP SPHINGOLIPID MEDIATED SIGNALING PATHWAY
|
18
|
3.61e-01
|
8.03e-01
|
0.20200
|
-1.83e-01
|
8.57e-02
|
1.78e-01
|
5.29e-01
|
GOBP NEGATIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION
|
7
|
6.18e-01
|
9.00e-01
|
0.20200
|
1.76e-01
|
9.98e-02
|
4.20e-01
|
6.48e-01
|
GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT
|
48
|
4.75e-02
|
4.38e-01
|
0.20200
|
1.71e-02
|
2.02e-01
|
8.38e-01
|
1.56e-02
|
GOBP DENDRITIC CELL APOPTOTIC PROCESS
|
11
|
4.70e-01
|
8.51e-01
|
0.20200
|
1.78e-01
|
9.54e-02
|
3.05e-01
|
5.84e-01
|
GOMF ATPASE COUPLED ION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
24
|
2.65e-01
|
7.41e-01
|
0.20200
|
-1.69e-01
|
1.11e-01
|
1.51e-01
|
3.47e-01
|
GOCC MITOTIC SPINDLE MICROTUBULE
|
13
|
4.24e-01
|
8.35e-01
|
0.20200
|
-5.12e-02
|
-1.96e-01
|
7.49e-01
|
2.22e-01
|
GOBP CARDIOBLAST PROLIFERATION
|
11
|
4.70e-01
|
8.51e-01
|
0.20200
|
-1.77e-01
|
-9.70e-02
|
3.08e-01
|
5.77e-01
|
GOBP REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION
|
61
|
3.02e-02
|
3.61e-01
|
0.20200
|
-6.73e-02
|
1.91e-01
|
3.64e-01
|
9.97e-03
|
GOBP SENSORY PERCEPTION OF CHEMICAL STIMULUS
|
442
|
6.57e-12
|
1.68e-08
|
0.20200
|
1.98e-01
|
-3.94e-02
|
8.42e-13
|
1.55e-01
|
GOBP REGULATION OF INTRACELLULAR LIPID TRANSPORT
|
10
|
5.03e-01
|
8.64e-01
|
0.20200
|
-1.75e-01
|
-1.01e-01
|
3.37e-01
|
5.81e-01
|
GOBP AMELOBLAST DIFFERENTIATION
|
5
|
7.61e-01
|
9.45e-01
|
0.20200
|
-1.40e-01
|
1.46e-01
|
5.88e-01
|
5.72e-01
|
GOMF PROTON CHANNEL ACTIVITY
|
24
|
2.60e-01
|
7.37e-01
|
0.20200
|
8.97e-02
|
-1.81e-01
|
4.47e-01
|
1.24e-01
|
GOMF SPLICING FACTOR BINDING
|
5
|
7.61e-01
|
9.45e-01
|
0.20200
|
1.46e-01
|
-1.39e-01
|
5.71e-01
|
5.89e-01
|
GOMF ATP TRANSMEMBRANE TRANSPORTER ACTIVITY
|
11
|
5.47e-01
|
8.78e-01
|
0.20200
|
-1.60e-01
|
1.24e-01
|
3.59e-01
|
4.78e-01
|
GOMF DNA POLYMERASE ACTIVITY
|
29
|
1.82e-01
|
6.72e-01
|
0.20200
|
-1.97e-01
|
4.56e-02
|
6.66e-02
|
6.71e-01
|
GOMF GAP JUNCTION CHANNEL ACTIVITY
|
22
|
2.62e-01
|
7.39e-01
|
0.20200
|
2.01e-01
|
-1.60e-02
|
1.02e-01
|
8.97e-01
|
GOBP MAINTENANCE OF SYNAPSE STRUCTURE
|
25
|
2.47e-01
|
7.26e-01
|
0.20200
|
-1.81e-01
|
9.05e-02
|
1.18e-01
|
4.34e-01
|
GOBP PROTEIN INSERTION INTO ER MEMBRANE BY STOP TRANSFER MEMBRANE ANCHOR SEQUENCE
|
10
|
5.53e-01
|
8.80e-01
|
0.20200
|
3.62e-02
|
-1.99e-01
|
8.43e-01
|
2.77e-01
|
GOBP REGULATION OF NEURON MATURATION
|
8
|
6.24e-01
|
9.01e-01
|
0.20200
|
-1.97e-01
|
4.16e-02
|
3.34e-01
|
8.38e-01
|
GOBP ANTIGEN PROCESSING AND PRESENTATION OF LIPID ANTIGEN VIA MHC CLASS IB
|
7
|
6.54e-01
|
9.09e-01
|
0.20200
|
-1.70e-02
|
2.01e-01
|
9.38e-01
|
3.57e-01
|
GOBP REGULATION OF TYPE B PANCREATIC CELL DEVELOPMENT
|
9
|
5.96e-01
|
8.95e-01
|
0.20200
|
-1.92e-01
|
6.34e-02
|
3.20e-01
|
7.42e-01
|
GOBP HISTAMINE SECRETION
|
12
|
5.13e-01
|
8.67e-01
|
0.20200
|
-9.41e-02
|
1.78e-01
|
5.73e-01
|
2.85e-01
|
GOBP MEIOTIC CELL CYCLE CHECKPOINT SIGNALING
|
8
|
6.17e-01
|
9.00e-01
|
0.20200
|
-2.01e-01
|
2.03e-02
|
3.26e-01
|
9.21e-01
|
GOBP NEUROTRANSMITTER CATABOLIC PROCESS
|
8
|
5.95e-01
|
8.95e-01
|
0.20100
|
-4.22e-02
|
-1.97e-01
|
8.36e-01
|
3.35e-01
|
GOBP POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION
|
33
|
1.07e-01
|
5.79e-01
|
0.20100
|
9.25e-02
|
1.79e-01
|
3.58e-01
|
7.51e-02
|
GOBP CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS
|
25
|
2.22e-01
|
7.11e-01
|
0.20100
|
-2.00e-01
|
2.02e-02
|
8.28e-02
|
8.61e-01
|
GOCC FACIT COLLAGEN TRIMER
|
6
|
6.60e-01
|
9.09e-01
|
0.20100
|
1.42e-01
|
1.43e-01
|
5.47e-01
|
5.44e-01
|
GOMF NEUROTRANSMITTER RECEPTOR REGULATOR ACTIVITY
|
13
|
4.55e-01
|
8.46e-01
|
0.20100
|
1.44e-02
|
-2.01e-01
|
9.29e-01
|
2.10e-01
|
GOBP PROTEIN LOCALIZATION TO MICROTUBULE
|
17
|
3.71e-01
|
8.09e-01
|
0.20100
|
-1.96e-01
|
4.67e-02
|
1.62e-01
|
7.39e-01
|
GOBP HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS
|
15
|
4.43e-01
|
8.40e-01
|
0.20100
|
-1.50e-01
|
1.34e-01
|
3.15e-01
|
3.68e-01
|
GOBP REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT
|
25
|
2.56e-01
|
7.35e-01
|
0.20100
|
1.63e-01
|
-1.18e-01
|
1.58e-01
|
3.08e-01
|
GOBP 2 OXOGLUTARATE METABOLIC PROCESS
|
15
|
3.82e-01
|
8.16e-01
|
0.20100
|
-3.45e-02
|
-1.98e-01
|
8.17e-01
|
1.84e-01
|
GOCC PLATELET DENSE GRANULE LUMEN
|
14
|
4.43e-01
|
8.40e-01
|
0.20100
|
-1.95e-01
|
4.88e-02
|
2.06e-01
|
7.52e-01
|
GOCC CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX
|
50
|
5.76e-02
|
4.68e-01
|
0.20100
|
6.23e-02
|
-1.91e-01
|
4.46e-01
|
1.93e-02
|
GOBP REGULATION OF DENDRITIC SPINE MAINTENANCE
|
12
|
4.51e-01
|
8.44e-01
|
0.20100
|
-1.89e-01
|
-6.99e-02
|
2.58e-01
|
6.75e-01
|
GOBP NEGATIVE REGULATION OF TUBULIN DEACETYLATION
|
5
|
7.53e-01
|
9.41e-01
|
0.20100
|
-7.09e-02
|
1.88e-01
|
7.84e-01
|
4.66e-01
|
GOBP NEUROTRANSMITTER UPTAKE
|
44
|
5.03e-02
|
4.44e-01
|
0.20100
|
1.02e-01
|
1.73e-01
|
2.40e-01
|
4.70e-02
|
GOBP NEGATIVE REGULATION OF COMPLEMENT ACTIVATION
|
12
|
5.20e-01
|
8.69e-01
|
0.20100
|
1.63e-01
|
-1.18e-01
|
3.28e-01
|
4.80e-01
|
GOBP POSITIVE REGULATION OF MITOCHONDRIAL FISSION
|
21
|
2.91e-01
|
7.62e-01
|
0.20100
|
3.77e-02
|
-1.97e-01
|
7.65e-01
|
1.17e-01
|
GOBP REGULATION OF ENDODERMAL CELL DIFFERENTIATION
|
7
|
6.20e-01
|
9.00e-01
|
0.20100
|
-1.11e-01
|
-1.68e-01
|
6.12e-01
|
4.42e-01
|
GOBP CELLULAR RESPONSE TO OSMOTIC STRESS
|
51
|
5.11e-02
|
4.47e-01
|
0.20100
|
-1.97e-01
|
4.23e-02
|
1.52e-02
|
6.01e-01
|
GOBP CENTRAL NERVOUS SYSTEM MYELIN FORMATION
|
8
|
5.86e-01
|
8.90e-01
|
0.20100
|
-1.85e-01
|
-7.91e-02
|
3.65e-01
|
6.98e-01
|
GOBP REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS
|
24
|
1.95e-01
|
6.87e-01
|
0.20100
|
-1.69e-01
|
-1.09e-01
|
1.52e-01
|
3.57e-01
|
GOCC PROTEIN FOLDING CHAPERONE COMPLEX
|
40
|
1.03e-01
|
5.75e-01
|
0.20100
|
6.57e-02
|
-1.90e-01
|
4.72e-01
|
3.77e-02
|
GOMF ATPASE COUPLED MONOATOMIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
50
|
6.76e-02
|
4.99e-01
|
0.20100
|
-1.49e-01
|
1.35e-01
|
6.88e-02
|
9.88e-02
|
GOMF BETA 1 3 GALACTOSYLTRANSFERASE ACTIVITY
|
14
|
4.70e-01
|
8.51e-01
|
0.20100
|
-1.36e-01
|
1.48e-01
|
3.77e-01
|
3.39e-01
|
GOBP NEGATIVE REGULATION OF MACROAUTOPHAGY
|
31
|
1.78e-01
|
6.67e-01
|
0.20100
|
-1.83e-01
|
8.24e-02
|
7.76e-02
|
4.27e-01
|
GOCC SMALL SUBUNIT PROCESSOME
|
70
|
9.84e-03
|
2.11e-01
|
0.20100
|
-7.07e-02
|
-1.88e-01
|
3.06e-01
|
6.57e-03
|
GOBP REGULATION OF KERATINOCYTE MIGRATION
|
14
|
4.53e-01
|
8.46e-01
|
0.20100
|
-1.89e-01
|
6.77e-02
|
2.21e-01
|
6.61e-01
|
GOMF FATTY ACID LIGASE ACTIVITY
|
21
|
3.22e-01
|
7.79e-01
|
0.20100
|
-1.55e-01
|
1.27e-01
|
2.19e-01
|
3.13e-01
|
GOBP REGULATION OF AUTOPHAGY OF MITOCHONDRION
|
38
|
1.30e-01
|
6.09e-01
|
0.20000
|
-1.37e-01
|
1.46e-01
|
1.44e-01
|
1.18e-01
|
GOBP HEPATIC STELLATE CELL ACTIVATION
|
9
|
5.41e-01
|
8.78e-01
|
0.20000
|
-1.24e-01
|
-1.57e-01
|
5.20e-01
|
4.13e-01
|
GOMF HISTONE MODIFYING ACTIVITY
|
188
|
2.17e-05
|
2.92e-03
|
0.20000
|
-1.94e-01
|
4.97e-02
|
4.38e-06
|
2.40e-01
|
GOBP REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY
|
15
|
3.80e-01
|
8.15e-01
|
0.20000
|
-1.95e-01
|
-4.74e-02
|
1.92e-01
|
7.51e-01
|
GOBP REGULATION OF CARDIAC MUSCLE CELL MEMBRANE POTENTIAL
|
7
|
6.33e-01
|
9.03e-01
|
0.20000
|
6.17e-02
|
1.91e-01
|
7.77e-01
|
3.82e-01
|
GOBP CATECHOLAMINE UPTAKE
|
18
|
2.92e-01
|
7.63e-01
|
0.20000
|
1.45e-01
|
1.38e-01
|
2.86e-01
|
3.11e-01
|
GOBP SMOOTH MUSCLE ADAPTATION
|
5
|
7.11e-01
|
9.26e-01
|
0.20000
|
-1.54e-01
|
-1.28e-01
|
5.50e-01
|
6.21e-01
|
GOMF PSEUDOURIDINE SYNTHASE ACTIVITY
|
12
|
4.67e-01
|
8.51e-01
|
0.20000
|
-1.98e-01
|
-3.19e-02
|
2.35e-01
|
8.48e-01
|
GOBP POSITIVE REGULATION OF VIRAL PROCESS
|
62
|
1.78e-02
|
2.85e-01
|
0.20000
|
-1.92e-01
|
-5.69e-02
|
8.90e-03
|
4.38e-01
|
GOMF PROTEIN KINASE C ACTIVITY
|
16
|
4.01e-01
|
8.26e-01
|
0.20000
|
-5.45e-02
|
1.93e-01
|
7.06e-01
|
1.82e-01
|
GOBP CELLULAR RESPONSE TO ELECTRICAL STIMULUS
|
13
|
4.23e-01
|
8.34e-01
|
0.20000
|
7.80e-02
|
1.84e-01
|
6.26e-01
|
2.50e-01
|
GOBP REGULATION OF SYNAPTIC VESICLE TRANSPORT
|
5
|
7.63e-01
|
9.45e-01
|
0.20000
|
1.13e-01
|
-1.65e-01
|
6.63e-01
|
5.22e-01
|
GOMF DYSTROGLYCAN BINDING
|
10
|
5.85e-01
|
8.90e-01
|
0.20000
|
-1.48e-01
|
1.35e-01
|
4.19e-01
|
4.60e-01
|
GOBP REGULATION OF NATURAL KILLER CELL PROLIFERATION
|
12
|
4.69e-01
|
8.51e-01
|
0.20000
|
-2.96e-02
|
-1.98e-01
|
8.59e-01
|
2.35e-01
|
GOBP URETERIC BUD ELONGATION
|
8
|
5.85e-01
|
8.90e-01
|
0.20000
|
9.39e-02
|
1.77e-01
|
6.45e-01
|
3.87e-01
|
GOBP TRYPTOPHAN METABOLIC PROCESS
|
10
|
5.85e-01
|
8.90e-01
|
0.20000
|
1.52e-01
|
-1.30e-01
|
4.05e-01
|
4.77e-01
|
GOMF LIGAND GATED MONOATOMIC ANION CHANNEL ACTIVITY
|
16
|
3.53e-01
|
7.97e-01
|
0.20000
|
-6.19e-02
|
-1.90e-01
|
6.68e-01
|
1.88e-01
|
GOBP POSITIVE REGULATION OF GONAD DEVELOPMENT
|
8
|
6.18e-01
|
9.00e-01
|
0.20000
|
-9.65e-03
|
2.00e-01
|
9.62e-01
|
3.28e-01
|
GOBP SNRNA CATABOLIC PROCESS
|
5
|
7.37e-01
|
9.35e-01
|
0.20000
|
2.78e-03
|
2.00e-01
|
9.91e-01
|
4.39e-01
|
GOMF PHOSPHATIDYLCHOLINE TRANSPORTER ACTIVITY
|
18
|
3.23e-01
|
7.79e-01
|
0.20000
|
2.70e-02
|
1.98e-01
|
8.43e-01
|
1.46e-01
|
GOBP POSITIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY
|
8
|
6.12e-01
|
8.98e-01
|
0.20000
|
2.00e-01
|
8.41e-03
|
3.28e-01
|
9.67e-01
|
GOBP REGULATION OF CILIUM BEAT FREQUENCY INVOLVED IN CILIARY MOTILITY
|
9
|
5.92e-01
|
8.93e-01
|
0.20000
|
3.54e-02
|
-1.97e-01
|
8.54e-01
|
3.07e-01
|
GOMF CYTOKINE RECEPTOR ACTIVITY
|
87
|
2.74e-03
|
1.02e-01
|
0.20000
|
1.51e-01
|
1.31e-01
|
1.50e-02
|
3.47e-02
|
GOBP DETECTION OF LIPOPOLYSACCHARIDE
|
5
|
7.12e-01
|
9.27e-01
|
0.20000
|
-1.23e-01
|
-1.57e-01
|
6.33e-01
|
5.43e-01
|
GOMF MAP KINASE PHOSPHATASE ACTIVITY
|
14
|
3.86e-01
|
8.19e-01
|
0.20000
|
1.45e-01
|
1.37e-01
|
3.46e-01
|
3.75e-01
|
GOCC CLATHRIN COMPLEX
|
6
|
6.99e-01
|
9.21e-01
|
0.20000
|
-1.99e-01
|
1.35e-02
|
3.98e-01
|
9.54e-01
|
GOBP ADHESION OF SYMBIONT TO HOST
|
12
|
4.44e-01
|
8.40e-01
|
0.20000
|
-1.60e-01
|
-1.19e-01
|
3.36e-01
|
4.76e-01
|
GOCC PERICENTRIC HETEROCHROMATIN
|
29
|
1.73e-01
|
6.61e-01
|
0.20000
|
-2.00e-01
|
7.75e-04
|
6.27e-02
|
9.94e-01
|
GOBP PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER
|
15
|
3.62e-01
|
8.03e-01
|
0.19900
|
1.26e-01
|
1.55e-01
|
3.98e-01
|
3.00e-01
|
GOBP POLAR BODY EXTRUSION AFTER MEIOTIC DIVISIONS
|
5
|
7.22e-01
|
9.30e-01
|
0.19900
|
-1.87e-01
|
-6.83e-02
|
4.68e-01
|
7.91e-01
|
GOMF UBIQUITIN PROTEIN TRANSFERASE REGULATOR ACTIVITY
|
27
|
1.91e-01
|
6.85e-01
|
0.19900
|
-1.13e-02
|
-1.99e-01
|
9.19e-01
|
7.35e-02
|
GOBP DNA UNWINDING INVOLVED IN DNA REPLICATION
|
21
|
2.44e-01
|
7.26e-01
|
0.19900
|
-1.67e-01
|
-1.09e-01
|
1.86e-01
|
3.86e-01
|
GOMF ALPHA N ACETYLGALACTOSAMINIDE ALPHA 2 6 SIALYLTRANSFERASE ACTIVITY
|
6
|
6.67e-01
|
9.11e-01
|
0.19900
|
1.18e-01
|
1.60e-01
|
6.15e-01
|
4.97e-01
|
GOBP REGULATION OF LENS FIBER CELL DIFFERENTIATION
|
9
|
5.45e-01
|
8.78e-01
|
0.19900
|
1.25e-01
|
1.55e-01
|
5.17e-01
|
4.20e-01
|
GOBP DIRECT OSSIFICATION
|
7
|
6.56e-01
|
9.09e-01
|
0.19900
|
-2.16e-03
|
1.99e-01
|
9.92e-01
|
3.62e-01
|
GOBP PURINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS
|
10
|
5.14e-01
|
8.67e-01
|
0.19900
|
9.77e-02
|
1.74e-01
|
5.93e-01
|
3.42e-01
|
GOBP NEGATIVE REGULATION OF VITAMIN D BIOSYNTHETIC PROCESS
|
5
|
7.66e-01
|
9.45e-01
|
0.19900
|
1.63e-01
|
-1.15e-01
|
5.29e-01
|
6.57e-01
|
GOBP MIDBODY ABSCISSION
|
17
|
3.78e-01
|
8.14e-01
|
0.19900
|
-1.95e-01
|
4.11e-02
|
1.65e-01
|
7.69e-01
|
GOBP LIPOXYGENASE PATHWAY
|
11
|
5.42e-01
|
8.78e-01
|
0.19900
|
-6.40e-02
|
1.88e-01
|
7.13e-01
|
2.80e-01
|
GOBP REGULATION OF THE FORCE OF HEART CONTRACTION
|
26
|
1.76e-01
|
6.67e-01
|
0.19900
|
1.07e-01
|
1.68e-01
|
3.46e-01
|
1.39e-01
|
GOMF PHOSPHATIDYLINOSITOL BINDING
|
263
|
8.81e-07
|
2.65e-04
|
0.19900
|
-1.05e-01
|
1.69e-01
|
3.44e-03
|
2.39e-06
|
GOMF AMINO ACID MONOATOMIC CATION SYMPORTER ACTIVITY
|
27
|
1.78e-01
|
6.67e-01
|
0.19900
|
1.91e-01
|
5.48e-02
|
8.58e-02
|
6.22e-01
|
GOBP INTESTINAL EPITHELIAL STRUCTURE MAINTENANCE
|
8
|
6.47e-01
|
9.07e-01
|
0.19900
|
-8.73e-02
|
1.78e-01
|
6.69e-01
|
3.82e-01
|
GOMF 1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY
|
10
|
5.53e-01
|
8.80e-01
|
0.19900
|
1.98e-01
|
-1.04e-02
|
2.77e-01
|
9.55e-01
|
GOMF STAT FAMILY PROTEIN BINDING
|
11
|
4.77e-01
|
8.54e-01
|
0.19900
|
-1.44e-01
|
-1.37e-01
|
4.07e-01
|
4.33e-01
|
GOBP POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT
|
23
|
2.17e-01
|
7.07e-01
|
0.19900
|
1.02e-01
|
1.70e-01
|
3.98e-01
|
1.57e-01
|
GOBP REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY
|
27
|
2.41e-01
|
7.25e-01
|
0.19800
|
-1.33e-01
|
1.47e-01
|
2.30e-01
|
1.86e-01
|
GOBP STRESS GRANULE ASSEMBLY
|
29
|
1.87e-01
|
6.79e-01
|
0.19800
|
2.90e-02
|
-1.96e-01
|
7.87e-01
|
6.73e-02
|
GOBP NEUROMUSCULAR PROCESS CONTROLLING POSTURE
|
18
|
3.35e-01
|
7.88e-01
|
0.19800
|
-1.98e-01
|
-1.16e-02
|
1.46e-01
|
9.32e-01
|
GOMF CARBOHYDRATE KINASE ACTIVITY
|
20
|
3.46e-01
|
7.96e-01
|
0.19800
|
-1.14e-01
|
1.62e-01
|
3.77e-01
|
2.09e-01
|
GOMF UBIQUITIN CONJUGATING ENZYME BINDING
|
31
|
1.26e-01
|
6.06e-01
|
0.19800
|
-1.57e-01
|
-1.21e-01
|
1.30e-01
|
2.43e-01
|
GOBP NUCLEOBASE BIOSYNTHETIC PROCESS
|
16
|
3.64e-01
|
8.05e-01
|
0.19800
|
-4.74e-02
|
-1.93e-01
|
7.43e-01
|
1.82e-01
|
GOBP NEUTRAL LIPID BIOSYNTHETIC PROCESS
|
45
|
7.36e-02
|
5.13e-01
|
0.19800
|
-1.97e-01
|
2.39e-02
|
2.23e-02
|
7.81e-01
|
GOBP POINTED END ACTIN FILAMENT CAPPING
|
7
|
6.26e-01
|
9.01e-01
|
0.19800
|
1.52e-01
|
1.27e-01
|
4.86e-01
|
5.60e-01
|
GOBP REGULATION OF BILE ACID BIOSYNTHETIC PROCESS
|
12
|
4.87e-01
|
8.56e-01
|
0.19800
|
2.21e-03
|
1.98e-01
|
9.89e-01
|
2.35e-01
|
GOBP ANTERIOR HEAD DEVELOPMENT
|
7
|
6.77e-01
|
9.14e-01
|
0.19800
|
-5.84e-02
|
1.89e-01
|
7.89e-01
|
3.86e-01
|
GOBP NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE
|
47
|
7.23e-02
|
5.13e-01
|
0.19800
|
5.31e-02
|
-1.91e-01
|
5.29e-01
|
2.36e-02
|
GOBP CARDIAC CHAMBER FORMATION
|
12
|
4.84e-01
|
8.54e-01
|
0.19800
|
-1.09e-02
|
-1.98e-01
|
9.48e-01
|
2.36e-01
|
GOBP TRNA PSEUDOURIDINE SYNTHESIS
|
6
|
7.13e-01
|
9.27e-01
|
0.19800
|
-1.92e-01
|
4.71e-02
|
4.15e-01
|
8.42e-01
|
GOBP PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING
|
6
|
6.70e-01
|
9.11e-01
|
0.19800
|
1.40e-01
|
1.40e-01
|
5.54e-01
|
5.52e-01
|
GOMF RNA 7 METHYLGUANOSINE CAP BINDING
|
13
|
4.48e-01
|
8.42e-01
|
0.19800
|
-1.96e-01
|
-2.90e-02
|
2.22e-01
|
8.57e-01
|
GOBP REGULATION OF CALCIUM ION IMPORT
|
31
|
1.37e-01
|
6.20e-01
|
0.19800
|
6.68e-02
|
1.86e-01
|
5.20e-01
|
7.26e-02
|
GOBP MALE MATING BEHAVIOR
|
6
|
6.71e-01
|
9.11e-01
|
0.19800
|
1.25e-01
|
1.53e-01
|
5.96e-01
|
5.16e-01
|
GOBP REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY
|
16
|
3.65e-01
|
8.05e-01
|
0.19800
|
1.91e-01
|
5.09e-02
|
1.86e-01
|
7.25e-01
|
GOCC HOPS COMPLEX
|
9
|
6.11e-01
|
8.98e-01
|
0.19800
|
6.98e-02
|
-1.85e-01
|
7.17e-01
|
3.37e-01
|
GOMF AMINO ACID SODIUM SYMPORTER ACTIVITY
|
21
|
2.49e-01
|
7.27e-01
|
0.19800
|
1.61e-01
|
1.14e-01
|
2.00e-01
|
3.66e-01
|
GOBP PROTEIN LIPID COMPLEX ASSEMBLY
|
30
|
2.03e-01
|
6.92e-01
|
0.19800
|
-1.73e-01
|
9.63e-02
|
1.02e-01
|
3.61e-01
|
GOBP GLUCOCORTICOID METABOLIC PROCESS
|
24
|
2.27e-01
|
7.14e-01
|
0.19800
|
-1.95e-01
|
-3.46e-02
|
9.91e-02
|
7.69e-01
|
GOCC CALCITONIN FAMILY RECEPTOR COMPLEX
|
5
|
7.64e-01
|
9.45e-01
|
0.19800
|
8.48e-02
|
-1.78e-01
|
7.43e-01
|
4.90e-01
|
GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III
|
17
|
4.04e-01
|
8.26e-01
|
0.19700
|
-1.73e-01
|
9.48e-02
|
2.16e-01
|
4.99e-01
|
GOBP POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY
|
12
|
4.57e-01
|
8.48e-01
|
0.19700
|
-9.37e-02
|
-1.74e-01
|
5.74e-01
|
2.97e-01
|
GOBP DEOXYRIBONUCLEOSIDE CATABOLIC PROCESS
|
6
|
6.77e-01
|
9.14e-01
|
0.19700
|
8.65e-02
|
1.78e-01
|
7.14e-01
|
4.51e-01
|
GOBP POSITIVE REGULATION OF MEMORY T CELL DIFFERENTIATION
|
9
|
5.57e-01
|
8.82e-01
|
0.19700
|
1.77e-01
|
8.71e-02
|
3.57e-01
|
6.51e-01
|
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION
|
19
|
2.85e-01
|
7.57e-01
|
0.19700
|
1.13e-01
|
1.62e-01
|
3.92e-01
|
2.23e-01
|
GOBP REGULATION OF P38MAPK CASCADE
|
46
|
4.74e-02
|
4.38e-01
|
0.19700
|
-1.39e-01
|
-1.40e-01
|
1.02e-01
|
1.01e-01
|
GOBP AMYLOID BETA CLEARANCE BY CELLULAR CATABOLIC PROCESS
|
8
|
6.09e-01
|
8.97e-01
|
0.19700
|
3.90e-02
|
1.93e-01
|
8.49e-01
|
3.44e-01
|
GOBP HIPPOCAMPAL NEURON APOPTOTIC PROCESS
|
6
|
7.15e-01
|
9.27e-01
|
0.19700
|
-4.57e-02
|
1.92e-01
|
8.46e-01
|
4.16e-01
|
GOBP NEGATIVE REGULATION OF VASCULAR PERMEABILITY
|
18
|
3.07e-01
|
7.71e-01
|
0.19700
|
1.63e-01
|
1.10e-01
|
2.30e-01
|
4.18e-01
|
GOCC PREFOLDIN COMPLEX
|
6
|
7.25e-01
|
9.30e-01
|
0.19700
|
-1.79e-01
|
8.17e-02
|
4.47e-01
|
7.29e-01
|
GOBP REGULATION OF RENAL SYSTEM PROCESS
|
21
|
2.89e-01
|
7.60e-01
|
0.19700
|
-1.04e-03
|
-1.97e-01
|
9.93e-01
|
1.18e-01
|
GOBP RESPONSE TO ALDOSTERONE
|
16
|
4.24e-01
|
8.35e-01
|
0.19700
|
-8.18e-02
|
1.79e-01
|
5.71e-01
|
2.15e-01
|
GOBP ADP METABOLIC PROCESS
|
8
|
6.57e-01
|
9.09e-01
|
0.19700
|
-1.66e-01
|
1.05e-01
|
4.15e-01
|
6.06e-01
|
GOBP ALPHA KETOGLUTARATE TRANSPORT
|
7
|
6.46e-01
|
9.07e-01
|
0.19700
|
1.91e-01
|
4.96e-02
|
3.83e-01
|
8.20e-01
|
GOBP DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN
|
17
|
3.93e-01
|
8.23e-01
|
0.19700
|
1.88e-01
|
-5.88e-02
|
1.80e-01
|
6.75e-01
|
GOBP RIBOSOME ASSEMBLY
|
58
|
2.91e-02
|
3.54e-01
|
0.19700
|
-3.03e-02
|
-1.94e-01
|
6.90e-01
|
1.04e-02
|
GOMF RECEPTOR ANTAGONIST ACTIVITY
|
16
|
3.99e-01
|
8.25e-01
|
0.19700
|
-1.96e-01
|
2.12e-02
|
1.75e-01
|
8.83e-01
|
GOBP REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS
|
15
|
3.82e-01
|
8.16e-01
|
0.19700
|
7.83e-02
|
1.81e-01
|
5.99e-01
|
2.26e-01
|
GOBP REGULATION OF TRANSLATIONAL FIDELITY
|
18
|
3.72e-01
|
8.09e-01
|
0.19700
|
5.74e-02
|
-1.88e-01
|
6.73e-01
|
1.67e-01
|
GOMF TRANSLATION REGULATOR ACTIVITY NUCLEIC ACID BINDING
|
96
|
4.40e-03
|
1.36e-01
|
0.19700
|
2.97e-02
|
-1.94e-01
|
6.16e-01
|
9.91e-04
|
GOMF INSULIN RECEPTOR SUBSTRATE BINDING
|
13
|
4.83e-01
|
8.54e-01
|
0.19700
|
-1.93e-01
|
3.94e-02
|
2.29e-01
|
8.06e-01
|
GOCC RNA CAP BINDING COMPLEX
|
19
|
3.24e-01
|
7.80e-01
|
0.19700
|
-6.57e-03
|
-1.96e-01
|
9.60e-01
|
1.38e-01
|
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX
|
6
|
6.75e-01
|
9.13e-01
|
0.19700
|
1.61e-01
|
1.13e-01
|
4.96e-01
|
6.31e-01
|
GOBP MONOSACCHARIDE CATABOLIC PROCESS
|
49
|
5.37e-02
|
4.58e-01
|
0.19700
|
-1.96e-01
|
-1.41e-02
|
1.76e-02
|
8.65e-01
|
GOBP POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION
|
31
|
2.01e-01
|
6.90e-01
|
0.19600
|
-1.19e-01
|
1.56e-01
|
2.52e-01
|
1.32e-01
|
GOBP POSITIVE REGULATION OF CELLULAR EXTRAVASATION
|
15
|
4.40e-01
|
8.40e-01
|
0.19600
|
-1.88e-01
|
5.78e-02
|
2.08e-01
|
6.98e-01
|
GOBP VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS
|
46
|
9.11e-02
|
5.51e-01
|
0.19600
|
-1.64e-01
|
1.08e-01
|
5.44e-02
|
2.04e-01
|
GOBP NEGATIVE REGULATION OF OXIDATIVE PHOSPHORYLATION
|
8
|
6.04e-01
|
8.96e-01
|
0.19600
|
-6.45e-02
|
-1.85e-01
|
7.52e-01
|
3.64e-01
|
GOMF RETINOL BINDING
|
16
|
4.37e-01
|
8.39e-01
|
0.19600
|
1.19e-01
|
-1.56e-01
|
4.11e-01
|
2.79e-01
|
GOBP CELLULAR RESPONSE TO HISTAMINE
|
7
|
6.31e-01
|
9.03e-01
|
0.19600
|
-1.43e-01
|
-1.35e-01
|
5.13e-01
|
5.37e-01
|
GOBP REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS
|
7
|
6.96e-01
|
9.21e-01
|
0.19600
|
-1.24e-01
|
1.52e-01
|
5.71e-01
|
4.85e-01
|
GOMF G RICH STRAND TELOMERIC DNA BINDING
|
10
|
5.33e-01
|
8.76e-01
|
0.19600
|
1.85e-01
|
6.42e-02
|
3.10e-01
|
7.25e-01
|
GOMF UBIQUITIN SPECIFIC PROTEASE BINDING
|
21
|
3.19e-01
|
7.78e-01
|
0.19600
|
-1.86e-01
|
6.13e-02
|
1.39e-01
|
6.27e-01
|
GOMF SNRNA BINDING
|
48
|
5.11e-02
|
4.47e-01
|
0.19600
|
-4.94e-02
|
-1.90e-01
|
5.53e-01
|
2.28e-02
|
GOBP RESPONSE TO INSECTICIDE
|
6
|
7.24e-01
|
9.30e-01
|
0.19600
|
1.83e-01
|
-7.16e-02
|
4.38e-01
|
7.61e-01
|
GOBP MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION
|
17
|
4.01e-01
|
8.26e-01
|
0.19600
|
-1.83e-01
|
7.12e-02
|
1.92e-01
|
6.11e-01
|
GOMF TRANSCRIPTION COACTIVATOR BINDING
|
42
|
9.27e-02
|
5.54e-01
|
0.19600
|
-1.94e-01
|
2.59e-02
|
2.92e-02
|
7.71e-01
|
GOCC MPP7 DLG1 LIN7 COMPLEX
|
5
|
7.71e-01
|
9.48e-01
|
0.19600
|
-1.12e-01
|
1.61e-01
|
6.63e-01
|
5.34e-01
|
GOMF SIGNALING RECEPTOR COMPLEX ADAPTOR ACTIVITY
|
51
|
4.47e-02
|
4.29e-01
|
0.19600
|
3.59e-02
|
1.93e-01
|
6.57e-01
|
1.72e-02
|
GOBP POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION
|
34
|
1.72e-01
|
6.60e-01
|
0.19600
|
-1.61e-01
|
1.12e-01
|
1.04e-01
|
2.60e-01
|
GOBP POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION
|
31
|
1.65e-01
|
6.49e-01
|
0.19600
|
4.43e-03
|
-1.96e-01
|
9.66e-01
|
5.89e-02
|
GOBP GLUTAMATE SECRETION
|
28
|
1.95e-01
|
6.88e-01
|
0.19600
|
-1.57e-03
|
1.96e-01
|
9.89e-01
|
7.26e-02
|
GOBP SCHWANN CELL DEVELOPMENT
|
30
|
2.14e-01
|
7.03e-01
|
0.19600
|
-1.37e-01
|
1.40e-01
|
1.94e-01
|
1.84e-01
|
GOBP REGULATION OF INOSITOL 1 4 5 TRISPHOSPHATE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY
|
5
|
7.73e-01
|
9.49e-01
|
0.19600
|
-1.41e-01
|
1.36e-01
|
5.85e-01
|
5.98e-01
|
GOBP NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION
|
13
|
4.76e-01
|
8.54e-01
|
0.19600
|
1.81e-02
|
-1.95e-01
|
9.10e-01
|
2.23e-01
|
GOBP POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR
|
16
|
4.35e-01
|
8.38e-01
|
0.19600
|
1.66e-01
|
-1.03e-01
|
2.49e-01
|
4.74e-01
|
GOBP REGULATION OF LONG TERM SYNAPTIC POTENTIATION
|
46
|
8.94e-02
|
5.51e-01
|
0.19600
|
-9.08e-02
|
1.74e-01
|
2.87e-01
|
4.16e-02
|
GOBP FEMALE MEIOSIS CHROMOSOME SEGREGATION
|
6
|
7.22e-01
|
9.30e-01
|
0.19600
|
-1.86e-01
|
6.12e-02
|
4.30e-01
|
7.95e-01
|
GOBP REGULATION OF DNA TEMPLATED DNA REPLICATION
|
46
|
4.95e-02
|
4.42e-01
|
0.19600
|
-1.38e-01
|
-1.39e-01
|
1.05e-01
|
1.03e-01
|
GOMF ALCOHOL DEHYDROGENASE NADPPLUS ACTIVITY
|
23
|
2.93e-01
|
7.63e-01
|
0.19600
|
7.42e-02
|
-1.81e-01
|
5.38e-01
|
1.32e-01
|
GOBP CORTICAL CYTOSKELETON ORGANIZATION
|
50
|
6.47e-02
|
4.90e-01
|
0.19600
|
-1.89e-01
|
5.02e-02
|
2.06e-02
|
5.39e-01
|
GOBP MRNA PSEUDOURIDINE SYNTHESIS
|
8
|
6.11e-01
|
8.98e-01
|
0.19600
|
-1.91e-01
|
-4.47e-02
|
3.50e-01
|
8.27e-01
|
GOBP POSITIVE REGULATION OF NUCLEASE ACTIVITY
|
7
|
6.91e-01
|
9.20e-01
|
0.19600
|
1.76e-01
|
-8.58e-02
|
4.20e-01
|
6.94e-01
|
GOMF PEPTIDE HORMONE RECEPTOR BINDING
|
19
|
3.63e-01
|
8.04e-01
|
0.19600
|
-1.81e-01
|
7.41e-02
|
1.71e-01
|
5.76e-01
|
GOCC ENDOPLASMIC RETICULUM EXIT SITE
|
28
|
2.12e-01
|
7.01e-01
|
0.19600
|
4.09e-02
|
-1.91e-01
|
7.08e-01
|
7.96e-02
|
GOBP NEGATIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS
|
10
|
5.99e-01
|
8.95e-01
|
0.19600
|
-1.40e-01
|
1.37e-01
|
4.45e-01
|
4.53e-01
|
GOBP POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE
|
18
|
3.27e-01
|
7.82e-01
|
0.19600
|
1.87e-01
|
5.65e-02
|
1.69e-01
|
6.78e-01
|
GOBP PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY
|
6
|
7.34e-01
|
9.34e-01
|
0.19600
|
-1.15e-01
|
1.58e-01
|
6.26e-01
|
5.02e-01
|
GOMF HISTONE H3K36 METHYLTRANSFERASE ACTIVITY
|
13
|
4.70e-01
|
8.51e-01
|
0.19600
|
-1.96e-01
|
1.64e-03
|
2.22e-01
|
9.92e-01
|
GOBP PYRIMIDINE NUCLEOBASE METABOLIC PROCESS
|
20
|
3.33e-01
|
7.86e-01
|
0.19600
|
-4.54e-02
|
1.90e-01
|
7.25e-01
|
1.41e-01
|
GOBP CARTILAGE MORPHOGENESIS
|
10
|
5.41e-01
|
8.78e-01
|
0.19600
|
-4.64e-02
|
-1.90e-01
|
7.99e-01
|
2.98e-01
|
GOBP G PROTEIN COUPLED SEROTONIN RECEPTOR SIGNALING PATHWAY
|
22
|
3.23e-01
|
7.79e-01
|
0.19600
|
-1.19e-01
|
1.56e-01
|
3.36e-01
|
2.07e-01
|
GOBP CORTICAL ACTIN CYTOSKELETON ORGANIZATION
|
42
|
9.70e-02
|
5.61e-01
|
0.19600
|
-1.92e-01
|
3.58e-02
|
3.11e-02
|
6.88e-01
|
GOCC ATPASE DEPENDENT TRANSMEMBRANE TRANSPORT COMPLEX
|
24
|
2.90e-01
|
7.61e-01
|
0.19500
|
-1.62e-01
|
1.10e-01
|
1.70e-01
|
3.53e-01
|
GOBP LEUKOTRIENE CATABOLIC PROCESS
|
6
|
7.04e-01
|
9.24e-01
|
0.19500
|
-4.41e-03
|
-1.95e-01
|
9.85e-01
|
4.07e-01
|
GOBP DOUBLE STRAND BREAK REPAIR INVOLVED IN MEIOTIC RECOMBINATION
|
11
|
4.91e-01
|
8.57e-01
|
0.19500
|
1.59e-01
|
1.13e-01
|
3.60e-01
|
5.17e-01
|
GOBP EPITHELIAL CILIUM MOVEMENT INVOLVED IN DETERMINATION OF LEFT RIGHT ASYMMETRY
|
12
|
4.59e-01
|
8.48e-01
|
0.19500
|
1.19e-01
|
1.55e-01
|
4.77e-01
|
3.51e-01
|
GOBP POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY
|
27
|
2.02e-01
|
6.92e-01
|
0.19500
|
1.63e-02
|
1.95e-01
|
8.83e-01
|
7.99e-02
|
GOCC SM LIKE PROTEIN FAMILY COMPLEX
|
89
|
7.15e-03
|
1.77e-01
|
0.19500
|
3.35e-02
|
-1.92e-01
|
5.85e-01
|
1.70e-03
|
GOBP POSITIVE REGULATION OF CALCIUM ION IMPORT
|
14
|
4.35e-01
|
8.38e-01
|
0.19500
|
2.06e-02
|
1.94e-01
|
8.94e-01
|
2.08e-01
|
GOBP POSITIVE REGULATION OF KILLING OF CELLS OF ANOTHER ORGANISM
|
8
|
6.61e-01
|
9.09e-01
|
0.19500
|
-1.03e-01
|
1.66e-01
|
6.14e-01
|
4.16e-01
|
GOBP NEURONAL ACTION POTENTIAL
|
32
|
1.45e-01
|
6.29e-01
|
0.19500
|
-3.24e-02
|
-1.93e-01
|
7.51e-01
|
5.93e-02
|
GOCC CLATHRIN SCULPTED VESICLE
|
12
|
5.42e-01
|
8.78e-01
|
0.19500
|
1.41e-01
|
-1.36e-01
|
3.99e-01
|
4.16e-01
|
GOBP MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION
|
17
|
3.37e-01
|
7.89e-01
|
0.19500
|
9.45e-02
|
1.71e-01
|
5.00e-01
|
2.23e-01
|
GOCC CATION TRANSPORTING ATPASE COMPLEX
|
18
|
3.71e-01
|
8.09e-01
|
0.19500
|
-3.96e-02
|
1.91e-01
|
7.71e-01
|
1.60e-01
|
GOBP REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE
|
30
|
1.92e-01
|
6.85e-01
|
0.19500
|
-1.91e-01
|
4.13e-02
|
7.06e-02
|
6.95e-01
|
GOBP LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS
|
6
|
7.36e-01
|
9.35e-01
|
0.19500
|
-1.50e-01
|
1.25e-01
|
5.26e-01
|
5.96e-01
|
GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX CATALYTIC DOMAIN
|
19
|
3.28e-01
|
7.83e-01
|
0.19500
|
-1.09e-02
|
-1.95e-01
|
9.34e-01
|
1.42e-01
|
GOMF NUCLEOSIDE BINDING
|
8
|
6.03e-01
|
8.96e-01
|
0.19500
|
8.30e-02
|
1.76e-01
|
6.84e-01
|
3.87e-01
|
GOCC NPBAF COMPLEX
|
14
|
4.89e-01
|
8.57e-01
|
0.19500
|
-1.53e-01
|
1.20e-01
|
3.20e-01
|
4.36e-01
|
GOCC CLATHRIN SCULPTED GAMMA AMINOBUTYRIC ACID TRANSPORT VESICLE
|
8
|
6.52e-01
|
9.08e-01
|
0.19500
|
1.84e-01
|
-6.40e-02
|
3.67e-01
|
7.54e-01
|
GOBP POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY
|
41
|
1.25e-01
|
6.06e-01
|
0.19500
|
-1.27e-01
|
1.48e-01
|
1.59e-01
|
1.02e-01
|
GOBP DE NOVO PROTEIN FOLDING
|
41
|
1.03e-01
|
5.75e-01
|
0.19500
|
3.23e-02
|
-1.92e-01
|
7.21e-01
|
3.32e-02
|
GOBP REGULATION OF CARDIOCYTE DIFFERENTIATION
|
32
|
1.96e-01
|
6.88e-01
|
0.19500
|
-1.53e-01
|
1.21e-01
|
1.34e-01
|
2.38e-01
|
GOBP REGULATION OF DENDRITIC CELL CHEMOTAXIS
|
11
|
5.39e-01
|
8.78e-01
|
0.19500
|
1.94e-01
|
-2.15e-02
|
2.66e-01
|
9.02e-01
|
GOCC DENDRITE CYTOPLASM
|
26
|
2.67e-01
|
7.43e-01
|
0.19500
|
-1.29e-01
|
1.46e-01
|
2.54e-01
|
1.99e-01
|
GOBP MAST CELL ACTIVATION
|
66
|
1.43e-02
|
2.59e-01
|
0.19500
|
1.22e-01
|
1.52e-01
|
8.56e-02
|
3.33e-02
|
GOBP BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS
|
20
|
3.61e-01
|
8.03e-01
|
0.19500
|
-1.54e-01
|
1.19e-01
|
2.33e-01
|
3.56e-01
|
GOBP REGULATION OF PHOSPHOLIPID METABOLIC PROCESS
|
32
|
1.76e-01
|
6.66e-01
|
0.19500
|
-4.85e-02
|
1.89e-01
|
6.35e-01
|
6.49e-02
|
GOBP LATERAL MESODERM DEVELOPMENT
|
15
|
3.90e-01
|
8.21e-01
|
0.19500
|
1.78e-01
|
7.95e-02
|
2.33e-01
|
5.94e-01
|
GOBP CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS
|
20
|
2.90e-01
|
7.61e-01
|
0.19500
|
-1.84e-01
|
-6.34e-02
|
1.54e-01
|
6.23e-01
|
GOCC CATSPER COMPLEX
|
14
|
4.91e-01
|
8.58e-01
|
0.19500
|
1.49e-01
|
-1.25e-01
|
3.34e-01
|
4.18e-01
|
GOBP REGULATION OF ATPASE COUPLED CALCIUM TRANSMEMBRANE TRANSPORTER ACTIVITY
|
6
|
6.99e-01
|
9.21e-01
|
0.19500
|
2.85e-02
|
1.92e-01
|
9.04e-01
|
4.14e-01
|
GOMF COMPLEMENT BINDING
|
23
|
2.30e-01
|
7.18e-01
|
0.19500
|
-1.03e-01
|
-1.65e-01
|
3.92e-01
|
1.71e-01
|
GOMF SINGLE STRANDED DNA EXODEOXYRIBONUCLEASE ACTIVITY
|
9
|
5.66e-01
|
8.85e-01
|
0.19500
|
8.72e-02
|
1.74e-01
|
6.51e-01
|
3.66e-01
|
GOBP DESMOSOME ORGANIZATION
|
10
|
5.71e-01
|
8.87e-01
|
0.19500
|
-2.26e-02
|
1.93e-01
|
9.01e-01
|
2.90e-01
|
GOMF VOLTAGE GATED SODIUM CHANNEL ACTIVITY INVOLVED IN CARDIAC MUSCLE CELL ACTION POTENTIAL
|
5
|
7.64e-01
|
9.45e-01
|
0.19400
|
1.87e-01
|
-5.41e-02
|
4.70e-01
|
8.34e-01
|
GOBP SPHINGOLIPID CATABOLIC PROCESS
|
32
|
1.76e-01
|
6.67e-01
|
0.19400
|
-1.89e-01
|
4.69e-02
|
6.47e-02
|
6.46e-01
|
GOBP COPPER ION HOMEOSTASIS
|
17
|
3.37e-01
|
7.89e-01
|
0.19400
|
-1.59e-01
|
-1.12e-01
|
2.56e-01
|
4.25e-01
|
GOBP NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION
|
23
|
3.03e-01
|
7.68e-01
|
0.19400
|
-8.56e-02
|
1.75e-01
|
4.77e-01
|
1.47e-01
|
GOBP NEGATIVE REGULATION OF AMINO ACID TRANSPORT
|
16
|
4.41e-01
|
8.40e-01
|
0.19400
|
1.05e-01
|
-1.63e-01
|
4.66e-01
|
2.58e-01
|
GOBP CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY
|
21
|
3.35e-01
|
7.88e-01
|
0.19400
|
8.25e-02
|
-1.76e-01
|
5.13e-01
|
1.63e-01
|
GOBP NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL
|
11
|
5.74e-01
|
8.88e-01
|
0.19400
|
1.38e-01
|
-1.36e-01
|
4.26e-01
|
4.34e-01
|
GOBP POSITIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS
|
10
|
6.04e-01
|
8.96e-01
|
0.19400
|
1.40e-01
|
-1.35e-01
|
4.43e-01
|
4.61e-01
|
GOBP RESPONSE TO PLATELET DERIVED GROWTH FACTOR
|
21
|
3.47e-01
|
7.96e-01
|
0.19400
|
-1.41e-01
|
1.33e-01
|
2.62e-01
|
2.91e-01
|
GOBP ERYTHROCYTE DEVELOPMENT
|
37
|
9.70e-02
|
5.61e-01
|
0.19400
|
-9.14e-02
|
-1.71e-01
|
3.36e-01
|
7.14e-02
|
GOMF GABA RECEPTOR ACTIVITY
|
19
|
3.83e-01
|
8.16e-01
|
0.19400
|
1.26e-01
|
-1.47e-01
|
3.40e-01
|
2.66e-01
|
GOBP REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY
|
13
|
4.42e-01
|
8.40e-01
|
0.19400
|
8.54e-02
|
1.74e-01
|
5.94e-01
|
2.76e-01
|
GOBP MITOCHONDRIAL GENOME MAINTENANCE
|
31
|
1.49e-01
|
6.35e-01
|
0.19400
|
-1.84e-01
|
-6.14e-02
|
7.60e-02
|
5.54e-01
|
GOBP CDC42 PROTEIN SIGNAL TRANSDUCTION
|
16
|
3.58e-01
|
8.00e-01
|
0.19400
|
1.28e-01
|
1.46e-01
|
3.74e-01
|
3.13e-01
|
GOCC X CHROMOSOME
|
11
|
5.49e-01
|
8.80e-01
|
0.19400
|
-1.90e-01
|
4.02e-02
|
2.76e-01
|
8.18e-01
|
GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR
|
22
|
3.11e-01
|
7.75e-01
|
0.19400
|
1.84e-01
|
-6.17e-02
|
1.35e-01
|
6.16e-01
|
GOBP RESPONSE TO HISTAMINE
|
11
|
5.74e-01
|
8.88e-01
|
0.19400
|
-1.26e-01
|
1.48e-01
|
4.70e-01
|
3.96e-01
|
GOMF ALANINE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
14
|
4.57e-01
|
8.48e-01
|
0.19400
|
1.93e-01
|
-1.88e-02
|
2.11e-01
|
9.03e-01
|
GOBP NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY
|
15
|
4.70e-01
|
8.51e-01
|
0.19400
|
1.42e-01
|
-1.32e-01
|
3.40e-01
|
3.76e-01
|
GOBP POSITIVE REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS
|
6
|
7.32e-01
|
9.33e-01
|
0.19400
|
8.08e-02
|
-1.76e-01
|
7.32e-01
|
4.55e-01
|
GOBP ETHANOLAMINE CONTAINING COMPOUND METABOLIC PROCESS
|
8
|
6.33e-01
|
9.03e-01
|
0.19400
|
1.83e-03
|
1.94e-01
|
9.93e-01
|
3.43e-01
|
GOBP ESTABLISHMENT OR MAINTENANCE OF CYTOSKELETON POLARITY
|
7
|
6.47e-01
|
9.07e-01
|
0.19400
|
-1.77e-01
|
-7.82e-02
|
4.17e-01
|
7.20e-01
|
GOCC DYSTROGLYCAN COMPLEX
|
7
|
7.03e-01
|
9.23e-01
|
0.19400
|
-1.53e-01
|
1.19e-01
|
4.83e-01
|
5.87e-01
|
GOBP NEGATIVE REGULATION OF GLIOGENESIS
|
44
|
9.00e-02
|
5.51e-01
|
0.19400
|
-1.91e-01
|
3.27e-02
|
2.84e-02
|
7.07e-01
|
GOBP REGULATION OF SYNAPSE PRUNING
|
6
|
7.35e-01
|
9.34e-01
|
0.19400
|
9.00e-02
|
-1.72e-01
|
7.03e-01
|
4.67e-01
|
GOMF HISTONE H3K36 TRIMETHYLTRANSFERASE ACTIVITY
|
5
|
7.41e-01
|
9.37e-01
|
0.19400
|
-1.89e-01
|
-4.25e-02
|
4.64e-01
|
8.69e-01
|
GOBP PEPTIDYL HISTIDINE MODIFICATION
|
8
|
6.24e-01
|
9.01e-01
|
0.19400
|
-1.92e-01
|
-2.79e-02
|
3.48e-01
|
8.91e-01
|
GOBP ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE
|
49
|
5.83e-02
|
4.71e-01
|
0.19400
|
-1.47e-02
|
-1.93e-01
|
8.59e-01
|
1.94e-02
|
GOBP PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS
|
32
|
1.31e-01
|
6.11e-01
|
0.19400
|
-1.14e-01
|
-1.57e-01
|
2.65e-01
|
1.25e-01
|
GOBP REGULATION OF PH
|
96
|
8.19e-03
|
1.89e-01
|
0.19400
|
-1.50e-01
|
1.23e-01
|
1.13e-02
|
3.75e-02
|
GOBP OSTEOBLAST DEVELOPMENT
|
17
|
4.26e-01
|
8.36e-01
|
0.19300
|
-1.52e-01
|
1.20e-01
|
2.79e-01
|
3.92e-01
|
GOBP INTRACELLULAR ZINC ION HOMEOSTASIS
|
36
|
1.06e-01
|
5.79e-01
|
0.19300
|
1.74e-01
|
8.44e-02
|
7.08e-02
|
3.81e-01
|
GOCC AZUROPHIL GRANULE
|
149
|
1.29e-04
|
1.15e-02
|
0.19300
|
-1.86e-01
|
-5.35e-02
|
9.12e-05
|
2.60e-01
|
GOBP PSEUDOURIDINE SYNTHESIS
|
17
|
3.42e-01
|
7.93e-01
|
0.19300
|
-1.09e-01
|
-1.60e-01
|
4.38e-01
|
2.54e-01
|
GOMF RIBOSOME BINDING
|
99
|
3.56e-03
|
1.21e-01
|
0.19300
|
-5.21e-03
|
-1.93e-01
|
9.29e-01
|
8.97e-04
|
GOMF NEUREXIN FAMILY PROTEIN BINDING
|
9
|
5.65e-01
|
8.85e-01
|
0.19300
|
1.52e-01
|
1.19e-01
|
4.29e-01
|
5.37e-01
|
GOBP OLEFINIC COMPOUND BIOSYNTHETIC PROCESS
|
28
|
1.93e-01
|
6.85e-01
|
0.19300
|
-2.75e-02
|
-1.91e-01
|
8.01e-01
|
7.99e-02
|
GOBP REGULATION OF DENDRITE MORPHOGENESIS
|
57
|
4.85e-02
|
4.41e-01
|
0.19300
|
-5.17e-02
|
1.86e-01
|
4.99e-01
|
1.51e-02
|
GOBP REGULATION OF MAST CELL ACTIVATION
|
38
|
1.38e-01
|
6.21e-01
|
0.19300
|
-6.75e-02
|
1.81e-01
|
4.71e-01
|
5.36e-02
|
GOMF FAD BINDING
|
39
|
1.24e-01
|
6.06e-01
|
0.19300
|
-1.87e-01
|
4.65e-02
|
4.28e-02
|
6.16e-01
|
GOBP PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER
|
35
|
1.09e-01
|
5.84e-01
|
0.19300
|
-1.52e-01
|
-1.19e-01
|
1.20e-01
|
2.23e-01
|
GOBP PHOSPHATIDYLSERINE METABOLIC PROCESS
|
23
|
3.16e-01
|
7.77e-01
|
0.19300
|
-1.15e-01
|
1.55e-01
|
3.40e-01
|
1.98e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY
|
29
|
2.18e-01
|
7.07e-01
|
0.19300
|
-6.07e-02
|
1.83e-01
|
5.71e-01
|
8.79e-02
|
GOMF GLYCOLIPID MANNOSYLTRANSFERASE ACTIVITY
|
5
|
7.41e-01
|
9.37e-01
|
0.19300
|
-4.89e-02
|
-1.87e-01
|
8.50e-01
|
4.70e-01
|
GOBP SKELETAL MYOFIBRIL ASSEMBLY
|
10
|
5.93e-01
|
8.94e-01
|
0.19300
|
-6.40e-02
|
1.82e-01
|
7.26e-01
|
3.20e-01
|
GOMF EXTRACELLULAR MATRIX CONSTITUENT CONFERRING ELASTICITY
|
10
|
5.47e-01
|
8.78e-01
|
0.19300
|
1.84e-01
|
5.80e-02
|
3.14e-01
|
7.51e-01
|
GOCC GLYCOPROTEIN COMPLEX
|
21
|
3.03e-01
|
7.68e-01
|
0.19300
|
6.61e-03
|
1.93e-01
|
9.58e-01
|
1.27e-01
|
GOMF ACETYLCHOLINE BINDING
|
11
|
5.24e-01
|
8.70e-01
|
0.19300
|
3.24e-02
|
1.90e-01
|
8.52e-01
|
2.75e-01
|
GOBP REGULATION OF HAIR CYCLE
|
28
|
2.49e-01
|
7.27e-01
|
0.19300
|
-1.50e-01
|
1.21e-01
|
1.70e-01
|
2.68e-01
|
GOBP POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY
|
101
|
6.26e-03
|
1.64e-01
|
0.19300
|
-9.80e-02
|
1.66e-01
|
8.88e-02
|
3.99e-03
|
GOBP RIBOSOMAL SUBUNIT EXPORT FROM NUCLEUS
|
14
|
4.73e-01
|
8.53e-01
|
0.19300
|
1.88e-01
|
-4.24e-02
|
2.24e-01
|
7.83e-01
|
GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ADAPTOR ACTIVITY
|
17
|
3.46e-01
|
7.96e-01
|
0.19300
|
1.00e-01
|
1.64e-01
|
4.74e-01
|
2.41e-01
|
GOMF TELOMERASE INHIBITOR ACTIVITY
|
5
|
7.45e-01
|
9.38e-01
|
0.19300
|
-3.50e-02
|
-1.89e-01
|
8.92e-01
|
4.64e-01
|
GOCC GABA RECEPTOR COMPLEX
|
18
|
4.04e-01
|
8.26e-01
|
0.19300
|
9.91e-02
|
-1.65e-01
|
4.67e-01
|
2.25e-01
|
GOCC AZUROPHIL GRANULE MEMBRANE
|
56
|
3.83e-02
|
3.99e-01
|
0.19200
|
-1.90e-01
|
-2.90e-02
|
1.38e-02
|
7.07e-01
|
GOMF 3 5 CYCLIC AMP PHOSPHODIESTERASE ACTIVITY
|
17
|
3.98e-01
|
8.25e-01
|
0.19200
|
1.90e-01
|
-3.08e-02
|
1.75e-01
|
8.26e-01
|
GOBP REGULATION OF CYTOPLASMIC TRANSPORT
|
29
|
2.36e-01
|
7.24e-01
|
0.19200
|
-1.55e-01
|
1.14e-01
|
1.48e-01
|
2.88e-01
|
GOCC MHC CLASS II PROTEIN COMPLEX
|
15
|
4.76e-01
|
8.54e-01
|
0.19200
|
1.42e-01
|
-1.30e-01
|
3.42e-01
|
3.83e-01
|
GOMF TITIN BINDING
|
13
|
5.25e-01
|
8.71e-01
|
0.19200
|
-1.49e-01
|
1.22e-01
|
3.54e-01
|
4.46e-01
|
GOBP FUCOSYLATION
|
17
|
3.42e-01
|
7.93e-01
|
0.19200
|
-1.39e-01
|
-1.33e-01
|
3.20e-01
|
3.44e-01
|
GOBP POSITIVE REGULATION OF PYROPTOSIS
|
5
|
7.81e-01
|
9.52e-01
|
0.19200
|
1.26e-01
|
-1.45e-01
|
6.25e-01
|
5.74e-01
|
GOBP REGULATION OF CALCIDIOL 1 MONOOXYGENASE ACTIVITY
|
7
|
6.65e-01
|
9.11e-01
|
0.19200
|
-2.80e-02
|
-1.90e-01
|
8.98e-01
|
3.84e-01
|
GOBP POSITIVE REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY
|
9
|
6.39e-01
|
9.06e-01
|
0.19200
|
1.55e-01
|
-1.13e-01
|
4.19e-01
|
5.57e-01
|
GOBP ATRIOVENTRICULAR VALVE DEVELOPMENT
|
29
|
2.26e-01
|
7.14e-01
|
0.19200
|
-7.56e-02
|
1.77e-01
|
4.81e-01
|
9.96e-02
|
GOBP REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS
|
13
|
4.42e-01
|
8.40e-01
|
0.19200
|
-1.21e-01
|
-1.49e-01
|
4.49e-01
|
3.52e-01
|
GOBP NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION
|
19
|
3.89e-01
|
8.21e-01
|
0.19200
|
-1.55e-01
|
1.14e-01
|
2.44e-01
|
3.89e-01
|
GOBP RAC PROTEIN SIGNAL TRANSDUCTION
|
41
|
1.30e-01
|
6.09e-01
|
0.19200
|
-1.60e-01
|
1.07e-01
|
7.71e-02
|
2.36e-01
|
GOBP NEGATIVE REGULATION OF GLIAL CELL MIGRATION
|
6
|
6.89e-01
|
9.19e-01
|
0.19200
|
1.67e-01
|
9.53e-02
|
4.79e-01
|
6.86e-01
|
GOBP NUCLEOTIDE TRANSPORT
|
40
|
1.10e-01
|
5.87e-01
|
0.19200
|
-1.92e-01
|
1.38e-02
|
3.60e-02
|
8.80e-01
|
GOMF AMMONIA LYASE ACTIVITY
|
5
|
7.50e-01
|
9.40e-01
|
0.19200
|
-1.91e-01
|
-1.81e-02
|
4.59e-01
|
9.44e-01
|
GOBP CELL CYCLE DNA REPLICATION
|
42
|
7.30e-02
|
5.13e-01
|
0.19200
|
-1.07e-01
|
-1.60e-01
|
2.32e-01
|
7.33e-02
|
GOBP PROTEIN RNA COMPLEX DISASSEMBLY
|
8
|
6.74e-01
|
9.13e-01
|
0.19200
|
-1.26e-01
|
1.45e-01
|
5.37e-01
|
4.78e-01
|
GOBP GANGLIOSIDE METABOLIC PROCESS
|
28
|
2.41e-01
|
7.25e-01
|
0.19200
|
-1.74e-01
|
8.21e-02
|
1.12e-01
|
4.52e-01
|
GOMF ATP DEPENDENT ACTIVITY ACTING ON RNA
|
74
|
9.67e-03
|
2.08e-01
|
0.19200
|
-1.42e-01
|
-1.29e-01
|
3.46e-02
|
5.47e-02
|
GOBP NOTOCHORD MORPHOGENESIS
|
8
|
6.05e-01
|
8.96e-01
|
0.19200
|
1.25e-01
|
1.45e-01
|
5.39e-01
|
4.77e-01
|
GOCC CYTOPLASMIC SIDE OF ENDOPLASMIC RETICULUM MEMBRANE
|
16
|
3.75e-01
|
8.11e-01
|
0.19200
|
-1.72e-01
|
-8.42e-02
|
2.32e-01
|
5.60e-01
|
GOBP METANEPHRIC MESENCHYMAL CELL DIFFERENTIATION
|
5
|
7.70e-01
|
9.48e-01
|
0.19200
|
1.84e-01
|
-5.59e-02
|
4.77e-01
|
8.29e-01
|
GOCC RESPIRATORY CHAIN COMPLEX IV
|
22
|
3.04e-01
|
7.68e-01
|
0.19200
|
2.56e-02
|
-1.90e-01
|
8.35e-01
|
1.23e-01
|
GOBP SUCCINYL COA METABOLIC PROCESS
|
10
|
6.11e-01
|
8.98e-01
|
0.19200
|
1.26e-01
|
-1.44e-01
|
4.89e-01
|
4.29e-01
|
GOBP REGULATION OF STEM CELL DIVISION
|
11
|
5.05e-01
|
8.65e-01
|
0.19200
|
-1.06e-01
|
-1.59e-01
|
5.41e-01
|
3.60e-01
|
GOBP NEGATIVE REGULATION OF METALLOENDOPEPTIDASE ACTIVITY
|
8
|
6.47e-01
|
9.07e-01
|
0.19200
|
2.17e-02
|
-1.90e-01
|
9.15e-01
|
3.51e-01
|
GOBP POSITIVE REGULATION OF BEHAVIOR
|
24
|
2.70e-01
|
7.45e-01
|
0.19200
|
1.82e-02
|
-1.91e-01
|
8.77e-01
|
1.06e-01
|
GOBP INSULIN METABOLIC PROCESS
|
16
|
4.00e-01
|
8.25e-01
|
0.19200
|
-1.90e-01
|
-2.11e-02
|
1.87e-01
|
8.84e-01
|
GOCC POST MRNA RELEASE SPLICEOSOMAL COMPLEX
|
10
|
5.67e-01
|
8.85e-01
|
0.19200
|
-1.91e-01
|
-1.34e-02
|
2.95e-01
|
9.41e-01
|
GOBP METANEPHRIC S SHAPED BODY MORPHOGENESIS
|
5
|
7.81e-01
|
9.52e-01
|
0.19100
|
-1.08e-01
|
1.58e-01
|
6.75e-01
|
5.41e-01
|
GOBP REGULATION OF HETEROTYPIC CELL CELL ADHESION
|
24
|
3.00e-01
|
7.67e-01
|
0.19100
|
-8.92e-02
|
1.69e-01
|
4.50e-01
|
1.51e-01
|
GOBP POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY
|
7
|
6.46e-01
|
9.07e-01
|
0.19100
|
1.27e-01
|
1.43e-01
|
5.61e-01
|
5.11e-01
|
GOMF PENTOSYLTRANSFERASE ACTIVITY
|
53
|
4.00e-02
|
4.11e-01
|
0.19100
|
-1.74e-01
|
-7.92e-02
|
2.82e-02
|
3.19e-01
|
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME
|
7
|
6.76e-01
|
9.13e-01
|
0.19100
|
-1.91e-01
|
-3.18e-03
|
3.81e-01
|
9.88e-01
|
GOMF MANNOSYL OLIGOSACCHARIDE MANNOSIDASE ACTIVITY
|
9
|
6.05e-01
|
8.96e-01
|
0.19100
|
1.24e-03
|
1.91e-01
|
9.95e-01
|
3.20e-01
|
GOBP CLATHRIN DEPENDENT ENDOCYTOSIS
|
47
|
8.78e-02
|
5.47e-01
|
0.19100
|
-1.83e-01
|
5.73e-02
|
3.04e-02
|
4.96e-01
|
GOBP POTASSIUM ION HOMEOSTASIS
|
34
|
1.68e-01
|
6.54e-01
|
0.19100
|
-4.60e-02
|
1.86e-01
|
6.43e-01
|
6.09e-02
|
GOBP NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT
|
31
|
1.74e-01
|
6.64e-01
|
0.19100
|
1.10e-02
|
1.91e-01
|
9.15e-01
|
6.58e-02
|
GOBP ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE
|
21
|
2.84e-01
|
7.57e-01
|
0.19100
|
-6.66e-02
|
-1.79e-01
|
5.97e-01
|
1.55e-01
|
GOBP POSITIVE REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY
|
10
|
5.53e-01
|
8.80e-01
|
0.19100
|
5.28e-02
|
1.84e-01
|
7.73e-01
|
3.14e-01
|
GOCC SWR1 COMPLEX
|
13
|
5.17e-01
|
8.69e-01
|
0.19100
|
-1.76e-01
|
7.54e-02
|
2.73e-01
|
6.38e-01
|
GOBP LUNG SECRETORY CELL DIFFERENTIATION
|
11
|
5.63e-01
|
8.84e-01
|
0.19100
|
1.85e-01
|
-4.89e-02
|
2.88e-01
|
7.79e-01
|
GOBP NEGATIVE REGULATION OF GENE EXPRESSION VIA CPG ISLAND METHYLATION
|
7
|
7.03e-01
|
9.23e-01
|
0.19100
|
-8.36e-02
|
1.72e-01
|
7.02e-01
|
4.31e-01
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH2 GROUP OF DONORS
|
17
|
3.47e-01
|
7.96e-01
|
0.19100
|
-1.48e-01
|
-1.22e-01
|
2.92e-01
|
3.86e-01
|
GOBP REGULATION OF AMYLOID FIBRIL FORMATION
|
16
|
4.26e-01
|
8.36e-01
|
0.19100
|
3.15e-02
|
-1.89e-01
|
8.27e-01
|
1.92e-01
|
GOBP POSITIVE REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION
|
11
|
5.55e-01
|
8.81e-01
|
0.19100
|
3.01e-02
|
-1.89e-01
|
8.63e-01
|
2.79e-01
|
GOCC COPI VESICLE COAT
|
13
|
4.46e-01
|
8.40e-01
|
0.19100
|
-1.43e-01
|
-1.27e-01
|
3.73e-01
|
4.27e-01
|
GOCC HETEROCHROMATIN
|
76
|
1.52e-02
|
2.62e-01
|
0.19100
|
-1.91e-01
|
4.02e-03
|
4.00e-03
|
9.52e-01
|
GOBP ASPARAGINE METABOLIC PROCESS
|
5
|
7.50e-01
|
9.40e-01
|
0.19100
|
-2.92e-02
|
-1.89e-01
|
9.10e-01
|
4.65e-01
|
GOBP THYROID HORMONE TRANSPORT
|
10
|
5.39e-01
|
8.78e-01
|
0.19100
|
1.09e-01
|
1.57e-01
|
5.50e-01
|
3.91e-01
|
GOMF SECONDARY ACTIVE SULFATE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
11
|
5.83e-01
|
8.90e-01
|
0.19100
|
-1.12e-01
|
1.55e-01
|
5.22e-01
|
3.74e-01
|
GOBP CEREBRAL CORTEX GABAERGIC INTERNEURON DEVELOPMENT
|
6
|
7.38e-01
|
9.35e-01
|
0.19100
|
-1.77e-01
|
7.26e-02
|
4.54e-01
|
7.58e-01
|
GOBP AMINO ACID BETAINE METABOLIC PROCESS
|
16
|
3.82e-01
|
8.16e-01
|
0.19100
|
1.76e-01
|
7.35e-02
|
2.22e-01
|
6.11e-01
|
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE
|
63
|
3.44e-02
|
3.78e-01
|
0.19100
|
-1.89e-01
|
2.51e-02
|
9.45e-03
|
7.30e-01
|
GOBP PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS
|
20
|
2.90e-01
|
7.61e-01
|
0.19100
|
-1.46e-01
|
-1.23e-01
|
2.60e-01
|
3.40e-01
|
GOBP ENDOPLASMIC RETICULUM LOCALIZATION
|
10
|
6.15e-01
|
8.99e-01
|
0.19100
|
1.36e-01
|
-1.34e-01
|
4.57e-01
|
4.63e-01
|
GOBP REGULATION OF RECEPTOR CATABOLIC PROCESS
|
11
|
5.17e-01
|
8.69e-01
|
0.19100
|
7.12e-02
|
1.77e-01
|
6.83e-01
|
3.10e-01
|
GOBP POSITIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION
|
9
|
6.45e-01
|
9.07e-01
|
0.19100
|
-1.47e-01
|
1.21e-01
|
4.44e-01
|
5.30e-01
|
GOBP NEGATIVE REGULATION OF MYOBLAST PROLIFERATION
|
9
|
5.80e-01
|
8.90e-01
|
0.19100
|
1.72e-01
|
8.25e-02
|
3.72e-01
|
6.68e-01
|
GOBP LATE ENDOSOME TO LYSOSOME TRANSPORT
|
21
|
3.40e-01
|
7.91e-01
|
0.19000
|
-1.82e-01
|
5.59e-02
|
1.49e-01
|
6.57e-01
|
GOBP EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION
|
13
|
5.05e-01
|
8.65e-01
|
0.19000
|
3.83e-02
|
-1.87e-01
|
8.11e-01
|
2.44e-01
|
GOCC 90S PRERIBOSOME
|
28
|
2.19e-01
|
7.07e-01
|
0.19000
|
-1.90e-01
|
1.18e-02
|
8.17e-02
|
9.14e-01
|
GOBP SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS
|
18
|
3.55e-01
|
7.97e-01
|
0.19000
|
-3.47e-02
|
-1.87e-01
|
7.99e-01
|
1.69e-01
|
GOBP ENDOLYSOSOMAL TOLL LIKE RECEPTOR SIGNALING PATHWAY
|
41
|
1.37e-01
|
6.21e-01
|
0.19000
|
-1.41e-01
|
1.28e-01
|
1.19e-01
|
1.55e-01
|
GOBP ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE
|
9
|
5.80e-01
|
8.90e-01
|
0.19000
|
-8.75e-02
|
-1.69e-01
|
6.50e-01
|
3.80e-01
|
GOBP ALDITOL CATABOLIC PROCESS
|
6
|
7.46e-01
|
9.39e-01
|
0.19000
|
-1.53e-01
|
1.14e-01
|
5.17e-01
|
6.30e-01
|
GOBP NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY
|
14
|
4.73e-01
|
8.53e-01
|
0.19000
|
2.27e-02
|
-1.89e-01
|
8.83e-01
|
2.21e-01
|
GOBP ANDROGEN RECEPTOR SIGNALING PATHWAY
|
45
|
1.13e-01
|
5.91e-01
|
0.19000
|
-1.44e-01
|
1.24e-01
|
9.42e-02
|
1.50e-01
|
GOBP CELLULAR RESPONSE TO CHOLESTEROL
|
20
|
3.40e-01
|
7.91e-01
|
0.19000
|
-1.90e-01
|
1.66e-02
|
1.42e-01
|
8.98e-01
|
GOBP LACRIMAL GLAND DEVELOPMENT
|
7
|
6.49e-01
|
9.07e-01
|
0.19000
|
-1.33e-01
|
-1.36e-01
|
5.42e-01
|
5.34e-01
|
GOBP REGULATION OF CELL PROLIFERATION IN BONE MARROW
|
8
|
6.11e-01
|
8.98e-01
|
0.19000
|
-1.42e-01
|
-1.27e-01
|
4.87e-01
|
5.35e-01
|
GOBP REGULATION OF TOLERANCE INDUCTION
|
19
|
3.32e-01
|
7.86e-01
|
0.19000
|
1.85e-01
|
4.41e-02
|
1.63e-01
|
7.39e-01
|
GOBP POSITIVE REGULATION OF JUN KINASE ACTIVITY
|
31
|
1.97e-01
|
6.88e-01
|
0.19000
|
-1.87e-01
|
3.66e-02
|
7.21e-02
|
7.24e-01
|
GOBP FOREBRAIN REGIONALIZATION
|
24
|
2.39e-01
|
7.25e-01
|
0.19000
|
-7.21e-02
|
-1.76e-01
|
5.41e-01
|
1.36e-01
|
GOBP NEGATIVE REGULATION OF AUTOPHAGY
|
86
|
1.51e-02
|
2.62e-01
|
0.19000
|
-1.60e-01
|
1.02e-01
|
1.02e-02
|
1.02e-01
|
GOBP SYNAPTIC VESICLE CLUSTERING
|
15
|
4.79e-01
|
8.54e-01
|
0.19000
|
-9.91e-02
|
1.62e-01
|
5.06e-01
|
2.77e-01
|
GOMF PROTEIN BINDING INVOLVED IN HETEROTYPIC CELL CELL ADHESION
|
12
|
5.34e-01
|
8.76e-01
|
0.19000
|
1.86e-01
|
-3.97e-02
|
2.65e-01
|
8.12e-01
|
GOBP COLLATERAL SPROUTING IN ABSENCE OF INJURY
|
5
|
7.73e-01
|
9.48e-01
|
0.19000
|
1.84e-01
|
-4.89e-02
|
4.77e-01
|
8.50e-01
|
GOMF PHOSPHATIDYLINOSITOL PHOSPHATE BINDING
|
170
|
2.21e-04
|
1.62e-02
|
0.19000
|
-7.93e-02
|
1.73e-01
|
7.45e-02
|
1.03e-04
|
GOBP OLFACTORY BULB INTERNEURON DIFFERENTIATION
|
12
|
5.21e-01
|
8.69e-01
|
0.19000
|
-1.90e-01
|
8.24e-03
|
2.55e-01
|
9.61e-01
|
GOMF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE ACTIVITY
|
19
|
3.95e-01
|
8.24e-01
|
0.19000
|
-1.00e-01
|
1.61e-01
|
4.50e-01
|
2.23e-01
|
GOBP RUFFLE ORGANIZATION
|
56
|
6.41e-02
|
4.87e-01
|
0.19000
|
-9.41e-02
|
1.65e-01
|
2.23e-01
|
3.27e-02
|
GOBP ACTIVATION OF ADENYLATE CYCLASE ACTIVITY
|
25
|
2.78e-01
|
7.51e-01
|
0.19000
|
1.82e-01
|
-5.29e-02
|
1.14e-01
|
6.47e-01
|
GOBP POSITIVE REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION
|
6
|
7.49e-01
|
9.40e-01
|
0.19000
|
1.28e-01
|
-1.41e-01
|
5.88e-01
|
5.51e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY
|
24
|
2.71e-01
|
7.47e-01
|
0.19000
|
-6.92e-03
|
1.90e-01
|
9.53e-01
|
1.08e-01
|
GOBP REGULATION OF CYTOPLASMIC TRANSLATIONAL INITIATION
|
7
|
6.51e-01
|
9.07e-01
|
0.19000
|
-1.44e-01
|
-1.24e-01
|
5.10e-01
|
5.70e-01
|
GOBP POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION
|
10
|
5.94e-01
|
8.94e-01
|
0.19000
|
-4.02e-02
|
1.86e-01
|
8.26e-01
|
3.10e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION
|
11
|
5.20e-01
|
8.69e-01
|
0.19000
|
-7.12e-02
|
-1.76e-01
|
6.83e-01
|
3.12e-01
|
GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX CLASS III
|
7
|
6.53e-01
|
9.08e-01
|
0.19000
|
-1.59e-01
|
-1.04e-01
|
4.67e-01
|
6.34e-01
|
GOBP NEGATIVE REGULATION OF ORGAN GROWTH
|
35
|
1.86e-01
|
6.77e-01
|
0.19000
|
-1.26e-01
|
1.42e-01
|
1.98e-01
|
1.46e-01
|
GOBP CYTOLYSIS
|
7
|
7.14e-01
|
9.27e-01
|
0.19000
|
-1.31e-01
|
1.37e-01
|
5.49e-01
|
5.29e-01
|
GOMF NEUTRAL L AMINO ACID SODIUM SYMPORTER ACTIVITY
|
8
|
6.15e-01
|
8.99e-01
|
0.19000
|
1.56e-01
|
1.07e-01
|
4.44e-01
|
6.00e-01
|
GOBP REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY
|
33
|
1.58e-01
|
6.46e-01
|
0.19000
|
1.87e-02
|
1.89e-01
|
8.52e-01
|
6.07e-02
|
GOBP ENTRAINMENT OF CIRCADIAN CLOCK
|
29
|
2.24e-01
|
7.12e-01
|
0.18900
|
-1.84e-01
|
4.35e-02
|
8.56e-02
|
6.85e-01
|
GOBP POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR
|
5
|
7.59e-01
|
9.44e-01
|
0.18900
|
-1.89e-01
|
-6.56e-03
|
4.64e-01
|
9.80e-01
|
GOBP SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY
|
19
|
3.14e-01
|
7.76e-01
|
0.18900
|
-1.19e-01
|
-1.48e-01
|
3.71e-01
|
2.65e-01
|
GOBP NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS
|
57
|
3.11e-02
|
3.62e-01
|
0.18900
|
1.19e-01
|
1.47e-01
|
1.21e-01
|
5.42e-02
|
GOBP NEGATIVE REGULATION OF T HELPER 2 CELL DIFFERENTIATION
|
5
|
7.46e-01
|
9.38e-01
|
0.18900
|
-6.09e-02
|
-1.79e-01
|
8.13e-01
|
4.88e-01
|
GOBP NEGATIVE REGULATION OF ERAD PATHWAY
|
6
|
6.96e-01
|
9.21e-01
|
0.18900
|
-9.82e-02
|
-1.62e-01
|
6.77e-01
|
4.92e-01
|
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS
|
6
|
6.99e-01
|
9.21e-01
|
0.18900
|
-8.25e-02
|
-1.70e-01
|
7.26e-01
|
4.70e-01
|
GOCC PHAGOPHORE ASSEMBLY SITE MEMBRANE
|
20
|
3.78e-01
|
8.14e-01
|
0.18900
|
-1.62e-01
|
9.82e-02
|
2.10e-01
|
4.47e-01
|
GOBP NEGATIVE REGULATION OF POST TRANSCRIPTIONAL GENE SILENCING
|
12
|
4.91e-01
|
8.57e-01
|
0.18900
|
-1.73e-01
|
-7.66e-02
|
2.99e-01
|
6.46e-01
|
GOBP ISOPRENOID BIOSYNTHETIC PROCESS
|
29
|
1.83e-01
|
6.72e-01
|
0.18900
|
-1.78e-01
|
-6.39e-02
|
9.69e-02
|
5.52e-01
|
GOBP THYROID HORMONE METABOLIC PROCESS
|
28
|
2.33e-01
|
7.20e-01
|
0.18900
|
1.86e-01
|
-3.51e-02
|
8.86e-02
|
7.48e-01
|
GOBP REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION
|
54
|
5.30e-02
|
4.54e-01
|
0.18900
|
-1.16e-03
|
-1.89e-01
|
9.88e-01
|
1.62e-02
|
GOBP REGULATION OF ANTIMICROBIAL PEPTIDE PRODUCTION
|
9
|
5.79e-01
|
8.89e-01
|
0.18900
|
-1.50e-01
|
-1.14e-01
|
4.34e-01
|
5.52e-01
|
GOBP T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL
|
10
|
6.03e-01
|
8.96e-01
|
0.18900
|
-1.80e-01
|
5.61e-02
|
3.23e-01
|
7.59e-01
|
GOBP TELOMERE TETHERING AT NUCLEAR PERIPHERY
|
6
|
7.22e-01
|
9.30e-01
|
0.18900
|
-5.76e-04
|
1.89e-01
|
9.98e-01
|
4.23e-01
|
GOBP COLLAGEN ACTIVATED SIGNALING PATHWAY
|
13
|
4.61e-01
|
8.48e-01
|
0.18900
|
1.69e-01
|
8.48e-02
|
2.92e-01
|
5.97e-01
|
GOBP 2FE 2S CLUSTER ASSEMBLY
|
9
|
5.83e-01
|
8.90e-01
|
0.18900
|
-9.51e-02
|
-1.63e-01
|
6.21e-01
|
3.97e-01
|
GOBP FOLATE TRANSMEMBRANE TRANSPORT
|
5
|
7.88e-01
|
9.54e-01
|
0.18900
|
1.37e-01
|
-1.30e-01
|
5.96e-01
|
6.16e-01
|
GOBP GAMMA AMINOBUTYRIC ACID METABOLIC PROCESS
|
8
|
6.46e-01
|
9.07e-01
|
0.18900
|
-5.94e-03
|
-1.89e-01
|
9.77e-01
|
3.56e-01
|
GOBP POSITIVE REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION
|
6
|
7.24e-01
|
9.30e-01
|
0.18900
|
-1.89e-01
|
3.50e-03
|
4.24e-01
|
9.88e-01
|
GOBP MECHANOSENSORY BEHAVIOR
|
14
|
4.28e-01
|
8.36e-01
|
0.18900
|
1.22e-01
|
1.44e-01
|
4.31e-01
|
3.50e-01
|
GOBP PROTEIN DE ADP RIBOSYLATION
|
5
|
7.39e-01
|
9.35e-01
|
0.18900
|
1.43e-01
|
1.23e-01
|
5.80e-01
|
6.34e-01
|
GOBP PROSTATE GLAND GROWTH
|
10
|
5.47e-01
|
8.78e-01
|
0.18900
|
1.51e-01
|
1.12e-01
|
4.07e-01
|
5.39e-01
|
GOBP POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE
|
13
|
5.09e-01
|
8.66e-01
|
0.18800
|
-1.86e-01
|
2.91e-02
|
2.45e-01
|
8.56e-01
|
GOBP FIBROBLAST PROLIFERATION
|
104
|
3.65e-03
|
1.23e-01
|
0.18800
|
-2.47e-03
|
-1.88e-01
|
9.65e-01
|
9.00e-04
|
GOBP MYOBLAST PROLIFERATION
|
34
|
1.40e-01
|
6.23e-01
|
0.18800
|
5.99e-02
|
1.79e-01
|
5.45e-01
|
7.15e-02
|
GOBP MALATE METABOLIC PROCESS
|
9
|
5.81e-01
|
8.90e-01
|
0.18800
|
-1.15e-01
|
-1.49e-01
|
5.50e-01
|
4.38e-01
|
GOBP CHAPERONE MEDIATED PROTEIN FOLDING
|
74
|
1.82e-02
|
2.89e-01
|
0.18800
|
-4.61e-03
|
-1.88e-01
|
9.45e-01
|
5.10e-03
|
GOBP COBALAMIN METABOLIC PROCESS
|
9
|
6.20e-01
|
9.00e-01
|
0.18800
|
-1.13e-02
|
1.88e-01
|
9.53e-01
|
3.29e-01
|
GOBP SULFUR AMINO ACID TRANSPORT
|
12
|
5.05e-01
|
8.65e-01
|
0.18800
|
4.55e-02
|
1.83e-01
|
7.85e-01
|
2.73e-01
|
GOMF ATP DEPENDENT DNA DAMAGE SENSOR ACTIVITY
|
19
|
3.17e-01
|
7.77e-01
|
0.18800
|
-1.37e-01
|
-1.29e-01
|
3.00e-01
|
3.32e-01
|
GOMF INTRACELLULAR CAMP ACTIVATED CATION CHANNEL ACTIVITY
|
8
|
6.20e-01
|
9.00e-01
|
0.18800
|
1.60e-01
|
9.93e-02
|
4.34e-01
|
6.27e-01
|
GOMF PHOSPHOLIPASE ACTIVATOR ACTIVITY
|
13
|
5.24e-01
|
8.70e-01
|
0.18800
|
-6.30e-02
|
1.77e-01
|
6.94e-01
|
2.68e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS
|
15
|
4.41e-01
|
8.40e-01
|
0.18800
|
1.88e-01
|
1.14e-02
|
2.08e-01
|
9.39e-01
|
GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA
|
5
|
7.62e-01
|
9.45e-01
|
0.18800
|
-1.88e-01
|
-7.51e-03
|
4.67e-01
|
9.77e-01
|
GOBP INTESTINE SMOOTH MUSCLE CONTRACTION
|
8
|
6.20e-01
|
9.00e-01
|
0.18800
|
1.59e-01
|
1.00e-01
|
4.35e-01
|
6.24e-01
|
GOBP REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY
|
44
|
8.62e-02
|
5.45e-01
|
0.18800
|
-2.89e-02
|
-1.86e-01
|
7.40e-01
|
3.29e-02
|
GOMF O METHYLTRANSFERASE ACTIVITY
|
20
|
3.07e-01
|
7.71e-01
|
0.18800
|
-1.67e-01
|
-8.57e-02
|
1.95e-01
|
5.07e-01
|
GOBP NEGATIVE REGULATION OF MACROPHAGE DIFFERENTIATION
|
8
|
6.18e-01
|
9.00e-01
|
0.18800
|
-1.41e-01
|
-1.24e-01
|
4.89e-01
|
5.44e-01
|
GOBP MATURATION OF LSU RRNA
|
27
|
2.19e-01
|
7.08e-01
|
0.18800
|
-3.73e-02
|
-1.84e-01
|
7.37e-01
|
9.77e-02
|
GOBP DERMATAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS
|
8
|
6.75e-01
|
9.13e-01
|
0.18800
|
-1.74e-01
|
7.03e-02
|
3.94e-01
|
7.31e-01
|
GOBP THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY
|
13
|
4.89e-01
|
8.56e-01
|
0.18800
|
-1.87e-01
|
-2.10e-02
|
2.44e-01
|
8.96e-01
|
GOBP REGULATION OF HIPPO SIGNALING
|
25
|
3.08e-01
|
7.72e-01
|
0.18800
|
-1.39e-01
|
1.26e-01
|
2.29e-01
|
2.75e-01
|
GOBP PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS
|
11
|
5.41e-01
|
8.78e-01
|
0.18800
|
-1.84e-01
|
-3.50e-02
|
2.90e-01
|
8.41e-01
|
GOBP CONSTITUTIVE SECRETORY PATHWAY
|
7
|
7.10e-01
|
9.26e-01
|
0.18800
|
-1.73e-01
|
7.30e-02
|
4.29e-01
|
7.38e-01
|
GOBP CANONICAL WNT SIGNALING PATHWAY INVOLVED IN CARDIAC MUSCLE CELL FATE COMMITMENT
|
5
|
7.63e-01
|
9.45e-01
|
0.18800
|
-9.53e-03
|
-1.87e-01
|
9.71e-01
|
4.68e-01
|
GOBP PENILE ERECTION
|
7
|
6.98e-01
|
9.21e-01
|
0.18800
|
-3.15e-02
|
1.85e-01
|
8.85e-01
|
3.97e-01
|
GOBP REGULATION OF HEPATOCYTE APOPTOTIC PROCESS
|
10
|
5.55e-01
|
8.81e-01
|
0.18700
|
-8.74e-02
|
-1.66e-01
|
6.32e-01
|
3.64e-01
|
GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS
|
8
|
6.83e-01
|
9.17e-01
|
0.18700
|
-1.60e-01
|
9.72e-02
|
4.33e-01
|
6.34e-01
|
GOBP ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS
|
25
|
2.73e-01
|
7.48e-01
|
0.18700
|
-1.86e-01
|
2.07e-02
|
1.07e-01
|
8.58e-01
|
GOBP MITOCHONDRIAL ELECTRON TRANSPORT CYTOCHROME C TO OXYGEN
|
19
|
3.76e-01
|
8.11e-01
|
0.18700
|
2.63e-02
|
-1.85e-01
|
8.43e-01
|
1.62e-01
|
GOBP CELLULAR RESPONSE TO OXYGEN RADICAL
|
23
|
2.65e-01
|
7.41e-01
|
0.18700
|
-7.09e-02
|
-1.73e-01
|
5.56e-01
|
1.50e-01
|
GOBP RIBOFLAVIN METABOLIC PROCESS
|
5
|
7.42e-01
|
9.37e-01
|
0.18700
|
-1.38e-01
|
-1.26e-01
|
5.93e-01
|
6.25e-01
|
GOMF HEPARAN SULFATE SULFOTRANSFERASE ACTIVITY
|
14
|
5.14e-01
|
8.67e-01
|
0.18700
|
-1.61e-01
|
9.61e-02
|
2.98e-01
|
5.34e-01
|
GOBP REGULATION OF BONE MINERALIZATION
|
76
|
2.88e-02
|
3.53e-01
|
0.18700
|
-1.35e-01
|
1.30e-01
|
4.21e-02
|
5.05e-02
|
GOBP METANEPHRIC NEPHRON TUBULE MORPHOGENESIS
|
8
|
6.60e-01
|
9.09e-01
|
0.18700
|
-2.02e-02
|
1.86e-01
|
9.21e-01
|
3.62e-01
|
GOBP CELLULAR RESPONSE TO INDOLE 3 METHANOL
|
5
|
7.90e-01
|
9.54e-01
|
0.18700
|
-1.12e-01
|
1.50e-01
|
6.65e-01
|
5.62e-01
|
GOBP PROTEIN NEDDYLATION
|
28
|
2.66e-01
|
7.42e-01
|
0.18700
|
-1.56e-01
|
1.03e-01
|
1.53e-01
|
3.46e-01
|
GOMF 3 HYDROXYACYL COA DEHYDROGENASE ACTIVITY
|
6
|
7.26e-01
|
9.30e-01
|
0.18700
|
-2.85e-03
|
-1.87e-01
|
9.90e-01
|
4.28e-01
|
GOMF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY INVOLVED IN CARDIAC MUSCLE CELL ACTION POTENTIAL REPOLARIZATION
|
14
|
4.60e-01
|
8.48e-01
|
0.18700
|
3.41e-02
|
1.84e-01
|
8.25e-01
|
2.34e-01
|
GOBP RESPONSE TO IMMOBILIZATION STRESS
|
21
|
3.00e-01
|
7.67e-01
|
0.18700
|
6.56e-02
|
1.75e-01
|
6.03e-01
|
1.65e-01
|
GOBP INNER EAR RECEPTOR CELL FATE COMMITMENT
|
5
|
7.87e-01
|
9.53e-01
|
0.18700
|
-1.65e-01
|
8.70e-02
|
5.22e-01
|
7.36e-01
|
GOMF CLATHRIN BINDING
|
67
|
4.27e-02
|
4.25e-01
|
0.18700
|
-1.55e-01
|
1.05e-01
|
2.83e-02
|
1.39e-01
|
GOBP ENDOSOME TO LYSOSOME TRANSPORT
|
70
|
3.02e-02
|
3.61e-01
|
0.18700
|
-1.81e-01
|
4.44e-02
|
8.64e-03
|
5.21e-01
|
GOBP CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS
|
8
|
6.62e-01
|
9.09e-01
|
0.18700
|
2.11e-02
|
-1.86e-01
|
9.18e-01
|
3.63e-01
|
GOBP LATERAL SPROUTING FROM AN EPITHELIUM
|
10
|
5.68e-01
|
8.86e-01
|
0.18700
|
-1.79e-01
|
-5.31e-02
|
3.27e-01
|
7.71e-01
|
GOBP MEIOTIC SPINDLE ORGANIZATION
|
18
|
4.32e-01
|
8.37e-01
|
0.18700
|
1.38e-01
|
-1.26e-01
|
3.12e-01
|
3.54e-01
|
GOBP ENGULFMENT OF APOPTOTIC CELL
|
15
|
4.10e-01
|
8.27e-01
|
0.18700
|
1.38e-01
|
1.26e-01
|
3.56e-01
|
3.97e-01
|
GOBP POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION
|
19
|
4.10e-01
|
8.27e-01
|
0.18700
|
1.52e-01
|
-1.09e-01
|
2.53e-01
|
4.11e-01
|
GOBP REGULATION OF NATURAL KILLER CELL CHEMOTAXIS
|
8
|
6.74e-01
|
9.13e-01
|
0.18700
|
-5.71e-02
|
1.78e-01
|
7.80e-01
|
3.84e-01
|
GOMF MRNA 5 UTR BINDING
|
23
|
3.29e-01
|
7.83e-01
|
0.18700
|
7.15e-02
|
-1.72e-01
|
5.53e-01
|
1.52e-01
|
GOMF PHOSPHATIDYLETHANOLAMINE BINDING
|
13
|
4.76e-01
|
8.54e-01
|
0.18700
|
-6.55e-02
|
-1.75e-01
|
6.82e-01
|
2.76e-01
|
GOMF BH3 DOMAIN BINDING
|
6
|
7.01e-01
|
9.22e-01
|
0.18600
|
-1.43e-01
|
-1.19e-01
|
5.43e-01
|
6.13e-01
|
GOBP NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL
|
22
|
2.76e-01
|
7.49e-01
|
0.18600
|
9.71e-02
|
1.59e-01
|
4.30e-01
|
1.96e-01
|
GOBP REGULATION OF CELL CYCLE G2 M PHASE TRANSITION
|
109
|
1.67e-03
|
7.41e-02
|
0.18600
|
-1.09e-01
|
-1.51e-01
|
4.85e-02
|
6.48e-03
|
GOBP POSITIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS
|
39
|
1.56e-01
|
6.43e-01
|
0.18600
|
-1.67e-01
|
8.35e-02
|
7.18e-02
|
3.67e-01
|
GOBP POSITIVE REGULATION OF METALLOPEPTIDASE ACTIVITY
|
10
|
5.74e-01
|
8.88e-01
|
0.18600
|
-3.98e-02
|
-1.82e-01
|
8.27e-01
|
3.19e-01
|
GOBP TOLL LIKE RECEPTOR SIGNALING PATHWAY
|
67
|
2.09e-02
|
3.06e-01
|
0.18600
|
-1.67e-01
|
-8.30e-02
|
1.83e-02
|
2.40e-01
|
GOMF GTPASE INHIBITOR ACTIVITY
|
12
|
4.98e-01
|
8.61e-01
|
0.18600
|
-9.05e-02
|
-1.63e-01
|
5.87e-01
|
3.29e-01
|
GOCC INTERCALATED DISC
|
49
|
6.58e-02
|
4.95e-01
|
0.18600
|
1.81e-01
|
4.38e-02
|
2.84e-02
|
5.96e-01
|
GOMF NADP RETINOL DEHYDROGENASE ACTIVITY
|
13
|
5.13e-01
|
8.67e-01
|
0.18600
|
2.01e-02
|
-1.85e-01
|
9.00e-01
|
2.48e-01
|
GOBP REGULATION OF INTESTINAL ABSORPTION
|
12
|
4.95e-01
|
8.58e-01
|
0.18600
|
-1.06e-01
|
-1.53e-01
|
5.24e-01
|
3.59e-01
|
GOBP NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS
|
38
|
1.07e-01
|
5.79e-01
|
0.18600
|
1.18e-01
|
1.44e-01
|
2.10e-01
|
1.24e-01
|
GOBP POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION
|
22
|
3.36e-01
|
7.88e-01
|
0.18600
|
-4.65e-02
|
1.80e-01
|
7.06e-01
|
1.44e-01
|
GOBP ALANINE TRANSPORT
|
16
|
4.09e-01
|
8.27e-01
|
0.18600
|
1.80e-01
|
4.85e-02
|
2.14e-01
|
7.37e-01
|
GOBP CEREBROSPINAL FLUID CIRCULATION
|
15
|
5.00e-01
|
8.62e-01
|
0.18600
|
1.34e-01
|
-1.29e-01
|
3.70e-01
|
3.86e-01
|
GOMF CLATHRIN HEAVY CHAIN BINDING
|
10
|
5.98e-01
|
8.95e-01
|
0.18600
|
-1.85e-01
|
1.77e-02
|
3.11e-01
|
9.23e-01
|
GOCC F ACTIN CAPPING PROTEIN COMPLEX
|
8
|
6.28e-01
|
9.02e-01
|
0.18600
|
-9.26e-02
|
-1.61e-01
|
6.50e-01
|
4.30e-01
|
GOBP ATP SYNTHESIS COUPLED ELECTRON TRANSPORT
|
85
|
1.32e-02
|
2.50e-01
|
0.18600
|
2.15e-02
|
-1.85e-01
|
7.31e-01
|
3.26e-03
|
GOBP OXIDATIVE PHOSPHORYLATION
|
126
|
1.44e-03
|
6.64e-02
|
0.18600
|
5.40e-03
|
-1.86e-01
|
9.17e-01
|
3.16e-04
|
GOBP IMMUNE RESPONSE TO TUMOR CELL
|
26
|
2.98e-01
|
7.67e-01
|
0.18600
|
1.54e-01
|
-1.05e-01
|
1.75e-01
|
3.56e-01
|
GOBP CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION
|
32
|
1.77e-01
|
6.67e-01
|
0.18600
|
1.84e-01
|
2.31e-02
|
7.11e-02
|
8.21e-01
|
GOBP PROSTATIC BUD FORMATION
|
8
|
6.47e-01
|
9.07e-01
|
0.18600
|
-1.84e-01
|
-2.84e-02
|
3.68e-01
|
8.89e-01
|
GOBP POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION
|
14
|
4.44e-01
|
8.40e-01
|
0.18600
|
9.45e-02
|
1.60e-01
|
5.41e-01
|
3.00e-01
|
GOBP XENOBIOTIC TRANSMEMBRANE TRANSPORT
|
16
|
3.91e-01
|
8.21e-01
|
0.18600
|
-1.22e-01
|
-1.40e-01
|
3.98e-01
|
3.33e-01
|
GOBP XENOBIOTIC TRANSPORT ACROSS BLOOD BRAIN BARRIER
|
6
|
7.13e-01
|
9.27e-01
|
0.18600
|
5.93e-02
|
1.76e-01
|
8.01e-01
|
4.56e-01
|
GOBP RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE
|
9
|
6.60e-01
|
9.09e-01
|
0.18600
|
1.39e-01
|
-1.23e-01
|
4.71e-01
|
5.23e-01
|
GOBP REGULATION OF FATTY ACID OXIDATION
|
33
|
2.09e-01
|
6.97e-01
|
0.18600
|
-7.90e-02
|
1.68e-01
|
4.32e-01
|
9.50e-02
|
GOBP SINOATRIAL NODE CELL DEVELOPMENT
|
5
|
7.59e-01
|
9.44e-01
|
0.18600
|
1.81e-01
|
3.93e-02
|
4.83e-01
|
8.79e-01
|
GOBP MICROGLIA DIFFERENTIATION
|
11
|
5.97e-01
|
8.95e-01
|
0.18600
|
-1.60e-01
|
9.38e-02
|
3.58e-01
|
5.90e-01
|
GOBP PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS
|
9
|
5.97e-01
|
8.95e-01
|
0.18500
|
-1.67e-01
|
-7.99e-02
|
3.84e-01
|
6.78e-01
|
GOCC CUL4 RING E3 UBIQUITIN LIGASE COMPLEX
|
32
|
1.60e-01
|
6.48e-01
|
0.18500
|
-1.66e-01
|
-8.21e-02
|
1.04e-01
|
4.21e-01
|
GOBP SULFUR AMINO ACID BIOSYNTHETIC PROCESS
|
15
|
4.21e-01
|
8.33e-01
|
0.18500
|
-1.60e-01
|
-9.39e-02
|
2.84e-01
|
5.29e-01
|
GOCC U6 SNRNP
|
8
|
6.27e-01
|
9.02e-01
|
0.18500
|
-1.21e-01
|
-1.40e-01
|
5.54e-01
|
4.92e-01
|
GOBP POSITIVE REGULATION OF TOOTH MINERALIZATION
|
7
|
7.25e-01
|
9.30e-01
|
0.18500
|
1.38e-01
|
-1.23e-01
|
5.26e-01
|
5.73e-01
|
GOBP POSITIVE REGULATION OF NEUTROPHIL MIGRATION
|
30
|
2.19e-01
|
7.08e-01
|
0.18500
|
-2.16e-02
|
1.84e-01
|
8.38e-01
|
8.13e-02
|
GOMF RNA POLYMERASE BINDING
|
57
|
4.03e-02
|
4.13e-01
|
0.18500
|
-1.72e-01
|
-6.78e-02
|
2.45e-02
|
3.76e-01
|
GOBP REGULATION OF CILIUM BEAT FREQUENCY
|
17
|
4.45e-01
|
8.40e-01
|
0.18500
|
6.96e-02
|
-1.71e-01
|
6.19e-01
|
2.21e-01
|
GOBP CYCLOOXYGENASE PATHWAY
|
9
|
6.06e-01
|
8.97e-01
|
0.18500
|
-5.37e-02
|
-1.77e-01
|
7.80e-01
|
3.58e-01
|
GOBP MIRNA PROCESSING
|
45
|
1.13e-01
|
5.91e-01
|
0.18500
|
-1.76e-01
|
5.57e-02
|
4.06e-02
|
5.18e-01
|
GOBP INHIBITORY SYNAPSE ASSEMBLY
|
18
|
3.97e-01
|
8.25e-01
|
0.18500
|
-1.85e-01
|
1.05e-02
|
1.75e-01
|
9.39e-01
|
GOBP RESPONSE TO ANGIOTENSIN
|
35
|
1.56e-01
|
6.43e-01
|
0.18500
|
1.57e-02
|
1.84e-01
|
8.72e-01
|
5.92e-02
|
GOCC MRNA CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR COMPLEX
|
14
|
4.93e-01
|
8.58e-01
|
0.18500
|
-1.84e-01
|
2.10e-02
|
2.34e-01
|
8.92e-01
|
GOMF HISTONE BINDING
|
220
|
1.97e-05
|
2.73e-03
|
0.18500
|
-1.82e-01
|
3.38e-02
|
3.40e-06
|
3.88e-01
|
GOBP POSITIVE REGULATION OF GLOMERULAR MESANGIAL CELL PROLIFERATION
|
7
|
7.26e-01
|
9.30e-01
|
0.18500
|
1.22e-01
|
-1.39e-01
|
5.75e-01
|
5.26e-01
|
GOBP MAST CELL MEDIATED IMMUNITY
|
55
|
4.99e-02
|
4.44e-01
|
0.18500
|
4.02e-02
|
1.80e-01
|
6.06e-01
|
2.07e-02
|
GOCC MITOCHONDRIA ASSOCIATED ENDOPLASMIC RETICULUM MEMBRANE
|
18
|
3.84e-01
|
8.17e-01
|
0.18500
|
-1.91e-02
|
-1.84e-01
|
8.88e-01
|
1.77e-01
|
GOBP POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION
|
26
|
2.80e-01
|
7.53e-01
|
0.18500
|
-4.42e-02
|
1.79e-01
|
6.97e-01
|
1.13e-01
|
GOBP CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION
|
58
|
4.27e-02
|
4.25e-01
|
0.18500
|
1.80e-01
|
3.92e-02
|
1.74e-02
|
6.05e-01
|
GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM CALCIUM ION CONCENTRATION
|
7
|
7.23e-01
|
9.30e-01
|
0.18500
|
-1.58e-01
|
9.62e-02
|
4.70e-01
|
6.59e-01
|
GOMF U6 SNRNA BINDING
|
14
|
4.83e-01
|
8.54e-01
|
0.18500
|
-1.85e-01
|
-8.64e-04
|
2.32e-01
|
9.96e-01
|
GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE SPINDLE ASSEMBLY CHECKPOINT
|
12
|
5.10e-01
|
8.66e-01
|
0.18500
|
-1.72e-01
|
-6.73e-02
|
3.02e-01
|
6.86e-01
|
GOBP ISOLEUCINE METABOLIC PROCESS
|
6
|
7.12e-01
|
9.27e-01
|
0.18500
|
-1.68e-01
|
-7.66e-02
|
4.76e-01
|
7.45e-01
|
GOMF FATTY ACID DERIVATIVE BINDING
|
17
|
3.75e-01
|
8.11e-01
|
0.18500
|
-1.04e-01
|
-1.53e-01
|
4.60e-01
|
2.75e-01
|
GOBP HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN
|
46
|
1.23e-01
|
6.06e-01
|
0.18500
|
1.36e-01
|
-1.24e-01
|
1.10e-01
|
1.44e-01
|
GOBP MORPHOGENESIS OF AN EPITHELIAL SHEET
|
59
|
5.82e-02
|
4.70e-01
|
0.18500
|
-1.76e-01
|
5.38e-02
|
1.90e-02
|
4.75e-01
|
GOBP REGULATION OF TYPE 2 IMMUNE RESPONSE
|
34
|
1.42e-01
|
6.26e-01
|
0.18400
|
-1.54e-01
|
-1.02e-01
|
1.21e-01
|
3.03e-01
|
GOBP THIAMINE TRANSPORT
|
8
|
6.90e-01
|
9.20e-01
|
0.18400
|
1.60e-01
|
-9.15e-02
|
4.33e-01
|
6.54e-01
|
GOBP NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY
|
27
|
2.88e-01
|
7.60e-01
|
0.18400
|
-1.56e-01
|
9.88e-02
|
1.61e-01
|
3.74e-01
|
GOMF ATP DEPENDENT PROTEIN DISAGGREGASE ACTIVITY
|
6
|
7.15e-01
|
9.27e-01
|
0.18400
|
-1.73e-01
|
-6.42e-02
|
4.63e-01
|
7.85e-01
|
GOBP MRNA POLYADENYLATION
|
24
|
2.84e-01
|
7.57e-01
|
0.18400
|
-1.02e-02
|
-1.84e-01
|
9.31e-01
|
1.18e-01
|
GOBP U4 SNRNA 3 END PROCESSING
|
8
|
6.95e-01
|
9.21e-01
|
0.18400
|
1.25e-01
|
-1.36e-01
|
5.42e-01
|
5.06e-01
|
GOBP CIRCADIAN SLEEP WAKE CYCLE SLEEP
|
16
|
4.83e-01
|
8.54e-01
|
0.18400
|
-1.25e-01
|
1.36e-01
|
3.87e-01
|
3.47e-01
|
GOBP INTERMEMBRANE LIPID TRANSFER
|
54
|
8.21e-02
|
5.33e-01
|
0.18400
|
-1.61e-01
|
8.96e-02
|
4.06e-02
|
2.55e-01
|
GOMF LIPID TRANSFER ACTIVITY
|
54
|
8.21e-02
|
5.33e-01
|
0.18400
|
-1.61e-01
|
8.96e-02
|
4.06e-02
|
2.55e-01
|
GOBP RIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS
|
14
|
5.10e-01
|
8.66e-01
|
0.18400
|
-5.59e-02
|
1.76e-01
|
7.17e-01
|
2.55e-01
|
GOBP ANTEROGRADE NEURONAL DENSE CORE VESICLE TRANSPORT
|
6
|
7.60e-01
|
9.44e-01
|
0.18400
|
-1.11e-01
|
1.48e-01
|
6.39e-01
|
5.32e-01
|
GOCC CATALYTIC STEP 2 SPLICEOSOME
|
86
|
7.84e-03
|
1.84e-01
|
0.18400
|
-7.99e-02
|
-1.66e-01
|
2.00e-01
|
7.76e-03
|
GOBP CELL PROLIFERATION IN FOREBRAIN
|
26
|
3.00e-01
|
7.67e-01
|
0.18400
|
8.85e-02
|
-1.62e-01
|
4.35e-01
|
1.54e-01
|
GOCC PAR POLARITY COMPLEX
|
6
|
7.08e-01
|
9.25e-01
|
0.18400
|
-1.51e-01
|
-1.06e-01
|
5.23e-01
|
6.54e-01
|
GOBP PULMONARY VALVE MORPHOGENESIS
|
19
|
4.03e-01
|
8.26e-01
|
0.18400
|
-1.75e-01
|
5.84e-02
|
1.87e-01
|
6.60e-01
|
GOBP REGULATION OF MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL
|
5
|
7.49e-01
|
9.40e-01
|
0.18400
|
1.24e-01
|
1.36e-01
|
6.32e-01
|
5.98e-01
|
GOMF MAP KINASE ACTIVITY
|
16
|
4.04e-01
|
8.26e-01
|
0.18400
|
8.50e-02
|
1.63e-01
|
5.56e-01
|
2.58e-01
|
GOBP MYELOID DENDRITIC CELL CYTOKINE PRODUCTION
|
8
|
6.73e-01
|
9.13e-01
|
0.18400
|
-1.82e-01
|
3.01e-02
|
3.74e-01
|
8.83e-01
|
GOBP REGULATION OF GONADOTROPIN SECRETION
|
11
|
5.66e-01
|
8.85e-01
|
0.18400
|
-3.04e-03
|
-1.84e-01
|
9.86e-01
|
2.91e-01
|
GOBP ISOPRENOID CATABOLIC PROCESS
|
10
|
5.74e-01
|
8.88e-01
|
0.18400
|
-6.23e-02
|
-1.73e-01
|
7.33e-01
|
3.43e-01
|
GOMF NEUROPEPTIDE RECEPTOR BINDING
|
33
|
2.07e-01
|
6.96e-01
|
0.18400
|
-5.67e-02
|
1.75e-01
|
5.73e-01
|
8.20e-02
|
GOBP NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY
|
14
|
5.30e-01
|
8.74e-01
|
0.18400
|
1.42e-01
|
-1.17e-01
|
3.57e-01
|
4.50e-01
|
GOBP NEGATIVE REGULATION OF CHROMOSOME SEGREGATION
|
50
|
8.99e-02
|
5.51e-01
|
0.18400
|
4.87e-02
|
-1.77e-01
|
5.52e-01
|
3.01e-02
|
GOBP REGULATION OF STEM CELL POPULATION MAINTENANCE
|
71
|
3.93e-02
|
4.06e-01
|
0.18400
|
-1.55e-01
|
9.81e-02
|
2.37e-02
|
1.53e-01
|
GOBP POSITIVE REGULATION OF RECEPTOR CATABOLIC PROCESS
|
7
|
6.72e-01
|
9.13e-01
|
0.18400
|
9.22e-02
|
1.59e-01
|
6.73e-01
|
4.67e-01
|
GOBP NUCLEOSIDE SALVAGE
|
8
|
6.38e-01
|
9.06e-01
|
0.18300
|
-8.19e-02
|
-1.64e-01
|
6.88e-01
|
4.21e-01
|
GOBP AGGREPHAGY
|
10
|
6.24e-01
|
9.01e-01
|
0.18300
|
-6.53e-02
|
1.71e-01
|
7.21e-01
|
3.48e-01
|
GOBP MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY
|
53
|
8.45e-02
|
5.39e-01
|
0.18300
|
-1.69e-01
|
7.25e-02
|
3.38e-02
|
3.61e-01
|
GOBP SALIVARY GLAND DEVELOPMENT
|
33
|
2.13e-01
|
7.02e-01
|
0.18300
|
-6.92e-02
|
1.70e-01
|
4.91e-01
|
9.13e-02
|
GOCC PHOTORECEPTOR RIBBON SYNAPSE
|
10
|
6.22e-01
|
9.01e-01
|
0.18300
|
-5.66e-02
|
1.74e-01
|
7.57e-01
|
3.39e-01
|
GOBP RESPONSE TO INTERLEUKIN 18
|
11
|
5.46e-01
|
8.78e-01
|
0.18300
|
-6.00e-02
|
-1.73e-01
|
7.30e-01
|
3.20e-01
|
GOBP POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION
|
23
|
3.26e-01
|
7.82e-01
|
0.18300
|
-3.64e-02
|
1.80e-01
|
7.62e-01
|
1.36e-01
|
GOBP REGULATION OF CARDIAC MUSCLE ADAPTATION
|
17
|
4.39e-01
|
8.40e-01
|
0.18300
|
-4.10e-02
|
1.79e-01
|
7.70e-01
|
2.02e-01
|
GOBP NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS
|
25
|
3.25e-01
|
7.80e-01
|
0.18300
|
-1.41e-01
|
1.17e-01
|
2.23e-01
|
3.10e-01
|
GOBP NEGATIVE REGULATION OF NEUROBLAST PROLIFERATION
|
11
|
6.05e-01
|
8.96e-01
|
0.18300
|
9.04e-02
|
-1.59e-01
|
6.04e-01
|
3.60e-01
|
GOMF ABC TYPE XENOBIOTIC TRANSPORTER ACTIVITY
|
14
|
4.54e-01
|
8.46e-01
|
0.18300
|
-1.57e-01
|
-9.38e-02
|
3.09e-01
|
5.43e-01
|
GOBP NUCLEAR BODY ORGANIZATION
|
15
|
5.11e-01
|
8.66e-01
|
0.18300
|
-1.32e-01
|
1.26e-01
|
3.74e-01
|
3.97e-01
|
GOBP RECEPTOR INTERNALIZATION
|
123
|
4.12e-03
|
1.32e-01
|
0.18300
|
-1.19e-01
|
1.39e-01
|
2.27e-02
|
7.71e-03
|
GOBP LIPOPROTEIN CATABOLIC PROCESS
|
15
|
4.88e-01
|
8.56e-01
|
0.18300
|
-1.77e-01
|
4.79e-02
|
2.36e-01
|
7.48e-01
|
GOBP REGULATION OF HETEROCHROMATIN ORGANIZATION
|
23
|
2.93e-01
|
7.63e-01
|
0.18300
|
-3.75e-02
|
-1.79e-01
|
7.56e-01
|
1.37e-01
|
GOBP METHIONINE BIOSYNTHETIC PROCESS
|
12
|
5.05e-01
|
8.65e-01
|
0.18300
|
-1.16e-01
|
-1.42e-01
|
4.88e-01
|
3.95e-01
|
GOBP PEPTIDYL THREONINE MODIFICATION
|
107
|
8.48e-03
|
1.94e-01
|
0.18300
|
-1.36e-01
|
1.22e-01
|
1.48e-02
|
2.94e-02
|
GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR
|
82
|
2.25e-02
|
3.17e-01
|
0.18300
|
-1.68e-01
|
7.20e-02
|
8.50e-03
|
2.60e-01
|
GOBP RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM
|
35
|
1.38e-01
|
6.22e-01
|
0.18300
|
1.51e-01
|
1.03e-01
|
1.22e-01
|
2.91e-01
|
GOBP SERINE PHOSPHORYLATION OF STAT PROTEIN
|
21
|
3.35e-01
|
7.88e-01
|
0.18300
|
-1.82e-02
|
-1.82e-01
|
8.85e-01
|
1.49e-01
|
GOBP FREE UBIQUITIN CHAIN POLYMERIZATION
|
9
|
6.00e-01
|
8.96e-01
|
0.18300
|
1.46e-01
|
1.10e-01
|
4.49e-01
|
5.67e-01
|
GOBP VESICLE TARGETING
|
65
|
5.53e-02
|
4.63e-01
|
0.18300
|
-1.29e-01
|
1.30e-01
|
7.32e-02
|
7.02e-02
|
GOBP REGULATION OF MESENCHYMAL CELL PROLIFERATION
|
32
|
1.98e-01
|
6.88e-01
|
0.18300
|
-1.50e-03
|
1.83e-01
|
9.88e-01
|
7.37e-02
|
GOBP MITOTIC CHROMOSOME CONDENSATION
|
19
|
3.47e-01
|
7.96e-01
|
0.18300
|
-1.63e-01
|
-8.33e-02
|
2.20e-01
|
5.30e-01
|
GOBP PROTEIN LOCALIZATION TO PLASMA MEMBRANE RAFT
|
5
|
7.99e-01
|
9.56e-01
|
0.18300
|
1.49e-01
|
-1.06e-01
|
5.65e-01
|
6.81e-01
|
GOBP REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY
|
11
|
5.36e-01
|
8.77e-01
|
0.18300
|
1.45e-01
|
1.11e-01
|
4.06e-01
|
5.23e-01
|
GOBP REGULATION OF MITOCHONDRIAL TRANSCRIPTION
|
5
|
7.58e-01
|
9.44e-01
|
0.18300
|
-7.53e-02
|
-1.66e-01
|
7.71e-01
|
5.20e-01
|
GOBP MODIFICATION OF POSTSYNAPTIC STRUCTURE
|
21
|
3.67e-01
|
8.07e-01
|
0.18200
|
4.38e-02
|
-1.77e-01
|
7.28e-01
|
1.60e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN MATURATION
|
26
|
2.29e-01
|
7.18e-01
|
0.18200
|
-1.23e-01
|
-1.35e-01
|
2.79e-01
|
2.34e-01
|
GOBP ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY
|
9
|
6.59e-01
|
9.09e-01
|
0.18200
|
6.95e-02
|
-1.69e-01
|
7.18e-01
|
3.81e-01
|
GOMF G PROTEIN COUPLED GLUTAMATE RECEPTOR ACTIVITY
|
9
|
6.59e-01
|
9.09e-01
|
0.18200
|
6.95e-02
|
-1.69e-01
|
7.18e-01
|
3.81e-01
|
GOBP REGULATION OF GLYCOLYTIC PROCESS
|
50
|
6.86e-02
|
5.00e-01
|
0.18200
|
-1.76e-01
|
-4.85e-02
|
3.16e-02
|
5.53e-01
|
GOBP MEIOTIC DNA DOUBLE STRAND BREAK FORMATION
|
6
|
7.26e-01
|
9.30e-01
|
0.18200
|
1.77e-01
|
4.38e-02
|
4.53e-01
|
8.53e-01
|
GOBP INTERLEUKIN 13 PRODUCTION
|
21
|
3.43e-01
|
7.94e-01
|
0.18200
|
-7.14e-03
|
-1.82e-01
|
9.55e-01
|
1.49e-01
|
GOMF PEPTIDOGLYCAN BINDING
|
18
|
3.69e-01
|
8.09e-01
|
0.18200
|
-8.32e-02
|
-1.62e-01
|
5.41e-01
|
2.34e-01
|
GOBP RESPONSE TO COPPER ION
|
35
|
1.73e-01
|
6.61e-01
|
0.18200
|
1.82e-01
|
-3.85e-03
|
6.23e-02
|
9.69e-01
|
GOBP PLANAR CELL POLARITY PATHWAY INVOLVED IN AXIS ELONGATION
|
6
|
7.35e-01
|
9.34e-01
|
0.18200
|
1.82e-01
|
1.13e-02
|
4.41e-01
|
9.62e-01
|
GOBP RESPONSE TO DISACCHARIDE
|
7
|
6.73e-01
|
9.13e-01
|
0.18200
|
1.33e-01
|
1.24e-01
|
5.43e-01
|
5.69e-01
|
GOBP NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY
|
15
|
4.66e-01
|
8.51e-01
|
0.18200
|
1.82e-01
|
7.03e-03
|
2.23e-01
|
9.62e-01
|
GOCC MRNA CAP BINDING COMPLEX
|
11
|
5.52e-01
|
8.80e-01
|
0.18200
|
-5.73e-02
|
-1.73e-01
|
7.42e-01
|
3.21e-01
|
GOMF ATP ACTIVATED INWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY
|
6
|
7.31e-01
|
9.32e-01
|
0.18200
|
1.80e-01
|
2.76e-02
|
4.46e-01
|
9.07e-01
|
GOBP VESICLE DOCKING INVOLVED IN EXOCYTOSIS
|
42
|
9.46e-02
|
5.59e-01
|
0.18200
|
1.46e-01
|
1.09e-01
|
1.02e-01
|
2.21e-01
|
GOMF VITAMIN B6 BINDING
|
53
|
6.01e-02
|
4.78e-01
|
0.18200
|
-4.28e-02
|
-1.77e-01
|
5.90e-01
|
2.59e-02
|
GOBP NEURAL CREST CELL FATE COMMITMENT
|
6
|
7.53e-01
|
9.41e-01
|
0.18200
|
-1.76e-01
|
4.77e-02
|
4.56e-01
|
8.40e-01
|
GOCC KINOCILIUM
|
10
|
6.42e-01
|
9.07e-01
|
0.18200
|
1.36e-01
|
-1.21e-01
|
4.56e-01
|
5.09e-01
|
GOBP STEROID CATABOLIC PROCESS
|
24
|
3.36e-01
|
7.88e-01
|
0.18200
|
1.64e-01
|
-7.97e-02
|
1.66e-01
|
4.99e-01
|
GOBP POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY
|
19
|
4.05e-01
|
8.26e-01
|
0.18200
|
-1.77e-01
|
4.27e-02
|
1.82e-01
|
7.47e-01
|
GOBP OLIGOSACCHARIDE METABOLIC PROCESS
|
65
|
3.12e-02
|
3.63e-01
|
0.18200
|
-4.95e-02
|
-1.75e-01
|
4.90e-01
|
1.47e-02
|
GOMF PHOSPHATIDYLCHOLINE FLOPPASE ACTIVITY
|
8
|
6.50e-01
|
9.07e-01
|
0.18200
|
5.53e-02
|
1.73e-01
|
7.86e-01
|
3.97e-01
|
GOCC PRECATALYTIC SPLICEOSOME
|
50
|
9.65e-02
|
5.61e-01
|
0.18200
|
5.25e-02
|
-1.74e-01
|
5.21e-01
|
3.34e-02
|
GOBP TRNA MODIFICATION
|
89
|
6.80e-03
|
1.72e-01
|
0.18200
|
-1.28e-01
|
-1.29e-01
|
3.75e-02
|
3.50e-02
|
GOBP NEGATIVE REGULATION OF CILIUM ASSEMBLY
|
18
|
4.21e-01
|
8.34e-01
|
0.18200
|
3.24e-02
|
-1.79e-01
|
8.12e-01
|
1.89e-01
|
GOBP CD8 POSITIVE ALPHA BETA T CELL PROLIFERATION
|
9
|
6.60e-01
|
9.09e-01
|
0.18200
|
6.49e-02
|
-1.70e-01
|
7.36e-01
|
3.78e-01
|
GOBP 3 UTR MEDIATED MRNA STABILIZATION
|
20
|
3.64e-01
|
8.05e-01
|
0.18200
|
-1.81e-01
|
-6.75e-03
|
1.60e-01
|
9.58e-01
|
GOCC HISTONE DEACETYLASE COMPLEX
|
76
|
2.86e-02
|
3.52e-01
|
0.18200
|
-1.74e-01
|
5.03e-02
|
8.57e-03
|
4.48e-01
|
GOBP POSITIVE REGULATION OF RUFFLE ASSEMBLY
|
15
|
5.01e-01
|
8.63e-01
|
0.18100
|
-1.69e-01
|
6.52e-02
|
2.56e-01
|
6.62e-01
|
GOBP CARDIAC MUSCLE TISSUE REGENERATION
|
8
|
6.56e-01
|
9.09e-01
|
0.18100
|
-3.81e-02
|
-1.77e-01
|
8.52e-01
|
3.85e-01
|
GOBP T CELL TOLERANCE INDUCTION
|
14
|
4.56e-01
|
8.48e-01
|
0.18100
|
1.42e-01
|
1.13e-01
|
3.58e-01
|
4.63e-01
|
GOBP IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE
|
20
|
3.64e-01
|
8.05e-01
|
0.18100
|
-1.81e-01
|
-6.49e-03
|
1.60e-01
|
9.60e-01
|
GOCC SCAR COMPLEX
|
12
|
5.56e-01
|
8.81e-01
|
0.18100
|
-1.81e-01
|
1.65e-02
|
2.78e-01
|
9.21e-01
|
GOBP POSITIVE REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS
|
6
|
7.68e-01
|
9.46e-01
|
0.18100
|
-1.27e-01
|
1.29e-01
|
5.89e-01
|
5.84e-01
|
GOCC ORGANELLAR RIBOSOME
|
89
|
1.55e-02
|
2.64e-01
|
0.18100
|
4.68e-02
|
-1.75e-01
|
4.45e-01
|
4.28e-03
|
GOBP MATERNAL PLACENTA DEVELOPMENT
|
33
|
2.27e-01
|
7.14e-01
|
0.18100
|
-1.60e-01
|
8.46e-02
|
1.11e-01
|
4.00e-01
|
GOCC COPI COATED VESICLE
|
25
|
2.51e-01
|
7.29e-01
|
0.18100
|
-1.56e-01
|
-9.25e-02
|
1.77e-01
|
4.23e-01
|
GOBP REGULATION OF MIRNA METABOLIC PROCESS
|
83
|
1.46e-02
|
2.59e-01
|
0.18100
|
-1.80e-01
|
-1.68e-02
|
4.50e-03
|
7.91e-01
|
GOMF CHLORIDE ION BINDING
|
9
|
6.33e-01
|
9.03e-01
|
0.18100
|
-1.81e-01
|
-1.29e-02
|
3.48e-01
|
9.47e-01
|
GOBP OBSERVATIONAL LEARNING
|
7
|
7.06e-01
|
9.24e-01
|
0.18100
|
1.81e-01
|
-3.26e-03
|
4.07e-01
|
9.88e-01
|
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION
|
26
|
2.65e-01
|
7.41e-01
|
0.18100
|
1.91e-02
|
1.80e-01
|
8.66e-01
|
1.12e-01
|
GOBP MITOTIC SISTER CHROMATID SEPARATION
|
62
|
4.04e-02
|
4.13e-01
|
0.18100
|
-3.00e-02
|
-1.79e-01
|
6.83e-01
|
1.50e-02
|
GOBP BONE CELL DEVELOPMENT
|
17
|
4.53e-01
|
8.45e-01
|
0.18100
|
-5.03e-02
|
1.74e-01
|
7.19e-01
|
2.15e-01
|
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYPOXIA
|
9
|
6.17e-01
|
9.00e-01
|
0.18100
|
-1.71e-01
|
-6.01e-02
|
3.75e-01
|
7.55e-01
|
GOBP POSITIVE REGULATION OF GAMMA DELTA T CELL ACTIVATION
|
9
|
6.30e-01
|
9.03e-01
|
0.18100
|
2.33e-02
|
1.79e-01
|
9.04e-01
|
3.51e-01
|
GOCC ROD PHOTORECEPTOR OUTER SEGMENT
|
5
|
7.91e-01
|
9.54e-01
|
0.18100
|
-1.76e-01
|
4.32e-02
|
4.96e-01
|
8.67e-01
|
GOMF LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY
|
15
|
4.66e-01
|
8.51e-01
|
0.18100
|
-1.64e-02
|
-1.80e-01
|
9.12e-01
|
2.27e-01
|
GOBP VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION
|
27
|
2.27e-01
|
7.14e-01
|
0.18100
|
9.14e-02
|
1.56e-01
|
4.11e-01
|
1.61e-01
|
GOBP RESPONSE TO LECTIN
|
21
|
3.95e-01
|
8.24e-01
|
0.18100
|
-9.67e-02
|
1.53e-01
|
4.43e-01
|
2.26e-01
|
GOBP REGULATION OF MITOCHONDRIAL FISSION
|
30
|
2.52e-01
|
7.31e-01
|
0.18100
|
5.85e-02
|
-1.71e-01
|
5.79e-01
|
1.05e-01
|
GOBP INNERVATION
|
26
|
2.41e-01
|
7.25e-01
|
0.18100
|
1.56e-01
|
9.08e-02
|
1.68e-01
|
4.23e-01
|
GOBP HEXOSE CATABOLIC PROCESS
|
42
|
1.30e-01
|
6.09e-01
|
0.18000
|
-1.80e-01
|
1.42e-02
|
4.37e-02
|
8.73e-01
|
GOCC PHOTORECEPTOR CONNECTING CILIUM
|
39
|
1.15e-01
|
5.94e-01
|
0.18000
|
1.27e-01
|
1.28e-01
|
1.70e-01
|
1.66e-01
|
GOBP REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION
|
10
|
5.98e-01
|
8.95e-01
|
0.18000
|
-3.01e-02
|
-1.78e-01
|
8.69e-01
|
3.30e-01
|
GOBP T HELPER 2 CELL DIFFERENTIATION
|
19
|
3.53e-01
|
7.97e-01
|
0.18000
|
-1.52e-01
|
-9.63e-02
|
2.50e-01
|
4.67e-01
|
GOBP REGULATION OF NCRNA TRANSCRIPTION
|
91
|
1.18e-02
|
2.32e-01
|
0.18000
|
-1.80e-01
|
7.32e-03
|
2.98e-03
|
9.04e-01
|
GOBP REGULATION OF ENDOCYTIC RECYCLING
|
20
|
4.20e-01
|
8.33e-01
|
0.18000
|
-1.25e-01
|
1.30e-01
|
3.35e-01
|
3.13e-01
|
GOCC MITOCHONDRIAL PROTON TRANSPORTING ATP SYNTHASE COMPLEX COUPLING FACTOR F O
|
10
|
6.40e-01
|
9.06e-01
|
0.18000
|
7.92e-02
|
-1.62e-01
|
6.65e-01
|
3.75e-01
|
GOBP AORTA MORPHOGENESIS
|
38
|
1.92e-01
|
6.85e-01
|
0.18000
|
-1.18e-01
|
1.36e-01
|
2.09e-01
|
1.46e-01
|
GOBP REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY
|
52
|
7.57e-02
|
5.19e-01
|
0.18000
|
5.59e-03
|
1.80e-01
|
9.44e-01
|
2.47e-02
|
GOBP BRANCHED CHAIN AMINO ACID CATABOLIC PROCESS
|
20
|
3.48e-01
|
7.96e-01
|
0.18000
|
-1.72e-01
|
-5.48e-02
|
1.84e-01
|
6.72e-01
|
GOBP POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY
|
9
|
6.76e-01
|
9.13e-01
|
0.18000
|
1.43e-01
|
-1.09e-01
|
4.57e-01
|
5.70e-01
|
GOBP RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS
|
211
|
9.90e-06
|
1.56e-03
|
0.18000
|
-1.44e-01
|
-1.09e-01
|
3.21e-04
|
6.56e-03
|
GOMF STEROID HORMONE BINDING
|
6
|
7.69e-01
|
9.47e-01
|
0.18000
|
1.50e-01
|
-9.99e-02
|
5.25e-01
|
6.72e-01
|
GOBP DICARBOXYLIC ACID BIOSYNTHETIC PROCESS
|
12
|
5.31e-01
|
8.75e-01
|
0.18000
|
-5.50e-02
|
-1.71e-01
|
7.41e-01
|
3.04e-01
|
GOMF PHOSPHATIDYLSERINE 1 ACYLHYDROLASE ACTIVITY
|
11
|
5.92e-01
|
8.93e-01
|
0.18000
|
-2.48e-02
|
1.78e-01
|
8.87e-01
|
3.06e-01
|
GOBP REGULATION OF BONE MINERALIZATION INVOLVED IN BONE MATURATION
|
7
|
6.86e-01
|
9.18e-01
|
0.18000
|
-7.84e-02
|
-1.62e-01
|
7.20e-01
|
4.58e-01
|
GOBP NEURON PROJECTION REGENERATION
|
54
|
9.72e-02
|
5.61e-01
|
0.18000
|
-1.32e-01
|
1.22e-01
|
9.33e-02
|
1.21e-01
|
GOBP NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS
|
15
|
4.57e-01
|
8.48e-01
|
0.18000
|
-4.84e-02
|
-1.73e-01
|
7.46e-01
|
2.46e-01
|
GOBP SULFUR AMINO ACID CATABOLIC PROCESS
|
9
|
6.12e-01
|
8.98e-01
|
0.18000
|
-1.51e-01
|
-9.71e-02
|
4.32e-01
|
6.14e-01
|
GOBP REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION
|
48
|
1.09e-01
|
5.84e-01
|
0.18000
|
-4.55e-02
|
1.74e-01
|
5.85e-01
|
3.71e-02
|
GOCC PERICENTRIOLAR MATERIAL
|
22
|
3.82e-01
|
8.16e-01
|
0.18000
|
9.77e-02
|
-1.51e-01
|
4.28e-01
|
2.21e-01
|
GOMF TELOMERASE RNA BINDING
|
21
|
3.38e-01
|
7.90e-01
|
0.18000
|
-3.84e-02
|
-1.76e-01
|
7.61e-01
|
1.64e-01
|
GOMF THREONINE TYPE PEPTIDASE ACTIVITY
|
17
|
3.96e-01
|
8.24e-01
|
0.18000
|
-1.51e-01
|
-9.79e-02
|
2.82e-01
|
4.85e-01
|
GOMF OUTWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY
|
26
|
2.45e-01
|
7.26e-01
|
0.18000
|
1.57e-01
|
8.68e-02
|
1.65e-01
|
4.44e-01
|
GOBP MULTINUCLEAR OSTEOCLAST DIFFERENTIATION
|
8
|
6.45e-01
|
9.07e-01
|
0.18000
|
1.07e-01
|
1.44e-01
|
6.00e-01
|
4.80e-01
|
GOBP REGULATION OF CHRONIC INFLAMMATORY RESPONSE
|
9
|
6.19e-01
|
9.00e-01
|
0.18000
|
6.72e-02
|
1.67e-01
|
7.27e-01
|
3.87e-01
|
GOBP RENAL WATER TRANSPORT
|
9
|
6.66e-01
|
9.11e-01
|
0.18000
|
-6.33e-02
|
1.68e-01
|
7.42e-01
|
3.83e-01
|
GOMF NFAT PROTEIN BINDING
|
5
|
7.87e-01
|
9.53e-01
|
0.18000
|
-1.79e-01
|
1.93e-02
|
4.89e-01
|
9.40e-01
|
GOBP CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION
|
37
|
1.32e-01
|
6.13e-01
|
0.18000
|
1.12e-01
|
1.40e-01
|
2.37e-01
|
1.41e-01
|
GOBP CARDIOLIPIN METABOLIC PROCESS
|
14
|
4.64e-01
|
8.48e-01
|
0.17900
|
-1.18e-01
|
-1.36e-01
|
4.46e-01
|
3.80e-01
|
GOBP GLUCOCORTICOID BIOSYNTHETIC PROCESS
|
16
|
4.57e-01
|
8.48e-01
|
0.17900
|
-1.79e-01
|
1.56e-03
|
2.14e-01
|
9.91e-01
|
GOBP POSTSYNAPTIC MEMBRANE ORGANIZATION
|
35
|
1.92e-01
|
6.85e-01
|
0.17900
|
-1.77e-01
|
2.79e-02
|
6.95e-02
|
7.75e-01
|
GOCC MITOCHONDRIAL PROTEIN CONTAINING COMPLEX
|
271
|
1.49e-06
|
3.82e-04
|
0.17900
|
-1.63e-02
|
-1.79e-01
|
6.45e-01
|
4.08e-07
|
GOBP POSITIVE REGULATION OF OSSIFICATION
|
52
|
1.02e-01
|
5.72e-01
|
0.17900
|
-1.57e-01
|
8.73e-02
|
5.05e-02
|
2.76e-01
|
GOMF LIGASE ACTIVITY FORMING CARBON SULFUR BONDS
|
39
|
1.76e-01
|
6.65e-01
|
0.17900
|
-1.65e-01
|
7.08e-02
|
7.48e-02
|
4.44e-01
|
GOBP POSITIVE REGULATION OF THE FORCE OF HEART CONTRACTION
|
5
|
7.99e-01
|
9.56e-01
|
0.17900
|
1.67e-01
|
-6.50e-02
|
5.17e-01
|
8.01e-01
|
GOCC G PROTEIN COUPLED RECEPTOR COMPLEX
|
11
|
6.21e-01
|
9.01e-01
|
0.17900
|
1.43e-01
|
-1.08e-01
|
4.10e-01
|
5.36e-01
|
GOBP REGULATION OF PRO B CELL DIFFERENTIATION
|
8
|
7.05e-01
|
9.24e-01
|
0.17900
|
-1.55e-01
|
9.06e-02
|
4.48e-01
|
6.57e-01
|
GOBP POSITIVE REGULATION OF AMYLOID BETA FORMATION
|
20
|
3.34e-01
|
7.88e-01
|
0.17900
|
-1.33e-01
|
-1.20e-01
|
3.03e-01
|
3.52e-01
|
GOCC GAP JUNCTION
|
29
|
2.35e-01
|
7.23e-01
|
0.17900
|
1.78e-01
|
1.74e-02
|
9.64e-02
|
8.71e-01
|
GOBP REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION
|
22
|
3.18e-01
|
7.77e-01
|
0.17900
|
5.27e-02
|
1.71e-01
|
6.69e-01
|
1.64e-01
|
GOBP APICAL PROTEIN LOCALIZATION
|
14
|
4.94e-01
|
8.58e-01
|
0.17900
|
1.77e-01
|
2.50e-02
|
2.51e-01
|
8.71e-01
|
GOBP REGULATION OF NITRIC OXIDE METABOLIC PROCESS
|
57
|
8.76e-02
|
5.47e-01
|
0.17900
|
-1.24e-01
|
1.29e-01
|
1.04e-01
|
9.32e-02
|
GOBP REGULATION OF APOPTOTIC DNA FRAGMENTATION
|
10
|
5.80e-01
|
8.90e-01
|
0.17900
|
-1.16e-01
|
-1.36e-01
|
5.26e-01
|
4.55e-01
|
GOCC LATERAL PART OF CELL
|
5
|
8.04e-01
|
9.57e-01
|
0.17900
|
-1.55e-01
|
9.00e-02
|
5.49e-01
|
7.27e-01
|
GOBP SYNAPTIC VESICLE DOCKING
|
10
|
5.92e-01
|
8.93e-01
|
0.17900
|
6.20e-02
|
1.68e-01
|
7.34e-01
|
3.58e-01
|
GOCC INTRACILIARY TRANSPORT PARTICLE A
|
8
|
6.81e-01
|
9.16e-01
|
0.17900
|
-1.79e-01
|
1.05e-02
|
3.82e-01
|
9.59e-01
|
GOBP CORTICOSTEROID HORMONE SECRETION
|
19
|
4.06e-01
|
8.26e-01
|
0.17900
|
-1.78e-01
|
1.84e-02
|
1.80e-01
|
8.90e-01
|
GOBP TRYPTOPHAN TRANSPORT
|
5
|
7.86e-01
|
9.53e-01
|
0.17900
|
-6.18e-03
|
1.79e-01
|
9.81e-01
|
4.89e-01
|
GOBP MICROTUBULE POLYMERIZATION
|
91
|
1.94e-02
|
2.99e-01
|
0.17900
|
-1.54e-01
|
9.06e-02
|
1.11e-02
|
1.35e-01
|
GOBP SEQUESTERING OF METAL ION
|
10
|
5.95e-01
|
8.95e-01
|
0.17900
|
5.16e-02
|
1.71e-01
|
7.77e-01
|
3.49e-01
|
GOMF CATECHOLAMINE BINDING
|
12
|
5.21e-01
|
8.69e-01
|
0.17900
|
1.34e-01
|
1.18e-01
|
4.21e-01
|
4.79e-01
|
GOBP POSITIVE REGULATION OF STRESS FIBER ASSEMBLY
|
51
|
8.86e-02
|
5.50e-01
|
0.17900
|
-1.47e-02
|
1.78e-01
|
8.56e-01
|
2.78e-02
|
GOMF OPIOID RECEPTOR BINDING
|
7
|
6.84e-01
|
9.17e-01
|
0.17900
|
1.09e-01
|
1.41e-01
|
6.17e-01
|
5.17e-01
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON METAL IONS OXYGEN AS ACCEPTOR
|
5
|
7.68e-01
|
9.46e-01
|
0.17900
|
-6.94e-02
|
-1.65e-01
|
7.88e-01
|
5.24e-01
|
GOBP EMBRYONIC CRANIAL SKELETON MORPHOGENESIS
|
44
|
1.42e-01
|
6.26e-01
|
0.17900
|
-1.66e-01
|
6.68e-02
|
5.73e-02
|
4.43e-01
|
GOBP GLUTATHIONE TRANSPORT
|
9
|
6.36e-01
|
9.06e-01
|
0.17900
|
-1.76e-01
|
-2.73e-02
|
3.59e-01
|
8.87e-01
|
GOBP REGULATION OF MEMBRANE INVAGINATION
|
15
|
4.43e-01
|
8.40e-01
|
0.17800
|
-1.37e-01
|
-1.15e-01
|
3.59e-01
|
4.42e-01
|
GOBP SYNAPTIC VESICLE MEMBRANE ORGANIZATION
|
27
|
3.16e-01
|
7.76e-01
|
0.17800
|
-1.10e-01
|
1.40e-01
|
3.22e-01
|
2.06e-01
|
GOBP REGULATION OF NEUROTRANSMITTER UPTAKE
|
18
|
4.37e-01
|
8.40e-01
|
0.17800
|
-3.84e-02
|
1.74e-01
|
7.78e-01
|
2.01e-01
|
GOBP INSULIN PROCESSING
|
8
|
6.51e-01
|
9.08e-01
|
0.17800
|
9.11e-02
|
1.53e-01
|
6.55e-01
|
4.53e-01
|
GOBP REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT
|
8
|
6.52e-01
|
9.08e-01
|
0.17800
|
8.63e-02
|
1.56e-01
|
6.72e-01
|
4.45e-01
|
GOBP MITOTIC SISTER CHROMATID COHESION
|
26
|
2.90e-01
|
7.61e-01
|
0.17800
|
1.20e-02
|
-1.78e-01
|
9.16e-01
|
1.16e-01
|
GOBP CGMP MEDIATED SIGNALING
|
30
|
2.78e-01
|
7.52e-01
|
0.17800
|
1.38e-01
|
-1.12e-01
|
1.90e-01
|
2.86e-01
|
GOBP OXIDATIVE DEMETHYLATION
|
14
|
4.79e-01
|
8.54e-01
|
0.17800
|
1.64e-01
|
7.04e-02
|
2.88e-01
|
6.48e-01
|
GOBP POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION
|
16
|
4.68e-01
|
8.51e-01
|
0.17800
|
-1.78e-01
|
1.43e-02
|
2.18e-01
|
9.21e-01
|
GOBP REGULATION OF TOLL LIKE RECEPTOR 7 SIGNALING PATHWAY
|
5
|
7.95e-01
|
9.55e-01
|
0.17800
|
-1.74e-01
|
3.69e-02
|
4.99e-01
|
8.86e-01
|
GOBP COLLECTING DUCT DEVELOPMENT
|
15
|
5.22e-01
|
8.70e-01
|
0.17800
|
-1.55e-01
|
8.85e-02
|
2.99e-01
|
5.53e-01
|
GOMF N ACETYLGLUCOSAMINE 6 O SULFOTRANSFERASE ACTIVITY
|
6
|
7.62e-01
|
9.45e-01
|
0.17800
|
-4.83e-02
|
1.72e-01
|
8.38e-01
|
4.67e-01
|
GOMF HISTONE H4 ACETYLTRANSFERASE ACTIVITY
|
21
|
3.70e-01
|
8.09e-01
|
0.17800
|
-1.78e-01
|
1.52e-02
|
1.59e-01
|
9.04e-01
|
GOBP MITOCHONDRIAL TRANSLATION
|
130
|
2.95e-03
|
1.06e-01
|
0.17800
|
5.13e-02
|
-1.71e-01
|
3.12e-01
|
7.82e-04
|
GOMF D1 DOPAMINE RECEPTOR BINDING
|
6
|
7.75e-01
|
9.50e-01
|
0.17800
|
1.25e-01
|
-1.27e-01
|
5.96e-01
|
5.91e-01
|
GOMF DOPAMINE BINDING
|
6
|
7.66e-01
|
9.45e-01
|
0.17800
|
-6.00e-02
|
1.68e-01
|
7.99e-01
|
4.77e-01
|
GOBP POSITIVE REGULATION OF ATP METABOLIC PROCESS
|
10
|
5.83e-01
|
8.90e-01
|
0.17800
|
-1.32e-01
|
-1.20e-01
|
4.71e-01
|
5.12e-01
|
GOBP AV NODE CELL TO BUNDLE OF HIS CELL SIGNALING
|
11
|
5.81e-01
|
8.90e-01
|
0.17800
|
1.77e-01
|
1.79e-02
|
3.09e-01
|
9.18e-01
|
GOBP REGULATION OF PIGMENTATION
|
17
|
4.15e-01
|
8.30e-01
|
0.17800
|
-1.68e-01
|
-5.80e-02
|
2.30e-01
|
6.79e-01
|
GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR ACTIVITY
|
13
|
5.61e-01
|
8.83e-01
|
0.17800
|
-5.89e-02
|
1.68e-01
|
7.13e-01
|
2.95e-01
|
GOBP REGULATION OF NEUTROPHIL MEDIATED CYTOTOXICITY
|
5
|
7.64e-01
|
9.45e-01
|
0.17800
|
-1.19e-01
|
-1.32e-01
|
6.45e-01
|
6.09e-01
|
GOBP IRIS MORPHOGENESIS
|
10
|
5.84e-01
|
8.90e-01
|
0.17800
|
1.10e-01
|
1.40e-01
|
5.46e-01
|
4.45e-01
|
GOBP MORPHOGENESIS OF A POLARIZED EPITHELIUM
|
89
|
2.05e-02
|
3.05e-01
|
0.17800
|
-7.18e-02
|
1.63e-01
|
2.42e-01
|
7.98e-03
|
GOMF INTRACELLULAR CHLORIDE CHANNEL ACTIVITY
|
19
|
4.32e-01
|
8.37e-01
|
0.17800
|
1.66e-01
|
-6.43e-02
|
2.11e-01
|
6.28e-01
|
GOBP NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE
|
15
|
4.46e-01
|
8.40e-01
|
0.17800
|
-1.32e-01
|
-1.19e-01
|
3.75e-01
|
4.25e-01
|
GOBP POSITIVE REGULATION OF SODIUM ION TRANSPORT
|
29
|
2.32e-01
|
7.18e-01
|
0.17800
|
3.70e-02
|
1.74e-01
|
7.30e-01
|
1.05e-01
|
GOBP OVULATION CYCLE PROCESS
|
50
|
1.09e-01
|
5.84e-01
|
0.17800
|
-1.67e-01
|
6.08e-02
|
4.10e-02
|
4.57e-01
|
GOBP N TERMINAL PROTEIN AMINO ACID MODIFICATION
|
27
|
2.36e-01
|
7.24e-01
|
0.17800
|
-1.04e-01
|
-1.44e-01
|
3.51e-01
|
1.94e-01
|
GOBP LEARNED VOCALIZATION BEHAVIOR OR VOCAL LEARNING
|
10
|
5.84e-01
|
8.90e-01
|
0.17800
|
1.17e-01
|
1.34e-01
|
5.22e-01
|
4.63e-01
|
GOBP POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE
|
23
|
3.69e-01
|
8.09e-01
|
0.17800
|
8.00e-02
|
-1.59e-01
|
5.07e-01
|
1.88e-01
|
GOCC CORNIFIED ENVELOPE
|
57
|
5.75e-02
|
4.68e-01
|
0.17800
|
1.74e-01
|
3.43e-02
|
2.29e-02
|
6.54e-01
|
GOCC MICROVILLUS MEMBRANE
|
32
|
2.41e-01
|
7.25e-01
|
0.17800
|
-5.55e-02
|
1.69e-01
|
5.87e-01
|
9.87e-02
|
GOBP LYMPHOID PROGENITOR CELL DIFFERENTIATION
|
24
|
3.44e-01
|
7.95e-01
|
0.17800
|
-1.69e-01
|
5.50e-02
|
1.52e-01
|
6.41e-01
|
GOBP POSITIVE REGULATION OF MAST CELL CHEMOTAXIS
|
5
|
8.08e-01
|
9.59e-01
|
0.17700
|
-9.62e-02
|
1.49e-01
|
7.09e-01
|
5.64e-01
|
GOBP REGULATION OF VASCULAR PERMEABILITY
|
50
|
1.15e-01
|
5.93e-01
|
0.17700
|
-7.63e-02
|
1.60e-01
|
3.50e-01
|
5.01e-02
|
GOBP DNA CYTOSINE DEAMINATION
|
9
|
6.64e-01
|
9.10e-01
|
0.17700
|
-1.74e-01
|
3.60e-02
|
3.67e-01
|
8.52e-01
|
GOBP TRANSFORMING GROWTH FACTOR BETA2 PRODUCTION
|
9
|
6.38e-01
|
9.06e-01
|
0.17700
|
3.29e-02
|
1.74e-01
|
8.64e-01
|
3.66e-01
|
GOBP ADP TRANSPORT
|
10
|
6.49e-01
|
9.07e-01
|
0.17700
|
-1.59e-01
|
7.80e-02
|
3.83e-01
|
6.69e-01
|
GOMF KINESIN BINDING
|
43
|
1.43e-01
|
6.28e-01
|
0.17700
|
-3.88e-02
|
1.73e-01
|
6.60e-01
|
4.99e-02
|
GOBP NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION
|
8
|
6.55e-01
|
9.09e-01
|
0.17700
|
9.18e-02
|
1.51e-01
|
6.53e-01
|
4.58e-01
|
GOBP GENOMIC IMPRINTING
|
18
|
4.62e-01
|
8.48e-01
|
0.17700
|
-8.26e-02
|
1.57e-01
|
5.44e-01
|
2.50e-01
|
GOMF S ADENOSYL L METHIONINE BINDING
|
18
|
3.95e-01
|
8.24e-01
|
0.17700
|
-1.65e-01
|
-6.44e-02
|
2.26e-01
|
6.36e-01
|
GOCC SPECTRIN
|
9
|
6.19e-01
|
9.00e-01
|
0.17700
|
1.06e-01
|
1.42e-01
|
5.82e-01
|
4.62e-01
|
GOMF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE BINDING
|
19
|
3.98e-01
|
8.25e-01
|
0.17700
|
1.25e-02
|
1.77e-01
|
9.25e-01
|
1.83e-01
|
GOBP POSITIVE REGULATION OF MITOCHONDRIAL DEPOLARIZATION
|
9
|
6.58e-01
|
9.09e-01
|
0.17700
|
-1.90e-02
|
1.76e-01
|
9.21e-01
|
3.61e-01
|
GOBP STOMACH DEVELOPMENT
|
5
|
7.72e-01
|
9.48e-01
|
0.17700
|
1.64e-01
|
6.75e-02
|
5.26e-01
|
7.94e-01
|
GOBP NEGATIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION
|
7
|
7.30e-01
|
9.32e-01
|
0.17700
|
4.23e-02
|
-1.72e-01
|
8.46e-01
|
4.31e-01
|
GOBP FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS
|
26
|
2.50e-01
|
7.28e-01
|
0.17700
|
-1.14e-01
|
-1.35e-01
|
3.13e-01
|
2.33e-01
|
GOBP REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS
|
115
|
8.10e-03
|
1.88e-01
|
0.17700
|
-1.41e-01
|
1.07e-01
|
9.06e-03
|
4.74e-02
|
GOBP LUNG MORPHOGENESIS
|
54
|
8.95e-02
|
5.51e-01
|
0.17700
|
-1.71e-01
|
4.49e-02
|
2.96e-02
|
5.68e-01
|
GOCC MITOCHONDRIAL SMALL RIBOSOMAL SUBUNIT
|
32
|
2.25e-01
|
7.13e-01
|
0.17700
|
1.45e-02
|
-1.76e-01
|
8.87e-01
|
8.44e-02
|
GOBP REGULATION OF CELL PROJECTION SIZE
|
12
|
6.05e-01
|
8.96e-01
|
0.17700
|
-1.16e-01
|
1.33e-01
|
4.86e-01
|
4.24e-01
|
GOCC U4 SNRNP
|
10
|
6.56e-01
|
9.09e-01
|
0.17700
|
9.85e-02
|
-1.47e-01
|
5.89e-01
|
4.22e-01
|
GOBP REGULATION OF VOLTAGE GATED SODIUM CHANNEL ACTIVITY
|
8
|
7.08e-01
|
9.25e-01
|
0.17700
|
-7.42e-02
|
1.60e-01
|
7.16e-01
|
4.32e-01
|
GOBP CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS
|
10
|
6.30e-01
|
9.03e-01
|
0.17700
|
-1.76e-01
|
2.02e-02
|
3.36e-01
|
9.12e-01
|
GOBP REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION
|
15
|
4.53e-01
|
8.46e-01
|
0.17700
|
-9.65e-02
|
-1.48e-01
|
5.17e-01
|
3.21e-01
|
GOBP SPERM AXONEME ASSEMBLY
|
27
|
2.41e-01
|
7.25e-01
|
0.17700
|
9.55e-02
|
1.49e-01
|
3.90e-01
|
1.81e-01
|
GOBP REGULATION OF NOTCH SIGNALING PATHWAY
|
93
|
1.50e-02
|
2.62e-01
|
0.17700
|
-1.73e-01
|
3.40e-02
|
3.86e-03
|
5.71e-01
|
GOBP ADULT HEART DEVELOPMENT
|
13
|
5.19e-01
|
8.69e-01
|
0.17700
|
4.76e-02
|
1.70e-01
|
7.66e-01
|
2.88e-01
|
GOBP REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING SIGNALING PATHWAY
|
14
|
5.58e-01
|
8.82e-01
|
0.17700
|
1.21e-01
|
-1.28e-01
|
4.32e-01
|
4.06e-01
|
GOBP ARGININE CATABOLIC PROCESS
|
11
|
6.31e-01
|
9.03e-01
|
0.17600
|
1.40e-01
|
-1.08e-01
|
4.22e-01
|
5.36e-01
|
GOBP REGULATION OF MIRNA TRANSCRIPTION
|
69
|
3.86e-02
|
4.02e-01
|
0.17600
|
-1.76e-01
|
1.57e-03
|
1.12e-02
|
9.82e-01
|
GOMF G PROTEIN BETA GAMMA SUBUNIT COMPLEX BINDING
|
21
|
4.11e-01
|
8.28e-01
|
0.17600
|
-9.03e-02
|
1.52e-01
|
4.74e-01
|
2.29e-01
|
GOBP TRIGLYCERIDE BIOSYNTHETIC PROCESS
|
39
|
1.61e-01
|
6.48e-01
|
0.17600
|
-1.76e-01
|
5.59e-03
|
5.68e-02
|
9.52e-01
|
GOCC COMPACT MYELIN
|
14
|
4.97e-01
|
8.61e-01
|
0.17600
|
4.09e-02
|
1.72e-01
|
7.91e-01
|
2.66e-01
|
GOBP WHITE FAT CELL DIFFERENTIATION
|
17
|
4.81e-01
|
8.54e-01
|
0.17600
|
-1.62e-01
|
7.06e-02
|
2.49e-01
|
6.15e-01
|
GOBP GLYCEROPHOSPHOLIPID CATABOLIC PROCESS
|
34
|
2.44e-01
|
7.26e-01
|
0.17600
|
-1.20e-01
|
1.29e-01
|
2.27e-01
|
1.92e-01
|
GOMF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY
|
23
|
3.76e-01
|
8.11e-01
|
0.17600
|
1.57e-01
|
-8.04e-02
|
1.93e-01
|
5.05e-01
|
GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE BINDING
|
27
|
3.20e-01
|
7.78e-01
|
0.17600
|
-8.91e-02
|
1.52e-01
|
4.23e-01
|
1.72e-01
|
GOBP CHEMOKINE PRODUCTION
|
101
|
6.16e-03
|
1.63e-01
|
0.17600
|
-1.67e-01
|
-5.53e-02
|
3.68e-03
|
3.37e-01
|
GOBP SKELETAL MUSCLE SATELLITE CELL PROLIFERATION
|
17
|
4.75e-01
|
8.54e-01
|
0.17600
|
5.54e-02
|
-1.67e-01
|
6.93e-01
|
2.33e-01
|
GOMF PEPTIDOGLYCAN IMMUNE RECEPTOR ACTIVITY
|
5
|
8.03e-01
|
9.57e-01
|
0.17600
|
-5.37e-02
|
1.68e-01
|
8.35e-01
|
5.16e-01
|
GOMF ACID PHOSPHATASE ACTIVITY
|
9
|
6.89e-01
|
9.19e-01
|
0.17600
|
-1.33e-01
|
1.16e-01
|
4.91e-01
|
5.48e-01
|
GOBP SEMICIRCULAR CANAL MORPHOGENESIS
|
7
|
6.93e-01
|
9.21e-01
|
0.17600
|
-1.46e-01
|
-9.74e-02
|
5.02e-01
|
6.55e-01
|
GOCC APICOLATERAL PLASMA MEMBRANE
|
22
|
3.81e-01
|
8.16e-01
|
0.17600
|
-5.11e-02
|
1.68e-01
|
6.78e-01
|
1.72e-01
|
GOBP INTERFERON ALPHA PRODUCTION
|
27
|
2.61e-01
|
7.39e-01
|
0.17600
|
-4.27e-02
|
-1.71e-01
|
7.01e-01
|
1.25e-01
|
GOBP CANNABINOID SIGNALING PATHWAY
|
9
|
6.40e-01
|
9.06e-01
|
0.17600
|
4.01e-02
|
1.71e-01
|
8.35e-01
|
3.74e-01
|
GOBP METANEPHRIC PROXIMAL TUBULE DEVELOPMENT
|
5
|
8.10e-01
|
9.59e-01
|
0.17600
|
-1.51e-01
|
8.96e-02
|
5.58e-01
|
7.28e-01
|
GOBP ATP BIOSYNTHETIC PROCESS
|
89
|
1.14e-02
|
2.27e-01
|
0.17600
|
-5.80e-02
|
-1.66e-01
|
3.44e-01
|
6.85e-03
|
GOBP GALACTOLIPID METABOLIC PROCESS
|
9
|
6.88e-01
|
9.19e-01
|
0.17600
|
1.44e-01
|
-1.00e-01
|
4.54e-01
|
6.03e-01
|
GOBP NEGATIVE REGULATION OF TRANSLATIONAL INITIATION
|
21
|
3.54e-01
|
7.97e-01
|
0.17600
|
-4.17e-02
|
-1.71e-01
|
7.41e-01
|
1.76e-01
|
GOBP REGULATION OF COLLAGEN FIBRIL ORGANIZATION
|
8
|
7.11e-01
|
9.26e-01
|
0.17600
|
-1.60e-01
|
7.13e-02
|
4.32e-01
|
7.27e-01
|
GOBP RRNA 3 END PROCESSING
|
10
|
5.91e-01
|
8.93e-01
|
0.17600
|
-1.21e-01
|
-1.27e-01
|
5.08e-01
|
4.86e-01
|
GOMF MOLECULAR CONDENSATE SCAFFOLD ACTIVITY
|
27
|
2.67e-01
|
7.43e-01
|
0.17600
|
-3.10e-02
|
-1.73e-01
|
7.81e-01
|
1.20e-01
|
GOBP LOOP OF HENLE DEVELOPMENT
|
12
|
6.01e-01
|
8.96e-01
|
0.17600
|
-1.58e-01
|
7.75e-02
|
3.45e-01
|
6.42e-01
|
GOBP NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY
|
35
|
1.69e-01
|
6.56e-01
|
0.17600
|
1.63e-01
|
6.49e-02
|
9.49e-02
|
5.06e-01
|
GOBP NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS
|
17
|
4.96e-01
|
8.59e-01
|
0.17600
|
-1.32e-01
|
1.16e-01
|
3.46e-01
|
4.09e-01
|
GOMF CYTOKINE BINDING
|
133
|
9.75e-04
|
5.01e-02
|
0.17600
|
1.10e-01
|
1.37e-01
|
2.81e-02
|
6.54e-03
|
GOMF GPI ANCHOR BINDING
|
8
|
6.79e-01
|
9.14e-01
|
0.17500
|
-1.74e-01
|
-2.38e-02
|
3.94e-01
|
9.07e-01
|
GOBP POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY
|
60
|
6.63e-02
|
4.97e-01
|
0.17500
|
-2.30e-02
|
1.74e-01
|
7.58e-01
|
1.98e-02
|
GOBP NEURAL PLATE MORPHOGENESIS
|
5
|
8.14e-01
|
9.59e-01
|
0.17500
|
-1.09e-01
|
1.37e-01
|
6.73e-01
|
5.95e-01
|
GOBP NEGATIVE REGULATION OF CALCIUM ION IMPORT
|
10
|
6.20e-01
|
9.00e-01
|
0.17500
|
1.74e-01
|
1.71e-02
|
3.39e-01
|
9.25e-01
|
GOBP MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL
|
15
|
4.80e-01
|
8.54e-01
|
0.17500
|
3.63e-02
|
1.71e-01
|
8.08e-01
|
2.50e-01
|
GOCC PODOSOME
|
31
|
2.72e-01
|
7.47e-01
|
0.17500
|
-8.03e-02
|
1.56e-01
|
4.39e-01
|
1.34e-01
|
GOBP POSITIVE REGULATION OF STEM CELL POPULATION MAINTENANCE
|
46
|
1.49e-01
|
6.35e-01
|
0.17500
|
-1.47e-01
|
9.56e-02
|
8.50e-02
|
2.62e-01
|
GOBP INTEGRIN MEDIATED SIGNALING PATHWAY
|
110
|
8.12e-03
|
1.88e-01
|
0.17500
|
-4.38e-02
|
1.70e-01
|
4.27e-01
|
2.12e-03
|
GOBP NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION
|
22
|
4.05e-01
|
8.26e-01
|
0.17500
|
-1.32e-01
|
1.15e-01
|
2.85e-01
|
3.49e-01
|
GOBP LUNG SACCULE DEVELOPMENT
|
10
|
6.07e-01
|
8.97e-01
|
0.17500
|
-5.43e-02
|
-1.67e-01
|
7.66e-01
|
3.62e-01
|
GOBP CELLULAR RESPONSE TO MURAMYL DIPEPTIDE
|
8
|
6.70e-01
|
9.11e-01
|
0.17500
|
-1.66e-01
|
-5.46e-02
|
4.15e-01
|
7.89e-01
|
GOBP VITAMIN D METABOLIC PROCESS
|
20
|
3.97e-01
|
8.25e-01
|
0.17500
|
1.75e-01
|
-6.16e-03
|
1.75e-01
|
9.62e-01
|
GOBP POLYOL TRANSMEMBRANE TRANSPORT
|
10
|
6.56e-01
|
9.09e-01
|
0.17500
|
-1.56e-01
|
7.88e-02
|
3.92e-01
|
6.66e-01
|
GOBP PROTEIN K11 LINKED DEUBIQUITINATION
|
9
|
6.88e-01
|
9.19e-01
|
0.17500
|
-1.47e-01
|
9.52e-02
|
4.45e-01
|
6.21e-01
|
GOMF NUCLEAR GLUCOCORTICOID RECEPTOR BINDING
|
12
|
5.47e-01
|
8.78e-01
|
0.17500
|
-6.10e-02
|
-1.64e-01
|
7.14e-01
|
3.25e-01
|
GOBP ISOLEUCINE TRANSPORT
|
5
|
7.85e-01
|
9.52e-01
|
0.17500
|
-1.73e-01
|
-2.84e-02
|
5.04e-01
|
9.12e-01
|
GOBP POSITIVE REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS
|
8
|
6.69e-01
|
9.11e-01
|
0.17500
|
-1.65e-01
|
-5.89e-02
|
4.20e-01
|
7.73e-01
|
GOMF LYSINE N METHYLTRANSFERASE ACTIVITY
|
60
|
7.31e-02
|
5.13e-01
|
0.17500
|
-1.69e-01
|
4.61e-02
|
2.38e-02
|
5.37e-01
|
GOBP LIPID DROPLET ORGANIZATION
|
34
|
1.97e-01
|
6.88e-01
|
0.17500
|
-1.74e-01
|
-2.14e-02
|
7.99e-02
|
8.29e-01
|
GOBP BONE RESORPTION
|
65
|
6.40e-02
|
4.87e-01
|
0.17500
|
-7.00e-02
|
1.60e-01
|
3.29e-01
|
2.54e-02
|
GOBP REGULATION OF MYOBLAST DIFFERENTIATION
|
72
|
3.74e-02
|
3.93e-01
|
0.17500
|
-1.74e-01
|
1.16e-02
|
1.05e-02
|
8.65e-01
|
GOBP REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE
|
21
|
3.44e-01
|
7.95e-01
|
0.17500
|
-1.58e-01
|
-7.41e-02
|
2.09e-01
|
5.57e-01
|
GOBP MITOCHONDRIAL GENE EXPRESSION
|
162
|
8.43e-04
|
4.61e-02
|
0.17500
|
3.92e-02
|
-1.70e-01
|
3.89e-01
|
1.84e-04
|
GOBP REGULATION OF ADIPONECTIN SECRETION
|
7
|
7.51e-01
|
9.40e-01
|
0.17500
|
-1.09e-01
|
1.37e-01
|
6.18e-01
|
5.31e-01
|
GOBP PHOSPHOLIPID CATABOLIC PROCESS
|
55
|
1.05e-01
|
5.77e-01
|
0.17500
|
-1.05e-01
|
1.39e-01
|
1.77e-01
|
7.38e-02
|
GOBP CHEMOSENSORY BEHAVIOR
|
18
|
3.92e-01
|
8.22e-01
|
0.17500
|
-1.23e-01
|
-1.24e-01
|
3.65e-01
|
3.64e-01
|
GOBP ESTABLISHMENT OF TISSUE POLARITY
|
67
|
5.53e-02
|
4.63e-01
|
0.17500
|
-4.99e-02
|
1.67e-01
|
4.80e-01
|
1.78e-02
|
GOBP POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY
|
44
|
1.46e-01
|
6.31e-01
|
0.17500
|
-1.70e-01
|
4.10e-02
|
5.15e-02
|
6.38e-01
|
GOBP NEGATIVE REGULATION OF ATP DEPENDENT ACTIVITY
|
17
|
4.98e-01
|
8.61e-01
|
0.17500
|
-1.40e-01
|
1.04e-01
|
3.17e-01
|
4.58e-01
|
GOMF LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY INVOLVED IN REGULATION OF PRESYNAPTIC MEMBRANE POTENTIAL
|
14
|
5.47e-01
|
8.78e-01
|
0.17500
|
5.24e-02
|
-1.66e-01
|
7.34e-01
|
2.81e-01
|
GOBP CELLULAR RESPONSE TO COPPER ION
|
25
|
3.33e-01
|
7.86e-01
|
0.17400
|
1.71e-01
|
-3.61e-02
|
1.40e-01
|
7.54e-01
|
GOBP NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY
|
12
|
6.07e-01
|
8.97e-01
|
0.17400
|
-1.52e-01
|
8.51e-02
|
3.61e-01
|
6.10e-01
|
GOBP MRNA 5 SPLICE SITE RECOGNITION
|
10
|
6.61e-01
|
9.09e-01
|
0.17400
|
1.52e-01
|
-8.62e-02
|
4.07e-01
|
6.37e-01
|
GOBP ER NUCLEUS SIGNALING PATHWAY
|
45
|
1.21e-01
|
6.03e-01
|
0.17400
|
-1.74e-01
|
-1.09e-02
|
4.34e-02
|
9.00e-01
|
GOBP RESPONSE TO AMINE
|
45
|
1.22e-01
|
6.03e-01
|
0.17400
|
1.74e-01
|
8.11e-03
|
4.33e-02
|
9.25e-01
|
GOMF PROTEIN KINASE A CATALYTIC SUBUNIT BINDING
|
13
|
5.85e-01
|
8.90e-01
|
0.17400
|
-1.48e-01
|
9.27e-02
|
3.57e-01
|
5.63e-01
|
GOBP NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT
|
23
|
3.59e-01
|
8.01e-01
|
0.17400
|
1.72e-01
|
-2.55e-02
|
1.52e-01
|
8.32e-01
|
GOBP VACUOLAR TRANSPORT
|
163
|
9.45e-04
|
4.96e-02
|
0.17400
|
-1.66e-01
|
5.21e-02
|
2.48e-04
|
2.51e-01
|
GOBP REGULATION OF CELLULAR RESPIRATION
|
46
|
1.11e-01
|
5.87e-01
|
0.17400
|
-1.72e-01
|
-2.71e-02
|
4.34e-02
|
7.50e-01
|
GOBP INTESTINAL LIPID ABSORPTION
|
22
|
3.23e-01
|
7.79e-01
|
0.17400
|
-1.00e-01
|
-1.42e-01
|
4.15e-01
|
2.48e-01
|
GOMF SEQUENCE SPECIFIC SINGLE STRANDED DNA BINDING
|
14
|
5.20e-01
|
8.69e-01
|
0.17400
|
1.74e-01
|
8.14e-03
|
2.60e-01
|
9.58e-01
|
GOMF CHITIN BINDING
|
8
|
6.81e-01
|
9.16e-01
|
0.17400
|
2.84e-02
|
1.72e-01
|
8.89e-01
|
4.00e-01
|
GOMF 3 5 EXONUCLEASE ACTIVITY
|
54
|
6.19e-02
|
4.82e-01
|
0.17400
|
-1.12e-01
|
-1.33e-01
|
1.55e-01
|
8.97e-02
|
GOBP P38MAPK CASCADE
|
57
|
5.33e-02
|
4.56e-01
|
0.17400
|
-1.36e-01
|
-1.08e-01
|
7.48e-02
|
1.58e-01
|
GOMF CHONDROITIN SULFATE BINDING
|
10
|
6.03e-01
|
8.96e-01
|
0.17400
|
7.75e-02
|
1.56e-01
|
6.71e-01
|
3.93e-01
|
GOBP RUFFLE ASSEMBLY
|
44
|
1.69e-01
|
6.55e-01
|
0.17400
|
-1.23e-01
|
1.23e-01
|
1.59e-01
|
1.57e-01
|
GOBP HOMOCYSTEINE METABOLIC PROCESS
|
12
|
5.68e-01
|
8.86e-01
|
0.17400
|
-1.73e-01
|
-1.55e-02
|
2.98e-01
|
9.26e-01
|
GOMF RNA 2 O METHYLTRANSFERASE ACTIVITY
|
8
|
6.63e-01
|
9.10e-01
|
0.17400
|
-1.05e-01
|
-1.38e-01
|
6.06e-01
|
4.98e-01
|
GOBP REGULATION OF INOSITOL TRISPHOSPHATE BIOSYNTHETIC PROCESS
|
6
|
7.49e-01
|
9.40e-01
|
0.17400
|
1.70e-01
|
3.63e-02
|
4.71e-01
|
8.78e-01
|
GOMF VOLTAGE GATED SODIUM CHANNEL ACTIVITY
|
23
|
3.76e-01
|
8.11e-01
|
0.17400
|
1.64e-01
|
-5.65e-02
|
1.72e-01
|
6.39e-01
|
GOCC T TUBULE
|
51
|
8.30e-02
|
5.35e-01
|
0.17400
|
4.80e-02
|
1.67e-01
|
5.53e-01
|
3.91e-02
|
GOBP NEGATIVE REGULATION OF PHAGOCYTOSIS
|
20
|
3.87e-01
|
8.19e-01
|
0.17400
|
-2.51e-02
|
-1.72e-01
|
8.46e-01
|
1.83e-01
|
GOBP REGULATION OF INFLAMMATORY RESPONSE TO WOUNDING
|
12
|
5.97e-01
|
8.95e-01
|
0.17400
|
-1.67e-01
|
4.72e-02
|
3.16e-01
|
7.77e-01
|
GOBP CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION
|
35
|
2.42e-01
|
7.25e-01
|
0.17400
|
-1.04e-01
|
1.39e-01
|
2.85e-01
|
1.55e-01
|
GOBP CELL COMMUNICATION BY ELECTRICAL COUPLING
|
34
|
1.77e-01
|
6.67e-01
|
0.17400
|
1.47e-01
|
9.29e-02
|
1.39e-01
|
3.48e-01
|
GOBP MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT
|
18
|
4.67e-01
|
8.51e-01
|
0.17400
|
-1.64e-01
|
5.81e-02
|
2.29e-01
|
6.69e-01
|
GOBP NEPHRIC DUCT DEVELOPMENT
|
14
|
5.24e-01
|
8.70e-01
|
0.17400
|
-1.73e-01
|
-5.55e-03
|
2.61e-01
|
9.71e-01
|
GOCC NUCLEAR EXOSOME RNASE COMPLEX
|
12
|
6.04e-01
|
8.96e-01
|
0.17300
|
1.61e-01
|
-6.39e-02
|
3.33e-01
|
7.01e-01
|
GOBP REGULATION OF CENTRIOLE REPLICATION
|
23
|
3.56e-01
|
7.97e-01
|
0.17300
|
1.26e-02
|
-1.73e-01
|
9.17e-01
|
1.51e-01
|
GOBP NEUROTRANSMITTER REUPTAKE
|
34
|
1.76e-01
|
6.65e-01
|
0.17300
|
1.34e-01
|
1.10e-01
|
1.77e-01
|
2.65e-01
|
GOBP CORNIFICATION
|
9
|
6.95e-01
|
9.21e-01
|
0.17300
|
1.07e-01
|
-1.36e-01
|
5.78e-01
|
4.78e-01
|
GOBP RESPONSE TO STILBENOID
|
8
|
6.67e-01
|
9.11e-01
|
0.17300
|
-9.24e-02
|
-1.47e-01
|
6.51e-01
|
4.73e-01
|
GOBP REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME
|
12
|
5.69e-01
|
8.86e-01
|
0.17300
|
-1.72e-01
|
-2.16e-02
|
3.03e-01
|
8.97e-01
|
GOCC PRERIBOSOME SMALL SUBUNIT PRECURSOR
|
15
|
5.46e-01
|
8.78e-01
|
0.17300
|
-1.00e-01
|
1.41e-01
|
5.01e-01
|
3.44e-01
|
GOCC ACTIN FILAMENT
|
106
|
1.27e-02
|
2.44e-01
|
0.17300
|
-7.35e-02
|
1.57e-01
|
1.91e-01
|
5.30e-03
|
GOBP RESPIRATORY CHAIN COMPLEX IV ASSEMBLY
|
29
|
2.46e-01
|
7.26e-01
|
0.17300
|
-4.50e-02
|
-1.67e-01
|
6.75e-01
|
1.19e-01
|
GOBP NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION
|
49
|
1.10e-01
|
5.87e-01
|
0.17300
|
-1.73e-01
|
8.26e-03
|
3.63e-02
|
9.20e-01
|
GOBP POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS
|
32
|
2.76e-01
|
7.50e-01
|
0.17300
|
-1.39e-01
|
1.03e-01
|
1.73e-01
|
3.14e-01
|
GOBP OTIC VESICLE FORMATION
|
8
|
7.18e-01
|
9.29e-01
|
0.17300
|
-7.19e-02
|
1.57e-01
|
7.25e-01
|
4.41e-01
|
GOBP ESCRT COMPLEX DISASSEMBLY
|
10
|
6.18e-01
|
9.00e-01
|
0.17300
|
-1.68e-01
|
-4.23e-02
|
3.58e-01
|
8.17e-01
|
GOBP NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS
|
18
|
4.68e-01
|
8.51e-01
|
0.17300
|
5.62e-02
|
-1.64e-01
|
6.80e-01
|
2.29e-01
|
GOCC PROTEIN COMPLEX INVOLVED IN CELL ADHESION
|
56
|
7.34e-02
|
5.13e-01
|
0.17300
|
1.93e-02
|
1.72e-01
|
8.03e-01
|
2.61e-02
|
GOMF PHOSPHATIDYLCHOLINE BINDING
|
28
|
2.80e-01
|
7.53e-01
|
0.17300
|
-1.73e-01
|
8.19e-04
|
1.13e-01
|
9.94e-01
|
GOBP RESPONSE TO IRON ION
|
28
|
3.11e-01
|
7.74e-01
|
0.17300
|
-6.28e-02
|
1.61e-01
|
5.65e-01
|
1.40e-01
|
GOBP O GLYCAN PROCESSING
|
42
|
1.70e-01
|
6.57e-01
|
0.17300
|
-5.37e-02
|
1.64e-01
|
5.47e-01
|
6.53e-02
|
GOBP NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION
|
66
|
3.50e-02
|
3.81e-01
|
0.17300
|
-1.28e-01
|
-1.16e-01
|
7.25e-02
|
1.02e-01
|
GOCC FEMALE GERM CELL NUCLEUS
|
17
|
4.38e-01
|
8.40e-01
|
0.17300
|
-5.10e-02
|
-1.65e-01
|
7.16e-01
|
2.39e-01
|
GOBP NEGATIVE REGULATION OF MACROPHAGE ACTIVATION
|
17
|
4.25e-01
|
8.35e-01
|
0.17300
|
9.51e-02
|
1.44e-01
|
4.97e-01
|
3.04e-01
|
GOBP REGULATION OF RESPONSE TO DRUG
|
15
|
4.67e-01
|
8.51e-01
|
0.17300
|
1.32e-01
|
1.11e-01
|
3.76e-01
|
4.55e-01
|
GOBP POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION
|
15
|
5.48e-01
|
8.79e-01
|
0.17300
|
1.02e-01
|
-1.39e-01
|
4.95e-01
|
3.50e-01
|
GOBP POSITIVE REGULATION OF CELL DIVISION
|
89
|
2.48e-02
|
3.31e-01
|
0.17300
|
-6.19e-02
|
1.61e-01
|
3.13e-01
|
8.59e-03
|
GOBP NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE
|
16
|
5.05e-01
|
8.65e-01
|
0.17200
|
-1.67e-01
|
4.17e-02
|
2.47e-01
|
7.73e-01
|
GOBP REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
76
|
2.78e-02
|
3.46e-01
|
0.17200
|
3.34e-02
|
1.69e-01
|
6.15e-01
|
1.08e-02
|
GOCC MUSCLE MYOSIN COMPLEX
|
15
|
5.21e-01
|
8.69e-01
|
0.17200
|
1.70e-01
|
-2.77e-02
|
2.54e-01
|
8.53e-01
|
GOBP POSITIVE REGULATION OF ORGANIC ACID TRANSPORT
|
44
|
1.19e-01
|
6.00e-01
|
0.17200
|
5.58e-02
|
1.63e-01
|
5.22e-01
|
6.14e-02
|
GOBP REGULATION OF PROTEIN OLIGOMERIZATION
|
5
|
7.94e-01
|
9.55e-01
|
0.17200
|
-1.48e-02
|
-1.72e-01
|
9.54e-01
|
5.06e-01
|
GOBP SPERM EGG RECOGNITION
|
51
|
9.18e-02
|
5.52e-01
|
0.17200
|
-2.82e-02
|
-1.70e-01
|
7.27e-01
|
3.58e-02
|
GOBP CELLULAR LIPID BIOSYNTHETIC PROCESS
|
12
|
6.21e-01
|
9.00e-01
|
0.17200
|
-1.19e-01
|
1.25e-01
|
4.75e-01
|
4.55e-01
|
GOBP POSITIVE REGULATION OF INTERLEUKIN 5 PRODUCTION
|
10
|
6.72e-01
|
9.13e-01
|
0.17200
|
1.15e-01
|
-1.28e-01
|
5.30e-01
|
4.82e-01
|
GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY
|
6
|
7.60e-01
|
9.44e-01
|
0.17200
|
-1.72e-01
|
-1.02e-02
|
4.66e-01
|
9.66e-01
|
GOBP L SERINE BIOSYNTHETIC PROCESS
|
5
|
8.16e-01
|
9.59e-01
|
0.17200
|
7.76e-02
|
-1.54e-01
|
7.64e-01
|
5.52e-01
|
GOBP INTRACELLULAR MONOATOMIC ANION HOMEOSTASIS
|
10
|
6.54e-01
|
9.09e-01
|
0.17200
|
-4.29e-02
|
1.67e-01
|
8.14e-01
|
3.61e-01
|
GOBP POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY
|
14
|
5.74e-01
|
8.88e-01
|
0.17200
|
1.11e-01
|
-1.31e-01
|
4.71e-01
|
3.95e-01
|
GOCC MLL3 4 COMPLEX
|
10
|
6.71e-01
|
9.12e-01
|
0.17200
|
-1.39e-01
|
1.02e-01
|
4.47e-01
|
5.78e-01
|
GOBP REGULATION OF CAMP MEDIATED SIGNALING
|
29
|
2.34e-01
|
7.21e-01
|
0.17200
|
9.58e-02
|
1.43e-01
|
3.72e-01
|
1.82e-01
|
GOBP MEMBRANE REPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL
|
23
|
3.40e-01
|
7.91e-01
|
0.17200
|
3.02e-02
|
1.69e-01
|
8.02e-01
|
1.59e-01
|
GOBP GLOMERULAR EPITHELIUM DEVELOPMENT
|
24
|
3.15e-01
|
7.76e-01
|
0.17200
|
4.99e-02
|
1.65e-01
|
6.72e-01
|
1.62e-01
|
GOBP POSITIVE REGULATION OF FAT CELL DIFFERENTIATION
|
67
|
3.59e-02
|
3.87e-01
|
0.17200
|
-1.50e-01
|
-8.49e-02
|
3.40e-02
|
2.30e-01
|
GOBP BARBED END ACTIN FILAMENT CAPPING
|
25
|
3.71e-01
|
8.09e-01
|
0.17200
|
-1.13e-01
|
1.30e-01
|
3.27e-01
|
2.62e-01
|
GOBP NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY
|
46
|
1.47e-01
|
6.34e-01
|
0.17200
|
-5.52e-02
|
1.63e-01
|
5.17e-01
|
5.58e-02
|
GOBP POSITIVE REGULATION OF B CELL DIFFERENTIATION
|
14
|
5.08e-01
|
8.66e-01
|
0.17200
|
-1.63e-01
|
-5.56e-02
|
2.92e-01
|
7.19e-01
|
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYDROGEN PEROXIDE
|
9
|
6.40e-01
|
9.06e-01
|
0.17200
|
-8.29e-02
|
-1.51e-01
|
6.67e-01
|
4.34e-01
|
GOBP EMBRYONIC SKELETAL JOINT DEVELOPMENT
|
15
|
5.52e-01
|
8.80e-01
|
0.17200
|
-1.11e-01
|
1.31e-01
|
4.56e-01
|
3.79e-01
|
GOMF FRUCTOSE BINDING
|
6
|
7.89e-01
|
9.54e-01
|
0.17200
|
-1.27e-01
|
1.16e-01
|
5.91e-01
|
6.22e-01
|
GOBP POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION
|
17
|
4.31e-01
|
8.37e-01
|
0.17200
|
8.23e-02
|
1.51e-01
|
5.57e-01
|
2.81e-01
|
GOMF TELOMERIC DNA BINDING
|
38
|
2.23e-01
|
7.12e-01
|
0.17200
|
1.10e-01
|
-1.32e-01
|
2.41e-01
|
1.59e-01
|
GOBP REGULATION OF CYTOPLASMIC TRANSLATION
|
30
|
2.67e-01
|
7.42e-01
|
0.17200
|
1.26e-02
|
-1.71e-01
|
9.05e-01
|
1.04e-01
|
GOBP PUTRESCINE METABOLIC PROCESS
|
7
|
7.44e-01
|
9.38e-01
|
0.17200
|
4.40e-02
|
-1.66e-01
|
8.40e-01
|
4.47e-01
|
GOBP CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION
|
38
|
2.23e-01
|
7.12e-01
|
0.17200
|
-1.32e-01
|
1.10e-01
|
1.59e-01
|
2.42e-01
|
GOBP NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS
|
16
|
4.49e-01
|
8.42e-01
|
0.17200
|
-1.36e-01
|
-1.05e-01
|
3.47e-01
|
4.67e-01
|
GOBP CARDIAC MUSCLE CELL CARDIAC MUSCLE CELL ADHESION
|
7
|
7.52e-01
|
9.41e-01
|
0.17200
|
1.55e-01
|
-7.31e-02
|
4.77e-01
|
7.38e-01
|
GOBP UBIQUITIN RECYCLING
|
13
|
5.27e-01
|
8.72e-01
|
0.17200
|
1.52e-01
|
8.05e-02
|
3.44e-01
|
6.15e-01
|
GOBP NEGATIVE REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY
|
15
|
4.77e-01
|
8.54e-01
|
0.17200
|
-8.13e-02
|
-1.51e-01
|
5.86e-01
|
3.11e-01
|
GOBP TRNA CATABOLIC PROCESS
|
16
|
4.74e-01
|
8.54e-01
|
0.17200
|
2.98e-02
|
1.69e-01
|
8.36e-01
|
2.42e-01
|
GOCC PIGMENT GRANULE
|
109
|
8.92e-03
|
1.97e-01
|
0.17100
|
-1.70e-01
|
2.01e-02
|
2.12e-03
|
7.17e-01
|
GOBP PENETRATION OF ZONA PELLUCIDA
|
9
|
6.45e-01
|
9.07e-01
|
0.17100
|
-7.05e-02
|
-1.56e-01
|
7.14e-01
|
4.17e-01
|
GOBP RESPONSE TO OXYGEN GLUCOSE DEPRIVATION
|
11
|
6.36e-01
|
9.06e-01
|
0.17100
|
-6.05e-02
|
1.60e-01
|
7.28e-01
|
3.57e-01
|
GOBP CELLULAR RESPONSE TO ESTRADIOL STIMULUS
|
37
|
1.59e-01
|
6.48e-01
|
0.17100
|
-1.39e-01
|
-1.00e-01
|
1.44e-01
|
2.91e-01
|
GOMF NUCLEOSOME BINDING
|
67
|
5.17e-02
|
4.48e-01
|
0.17100
|
-1.71e-01
|
4.64e-03
|
1.54e-02
|
9.48e-01
|
GOBP MITOTIC METAPHASE CHROMOSOME ALIGNMENT
|
58
|
5.56e-02
|
4.63e-01
|
0.17100
|
-1.31e-01
|
-1.10e-01
|
8.47e-02
|
1.46e-01
|
GOCC REPLICATION FORK
|
64
|
7.04e-02
|
5.06e-01
|
0.17100
|
-1.64e-01
|
5.04e-02
|
2.36e-02
|
4.86e-01
|
GOMF SULFATE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
16
|
4.70e-01
|
8.51e-01
|
0.17100
|
4.26e-02
|
1.66e-01
|
7.68e-01
|
2.51e-01
|
GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR
|
125
|
5.22e-03
|
1.50e-01
|
0.17100
|
-1.67e-01
|
3.78e-02
|
1.26e-03
|
4.66e-01
|
GOBP PROTEIN RETENTION IN ER LUMEN
|
8
|
7.16e-01
|
9.28e-01
|
0.17100
|
4.60e-02
|
-1.65e-01
|
8.22e-01
|
4.19e-01
|
GOBP MATING BEHAVIOR
|
36
|
2.17e-01
|
7.07e-01
|
0.17100
|
-3.41e-02
|
1.68e-01
|
7.24e-01
|
8.17e-02
|
GOBP RECEPTOR DIFFUSION TRAPPING
|
10
|
6.67e-01
|
9.11e-01
|
0.17100
|
-1.56e-01
|
7.11e-02
|
3.94e-01
|
6.97e-01
|
GOBP PHOSPHOLIPID DEPHOSPHORYLATION
|
37
|
1.92e-01
|
6.85e-01
|
0.17100
|
-1.71e-01
|
-2.33e-03
|
7.17e-02
|
9.80e-01
|
GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN LINEAR AMIDINES
|
11
|
5.78e-01
|
8.89e-01
|
0.17100
|
1.29e-01
|
1.13e-01
|
4.60e-01
|
5.17e-01
|
GOBP REGULATION OF NEURON PROJECTION REGENERATION
|
29
|
3.21e-01
|
7.79e-01
|
0.17100
|
-1.08e-01
|
1.32e-01
|
3.13e-01
|
2.17e-01
|
GOBP NEGATIVE REGULATION OF CENTROSOME DUPLICATION
|
12
|
5.75e-01
|
8.88e-01
|
0.17100
|
-2.61e-02
|
-1.69e-01
|
8.76e-01
|
3.11e-01
|
GOBP RESPONSE TO CGMP
|
8
|
6.95e-01
|
9.21e-01
|
0.17100
|
1.53e-02
|
1.70e-01
|
9.40e-01
|
4.04e-01
|
GOBP REGULATION OF DNA DEMETHYLATION
|
11
|
5.93e-01
|
8.93e-01
|
0.17100
|
-5.18e-02
|
-1.63e-01
|
7.66e-01
|
3.49e-01
|
GOBP SEMI LUNAR VALVE DEVELOPMENT
|
47
|
1.42e-01
|
6.26e-01
|
0.17100
|
-1.65e-01
|
4.64e-02
|
5.10e-02
|
5.82e-01
|
GOBP POSITIVE REGULATION OF BLOOD CIRCULATION
|
38
|
1.51e-01
|
6.38e-01
|
0.17100
|
1.19e-01
|
1.22e-01
|
2.03e-01
|
1.92e-01
|
GOBP POSITIVE REGULATION OF RNA SPLICING
|
37
|
1.94e-01
|
6.86e-01
|
0.17100
|
-1.71e-01
|
1.23e-03
|
7.21e-02
|
9.90e-01
|
GOBP REGULATION OF T CELL APOPTOTIC PROCESS
|
39
|
1.96e-01
|
6.88e-01
|
0.17100
|
-4.26e-02
|
1.65e-01
|
6.45e-01
|
7.39e-02
|
GOBP SPHINGOID METABOLIC PROCESS
|
22
|
3.61e-01
|
8.03e-01
|
0.17100
|
-3.22e-02
|
-1.68e-01
|
7.94e-01
|
1.73e-01
|
GOBP PRESYNAPTIC MEMBRANE ORGANIZATION
|
6
|
7.61e-01
|
9.45e-01
|
0.17100
|
-1.72e-02
|
-1.70e-01
|
9.42e-01
|
4.71e-01
|
GOBP NEGATIVE REGULATION OF HORMONE METABOLIC PROCESS
|
12
|
6.13e-01
|
8.98e-01
|
0.17100
|
1.60e-01
|
-5.99e-02
|
3.38e-01
|
7.19e-01
|
GOBP DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION
|
13
|
5.25e-01
|
8.71e-01
|
0.17100
|
1.33e-01
|
1.07e-01
|
4.06e-01
|
5.04e-01
|
GOBP POSITIVE REGULATION OF AMINE TRANSPORT
|
39
|
1.56e-01
|
6.43e-01
|
0.17100
|
5.71e-02
|
1.61e-01
|
5.37e-01
|
8.21e-02
|
GOBP REGULATION OF BIOMINERAL TISSUE DEVELOPMENT
|
95
|
2.49e-02
|
3.31e-01
|
0.17100
|
-1.13e-01
|
1.28e-01
|
5.68e-02
|
3.12e-02
|
GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION
|
20
|
3.71e-01
|
8.09e-01
|
0.17100
|
1.25e-01
|
1.16e-01
|
3.32e-01
|
3.70e-01
|
GOBP POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT
|
59
|
8.92e-02
|
5.50e-01
|
0.17100
|
-1.62e-01
|
5.37e-02
|
3.15e-02
|
4.76e-01
|
GOCC RNA POLYMERASE I TRANSCRIPTION REGULATOR COMPLEX
|
6
|
7.83e-01
|
9.52e-01
|
0.17100
|
5.81e-02
|
-1.60e-01
|
8.05e-01
|
4.96e-01
|
GOCC NLRP3 INFLAMMASOME COMPLEX
|
7
|
7.11e-01
|
9.27e-01
|
0.17000
|
-8.12e-02
|
-1.50e-01
|
7.10e-01
|
4.92e-01
|
GOBP EPITHELIAL CELL MATURATION
|
24
|
3.56e-01
|
7.97e-01
|
0.17000
|
1.73e-02
|
-1.70e-01
|
8.83e-01
|
1.50e-01
|
GOMF ENONE REDUCTASE ACTIVITY
|
5
|
8.13e-01
|
9.59e-01
|
0.17000
|
4.50e-02
|
-1.64e-01
|
8.62e-01
|
5.24e-01
|
GOMF ENOYL COA HYDRATASE ACTIVITY
|
11
|
5.80e-01
|
8.90e-01
|
0.17000
|
-1.20e-01
|
-1.21e-01
|
4.92e-01
|
4.86e-01
|
GOBP NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT
|
13
|
6.01e-01
|
8.96e-01
|
0.17000
|
-1.39e-01
|
9.82e-02
|
3.85e-01
|
5.40e-01
|
GOBP REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE
|
9
|
6.98e-01
|
9.21e-01
|
0.17000
|
-7.41e-02
|
1.53e-01
|
7.00e-01
|
4.26e-01
|
GOBP REGULATION OF MITOTIC CYTOKINESIS
|
11
|
6.53e-01
|
9.08e-01
|
0.17000
|
-1.12e-01
|
1.29e-01
|
5.22e-01
|
4.60e-01
|
GOBP LYSOSOMAL MEMBRANE ORGANIZATION
|
14
|
5.81e-01
|
8.90e-01
|
0.17000
|
-1.21e-01
|
1.19e-01
|
4.32e-01
|
4.39e-01
|
GOBP MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C
|
12
|
6.24e-01
|
9.01e-01
|
0.17000
|
8.83e-02
|
-1.45e-01
|
5.96e-01
|
3.83e-01
|
GOBP CELL ADHESION MEDIATED BY INTEGRIN
|
86
|
3.10e-02
|
3.62e-01
|
0.17000
|
-5.90e-02
|
1.59e-01
|
3.44e-01
|
1.06e-02
|
GOMF CALCIUM MONOATOMIC CATION ANTIPORTER ACTIVITY
|
13
|
5.42e-01
|
8.78e-01
|
0.17000
|
-1.62e-01
|
-5.19e-02
|
3.12e-01
|
7.46e-01
|
GOCC DNA REPLICATION PREINITIATION COMPLEX
|
13
|
5.27e-01
|
8.72e-01
|
0.17000
|
-1.09e-01
|
-1.30e-01
|
4.95e-01
|
4.16e-01
|
GOBP NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN
|
11
|
5.87e-01
|
8.91e-01
|
0.17000
|
8.18e-02
|
1.49e-01
|
6.39e-01
|
3.92e-01
|
GOCC ATPASE COMPLEX
|
140
|
2.72e-03
|
1.02e-01
|
0.17000
|
-1.68e-01
|
2.49e-02
|
5.92e-04
|
6.11e-01
|
GOBP FOAM CELL DIFFERENTIATION
|
41
|
1.91e-01
|
6.85e-01
|
0.17000
|
6.10e-02
|
-1.59e-01
|
4.99e-01
|
7.88e-02
|
GOBP INTRACELLULAR LIPID TRANSPORT
|
50
|
1.18e-01
|
5.99e-01
|
0.17000
|
-1.69e-01
|
1.75e-02
|
3.86e-02
|
8.31e-01
|
GOBP REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL
|
12
|
6.01e-01
|
8.96e-01
|
0.17000
|
-2.47e-02
|
1.68e-01
|
8.82e-01
|
3.13e-01
|
GOBP POSITIVE REGULATION OF NK T CELL ACTIVATION
|
9
|
6.92e-01
|
9.21e-01
|
0.17000
|
5.12e-02
|
-1.62e-01
|
7.90e-01
|
4.00e-01
|
GOMF CALMODULIN DEPENDENT PROTEIN KINASE ACTIVITY
|
24
|
3.96e-01
|
8.24e-01
|
0.17000
|
-1.09e-01
|
1.31e-01
|
3.57e-01
|
2.68e-01
|
GOBP NUCLEAR PORE COMPLEX ASSEMBLY
|
11
|
6.49e-01
|
9.07e-01
|
0.17000
|
8.59e-02
|
-1.47e-01
|
6.22e-01
|
4.00e-01
|
GOBP MHC CLASS II BIOSYNTHETIC PROCESS
|
20
|
3.78e-01
|
8.14e-01
|
0.17000
|
-9.05e-02
|
-1.44e-01
|
4.84e-01
|
2.66e-01
|
GOBP OLIGOSACCHARIDE CATABOLIC PROCESS
|
17
|
4.34e-01
|
8.38e-01
|
0.17000
|
-1.25e-01
|
-1.14e-01
|
3.70e-01
|
4.14e-01
|
GOBP NEGATIVE REGULATION OF CELL FATE COMMITMENT
|
11
|
6.10e-01
|
8.98e-01
|
0.17000
|
-1.69e-01
|
-1.84e-02
|
3.32e-01
|
9.16e-01
|
GOBP REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION
|
101
|
1.50e-02
|
2.62e-01
|
0.17000
|
-3.39e-02
|
1.66e-01
|
5.55e-01
|
3.87e-03
|
GOBP REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS
|
11
|
6.42e-01
|
9.07e-01
|
0.17000
|
5.99e-02
|
-1.59e-01
|
7.31e-01
|
3.62e-01
|
GOMF APOLIPOPROTEIN RECEPTOR BINDING
|
7
|
7.38e-01
|
9.35e-01
|
0.17000
|
-1.70e-01
|
7.49e-03
|
4.37e-01
|
9.73e-01
|
GOBP BRANCHING MORPHOGENESIS OF A NERVE
|
10
|
6.18e-01
|
9.00e-01
|
0.17000
|
-7.90e-02
|
-1.50e-01
|
6.65e-01
|
4.11e-01
|
GOMF DYNEIN HEAVY CHAIN BINDING
|
16
|
4.81e-01
|
8.54e-01
|
0.17000
|
3.24e-02
|
1.67e-01
|
8.23e-01
|
2.49e-01
|
GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYDROGEN PEROXIDE
|
6
|
7.90e-01
|
9.54e-01
|
0.17000
|
8.30e-02
|
-1.48e-01
|
7.25e-01
|
5.30e-01
|
GOBP POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS
|
31
|
2.94e-01
|
7.64e-01
|
0.17000
|
-1.52e-01
|
7.60e-02
|
1.44e-01
|
4.64e-01
|
GOCC SEX CHROMATIN
|
6
|
7.55e-01
|
9.42e-01
|
0.17000
|
-1.61e-01
|
-5.23e-02
|
4.94e-01
|
8.25e-01
|
GOBP POSITIVE REGULATION OF GTPASE ACTIVITY
|
216
|
1.95e-04
|
1.48e-02
|
0.17000
|
-6.76e-02
|
1.56e-01
|
8.68e-02
|
8.10e-05
|
GOBP SKELETAL MUSCLE SATELLITE CELL DIFFERENTIATION
|
9
|
7.01e-01
|
9.22e-01
|
0.17000
|
7.59e-02
|
-1.52e-01
|
6.93e-01
|
4.31e-01
|
GOBP REGULATION OF GONAD DEVELOPMENT
|
12
|
6.29e-01
|
9.02e-01
|
0.17000
|
-1.36e-01
|
1.01e-01
|
4.15e-01
|
5.43e-01
|
GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX
|
9
|
6.59e-01
|
9.09e-01
|
0.17000
|
1.64e-01
|
4.17e-02
|
3.93e-01
|
8.28e-01
|
GOBP POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION
|
71
|
3.30e-02
|
3.70e-01
|
0.17000
|
-1.50e-01
|
-8.00e-02
|
2.93e-02
|
2.44e-01
|
GOBP STEROID HORMONE BIOSYNTHETIC PROCESS
|
44
|
1.18e-01
|
5.99e-01
|
0.17000
|
-9.57e-02
|
-1.40e-01
|
2.72e-01
|
1.08e-01
|
GOBP T HELPER 17 TYPE IMMUNE RESPONSE
|
46
|
1.09e-01
|
5.84e-01
|
0.17000
|
8.05e-02
|
1.49e-01
|
3.45e-01
|
8.00e-02
|
GOBP S SHAPED BODY MORPHOGENESIS
|
7
|
7.13e-01
|
9.27e-01
|
0.16900
|
8.42e-02
|
1.47e-01
|
7.00e-01
|
5.00e-01
|
GOBP CELLULAR RESPONSE TO ZINC ION
|
23
|
3.33e-01
|
7.87e-01
|
0.16900
|
7.19e-02
|
1.53e-01
|
5.50e-01
|
2.03e-01
|
GOBP NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION
|
33
|
1.99e-01
|
6.89e-01
|
0.16900
|
-1.22e-01
|
-1.18e-01
|
2.25e-01
|
2.42e-01
|
GOMF DNA SECONDARY STRUCTURE BINDING
|
36
|
1.76e-01
|
6.65e-01
|
0.16900
|
-8.70e-02
|
-1.45e-01
|
3.66e-01
|
1.31e-01
|
GOBP GLYCOSPHINGOLIPID METABOLIC PROCESS
|
62
|
8.89e-02
|
5.50e-01
|
0.16900
|
-1.47e-01
|
8.43e-02
|
4.53e-02
|
2.51e-01
|
GOBP VESTIBULOCOCHLEAR NERVE MORPHOGENESIS
|
7
|
7.19e-01
|
9.29e-01
|
0.16900
|
6.06e-02
|
1.58e-01
|
7.81e-01
|
4.69e-01
|
GOCC SPECIFIC GRANULE MEMBRANE
|
88
|
3.39e-02
|
3.76e-01
|
0.16900
|
-1.35e-01
|
1.02e-01
|
2.84e-02
|
9.77e-02
|
GOBP NEGATIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS
|
14
|
5.55e-01
|
8.81e-01
|
0.16900
|
-1.67e-01
|
2.64e-02
|
2.78e-01
|
8.64e-01
|
GOBP ATRIOVENTRICULAR CANAL DEVELOPMENT
|
13
|
6.02e-01
|
8.96e-01
|
0.16900
|
8.53e-02
|
-1.46e-01
|
5.95e-01
|
3.61e-01
|
GOCC HIGH DENSITY LIPOPROTEIN PARTICLE
|
25
|
3.52e-01
|
7.96e-01
|
0.16900
|
-1.67e-01
|
2.97e-02
|
1.49e-01
|
7.97e-01
|
GOBP LEUKOCYTE ADHESION TO ARTERIAL ENDOTHELIAL CELL
|
6
|
7.94e-01
|
9.55e-01
|
0.16900
|
-1.35e-01
|
1.02e-01
|
5.67e-01
|
6.64e-01
|
GOBP REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY
|
24
|
3.63e-01
|
8.04e-01
|
0.16900
|
2.12e-02
|
-1.68e-01
|
8.57e-01
|
1.55e-01
|
GOBP SEBACEOUS GLAND DEVELOPMENT
|
10
|
6.55e-01
|
9.09e-01
|
0.16900
|
1.68e-01
|
-2.13e-02
|
3.58e-01
|
9.07e-01
|
GOBP REGULATION OF MITOTIC SPINDLE ASSEMBLY
|
22
|
3.53e-01
|
7.97e-01
|
0.16900
|
-1.55e-01
|
-6.70e-02
|
2.07e-01
|
5.87e-01
|
GOBP NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION
|
52
|
1.29e-01
|
6.09e-01
|
0.16900
|
-7.03e-02
|
1.54e-01
|
3.81e-01
|
5.53e-02
|
GOMF MINOR GROOVE OF ADENINE THYMINE RICH DNA BINDING
|
10
|
6.44e-01
|
9.07e-01
|
0.16900
|
-1.03e-02
|
-1.69e-01
|
9.55e-01
|
3.56e-01
|
GOBP REGULATION OF VASCULAR WOUND HEALING
|
13
|
5.50e-01
|
8.80e-01
|
0.16900
|
-1.63e-01
|
-4.26e-02
|
3.08e-01
|
7.90e-01
|
GOBP PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION
|
28
|
3.14e-01
|
7.76e-01
|
0.16900
|
3.27e-02
|
-1.66e-01
|
7.64e-01
|
1.29e-01
|
GOBP NEUROMUSCULAR SYNAPTIC TRANSMISSION
|
28
|
2.90e-01
|
7.61e-01
|
0.16900
|
-1.68e-01
|
-1.42e-02
|
1.23e-01
|
8.96e-01
|
GOBP NEGATIVE REGULATION OF DNA REPAIR
|
33
|
2.43e-01
|
7.25e-01
|
0.16900
|
-1.69e-01
|
7.82e-03
|
9.37e-02
|
9.38e-01
|
GOMF IMMUNE RECEPTOR ACTIVITY
|
130
|
1.87e-03
|
8.02e-02
|
0.16900
|
1.19e-01
|
1.20e-01
|
1.90e-02
|
1.85e-02
|
GOBP REGULATION OF CHROMATIN ORGANIZATION
|
44
|
1.29e-01
|
6.09e-01
|
0.16900
|
-1.59e-01
|
-5.55e-02
|
6.73e-02
|
5.24e-01
|
GOBP NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION
|
9
|
6.66e-01
|
9.11e-01
|
0.16900
|
-3.00e-02
|
-1.66e-01
|
8.76e-01
|
3.88e-01
|
GOBP PERIPHERAL NERVOUS SYSTEM AXON REGENERATION
|
8
|
7.33e-01
|
9.33e-01
|
0.16900
|
-1.46e-01
|
8.47e-02
|
4.75e-01
|
6.78e-01
|
GOBP POSITIVE REGULATION OF TAU PROTEIN KINASE ACTIVITY
|
8
|
6.78e-01
|
9.14e-01
|
0.16900
|
-1.29e-01
|
-1.09e-01
|
5.29e-01
|
5.93e-01
|
GOMF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY
|
97
|
9.19e-03
|
2.02e-01
|
0.16900
|
1.16e-01
|
1.23e-01
|
4.88e-02
|
3.68e-02
|
GOBP HINDGUT DEVELOPMENT
|
8
|
6.85e-01
|
9.18e-01
|
0.16900
|
1.53e-01
|
7.20e-02
|
4.55e-01
|
7.24e-01
|
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS
|
61
|
5.73e-02
|
4.68e-01
|
0.16900
|
-6.43e-02
|
-1.56e-01
|
3.85e-01
|
3.52e-02
|
GOBP REGULATION OF MACROPHAGE DIFFERENTIATION
|
24
|
3.38e-01
|
7.90e-01
|
0.16900
|
-1.66e-01
|
-3.18e-02
|
1.60e-01
|
7.88e-01
|
GOBP NUCLEAR PORE ORGANIZATION
|
15
|
5.64e-01
|
8.85e-01
|
0.16900
|
1.05e-01
|
-1.32e-01
|
4.82e-01
|
3.76e-01
|
GOBP MYOBLAST FUSION
|
47
|
1.18e-01
|
6.00e-01
|
0.16900
|
3.71e-02
|
1.65e-01
|
6.60e-01
|
5.10e-02
|
GOBP TORC2 SIGNALING
|
12
|
5.69e-01
|
8.86e-01
|
0.16900
|
-1.55e-01
|
-6.67e-02
|
3.53e-01
|
6.89e-01
|
GOMF PHOSPHOLIPASE ACTIVITY
|
107
|
1.46e-02
|
2.59e-01
|
0.16900
|
-6.25e-02
|
1.57e-01
|
2.64e-01
|
5.12e-03
|
GOBP OLIGOPEPTIDE TRANSMEMBRANE TRANSPORT
|
9
|
6.47e-01
|
9.07e-01
|
0.16900
|
1.23e-01
|
1.16e-01
|
5.24e-01
|
5.48e-01
|
GOBP HYPOTHALAMUS CELL DIFFERENTIATION
|
12
|
5.78e-01
|
8.89e-01
|
0.16900
|
-4.17e-02
|
-1.63e-01
|
8.02e-01
|
3.27e-01
|
GOBP NCRNA TRANSCRIPTION
|
134
|
3.56e-03
|
1.21e-01
|
0.16800
|
-1.68e-01
|
1.41e-02
|
7.91e-04
|
7.78e-01
|
GOBP INFLAMMATORY RESPONSE TO WOUNDING
|
27
|
3.19e-01
|
7.78e-01
|
0.16800
|
-1.68e-01
|
1.42e-02
|
1.31e-01
|
8.99e-01
|
GOBP MACROPHAGE APOPTOTIC PROCESS
|
14
|
5.48e-01
|
8.79e-01
|
0.16800
|
3.51e-03
|
-1.68e-01
|
9.82e-01
|
2.75e-01
|
GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE
|
31
|
2.68e-01
|
7.43e-01
|
0.16800
|
-1.68e-01
|
9.41e-03
|
1.05e-01
|
9.28e-01
|
GOMF GLUTATHIONE BINDING
|
10
|
6.23e-01
|
9.01e-01
|
0.16800
|
-1.51e-01
|
-7.39e-02
|
4.07e-01
|
6.86e-01
|
GOBP GLOMERULAR EPITHELIAL CELL DIFFERENTIATION
|
21
|
3.99e-01
|
8.25e-01
|
0.16800
|
9.75e-03
|
1.68e-01
|
9.38e-01
|
1.82e-01
|
GOCC ACETYLCHOLINE GATED CHANNEL COMPLEX
|
16
|
4.80e-01
|
8.54e-01
|
0.16800
|
1.62e-01
|
4.72e-02
|
2.63e-01
|
7.44e-01
|
GOBP REGULATION OF GRANULOCYTE DIFFERENTIATION
|
16
|
5.20e-01
|
8.69e-01
|
0.16800
|
-3.68e-02
|
1.64e-01
|
7.99e-01
|
2.55e-01
|
GOBP MITOCHONDRIAL RNA PROCESSING
|
20
|
4.50e-01
|
8.43e-01
|
0.16800
|
5.29e-02
|
-1.60e-01
|
6.82e-01
|
2.16e-01
|
GOBP RECOGNITION OF APOPTOTIC CELL
|
7
|
7.63e-01
|
9.45e-01
|
0.16800
|
7.89e-02
|
-1.48e-01
|
7.18e-01
|
4.96e-01
|
GOBP CALMODULIN DEPENDENT KINASE SIGNALING PATHWAY
|
11
|
6.50e-01
|
9.07e-01
|
0.16800
|
-6.77e-02
|
1.54e-01
|
6.97e-01
|
3.77e-01
|
GOMF CALCITONIN FAMILY RECEPTOR ACTIVITY
|
6
|
7.87e-01
|
9.53e-01
|
0.16800
|
5.10e-02
|
-1.60e-01
|
8.29e-01
|
4.97e-01
|
GOMF RNA DIRECTED DNA POLYMERASE ACTIVITY
|
6
|
7.76e-01
|
9.50e-01
|
0.16800
|
1.13e-02
|
-1.68e-01
|
9.62e-01
|
4.77e-01
|
GOMF TELOMERASE ACTIVITY
|
6
|
7.76e-01
|
9.50e-01
|
0.16800
|
1.13e-02
|
-1.68e-01
|
9.62e-01
|
4.77e-01
|
GOBP NEUROTRANSMITTER BIOSYNTHETIC PROCESS
|
14
|
5.69e-01
|
8.86e-01
|
0.16800
|
1.62e-01
|
-4.46e-02
|
2.94e-01
|
7.73e-01
|
GOBP MALE MEIOSIS I
|
27
|
3.47e-01
|
7.96e-01
|
0.16800
|
-6.61e-02
|
1.55e-01
|
5.52e-01
|
1.65e-01
|
GOBP MIRNA METABOLIC PROCESS
|
101
|
1.57e-02
|
2.65e-01
|
0.16800
|
-1.66e-01
|
2.79e-02
|
4.00e-03
|
6.28e-01
|
GOBP PROTEIN TARGETING TO VACUOLE
|
46
|
1.61e-01
|
6.48e-01
|
0.16800
|
-1.59e-01
|
5.32e-02
|
6.15e-02
|
5.32e-01
|
GOBP PROTEIN METHYLATION
|
75
|
3.04e-02
|
3.61e-01
|
0.16800
|
-1.54e-01
|
-6.64e-02
|
2.09e-02
|
3.20e-01
|
GOBP CERAMIDE BIOSYNTHETIC PROCESS
|
68
|
5.02e-02
|
4.44e-01
|
0.16800
|
-1.67e-01
|
-1.90e-02
|
1.73e-02
|
7.87e-01
|
GOMF ACID THIOL LIGASE ACTIVITY
|
30
|
3.08e-01
|
7.72e-01
|
0.16800
|
-1.55e-01
|
6.38e-02
|
1.41e-01
|
5.46e-01
|
GOBP RESPONSE TO GROWTH HORMONE
|
36
|
2.43e-01
|
7.25e-01
|
0.16800
|
-1.56e-01
|
6.26e-02
|
1.06e-01
|
5.16e-01
|
GOBP MITOTIC SPINDLE ASSEMBLY
|
67
|
5.16e-02
|
4.48e-01
|
0.16800
|
-1.66e-01
|
-2.51e-02
|
1.89e-02
|
7.23e-01
|
GOBP APOPTOTIC PROCESS INVOLVED IN BLOOD VESSEL MORPHOGENESIS
|
5
|
7.97e-01
|
9.55e-01
|
0.16800
|
4.34e-02
|
1.62e-01
|
8.66e-01
|
5.30e-01
|
GOBP RENAL PROTEIN ABSORPTION
|
7
|
7.15e-01
|
9.27e-01
|
0.16800
|
1.05e-01
|
1.31e-01
|
6.32e-01
|
5.48e-01
|
GOBP REGULATION OF NK T CELL PROLIFERATION
|
7
|
7.17e-01
|
9.28e-01
|
0.16800
|
1.40e-01
|
9.25e-02
|
5.21e-01
|
6.72e-01
|
GOBP THIAMINE CONTAINING COMPOUND METABOLIC PROCESS
|
6
|
7.65e-01
|
9.45e-01
|
0.16800
|
-3.06e-02
|
-1.65e-01
|
8.97e-01
|
4.84e-01
|
GOBP BRANCHED CHAIN AMINO ACID BIOSYNTHETIC PROCESS
|
5
|
7.95e-01
|
9.55e-01
|
0.16800
|
1.59e-01
|
5.24e-02
|
5.37e-01
|
8.39e-01
|
GOBP POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING
|
36
|
2.55e-01
|
7.34e-01
|
0.16800
|
9.16e-02
|
-1.40e-01
|
3.42e-01
|
1.45e-01
|
GOBP POSITIVE REGULATION OF CELL SIZE
|
10
|
6.20e-01
|
9.00e-01
|
0.16800
|
1.30e-01
|
1.06e-01
|
4.77e-01
|
5.62e-01
|
GOBP PURINE NUCLEOTIDE TRANSPORT
|
34
|
2.58e-01
|
7.35e-01
|
0.16800
|
-1.61e-01
|
4.72e-02
|
1.05e-01
|
6.34e-01
|
GOBP ACETYL COA METABOLIC PROCESS
|
31
|
2.40e-01
|
7.25e-01
|
0.16800
|
-1.57e-01
|
-5.75e-02
|
1.29e-01
|
5.79e-01
|
GOBP PRIMARY MIRNA PROCESSING
|
18
|
4.44e-01
|
8.40e-01
|
0.16800
|
-1.62e-01
|
-4.15e-02
|
2.33e-01
|
7.60e-01
|
GOCC KERATIN FILAMENT
|
92
|
2.17e-02
|
3.13e-01
|
0.16800
|
1.67e-01
|
-1.49e-02
|
5.67e-03
|
8.05e-01
|
GOBP RESCUE OF STALLED RIBOSOME
|
29
|
2.54e-01
|
7.33e-01
|
0.16700
|
-8.71e-02
|
-1.43e-01
|
4.17e-01
|
1.82e-01
|
GOBP FACIAL NERVE STRUCTURAL ORGANIZATION
|
7
|
7.25e-01
|
9.30e-01
|
0.16700
|
-1.58e-01
|
-5.45e-02
|
4.68e-01
|
8.03e-01
|
GOBP STRAND INVASION
|
6
|
7.88e-01
|
9.54e-01
|
0.16700
|
5.10e-02
|
-1.59e-01
|
8.29e-01
|
4.99e-01
|
GOBP GONADOTROPIN SECRETION
|
17
|
4.70e-01
|
8.51e-01
|
0.16700
|
-2.96e-02
|
-1.65e-01
|
8.33e-01
|
2.40e-01
|
GOCC FILOPODIUM TIP
|
18
|
5.00e-01
|
8.62e-01
|
0.16700
|
1.50e-01
|
-7.48e-02
|
2.71e-01
|
5.83e-01
|
GOCC CATENIN COMPLEX
|
31
|
2.98e-01
|
7.67e-01
|
0.16700
|
6.27e-02
|
-1.55e-01
|
5.45e-01
|
1.35e-01
|
GOMF TRANSCRIPTION REGULATOR INHIBITOR ACTIVITY
|
21
|
3.67e-01
|
8.07e-01
|
0.16700
|
-1.21e-01
|
-1.16e-01
|
3.38e-01
|
3.58e-01
|
GOBP ALDEHYDE BIOSYNTHETIC PROCESS
|
16
|
4.88e-01
|
8.56e-01
|
0.16700
|
-3.84e-02
|
-1.63e-01
|
7.90e-01
|
2.59e-01
|
GOBP RIBOSOMAL LARGE SUBUNIT BIOGENESIS
|
70
|
4.23e-02
|
4.24e-01
|
0.16700
|
-4.60e-02
|
-1.61e-01
|
5.06e-01
|
2.00e-02
|
GOBP INTERLEUKIN 11 MEDIATED SIGNALING PATHWAY
|
6
|
7.77e-01
|
9.50e-01
|
0.16700
|
1.67e-01
|
-9.20e-03
|
4.79e-01
|
9.69e-01
|
GOBP TOLERANCE INDUCTION
|
29
|
3.38e-01
|
7.90e-01
|
0.16700
|
1.28e-01
|
-1.08e-01
|
2.34e-01
|
3.15e-01
|
GOMF STRUCTURAL MOLECULE ACTIVITY CONFERRING ELASTICITY
|
12
|
5.91e-01
|
8.93e-01
|
0.16700
|
1.66e-01
|
2.14e-02
|
3.20e-01
|
8.98e-01
|
GOCC CMG COMPLEX
|
11
|
5.99e-01
|
8.95e-01
|
0.16700
|
-1.49e-01
|
-7.50e-02
|
3.91e-01
|
6.67e-01
|
GOMF INSULIN RECEPTOR BINDING
|
21
|
4.28e-01
|
8.36e-01
|
0.16700
|
-3.26e-02
|
1.64e-01
|
7.96e-01
|
1.94e-01
|
GOBP FATTY ACID TRANSMEMBRANE TRANSPORT
|
19
|
4.92e-01
|
8.58e-01
|
0.16700
|
-1.14e-01
|
1.22e-01
|
3.90e-01
|
3.57e-01
|
GOCC VOLTAGE GATED CALCIUM CHANNEL COMPLEX
|
54
|
1.25e-01
|
6.06e-01
|
0.16700
|
1.52e-01
|
-6.97e-02
|
5.37e-02
|
3.76e-01
|
GOCC AUTOLYSOSOME
|
11
|
6.47e-01
|
9.07e-01
|
0.16700
|
-1.60e-01
|
4.81e-02
|
3.59e-01
|
7.82e-01
|
GOBP BLEB ASSEMBLY
|
11
|
6.61e-01
|
9.09e-01
|
0.16700
|
-9.24e-02
|
1.39e-01
|
5.96e-01
|
4.25e-01
|
GOBP ANIMAL ORGAN MATURATION
|
30
|
2.47e-01
|
7.26e-01
|
0.16700
|
-1.47e-01
|
-7.92e-02
|
1.64e-01
|
4.52e-01
|
GOMF TROPOMYOSIN BINDING
|
15
|
5.02e-01
|
8.63e-01
|
0.16700
|
6.32e-02
|
1.54e-01
|
6.72e-01
|
3.01e-01
|
GOBP MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY
|
18
|
4.51e-01
|
8.45e-01
|
0.16700
|
-3.12e-02
|
-1.64e-01
|
8.19e-01
|
2.29e-01
|
GOBP CELLULAR RESPONSE TO STEROL
|
25
|
3.64e-01
|
8.05e-01
|
0.16700
|
-1.64e-01
|
3.01e-02
|
1.56e-01
|
7.95e-01
|
GOBP PRO B CELL DIFFERENTIATION
|
12
|
6.31e-01
|
9.03e-01
|
0.16700
|
-1.51e-01
|
7.03e-02
|
3.65e-01
|
6.73e-01
|
GOBP INTRACELLULAR PHOSPHATE ION HOMEOSTASIS
|
10
|
6.37e-01
|
9.06e-01
|
0.16700
|
-1.60e-01
|
-4.81e-02
|
3.82e-01
|
7.92e-01
|
GOCC ZONULA ADHERENS
|
8
|
7.14e-01
|
9.27e-01
|
0.16700
|
-1.67e-01
|
2.00e-03
|
4.14e-01
|
9.92e-01
|
GOBP POSITIVE REGULATION OF CYCLASE ACTIVITY
|
38
|
1.97e-01
|
6.88e-01
|
0.16700
|
1.66e-01
|
7.98e-03
|
7.57e-02
|
9.32e-01
|
GOBP MEGAKARYOCYTE DEVELOPMENT
|
22
|
4.42e-01
|
8.40e-01
|
0.16700
|
-1.23e-01
|
1.13e-01
|
3.19e-01
|
3.60e-01
|
GOBP DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION
|
12
|
6.22e-01
|
9.01e-01
|
0.16700
|
4.51e-02
|
-1.60e-01
|
7.87e-01
|
3.36e-01
|
GOBP RIBOSOME BIOGENESIS
|
302
|
1.08e-06
|
3.07e-04
|
0.16700
|
-6.98e-02
|
-1.51e-01
|
3.70e-02
|
6.16e-06
|
GOBP MAINTENANCE OF ANIMAL ORGAN IDENTITY
|
5
|
7.90e-01
|
9.54e-01
|
0.16700
|
1.28e-01
|
1.06e-01
|
6.19e-01
|
6.81e-01
|
GOBP POSITIVE REGULATION OF LYASE ACTIVITY
|
39
|
1.90e-01
|
6.85e-01
|
0.16600
|
1.66e-01
|
6.83e-03
|
7.23e-02
|
9.41e-01
|
GOBP REGULATION OF T HELPER 1 CELL DIFFERENTIATION
|
11
|
5.96e-01
|
8.95e-01
|
0.16600
|
-9.72e-02
|
-1.35e-01
|
5.77e-01
|
4.38e-01
|
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CILIUM
|
7
|
7.20e-01
|
9.29e-01
|
0.16600
|
-1.37e-01
|
-9.49e-02
|
5.31e-01
|
6.64e-01
|
GOBP MUSCLE CELL FATE COMMITMENT
|
20
|
4.58e-01
|
8.48e-01
|
0.16600
|
1.58e-01
|
-5.24e-02
|
2.21e-01
|
6.85e-01
|
GOMF AXON GUIDANCE RECEPTOR ACTIVITY
|
10
|
6.25e-01
|
9.01e-01
|
0.16600
|
-1.01e-01
|
-1.32e-01
|
5.80e-01
|
4.69e-01
|
GOBP POSITIVE CHEMOTAXIS
|
61
|
6.62e-02
|
4.97e-01
|
0.16600
|
4.19e-02
|
1.61e-01
|
5.72e-01
|
2.96e-02
|
GOBP NUCLEOLAR CHROMATIN ORGANIZATION
|
9
|
6.70e-01
|
9.11e-01
|
0.16600
|
-3.98e-02
|
-1.62e-01
|
8.36e-01
|
4.01e-01
|
GOBP DEOXYRIBONUCLEOSIDE METABOLIC PROCESS
|
11
|
6.59e-01
|
9.09e-01
|
0.16600
|
-7.83e-02
|
1.47e-01
|
6.53e-01
|
3.99e-01
|
GOBP REGULATION OF KIDNEY SIZE
|
5
|
8.03e-01
|
9.57e-01
|
0.16600
|
1.64e-01
|
2.87e-02
|
5.26e-01
|
9.12e-01
|
GOCC CYTOCHROME COMPLEX
|
34
|
2.57e-01
|
7.35e-01
|
0.16600
|
3.35e-02
|
-1.63e-01
|
7.35e-01
|
1.00e-01
|
GOBP TYPE B PANCREATIC CELL DEVELOPMENT
|
24
|
3.94e-01
|
8.24e-01
|
0.16600
|
-1.56e-01
|
5.67e-02
|
1.85e-01
|
6.31e-01
|
GOBP UBIQUITIN DEPENDENT ENDOCYTOSIS
|
7
|
7.69e-01
|
9.47e-01
|
0.16600
|
-8.44e-02
|
1.43e-01
|
6.99e-01
|
5.12e-01
|
GOBP SPERM FLAGELLUM ASSEMBLY
|
39
|
1.64e-01
|
6.49e-01
|
0.16600
|
1.45e-01
|
8.19e-02
|
1.18e-01
|
3.76e-01
|
GOBP TRANSCRIPTION BY RNA POLYMERASE I
|
67
|
6.24e-02
|
4.82e-01
|
0.16600
|
-1.66e-01
|
8.45e-03
|
1.88e-02
|
9.05e-01
|
GOCC APOLIPOPROTEIN B MRNA EDITING ENZYME COMPLEX
|
5
|
8.08e-01
|
9.59e-01
|
0.16600
|
-9.69e-03
|
-1.66e-01
|
9.70e-01
|
5.21e-01
|
GOBP COLLAGEN BIOSYNTHETIC PROCESS
|
46
|
1.41e-01
|
6.25e-01
|
0.16600
|
1.16e-02
|
1.66e-01
|
8.92e-01
|
5.17e-02
|
GOMF PROTEASOME BINDING
|
17
|
4.95e-01
|
8.58e-01
|
0.16600
|
-1.66e-01
|
9.38e-03
|
2.36e-01
|
9.47e-01
|
GOMF TRANSCRIPTION ELONGATION FACTOR ACTIVITY
|
6
|
8.01e-01
|
9.57e-01
|
0.16600
|
1.29e-01
|
-1.05e-01
|
5.85e-01
|
6.57e-01
|
GOCC ENDOPLASMIC RETICULUM PROTEIN CONTAINING COMPLEX
|
121
|
4.79e-03
|
1.43e-01
|
0.16600
|
-4.04e-02
|
-1.61e-01
|
4.43e-01
|
2.20e-03
|
GOBP TYPE 2 IMMUNE RESPONSE
|
42
|
1.55e-01
|
6.42e-01
|
0.16600
|
-1.60e-01
|
-4.24e-02
|
7.19e-02
|
6.34e-01
|
GOBP POSITIVE REGULATION BY HOST OF VIRAL PROCESS
|
20
|
4.40e-01
|
8.40e-01
|
0.16600
|
-1.65e-01
|
1.50e-02
|
2.01e-01
|
9.08e-01
|
GOBP COMPLEMENT DEPENDENT CYTOTOXICITY
|
13
|
5.47e-01
|
8.78e-01
|
0.16600
|
-1.41e-01
|
-8.67e-02
|
3.77e-01
|
5.88e-01
|
GOCC OMEGASOME
|
5
|
8.20e-01
|
9.60e-01
|
0.16600
|
3.88e-02
|
-1.61e-01
|
8.81e-01
|
5.32e-01
|
GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX RECEPTOR RECYCLING
|
6
|
7.56e-01
|
9.42e-01
|
0.16600
|
-1.33e-01
|
-9.96e-02
|
5.74e-01
|
6.73e-01
|
GOMF FIBROBLAST GROWTH FACTOR BINDING
|
23
|
3.95e-01
|
8.24e-01
|
0.16600
|
1.64e-01
|
-2.38e-02
|
1.73e-01
|
8.43e-01
|
GOMF ATP GATED ION CHANNEL ACTIVITY
|
9
|
6.82e-01
|
9.16e-01
|
0.16600
|
-1.65e-01
|
-1.05e-02
|
3.90e-01
|
9.57e-01
|
GOBP ANTERIOR POSTERIOR AXIS SPECIFICATION
|
54
|
1.35e-01
|
6.16e-01
|
0.16600
|
-9.10e-02
|
1.39e-01
|
2.47e-01
|
7.82e-02
|
GOBP REGULATION OF PRESYNAPSE ORGANIZATION
|
28
|
3.07e-01
|
7.71e-01
|
0.16600
|
-1.66e-01
|
-7.25e-03
|
1.29e-01
|
9.47e-01
|
GOMF CALCIUM POTASSIUM SODIUM ANTIPORTER ACTIVITY
|
5
|
7.95e-01
|
9.55e-01
|
0.16600
|
-1.48e-01
|
-7.49e-02
|
5.67e-01
|
7.72e-01
|
GOCC ANAPHASE PROMOTING COMPLEX
|
21
|
4.62e-01
|
8.48e-01
|
0.16600
|
1.26e-01
|
-1.07e-01
|
3.17e-01
|
3.94e-01
|
GOBP VIRION ASSEMBLY
|
34
|
2.56e-01
|
7.35e-01
|
0.16600
|
-1.63e-01
|
2.66e-02
|
9.90e-02
|
7.88e-01
|
GOBP SPINAL CORD OLIGODENDROCYTE CELL DIFFERENTIATION
|
5
|
8.20e-01
|
9.60e-01
|
0.16600
|
1.62e-01
|
-3.24e-02
|
5.29e-01
|
9.00e-01
|
GOBP REGULATION OF DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION
|
10
|
6.50e-01
|
9.07e-01
|
0.16600
|
1.64e-01
|
2.42e-02
|
3.70e-01
|
8.95e-01
|
GOMF RETINOIC ACID RESPONSIVE ELEMENT BINDING
|
6
|
7.56e-01
|
9.42e-01
|
0.16500
|
1.23e-01
|
1.11e-01
|
6.02e-01
|
6.38e-01
|
GOCC CYTOPLASMIC DYNEIN COMPLEX
|
22
|
4.26e-01
|
8.36e-01
|
0.16500
|
-1.58e-01
|
4.72e-02
|
1.98e-01
|
7.02e-01
|
GOBP HYPERSENSITIVITY
|
10
|
6.28e-01
|
9.02e-01
|
0.16500
|
-1.24e-01
|
-1.10e-01
|
4.99e-01
|
5.48e-01
|
GOBP REGULATION OF POSTSYNAPTIC DENSITY ASSEMBLY
|
11
|
6.32e-01
|
9.03e-01
|
0.16500
|
-1.65e-01
|
-3.03e-03
|
3.43e-01
|
9.86e-01
|
GOBP TYPE I INTERFERON PRODUCTION
|
115
|
4.97e-03
|
1.45e-01
|
0.16500
|
-1.34e-01
|
-9.67e-02
|
1.30e-02
|
7.32e-02
|
GOBP POSITIVE REGULATION OF VASOCONSTRICTION
|
30
|
2.58e-01
|
7.35e-01
|
0.16500
|
6.56e-02
|
1.52e-01
|
5.34e-01
|
1.50e-01
|
GOBP REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE
|
31
|
2.41e-01
|
7.25e-01
|
0.16500
|
8.32e-02
|
1.43e-01
|
4.23e-01
|
1.69e-01
|
GOBP POSITIVE REGULATION OF B CELL PROLIFERATION
|
43
|
1.35e-01
|
6.17e-01
|
0.16500
|
1.10e-01
|
1.24e-01
|
2.13e-01
|
1.61e-01
|
GOCC CCAAT BINDING FACTOR COMPLEX
|
5
|
8.22e-01
|
9.61e-01
|
0.16500
|
-1.61e-01
|
3.88e-02
|
5.34e-01
|
8.81e-01
|
GOCC NUCLEOCYTOPLASMIC TRANSPORT COMPLEX
|
12
|
5.88e-01
|
8.91e-01
|
0.16500
|
-1.59e-01
|
-4.59e-02
|
3.41e-01
|
7.83e-01
|
GOBP STRIATED MUSCLE CELL APOPTOTIC PROCESS
|
58
|
7.08e-02
|
5.07e-01
|
0.16500
|
-1.45e-01
|
-7.93e-02
|
5.62e-02
|
2.96e-01
|
GOBP REGULATION OF GLIAL CELL PROLIFERATION
|
37
|
2.55e-01
|
7.34e-01
|
0.16500
|
-1.40e-01
|
8.72e-02
|
1.40e-01
|
3.59e-01
|
GOBP REGULATION OF HEPATIC STELLATE CELL ACTIVATION
|
7
|
7.22e-01
|
9.30e-01
|
0.16500
|
-1.10e-01
|
-1.23e-01
|
6.14e-01
|
5.73e-01
|
GOBP REGULATION OF EXECUTION PHASE OF APOPTOSIS
|
17
|
4.60e-01
|
8.48e-01
|
0.16500
|
7.76e-02
|
1.46e-01
|
5.80e-01
|
2.98e-01
|
GOCC SPLICEOSOMAL SNRNP COMPLEX
|
70
|
5.87e-02
|
4.71e-01
|
0.16500
|
1.42e-02
|
-1.64e-01
|
8.37e-01
|
1.73e-02
|
GOBP INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY
|
7
|
7.42e-01
|
9.37e-01
|
0.16500
|
2.13e-02
|
1.64e-01
|
9.22e-01
|
4.54e-01
|
GOBP ENDOCARDIAL CUSHION MORPHOGENESIS
|
44
|
2.01e-01
|
6.90e-01
|
0.16500
|
-9.94e-02
|
1.32e-01
|
2.54e-01
|
1.31e-01
|
GOMF DYNACTIN BINDING
|
12
|
5.87e-01
|
8.91e-01
|
0.16500
|
5.21e-02
|
1.56e-01
|
7.54e-01
|
3.48e-01
|
GOCC R2TP COMPLEX
|
5
|
7.95e-01
|
9.55e-01
|
0.16500
|
1.39e-01
|
8.85e-02
|
5.90e-01
|
7.32e-01
|
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE
|
33
|
2.21e-01
|
7.11e-01
|
0.16500
|
-1.41e-01
|
-8.54e-02
|
1.61e-01
|
3.96e-01
|
GOBP VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY
|
12
|
6.45e-01
|
9.07e-01
|
0.16500
|
-1.34e-01
|
9.63e-02
|
4.22e-01
|
5.63e-01
|
GOBP REGULATION OF DNA TOPOISOMERASE ATP HYDROLYZING ACTIVITY
|
5
|
8.12e-01
|
9.59e-01
|
0.16500
|
-1.65e-01
|
-6.53e-03
|
5.24e-01
|
9.80e-01
|
GOBP INTERLEUKIN 18 MEDIATED SIGNALING PATHWAY
|
9
|
6.79e-01
|
9.14e-01
|
0.16500
|
-1.62e-01
|
-2.80e-02
|
3.99e-01
|
8.84e-01
|
GOMF DAMAGED DNA BINDING
|
70
|
4.36e-02
|
4.28e-01
|
0.16500
|
-6.33e-02
|
-1.52e-01
|
3.60e-01
|
2.77e-02
|
GOBP XENOBIOTIC EXPORT FROM CELL
|
26
|
3.37e-01
|
7.89e-01
|
0.16500
|
1.64e-01
|
9.66e-03
|
1.47e-01
|
9.32e-01
|
GOBP POSITIVE REGULATION OF STEM CELL DIFFERENTIATION
|
21
|
4.15e-01
|
8.30e-01
|
0.16500
|
1.64e-01
|
1.07e-02
|
1.92e-01
|
9.33e-01
|
GOBP RECEPTOR GUANYLYL CYCLASE SIGNALING PATHWAY
|
10
|
6.63e-01
|
9.10e-01
|
0.16500
|
-1.65e-01
|
3.69e-03
|
3.67e-01
|
9.84e-01
|
GOBP ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE
|
74
|
5.64e-02
|
4.67e-01
|
0.16500
|
-1.60e-01
|
3.95e-02
|
1.74e-02
|
5.57e-01
|
GOBP PROTEIN LOCALIZATION TO VACUOLE
|
85
|
3.33e-02
|
3.71e-01
|
0.16500
|
-1.64e-01
|
1.79e-02
|
9.08e-03
|
7.75e-01
|
GOBP REGULATION OF VASOCONSTRICTION
|
61
|
6.45e-02
|
4.89e-01
|
0.16500
|
6.90e-02
|
1.49e-01
|
3.51e-01
|
4.35e-02
|
GOBP MEMBRANE HYPERPOLARIZATION
|
10
|
6.46e-01
|
9.07e-01
|
0.16500
|
1.59e-01
|
4.14e-02
|
3.83e-01
|
8.21e-01
|
GOCC ANNULATE LAMELLAE
|
5
|
8.19e-01
|
9.60e-01
|
0.16500
|
2.18e-02
|
-1.63e-01
|
9.33e-01
|
5.28e-01
|
GOMF PRE MRNA INTRONIC BINDING
|
12
|
6.02e-01
|
8.96e-01
|
0.16500
|
1.63e-01
|
1.91e-02
|
3.27e-01
|
9.09e-01
|
GOBP POSITIVE REGULATION OF NATURAL KILLER CELL PROLIFERATION
|
10
|
6.69e-01
|
9.11e-01
|
0.16500
|
1.72e-02
|
-1.64e-01
|
9.25e-01
|
3.70e-01
|
GOCC CELL BODY MEMBRANE
|
32
|
2.56e-01
|
7.35e-01
|
0.16500
|
1.63e-01
|
2.34e-02
|
1.11e-01
|
8.19e-01
|
GOBP REGULATION OF MYOTUBE DIFFERENTIATION
|
47
|
1.79e-01
|
6.69e-01
|
0.16500
|
-9.03e-02
|
1.38e-01
|
2.84e-01
|
1.03e-01
|
GOBP ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT
|
11
|
6.28e-01
|
9.02e-01
|
0.16400
|
2.03e-02
|
1.63e-01
|
9.07e-01
|
3.49e-01
|
GOBP EPITHELIAL CELL MORPHOGENESIS
|
29
|
2.93e-01
|
7.63e-01
|
0.16400
|
2.11e-02
|
1.63e-01
|
8.44e-01
|
1.29e-01
|
GOBP N ACETYLNEURAMINATE CATABOLIC PROCESS
|
6
|
7.74e-01
|
9.49e-01
|
0.16400
|
-2.61e-02
|
-1.62e-01
|
9.12e-01
|
4.91e-01
|
GOBP TETRAHYDROFOLATE INTERCONVERSION
|
9
|
6.60e-01
|
9.09e-01
|
0.16400
|
-1.16e-01
|
-1.16e-01
|
5.45e-01
|
5.47e-01
|
GOBP POSITIVE REGULATION OF FOCAL ADHESION ASSEMBLY
|
26
|
3.74e-01
|
8.11e-01
|
0.16400
|
-5.74e-02
|
1.54e-01
|
6.12e-01
|
1.74e-01
|
GOBP RIBONUCLEOPROTEIN COMPLEX BIOGENESIS
|
446
|
4.35e-09
|
4.46e-06
|
0.16400
|
-5.07e-02
|
-1.56e-01
|
6.66e-02
|
1.50e-08
|
GOBP ACROSOME ASSEMBLY
|
27
|
3.23e-01
|
7.79e-01
|
0.16400
|
1.38e-02
|
1.64e-01
|
9.01e-01
|
1.41e-01
|
GOBP ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY
|
25
|
4.06e-01
|
8.26e-01
|
0.16400
|
-1.20e-01
|
1.12e-01
|
3.00e-01
|
3.31e-01
|
GOBP REGULATION OF LYMPHOID PROGENITOR CELL DIFFERENTIATION
|
12
|
6.12e-01
|
8.98e-01
|
0.16400
|
-1.64e-01
|
2.31e-03
|
3.25e-01
|
9.89e-01
|
GOMF TRANSCRIPTION COREPRESSOR BINDING
|
45
|
1.98e-01
|
6.88e-01
|
0.16400
|
-1.23e-01
|
1.08e-01
|
1.52e-01
|
2.09e-01
|
GOBP REGULATION OF LYMPHOCYTE MIGRATION
|
66
|
8.63e-02
|
5.45e-01
|
0.16400
|
-6.91e-02
|
1.49e-01
|
3.31e-01
|
3.64e-02
|
GOMF ADENOSINE DEAMINASE ACTIVITY
|
13
|
6.21e-01
|
9.01e-01
|
0.16400
|
-1.41e-01
|
8.47e-02
|
3.80e-01
|
5.97e-01
|
GOCC GPI ANCHOR TRANSAMIDASE COMPLEX
|
5
|
8.29e-01
|
9.62e-01
|
0.16400
|
-1.53e-01
|
5.93e-02
|
5.54e-01
|
8.18e-01
|
GOBP HEMATOPOIETIC STEM CELL HOMEOSTASIS
|
20
|
4.31e-01
|
8.37e-01
|
0.16400
|
-1.63e-01
|
-1.87e-02
|
2.07e-01
|
8.85e-01
|
GOCC ORIGIN RECOGNITION COMPLEX
|
9
|
6.65e-01
|
9.10e-01
|
0.16400
|
-8.52e-02
|
-1.40e-01
|
6.58e-01
|
4.67e-01
|
GOBP MACROPHAGE COLONY STIMULATING FACTOR SIGNALING PATHWAY
|
7
|
7.31e-01
|
9.32e-01
|
0.16400
|
-1.47e-01
|
-7.21e-02
|
5.00e-01
|
7.41e-01
|
GOBP LIPID DIGESTION
|
21
|
3.87e-01
|
8.19e-01
|
0.16400
|
-8.54e-02
|
-1.40e-01
|
4.98e-01
|
2.67e-01
|
GOBP SEMICIRCULAR CANAL DEVELOPMENT
|
9
|
6.78e-01
|
9.14e-01
|
0.16400
|
-3.98e-02
|
-1.59e-01
|
8.36e-01
|
4.09e-01
|
GOBP PROTEIN TRANSMEMBRANE TRANSPORT
|
64
|
8.90e-02
|
5.50e-01
|
0.16400
|
5.20e-02
|
-1.55e-01
|
4.72e-01
|
3.15e-02
|
GOBP POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY
|
27
|
3.32e-01
|
7.85e-01
|
0.16400
|
-2.06e-04
|
-1.64e-01
|
9.99e-01
|
1.41e-01
|
GOMF MONOOXYGENASE ACTIVITY
|
103
|
1.88e-02
|
2.92e-01
|
0.16400
|
1.60e-01
|
-3.53e-02
|
5.02e-03
|
5.36e-01
|
GOBP MYELOID LEUKOCYTE MEDIATED IMMUNITY
|
105
|
2.33e-02
|
3.23e-01
|
0.16400
|
-1.25e-01
|
1.06e-01
|
2.68e-02
|
6.09e-02
|
GOBP REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION
|
26
|
3.06e-01
|
7.70e-01
|
0.16400
|
9.84e-02
|
1.31e-01
|
3.85e-01
|
2.48e-01
|
GOMF DYNEIN LIGHT CHAIN BINDING
|
9
|
6.63e-01
|
9.10e-01
|
0.16400
|
1.10e-01
|
1.21e-01
|
5.68e-01
|
5.29e-01
|
GOMF RIBONUCLEOPROTEIN COMPLEX BINDING
|
154
|
1.92e-03
|
8.07e-02
|
0.16400
|
-1.69e-03
|
-1.64e-01
|
9.71e-01
|
4.53e-04
|
GOMF MISMATCH REPAIR COMPLEX BINDING
|
11
|
6.44e-01
|
9.07e-01
|
0.16400
|
1.20e-02
|
-1.63e-01
|
9.45e-01
|
3.48e-01
|
GOBP GLOMERULAR MESANGIAL CELL PROLIFERATION
|
13
|
5.69e-01
|
8.86e-01
|
0.16400
|
4.60e-02
|
1.57e-01
|
7.74e-01
|
3.27e-01
|
GOBP EYE PHOTORECEPTOR CELL DEVELOPMENT
|
34
|
2.94e-01
|
7.63e-01
|
0.16400
|
1.34e-01
|
-9.44e-02
|
1.78e-01
|
3.41e-01
|
GOMF MONOCARBOXYLATE SODIUM SYMPORTER ACTIVITY
|
13
|
6.28e-01
|
9.02e-01
|
0.16400
|
1.05e-01
|
-1.25e-01
|
5.10e-01
|
4.35e-01
|
GOBP NEUROMUSCULAR JUNCTION DEVELOPMENT
|
50
|
1.65e-01
|
6.49e-01
|
0.16400
|
-1.36e-01
|
9.12e-02
|
9.69e-02
|
2.65e-01
|
GOBP RIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS
|
28
|
3.20e-01
|
7.78e-01
|
0.16300
|
-1.63e-01
|
-1.72e-03
|
1.34e-01
|
9.87e-01
|
GOBP T CELL LINEAGE COMMITMENT
|
31
|
3.17e-01
|
7.77e-01
|
0.16300
|
-6.51e-02
|
1.50e-01
|
5.31e-01
|
1.48e-01
|
GOMF PURINE RIBONUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
19
|
5.03e-01
|
8.63e-01
|
0.16300
|
-1.38e-01
|
8.70e-02
|
2.96e-01
|
5.11e-01
|
GOBP NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM
|
9
|
6.68e-01
|
9.11e-01
|
0.16300
|
1.42e-01
|
8.07e-02
|
4.60e-01
|
6.75e-01
|
GOBP REGULATION OF ELECTRON TRANSFER ACTIVITY
|
6
|
8.03e-01
|
9.57e-01
|
0.16300
|
-1.44e-01
|
7.80e-02
|
5.42e-01
|
7.41e-01
|
GOMF NUCLEAR STEROID RECEPTOR ACTIVITY
|
25
|
3.22e-01
|
7.79e-01
|
0.16300
|
-9.83e-02
|
-1.31e-01
|
3.95e-01
|
2.59e-01
|
GOBP MACROPHAGE DIFFERENTIATION
|
61
|
9.68e-02
|
5.61e-01
|
0.16300
|
-1.59e-01
|
3.87e-02
|
3.20e-02
|
6.01e-01
|
GOBP TRABECULA MORPHOGENESIS
|
47
|
1.87e-01
|
6.79e-01
|
0.16300
|
-1.21e-01
|
1.10e-01
|
1.51e-01
|
1.93e-01
|
GOCC GLIAL CELL PROJECTION
|
36
|
2.44e-01
|
7.25e-01
|
0.16300
|
-2.27e-02
|
1.62e-01
|
8.14e-01
|
9.29e-02
|
GOBP CHOLESTEROL IMPORT
|
9
|
7.26e-01
|
9.30e-01
|
0.16300
|
-1.21e-01
|
1.10e-01
|
5.31e-01
|
5.68e-01
|
GOCC CLATHRIN VESICLE COAT
|
33
|
3.02e-01
|
7.68e-01
|
0.16300
|
-8.12e-02
|
1.42e-01
|
4.19e-01
|
1.59e-01
|
GOBP REGULATION OF POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE
|
8
|
7.38e-01
|
9.35e-01
|
0.16300
|
1.57e-01
|
-4.32e-02
|
4.41e-01
|
8.32e-01
|
GOBP NEGATIVE REGULATION OF TRANSLATIONAL ELONGATION
|
5
|
8.31e-01
|
9.64e-01
|
0.16300
|
1.51e-01
|
-6.10e-02
|
5.58e-01
|
8.13e-01
|
GOBP POSITIVE REGULATION OF VIRAL GENOME REPLICATION
|
30
|
2.75e-01
|
7.49e-01
|
0.16300
|
-1.57e-01
|
-4.45e-02
|
1.37e-01
|
6.73e-01
|
GOBP SYNAPTIC VESICLE TRANSPORT
|
40
|
1.65e-01
|
6.49e-01
|
0.16300
|
-9.44e-02
|
-1.33e-01
|
3.01e-01
|
1.46e-01
|
GOBP SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE
|
20
|
4.82e-01
|
8.54e-01
|
0.16300
|
-7.26e-02
|
1.46e-01
|
5.74e-01
|
2.59e-01
|
GOBP ENDONUCLEOLYTIC CLEAVAGE OF TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA
|
17
|
5.36e-01
|
8.76e-01
|
0.16300
|
-1.49e-01
|
6.64e-02
|
2.88e-01
|
6.35e-01
|
GOMF ACETYLTRANSFERASE ACTIVITY
|
87
|
3.03e-02
|
3.61e-01
|
0.16300
|
-1.63e-01
|
1.10e-03
|
8.62e-03
|
9.86e-01
|
GOBP REGULATION OF SYNAPTIC VESICLE RECYCLING
|
24
|
3.54e-01
|
7.97e-01
|
0.16300
|
-5.06e-02
|
-1.55e-01
|
6.68e-01
|
1.89e-01
|
GOMF CYCLASE ACTIVATOR ACTIVITY
|
11
|
6.75e-01
|
9.13e-01
|
0.16300
|
1.32e-01
|
-9.52e-02
|
4.48e-01
|
5.84e-01
|
GOBP LIPOPROTEIN BIOSYNTHETIC PROCESS
|
91
|
3.02e-02
|
3.61e-01
|
0.16300
|
-1.60e-01
|
2.93e-02
|
8.28e-03
|
6.29e-01
|
GOCC SPERM FIBROUS SHEATH
|
6
|
7.64e-01
|
9.45e-01
|
0.16300
|
1.37e-01
|
8.84e-02
|
5.62e-01
|
7.08e-01
|
GOBP TRUNK SEGMENTATION
|
5
|
8.04e-01
|
9.57e-01
|
0.16300
|
1.51e-01
|
5.96e-02
|
5.57e-01
|
8.18e-01
|
GOMF NUCLEAR RETINOID X RECEPTOR BINDING
|
17
|
4.64e-01
|
8.48e-01
|
0.16300
|
-1.10e-01
|
-1.20e-01
|
4.32e-01
|
3.92e-01
|
GOBP MESENCHYMAL STEM CELL MAINTENANCE INVOLVED IN NEPHRON MORPHOGENESIS
|
6
|
7.83e-01
|
9.52e-01
|
0.16300
|
-1.63e-01
|
-6.09e-03
|
4.90e-01
|
9.79e-01
|
GOCC NUCLEAR PORE CENTRAL TRANSPORT CHANNEL
|
5
|
8.37e-01
|
9.64e-01
|
0.16300
|
-1.04e-01
|
1.25e-01
|
6.87e-01
|
6.29e-01
|
GOBP NEGATIVE REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY
|
10
|
7.00e-01
|
9.22e-01
|
0.16300
|
-1.32e-01
|
9.50e-02
|
4.70e-01
|
6.03e-01
|
GOBP POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION
|
57
|
1.01e-01
|
5.71e-01
|
0.16300
|
-3.61e-04
|
1.63e-01
|
9.96e-01
|
3.37e-02
|
GOMF SUPERCOILED DNA BINDING
|
6
|
8.05e-01
|
9.57e-01
|
0.16300
|
1.44e-01
|
-7.61e-02
|
5.42e-01
|
7.47e-01
|
GOBP INTERLEUKIN 2 PRODUCTION
|
60
|
1.12e-01
|
5.91e-01
|
0.16300
|
-6.85e-02
|
1.48e-01
|
3.59e-01
|
4.81e-02
|
GOBP REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS
|
23
|
3.55e-01
|
7.97e-01
|
0.16300
|
-1.07e-01
|
-1.22e-01
|
3.74e-01
|
3.09e-01
|
GOBP QUINOLINATE METABOLIC PROCESS
|
5
|
8.36e-01
|
9.64e-01
|
0.16300
|
-1.34e-01
|
9.14e-02
|
6.02e-01
|
7.23e-01
|
GOBP REGULATION OF MUSCLE ORGAN DEVELOPMENT
|
23
|
4.10e-01
|
8.27e-01
|
0.16300
|
-2.50e-02
|
1.61e-01
|
8.35e-01
|
1.82e-01
|
GOBP NEGATIVE REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE
|
26
|
3.19e-01
|
7.78e-01
|
0.16300
|
7.06e-02
|
1.46e-01
|
5.33e-01
|
1.96e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MICROTUBULE
|
5
|
8.05e-01
|
9.57e-01
|
0.16300
|
-1.53e-01
|
-5.59e-02
|
5.54e-01
|
8.29e-01
|
GOBP PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING
|
11
|
6.12e-01
|
8.98e-01
|
0.16200
|
9.15e-02
|
1.34e-01
|
5.99e-01
|
4.41e-01
|
GOMF PHOTORECEPTOR ACTIVITY
|
13
|
6.17e-01
|
9.00e-01
|
0.16200
|
-1.53e-01
|
5.35e-02
|
3.38e-01
|
7.38e-01
|
GOBP HEART VALVE MORPHOGENESIS
|
60
|
1.18e-01
|
5.98e-01
|
0.16200
|
-1.38e-01
|
8.53e-02
|
6.42e-02
|
2.53e-01
|
GOBP REGULATION OF CILIUM DEPENDENT CELL MOTILITY
|
27
|
3.19e-01
|
7.78e-01
|
0.16200
|
-3.99e-02
|
-1.57e-01
|
7.20e-01
|
1.57e-01
|
GOBP METANEPHRIC PART OF URETERIC BUD DEVELOPMENT
|
6
|
7.67e-01
|
9.46e-01
|
0.16200
|
7.99e-02
|
1.41e-01
|
7.35e-01
|
5.49e-01
|
GOMF SERINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY
|
95
|
2.52e-02
|
3.31e-01
|
0.16200
|
1.61e-01
|
-1.92e-02
|
6.65e-03
|
7.46e-01
|
GOBP RETROGRADE TRANS SYNAPTIC SIGNALING
|
10
|
6.72e-01
|
9.13e-01
|
0.16200
|
-1.62e-01
|
5.72e-03
|
3.75e-01
|
9.75e-01
|
GOBP CELL PROLIFERATION IN MIDBRAIN
|
8
|
7.01e-01
|
9.22e-01
|
0.16200
|
1.38e-01
|
8.54e-02
|
4.99e-01
|
6.76e-01
|
GOCC CYCLIN CDK POSITIVE TRANSCRIPTION ELONGATION FACTOR COMPLEX
|
6
|
7.68e-01
|
9.46e-01
|
0.16200
|
-7.71e-02
|
-1.43e-01
|
7.44e-01
|
5.45e-01
|
GOMF PHOSPHOTYROSINE RESIDUE BINDING
|
46
|
1.54e-01
|
6.41e-01
|
0.16200
|
1.38e-02
|
1.61e-01
|
8.71e-01
|
5.81e-02
|
GOBP COLLAGEN CATABOLIC PROCESS
|
44
|
1.95e-01
|
6.88e-01
|
0.16200
|
-4.91e-02
|
1.54e-01
|
5.73e-01
|
7.63e-02
|
GOBP REGULATION OF MICROTUBULE NUCLEATION
|
17
|
4.84e-01
|
8.54e-01
|
0.16200
|
-4.98e-02
|
-1.54e-01
|
7.22e-01
|
2.71e-01
|
GOBP POSITIVE REGULATION OF DEOXYRIBONUCLEASE ACTIVITY
|
5
|
8.29e-01
|
9.62e-01
|
0.16200
|
-4.14e-02
|
1.57e-01
|
8.73e-01
|
5.44e-01
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN REDUCED IRON SULFUR PROTEIN AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN
|
9
|
7.28e-01
|
9.32e-01
|
0.16200
|
9.93e-02
|
-1.28e-01
|
6.06e-01
|
5.06e-01
|
GOCC GTPASE COMPLEX
|
38
|
2.42e-01
|
7.25e-01
|
0.16200
|
-1.56e-01
|
4.20e-02
|
9.55e-02
|
6.54e-01
|
GOCC CHROMATIN SILENCING COMPLEX
|
12
|
6.08e-01
|
8.97e-01
|
0.16200
|
-1.59e-01
|
-2.75e-02
|
3.39e-01
|
8.69e-01
|
GOMF TRANSCRIPTION COREGULATOR BINDING
|
108
|
1.99e-02
|
3.00e-01
|
0.16200
|
-1.50e-01
|
6.12e-02
|
7.17e-03
|
2.71e-01
|
GOBP ESTABLISHMENT OF MEIOTIC SPINDLE LOCALIZATION
|
6
|
7.65e-01
|
9.45e-01
|
0.16200
|
1.23e-01
|
1.05e-01
|
6.02e-01
|
6.56e-01
|
GOMF MICROTUBULE SEVERING ATPASE ACTIVITY
|
9
|
6.84e-01
|
9.17e-01
|
0.16200
|
-4.07e-02
|
-1.57e-01
|
8.33e-01
|
4.16e-01
|
GOBP POSITIVE REGULATION OF CELLULAR SENESCENCE
|
17
|
5.21e-01
|
8.69e-01
|
0.16200
|
2.50e-02
|
-1.60e-01
|
8.58e-01
|
2.54e-01
|
GOBP CELL MIGRATION IN HINDBRAIN
|
16
|
4.90e-01
|
8.57e-01
|
0.16200
|
1.23e-01
|
1.05e-01
|
3.94e-01
|
4.68e-01
|
GOBP DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION
|
28
|
3.50e-01
|
7.96e-01
|
0.16200
|
3.72e-02
|
-1.57e-01
|
7.34e-01
|
1.50e-01
|
GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC CLASS II PROTEIN COMPLEX
|
14
|
6.13e-01
|
8.98e-01
|
0.16200
|
1.14e-01
|
-1.14e-01
|
4.59e-01
|
4.59e-01
|
GOBP MITOCHONDRIAL DEPOLARIZATION
|
22
|
4.23e-01
|
8.34e-01
|
0.16100
|
-8.61e-03
|
1.61e-01
|
9.44e-01
|
1.90e-01
|
GOBP REGULATION OF TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY
|
12
|
6.58e-01
|
9.09e-01
|
0.16100
|
-1.21e-01
|
1.07e-01
|
4.68e-01
|
5.21e-01
|
GOCC PLASMA MEMBRANE SIGNALING RECEPTOR COMPLEX
|
179
|
5.12e-04
|
3.16e-02
|
0.16100
|
5.41e-02
|
1.52e-01
|
2.12e-01
|
4.50e-04
|
GOBP POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE
|
18
|
4.51e-01
|
8.45e-01
|
0.16100
|
-1.28e-01
|
-9.84e-02
|
3.48e-01
|
4.70e-01
|
GOBP CILIARY NEUROTROPHIC FACTOR MEDIATED SIGNALING PATHWAY
|
5
|
8.10e-01
|
9.59e-01
|
0.16100
|
1.55e-01
|
4.55e-02
|
5.49e-01
|
8.60e-01
|
GOBP POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY
|
19
|
5.16e-01
|
8.69e-01
|
0.16100
|
1.06e-01
|
-1.21e-01
|
4.22e-01
|
3.60e-01
|
GOMF LYSOPHOSPHATIDIC ACID BINDING
|
7
|
7.69e-01
|
9.47e-01
|
0.16100
|
-3.61e-02
|
1.57e-01
|
8.69e-01
|
4.72e-01
|
GOBP POLYPRENOL METABOLIC PROCESS
|
23
|
3.74e-01
|
8.11e-01
|
0.16100
|
-5.93e-02
|
-1.50e-01
|
6.22e-01
|
2.13e-01
|
GOBP PEPTIDYL LYSINE METHYLATION
|
48
|
1.51e-01
|
6.38e-01
|
0.16100
|
-1.61e-01
|
2.37e-03
|
5.34e-02
|
9.77e-01
|
GOBP REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES
|
13
|
5.84e-01
|
8.90e-01
|
0.16100
|
3.11e-02
|
1.58e-01
|
8.46e-01
|
3.24e-01
|
GOBP POSITIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY
|
31
|
2.85e-01
|
7.57e-01
|
0.16100
|
1.60e-01
|
1.68e-02
|
1.22e-01
|
8.71e-01
|
GOCC DENDRITE TERMINUS
|
12
|
6.19e-01
|
9.00e-01
|
0.16100
|
1.61e-01
|
7.27e-03
|
3.34e-01
|
9.65e-01
|
GOBP REGULATION OF FIBROBLAST PROLIFERATION
|
87
|
3.30e-02
|
3.70e-01
|
0.16100
|
2.56e-03
|
-1.61e-01
|
9.67e-01
|
9.39e-03
|
GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY
|
14
|
5.57e-01
|
8.82e-01
|
0.16100
|
-1.56e-01
|
-4.03e-02
|
3.12e-01
|
7.94e-01
|
GOBP REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY
|
23
|
3.66e-01
|
8.07e-01
|
0.16100
|
8.37e-02
|
1.38e-01
|
4.87e-01
|
2.53e-01
|
GOMF D LOOP DNA BINDING
|
5
|
8.41e-01
|
9.66e-01
|
0.16100
|
-1.16e-01
|
1.12e-01
|
6.54e-01
|
6.65e-01
|
GOBP LYMPH VESSEL DEVELOPMENT
|
31
|
2.93e-01
|
7.63e-01
|
0.16100
|
3.43e-03
|
1.61e-01
|
9.74e-01
|
1.21e-01
|
GOMF INORGANIC PHOSPHATE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
8
|
7.16e-01
|
9.27e-01
|
0.16100
|
-1.55e-01
|
-4.26e-02
|
4.47e-01
|
8.35e-01
|
GOCC TRICARBOXYLIC ACID CYCLE ENZYME COMPLEX
|
14
|
6.13e-01
|
8.98e-01
|
0.16100
|
8.97e-02
|
-1.34e-01
|
5.61e-01
|
3.87e-01
|
GOBP RHO PROTEIN SIGNAL TRANSDUCTION
|
128
|
8.28e-03
|
1.90e-01
|
0.16100
|
-2.98e-02
|
1.58e-01
|
5.61e-01
|
2.01e-03
|
GOMF BUBBLE DNA BINDING
|
8
|
7.50e-01
|
9.40e-01
|
0.16100
|
-1.48e-01
|
6.27e-02
|
4.68e-01
|
7.59e-01
|
GOBP AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS
|
25
|
3.51e-01
|
7.96e-01
|
0.16100
|
-4.50e-02
|
-1.54e-01
|
6.97e-01
|
1.81e-01
|
GOMF NITRIC OXIDE SYNTHASE REGULATOR ACTIVITY
|
6
|
7.90e-01
|
9.54e-01
|
0.16100
|
-1.61e-01
|
2.95e-03
|
4.95e-01
|
9.90e-01
|
GOMF 1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE ACTIVITY
|
8
|
7.58e-01
|
9.44e-01
|
0.16100
|
-1.16e-01
|
1.12e-01
|
5.71e-01
|
5.84e-01
|
GOBP SINOATRIAL NODE CELL DIFFERENTIATION
|
6
|
8.04e-01
|
9.57e-01
|
0.16100
|
1.51e-01
|
-5.50e-02
|
5.22e-01
|
8.15e-01
|
GOMF NUCLEOSOMAL DNA BINDING
|
39
|
1.82e-01
|
6.72e-01
|
0.16100
|
-1.31e-01
|
-9.37e-02
|
1.58e-01
|
3.11e-01
|
GOBP REGULATION OF MITOTIC CELL CYCLE SPINDLE ASSEMBLY CHECKPOINT
|
21
|
4.03e-01
|
8.26e-01
|
0.16100
|
-7.80e-02
|
-1.40e-01
|
5.36e-01
|
2.65e-01
|
GOBP PROTEIN DEGLYCOSYLATION
|
15
|
5.24e-01
|
8.70e-01
|
0.16100
|
1.43e-01
|
7.34e-02
|
3.38e-01
|
6.22e-01
|
GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS
|
49
|
1.27e-01
|
6.07e-01
|
0.16100
|
-1.52e-01
|
-5.18e-02
|
6.57e-02
|
5.31e-01
|
GOBP FEAR RESPONSE
|
43
|
1.55e-01
|
6.42e-01
|
0.16100
|
1.38e-01
|
8.14e-02
|
1.16e-01
|
3.56e-01
|
GOMF RNA ENDONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS
|
31
|
3.35e-01
|
7.88e-01
|
0.16100
|
7.49e-02
|
-1.42e-01
|
4.71e-01
|
1.71e-01
|
GOBP NEGATIVE REGULATION OF DOPAMINE SECRETION
|
5
|
8.09e-01
|
9.59e-01
|
0.16100
|
1.50e-01
|
5.70e-02
|
5.61e-01
|
8.25e-01
|
GOBP NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS
|
272
|
7.54e-06
|
1.23e-03
|
0.16000
|
-1.22e-01
|
-1.04e-01
|
5.44e-04
|
3.01e-03
|
GOBP POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION
|
19
|
5.10e-01
|
8.66e-01
|
0.16000
|
1.44e-01
|
-7.01e-02
|
2.76e-01
|
5.97e-01
|
GOMF CALCIUM INDEPENDENT PHOSPHOLIPASE A2 ACTIVITY
|
9
|
7.08e-01
|
9.25e-01
|
0.16000
|
-1.60e-01
|
1.42e-02
|
4.06e-01
|
9.41e-01
|
GOBP T CELL MEDIATED CYTOTOXICITY
|
58
|
1.12e-01
|
5.91e-01
|
0.16000
|
1.59e-01
|
-2.40e-02
|
3.67e-02
|
7.52e-01
|
GOBP PROXIMAL TUBULE DEVELOPMENT
|
10
|
7.09e-01
|
9.25e-01
|
0.16000
|
-1.19e-01
|
1.08e-01
|
5.15e-01
|
5.56e-01
|
GOBP AORTA DEVELOPMENT
|
65
|
1.07e-01
|
5.80e-01
|
0.16000
|
-1.12e-01
|
1.15e-01
|
1.19e-01
|
1.08e-01
|
GOBP REGULATION OF OSSIFICATION
|
116
|
1.88e-02
|
2.93e-01
|
0.16000
|
-1.16e-01
|
1.10e-01
|
3.04e-02
|
4.00e-02
|
GOCC SHELTERIN COMPLEX
|
6
|
7.87e-01
|
9.53e-01
|
0.16000
|
-1.48e-02
|
-1.60e-01
|
9.50e-01
|
4.98e-01
|
GOMF NOTCH BINDING
|
23
|
4.54e-01
|
8.46e-01
|
0.16000
|
-1.10e-01
|
1.17e-01
|
3.61e-01
|
3.33e-01
|
GOBP SECONDARY METABOLIC PROCESS
|
54
|
1.32e-01
|
6.13e-01
|
0.16000
|
1.58e-01
|
-2.65e-02
|
4.45e-02
|
7.36e-01
|
GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 BINDING
|
9
|
7.10e-01
|
9.26e-01
|
0.16000
|
1.70e-02
|
-1.59e-01
|
9.30e-01
|
4.08e-01
|
GOBP REGULATION OF STORE OPERATED CALCIUM ENTRY
|
15
|
5.23e-01
|
8.70e-01
|
0.16000
|
8.28e-02
|
1.37e-01
|
5.79e-01
|
3.58e-01
|
GOBP DNA TEMPLATED DNA REPLICATION MAINTENANCE OF FIDELITY
|
54
|
1.02e-01
|
5.72e-01
|
0.16000
|
-1.48e-01
|
-6.06e-02
|
5.94e-02
|
4.41e-01
|
GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY TRANSPOSING C C BONDS
|
15
|
5.93e-01
|
8.94e-01
|
0.16000
|
8.26e-02
|
-1.37e-01
|
5.80e-01
|
3.58e-01
|
GOBP T HELPER CELL LINEAGE COMMITMENT
|
20
|
4.51e-01
|
8.44e-01
|
0.16000
|
1.51e-02
|
1.59e-01
|
9.07e-01
|
2.17e-01
|
GOBP RESPONSE TO OSMOTIC STRESS
|
78
|
6.73e-02
|
4.98e-01
|
0.16000
|
-1.36e-01
|
8.43e-02
|
3.79e-02
|
1.98e-01
|
GOBP RESPONSE TO THYROXINE
|
5
|
8.16e-01
|
9.60e-01
|
0.16000
|
1.57e-01
|
2.81e-02
|
5.42e-01
|
9.13e-01
|
GOBP POSITIVE REGULATION OF BONE MINERALIZATION
|
43
|
2.27e-01
|
7.14e-01
|
0.16000
|
-1.34e-01
|
8.80e-02
|
1.30e-01
|
3.18e-01
|
GOBP PLASMA MEMBRANE REPAIR
|
27
|
3.97e-01
|
8.25e-01
|
0.16000
|
-1.02e-01
|
1.23e-01
|
3.58e-01
|
2.68e-01
|
GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY
|
48
|
1.48e-01
|
6.35e-01
|
0.16000
|
1.59e-01
|
1.71e-02
|
5.68e-02
|
8.37e-01
|
GOCC RNA N6 METHYLADENOSINE METHYLTRANSFERASE COMPLEX
|
9
|
6.87e-01
|
9.19e-01
|
0.16000
|
5.12e-02
|
1.51e-01
|
7.90e-01
|
4.32e-01
|
GOBP NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT
|
24
|
3.55e-01
|
7.97e-01
|
0.16000
|
-8.59e-02
|
-1.35e-01
|
4.67e-01
|
2.53e-01
|
GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC
|
15
|
5.99e-01
|
8.95e-01
|
0.16000
|
1.19e-01
|
-1.06e-01
|
4.24e-01
|
4.75e-01
|
GOMF PEROXISOME TARGETING SEQUENCE BINDING
|
5
|
8.20e-01
|
9.60e-01
|
0.16000
|
1.43e-02
|
1.59e-01
|
9.56e-01
|
5.38e-01
|
GOBP RESPONSE TO DSRNA
|
53
|
1.35e-01
|
6.16e-01
|
0.16000
|
1.76e-02
|
-1.59e-01
|
8.25e-01
|
4.55e-02
|
GOBP INTERMEDIATE FILAMENT ORGANIZATION
|
72
|
4.43e-02
|
4.29e-01
|
0.16000
|
1.01e-01
|
1.24e-01
|
1.38e-01
|
6.95e-02
|
GOBP POSITIVE REGULATION OF TISSUE REMODELING
|
23
|
3.87e-01
|
8.19e-01
|
0.16000
|
4.35e-02
|
1.54e-01
|
7.18e-01
|
2.02e-01
|
GOMF PHOSPHATASE INHIBITOR ACTIVITY
|
44
|
1.48e-01
|
6.35e-01
|
0.16000
|
1.19e-01
|
1.07e-01
|
1.73e-01
|
2.21e-01
|
GOMF L ALANINE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
9
|
7.36e-01
|
9.34e-01
|
0.16000
|
1.08e-01
|
-1.18e-01
|
5.76e-01
|
5.41e-01
|
GOBP NEGATIVE REGULATION OF GTPASE ACTIVITY
|
20
|
4.92e-01
|
8.58e-01
|
0.16000
|
-5.99e-02
|
1.48e-01
|
6.43e-01
|
2.52e-01
|
GOBP REGULATION OF MULTICELLULAR ORGANISM GROWTH
|
63
|
9.62e-02
|
5.61e-01
|
0.16000
|
-1.57e-01
|
2.58e-02
|
3.06e-02
|
7.23e-01
|
GOBP PROTEIN K11 LINKED UBIQUITINATION
|
28
|
3.69e-01
|
8.09e-01
|
0.16000
|
5.67e-02
|
-1.49e-01
|
6.03e-01
|
1.72e-01
|
GOBP PURINE NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS
|
18
|
5.02e-01
|
8.63e-01
|
0.16000
|
-1.59e-01
|
7.14e-03
|
2.42e-01
|
9.58e-01
|
GOBP PLASMA MEMBRANE TUBULATION
|
19
|
5.21e-01
|
8.69e-01
|
0.16000
|
-9.19e-02
|
1.30e-01
|
4.88e-01
|
3.25e-01
|
GOBP REGULATION OF CELLULAR RESPONSE TO HYPOXIA
|
20
|
4.30e-01
|
8.37e-01
|
0.16000
|
-1.45e-01
|
-6.56e-02
|
2.60e-01
|
6.12e-01
|
GOBP GAP JUNCTION MEDIATED INTERCELLULAR TRANSPORT
|
6
|
8.14e-01
|
9.59e-01
|
0.15900
|
9.33e-02
|
-1.29e-01
|
6.92e-01
|
5.83e-01
|
GOBP POSITIVE REGULATION OF INTERLEUKIN 1 ALPHA PRODUCTION
|
6
|
8.13e-01
|
9.59e-01
|
0.15900
|
8.46e-02
|
-1.35e-01
|
7.20e-01
|
5.67e-01
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OR CH2 GROUPS
|
11
|
6.50e-01
|
9.07e-01
|
0.15900
|
9.70e-03
|
1.59e-01
|
9.56e-01
|
3.61e-01
|
GOBP TYPE B PANCREATIC CELL PROLIFERATION
|
27
|
3.11e-01
|
7.74e-01
|
0.15900
|
-1.12e-01
|
-1.14e-01
|
3.15e-01
|
3.07e-01
|
GOBP REGULATION OF REGULATED SECRETORY PATHWAY
|
114
|
2.10e-02
|
3.06e-01
|
0.15900
|
-1.23e-01
|
1.02e-01
|
2.38e-02
|
6.03e-02
|
GOBP INTERLEUKIN 8 PRODUCTION
|
97
|
1.70e-02
|
2.77e-01
|
0.15900
|
-6.67e-02
|
-1.45e-01
|
2.56e-01
|
1.38e-02
|
GOBP RESPIRATORY ELECTRON TRANSPORT CHAIN
|
107
|
1.40e-02
|
2.57e-01
|
0.15900
|
-2.52e-02
|
-1.57e-01
|
6.53e-01
|
4.94e-03
|
GOBP POSITIVE REGULATION OF MACROPHAGE ACTIVATION
|
30
|
3.62e-01
|
8.03e-01
|
0.15900
|
1.10e-01
|
-1.15e-01
|
2.99e-01
|
2.74e-01
|
GOBP TRANSLATIONAL INITIATION
|
108
|
1.76e-02
|
2.83e-01
|
0.15900
|
1.63e-02
|
-1.58e-01
|
7.70e-01
|
4.48e-03
|
GOBP POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING
|
21
|
4.05e-01
|
8.26e-01
|
0.15900
|
1.03e-01
|
1.21e-01
|
4.12e-01
|
3.38e-01
|
GOBP REGULATION OF HISTONE MODIFICATION
|
36
|
2.44e-01
|
7.25e-01
|
0.15900
|
-1.59e-01
|
-1.32e-02
|
9.98e-02
|
8.91e-01
|
GOBP REGULATION OF HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE
|
10
|
6.51e-01
|
9.07e-01
|
0.15900
|
-1.28e-01
|
-9.48e-02
|
4.85e-01
|
6.04e-01
|
GOBP ACTIVATION OF GTPASE ACTIVITY
|
90
|
4.31e-02
|
4.26e-01
|
0.15900
|
-6.31e-02
|
1.46e-01
|
3.01e-01
|
1.67e-02
|
GOBP METANEPHRIC MESENCHYME DEVELOPMENT
|
14
|
6.01e-01
|
8.96e-01
|
0.15900
|
-3.66e-02
|
1.55e-01
|
8.13e-01
|
3.16e-01
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS
|
60
|
7.70e-02
|
5.23e-01
|
0.15900
|
-9.17e-02
|
-1.30e-01
|
2.19e-01
|
8.20e-02
|
GOBP MEMBRANE RAFT ASSEMBLY
|
11
|
6.25e-01
|
9.01e-01
|
0.15900
|
9.08e-02
|
1.30e-01
|
6.02e-01
|
4.54e-01
|
GOBP PYRAMIDAL NEURON DIFFERENTIATION
|
12
|
6.28e-01
|
9.02e-01
|
0.15900
|
-1.59e-01
|
-5.50e-03
|
3.41e-01
|
9.74e-01
|
GOBP PLATELET AGGREGATION
|
71
|
6.28e-02
|
4.83e-01
|
0.15900
|
1.12e-02
|
1.59e-01
|
8.71e-01
|
2.09e-02
|
GOCC POLYSOME
|
60
|
1.01e-01
|
5.70e-01
|
0.15900
|
2.30e-03
|
-1.59e-01
|
9.75e-01
|
3.33e-02
|
GOMF CHEMOREPELLENT ACTIVITY
|
28
|
3.04e-01
|
7.68e-01
|
0.15900
|
1.35e-01
|
8.41e-02
|
2.17e-01
|
4.41e-01
|
GOBP REGULATION OF MESODERMAL CELL DIFFERENTIATION
|
9
|
6.79e-01
|
9.14e-01
|
0.15900
|
1.06e-01
|
1.18e-01
|
5.82e-01
|
5.38e-01
|
GOBP REGULATION OF CALCIUM ION TRANSPORT
|
241
|
9.63e-05
|
9.04e-03
|
0.15900
|
6.71e-03
|
1.59e-01
|
8.58e-01
|
2.20e-05
|
GOBP LIPOPROTEIN METABOLIC PROCESS
|
129
|
6.37e-03
|
1.66e-01
|
0.15900
|
-1.58e-01
|
-1.78e-02
|
1.97e-03
|
7.27e-01
|
GOBP GOLGI VESICLE TRANSPORT
|
283
|
1.19e-05
|
1.81e-03
|
0.15900
|
-1.54e-01
|
-3.89e-02
|
8.33e-06
|
2.60e-01
|
GOBP SUBSTRATE ADHESION DEPENDENT CELL SPREADING
|
99
|
2.42e-02
|
3.30e-01
|
0.15900
|
-1.06e-02
|
1.58e-01
|
8.55e-01
|
6.45e-03
|
GOMF MAP KINASE TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY
|
11
|
6.25e-01
|
9.01e-01
|
0.15900
|
9.27e-02
|
1.29e-01
|
5.95e-01
|
4.59e-01
|
GOCC LOW DENSITY LIPOPROTEIN PARTICLE
|
12
|
6.58e-01
|
9.09e-01
|
0.15900
|
-6.52e-02
|
1.45e-01
|
6.96e-01
|
3.85e-01
|
GOBP MITOCHONDRIAL FUSION
|
32
|
2.69e-01
|
7.44e-01
|
0.15900
|
-1.51e-01
|
-5.03e-02
|
1.41e-01
|
6.22e-01
|
GOBP HEART VALVE DEVELOPMENT
|
72
|
8.60e-02
|
5.45e-01
|
0.15900
|
-1.35e-01
|
8.34e-02
|
4.75e-02
|
2.21e-01
|
GOBP CELLULAR DETOXIFICATION OF ALDEHYDE
|
9
|
7.34e-01
|
9.34e-01
|
0.15900
|
7.66e-02
|
-1.39e-01
|
6.91e-01
|
4.70e-01
|
GOBP GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION
|
12
|
5.98e-01
|
8.95e-01
|
0.15900
|
1.22e-01
|
1.01e-01
|
4.64e-01
|
5.43e-01
|
GOBP REGULATION OF TRANSLATION INITIATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS
|
8
|
7.25e-01
|
9.30e-01
|
0.15900
|
-3.45e-02
|
-1.55e-01
|
8.66e-01
|
4.48e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM
|
10
|
7.13e-01
|
9.27e-01
|
0.15900
|
-9.32e-02
|
1.28e-01
|
6.10e-01
|
4.82e-01
|
GOBP DETECTION OF STIMULUS
|
576
|
1.74e-09
|
2.23e-06
|
0.15900
|
1.53e-01
|
-4.12e-02
|
3.35e-10
|
9.12e-02
|
GOCC GOLGI CISTERNA MEMBRANE
|
73
|
5.39e-02
|
4.59e-01
|
0.15900
|
-1.55e-01
|
-3.30e-02
|
2.20e-02
|
6.26e-01
|
GOBP THROMBOPOIETIN MEDIATED SIGNALING PATHWAY
|
5
|
8.21e-01
|
9.60e-01
|
0.15800
|
-2.16e-02
|
-1.57e-01
|
9.33e-01
|
5.43e-01
|
GOBP CGMP METABOLIC PROCESS
|
16
|
5.78e-01
|
8.89e-01
|
0.15800
|
7.66e-02
|
-1.39e-01
|
5.96e-01
|
3.37e-01
|
GOBP RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS
|
54
|
1.14e-01
|
5.91e-01
|
0.15800
|
-1.54e-01
|
-3.90e-02
|
5.10e-02
|
6.20e-01
|
GOBP NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS
|
19
|
5.12e-01
|
8.66e-01
|
0.15800
|
-1.49e-01
|
5.23e-02
|
2.59e-01
|
6.93e-01
|
GOCC SODIUM CHANNEL COMPLEX
|
24
|
4.47e-01
|
8.41e-01
|
0.15800
|
1.07e-01
|
-1.16e-01
|
3.63e-01
|
3.23e-01
|
GOBP CELLULAR COMPONENT MAINTENANCE
|
71
|
8.34e-02
|
5.37e-01
|
0.15800
|
-1.48e-01
|
5.57e-02
|
3.08e-02
|
4.17e-01
|
GOCC SITE OF DOUBLE STRAND BREAK
|
82
|
3.08e-02
|
3.61e-01
|
0.15800
|
-9.80e-02
|
-1.24e-01
|
1.25e-01
|
5.19e-02
|
GOBP TRNA METHYLATION
|
40
|
1.87e-01
|
6.78e-01
|
0.15800
|
-1.38e-01
|
-7.66e-02
|
1.30e-01
|
4.02e-01
|
GOMF 3 5 DNA HELICASE ACTIVITY
|
15
|
5.44e-01
|
8.78e-01
|
0.15800
|
-4.52e-02
|
-1.52e-01
|
7.62e-01
|
3.09e-01
|
GOBP REGULATION OF NOREPINEPHRINE SECRETION
|
13
|
5.75e-01
|
8.89e-01
|
0.15800
|
1.26e-01
|
9.62e-02
|
4.33e-01
|
5.48e-01
|
GOBP POSITIVE REGULATION OF GONADOTROPIN SECRETION
|
7
|
7.59e-01
|
9.44e-01
|
0.15800
|
-1.57e-01
|
-2.19e-02
|
4.73e-01
|
9.20e-01
|
GOBP DNA REPLICATION SYNTHESIS OF RNA PRIMER
|
6
|
8.09e-01
|
9.59e-01
|
0.15800
|
4.80e-02
|
-1.51e-01
|
8.39e-01
|
5.23e-01
|
GOBP FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY
|
31
|
3.39e-01
|
7.91e-01
|
0.15800
|
-5.76e-02
|
1.47e-01
|
5.79e-01
|
1.56e-01
|
GOBP TRNA PROCESSING
|
128
|
5.10e-03
|
1.48e-01
|
0.15800
|
-6.46e-02
|
-1.44e-01
|
2.07e-01
|
4.82e-03
|
GOBP REGULATION OF SPINDLE ASSEMBLY
|
32
|
2.59e-01
|
7.37e-01
|
0.15800
|
-1.32e-01
|
-8.75e-02
|
1.98e-01
|
3.92e-01
|
GOBP POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS
|
54
|
1.17e-01
|
5.97e-01
|
0.15800
|
-1.55e-01
|
-3.25e-02
|
4.93e-02
|
6.80e-01
|
GOBP POSITIVE REGULATION OF AXONOGENESIS
|
72
|
9.10e-02
|
5.51e-01
|
0.15800
|
-1.09e-01
|
1.14e-01
|
1.08e-01
|
9.45e-02
|
GOBP PROTEIN MONOUBIQUITINATION
|
41
|
1.75e-01
|
6.65e-01
|
0.15800
|
-1.18e-01
|
-1.05e-01
|
1.92e-01
|
2.43e-01
|
GOBP LYTIC VACUOLE ORGANIZATION
|
103
|
2.13e-02
|
3.09e-01
|
0.15800
|
-1.58e-01
|
7.63e-03
|
5.67e-03
|
8.94e-01
|
GOBP SPONTANEOUS SYNAPTIC TRANSMISSION
|
14
|
6.24e-01
|
9.01e-01
|
0.15800
|
-8.64e-02
|
1.32e-01
|
5.76e-01
|
3.92e-01
|
GOBP SEMAPHORIN PLEXIN SIGNALING PATHWAY
|
41
|
1.98e-01
|
6.88e-01
|
0.15800
|
2.76e-02
|
1.55e-01
|
7.60e-01
|
8.50e-02
|
GOBP CARBOHYDRATE CATABOLIC PROCESS
|
154
|
2.02e-03
|
8.28e-02
|
0.15800
|
-1.50e-01
|
-4.80e-02
|
1.28e-03
|
3.04e-01
|
GOBP REGULATION OF FLAGELLATED SPERM MOTILITY
|
18
|
4.71e-01
|
8.52e-01
|
0.15800
|
-7.76e-02
|
-1.37e-01
|
5.69e-01
|
3.13e-01
|
GOMF CATALYTIC ACTIVITY ACTING ON A GLYCOPROTEIN
|
22
|
4.58e-01
|
8.48e-01
|
0.15800
|
-4.22e-02
|
1.52e-01
|
7.32e-01
|
2.17e-01
|
GOMF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY
|
27
|
3.20e-01
|
7.78e-01
|
0.15800
|
1.28e-01
|
9.23e-02
|
2.50e-01
|
4.07e-01
|
GOBP CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT
|
25
|
3.89e-01
|
8.20e-01
|
0.15800
|
-1.34e-03
|
1.58e-01
|
9.91e-01
|
1.72e-01
|
GOBP REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST
|
42
|
2.04e-01
|
6.94e-01
|
0.15800
|
-2.97e-04
|
-1.58e-01
|
9.97e-01
|
7.69e-02
|
GOBP REGULATION OF RETROGRADE TRANSPORT ENDOSOME TO GOLGI
|
7
|
7.43e-01
|
9.38e-01
|
0.15800
|
1.06e-01
|
1.17e-01
|
6.27e-01
|
5.93e-01
|
GOBP NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY
|
33
|
3.04e-01
|
7.69e-01
|
0.15800
|
-3.03e-02
|
1.55e-01
|
7.63e-01
|
1.24e-01
|
GOBP POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION
|
61
|
8.51e-02
|
5.41e-01
|
0.15800
|
-4.82e-02
|
-1.50e-01
|
5.15e-01
|
4.25e-02
|
GOBP METANEPHRIC NEPHRON DEVELOPMENT
|
40
|
2.65e-01
|
7.41e-01
|
0.15800
|
-1.10e-01
|
1.13e-01
|
2.27e-01
|
2.18e-01
|
GOBP GROWTH HORMONE SECRETION
|
13
|
6.49e-01
|
9.07e-01
|
0.15800
|
1.02e-01
|
-1.21e-01
|
5.26e-01
|
4.52e-01
|
GOCC LIPID DROPLET
|
93
|
3.31e-02
|
3.70e-01
|
0.15800
|
-1.57e-01
|
1.75e-02
|
9.04e-03
|
7.71e-01
|
GOBP PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT
|
16
|
5.39e-01
|
8.78e-01
|
0.15800
|
-1.53e-02
|
-1.57e-01
|
9.15e-01
|
2.77e-01
|
GOMF PROTEIN KINASE C BINDING
|
50
|
1.60e-01
|
6.48e-01
|
0.15800
|
-1.76e-02
|
1.57e-01
|
8.30e-01
|
5.55e-02
|
GOBP HETEROTYPIC CELL CELL ADHESION
|
61
|
1.10e-01
|
5.87e-01
|
0.15800
|
-2.73e-02
|
1.55e-01
|
7.13e-01
|
3.61e-02
|
GOBP OXIDATIVE RNA DEMETHYLATION
|
5
|
8.23e-01
|
9.61e-01
|
0.15800
|
-1.93e-02
|
-1.56e-01
|
9.41e-01
|
5.45e-01
|
GOMF OXIDATIVE RNA DEMETHYLASE ACTIVITY
|
5
|
8.23e-01
|
9.61e-01
|
0.15800
|
-1.93e-02
|
-1.56e-01
|
9.41e-01
|
5.45e-01
|
GOBP POSITIVE REGULATION OF AUTOPHAGOSOME MATURATION
|
7
|
7.67e-01
|
9.46e-01
|
0.15800
|
1.08e-03
|
1.58e-01
|
9.96e-01
|
4.71e-01
|
GOMF POLY A SPECIFIC RIBONUCLEASE ACTIVITY
|
13
|
5.83e-01
|
8.90e-01
|
0.15700
|
-7.49e-02
|
-1.39e-01
|
6.40e-01
|
3.87e-01
|
GOMF METHYL CPG BINDING
|
24
|
4.06e-01
|
8.26e-01
|
0.15700
|
-1.57e-01
|
1.52e-03
|
1.82e-01
|
9.90e-01
|
GOBP BONE MATURATION
|
26
|
3.48e-01
|
7.96e-01
|
0.15700
|
-1.48e-01
|
-5.45e-02
|
1.92e-01
|
6.31e-01
|
GOBP REGULATION OF GTPASE ACTIVITY
|
279
|
6.60e-05
|
6.83e-03
|
0.15700
|
-5.03e-02
|
1.49e-01
|
1.48e-01
|
1.81e-05
|
GOBP POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE
|
26
|
3.56e-01
|
7.97e-01
|
0.15700
|
1.53e-01
|
3.80e-02
|
1.78e-01
|
7.38e-01
|
GOBP GLYCINE IMPORT ACROSS PLASMA MEMBRANE
|
5
|
8.47e-01
|
9.66e-01
|
0.15700
|
1.03e-01
|
-1.19e-01
|
6.91e-01
|
6.44e-01
|
GOBP SEROTONIN TRANSPORT
|
20
|
4.30e-01
|
8.37e-01
|
0.15700
|
1.14e-01
|
1.08e-01
|
3.76e-01
|
4.03e-01
|
GOBP ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER
|
14
|
6.28e-01
|
9.02e-01
|
0.15700
|
1.25e-01
|
-9.52e-02
|
4.17e-01
|
5.37e-01
|
GOBP POSITIVE REGULATION OF ERAD PATHWAY
|
13
|
5.99e-01
|
8.95e-01
|
0.15700
|
-3.09e-02
|
-1.54e-01
|
8.47e-01
|
3.36e-01
|
GOBP NEUROEPITHELIAL CELL DIFFERENTIATION
|
38
|
2.75e-01
|
7.49e-01
|
0.15700
|
-1.42e-01
|
6.84e-02
|
1.31e-01
|
4.66e-01
|
GOBP RAP PROTEIN SIGNAL TRANSDUCTION
|
12
|
6.05e-01
|
8.96e-01
|
0.15700
|
8.87e-02
|
1.30e-01
|
5.95e-01
|
4.36e-01
|
GOCC PCG PROTEIN COMPLEX
|
35
|
2.54e-01
|
7.32e-01
|
0.15700
|
-1.54e-01
|
-2.93e-02
|
1.14e-01
|
7.64e-01
|
GOBP MACROMOLECULE DEACYLATION
|
63
|
1.03e-01
|
5.75e-01
|
0.15700
|
-1.55e-01
|
2.60e-02
|
3.33e-02
|
7.22e-01
|
GOBP CELLULAR METABOLIC COMPOUND SALVAGE
|
29
|
3.66e-01
|
8.06e-01
|
0.15700
|
-1.49e-01
|
5.11e-02
|
1.66e-01
|
6.34e-01
|
GOBP FATTY ACID DERIVATIVE CATABOLIC PROCESS
|
16
|
5.33e-01
|
8.76e-01
|
0.15700
|
-1.54e-01
|
-3.20e-02
|
2.87e-01
|
8.25e-01
|
GOBP REGULATION OF FATTY ACID TRANSPORT
|
31
|
3.38e-01
|
7.90e-01
|
0.15700
|
-4.55e-02
|
1.50e-01
|
6.61e-01
|
1.48e-01
|
GOBP ONE CARBON COMPOUND TRANSPORT
|
60
|
8.95e-02
|
5.51e-01
|
0.15700
|
5.21e-02
|
1.48e-01
|
4.85e-01
|
4.73e-02
|
GOBP ACTIN FILAMENT BUNDLE ORGANIZATION
|
160
|
4.33e-03
|
1.34e-01
|
0.15700
|
-6.06e-02
|
1.45e-01
|
1.86e-01
|
1.57e-03
|
GOBP NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING
|
34
|
3.27e-01
|
7.82e-01
|
0.15700
|
-1.10e-01
|
1.12e-01
|
2.68e-01
|
2.58e-01
|
GOBP REGULATION OF LEUKOCYTE ADHESION TO ARTERIAL ENDOTHELIAL CELL
|
5
|
8.46e-01
|
9.66e-01
|
0.15700
|
-1.36e-01
|
7.80e-02
|
5.98e-01
|
7.62e-01
|
GOMF LIGAND GATED MONOATOMIC CATION CHANNEL ACTIVITY
|
108
|
1.80e-02
|
2.86e-01
|
0.15700
|
-7.34e-04
|
1.57e-01
|
9.89e-01
|
4.86e-03
|
GOBP REGULATION OF AUTOPHAGY
|
338
|
1.53e-05
|
2.14e-03
|
0.15700
|
-1.32e-01
|
8.41e-02
|
2.90e-05
|
7.90e-03
|
GOBP NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION
|
14
|
5.57e-01
|
8.82e-01
|
0.15700
|
-9.69e-02
|
-1.23e-01
|
5.30e-01
|
4.25e-01
|
GOCC PHAGOPHORE ASSEMBLY SITE
|
37
|
2.53e-01
|
7.32e-01
|
0.15700
|
-1.57e-01
|
3.28e-03
|
9.91e-02
|
9.72e-01
|
GOBP COPII COATED VESICLE BUDDING
|
42
|
2.01e-01
|
6.90e-01
|
0.15700
|
-1.56e-01
|
-1.59e-02
|
8.04e-02
|
8.59e-01
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS DISULFIDE AS ACCEPTOR
|
7
|
7.51e-01
|
9.40e-01
|
0.15700
|
-6.63e-02
|
-1.42e-01
|
7.61e-01
|
5.15e-01
|
GOBP ACTIN FILAMENT NETWORK FORMATION
|
8
|
7.47e-01
|
9.39e-01
|
0.15700
|
-1.46e-02
|
1.56e-01
|
9.43e-01
|
4.45e-01
|
GOBP POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH
|
31
|
3.31e-01
|
7.85e-01
|
0.15700
|
-1.54e-01
|
2.80e-02
|
1.38e-01
|
7.87e-01
|
GOBP CHROMATIN LOOPING
|
11
|
6.94e-01
|
9.21e-01
|
0.15700
|
1.32e-01
|
-8.34e-02
|
4.47e-01
|
6.32e-01
|
GOBP REGULATION OF EXIT FROM MITOSIS
|
18
|
4.98e-01
|
8.61e-01
|
0.15600
|
1.54e-01
|
2.61e-02
|
2.57e-01
|
8.48e-01
|
GOBP COLLAGEN METABOLIC PROCESS
|
103
|
2.18e-02
|
3.13e-01
|
0.15600
|
1.10e-03
|
1.56e-01
|
9.85e-01
|
6.08e-03
|
GOBP CORTISOL METABOLIC PROCESS
|
12
|
6.09e-01
|
8.97e-01
|
0.15600
|
-1.31e-01
|
-8.49e-02
|
4.31e-01
|
6.11e-01
|
GOMF CLATHRIN LIGHT CHAIN BINDING
|
7
|
7.92e-01
|
9.54e-01
|
0.15600
|
-1.34e-01
|
8.09e-02
|
5.40e-01
|
7.11e-01
|
GOBP GMP METABOLIC PROCESS
|
25
|
3.61e-01
|
8.03e-01
|
0.15600
|
-6.84e-02
|
-1.41e-01
|
5.54e-01
|
2.23e-01
|
GOBP PYRIDINE CONTAINING COMPOUND CATABOLIC PROCESS
|
8
|
7.67e-01
|
9.46e-01
|
0.15600
|
8.19e-02
|
-1.33e-01
|
6.88e-01
|
5.14e-01
|
GOMF L GLUTAMATE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
14
|
5.76e-01
|
8.89e-01
|
0.15600
|
1.51e-01
|
3.94e-02
|
3.27e-01
|
7.99e-01
|
GOBP RESPONSE TO LEAD ION
|
19
|
5.37e-01
|
8.78e-01
|
0.15600
|
-1.19e-01
|
1.02e-01
|
3.71e-01
|
4.42e-01
|
GOBP HINDLIMB MORPHOGENESIS
|
35
|
2.98e-01
|
7.67e-01
|
0.15600
|
-4.70e-02
|
1.49e-01
|
6.30e-01
|
1.27e-01
|
GOBP TERTIARY ALCOHOL METABOLIC PROCESS
|
22
|
4.46e-01
|
8.40e-01
|
0.15600
|
7.29e-03
|
-1.56e-01
|
9.53e-01
|
2.05e-01
|
GOBP ALDEHYDE CATABOLIC PROCESS
|
14
|
5.64e-01
|
8.85e-01
|
0.15600
|
-7.37e-02
|
-1.38e-01
|
6.33e-01
|
3.72e-01
|
GOMF SMAD BINDING
|
75
|
8.08e-02
|
5.31e-01
|
0.15600
|
-6.74e-02
|
1.41e-01
|
3.13e-01
|
3.48e-02
|
GOBP NEGATIVE REGULATION OF AMYLOID FIBRIL FORMATION
|
12
|
6.45e-01
|
9.07e-01
|
0.15600
|
1.09e-02
|
-1.56e-01
|
9.48e-01
|
3.50e-01
|
GOCC SPLICEOSOMAL TRI SNRNP COMPLEX
|
39
|
2.43e-01
|
7.25e-01
|
0.15600
|
1.45e-02
|
-1.56e-01
|
8.75e-01
|
9.28e-02
|
GOBP NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS
|
12
|
6.37e-01
|
9.06e-01
|
0.15600
|
-1.56e-01
|
-7.26e-03
|
3.49e-01
|
9.65e-01
|
GOBP SUBSTRATE DEPENDENT CELL MIGRATION CELL EXTENSION
|
8
|
7.24e-01
|
9.30e-01
|
0.15600
|
6.31e-02
|
1.43e-01
|
7.57e-01
|
4.84e-01
|
GOBP T CELL PROLIFERATION INVOLVED IN IMMUNE RESPONSE
|
5
|
8.12e-01
|
9.59e-01
|
0.15600
|
-1.13e-01
|
-1.08e-01
|
6.62e-01
|
6.76e-01
|
GOBP ADAPTATION OF SIGNALING PATHWAY
|
20
|
4.93e-01
|
8.58e-01
|
0.15600
|
-3.04e-02
|
1.53e-01
|
8.14e-01
|
2.36e-01
|
GOMF VOLTAGE GATED MONOATOMIC ANION CHANNEL ACTIVITY
|
14
|
6.04e-01
|
8.96e-01
|
0.15600
|
-1.55e-01
|
1.80e-02
|
3.15e-01
|
9.07e-01
|
GOBP CALCIUM MEDIATED SIGNALING
|
203
|
6.73e-04
|
3.96e-02
|
0.15600
|
-1.31e-02
|
1.55e-01
|
7.47e-01
|
1.34e-04
|
GOBP REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS
|
30
|
2.94e-01
|
7.63e-01
|
0.15600
|
1.36e-01
|
7.68e-02
|
1.98e-01
|
4.66e-01
|
GOBP AXON CHOICE POINT RECOGNITION
|
7
|
7.93e-01
|
9.55e-01
|
0.15600
|
8.01e-02
|
-1.34e-01
|
7.14e-01
|
5.40e-01
|
GOBP NEGATIVE REGULATION OF ACTION POTENTIAL
|
6
|
8.11e-01
|
9.59e-01
|
0.15600
|
-1.51e-01
|
3.83e-02
|
5.21e-01
|
8.71e-01
|
GOBP RESPONSE TO FOLIC ACID
|
9
|
7.19e-01
|
9.29e-01
|
0.15600
|
5.50e-03
|
-1.56e-01
|
9.77e-01
|
4.18e-01
|
GOMF PHOSPHATIDYLINOSITOL BISPHOSPHATE BINDING
|
103
|
3.29e-02
|
3.70e-01
|
0.15600
|
-7.39e-02
|
1.37e-01
|
1.95e-01
|
1.60e-02
|
GOBP NAD TRANSPORT
|
5
|
8.17e-01
|
9.60e-01
|
0.15600
|
-1.42e-01
|
-6.36e-02
|
5.81e-01
|
8.05e-01
|
GOBP HISTONE MODIFICATION
|
106
|
2.08e-02
|
3.05e-01
|
0.15600
|
-1.56e-01
|
5.44e-03
|
5.56e-03
|
9.23e-01
|
GOBP POSITIVE REGULATION OF RECEPTOR INTERNALIZATION
|
26
|
3.76e-01
|
8.11e-01
|
0.15600
|
-1.56e-01
|
-1.09e-02
|
1.70e-01
|
9.23e-01
|
GOCC RNA POLYMERASE II TRANSCRIPTION REPRESSOR COMPLEX
|
15
|
5.52e-01
|
8.80e-01
|
0.15600
|
-1.48e-01
|
-4.88e-02
|
3.21e-01
|
7.43e-01
|
GOBP UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS
|
14
|
6.29e-01
|
9.02e-01
|
0.15600
|
7.79e-02
|
-1.35e-01
|
6.14e-01
|
3.82e-01
|
GOBP NEGATIVE REGULATION OF FIBRINOLYSIS
|
13
|
5.95e-01
|
8.95e-01
|
0.15600
|
-5.68e-02
|
-1.45e-01
|
7.23e-01
|
3.65e-01
|
GOBP CORNEA DEVELOPMENT IN CAMERA TYPE EYE
|
12
|
6.66e-01
|
9.11e-01
|
0.15600
|
-1.45e-01
|
5.62e-02
|
3.83e-01
|
7.36e-01
|
GOBP CELL CYCLE G2 M PHASE TRANSITION
|
147
|
2.40e-03
|
9.44e-02
|
0.15600
|
-9.86e-02
|
-1.21e-01
|
3.91e-02
|
1.16e-02
|
GOMF COMPLEMENT COMPONENT C1Q COMPLEX BINDING
|
8
|
7.70e-01
|
9.48e-01
|
0.15600
|
1.24e-01
|
-9.39e-02
|
5.43e-01
|
6.45e-01
|
GOMF POLYAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
10
|
6.65e-01
|
9.10e-01
|
0.15600
|
1.34e-01
|
8.02e-02
|
4.65e-01
|
6.61e-01
|
GOCC SPERM PLASMA MEMBRANE
|
14
|
5.96e-01
|
8.95e-01
|
0.15600
|
-2.25e-03
|
-1.56e-01
|
9.88e-01
|
3.13e-01
|
GOMF ADENOSINE 3 5 BISPHOSPHATE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
5
|
8.47e-01
|
9.66e-01
|
0.15600
|
1.38e-01
|
-7.17e-02
|
5.93e-01
|
7.81e-01
|
GOBP MUCOPOLYSACCHARIDE METABOLIC PROCESS
|
89
|
4.96e-02
|
4.42e-01
|
0.15600
|
-1.45e-01
|
5.54e-02
|
1.77e-02
|
3.66e-01
|
GOBP PROTEIN DESUMOYLATION
|
8
|
7.72e-01
|
9.48e-01
|
0.15600
|
1.14e-01
|
-1.06e-01
|
5.75e-01
|
6.05e-01
|
GOBP REGULATION OF CARDIOBLAST DIFFERENTIATION
|
5
|
8.28e-01
|
9.62e-01
|
0.15600
|
1.44e-02
|
1.55e-01
|
9.55e-01
|
5.49e-01
|
GOBP REGULATION OF DNA CATABOLIC PROCESS
|
11
|
6.40e-01
|
9.06e-01
|
0.15500
|
-7.50e-02
|
-1.36e-01
|
6.67e-01
|
4.34e-01
|
GOBP REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE
|
103
|
3.35e-02
|
3.72e-01
|
0.15500
|
-1.38e-01
|
7.11e-02
|
1.54e-02
|
2.12e-01
|
GOBP MITOCHONDRIAL FISSION
|
40
|
2.63e-01
|
7.40e-01
|
0.15500
|
6.37e-02
|
-1.42e-01
|
4.86e-01
|
1.21e-01
|
GOBP WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY
|
5
|
8.22e-01
|
9.61e-01
|
0.15500
|
-1.49e-01
|
-4.32e-02
|
5.63e-01
|
8.67e-01
|
GOBP SPERMATID NUCLEUS DIFFERENTIATION
|
27
|
3.94e-01
|
8.23e-01
|
0.15500
|
-1.50e-01
|
3.88e-02
|
1.76e-01
|
7.27e-01
|
GOCC INO80 TYPE COMPLEX
|
26
|
4.02e-01
|
8.26e-01
|
0.15500
|
-1.53e-01
|
2.94e-02
|
1.78e-01
|
7.95e-01
|
GOBP SMOOTH MUSCLE CELL APOPTOTIC PROCESS
|
32
|
3.35e-01
|
7.88e-01
|
0.15500
|
4.49e-02
|
-1.49e-01
|
6.60e-01
|
1.45e-01
|
GOBP NATURAL KILLER CELL CHEMOTAXIS
|
10
|
6.91e-01
|
9.20e-01
|
0.15500
|
5.92e-03
|
1.55e-01
|
9.74e-01
|
3.96e-01
|
GOMF GTPASE BINDING
|
297
|
7.81e-05
|
7.69e-03
|
0.15500
|
-1.06e-01
|
1.13e-01
|
1.65e-03
|
7.78e-04
|
GOBP GLYOXYLATE METABOLIC PROCESS
|
8
|
7.23e-01
|
9.30e-01
|
0.15500
|
-7.86e-02
|
-1.34e-01
|
7.00e-01
|
5.12e-01
|
GOBP REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING
|
37
|
2.25e-01
|
7.13e-01
|
0.15500
|
-1.36e-01
|
-7.41e-02
|
1.51e-01
|
4.35e-01
|
GOMF PHOSPHOLIPID SCRAMBLASE ACTIVITY
|
15
|
5.78e-01
|
8.89e-01
|
0.15500
|
2.71e-03
|
-1.55e-01
|
9.86e-01
|
2.98e-01
|
GOBP HYALOID VASCULAR PLEXUS REGRESSION
|
7
|
7.96e-01
|
9.55e-01
|
0.15500
|
1.31e-01
|
-8.40e-02
|
5.50e-01
|
7.00e-01
|
GOBP ISOCITRATE METABOLIC PROCESS
|
5
|
8.47e-01
|
9.66e-01
|
0.15500
|
6.54e-02
|
-1.41e-01
|
8.00e-01
|
5.86e-01
|
GOBP RIBOSOMAL SMALL SUBUNIT ASSEMBLY
|
18
|
5.53e-01
|
8.80e-01
|
0.15500
|
7.25e-02
|
-1.37e-01
|
5.94e-01
|
3.14e-01
|
GOBP NEPHRON TUBULE FORMATION
|
20
|
5.25e-01
|
8.71e-01
|
0.15500
|
-1.14e-01
|
1.05e-01
|
3.78e-01
|
4.14e-01
|
GOBP GAMMA AMINOBUTYRIC ACID IMPORT
|
6
|
7.88e-01
|
9.53e-01
|
0.15500
|
6.11e-02
|
1.43e-01
|
7.95e-01
|
5.46e-01
|
GOMF JUN KINASE KINASE KINASE ACTIVITY
|
11
|
6.73e-01
|
9.13e-01
|
0.15500
|
-1.55e-01
|
8.85e-03
|
3.74e-01
|
9.59e-01
|
GOBP KETONE BIOSYNTHETIC PROCESS
|
48
|
1.50e-01
|
6.36e-01
|
0.15500
|
-5.90e-02
|
-1.43e-01
|
4.80e-01
|
8.58e-02
|
GOBP AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION
|
14
|
5.83e-01
|
8.90e-01
|
0.15500
|
1.50e-01
|
3.72e-02
|
3.30e-01
|
8.10e-01
|
GOBP MULTICELLULAR ORGANISMAL LEVEL IRON ION HOMEOSTASIS
|
25
|
4.18e-01
|
8.32e-01
|
0.15500
|
-2.86e-02
|
1.52e-01
|
8.05e-01
|
1.88e-01
|
GOBP CELLULAR RESPONSE TO THYROID HORMONE STIMULUS
|
16
|
5.80e-01
|
8.90e-01
|
0.15500
|
-1.48e-01
|
4.40e-02
|
3.04e-01
|
7.60e-01
|
GOBP CIRCADIAN SLEEP WAKE CYCLE NON REM SLEEP
|
6
|
7.83e-01
|
9.52e-01
|
0.15500
|
1.24e-01
|
9.25e-02
|
5.99e-01
|
6.95e-01
|
GOMF CARGO RECEPTOR ACTIVITY
|
63
|
9.02e-02
|
5.51e-01
|
0.15500
|
-1.51e-01
|
-3.33e-02
|
3.81e-02
|
6.47e-01
|
GOBP POSITIVE REGULATION OF MIRNA METABOLIC PROCESS
|
60
|
9.70e-02
|
5.61e-01
|
0.15500
|
-1.47e-01
|
-4.72e-02
|
4.84e-02
|
5.27e-01
|
GOMF CARBOXYLESTERASE ACTIVITY
|
6
|
8.08e-01
|
9.59e-01
|
0.15400
|
1.34e-02
|
-1.54e-01
|
9.55e-01
|
5.14e-01
|
GOBP AUTOPHAGY OF PEROXISOME
|
10
|
6.70e-01
|
9.11e-01
|
0.15400
|
-7.42e-02
|
-1.35e-01
|
6.84e-01
|
4.58e-01
|
GOBP POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS
|
38
|
2.76e-01
|
7.50e-01
|
0.15400
|
-1.48e-01
|
4.38e-02
|
1.14e-01
|
6.40e-01
|
GOMF SH3 DOMAIN BINDING
|
114
|
2.55e-02
|
3.32e-01
|
0.15400
|
-7.99e-02
|
1.32e-01
|
1.41e-01
|
1.49e-02
|
GOBP MESENCHYMAL CELL PROLIFERATION
|
43
|
2.29e-01
|
7.18e-01
|
0.15400
|
-3.41e-02
|
1.50e-01
|
6.99e-01
|
8.79e-02
|
GOMF LACTATE DEHYDROGENASE ACTIVITY
|
6
|
8.18e-01
|
9.60e-01
|
0.15400
|
5.15e-02
|
-1.45e-01
|
8.27e-01
|
5.38e-01
|
GOBP POSITIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION
|
16
|
5.74e-01
|
8.88e-01
|
0.15400
|
-2.59e-02
|
1.52e-01
|
8.58e-01
|
2.93e-01
|
GOBP EXCITATORY SYNAPSE ASSEMBLY
|
31
|
3.32e-01
|
7.86e-01
|
0.15400
|
-1.54e-01
|
9.92e-03
|
1.38e-01
|
9.24e-01
|
GOBP GLYCOLYTIC PROCESS
|
85
|
4.25e-02
|
4.25e-01
|
0.15400
|
-1.53e-01
|
-2.05e-02
|
1.49e-02
|
7.44e-01
|
GOBP PROTEIN RNA COMPLEX ORGANIZATION
|
205
|
4.83e-04
|
3.03e-02
|
0.15400
|
-2.61e-02
|
-1.52e-01
|
5.19e-01
|
1.78e-04
|
GOBP POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION
|
25
|
4.00e-01
|
8.26e-01
|
0.15400
|
1.01e-02
|
1.54e-01
|
9.31e-01
|
1.84e-01
|
GOBP REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS
|
14
|
6.30e-01
|
9.03e-01
|
0.15400
|
5.89e-02
|
-1.42e-01
|
7.03e-01
|
3.57e-01
|
GOBP POSITIVE REGULATION OF CAMP MEDIATED SIGNALING
|
15
|
5.47e-01
|
8.78e-01
|
0.15400
|
1.23e-01
|
9.29e-02
|
4.11e-01
|
5.33e-01
|
GOCC U5 SNRNP
|
22
|
4.27e-01
|
8.36e-01
|
0.15400
|
-5.08e-02
|
-1.45e-01
|
6.80e-01
|
2.38e-01
|
GOMF DIACYLGLYCEROL BINDING
|
13
|
6.57e-01
|
9.09e-01
|
0.15400
|
-7.56e-02
|
1.34e-01
|
6.37e-01
|
4.03e-01
|
GOBP N TERMINAL PROTEIN LIPIDATION
|
6
|
8.20e-01
|
9.60e-01
|
0.15400
|
5.73e-02
|
-1.43e-01
|
8.08e-01
|
5.45e-01
|
GOBP LAMELLIPODIUM ORGANIZATION
|
86
|
5.75e-02
|
4.68e-01
|
0.15400
|
-5.00e-02
|
1.45e-01
|
4.23e-01
|
1.97e-02
|
GOBP CELL REDOX HOMEOSTASIS
|
38
|
2.16e-01
|
7.07e-01
|
0.15400
|
-1.11e-01
|
-1.07e-01
|
2.38e-01
|
2.55e-01
|
GOBP REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT
|
9
|
7.31e-01
|
9.32e-01
|
0.15400
|
-2.18e-02
|
1.52e-01
|
9.10e-01
|
4.29e-01
|
GOCC NODE OF RANVIER
|
16
|
5.84e-01
|
8.90e-01
|
0.15400
|
1.48e-01
|
-4.22e-02
|
3.06e-01
|
7.70e-01
|
GOMF BH DOMAIN BINDING
|
9
|
7.11e-01
|
9.27e-01
|
0.15400
|
-1.50e-01
|
-3.36e-02
|
4.36e-01
|
8.61e-01
|
GOBP STRESS FIBER ASSEMBLY
|
108
|
3.02e-02
|
3.61e-01
|
0.15400
|
-6.68e-02
|
1.38e-01
|
2.30e-01
|
1.29e-02
|
GOBP UREA TRANSPORT
|
11
|
6.74e-01
|
9.13e-01
|
0.15400
|
-1.54e-01
|
1.88e-03
|
3.77e-01
|
9.91e-01
|
GOBP LOCOMOTORY EXPLORATION BEHAVIOR
|
14
|
6.43e-01
|
9.07e-01
|
0.15400
|
1.06e-01
|
-1.11e-01
|
4.91e-01
|
4.72e-01
|
GOBP RIBOSOMAL SMALL SUBUNIT BIOGENESIS
|
100
|
2.11e-02
|
3.07e-01
|
0.15400
|
-5.34e-02
|
-1.44e-01
|
3.56e-01
|
1.28e-02
|
GOBP POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION
|
6
|
8.03e-01
|
9.57e-01
|
0.15400
|
1.53e-01
|
1.00e-02
|
5.16e-01
|
9.66e-01
|
GOMF G PROTEIN ALPHA SUBUNIT BINDING
|
29
|
3.12e-01
|
7.75e-01
|
0.15400
|
1.05e-01
|
1.13e-01
|
3.30e-01
|
2.94e-01
|
GOBP CELL SUBSTRATE JUNCTION ORGANIZATION
|
100
|
3.83e-02
|
4.00e-01
|
0.15400
|
-6.02e-02
|
1.41e-01
|
2.98e-01
|
1.46e-02
|
GOBP HEAT GENERATION
|
17
|
5.16e-01
|
8.69e-01
|
0.15300
|
5.90e-02
|
1.42e-01
|
6.74e-01
|
3.12e-01
|
GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT KINASE ACTIVITY
|
10
|
6.96e-01
|
9.21e-01
|
0.15300
|
-1.53e-01
|
-7.70e-03
|
4.01e-01
|
9.66e-01
|
GOBP TRIF DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY
|
11
|
6.86e-01
|
9.18e-01
|
0.15300
|
-1.51e-01
|
2.69e-02
|
3.86e-01
|
8.77e-01
|
GOBP VISUAL BEHAVIOR
|
55
|
1.16e-01
|
5.96e-01
|
0.15300
|
6.77e-02
|
1.38e-01
|
3.85e-01
|
7.74e-02
|
GOBP NEUTROPHIL HOMEOSTASIS
|
20
|
4.61e-01
|
8.48e-01
|
0.15300
|
1.42e-01
|
5.74e-02
|
2.71e-01
|
6.57e-01
|
GOBP REGULATION OF PLATELET ACTIVATION
|
47
|
1.77e-01
|
6.67e-01
|
0.15300
|
2.02e-02
|
1.52e-01
|
8.10e-01
|
7.14e-02
|
GOBP CELLULAR SENESCENCE
|
106
|
1.58e-02
|
2.65e-01
|
0.15300
|
-7.14e-02
|
-1.36e-01
|
2.04e-01
|
1.58e-02
|
GOBP PROTEIN PEPTIDYL PROLYL ISOMERIZATION
|
18
|
5.62e-01
|
8.84e-01
|
0.15300
|
7.47e-02
|
-1.34e-01
|
5.83e-01
|
3.26e-01
|
GOMF FLOPPASE ACTIVITY
|
15
|
6.20e-01
|
9.00e-01
|
0.15300
|
-8.01e-02
|
1.31e-01
|
5.91e-01
|
3.81e-01
|
GOBP REGULATION OF MRNA 3 END PROCESSING
|
12
|
6.47e-01
|
9.07e-01
|
0.15300
|
1.53e-01
|
1.14e-02
|
3.60e-01
|
9.46e-01
|
GOBP LIPID TRANSPORT ACROSS BLOOD BRAIN BARRIER
|
6
|
8.29e-01
|
9.62e-01
|
0.15300
|
-1.07e-01
|
1.09e-01
|
6.49e-01
|
6.44e-01
|
GOBP FACE MORPHOGENESIS
|
30
|
3.53e-01
|
7.97e-01
|
0.15300
|
-1.70e-02
|
1.52e-01
|
8.72e-01
|
1.49e-01
|
GOBP MDA 5 SIGNALING PATHWAY
|
10
|
7.30e-01
|
9.32e-01
|
0.15300
|
9.29e-02
|
-1.22e-01
|
6.11e-01
|
5.05e-01
|
GOBP NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS
|
36
|
2.49e-01
|
7.27e-01
|
0.15300
|
-1.41e-01
|
-5.90e-02
|
1.43e-01
|
5.40e-01
|
GOBP REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT
|
16
|
5.49e-01
|
8.80e-01
|
0.15300
|
3.36e-02
|
1.49e-01
|
8.16e-01
|
3.01e-01
|
GOBP PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION
|
38
|
2.58e-01
|
7.35e-01
|
0.15300
|
1.53e-01
|
2.51e-03
|
1.03e-01
|
9.79e-01
|
GOBP LYSOSOMAL TRANSPORT
|
128
|
1.56e-02
|
2.64e-01
|
0.15300
|
-1.43e-01
|
5.55e-02
|
5.36e-03
|
2.78e-01
|
GOBP POSITIVE REGULATION OF FILOPODIUM ASSEMBLY
|
28
|
3.29e-01
|
7.84e-01
|
0.15300
|
9.21e-02
|
1.22e-01
|
3.99e-01
|
2.63e-01
|
GOBP ISOTYPE SWITCHING TO IGA ISOTYPES
|
8
|
7.42e-01
|
9.37e-01
|
0.15300
|
1.50e-01
|
2.99e-02
|
4.63e-01
|
8.84e-01
|
GOBP NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION
|
15
|
6.23e-01
|
9.01e-01
|
0.15300
|
-8.54e-02
|
1.27e-01
|
5.67e-01
|
3.95e-01
|
GOBP NEURAL PLATE DEVELOPMENT
|
8
|
7.45e-01
|
9.38e-01
|
0.15300
|
2.07e-02
|
1.51e-01
|
9.19e-01
|
4.58e-01
|
GOBP MEMBRANE INVAGINATION
|
62
|
1.45e-01
|
6.29e-01
|
0.15300
|
-1.07e-01
|
1.09e-01
|
1.43e-01
|
1.39e-01
|
GOBP NEURAL CREST CELL MIGRATION INVOLVED IN AUTONOMIC NERVOUS SYSTEM DEVELOPMENT
|
6
|
8.28e-01
|
9.62e-01
|
0.15300
|
1.20e-01
|
-9.47e-02
|
6.11e-01
|
6.88e-01
|
GOBP NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY
|
50
|
2.08e-01
|
6.97e-01
|
0.15300
|
-8.85e-02
|
1.25e-01
|
2.79e-01
|
1.27e-01
|
GOBP REGULATION OF LAMELLIPODIUM ORGANIZATION
|
49
|
1.98e-01
|
6.88e-01
|
0.15300
|
-4.42e-02
|
1.46e-01
|
5.92e-01
|
7.64e-02
|
GOBP REGULATION OF CARBOHYDRATE CATABOLIC PROCESS
|
61
|
9.19e-02
|
5.52e-01
|
0.15300
|
-1.33e-01
|
-7.53e-02
|
7.24e-02
|
3.09e-01
|
GOBP GRANZYME MEDIATED PROGRAMMED CELL DEATH SIGNALING PATHWAY
|
8
|
7.77e-01
|
9.50e-01
|
0.15300
|
-8.79e-02
|
1.25e-01
|
6.67e-01
|
5.41e-01
|
GOBP MORPHOGENESIS OF AN EPITHELIAL BUD
|
14
|
5.80e-01
|
8.90e-01
|
0.15300
|
-1.37e-01
|
-6.78e-02
|
3.75e-01
|
6.60e-01
|
GOMF ACETYLCHOLINE RECEPTOR INHIBITOR ACTIVITY
|
6
|
8.29e-01
|
9.62e-01
|
0.15300
|
1.23e-01
|
-9.03e-02
|
6.02e-01
|
7.02e-01
|
GOBP PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS
|
28
|
3.89e-01
|
8.20e-01
|
0.15300
|
-1.50e-01
|
3.02e-02
|
1.71e-01
|
7.82e-01
|
GOBP MUCUS SECRETION
|
18
|
4.99e-01
|
8.62e-01
|
0.15200
|
-1.39e-01
|
-6.33e-02
|
3.08e-01
|
6.42e-01
|
GOBP PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY
|
26
|
3.92e-01
|
8.22e-01
|
0.15200
|
1.17e-02
|
1.52e-01
|
9.17e-01
|
1.80e-01
|
GOCC POSTSYNAPTIC CYTOSOL
|
13
|
6.61e-01
|
9.09e-01
|
0.15200
|
-1.36e-01
|
6.79e-02
|
3.95e-01
|
6.72e-01
|
GOBP BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS
|
12
|
6.62e-01
|
9.10e-01
|
0.15200
|
1.51e-01
|
-1.76e-02
|
3.64e-01
|
9.16e-01
|
GOCC CILIARY MEMBRANE
|
72
|
8.38e-02
|
5.37e-01
|
0.15200
|
-1.52e-01
|
1.31e-02
|
2.61e-02
|
8.48e-01
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON OTHER NITROGENOUS COMPOUNDS AS DONORS
|
9
|
7.26e-01
|
9.30e-01
|
0.15200
|
6.66e-03
|
1.52e-01
|
9.72e-01
|
4.30e-01
|
GOCC NUCLEAR UBIQUITIN LIGASE COMPLEX
|
42
|
2.17e-01
|
7.07e-01
|
0.15200
|
-2.15e-02
|
-1.51e-01
|
8.10e-01
|
9.11e-02
|
GOBP NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS
|
50
|
1.39e-01
|
6.23e-01
|
0.15200
|
-1.08e-01
|
-1.07e-01
|
1.86e-01
|
1.91e-01
|
GOBP PROTEIN LOCALIZATION TO LYSOSOME
|
57
|
1.60e-01
|
6.48e-01
|
0.15200
|
-1.40e-01
|
5.85e-02
|
6.67e-02
|
4.45e-01
|
GOBP POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION
|
27
|
4.34e-01
|
8.38e-01
|
0.15200
|
-1.02e-01
|
1.13e-01
|
3.60e-01
|
3.09e-01
|
GOBP SPLICEOSOMAL COMPLEX ASSEMBLY
|
75
|
7.71e-02
|
5.23e-01
|
0.15200
|
1.64e-02
|
-1.51e-01
|
8.06e-01
|
2.36e-02
|
GOBP NEGATIVE REGULATION OF TYPE B PANCREATIC CELL APOPTOTIC PROCESS
|
6
|
8.28e-01
|
9.62e-01
|
0.15200
|
-7.78e-02
|
1.31e-01
|
7.41e-01
|
5.80e-01
|
GOMF ACTIN FILAMENT BINDING
|
203
|
1.47e-03
|
6.73e-02
|
0.15200
|
-5.26e-02
|
1.43e-01
|
1.96e-01
|
4.59e-04
|
GOBP REGULATION OF PROTEIN EXPORT FROM NUCLEUS
|
32
|
2.87e-01
|
7.59e-01
|
0.15200
|
-8.30e-02
|
-1.27e-01
|
4.17e-01
|
2.12e-01
|
GOBP OLFACTORY BULB INTERNEURON DEVELOPMENT
|
7
|
7.72e-01
|
9.48e-01
|
0.15200
|
-1.48e-01
|
-3.31e-02
|
4.97e-01
|
8.79e-01
|
GOCC CTF18 RFC LIKE COMPLEX
|
7
|
7.85e-01
|
9.52e-01
|
0.15200
|
9.79e-03
|
-1.52e-01
|
9.64e-01
|
4.87e-01
|
GOMF NUCLEOCYTOPLASMIC CARRIER ACTIVITY
|
32
|
2.84e-01
|
7.57e-01
|
0.15200
|
-1.16e-01
|
-9.82e-02
|
2.56e-01
|
3.36e-01
|
GOBP POSITIVE REGULATION OF CHROMOSOME SEGREGATION
|
27
|
3.48e-01
|
7.96e-01
|
0.15200
|
-8.55e-02
|
-1.26e-01
|
4.42e-01
|
2.59e-01
|
GOBP UTERUS DEVELOPMENT
|
23
|
4.29e-01
|
8.36e-01
|
0.15200
|
-1.49e-01
|
-3.16e-02
|
2.17e-01
|
7.93e-01
|
GOBP MYELOID CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE
|
95
|
4.99e-02
|
4.43e-01
|
0.15200
|
-6.92e-02
|
1.35e-01
|
2.44e-01
|
2.27e-02
|
GOMF PROTEIN CONTAINING COMPLEX DESTABILIZING ACTIVITY
|
15
|
5.55e-01
|
8.81e-01
|
0.15200
|
-9.36e-02
|
-1.20e-01
|
5.30e-01
|
4.22e-01
|
GOBP MITOCHONDRION LOCALIZATION
|
46
|
1.64e-01
|
6.49e-01
|
0.15200
|
1.01e-01
|
1.13e-01
|
2.35e-01
|
1.83e-01
|
GOBP REGULATION OF AMPA RECEPTOR ACTIVITY
|
23
|
4.49e-01
|
8.43e-01
|
0.15200
|
-1.52e-01
|
4.66e-03
|
2.08e-01
|
9.69e-01
|
GOBP HINDBRAIN MORPHOGENESIS
|
43
|
2.19e-01
|
7.07e-01
|
0.15200
|
-5.99e-03
|
-1.52e-01
|
9.46e-01
|
8.52e-02
|
GOBP NEUROMUSCULAR PROCESS CONTROLLING BALANCE
|
51
|
2.01e-01
|
6.90e-01
|
0.15200
|
-7.10e-02
|
1.34e-01
|
3.80e-01
|
9.74e-02
|
GOMF PATTERN RECOGNITION RECEPTOR ACTIVITY
|
32
|
3.01e-01
|
7.67e-01
|
0.15200
|
-1.44e-01
|
-4.73e-02
|
1.58e-01
|
6.43e-01
|
GOBP GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS
|
34
|
3.50e-01
|
7.96e-01
|
0.15200
|
-9.45e-02
|
1.19e-01
|
3.40e-01
|
2.31e-01
|
GOBP LENS FIBER CELL DEVELOPMENT
|
14
|
6.05e-01
|
8.96e-01
|
0.15200
|
1.51e-01
|
1.51e-02
|
3.28e-01
|
9.22e-01
|
GOBP EXCRETION
|
29
|
3.93e-01
|
8.22e-01
|
0.15200
|
5.17e-02
|
-1.43e-01
|
6.30e-01
|
1.84e-01
|
GOBP NEGATIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY
|
12
|
6.74e-01
|
9.13e-01
|
0.15200
|
3.79e-02
|
-1.47e-01
|
8.20e-01
|
3.79e-01
|
GOBP RESPONSE TO ERYTHROPOIETIN
|
7
|
8.04e-01
|
9.57e-01
|
0.15200
|
8.04e-02
|
-1.29e-01
|
7.13e-01
|
5.56e-01
|
GOBP MAINTENANCE OF PROTEIN LOCATION
|
85
|
5.41e-02
|
4.60e-01
|
0.15100
|
-1.51e-01
|
8.84e-03
|
1.59e-02
|
8.88e-01
|
GOBP POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION
|
43
|
2.54e-01
|
7.32e-01
|
0.15100
|
-1.40e-01
|
5.71e-02
|
1.11e-01
|
5.17e-01
|
GOBP INTRACELLULAR NITROGEN HOMEOSTASIS
|
5
|
8.57e-01
|
9.68e-01
|
0.15100
|
-8.90e-02
|
1.23e-01
|
7.30e-01
|
6.35e-01
|
GOBP SYNCYTIUM FORMATION
|
65
|
7.96e-02
|
5.27e-01
|
0.15100
|
1.18e-01
|
9.44e-02
|
9.87e-02
|
1.88e-01
|
GOMF PROTEIN MEMBRANE ADAPTOR ACTIVITY
|
36
|
2.49e-01
|
7.27e-01
|
0.15100
|
-1.29e-01
|
-7.92e-02
|
1.80e-01
|
4.11e-01
|
GOMF CALCIUM DEPENDENT PROTEIN KINASE ACTIVITY
|
23
|
4.91e-01
|
8.58e-01
|
0.15100
|
-8.65e-02
|
1.24e-01
|
4.73e-01
|
3.02e-01
|
GOBP POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS
|
10
|
7.15e-01
|
9.27e-01
|
0.15100
|
-2.34e-02
|
1.50e-01
|
8.98e-01
|
4.13e-01
|
GOMF HIGH DENSITY LIPOPROTEIN PARTICLE BINDING
|
13
|
6.11e-01
|
8.98e-01
|
0.15100
|
6.09e-02
|
1.39e-01
|
7.04e-01
|
3.87e-01
|
GOMF FOUR WAY JUNCTION DNA BINDING
|
16
|
5.36e-01
|
8.77e-01
|
0.15100
|
-9.69e-02
|
-1.16e-01
|
5.02e-01
|
4.21e-01
|
GOBP REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY
|
28
|
4.01e-01
|
8.26e-01
|
0.15100
|
-4.12e-02
|
1.46e-01
|
7.06e-01
|
1.82e-01
|
GOCC PROTEIN COMPLEX INVOLVED IN CELL MATRIX ADHESION
|
17
|
5.59e-01
|
8.82e-01
|
0.15100
|
1.51e-01
|
-1.02e-02
|
2.81e-01
|
9.42e-01
|
GOBP INTERSTRAND CROSS LINK REPAIR
|
37
|
2.67e-01
|
7.43e-01
|
0.15100
|
-1.63e-02
|
-1.50e-01
|
8.63e-01
|
1.13e-01
|
GOBP POSITIVE REGULATION OF CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY
|
6
|
8.11e-01
|
9.59e-01
|
0.15100
|
-1.05e-03
|
-1.51e-01
|
9.96e-01
|
5.21e-01
|
GOBP NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE
|
89
|
3.24e-02
|
3.68e-01
|
0.15100
|
-8.37e-02
|
-1.26e-01
|
1.72e-01
|
4.00e-02
|
GOBP MACROPHAGE CHEMOTAXIS
|
41
|
2.70e-01
|
7.45e-01
|
0.15100
|
-1.41e-01
|
5.44e-02
|
1.18e-01
|
5.47e-01
|
GOMF BETA N ACETYLHEXOSAMINIDASE ACTIVITY
|
5
|
8.34e-01
|
9.64e-01
|
0.15100
|
-1.49e-01
|
-2.59e-02
|
5.64e-01
|
9.20e-01
|
GOBP METAPHASE CHROMOSOME ALIGNMENT
|
97
|
2.31e-02
|
3.22e-01
|
0.15100
|
-1.07e-01
|
-1.06e-01
|
6.76e-02
|
7.00e-02
|
GOBP POSITIVE REGULATION OF CORTICOSTEROID HORMONE SECRETION
|
7
|
7.84e-01
|
9.52e-01
|
0.15100
|
-1.51e-01
|
9.61e-04
|
4.89e-01
|
9.96e-01
|
GOBP LINOLEIC ACID METABOLIC PROCESS
|
20
|
4.62e-01
|
8.48e-01
|
0.15100
|
-1.26e-01
|
-8.29e-02
|
3.28e-01
|
5.21e-01
|
GOBP SKELETAL MUSCLE TISSUE REGENERATION
|
37
|
2.54e-01
|
7.32e-01
|
0.15100
|
-4.51e-02
|
-1.44e-01
|
6.35e-01
|
1.29e-01
|
GOCC EXTRINSIC COMPONENT OF POSTSYNAPTIC MEMBRANE
|
7
|
7.83e-01
|
9.52e-01
|
0.15100
|
5.69e-03
|
1.51e-01
|
9.79e-01
|
4.89e-01
|
GOMF HEXOSE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
25
|
4.63e-01
|
8.48e-01
|
0.15100
|
-8.30e-02
|
1.26e-01
|
4.73e-01
|
2.75e-01
|
GOBP URETER DEVELOPMENT
|
18
|
5.06e-01
|
8.65e-01
|
0.15100
|
-1.37e-01
|
-6.30e-02
|
3.14e-01
|
6.44e-01
|
GOMF PRENYLTRANSFERASE ACTIVITY
|
16
|
5.81e-01
|
8.90e-01
|
0.15100
|
-1.50e-01
|
1.24e-02
|
2.98e-01
|
9.32e-01
|
GOBP C TERMINAL PROTEIN AMINO ACID MODIFICATION
|
12
|
6.28e-01
|
9.02e-01
|
0.15100
|
-1.08e-01
|
-1.05e-01
|
5.16e-01
|
5.29e-01
|
GOCC LAMELLAR BODY
|
17
|
5.85e-01
|
8.90e-01
|
0.15100
|
1.38e-01
|
-6.07e-02
|
3.24e-01
|
6.65e-01
|
GOCC RNA POLYMERASE TRANSCRIPTION FACTOR SL1 COMPLEX
|
5
|
8.43e-01
|
9.66e-01
|
0.15100
|
9.67e-03
|
-1.50e-01
|
9.70e-01
|
5.60e-01
|
GOMF STRUCTURAL CONSTITUENT OF MUSCLE
|
41
|
2.80e-01
|
7.52e-01
|
0.15100
|
-7.14e-02
|
1.33e-01
|
4.29e-01
|
1.41e-01
|
GOBP ADHESION OF SYMBIONT TO HOST CELL
|
8
|
7.65e-01
|
9.45e-01
|
0.15100
|
1.94e-02
|
-1.50e-01
|
9.24e-01
|
4.64e-01
|
GOBP POSTSYNAPTIC SPECIALIZATION ORGANIZATION
|
41
|
2.05e-01
|
6.95e-01
|
0.15100
|
-1.18e-01
|
-9.41e-02
|
1.92e-01
|
2.97e-01
|
GOBP NUCLEOTIDE EXCISION REPAIR
|
81
|
6.87e-02
|
5.00e-01
|
0.15100
|
-1.49e-01
|
2.60e-02
|
2.08e-02
|
6.86e-01
|
GOMF STEROL TRANSFER ACTIVITY
|
23
|
4.88e-01
|
8.56e-01
|
0.15100
|
-1.34e-01
|
6.89e-02
|
2.66e-01
|
5.67e-01
|
GOBP REGULATION OF SEROTONIN SECRETION
|
6
|
7.96e-01
|
9.55e-01
|
0.15100
|
1.33e-01
|
7.18e-02
|
5.74e-01
|
7.61e-01
|
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE
|
17
|
5.77e-01
|
8.89e-01
|
0.15100
|
4.13e-02
|
-1.45e-01
|
7.68e-01
|
3.01e-01
|
GOMF 3 5 RNA HELICASE ACTIVITY
|
6
|
8.10e-01
|
9.59e-01
|
0.15100
|
-9.89e-03
|
-1.50e-01
|
9.67e-01
|
5.24e-01
|
GOBP NEURON REMODELING
|
15
|
5.92e-01
|
8.93e-01
|
0.15100
|
-8.10e-03
|
-1.50e-01
|
9.57e-01
|
3.13e-01
|
GOBP MRNA EXPORT FROM NUCLEUS
|
62
|
1.06e-01
|
5.79e-01
|
0.15100
|
-1.47e-01
|
-3.22e-02
|
4.51e-02
|
6.61e-01
|
GOMF DNA ENDONUCLEASE ACTIVITY PRODUCING 3 PHOSPHOMONOESTERS
|
9
|
7.06e-01
|
9.24e-01
|
0.15100
|
-1.14e-01
|
-9.85e-02
|
5.54e-01
|
6.09e-01
|
GOBP EOSINOPHIL MIGRATION
|
29
|
3.89e-01
|
8.20e-01
|
0.15100
|
-1.46e-01
|
3.55e-02
|
1.73e-01
|
7.41e-01
|
GOBP MITOTIC NUCLEAR MEMBRANE DISASSEMBLY
|
7
|
8.03e-01
|
9.57e-01
|
0.15100
|
-6.44e-02
|
1.36e-01
|
7.68e-01
|
5.33e-01
|
GOMF POTASSIUM CHANNEL ACTIVITY
|
120
|
1.21e-02
|
2.36e-01
|
0.15100
|
1.43e-01
|
4.72e-02
|
6.83e-03
|
3.72e-01
|
GOBP PROTEIN LOCALIZATION TO CYTOSKELETON
|
57
|
1.32e-01
|
6.13e-01
|
0.15100
|
-1.49e-01
|
-1.93e-02
|
5.12e-02
|
8.01e-01
|
GOMF PHOSPHATIDYLGLYCEROL BINDING
|
15
|
6.05e-01
|
8.96e-01
|
0.15000
|
-1.65e-02
|
1.50e-01
|
9.12e-01
|
3.16e-01
|
GOBP REGULATION OF COLLAGEN METABOLIC PROCESS
|
41
|
2.42e-01
|
7.25e-01
|
0.15000
|
3.80e-03
|
1.50e-01
|
9.66e-01
|
9.57e-02
|
GOBP AXO DENDRITIC PROTEIN TRANSPORT
|
9
|
7.08e-01
|
9.25e-01
|
0.15000
|
8.51e-02
|
1.24e-01
|
6.58e-01
|
5.20e-01
|
GOMF SPHINGOSINE 1 PHOSPHATE PHOSPHATASE ACTIVITY
|
7
|
7.95e-01
|
9.55e-01
|
0.15000
|
2.88e-02
|
-1.48e-01
|
8.95e-01
|
4.99e-01
|
GOBP SURFACTANT HOMEOSTASIS
|
17
|
5.89e-01
|
8.92e-01
|
0.15000
|
6.55e-02
|
-1.35e-01
|
6.40e-01
|
3.34e-01
|
GOBP REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE
|
170
|
4.92e-03
|
1.45e-01
|
0.15000
|
-1.39e-01
|
5.65e-02
|
1.73e-03
|
2.04e-01
|
GOMF METAL CLUSTER BINDING
|
66
|
9.41e-02
|
5.57e-01
|
0.15000
|
-1.48e-01
|
-2.83e-02
|
3.81e-02
|
6.91e-01
|
GOCC RPAP3 R2TP PREFOLDIN LIKE COMPLEX
|
10
|
7.39e-01
|
9.35e-01
|
0.15000
|
1.01e-01
|
-1.11e-01
|
5.80e-01
|
5.43e-01
|
GOCC RESPIRASOME
|
85
|
4.77e-02
|
4.38e-01
|
0.15000
|
-2.90e-02
|
-1.47e-01
|
6.43e-01
|
1.88e-02
|
GOBP ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS
|
24
|
4.60e-01
|
8.48e-01
|
0.15000
|
3.70e-02
|
-1.46e-01
|
7.54e-01
|
2.17e-01
|
GOBP POSITIVE REGULATION OF HORMONE METABOLIC PROCESS
|
15
|
5.82e-01
|
8.90e-01
|
0.15000
|
1.46e-01
|
3.38e-02
|
3.27e-01
|
8.21e-01
|
GOBP NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY
|
26
|
4.57e-01
|
8.48e-01
|
0.15000
|
-9.99e-02
|
1.12e-01
|
3.78e-01
|
3.23e-01
|
GOBP REGULATION OF ATP DEPENDENT ACTIVITY
|
61
|
1.35e-01
|
6.16e-01
|
0.15000
|
-1.48e-01
|
2.33e-02
|
4.53e-02
|
7.53e-01
|
GOMF L ASPARTATE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
9
|
7.23e-01
|
9.30e-01
|
0.15000
|
-3.36e-02
|
-1.46e-01
|
8.61e-01
|
4.48e-01
|
GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DEDIFFERENTIATION
|
5
|
8.36e-01
|
9.64e-01
|
0.15000
|
-1.47e-01
|
-2.75e-02
|
5.68e-01
|
9.15e-01
|
GOBP TRANSLOCATION OF MOLECULES INTO HOST
|
7
|
7.68e-01
|
9.46e-01
|
0.15000
|
-1.32e-01
|
-7.16e-02
|
5.46e-01
|
7.43e-01
|
GOBP HISTONE H3 ACETYLATION
|
6
|
8.04e-01
|
9.57e-01
|
0.15000
|
-4.03e-02
|
-1.44e-01
|
8.64e-01
|
5.40e-01
|
GOBP GLYCEROL TRANSMEMBRANE TRANSPORT
|
7
|
7.66e-01
|
9.45e-01
|
0.15000
|
8.78e-02
|
1.21e-01
|
6.87e-01
|
5.78e-01
|
GOMF GLYCEROL TRANSMEMBRANE TRANSPORTER ACTIVITY
|
7
|
7.66e-01
|
9.45e-01
|
0.15000
|
8.78e-02
|
1.21e-01
|
6.87e-01
|
5.78e-01
|
GOBP REGULATION OF BASEMENT MEMBRANE ORGANIZATION
|
11
|
7.08e-01
|
9.25e-01
|
0.15000
|
-1.40e-01
|
5.22e-02
|
4.20e-01
|
7.64e-01
|
GOBP PROTEIN C LINKED GLYCOSYLATION
|
5
|
8.35e-01
|
9.64e-01
|
0.15000
|
-1.45e-01
|
-3.65e-02
|
5.74e-01
|
8.88e-01
|
GOMF RNA POLYMERASE II ACTIVITY
|
9
|
7.63e-01
|
9.45e-01
|
0.15000
|
-9.91e-02
|
1.12e-01
|
6.07e-01
|
5.60e-01
|
GOBP INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY
|
25
|
4.35e-01
|
8.38e-01
|
0.15000
|
-1.31e-02
|
1.49e-01
|
9.09e-01
|
1.97e-01
|
GOBP MEMBRANE DEPOLARIZATION
|
78
|
5.14e-02
|
4.48e-01
|
0.15000
|
1.09e-01
|
1.03e-01
|
9.67e-02
|
1.17e-01
|
GOBP HEAD MORPHOGENESIS
|
35
|
3.32e-01
|
7.85e-01
|
0.15000
|
-4.77e-02
|
1.42e-01
|
6.26e-01
|
1.47e-01
|
GOBP DNA STRAND RESECTION INVOLVED IN REPLICATION FORK PROCESSING
|
8
|
7.39e-01
|
9.35e-01
|
0.15000
|
-8.55e-02
|
-1.23e-01
|
6.75e-01
|
5.48e-01
|
GOMF HORMONE RECEPTOR BINDING
|
31
|
3.17e-01
|
7.77e-01
|
0.15000
|
-1.37e-01
|
-6.08e-02
|
1.88e-01
|
5.58e-01
|
GOCC AUTOPHAGOSOME
|
110
|
3.22e-02
|
3.67e-01
|
0.15000
|
-1.41e-01
|
5.07e-02
|
1.08e-02
|
3.59e-01
|
GOBP ASYMMETRIC CELL DIVISION
|
18
|
5.84e-01
|
8.90e-01
|
0.14900
|
-1.14e-01
|
9.67e-02
|
4.02e-01
|
4.78e-01
|
GOBP POSITIVE REGULATION OF CATION CHANNEL ACTIVITY
|
47
|
1.68e-01
|
6.55e-01
|
0.14900
|
1.18e-01
|
9.19e-02
|
1.62e-01
|
2.76e-01
|
GOBP MITOCHONDRIAL CALCIUM ION HOMEOSTASIS
|
24
|
4.37e-01
|
8.39e-01
|
0.14900
|
1.04e-02
|
1.49e-01
|
9.30e-01
|
2.06e-01
|
GOBP NEGATIVE REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION
|
5
|
8.44e-01
|
9.66e-01
|
0.14900
|
-2.82e-03
|
1.49e-01
|
9.91e-01
|
5.63e-01
|
GOBP FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE
|
12
|
6.77e-01
|
9.14e-01
|
0.14900
|
-1.47e-01
|
2.71e-02
|
3.78e-01
|
8.71e-01
|
GOMF ACETYLCHOLINE GATED MONOATOMIC CATION SELECTIVE CHANNEL ACTIVITY
|
23
|
4.30e-01
|
8.36e-01
|
0.14900
|
1.39e-01
|
5.52e-02
|
2.49e-01
|
6.47e-01
|
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE
|
58
|
1.62e-01
|
6.48e-01
|
0.14900
|
-1.42e-01
|
4.69e-02
|
6.19e-02
|
5.36e-01
|
GOBP CENTROSOME DUPLICATION
|
74
|
6.08e-02
|
4.78e-01
|
0.14900
|
-9.72e-02
|
-1.13e-01
|
1.48e-01
|
9.21e-02
|
GOBP CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES
|
22
|
4.43e-01
|
8.40e-01
|
0.14900
|
1.36e-01
|
6.24e-02
|
2.71e-01
|
6.13e-01
|
GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING TO IGA ISOTYPES
|
6
|
8.36e-01
|
9.64e-01
|
0.14900
|
1.20e-01
|
-8.89e-02
|
6.11e-01
|
7.06e-01
|
GOBP NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION
|
28
|
3.61e-01
|
8.03e-01
|
0.14900
|
-1.40e-01
|
-5.06e-02
|
1.99e-01
|
6.43e-01
|
GOCC MICROTUBULE PLUS END
|
24
|
4.15e-01
|
8.30e-01
|
0.14900
|
-5.50e-02
|
-1.39e-01
|
6.41e-01
|
2.40e-01
|
GOBP MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE
|
41
|
2.49e-01
|
7.27e-01
|
0.14900
|
-1.49e-01
|
-3.31e-03
|
9.86e-02
|
9.71e-01
|
GOBP REGULATION OF DEOXYRIBONUCLEASE ACTIVITY
|
10
|
6.95e-01
|
9.21e-01
|
0.14900
|
1.40e-01
|
5.09e-02
|
4.43e-01
|
7.81e-01
|
GOBP POSITIVE REGULATION OF HEART RATE
|
27
|
3.84e-01
|
8.17e-01
|
0.14900
|
3.00e-02
|
1.46e-01
|
7.87e-01
|
1.89e-01
|
GOMF SIALIC ACID BINDING
|
22
|
5.19e-01
|
8.69e-01
|
0.14900
|
9.46e-02
|
-1.15e-01
|
4.42e-01
|
3.50e-01
|
GOBP CERAMIDE METABOLIC PROCESS
|
106
|
1.99e-02
|
3.00e-01
|
0.14900
|
-1.33e-01
|
-6.70e-02
|
1.78e-02
|
2.33e-01
|
GOCC SIN3 TYPE COMPLEX
|
20
|
5.00e-01
|
8.62e-01
|
0.14900
|
-1.48e-01
|
-1.66e-02
|
2.52e-01
|
8.98e-01
|
GOBP HOMOTYPIC CELL CELL ADHESION
|
93
|
3.69e-02
|
3.91e-01
|
0.14900
|
3.48e-02
|
1.45e-01
|
5.62e-01
|
1.58e-02
|
GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE III PROMOTER
|
8
|
7.63e-01
|
9.45e-01
|
0.14900
|
-1.49e-01
|
-1.41e-03
|
4.66e-01
|
9.94e-01
|
GOBP GOLGI RIBBON FORMATION
|
10
|
6.87e-01
|
9.19e-01
|
0.14900
|
-8.16e-02
|
-1.25e-01
|
6.55e-01
|
4.95e-01
|
GOCC H4 HISTONE ACETYLTRANSFERASE COMPLEX
|
37
|
2.62e-01
|
7.39e-01
|
0.14900
|
-1.41e-01
|
-4.84e-02
|
1.38e-01
|
6.10e-01
|
GOBP NEGATIVE REGULATION OF CYTOPLASMIC TRANSLATION
|
8
|
7.83e-01
|
9.52e-01
|
0.14900
|
6.38e-02
|
-1.34e-01
|
7.55e-01
|
5.10e-01
|
GOMF VITAMIN BINDING
|
143
|
5.31e-03
|
1.52e-01
|
0.14900
|
-6.33e-02
|
-1.35e-01
|
1.92e-01
|
5.40e-03
|
GOMF AMIDINE LYASE ACTIVITY
|
7
|
7.84e-01
|
9.52e-01
|
0.14900
|
-1.48e-01
|
-1.88e-02
|
4.99e-01
|
9.31e-01
|
GOBP FEVER GENERATION
|
11
|
6.87e-01
|
9.19e-01
|
0.14900
|
6.95e-03
|
1.49e-01
|
9.68e-01
|
3.93e-01
|
GOBP CD8 POSITIVE ALPHA BETA T CELL ACTIVATION
|
29
|
3.55e-01
|
7.97e-01
|
0.14900
|
1.44e-01
|
3.87e-02
|
1.81e-01
|
7.18e-01
|
GOMF ANAPHASE PROMOTING COMPLEX BINDING
|
9
|
7.30e-01
|
9.32e-01
|
0.14900
|
-2.41e-02
|
-1.47e-01
|
9.01e-01
|
4.46e-01
|
GOCC PML BODY
|
104
|
4.60e-02
|
4.34e-01
|
0.14900
|
-1.18e-01
|
9.10e-02
|
3.81e-02
|
1.09e-01
|
GOCC SITE OF DNA DAMAGE
|
113
|
1.51e-02
|
2.62e-01
|
0.14900
|
-7.63e-02
|
-1.28e-01
|
1.61e-01
|
1.90e-02
|
GOBP EXONUCLEOLYTIC CATABOLISM OF DEADENYLATED MRNA
|
13
|
6.28e-01
|
9.02e-01
|
0.14900
|
1.43e-01
|
4.06e-02
|
3.72e-01
|
8.00e-01
|
GOBP INTRACELLULAR MRNA LOCALIZATION
|
13
|
6.80e-01
|
9.15e-01
|
0.14900
|
-9.21e-02
|
1.17e-01
|
5.65e-01
|
4.66e-01
|
GOCC 9PLUS0 MOTILE CILIUM
|
5
|
8.42e-01
|
9.66e-01
|
0.14900
|
1.48e-01
|
1.49e-02
|
5.67e-01
|
9.54e-01
|
GOBP EMBRYONIC PLACENTA MORPHOGENESIS
|
27
|
4.49e-01
|
8.43e-01
|
0.14900
|
1.16e-01
|
-9.23e-02
|
2.95e-01
|
4.06e-01
|
GOMF LIPASE INHIBITOR ACTIVITY
|
18
|
5.13e-01
|
8.67e-01
|
0.14900
|
-7.47e-02
|
-1.28e-01
|
5.83e-01
|
3.45e-01
|
GOBP POSITIVE REGULATION OF ACTION POTENTIAL
|
8
|
7.43e-01
|
9.37e-01
|
0.14900
|
-1.27e-01
|
-7.65e-02
|
5.33e-01
|
7.08e-01
|
GOMF SULFATIDE BINDING
|
6
|
8.05e-01
|
9.57e-01
|
0.14900
|
-5.11e-02
|
-1.39e-01
|
8.28e-01
|
5.54e-01
|
GOMF CALCIUM DEPENDENT PHOSPHOLIPASE A2 ACTIVITY
|
17
|
6.04e-01
|
8.96e-01
|
0.14900
|
9.04e-02
|
-1.18e-01
|
5.19e-01
|
4.00e-01
|
GOBP REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS
|
16
|
6.23e-01
|
9.01e-01
|
0.14900
|
-1.16e-01
|
9.23e-02
|
4.20e-01
|
5.23e-01
|
GOCC PERIKARYON
|
142
|
5.42e-03
|
1.53e-01
|
0.14900
|
1.31e-01
|
7.05e-02
|
7.16e-03
|
1.47e-01
|
GOBP DETECTION OF VISIBLE LIGHT
|
46
|
2.53e-01
|
7.32e-01
|
0.14900
|
-1.26e-01
|
7.87e-02
|
1.39e-01
|
3.56e-01
|
GOMF MONOSACCHARIDE BINDING
|
73
|
1.01e-01
|
5.69e-01
|
0.14800
|
-1.44e-01
|
3.77e-02
|
3.39e-02
|
5.78e-01
|
GOBP AEROBIC RESPIRATION
|
170
|
2.89e-03
|
1.04e-01
|
0.14800
|
-2.02e-02
|
-1.47e-01
|
6.49e-01
|
9.36e-04
|
GOBP REGULATION OF OLIGODENDROCYTE DIFFERENTIATION
|
45
|
2.66e-01
|
7.42e-01
|
0.14800
|
-1.04e-01
|
1.06e-01
|
2.27e-01
|
2.20e-01
|
GOBP THIOESTER METABOLIC PROCESS
|
89
|
4.43e-02
|
4.29e-01
|
0.14800
|
-1.45e-01
|
-3.04e-02
|
1.78e-02
|
6.20e-01
|
GOBP NEURONAL ION CHANNEL CLUSTERING
|
12
|
6.75e-01
|
9.13e-01
|
0.14800
|
1.42e-02
|
-1.48e-01
|
9.32e-01
|
3.76e-01
|
GOBP POST GOLGI VESICLE MEDIATED TRANSPORT
|
101
|
2.82e-02
|
3.48e-01
|
0.14800
|
-1.43e-01
|
-3.83e-02
|
1.28e-02
|
5.06e-01
|
GOCC SPECIFIC GRANULE
|
155
|
5.93e-03
|
1.61e-01
|
0.14800
|
-1.48e-01
|
2.94e-03
|
1.44e-03
|
9.50e-01
|
GOMF TRANSITION METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
40
|
3.04e-01
|
7.68e-01
|
0.14800
|
-1.26e-01
|
7.82e-02
|
1.68e-01
|
3.92e-01
|
GOMF N METHYLTRANSFERASE ACTIVITY
|
97
|
4.07e-02
|
4.15e-01
|
0.14800
|
-1.48e-01
|
5.74e-03
|
1.17e-02
|
9.22e-01
|
GOCC GUANYL NUCLEOTIDE EXCHANGE FACTOR COMPLEX
|
17
|
5.38e-01
|
8.78e-01
|
0.14800
|
6.01e-02
|
1.36e-01
|
6.68e-01
|
3.33e-01
|
GOBP SYNAPSE PRUNING
|
14
|
6.11e-01
|
8.98e-01
|
0.14800
|
-3.30e-02
|
-1.45e-01
|
8.31e-01
|
3.49e-01
|
GOBP NOREPINEPHRINE TRANSPORT
|
22
|
4.43e-01
|
8.40e-01
|
0.14800
|
7.84e-02
|
1.26e-01
|
5.25e-01
|
3.07e-01
|
GOBP MEMBRANE LIPID BIOSYNTHETIC PROCESS
|
148
|
6.46e-03
|
1.66e-01
|
0.14800
|
-1.47e-01
|
-1.61e-02
|
1.98e-03
|
7.36e-01
|
GOBP ESTABLISHMENT OF CELL POLARITY
|
153
|
1.13e-02
|
2.27e-01
|
0.14800
|
-9.07e-02
|
1.17e-01
|
5.29e-02
|
1.24e-02
|
GOBP NEGATIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY
|
9
|
7.22e-01
|
9.30e-01
|
0.14800
|
1.38e-01
|
5.40e-02
|
4.74e-01
|
7.79e-01
|
GOMF MUSCLE ALPHA ACTININ BINDING
|
15
|
6.44e-01
|
9.07e-01
|
0.14800
|
-1.13e-01
|
9.62e-02
|
4.50e-01
|
5.19e-01
|
GOBP AROMATIC AMINO ACID METABOLIC PROCESS
|
31
|
4.03e-01
|
8.26e-01
|
0.14800
|
1.07e-01
|
-1.03e-01
|
3.04e-01
|
3.22e-01
|
GOBP IMP METABOLIC PROCESS
|
17
|
5.98e-01
|
8.95e-01
|
0.14800
|
-6.21e-02
|
1.34e-01
|
6.57e-01
|
3.37e-01
|
GOMF BICARBONATE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
30
|
3.86e-01
|
8.19e-01
|
0.14800
|
-2.98e-02
|
1.45e-01
|
7.78e-01
|
1.69e-01
|
GOBP DENDRITIC CELL MIGRATION
|
32
|
3.80e-01
|
8.15e-01
|
0.14800
|
-6.34e-02
|
1.34e-01
|
5.35e-01
|
1.90e-01
|
GOMF PROTEIN ARGININE OMEGA N MONOMETHYLTRANSFERASE ACTIVITY
|
6
|
8.00e-01
|
9.56e-01
|
0.14800
|
-1.20e-01
|
-8.64e-02
|
6.10e-01
|
7.14e-01
|
GOBP REGULATION OF SENSORY PERCEPTION
|
17
|
6.07e-01
|
8.97e-01
|
0.14800
|
1.11e-01
|
-9.75e-02
|
4.27e-01
|
4.86e-01
|
GOBP REGULATION OF PROTEIN DEUBIQUITINATION
|
10
|
6.93e-01
|
9.21e-01
|
0.14800
|
-1.30e-01
|
-7.11e-02
|
4.77e-01
|
6.97e-01
|
GOBP CELLULAR DEFENSE RESPONSE
|
48
|
2.24e-01
|
7.13e-01
|
0.14800
|
-3.99e-02
|
1.43e-01
|
6.33e-01
|
8.76e-02
|
GOBP REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN
|
20
|
5.11e-01
|
8.66e-01
|
0.14800
|
4.34e-03
|
1.48e-01
|
9.73e-01
|
2.52e-01
|
GOMF PROMOTER SPECIFIC CHROMATIN BINDING
|
63
|
1.06e-01
|
5.77e-01
|
0.14800
|
-1.40e-01
|
-4.76e-02
|
5.44e-02
|
5.13e-01
|
GOBP GLUCOSAMINE CONTAINING COMPOUND CATABOLIC PROCESS
|
9
|
7.15e-01
|
9.27e-01
|
0.14800
|
9.79e-02
|
1.11e-01
|
6.11e-01
|
5.65e-01
|
GOBP REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION
|
66
|
1.45e-01
|
6.29e-01
|
0.14800
|
-1.18e-01
|
8.88e-02
|
9.69e-02
|
2.12e-01
|
GOBP B CELL PROLIFERATION INVOLVED IN IMMUNE RESPONSE
|
6
|
8.18e-01
|
9.60e-01
|
0.14800
|
4.91e-03
|
1.48e-01
|
9.83e-01
|
5.31e-01
|
GOBP DEVELOPMENTAL INDUCTION
|
33
|
3.76e-01
|
8.11e-01
|
0.14800
|
-7.55e-02
|
1.27e-01
|
4.53e-01
|
2.07e-01
|
GOBP NECROPTOTIC PROCESS
|
45
|
2.42e-01
|
7.25e-01
|
0.14800
|
-3.02e-02
|
1.45e-01
|
7.26e-01
|
9.32e-02
|
GOBP PERICENTRIC HETEROCHROMATIN FORMATION
|
5
|
8.31e-01
|
9.64e-01
|
0.14800
|
-8.36e-02
|
-1.22e-01
|
7.46e-01
|
6.37e-01
|
GOBP GLYCEROLIPID CATABOLIC PROCESS
|
64
|
1.49e-01
|
6.36e-01
|
0.14800
|
-1.30e-01
|
7.07e-02
|
7.29e-02
|
3.28e-01
|
GOBP NEGATIVE REGULATION OF CELL VOLUME
|
5
|
8.31e-01
|
9.64e-01
|
0.14800
|
-8.44e-02
|
-1.21e-01
|
7.44e-01
|
6.39e-01
|
GOCC CIS GOLGI NETWORK
|
54
|
1.54e-01
|
6.41e-01
|
0.14800
|
-1.45e-01
|
-2.93e-02
|
6.59e-02
|
7.10e-01
|
GOBP REGULATION OF OOCYTE MATURATION
|
7
|
7.99e-01
|
9.56e-01
|
0.14800
|
-1.46e-01
|
1.94e-02
|
5.03e-01
|
9.29e-01
|
GOMF PHOSPHOPROTEIN BINDING
|
88
|
7.76e-02
|
5.24e-01
|
0.14800
|
-1.01e-01
|
1.08e-01
|
1.01e-01
|
8.11e-02
|
GOCC GAMMA TUBULIN RING COMPLEX
|
7
|
7.93e-01
|
9.54e-01
|
0.14800
|
-1.30e-03
|
-1.48e-01
|
9.95e-01
|
4.99e-01
|
GOBP NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE
|
12
|
6.90e-01
|
9.20e-01
|
0.14800
|
4.26e-02
|
-1.41e-01
|
7.99e-01
|
3.97e-01
|
GOCC SPERM MIDPIECE
|
51
|
2.25e-01
|
7.13e-01
|
0.14800
|
-1.20e-01
|
8.52e-02
|
1.37e-01
|
2.93e-01
|
GOBP REGULATION OF MACROPHAGE CHEMOTAXIS
|
28
|
4.42e-01
|
8.40e-01
|
0.14800
|
-1.15e-01
|
9.22e-02
|
2.91e-01
|
3.99e-01
|
GOBP COPII COATED VESICLE CARGO LOADING
|
16
|
5.78e-01
|
8.89e-01
|
0.14700
|
-1.46e-01
|
-2.18e-02
|
3.13e-01
|
8.80e-01
|
GOMF GTPASE ACTIVATOR ACTIVITY
|
244
|
7.79e-04
|
4.38e-02
|
0.14700
|
-7.13e-02
|
1.29e-01
|
5.51e-02
|
5.22e-04
|
GOBP SKELETAL MUSCLE ADAPTATION
|
25
|
4.71e-01
|
8.52e-01
|
0.14700
|
5.85e-02
|
-1.35e-01
|
6.13e-01
|
2.42e-01
|
GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING
|
24
|
4.21e-01
|
8.33e-01
|
0.14700
|
6.27e-02
|
1.33e-01
|
5.95e-01
|
2.59e-01
|
GOBP POSITIVE REGULATION OF ATP DEPENDENT ACTIVITY
|
39
|
2.58e-01
|
7.35e-01
|
0.14700
|
-1.43e-01
|
-3.50e-02
|
1.22e-01
|
7.05e-01
|
GOBP MITOTIC CYTOKINESIS
|
85
|
7.48e-02
|
5.16e-01
|
0.14700
|
-1.40e-01
|
4.60e-02
|
2.58e-02
|
4.64e-01
|
GOBP REGULATION OF NK T CELL ACTIVATION
|
11
|
7.14e-01
|
9.27e-01
|
0.14700
|
4.47e-02
|
-1.40e-01
|
7.97e-01
|
4.21e-01
|
GOBP IMP BIOSYNTHETIC PROCESS
|
10
|
7.15e-01
|
9.27e-01
|
0.14700
|
-1.47e-01
|
-9.59e-03
|
4.21e-01
|
9.58e-01
|
GOBP NEGATIVE REGULATION OF T CELL CYTOKINE PRODUCTION
|
10
|
7.41e-01
|
9.37e-01
|
0.14700
|
-1.35e-01
|
5.97e-02
|
4.61e-01
|
7.44e-01
|
GOBP REGULATION OF CALCIUM ION EXPORT ACROSS PLASMA MEMBRANE
|
5
|
8.60e-01
|
9.68e-01
|
0.14700
|
-5.53e-02
|
1.36e-01
|
8.31e-01
|
5.98e-01
|
GOBP MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA
|
25
|
4.52e-01
|
8.45e-01
|
0.14700
|
-1.46e-01
|
2.08e-02
|
2.08e-01
|
8.57e-01
|
GOBP CYTOCHROME COMPLEX ASSEMBLY
|
38
|
2.48e-01
|
7.26e-01
|
0.14700
|
-8.97e-02
|
-1.16e-01
|
3.39e-01
|
2.14e-01
|
GOBP AUTOPHAGOSOME MATURATION
|
60
|
1.47e-01
|
6.33e-01
|
0.14700
|
-1.46e-01
|
1.49e-02
|
5.01e-02
|
8.41e-01
|
GOBP POSITIVE REGULATION OF CHEMOKINE PRODUCTION
|
70
|
8.73e-02
|
5.46e-01
|
0.14700
|
-1.42e-01
|
-3.96e-02
|
4.06e-02
|
5.67e-01
|
GOBP MEMBRANE DISASSEMBLY
|
11
|
6.79e-01
|
9.14e-01
|
0.14700
|
4.49e-02
|
1.40e-01
|
7.96e-01
|
4.22e-01
|
GOBP PURINE DEOXYRIBONUCLEOSIDE METABOLIC PROCESS
|
5
|
8.35e-01
|
9.64e-01
|
0.14700
|
6.46e-02
|
1.32e-01
|
8.02e-01
|
6.09e-01
|
GOBP INTERNEURON MIGRATION FROM THE SUBPALLIUM TO THE CORTEX
|
7
|
8.13e-01
|
9.59e-01
|
0.14700
|
6.77e-02
|
-1.30e-01
|
7.57e-01
|
5.50e-01
|
GOBP POSITIVE REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY
|
5
|
8.52e-01
|
9.67e-01
|
0.14700
|
1.63e-02
|
-1.46e-01
|
9.50e-01
|
5.72e-01
|
GOBP NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION
|
53
|
1.43e-01
|
6.28e-01
|
0.14700
|
-1.13e-01
|
-9.35e-02
|
1.53e-01
|
2.39e-01
|
GOBP POSITIVE REGULATION OF CEREBELLAR GRANULE CELL PRECURSOR PROLIFERATION
|
8
|
7.87e-01
|
9.53e-01
|
0.14700
|
1.35e-01
|
-5.81e-02
|
5.09e-01
|
7.76e-01
|
GOMF PHOSPHATE ION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
11
|
7.23e-01
|
9.30e-01
|
0.14700
|
-1.30e-01
|
6.82e-02
|
4.55e-01
|
6.95e-01
|
GOBP B CELL PROLIFERATION
|
97
|
3.05e-02
|
3.61e-01
|
0.14700
|
6.96e-02
|
1.29e-01
|
2.36e-01
|
2.77e-02
|
GOCC VACUOLAR MEMBRANE
|
462
|
4.55e-07
|
1.66e-04
|
0.14700
|
-1.46e-01
|
1.02e-02
|
6.77e-08
|
7.06e-01
|
GOBP POSITIVE REGULATION OF ANTIMICROBIAL HUMORAL RESPONSE
|
8
|
7.48e-01
|
9.40e-01
|
0.14700
|
-7.65e-02
|
-1.25e-01
|
7.08e-01
|
5.40e-01
|
GOBP POSITIVE REGULATION OF CELL CYCLE CHECKPOINT
|
18
|
5.83e-01
|
8.90e-01
|
0.14700
|
-1.35e-01
|
5.65e-02
|
3.20e-01
|
6.78e-01
|
GOBP REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN
|
48
|
2.26e-01
|
7.14e-01
|
0.14700
|
-3.19e-02
|
1.43e-01
|
7.02e-01
|
8.61e-02
|
GOCC INTEGRATOR COMPLEX
|
16
|
5.82e-01
|
8.90e-01
|
0.14700
|
-1.45e-01
|
-2.14e-02
|
3.15e-01
|
8.82e-01
|
GOCC STRIATED MUSCLE THIN FILAMENT
|
22
|
5.31e-01
|
8.74e-01
|
0.14700
|
-9.33e-02
|
1.13e-01
|
4.49e-01
|
3.58e-01
|
GOBP MEMBRANE LIPID CATABOLIC PROCESS
|
38
|
3.13e-01
|
7.76e-01
|
0.14700
|
-1.41e-01
|
4.01e-02
|
1.33e-01
|
6.69e-01
|
GOBP NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS
|
169
|
2.22e-03
|
8.91e-02
|
0.14600
|
-8.82e-02
|
-1.17e-01
|
4.78e-02
|
8.78e-03
|
GOCC FICOLIN 1 RICH GRANULE MEMBRANE
|
59
|
1.54e-01
|
6.41e-01
|
0.14600
|
-1.46e-01
|
1.52e-02
|
5.30e-02
|
8.40e-01
|
GOBP CELLULAR RESPONSE TO CGMP
|
7
|
7.85e-01
|
9.52e-01
|
0.14600
|
3.67e-02
|
1.42e-01
|
8.66e-01
|
5.16e-01
|
GOCC CHROMOSOME TELOMERIC REPEAT REGION
|
13
|
6.88e-01
|
9.19e-01
|
0.14600
|
8.89e-02
|
-1.16e-01
|
5.79e-01
|
4.68e-01
|
GOBP RESPONSE TO STEROL
|
35
|
3.33e-01
|
7.86e-01
|
0.14600
|
-1.45e-01
|
2.05e-02
|
1.38e-01
|
8.34e-01
|
GOBP RESPONSE TO THYROGLOBULIN TRIIODOTHYRONINE
|
5
|
8.44e-01
|
9.66e-01
|
0.14600
|
-1.44e-01
|
-2.72e-02
|
5.78e-01
|
9.16e-01
|
GOMF SEMAPHORIN RECEPTOR BINDING
|
23
|
4.33e-01
|
8.37e-01
|
0.14600
|
1.09e-01
|
9.77e-02
|
3.66e-01
|
4.17e-01
|
GOBP POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING
|
42
|
2.24e-01
|
7.13e-01
|
0.14600
|
6.52e-02
|
1.31e-01
|
4.64e-01
|
1.42e-01
|
GOBP CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION
|
12
|
7.05e-01
|
9.24e-01
|
0.14600
|
-6.98e-02
|
1.28e-01
|
6.76e-01
|
4.41e-01
|
GOBP REGULATION OF CYTOCHROME C OXIDASE ACTIVITY
|
5
|
8.43e-01
|
9.66e-01
|
0.14600
|
-1.42e-01
|
-3.24e-02
|
5.81e-01
|
9.00e-01
|
GOBP POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY
|
17
|
5.73e-01
|
8.88e-01
|
0.14600
|
5.56e-03
|
1.46e-01
|
9.68e-01
|
2.98e-01
|
GOCC DNA REPAIR COMPLEX
|
22
|
4.85e-01
|
8.56e-01
|
0.14600
|
-8.33e-03
|
-1.46e-01
|
9.46e-01
|
2.37e-01
|
GOBP TUBULIN COMPLEX ASSEMBLY
|
8
|
7.77e-01
|
9.50e-01
|
0.14600
|
1.45e-01
|
-1.59e-02
|
4.77e-01
|
9.38e-01
|
GOBP ANGIOTENSIN ACTIVATED SIGNALING PATHWAY
|
18
|
5.45e-01
|
8.78e-01
|
0.14600
|
2.43e-02
|
1.44e-01
|
8.58e-01
|
2.90e-01
|
GOBP POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION OF STAT PROTEIN
|
17
|
5.76e-01
|
8.89e-01
|
0.14600
|
-1.18e-03
|
-1.46e-01
|
9.93e-01
|
2.97e-01
|
GOBP REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN
|
17
|
5.60e-01
|
8.83e-01
|
0.14600
|
1.42e-01
|
3.24e-02
|
3.10e-01
|
8.17e-01
|
GOMF PEPTIDE LYSINE N ACETYLTRANSFERASE ACTIVITY
|
42
|
2.49e-01
|
7.27e-01
|
0.14600
|
-1.45e-01
|
-1.29e-02
|
1.03e-01
|
8.85e-01
|
GOBP MUSCLE ORGAN MORPHOGENESIS
|
82
|
6.48e-02
|
4.91e-01
|
0.14600
|
2.00e-02
|
1.45e-01
|
7.54e-01
|
2.36e-02
|
GOBP MULTICELLULAR ORGANISMAL MOVEMENT
|
57
|
1.95e-01
|
6.87e-01
|
0.14600
|
-1.20e-01
|
8.31e-02
|
1.17e-01
|
2.78e-01
|
GOBP NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION
|
63
|
1.54e-01
|
6.41e-01
|
0.14600
|
-1.36e-01
|
5.29e-02
|
6.19e-02
|
4.67e-01
|
GOBP NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS
|
18
|
5.51e-01
|
8.80e-01
|
0.14600
|
-1.32e-02
|
-1.45e-01
|
9.23e-01
|
2.86e-01
|
GOMF CHEMOATTRACTANT ACTIVITY
|
34
|
3.30e-01
|
7.85e-01
|
0.14600
|
4.14e-03
|
1.46e-01
|
9.67e-01
|
1.41e-01
|
GOBP GASTRULATION WITH MOUTH FORMING SECOND
|
26
|
4.77e-01
|
8.54e-01
|
0.14600
|
-1.07e-01
|
9.88e-02
|
3.44e-01
|
3.83e-01
|
GOMF FOUR WAY JUNCTION HELICASE ACTIVITY
|
6
|
8.42e-01
|
9.66e-01
|
0.14600
|
-8.81e-02
|
1.16e-01
|
7.09e-01
|
6.22e-01
|
GOCC COPII COATED ER TO GOLGI TRANSPORT VESICLE
|
88
|
4.17e-02
|
4.21e-01
|
0.14600
|
-9.44e-02
|
-1.11e-01
|
1.26e-01
|
7.15e-02
|
GOBP NCRNA EXPORT FROM NUCLEUS
|
9
|
7.49e-01
|
9.40e-01
|
0.14600
|
4.91e-03
|
-1.46e-01
|
9.80e-01
|
4.49e-01
|
GOBP NEUTRAL LIPID CATABOLIC PROCESS
|
37
|
3.46e-01
|
7.96e-01
|
0.14600
|
-1.21e-01
|
8.19e-02
|
2.04e-01
|
3.89e-01
|
GOBP PYRAMIDAL NEURON DEVELOPMENT
|
9
|
7.74e-01
|
9.49e-01
|
0.14600
|
-1.05e-01
|
1.01e-01
|
5.86e-01
|
5.99e-01
|
GOBP NADP METABOLIC PROCESS
|
41
|
2.45e-01
|
7.26e-01
|
0.14600
|
-1.40e-01
|
-3.88e-02
|
1.20e-01
|
6.67e-01
|
GOBP POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY
|
59
|
1.22e-01
|
6.03e-01
|
0.14600
|
-1.26e-01
|
-7.28e-02
|
9.35e-02
|
3.34e-01
|
GOBP POSITIVE REGULATION OF PROTEIN DEACETYLATION
|
10
|
6.97e-01
|
9.21e-01
|
0.14600
|
-1.10e-01
|
-9.56e-02
|
5.47e-01
|
6.01e-01
|
GOMF HISTONE METHYLTRANSFERASE BINDING
|
15
|
6.53e-01
|
9.08e-01
|
0.14600
|
9.55e-02
|
-1.10e-01
|
5.22e-01
|
4.61e-01
|
GOMF VOLTAGE GATED CHLORIDE CHANNEL ACTIVITY
|
9
|
7.74e-01
|
9.49e-01
|
0.14600
|
-9.47e-02
|
1.11e-01
|
6.23e-01
|
5.66e-01
|
GOMF PHOSPHOLIPASE INHIBITOR ACTIVITY
|
14
|
6.08e-01
|
8.97e-01
|
0.14600
|
-7.06e-02
|
-1.27e-01
|
6.48e-01
|
4.09e-01
|
GOBP POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION
|
25
|
4.06e-01
|
8.26e-01
|
0.14600
|
1.07e-01
|
9.86e-02
|
3.55e-01
|
3.93e-01
|
GOMF EXONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 5 PHOSPHOMONOESTERS
|
58
|
1.31e-01
|
6.12e-01
|
0.14500
|
-5.87e-02
|
-1.33e-01
|
4.39e-01
|
7.95e-02
|
GOBP POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION
|
10
|
6.97e-01
|
9.21e-01
|
0.14500
|
9.96e-02
|
1.06e-01
|
5.85e-01
|
5.62e-01
|
GOBP REGULATION OF PHOSPHOLIPID CATABOLIC PROCESS
|
7
|
7.98e-01
|
9.56e-01
|
0.14500
|
1.45e-01
|
9.22e-04
|
5.05e-01
|
9.97e-01
|
GOBP REGULATION OF T CELL MIGRATION
|
47
|
2.53e-01
|
7.32e-01
|
0.14500
|
-5.97e-02
|
1.33e-01
|
4.79e-01
|
1.16e-01
|
GOBP PYRIMIDINE RIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS
|
7
|
7.85e-01
|
9.52e-01
|
0.14500
|
-1.37e-01
|
-4.85e-02
|
5.30e-01
|
8.24e-01
|
GOMF CHOLESTEROL BINDING
|
51
|
2.32e-01
|
7.18e-01
|
0.14500
|
-1.24e-01
|
7.56e-02
|
1.25e-01
|
3.50e-01
|
GOBP PROTEIN AUTOPROCESSING
|
28
|
4.00e-01
|
8.25e-01
|
0.14500
|
-1.45e-01
|
-1.10e-02
|
1.84e-01
|
9.19e-01
|
GOBP HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES
|
164
|
2.88e-03
|
1.04e-01
|
0.14500
|
1.15e-01
|
8.89e-02
|
1.10e-02
|
4.95e-02
|
GOBP VERY LONG CHAIN FATTY ACID METABOLIC PROCESS
|
34
|
3.68e-01
|
8.07e-01
|
0.14500
|
-1.35e-01
|
5.39e-02
|
1.73e-01
|
5.86e-01
|
GOBP FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY
|
81
|
6.12e-02
|
4.80e-01
|
0.14500
|
4.85e-02
|
1.37e-01
|
4.51e-01
|
3.30e-02
|
GOBP POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS
|
34
|
3.79e-01
|
8.14e-01
|
0.14500
|
-7.74e-02
|
1.23e-01
|
4.35e-01
|
2.15e-01
|
GOBP MESENCHYMAL CELL DEVELOPMENT
|
6
|
8.39e-01
|
9.65e-01
|
0.14500
|
-1.33e-01
|
5.92e-02
|
5.74e-01
|
8.02e-01
|
GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION
|
93
|
6.84e-02
|
5.00e-01
|
0.14500
|
-6.54e-02
|
1.30e-01
|
2.76e-01
|
3.07e-02
|
GOBP INTERNEURON MIGRATION
|
14
|
6.73e-01
|
9.13e-01
|
0.14500
|
-9.27e-02
|
1.12e-01
|
5.48e-01
|
4.69e-01
|
GOCC SPINDLE MIDZONE
|
35
|
3.02e-01
|
7.68e-01
|
0.14500
|
-1.39e-01
|
-4.20e-02
|
1.55e-01
|
6.67e-01
|
GOBP NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY
|
21
|
4.73e-01
|
8.53e-01
|
0.14500
|
-8.40e-02
|
-1.18e-01
|
5.05e-01
|
3.48e-01
|
GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE
|
15
|
6.26e-01
|
9.01e-01
|
0.14500
|
-1.44e-01
|
1.49e-02
|
3.33e-01
|
9.21e-01
|
GOCC POTASSIUM CHANNEL COMPLEX
|
88
|
4.54e-02
|
4.31e-01
|
0.14500
|
1.28e-01
|
6.91e-02
|
3.87e-02
|
2.62e-01
|
GOBP POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION
|
31
|
4.04e-01
|
8.26e-01
|
0.14500
|
-1.34e-01
|
5.63e-02
|
1.98e-01
|
5.87e-01
|
GOBP PEPTIDYL TYROSINE AUTOPHOSPHORYLATION
|
18
|
5.29e-01
|
8.73e-01
|
0.14500
|
7.29e-02
|
1.25e-01
|
5.92e-01
|
3.57e-01
|
GOMF ALPHA N ACETYLNEURAMINATE ALPHA 2 8 SIALYLTRANSFERASE ACTIVITY
|
6
|
8.19e-01
|
9.60e-01
|
0.14500
|
1.43e-01
|
2.49e-02
|
5.45e-01
|
9.16e-01
|
GOCC MULTIVESICULAR BODY
|
65
|
1.32e-01
|
6.13e-01
|
0.14500
|
-1.44e-01
|
1.34e-02
|
4.42e-02
|
8.52e-01
|
GOBP ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT
|
127
|
1.19e-02
|
2.33e-01
|
0.14500
|
-1.29e-01
|
-6.57e-02
|
1.19e-02
|
2.01e-01
|
GOBP POSITIVE REGULATION OF MIRNA TRANSCRIPTION
|
50
|
1.83e-01
|
6.73e-01
|
0.14500
|
-1.39e-01
|
-3.96e-02
|
8.81e-02
|
6.28e-01
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H QUINONE OR SIMILAR COMPOUND AS ACCEPTOR
|
49
|
1.89e-01
|
6.81e-01
|
0.14500
|
-4.17e-02
|
-1.39e-01
|
6.13e-01
|
9.28e-02
|
GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN
|
68
|
1.04e-01
|
5.75e-01
|
0.14500
|
-2.61e-02
|
-1.43e-01
|
7.10e-01
|
4.21e-02
|
GOMF NUCLEOSIDE TRIPHOSPHATASE REGULATOR ACTIVITY
|
447
|
2.23e-06
|
5.44e-04
|
0.14500
|
-4.36e-02
|
1.38e-01
|
1.14e-01
|
5.55e-07
|
GOBP POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION
|
97
|
6.38e-02
|
4.87e-01
|
0.14500
|
-1.24e-01
|
7.38e-02
|
3.41e-02
|
2.09e-01
|
GOCC GTPASE ACTIVATOR COMPLEX
|
11
|
7.15e-01
|
9.27e-01
|
0.14500
|
-2.54e-02
|
1.42e-01
|
8.84e-01
|
4.14e-01
|
GOBP N ACETYLNEURAMINATE METABOLIC PROCESS
|
11
|
6.81e-01
|
9.16e-01
|
0.14500
|
-6.61e-02
|
-1.29e-01
|
7.04e-01
|
4.60e-01
|
GOBP ENDOCRINE PROCESS
|
87
|
4.59e-02
|
4.33e-01
|
0.14500
|
-1.14e-01
|
-8.95e-02
|
6.72e-02
|
1.49e-01
|
GOBP REGULATION OF POSITIVE CHEMOTAXIS
|
25
|
4.11e-01
|
8.27e-01
|
0.14500
|
1.00e-01
|
1.04e-01
|
3.85e-01
|
3.68e-01
|
GOMF UNIPORTER ACTIVITY
|
8
|
7.93e-01
|
9.54e-01
|
0.14500
|
1.34e-01
|
-5.53e-02
|
5.13e-01
|
7.87e-01
|
GOMF NUCLEAR ANDROGEN RECEPTOR BINDING
|
25
|
4.97e-01
|
8.61e-01
|
0.14400
|
-9.43e-02
|
1.10e-01
|
4.15e-01
|
3.43e-01
|
GOBP POSITIVE REGULATION OF GROWTH HORMONE SECRETION
|
9
|
7.75e-01
|
9.50e-01
|
0.14400
|
1.23e-01
|
-7.60e-02
|
5.23e-01
|
6.93e-01
|
GOMF AMINO ACID BINDING
|
47
|
2.36e-01
|
7.24e-01
|
0.14400
|
1.43e-01
|
-1.86e-02
|
8.94e-02
|
8.25e-01
|
GOMF CHROMATIN DNA BINDING
|
110
|
3.23e-02
|
3.67e-01
|
0.14400
|
-1.44e-01
|
6.75e-03
|
8.97e-03
|
9.03e-01
|
GOBP POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION
|
51
|
1.72e-01
|
6.60e-01
|
0.14400
|
1.31e-01
|
5.96e-02
|
1.04e-01
|
4.62e-01
|
GOBP RESPONSE TO LEUCINE
|
15
|
6.33e-01
|
9.03e-01
|
0.14400
|
-2.22e-02
|
1.43e-01
|
8.82e-01
|
3.39e-01
|
GOBP MAINTENANCE OF PROTEIN LOCATION IN CELL
|
60
|
1.39e-01
|
6.22e-01
|
0.14400
|
-1.42e-01
|
-2.61e-02
|
5.74e-02
|
7.27e-01
|
GOBP TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING
|
77
|
1.05e-01
|
5.77e-01
|
0.14400
|
4.55e-02
|
-1.37e-01
|
4.90e-01
|
3.79e-02
|
GOBP CARDIAC RIGHT VENTRICLE MORPHOGENESIS
|
21
|
5.46e-01
|
8.78e-01
|
0.14400
|
-1.33e-01
|
5.61e-02
|
2.92e-01
|
6.56e-01
|
GOBP NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY
|
22
|
4.77e-01
|
8.54e-01
|
0.14400
|
-1.38e-01
|
-4.07e-02
|
2.62e-01
|
7.41e-01
|
GOCC COLLAGEN TRIMER
|
83
|
5.74e-02
|
4.68e-01
|
0.14400
|
1.31e-01
|
6.11e-02
|
3.98e-02
|
3.36e-01
|
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY
|
70
|
1.28e-01
|
6.07e-01
|
0.14400
|
-1.38e-01
|
4.12e-02
|
4.57e-02
|
5.51e-01
|
GOBP REGULATION OF BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION
|
64
|
1.61e-01
|
6.48e-01
|
0.14400
|
-1.30e-01
|
6.27e-02
|
7.27e-02
|
3.86e-01
|
GOMF COLLAGEN RECEPTOR ACTIVITY
|
5
|
8.68e-01
|
9.72e-01
|
0.14400
|
1.26e-01
|
-7.05e-02
|
6.27e-01
|
7.85e-01
|
GOBP G PROTEIN COUPLED RECEPTOR INTERNALIZATION
|
10
|
7.57e-01
|
9.43e-01
|
0.14400
|
-1.11e-01
|
9.21e-02
|
5.45e-01
|
6.14e-01
|
GOBP REGULATION OF TRIGLYCERIDE METABOLIC PROCESS
|
42
|
2.42e-01
|
7.25e-01
|
0.14400
|
-1.37e-01
|
-4.54e-02
|
1.25e-01
|
6.11e-01
|
GOMF PEPTIDE N ACETYLTRANSFERASE ACTIVITY
|
46
|
2.18e-01
|
7.07e-01
|
0.14400
|
-1.40e-01
|
-3.14e-02
|
9.93e-02
|
7.12e-01
|
GOMF GLUCURONOSYLTRANSFERASE ACTIVITY
|
33
|
3.69e-01
|
8.09e-01
|
0.14400
|
1.42e-01
|
-2.51e-02
|
1.59e-01
|
8.03e-01
|
GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY
|
129
|
2.47e-02
|
3.31e-01
|
0.14400
|
-1.33e-01
|
5.43e-02
|
8.94e-03
|
2.86e-01
|
GOMF N ACYLSPHINGOSINE AMIDOHYDROLASE ACTIVITY
|
7
|
8.19e-01
|
9.60e-01
|
0.14400
|
-6.31e-02
|
1.29e-01
|
7.73e-01
|
5.54e-01
|
GOBP REGULATION OF LYSOSOME SIZE
|
8
|
7.64e-01
|
9.45e-01
|
0.14400
|
-4.48e-02
|
-1.37e-01
|
8.26e-01
|
5.03e-01
|
GOCC BORC COMPLEX
|
8
|
7.64e-01
|
9.45e-01
|
0.14400
|
-4.48e-02
|
-1.37e-01
|
8.26e-01
|
5.03e-01
|
GOMF HELICASE ACTIVITY
|
149
|
5.52e-03
|
1.54e-01
|
0.14400
|
-1.14e-01
|
-8.80e-02
|
1.67e-02
|
6.37e-02
|
GOBP NEGATIVE REGULATION OF PEPTIDE SECRETION
|
44
|
2.46e-01
|
7.26e-01
|
0.14400
|
-1.43e-01
|
-1.00e-02
|
1.00e-01
|
9.08e-01
|
GOBP TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE
|
29
|
3.73e-01
|
8.10e-01
|
0.14400
|
-1.33e-01
|
-5.32e-02
|
2.14e-01
|
6.20e-01
|
GOBP MAMMARY GLAND DUCT MORPHOGENESIS
|
28
|
4.53e-01
|
8.45e-01
|
0.14400
|
-1.28e-01
|
6.58e-02
|
2.42e-01
|
5.47e-01
|
GOBP INTERLEUKIN 1 PRODUCTION
|
123
|
1.97e-02
|
3.00e-01
|
0.14400
|
-1.43e-01
|
-1.35e-02
|
6.18e-03
|
7.95e-01
|
GOBP HYDROCARBON METABOLIC PROCESS
|
7
|
7.82e-01
|
9.52e-01
|
0.14400
|
1.12e-01
|
8.95e-02
|
6.07e-01
|
6.82e-01
|
GOBP NUCLEAR PORE LOCALIZATION
|
5
|
8.58e-01
|
9.68e-01
|
0.14400
|
1.12e-02
|
-1.43e-01
|
9.65e-01
|
5.80e-01
|
GOBP SERINE FAMILY AMINO ACID METABOLIC PROCESS
|
36
|
3.36e-01
|
7.88e-01
|
0.14300
|
1.92e-02
|
-1.42e-01
|
8.42e-01
|
1.40e-01
|
GOCC PERICILIARY MEMBRANE COMPARTMENT
|
5
|
8.40e-01
|
9.65e-01
|
0.14300
|
8.33e-02
|
1.17e-01
|
7.47e-01
|
6.51e-01
|
GOBP HIPPO SIGNALING
|
42
|
3.15e-01
|
7.76e-01
|
0.14300
|
-1.04e-01
|
9.89e-02
|
2.44e-01
|
2.67e-01
|
GOBP MITOCHONDRIAL ELECTRON TRANSPORT SUCCINATE TO UBIQUINONE
|
5
|
8.57e-01
|
9.68e-01
|
0.14300
|
7.44e-03
|
-1.43e-01
|
9.77e-01
|
5.79e-01
|
GOBP NEUROTRANSMITTER RECEPTOR INTERNALIZATION
|
30
|
4.32e-01
|
8.37e-01
|
0.14300
|
-7.13e-02
|
1.24e-01
|
4.99e-01
|
2.38e-01
|
GOMF SOLUTE MONOATOMIC CATION SYMPORTER ACTIVITY
|
114
|
2.42e-02
|
3.30e-01
|
0.14300
|
2.89e-02
|
1.40e-01
|
5.94e-01
|
9.57e-03
|
GOBP FIBROBLAST ACTIVATION
|
15
|
6.41e-01
|
9.06e-01
|
0.14300
|
-1.40e-01
|
3.13e-02
|
3.48e-01
|
8.34e-01
|
GOMF G PROTEIN COUPLED RECEPTOR ACTIVITY
|
745
|
1.87e-10
|
2.73e-07
|
0.14300
|
1.43e-01
|
-3.87e-03
|
2.67e-11
|
8.57e-01
|
GOBP SODIUM ION EXPORT ACROSS PLASMA MEMBRANE
|
15
|
6.28e-01
|
9.02e-01
|
0.14300
|
-4.43e-03
|
1.43e-01
|
9.76e-01
|
3.37e-01
|
GOBP POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION
|
66
|
1.18e-01
|
5.98e-01
|
0.14300
|
-2.40e-02
|
-1.41e-01
|
7.36e-01
|
4.70e-02
|
GOBP SEQUESTERING OF CALCIUM ION
|
138
|
1.09e-02
|
2.23e-01
|
0.14300
|
3.26e-02
|
1.40e-01
|
5.08e-01
|
4.63e-03
|
GOBP MICROTUBULE NUCLEATION
|
43
|
2.84e-01
|
7.57e-01
|
0.14300
|
-1.38e-01
|
3.88e-02
|
1.17e-01
|
6.60e-01
|
GOBP CO TRANSCRIPTIONAL RNA 3 END PROCESSING CLEAVAGE AND POLYADENYLATION PATHWAY
|
6
|
8.46e-01
|
9.66e-01
|
0.14300
|
-1.22e-01
|
7.52e-02
|
6.05e-01
|
7.50e-01
|
GOBP REGULATION OF NEUTROPHIL MIGRATION
|
40
|
3.10e-01
|
7.73e-01
|
0.14300
|
-3.73e-02
|
1.38e-01
|
6.83e-01
|
1.30e-01
|
GOMF GENERAL TRANSCRIPTION INITIATION FACTOR BINDING
|
52
|
1.78e-01
|
6.67e-01
|
0.14300
|
-1.37e-01
|
-4.04e-02
|
8.63e-02
|
6.15e-01
|
GOBP TAIL ANCHORED MEMBRANE PROTEIN INSERTION INTO ER MEMBRANE
|
15
|
6.29e-01
|
9.02e-01
|
0.14300
|
6.22e-03
|
-1.43e-01
|
9.67e-01
|
3.37e-01
|
GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE 3 PHOSPHATASE ACTIVITY
|
8
|
8.01e-01
|
9.57e-01
|
0.14300
|
-8.19e-02
|
1.18e-01
|
6.88e-01
|
5.65e-01
|
GOBP HEPARIN METABOLIC PROCESS
|
17
|
6.01e-01
|
8.96e-01
|
0.14300
|
-2.35e-02
|
1.41e-01
|
8.67e-01
|
3.13e-01
|
GOBP PIGMENT GRANULE LOCALIZATION
|
23
|
4.98e-01
|
8.61e-01
|
0.14300
|
1.49e-02
|
-1.42e-01
|
9.01e-01
|
2.37e-01
|
GOBP SCHWANN CELL DIFFERENTIATION
|
38
|
3.54e-01
|
7.97e-01
|
0.14300
|
-9.72e-02
|
1.05e-01
|
3.00e-01
|
2.63e-01
|
GOMF PROTEIN FOLDING CHAPERONE
|
61
|
1.62e-01
|
6.48e-01
|
0.14300
|
2.39e-02
|
-1.41e-01
|
7.47e-01
|
5.68e-02
|
GOBP DNA TEMPLATED DNA REPLICATION
|
158
|
4.30e-03
|
1.34e-01
|
0.14300
|
-1.14e-01
|
-8.62e-02
|
1.34e-02
|
6.14e-02
|
GOMF PYRIMIDINE NUCLEOBASE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
7
|
8.22e-01
|
9.61e-01
|
0.14300
|
6.64e-02
|
-1.27e-01
|
7.61e-01
|
5.62e-01
|
GOBP PROCESS UTILIZING AUTOPHAGIC MECHANISM
|
552
|
2.38e-07
|
1.10e-04
|
0.14300
|
-1.31e-01
|
5.73e-02
|
1.43e-07
|
2.13e-02
|
GOBP PROTEIN FOLDING IN ENDOPLASMIC RETICULUM
|
12
|
6.59e-01
|
9.09e-01
|
0.14300
|
-1.04e-01
|
-9.80e-02
|
5.33e-01
|
5.57e-01
|
GOCC CLATHRIN COATED ENDOCYTIC VESICLE MEMBRANE
|
68
|
1.09e-01
|
5.84e-01
|
0.14300
|
1.39e-01
|
3.22e-02
|
4.72e-02
|
6.46e-01
|
GOBP MAGNESIUM ION HOMEOSTASIS
|
10
|
7.28e-01
|
9.32e-01
|
0.14300
|
-1.35e-02
|
-1.42e-01
|
9.41e-01
|
4.36e-01
|
GOBP GAMMA AMINOBUTYRIC ACID SECRETION
|
12
|
6.63e-01
|
9.10e-01
|
0.14300
|
6.99e-02
|
1.25e-01
|
6.75e-01
|
4.55e-01
|
GOMF LBD DOMAIN BINDING
|
6
|
8.16e-01
|
9.59e-01
|
0.14300
|
6.05e-02
|
1.29e-01
|
7.97e-01
|
5.83e-01
|
GOBP HEART TRABECULA MORPHOGENESIS
|
32
|
4.13e-01
|
8.29e-01
|
0.14300
|
-7.61e-02
|
1.21e-01
|
4.56e-01
|
2.37e-01
|
GOBP PURINE CONTAINING COMPOUND SALVAGE
|
14
|
6.60e-01
|
9.09e-01
|
0.14300
|
-1.41e-01
|
2.51e-02
|
3.62e-01
|
8.71e-01
|
GOBP NUCLEOSIDE TRANSMEMBRANE TRANSPORT
|
8
|
7.63e-01
|
9.45e-01
|
0.14300
|
5.82e-02
|
1.30e-01
|
7.76e-01
|
5.23e-01
|
GOBP HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE
|
17
|
5.96e-01
|
8.95e-01
|
0.14300
|
-1.42e-01
|
9.23e-03
|
3.09e-01
|
9.47e-01
|
GOBP POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY
|
16
|
6.37e-01
|
9.06e-01
|
0.14300
|
-5.84e-02
|
1.30e-01
|
6.86e-01
|
3.67e-01
|
GOBP SPHINGOLIPID BIOSYNTHETIC PROCESS
|
110
|
3.54e-02
|
3.83e-01
|
0.14300
|
-1.42e-01
|
8.36e-03
|
9.88e-03
|
8.80e-01
|
GOBP TIGHT JUNCTION ORGANIZATION
|
78
|
6.77e-02
|
4.99e-01
|
0.14300
|
1.10e-01
|
9.08e-02
|
9.32e-02
|
1.65e-01
|
GOBP AUDITORY RECEPTOR CELL DEVELOPMENT
|
24
|
4.81e-01
|
8.54e-01
|
0.14300
|
-8.67e-03
|
1.42e-01
|
9.41e-01
|
2.27e-01
|
GOBP POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION
|
27
|
4.79e-01
|
8.54e-01
|
0.14300
|
-1.13e-01
|
8.74e-02
|
3.11e-01
|
4.32e-01
|
GOBP REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY
|
26
|
4.85e-01
|
8.56e-01
|
0.14300
|
-6.67e-02
|
1.26e-01
|
5.56e-01
|
2.66e-01
|
GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION
|
73
|
8.69e-02
|
5.46e-01
|
0.14300
|
1.31e-01
|
5.50e-02
|
5.21e-02
|
4.16e-01
|
GOMF LIPASE ACTIVITY
|
132
|
2.63e-02
|
3.39e-01
|
0.14200
|
-6.92e-02
|
1.25e-01
|
1.70e-01
|
1.35e-02
|
GOBP NEGATIVE REGULATION OF COLLATERAL SPROUTING
|
10
|
7.12e-01
|
9.27e-01
|
0.14200
|
-6.83e-02
|
-1.25e-01
|
7.08e-01
|
4.94e-01
|
GOBP POSITIVE REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT
|
8
|
7.91e-01
|
9.54e-01
|
0.14200
|
1.39e-01
|
-2.89e-02
|
4.95e-01
|
8.88e-01
|
GOBP REGULATION OF ODONTOGENESIS
|
18
|
5.37e-01
|
8.78e-01
|
0.14200
|
1.07e-01
|
9.33e-02
|
4.30e-01
|
4.93e-01
|
GOBP POSITIVE REGULATION OF STEROID HORMONE SECRETION
|
11
|
6.84e-01
|
9.17e-01
|
0.14200
|
-9.90e-02
|
-1.02e-01
|
5.70e-01
|
5.57e-01
|
GOBP SECRETORY GRANULE ORGANIZATION
|
63
|
1.82e-01
|
6.72e-01
|
0.14200
|
-1.07e-01
|
9.38e-02
|
1.42e-01
|
1.98e-01
|
GOBP ENDOPLASMIC RETICULUM TUBULAR NETWORK FORMATION
|
5
|
8.51e-01
|
9.67e-01
|
0.14200
|
-2.85e-02
|
-1.39e-01
|
9.12e-01
|
5.89e-01
|
GOBP REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION
|
12
|
7.06e-01
|
9.25e-01
|
0.14200
|
-3.58e-02
|
1.38e-01
|
8.30e-01
|
4.09e-01
|
GOBP REGULATION OF DEVELOPMENT HETEROCHRONIC
|
12
|
7.16e-01
|
9.28e-01
|
0.14200
|
1.28e-01
|
-6.22e-02
|
4.43e-01
|
7.09e-01
|
GOMF PHOSPHORIC DIESTER HYDROLASE ACTIVITY
|
86
|
8.37e-02
|
5.37e-01
|
0.14200
|
-3.59e-02
|
1.38e-01
|
5.65e-01
|
2.74e-02
|
GOMF THIAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
7
|
8.27e-01
|
9.62e-01
|
0.14200
|
8.88e-02
|
-1.11e-01
|
6.84e-01
|
6.11e-01
|
GOBP TERPENOID CATABOLIC PROCESS
|
8
|
7.92e-01
|
9.54e-01
|
0.14200
|
3.17e-02
|
-1.39e-01
|
8.77e-01
|
4.97e-01
|
GOBP LOCOMOTOR RHYTHM
|
15
|
5.97e-01
|
8.95e-01
|
0.14200
|
9.80e-02
|
1.03e-01
|
5.11e-01
|
4.90e-01
|
GOBP REGULATION OF T CELL CHEMOTAXIS
|
16
|
5.83e-01
|
8.90e-01
|
0.14200
|
1.26e-01
|
6.51e-02
|
3.82e-01
|
6.52e-01
|
GOBP RECEPTOR CLUSTERING
|
53
|
2.36e-01
|
7.24e-01
|
0.14200
|
-1.19e-01
|
7.69e-02
|
1.32e-01
|
3.33e-01
|
GOBP AMINO ACID NEUROTRANSMITTER REUPTAKE
|
10
|
7.33e-01
|
9.33e-01
|
0.14200
|
7.37e-03
|
1.42e-01
|
9.68e-01
|
4.37e-01
|
GOMF NUCLEAR RECEPTOR COACTIVATOR ACTIVITY
|
52
|
2.16e-01
|
7.07e-01
|
0.14200
|
-2.34e-02
|
1.40e-01
|
7.70e-01
|
8.05e-02
|
GOBP MRNA METHYLATION
|
17
|
5.68e-01
|
8.86e-01
|
0.14200
|
-1.31e-01
|
-5.45e-02
|
3.49e-01
|
6.97e-01
|
GOBP MEIOTIC CELL CYCLE PROCESS INVOLVED IN OOCYTE MATURATION
|
6
|
8.43e-01
|
9.66e-01
|
0.14200
|
-1.35e-01
|
4.55e-02
|
5.68e-01
|
8.47e-01
|
GOBP STEROID HORMONE SECRETION
|
27
|
4.18e-01
|
8.32e-01
|
0.14200
|
-1.38e-01
|
-3.23e-02
|
2.14e-01
|
7.71e-01
|
GOBP CELLULAR RESPONSE TO PARATHYROID HORMONE STIMULUS
|
8
|
7.62e-01
|
9.45e-01
|
0.14200
|
7.39e-02
|
1.21e-01
|
7.17e-01
|
5.53e-01
|
GOCC EXOCYST
|
14
|
6.71e-01
|
9.11e-01
|
0.14200
|
-1.36e-01
|
4.19e-02
|
3.80e-01
|
7.86e-01
|
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM
|
42
|
3.11e-01
|
7.74e-01
|
0.14200
|
5.77e-02
|
-1.30e-01
|
5.18e-01
|
1.46e-01
|
GOBP NEUTROPHIL CHEMOTAXIS
|
100
|
5.55e-02
|
4.63e-01
|
0.14200
|
-3.12e-02
|
1.38e-01
|
5.90e-01
|
1.68e-02
|
GOBP CELLULAR RESPONSE TO TESTOSTERONE STIMULUS
|
8
|
7.67e-01
|
9.46e-01
|
0.14200
|
-5.44e-02
|
-1.31e-01
|
7.90e-01
|
5.21e-01
|
GOBP MODULATION BY SYMBIONT OF ENTRY INTO HOST
|
55
|
2.24e-01
|
7.13e-01
|
0.14200
|
-1.21e-01
|
7.44e-02
|
1.22e-01
|
3.40e-01
|
GOMF DEAD H BOX RNA HELICASE BINDING
|
8
|
7.83e-01
|
9.52e-01
|
0.14200
|
-5.45e-04
|
1.42e-01
|
9.98e-01
|
4.88e-01
|
GOMF DNA POLYMERASE BINDING
|
22
|
4.71e-01
|
8.52e-01
|
0.14200
|
-1.09e-01
|
-9.11e-02
|
3.78e-01
|
4.60e-01
|
GOBP THYROID HORMONE GENERATION
|
22
|
5.30e-01
|
8.73e-01
|
0.14200
|
1.38e-01
|
-3.29e-02
|
2.63e-01
|
7.89e-01
|
GOBP POSITIVE REGULATION OF VASCULAR PERMEABILITY
|
18
|
5.85e-01
|
8.90e-01
|
0.14200
|
-1.47e-02
|
1.41e-01
|
9.14e-01
|
3.00e-01
|
GOBP REGULATION OF ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS
|
5
|
8.49e-01
|
9.66e-01
|
0.14200
|
-4.43e-02
|
-1.35e-01
|
8.64e-01
|
6.02e-01
|
GOMF STEROL BINDING
|
61
|
1.93e-01
|
6.85e-01
|
0.14200
|
-1.14e-01
|
8.37e-02
|
1.23e-01
|
2.58e-01
|
GOBP SULFUR COMPOUND METABOLIC PROCESS
|
294
|
1.94e-04
|
1.48e-02
|
0.14200
|
-1.40e-01
|
2.07e-02
|
3.58e-05
|
5.42e-01
|
GOBP RNA 5 END PROCESSING
|
21
|
5.69e-01
|
8.86e-01
|
0.14200
|
1.07e-01
|
-9.24e-02
|
3.95e-01
|
4.63e-01
|
GOBP POSITIVE REGULATION OF PROTEIN KINASE C SIGNALING
|
9
|
7.57e-01
|
9.43e-01
|
0.14200
|
-9.76e-03
|
-1.41e-01
|
9.60e-01
|
4.63e-01
|
GOBP RRNA CATABOLIC PROCESS
|
21
|
4.97e-01
|
8.61e-01
|
0.14100
|
-6.03e-02
|
-1.28e-01
|
6.32e-01
|
3.10e-01
|
GOBP PEPTIDYL SERINE DEPHOSPHORYLATION
|
14
|
6.48e-01
|
9.07e-01
|
0.14100
|
-1.41e-01
|
-1.19e-02
|
3.62e-01
|
9.39e-01
|
GOBP LUNG VASCULATURE DEVELOPMENT
|
8
|
7.81e-01
|
9.52e-01
|
0.14100
|
-1.09e-02
|
-1.41e-01
|
9.57e-01
|
4.90e-01
|
GOBP NEGATIVE REGULATION OF LIPID LOCALIZATION
|
66
|
1.07e-01
|
5.80e-01
|
0.14100
|
-8.69e-02
|
-1.11e-01
|
2.22e-01
|
1.17e-01
|
GOBP POSITIVE REGULATION OF MEGAKARYOCYTE DIFFERENTIATION
|
10
|
7.12e-01
|
9.27e-01
|
0.14100
|
-1.08e-01
|
-9.05e-02
|
5.53e-01
|
6.20e-01
|
GOCC NUCLEAR PORE
|
90
|
6.84e-02
|
5.00e-01
|
0.14100
|
-1.41e-01
|
8.06e-03
|
2.08e-02
|
8.95e-01
|
GOBP NEGATIVE REGULATION OF PHOSPHATASE ACTIVITY
|
24
|
4.75e-01
|
8.54e-01
|
0.14100
|
1.38e-02
|
1.40e-01
|
9.07e-01
|
2.34e-01
|
GOBP POSITIVE REGULATION OF INTEGRIN ACTIVATION
|
11
|
7.46e-01
|
9.38e-01
|
0.14100
|
-1.05e-01
|
9.41e-02
|
5.46e-01
|
5.89e-01
|
GOBP GLYCEROLIPID BIOSYNTHETIC PROCESS
|
234
|
1.92e-03
|
8.07e-02
|
0.14100
|
-1.20e-01
|
7.48e-02
|
1.61e-03
|
4.86e-02
|
GOBP NADPH OXIDATION
|
5
|
8.62e-01
|
9.69e-01
|
0.14100
|
1.18e-02
|
-1.41e-01
|
9.63e-01
|
5.86e-01
|
GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING
|
12
|
7.19e-01
|
9.29e-01
|
0.14100
|
-1.29e-01
|
5.65e-02
|
4.38e-01
|
7.35e-01
|
GOCC PROTEIN LIPID COMPLEX
|
38
|
2.96e-01
|
7.65e-01
|
0.14100
|
-1.36e-01
|
-3.80e-02
|
1.48e-01
|
6.86e-01
|
GOBP POSITIVE REGULATION OF CHROMOSOME ORGANIZATION
|
104
|
4.42e-02
|
4.29e-01
|
0.14100
|
1.73e-03
|
-1.41e-01
|
9.76e-01
|
1.30e-02
|
GOBP MYOBLAST MIGRATION
|
13
|
6.48e-01
|
9.07e-01
|
0.14100
|
7.00e-02
|
1.22e-01
|
6.62e-01
|
4.45e-01
|
GOBP POSITIVE REGULATION OF DEVELOPMENTAL PIGMENTATION
|
9
|
7.57e-01
|
9.43e-01
|
0.14100
|
-1.40e-01
|
-1.47e-02
|
4.67e-01
|
9.39e-01
|
GOBP ENDOCARDIAL CUSHION FORMATION
|
31
|
4.40e-01
|
8.40e-01
|
0.14100
|
-9.49e-02
|
1.04e-01
|
3.61e-01
|
3.16e-01
|
GOBP INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE
|
132
|
2.43e-02
|
3.31e-01
|
0.14100
|
-3.64e-02
|
1.36e-01
|
4.70e-01
|
7.00e-03
|
GOBP ENDOSOME ORGANIZATION
|
92
|
7.24e-02
|
5.13e-01
|
0.14100
|
-1.38e-01
|
2.90e-02
|
2.25e-02
|
6.30e-01
|
GOBP NEGATIVE REGULATION OF JNK CASCADE
|
37
|
3.44e-01
|
7.95e-01
|
0.14100
|
2.35e-02
|
-1.39e-01
|
8.05e-01
|
1.44e-01
|
GOMF 2 IRON 2 SULFUR CLUSTER BINDING
|
22
|
4.85e-01
|
8.55e-01
|
0.14100
|
-6.03e-02
|
-1.27e-01
|
6.24e-01
|
3.02e-01
|
GOMF KINASE INHIBITOR ACTIVITY
|
75
|
9.70e-02
|
5.61e-01
|
0.14100
|
-1.39e-01
|
-2.16e-02
|
3.75e-02
|
7.46e-01
|
GOBP POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY
|
26
|
4.54e-01
|
8.46e-01
|
0.14100
|
-1.40e-01
|
-6.31e-03
|
2.15e-01
|
9.56e-01
|
GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE
|
29
|
4.28e-01
|
8.36e-01
|
0.14100
|
1.40e-01
|
-1.53e-02
|
1.93e-01
|
8.87e-01
|
GOBP MACROPHAGE FUSION
|
6
|
8.36e-01
|
9.64e-01
|
0.14100
|
1.40e-01
|
-5.18e-03
|
5.51e-01
|
9.82e-01
|
GOBP NEUROFILAMENT CYTOSKELETON ORGANIZATION
|
10
|
7.14e-01
|
9.27e-01
|
0.14100
|
-9.39e-02
|
-1.05e-01
|
6.07e-01
|
5.67e-01
|
GOCC PRESYNAPTIC CYTOSKELETON
|
11
|
6.92e-01
|
9.21e-01
|
0.14000
|
1.13e-01
|
8.28e-02
|
5.15e-01
|
6.34e-01
|
GOBP POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION
|
20
|
5.82e-01
|
8.90e-01
|
0.14000
|
-1.25e-01
|
6.49e-02
|
3.35e-01
|
6.15e-01
|
GOBP L GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE
|
17
|
5.65e-01
|
8.85e-01
|
0.14000
|
1.07e-01
|
9.16e-02
|
4.47e-01
|
5.13e-01
|
GOMF ATPASE ACTIVATOR ACTIVITY
|
25
|
4.36e-01
|
8.39e-01
|
0.14000
|
-7.22e-02
|
-1.20e-01
|
5.32e-01
|
2.97e-01
|
GOBP SUPEROXIDE METABOLIC PROCESS
|
64
|
1.72e-01
|
6.60e-01
|
0.14000
|
-1.31e-01
|
4.95e-02
|
6.90e-02
|
4.94e-01
|
GOMF WW DOMAIN BINDING
|
22
|
5.60e-01
|
8.83e-01
|
0.14000
|
-1.03e-01
|
9.56e-02
|
4.04e-01
|
4.37e-01
|
GOMF MANGANESE ION BINDING
|
63
|
1.47e-01
|
6.34e-01
|
0.14000
|
-1.40e-01
|
-1.03e-02
|
5.46e-02
|
8.87e-01
|
GOBP PHOSPHATIDIC ACID METABOLIC PROCESS
|
35
|
3.82e-01
|
8.16e-01
|
0.14000
|
-5.14e-02
|
1.31e-01
|
5.98e-01
|
1.81e-01
|
GOBP ESTABLISHMENT OF SPINDLE ORIENTATION
|
42
|
3.27e-01
|
7.82e-01
|
0.14000
|
-1.19e-01
|
7.50e-02
|
1.84e-01
|
4.00e-01
|
GOMF BETA GALACTOSIDASE ACTIVITY
|
5
|
8.50e-01
|
9.67e-01
|
0.14000
|
-5.61e-02
|
-1.29e-01
|
8.28e-01
|
6.19e-01
|
GOBP POSITIVE REGULATION OF PHAGOCYTOSIS
|
66
|
1.20e-01
|
6.00e-01
|
0.14000
|
-1.32e-01
|
-4.72e-02
|
6.35e-02
|
5.07e-01
|
GOBP RESPONSE TO FIBROBLAST GROWTH FACTOR
|
116
|
2.30e-02
|
3.21e-01
|
0.14000
|
5.89e-02
|
1.27e-01
|
2.73e-01
|
1.79e-02
|
GOBP POSITIVE REGULATION OF PROTEIN GLYCOSYLATION
|
8
|
8.04e-01
|
9.57e-01
|
0.14000
|
-5.64e-02
|
1.28e-01
|
7.82e-01
|
5.30e-01
|
GOBP NUCLEOSOME ORGANIZATION
|
117
|
2.19e-02
|
3.13e-01
|
0.14000
|
-1.24e-01
|
-6.47e-02
|
2.02e-02
|
2.27e-01
|
GOBP PYRUVATE METABOLIC PROCESS
|
112
|
3.00e-02
|
3.61e-01
|
0.14000
|
-1.37e-01
|
-3.14e-02
|
1.25e-02
|
5.66e-01
|
GOBP VITAMIN D BIOSYNTHETIC PROCESS
|
10
|
7.69e-01
|
9.47e-01
|
0.14000
|
9.50e-02
|
-1.03e-01
|
6.03e-01
|
5.73e-01
|
GOMF ACTIVIN RECEPTOR BINDING
|
8
|
7.95e-01
|
9.55e-01
|
0.14000
|
1.38e-01
|
-2.36e-02
|
4.99e-01
|
9.08e-01
|
GOBP ENDOCYTIC RECYCLING
|
83
|
1.13e-01
|
5.91e-01
|
0.14000
|
-8.44e-02
|
1.12e-01
|
1.84e-01
|
7.84e-02
|
GOBP REGULATION OF PROSTAGLANDIN SECRETION
|
13
|
6.48e-01
|
9.07e-01
|
0.14000
|
1.08e-01
|
8.94e-02
|
5.01e-01
|
5.77e-01
|
GOBP PROTEIN TARGETING TO PEROXISOME
|
19
|
6.05e-01
|
8.96e-01
|
0.14000
|
7.72e-02
|
-1.17e-01
|
5.60e-01
|
3.78e-01
|
GOBP CELL MIGRATION INVOLVED IN HEART DEVELOPMENT
|
21
|
5.77e-01
|
8.89e-01
|
0.14000
|
-1.02e-01
|
9.55e-02
|
4.17e-01
|
4.49e-01
|
GOBP POSITIVE REGULATION OF MRNA PROCESSING
|
28
|
4.18e-01
|
8.32e-01
|
0.14000
|
-1.37e-01
|
-2.76e-02
|
2.09e-01
|
8.00e-01
|
GOBP T HELPER 1 CELL DIFFERENTIATION
|
23
|
4.92e-01
|
8.58e-01
|
0.14000
|
-1.38e-01
|
-2.23e-02
|
2.52e-01
|
8.53e-01
|
GOMF CARBON CARBON LYASE ACTIVITY
|
51
|
1.83e-01
|
6.73e-01
|
0.14000
|
-9.93e-02
|
-9.85e-02
|
2.20e-01
|
2.24e-01
|
GOBP AMINOGLYCAN METABOLIC PROCESS
|
118
|
4.42e-02
|
4.29e-01
|
0.14000
|
-1.20e-01
|
7.18e-02
|
2.44e-02
|
1.78e-01
|
GOBP EXOCYTIC PROCESS
|
82
|
6.66e-02
|
4.98e-01
|
0.14000
|
8.48e-02
|
1.11e-01
|
1.84e-01
|
8.23e-02
|
GOBP GOLGI TO PLASMA MEMBRANE TRANSPORT
|
57
|
1.60e-01
|
6.48e-01
|
0.14000
|
-1.29e-01
|
-5.28e-02
|
9.13e-02
|
4.91e-01
|
GOBP LIPID DROPLET DISASSEMBLY
|
6
|
8.33e-01
|
9.64e-01
|
0.14000
|
-1.39e-01
|
-1.71e-02
|
5.57e-01
|
9.42e-01
|
GOBP GLIAL CELL FATE SPECIFICATION
|
7
|
8.32e-01
|
9.64e-01
|
0.14000
|
8.53e-02
|
-1.11e-01
|
6.96e-01
|
6.12e-01
|
GOMF HISTONE H3K4 DEMETHYLASE ACTIVITY
|
6
|
8.52e-01
|
9.67e-01
|
0.14000
|
-6.40e-02
|
1.24e-01
|
7.86e-01
|
5.99e-01
|
GOBP REGULATION OF ASTROCYTE DIFFERENTIATION
|
31
|
3.88e-01
|
8.20e-01
|
0.14000
|
-1.90e-02
|
-1.38e-01
|
8.55e-01
|
1.83e-01
|
GOCC MYOSIN COMPLEX
|
56
|
1.57e-01
|
6.45e-01
|
0.14000
|
1.10e-01
|
8.57e-02
|
1.54e-01
|
2.67e-01
|
GOBP CELLULAR RESPONSE TO GLUCOCORTICOID STIMULUS
|
49
|
2.80e-01
|
7.52e-01
|
0.14000
|
9.82e-02
|
-9.92e-02
|
2.35e-01
|
2.30e-01
|
GOBP VESICLE DOCKING
|
64
|
1.20e-01
|
6.00e-01
|
0.14000
|
9.53e-02
|
1.02e-01
|
1.87e-01
|
1.58e-01
|
GOBP AMYLOID BETA CLEARANCE
|
39
|
3.35e-01
|
7.88e-01
|
0.13900
|
-1.36e-01
|
3.05e-02
|
1.41e-01
|
7.42e-01
|
GOBP CELLULAR RESPONSE TO XENOBIOTIC STIMULUS
|
187
|
4.79e-03
|
1.43e-01
|
0.13900
|
1.39e-01
|
-1.58e-02
|
1.08e-03
|
7.09e-01
|
GOMF CERAMIDE BINDING
|
19
|
5.64e-01
|
8.85e-01
|
0.13900
|
-1.39e-01
|
-1.09e-02
|
2.94e-01
|
9.34e-01
|
GOCC NUCLEAR INCLUSION BODY
|
12
|
6.72e-01
|
9.13e-01
|
0.13900
|
-1.04e-01
|
-9.31e-02
|
5.34e-01
|
5.77e-01
|
GOBP MORPHOGENESIS OF AN ENDOTHELIUM
|
17
|
5.90e-01
|
8.92e-01
|
0.13900
|
2.96e-02
|
1.36e-01
|
8.33e-01
|
3.31e-01
|
GOBP TETRAPYRROLE BIOSYNTHETIC PROCESS
|
31
|
4.18e-01
|
8.32e-01
|
0.13900
|
2.81e-02
|
-1.37e-01
|
7.87e-01
|
1.88e-01
|
GOCC DOPAMINERGIC SYNAPSE
|
14
|
6.92e-01
|
9.21e-01
|
0.13900
|
7.50e-02
|
-1.17e-01
|
6.27e-01
|
4.47e-01
|
GOBP CARDIAC MYOFIBRIL ASSEMBLY
|
19
|
5.54e-01
|
8.81e-01
|
0.13900
|
3.14e-02
|
1.36e-01
|
8.12e-01
|
3.06e-01
|
GOBP REGULATION OF MITOCHONDRIAL FUSION
|
11
|
7.12e-01
|
9.27e-01
|
0.13900
|
-1.36e-01
|
-2.84e-02
|
4.34e-01
|
8.71e-01
|
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE
|
100
|
6.19e-02
|
4.82e-01
|
0.13900
|
-1.36e-01
|
3.11e-02
|
1.90e-02
|
5.91e-01
|
GOBP RRNA METABOLIC PROCESS
|
252
|
2.71e-04
|
1.89e-02
|
0.13900
|
-1.09e-01
|
-8.66e-02
|
2.89e-03
|
1.79e-02
|
GOMF SINGLE STRANDED RNA BINDING
|
80
|
7.91e-02
|
5.27e-01
|
0.13900
|
-1.30e-01
|
-4.86e-02
|
4.38e-02
|
4.52e-01
|
GOBP PROTEIN DEACETYLATION
|
51
|
2.32e-01
|
7.18e-01
|
0.13900
|
-1.38e-01
|
1.43e-02
|
8.72e-02
|
8.60e-01
|
GOBP REGULATION OF RIG I SIGNALING PATHWAY
|
19
|
6.11e-01
|
8.98e-01
|
0.13900
|
-1.08e-01
|
8.79e-02
|
4.16e-01
|
5.07e-01
|
GOMF UBIQUITIN BINDING
|
99
|
5.16e-02
|
4.48e-01
|
0.13900
|
-1.39e-01
|
-1.19e-02
|
1.71e-02
|
8.38e-01
|
GOBP REGULATION OF T CELL MEDIATED CYTOTOXICITY
|
49
|
2.74e-01
|
7.49e-01
|
0.13900
|
1.22e-01
|
-6.68e-02
|
1.40e-01
|
4.19e-01
|
GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA SIGNALING PATHWAY
|
5
|
8.77e-01
|
9.75e-01
|
0.13900
|
-1.17e-01
|
7.53e-02
|
6.51e-01
|
7.71e-01
|
GOBP RETINAL CELL APOPTOTIC PROCESS
|
7
|
8.00e-01
|
9.56e-01
|
0.13900
|
5.25e-02
|
1.29e-01
|
8.10e-01
|
5.55e-01
|
GOCC SPERM MITOCHONDRIAL SHEATH
|
5
|
8.57e-01
|
9.68e-01
|
0.13900
|
-1.35e-01
|
-3.11e-02
|
6.00e-01
|
9.04e-01
|
GOCC CALYX OF HELD
|
19
|
5.52e-01
|
8.80e-01
|
0.13900
|
3.90e-02
|
1.33e-01
|
7.68e-01
|
3.14e-01
|
GOBP NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION
|
27
|
4.61e-01
|
8.48e-01
|
0.13900
|
-1.38e-01
|
1.39e-02
|
2.14e-01
|
9.01e-01
|
GOBP RENAL VESICLE DEVELOPMENT
|
18
|
6.09e-01
|
8.97e-01
|
0.13900
|
-1.34e-01
|
3.56e-02
|
3.24e-01
|
7.94e-01
|
GOBP REGULATION OF ADIPOSE TISSUE DEVELOPMENT
|
16
|
6.60e-01
|
9.09e-01
|
0.13900
|
-8.25e-02
|
1.12e-01
|
5.68e-01
|
4.39e-01
|
GOBP REGULATION OF VIRAL TRANSCRIPTION
|
18
|
6.06e-01
|
8.97e-01
|
0.13900
|
-1.35e-01
|
3.04e-02
|
3.20e-01
|
8.23e-01
|
GOBP TERPENOID BIOSYNTHETIC PROCESS
|
16
|
5.97e-01
|
8.95e-01
|
0.13900
|
-6.46e-02
|
-1.23e-01
|
6.55e-01
|
3.95e-01
|
GOMF PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY
|
56
|
1.64e-01
|
6.48e-01
|
0.13900
|
-1.20e-01
|
-6.91e-02
|
1.19e-01
|
3.71e-01
|
GOMF HORMONE BINDING
|
83
|
1.16e-01
|
5.95e-01
|
0.13900
|
7.55e-02
|
-1.16e-01
|
2.34e-01
|
6.67e-02
|
GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION
|
21
|
5.74e-01
|
8.88e-01
|
0.13900
|
1.25e-01
|
-6.04e-02
|
3.22e-01
|
6.32e-01
|
GOBP POSTSYNAPTIC DENSITY ASSEMBLY
|
21
|
5.11e-01
|
8.66e-01
|
0.13900
|
-1.26e-01
|
-5.87e-02
|
3.19e-01
|
6.42e-01
|
GOCC ACTIN FILAMENT BUNDLE
|
76
|
1.01e-01
|
5.69e-01
|
0.13900
|
2.15e-02
|
1.37e-01
|
7.46e-01
|
3.90e-02
|
GOBP NEGATIVE REGULATION OF STEM CELL POPULATION MAINTENANCE
|
24
|
5.05e-01
|
8.65e-01
|
0.13900
|
-1.38e-01
|
1.52e-02
|
2.43e-01
|
8.97e-01
|
GOBP POSITIVE REGULATION OF MYOBLAST FUSION
|
16
|
6.60e-01
|
9.09e-01
|
0.13900
|
-7.40e-02
|
1.17e-01
|
6.08e-01
|
4.17e-01
|
GOBP NEGATIVE REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE
|
20
|
5.67e-01
|
8.86e-01
|
0.13900
|
-1.65e-02
|
1.38e-01
|
8.98e-01
|
2.87e-01
|
GOBP MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY
|
16
|
6.48e-01
|
9.07e-01
|
0.13800
|
-1.32e-01
|
4.35e-02
|
3.62e-01
|
7.63e-01
|
GOBP MOTILE CILIUM ASSEMBLY
|
64
|
1.35e-01
|
6.16e-01
|
0.13800
|
1.31e-01
|
4.48e-02
|
6.98e-02
|
5.35e-01
|
GOBP CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE
|
77
|
1.13e-01
|
5.91e-01
|
0.13800
|
-1.38e-01
|
1.44e-02
|
3.67e-02
|
8.27e-01
|
GOBP REGULATION OF CELL FATE SPECIFICATION
|
24
|
5.34e-01
|
8.76e-01
|
0.13800
|
-6.65e-02
|
1.21e-01
|
5.73e-01
|
3.03e-01
|
GOBP CONNECTIVE TISSUE REPLACEMENT INVOLVED IN INFLAMMATORY RESPONSE WOUND HEALING
|
6
|
8.57e-01
|
9.68e-01
|
0.13800
|
-1.04e-01
|
9.07e-02
|
6.58e-01
|
7.00e-01
|
GOBP PROTEIN N LINKED GLYCOSYLATION VIA ASPARAGINE
|
23
|
5.35e-01
|
8.76e-01
|
0.13800
|
-1.33e-01
|
3.96e-02
|
2.71e-01
|
7.42e-01
|
GOBP ACROSOME REACTION
|
40
|
2.88e-01
|
7.59e-01
|
0.13800
|
-4.25e-02
|
-1.32e-01
|
6.42e-01
|
1.50e-01
|
GOMF 1 PHOSPHATIDYLINOSITOL BINDING
|
15
|
6.51e-01
|
9.07e-01
|
0.13800
|
-8.99e-03
|
1.38e-01
|
9.52e-01
|
3.55e-01
|
GOBP POSITIVE REGULATION OF EXOCYTOSIS
|
73
|
1.55e-01
|
6.42e-01
|
0.13800
|
-8.97e-02
|
1.05e-01
|
1.85e-01
|
1.20e-01
|
GOBP SUBSTANTIA NIGRA DEVELOPMENT
|
40
|
3.09e-01
|
7.72e-01
|
0.13800
|
-1.38e-01
|
-6.17e-03
|
1.31e-01
|
9.46e-01
|
GOBP ALPHA BETA T CELL PROLIFERATION
|
42
|
2.68e-01
|
7.43e-01
|
0.13800
|
1.29e-01
|
4.96e-02
|
1.48e-01
|
5.78e-01
|
GOBP INDOLE CONTAINING COMPOUND METABOLIC PROCESS
|
22
|
5.50e-01
|
8.80e-01
|
0.13800
|
1.33e-01
|
-3.90e-02
|
2.82e-01
|
7.51e-01
|
GOBP GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS
|
26
|
4.99e-01
|
8.62e-01
|
0.13800
|
4.87e-02
|
-1.29e-01
|
6.68e-01
|
2.54e-01
|
GOMF DEATH RECEPTOR BINDING
|
19
|
6.06e-01
|
8.97e-01
|
0.13800
|
-5.73e-02
|
1.26e-01
|
6.65e-01
|
3.43e-01
|
GOMF TELETHONIN BINDING
|
7
|
8.35e-01
|
9.64e-01
|
0.13800
|
7.84e-02
|
-1.14e-01
|
7.20e-01
|
6.02e-01
|
GOBP REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL
|
80
|
8.52e-02
|
5.41e-01
|
0.13800
|
3.76e-02
|
1.33e-01
|
5.61e-01
|
3.98e-02
|
GOBP POST TRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE
|
15
|
6.44e-01
|
9.07e-01
|
0.13800
|
-5.98e-03
|
-1.38e-01
|
9.68e-01
|
3.55e-01
|
GOBP NEGATIVE REGULATION OF STEM CELL PROLIFERATION
|
26
|
4.34e-01
|
8.38e-01
|
0.13800
|
1.20e-01
|
6.93e-02
|
2.91e-01
|
5.41e-01
|
GOBP CYTOSOLIC TRANSPORT
|
175
|
8.85e-03
|
1.97e-01
|
0.13800
|
-1.33e-01
|
3.72e-02
|
2.39e-03
|
3.96e-01
|
GOBP EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS
|
17
|
6.06e-01
|
8.97e-01
|
0.13800
|
-9.71e-03
|
-1.38e-01
|
9.45e-01
|
3.25e-01
|
GOMF POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING
|
52
|
2.42e-01
|
7.25e-01
|
0.13800
|
-1.34e-01
|
3.32e-02
|
9.45e-02
|
6.79e-01
|
GOMF RNA EXONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS
|
39
|
3.03e-01
|
7.68e-01
|
0.13800
|
-3.31e-02
|
-1.34e-01
|
7.20e-01
|
1.47e-01
|
GOBP VESICLE FUSION TO PLASMA MEMBRANE
|
24
|
5.26e-01
|
8.71e-01
|
0.13800
|
-4.52e-02
|
1.30e-01
|
7.02e-01
|
2.69e-01
|
GOCC SITE OF POLARIZED GROWTH
|
162
|
1.36e-02
|
2.52e-01
|
0.13800
|
-4.63e-02
|
1.30e-01
|
3.09e-01
|
4.33e-03
|
GOMF 3 5 DNA EXONUCLEASE ACTIVITY
|
13
|
6.81e-01
|
9.16e-01
|
0.13800
|
-1.37e-01
|
-1.16e-02
|
3.91e-01
|
9.42e-01
|
GOBP NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY
|
28
|
4.79e-01
|
8.54e-01
|
0.13800
|
5.71e-02
|
-1.25e-01
|
6.01e-01
|
2.50e-01
|
GOBP FATTY ACID BETA OXIDATION
|
74
|
1.29e-01
|
6.09e-01
|
0.13800
|
-1.36e-01
|
2.16e-02
|
4.29e-02
|
7.48e-01
|
GOBP SULFATE TRANSPORT
|
17
|
6.17e-01
|
9.00e-01
|
0.13800
|
-1.01e-02
|
1.37e-01
|
9.42e-01
|
3.27e-01
|
GOMF BILE ACID SODIUM SYMPORTER ACTIVITY
|
5
|
8.81e-01
|
9.75e-01
|
0.13800
|
9.36e-02
|
-1.01e-01
|
7.17e-01
|
6.96e-01
|
GOBP CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT
|
23
|
5.34e-01
|
8.76e-01
|
0.13800
|
-1.34e-01
|
3.13e-02
|
2.66e-01
|
7.95e-01
|
GOMF UBIQUITIN LIKE PROTEIN BINDING
|
117
|
3.69e-02
|
3.91e-01
|
0.13800
|
-1.37e-01
|
9.74e-03
|
1.03e-02
|
8.56e-01
|
GOMF PYRIMIDINE NUCLEOSIDE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
8
|
7.74e-01
|
9.49e-01
|
0.13800
|
7.80e-02
|
1.13e-01
|
7.02e-01
|
5.79e-01
|
GOMF RNA POLYMERASE CORE ENZYME BINDING
|
41
|
3.00e-01
|
7.67e-01
|
0.13800
|
-1.37e-01
|
-1.22e-02
|
1.29e-01
|
8.92e-01
|
GOBP SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION
|
461
|
4.47e-06
|
8.51e-04
|
0.13800
|
-3.15e-02
|
1.34e-01
|
2.47e-01
|
8.18e-07
|
GOBP INCLUSION BODY ASSEMBLY
|
23
|
5.15e-01
|
8.68e-01
|
0.13800
|
-1.38e-01
|
-6.17e-04
|
2.53e-01
|
9.96e-01
|
GOBP POSITIVE REGULATION OF LEUKOCYTE MIGRATION
|
142
|
2.76e-02
|
3.45e-01
|
0.13800
|
-1.09e-01
|
8.34e-02
|
2.43e-02
|
8.64e-02
|
GOBP NEGATIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS
|
6
|
8.32e-01
|
9.64e-01
|
0.13800
|
-4.02e-02
|
-1.32e-01
|
8.65e-01
|
5.77e-01
|
GOBP POSITIVE REGULATION OF SYNAPSE ASSEMBLY
|
56
|
1.66e-01
|
6.50e-01
|
0.13800
|
8.46e-02
|
1.08e-01
|
2.74e-01
|
1.60e-01
|
GOMF POLY A BINDING
|
23
|
4.78e-01
|
8.54e-01
|
0.13700
|
-8.20e-02
|
-1.10e-01
|
4.96e-01
|
3.60e-01
|
GOBP EXTRACELLULAR MATRIX ASSEMBLY
|
42
|
3.14e-01
|
7.76e-01
|
0.13700
|
-2.27e-02
|
1.36e-01
|
7.99e-01
|
1.28e-01
|
GOMF RNA EXONUCLEASE ACTIVITY
|
44
|
2.75e-01
|
7.49e-01
|
0.13700
|
-1.35e-02
|
-1.37e-01
|
8.77e-01
|
1.17e-01
|
GOBP POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION
|
13
|
7.20e-01
|
9.29e-01
|
0.13700
|
8.76e-02
|
-1.06e-01
|
5.85e-01
|
5.09e-01
|
GOMF SOLUTE INORGANIC ANION ANTIPORTER ACTIVITY
|
28
|
4.68e-01
|
8.51e-01
|
0.13700
|
-1.34e-01
|
3.20e-02
|
2.21e-01
|
7.70e-01
|
GOBP PHOSPHATIDYLCHOLINE METABOLIC PROCESS
|
74
|
1.56e-01
|
6.43e-01
|
0.13700
|
-9.77e-02
|
9.64e-02
|
1.46e-01
|
1.51e-01
|
GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY
|
51
|
2.05e-01
|
6.95e-01
|
0.13700
|
-1.27e-01
|
-5.19e-02
|
1.16e-01
|
5.21e-01
|
GOCC AP TYPE MEMBRANE COAT ADAPTOR COMPLEX
|
37
|
3.27e-01
|
7.83e-01
|
0.13700
|
-1.34e-01
|
-3.18e-02
|
1.60e-01
|
7.38e-01
|
GOCC I BAND
|
141
|
1.12e-02
|
2.25e-01
|
0.13700
|
8.74e-02
|
1.06e-01
|
7.32e-02
|
3.01e-02
|
GOBP POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS
|
19
|
6.17e-01
|
9.00e-01
|
0.13700
|
-7.78e-02
|
1.13e-01
|
5.57e-01
|
3.94e-01
|
GOCC KINETOCHORE MICROTUBULE
|
20
|
5.71e-01
|
8.87e-01
|
0.13700
|
-1.37e-01
|
1.22e-02
|
2.90e-01
|
9.25e-01
|
GOBP ANOIKIS
|
32
|
4.43e-01
|
8.40e-01
|
0.13700
|
-1.16e-01
|
7.36e-02
|
2.58e-01
|
4.71e-01
|
GOMF DELTA CATENIN BINDING
|
9
|
7.55e-01
|
9.42e-01
|
0.13700
|
5.97e-02
|
1.23e-01
|
7.56e-01
|
5.22e-01
|
GOBP MRNA 3 SPLICE SITE RECOGNITION
|
6
|
8.54e-01
|
9.68e-01
|
0.13700
|
4.60e-02
|
-1.29e-01
|
8.45e-01
|
5.84e-01
|
GOMF PROSTAGLANDIN E RECEPTOR ACTIVITY
|
5
|
8.80e-01
|
9.75e-01
|
0.13700
|
6.88e-02
|
-1.18e-01
|
7.90e-01
|
6.47e-01
|
GOBP REGULATORY T CELL DIFFERENTIATION
|
39
|
2.91e-01
|
7.61e-01
|
0.13700
|
-1.13e-01
|
-7.71e-02
|
2.22e-01
|
4.05e-01
|
GOBP CRANIAL SKELETAL SYSTEM DEVELOPMENT
|
70
|
1.69e-01
|
6.55e-01
|
0.13700
|
-1.18e-01
|
6.94e-02
|
8.78e-02
|
3.15e-01
|
GOBP POSITIVE REGULATION OF TOR SIGNALING
|
65
|
1.49e-01
|
6.35e-01
|
0.13700
|
-1.36e-01
|
-1.80e-02
|
5.85e-02
|
8.01e-01
|
GOBP NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS
|
41
|
3.42e-01
|
7.93e-01
|
0.13700
|
-4.88e-02
|
1.28e-01
|
5.88e-01
|
1.57e-01
|
GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX COUPLING FACTOR F O
|
12
|
7.38e-01
|
9.35e-01
|
0.13700
|
7.41e-02
|
-1.15e-01
|
6.57e-01
|
4.91e-01
|
GOMF RECEPTOR SIGNALING PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY
|
5
|
8.60e-01
|
9.68e-01
|
0.13700
|
3.58e-02
|
1.32e-01
|
8.90e-01
|
6.10e-01
|
GOBP GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT
|
39
|
2.92e-01
|
7.63e-01
|
0.13700
|
-7.64e-02
|
-1.13e-01
|
4.09e-01
|
2.21e-01
|
GOBP CENTRIOLE ASSEMBLY
|
47
|
2.57e-01
|
7.35e-01
|
0.13700
|
-1.13e-02
|
-1.36e-01
|
8.94e-01
|
1.06e-01
|
GOBP LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL
|
55
|
1.89e-01
|
6.81e-01
|
0.13700
|
-1.30e-01
|
-4.14e-02
|
9.49e-02
|
5.96e-01
|
GOMF SUMO BINDING
|
16
|
6.67e-01
|
9.11e-01
|
0.13700
|
-7.16e-02
|
1.16e-01
|
6.20e-01
|
4.21e-01
|
GOBP MYELOID LEUKOCYTE MIGRATION
|
231
|
3.33e-03
|
1.15e-01
|
0.13700
|
-9.33e-02
|
9.98e-02
|
1.46e-02
|
9.00e-03
|
GOBP ENDOCANNABINOID SIGNALING PATHWAY
|
5
|
8.53e-01
|
9.68e-01
|
0.13700
|
8.68e-02
|
1.05e-01
|
7.37e-01
|
6.83e-01
|
GOBP BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR SIGNALING PATHWAY
|
6
|
8.61e-01
|
9.69e-01
|
0.13600
|
1.03e-01
|
-8.96e-02
|
6.62e-01
|
7.04e-01
|
GOCC POLYSOMAL RIBOSOME
|
28
|
4.91e-01
|
8.57e-01
|
0.13600
|
6.55e-02
|
-1.20e-01
|
5.48e-01
|
2.73e-01
|
GOBP SKELETAL MUSCLE CONTRACTION
|
43
|
3.24e-01
|
7.80e-01
|
0.13600
|
-1.29e-01
|
4.37e-02
|
1.43e-01
|
6.20e-01
|
GOMF ALKALI METAL ION BINDING
|
19
|
5.61e-01
|
8.83e-01
|
0.13600
|
-1.29e-01
|
-4.57e-02
|
3.32e-01
|
7.30e-01
|
GOBP MITOTIC SISTER CHROMATID SEGREGATION
|
180
|
3.75e-03
|
1.24e-01
|
0.13600
|
-6.83e-02
|
-1.18e-01
|
1.14e-01
|
6.30e-03
|
GOBP CHROMOSOME SEPARATION
|
81
|
9.04e-02
|
5.51e-01
|
0.13600
|
-2.98e-02
|
-1.33e-01
|
6.42e-01
|
3.84e-02
|
GOBP METANEPHROS MORPHOGENESIS
|
30
|
4.70e-01
|
8.51e-01
|
0.13600
|
-7.34e-02
|
1.15e-01
|
4.87e-01
|
2.76e-01
|
GOBP NATURAL KILLER CELL PROLIFERATION
|
14
|
6.98e-01
|
9.21e-01
|
0.13600
|
5.70e-02
|
-1.24e-01
|
7.12e-01
|
4.22e-01
|
GOCC EXORIBONUCLEASE COMPLEX
|
18
|
6.39e-01
|
9.06e-01
|
0.13600
|
9.12e-02
|
-1.01e-01
|
5.03e-01
|
4.57e-01
|
GOBP DEFENSE RESPONSE TO FUNGUS
|
49
|
2.70e-01
|
7.45e-01
|
0.13600
|
-3.06e-02
|
1.33e-01
|
7.11e-01
|
1.08e-01
|
GOBP PROTON TRANSPORTING V TYPE ATPASE COMPLEX ASSEMBLY
|
7
|
8.36e-01
|
9.64e-01
|
0.13600
|
-1.23e-01
|
5.78e-02
|
5.72e-01
|
7.91e-01
|
GOBP RESPONSE TO AUDITORY STIMULUS
|
31
|
4.17e-01
|
8.31e-01
|
0.13600
|
1.36e-01
|
-5.87e-05
|
1.89e-01
|
1.00e+00
|
GOBP DNA REPLICATION INITIATION
|
35
|
3.31e-01
|
7.85e-01
|
0.13600
|
-8.84e-02
|
-1.04e-01
|
3.65e-01
|
2.89e-01
|
GOBP REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION
|
10
|
7.68e-01
|
9.46e-01
|
0.13600
|
-1.31e-01
|
3.65e-02
|
4.73e-01
|
8.41e-01
|
GOBP OTIC VESICLE DEVELOPMENT
|
15
|
6.29e-01
|
9.02e-01
|
0.13600
|
-1.23e-01
|
-5.86e-02
|
4.10e-01
|
6.94e-01
|
GOBP REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION
|
33
|
4.39e-01
|
8.40e-01
|
0.13600
|
8.15e-02
|
-1.09e-01
|
4.18e-01
|
2.78e-01
|
GOMF LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY
|
18
|
5.67e-01
|
8.86e-01
|
0.13600
|
-8.42e-02
|
-1.07e-01
|
5.36e-01
|
4.32e-01
|
GOBP NEGATIVE REGULATION OF ORGANELLE ASSEMBLY
|
42
|
3.37e-01
|
7.89e-01
|
0.13600
|
4.78e-02
|
-1.27e-01
|
5.92e-01
|
1.53e-01
|
GOBP POSITIVE REGULATION OF CELL MATURATION
|
7
|
8.06e-01
|
9.57e-01
|
0.13600
|
-1.22e-01
|
-5.98e-02
|
5.76e-01
|
7.84e-01
|
GOBP NUCLEOTIDE SUGAR METABOLIC PROCESS
|
37
|
3.15e-01
|
7.76e-01
|
0.13600
|
-7.67e-02
|
-1.12e-01
|
4.20e-01
|
2.37e-01
|
GOBP MIDDLE EAR MORPHOGENESIS
|
20
|
5.70e-01
|
8.86e-01
|
0.13600
|
-1.36e-01
|
-7.46e-04
|
2.93e-01
|
9.95e-01
|
GOBP VESICLE TARGETING ROUGH ER TO CIS GOLGI
|
25
|
5.06e-01
|
8.65e-01
|
0.13600
|
-1.35e-01
|
1.70e-02
|
2.43e-01
|
8.83e-01
|
GOMF 5 3 DNA HELICASE ACTIVITY
|
8
|
8.10e-01
|
9.59e-01
|
0.13600
|
3.75e-02
|
-1.31e-01
|
8.54e-01
|
5.22e-01
|
GOCC ENDOPLASMIC RETICULUM TUBULAR NETWORK MEMBRANE
|
5
|
8.82e-01
|
9.75e-01
|
0.13600
|
-1.17e-01
|
6.88e-02
|
6.50e-01
|
7.90e-01
|
GOBP MUSCLE HYPERTROPHY IN RESPONSE TO STRESS
|
31
|
4.65e-01
|
8.50e-01
|
0.13600
|
-9.14e-02
|
1.00e-01
|
3.78e-01
|
3.33e-01
|
GOBP SECONDARY HEART FIELD SPECIFICATION
|
11
|
7.07e-01
|
9.25e-01
|
0.13600
|
9.45e-02
|
9.76e-02
|
5.87e-01
|
5.75e-01
|
GOCC GOLGI ASSOCIATED VESICLE MEMBRANE
|
55
|
2.48e-01
|
7.26e-01
|
0.13600
|
-1.22e-01
|
5.87e-02
|
1.16e-01
|
4.52e-01
|
GOBP PARACRINE SIGNALING
|
7
|
8.03e-01
|
9.57e-01
|
0.13600
|
-8.16e-02
|
-1.08e-01
|
7.08e-01
|
6.19e-01
|
GOBP SPONTANEOUS NEUROTRANSMITTER SECRETION
|
8
|
7.83e-01
|
9.52e-01
|
0.13600
|
5.78e-02
|
1.23e-01
|
7.77e-01
|
5.48e-01
|
GOBP REGULATION OF DENDRITIC SPINE MORPHOGENESIS
|
39
|
3.30e-01
|
7.85e-01
|
0.13600
|
9.61e-03
|
1.35e-01
|
9.17e-01
|
1.44e-01
|
GOBP POSITIVE REGULATION OF T HELPER 17 CELL DIFFERENTIATION
|
8
|
7.79e-01
|
9.51e-01
|
0.13600
|
8.35e-02
|
1.07e-01
|
6.82e-01
|
6.01e-01
|
GOBP FOCAL ADHESION ASSEMBLY
|
83
|
1.30e-01
|
6.09e-01
|
0.13600
|
-8.35e-02
|
1.07e-01
|
1.89e-01
|
9.25e-02
|
GOMF HEXOSAMINIDASE ACTIVITY
|
15
|
6.48e-01
|
9.07e-01
|
0.13600
|
-1.34e-01
|
-2.02e-02
|
3.69e-01
|
8.92e-01
|
GOBP REGULATION OF CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY
|
7
|
8.23e-01
|
9.61e-01
|
0.13600
|
1.36e-01
|
-1.82e-03
|
5.35e-01
|
9.93e-01
|
GOCC CARDIAC MYOFIBRIL
|
6
|
8.29e-01
|
9.62e-01
|
0.13600
|
8.74e-02
|
1.04e-01
|
7.11e-01
|
6.60e-01
|
GOBP N ACYLPHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS
|
9
|
7.56e-01
|
9.42e-01
|
0.13500
|
1.12e-01
|
7.66e-02
|
5.62e-01
|
6.91e-01
|
GOMF ALPHA TUBULIN BINDING
|
37
|
3.97e-01
|
8.25e-01
|
0.13500
|
-1.17e-01
|
6.81e-02
|
2.18e-01
|
4.73e-01
|
GOBP POSITIVE REGULATION OF COA TRANSFERASE ACTIVITY
|
8
|
7.83e-01
|
9.52e-01
|
0.13500
|
-1.22e-01
|
-5.85e-02
|
5.50e-01
|
7.75e-01
|
GOBP BEHAVIORAL RESPONSE TO PAIN
|
19
|
6.28e-01
|
9.02e-01
|
0.13500
|
-9.51e-02
|
9.64e-02
|
4.73e-01
|
4.67e-01
|
GOCC PRESYNAPTIC ACTIVE ZONE CYTOPLASMIC COMPONENT
|
18
|
6.26e-01
|
9.01e-01
|
0.13500
|
-3.95e-02
|
1.30e-01
|
7.72e-01
|
3.41e-01
|
GOBP NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS
|
145
|
1.10e-02
|
2.23e-01
|
0.13500
|
-9.13e-02
|
-1.00e-01
|
5.76e-02
|
3.76e-02
|
GOBP ACTIN POLYMERIZATION DEPENDENT CELL MOTILITY
|
7
|
8.06e-01
|
9.57e-01
|
0.13500
|
6.95e-02
|
1.16e-01
|
7.50e-01
|
5.94e-01
|
GOBP MESENCHYMAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT
|
6
|
8.51e-01
|
9.67e-01
|
0.13500
|
1.34e-01
|
-2.15e-02
|
5.71e-01
|
9.27e-01
|
GOCC ENDOLYSOSOME MEMBRANE
|
17
|
6.59e-01
|
9.09e-01
|
0.13500
|
-9.65e-02
|
9.50e-02
|
4.91e-01
|
4.98e-01
|
GOBP GLYCEROLIPID METABOLIC PROCESS
|
370
|
1.30e-04
|
1.15e-02
|
0.13500
|
-1.05e-01
|
8.56e-02
|
5.28e-04
|
4.71e-03
|
GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION
|
12
|
7.01e-01
|
9.22e-01
|
0.13500
|
-3.52e-02
|
-1.31e-01
|
8.33e-01
|
4.33e-01
|
GOBP POSITIVE REGULATION OF TOLERANCE INDUCTION
|
11
|
7.46e-01
|
9.38e-01
|
0.13500
|
1.33e-01
|
-2.49e-02
|
4.45e-01
|
8.86e-01
|
GOCC DENDRITIC GROWTH CONE
|
8
|
8.07e-01
|
9.59e-01
|
0.13500
|
2.21e-02
|
-1.33e-01
|
9.14e-01
|
5.13e-01
|
GOCC CAMP DEPENDENT PROTEIN KINASE COMPLEX
|
7
|
8.36e-01
|
9.64e-01
|
0.13500
|
-1.27e-01
|
4.66e-02
|
5.61e-01
|
8.31e-01
|
GOMF 3 CHLOROALLYL ALDEHYDE DEHYDROGENASE ACTIVITY
|
5
|
8.66e-01
|
9.70e-01
|
0.13500
|
-1.90e-02
|
-1.34e-01
|
9.41e-01
|
6.04e-01
|
GOBP DENDRITE ARBORIZATION
|
10
|
7.82e-01
|
9.52e-01
|
0.13500
|
8.41e-02
|
-1.06e-01
|
6.45e-01
|
5.62e-01
|
GOBP POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS
|
38
|
3.11e-01
|
7.75e-01
|
0.13500
|
-6.76e-02
|
-1.17e-01
|
4.71e-01
|
2.12e-01
|
GOMF HEAT SHOCK PROTEIN BINDING
|
124
|
2.69e-02
|
3.41e-01
|
0.13500
|
-3.07e-02
|
-1.32e-01
|
5.54e-01
|
1.13e-02
|
GOCC NUCLEAR REPLICATION FORK
|
32
|
4.57e-01
|
8.48e-01
|
0.13500
|
-1.03e-01
|
8.79e-02
|
3.15e-01
|
3.90e-01
|
GOMF CARBOHYDRATE DERIVATIVE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
52
|
2.67e-01
|
7.43e-01
|
0.13500
|
-1.25e-01
|
5.10e-02
|
1.18e-01
|
5.25e-01
|
GOBP EYE PIGMENTATION
|
5
|
8.83e-01
|
9.76e-01
|
0.13500
|
-1.19e-01
|
6.42e-02
|
6.45e-01
|
8.04e-01
|
GOBP INTERLEUKIN 10 PRODUCTION
|
58
|
2.35e-01
|
7.23e-01
|
0.13500
|
-6.29e-02
|
1.20e-01
|
4.07e-01
|
1.15e-01
|
GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSPORT
|
66
|
1.61e-01
|
6.48e-01
|
0.13500
|
-4.49e-04
|
1.35e-01
|
9.95e-01
|
5.77e-02
|
GOBP POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY
|
27
|
4.92e-01
|
8.58e-01
|
0.13500
|
-2.99e-02
|
1.32e-01
|
7.88e-01
|
2.36e-01
|
GOBP REGULATION OF GLOMERULAR FILTRATION
|
8
|
8.13e-01
|
9.59e-01
|
0.13500
|
1.30e-01
|
-3.80e-02
|
5.25e-01
|
8.52e-01
|
GOBP SNARE COMPLEX ASSEMBLY
|
22
|
5.25e-01
|
8.71e-01
|
0.13500
|
-3.23e-02
|
-1.31e-01
|
7.93e-01
|
2.87e-01
|
GOCC JUXTAPARANODE REGION OF AXON
|
12
|
7.34e-01
|
9.34e-01
|
0.13500
|
1.28e-01
|
-4.22e-02
|
4.42e-01
|
8.00e-01
|
GOBP NEGATIVE REGULATION OF MOTOR NEURON APOPTOTIC PROCESS
|
11
|
7.48e-01
|
9.40e-01
|
0.13500
|
-2.65e-02
|
1.32e-01
|
8.79e-01
|
4.47e-01
|
GOBP STRIATED MUSCLE CELL DEVELOPMENT
|
73
|
1.28e-01
|
6.08e-01
|
0.13500
|
1.14e-02
|
1.34e-01
|
8.66e-01
|
4.70e-02
|
GOCC GOLGI CISTERNA
|
97
|
6.62e-02
|
4.97e-01
|
0.13500
|
-1.35e-01
|
-8.07e-03
|
2.19e-02
|
8.91e-01
|
GOBP PLATELET ACTIVATION
|
128
|
2.24e-02
|
3.17e-01
|
0.13500
|
4.56e-02
|
1.27e-01
|
3.73e-01
|
1.31e-02
|
GOBP L SERINE METABOLIC PROCESS
|
11
|
7.65e-01
|
9.45e-01
|
0.13500
|
9.09e-02
|
-9.96e-02
|
6.02e-01
|
5.67e-01
|
GOBP TRANSLATIONAL ELONGATION
|
68
|
1.29e-01
|
6.09e-01
|
0.13500
|
-5.64e-02
|
-1.22e-01
|
4.21e-01
|
8.07e-02
|
GOBP CLATHRIN COAT ASSEMBLY
|
17
|
6.16e-01
|
8.99e-01
|
0.13500
|
-1.34e-01
|
-1.79e-02
|
3.40e-01
|
8.98e-01
|
GOMF DIOXYGENASE ACTIVITY
|
86
|
1.07e-01
|
5.80e-01
|
0.13500
|
-1.31e-01
|
3.35e-02
|
3.64e-02
|
5.91e-01
|
GOBP MATURATION OF SSU RRNA
|
51
|
2.07e-01
|
6.95e-01
|
0.13500
|
-9.44e-02
|
-9.61e-02
|
2.43e-01
|
2.35e-01
|
GOBP POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY
|
26
|
5.32e-01
|
8.76e-01
|
0.13500
|
-9.31e-02
|
9.74e-02
|
4.11e-01
|
3.90e-01
|
GOCC MKS COMPLEX
|
13
|
7.10e-01
|
9.26e-01
|
0.13500
|
1.32e-01
|
-2.57e-02
|
4.09e-01
|
8.72e-01
|
GOBP NON CANONICAL WNT SIGNALING PATHWAY VIA JNK CASCADE
|
6
|
8.63e-01
|
9.69e-01
|
0.13500
|
-7.32e-02
|
1.13e-01
|
7.56e-01
|
6.32e-01
|
GOBP REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL
|
28
|
4.61e-01
|
8.48e-01
|
0.13500
|
1.35e-01
|
1.25e-03
|
2.17e-01
|
9.91e-01
|
GOBP MICROVILLUS ASSEMBLY
|
20
|
6.11e-01
|
8.98e-01
|
0.13500
|
-1.16e-01
|
6.82e-02
|
3.69e-01
|
5.97e-01
|
GOMF ACIDIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY
|
18
|
5.90e-01
|
8.92e-01
|
0.13500
|
1.29e-01
|
3.72e-02
|
3.42e-01
|
7.85e-01
|
GOMF POTASSIUM CHANNEL ACTIVATOR ACTIVITY
|
5
|
8.85e-01
|
9.76e-01
|
0.13500
|
-7.45e-02
|
1.12e-01
|
7.73e-01
|
6.64e-01
|
GOBP POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE
|
48
|
2.77e-01
|
7.51e-01
|
0.13500
|
-1.34e-01
|
1.52e-02
|
1.09e-01
|
8.55e-01
|
GOBP CHONDROCYTE DEVELOPMENT
|
32
|
4.46e-01
|
8.40e-01
|
0.13400
|
-4.91e-02
|
1.25e-01
|
6.31e-01
|
2.20e-01
|
GOCC PRERIBOSOME
|
104
|
4.32e-02
|
4.26e-01
|
0.13400
|
-6.73e-02
|
-1.16e-01
|
2.36e-01
|
4.05e-02
|
GOMF HISTONE H3K9 MONOMETHYLTRANSFERASE ACTIVITY
|
6
|
8.43e-01
|
9.66e-01
|
0.13400
|
-2.12e-02
|
-1.33e-01
|
9.28e-01
|
5.74e-01
|
GOBP NEGATIVE REGULATION OF MEMBRANE PERMEABILITY
|
20
|
5.44e-01
|
8.78e-01
|
0.13400
|
-1.12e-01
|
-7.37e-02
|
3.85e-01
|
5.68e-01
|
GOBP NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY
|
12
|
6.97e-01
|
9.21e-01
|
0.13400
|
-5.85e-02
|
-1.21e-01
|
7.26e-01
|
4.68e-01
|
GOBP EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT
|
10
|
7.37e-01
|
9.35e-01
|
0.13400
|
7.66e-02
|
1.10e-01
|
6.75e-01
|
5.46e-01
|
GOMF TRNA METHYLTRANSFERASE ACTIVITY
|
31
|
4.31e-01
|
8.37e-01
|
0.13400
|
-1.34e-01
|
3.99e-03
|
1.96e-01
|
9.69e-01
|
GOBP UTERINE SMOOTH MUSCLE CONTRACTION
|
9
|
7.83e-01
|
9.52e-01
|
0.13400
|
2.83e-03
|
-1.34e-01
|
9.88e-01
|
4.86e-01
|
GOBP ARACHIDONIC ACID METABOLIC PROCESS
|
55
|
2.60e-01
|
7.38e-01
|
0.13400
|
1.16e-01
|
-6.68e-02
|
1.35e-01
|
3.92e-01
|
GOBP DNA REPLICATION CHECKPOINT SIGNALING
|
18
|
5.76e-01
|
8.89e-01
|
0.13400
|
-9.20e-02
|
-9.77e-02
|
4.99e-01
|
4.73e-01
|
GOBP CELLULAR RESPONSE TO VITAMIN
|
28
|
4.39e-01
|
8.40e-01
|
0.13400
|
4.33e-02
|
1.27e-01
|
6.91e-01
|
2.45e-01
|
GOMF METALLOCARBOXYPEPTIDASE ACTIVITY
|
29
|
4.70e-01
|
8.51e-01
|
0.13400
|
1.32e-01
|
-2.62e-02
|
2.20e-01
|
8.07e-01
|
GOBP VALINE METABOLIC PROCESS
|
7
|
8.08e-01
|
9.59e-01
|
0.13400
|
1.09e-01
|
7.84e-02
|
6.18e-01
|
7.19e-01
|
GOBP REGULATION OF NERVOUS SYSTEM PROCESS
|
114
|
4.95e-02
|
4.42e-01
|
0.13400
|
-1.33e-01
|
1.69e-02
|
1.42e-02
|
7.55e-01
|
GOBP ETHER METABOLIC PROCESS
|
26
|
5.32e-01
|
8.75e-01
|
0.13400
|
-7.16e-02
|
1.13e-01
|
5.27e-01
|
3.18e-01
|
GOMF STRUCTURAL CONSTITUENT OF EYE LENS
|
22
|
5.11e-01
|
8.66e-01
|
0.13400
|
1.06e-01
|
8.24e-02
|
3.91e-01
|
5.04e-01
|
GOBP NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION
|
22
|
5.10e-01
|
8.66e-01
|
0.13400
|
9.40e-02
|
9.54e-02
|
4.45e-01
|
4.39e-01
|
GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE PHOSPHATASE ACTIVITY
|
11
|
7.21e-01
|
9.30e-01
|
0.13400
|
-1.22e-01
|
-5.53e-02
|
4.84e-01
|
7.51e-01
|
GOCC MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX III
|
11
|
7.40e-01
|
9.36e-01
|
0.13400
|
-3.25e-03
|
-1.34e-01
|
9.85e-01
|
4.42e-01
|
GOBP INTERNAL PROTEIN AMINO ACID ACETYLATION
|
53
|
2.34e-01
|
7.21e-01
|
0.13400
|
-1.34e-01
|
-4.85e-03
|
9.22e-02
|
9.51e-01
|
GOBP LIPOSACCHARIDE METABOLIC PROCESS
|
106
|
5.76e-02
|
4.68e-01
|
0.13400
|
-1.34e-01
|
3.72e-03
|
1.74e-02
|
9.47e-01
|
GOMF MAP KINASE KINASE ACTIVITY
|
17
|
6.50e-01
|
9.07e-01
|
0.13400
|
-1.28e-01
|
4.01e-02
|
3.62e-01
|
7.75e-01
|
GOBP REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY
|
132
|
1.99e-02
|
3.00e-01
|
0.13400
|
-1.20e-01
|
-5.98e-02
|
1.77e-02
|
2.35e-01
|
GOCC CHROMATOID BODY
|
13
|
7.04e-01
|
9.23e-01
|
0.13400
|
-3.80e-03
|
1.34e-01
|
9.81e-01
|
4.04e-01
|
GOBP POSITIVE REGULATION OF CHROMOSOME SEPARATION
|
29
|
4.31e-01
|
8.37e-01
|
0.13400
|
-3.95e-02
|
-1.28e-01
|
7.12e-01
|
2.34e-01
|
GOBP NEGATIVE REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY
|
35
|
3.83e-01
|
8.16e-01
|
0.13400
|
-1.33e-01
|
-5.65e-03
|
1.72e-01
|
9.54e-01
|
GOBP REGULATION OF VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING
|
6
|
8.37e-01
|
9.64e-01
|
0.13400
|
-1.22e-01
|
-5.50e-02
|
6.05e-01
|
8.16e-01
|
GOBP CYTIDINE TO URIDINE EDITING
|
12
|
7.34e-01
|
9.34e-01
|
0.13400
|
1.30e-01
|
-2.91e-02
|
4.34e-01
|
8.61e-01
|
GOBP L ARGININE TRANSMEMBRANE TRANSPORT
|
14
|
7.16e-01
|
9.27e-01
|
0.13400
|
-1.03e-01
|
8.54e-02
|
5.06e-01
|
5.80e-01
|
GOBP RENAL WATER HOMEOSTASIS
|
24
|
5.58e-01
|
8.82e-01
|
0.13400
|
1.16e-01
|
-6.60e-02
|
3.25e-01
|
5.75e-01
|
GOBP 10 FORMYLTETRAHYDROFOLATE METABOLIC PROCESS
|
6
|
8.62e-01
|
9.69e-01
|
0.13400
|
-1.22e-01
|
5.48e-02
|
6.06e-01
|
8.16e-01
|
GOBP NEGATIVE REGULATION OF CELL DIVISION
|
17
|
6.46e-01
|
9.07e-01
|
0.13400
|
-1.30e-01
|
2.89e-02
|
3.52e-01
|
8.37e-01
|
GOBP CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS
|
24
|
5.26e-01
|
8.71e-01
|
0.13400
|
1.33e-01
|
-7.57e-03
|
2.58e-01
|
9.49e-01
|
GOBP MEIOTIC TELOMERE CLUSTERING
|
10
|
7.38e-01
|
9.35e-01
|
0.13300
|
9.54e-02
|
9.33e-02
|
6.01e-01
|
6.09e-01
|
GOBP CELLULAR ALDEHYDE METABOLIC PROCESS
|
70
|
1.20e-01
|
6.00e-01
|
0.13300
|
-1.01e-01
|
-8.71e-02
|
1.43e-01
|
2.07e-01
|
GOBP EPIDERMIS MORPHOGENESIS
|
36
|
3.98e-01
|
8.25e-01
|
0.13300
|
-1.30e-01
|
3.16e-02
|
1.78e-01
|
7.43e-01
|
GOBP MRNA MODIFICATION
|
31
|
4.12e-01
|
8.28e-01
|
0.13300
|
-3.25e-02
|
-1.29e-01
|
7.54e-01
|
2.12e-01
|
GOBP TETRAPYRROLE CATABOLIC PROCESS
|
13
|
7.25e-01
|
9.30e-01
|
0.13300
|
1.23e-01
|
-5.15e-02
|
4.42e-01
|
7.48e-01
|
GOBP POSITIVE REGULATION OF GLIOGENESIS
|
68
|
1.95e-01
|
6.88e-01
|
0.13300
|
-1.12e-01
|
7.26e-02
|
1.10e-01
|
3.01e-01
|
GOBP GLYCEROPHOSPHOLIPID METABOLIC PROCESS
|
285
|
1.20e-03
|
5.80e-02
|
0.13300
|
-1.05e-01
|
8.23e-02
|
2.29e-03
|
1.68e-02
|
GOMF QUATERNARY AMMONIUM GROUP TRANSMEMBRANE TRANSPORTER ACTIVITY
|
19
|
6.09e-01
|
8.97e-01
|
0.13300
|
1.32e-01
|
-1.99e-02
|
3.20e-01
|
8.81e-01
|
GOMF SIGNALING ADAPTOR ACTIVITY
|
93
|
9.94e-02
|
5.68e-01
|
0.13300
|
-4.67e-02
|
1.25e-01
|
4.36e-01
|
3.73e-02
|
GOMF STRUCTURAL CONSTITUENT OF NUCLEAR PORE
|
23
|
4.98e-01
|
8.61e-01
|
0.13300
|
-8.63e-02
|
-1.02e-01
|
4.74e-01
|
3.99e-01
|
GOBP MAINTENANCE OF SISTER CHROMATID COHESION
|
11
|
7.40e-01
|
9.36e-01
|
0.13300
|
-7.18e-03
|
-1.33e-01
|
9.67e-01
|
4.44e-01
|
GOBP REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS
|
13
|
6.76e-01
|
9.13e-01
|
0.13300
|
-1.08e-01
|
-7.82e-02
|
5.00e-01
|
6.25e-01
|
GOBP REGULATION OF MOTOR NEURON APOPTOTIC PROCESS
|
15
|
6.95e-01
|
9.21e-01
|
0.13300
|
-6.32e-02
|
1.17e-01
|
6.72e-01
|
4.32e-01
|
GOBP INHIBITION OF NEUROEPITHELIAL CELL DIFFERENTIATION
|
5
|
8.66e-01
|
9.70e-01
|
0.13300
|
3.69e-02
|
1.28e-01
|
8.86e-01
|
6.20e-01
|
GOBP POSITIVE REGULATION OF APOPTOTIC CELL CLEARANCE
|
8
|
7.91e-01
|
9.54e-01
|
0.13300
|
-1.23e-01
|
-5.18e-02
|
5.48e-01
|
8.00e-01
|
GOBP REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT
|
167
|
1.18e-02
|
2.32e-01
|
0.13300
|
-3.54e-03
|
1.33e-01
|
9.37e-01
|
3.01e-03
|
GOBP REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY
|
102
|
7.79e-02
|
5.25e-01
|
0.13300
|
-3.88e-02
|
1.27e-01
|
4.99e-01
|
2.63e-02
|
GOBP NCRNA PROCESSING
|
417
|
4.25e-06
|
8.51e-04
|
0.13300
|
-9.31e-02
|
-9.51e-02
|
1.11e-03
|
8.65e-04
|
GOMF ELECTRON TRANSFER ACTIVITY
|
99
|
5.13e-02
|
4.48e-01
|
0.13300
|
-8.24e-02
|
-1.05e-01
|
1.57e-01
|
7.23e-02
|
GOBP PROTEIN DESTABILIZATION
|
46
|
2.58e-01
|
7.35e-01
|
0.13300
|
-1.20e-01
|
-5.78e-02
|
1.60e-01
|
4.97e-01
|
GOBP CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION
|
7
|
8.27e-01
|
9.62e-01
|
0.13300
|
4.22e-03
|
1.33e-01
|
9.85e-01
|
5.42e-01
|
GOBP ASPARTATE METABOLIC PROCESS
|
8
|
8.27e-01
|
9.62e-01
|
0.13300
|
8.90e-02
|
-9.88e-02
|
6.63e-01
|
6.29e-01
|
GOBP NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS
|
46
|
2.87e-01
|
7.59e-01
|
0.13300
|
-1.33e-01
|
-6.26e-03
|
1.19e-01
|
9.41e-01
|
GOMF HYDROLASE ACTIVITY HYDROLYZING O GLYCOSYL COMPOUNDS
|
88
|
9.71e-02
|
5.61e-01
|
0.13300
|
-1.33e-01
|
5.03e-03
|
3.14e-02
|
9.35e-01
|
GOBP CUT CATABOLIC PROCESS
|
5
|
8.85e-01
|
9.76e-01
|
0.13300
|
1.22e-01
|
-5.21e-02
|
6.36e-01
|
8.40e-01
|
GOMF MRNA 3 UTR AU RICH REGION BINDING
|
28
|
5.01e-01
|
8.62e-01
|
0.13300
|
1.24e-01
|
-4.64e-02
|
2.54e-01
|
6.71e-01
|
GOBP RNA EXPORT FROM NUCLEUS
|
83
|
8.85e-02
|
5.50e-01
|
0.13300
|
-1.20e-01
|
-5.58e-02
|
5.77e-02
|
3.79e-01
|
GOBP SYNAPTIC VESICLE RECYCLING
|
76
|
1.17e-01
|
5.98e-01
|
0.13300
|
-1.29e-01
|
-3.19e-02
|
5.21e-02
|
6.31e-01
|
GOBP SPINDLE ASSEMBLY
|
124
|
3.23e-02
|
3.67e-01
|
0.13300
|
-1.31e-01
|
-2.14e-02
|
1.18e-02
|
6.81e-01
|
GOCC CELL CORTEX REGION
|
38
|
3.94e-01
|
8.24e-01
|
0.13300
|
-5.00e-02
|
1.23e-01
|
5.94e-01
|
1.90e-01
|
GOMF 3 HYDROXYACYL COA DEHYDRATASE ACTIVITY
|
7
|
8.47e-01
|
9.66e-01
|
0.13300
|
8.11e-02
|
-1.05e-01
|
7.10e-01
|
6.31e-01
|
GOMF LOW DENSITY LIPOPROTEIN PARTICLE BINDING
|
17
|
6.33e-01
|
9.03e-01
|
0.13300
|
-2.74e-03
|
-1.33e-01
|
9.84e-01
|
3.44e-01
|
GOBP REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY
|
83
|
1.18e-01
|
5.98e-01
|
0.13300
|
1.83e-02
|
-1.31e-01
|
7.74e-01
|
3.86e-02
|
GOMF CATALYTIC ACTIVITY ACTING ON RNA
|
390
|
1.05e-05
|
1.64e-03
|
0.13300
|
-8.19e-02
|
-1.04e-01
|
5.52e-03
|
4.07e-04
|
GOBP POSITIVE REGULATION OF CALCIUM ION TRANSPORT
|
113
|
5.04e-02
|
4.45e-01
|
0.13300
|
-3.61e-03
|
1.33e-01
|
9.47e-01
|
1.49e-02
|
GOBP ALDITOL METABOLIC PROCESS
|
21
|
6.11e-01
|
8.98e-01
|
0.13200
|
-9.85e-02
|
8.86e-02
|
4.34e-01
|
4.82e-01
|
GOBP PROTEIN DNA COMPLEX ASSEMBLY
|
200
|
2.86e-03
|
1.04e-01
|
0.13200
|
-6.72e-02
|
-1.14e-01
|
1.01e-01
|
5.38e-03
|
GOMF UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME BINDING
|
37
|
3.31e-01
|
7.85e-01
|
0.13200
|
-9.18e-02
|
-9.55e-02
|
3.34e-01
|
3.15e-01
|
GOBP NEGATIVE REGULATION OF CHEMOTAXIS
|
65
|
1.56e-01
|
6.43e-01
|
0.13200
|
1.26e-01
|
4.19e-02
|
7.97e-02
|
5.60e-01
|
GOBP IRON ION TRANSMEMBRANE TRANSPORT
|
27
|
4.65e-01
|
8.50e-01
|
0.13200
|
3.56e-02
|
1.28e-01
|
7.48e-01
|
2.51e-01
|
GOBP POSITIVE REGULATION OF AXON EXTENSION
|
33
|
4.55e-01
|
8.47e-01
|
0.13200
|
-1.14e-01
|
6.68e-02
|
2.56e-01
|
5.07e-01
|
GOBP REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY
|
43
|
3.08e-01
|
7.72e-01
|
0.13200
|
-1.31e-01
|
-1.62e-02
|
1.36e-01
|
8.54e-01
|
GOBP REGULATION OF GLYCOGEN CATABOLIC PROCESS
|
7
|
8.11e-01
|
9.59e-01
|
0.13200
|
-9.08e-02
|
-9.63e-02
|
6.77e-01
|
6.59e-01
|
GOBP CRANIAL GANGLION DEVELOPMENT
|
5
|
8.62e-01
|
9.69e-01
|
0.13200
|
7.34e-02
|
1.10e-01
|
7.76e-01
|
6.70e-01
|
GOBP LNCRNA MEDIATED POST TRANSCRIPTIONAL GENE SILENCING
|
9
|
7.65e-01
|
9.45e-01
|
0.13200
|
-1.03e-01
|
-8.33e-02
|
5.93e-01
|
6.65e-01
|
GOBP MITOTIC G1 S TRANSITION CHECKPOINT SIGNALING
|
29
|
4.81e-01
|
8.54e-01
|
0.13200
|
2.91e-02
|
-1.29e-01
|
7.86e-01
|
2.29e-01
|
GOBP PHOSPHATIDYLINOSITOL MEDIATED SIGNALING
|
25
|
5.28e-01
|
8.72e-01
|
0.13200
|
-2.16e-02
|
1.30e-01
|
8.52e-01
|
2.59e-01
|
GOCC AXONEMAL DYNEIN COMPLEX
|
22
|
5.24e-01
|
8.70e-01
|
0.13200
|
6.72e-02
|
1.14e-01
|
5.85e-01
|
3.55e-01
|
GOBP VASOCONSTRICTION
|
80
|
1.02e-01
|
5.72e-01
|
0.13200
|
4.39e-02
|
1.25e-01
|
4.97e-01
|
5.38e-02
|
GOCC KINESIN COMPLEX
|
46
|
3.01e-01
|
7.67e-01
|
0.13200
|
-1.32e-01
|
9.39e-03
|
1.22e-01
|
9.12e-01
|
GOMF D GLUCOSE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
12
|
7.04e-01
|
9.23e-01
|
0.13200
|
-1.16e-01
|
-6.27e-02
|
4.85e-01
|
7.07e-01
|
GOBP REGULATION OF CHONDROCYTE DIFFERENTIATION
|
52
|
2.88e-01
|
7.60e-01
|
0.13200
|
-5.99e-02
|
1.18e-01
|
4.55e-01
|
1.42e-01
|
GOBP POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION
|
25
|
4.82e-01
|
8.54e-01
|
0.13200
|
1.17e-01
|
6.11e-02
|
3.11e-01
|
5.97e-01
|
GOBP NUCLEAR ENVELOPE ORGANIZATION
|
52
|
2.79e-01
|
7.52e-01
|
0.13200
|
-1.25e-01
|
4.20e-02
|
1.18e-01
|
6.00e-01
|
GOBP REGULATION OF INWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY
|
7
|
8.49e-01
|
9.66e-01
|
0.13200
|
1.06e-01
|
-7.84e-02
|
6.26e-01
|
7.20e-01
|
GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN LINEAR AMIDES
|
70
|
1.96e-01
|
6.88e-01
|
0.13200
|
-9.21e-02
|
9.46e-02
|
1.83e-01
|
1.71e-01
|
GOMF POLY ADP D RIBOSE BINDING
|
5
|
8.70e-01
|
9.73e-01
|
0.13200
|
-3.04e-02
|
-1.28e-01
|
9.06e-01
|
6.19e-01
|
GOBP NEGATIVE REGULATION OF CELL MATRIX ADHESION
|
37
|
3.87e-01
|
8.19e-01
|
0.13200
|
-1.31e-01
|
1.66e-02
|
1.68e-01
|
8.61e-01
|
GOBP LIGAND GATED ION CHANNEL SIGNALING PATHWAY
|
31
|
4.76e-01
|
8.54e-01
|
0.13200
|
-5.85e-02
|
1.18e-01
|
5.73e-01
|
2.54e-01
|
GOCC SEROTONIN RECEPTOR COMPLEX
|
8
|
8.17e-01
|
9.60e-01
|
0.13200
|
1.29e-01
|
-2.70e-02
|
5.27e-01
|
8.95e-01
|
GOBP NEGATIVE REGULATION OF TELOMERE CAPPING
|
8
|
7.98e-01
|
9.56e-01
|
0.13200
|
-1.26e-01
|
-3.75e-02
|
5.36e-01
|
8.54e-01
|
GOBP RHYTHMIC BEHAVIOR
|
44
|
2.95e-01
|
7.65e-01
|
0.13200
|
2.69e-02
|
1.29e-01
|
7.58e-01
|
1.38e-01
|
GOBP MITOCHONDRION DISTRIBUTION
|
16
|
6.81e-01
|
9.16e-01
|
0.13200
|
-5.61e-02
|
1.19e-01
|
6.97e-01
|
4.09e-01
|
GOMF INTEGRIN BINDING
|
150
|
1.67e-02
|
2.74e-01
|
0.13200
|
2.10e-02
|
1.30e-01
|
6.57e-01
|
5.92e-03
|
GOBP ENDOTHELIAL CELL MORPHOGENESIS
|
9
|
7.87e-01
|
9.53e-01
|
0.13200
|
3.11e-03
|
1.32e-01
|
9.87e-01
|
4.93e-01
|
GOBP POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION
|
35
|
4.37e-01
|
8.39e-01
|
0.13200
|
-6.52e-02
|
1.15e-01
|
5.05e-01
|
2.41e-01
|
GOBP MIRNA CATABOLIC PROCESS
|
18
|
6.43e-01
|
9.07e-01
|
0.13200
|
-1.25e-01
|
4.12e-02
|
3.58e-01
|
7.62e-01
|
GOMF TBP CLASS PROTEIN BINDING
|
24
|
5.58e-01
|
8.82e-01
|
0.13200
|
-1.23e-01
|
4.63e-02
|
2.96e-01
|
6.95e-01
|
GOBP RETINOL METABOLIC PROCESS
|
50
|
2.50e-01
|
7.28e-01
|
0.13200
|
-2.90e-02
|
-1.29e-01
|
7.23e-01
|
1.16e-01
|
GOBP RETINA HOMEOSTASIS
|
75
|
1.72e-01
|
6.61e-01
|
0.13200
|
1.11e-01
|
-7.07e-02
|
9.61e-02
|
2.90e-01
|
GOBP POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION
|
27
|
5.27e-01
|
8.72e-01
|
0.13200
|
-6.25e-02
|
1.16e-01
|
5.74e-01
|
2.97e-01
|
GOBP GLYCEROPHOSPHOLIPID BIOSYNTHETIC PROCESS
|
199
|
1.01e-02
|
2.15e-01
|
0.13200
|
-1.03e-01
|
8.25e-02
|
1.25e-02
|
4.49e-02
|
GOBP POSITIVE REGULATION OF CELL MATRIX ADHESION
|
56
|
1.95e-01
|
6.86e-01
|
0.13200
|
7.19e-02
|
1.10e-01
|
3.52e-01
|
1.53e-01
|
GOBP POLYADENYLATION DEPENDENT RNA CATABOLIC PROCESS
|
8
|
7.97e-01
|
9.55e-01
|
0.13200
|
4.36e-02
|
1.24e-01
|
8.31e-01
|
5.43e-01
|
GOBP APOPTOTIC PROCESS INVOLVED IN HEART MORPHOGENESIS
|
7
|
8.50e-01
|
9.67e-01
|
0.13200
|
-8.42e-02
|
1.01e-01
|
7.00e-01
|
6.43e-01
|
GOBP CARBOHYDRATE TRANSPORT
|
154
|
2.45e-02
|
3.31e-01
|
0.13200
|
-1.23e-01
|
4.59e-02
|
8.28e-03
|
3.25e-01
|
GOBP SNRNA 3 END PROCESSING
|
20
|
5.62e-01
|
8.84e-01
|
0.13200
|
-1.18e-01
|
-5.75e-02
|
3.60e-01
|
6.56e-01
|
GOBP PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS
|
49
|
3.21e-01
|
7.79e-01
|
0.13200
|
8.13e-02
|
-1.03e-01
|
3.25e-01
|
2.11e-01
|
GOBP TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY
|
225
|
5.70e-03
|
1.58e-01
|
0.13100
|
-1.03e-01
|
8.14e-02
|
7.63e-03
|
3.55e-02
|
GOBP LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS
|
26
|
5.48e-01
|
8.79e-01
|
0.13100
|
-1.02e-01
|
8.22e-02
|
3.66e-01
|
4.68e-01
|
GOBP REGULATION OF ENDOSOME SIZE
|
13
|
6.87e-01
|
9.19e-01
|
0.13100
|
-6.19e-02
|
-1.16e-01
|
6.99e-01
|
4.69e-01
|
GOCC MATRIX SIDE OF MITOCHONDRIAL INNER MEMBRANE
|
6
|
8.44e-01
|
9.66e-01
|
0.13100
|
-1.24e-01
|
-4.35e-02
|
5.99e-01
|
8.54e-01
|
GOBP CANONICAL WNT SIGNALING PATHWAY INVOLVED IN OSTEOBLAST DIFFERENTIATION
|
7
|
8.47e-01
|
9.66e-01
|
0.13100
|
-1.18e-01
|
5.80e-02
|
5.89e-01
|
7.91e-01
|
GOBP POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT
|
21
|
6.15e-01
|
8.99e-01
|
0.13100
|
8.12e-02
|
-1.03e-01
|
5.19e-01
|
4.13e-01
|
GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION
|
28
|
5.13e-01
|
8.67e-01
|
0.13100
|
-5.36e-02
|
1.20e-01
|
6.23e-01
|
2.72e-01
|
GOBP REGULATION OF RECEPTOR BINDING
|
17
|
6.75e-01
|
9.13e-01
|
0.13100
|
-1.01e-01
|
8.36e-02
|
4.70e-01
|
5.51e-01
|
GOCC NEURONAL DENSE CORE VESICLE
|
25
|
5.59e-01
|
8.82e-01
|
0.13100
|
-1.09e-01
|
7.30e-02
|
3.45e-01
|
5.28e-01
|
GOBP POSITIVE REGULATION OF GLUCONEOGENESIS
|
21
|
5.70e-01
|
8.86e-01
|
0.13100
|
-1.31e-01
|
-1.14e-02
|
2.99e-01
|
9.28e-01
|
GOBP MATURATION OF 5 8S RRNA
|
35
|
3.93e-01
|
8.22e-01
|
0.13100
|
-1.31e-01
|
-1.05e-02
|
1.80e-01
|
9.14e-01
|
GOBP RESPONSE TO INACTIVITY
|
12
|
7.51e-01
|
9.40e-01
|
0.13100
|
-1.20e-01
|
5.37e-02
|
4.72e-01
|
7.48e-01
|
GOBP RELEASE OF CYTOCHROME C FROM MITOCHONDRIA
|
55
|
1.99e-01
|
6.89e-01
|
0.13100
|
-9.54e-02
|
-9.02e-02
|
2.21e-01
|
2.47e-01
|
GOBP RENAL FILTRATION
|
25
|
4.85e-01
|
8.55e-01
|
0.13100
|
1.12e-01
|
6.78e-02
|
3.31e-01
|
5.57e-01
|
GOBP METHIONINE METABOLIC PROCESS
|
15
|
6.48e-01
|
9.07e-01
|
0.13100
|
-1.14e-01
|
-6.57e-02
|
4.46e-01
|
6.60e-01
|
GOBP REGULATION OF ERYTHROCYTE DIFFERENTIATION
|
44
|
3.57e-01
|
7.98e-01
|
0.13100
|
-1.14e-01
|
6.43e-02
|
1.90e-01
|
4.60e-01
|
GOMF PYRUVATE DEHYDROGENASE LIPOAMIDE PHOSPHATASE ACTIVITY
|
5
|
8.91e-01
|
9.76e-01
|
0.13100
|
8.70e-02
|
-9.82e-02
|
7.36e-01
|
7.04e-01
|
GOBP INFLAMMATORY CELL APOPTOTIC PROCESS
|
24
|
5.09e-01
|
8.66e-01
|
0.13100
|
1.24e-01
|
4.33e-02
|
2.94e-01
|
7.14e-01
|
GOBP CALCIUM ION IMPORT INTO SARCOPLASMIC RETICULUM
|
5
|
8.90e-01
|
9.76e-01
|
0.13100
|
-6.93e-02
|
1.11e-01
|
7.88e-01
|
6.66e-01
|
GOMF SOLUTE SODIUM SYMPORTER ACTIVITY
|
77
|
1.07e-01
|
5.79e-01
|
0.13100
|
7.73e-02
|
1.06e-01
|
2.41e-01
|
1.08e-01
|
GOMF 1 PHOSPHATIDYLINOSITOL 3 KINASE REGULATOR ACTIVITY
|
15
|
7.06e-01
|
9.24e-01
|
0.13100
|
-7.24e-02
|
1.09e-01
|
6.27e-01
|
4.64e-01
|
GOMF PATCHED BINDING
|
8
|
8.24e-01
|
9.62e-01
|
0.13100
|
4.36e-02
|
-1.24e-01
|
8.31e-01
|
5.45e-01
|
GOCC PIP BODY
|
5
|
8.71e-01
|
9.73e-01
|
0.13100
|
3.38e-02
|
1.27e-01
|
8.96e-01
|
6.24e-01
|
GOBP LUTEINIZATION
|
12
|
7.11e-01
|
9.27e-01
|
0.13100
|
-1.20e-01
|
-5.19e-02
|
4.71e-01
|
7.56e-01
|
GOBP POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS
|
25
|
5.21e-01
|
8.69e-01
|
0.13100
|
7.46e-04
|
1.31e-01
|
9.95e-01
|
2.57e-01
|
GOBP CORONARY ARTERY MORPHOGENESIS
|
9
|
7.86e-01
|
9.53e-01
|
0.13100
|
-1.30e-01
|
-1.35e-02
|
4.99e-01
|
9.44e-01
|
GOBP PATTERN SPECIFICATION INVOLVED IN KIDNEY DEVELOPMENT
|
8
|
8.21e-01
|
9.60e-01
|
0.13100
|
2.87e-02
|
-1.28e-01
|
8.88e-01
|
5.32e-01
|
GOBP TORC1 SIGNALING
|
95
|
7.95e-02
|
5.27e-01
|
0.13100
|
-1.30e-01
|
-1.46e-02
|
2.85e-02
|
8.06e-01
|
GOBP NEGATIVE REGULATION OF HORMONE SECRETION
|
65
|
1.63e-01
|
6.48e-01
|
0.13100
|
-1.24e-01
|
-4.29e-02
|
8.50e-02
|
5.50e-01
|
GOBP MITOTIC G2 DNA DAMAGE CHECKPOINT SIGNALING
|
34
|
3.82e-01
|
8.16e-01
|
0.13100
|
-1.19e-01
|
-5.40e-02
|
2.30e-01
|
5.86e-01
|
GOMF ATPASE COUPLED INTRAMEMBRANE LIPID TRANSPORTER ACTIVITY
|
26
|
5.52e-01
|
8.80e-01
|
0.13100
|
-8.80e-02
|
9.66e-02
|
4.37e-01
|
3.94e-01
|
GOBP VENTRICULAR SEPTUM MORPHOGENESIS
|
43
|
3.74e-01
|
8.11e-01
|
0.13100
|
-8.36e-02
|
1.00e-01
|
3.43e-01
|
2.55e-01
|
GOBP POSITIVE REGULATION OF LYMPHOCYTE MIGRATION
|
40
|
3.92e-01
|
8.22e-01
|
0.13100
|
-1.17e-01
|
5.83e-02
|
2.01e-01
|
5.23e-01
|
GOBP REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS
|
51
|
2.63e-01
|
7.40e-01
|
0.13100
|
-1.30e-01
|
-6.42e-03
|
1.07e-01
|
9.37e-01
|
GOBP SYNAPTIC TRANSMISSION CHOLINERGIC
|
31
|
4.31e-01
|
8.37e-01
|
0.13100
|
1.28e-01
|
2.67e-02
|
2.18e-01
|
7.97e-01
|
GOMF PHOSPHATIDYLCHOLINE TRANSFER ACTIVITY
|
5
|
8.76e-01
|
9.75e-01
|
0.13000
|
-1.30e-01
|
-1.15e-02
|
6.15e-01
|
9.65e-01
|
GOBP REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION
|
13
|
7.25e-01
|
9.30e-01
|
0.13000
|
1.28e-01
|
-2.42e-02
|
4.24e-01
|
8.80e-01
|
GOBP TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION
|
9
|
7.90e-01
|
9.54e-01
|
0.13000
|
-1.30e-01
|
-5.57e-03
|
4.98e-01
|
9.77e-01
|
GOMF TUMOR NECROSIS FACTOR RECEPTOR BINDING
|
29
|
4.33e-01
|
8.37e-01
|
0.13000
|
7.79e-02
|
1.05e-01
|
4.68e-01
|
3.29e-01
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OH GROUP OF DONORS
|
131
|
2.47e-02
|
3.31e-01
|
0.13000
|
-5.94e-02
|
-1.16e-01
|
2.41e-01
|
2.17e-02
|
GOBP RNA SURVEILLANCE
|
17
|
6.78e-01
|
9.14e-01
|
0.13000
|
7.95e-02
|
-1.03e-01
|
5.71e-01
|
4.60e-01
|
GOBP PROTEIN TARGETING TO LYSOSOME
|
31
|
4.93e-01
|
8.58e-01
|
0.13000
|
-1.03e-01
|
8.05e-02
|
3.23e-01
|
4.38e-01
|
GOBP FUCOSE METABOLIC PROCESS
|
16
|
6.35e-01
|
9.05e-01
|
0.13000
|
-1.16e-01
|
-5.95e-02
|
4.22e-01
|
6.80e-01
|
GOCC SUMO LIGASE COMPLEX
|
13
|
7.44e-01
|
9.38e-01
|
0.13000
|
8.89e-02
|
-9.54e-02
|
5.79e-01
|
5.52e-01
|
GOBP REGULATION OF NUCLEOTIDE METABOLIC PROCESS
|
45
|
3.11e-01
|
7.74e-01
|
0.13000
|
-1.30e-01
|
-2.80e-03
|
1.30e-01
|
9.74e-01
|
GOBP SODIUM DEPENDENT PHOSPHATE TRANSPORT
|
12
|
7.61e-01
|
9.45e-01
|
0.13000
|
9.76e-02
|
-8.65e-02
|
5.58e-01
|
6.04e-01
|
GOBP NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS
|
71
|
1.32e-01
|
6.13e-01
|
0.13000
|
-1.13e-01
|
-6.48e-02
|
9.93e-02
|
3.45e-01
|
GOBP INTERCELLULAR TRANSPORT
|
10
|
7.54e-01
|
9.41e-01
|
0.13000
|
1.18e-01
|
5.63e-02
|
5.20e-01
|
7.58e-01
|
GOBP MECHANORECEPTOR DIFFERENTIATION
|
68
|
1.41e-01
|
6.25e-01
|
0.13000
|
1.01e-01
|
8.23e-02
|
1.50e-01
|
2.41e-01
|
GOBP EMBRYONIC BRAIN DEVELOPMENT
|
16
|
6.62e-01
|
9.09e-01
|
0.13000
|
-1.14e-05
|
1.30e-01
|
1.00e+00
|
3.67e-01
|
GOMF PEPTIDE ANTIGEN BINDING
|
35
|
4.27e-01
|
8.36e-01
|
0.13000
|
3.15e-02
|
-1.26e-01
|
7.47e-01
|
1.96e-01
|
GOBP NEGATIVE REGULATION OF DNA RECOMBINATION
|
45
|
2.94e-01
|
7.63e-01
|
0.13000
|
-1.26e-01
|
-3.13e-02
|
1.42e-01
|
7.17e-01
|
GOCC BETA CATENIN DESTRUCTION COMPLEX
|
11
|
7.78e-01
|
9.51e-01
|
0.13000
|
-7.65e-02
|
1.05e-01
|
6.60e-01
|
5.45e-01
|
GOBP REGULATION OF REMOVAL OF SUPEROXIDE RADICALS
|
9
|
8.04e-01
|
9.57e-01
|
0.13000
|
-3.29e-02
|
1.26e-01
|
8.64e-01
|
5.13e-01
|
GOMF PROTEIN PHOSPHORYLATED AMINO ACID BINDING
|
58
|
2.43e-01
|
7.25e-01
|
0.13000
|
-2.79e-02
|
1.27e-01
|
7.13e-01
|
9.41e-02
|
GOBP FLUID TRANSPORT
|
37
|
3.58e-01
|
8.00e-01
|
0.13000
|
-1.22e-01
|
-4.61e-02
|
2.00e-01
|
6.28e-01
|
GOMF DNA CLAMP LOADER ACTIVITY
|
9
|
7.79e-01
|
9.51e-01
|
0.13000
|
-4.36e-02
|
-1.23e-01
|
8.21e-01
|
5.24e-01
|
GOCC MAIN AXON
|
67
|
1.49e-01
|
6.35e-01
|
0.13000
|
1.11e-01
|
6.74e-02
|
1.15e-01
|
3.40e-01
|
GOBP CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL
|
198
|
5.44e-03
|
1.53e-01
|
0.13000
|
1.78e-02
|
1.29e-01
|
6.66e-01
|
1.78e-03
|
GOBP ORGANELLE TRANSPORT ALONG MICROTUBULE
|
84
|
1.44e-01
|
6.28e-01
|
0.13000
|
-5.99e-02
|
1.15e-01
|
3.43e-01
|
6.78e-02
|
GOBP RNA 3 URIDYLATION
|
5
|
8.84e-01
|
9.76e-01
|
0.13000
|
-1.28e-01
|
2.12e-02
|
6.20e-01
|
9.35e-01
|
GOBP IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY
|
22
|
5.69e-01
|
8.86e-01
|
0.13000
|
3.68e-04
|
1.30e-01
|
9.98e-01
|
2.92e-01
|
GOBP NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS
|
35
|
4.06e-01
|
8.26e-01
|
0.13000
|
-1.30e-01
|
-3.39e-03
|
1.84e-01
|
9.72e-01
|
GOBP ADAPTIVE THERMOGENESIS
|
165
|
2.39e-02
|
3.28e-01
|
0.13000
|
-1.09e-01
|
7.01e-02
|
1.55e-02
|
1.20e-01
|
GOBP CAMKK AMPK SIGNALING CASCADE
|
9
|
8.17e-01
|
9.60e-01
|
0.13000
|
-9.09e-02
|
9.26e-02
|
6.37e-01
|
6.30e-01
|
GOBP GLYCOLIPID BIOSYNTHETIC PROCESS
|
72
|
1.65e-01
|
6.49e-01
|
0.13000
|
-1.29e-01
|
1.04e-02
|
5.78e-02
|
8.79e-01
|
GOBP EPITHELIAL CELL CELL ADHESION
|
15
|
6.85e-01
|
9.18e-01
|
0.13000
|
-7.72e-03
|
1.30e-01
|
9.59e-01
|
3.85e-01
|
GOBP LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT
|
18
|
6.62e-01
|
9.09e-01
|
0.13000
|
-1.13e-01
|
6.38e-02
|
4.07e-01
|
6.39e-01
|
GOBP BILE ACID SIGNALING PATHWAY
|
11
|
7.30e-01
|
9.32e-01
|
0.13000
|
-1.01e-01
|
-8.12e-02
|
5.61e-01
|
6.41e-01
|
GOBP CARDIOLIPIN ACYL CHAIN REMODELING
|
5
|
8.74e-01
|
9.74e-01
|
0.13000
|
-1.27e-01
|
-2.77e-02
|
6.24e-01
|
9.15e-01
|
GOBP MACROPHAGE CYTOKINE PRODUCTION
|
36
|
4.15e-01
|
8.30e-01
|
0.13000
|
-1.27e-01
|
2.45e-02
|
1.86e-01
|
7.99e-01
|
GOMF VOLTAGE GATED MONOATOMIC CATION CHANNEL ACTIVITY
|
150
|
1.40e-02
|
2.56e-01
|
0.13000
|
8.75e-02
|
9.56e-02
|
6.43e-02
|
4.32e-02
|
GOCC DENSE BODY
|
5
|
8.67e-01
|
9.71e-01
|
0.13000
|
1.05e-01
|
7.60e-02
|
6.84e-01
|
7.68e-01
|
GOBP POSITIVE REGULATION OF ER ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS
|
5
|
8.84e-01
|
9.76e-01
|
0.13000
|
1.28e-01
|
-2.09e-02
|
6.20e-01
|
9.35e-01
|
GOMF SODIUM PROTON ANTIPORTER ACTIVITY
|
13
|
7.34e-01
|
9.34e-01
|
0.13000
|
-3.87e-02
|
1.24e-01
|
8.09e-01
|
4.40e-01
|
GOBP MAINTENANCE OF LENS TRANSPARENCY
|
7
|
8.32e-01
|
9.64e-01
|
0.13000
|
1.29e-01
|
1.62e-02
|
5.56e-01
|
9.41e-01
|
GOMF ANDROSTAN 3 ALPHA 17 BETA DIOL DEHYDROGENASE ACTIVITY
|
8
|
7.99e-01
|
9.56e-01
|
0.13000
|
-1.14e-01
|
-6.11e-02
|
5.76e-01
|
7.65e-01
|
GOMF NUCLEASE ACTIVITY
|
206
|
2.98e-03
|
1.06e-01
|
0.13000
|
-7.56e-02
|
-1.05e-01
|
6.14e-02
|
9.22e-03
|
GOBP CELL ADHESION MOLECULE PRODUCTION
|
18
|
6.26e-01
|
9.01e-01
|
0.12900
|
-1.06e-02
|
-1.29e-01
|
9.38e-01
|
3.43e-01
|
GOBP RESPONSE TO HYDROPEROXIDE
|
18
|
5.99e-01
|
8.95e-01
|
0.12900
|
-8.20e-02
|
-1.00e-01
|
5.47e-01
|
4.62e-01
|
GOBP FRUCTOSE METABOLIC PROCESS
|
13
|
6.91e-01
|
9.20e-01
|
0.12900
|
1.04e-01
|
7.69e-02
|
5.16e-01
|
6.31e-01
|
GOBP MAMMARY GLAND EPITHELIUM DEVELOPMENT
|
65
|
2.27e-01
|
7.14e-01
|
0.12900
|
-1.13e-01
|
6.26e-02
|
1.14e-01
|
3.83e-01
|
GOBP REGULATION OF B CELL PROLIFERATION
|
62
|
1.98e-01
|
6.88e-01
|
0.12900
|
1.45e-02
|
1.29e-01
|
8.43e-01
|
8.00e-02
|
GOBP POSITIVE REGULATION OF TRANSPORTER ACTIVITY
|
89
|
8.62e-02
|
5.45e-01
|
0.12900
|
4.97e-02
|
1.19e-01
|
4.18e-01
|
5.15e-02
|
GOCC BCL 2 FAMILY PROTEIN COMPLEX
|
10
|
7.78e-01
|
9.51e-01
|
0.12900
|
7.16e-03
|
-1.29e-01
|
9.69e-01
|
4.79e-01
|
GOBP HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE
|
32
|
4.89e-01
|
8.56e-01
|
0.12900
|
-8.50e-02
|
9.75e-02
|
4.05e-01
|
3.40e-01
|
GOBP CHROMATIN REMODELING
|
577
|
5.87e-07
|
2.05e-04
|
0.12900
|
-1.29e-01
|
-1.43e-03
|
1.10e-07
|
9.53e-01
|
GOBP REGULATION OF SPINDLE ORGANIZATION
|
46
|
2.98e-01
|
7.67e-01
|
0.12900
|
-1.28e-01
|
-2.03e-02
|
1.34e-01
|
8.11e-01
|
GOBP TRANSFORMING GROWTH FACTOR BETA ACTIVATION
|
13
|
7.39e-01
|
9.35e-01
|
0.12900
|
-4.74e-02
|
1.20e-01
|
7.67e-01
|
4.53e-01
|
GOBP REGULATION OF SYNAPSE MATURATION
|
20
|
5.73e-01
|
8.88e-01
|
0.12900
|
5.79e-02
|
1.16e-01
|
6.54e-01
|
3.71e-01
|
GOBP ARGININE METABOLIC PROCESS
|
19
|
6.05e-01
|
8.96e-01
|
0.12900
|
1.27e-01
|
2.25e-02
|
3.37e-01
|
8.65e-01
|
GOCC SAGA COMPLEX
|
23
|
5.56e-01
|
8.81e-01
|
0.12900
|
-1.29e-01
|
-2.58e-03
|
2.84e-01
|
9.83e-01
|
GOBP POSITIVE REGULATION OF ENDOCYTOSIS
|
147
|
3.06e-02
|
3.61e-01
|
0.12900
|
-1.25e-01
|
3.29e-02
|
8.95e-03
|
4.91e-01
|
GOBP REGULATION OF BARBED END ACTIN FILAMENT CAPPING
|
5
|
8.85e-01
|
9.76e-01
|
0.12900
|
1.27e-01
|
-2.20e-02
|
6.22e-01
|
9.32e-01
|
GOBP NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION
|
61
|
2.58e-01
|
7.35e-01
|
0.12900
|
-8.29e-02
|
9.88e-02
|
2.63e-01
|
1.82e-01
|
GOBP POSITIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY
|
18
|
6.42e-01
|
9.07e-01
|
0.12900
|
-1.37e-02
|
1.28e-01
|
9.20e-01
|
3.46e-01
|
GOMF STORE OPERATED CALCIUM CHANNEL ACTIVITY
|
9
|
7.76e-01
|
9.50e-01
|
0.12900
|
1.07e-01
|
7.19e-02
|
5.78e-01
|
7.09e-01
|
GOBP SARCOMERE ORGANIZATION
|
45
|
3.35e-01
|
7.88e-01
|
0.12900
|
-2.02e-02
|
1.27e-01
|
8.15e-01
|
1.39e-01
|
GOMF SIALYLTRANSFERASE ACTIVITY
|
21
|
6.23e-01
|
9.01e-01
|
0.12900
|
-6.88e-02
|
1.09e-01
|
5.85e-01
|
3.87e-01
|
GOBP NEGATIVE REGULATION OF MEIOTIC CELL CYCLE
|
17
|
6.79e-01
|
9.14e-01
|
0.12900
|
-5.90e-02
|
1.15e-01
|
6.74e-01
|
4.13e-01
|
GOBP RESPONSE TO PROTOZOAN
|
29
|
4.62e-01
|
8.48e-01
|
0.12900
|
-1.25e-01
|
-2.96e-02
|
2.42e-01
|
7.82e-01
|
GOBP RESPONSE TO CHEMOKINE
|
94
|
7.09e-02
|
5.07e-01
|
0.12900
|
9.85e-02
|
8.30e-02
|
9.87e-02
|
1.64e-01
|
GOBP SPINDLE LOCALIZATION
|
62
|
2.26e-01
|
7.14e-01
|
0.12900
|
-1.26e-01
|
2.53e-02
|
8.56e-02
|
7.31e-01
|
GOBP REGULATION OF HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS
|
7
|
8.56e-01
|
9.68e-01
|
0.12900
|
9.33e-02
|
-8.87e-02
|
6.69e-01
|
6.84e-01
|
GOBP MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA
|
34
|
3.88e-01
|
8.20e-01
|
0.12900
|
-1.11e-01
|
-6.48e-02
|
2.62e-01
|
5.13e-01
|
GOBP PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS
|
12
|
7.25e-01
|
9.30e-01
|
0.12900
|
-3.60e-02
|
-1.24e-01
|
8.29e-01
|
4.59e-01
|
GOBP METANEPHRIC EPITHELIUM DEVELOPMENT
|
29
|
5.23e-01
|
8.70e-01
|
0.12900
|
-1.07e-01
|
7.19e-02
|
3.20e-01
|
5.03e-01
|
GOBP INTERLEUKIN 6 PRODUCTION
|
165
|
2.40e-02
|
3.29e-01
|
0.12900
|
-1.15e-01
|
5.76e-02
|
1.07e-02
|
2.02e-01
|
GOBP MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA
|
16
|
6.43e-01
|
9.07e-01
|
0.12900
|
-5.61e-02
|
-1.16e-01
|
6.97e-01
|
4.23e-01
|
GOBP MACROPHAGE ACTIVATION
|
108
|
9.12e-02
|
5.51e-01
|
0.12900
|
-1.04e-01
|
7.54e-02
|
6.14e-02
|
1.76e-01
|
GOBP RAS PROTEIN SIGNAL TRANSDUCTION
|
318
|
6.53e-04
|
3.91e-02
|
0.12900
|
-3.95e-02
|
1.22e-01
|
2.26e-01
|
1.75e-04
|
GOBP NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION
|
26
|
4.83e-01
|
8.54e-01
|
0.12900
|
1.05e-01
|
7.37e-02
|
3.52e-01
|
5.15e-01
|
GOMF POLYSACCHARIDE BINDING
|
21
|
6.27e-01
|
9.02e-01
|
0.12900
|
-1.02e-01
|
7.77e-02
|
4.16e-01
|
5.38e-01
|
GOBP REGULATION OF ADENYLATE CYCLASE ACTIVITY
|
44
|
3.13e-01
|
7.76e-01
|
0.12900
|
1.25e-01
|
2.85e-02
|
1.50e-01
|
7.44e-01
|
GOBP REGULATION OF LYMPHOCYTE CHEMOTAXIS
|
26
|
4.82e-01
|
8.54e-01
|
0.12900
|
8.26e-02
|
9.85e-02
|
4.66e-01
|
3.85e-01
|
GOMF SMALL MOLECULE SENSOR ACTIVITY
|
40
|
3.99e-01
|
8.25e-01
|
0.12900
|
-1.19e-01
|
4.80e-02
|
1.92e-01
|
5.99e-01
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON SINGLE DONORS WITH INCORPORATION OF MOLECULAR OXYGEN
|
24
|
5.52e-01
|
8.80e-01
|
0.12800
|
-1.28e-01
|
5.89e-03
|
2.77e-01
|
9.60e-01
|
GOBP POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION
|
24
|
5.89e-01
|
8.92e-01
|
0.12800
|
8.54e-02
|
-9.59e-02
|
4.69e-01
|
4.16e-01
|
GOBP PHOTOTRANSDUCTION
|
42
|
3.92e-01
|
8.22e-01
|
0.12800
|
-6.95e-02
|
1.08e-01
|
4.36e-01
|
2.26e-01
|
GOBP POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION
|
27
|
4.77e-01
|
8.54e-01
|
0.12800
|
-1.15e-01
|
-5.63e-02
|
3.00e-01
|
6.13e-01
|
GOMF PHOSPHATIDATE PHOSPHATASE ACTIVITY
|
14
|
6.91e-01
|
9.20e-01
|
0.12800
|
-1.25e-01
|
-2.99e-02
|
4.19e-01
|
8.47e-01
|
GOBP DICARBOXYLIC ACID METABOLIC PROCESS
|
92
|
7.68e-02
|
5.22e-01
|
0.12800
|
-7.95e-02
|
-1.01e-01
|
1.88e-01
|
9.48e-02
|
GOBP FILOPODIUM ASSEMBLY
|
65
|
1.70e-01
|
6.57e-01
|
0.12800
|
5.21e-02
|
1.17e-01
|
4.68e-01
|
1.02e-01
|
GOBP REGULATION OF GLIAL CELL APOPTOTIC PROCESS
|
10
|
7.75e-01
|
9.50e-01
|
0.12800
|
1.02e-02
|
1.28e-01
|
9.55e-01
|
4.84e-01
|
GOMF ALDO KETO REDUCTASE NADP ACTIVITY
|
30
|
4.88e-01
|
8.56e-01
|
0.12800
|
2.30e-02
|
-1.26e-01
|
8.27e-01
|
2.32e-01
|
GOMF SIRNA BINDING
|
7
|
8.53e-01
|
9.68e-01
|
0.12800
|
-1.15e-01
|
5.61e-02
|
5.97e-01
|
7.97e-01
|
GOMF LONG CHAIN FATTY ACID TRANSPORTER ACTIVITY
|
16
|
7.00e-01
|
9.22e-01
|
0.12800
|
-6.77e-02
|
1.09e-01
|
6.39e-01
|
4.51e-01
|
GOBP REGULATION OF PHOSPHOLIPASE A2 ACTIVITY
|
8
|
8.28e-01
|
9.62e-01
|
0.12800
|
-1.24e-01
|
3.28e-02
|
5.44e-01
|
8.73e-01
|
GOBP RESPONSE TO BLUE LIGHT
|
6
|
8.76e-01
|
9.75e-01
|
0.12800
|
7.72e-02
|
-1.02e-01
|
7.43e-01
|
6.64e-01
|
GOCC GAMMA TUBULIN COMPLEX
|
16
|
7.01e-01
|
9.22e-01
|
0.12800
|
7.12e-02
|
-1.07e-01
|
6.22e-01
|
4.61e-01
|
GOMF CYCLASE REGULATOR ACTIVITY
|
16
|
7.03e-01
|
9.23e-01
|
0.12800
|
8.20e-02
|
-9.85e-02
|
5.70e-01
|
4.95e-01
|
GOMF ENDONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 5 PHOSPHOMONOESTERS
|
37
|
4.31e-01
|
8.37e-01
|
0.12800
|
5.10e-02
|
-1.18e-01
|
5.92e-01
|
2.16e-01
|
GOBP RENAL TUBULAR SECRETION
|
19
|
6.08e-01
|
8.97e-01
|
0.12800
|
-2.60e-02
|
-1.25e-01
|
8.44e-01
|
3.44e-01
|
GOBP RESPONSE TO CORTISOL
|
6
|
8.72e-01
|
9.73e-01
|
0.12800
|
4.85e-02
|
-1.19e-01
|
8.37e-01
|
6.15e-01
|
GOBP TONIC SMOOTH MUSCLE CONTRACTION
|
11
|
7.59e-01
|
9.44e-01
|
0.12800
|
1.84e-03
|
1.28e-01
|
9.92e-01
|
4.62e-01
|
GOBP REGULATION OF GLIOGENESIS
|
106
|
8.07e-02
|
5.30e-01
|
0.12800
|
-1.26e-01
|
2.40e-02
|
2.52e-02
|
6.69e-01
|
GOBP PROTEIN LOCALIZATION TO CELL CORTEX
|
11
|
7.44e-01
|
9.38e-01
|
0.12800
|
1.21e-01
|
4.23e-02
|
4.87e-01
|
8.08e-01
|
GOMF S METHYLTRANSFERASE ACTIVITY
|
8
|
8.00e-01
|
9.56e-01
|
0.12800
|
8.63e-02
|
9.45e-02
|
6.72e-01
|
6.43e-01
|
GOBP SULFUR COMPOUND CATABOLIC PROCESS
|
34
|
4.21e-01
|
8.33e-01
|
0.12800
|
-1.27e-01
|
-1.18e-02
|
1.98e-01
|
9.06e-01
|
GOBP DERMATAN SULFATE BIOSYNTHETIC PROCESS
|
5
|
8.70e-01
|
9.73e-01
|
0.12800
|
-9.01e-02
|
-9.09e-02
|
7.27e-01
|
7.25e-01
|
GOBP SMOOTH MUSCLE CELL CHEMOTAXIS
|
9
|
8.15e-01
|
9.59e-01
|
0.12800
|
1.18e-01
|
-5.00e-02
|
5.41e-01
|
7.95e-01
|
GOCC RIBBON SYNAPSE
|
15
|
7.20e-01
|
9.29e-01
|
0.12800
|
-9.93e-02
|
8.06e-02
|
5.05e-01
|
5.89e-01
|
GOCC ASTER
|
10
|
7.65e-01
|
9.45e-01
|
0.12800
|
-4.13e-02
|
-1.21e-01
|
8.21e-01
|
5.07e-01
|
GOMF PROTEIN TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY
|
40
|
3.37e-01
|
7.89e-01
|
0.12800
|
5.62e-02
|
1.15e-01
|
5.39e-01
|
2.09e-01
|
GOBP NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING
|
15
|
6.82e-01
|
9.16e-01
|
0.12800
|
1.39e-02
|
1.27e-01
|
9.26e-01
|
3.94e-01
|
GOBP HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING
|
16
|
7.05e-01
|
9.24e-01
|
0.12800
|
-8.59e-02
|
9.46e-02
|
5.52e-01
|
5.12e-01
|
GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT MODIFYING ACTIVITY
|
17
|
6.24e-01
|
9.01e-01
|
0.12800
|
-7.90e-02
|
-1.00e-01
|
5.73e-01
|
4.74e-01
|
GOMF ADENYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY
|
15
|
6.60e-01
|
9.09e-01
|
0.12800
|
-1.01e-01
|
-7.78e-02
|
4.97e-01
|
6.02e-01
|
GOBP RESPONSE TO GAMMA RADIATION
|
50
|
2.72e-01
|
7.47e-01
|
0.12800
|
1.25e-01
|
2.76e-02
|
1.27e-01
|
7.35e-01
|
GOCC VESICLE TETHERING COMPLEX
|
56
|
2.48e-01
|
7.26e-01
|
0.12800
|
-1.28e-01
|
-3.59e-03
|
9.84e-02
|
9.63e-01
|
GOBP RESPONSE TO ZINC ION
|
48
|
2.92e-01
|
7.63e-01
|
0.12800
|
1.86e-02
|
1.26e-01
|
8.23e-01
|
1.30e-01
|
GOMF SEROTONIN RECEPTOR ACTIVITY
|
26
|
5.44e-01
|
8.78e-01
|
0.12800
|
-2.97e-02
|
1.24e-01
|
7.93e-01
|
2.73e-01
|
GOBP RECEPTOR LOCALIZATION TO SYNAPSE
|
57
|
2.85e-01
|
7.57e-01
|
0.12800
|
-1.08e-01
|
6.73e-02
|
1.57e-01
|
3.79e-01
|
GOBP SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING
|
36
|
4.12e-01
|
8.28e-01
|
0.12800
|
-2.84e-03
|
1.28e-01
|
9.76e-01
|
1.85e-01
|
GOCC MYELIN SHEATH ADAXONAL REGION
|
6
|
8.71e-01
|
9.73e-01
|
0.12800
|
-1.21e-01
|
3.95e-02
|
6.07e-01
|
8.67e-01
|
GOBP POSITIVE REGULATION OF CELL SUBSTRATE ADHESION
|
121
|
4.68e-02
|
4.37e-01
|
0.12800
|
1.45e-02
|
1.27e-01
|
7.82e-01
|
1.61e-02
|
GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA SIGNALING PATHWAY
|
7
|
8.48e-01
|
9.66e-01
|
0.12800
|
-1.25e-01
|
2.46e-02
|
5.66e-01
|
9.10e-01
|
GOBP PROTEIN KINASE A SIGNALING
|
37
|
4.47e-01
|
8.41e-01
|
0.12800
|
9.49e-02
|
-8.52e-02
|
3.18e-01
|
3.70e-01
|
GOBP PREVENTION OF POLYSPERMY
|
7
|
8.26e-01
|
9.62e-01
|
0.12700
|
1.12e-01
|
6.04e-02
|
6.07e-01
|
7.82e-01
|
GOBP PROTEIN HISTIDYL MODIFICATION TO DIPHTHAMIDE
|
6
|
8.58e-01
|
9.68e-01
|
0.12700
|
-1.26e-01
|
-1.59e-02
|
5.92e-01
|
9.46e-01
|
GOMF DNA INSERTION OR DELETION BINDING
|
6
|
8.78e-01
|
9.75e-01
|
0.12700
|
8.38e-02
|
-9.61e-02
|
7.22e-01
|
6.84e-01
|
GOBP PHOSPHOLIPID BIOSYNTHETIC PROCESS
|
243
|
3.96e-03
|
1.30e-01
|
0.12700
|
-1.22e-01
|
3.81e-02
|
1.09e-03
|
3.06e-01
|
GOMF INTERLEUKIN 2 RECEPTOR BINDING
|
5
|
8.75e-01
|
9.75e-01
|
0.12700
|
-4.42e-02
|
-1.20e-01
|
8.64e-01
|
6.44e-01
|
GOBP POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY
|
66
|
2.39e-01
|
7.25e-01
|
0.12700
|
8.70e-02
|
-9.31e-02
|
2.22e-01
|
1.91e-01
|
GOBP NEURAL TUBE PATTERNING
|
39
|
4.26e-01
|
8.36e-01
|
0.12700
|
7.15e-02
|
-1.05e-01
|
4.40e-01
|
2.55e-01
|
GOBP REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
45
|
2.93e-01
|
7.63e-01
|
0.12700
|
6.64e-02
|
1.09e-01
|
4.41e-01
|
2.07e-01
|
GOBP NADH METABOLIC PROCESS
|
11
|
7.40e-01
|
9.36e-01
|
0.12700
|
-1.07e-01
|
-6.86e-02
|
5.38e-01
|
6.94e-01
|
GOBP REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY
|
45
|
2.89e-01
|
7.60e-01
|
0.12700
|
9.80e-02
|
8.13e-02
|
2.55e-01
|
3.45e-01
|
GOBP POSITIVE REGULATION OF NEUROGENESIS
|
228
|
7.30e-03
|
1.78e-01
|
0.12700
|
-7.74e-02
|
1.01e-01
|
4.39e-02
|
8.53e-03
|
GOBP BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS
|
51
|
2.65e-01
|
7.41e-01
|
0.12700
|
3.19e-02
|
1.23e-01
|
6.94e-01
|
1.28e-01
|
GOBP REGULATION OF SKELETAL MUSCLE ADAPTATION
|
14
|
7.15e-01
|
9.27e-01
|
0.12700
|
1.51e-02
|
-1.26e-01
|
9.22e-01
|
4.13e-01
|
GOBP POSITIVE REGULATION OF DOPAMINE SECRETION
|
6
|
8.62e-01
|
9.69e-01
|
0.12700
|
1.27e-01
|
3.62e-03
|
5.89e-01
|
9.88e-01
|
GOBP REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING
|
8
|
8.08e-01
|
9.59e-01
|
0.12700
|
-1.18e-01
|
-4.74e-02
|
5.63e-01
|
8.16e-01
|
GOBP RETROGRADE AXONAL TRANSPORT
|
21
|
5.62e-01
|
8.84e-01
|
0.12700
|
1.05e-01
|
7.21e-02
|
4.05e-01
|
5.67e-01
|
GOBP RESPONSE TO MUSCLE ACTIVITY
|
28
|
5.23e-01
|
8.70e-01
|
0.12700
|
-1.23e-01
|
3.29e-02
|
2.60e-01
|
7.63e-01
|
GOBP RENAL SYSTEM VASCULATURE DEVELOPMENT
|
32
|
4.43e-01
|
8.40e-01
|
0.12700
|
1.80e-02
|
1.26e-01
|
8.60e-01
|
2.17e-01
|
GOBP CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS
|
613
|
1.33e-07
|
7.97e-05
|
0.12700
|
-1.20e-01
|
-4.33e-02
|
4.18e-07
|
6.72e-02
|
GOBP ACTIN FILAMENT ORGANIZATION
|
443
|
3.65e-05
|
4.29e-03
|
0.12700
|
-2.41e-02
|
1.25e-01
|
3.85e-01
|
6.51e-06
|
GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE BINDING
|
80
|
1.70e-01
|
6.57e-01
|
0.12700
|
-5.73e-02
|
1.14e-01
|
3.76e-01
|
7.90e-02
|
GOBP MICROGLIAL CELL PROLIFERATION
|
8
|
8.04e-01
|
9.57e-01
|
0.12700
|
-6.62e-02
|
-1.09e-01
|
7.46e-01
|
5.95e-01
|
GOBP PINOCYTOSIS
|
22
|
6.08e-01
|
8.97e-01
|
0.12700
|
-1.19e-01
|
4.60e-02
|
3.36e-01
|
7.09e-01
|
GOBP METANEPHRIC GLOMERULUS VASCULATURE DEVELOPMENT
|
9
|
8.19e-01
|
9.60e-01
|
0.12700
|
1.12e-01
|
-5.99e-02
|
5.60e-01
|
7.56e-01
|
GOBP REGULATION OF DNA REPAIR
|
205
|
6.25e-03
|
1.64e-01
|
0.12700
|
-1.27e-01
|
-8.39e-03
|
1.74e-03
|
8.36e-01
|
GOBP REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS
|
54
|
2.44e-01
|
7.26e-01
|
0.12700
|
-1.22e-01
|
-3.53e-02
|
1.21e-01
|
6.53e-01
|
GOBP RNA TEMPLATED DNA BIOSYNTHETIC PROCESS
|
68
|
2.14e-01
|
7.03e-01
|
0.12700
|
4.21e-02
|
-1.20e-01
|
5.49e-01
|
8.72e-02
|
GOBP REGULATION OF TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE
|
19
|
6.15e-01
|
8.99e-01
|
0.12700
|
-1.25e-01
|
-2.18e-02
|
3.45e-01
|
8.69e-01
|
GOBP POSTSYNAPTIC MEMBRANE ASSEMBLY
|
7
|
8.27e-01
|
9.62e-01
|
0.12700
|
-6.35e-02
|
-1.10e-01
|
7.71e-01
|
6.14e-01
|
GOBP RESPONSE TO THYROID HORMONE
|
28
|
5.45e-01
|
8.78e-01
|
0.12700
|
-1.00e-01
|
7.80e-02
|
3.58e-01
|
4.75e-01
|
GOBP POST EMBRYONIC ANIMAL MORPHOGENESIS
|
16
|
6.83e-01
|
9.17e-01
|
0.12700
|
1.56e-02
|
-1.26e-01
|
9.14e-01
|
3.83e-01
|
GOBP CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT
|
27
|
4.80e-01
|
8.54e-01
|
0.12700
|
-6.68e-02
|
-1.08e-01
|
5.48e-01
|
3.31e-01
|
GOBP VITAMIN TRANSMEMBRANE TRANSPORT
|
21
|
5.88e-01
|
8.91e-01
|
0.12700
|
-1.69e-02
|
-1.26e-01
|
8.93e-01
|
3.18e-01
|
GOMF NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
28
|
4.83e-01
|
8.54e-01
|
0.12700
|
-1.22e-01
|
-3.39e-02
|
2.63e-01
|
7.56e-01
|
GOMF PHOSPHOLIPID BINDING
|
459
|
5.34e-05
|
5.82e-03
|
0.12700
|
-6.58e-02
|
1.08e-01
|
1.56e-02
|
6.79e-05
|
GOBP NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
69
|
1.92e-01
|
6.85e-01
|
0.12700
|
-1.09e-02
|
1.26e-01
|
8.76e-01
|
6.94e-02
|
GOBP CLEAVAGE FURROW FORMATION
|
7
|
8.47e-01
|
9.66e-01
|
0.12700
|
-1.26e-01
|
1.72e-02
|
5.65e-01
|
9.37e-01
|
GOMF G PROTEIN ACTIVITY
|
42
|
3.76e-01
|
8.11e-01
|
0.12700
|
-1.24e-01
|
2.55e-02
|
1.64e-01
|
7.75e-01
|
GOBP MACROPHAGE PROLIFERATION
|
12
|
7.19e-01
|
9.29e-01
|
0.12700
|
-8.89e-02
|
-9.04e-02
|
5.94e-01
|
5.88e-01
|
GOBP CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS
|
20
|
6.38e-01
|
9.06e-01
|
0.12700
|
-1.18e-01
|
4.59e-02
|
3.60e-01
|
7.22e-01
|
GOBP PURINE NUCLEOBASE TRANSMEMBRANE TRANSPORT
|
8
|
8.32e-01
|
9.64e-01
|
0.12700
|
3.08e-02
|
-1.23e-01
|
8.80e-01
|
5.47e-01
|
GOBP RESPONSE TO GLUCAGON
|
20
|
6.40e-01
|
9.06e-01
|
0.12700
|
-5.01e-02
|
1.16e-01
|
6.98e-01
|
3.67e-01
|
GOBP CRANIAL NERVE DEVELOPMENT
|
61
|
2.18e-01
|
7.07e-01
|
0.12700
|
1.27e-02
|
1.26e-01
|
8.64e-01
|
8.85e-02
|
GOBP RNA MODIFICATION
|
169
|
1.14e-02
|
2.28e-01
|
0.12700
|
-5.28e-02
|
-1.15e-01
|
2.36e-01
|
9.79e-03
|
GOBP POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY
|
14
|
7.39e-01
|
9.35e-01
|
0.12700
|
-1.03e-01
|
7.35e-02
|
5.04e-01
|
6.34e-01
|
GOBP NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION
|
65
|
2.24e-01
|
7.12e-01
|
0.12700
|
-1.23e-01
|
2.90e-02
|
8.55e-02
|
6.86e-01
|
GOBP OLIGODENDROCYTE DIFFERENTIATION
|
102
|
1.13e-01
|
5.91e-01
|
0.12700
|
-8.71e-02
|
9.19e-02
|
1.28e-01
|
1.09e-01
|
GOCC UBIQUITIN CONJUGATING ENZYME COMPLEX
|
7
|
8.41e-01
|
9.66e-01
|
0.12700
|
-1.26e-01
|
-6.95e-03
|
5.62e-01
|
9.75e-01
|
GOBP REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS
|
17
|
6.29e-01
|
9.02e-01
|
0.12700
|
-8.25e-02
|
-9.60e-02
|
5.56e-01
|
4.93e-01
|
GOBP PEPTIDYL PROLINE HYDROXYLATION TO 4 HYDROXY L PROLINE
|
8
|
8.40e-01
|
9.65e-01
|
0.12700
|
-1.09e-01
|
6.43e-02
|
5.94e-01
|
7.53e-01
|
GOMF PEPTIDYL PROLINE 4 DIOXYGENASE ACTIVITY
|
8
|
8.40e-01
|
9.65e-01
|
0.12700
|
-1.09e-01
|
6.43e-02
|
5.94e-01
|
7.53e-01
|
GOBP REGULATION OF FAS SIGNALING PATHWAY
|
6
|
8.57e-01
|
9.68e-01
|
0.12600
|
3.26e-02
|
1.22e-01
|
8.90e-01
|
6.04e-01
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON METAL IONS NAD OR NADP AS ACCEPTOR
|
6
|
8.79e-01
|
9.75e-01
|
0.12600
|
-8.32e-02
|
9.52e-02
|
7.24e-01
|
6.86e-01
|
GOBP ENDOCARDIAL CUSHION DEVELOPMENT
|
54
|
3.16e-01
|
7.76e-01
|
0.12600
|
-9.47e-02
|
8.37e-02
|
2.29e-01
|
2.87e-01
|
GOCC FILOPODIUM MEMBRANE
|
17
|
6.66e-01
|
9.11e-01
|
0.12600
|
1.26e-01
|
-8.35e-03
|
3.68e-01
|
9.52e-01
|
GOBP MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL
|
29
|
4.74e-01
|
8.54e-01
|
0.12600
|
3.24e-02
|
1.22e-01
|
7.62e-01
|
2.55e-01
|
GOBP BROWN FAT CELL DIFFERENTIATION
|
53
|
2.37e-01
|
7.24e-01
|
0.12600
|
-9.14e-02
|
-8.72e-02
|
2.50e-01
|
2.72e-01
|
GOMF MOLECULAR CARRIER ACTIVITY
|
92
|
1.35e-01
|
6.16e-01
|
0.12600
|
6.03e-02
|
-1.11e-01
|
3.18e-01
|
6.57e-02
|
GOBP POSITIVE REGULATION OF MRNA 3 END PROCESSING
|
6
|
8.69e-01
|
9.72e-01
|
0.12600
|
1.25e-01
|
-1.92e-02
|
5.96e-01
|
9.35e-01
|
GOBP CYTOPLASMIC MICROTUBULE ORGANIZATION
|
59
|
2.40e-01
|
7.25e-01
|
0.12600
|
-1.26e-01
|
8.68e-04
|
9.34e-02
|
9.91e-01
|
GOMF AZOLE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
12
|
7.39e-01
|
9.35e-01
|
0.12600
|
-2.17e-02
|
-1.24e-01
|
8.96e-01
|
4.56e-01
|
GOBP DNA DOUBLE STRAND BREAK PROCESSING
|
19
|
6.16e-01
|
8.99e-01
|
0.12600
|
-1.23e-01
|
-2.87e-02
|
3.53e-01
|
8.29e-01
|
GOCC U2 TYPE SPLICEOSOMAL COMPLEX
|
88
|
1.01e-01
|
5.70e-01
|
0.12600
|
-4.38e-02
|
-1.18e-01
|
4.78e-01
|
5.49e-02
|
GOMF GTP DEPENDENT PROTEIN BINDING
|
21
|
6.38e-01
|
9.06e-01
|
0.12600
|
-7.63e-02
|
1.01e-01
|
5.45e-01
|
4.25e-01
|
GOBP HYPOTHALAMUS DEVELOPMENT
|
24
|
5.76e-01
|
8.89e-01
|
0.12600
|
2.62e-02
|
-1.23e-01
|
8.24e-01
|
2.95e-01
|
GOBP LEUKOCYTE DEGRANULATION
|
76
|
1.90e-01
|
6.83e-01
|
0.12600
|
-5.41e-02
|
1.14e-01
|
4.15e-01
|
8.59e-02
|
GOBP REGULATION OF PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY
|
6
|
8.70e-01
|
9.73e-01
|
0.12600
|
1.24e-01
|
-2.07e-02
|
5.98e-01
|
9.30e-01
|
GOMF ARYLSULFATASE ACTIVITY
|
9
|
7.88e-01
|
9.54e-01
|
0.12600
|
-5.34e-02
|
-1.14e-01
|
7.82e-01
|
5.53e-01
|
GOCC PHOTORECEPTOR INNER SEGMENT
|
68
|
1.59e-01
|
6.48e-01
|
0.12600
|
9.50e-02
|
8.29e-02
|
1.75e-01
|
2.37e-01
|
GOMF EXONUCLEASE ACTIVITY
|
81
|
1.13e-01
|
5.91e-01
|
0.12600
|
-7.49e-02
|
-1.01e-01
|
2.44e-01
|
1.15e-01
|
GOBP CORONARY VASCULATURE DEVELOPMENT
|
48
|
3.47e-01
|
7.96e-01
|
0.12600
|
-4.85e-02
|
1.16e-01
|
5.61e-01
|
1.63e-01
|
GOBP POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY
|
32
|
4.71e-01
|
8.51e-01
|
0.12600
|
1.25e-01
|
-1.34e-02
|
2.20e-01
|
8.96e-01
|
GOMF DISORDERED DOMAIN SPECIFIC BINDING
|
29
|
5.40e-01
|
8.78e-01
|
0.12600
|
-9.50e-02
|
8.28e-02
|
3.76e-01
|
4.40e-01
|
GOCC COP9 SIGNALOSOME
|
16
|
6.99e-01
|
9.21e-01
|
0.12600
|
3.99e-02
|
-1.20e-01
|
7.82e-01
|
4.08e-01
|
GOBP NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION
|
61
|
2.62e-01
|
7.39e-01
|
0.12600
|
-5.13e-02
|
1.15e-01
|
4.89e-01
|
1.20e-01
|
GOBP POSITIVE REGULATION OF DNA REPAIR
|
124
|
4.92e-02
|
4.42e-01
|
0.12600
|
-1.26e-01
|
-5.78e-03
|
1.55e-02
|
9.12e-01
|
GOBP CRANIAL NERVE MORPHOGENESIS
|
29
|
4.80e-01
|
8.54e-01
|
0.12600
|
2.64e-02
|
1.23e-01
|
8.05e-01
|
2.51e-01
|
GOBP COENZYME A BIOSYNTHETIC PROCESS
|
11
|
7.56e-01
|
9.42e-01
|
0.12600
|
-2.97e-02
|
-1.22e-01
|
8.65e-01
|
4.82e-01
|
GOBP CEREBELLAR CORTEX MORPHOGENESIS
|
34
|
4.16e-01
|
8.30e-01
|
0.12600
|
-3.90e-02
|
-1.20e-01
|
6.94e-01
|
2.27e-01
|
GOBP ODONTOGENESIS
|
126
|
6.01e-02
|
4.78e-01
|
0.12600
|
-3.80e-02
|
1.20e-01
|
4.61e-01
|
2.00e-02
|
GOBP NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY
|
24
|
5.30e-01
|
8.73e-01
|
0.12600
|
-5.82e-02
|
-1.12e-01
|
6.22e-01
|
3.44e-01
|
GOBP NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION
|
48
|
2.90e-01
|
7.61e-01
|
0.12600
|
-1.20e-01
|
-3.87e-02
|
1.51e-01
|
6.42e-01
|
GOCC SCHAFFER COLLATERAL CA1 SYNAPSE
|
88
|
1.53e-01
|
6.41e-01
|
0.12600
|
-1.05e-01
|
6.89e-02
|
8.79e-02
|
2.64e-01
|
GOBP REGULATION OF CILIUM MOVEMENT
|
38
|
3.92e-01
|
8.22e-01
|
0.12600
|
-1.34e-02
|
-1.25e-01
|
8.86e-01
|
1.82e-01
|
GOBP POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY
|
134
|
4.78e-02
|
4.38e-01
|
0.12600
|
-1.23e-01
|
2.76e-02
|
1.42e-02
|
5.81e-01
|
GOBP HYPOTHALAMUS GONADOTROPHIN RELEASING HORMONE NEURON DIFFERENTIATION
|
7
|
8.62e-01
|
9.69e-01
|
0.12600
|
7.91e-02
|
-9.78e-02
|
7.17e-01
|
6.54e-01
|
GOBP REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY
|
19
|
6.63e-01
|
9.10e-01
|
0.12600
|
-5.83e-02
|
1.11e-01
|
6.60e-01
|
4.01e-01
|
GOBP REGULATION OF BILE ACID METABOLIC PROCESS
|
15
|
6.86e-01
|
9.19e-01
|
0.12600
|
2.34e-02
|
1.23e-01
|
8.75e-01
|
4.08e-01
|
GOBP POSITIVE REGULATION OF DENDRITE DEVELOPMENT
|
15
|
7.04e-01
|
9.23e-01
|
0.12600
|
1.25e-01
|
-1.23e-02
|
4.02e-01
|
9.35e-01
|
GOBP RESPONSE TO PAIN
|
34
|
4.17e-01
|
8.32e-01
|
0.12600
|
3.95e-02
|
1.19e-01
|
6.90e-01
|
2.29e-01
|
GOBP RETINOIC ACID RECEPTOR SIGNALING PATHWAY
|
32
|
4.26e-01
|
8.36e-01
|
0.12600
|
1.05e-01
|
6.95e-02
|
3.06e-01
|
4.96e-01
|
GOMF HISTONE H4 METHYLTRANSFERASE ACTIVITY
|
17
|
6.47e-01
|
9.07e-01
|
0.12600
|
-1.20e-01
|
-3.61e-02
|
3.91e-01
|
7.97e-01
|
GOCC DENDRITIC SPINE MEMBRANE
|
13
|
7.29e-01
|
9.32e-01
|
0.12500
|
1.25e-01
|
7.83e-03
|
4.34e-01
|
9.61e-01
|
GOBP RESPONSE TO PROSTAGLANDIN
|
31
|
4.83e-01
|
8.54e-01
|
0.12500
|
9.61e-03
|
-1.25e-01
|
9.26e-01
|
2.28e-01
|
GOMF DEOXYCYTIDINE DEAMINASE ACTIVITY
|
9
|
8.27e-01
|
9.62e-01
|
0.12500
|
-8.05e-02
|
9.62e-02
|
6.76e-01
|
6.17e-01
|
GOBP REGULATION OF CDC42 PROTEIN SIGNAL TRANSDUCTION
|
8
|
8.12e-01
|
9.59e-01
|
0.12500
|
4.75e-02
|
1.16e-01
|
8.16e-01
|
5.70e-01
|
GOCC LATE ENDOSOME
|
295
|
1.39e-03
|
6.48e-02
|
0.12500
|
-1.22e-01
|
3.02e-02
|
3.22e-04
|
3.72e-01
|
GOBP REGULATION OF NMDA RECEPTOR ACTIVITY
|
17
|
6.87e-01
|
9.19e-01
|
0.12500
|
-4.22e-02
|
1.18e-01
|
7.63e-01
|
3.99e-01
|
GOBP CELLULAR EXTRAVASATION
|
71
|
1.65e-01
|
6.49e-01
|
0.12500
|
-1.20e-01
|
-3.48e-02
|
7.94e-02
|
6.12e-01
|
GOCC PHAGOCYTIC CUP
|
28
|
5.42e-01
|
8.78e-01
|
0.12500
|
-1.16e-01
|
4.65e-02
|
2.87e-01
|
6.70e-01
|
GOBP INSULIN RECEPTOR SIGNALING PATHWAY
|
123
|
7.20e-02
|
5.12e-01
|
0.12500
|
-1.11e-01
|
5.77e-02
|
3.32e-02
|
2.69e-01
|
GOBP NEGATIVE REGULATION OF MONONUCLEAR CELL MIGRATION
|
24
|
5.46e-01
|
8.78e-01
|
0.12500
|
1.21e-01
|
3.05e-02
|
3.03e-01
|
7.96e-01
|
GOBP REGULATION OF NEUROBLAST PROLIFERATION
|
53
|
3.29e-01
|
7.84e-01
|
0.12500
|
9.55e-02
|
-8.09e-02
|
2.29e-01
|
3.09e-01
|
GOBP NUCLEAR MEMBRANE ORGANIZATION
|
42
|
4.09e-01
|
8.27e-01
|
0.12500
|
-1.08e-01
|
6.35e-02
|
2.27e-01
|
4.76e-01
|
GOBP SULFUR AMINO ACID METABOLIC PROCESS
|
31
|
4.78e-01
|
8.54e-01
|
0.12500
|
-1.25e-01
|
3.41e-04
|
2.28e-01
|
9.97e-01
|
GOBP IMPORT ACROSS PLASMA MEMBRANE
|
202
|
1.22e-02
|
2.37e-01
|
0.12500
|
-4.24e-02
|
1.18e-01
|
2.99e-01
|
3.92e-03
|
GOBP PLACENTA BLOOD VESSEL DEVELOPMENT
|
30
|
5.19e-01
|
8.69e-01
|
0.12500
|
-4.56e-02
|
1.17e-01
|
6.66e-01
|
2.69e-01
|
GOBP SINGLE FERTILIZATION
|
158
|
1.54e-02
|
2.64e-01
|
0.12500
|
-7.67e-02
|
-9.88e-02
|
9.61e-02
|
3.21e-02
|
GOBP CALCIUM ION TRANSMEMBRANE TRANSPORT
|
338
|
4.14e-04
|
2.73e-02
|
0.12500
|
-8.91e-03
|
1.25e-01
|
7.78e-01
|
8.07e-05
|
GOBP REGULATION OF KERATINOCYTE DIFFERENTIATION
|
40
|
4.27e-01
|
8.36e-01
|
0.12500
|
-1.08e-01
|
6.25e-02
|
2.36e-01
|
4.94e-01
|
GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY
|
110
|
5.46e-02
|
4.62e-01
|
0.12500
|
-7.63e-02
|
-9.90e-02
|
1.67e-01
|
7.30e-02
|
GOBP SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT
|
40
|
3.49e-01
|
7.96e-01
|
0.12500
|
1.05e-01
|
6.73e-02
|
2.49e-01
|
4.61e-01
|
GOMF HEPARAN SULFATE PROTEOGLYCAN BINDING
|
18
|
6.79e-01
|
9.14e-01
|
0.12500
|
-5.47e-02
|
1.12e-01
|
6.88e-01
|
4.09e-01
|
GOBP NEGATIVE REGULATION OF CIRCADIAN RHYTHM
|
11
|
7.46e-01
|
9.38e-01
|
0.12500
|
-8.74e-02
|
-8.93e-02
|
6.16e-01
|
6.08e-01
|
GOBP REGULATION OF PIGMENT CELL DIFFERENTIATION
|
8
|
8.14e-01
|
9.59e-01
|
0.12500
|
-4.75e-02
|
-1.16e-01
|
8.16e-01
|
5.72e-01
|
GOMF C METHYLTRANSFERASE ACTIVITY
|
6
|
8.77e-01
|
9.75e-01
|
0.12500
|
-4.24e-02
|
1.17e-01
|
8.57e-01
|
6.18e-01
|
GOBP EXOCRINE SYSTEM DEVELOPMENT
|
45
|
3.76e-01
|
8.11e-01
|
0.12500
|
-4.56e-02
|
1.16e-01
|
5.97e-01
|
1.77e-01
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS NAD OR NADP AS ACCEPTOR
|
32
|
4.33e-01
|
8.37e-01
|
0.12500
|
-1.08e-01
|
-6.25e-02
|
2.90e-01
|
5.41e-01
|
GOCC A BAND
|
33
|
4.39e-01
|
8.40e-01
|
0.12500
|
2.72e-02
|
1.22e-01
|
7.87e-01
|
2.26e-01
|
GOBP NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS
|
16
|
6.75e-01
|
9.13e-01
|
0.12500
|
1.23e-01
|
1.85e-02
|
3.92e-01
|
8.98e-01
|
GOBP ARACHIDONIC ACID SECRETION
|
31
|
4.80e-01
|
8.54e-01
|
0.12500
|
1.25e-01
|
-2.06e-04
|
2.29e-01
|
9.98e-01
|
GOBP REGULATION OF HYPERSENSITIVITY
|
7
|
8.31e-01
|
9.64e-01
|
0.12500
|
-8.05e-02
|
-9.53e-02
|
7.12e-01
|
6.62e-01
|
GOBP AMMONIUM ION METABOLIC PROCESS
|
22
|
5.79e-01
|
8.90e-01
|
0.12500
|
1.22e-01
|
2.58e-02
|
3.22e-01
|
8.34e-01
|
GOMF ALDEHYDE LYASE ACTIVITY
|
9
|
7.97e-01
|
9.56e-01
|
0.12500
|
-3.37e-02
|
-1.20e-01
|
8.61e-01
|
5.33e-01
|
GOBP PEPTIDYL ARGININE MODIFICATION
|
10
|
7.90e-01
|
9.54e-01
|
0.12500
|
1.06e-03
|
-1.25e-01
|
9.95e-01
|
4.95e-01
|
GOBP T CELL APOPTOTIC PROCESS
|
57
|
2.60e-01
|
7.37e-01
|
0.12500
|
1.17e-03
|
1.25e-01
|
9.88e-01
|
1.03e-01
|
GOMF 5 DEOXYRIBOSE 5 PHOSPHATE LYASE ACTIVITY
|
6
|
8.70e-01
|
9.73e-01
|
0.12500
|
1.24e-01
|
-1.09e-02
|
5.98e-01
|
9.63e-01
|
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS
|
13
|
7.12e-01
|
9.27e-01
|
0.12500
|
6.35e-02
|
1.07e-01
|
6.92e-01
|
5.03e-01
|
GOMF POLY G BINDING
|
7
|
8.50e-01
|
9.67e-01
|
0.12500
|
-8.42e-03
|
1.24e-01
|
9.69e-01
|
5.69e-01
|
GOBP NEGATIVE REGULATION OF STEROL TRANSPORT
|
31
|
4.63e-01
|
8.48e-01
|
0.12400
|
-2.89e-02
|
-1.21e-01
|
7.80e-01
|
2.43e-01
|
GOBP NEUTROPHIL MIGRATION
|
119
|
7.84e-02
|
5.26e-01
|
0.12400
|
-4.87e-02
|
1.14e-01
|
3.58e-01
|
3.10e-02
|
GOMF PEPTIDE RECEPTOR ACTIVITY
|
121
|
7.53e-02
|
5.18e-01
|
0.12400
|
4.92e-02
|
-1.14e-01
|
3.50e-01
|
2.99e-02
|
GOBP T CELL HOMEOSTASIS
|
44
|
4.02e-01
|
8.26e-01
|
0.12400
|
-9.56e-02
|
7.96e-02
|
2.73e-01
|
3.61e-01
|
GOCC CYTOPLASMIC EXOSOME RNASE COMPLEX
|
15
|
7.33e-01
|
9.33e-01
|
0.12400
|
8.45e-02
|
-9.13e-02
|
5.71e-01
|
5.41e-01
|
GOBP MRNA CIS SPLICING VIA SPLICEOSOME
|
26
|
5.39e-01
|
8.78e-01
|
0.12400
|
-4.79e-03
|
-1.24e-01
|
9.66e-01
|
2.73e-01
|
GOBP MITOTIC G2 M TRANSITION CHECKPOINT
|
50
|
2.73e-01
|
7.47e-01
|
0.12400
|
-6.32e-02
|
-1.07e-01
|
4.39e-01
|
1.90e-01
|
GOBP ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL COMMUNICATION
|
17
|
6.58e-01
|
9.09e-01
|
0.12400
|
1.22e-01
|
2.53e-02
|
3.85e-01
|
8.56e-01
|
GOBP EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS
|
30
|
5.04e-01
|
8.65e-01
|
0.12400
|
-1.23e-01
|
1.42e-02
|
2.42e-01
|
8.93e-01
|
GOBP HISTONE DEACETYLATION
|
19
|
6.57e-01
|
9.09e-01
|
0.12400
|
-1.20e-01
|
3.17e-02
|
3.65e-01
|
8.11e-01
|
GOBP POST EMBRYONIC DEVELOPMENT
|
91
|
1.16e-01
|
5.95e-01
|
0.12400
|
-1.24e-01
|
-6.23e-03
|
4.07e-02
|
9.18e-01
|
GOBP LIMB JOINT MORPHOGENESIS
|
5
|
9.02e-01
|
9.80e-01
|
0.12400
|
8.97e-02
|
-8.60e-02
|
7.28e-01
|
7.39e-01
|
GOBP TRANSPOSITION
|
38
|
4.33e-01
|
8.37e-01
|
0.12400
|
-3.28e-02
|
1.20e-01
|
7.26e-01
|
2.01e-01
|
GOBP SYNAPTIC VESICLE LOCALIZATION
|
53
|
2.50e-01
|
7.27e-01
|
0.12400
|
-9.71e-02
|
-7.74e-02
|
2.21e-01
|
3.29e-01
|
GOCC LAMELLIPODIUM
|
194
|
1.16e-02
|
2.30e-01
|
0.12400
|
-6.18e-03
|
1.24e-01
|
8.82e-01
|
2.89e-03
|
GOCC LATE ENDOSOME MEMBRANE
|
165
|
2.73e-02
|
3.44e-01
|
0.12400
|
-1.20e-01
|
3.37e-02
|
8.07e-03
|
4.55e-01
|
GOBP DETECTION OF EXTERNAL BIOTIC STIMULUS
|
26
|
5.06e-01
|
8.65e-01
|
0.12400
|
-7.82e-02
|
-9.64e-02
|
4.90e-01
|
3.95e-01
|
GOBP ARTERY DEVELOPMENT
|
111
|
1.02e-01
|
5.72e-01
|
0.12400
|
-7.63e-02
|
9.79e-02
|
1.65e-01
|
7.49e-02
|
GOBP CELLULAR RESPONSE TO STARVATION
|
171
|
2.50e-02
|
3.31e-01
|
0.12400
|
-1.18e-01
|
3.96e-02
|
7.96e-03
|
3.72e-01
|
GOBP REGULATION OF BLOOD BRAIN BARRIER PERMEABILITY
|
9
|
8.30e-01
|
9.64e-01
|
0.12400
|
-7.89e-02
|
9.58e-02
|
6.82e-01
|
6.19e-01
|
GOMF JUN KINASE BINDING
|
11
|
7.50e-01
|
9.40e-01
|
0.12400
|
-9.19e-02
|
-8.31e-02
|
5.98e-01
|
6.33e-01
|
GOBP PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE
|
102
|
1.10e-01
|
5.85e-01
|
0.12400
|
-1.18e-01
|
3.66e-02
|
3.88e-02
|
5.23e-01
|
GOBP REGULATION OF HEART MORPHOGENESIS
|
10
|
8.13e-01
|
9.59e-01
|
0.12400
|
-1.03e-01
|
6.85e-02
|
5.72e-01
|
7.07e-01
|
GOBP REGULATION OF VITAMIN METABOLIC PROCESS
|
12
|
7.31e-01
|
9.32e-01
|
0.12400
|
-8.01e-02
|
-9.44e-02
|
6.31e-01
|
5.71e-01
|
GOBP REGULATION OF ERBB SIGNALING PATHWAY
|
70
|
2.27e-01
|
7.14e-01
|
0.12400
|
-1.14e-01
|
4.91e-02
|
1.00e-01
|
4.77e-01
|
GOMF TRANSLATION ACTIVATOR ACTIVITY
|
9
|
8.28e-01
|
9.62e-01
|
0.12400
|
-1.09e-01
|
5.90e-02
|
5.72e-01
|
7.59e-01
|
GOMF CARBON SULFUR LYASE ACTIVITY
|
12
|
7.33e-01
|
9.33e-01
|
0.12400
|
-1.03e-01
|
-6.83e-02
|
5.36e-01
|
6.82e-01
|
GOCC SPHERICAL HIGH DENSITY LIPOPROTEIN PARTICLE
|
8
|
8.19e-01
|
9.60e-01
|
0.12400
|
-1.18e-01
|
-3.86e-02
|
5.65e-01
|
8.50e-01
|
GOBP ORGANOPHOSPHATE BIOSYNTHETIC PROCESS
|
562
|
1.04e-06
|
3.04e-04
|
0.12400
|
-1.16e-01
|
-4.32e-02
|
2.60e-06
|
8.00e-02
|
GOBP SKELETAL MUSCLE SATELLITE CELL MAINTENANCE INVOLVED IN SKELETAL MUSCLE REGENERATION
|
5
|
8.78e-01
|
9.75e-01
|
0.12400
|
7.82e-02
|
9.59e-02
|
7.62e-01
|
7.10e-01
|
GOMF K48 LINKED DEUBIQUITINASE ACTIVITY
|
13
|
7.17e-01
|
9.28e-01
|
0.12400
|
-1.09e-01
|
-5.87e-02
|
4.97e-01
|
7.14e-01
|
GOBP APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT
|
42
|
4.12e-01
|
8.28e-01
|
0.12400
|
-5.08e-02
|
1.13e-01
|
5.69e-01
|
2.06e-01
|
GOBP POSITIVE REGULATION OF SYNAPSE MATURATION
|
9
|
7.91e-01
|
9.54e-01
|
0.12400
|
9.00e-02
|
8.48e-02
|
6.40e-01
|
6.60e-01
|
GOBP INFLAMMASOME MEDIATED SIGNALING PATHWAY
|
39
|
3.64e-01
|
8.05e-01
|
0.12400
|
-7.36e-02
|
-9.93e-02
|
4.26e-01
|
2.83e-01
|
GOBP POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION
|
26
|
5.11e-01
|
8.66e-01
|
0.12400
|
6.80e-02
|
1.03e-01
|
5.49e-01
|
3.62e-01
|
GOBP MONOSACCHARIDE METABOLIC PROCESS
|
248
|
4.45e-03
|
1.36e-01
|
0.12400
|
-1.21e-01
|
2.62e-02
|
1.05e-03
|
4.78e-01
|
GOCC GOLGI STACK
|
128
|
4.68e-02
|
4.37e-01
|
0.12400
|
-1.22e-01
|
-1.83e-02
|
1.70e-02
|
7.20e-01
|
GOBP DENDRITIC CELL CHEMOTAXIS
|
25
|
5.69e-01
|
8.86e-01
|
0.12400
|
-1.44e-02
|
1.23e-01
|
9.01e-01
|
2.88e-01
|
GOBP PHOSPHATIDYLGLYCEROL METABOLIC PROCESS
|
33
|
5.09e-01
|
8.66e-01
|
0.12300
|
-9.76e-02
|
7.56e-02
|
3.32e-01
|
4.52e-01
|
GOBP NEGATIVE ADAPTATION OF SIGNALING PATHWAY
|
18
|
6.57e-01
|
9.09e-01
|
0.12300
|
3.54e-03
|
1.23e-01
|
9.79e-01
|
3.65e-01
|
GOBP GLIAL CELL DEVELOPMENT
|
118
|
9.04e-02
|
5.51e-01
|
0.12300
|
-9.69e-02
|
7.66e-02
|
6.91e-02
|
1.51e-01
|
GOBP ENDOSOMAL TRANSPORT
|
240
|
6.27e-03
|
1.64e-01
|
0.12300
|
-1.16e-01
|
4.34e-02
|
2.03e-03
|
2.47e-01
|
GOBP REGULATION OF KILLING OF CELLS OF ANOTHER ORGANISM
|
11
|
7.89e-01
|
9.54e-01
|
0.12300
|
-1.18e-01
|
3.75e-02
|
4.99e-01
|
8.30e-01
|
GOBP CORTICOTROPIN SECRETION
|
7
|
8.34e-01
|
9.64e-01
|
0.12300
|
-8.58e-02
|
-8.86e-02
|
6.94e-01
|
6.85e-01
|
GOBP NEGATIVE REGULATION OF NATURAL KILLER CELL ACTIVATION
|
10
|
8.11e-01
|
9.59e-01
|
0.12300
|
-1.10e-01
|
5.52e-02
|
5.46e-01
|
7.62e-01
|
GOBP REGULATION OF PROTEIN TARGETING TO MEMBRANE
|
31
|
5.22e-01
|
8.70e-01
|
0.12300
|
-1.12e-01
|
5.18e-02
|
2.81e-01
|
6.18e-01
|
GOBP PEROXISOMAL TRANSPORT
|
22
|
6.39e-01
|
9.06e-01
|
0.12300
|
8.01e-02
|
-9.37e-02
|
5.16e-01
|
4.47e-01
|
GOBP POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION
|
45
|
3.73e-01
|
8.10e-01
|
0.12300
|
-1.20e-01
|
2.67e-02
|
1.63e-01
|
7.57e-01
|
GOBP CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS
|
128
|
6.25e-02
|
4.82e-01
|
0.12300
|
-3.02e-02
|
1.19e-01
|
5.55e-01
|
1.96e-02
|
GOBP REGULATION OF TRANSLATIONAL ELONGATION
|
12
|
7.66e-01
|
9.46e-01
|
0.12300
|
1.94e-02
|
-1.22e-01
|
9.08e-01
|
4.66e-01
|
GOBP RESPONSE TO STARVATION
|
208
|
1.17e-02
|
2.31e-01
|
0.12300
|
-1.18e-01
|
3.43e-02
|
3.27e-03
|
3.94e-01
|
GOMF N ACETYLTRANSFERASE ACTIVITY
|
60
|
2.65e-01
|
7.41e-01
|
0.12300
|
-1.22e-01
|
1.98e-02
|
1.03e-01
|
7.91e-01
|
GOBP AMINE METABOLIC PROCESS
|
107
|
1.09e-01
|
5.84e-01
|
0.12300
|
1.10e-01
|
-5.61e-02
|
5.01e-02
|
3.16e-01
|
GOBP POSITIVE REGULATION OF ERBB SIGNALING PATHWAY
|
29
|
5.25e-01
|
8.71e-01
|
0.12300
|
-1.22e-01
|
1.79e-02
|
2.56e-01
|
8.67e-01
|
GOMF ACTIN MONOMER BINDING
|
24
|
5.39e-01
|
8.78e-01
|
0.12300
|
7.83e-02
|
9.49e-02
|
5.07e-01
|
4.21e-01
|
GOBP RETINAL BLOOD VESSEL MORPHOGENESIS
|
5
|
9.04e-01
|
9.80e-01
|
0.12300
|
8.07e-02
|
-9.28e-02
|
7.55e-01
|
7.19e-01
|
GOBP INOSITOL PHOSPHATE METABOLIC PROCESS
|
42
|
4.17e-01
|
8.31e-01
|
0.12300
|
-1.11e-01
|
5.28e-02
|
2.13e-01
|
5.54e-01
|
GOMF EFFLUX TRANSMEMBRANE TRANSPORTER ACTIVITY
|
15
|
7.35e-01
|
9.34e-01
|
0.12300
|
6.31e-02
|
-1.06e-01
|
6.72e-01
|
4.79e-01
|
GOCC SPLICEOSOMAL COMPLEX
|
183
|
1.01e-02
|
2.15e-01
|
0.12300
|
-5.70e-02
|
-1.09e-01
|
1.84e-01
|
1.10e-02
|
GOMF CATALYTIC ACTIVITY ACTING ON A NUCLEIC ACID
|
600
|
2.90e-07
|
1.17e-04
|
0.12300
|
-8.96e-02
|
-8.41e-02
|
1.76e-04
|
4.32e-04
|
GOBP VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT
|
10
|
8.16e-01
|
9.59e-01
|
0.12300
|
1.01e-01
|
-7.07e-02
|
5.82e-01
|
6.99e-01
|
GOBP POSITIVE REGULATION OF CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION
|
5
|
8.91e-01
|
9.76e-01
|
0.12300
|
-1.23e-01
|
-1.56e-03
|
6.34e-01
|
9.95e-01
|
GOBP NERVE DEVELOPMENT
|
94
|
9.60e-02
|
5.61e-01
|
0.12300
|
5.00e-02
|
1.12e-01
|
4.02e-01
|
6.01e-02
|
GOBP NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS
|
27
|
5.25e-01
|
8.71e-01
|
0.12300
|
-2.07e-02
|
-1.21e-01
|
8.53e-01
|
2.76e-01
|
GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO HYPOXIA
|
11
|
7.54e-01
|
9.42e-01
|
0.12300
|
-9.77e-02
|
-7.44e-02
|
5.75e-01
|
6.69e-01
|
GOMF METAL DEPENDENT DEUBIQUITINASE ACTIVITY
|
10
|
7.87e-01
|
9.53e-01
|
0.12300
|
-1.21e-01
|
-2.30e-02
|
5.09e-01
|
9.00e-01
|
GOBP TRANSFORMING GROWTH FACTOR BETA PRODUCTION
|
42
|
4.29e-01
|
8.36e-01
|
0.12300
|
-9.55e-02
|
7.71e-02
|
2.84e-01
|
3.87e-01
|
GOBP IRON SULFUR CLUSTER ASSEMBLY
|
27
|
5.65e-01
|
8.85e-01
|
0.12300
|
-1.16e-01
|
4.03e-02
|
2.97e-01
|
7.17e-01
|
GOBP ALDITOL BIOSYNTHETIC PROCESS
|
5
|
8.90e-01
|
9.76e-01
|
0.12300
|
-1.22e-01
|
-6.93e-03
|
6.35e-01
|
9.79e-01
|
GOBP T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL
|
9
|
8.28e-01
|
9.62e-01
|
0.12300
|
4.72e-02
|
-1.13e-01
|
8.06e-01
|
5.57e-01
|
GOBP NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND
|
34
|
4.20e-01
|
8.33e-01
|
0.12300
|
-7.26e-02
|
-9.88e-02
|
4.64e-01
|
3.19e-01
|
GOBP CGMP BIOSYNTHETIC PROCESS
|
10
|
7.78e-01
|
9.51e-01
|
0.12300
|
-5.46e-02
|
-1.10e-01
|
7.65e-01
|
5.48e-01
|
GOBP NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING
|
21
|
6.56e-01
|
9.09e-01
|
0.12300
|
-8.78e-02
|
8.55e-02
|
4.86e-01
|
4.98e-01
|
GOBP STEROL METABOLIC PROCESS
|
150
|
2.79e-02
|
3.47e-01
|
0.12300
|
-1.20e-01
|
-2.65e-02
|
1.14e-02
|
5.75e-01
|
GOBP MODIFICATION OF SYNAPTIC STRUCTURE
|
27
|
5.50e-01
|
8.80e-01
|
0.12300
|
1.46e-02
|
-1.22e-01
|
8.96e-01
|
2.74e-01
|
GOBP REGULATION OF CGMP MEDIATED SIGNALING
|
11
|
7.65e-01
|
9.45e-01
|
0.12200
|
1.17e-01
|
3.60e-02
|
5.02e-01
|
8.36e-01
|
GOMF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
143
|
5.57e-02
|
4.63e-01
|
0.12200
|
-6.42e-02
|
1.04e-01
|
1.85e-01
|
3.15e-02
|
GOBP AUTOPHAGY OF MITOCHONDRION
|
90
|
1.55e-01
|
6.42e-01
|
0.12200
|
-1.13e-01
|
4.71e-02
|
6.42e-02
|
4.40e-01
|
GOBP POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT
|
34
|
4.55e-01
|
8.47e-01
|
0.12200
|
9.15e-03
|
1.22e-01
|
9.26e-01
|
2.18e-01
|
GOBP EPINEPHRINE TRANSPORT
|
11
|
7.87e-01
|
9.53e-01
|
0.12200
|
-2.24e-02
|
1.20e-01
|
8.98e-01
|
4.90e-01
|
GOBP GALACTOLIPID BIOSYNTHETIC PROCESS
|
6
|
8.79e-01
|
9.75e-01
|
0.12200
|
-2.92e-02
|
1.19e-01
|
9.01e-01
|
6.15e-01
|
GOBP CYCLIC NUCLEOTIDE CATABOLIC PROCESS
|
14
|
7.17e-01
|
9.28e-01
|
0.12200
|
1.20e-01
|
2.41e-02
|
4.37e-01
|
8.76e-01
|
GOMF SUPEROXIDE GENERATING NADPH OXIDASE ACTIVATOR ACTIVITY
|
7
|
8.66e-01
|
9.70e-01
|
0.12200
|
-5.62e-02
|
1.09e-01
|
7.97e-01
|
6.19e-01
|
GOCC RUFFLE
|
178
|
2.90e-02
|
3.54e-01
|
0.12200
|
-7.63e-02
|
9.55e-02
|
7.90e-02
|
2.80e-02
|
GOBP CARDIAC MUSCLE CONTRACTION
|
131
|
3.64e-02
|
3.89e-01
|
0.12200
|
7.72e-02
|
9.47e-02
|
1.27e-01
|
6.12e-02
|
GOBP MATURE CONVENTIONAL DENDRITIC CELL DIFFERENTIATION
|
5
|
8.82e-01
|
9.75e-01
|
0.12200
|
-6.07e-02
|
-1.06e-01
|
8.14e-01
|
6.81e-01
|
GOBP POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS
|
8
|
8.34e-01
|
9.64e-01
|
0.12200
|
-6.93e-04
|
1.22e-01
|
9.97e-01
|
5.50e-01
|
GOMF PROTEIN KINASE B BINDING
|
10
|
8.08e-01
|
9.59e-01
|
0.12200
|
-1.18e-01
|
2.98e-02
|
5.17e-01
|
8.70e-01
|
GOMF SPECTRIN BINDING
|
26
|
5.69e-01
|
8.86e-01
|
0.12200
|
-2.20e-02
|
1.20e-01
|
8.46e-01
|
2.89e-01
|
GOBP TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION
|
15
|
7.26e-01
|
9.30e-01
|
0.12200
|
-1.18e-01
|
3.01e-02
|
4.28e-01
|
8.40e-01
|
GOBP MAMMARY GLAND EPITHELIAL CELL PROLIFERATION
|
26
|
5.23e-01
|
8.70e-01
|
0.12200
|
-1.06e-01
|
-5.98e-02
|
3.48e-01
|
5.98e-01
|
GOBP REGULATION OF CYTOKINESIS
|
87
|
1.62e-01
|
6.48e-01
|
0.12200
|
-1.16e-01
|
3.86e-02
|
6.23e-02
|
5.33e-01
|
GOMF LAMIN BINDING
|
15
|
7.18e-01
|
9.29e-01
|
0.12200
|
-1.21e-01
|
1.23e-02
|
4.16e-01
|
9.34e-01
|
GOBP PENTOSE METABOLIC PROCESS
|
11
|
7.79e-01
|
9.51e-01
|
0.12200
|
-1.22e-01
|
-3.34e-03
|
4.84e-01
|
9.85e-01
|
GOBP MITOCHONDRION MORPHOGENESIS
|
20
|
6.03e-01
|
8.96e-01
|
0.12200
|
-7.71e-02
|
-9.44e-02
|
5.51e-01
|
4.65e-01
|
GOBP POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS
|
26
|
5.33e-01
|
8.76e-01
|
0.12200
|
3.85e-02
|
1.16e-01
|
7.34e-01
|
3.08e-01
|
GOBP MESENCHYME MORPHOGENESIS
|
60
|
2.78e-01
|
7.51e-01
|
0.12200
|
-2.64e-02
|
1.19e-01
|
7.23e-01
|
1.11e-01
|
GOBP REGULATION OF FIBRINOLYSIS
|
18
|
6.55e-01
|
9.09e-01
|
0.12200
|
-2.09e-02
|
-1.20e-01
|
8.78e-01
|
3.78e-01
|
GOBP OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS
|
20
|
6.08e-01
|
8.97e-01
|
0.12200
|
-1.06e-01
|
-5.95e-02
|
4.11e-01
|
6.45e-01
|
GOBP POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS
|
16
|
7.16e-01
|
9.28e-01
|
0.12200
|
-3.89e-02
|
1.15e-01
|
7.88e-01
|
4.24e-01
|
GOMF TYPE I TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING
|
11
|
7.71e-01
|
9.48e-01
|
0.12200
|
-1.19e-01
|
-2.49e-02
|
4.94e-01
|
8.86e-01
|
GOMF TRANSFERASE ACTIVITY TRANSFERRING ONE CARBON GROUPS
|
211
|
6.14e-03
|
1.63e-01
|
0.12200
|
-1.14e-01
|
-4.38e-02
|
4.48e-03
|
2.73e-01
|
GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT
|
156
|
2.14e-02
|
3.10e-01
|
0.12200
|
1.07e-01
|
5.75e-02
|
2.08e-02
|
2.15e-01
|
GOCC NUCLEAR ENVELOPE LUMEN
|
10
|
8.14e-01
|
9.59e-01
|
0.12100
|
-1.13e-01
|
4.45e-02
|
5.36e-01
|
8.07e-01
|
GOBP IODIDE TRANSPORT
|
9
|
8.13e-01
|
9.59e-01
|
0.12100
|
-1.16e-02
|
-1.21e-01
|
9.52e-01
|
5.30e-01
|
GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY
|
19
|
6.85e-01
|
9.18e-01
|
0.12100
|
1.01e-01
|
-6.80e-02
|
4.48e-01
|
6.08e-01
|
GOCC TERTIARY GRANULE LUMEN
|
53
|
2.66e-01
|
7.42e-01
|
0.12100
|
-9.83e-02
|
-7.13e-02
|
2.16e-01
|
3.69e-01
|
GOBP PHOSPHOLIPID METABOLIC PROCESS
|
363
|
7.31e-04
|
4.25e-02
|
0.12100
|
-1.08e-01
|
5.62e-02
|
4.25e-04
|
6.60e-02
|
GOBP SNRNA METABOLIC PROCESS
|
53
|
2.94e-01
|
7.64e-01
|
0.12100
|
-1.57e-02
|
-1.20e-01
|
8.43e-01
|
1.29e-01
|
GOBP REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT
|
55
|
2.67e-01
|
7.42e-01
|
0.12100
|
3.89e-02
|
1.15e-01
|
6.18e-01
|
1.40e-01
|
GOBP MONOCYTE DIFFERENTIATION
|
34
|
5.08e-01
|
8.66e-01
|
0.12100
|
-6.55e-02
|
1.02e-01
|
5.09e-01
|
3.02e-01
|
GOBP ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION
|
21
|
6.31e-01
|
9.03e-01
|
0.12100
|
1.05e-02
|
-1.21e-01
|
9.34e-01
|
3.37e-01
|
GOBP PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS
|
85
|
1.25e-01
|
6.06e-01
|
0.12100
|
-1.10e-01
|
-5.23e-02
|
8.09e-02
|
4.05e-01
|
GOBP MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM
|
12
|
7.63e-01
|
9.45e-01
|
0.12100
|
-1.21e-01
|
-3.21e-03
|
4.67e-01
|
9.85e-01
|
GOBP CONSTITUTIVE HETEROCHROMATIN FORMATION
|
11
|
7.71e-01
|
9.48e-01
|
0.12100
|
-1.18e-01
|
-2.96e-02
|
4.99e-01
|
8.65e-01
|
GOBP RESPONSE TO INDOLE 3 METHANOL
|
6
|
8.88e-01
|
9.76e-01
|
0.12100
|
-7.26e-02
|
9.72e-02
|
7.58e-01
|
6.80e-01
|
GOBP NEGATIVE REGULATION OF B CELL ACTIVATION
|
30
|
5.50e-01
|
8.80e-01
|
0.12100
|
-6.55e-02
|
1.02e-01
|
5.35e-01
|
3.33e-01
|
GOBP REGULATION OF AUTOPHAGOSOME MATURATION
|
16
|
7.01e-01
|
9.22e-01
|
0.12100
|
-3.84e-03
|
1.21e-01
|
9.79e-01
|
4.01e-01
|
GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS
|
47
|
3.55e-01
|
7.97e-01
|
0.12100
|
1.21e-01
|
-6.41e-03
|
1.51e-01
|
9.39e-01
|
GOMF TAT PROTEIN BINDING
|
10
|
8.21e-01
|
9.60e-01
|
0.12100
|
9.22e-02
|
-7.88e-02
|
6.14e-01
|
6.66e-01
|
GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT
|
25
|
5.35e-01
|
8.76e-01
|
0.12100
|
-9.07e-02
|
-8.04e-02
|
4.32e-01
|
4.86e-01
|
GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY
|
57
|
3.22e-01
|
7.79e-01
|
0.12100
|
-6.34e-02
|
1.03e-01
|
4.08e-01
|
1.77e-01
|
GOBP CENTRAL NERVOUS SYSTEM MYELIN MAINTENANCE
|
5
|
9.06e-01
|
9.81e-01
|
0.12100
|
-8.85e-02
|
8.28e-02
|
7.32e-01
|
7.49e-01
|
GOBP POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION
|
42
|
4.27e-01
|
8.36e-01
|
0.12100
|
-1.10e-01
|
4.97e-02
|
2.15e-01
|
5.78e-01
|
GOCC ENDOCYTIC VESICLE LUMEN
|
23
|
6.33e-01
|
9.03e-01
|
0.12100
|
-6.43e-02
|
1.03e-01
|
5.94e-01
|
3.94e-01
|
GOBP REGULATION OF PROSTATIC BUD FORMATION
|
5
|
9.04e-01
|
9.80e-01
|
0.12100
|
-1.09e-01
|
5.36e-02
|
6.74e-01
|
8.36e-01
|
GOMF PALMITOYL COA HYDROLASE ACTIVITY
|
15
|
7.13e-01
|
9.27e-01
|
0.12100
|
-1.21e-01
|
-6.75e-03
|
4.18e-01
|
9.64e-01
|
GOMF ACYLTRANSFERASE ACTIVITY TRANSFERRING GROUPS OTHER THAN AMINO ACYL GROUPS
|
205
|
1.22e-02
|
2.37e-01
|
0.12100
|
-1.20e-01
|
1.33e-02
|
2.99e-03
|
7.43e-01
|
GOBP ANTIFUNGAL INNATE IMMUNE RESPONSE
|
19
|
6.70e-01
|
9.11e-01
|
0.12100
|
-1.18e-01
|
2.72e-02
|
3.74e-01
|
8.37e-01
|
GOBP POSITIVE REGULATION OF DENDRITIC SPINE MAINTENANCE
|
5
|
8.96e-01
|
9.78e-01
|
0.12100
|
-1.21e-01
|
5.45e-03
|
6.40e-01
|
9.83e-01
|
GOBP PROTEIN LOCALIZATION TO AXON
|
9
|
8.38e-01
|
9.64e-01
|
0.12100
|
9.64e-02
|
-7.29e-02
|
6.16e-01
|
7.05e-01
|
GOBP CARDIAC CONDUCTION
|
94
|
1.01e-01
|
5.71e-01
|
0.12100
|
1.07e-01
|
5.61e-02
|
7.28e-02
|
3.47e-01
|
GOBP CONVERGENT EXTENSION INVOLVED IN ORGANOGENESIS
|
5
|
8.84e-01
|
9.76e-01
|
0.12100
|
-9.97e-02
|
-6.82e-02
|
6.99e-01
|
7.92e-01
|
GOBP REGULATION OF CALCINEURIN MEDIATED SIGNALING
|
41
|
4.09e-01
|
8.27e-01
|
0.12100
|
-8.03e-03
|
1.20e-01
|
9.29e-01
|
1.82e-01
|
GOBP PEPTIDYL METHIONINE MODIFICATION
|
12
|
7.45e-01
|
9.38e-01
|
0.12100
|
-1.05e-01
|
-5.98e-02
|
5.29e-01
|
7.20e-01
|
GOMF DNA HELICASE ACTIVITY
|
58
|
2.56e-01
|
7.35e-01
|
0.12100
|
-3.19e-02
|
-1.16e-01
|
6.74e-01
|
1.25e-01
|
GOBP POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION
|
21
|
6.00e-01
|
8.96e-01
|
0.12100
|
-1.08e-01
|
-5.34e-02
|
3.90e-01
|
6.72e-01
|
GOBP BASE EXCISION REPAIR AP SITE FORMATION
|
12
|
7.91e-01
|
9.54e-01
|
0.12100
|
9.34e-02
|
-7.65e-02
|
5.75e-01
|
6.46e-01
|
GOBP REGULATION OF CORTICOTROPIN SECRETION
|
5
|
8.94e-01
|
9.77e-01
|
0.12100
|
-1.21e-01
|
-5.60e-03
|
6.41e-01
|
9.83e-01
|
GOBP SNRNA PROCESSING
|
25
|
5.42e-01
|
8.78e-01
|
0.12100
|
-6.34e-02
|
-1.03e-01
|
5.83e-01
|
3.75e-01
|
GOBP LUTEINIZING HORMONE SECRETION
|
10
|
8.10e-01
|
9.59e-01
|
0.12100
|
2.40e-02
|
-1.18e-01
|
8.95e-01
|
5.17e-01
|
GOBP REGULATION OF PHAGOCYTOSIS
|
94
|
9.80e-02
|
5.63e-01
|
0.12100
|
-8.91e-02
|
-8.13e-02
|
1.35e-01
|
1.73e-01
|
GOBP CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION
|
10
|
7.99e-01
|
9.56e-01
|
0.12100
|
-1.20e-01
|
-6.59e-03
|
5.10e-01
|
9.71e-01
|
GOBP AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM
|
25
|
6.14e-01
|
8.99e-01
|
0.12100
|
-7.63e-02
|
9.33e-02
|
5.09e-01
|
4.19e-01
|
GOMF UBIQUINONE BINDING
|
5
|
8.88e-01
|
9.76e-01
|
0.12100
|
-1.13e-01
|
-4.09e-02
|
6.60e-01
|
8.74e-01
|
GOBP REGULATION OF HEART CONTRACTION
|
199
|
8.09e-03
|
1.88e-01
|
0.12100
|
1.05e-01
|
5.95e-02
|
1.08e-02
|
1.48e-01
|
GOBP ATTACHMENT OF GPI ANCHOR TO PROTEIN
|
6
|
8.64e-01
|
9.70e-01
|
0.12100
|
-5.80e-02
|
-1.06e-01
|
8.06e-01
|
6.54e-01
|
GOBP MOLTING CYCLE PROCESS
|
93
|
1.41e-01
|
6.25e-01
|
0.12000
|
-2.13e-02
|
1.19e-01
|
7.23e-01
|
4.81e-02
|
GOBP GLYCOSYLATION
|
214
|
8.65e-03
|
1.95e-01
|
0.12000
|
-1.20e-01
|
-7.09e-03
|
2.42e-03
|
8.58e-01
|
GOBP NEGATIVE REGULATION OF LIPID TRANSPORT
|
48
|
3.13e-01
|
7.76e-01
|
0.12000
|
-1.07e-01
|
-5.55e-02
|
2.00e-01
|
5.06e-01
|
GOBP DELAMINATION
|
7
|
8.65e-01
|
9.70e-01
|
0.12000
|
-3.21e-02
|
1.16e-01
|
8.83e-01
|
5.95e-01
|
GOBP DNA CATABOLIC PROCESS
|
29
|
5.69e-01
|
8.86e-01
|
0.12000
|
-7.50e-02
|
9.42e-02
|
4.84e-01
|
3.80e-01
|
GOCC PHOSPHOLIPID TRANSLOCATING ATPASE COMPLEX
|
13
|
7.38e-01
|
9.35e-01
|
0.12000
|
-1.16e-01
|
-3.07e-02
|
4.67e-01
|
8.48e-01
|
GOBP CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE
|
118
|
7.74e-02
|
5.24e-01
|
0.12000
|
-1.20e-01
|
5.84e-03
|
2.40e-02
|
9.13e-01
|
GOMF TASTE RECEPTOR ACTIVITY
|
30
|
5.16e-01
|
8.69e-01
|
0.12000
|
-1.20e-01
|
-2.91e-04
|
2.54e-01
|
9.98e-01
|
GOMF GLUTAMATE RECEPTOR BINDING
|
42
|
4.23e-01
|
8.34e-01
|
0.12000
|
-1.15e-01
|
3.57e-02
|
1.97e-01
|
6.89e-01
|
GOMF GABA RECEPTOR BINDING
|
18
|
6.62e-01
|
9.10e-01
|
0.12000
|
-1.19e-01
|
-2.01e-02
|
3.83e-01
|
8.82e-01
|
GOBP NEGATIVE REGULATION OF DNA METABOLIC PROCESS
|
135
|
4.32e-02
|
4.26e-01
|
0.12000
|
-1.16e-01
|
-3.21e-02
|
2.00e-02
|
5.20e-01
|
GOBP NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION
|
21
|
6.57e-01
|
9.09e-01
|
0.12000
|
1.10e-01
|
-4.90e-02
|
3.83e-01
|
6.97e-01
|
GOBP AMYLOID BETA CLEARANCE BY TRANSCYTOSIS
|
7
|
8.55e-01
|
9.68e-01
|
0.12000
|
-1.20e-01
|
-6.94e-03
|
5.82e-01
|
9.75e-01
|
GOCC COMMITMENT COMPLEX
|
5
|
9.06e-01
|
9.81e-01
|
0.12000
|
-5.72e-02
|
1.06e-01
|
8.25e-01
|
6.82e-01
|
GOBP OVULATION CYCLE
|
72
|
2.32e-01
|
7.18e-01
|
0.12000
|
-1.14e-01
|
3.90e-02
|
9.51e-02
|
5.67e-01
|
GOBP POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS
|
65
|
2.83e-01
|
7.56e-01
|
0.12000
|
7.25e-02
|
-9.60e-02
|
3.12e-01
|
1.81e-01
|
GOBP REGULATION OF HOMOPHILIC CELL ADHESION
|
5
|
8.84e-01
|
9.76e-01
|
0.12000
|
8.48e-02
|
8.52e-02
|
7.43e-01
|
7.41e-01
|
GOBP SHORT CHAIN FATTY ACID METABOLIC PROCESS
|
16
|
7.00e-01
|
9.22e-01
|
0.12000
|
-1.20e-01
|
-7.24e-03
|
4.06e-01
|
9.60e-01
|
GOBP OPSONIZATION
|
16
|
6.77e-01
|
9.14e-01
|
0.12000
|
1.01e-01
|
6.51e-02
|
4.84e-01
|
6.52e-01
|
GOBP NCRNA METABOLIC PROCESS
|
605
|
6.01e-07
|
2.05e-04
|
0.12000
|
-1.03e-01
|
-6.23e-02
|
1.58e-05
|
8.87e-03
|
GOBP REGULATION OF PROTEIN AUTOPHOSPHORYLATION
|
39
|
4.43e-01
|
8.40e-01
|
0.12000
|
2.40e-02
|
-1.18e-01
|
7.96e-01
|
2.03e-01
|
GOBP RETROGRADE TRANSPORT ENDOSOME TO GOLGI
|
94
|
1.43e-01
|
6.28e-01
|
0.12000
|
-1.17e-01
|
2.81e-02
|
5.03e-02
|
6.38e-01
|
GOBP EPITHELIAL CELL FATE COMMITMENT
|
14
|
7.63e-01
|
9.45e-01
|
0.12000
|
8.67e-02
|
-8.31e-02
|
5.74e-01
|
5.90e-01
|
GOBP GRANULOCYTE MIGRATION
|
146
|
5.99e-02
|
4.77e-01
|
0.12000
|
-7.12e-02
|
9.67e-02
|
1.37e-01
|
4.38e-02
|
GOBP SEROTONIN RECEPTOR SIGNALING PATHWAY
|
27
|
5.80e-01
|
8.90e-01
|
0.12000
|
-4.14e-02
|
1.13e-01
|
7.09e-01
|
3.11e-01
|
GOBP POSITIVE REGULATION OF ODONTOGENESIS
|
7
|
8.64e-01
|
9.70e-01
|
0.12000
|
-2.57e-02
|
1.17e-01
|
9.06e-01
|
5.91e-01
|
GOBP NEGATIVE REGULATION OF VIRAL LIFE CYCLE
|
26
|
5.42e-01
|
8.78e-01
|
0.12000
|
1.13e-01
|
3.98e-02
|
3.18e-01
|
7.25e-01
|
GOBP TERMINATION OF RNA POLYMERASE II TRANSCRIPTION
|
10
|
7.83e-01
|
9.52e-01
|
0.12000
|
-7.50e-02
|
-9.37e-02
|
6.81e-01
|
6.08e-01
|
GOBP CELLULAR RESPONSE TO NITROSATIVE STRESS
|
6
|
8.63e-01
|
9.69e-01
|
0.12000
|
-7.77e-02
|
-9.15e-02
|
7.42e-01
|
6.98e-01
|
GOBP NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION
|
62
|
2.50e-01
|
7.28e-01
|
0.12000
|
-1.20e-01
|
-1.08e-02
|
1.04e-01
|
8.83e-01
|
GOBP VASODILATION
|
46
|
4.13e-01
|
8.29e-01
|
0.12000
|
8.07e-02
|
-8.87e-02
|
3.43e-01
|
2.98e-01
|
GOCC CLATHRIN COAT
|
47
|
4.02e-01
|
8.26e-01
|
0.12000
|
-9.84e-02
|
6.86e-02
|
2.43e-01
|
4.16e-01
|
GOBP CHONDROCYTE HYPERTROPHY
|
6
|
8.63e-01
|
9.69e-01
|
0.12000
|
7.49e-02
|
9.37e-02
|
7.51e-01
|
6.91e-01
|
GOBP PROTEIN O LINKED GLYCOSYLATION VIA THREONINE
|
10
|
8.23e-01
|
9.61e-01
|
0.12000
|
-1.02e-01
|
6.24e-02
|
5.75e-01
|
7.33e-01
|
GOBP DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING
|
65
|
2.06e-01
|
6.95e-01
|
0.12000
|
-9.61e-02
|
-7.17e-02
|
1.80e-01
|
3.18e-01
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS NAD OR NADP AS ACCEPTOR
|
38
|
4.32e-01
|
8.37e-01
|
0.12000
|
-5.40e-03
|
-1.20e-01
|
9.54e-01
|
2.02e-01
|
GOMF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY INVOLVED IN VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL REPOLARIZATION
|
11
|
7.97e-01
|
9.56e-01
|
0.12000
|
-2.97e-02
|
1.16e-01
|
8.65e-01
|
5.05e-01
|
GOBP NEGATIVE REGULATION OF TRANSPORTER ACTIVITY
|
93
|
1.42e-01
|
6.26e-01
|
0.12000
|
-1.76e-02
|
1.19e-01
|
7.69e-01
|
4.82e-02
|
GOMF TRANSMEMBRANE EPHRIN RECEPTOR ACTIVITY
|
15
|
7.39e-01
|
9.35e-01
|
0.12000
|
4.15e-02
|
-1.12e-01
|
7.81e-01
|
4.51e-01
|
GOCC TERTIARY GRANULE MEMBRANE
|
69
|
2.62e-01
|
7.39e-01
|
0.12000
|
-1.02e-01
|
6.20e-02
|
1.41e-01
|
3.73e-01
|
GOBP CELLULAR RESPONSE TO VITAMIN D
|
21
|
6.22e-01
|
9.01e-01
|
0.12000
|
1.85e-02
|
1.18e-01
|
8.84e-01
|
3.48e-01
|
GOMF CARDIOLIPIN BINDING
|
11
|
7.83e-01
|
9.52e-01
|
0.12000
|
1.07e-02
|
1.19e-01
|
9.51e-01
|
4.93e-01
|
GOBP VACUOLAR LOCALIZATION
|
82
|
1.73e-01
|
6.61e-01
|
0.12000
|
-7.67e-03
|
1.19e-01
|
9.04e-01
|
6.15e-02
|
GOBP DETECTION OF TEMPERATURE STIMULUS
|
24
|
5.99e-01
|
8.95e-01
|
0.12000
|
1.19e-01
|
-9.42e-03
|
3.12e-01
|
9.36e-01
|
GOBP REGULATION OF MICROTUBULE POLYMERIZATION
|
59
|
2.96e-01
|
7.65e-01
|
0.12000
|
-1.17e-01
|
2.51e-02
|
1.20e-01
|
7.38e-01
|
GOBP REGULATION OF ANIMAL ORGAN MORPHOGENESIS
|
121
|
7.74e-02
|
5.24e-01
|
0.12000
|
-1.16e-02
|
1.19e-01
|
8.26e-01
|
2.37e-02
|
GOBP NEUTRAL LIPID METABOLIC PROCESS
|
127
|
8.71e-02
|
5.46e-01
|
0.12000
|
-9.97e-02
|
6.60e-02
|
5.23e-02
|
1.99e-01
|
GOMF MICROFILAMENT MOTOR ACTIVITY
|
37
|
4.17e-01
|
8.31e-01
|
0.12000
|
1.09e-01
|
4.82e-02
|
2.50e-01
|
6.12e-01
|
GOBP RESPONSE TO PROSTAGLANDIN E
|
23
|
6.32e-01
|
9.03e-01
|
0.12000
|
4.39e-02
|
-1.11e-01
|
7.16e-01
|
3.56e-01
|
GOBP NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION
|
44
|
3.97e-01
|
8.25e-01
|
0.11900
|
-1.58e-02
|
1.18e-01
|
8.56e-01
|
1.74e-01
|
GOMF SODIUM PHOSPHATE SYMPORTER ACTIVITY
|
13
|
7.77e-01
|
9.50e-01
|
0.11900
|
1.02e-01
|
-6.26e-02
|
5.25e-01
|
6.96e-01
|
GOBP MONOCYTE CHEMOTAXIS
|
67
|
2.57e-01
|
7.35e-01
|
0.11900
|
-1.15e-01
|
3.21e-02
|
1.03e-01
|
6.50e-01
|
GOBP POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS
|
52
|
3.70e-01
|
8.09e-01
|
0.11900
|
-9.69e-02
|
6.96e-02
|
2.27e-01
|
3.86e-01
|
GOBP PIRNA PROCESSING
|
24
|
5.77e-01
|
8.89e-01
|
0.11900
|
2.98e-02
|
1.15e-01
|
8.00e-01
|
3.28e-01
|
GOMF THIOLESTER HYDROLASE ACTIVITY
|
37
|
4.44e-01
|
8.40e-01
|
0.11900
|
-1.19e-01
|
-7.69e-03
|
2.10e-01
|
9.35e-01
|
GOBP CARDIAC MUSCLE CELL ACTION POTENTIAL
|
72
|
1.76e-01
|
6.65e-01
|
0.11900
|
9.10e-02
|
7.70e-02
|
1.82e-01
|
2.58e-01
|
GOBP INSEMINATION
|
12
|
7.70e-01
|
9.48e-01
|
0.11900
|
2.82e-03
|
1.19e-01
|
9.87e-01
|
4.75e-01
|
GOBP REGULATION OF EXCITATORY SYNAPSE ASSEMBLY
|
15
|
7.47e-01
|
9.39e-01
|
0.11900
|
-1.05e-01
|
5.62e-02
|
4.81e-01
|
7.06e-01
|
GOBP SNO S RNA METABOLIC PROCESS
|
15
|
7.33e-01
|
9.33e-01
|
0.11900
|
-1.17e-01
|
2.00e-02
|
4.31e-01
|
8.93e-01
|
GOBP MITOCHONDRIAL MEMBRANE ORGANIZATION
|
113
|
6.95e-02
|
5.02e-01
|
0.11900
|
-5.36e-02
|
-1.06e-01
|
3.25e-01
|
5.07e-02
|
GOBP GRANULOCYTE CHEMOTAXIS
|
123
|
8.78e-02
|
5.47e-01
|
0.11900
|
-4.20e-02
|
1.11e-01
|
4.21e-01
|
3.27e-02
|
GOBP ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT
|
15
|
7.06e-01
|
9.24e-01
|
0.11900
|
-3.88e-02
|
-1.13e-01
|
7.95e-01
|
4.50e-01
|
GOBP CELLULAR RESPIRATION
|
216
|
6.51e-03
|
1.67e-01
|
0.11900
|
-4.79e-02
|
-1.09e-01
|
2.25e-01
|
5.72e-03
|
GOBP MONOCYTE EXTRAVASATION
|
10
|
8.12e-01
|
9.59e-01
|
0.11900
|
-1.65e-02
|
1.18e-01
|
9.28e-01
|
5.18e-01
|
GOBP TYPE II PNEUMOCYTE DIFFERENTIATION
|
6
|
8.73e-01
|
9.73e-01
|
0.11900
|
-2.59e-02
|
-1.16e-01
|
9.12e-01
|
6.22e-01
|
GOBP CYTOKINESIS
|
178
|
3.40e-02
|
3.76e-01
|
0.11900
|
-9.84e-02
|
6.71e-02
|
2.36e-02
|
1.22e-01
|
GOBP LENS DEVELOPMENT IN CAMERA TYPE EYE
|
84
|
1.93e-01
|
6.85e-01
|
0.11900
|
-4.76e-02
|
1.09e-01
|
4.50e-01
|
8.38e-02
|
GOBP ENDOMEMBRANE SYSTEM ORGANIZATION
|
562
|
2.13e-05
|
2.90e-03
|
0.11900
|
-1.09e-01
|
4.84e-02
|
1.04e-05
|
4.96e-02
|
GOCC TIGHT JUNCTION
|
122
|
6.40e-02
|
4.87e-01
|
0.11900
|
1.16e-01
|
2.55e-02
|
2.66e-02
|
6.27e-01
|
GOBP CALCIUM ION TRANSPORT
|
427
|
9.88e-05
|
9.19e-03
|
0.11900
|
1.07e-02
|
1.19e-01
|
7.05e-01
|
2.66e-05
|
GOBP NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA
|
19
|
6.38e-01
|
9.06e-01
|
0.11900
|
-1.06e-01
|
-5.34e-02
|
4.22e-01
|
6.87e-01
|
GOBP NEGATIVE REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION
|
189
|
1.41e-02
|
2.57e-01
|
0.11900
|
-2.89e-02
|
-1.15e-01
|
4.94e-01
|
6.23e-03
|
GOBP GLOMERULAR EPITHELIAL CELL DEVELOPMENT
|
12
|
7.73e-01
|
9.49e-01
|
0.11900
|
-1.98e-03
|
1.19e-01
|
9.91e-01
|
4.76e-01
|
GOCC HISTONE METHYLTRANSFERASE COMPLEX
|
57
|
3.20e-01
|
7.78e-01
|
0.11900
|
-1.14e-01
|
3.49e-02
|
1.38e-01
|
6.49e-01
|
GOBP REGULATION OF ICOSANOID SECRETION
|
20
|
6.23e-01
|
9.01e-01
|
0.11900
|
1.05e-01
|
5.55e-02
|
4.16e-01
|
6.67e-01
|
GOBP CIRCADIAN REGULATION OF GENE EXPRESSION
|
66
|
2.14e-01
|
7.03e-01
|
0.11900
|
-1.09e-01
|
-4.83e-02
|
1.27e-01
|
4.98e-01
|
GOBP REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS
|
41
|
4.02e-01
|
8.26e-01
|
0.11900
|
-1.18e-01
|
-1.78e-02
|
1.93e-01
|
8.43e-01
|
GOBP MESENCHYMAL EPITHELIAL CELL SIGNALING
|
7
|
8.75e-01
|
9.75e-01
|
0.11900
|
9.75e-02
|
-6.80e-02
|
6.55e-01
|
7.55e-01
|
GOMF FK506 BINDING
|
10
|
8.27e-01
|
9.62e-01
|
0.11900
|
6.64e-02
|
-9.85e-02
|
7.16e-01
|
5.90e-01
|
GOMF NEUROPEPTIDE ACTIVITY
|
29
|
5.77e-01
|
8.89e-01
|
0.11900
|
-7.20e-02
|
9.45e-02
|
5.02e-01
|
3.79e-01
|
GOBP REGULATION OF STRIATED MUSCLE CONTRACTION
|
92
|
1.11e-01
|
5.87e-01
|
0.11900
|
9.09e-02
|
7.64e-02
|
1.32e-01
|
2.05e-01
|
GOBP FACULTATIVE HETEROCHROMATIN FORMATION
|
40
|
4.00e-01
|
8.25e-01
|
0.11900
|
-3.64e-02
|
-1.13e-01
|
6.91e-01
|
2.16e-01
|
GOBP REGULATION OF NEURON PROJECTION ARBORIZATION
|
14
|
7.66e-01
|
9.46e-01
|
0.11900
|
-9.81e-02
|
6.69e-02
|
5.25e-01
|
6.65e-01
|
GOMF PROTEIN KINASE A BINDING
|
49
|
3.96e-01
|
8.24e-01
|
0.11900
|
-7.04e-02
|
9.55e-02
|
3.94e-01
|
2.47e-01
|
GOBP REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS
|
54
|
2.80e-01
|
7.52e-01
|
0.11900
|
-1.03e-01
|
-5.89e-02
|
1.90e-01
|
4.54e-01
|
GOBP REGULATION OF BLOOD VOLUME BY RENIN ANGIOTENSIN
|
6
|
8.89e-01
|
9.76e-01
|
0.11900
|
-4.29e-02
|
1.11e-01
|
8.55e-01
|
6.39e-01
|
GOBP NEGATIVE REGULATION OF CELL KILLING
|
28
|
5.37e-01
|
8.78e-01
|
0.11900
|
-1.17e-01
|
-1.89e-02
|
2.84e-01
|
8.63e-01
|
GOBP FATTY ACID BIOSYNTHETIC PROCESS
|
160
|
3.17e-02
|
3.65e-01
|
0.11900
|
-1.18e-01
|
-7.55e-03
|
9.81e-03
|
8.69e-01
|
GOBP RNA IMPORT INTO MITOCHONDRION
|
5
|
9.06e-01
|
9.81e-01
|
0.11900
|
1.12e-01
|
-3.89e-02
|
6.65e-01
|
8.80e-01
|
GOBP POSITIVE REGULATION OF RESPIRATORY BURST
|
7
|
8.53e-01
|
9.67e-01
|
0.11900
|
1.14e-01
|
3.27e-02
|
6.02e-01
|
8.81e-01
|
GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO WOUNDING
|
9
|
8.37e-01
|
9.64e-01
|
0.11900
|
-1.12e-01
|
3.77e-02
|
5.59e-01
|
8.45e-01
|
GOCC PROTON TRANSPORTING V TYPE ATPASE V1 DOMAIN
|
11
|
7.90e-01
|
9.54e-01
|
0.11800
|
-1.18e-01
|
-1.07e-03
|
4.96e-01
|
9.95e-01
|
GOCC DENSE CORE GRANULE
|
38
|
4.67e-01
|
8.51e-01
|
0.11800
|
-1.14e-01
|
3.06e-02
|
2.22e-01
|
7.44e-01
|
GOBP PROTEIN POLYMERIZATION
|
272
|
5.83e-03
|
1.60e-01
|
0.11800
|
-5.85e-02
|
1.03e-01
|
9.67e-02
|
3.45e-03
|
GOBP REGULATION OF FATTY ACID METABOLIC PROCESS
|
95
|
1.54e-01
|
6.41e-01
|
0.11800
|
-1.12e-01
|
3.89e-02
|
5.94e-02
|
5.12e-01
|
GOBP SEGMENTATION
|
99
|
1.51e-01
|
6.38e-01
|
0.11800
|
-5.68e-02
|
1.04e-01
|
3.28e-01
|
7.39e-02
|
GOMF SOLUTE PROTON SYMPORTER ACTIVITY
|
24
|
5.84e-01
|
8.90e-01
|
0.11800
|
2.54e-02
|
1.16e-01
|
8.29e-01
|
3.27e-01
|
GOMF SCAVENGER RECEPTOR ACTIVITY
|
27
|
5.79e-01
|
8.89e-01
|
0.11800
|
-1.16e-01
|
2.47e-02
|
2.98e-01
|
8.24e-01
|
GOBP TELOMERE LOCALIZATION
|
12
|
7.65e-01
|
9.45e-01
|
0.11800
|
2.36e-02
|
1.16e-01
|
8.87e-01
|
4.87e-01
|
GOBP INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION
|
45
|
3.44e-01
|
7.95e-01
|
0.11800
|
6.90e-02
|
9.62e-02
|
4.23e-01
|
2.64e-01
|
GOBP BENZENE CONTAINING COMPOUND METABOLIC PROCESS
|
26
|
6.10e-01
|
8.98e-01
|
0.11800
|
1.01e-01
|
-6.13e-02
|
3.72e-01
|
5.89e-01
|
GOMF TRANSFERASE ACTIVITY TRANSFERRING SULPHUR CONTAINING GROUPS
|
66
|
2.90e-01
|
7.61e-01
|
0.11800
|
-7.10e-02
|
9.46e-02
|
3.18e-01
|
1.84e-01
|
GOBP NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE
|
22
|
6.48e-01
|
9.07e-01
|
0.11800
|
-1.12e-01
|
3.67e-02
|
3.62e-01
|
7.66e-01
|
GOBP LUNG ALVEOLUS DEVELOPMENT
|
47
|
3.49e-01
|
7.96e-01
|
0.11800
|
-1.15e-01
|
-2.81e-02
|
1.73e-01
|
7.39e-01
|
GOCC CELL DIVISION SITE
|
70
|
2.62e-01
|
7.39e-01
|
0.11800
|
-5.29e-02
|
1.06e-01
|
4.44e-01
|
1.26e-01
|
GOBP COMMON MYELOID PROGENITOR CELL PROLIFERATION
|
9
|
8.21e-01
|
9.60e-01
|
0.11800
|
1.17e-01
|
1.65e-02
|
5.43e-01
|
9.32e-01
|
GOBP PEPTIDYL LYSINE ACETYLATION
|
64
|
2.50e-01
|
7.28e-01
|
0.11800
|
-1.18e-01
|
-1.01e-02
|
1.03e-01
|
8.89e-01
|
GOCC CLATHRIN ADAPTOR COMPLEX
|
25
|
5.99e-01
|
8.95e-01
|
0.11800
|
-1.17e-01
|
1.69e-02
|
3.11e-01
|
8.84e-01
|
GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE
|
19
|
6.37e-01
|
9.06e-01
|
0.11800
|
-7.68e-02
|
-8.97e-02
|
5.62e-01
|
4.98e-01
|
GOBP REGULATION OF BLOOD CIRCULATION
|
247
|
3.01e-03
|
1.06e-01
|
0.11800
|
7.73e-02
|
8.93e-02
|
3.64e-02
|
1.57e-02
|
GOBP SUCKLING BEHAVIOR
|
12
|
7.93e-01
|
9.55e-01
|
0.11800
|
-1.08e-01
|
4.88e-02
|
5.19e-01
|
7.70e-01
|
GOBP INTRACELLULAR PROTEIN TRANSMEMBRANE TRANSPORT
|
52
|
3.58e-01
|
7.99e-01
|
0.11800
|
3.34e-02
|
-1.13e-01
|
6.77e-01
|
1.58e-01
|
GOBP ERBB4 SIGNALING PATHWAY
|
10
|
7.92e-01
|
9.54e-01
|
0.11800
|
-5.48e-02
|
-1.04e-01
|
7.64e-01
|
5.67e-01
|
GOBP POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT
|
149
|
6.26e-02
|
4.83e-01
|
0.11800
|
-9.56e-02
|
6.89e-02
|
4.39e-02
|
1.46e-01
|
GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR
|
34
|
5.06e-01
|
8.65e-01
|
0.11800
|
1.15e-01
|
-2.55e-02
|
2.46e-01
|
7.97e-01
|
GOCC SCF UBIQUITIN LIGASE COMPLEX
|
65
|
2.98e-01
|
7.67e-01
|
0.11800
|
-7.12e-02
|
9.39e-02
|
3.21e-01
|
1.90e-01
|
GOBP NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY
|
11
|
7.77e-01
|
9.50e-01
|
0.11800
|
4.46e-02
|
1.09e-01
|
7.98e-01
|
5.31e-01
|
GOBP NEGATIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION
|
52
|
3.05e-01
|
7.69e-01
|
0.11800
|
-1.09e-01
|
-4.46e-02
|
1.74e-01
|
5.78e-01
|
GOBP TRANSLESION SYNTHESIS
|
25
|
5.60e-01
|
8.83e-01
|
0.11800
|
-1.05e-01
|
-5.43e-02
|
3.66e-01
|
6.39e-01
|
GOCC GOLGI CIS CISTERNA
|
13
|
7.85e-01
|
9.52e-01
|
0.11800
|
-6.96e-02
|
9.49e-02
|
6.64e-01
|
5.54e-01
|
GOBP DENDRITIC SPINE DEVELOPMENT
|
85
|
1.80e-01
|
6.70e-01
|
0.11800
|
-1.97e-02
|
1.16e-01
|
7.54e-01
|
6.44e-02
|
GOBP OLIGODENDROCYTE PROGENITOR PROLIFERATION
|
8
|
8.60e-01
|
9.68e-01
|
0.11800
|
-1.03e-01
|
5.67e-02
|
6.14e-01
|
7.81e-01
|
GOBP REGULATION OF TRANSLATION IN RESPONSE TO STRESS
|
19
|
6.45e-01
|
9.07e-01
|
0.11800
|
-5.34e-02
|
-1.05e-01
|
6.87e-01
|
4.29e-01
|
GOBP RESPONSE TO LITHIUM ION
|
15
|
7.03e-01
|
9.23e-01
|
0.11800
|
-7.16e-02
|
-9.33e-02
|
6.31e-01
|
5.32e-01
|
GOCC VACUOLAR LUMEN
|
165
|
2.67e-02
|
3.41e-01
|
0.11800
|
-1.15e-01
|
-2.50e-02
|
1.08e-02
|
5.80e-01
|
GOMF 5ALPHA ANDROSTANE 3BETA 17BETA DIOL DEHYDROGENASE ACTIVITY
|
6
|
8.92e-01
|
9.76e-01
|
0.11800
|
1.04e-01
|
-5.43e-02
|
6.58e-01
|
8.18e-01
|
GOBP NEGATIVE REGULATION OF BMP SIGNALING PATHWAY
|
67
|
2.25e-01
|
7.13e-01
|
0.11800
|
-3.12e-02
|
-1.13e-01
|
6.59e-01
|
1.08e-01
|
GOBP BRONCHIOLE DEVELOPMENT
|
5
|
8.89e-01
|
9.76e-01
|
0.11800
|
-7.50e-02
|
-9.06e-02
|
7.72e-01
|
7.26e-01
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS
|
46
|
3.99e-01
|
8.25e-01
|
0.11800
|
2.38e-02
|
-1.15e-01
|
7.80e-01
|
1.77e-01
|
GOMF CYSTEINE TYPE ENDOPEPTIDASE REGULATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS
|
38
|
4.10e-01
|
8.27e-01
|
0.11800
|
-9.03e-02
|
-7.52e-02
|
3.35e-01
|
4.22e-01
|
GOBP POST CHAPERONIN TUBULIN FOLDING PATHWAY
|
6
|
8.69e-01
|
9.72e-01
|
0.11700
|
9.27e-02
|
7.22e-02
|
6.94e-01
|
7.59e-01
|
GOBP ARTERY MORPHOGENESIS
|
81
|
2.22e-01
|
7.11e-01
|
0.11700
|
-6.38e-02
|
9.86e-02
|
3.21e-01
|
1.25e-01
|
GOMF PROTEIN FOLDING CHAPERONE BINDING
|
129
|
5.48e-02
|
4.62e-01
|
0.11700
|
-4.06e-02
|
-1.10e-01
|
4.25e-01
|
3.07e-02
|
GOBP INTRACILIARY RETROGRADE TRANSPORT
|
14
|
7.60e-01
|
9.44e-01
|
0.11700
|
-1.13e-01
|
3.35e-02
|
4.66e-01
|
8.28e-01
|
GOBP RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY
|
53
|
3.68e-01
|
8.08e-01
|
0.11700
|
5.41e-02
|
-1.04e-01
|
4.96e-01
|
1.89e-01
|
GOMF ATPASE COUPLED LIPID TRANSMEMBRANE TRANSPORTER ACTIVITY
|
8
|
8.29e-01
|
9.62e-01
|
0.11700
|
-7.67e-02
|
-8.89e-02
|
7.07e-01
|
6.63e-01
|
GOBP NEGATIVE REGULATION OF NUCLEAR DIVISION
|
63
|
2.49e-01
|
7.27e-01
|
0.11700
|
-2.78e-02
|
-1.14e-01
|
7.03e-01
|
1.17e-01
|
GOMF NUCLEOSIDE DIPHOSPHATE PHOSPHATASE ACTIVITY
|
17
|
6.76e-01
|
9.13e-01
|
0.11700
|
-1.03e-01
|
-5.56e-02
|
4.60e-01
|
6.92e-01
|
GOBP REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS
|
58
|
3.17e-01
|
7.77e-01
|
0.11700
|
-2.69e-02
|
1.14e-01
|
7.23e-01
|
1.32e-01
|
GOBP OTIC VESICLE MORPHOGENESIS
|
10
|
8.13e-01
|
9.59e-01
|
0.11700
|
-1.17e-01
|
6.72e-03
|
5.21e-01
|
9.71e-01
|
GOBP NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS
|
116
|
6.68e-02
|
4.98e-01
|
0.11700
|
-9.12e-02
|
-7.38e-02
|
8.96e-02
|
1.70e-01
|
GOBP AMP METABOLIC PROCESS
|
22
|
6.58e-01
|
9.09e-01
|
0.11700
|
-1.07e-01
|
4.72e-02
|
3.83e-01
|
7.02e-01
|
GOBP DENDRITE MORPHOGENESIS
|
129
|
7.59e-02
|
5.19e-01
|
0.11700
|
-1.93e-02
|
1.16e-01
|
7.05e-01
|
2.33e-02
|
GOCC EXTRINSIC COMPONENT OF ORGANELLE MEMBRANE
|
26
|
5.48e-01
|
8.79e-01
|
0.11700
|
-1.00e-01
|
-6.12e-02
|
3.78e-01
|
5.89e-01
|
GOBP MESODERMAL CELL FATE SPECIFICATION
|
12
|
7.60e-01
|
9.44e-01
|
0.11700
|
-5.12e-02
|
-1.05e-01
|
7.59e-01
|
5.27e-01
|
GOCC CILIARY ROOTLET
|
15
|
7.04e-01
|
9.23e-01
|
0.11700
|
8.10e-02
|
8.47e-02
|
5.87e-01
|
5.70e-01
|
GOBP RECEPTOR MEDIATED ENDOCYTOSIS
|
252
|
9.43e-03
|
2.06e-01
|
0.11700
|
-1.01e-01
|
5.88e-02
|
5.56e-03
|
1.08e-01
|
GOMF CATALYTIC ACTIVITY ACTING ON A TRNA
|
127
|
5.47e-02
|
4.62e-01
|
0.11700
|
-5.49e-02
|
-1.04e-01
|
2.85e-01
|
4.39e-02
|
GOBP REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY
|
25
|
6.30e-01
|
9.03e-01
|
0.11700
|
-7.08e-02
|
9.34e-02
|
5.40e-01
|
4.19e-01
|
GOBP REGULATION OF METALLOPEPTIDASE ACTIVITY
|
22
|
5.98e-01
|
8.95e-01
|
0.11700
|
-8.94e-02
|
-7.58e-02
|
4.68e-01
|
5.38e-01
|
GOMF NADPLUS PROTEIN ADP RIBOSYLTRANSFERASE ACTIVITY
|
28
|
5.44e-01
|
8.78e-01
|
0.11700
|
-1.15e-01
|
-2.05e-02
|
2.91e-01
|
8.51e-01
|
GOBP CARBOHYDRATE HOMEOSTASIS
|
247
|
1.07e-02
|
2.21e-01
|
0.11700
|
-9.81e-02
|
6.40e-02
|
7.90e-03
|
8.33e-02
|
GOBP NEGATIVE REGULATION OF OSSIFICATION
|
37
|
5.05e-01
|
8.65e-01
|
0.11700
|
-6.91e-02
|
9.46e-02
|
4.67e-01
|
3.19e-01
|
GOMF PROTEIN SERINE THREONINE TYROSINE KINASE ACTIVITY
|
44
|
4.12e-01
|
8.28e-01
|
0.11700
|
-1.16e-01
|
1.59e-02
|
1.83e-01
|
8.55e-01
|
GOCC TRANS GOLGI NETWORK TRANSPORT VESICLE
|
36
|
5.16e-01
|
8.69e-01
|
0.11700
|
-9.24e-02
|
7.19e-02
|
3.37e-01
|
4.55e-01
|
GOMF RNA CAP BINDING
|
20
|
6.31e-01
|
9.03e-01
|
0.11700
|
-1.02e-01
|
-5.68e-02
|
4.28e-01
|
6.60e-01
|
GOCC ORGANELLE INNER MEMBRANE
|
512
|
1.41e-05
|
2.05e-03
|
0.11700
|
-3.54e-02
|
-1.12e-01
|
1.70e-01
|
1.54e-05
|
GOBP TRANSLATIONAL TERMINATION
|
15
|
7.58e-01
|
9.44e-01
|
0.11700
|
6.78e-02
|
-9.54e-02
|
6.49e-01
|
5.22e-01
|
GOBP EMBRYONIC DIGIT MORPHOGENESIS
|
57
|
3.52e-01
|
7.96e-01
|
0.11700
|
-9.08e-02
|
7.38e-02
|
2.36e-01
|
3.35e-01
|
GOBP REGULATION OF DNA STRAND ELONGATION
|
17
|
7.30e-01
|
9.32e-01
|
0.11700
|
-9.87e-02
|
6.27e-02
|
4.81e-01
|
6.54e-01
|
GOBP BICARBONATE TRANSPORT
|
35
|
5.01e-01
|
8.62e-01
|
0.11700
|
-2.48e-02
|
1.14e-01
|
7.99e-01
|
2.42e-01
|
GOBP CELL CYCLE CHECKPOINT SIGNALING
|
188
|
1.65e-02
|
2.73e-01
|
0.11700
|
-2.82e-02
|
-1.14e-01
|
5.06e-01
|
7.26e-03
|
GOBP REGULATION OF SKELETAL MUSCLE CONTRACTION
|
15
|
7.55e-01
|
9.42e-01
|
0.11700
|
-1.03e-01
|
5.47e-02
|
4.88e-01
|
7.14e-01
|
GOBP CHROMOSOME LOCALIZATION
|
117
|
6.77e-02
|
4.99e-01
|
0.11700
|
-9.69e-02
|
-6.54e-02
|
7.02e-02
|
2.22e-01
|
GOBP ERYTHROCYTE HOMEOSTASIS
|
134
|
5.35e-02
|
4.57e-01
|
0.11700
|
-1.13e-01
|
-2.89e-02
|
2.37e-02
|
5.63e-01
|
GOMF TRANSCRIPTION COREPRESSOR ACTIVITY
|
177
|
3.62e-02
|
3.88e-01
|
0.11700
|
-1.07e-01
|
4.75e-02
|
1.43e-02
|
2.76e-01
|
GOBP MONOUBIQUITINATED PROTEIN DEUBIQUITINATION
|
7
|
8.69e-01
|
9.72e-01
|
0.11700
|
-1.16e-01
|
1.47e-02
|
5.96e-01
|
9.46e-01
|
GOBP ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY
|
15
|
7.46e-01
|
9.39e-01
|
0.11700
|
-2.95e-02
|
1.13e-01
|
8.43e-01
|
4.49e-01
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH2 GROUP OF DONORS OXYGEN AS ACCEPTOR
|
14
|
7.23e-01
|
9.30e-01
|
0.11700
|
-9.00e-02
|
-7.43e-02
|
5.60e-01
|
6.30e-01
|
GOBP NEURON MATURATION
|
47
|
3.48e-01
|
7.96e-01
|
0.11700
|
-4.35e-02
|
-1.08e-01
|
6.06e-01
|
1.99e-01
|
GOBP SKIN MORPHOGENESIS
|
13
|
7.65e-01
|
9.45e-01
|
0.11700
|
1.17e-01
|
-3.84e-03
|
4.66e-01
|
9.81e-01
|
GOBP FEMALE GENITALIA DEVELOPMENT
|
19
|
6.88e-01
|
9.19e-01
|
0.11700
|
2.35e-02
|
-1.14e-01
|
8.59e-01
|
3.88e-01
|
GOMF U1 SNRNA BINDING
|
8
|
8.33e-01
|
9.64e-01
|
0.11700
|
1.02e-01
|
5.70e-02
|
6.18e-01
|
7.80e-01
|
GOMF TRANSCRIPTION COACTIVATOR ACTIVITY
|
257
|
9.60e-03
|
2.08e-01
|
0.11700
|
-9.26e-02
|
7.10e-02
|
1.06e-02
|
5.02e-02
|
GOMF ACETYLCHOLINE RECEPTOR ACTIVITY
|
22
|
6.01e-01
|
8.96e-01
|
0.11700
|
8.19e-02
|
8.29e-02
|
5.06e-01
|
5.01e-01
|
GOMF CADHERIN BINDING INVOLVED IN CELL CELL ADHESION
|
18
|
7.21e-01
|
9.30e-01
|
0.11700
|
-7.57e-02
|
8.86e-02
|
5.78e-01
|
5.15e-01
|
GOBP PROTEIN DNA COMPLEX ORGANIZATION
|
793
|
9.28e-08
|
5.93e-05
|
0.11700
|
-1.16e-01
|
-1.15e-02
|
2.77e-08
|
5.80e-01
|
GOBP POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY
|
21
|
6.22e-01
|
9.01e-01
|
0.11600
|
1.05e-01
|
5.12e-02
|
4.07e-01
|
6.85e-01
|
GOBP POSITIVE REGULATION OF FATTY ACID TRANSPORT
|
23
|
5.89e-01
|
8.92e-01
|
0.11600
|
6.98e-02
|
9.33e-02
|
5.62e-01
|
4.39e-01
|
GOBP ALCOHOL BIOSYNTHETIC PROCESS
|
139
|
4.14e-02
|
4.20e-01
|
0.11600
|
-9.11e-02
|
-7.25e-02
|
6.37e-02
|
1.40e-01
|
GOBP POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS
|
30
|
5.13e-01
|
8.67e-01
|
0.11600
|
1.09e-01
|
4.09e-02
|
3.02e-01
|
6.98e-01
|
GOBP GAMMA AMINOBUTYRIC ACID BIOSYNTHETIC PROCESS
|
6
|
8.87e-01
|
9.76e-01
|
0.11600
|
1.16e-01
|
-1.34e-02
|
6.24e-01
|
9.55e-01
|
GOBP CELLULAR LIPID CATABOLIC PROCESS
|
220
|
1.39e-02
|
2.56e-01
|
0.11600
|
-1.14e-01
|
2.31e-02
|
3.56e-03
|
5.55e-01
|
GOBP CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS
|
9
|
8.41e-01
|
9.66e-01
|
0.11600
|
-3.44e-02
|
1.11e-01
|
8.58e-01
|
5.64e-01
|
GOBP ADENINE TRANSPORT
|
5
|
9.10e-01
|
9.82e-01
|
0.11600
|
-1.08e-01
|
4.40e-02
|
6.77e-01
|
8.65e-01
|
GOMF LACTATE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
6
|
8.85e-01
|
9.76e-01
|
0.11600
|
-1.16e-01
|
5.61e-03
|
6.22e-01
|
9.81e-01
|
GOBP MITOCHONDRIAL TRANSMEMBRANE TRANSPORT
|
59
|
2.73e-01
|
7.48e-01
|
0.11600
|
-1.10e-01
|
-3.67e-02
|
1.43e-01
|
6.26e-01
|
GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION
|
18
|
6.66e-01
|
9.11e-01
|
0.11600
|
-5.36e-02
|
-1.03e-01
|
6.94e-01
|
4.49e-01
|
GOMF BETA CATENIN BINDING
|
80
|
2.14e-01
|
7.03e-01
|
0.11600
|
-2.87e-02
|
1.13e-01
|
6.57e-01
|
8.18e-02
|
GOMF LIGASE ACTIVITY FORMING CARBON OXYGEN BONDS
|
39
|
4.13e-01
|
8.29e-01
|
0.11600
|
-5.96e-02
|
-9.97e-02
|
5.20e-01
|
2.81e-01
|
GOBP BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH HOST
|
206
|
1.56e-02
|
2.64e-01
|
0.11600
|
-1.16e-01
|
2.79e-03
|
4.08e-03
|
9.45e-01
|
GOBP OSTEOCLAST DIFFERENTIATION
|
103
|
1.57e-01
|
6.45e-01
|
0.11600
|
-8.61e-02
|
7.79e-02
|
1.31e-01
|
1.72e-01
|
GOBP POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS
|
33
|
4.69e-01
|
8.51e-01
|
0.11600
|
-8.04e-02
|
-8.37e-02
|
4.24e-01
|
4.05e-01
|
GOMF TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY BINDING
|
46
|
3.77e-01
|
8.13e-01
|
0.11600
|
1.75e-02
|
1.15e-01
|
8.38e-01
|
1.78e-01
|
GOCC PLATELET ALPHA GRANULE LUMEN
|
60
|
3.30e-01
|
7.85e-01
|
0.11600
|
-5.11e-02
|
1.04e-01
|
4.94e-01
|
1.63e-01
|
GOBP AXONEME ASSEMBLY
|
92
|
1.35e-01
|
6.16e-01
|
0.11600
|
1.11e-01
|
3.33e-02
|
6.55e-02
|
5.81e-01
|
GOMF HETEROTRIMERIC G PROTEIN BINDING
|
5
|
9.11e-01
|
9.82e-01
|
0.11600
|
1.07e-01
|
-4.35e-02
|
6.77e-01
|
8.66e-01
|
GOBP UBIQUINONE METABOLIC PROCESS
|
19
|
6.73e-01
|
9.13e-01
|
0.11600
|
-1.15e-01
|
-9.74e-03
|
3.83e-01
|
9.41e-01
|
GOBP ADIPOSE TISSUE DEVELOPMENT
|
57
|
2.79e-01
|
7.52e-01
|
0.11600
|
-1.03e-01
|
-5.29e-02
|
1.78e-01
|
4.90e-01
|
GOBP CELLULAR RESPONSE TO CADMIUM ION
|
34
|
4.76e-01
|
8.54e-01
|
0.11600
|
1.10e-01
|
3.55e-02
|
2.66e-01
|
7.20e-01
|
GOBP GLIAL CELL PROLIFERATION
|
54
|
3.55e-01
|
7.97e-01
|
0.11600
|
-1.12e-01
|
3.00e-02
|
1.55e-01
|
7.03e-01
|
GOBP MIDBRAIN DEVELOPMENT
|
86
|
1.68e-01
|
6.54e-01
|
0.11600
|
-1.15e-01
|
-9.72e-03
|
6.42e-02
|
8.76e-01
|
GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION
|
22
|
6.55e-01
|
9.09e-01
|
0.11600
|
-2.72e-02
|
1.13e-01
|
8.25e-01
|
3.61e-01
|
GOMF MYOSIN BINDING
|
71
|
2.35e-01
|
7.22e-01
|
0.11600
|
1.95e-03
|
1.16e-01
|
9.77e-01
|
9.16e-02
|
GOMF STEROL TRANSPORTER ACTIVITY
|
36
|
4.88e-01
|
8.56e-01
|
0.11600
|
-1.15e-01
|
1.01e-02
|
2.31e-01
|
9.16e-01
|
GOMF MANNOSYLTRANSFERASE ACTIVITY
|
24
|
6.39e-01
|
9.06e-01
|
0.11600
|
-1.08e-01
|
4.19e-02
|
3.60e-01
|
7.22e-01
|
GOBP CELLULAR RESPONSE TO ANTIBIOTIC
|
11
|
8.18e-01
|
9.60e-01
|
0.11600
|
-1.01e-01
|
5.64e-02
|
5.62e-01
|
7.46e-01
|
GOBP POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST
|
31
|
5.46e-01
|
8.78e-01
|
0.11600
|
1.88e-02
|
-1.14e-01
|
8.56e-01
|
2.71e-01
|
GOBP PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS
|
40
|
4.20e-01
|
8.33e-01
|
0.11600
|
-1.11e-01
|
-3.32e-02
|
2.25e-01
|
7.16e-01
|
GOBP ADRENAL GLAND DEVELOPMENT
|
27
|
6.08e-01
|
8.97e-01
|
0.11600
|
-5.01e-02
|
1.04e-01
|
6.52e-01
|
3.49e-01
|
GOMF CHEMOKINE RECEPTOR BINDING
|
63
|
2.40e-01
|
7.25e-01
|
0.11600
|
6.80e-02
|
9.35e-02
|
3.51e-01
|
1.99e-01
|
GOBP PEPTIDYL TYROSINE DEPHOSPHORYLATION
|
30
|
5.64e-01
|
8.85e-01
|
0.11600
|
-2.92e-02
|
1.12e-01
|
7.82e-01
|
2.89e-01
|
GOMF INORGANIC DIPHOSPHATE PHOSPHATASE ACTIVITY
|
5
|
9.04e-01
|
9.80e-01
|
0.11600
|
-1.16e-01
|
2.69e-03
|
6.55e-01
|
9.92e-01
|
GOBP RNA PROCESSING
|
1252
|
3.33e-11
|
5.68e-08
|
0.11600
|
-2.08e-03
|
-1.16e-01
|
9.01e-01
|
6.02e-12
|
GOBP CELLULAR RESPONSE TO ALCOHOL
|
99
|
1.32e-01
|
6.13e-01
|
0.11600
|
-1.15e-01
|
-5.10e-03
|
4.72e-02
|
9.30e-01
|
GOBP SOMATIC STEM CELL DIVISION
|
11
|
8.03e-01
|
9.57e-01
|
0.11500
|
1.15e-01
|
-7.83e-03
|
5.08e-01
|
9.64e-01
|
GOBP CELL CHEMOTAXIS
|
303
|
1.89e-03
|
8.04e-02
|
0.11500
|
1.65e-02
|
1.14e-01
|
6.21e-01
|
6.22e-04
|
GOBP POSITIVE REGULATION OF STEM CELL PROLIFERATION
|
53
|
3.39e-01
|
7.91e-01
|
0.11500
|
3.76e-03
|
1.15e-01
|
9.62e-01
|
1.46e-01
|
GOBP VESICLE MEDIATED TRANSPORT
|
1460
|
8.98e-12
|
1.84e-08
|
0.11500
|
-1.08e-01
|
4.13e-02
|
5.37e-12
|
8.22e-03
|
GOMF FLAVIN ADENINE DINUCLEOTIDE BINDING
|
84
|
1.68e-01
|
6.54e-01
|
0.11500
|
-1.13e-01
|
-2.55e-02
|
7.45e-02
|
6.86e-01
|
GOBP NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY
|
11
|
7.80e-01
|
9.51e-01
|
0.11500
|
7.23e-02
|
8.99e-02
|
6.78e-01
|
6.06e-01
|
GOCC VACUOLE
|
806
|
2.00e-07
|
1.02e-04
|
0.11500
|
-1.15e-01
|
9.40e-03
|
2.85e-08
|
6.50e-01
|
GOBP MAGNESIUM ION TRANSPORT
|
16
|
7.46e-01
|
9.38e-01
|
0.11500
|
4.93e-02
|
-1.04e-01
|
7.33e-01
|
4.70e-01
|
GOBP REGULATION OF CORTICOSTEROID HORMONE SECRETION
|
16
|
7.24e-01
|
9.30e-01
|
0.11500
|
-1.15e-01
|
6.65e-04
|
4.25e-01
|
9.96e-01
|
GOBP PLASMINOGEN ACTIVATION
|
26
|
6.04e-01
|
8.96e-01
|
0.11500
|
1.88e-02
|
-1.14e-01
|
8.68e-01
|
3.15e-01
|
GOMF ALPHA CATENIN BINDING
|
10
|
8.10e-01
|
9.59e-01
|
0.11500
|
-1.13e-01
|
-2.06e-02
|
5.34e-01
|
9.10e-01
|
GOCC CORE MEDIATOR COMPLEX
|
25
|
5.88e-01
|
8.91e-01
|
0.11500
|
-2.42e-02
|
-1.13e-01
|
8.34e-01
|
3.29e-01
|
GOBP RESPONSE TO DIETARY EXCESS
|
34
|
5.13e-01
|
8.67e-01
|
0.11500
|
-1.25e-02
|
1.14e-01
|
9.00e-01
|
2.48e-01
|
GOBP VENTRICULAR CARDIAC MUSCLE TISSUE MORPHOGENESIS
|
47
|
3.51e-01
|
7.96e-01
|
0.11500
|
5.77e-02
|
9.97e-02
|
4.94e-01
|
2.37e-01
|
GOBP RESPONSE TO VITAMIN A
|
15
|
7.63e-01
|
9.45e-01
|
0.11500
|
-5.88e-02
|
9.89e-02
|
6.93e-01
|
5.07e-01
|
GOBP PARENTAL BEHAVIOR
|
10
|
8.38e-01
|
9.64e-01
|
0.11500
|
8.40e-02
|
-7.87e-02
|
6.46e-01
|
6.67e-01
|
GOBP REGULATION OF ENDOCYTOSIS
|
282
|
4.51e-03
|
1.37e-01
|
0.11500
|
-1.14e-01
|
1.80e-02
|
1.02e-03
|
6.03e-01
|
GOBP ENDOCYTOSIS
|
682
|
6.01e-06
|
1.04e-03
|
0.11500
|
-1.03e-01
|
5.16e-02
|
4.70e-06
|
2.15e-02
|
GOBP DE NOVO PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS
|
6
|
8.98e-01
|
9.78e-01
|
0.11500
|
-5.82e-02
|
9.92e-02
|
8.05e-01
|
6.74e-01
|
GOBP LEFT RIGHT AXIS SPECIFICATION
|
13
|
7.67e-01
|
9.46e-01
|
0.11500
|
-7.30e-03
|
-1.15e-01
|
9.64e-01
|
4.74e-01
|
GOBP POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS
|
93
|
1.90e-01
|
6.84e-01
|
0.11500
|
-6.12e-02
|
9.74e-02
|
3.08e-01
|
1.05e-01
|
GOBP POSITIVE REGULATION OF CELL KILLING
|
74
|
2.25e-01
|
7.13e-01
|
0.11500
|
1.15e-01
|
2.57e-03
|
8.73e-02
|
9.69e-01
|
GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION
|
60
|
3.09e-01
|
7.72e-01
|
0.11500
|
-1.13e-02
|
1.14e-01
|
8.79e-01
|
1.25e-01
|
GOBP NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS
|
20
|
7.02e-01
|
9.23e-01
|
0.11500
|
-8.84e-02
|
7.33e-02
|
4.94e-01
|
5.71e-01
|
GOBP NEGATIVE CHEMOTAXIS
|
46
|
3.65e-01
|
8.06e-01
|
0.11500
|
1.04e-01
|
4.87e-02
|
2.22e-01
|
5.68e-01
|
GOBP NEGATIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY
|
20
|
6.48e-01
|
9.07e-01
|
0.11500
|
4.30e-02
|
1.06e-01
|
7.39e-01
|
4.10e-01
|
GOMF VOLTAGE GATED MONOATOMIC ION CHANNEL ACTIVITY INVOLVED IN REGULATION OF PRESYNAPTIC MEMBRANE POTENTIAL
|
12
|
7.64e-01
|
9.45e-01
|
0.11500
|
7.26e-02
|
8.88e-02
|
6.63e-01
|
5.94e-01
|
GOBP AMIDE CATABOLIC PROCESS
|
20
|
6.98e-01
|
9.21e-01
|
0.11500
|
-5.34e-02
|
1.01e-01
|
6.79e-01
|
4.32e-01
|
GOBP NATURAL KILLER CELL CYTOKINE PRODUCTION
|
9
|
8.45e-01
|
9.66e-01
|
0.11500
|
1.10e-01
|
-3.10e-02
|
5.66e-01
|
8.72e-01
|
GOBP PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION
|
15
|
7.30e-01
|
9.32e-01
|
0.11500
|
2.30e-02
|
1.12e-01
|
8.77e-01
|
4.51e-01
|
GOBP AGGRESOME ASSEMBLY
|
5
|
9.13e-01
|
9.82e-01
|
0.11500
|
1.06e-01
|
-4.46e-02
|
6.83e-01
|
8.63e-01
|
GOBP REGULATION OF AXON EXTENSION
|
85
|
2.05e-01
|
6.95e-01
|
0.11500
|
-3.08e-02
|
1.10e-01
|
6.23e-01
|
7.86e-02
|
GOMF VOLTAGE GATED CHANNEL ACTIVITY
|
192
|
1.44e-02
|
2.59e-01
|
0.11500
|
6.85e-02
|
9.18e-02
|
1.02e-01
|
2.82e-02
|
GOBP NEGATIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY
|
9
|
8.36e-01
|
9.64e-01
|
0.11400
|
1.14e-01
|
-2.54e-03
|
5.52e-01
|
9.89e-01
|
GOMF RNA POLYMERASE II CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING
|
18
|
6.74e-01
|
9.13e-01
|
0.11400
|
-1.01e-01
|
-5.31e-02
|
4.56e-01
|
6.97e-01
|
GOBP KETONE CATABOLIC PROCESS
|
14
|
7.31e-01
|
9.32e-01
|
0.11400
|
-8.04e-02
|
-8.15e-02
|
6.03e-01
|
5.97e-01
|
GOBP CARBOHYDRATE METABOLIC PROCESS
|
539
|
6.06e-05
|
6.46e-03
|
0.11400
|
-1.08e-01
|
3.71e-02
|
1.70e-05
|
1.40e-01
|
GOBP TRNA METABOLIC PROCESS
|
190
|
1.51e-02
|
2.62e-01
|
0.11400
|
-6.87e-02
|
-9.15e-02
|
1.03e-01
|
2.96e-02
|
GOBP IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY
|
311
|
1.23e-03
|
5.88e-02
|
0.11400
|
5.14e-02
|
1.02e-01
|
1.19e-01
|
1.93e-03
|
GOBP EMBRYONIC AXIS SPECIFICATION
|
39
|
4.98e-01
|
8.61e-01
|
0.11400
|
-1.01e-01
|
5.33e-02
|
2.74e-01
|
5.65e-01
|
GOBP NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION
|
52
|
3.96e-01
|
8.25e-01
|
0.11400
|
-9.99e-02
|
5.54e-02
|
2.12e-01
|
4.89e-01
|
GOBP POSITIVE REGULATION OF GLIAL CELL PROLIFERATION
|
19
|
7.10e-01
|
9.26e-01
|
0.11400
|
-4.89e-02
|
1.03e-01
|
7.12e-01
|
4.36e-01
|
GOBP ATP METABOLIC PROCESS
|
124
|
6.71e-02
|
4.98e-01
|
0.11400
|
-5.48e-02
|
-1.00e-01
|
2.92e-01
|
5.37e-02
|
GOBP NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS
|
18
|
6.98e-01
|
9.21e-01
|
0.11400
|
2.73e-03
|
1.14e-01
|
9.84e-01
|
4.01e-01
|
GOBP GLUCOSYLCERAMIDE METABOLIC PROCESS
|
7
|
8.56e-01
|
9.68e-01
|
0.11400
|
-7.78e-02
|
-8.36e-02
|
7.21e-01
|
7.02e-01
|
GOBP RIBONUCLEOSIDE CATABOLIC PROCESS
|
20
|
7.05e-01
|
9.24e-01
|
0.11400
|
8.16e-02
|
-7.99e-02
|
5.27e-01
|
5.36e-01
|
GOBP T CELL MIGRATION
|
66
|
2.95e-01
|
7.64e-01
|
0.11400
|
-3.14e-02
|
1.10e-01
|
6.59e-01
|
1.23e-01
|
GOBP SPLEEN DEVELOPMENT
|
38
|
4.35e-01
|
8.38e-01
|
0.11400
|
-5.96e-02
|
-9.73e-02
|
5.25e-01
|
2.99e-01
|
GOBP PURINE RIBONUCLEOSIDE METABOLIC PROCESS
|
20
|
6.61e-01
|
9.09e-01
|
0.11400
|
1.12e-01
|
2.23e-02
|
3.86e-01
|
8.63e-01
|
GOCC AXONAL GROWTH CONE
|
25
|
6.27e-01
|
9.02e-01
|
0.11400
|
1.11e-01
|
-2.67e-02
|
3.37e-01
|
8.17e-01
|
GOBP NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION
|
89
|
1.53e-01
|
6.41e-01
|
0.11400
|
-3.44e-02
|
-1.09e-01
|
5.75e-01
|
7.65e-02
|
GOMF S ADENOSYLMETHIONINE DEPENDENT METHYLTRANSFERASE ACTIVITY
|
173
|
2.82e-02
|
3.48e-01
|
0.11400
|
-1.11e-01
|
-2.52e-02
|
1.17e-02
|
5.67e-01
|
GOBP CALCINEURIN MEDIATED SIGNALING
|
48
|
4.21e-01
|
8.33e-01
|
0.11400
|
-4.29e-02
|
1.06e-01
|
6.07e-01
|
2.06e-01
|
GOMF LIPOPROTEIN PARTICLE RECEPTOR BINDING
|
29
|
5.70e-01
|
8.86e-01
|
0.11400
|
-1.14e-01
|
7.68e-03
|
2.89e-01
|
9.43e-01
|
GOBP PURINE NUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS
|
5
|
9.05e-01
|
9.80e-01
|
0.11400
|
4.20e-03
|
1.14e-01
|
9.87e-01
|
6.59e-01
|
GOBP MEMBRANE REPOLARIZATION
|
52
|
3.19e-01
|
7.78e-01
|
0.11400
|
6.67e-02
|
9.23e-02
|
4.06e-01
|
2.50e-01
|
GOBP NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION
|
34
|
4.97e-01
|
8.61e-01
|
0.11400
|
-2.09e-02
|
-1.12e-01
|
8.33e-01
|
2.59e-01
|
GOBP TISSUE REGENERATION
|
73
|
2.11e-01
|
7.00e-01
|
0.11400
|
-1.06e-01
|
-4.16e-02
|
1.17e-01
|
5.39e-01
|
GOBP NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS
|
38
|
4.59e-01
|
8.48e-01
|
0.11400
|
-1.12e-01
|
-2.00e-02
|
2.32e-01
|
8.31e-01
|
GOBP ACTIN POLYMERIZATION OR DEPOLYMERIZATION
|
186
|
3.03e-02
|
3.61e-01
|
0.11400
|
-1.84e-02
|
1.12e-01
|
6.65e-01
|
8.25e-03
|
GOCC GOLGI TRANSPORT COMPLEX
|
9
|
8.23e-01
|
9.61e-01
|
0.11400
|
-1.01e-01
|
-5.31e-02
|
6.01e-01
|
7.83e-01
|
GOBP REGULATION OF EPINEPHRINE SECRETION
|
7
|
8.60e-01
|
9.68e-01
|
0.11400
|
-1.02e-01
|
-5.11e-02
|
6.42e-01
|
8.15e-01
|
GOBP CELLULAR RESPONSE TO ALDEHYDE
|
16
|
7.35e-01
|
9.34e-01
|
0.11400
|
-1.13e-01
|
1.02e-02
|
4.33e-01
|
9.44e-01
|
GOBP CALCIUM ION HOMEOSTASIS
|
320
|
2.83e-03
|
1.04e-01
|
0.11400
|
-2.65e-02
|
1.11e-01
|
4.16e-01
|
6.70e-04
|
GOCC MLL1 2 COMPLEX
|
29
|
5.93e-01
|
8.94e-01
|
0.11400
|
-1.06e-01
|
4.09e-02
|
3.23e-01
|
7.03e-01
|
GOBP DIGESTIVE SYSTEM PROCESS
|
102
|
1.68e-01
|
6.54e-01
|
0.11400
|
-9.83e-02
|
5.70e-02
|
8.63e-02
|
3.20e-01
|
GOBP TELOMERE MAINTENANCE
|
149
|
5.01e-02
|
4.44e-01
|
0.11400
|
-1.42e-02
|
-1.13e-01
|
7.66e-01
|
1.76e-02
|
GOCC NUCLEAR PORE NUCLEAR BASKET
|
11
|
8.05e-01
|
9.57e-01
|
0.11400
|
-1.14e-01
|
-1.07e-03
|
5.14e-01
|
9.95e-01
|
GOBP NEUROMUSCULAR PROCESS
|
159
|
6.54e-02
|
4.94e-01
|
0.11400
|
-7.36e-02
|
8.64e-02
|
1.09e-01
|
6.00e-02
|
GOBP PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX ASSEMBLY
|
15
|
7.48e-01
|
9.40e-01
|
0.11300
|
6.19e-03
|
-1.13e-01
|
9.67e-01
|
4.47e-01
|
GOBP ESTABLISHMENT OF SKIN BARRIER
|
33
|
5.62e-01
|
8.84e-01
|
0.11300
|
-5.95e-02
|
9.66e-02
|
5.54e-01
|
3.37e-01
|
GOBP REGULATION OF PROGRAMMED NECROTIC CELL DEATH
|
36
|
4.81e-01
|
8.54e-01
|
0.11300
|
1.99e-02
|
1.12e-01
|
8.36e-01
|
2.46e-01
|
GOBP REGULATION OF TISSUE REMODELING
|
86
|
2.16e-01
|
7.06e-01
|
0.11300
|
-4.28e-02
|
1.05e-01
|
4.93e-01
|
9.23e-02
|
GOBP CHONDROCYTE PROLIFERATION
|
24
|
6.24e-01
|
9.01e-01
|
0.11300
|
-1.13e-01
|
-3.25e-03
|
3.37e-01
|
9.78e-01
|
GOBP OPTIC NERVE DEVELOPMENT
|
20
|
6.77e-01
|
9.14e-01
|
0.11300
|
1.13e-01
|
-1.46e-03
|
3.80e-01
|
9.91e-01
|
GOCC DYNACTIN COMPLEX
|
8
|
8.46e-01
|
9.66e-01
|
0.11300
|
-3.42e-02
|
-1.08e-01
|
8.67e-01
|
5.97e-01
|
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO EARLY ENDOSOME
|
8
|
8.41e-01
|
9.66e-01
|
0.11300
|
-6.03e-02
|
-9.58e-02
|
7.68e-01
|
6.39e-01
|
GOBP NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS
|
65
|
2.66e-01
|
7.42e-01
|
0.11300
|
-2.28e-02
|
-1.11e-01
|
7.50e-01
|
1.22e-01
|
GOCC TRANSCRIPTION EXPORT COMPLEX
|
9
|
8.44e-01
|
9.66e-01
|
0.11300
|
-1.12e-01
|
1.45e-02
|
5.60e-01
|
9.40e-01
|
GOBP SNORNA LOCALIZATION
|
6
|
8.97e-01
|
9.78e-01
|
0.11300
|
1.07e-01
|
-3.63e-02
|
6.49e-01
|
8.78e-01
|
GOBP POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION
|
69
|
2.91e-01
|
7.61e-01
|
0.11300
|
-1.06e-01
|
3.88e-02
|
1.27e-01
|
5.77e-01
|
GOBP CEREBRAL CORTEX NEURON DIFFERENTIATION
|
24
|
6.61e-01
|
9.09e-01
|
0.11300
|
9.39e-02
|
-6.30e-02
|
4.26e-01
|
5.93e-01
|
GOBP NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY
|
14
|
7.79e-01
|
9.51e-01
|
0.11300
|
-4.30e-02
|
1.05e-01
|
7.81e-01
|
4.98e-01
|
GOBP TRANSCRIPTION DEPENDENT TETHERING OF RNA POLYMERASE II GENE DNA AT NUCLEAR PERIPHERY
|
7
|
8.81e-01
|
9.75e-01
|
0.11300
|
-1.08e-01
|
3.27e-02
|
6.20e-01
|
8.81e-01
|
GOBP NEURON CELL CELL ADHESION
|
13
|
7.80e-01
|
9.52e-01
|
0.11300
|
8.48e-03
|
-1.13e-01
|
9.58e-01
|
4.81e-01
|
GOBP T CELL CYTOKINE PRODUCTION
|
36
|
4.78e-01
|
8.54e-01
|
0.11300
|
-1.10e-01
|
-2.69e-02
|
2.54e-01
|
7.80e-01
|
GOBP POSITIVE REGULATION OF RIG I SIGNALING PATHWAY
|
9
|
8.51e-01
|
9.67e-01
|
0.11300
|
-1.07e-01
|
3.65e-02
|
5.79e-01
|
8.50e-01
|
GOBP BRANCHED CHAIN AMINO ACID METABOLIC PROCESS
|
26
|
5.84e-01
|
8.90e-01
|
0.11300
|
-1.08e-01
|
-3.20e-02
|
3.39e-01
|
7.78e-01
|
GOMF PHOSPHOTRANSFERASE ACTIVITY NITROGENOUS GROUP AS ACCEPTOR
|
6
|
8.80e-01
|
9.75e-01
|
0.11300
|
-1.00e-01
|
-5.20e-02
|
6.71e-01
|
8.26e-01
|
GOMF ISOPRENOID BINDING
|
45
|
4.07e-01
|
8.26e-01
|
0.11300
|
1.12e-01
|
1.52e-02
|
1.94e-01
|
8.60e-01
|
GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS II
|
28
|
5.65e-01
|
8.85e-01
|
0.11300
|
-1.10e-01
|
-2.51e-02
|
3.13e-01
|
8.18e-01
|
GOMF SODIUM ION BINDING
|
8
|
8.65e-01
|
9.70e-01
|
0.11300
|
-3.13e-02
|
1.08e-01
|
8.78e-01
|
5.95e-01
|
GOBP SERINE FAMILY AMINO ACID CATABOLIC PROCESS
|
13
|
7.59e-01
|
9.44e-01
|
0.11300
|
-4.91e-02
|
-1.02e-01
|
7.59e-01
|
5.26e-01
|
GOBP REGULATION OF AMINO ACID TRANSPORT
|
41
|
4.46e-01
|
8.40e-01
|
0.11300
|
8.71e-03
|
1.12e-01
|
9.23e-01
|
2.13e-01
|
GOBP POSITIVE REGULATION OF CARTILAGE DEVELOPMENT
|
31
|
5.84e-01
|
8.90e-01
|
0.11300
|
-9.84e-02
|
5.52e-02
|
3.43e-01
|
5.95e-01
|
GOBP MONONUCLEAR CELL MIGRATION
|
195
|
3.70e-02
|
3.91e-01
|
0.11300
|
-7.38e-02
|
8.54e-02
|
7.57e-02
|
3.98e-02
|
GOBP POSITIVE REGULATION OF AUTOPHAGY
|
143
|
8.89e-02
|
5.50e-01
|
0.11300
|
-7.81e-02
|
8.14e-02
|
1.07e-01
|
9.29e-02
|
GOMF PHOSPHOLIPID TRANSFER ACTIVITY
|
25
|
6.52e-01
|
9.08e-01
|
0.11300
|
-6.81e-02
|
8.99e-02
|
5.56e-01
|
4.36e-01
|
GOBP INTERKINETIC NUCLEAR MIGRATION
|
5
|
9.05e-01
|
9.80e-01
|
0.11300
|
-1.25e-02
|
-1.12e-01
|
9.61e-01
|
6.64e-01
|
GOBP INTESTINAL EPITHELIAL CELL DIFFERENTIATION
|
27
|
6.30e-01
|
9.03e-01
|
0.11300
|
6.47e-02
|
-9.23e-02
|
5.61e-01
|
4.06e-01
|
GOBP PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS
|
23
|
6.10e-01
|
8.98e-01
|
0.11300
|
-9.34e-02
|
-6.30e-02
|
4.38e-01
|
6.01e-01
|
GOBP LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE
|
52
|
3.62e-01
|
8.03e-01
|
0.11300
|
-1.12e-01
|
-6.94e-03
|
1.61e-01
|
9.31e-01
|
GOBP NEGATIVE REGULATION OF REPRODUCTIVE PROCESS
|
72
|
2.43e-01
|
7.25e-01
|
0.11300
|
1.01e-02
|
1.12e-01
|
8.82e-01
|
9.97e-02
|
GOBP ACTIVATION OF PHOSPHOLIPASE C ACTIVITY
|
27
|
5.88e-01
|
8.91e-01
|
0.11300
|
1.00e-02
|
1.12e-01
|
9.28e-01
|
3.13e-01
|
GOBP EXECUTION PHASE OF APOPTOSIS
|
74
|
2.78e-01
|
7.51e-01
|
0.11300
|
-5.29e-02
|
9.94e-02
|
4.31e-01
|
1.39e-01
|
GOBP MINERALOCORTICOID METABOLIC PROCESS
|
14
|
7.75e-01
|
9.50e-01
|
0.11300
|
-1.10e-01
|
2.59e-02
|
4.78e-01
|
8.67e-01
|
GOBP FIBROBLAST MIGRATION
|
52
|
4.00e-01
|
8.26e-01
|
0.11300
|
-4.31e-02
|
1.04e-01
|
5.91e-01
|
1.94e-01
|
GOCC RECEPTOR COMPLEX
|
382
|
3.29e-04
|
2.26e-02
|
0.11300
|
5.81e-02
|
9.65e-02
|
5.14e-02
|
1.21e-03
|
GOBP INNER EAR RECEPTOR CELL DEVELOPMENT
|
46
|
3.72e-01
|
8.09e-01
|
0.11300
|
6.66e-02
|
9.07e-02
|
4.34e-01
|
2.87e-01
|
GOBP RNA DECAPPING
|
19
|
6.75e-01
|
9.13e-01
|
0.11300
|
-1.07e-01
|
-3.52e-02
|
4.20e-01
|
7.90e-01
|
GOBP LIPID EXPORT FROM CELL
|
47
|
3.79e-01
|
8.14e-01
|
0.11300
|
-1.07e-01
|
-3.53e-02
|
2.05e-01
|
6.76e-01
|
GOBP ENDOCRINE HORMONE SECRETION
|
56
|
3.00e-01
|
7.67e-01
|
0.11300
|
-7.03e-02
|
-8.79e-02
|
3.63e-01
|
2.55e-01
|
GOBP CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS
|
32
|
5.02e-01
|
8.63e-01
|
0.11300
|
7.38e-02
|
8.49e-02
|
4.70e-01
|
4.06e-01
|
GOBP KIDNEY MESENCHYME DEVELOPMENT
|
16
|
7.39e-01
|
9.35e-01
|
0.11300
|
-7.73e-03
|
1.12e-01
|
9.57e-01
|
4.37e-01
|
GOBP REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY
|
15
|
7.30e-01
|
9.32e-01
|
0.11200
|
4.49e-02
|
1.03e-01
|
7.63e-01
|
4.89e-01
|
GOBP NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS
|
53
|
3.22e-01
|
7.79e-01
|
0.11200
|
-9.17e-02
|
-6.51e-02
|
2.48e-01
|
4.13e-01
|
GOCC MULTIVESICULAR BODY INTERNAL VESICLE
|
6
|
8.99e-01
|
9.79e-01
|
0.11200
|
-1.05e-01
|
3.95e-02
|
6.55e-01
|
8.67e-01
|
GOBP MRNA 3 END PROCESSING
|
49
|
4.32e-01
|
8.37e-01
|
0.11200
|
5.86e-02
|
-9.59e-02
|
4.78e-01
|
2.45e-01
|
GOBP NEGATIVE REGULATION OF NEURON MIGRATION
|
9
|
8.52e-01
|
9.67e-01
|
0.11200
|
-1.06e-01
|
3.69e-02
|
5.81e-01
|
8.48e-01
|
GOBP FIBROBLAST GROWTH FACTOR PRODUCTION
|
9
|
8.24e-01
|
9.62e-01
|
0.11200
|
8.94e-02
|
6.81e-02
|
6.42e-01
|
7.24e-01
|
GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION
|
77
|
2.30e-01
|
7.18e-01
|
0.11200
|
1.31e-03
|
-1.12e-01
|
9.84e-01
|
8.82e-02
|
GOBP POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS
|
17
|
6.98e-01
|
9.21e-01
|
0.11200
|
-9.82e-02
|
-5.46e-02
|
4.83e-01
|
6.97e-01
|
GOBP MAST CELL DIFFERENTIATION
|
6
|
8.85e-01
|
9.76e-01
|
0.11200
|
2.92e-02
|
1.08e-01
|
9.02e-01
|
6.45e-01
|
GOBP REGULATION OF LIPID CATABOLIC PROCESS
|
60
|
3.22e-01
|
7.79e-01
|
0.11200
|
-1.12e-01
|
5.30e-03
|
1.33e-01
|
9.43e-01
|
GOBP POSITIVE REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE
|
7
|
8.68e-01
|
9.72e-01
|
0.11200
|
-2.59e-02
|
-1.09e-01
|
9.05e-01
|
6.17e-01
|
GOBP ACTIVIN RECEPTOR SIGNALING PATHWAY
|
43
|
4.68e-01
|
8.51e-01
|
0.11200
|
-3.77e-02
|
1.06e-01
|
6.69e-01
|
2.30e-01
|
GOBP CYTOSKELETON DEPENDENT CYTOKINESIS
|
113
|
1.45e-01
|
6.29e-01
|
0.11200
|
-9.75e-02
|
5.55e-02
|
7.35e-02
|
3.08e-01
|
GOBP PYRIMIDINE DIMER REPAIR
|
9
|
8.48e-01
|
9.66e-01
|
0.11200
|
2.16e-02
|
-1.10e-01
|
9.11e-01
|
5.68e-01
|
GOBP POSITIVE REGULATION OF INTRACELLULAR TRANSPORT
|
189
|
4.15e-02
|
4.20e-01
|
0.11200
|
-9.30e-02
|
6.26e-02
|
2.74e-02
|
1.38e-01
|
GOBP REGULATION OF VESICLE MEDIATED TRANSPORT
|
503
|
2.03e-04
|
1.53e-02
|
0.11200
|
-1.01e-01
|
4.91e-02
|
1.10e-04
|
5.92e-02
|
GOBP MACROMOLECULE METHYLATION
|
196
|
1.58e-02
|
2.65e-01
|
0.11200
|
-8.78e-02
|
-6.96e-02
|
3.40e-02
|
9.31e-02
|
GOCC ENDOSOME LUMEN
|
39
|
4.36e-01
|
8.39e-01
|
0.11200
|
-6.83e-02
|
-8.88e-02
|
4.61e-01
|
3.37e-01
|
GOBP RESPONSE TO TESTOSTERONE
|
41
|
4.23e-01
|
8.34e-01
|
0.11200
|
-5.34e-02
|
-9.85e-02
|
5.54e-01
|
2.75e-01
|
GOCC AMINOACYL TRNA SYNTHETASE MULTIENZYME COMPLEX
|
10
|
8.38e-01
|
9.64e-01
|
0.11200
|
3.45e-02
|
-1.07e-01
|
8.50e-01
|
5.60e-01
|
GOBP REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY
|
34
|
4.95e-01
|
8.58e-01
|
0.11200
|
-4.35e-02
|
-1.03e-01
|
6.61e-01
|
2.98e-01
|
GOBP BONE MINERALIZATION
|
116
|
1.43e-01
|
6.28e-01
|
0.11200
|
-9.02e-02
|
6.63e-02
|
9.34e-02
|
2.17e-01
|
GOBP ACID SECRETION
|
43
|
4.86e-01
|
8.56e-01
|
0.11200
|
-8.80e-02
|
6.92e-02
|
3.18e-01
|
4.33e-01
|
GOMF RNA NUCLEASE ACTIVITY
|
128
|
6.76e-02
|
4.99e-01
|
0.11200
|
-6.17e-02
|
-9.33e-02
|
2.28e-01
|
6.82e-02
|
GOCC MEMBRANE COAT
|
93
|
1.72e-01
|
6.60e-01
|
0.11200
|
-1.12e-01
|
1.10e-03
|
6.23e-02
|
9.85e-01
|
GOBP GLUCOSE IMPORT ACROSS PLASMA MEMBRANE
|
5
|
9.19e-01
|
9.84e-01
|
0.11200
|
-5.82e-02
|
9.55e-02
|
8.22e-01
|
7.12e-01
|
GOBP CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS
|
266
|
1.11e-02
|
2.24e-01
|
0.11200
|
-9.89e-02
|
5.23e-02
|
5.50e-03
|
1.42e-01
|
GOBP GLIAL CELL MIGRATION
|
57
|
3.71e-01
|
8.09e-01
|
0.11200
|
-4.25e-02
|
1.03e-01
|
5.79e-01
|
1.77e-01
|
GOBP REGULATION OF DEFENSE RESPONSE TO VIRUS
|
92
|
1.43e-01
|
6.28e-01
|
0.11200
|
-6.53e-02
|
-9.08e-02
|
2.79e-01
|
1.32e-01
|
GOBP NUCLEOTIDE TRANSMEMBRANE TRANSPORT
|
26
|
5.84e-01
|
8.90e-01
|
0.11200
|
-1.03e-01
|
-4.39e-02
|
3.64e-01
|
6.99e-01
|
GOMF TRANSCRIPTION COREGULATOR ACTIVITY
|
460
|
4.13e-04
|
2.73e-02
|
0.11200
|
-1.02e-01
|
4.64e-02
|
1.84e-04
|
8.79e-02
|
GOBP REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS
|
159
|
6.86e-02
|
5.00e-01
|
0.11200
|
-9.56e-02
|
5.78e-02
|
3.74e-02
|
2.08e-01
|
GOBP INTESTINAL ABSORPTION
|
41
|
4.36e-01
|
8.39e-01
|
0.11200
|
-1.07e-01
|
-3.21e-02
|
2.36e-01
|
7.22e-01
|
GOMF WNT PROTEIN BINDING
|
31
|
5.17e-01
|
8.69e-01
|
0.11200
|
8.26e-02
|
7.53e-02
|
4.26e-01
|
4.68e-01
|
GOCC CELL BODY FIBER
|
7
|
8.82e-01
|
9.75e-01
|
0.11200
|
1.08e-01
|
-2.72e-02
|
6.20e-01
|
9.01e-01
|
GOCC CELL TIP
|
5
|
9.20e-01
|
9.84e-01
|
0.11200
|
7.06e-02
|
-8.65e-02
|
7.84e-01
|
7.38e-01
|
GOBP RESPONSE TO FUNGUS
|
59
|
3.31e-01
|
7.85e-01
|
0.11200
|
-4.48e-03
|
1.12e-01
|
9.53e-01
|
1.38e-01
|
GOBP DNA REPLICATION
|
272
|
3.64e-03
|
1.23e-01
|
0.11200
|
-9.82e-02
|
-5.32e-02
|
5.32e-03
|
1.31e-01
|
GOBP NEGATIVE REGULATION OF KIDNEY DEVELOPMENT
|
5
|
9.12e-01
|
9.82e-01
|
0.11200
|
1.23e-02
|
-1.11e-01
|
9.62e-01
|
6.68e-01
|
GOBP CELLULAR RESPONSE TO LEPTIN STIMULUS
|
17
|
7.01e-01
|
9.22e-01
|
0.11200
|
-5.61e-02
|
-9.65e-02
|
6.89e-01
|
4.91e-01
|
GOMF MODIFIED AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY
|
35
|
4.93e-01
|
8.58e-01
|
0.11100
|
3.41e-02
|
1.06e-01
|
7.27e-01
|
2.77e-01
|
GOBP CELLULAR RESPONSE TO UNFOLDED PROTEIN
|
88
|
2.09e-01
|
6.97e-01
|
0.11100
|
-1.08e-01
|
2.60e-02
|
7.87e-02
|
6.73e-01
|
GOBP MULTICELLULAR ORGANISMAL RESPONSE TO STRESS
|
89
|
1.64e-01
|
6.49e-01
|
0.11100
|
1.04e-01
|
4.00e-02
|
9.05e-02
|
5.14e-01
|
GOBP REGULATION OF METAL ION TRANSPORT
|
380
|
7.51e-04
|
4.27e-02
|
0.11100
|
1.04e-02
|
1.11e-01
|
7.27e-01
|
2.09e-04
|
GOBP HISTONE MRNA METABOLIC PROCESS
|
24
|
6.25e-01
|
9.01e-01
|
0.11100
|
-1.99e-02
|
-1.09e-01
|
8.66e-01
|
3.53e-01
|
GOCC PERINUCLEAR ENDOPLASMIC RETICULUM
|
19
|
7.23e-01
|
9.30e-01
|
0.11100
|
-1.01e-01
|
4.62e-02
|
4.45e-01
|
7.27e-01
|
GOBP HYDROGEN PEROXIDE METABOLIC PROCESS
|
49
|
4.42e-01
|
8.40e-01
|
0.11100
|
9.15e-02
|
-6.31e-02
|
2.68e-01
|
4.45e-01
|
GOCC SECRETORY GRANULE MEMBRANE
|
303
|
4.17e-03
|
1.32e-01
|
0.11100
|
-1.11e-01
|
1.16e-02
|
9.32e-04
|
7.28e-01
|
GOBP ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY
|
223
|
2.56e-02
|
3.32e-01
|
0.11100
|
-6.75e-02
|
8.83e-02
|
8.24e-02
|
2.31e-02
|
GOCC MIDBODY
|
196
|
3.23e-02
|
3.67e-01
|
0.11100
|
-1.07e-01
|
2.84e-02
|
9.50e-03
|
4.92e-01
|
GOBP NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY
|
134
|
8.11e-02
|
5.31e-01
|
0.11100
|
1.67e-03
|
1.11e-01
|
9.73e-01
|
2.64e-02
|
GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY
|
62
|
3.36e-01
|
7.88e-01
|
0.11100
|
-1.07e-01
|
2.87e-02
|
1.44e-01
|
6.96e-01
|
GOMF ENDONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 3 PHOSPHOMONOESTERS
|
17
|
7.49e-01
|
9.40e-01
|
0.11100
|
-4.70e-02
|
1.01e-01
|
7.37e-01
|
4.72e-01
|
GOBP L GLUTAMATE TRANSMEMBRANE TRANSPORT
|
28
|
6.08e-01
|
8.97e-01
|
0.11100
|
1.08e-01
|
-2.51e-02
|
3.22e-01
|
8.18e-01
|
GOMF DISULFIDE OXIDOREDUCTASE ACTIVITY
|
34
|
5.28e-01
|
8.72e-01
|
0.11100
|
-1.11e-01
|
-6.37e-04
|
2.62e-01
|
9.95e-01
|
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE
|
61
|
2.79e-01
|
7.52e-01
|
0.11100
|
-6.73e-02
|
-8.84e-02
|
3.63e-01
|
2.32e-01
|
GOBP EXOCRINE PANCREAS DEVELOPMENT
|
7
|
8.72e-01
|
9.73e-01
|
0.11100
|
-1.85e-02
|
-1.10e-01
|
9.33e-01
|
6.16e-01
|
GOBP LIPID BIOSYNTHETIC PROCESS
|
705
|
4.57e-06
|
8.51e-04
|
0.11100
|
-1.09e-01
|
1.91e-02
|
7.36e-07
|
3.88e-01
|
GOBP ACTIVATION OF INNATE IMMUNE RESPONSE
|
261
|
4.43e-03
|
1.36e-01
|
0.11100
|
-8.50e-02
|
-7.14e-02
|
1.80e-02
|
4.69e-02
|
GOCC CAVEOLA
|
81
|
1.84e-01
|
6.73e-01
|
0.11100
|
7.33e-02
|
8.33e-02
|
2.54e-01
|
1.95e-01
|
GOBP REGULATION OF CELL SUBSTRATE ADHESION
|
213
|
2.08e-02
|
3.05e-01
|
0.11100
|
-9.16e-03
|
1.11e-01
|
8.18e-01
|
5.43e-03
|
GOMF FLIPPASE ACTIVITY
|
15
|
7.81e-01
|
9.52e-01
|
0.11100
|
-7.48e-02
|
8.18e-02
|
6.16e-01
|
5.83e-01
|
GOCC TRIGLYCERIDE RICH PLASMA LIPOPROTEIN PARTICLE
|
19
|
6.84e-01
|
9.17e-01
|
0.11100
|
-3.22e-02
|
-1.06e-01
|
8.08e-01
|
4.23e-01
|
GOBP REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION
|
19
|
7.22e-01
|
9.30e-01
|
0.11100
|
-1.03e-01
|
4.08e-02
|
4.36e-01
|
7.58e-01
|
GOBP RESPONSE TO CAFFEINE
|
15
|
7.37e-01
|
9.35e-01
|
0.11100
|
1.02e-01
|
4.42e-02
|
4.95e-01
|
7.67e-01
|
GOMF GAMMA AMINOBUTYRIC ACID SODIUM CHLORIDE SYMPORTER ACTIVITY
|
5
|
9.03e-01
|
9.80e-01
|
0.11100
|
1.01e-01
|
4.53e-02
|
6.96e-01
|
8.61e-01
|
GOMF RETINOIC ACID BINDING
|
27
|
5.90e-01
|
8.92e-01
|
0.11100
|
1.08e-01
|
2.28e-02
|
3.30e-01
|
8.38e-01
|
GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION
|
23
|
6.21e-01
|
9.00e-01
|
0.11100
|
-9.24e-02
|
-6.11e-02
|
4.43e-01
|
6.12e-01
|
GOMF HSP90 PROTEIN BINDING
|
40
|
4.93e-01
|
8.58e-01
|
0.11100
|
2.41e-02
|
-1.08e-01
|
7.92e-01
|
2.37e-01
|
GOBP RENAL ABSORPTION
|
32
|
5.87e-01
|
8.91e-01
|
0.11100
|
-5.61e-02
|
9.55e-02
|
5.83e-01
|
3.50e-01
|
GOBP REGULATION OF ENDOCRINE PROCESS
|
39
|
4.45e-01
|
8.40e-01
|
0.11100
|
-6.46e-02
|
-8.99e-02
|
4.85e-01
|
3.31e-01
|
GOBP T TUBULE ORGANIZATION
|
6
|
8.82e-01
|
9.75e-01
|
0.11100
|
-7.69e-02
|
-7.96e-02
|
7.44e-01
|
7.35e-01
|
GOBP SYNAPTIC VESICLE PRIMING
|
18
|
7.11e-01
|
9.26e-01
|
0.11100
|
1.10e-01
|
8.87e-03
|
4.18e-01
|
9.48e-01
|
GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY
|
8
|
8.74e-01
|
9.74e-01
|
0.11100
|
-9.96e-02
|
4.82e-02
|
6.26e-01
|
8.13e-01
|
GOBP REGULATION OF STEROID HORMONE SECRETION
|
22
|
6.39e-01
|
9.06e-01
|
0.11100
|
-9.99e-02
|
-4.76e-02
|
4.17e-01
|
6.99e-01
|
GOBP ADENOSINE TRANSPORT
|
5
|
9.17e-01
|
9.83e-01
|
0.11100
|
-3.52e-02
|
1.05e-01
|
8.91e-01
|
6.85e-01
|
GOBP BONE DEVELOPMENT
|
203
|
3.40e-02
|
3.76e-01
|
0.11100
|
-4.96e-02
|
9.89e-02
|
2.24e-01
|
1.52e-02
|
GOBP VASCULAR ENDOTHELIAL CELL PROLIFERATION
|
49
|
4.12e-01
|
8.28e-01
|
0.11100
|
1.10e-01
|
-1.16e-02
|
1.83e-01
|
8.89e-01
|
GOMF KINASE ACTIVITY
|
706
|
1.28e-05
|
1.92e-03
|
0.11100
|
-9.05e-02
|
6.34e-02
|
4.14e-05
|
4.09e-03
|
GOBP NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION
|
21
|
6.98e-01
|
9.21e-01
|
0.11100
|
-1.04e-01
|
3.79e-02
|
4.10e-01
|
7.64e-01
|
GOBP NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION
|
49
|
4.41e-01
|
8.40e-01
|
0.11100
|
-9.80e-02
|
5.11e-02
|
2.35e-01
|
5.36e-01
|
GOBP DETECTION OF BIOTIC STIMULUS
|
37
|
4.71e-01
|
8.51e-01
|
0.11000
|
-9.85e-02
|
-5.01e-02
|
3.00e-01
|
5.98e-01
|
GOBP LYMPHOCYTE APOPTOTIC PROCESS
|
80
|
2.46e-01
|
7.26e-01
|
0.11000
|
-2.49e-02
|
1.08e-01
|
7.00e-01
|
9.61e-02
|
GOCC CONDENSED CHROMOSOME CENTROMERIC REGION
|
171
|
2.94e-02
|
3.57e-01
|
0.11000
|
-7.12e-02
|
-8.45e-02
|
1.08e-01
|
5.66e-02
|
GOBP ELECTRON TRANSPORT CHAIN
|
155
|
4.38e-02
|
4.29e-01
|
0.11000
|
-4.76e-02
|
-9.97e-02
|
3.06e-01
|
3.22e-02
|
GOMF SIGNALING RECEPTOR INHIBITOR ACTIVITY
|
27
|
5.76e-01
|
8.89e-01
|
0.11000
|
-9.67e-02
|
-5.33e-02
|
3.84e-01
|
6.32e-01
|
GOBP S ADENOSYLMETHIONINE METABOLIC PROCESS
|
15
|
7.42e-01
|
9.37e-01
|
0.11000
|
-3.38e-02
|
-1.05e-01
|
8.21e-01
|
4.81e-01
|
GOBP NEGATIVE REGULATION OF AXONOGENESIS
|
60
|
2.88e-01
|
7.59e-01
|
0.11000
|
7.96e-02
|
7.65e-02
|
2.86e-01
|
3.05e-01
|
GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY
|
83
|
2.19e-01
|
7.07e-01
|
0.11000
|
-1.10e-01
|
4.26e-03
|
8.23e-02
|
9.47e-01
|
GOMF IRON ION BINDING
|
146
|
7.43e-02
|
5.15e-01
|
0.11000
|
1.09e-01
|
-1.53e-02
|
2.26e-02
|
7.50e-01
|
GOBP PROTEIN LOCALIZATION TO CHROMATIN
|
56
|
3.99e-01
|
8.25e-01
|
0.11000
|
-6.10e-02
|
9.19e-02
|
4.30e-01
|
2.34e-01
|
GOBP LONG CHAIN FATTY ACID CATABOLIC PROCESS
|
8
|
8.59e-01
|
9.68e-01
|
0.11000
|
-1.10e-01
|
-1.15e-02
|
5.91e-01
|
9.55e-01
|
GOMF DYNEIN LIGHT INTERMEDIATE CHAIN BINDING
|
28
|
6.17e-01
|
9.00e-01
|
0.11000
|
-1.05e-01
|
3.33e-02
|
3.35e-01
|
7.61e-01
|
GOBP HEMATOPOIETIC STEM CELL PROLIFERATION
|
33
|
5.70e-01
|
8.86e-01
|
0.11000
|
-1.03e-01
|
3.88e-02
|
3.05e-01
|
7.00e-01
|
GOBP REGULATION OF MRNA EXPORT FROM NUCLEUS
|
7
|
8.92e-01
|
9.76e-01
|
0.11000
|
-7.02e-02
|
8.51e-02
|
7.48e-01
|
6.97e-01
|
GOBP RESPONSE TO COCAINE
|
47
|
4.46e-01
|
8.41e-01
|
0.11000
|
-3.43e-02
|
1.05e-01
|
6.84e-01
|
2.14e-01
|
GOBP NEGATIVE REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS
|
5
|
9.09e-01
|
9.81e-01
|
0.11000
|
-1.69e-02
|
-1.09e-01
|
9.48e-01
|
6.73e-01
|
GOBP REGULATION OF INSULIN SECRETION
|
161
|
6.65e-02
|
4.98e-01
|
0.11000
|
-1.02e-01
|
4.11e-02
|
2.51e-02
|
3.68e-01
|
GOBP POSITIVE REGULATION OF VESICLE FUSION
|
11
|
8.00e-01
|
9.56e-01
|
0.11000
|
-9.87e-02
|
-4.90e-02
|
5.71e-01
|
7.78e-01
|
GOBP PROSTANOID BIOSYNTHETIC PROCESS
|
31
|
5.42e-01
|
8.78e-01
|
0.11000
|
-3.42e-02
|
-1.05e-01
|
7.42e-01
|
3.13e-01
|
GOMF NADPLUS BINDING
|
18
|
7.03e-01
|
9.23e-01
|
0.11000
|
-1.07e-01
|
-2.80e-02
|
4.34e-01
|
8.37e-01
|
GOBP CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION
|
51
|
3.49e-01
|
7.96e-01
|
0.11000
|
8.59e-02
|
6.90e-02
|
2.89e-01
|
3.94e-01
|
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS
|
91
|
2.22e-01
|
7.11e-01
|
0.11000
|
-9.70e-02
|
5.22e-02
|
1.10e-01
|
3.89e-01
|
GOBP SPERMIDINE METABOLIC PROCESS
|
6
|
8.98e-01
|
9.78e-01
|
0.11000
|
1.45e-02
|
-1.09e-01
|
9.51e-01
|
6.43e-01
|
GOBP NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION
|
14
|
7.66e-01
|
9.46e-01
|
0.11000
|
-1.38e-02
|
-1.09e-01
|
9.29e-01
|
4.79e-01
|
GOBP IMPORT INTO CELL
|
898
|
8.38e-07
|
2.60e-04
|
0.11000
|
-8.27e-02
|
7.26e-02
|
2.60e-05
|
2.22e-04
|
GOMF CELL CELL ADHESION MEDIATOR ACTIVITY
|
51
|
4.33e-01
|
8.37e-01
|
0.11000
|
9.42e-02
|
-5.69e-02
|
2.44e-01
|
4.82e-01
|
GOCC ORGANELLE MEMBRANE CONTACT SITE
|
44
|
4.64e-01
|
8.48e-01
|
0.11000
|
-1.07e-01
|
2.37e-02
|
2.18e-01
|
7.86e-01
|
GOBP NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS
|
44
|
4.22e-01
|
8.34e-01
|
0.11000
|
-1.05e-01
|
-3.16e-02
|
2.27e-01
|
7.17e-01
|
GOBP METANEPHRIC RENAL VESICLE MORPHOGENESIS
|
14
|
7.52e-01
|
9.41e-01
|
0.11000
|
-9.49e-02
|
-5.55e-02
|
5.39e-01
|
7.19e-01
|
GOBP POSITIVE REGULATION OF CELL DEVELOPMENT
|
426
|
1.11e-03
|
5.48e-02
|
0.11000
|
-6.37e-02
|
8.96e-02
|
2.41e-02
|
1.52e-03
|
GOBP SUBPALLIUM DEVELOPMENT
|
26
|
6.51e-01
|
9.07e-01
|
0.11000
|
9.74e-02
|
-5.09e-02
|
3.90e-01
|
6.53e-01
|
GOBP PROTEIN LOCALIZATION TO CELL JUNCTION
|
102
|
1.88e-01
|
6.81e-01
|
0.11000
|
-5.38e-02
|
9.57e-02
|
3.48e-01
|
9.47e-02
|
GOBP REPRODUCTIVE BEHAVIOR
|
42
|
4.81e-01
|
8.54e-01
|
0.11000
|
-2.26e-02
|
1.07e-01
|
8.00e-01
|
2.28e-01
|
GOMF ORGANIC ACID SODIUM SYMPORTER ACTIVITY
|
34
|
5.04e-01
|
8.64e-01
|
0.11000
|
9.67e-02
|
5.20e-02
|
3.29e-01
|
6.00e-01
|
GOBP GLYCOPROTEIN BIOSYNTHETIC PROCESS
|
290
|
5.83e-03
|
1.60e-01
|
0.11000
|
-1.09e-01
|
8.86e-03
|
1.35e-03
|
7.95e-01
|
GOCC CLATHRIN COATED PIT
|
73
|
3.00e-01
|
7.67e-01
|
0.11000
|
-4.94e-02
|
9.80e-02
|
4.66e-01
|
1.48e-01
|
GOBP AMINO ACID BIOSYNTHETIC PROCESS
|
73
|
2.33e-01
|
7.20e-01
|
0.11000
|
-4.67e-02
|
-9.93e-02
|
4.91e-01
|
1.42e-01
|
GOMF PH DOMAIN BINDING
|
8
|
8.49e-01
|
9.66e-01
|
0.11000
|
-7.97e-02
|
-7.54e-02
|
6.96e-01
|
7.12e-01
|
GOBP T HELPER 1 CELL CYTOKINE PRODUCTION
|
8
|
8.56e-01
|
9.68e-01
|
0.11000
|
1.05e-01
|
3.09e-02
|
6.07e-01
|
8.80e-01
|
GOBP RESPONSE TO ACTIVITY
|
72
|
2.89e-01
|
7.60e-01
|
0.11000
|
-1.07e-01
|
2.52e-02
|
1.18e-01
|
7.12e-01
|
GOBP REGULATION OF LYASE ACTIVITY
|
57
|
3.87e-01
|
8.19e-01
|
0.11000
|
1.01e-01
|
-4.16e-02
|
1.86e-01
|
5.87e-01
|
GOBP REGULATION OF JUN KINASE ACTIVITY
|
44
|
4.21e-01
|
8.33e-01
|
0.11000
|
-1.03e-01
|
-3.81e-02
|
2.39e-01
|
6.62e-01
|
GOBP ACTOMYOSIN STRUCTURE ORGANIZATION
|
205
|
3.29e-02
|
3.70e-01
|
0.10900
|
-3.78e-02
|
1.03e-01
|
3.51e-01
|
1.12e-02
|
GOBP REGULATION OF BONE REMODELING
|
49
|
4.48e-01
|
8.42e-01
|
0.10900
|
-5.17e-02
|
9.65e-02
|
5.31e-01
|
2.43e-01
|
GOBP POLYAMINE TRANSPORT
|
16
|
7.25e-01
|
9.30e-01
|
0.10900
|
9.57e-02
|
5.32e-02
|
5.08e-01
|
7.13e-01
|
GOMF CHROMATIN BINDING
|
551
|
9.60e-05
|
9.04e-03
|
0.10900
|
-1.06e-01
|
2.54e-02
|
1.94e-05
|
3.08e-01
|
GOMF SINGLE STRANDED DNA BINDING
|
114
|
1.12e-01
|
5.91e-01
|
0.10900
|
-2.75e-02
|
-1.06e-01
|
6.13e-01
|
5.10e-02
|
GOBP NEGATIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT
|
95
|
1.89e-01
|
6.83e-01
|
0.10900
|
-1.49e-02
|
1.08e-01
|
8.02e-01
|
6.81e-02
|
GOBP REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION
|
43
|
4.86e-01
|
8.56e-01
|
0.10900
|
-1.03e-01
|
3.55e-02
|
2.41e-01
|
6.87e-01
|
GOBP CATECHOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS
|
22
|
7.03e-01
|
9.23e-01
|
0.10900
|
7.07e-02
|
-8.34e-02
|
5.66e-01
|
4.99e-01
|
GOBP LYMPHOCYTE MIGRATION
|
113
|
1.52e-01
|
6.40e-01
|
0.10900
|
-3.81e-02
|
1.02e-01
|
4.84e-01
|
6.00e-02
|
GOBP POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE REGENERATION
|
5
|
9.09e-01
|
9.81e-01
|
0.10900
|
-1.06e-01
|
-2.53e-02
|
6.81e-01
|
9.22e-01
|
GOMF CYCLASE INHIBITOR ACTIVITY
|
5
|
9.08e-01
|
9.81e-01
|
0.10900
|
-2.83e-02
|
-1.06e-01
|
9.13e-01
|
6.83e-01
|
GOCC CYTOPLASMIC STRESS GRANULE
|
83
|
1.86e-01
|
6.78e-01
|
0.10900
|
-8.28e-02
|
-7.13e-02
|
1.92e-01
|
2.62e-01
|
GOBP PROTEIN SUMOYLATION
|
64
|
3.61e-01
|
8.03e-01
|
0.10900
|
-8.26e-02
|
7.15e-02
|
2.53e-01
|
3.23e-01
|
GOMF P53 BINDING
|
64
|
3.61e-01
|
8.03e-01
|
0.10900
|
-8.49e-02
|
6.85e-02
|
2.40e-01
|
3.43e-01
|
GOBP ACETATE ESTER METABOLIC PROCESS
|
6
|
8.87e-01
|
9.76e-01
|
0.10900
|
-5.07e-02
|
-9.66e-02
|
8.30e-01
|
6.82e-01
|
GOBP CARBOHYDRATE DERIVATIVE TRANSPORT
|
83
|
2.59e-01
|
7.36e-01
|
0.10900
|
-9.78e-02
|
4.81e-02
|
1.23e-01
|
4.49e-01
|
GOBP FACE DEVELOPMENT
|
49
|
4.35e-01
|
8.38e-01
|
0.10900
|
-2.63e-02
|
1.06e-01
|
7.50e-01
|
2.00e-01
|
GOCC UNCONVENTIONAL MYOSIN COMPLEX
|
9
|
8.47e-01
|
9.66e-01
|
0.10900
|
9.82e-03
|
1.09e-01
|
9.59e-01
|
5.73e-01
|
GOBP RESPONSE TO EPIDERMAL GROWTH FACTOR
|
44
|
4.58e-01
|
8.48e-01
|
0.10900
|
-7.31e-03
|
1.09e-01
|
9.33e-01
|
2.12e-01
|
GOBP INTRACELLULAR IRON ION HOMEOSTASIS
|
66
|
2.97e-01
|
7.66e-01
|
0.10900
|
1.04e-02
|
1.08e-01
|
8.84e-01
|
1.28e-01
|
GOBP URATE TRANSPORT
|
11
|
8.03e-01
|
9.57e-01
|
0.10900
|
9.38e-02
|
5.53e-02
|
5.90e-01
|
7.51e-01
|
GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION
|
35
|
5.38e-01
|
8.78e-01
|
0.10900
|
1.09e-01
|
-7.84e-03
|
2.66e-01
|
9.36e-01
|
GOMF ATPASE COUPLED TRANSMEMBRANE TRANSPORTER ACTIVITY
|
92
|
2.26e-01
|
7.14e-01
|
0.10900
|
-9.64e-02
|
5.06e-02
|
1.10e-01
|
4.02e-01
|
GOBP REGULATION OF TRANSLATIONAL TERMINATION
|
8
|
8.57e-01
|
9.68e-01
|
0.10900
|
1.04e-01
|
3.08e-02
|
6.09e-01
|
8.80e-01
|
GOBP NEGATIVE REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY
|
5
|
9.06e-01
|
9.81e-01
|
0.10900
|
-9.88e-02
|
-4.56e-02
|
7.02e-01
|
8.60e-01
|
GOMF LIGAND GATED SODIUM CHANNEL ACTIVITY
|
11
|
8.19e-01
|
9.60e-01
|
0.10900
|
-1.09e-01
|
-3.17e-03
|
5.32e-01
|
9.85e-01
|
GOMF S100 PROTEIN BINDING
|
14
|
7.99e-01
|
9.56e-01
|
0.10900
|
-9.20e-02
|
5.79e-02
|
5.51e-01
|
7.07e-01
|
GOBP POSITIVE REGULATION OF PROTEIN BINDING
|
59
|
3.33e-01
|
7.86e-01
|
0.10900
|
1.77e-02
|
1.07e-01
|
8.14e-01
|
1.54e-01
|
GOBP MITOTIC NUCLEAR MEMBRANE ORGANIZATION
|
10
|
8.37e-01
|
9.64e-01
|
0.10900
|
-1.09e-01
|
3.96e-03
|
5.52e-01
|
9.83e-01
|
GOBP PLASMA MEMBRANE ORGANIZATION
|
161
|
7.86e-02
|
5.26e-01
|
0.10900
|
-8.79e-02
|
6.39e-02
|
5.42e-02
|
1.62e-01
|
GOCC OLIGOSACCHARYLTRANSFERASE COMPLEX
|
13
|
8.00e-01
|
9.56e-01
|
0.10900
|
-1.07e-01
|
2.09e-02
|
5.06e-01
|
8.96e-01
|
GOBP CARDIAC SEPTUM DEVELOPMENT
|
108
|
1.58e-01
|
6.46e-01
|
0.10900
|
-2.01e-02
|
1.07e-01
|
7.18e-01
|
5.52e-02
|
GOBP PROTEIN ACYLATION
|
134
|
9.03e-02
|
5.51e-01
|
0.10900
|
-1.09e-01
|
-2.45e-03
|
3.00e-02
|
9.61e-01
|
GOBP SINOATRIAL NODE DEVELOPMENT
|
12
|
8.11e-01
|
9.59e-01
|
0.10900
|
1.27e-02
|
-1.08e-01
|
9.39e-01
|
5.18e-01
|
GOBP REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY
|
137
|
6.90e-02
|
5.01e-01
|
0.10900
|
-9.81e-02
|
-4.66e-02
|
4.75e-02
|
3.46e-01
|
GOBP SPHINGOLIPID METABOLIC PROCESS
|
162
|
5.91e-02
|
4.73e-01
|
0.10900
|
-1.08e-01
|
8.66e-03
|
1.75e-02
|
8.49e-01
|
GOMF SYMPORTER ACTIVITY
|
146
|
7.01e-02
|
5.04e-01
|
0.10900
|
9.70e-03
|
1.08e-01
|
8.40e-01
|
2.41e-02
|
GOMF ACTIN BINDING
|
415
|
9.14e-04
|
4.87e-02
|
0.10900
|
-1.89e-02
|
1.07e-01
|
5.09e-01
|
1.88e-04
|
GOBP POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT
|
272
|
1.31e-02
|
2.49e-01
|
0.10800
|
-5.00e-02
|
9.63e-02
|
1.56e-01
|
6.27e-03
|
GOMF SCAFFOLD PROTEIN BINDING
|
64
|
3.35e-01
|
7.88e-01
|
0.10800
|
-1.96e-02
|
1.07e-01
|
7.87e-01
|
1.40e-01
|
GOCC VARICOSITY
|
8
|
8.79e-01
|
9.75e-01
|
0.10800
|
-9.64e-02
|
4.98e-02
|
6.37e-01
|
8.07e-01
|
GOBP NEGATIVE REGULATION OF SOMATIC STEM CELL POPULATION MAINTENANCE
|
5
|
9.10e-01
|
9.82e-01
|
0.10800
|
-1.06e-01
|
-2.31e-02
|
6.82e-01
|
9.29e-01
|
GOCC NUCLEAR CHROMOSOME
|
213
|
2.24e-02
|
3.17e-01
|
0.10800
|
-1.08e-01
|
-3.12e-03
|
6.43e-03
|
9.37e-01
|
GOBP WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT
|
12
|
8.26e-01
|
9.62e-01
|
0.10800
|
5.78e-02
|
-9.15e-02
|
7.29e-01
|
5.83e-01
|
GOBP REGULATION OF HORMONE BIOSYNTHETIC PROCESS
|
24
|
6.21e-01
|
9.00e-01
|
0.10800
|
8.85e-02
|
6.24e-02
|
4.53e-01
|
5.97e-01
|
GOBP NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS
|
7
|
8.73e-01
|
9.73e-01
|
0.10800
|
4.26e-02
|
9.95e-02
|
8.45e-01
|
6.48e-01
|
GOBP REGULATION OF CALCIUM MEDIATED SIGNALING
|
81
|
2.50e-01
|
7.28e-01
|
0.10800
|
-1.66e-02
|
1.07e-01
|
7.96e-01
|
9.60e-02
|
GOBP MALE MEIOTIC NUCLEAR DIVISION
|
54
|
4.08e-01
|
8.27e-01
|
0.10800
|
-3.16e-02
|
1.04e-01
|
6.88e-01
|
1.88e-01
|
GOMF U3 SNORNA BINDING
|
10
|
8.41e-01
|
9.66e-01
|
0.10800
|
-1.08e-01
|
1.14e-02
|
5.56e-01
|
9.50e-01
|
GOBP PERK MEDIATED UNFOLDED PROTEIN RESPONSE
|
18
|
7.04e-01
|
9.23e-01
|
0.10800
|
-4.76e-02
|
-9.71e-02
|
7.27e-01
|
4.76e-01
|
GOMF TOXIC SUBSTANCE BINDING
|
10
|
8.32e-01
|
9.64e-01
|
0.10800
|
1.07e-01
|
1.47e-02
|
5.57e-01
|
9.36e-01
|
GOBP DOUBLE STRAND BREAK REPAIR VIA CLASSICAL NONHOMOLOGOUS END JOINING
|
6
|
9.04e-01
|
9.80e-01
|
0.10800
|
-1.05e-01
|
2.65e-02
|
6.57e-01
|
9.11e-01
|
GOMF IMMUNOGLOBULIN RECEPTOR BINDING
|
7
|
8.95e-01
|
9.78e-01
|
0.10800
|
-5.95e-02
|
9.02e-02
|
7.85e-01
|
6.79e-01
|
GOBP REGULATION OF RUFFLE ASSEMBLY
|
31
|
6.07e-01
|
8.97e-01
|
0.10800
|
-4.56e-02
|
9.80e-02
|
6.60e-01
|
3.45e-01
|
GOBP ACTIN FILAMENT BASED PROCESS
|
774
|
4.23e-06
|
8.51e-04
|
0.10800
|
-3.14e-02
|
1.03e-01
|
1.37e-01
|
9.96e-07
|
GOMF METALLOEXOPEPTIDASE ACTIVITY
|
64
|
3.69e-01
|
8.08e-01
|
0.10800
|
-8.32e-02
|
6.89e-02
|
2.50e-01
|
3.40e-01
|
GOBP ODONTOGENESIS OF DENTIN CONTAINING TOOTH
|
90
|
2.26e-01
|
7.14e-01
|
0.10800
|
-3.00e-02
|
1.04e-01
|
6.23e-01
|
8.90e-02
|
GOBP THYROID STIMULATING HORMONE SECRETING CELL DIFFERENTIATION
|
6
|
8.92e-01
|
9.76e-01
|
0.10800
|
3.51e-02
|
1.02e-01
|
8.81e-01
|
6.65e-01
|
GOBP RESPONSE TO AXON INJURY
|
79
|
2.94e-01
|
7.63e-01
|
0.10800
|
-7.56e-02
|
7.69e-02
|
2.45e-01
|
2.37e-01
|
GOBP POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
30
|
5.80e-01
|
8.90e-01
|
0.10800
|
1.26e-02
|
1.07e-01
|
9.05e-01
|
3.10e-01
|
GOBP NEGATIVE REGULATION OF NEURON DIFFERENTIATION
|
72
|
2.58e-01
|
7.35e-01
|
0.10800
|
-1.03e-01
|
-3.11e-02
|
1.30e-01
|
6.48e-01
|
GOBP AMYLOID BETA METABOLIC PROCESS
|
64
|
3.15e-01
|
7.76e-01
|
0.10800
|
-1.07e-01
|
-1.08e-02
|
1.38e-01
|
8.81e-01
|
GOBP DICARBOXYLIC ACID CATABOLIC PROCESS
|
18
|
7.54e-01
|
9.42e-01
|
0.10800
|
-6.15e-02
|
8.85e-02
|
6.52e-01
|
5.16e-01
|
GOBP RIBOSE PHOSPHATE METABOLIC PROCESS
|
361
|
8.82e-04
|
4.77e-02
|
0.10800
|
-7.39e-02
|
-7.84e-02
|
1.59e-02
|
1.05e-02
|
GOBP REGULATION OF CYCLASE ACTIVITY
|
53
|
4.02e-01
|
8.26e-01
|
0.10800
|
1.07e-01
|
-1.03e-02
|
1.77e-01
|
8.97e-01
|
GOBP FOLIC ACID CONTAINING COMPOUND BIOSYNTHETIC PROCESS
|
7
|
8.81e-01
|
9.75e-01
|
0.10800
|
-9.57e-03
|
-1.07e-01
|
9.65e-01
|
6.23e-01
|
GOBP REGULATION OF HYDROGEN PEROXIDE MEDIATED PROGRAMMED CELL DEATH
|
14
|
7.66e-01
|
9.46e-01
|
0.10800
|
3.64e-02
|
1.01e-01
|
8.14e-01
|
5.11e-01
|
GOBP REGULATION OF VIRAL GENOME REPLICATION
|
83
|
2.01e-01
|
6.91e-01
|
0.10800
|
-9.58e-02
|
-4.93e-02
|
1.32e-01
|
4.38e-01
|
GOMF ATP DEPENDENT CHROMATIN REMODELER ACTIVITY
|
33
|
5.80e-01
|
8.90e-01
|
0.10800
|
-1.04e-01
|
2.91e-02
|
3.03e-01
|
7.73e-01
|
GOMF CHEMOKINE ACTIVITY
|
46
|
4.06e-01
|
8.26e-01
|
0.10800
|
8.79e-02
|
6.22e-02
|
3.02e-01
|
4.65e-01
|
GOBP POSITIVE REGULATION OF NUCLEAR DIVISION
|
60
|
3.09e-01
|
7.72e-01
|
0.10800
|
9.01e-02
|
5.90e-02
|
2.28e-01
|
4.29e-01
|
GOBP NEGATIVE REGULATION OF ENDOCYTOSIS
|
75
|
2.30e-01
|
7.18e-01
|
0.10800
|
-8.83e-02
|
-6.16e-02
|
1.86e-01
|
3.57e-01
|
GOBP PEPTIDYL GLUTAMIC ACID MODIFICATION
|
26
|
5.98e-01
|
8.95e-01
|
0.10800
|
-7.55e-02
|
-7.67e-02
|
5.05e-01
|
4.98e-01
|
GOBP POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA
|
25
|
6.27e-01
|
9.02e-01
|
0.10800
|
-2.75e-02
|
-1.04e-01
|
8.12e-01
|
3.68e-01
|
GOCC ACTOMYOSIN
|
76
|
2.47e-01
|
7.26e-01
|
0.10800
|
2.18e-02
|
1.05e-01
|
7.43e-01
|
1.12e-01
|
GOMF ANKYRIN REPEAT BINDING
|
6
|
9.11e-01
|
9.82e-01
|
0.10800
|
6.79e-02
|
-8.34e-02
|
7.73e-01
|
7.24e-01
|
GOBP POSITIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS
|
90
|
2.22e-01
|
7.11e-01
|
0.10800
|
-1.05e-01
|
2.10e-02
|
8.37e-02
|
7.31e-01
|
GOBP REGULATION OF SYNAPSE ASSEMBLY
|
104
|
1.44e-01
|
6.28e-01
|
0.10800
|
2.90e-02
|
1.04e-01
|
6.09e-01
|
6.81e-02
|
GOMF FRIZZLED BINDING
|
36
|
5.07e-01
|
8.65e-01
|
0.10800
|
3.48e-02
|
1.02e-01
|
7.18e-01
|
2.91e-01
|
GOMF DNA EXONUCLEASE ACTIVITY
|
23
|
6.63e-01
|
9.10e-01
|
0.10800
|
-7.11e-03
|
-1.07e-01
|
9.53e-01
|
3.73e-01
|
GOBP REGULATION OF DENDRITIC SPINE DEVELOPMENT
|
51
|
4.14e-01
|
8.29e-01
|
0.10700
|
-6.03e-03
|
1.07e-01
|
9.41e-01
|
1.85e-01
|
GOMF FIBRONECTIN BINDING
|
29
|
5.69e-01
|
8.86e-01
|
0.10700
|
-9.07e-02
|
-5.76e-02
|
3.98e-01
|
5.91e-01
|
GOBP TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY
|
65
|
2.92e-01
|
7.63e-01
|
0.10700
|
-3.89e-02
|
-1.00e-01
|
5.88e-01
|
1.63e-01
|
GOBP MEMBRANE LIPID METABOLIC PROCESS
|
208
|
2.23e-02
|
3.16e-01
|
0.10700
|
-1.05e-01
|
-2.32e-02
|
9.11e-03
|
5.65e-01
|
GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING
|
24
|
6.24e-01
|
9.01e-01
|
0.10700
|
-7.37e-02
|
-7.81e-02
|
5.32e-01
|
5.08e-01
|
GOBP REACTIVE NITROGEN SPECIES METABOLIC PROCESS
|
76
|
3.09e-01
|
7.72e-01
|
0.10700
|
-6.37e-02
|
8.64e-02
|
3.37e-01
|
1.93e-01
|
GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE
|
37
|
5.62e-01
|
8.84e-01
|
0.10700
|
-8.95e-02
|
5.93e-02
|
3.46e-01
|
5.32e-01
|
GOBP REGULATION OF AXON GUIDANCE
|
13
|
7.82e-01
|
9.52e-01
|
0.10700
|
-1.01e-01
|
-3.59e-02
|
5.28e-01
|
8.23e-01
|
GOBP PROSTATE GLANDULAR ACINUS DEVELOPMENT
|
10
|
8.57e-01
|
9.68e-01
|
0.10700
|
6.63e-02
|
-8.44e-02
|
7.17e-01
|
6.44e-01
|
GOCC CILIARY TRANSITION FIBER
|
8
|
8.76e-01
|
9.75e-01
|
0.10700
|
-1.05e-01
|
2.41e-02
|
6.08e-01
|
9.06e-01
|
GOMF ADP TRANSMEMBRANE TRANSPORTER ACTIVITY
|
9
|
8.56e-01
|
9.68e-01
|
0.10700
|
-1.07e-01
|
7.75e-03
|
5.78e-01
|
9.68e-01
|
GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION
|
40
|
4.69e-01
|
8.51e-01
|
0.10700
|
3.94e-02
|
9.98e-02
|
6.67e-01
|
2.75e-01
|
GOBP RECEPTOR CATABOLIC PROCESS
|
27
|
6.56e-01
|
9.09e-01
|
0.10700
|
-9.25e-02
|
5.42e-02
|
4.05e-01
|
6.26e-01
|
GOCC CLATHRIN COATED ENDOCYTIC VESICLE
|
86
|
2.01e-01
|
6.91e-01
|
0.10700
|
1.02e-01
|
3.22e-02
|
1.01e-01
|
6.06e-01
|
GOCC CLATHRIN COAT OF COATED PIT
|
17
|
7.43e-01
|
9.38e-01
|
0.10700
|
-3.69e-04
|
-1.07e-01
|
9.98e-01
|
4.44e-01
|
GOBP POSITIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION
|
185
|
5.61e-02
|
4.65e-01
|
0.10700
|
-9.45e-02
|
5.04e-02
|
2.66e-02
|
2.37e-01
|
GOBP VESICLE LOCALIZATION
|
208
|
3.70e-02
|
3.91e-01
|
0.10700
|
-9.94e-02
|
3.97e-02
|
1.34e-02
|
3.24e-01
|
GOBP GLOMERULUS DEVELOPMENT
|
68
|
2.66e-01
|
7.42e-01
|
0.10700
|
8.01e-02
|
7.11e-02
|
2.54e-01
|
3.11e-01
|
GOBP PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY
|
103
|
2.06e-01
|
6.95e-01
|
0.10700
|
-6.43e-02
|
8.55e-02
|
2.59e-01
|
1.34e-01
|
GOBP REGULATION OF INTRACELLULAR TRANSPORT
|
319
|
6.56e-03
|
1.68e-01
|
0.10700
|
-9.96e-02
|
3.90e-02
|
2.22e-03
|
2.30e-01
|
GOBP PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL
|
104
|
1.58e-01
|
6.46e-01
|
0.10700
|
-1.06e-01
|
-1.10e-02
|
6.08e-02
|
8.46e-01
|
GOBP REGULATION OF LEUKOCYTE APOPTOTIC PROCESS
|
90
|
1.82e-01
|
6.72e-01
|
0.10700
|
4.53e-02
|
9.69e-02
|
4.58e-01
|
1.12e-01
|
GOBP CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT
|
26
|
6.63e-01
|
9.10e-01
|
0.10700
|
-9.71e-02
|
4.48e-02
|
3.91e-01
|
6.93e-01
|
GOBP PERICARDIUM MORPHOGENESIS
|
8
|
8.81e-01
|
9.75e-01
|
0.10700
|
-9.69e-02
|
4.52e-02
|
6.35e-01
|
8.25e-01
|
GOBP TRYPTOPHAN CATABOLIC PROCESS
|
9
|
8.67e-01
|
9.71e-01
|
0.10700
|
9.82e-02
|
-4.22e-02
|
6.10e-01
|
8.26e-01
|
GOBP SENSORY PERCEPTION OF TEMPERATURE STIMULUS
|
27
|
6.54e-01
|
9.09e-01
|
0.10700
|
9.69e-02
|
-4.48e-02
|
3.83e-01
|
6.87e-01
|
GOBP TRANSDIFFERENTIATION
|
7
|
8.74e-01
|
9.74e-01
|
0.10700
|
8.74e-02
|
6.14e-02
|
6.89e-01
|
7.79e-01
|
GOBP REGULATION OF CARTILAGE DEVELOPMENT
|
70
|
3.26e-01
|
7.82e-01
|
0.10700
|
-3.52e-02
|
1.01e-01
|
6.11e-01
|
1.45e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION
|
207
|
4.37e-02
|
4.28e-01
|
0.10700
|
-8.08e-02
|
6.98e-02
|
4.52e-02
|
8.33e-02
|
GOBP POSITIVE REGULATION OF MONOATOMIC ION TRANSPORT
|
202
|
2.28e-02
|
3.20e-01
|
0.10700
|
4.30e-02
|
9.77e-02
|
2.93e-01
|
1.67e-02
|
GOBP POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS
|
19
|
6.95e-01
|
9.21e-01
|
0.10700
|
-9.28e-02
|
-5.28e-02
|
4.84e-01
|
6.90e-01
|
GOBP GAMMA AMINOBUTYRIC ACID TRANSPORT
|
19
|
6.93e-01
|
9.21e-01
|
0.10700
|
8.58e-02
|
6.35e-02
|
5.17e-01
|
6.32e-01
|
GOBP REGULATION OF GLYCOGEN BIOSYNTHETIC PROCESS
|
30
|
5.83e-01
|
8.90e-01
|
0.10700
|
-1.79e-02
|
-1.05e-01
|
8.65e-01
|
3.19e-01
|
GOCC INTERMEDIATE FILAMENT CYTOSKELETON
|
234
|
1.84e-02
|
2.90e-01
|
0.10700
|
1.07e-01
|
-1.96e-03
|
4.93e-03
|
9.59e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN SECRETION
|
71
|
3.14e-01
|
7.76e-01
|
0.10700
|
-1.04e-01
|
2.48e-02
|
1.31e-01
|
7.17e-01
|
GOBP DETERMINATION OF ADULT LIFESPAN
|
35
|
5.75e-01
|
8.89e-01
|
0.10700
|
-9.86e-02
|
4.08e-02
|
3.13e-01
|
6.76e-01
|
GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN
|
36
|
5.11e-01
|
8.66e-01
|
0.10700
|
-1.00e-01
|
-3.67e-02
|
2.99e-01
|
7.03e-01
|
GOBP MAINTENANCE OF CELL POLARITY
|
17
|
7.72e-01
|
9.48e-01
|
0.10700
|
-8.30e-02
|
6.69e-02
|
5.54e-01
|
6.33e-01
|
GOCC MYOSIN II COMPLEX
|
26
|
6.05e-01
|
8.96e-01
|
0.10700
|
7.68e-02
|
7.38e-02
|
4.98e-01
|
5.15e-01
|
GOBP CARDIAC MUSCLE TISSUE MORPHOGENESIS
|
61
|
3.34e-01
|
7.87e-01
|
0.10700
|
1.98e-02
|
1.05e-01
|
7.89e-01
|
1.57e-01
|
GOBP REGULATION OF TRANSLATIONAL INITIATION
|
76
|
2.58e-01
|
7.35e-01
|
0.10700
|
-1.61e-02
|
-1.05e-01
|
8.08e-01
|
1.12e-01
|
GOBP MITOTIC CELL CYCLE CHECKPOINT SIGNALING
|
139
|
7.72e-02
|
5.23e-01
|
0.10700
|
-3.42e-02
|
-1.01e-01
|
4.86e-01
|
4.00e-02
|
GOBP PHARYNGEAL ARCH ARTERY MORPHOGENESIS
|
10
|
8.26e-01
|
9.62e-01
|
0.10700
|
5.42e-02
|
9.17e-02
|
7.67e-01
|
6.16e-01
|
GOBP TELOMERE ORGANIZATION
|
178
|
4.69e-02
|
4.37e-01
|
0.10600
|
-1.63e-03
|
-1.06e-01
|
9.70e-01
|
1.43e-02
|
GOMF DYNEIN INTERMEDIATE CHAIN BINDING
|
35
|
5.89e-01
|
8.91e-01
|
0.10600
|
-7.17e-02
|
7.87e-02
|
4.63e-01
|
4.21e-01
|
GOCC CEREBELLAR MOSSY FIBER
|
7
|
8.91e-01
|
9.76e-01
|
0.10600
|
1.92e-02
|
-1.05e-01
|
9.30e-01
|
6.32e-01
|
GOBP LIPOPROTEIN LOCALIZATION
|
21
|
7.26e-01
|
9.30e-01
|
0.10600
|
6.26e-02
|
-8.60e-02
|
6.19e-01
|
4.95e-01
|
GOBP LONG CHAIN FATTY ACID TRANSPORT
|
66
|
3.13e-01
|
7.76e-01
|
0.10600
|
1.16e-02
|
1.06e-01
|
8.70e-01
|
1.37e-01
|
GOBP AMMONIUM TRANSMEMBRANE TRANSPORT
|
12
|
8.22e-01
|
9.61e-01
|
0.10600
|
-1.04e-01
|
2.31e-02
|
5.34e-01
|
8.90e-01
|
GOMF AMMONIUM TRANSMEMBRANE TRANSPORTER ACTIVITY
|
12
|
8.22e-01
|
9.61e-01
|
0.10600
|
-1.04e-01
|
2.31e-02
|
5.34e-01
|
8.90e-01
|
GOBP NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION
|
34
|
5.24e-01
|
8.70e-01
|
0.10600
|
-9.10e-02
|
-5.50e-02
|
3.58e-01
|
5.79e-01
|
GOBP NEGATIVE REGULATION OF MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION
|
6
|
8.99e-01
|
9.79e-01
|
0.10600
|
-1.05e-01
|
-1.34e-02
|
6.55e-01
|
9.55e-01
|
GOBP TRANSLATIONAL READTHROUGH
|
9
|
8.54e-01
|
9.68e-01
|
0.10600
|
-9.96e-03
|
-1.06e-01
|
9.59e-01
|
5.83e-01
|
GOBP CELLULAR RESPONSE TO COCAINE
|
8
|
8.62e-01
|
9.69e-01
|
0.10600
|
3.93e-02
|
9.86e-02
|
8.48e-01
|
6.29e-01
|
GOBP UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS
|
49
|
3.91e-01
|
8.21e-01
|
0.10600
|
-7.97e-02
|
-7.01e-02
|
3.35e-01
|
3.96e-01
|
GOMF ACTIVE MONOATOMIC ION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
230
|
2.69e-02
|
3.41e-01
|
0.10600
|
-3.39e-02
|
1.01e-01
|
3.75e-01
|
8.61e-03
|
GOBP CELLULAR RESPONSE TO CHEMICAL STRESS
|
306
|
4.42e-03
|
1.36e-01
|
0.10600
|
-1.04e-01
|
-2.16e-02
|
1.77e-03
|
5.15e-01
|
GOBP TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY
|
55
|
3.55e-01
|
7.97e-01
|
0.10600
|
-9.22e-02
|
-5.23e-02
|
2.37e-01
|
5.03e-01
|
GOCC MESSENGER RIBONUCLEOPROTEIN COMPLEX
|
12
|
7.95e-01
|
9.55e-01
|
0.10600
|
-7.77e-02
|
-7.21e-02
|
6.41e-01
|
6.66e-01
|
GOBP ENDOPLASMIC RETICULUM PLASMA MEMBRANE TETHERING
|
6
|
8.91e-01
|
9.76e-01
|
0.10600
|
-7.65e-02
|
-7.33e-02
|
7.46e-01
|
7.56e-01
|
GOBP IRON ION IMPORT ACROSS PLASMA MEMBRANE
|
5
|
9.12e-01
|
9.82e-01
|
0.10600
|
-3.99e-02
|
-9.81e-02
|
8.77e-01
|
7.04e-01
|
GOBP POSITIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION
|
65
|
2.94e-01
|
7.64e-01
|
0.10600
|
-5.41e-02
|
-9.10e-02
|
4.51e-01
|
2.04e-01
|
GOBP SKIN EPIDERMIS DEVELOPMENT
|
125
|
1.36e-01
|
6.18e-01
|
0.10600
|
-2.63e-02
|
1.02e-01
|
6.11e-01
|
4.78e-02
|
GOMF BASAL TRANSCRIPTION MACHINERY BINDING
|
58
|
3.66e-01
|
8.06e-01
|
0.10600
|
-1.05e-01
|
-9.85e-03
|
1.66e-01
|
8.97e-01
|
GOBP REGULATION OF DNA BINDING
|
82
|
2.28e-01
|
7.15e-01
|
0.10600
|
-2.97e-02
|
-1.01e-01
|
6.42e-01
|
1.12e-01
|
GOMF PROTEIN SERINE THREONINE KINASE ACTIVITY
|
405
|
2.61e-03
|
9.94e-02
|
0.10600
|
-8.05e-02
|
6.84e-02
|
5.44e-03
|
1.81e-02
|
GOBP NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS
|
39
|
4.78e-01
|
8.54e-01
|
0.10600
|
8.24e-02
|
6.61e-02
|
3.73e-01
|
4.75e-01
|
GOBP POSITIVE REGULATION OF ADIPOSE TISSUE DEVELOPMENT
|
10
|
8.46e-01
|
9.66e-01
|
0.10600
|
-1.05e-01
|
6.05e-03
|
5.64e-01
|
9.74e-01
|
GOBP INTERLEUKIN 1 ALPHA PRODUCTION
|
11
|
8.12e-01
|
9.59e-01
|
0.10600
|
-6.35e-02
|
-8.44e-02
|
7.15e-01
|
6.28e-01
|
GOMF ARP2 3 COMPLEX BINDING
|
14
|
7.99e-01
|
9.56e-01
|
0.10600
|
-2.54e-02
|
1.02e-01
|
8.69e-01
|
5.07e-01
|
GOBP HYALURONAN BIOSYNTHETIC PROCESS
|
14
|
7.94e-01
|
9.55e-01
|
0.10600
|
1.05e-01
|
-1.30e-02
|
4.98e-01
|
9.33e-01
|
GOCC VESICLE LUMEN
|
309
|
4.90e-03
|
1.44e-01
|
0.10600
|
-1.05e-01
|
-1.31e-02
|
1.55e-03
|
6.91e-01
|
GOBP POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION
|
71
|
2.68e-01
|
7.43e-01
|
0.10600
|
4.75e-02
|
9.42e-02
|
4.89e-01
|
1.70e-01
|
GOBP CELLULAR RESPONSE TO GONADOTROPIN STIMULUS
|
17
|
7.25e-01
|
9.30e-01
|
0.10500
|
7.88e-02
|
7.01e-02
|
5.74e-01
|
6.17e-01
|
GOBP INTRACILIARY ANTEROGRADE TRANSPORT
|
17
|
7.27e-01
|
9.31e-01
|
0.10500
|
-5.43e-02
|
-9.04e-02
|
6.98e-01
|
5.19e-01
|
GOBP SENSORY PERCEPTION
|
866
|
1.35e-06
|
3.63e-04
|
0.10500
|
1.04e-01
|
-1.78e-02
|
2.07e-07
|
3.74e-01
|
GOMF SNARE BINDING
|
103
|
1.66e-01
|
6.50e-01
|
0.10500
|
-1.04e-01
|
-1.63e-02
|
6.78e-02
|
7.75e-01
|
GOBP MYELOID DENDRITIC CELL ACTIVATION
|
29
|
5.92e-01
|
8.93e-01
|
0.10500
|
1.01e-01
|
3.17e-02
|
3.49e-01
|
7.68e-01
|
GOBP L GLUTAMATE IMPORT
|
38
|
5.15e-01
|
8.68e-01
|
0.10500
|
1.04e-01
|
1.49e-02
|
2.66e-01
|
8.74e-01
|
GOBP FERTILIZATION
|
194
|
2.65e-02
|
3.40e-01
|
0.10500
|
-6.48e-02
|
-8.31e-02
|
1.20e-01
|
4.60e-02
|
GOBP REGULATION OF MONOATOMIC ION TRANSPORT
|
544
|
8.68e-05
|
8.37e-03
|
0.10500
|
1.90e-02
|
1.04e-01
|
4.49e-01
|
3.54e-05
|
GOBP RESPONSE TO INTERFERON ALPHA
|
17
|
7.76e-01
|
9.50e-01
|
0.10500
|
8.58e-02
|
-6.10e-02
|
5.40e-01
|
6.63e-01
|
GOBP MYELIN ASSEMBLY
|
24
|
6.98e-01
|
9.21e-01
|
0.10500
|
-8.81e-02
|
5.77e-02
|
4.55e-01
|
6.25e-01
|
GOBP RESPONSE TO INTERLEUKIN 9
|
5
|
9.12e-01
|
9.82e-01
|
0.10500
|
-9.42e-02
|
-4.69e-02
|
7.15e-01
|
8.56e-01
|
GOBP REGULATION OF ATP METABOLIC PROCESS
|
22
|
7.21e-01
|
9.30e-01
|
0.10500
|
-6.37e-02
|
8.38e-02
|
6.05e-01
|
4.96e-01
|
GOBP NEGATIVE REGULATION OF SECRETION
|
163
|
7.57e-02
|
5.19e-01
|
0.10500
|
-1.03e-01
|
2.28e-02
|
2.38e-02
|
6.15e-01
|
GOBP SHORT TERM MEMORY
|
10
|
8.57e-01
|
9.68e-01
|
0.10500
|
-9.84e-02
|
3.68e-02
|
5.90e-01
|
8.40e-01
|
GOBP REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA
|
44
|
4.38e-01
|
8.40e-01
|
0.10500
|
-6.79e-02
|
-8.01e-02
|
4.36e-01
|
3.58e-01
|
GOBP REGULATION OF EXOCYTOSIS
|
175
|
7.60e-02
|
5.19e-01
|
0.10500
|
-6.20e-02
|
8.47e-02
|
1.57e-01
|
5.31e-02
|
GOBP PROTEIN AUTO ADP RIBOSYLATION
|
11
|
8.46e-01
|
9.66e-01
|
0.10500
|
-9.56e-02
|
4.32e-02
|
5.83e-01
|
8.04e-01
|
GOMF NUCLEAR RETINOIC ACID RECEPTOR BINDING
|
26
|
6.15e-01
|
8.99e-01
|
0.10500
|
-8.24e-02
|
-6.50e-02
|
4.67e-01
|
5.66e-01
|
GOCC PROTEASOME ACCESSORY COMPLEX
|
23
|
7.13e-01
|
9.27e-01
|
0.10500
|
7.51e-02
|
-7.32e-02
|
5.33e-01
|
5.43e-01
|
GOMF COPPER ION BINDING
|
58
|
4.19e-01
|
8.32e-01
|
0.10500
|
4.91e-02
|
-9.27e-02
|
5.18e-01
|
2.22e-01
|
GOCC DENDRITIC SPINE HEAD
|
7
|
8.96e-01
|
9.78e-01
|
0.10500
|
-1.01e-01
|
2.73e-02
|
6.43e-01
|
9.00e-01
|
GOBP MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS
|
158
|
6.87e-02
|
5.00e-01
|
0.10500
|
-1.04e-01
|
-8.99e-03
|
2.35e-02
|
8.45e-01
|
GOBP DOPAMINERGIC NEURON DIFFERENTIATION
|
40
|
4.88e-01
|
8.56e-01
|
0.10500
|
-9.90e-02
|
-3.44e-02
|
2.79e-01
|
7.07e-01
|
GOBP REGULATION OF MEGAKARYOCYTE DIFFERENTIATION
|
35
|
5.51e-01
|
8.80e-01
|
0.10500
|
1.04e-01
|
9.33e-03
|
2.85e-01
|
9.24e-01
|
GOBP REGULATION OF AMINE METABOLIC PROCESS
|
31
|
5.93e-01
|
8.94e-01
|
0.10500
|
1.05e-01
|
4.13e-03
|
3.13e-01
|
9.68e-01
|
GOBP DEFENSE RESPONSE TO SYMBIONT
|
320
|
2.83e-03
|
1.04e-01
|
0.10500
|
-6.00e-02
|
-8.59e-02
|
6.50e-02
|
8.27e-03
|
GOMF LIPOPOLYSACCHARIDE BINDING
|
38
|
5.43e-01
|
8.78e-01
|
0.10500
|
-1.03e-01
|
1.63e-02
|
2.70e-01
|
8.62e-01
|
GOBP ACTIN FILAMENT SEVERING
|
16
|
7.89e-01
|
9.54e-01
|
0.10500
|
-5.94e-02
|
8.63e-02
|
6.81e-01
|
5.50e-01
|
GOBP PURINE NUCLEOBASE METABOLIC PROCESS
|
19
|
7.50e-01
|
9.40e-01
|
0.10500
|
9.53e-02
|
-4.34e-02
|
4.72e-01
|
7.43e-01
|
GOBP REGULATION OF ASYMMETRIC CELL DIVISION
|
5
|
9.12e-01
|
9.82e-01
|
0.10500
|
-4.90e-02
|
-9.25e-02
|
8.50e-01
|
7.20e-01
|
GOBP REGULATION OF MAP KINASE ACTIVITY
|
140
|
1.26e-01
|
6.06e-01
|
0.10500
|
-9.03e-02
|
5.29e-02
|
6.52e-02
|
2.80e-01
|
GOBP CELLULAR RESPONSE TO LIGHT STIMULUS
|
114
|
1.45e-01
|
6.29e-01
|
0.10500
|
-1.04e-01
|
-9.89e-03
|
5.48e-02
|
8.55e-01
|
GOBP SMALL MOLECULE BIOSYNTHETIC PROCESS
|
577
|
2.78e-05
|
3.54e-03
|
0.10500
|
-7.37e-02
|
-7.42e-02
|
2.48e-03
|
2.31e-03
|
GOMF NUCLEOTIDYLTRANSFERASE ACTIVITY
|
137
|
8.66e-02
|
5.46e-01
|
0.10500
|
-9.80e-02
|
-3.65e-02
|
4.76e-02
|
4.61e-01
|
GOBP REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY
|
25
|
6.86e-01
|
9.18e-01
|
0.10500
|
-4.36e-02
|
9.51e-02
|
7.06e-01
|
4.11e-01
|
GOBP REGULATION OF PROTEIN KINASE A SIGNALING
|
20
|
7.33e-01
|
9.33e-01
|
0.10500
|
3.03e-02
|
-1.00e-01
|
8.14e-01
|
4.38e-01
|
GOBP IRON IMPORT INTO CELL
|
10
|
8.61e-01
|
9.69e-01
|
0.10500
|
-4.75e-02
|
9.31e-02
|
7.95e-01
|
6.10e-01
|
GOBP CARBOHYDRATE TRANSMEMBRANE TRANSPORT
|
132
|
1.42e-01
|
6.26e-01
|
0.10500
|
-8.97e-02
|
5.36e-02
|
7.50e-02
|
2.87e-01
|
GOBP MUSCLE CELL APOPTOTIC PROCESS
|
91
|
1.87e-01
|
6.78e-01
|
0.10400
|
-6.16e-02
|
-8.43e-02
|
3.09e-01
|
1.65e-01
|
GOMF PROTEIN DOMAIN SPECIFIC BINDING
|
617
|
1.59e-04
|
1.31e-02
|
0.10400
|
-7.53e-02
|
7.22e-02
|
1.39e-03
|
2.18e-03
|
GOBP NEGATIVE REGULATION OF HEMOPOIESIS
|
114
|
1.27e-01
|
6.07e-01
|
0.10400
|
-9.27e-02
|
-4.80e-02
|
8.74e-02
|
3.76e-01
|
GOMF TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS
|
865
|
3.86e-06
|
8.22e-04
|
0.10400
|
-9.39e-02
|
4.54e-02
|
2.73e-06
|
2.34e-02
|
GOBP POSITIVE REGULATION OF HISTONE ACETYLATION
|
10
|
8.45e-01
|
9.66e-01
|
0.10400
|
-7.71e-03
|
-1.04e-01
|
9.66e-01
|
5.69e-01
|
GOBP REGULATION OF PHOSPHATE TRANSPORT
|
6
|
9.03e-01
|
9.80e-01
|
0.10400
|
1.27e-02
|
1.04e-01
|
9.57e-01
|
6.61e-01
|
GOBP LEUKOCYTE CHEMOTAXIS
|
229
|
3.26e-02
|
3.69e-01
|
0.10400
|
-4.13e-02
|
9.58e-02
|
2.82e-01
|
1.25e-02
|
GOBP RESPONSE TO MINERALOCORTICOID
|
33
|
5.95e-01
|
8.95e-01
|
0.10400
|
-2.03e-02
|
1.02e-01
|
8.40e-01
|
3.09e-01
|
GOBP THYMUS DEVELOPMENT
|
49
|
4.91e-01
|
8.58e-01
|
0.10400
|
-6.93e-02
|
7.79e-02
|
4.02e-01
|
3.46e-01
|
GOBP VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL
|
34
|
5.56e-01
|
8.81e-01
|
0.10400
|
2.06e-02
|
1.02e-01
|
8.36e-01
|
3.03e-01
|
GOBP SISTER CHROMATID SEGREGATION
|
221
|
1.76e-02
|
2.83e-01
|
0.10400
|
-8.28e-02
|
-6.33e-02
|
3.39e-02
|
1.05e-01
|
GOCC CATION CHANNEL COMPLEX
|
188
|
4.22e-02
|
4.24e-01
|
0.10400
|
1.04e-01
|
1.18e-02
|
1.44e-02
|
7.80e-01
|
GOMF VITAMIN TRANSMEMBRANE TRANSPORTER ACTIVITY
|
36
|
5.28e-01
|
8.72e-01
|
0.10400
|
-3.51e-02
|
-9.81e-02
|
7.15e-01
|
3.08e-01
|
GOBP POSITIVE REGULATION OF FEVER GENERATION
|
7
|
8.87e-01
|
9.76e-01
|
0.10400
|
1.03e-01
|
1.61e-02
|
6.37e-01
|
9.41e-01
|
GOBP DNA STRAND ELONGATION
|
36
|
5.57e-01
|
8.82e-01
|
0.10400
|
-1.04e-01
|
5.90e-03
|
2.80e-01
|
9.51e-01
|
GOBP REGULATION OF VITAMIN D BIOSYNTHETIC PROCESS
|
7
|
8.86e-01
|
9.76e-01
|
0.10400
|
-2.28e-02
|
-1.02e-01
|
9.17e-01
|
6.42e-01
|
GOBP POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION
|
15
|
7.61e-01
|
9.45e-01
|
0.10400
|
5.15e-02
|
9.04e-02
|
7.30e-01
|
5.44e-01
|
GOBP URETERIC BUD FORMATION
|
7
|
8.90e-01
|
9.76e-01
|
0.10400
|
-1.04e-01
|
-4.51e-03
|
6.34e-01
|
9.84e-01
|
GOBP CYCLIC NUCLEOTIDE MEDIATED SIGNALING
|
80
|
2.83e-01
|
7.56e-01
|
0.10400
|
1.03e-01
|
-1.66e-02
|
1.13e-01
|
7.97e-01
|
GOBP NEGATIVE REGULATION OF VIRAL GENOME REPLICATION
|
54
|
3.75e-01
|
8.11e-01
|
0.10400
|
-8.96e-02
|
-5.27e-02
|
2.55e-01
|
5.03e-01
|
GOMF EPHRIN RECEPTOR BINDING
|
26
|
6.21e-01
|
9.00e-01
|
0.10400
|
6.41e-02
|
8.18e-02
|
5.71e-01
|
4.70e-01
|
GOMF FIBRINOGEN BINDING
|
5
|
9.12e-01
|
9.82e-01
|
0.10400
|
6.90e-02
|
7.76e-02
|
7.89e-01
|
7.64e-01
|
GOBP MEMBRANE PROTEIN PROTEOLYSIS
|
56
|
3.72e-01
|
8.09e-01
|
0.10400
|
-9.73e-02
|
-3.62e-02
|
2.08e-01
|
6.39e-01
|
GOBP DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION
|
14
|
7.94e-01
|
9.55e-01
|
0.10400
|
-1.04e-01
|
-1.93e-03
|
5.01e-01
|
9.90e-01
|
GOMF CALCIUM CHANNEL INHIBITOR ACTIVITY
|
12
|
8.19e-01
|
9.60e-01
|
0.10400
|
-1.04e-01
|
-7.45e-03
|
5.34e-01
|
9.64e-01
|
GOBP NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS
|
24
|
6.52e-01
|
9.08e-01
|
0.10400
|
-9.58e-02
|
-3.99e-02
|
4.16e-01
|
7.35e-01
|
GOMF CO RECEPTOR BINDING
|
13
|
8.01e-01
|
9.57e-01
|
0.10400
|
1.90e-02
|
1.02e-01
|
9.06e-01
|
5.25e-01
|
GOBP GERMINAL CENTER FORMATION
|
14
|
8.16e-01
|
9.59e-01
|
0.10400
|
-5.77e-02
|
8.62e-02
|
7.09e-01
|
5.77e-01
|
GOBP GLUCOSE METABOLIC PROCESS
|
182
|
6.09e-02
|
4.78e-01
|
0.10400
|
-1.01e-01
|
2.31e-02
|
1.87e-02
|
5.91e-01
|
GOBP LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR
|
11
|
8.45e-01
|
9.66e-01
|
0.10400
|
2.87e-02
|
-9.96e-02
|
8.69e-01
|
5.67e-01
|
GOBP REGULATION OF ATP BIOSYNTHETIC PROCESS
|
17
|
7.83e-01
|
9.52e-01
|
0.10400
|
-8.01e-02
|
6.58e-02
|
5.67e-01
|
6.39e-01
|
GOBP VITAMIN TRANSPORT
|
52
|
3.87e-01
|
8.19e-01
|
0.10400
|
-7.48e-02
|
-7.17e-02
|
3.51e-01
|
3.71e-01
|
GOBP REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS
|
28
|
6.09e-01
|
8.97e-01
|
0.10400
|
-9.58e-02
|
-3.95e-02
|
3.80e-01
|
7.17e-01
|
GOBP SYNAPTIC MEMBRANE ADHESION
|
25
|
6.91e-01
|
9.20e-01
|
0.10400
|
4.50e-02
|
-9.33e-02
|
6.97e-01
|
4.19e-01
|
GOBP PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY
|
23
|
6.92e-01
|
9.21e-01
|
0.10400
|
1.03e-01
|
-8.70e-03
|
3.92e-01
|
9.42e-01
|
GOBP NOTCH SIGNALING PATHWAY
|
173
|
7.64e-02
|
5.21e-01
|
0.10400
|
-9.64e-02
|
3.79e-02
|
2.87e-02
|
3.90e-01
|
GOMF LIGAND GATED CHANNEL ACTIVITY
|
140
|
9.61e-02
|
5.61e-01
|
0.10400
|
1.36e-02
|
1.03e-01
|
7.82e-01
|
3.60e-02
|
GOBP INSULIN SECRETION
|
193
|
5.86e-02
|
4.71e-01
|
0.10400
|
-9.41e-02
|
4.32e-02
|
2.41e-02
|
3.01e-01
|
GOBP LEUKOCYTE MIGRATION
|
379
|
4.73e-03
|
1.42e-01
|
0.10400
|
-6.67e-02
|
7.92e-02
|
2.57e-02
|
8.15e-03
|
GOBP REGULATION OF MONOCYTE DIFFERENTIATION
|
20
|
7.30e-01
|
9.32e-01
|
0.10400
|
1.02e-01
|
-1.54e-02
|
4.28e-01
|
9.05e-01
|
GOBP POSITIVE REGULATION OF TORC1 SIGNALING
|
50
|
4.14e-01
|
8.29e-01
|
0.10300
|
-9.57e-02
|
-3.93e-02
|
2.42e-01
|
6.31e-01
|
GOBP POSITIVE REGULATION OF WNT SIGNALING PATHWAY
|
138
|
1.39e-01
|
6.23e-01
|
0.10300
|
-8.04e-02
|
6.52e-02
|
1.03e-01
|
1.86e-01
|
GOBP MEMBRANE DEPOLARIZATION DURING SA NODE CELL ACTION POTENTIAL
|
5
|
9.23e-01
|
9.84e-01
|
0.10300
|
1.03e-01
|
-4.49e-03
|
6.89e-01
|
9.86e-01
|
GOMF RNA POLYMERASE I ACTIVITY
|
10
|
8.67e-01
|
9.71e-01
|
0.10300
|
7.50e-02
|
-7.12e-02
|
6.81e-01
|
6.97e-01
|
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY
|
309
|
6.22e-03
|
1.64e-01
|
0.10300
|
-1.03e-01
|
-1.08e-02
|
1.88e-03
|
7.45e-01
|
GOBP GABAERGIC NEURON DIFFERENTIATION
|
19
|
7.43e-01
|
9.38e-01
|
0.10300
|
-1.02e-01
|
1.70e-02
|
4.42e-01
|
8.98e-01
|
GOBP NEGATIVE REGULATION OF RNA SPLICING
|
25
|
6.74e-01
|
9.13e-01
|
0.10300
|
1.14e-02
|
-1.03e-01
|
9.22e-01
|
3.74e-01
|
GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION
|
30
|
6.45e-01
|
9.07e-01
|
0.10300
|
-9.13e-02
|
4.83e-02
|
3.87e-01
|
6.47e-01
|
GOBP CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL
|
18
|
7.22e-01
|
9.30e-01
|
0.10300
|
6.29e-02
|
8.19e-02
|
6.44e-01
|
5.48e-01
|
GOBP T CELL DIFFERENTIATION IN THYMUS
|
84
|
2.31e-01
|
7.18e-01
|
0.10300
|
3.67e-02
|
9.65e-02
|
5.61e-01
|
1.26e-01
|
GOBP NUCLEUS ORGANIZATION
|
142
|
1.07e-01
|
5.79e-01
|
0.10300
|
-1.03e-01
|
9.62e-03
|
3.45e-02
|
8.43e-01
|
GOCC INTRACILIARY TRANSPORT PARTICLE B
|
15
|
7.67e-01
|
9.46e-01
|
0.10300
|
-4.48e-02
|
-9.30e-02
|
7.64e-01
|
5.33e-01
|
GOBP SEMINIFEROUS TUBULE DEVELOPMENT
|
14
|
8.15e-01
|
9.59e-01
|
0.10300
|
-4.75e-02
|
9.16e-02
|
7.58e-01
|
5.53e-01
|
GOBP REGULATION OF CELLULAR EXTRAVASATION
|
38
|
5.17e-01
|
8.69e-01
|
0.10300
|
-9.79e-02
|
-3.26e-02
|
2.96e-01
|
7.28e-01
|
GOBP PREPULSE INHIBITION
|
13
|
8.11e-01
|
9.59e-01
|
0.10300
|
-1.37e-03
|
1.03e-01
|
9.93e-01
|
5.20e-01
|
GOBP NK T CELL DIFFERENTIATION
|
11
|
8.33e-01
|
9.64e-01
|
0.10300
|
1.25e-02
|
1.02e-01
|
9.43e-01
|
5.57e-01
|
GOBP POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS
|
16
|
7.52e-01
|
9.41e-01
|
0.10300
|
-9.05e-02
|
-4.93e-02
|
5.31e-01
|
7.33e-01
|
GOBP STEM CELL DIVISION
|
30
|
5.83e-01
|
8.90e-01
|
0.10300
|
-5.77e-02
|
-8.54e-02
|
5.84e-01
|
4.18e-01
|
GOBP HEART TRABECULA FORMATION
|
15
|
7.64e-01
|
9.45e-01
|
0.10300
|
-8.53e-02
|
-5.79e-02
|
5.68e-01
|
6.98e-01
|
GOBP SELECTIVE AUTOPHAGY
|
92
|
1.93e-01
|
6.85e-01
|
0.10300
|
-8.70e-02
|
-5.52e-02
|
1.49e-01
|
3.60e-01
|
GOBP CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER
|
21
|
7.38e-01
|
9.35e-01
|
0.10300
|
-4.95e-02
|
9.04e-02
|
6.95e-01
|
4.73e-01
|
GOBP MACROAUTOPHAGY
|
317
|
7.68e-03
|
1.83e-01
|
0.10300
|
-1.02e-01
|
1.53e-02
|
1.81e-03
|
6.39e-01
|
GOBP REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION
|
21
|
7.26e-01
|
9.30e-01
|
0.10300
|
1.00e-01
|
-2.35e-02
|
4.26e-01
|
8.52e-01
|
GOBP RESPONSE TO NICOTINE
|
49
|
4.58e-01
|
8.48e-01
|
0.10300
|
-4.58e-03
|
1.03e-01
|
9.56e-01
|
2.13e-01
|
GOBP NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION
|
108
|
1.51e-01
|
6.38e-01
|
0.10300
|
9.42e-02
|
4.16e-02
|
9.08e-02
|
4.55e-01
|
GOBP REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS
|
13
|
7.91e-01
|
9.54e-01
|
0.10300
|
-8.15e-02
|
-6.29e-02
|
6.11e-01
|
6.95e-01
|
GOBP RETINAL CONE CELL DIFFERENTIATION
|
13
|
8.30e-01
|
9.64e-01
|
0.10300
|
-5.60e-02
|
8.63e-02
|
7.27e-01
|
5.90e-01
|
GOMF RECEPTOR TYROSINE KINASE BINDING
|
78
|
2.52e-01
|
7.30e-01
|
0.10300
|
5.00e-02
|
8.99e-02
|
4.45e-01
|
1.70e-01
|
GOMF CAMP BINDING
|
22
|
6.91e-01
|
9.20e-01
|
0.10300
|
1.01e-01
|
1.94e-02
|
4.12e-01
|
8.75e-01
|
GOBP DEADENYLATION DEPENDENT DECAPPING OF NUCLEAR TRANSCRIBED MRNA
|
11
|
8.40e-01
|
9.65e-01
|
0.10300
|
1.03e-01
|
-5.24e-03
|
5.56e-01
|
9.76e-01
|
GOBP FATTY ACID CATABOLIC PROCESS
|
104
|
1.96e-01
|
6.88e-01
|
0.10300
|
-1.02e-01
|
8.49e-03
|
7.11e-02
|
8.81e-01
|
GOBP MAINTENANCE OF CELL NUMBER
|
179
|
6.87e-02
|
5.00e-01
|
0.10300
|
-9.91e-02
|
2.71e-02
|
2.22e-02
|
5.32e-01
|
GOCC CELL LEADING EDGE
|
408
|
2.27e-03
|
9.05e-02
|
0.10300
|
-2.35e-02
|
1.00e-01
|
4.16e-01
|
5.27e-04
|
GOBP MRNA PROCESSING
|
449
|
5.61e-04
|
3.42e-02
|
0.10300
|
-2.61e-02
|
-9.94e-02
|
3.44e-01
|
3.07e-04
|
GOBP TRNA 3 END PROCESSING
|
6
|
9.03e-01
|
9.80e-01
|
0.10300
|
-2.61e-02
|
-9.93e-02
|
9.12e-01
|
6.73e-01
|
GOMF PRE MRNA BINDING
|
38
|
5.41e-01
|
8.78e-01
|
0.10300
|
-3.40e-03
|
-1.03e-01
|
9.71e-01
|
2.73e-01
|
GOMF SODIUM CHANNEL ACTIVITY
|
42
|
5.33e-01
|
8.76e-01
|
0.10300
|
2.86e-02
|
-9.86e-02
|
7.49e-01
|
2.69e-01
|
GOBP RESPONSE TO LEPTIN
|
21
|
6.99e-01
|
9.22e-01
|
0.10300
|
-2.73e-02
|
-9.90e-02
|
8.29e-01
|
4.32e-01
|
GOBP MAINTENANCE OF BLOOD BRAIN BARRIER
|
36
|
5.49e-01
|
8.80e-01
|
0.10300
|
1.69e-02
|
1.01e-01
|
8.61e-01
|
2.93e-01
|
GOBP FAT CELL DIFFERENTIATION
|
243
|
1.56e-02
|
2.64e-01
|
0.10300
|
-9.60e-02
|
-3.62e-02
|
9.94e-03
|
3.31e-01
|
GOBP REGULATION OF CILIUM ASSEMBLY
|
92
|
1.98e-01
|
6.88e-01
|
0.10300
|
-9.01e-02
|
-4.92e-02
|
1.35e-01
|
4.15e-01
|
GOBP LIPID STORAGE
|
93
|
1.98e-01
|
6.88e-01
|
0.10300
|
-9.32e-02
|
-4.27e-02
|
1.20e-01
|
4.77e-01
|
GOBP PERISTALSIS
|
12
|
8.13e-01
|
9.59e-01
|
0.10300
|
-9.66e-02
|
-3.43e-02
|
5.62e-01
|
8.37e-01
|
GOBP POST EMBRYONIC EYE MORPHOGENESIS
|
7
|
9.06e-01
|
9.81e-01
|
0.10300
|
6.49e-02
|
-7.93e-02
|
7.66e-01
|
7.16e-01
|
GOBP AMINO ACID ACTIVATION
|
43
|
4.87e-01
|
8.56e-01
|
0.10300
|
-2.06e-02
|
-1.00e-01
|
8.15e-01
|
2.55e-01
|
GOBP CHOLESTEROL STORAGE
|
25
|
6.46e-01
|
9.07e-01
|
0.10300
|
-4.39e-02
|
-9.26e-02
|
7.04e-01
|
4.23e-01
|
GOBP REGULATION OF LEUKOCYTE TETHERING OR ROLLING
|
18
|
7.29e-01
|
9.32e-01
|
0.10200
|
-4.86e-02
|
-9.03e-02
|
7.21e-01
|
5.07e-01
|
GOMF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
153
|
6.67e-02
|
4.98e-01
|
0.10200
|
8.35e-02
|
5.94e-02
|
7.46e-02
|
2.05e-01
|
GOBP DOUBLE STRAND BREAK REPAIR VIA SINGLE STRAND ANNEALING
|
6
|
9.10e-01
|
9.82e-01
|
0.10200
|
7.94e-03
|
-1.02e-01
|
9.73e-01
|
6.65e-01
|
GOMF HISTONE KINASE ACTIVITY
|
20
|
7.18e-01
|
9.29e-01
|
0.10200
|
-1.01e-01
|
-1.69e-02
|
4.34e-01
|
8.96e-01
|
GOBP REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY
|
45
|
4.86e-01
|
8.56e-01
|
0.10200
|
-1.02e-01
|
-2.93e-03
|
2.35e-01
|
9.73e-01
|
GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE II PROMOTER
|
95
|
2.15e-01
|
7.04e-01
|
0.10200
|
-8.50e-03
|
-1.02e-01
|
8.86e-01
|
8.58e-02
|
GOBP AGGRESSIVE BEHAVIOR
|
7
|
8.94e-01
|
9.77e-01
|
0.10200
|
1.02e-01
|
3.87e-03
|
6.40e-01
|
9.86e-01
|
GOBP REGULATION OF MACROAUTOPHAGY
|
150
|
1.21e-01
|
6.02e-01
|
0.10200
|
-8.75e-02
|
5.27e-02
|
6.43e-02
|
2.65e-01
|
GOBP DIGESTION
|
127
|
1.71e-01
|
6.58e-01
|
0.10200
|
-7.95e-02
|
6.41e-02
|
1.22e-01
|
2.12e-01
|
GOCC CUL2 RING UBIQUITIN LIGASE COMPLEX
|
23
|
6.65e-01
|
9.10e-01
|
0.10200
|
6.38e-02
|
7.97e-02
|
5.96e-01
|
5.08e-01
|
GOBP PROTEIN ACETYLATION
|
97
|
1.83e-01
|
6.72e-01
|
0.10200
|
-8.65e-02
|
-5.43e-02
|
1.41e-01
|
3.56e-01
|
GOBP REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS
|
77
|
2.56e-01
|
7.35e-01
|
0.10200
|
-7.84e-02
|
-6.54e-02
|
2.34e-01
|
3.21e-01
|
GOBP REGULATION OF ACTIN FILAMENT ORGANIZATION
|
259
|
2.07e-02
|
3.05e-01
|
0.10200
|
-1.91e-02
|
1.00e-01
|
5.96e-01
|
5.48e-03
|
GOBP REGULATION OF CELLULAR LOCALIZATION
|
944
|
2.63e-06
|
6.11e-04
|
0.10200
|
-8.91e-02
|
4.96e-02
|
3.46e-06
|
9.76e-03
|
GOBP BASEMENT MEMBRANE ORGANIZATION
|
36
|
5.49e-01
|
8.80e-01
|
0.10200
|
-2.33e-02
|
-9.93e-02
|
8.09e-01
|
3.02e-01
|
GOCC CEREBELLAR CLIMBING FIBER TO PURKINJE CELL SYNAPSE
|
7
|
8.98e-01
|
9.78e-01
|
0.10200
|
1.01e-01
|
-1.04e-02
|
6.42e-01
|
9.62e-01
|
GOBP GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY
|
27
|
6.58e-01
|
9.09e-01
|
0.10200
|
1.02e-01
|
-8.42e-03
|
3.61e-01
|
9.40e-01
|
GOBP SENSORY PERCEPTION OF TASTE
|
66
|
3.65e-01
|
8.06e-01
|
0.10200
|
-1.01e-01
|
1.38e-02
|
1.56e-01
|
8.47e-01
|
GOMF CENTROMERIC DNA BINDING
|
6
|
9.12e-01
|
9.82e-01
|
0.10200
|
1.33e-02
|
-1.01e-01
|
9.55e-01
|
6.68e-01
|
GOBP ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION
|
44
|
4.87e-01
|
8.56e-01
|
0.10200
|
-1.01e-01
|
-1.58e-02
|
2.48e-01
|
8.56e-01
|
GOBP INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY
|
51
|
4.89e-01
|
8.57e-01
|
0.10200
|
-8.58e-02
|
5.49e-02
|
2.89e-01
|
4.98e-01
|
GOBP ADENOHYPOPHYSIS DEVELOPMENT
|
16
|
8.00e-01
|
9.56e-01
|
0.10200
|
6.04e-02
|
-8.20e-02
|
6.76e-01
|
5.70e-01
|
GOBP DOUBLE STRAND BREAK REPAIR
|
294
|
8.04e-03
|
1.88e-01
|
0.10200
|
-9.92e-02
|
-2.29e-02
|
3.42e-03
|
4.99e-01
|
GOBP MONOCYTE ACTIVATION
|
12
|
8.44e-01
|
9.66e-01
|
0.10200
|
-8.92e-02
|
4.92e-02
|
5.93e-01
|
7.68e-01
|
GOBP MESODERM MORPHOGENESIS
|
76
|
3.44e-01
|
7.95e-01
|
0.10200
|
-5.12e-02
|
8.80e-02
|
4.40e-01
|
1.85e-01
|
GOBP REGULATION OF VESICLE SIZE
|
19
|
7.17e-01
|
9.28e-01
|
0.10200
|
-8.42e-02
|
-5.72e-02
|
5.25e-01
|
6.66e-01
|
GOBP NEURONAL ACTION POTENTIAL PROPAGATION
|
9
|
8.59e-01
|
9.68e-01
|
0.10200
|
3.08e-02
|
9.70e-02
|
8.73e-01
|
6.14e-01
|
GOBP PEPTIDYL PROLINE HYDROXYLATION
|
11
|
8.57e-01
|
9.68e-01
|
0.10200
|
-5.36e-02
|
8.64e-02
|
7.58e-01
|
6.20e-01
|
GOBP NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE
|
44
|
4.86e-01
|
8.56e-01
|
0.10200
|
-9.98e-02
|
-1.92e-02
|
2.52e-01
|
8.25e-01
|
GOBP INOSITOL METABOLIC PROCESS
|
8
|
8.88e-01
|
9.76e-01
|
0.10200
|
-9.91e-02
|
2.26e-02
|
6.27e-01
|
9.12e-01
|
GOBP REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS
|
10
|
8.48e-01
|
9.66e-01
|
0.10200
|
-9.96e-02
|
-2.01e-02
|
5.86e-01
|
9.12e-01
|
GOBP SEROTONIN METABOLIC PROCESS
|
10
|
8.41e-01
|
9.66e-01
|
0.10200
|
8.84e-02
|
4.99e-02
|
6.28e-01
|
7.85e-01
|
GOBP REGULATION OF DEFENSE RESPONSE TO FUNGUS
|
5
|
9.16e-01
|
9.83e-01
|
0.10100
|
-6.26e-02
|
-7.98e-02
|
8.08e-01
|
7.57e-01
|
GOBP REGULATION OF MONONUCLEAR CELL MIGRATION
|
119
|
1.96e-01
|
6.88e-01
|
0.10100
|
-7.64e-02
|
6.67e-02
|
1.50e-01
|
2.09e-01
|
GOMF CATALYTIC ACTIVITY ACTING ON DNA
|
235
|
1.93e-02
|
2.98e-01
|
0.10100
|
-9.40e-02
|
-3.82e-02
|
1.31e-02
|
3.13e-01
|
GOBP AUDITORY RECEPTOR CELL MORPHOGENESIS
|
20
|
7.36e-01
|
9.35e-01
|
0.10100
|
-8.65e-03
|
1.01e-01
|
9.47e-01
|
4.34e-01
|
GOBP TOR SIGNALING
|
157
|
8.16e-02
|
5.33e-01
|
0.10100
|
-1.01e-01
|
-1.15e-02
|
2.94e-02
|
8.04e-01
|
GOBP POSITIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE
|
7
|
9.08e-01
|
9.81e-01
|
0.10100
|
8.26e-02
|
-5.88e-02
|
7.05e-01
|
7.88e-01
|
GOBP VIRAL PROTEIN PROCESSING
|
31
|
6.38e-01
|
9.06e-01
|
0.10100
|
-9.62e-02
|
3.18e-02
|
3.54e-01
|
7.59e-01
|
GOBP LIPID MODIFICATION
|
185
|
7.75e-02
|
5.24e-01
|
0.10100
|
-8.65e-02
|
5.27e-02
|
4.24e-02
|
2.16e-01
|
GOBP INNER CELL MASS CELL PROLIFERATION
|
14
|
8.18e-01
|
9.60e-01
|
0.10100
|
-9.47e-02
|
3.58e-02
|
5.39e-01
|
8.17e-01
|
GOBP CORTISOL BIOSYNTHETIC PROCESS
|
10
|
8.42e-01
|
9.66e-01
|
0.10100
|
-4.92e-02
|
-8.85e-02
|
7.88e-01
|
6.28e-01
|
GOBP DOPAMINE METABOLIC PROCESS
|
35
|
5.44e-01
|
8.78e-01
|
0.10100
|
7.86e-02
|
6.37e-02
|
4.21e-01
|
5.14e-01
|
GOBP REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC
|
35
|
5.89e-01
|
8.91e-01
|
0.10100
|
1.01e-01
|
-1.05e-02
|
3.03e-01
|
9.14e-01
|
GOBP CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN
|
106
|
1.72e-01
|
6.60e-01
|
0.10100
|
-9.58e-02
|
-3.24e-02
|
8.84e-02
|
5.65e-01
|
GOBP NAD METABOLIC PROCESS
|
42
|
5.43e-01
|
8.78e-01
|
0.10100
|
-9.71e-02
|
2.79e-02
|
2.76e-01
|
7.54e-01
|
GOBP CELLULAR RESPONSE TO POTASSIUM ION
|
12
|
8.46e-01
|
9.66e-01
|
0.10100
|
4.79e-02
|
-8.90e-02
|
7.74e-01
|
5.94e-01
|
GOBP DNA TEMPLATED TRANSCRIPTION INITIATION
|
134
|
1.00e-01
|
5.69e-01
|
0.10100
|
-5.45e-02
|
-8.51e-02
|
2.76e-01
|
8.89e-02
|
GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION
|
34
|
6.07e-01
|
8.97e-01
|
0.10100
|
2.28e-02
|
-9.84e-02
|
8.18e-01
|
3.21e-01
|
GOBP CENTRIOLE CENTRIOLE COHESION
|
15
|
7.90e-01
|
9.54e-01
|
0.10100
|
6.52e-03
|
1.01e-01
|
9.65e-01
|
4.99e-01
|
GOBP LAMELLIPODIUM ASSEMBLY
|
67
|
4.00e-01
|
8.25e-01
|
0.10100
|
-6.04e-02
|
8.09e-02
|
3.92e-01
|
2.52e-01
|
GOBP NEGATIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION
|
5
|
9.32e-01
|
9.86e-01
|
0.10100
|
4.55e-02
|
-9.01e-02
|
8.60e-01
|
7.27e-01
|
GOBP NEGATIVE REGULATION OF DEPHOSPHORYLATION
|
35
|
6.21e-01
|
9.00e-01
|
0.10100
|
-7.69e-02
|
6.53e-02
|
4.31e-01
|
5.04e-01
|
GOCC SPERM CONNECTING PIECE
|
9
|
8.63e-01
|
9.69e-01
|
0.10100
|
9.78e-02
|
2.47e-02
|
6.11e-01
|
8.98e-01
|
GOBP GANGLION DEVELOPMENT
|
17
|
7.49e-01
|
9.40e-01
|
0.10100
|
4.80e-02
|
8.87e-02
|
7.32e-01
|
5.27e-01
|
GOBP MONOSACCHARIDE BIOSYNTHETIC PROCESS
|
95
|
1.98e-01
|
6.88e-01
|
0.10100
|
-8.71e-02
|
-5.09e-02
|
1.42e-01
|
3.92e-01
|
GOBP ORGANELLE DISASSEMBLY
|
137
|
1.14e-01
|
5.92e-01
|
0.10100
|
-1.00e-01
|
-1.27e-02
|
4.33e-02
|
7.97e-01
|
GOMF PROTEIN TYROSINE THREONINE PHOSPHATASE ACTIVITY
|
9
|
8.56e-01
|
9.68e-01
|
0.10100
|
6.26e-02
|
7.90e-02
|
7.45e-01
|
6.82e-01
|
GOBP NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE
|
61
|
3.64e-01
|
8.05e-01
|
0.10100
|
3.30e-02
|
9.52e-02
|
6.56e-01
|
1.98e-01
|
GOBP PROTEIN HOMOTETRAMERIZATION
|
57
|
3.99e-01
|
8.25e-01
|
0.10100
|
-9.87e-02
|
-1.98e-02
|
1.97e-01
|
7.96e-01
|
GOMF SELENIUM BINDING
|
9
|
8.72e-01
|
9.73e-01
|
0.10100
|
1.01e-01
|
-4.37e-03
|
6.01e-01
|
9.82e-01
|
GOMF BIOACTIVE LIPID RECEPTOR ACTIVITY
|
14
|
7.95e-01
|
9.55e-01
|
0.10100
|
2.82e-02
|
9.66e-02
|
8.55e-01
|
5.31e-01
|
GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY
|
183
|
4.78e-02
|
4.38e-01
|
0.10100
|
-9.24e-02
|
-3.99e-02
|
3.12e-02
|
3.52e-01
|
GOCC GOLGI APPARATUS SUBCOMPARTMENT
|
348
|
6.04e-03
|
1.62e-01
|
0.10100
|
-9.97e-02
|
1.33e-02
|
1.39e-03
|
6.69e-01
|
GOBP POSITIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY
|
6
|
9.03e-01
|
9.80e-01
|
0.10100
|
5.06e-02
|
8.69e-02
|
8.30e-01
|
7.12e-01
|
GOBP EPIGENETIC REGULATION OF GENE EXPRESSION
|
210
|
4.02e-02
|
4.12e-01
|
0.10000
|
-1.00e-01
|
-2.19e-03
|
1.21e-02
|
9.56e-01
|
GOBP MITOCHONDRION ORGANIZATION
|
523
|
1.54e-04
|
1.30e-02
|
0.10000
|
-7.79e-02
|
-6.35e-02
|
2.30e-03
|
1.30e-02
|
GOBP CELL JUNCTION DISASSEMBLY
|
27
|
6.94e-01
|
9.21e-01
|
0.10000
|
-6.44e-02
|
7.71e-02
|
5.62e-01
|
4.88e-01
|
GOBP METHYLGLYOXAL METABOLIC PROCESS
|
6
|
9.07e-01
|
9.81e-01
|
0.10000
|
-9.69e-02
|
-2.63e-02
|
6.81e-01
|
9.11e-01
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS
|
54
|
4.59e-01
|
8.48e-01
|
0.10000
|
-9.72e-02
|
2.52e-02
|
2.17e-01
|
7.48e-01
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH GROUP OF DONORS
|
27
|
6.84e-01
|
9.17e-01
|
0.10000
|
-9.37e-02
|
3.61e-02
|
3.99e-01
|
7.46e-01
|
GOBP RENAL SODIUM ION TRANSPORT
|
15
|
7.99e-01
|
9.56e-01
|
0.10000
|
-9.99e-02
|
1.05e-02
|
5.03e-01
|
9.44e-01
|
GOMF MRNA METHYLTRANSFERASE ACTIVITY
|
12
|
8.14e-01
|
9.59e-01
|
0.10000
|
-6.46e-02
|
-7.67e-02
|
6.98e-01
|
6.45e-01
|
GOBP CELL MATRIX ADHESION
|
232
|
3.50e-02
|
3.81e-01
|
0.10000
|
-1.98e-02
|
9.83e-02
|
6.03e-01
|
9.85e-03
|
GOMF NADP BINDING
|
50
|
4.25e-01
|
8.35e-01
|
0.10000
|
-6.91e-02
|
-7.27e-02
|
3.98e-01
|
3.74e-01
|
GOBP POSITIVE REGULATION OF HAIR FOLLICLE MATURATION
|
5
|
9.18e-01
|
9.83e-01
|
0.10000
|
-7.82e-02
|
-6.29e-02
|
7.62e-01
|
8.08e-01
|
GOBP PROTEIN LOCALIZATION TO PRESYNAPSE
|
11
|
8.57e-01
|
9.68e-01
|
0.10000
|
-3.48e-02
|
9.40e-02
|
8.42e-01
|
5.89e-01
|
GOBP NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS
|
30
|
6.17e-01
|
9.00e-01
|
0.10000
|
-2.35e-02
|
-9.74e-02
|
8.24e-01
|
3.56e-01
|
GOBP NOTOCHORD DEVELOPMENT
|
19
|
7.26e-01
|
9.30e-01
|
0.10000
|
8.82e-02
|
4.75e-02
|
5.06e-01
|
7.20e-01
|
GOBP POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS
|
100
|
2.61e-01
|
7.38e-01
|
0.10000
|
-7.99e-02
|
6.05e-02
|
1.68e-01
|
2.96e-01
|
GOMF GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY
|
49
|
4.37e-01
|
8.39e-01
|
0.10000
|
-8.41e-02
|
-5.44e-02
|
3.09e-01
|
5.10e-01
|
GOBP VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE
|
145
|
1.42e-01
|
6.26e-01
|
0.10000
|
-8.39e-02
|
5.46e-02
|
8.11e-02
|
2.57e-01
|
GOCC ENDONUCLEASE COMPLEX
|
37
|
5.86e-01
|
8.90e-01
|
0.10000
|
2.04e-02
|
-9.79e-02
|
8.30e-01
|
3.03e-01
|
GOBP VENTRICULAR SYSTEM DEVELOPMENT
|
32
|
6.25e-01
|
9.01e-01
|
0.10000
|
9.90e-02
|
-1.43e-02
|
3.33e-01
|
8.89e-01
|
GOBP CEREBRAL CORTEX CELL MIGRATION
|
45
|
5.48e-01
|
8.79e-01
|
0.10000
|
-7.32e-02
|
6.81e-02
|
3.95e-01
|
4.29e-01
|
GOBP BIOMINERAL TISSUE DEVELOPMENT
|
165
|
1.08e-01
|
5.80e-01
|
0.10000
|
-5.00e-02
|
8.66e-02
|
2.68e-01
|
5.51e-02
|
GOMF G PROTEIN COUPLED OPIOID RECEPTOR ACTIVITY
|
7
|
9.04e-01
|
9.80e-01
|
0.10000
|
9.78e-02
|
-2.08e-02
|
6.54e-01
|
9.24e-01
|
GOMF ATP DEPENDENT ACTIVITY ACTING ON DNA
|
116
|
1.43e-01
|
6.28e-01
|
0.09990
|
-8.47e-02
|
-5.31e-02
|
1.15e-01
|
3.23e-01
|
GOMF MHC CLASS IB PROTEIN BINDING
|
7
|
9.02e-01
|
9.80e-01
|
0.09990
|
-1.15e-02
|
9.92e-02
|
9.58e-01
|
6.49e-01
|
GOBP RESPONSE TO MUSCLE INACTIVITY
|
9
|
8.86e-01
|
9.76e-01
|
0.09980
|
-6.02e-02
|
7.97e-02
|
7.54e-01
|
6.79e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN POLYMERIZATION
|
75
|
3.66e-01
|
8.07e-01
|
0.09980
|
-8.13e-02
|
5.80e-02
|
2.23e-01
|
3.86e-01
|
GOBP REGULATION OF MODIFICATION OF POSTSYNAPTIC STRUCTURE
|
9
|
8.58e-01
|
9.68e-01
|
0.09980
|
-6.72e-02
|
-7.38e-02
|
7.27e-01
|
7.01e-01
|
GOBP CARDIAC MUSCLE CELL CONTRACTION
|
72
|
3.08e-01
|
7.72e-01
|
0.09980
|
9.28e-02
|
3.65e-02
|
1.73e-01
|
5.93e-01
|
GOBP MESENCHYMAL CELL APOPTOTIC PROCESS
|
15
|
8.10e-01
|
9.59e-01
|
0.09970
|
-3.14e-02
|
9.47e-02
|
8.33e-01
|
5.26e-01
|
GOBP LYMPHOCYTE MIGRATION INTO LYMPHOID ORGANS
|
9
|
8.79e-01
|
9.75e-01
|
0.09970
|
2.02e-02
|
-9.76e-02
|
9.17e-01
|
6.12e-01
|
GOBP REGULATION OF CELL MORPHOGENESIS
|
233
|
3.90e-02
|
4.04e-01
|
0.09970
|
-3.00e-02
|
9.51e-02
|
4.30e-01
|
1.24e-02
|
GOMF MYOSIN LIGHT CHAIN BINDING
|
8
|
8.89e-01
|
9.76e-01
|
0.09960
|
1.23e-02
|
-9.89e-02
|
9.52e-01
|
6.28e-01
|
GOCC TRANSCRIPTION REPRESSOR COMPLEX
|
73
|
3.04e-01
|
7.68e-01
|
0.09960
|
-9.21e-02
|
-3.78e-02
|
1.74e-01
|
5.77e-01
|
GOBP DNA REPAIR
|
563
|
1.00e-04
|
9.23e-03
|
0.09960
|
-8.25e-02
|
-5.57e-02
|
8.18e-04
|
2.38e-02
|
GOCC CALCIUM CHANNEL COMPLEX
|
77
|
3.53e-01
|
7.97e-01
|
0.09950
|
8.83e-02
|
-4.59e-02
|
1.80e-01
|
4.86e-01
|
GOMF INTRAMOLECULAR TRANSFERASE ACTIVITY
|
26
|
6.58e-01
|
9.09e-01
|
0.09950
|
-9.51e-02
|
-2.92e-02
|
4.01e-01
|
7.97e-01
|
GOBP CELL SUBSTRATE ADHESION
|
344
|
6.06e-03
|
1.62e-01
|
0.09940
|
5.63e-04
|
9.94e-02
|
9.86e-01
|
1.53e-03
|
GOBP CANONICAL NF KAPPAB SIGNAL TRANSDUCTION
|
284
|
1.99e-02
|
3.00e-01
|
0.09940
|
-9.44e-02
|
3.11e-02
|
6.18e-03
|
3.67e-01
|
GOBP DNA TEMPLATED TRANSCRIPTION ELONGATION
|
132
|
1.42e-01
|
6.26e-01
|
0.09940
|
-9.93e-02
|
4.57e-03
|
4.88e-02
|
9.28e-01
|
GOBP NEGATIVE REGULATION OF TORC1 SIGNALING
|
45
|
5.13e-01
|
8.67e-01
|
0.09940
|
4.36e-03
|
-9.93e-02
|
9.60e-01
|
2.49e-01
|
GOBP PRESYNAPSE ORGANIZATION
|
44
|
5.34e-01
|
8.76e-01
|
0.09940
|
-9.71e-02
|
2.12e-02
|
2.65e-01
|
8.08e-01
|
GOMF C2H2 ZINC FINGER DOMAIN BINDING
|
12
|
8.35e-01
|
9.64e-01
|
0.09930
|
-9.92e-02
|
-1.26e-03
|
5.52e-01
|
9.94e-01
|
GOBP ENSHEATHMENT OF NEURONS
|
143
|
1.53e-01
|
6.41e-01
|
0.09920
|
-6.13e-02
|
7.81e-02
|
2.06e-01
|
1.07e-01
|
GOMF CARBON NITROGEN LIGASE ACTIVITY WITH GLUTAMINE AS AMIDO N DONOR
|
10
|
8.70e-01
|
9.73e-01
|
0.09920
|
9.42e-02
|
-3.11e-02
|
6.06e-01
|
8.65e-01
|
GOCC SYNAPTIC CLEFT
|
21
|
7.04e-01
|
9.24e-01
|
0.09920
|
5.83e-02
|
8.03e-02
|
6.44e-01
|
5.24e-01
|
GOBP CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION
|
12
|
8.18e-01
|
9.60e-01
|
0.09920
|
7.86e-02
|
6.05e-02
|
6.37e-01
|
7.17e-01
|
GOMF UNFOLDED PROTEIN BINDING
|
114
|
1.91e-01
|
6.85e-01
|
0.09920
|
1.04e-02
|
-9.86e-02
|
8.47e-01
|
6.89e-02
|
GOMF PRIMARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
145
|
9.44e-02
|
5.58e-01
|
0.09910
|
-8.92e-02
|
-4.33e-02
|
6.38e-02
|
3.68e-01
|
GOBP POSITIVE REGULATION OF VASCULATURE DEVELOPMENT
|
182
|
5.67e-02
|
4.68e-01
|
0.09910
|
2.67e-02
|
9.55e-02
|
5.35e-01
|
2.63e-02
|
GOBP ERAD PATHWAY
|
108
|
1.66e-01
|
6.50e-01
|
0.09910
|
-7.73e-02
|
-6.20e-02
|
1.65e-01
|
2.65e-01
|
GOCC PERINUCLEAR REGION OF CYTOPLASM
|
700
|
1.02e-04
|
9.34e-03
|
0.09910
|
-8.97e-02
|
4.21e-02
|
5.24e-05
|
5.76e-02
|
GOBP REGULATION OF CHROMOSOME SEGREGATION
|
129
|
1.18e-01
|
5.99e-01
|
0.09910
|
-7.98e-02
|
-5.87e-02
|
1.18e-01
|
2.49e-01
|
GOBP LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY
|
57
|
4.71e-01
|
8.52e-01
|
0.09910
|
-8.10e-02
|
5.70e-02
|
2.90e-01
|
4.57e-01
|
GOBP CARTILAGE DEVELOPMENT
|
198
|
6.69e-02
|
4.98e-01
|
0.09910
|
-3.37e-02
|
9.32e-02
|
4.14e-01
|
2.38e-02
|
GOMF EUKARYOTIC TRANSLATION INITIATION FACTOR 2ALPHA KINASE ACTIVITY
|
6
|
9.24e-01
|
9.84e-01
|
0.09900
|
-8.18e-02
|
5.58e-02
|
7.29e-01
|
8.13e-01
|
GOBP REGULATION OF DENDRITE DEVELOPMENT
|
91
|
2.92e-01
|
7.63e-01
|
0.09900
|
-3.96e-02
|
9.07e-02
|
5.14e-01
|
1.35e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY
|
140
|
1.48e-01
|
6.35e-01
|
0.09900
|
-9.26e-02
|
3.50e-02
|
5.86e-02
|
4.74e-01
|
GOBP POSITIVE REGULATION OF MUSCLE HYPERTROPHY
|
36
|
5.74e-01
|
8.88e-01
|
0.09900
|
9.78e-02
|
1.53e-02
|
3.10e-01
|
8.74e-01
|
GOBP PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING
|
24
|
7.28e-01
|
9.32e-01
|
0.09900
|
8.17e-02
|
-5.58e-02
|
4.88e-01
|
6.36e-01
|
GOBP DEVELOPMENT OF SECONDARY SEXUAL CHARACTERISTICS
|
9
|
8.64e-01
|
9.70e-01
|
0.09890
|
-4.15e-02
|
-8.98e-02
|
8.29e-01
|
6.41e-01
|
GOBP STEM CELL PROLIFERATION
|
120
|
1.86e-01
|
6.77e-01
|
0.09890
|
-2.21e-02
|
9.64e-02
|
6.76e-01
|
6.81e-02
|
GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION
|
32
|
6.58e-01
|
9.09e-01
|
0.09880
|
-6.62e-02
|
7.34e-02
|
5.17e-01
|
4.72e-01
|
GOBP CELLULAR RESPONSE TO INSULIN STIMULUS
|
203
|
6.27e-02
|
4.83e-01
|
0.09880
|
-9.37e-02
|
3.12e-02
|
2.14e-02
|
4.43e-01
|
GOBP NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION
|
18
|
7.80e-01
|
9.51e-01
|
0.09870
|
-2.86e-02
|
9.45e-02
|
8.34e-01
|
4.87e-01
|
GOMF DOPAMINE RECEPTOR BINDING
|
14
|
8.09e-01
|
9.59e-01
|
0.09870
|
9.82e-02
|
9.72e-03
|
5.25e-01
|
9.50e-01
|
GOBP MITOPHAGY
|
34
|
5.69e-01
|
8.86e-01
|
0.09870
|
-7.42e-02
|
-6.51e-02
|
4.54e-01
|
5.11e-01
|
GOBP PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS
|
83
|
2.88e-01
|
7.59e-01
|
0.09870
|
-9.85e-02
|
-6.37e-03
|
1.21e-01
|
9.20e-01
|
GOMF UBIQUITIN LIGASE SUBSTRATE ADAPTOR ACTIVITY
|
50
|
4.89e-01
|
8.57e-01
|
0.09870
|
-9.77e-02
|
1.37e-02
|
2.32e-01
|
8.67e-01
|
GOBP PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS
|
16
|
7.86e-01
|
9.53e-01
|
0.09860
|
6.74e-03
|
9.84e-02
|
9.63e-01
|
4.96e-01
|
GOCC POLE PLASM
|
24
|
7.20e-01
|
9.30e-01
|
0.09860
|
-3.28e-02
|
9.30e-02
|
7.81e-01
|
4.30e-01
|
GOBP REGULATION OF CATION CHANNEL ACTIVITY
|
115
|
1.75e-01
|
6.65e-01
|
0.09860
|
1.21e-02
|
9.79e-02
|
8.23e-01
|
6.98e-02
|
GOMF ADP BINDING
|
35
|
6.24e-01
|
9.01e-01
|
0.09860
|
-3.86e-02
|
9.07e-02
|
6.93e-01
|
3.53e-01
|
GOBP POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT
|
82
|
3.24e-01
|
7.80e-01
|
0.09850
|
-2.82e-02
|
9.44e-02
|
6.59e-01
|
1.39e-01
|
GOBP RESPONSE TO NERVE GROWTH FACTOR
|
47
|
4.83e-01
|
8.54e-01
|
0.09850
|
2.04e-02
|
9.64e-02
|
8.09e-01
|
2.53e-01
|
GOCC DNA REPLICATION FACTOR C COMPLEX
|
5
|
9.21e-01
|
9.84e-01
|
0.09850
|
5.24e-02
|
8.34e-02
|
8.39e-01
|
7.47e-01
|
GOBP NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR
|
32
|
6.44e-01
|
9.07e-01
|
0.09850
|
9.41e-02
|
-2.90e-02
|
3.57e-01
|
7.76e-01
|
GOBP RECEPTOR TRANSACTIVATION
|
5
|
9.37e-01
|
9.88e-01
|
0.09850
|
-6.00e-02
|
7.80e-02
|
8.16e-01
|
7.62e-01
|
GOMF ATPASE COUPLED INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
10
|
8.53e-01
|
9.67e-01
|
0.09840
|
-3.54e-02
|
-9.19e-02
|
8.46e-01
|
6.15e-01
|
GOBP RESPONSE TO L GLUTAMATE
|
14
|
7.98e-01
|
9.56e-01
|
0.09840
|
8.91e-02
|
4.19e-02
|
5.64e-01
|
7.86e-01
|
GOBP CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES
|
148
|
1.09e-01
|
5.84e-01
|
0.09840
|
-9.80e-02
|
-9.36e-03
|
3.96e-02
|
8.44e-01
|
GOBP TRABECULA FORMATION
|
26
|
6.68e-01
|
9.11e-01
|
0.09840
|
-9.59e-02
|
-2.21e-02
|
3.97e-01
|
8.45e-01
|
GOBP SMOOTH MUSCLE CONTRACTION
|
109
|
2.40e-01
|
7.25e-01
|
0.09840
|
-5.02e-02
|
8.46e-02
|
3.66e-01
|
1.27e-01
|
GOBP REGULATION OF MONOOXYGENASE ACTIVITY
|
42
|
5.74e-01
|
8.88e-01
|
0.09840
|
-4.69e-02
|
8.65e-02
|
5.99e-01
|
3.32e-01
|
GOBP PHOSPHATIDYLINOSITOL METABOLIC PROCESS
|
146
|
1.51e-01
|
6.38e-01
|
0.09830
|
-7.90e-02
|
5.86e-02
|
9.95e-02
|
2.21e-01
|
GOBP NEGATIVE REGULATION OF MAST CELL ACTIVATION
|
12
|
8.52e-01
|
9.67e-01
|
0.09830
|
-8.98e-02
|
4.00e-02
|
5.90e-01
|
8.10e-01
|
GOBP CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS
|
72
|
3.51e-01
|
7.96e-01
|
0.09830
|
9.83e-02
|
-3.04e-03
|
1.49e-01
|
9.64e-01
|
GOBP REGULATION OF MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL
|
9
|
8.90e-01
|
9.76e-01
|
0.09830
|
7.61e-02
|
-6.22e-02
|
6.92e-01
|
7.47e-01
|
GOBP ACTIN FILAMENT DEPOLYMERIZATION
|
58
|
4.07e-01
|
8.26e-01
|
0.09820
|
2.38e-02
|
9.53e-02
|
7.54e-01
|
2.09e-01
|
GOBP BONE REMODELING
|
89
|
2.89e-01
|
7.60e-01
|
0.09820
|
-1.89e-02
|
9.64e-02
|
7.58e-01
|
1.16e-01
|
GOBP REGULATION OF SYNAPTIC PLASTICITY
|
204
|
6.64e-02
|
4.98e-01
|
0.09820
|
-3.79e-02
|
9.06e-02
|
3.50e-01
|
2.57e-02
|
GOBP RESPONSE TO INSULIN
|
262
|
2.74e-02
|
3.45e-01
|
0.09820
|
-9.56e-02
|
2.20e-02
|
7.68e-03
|
5.39e-01
|
GOCC TRANS GOLGI NETWORK
|
246
|
3.25e-02
|
3.68e-01
|
0.09820
|
-9.68e-02
|
1.61e-02
|
8.91e-03
|
6.63e-01
|
GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II
|
34
|
5.74e-01
|
8.88e-01
|
0.09810
|
-7.69e-02
|
-6.09e-02
|
4.38e-01
|
5.39e-01
|
GOBP REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY
|
133
|
1.82e-01
|
6.72e-01
|
0.09810
|
-6.73e-02
|
7.14e-02
|
1.80e-01
|
1.55e-01
|
GOBP REGULATION OF CELL FATE COMMITMENT
|
41
|
5.78e-01
|
8.89e-01
|
0.09810
|
-3.77e-02
|
9.05e-02
|
6.76e-01
|
3.16e-01
|
GOBP BEHAVIORAL RESPONSE TO ETHANOL
|
10
|
8.73e-01
|
9.73e-01
|
0.09810
|
-2.95e-02
|
9.35e-02
|
8.72e-01
|
6.09e-01
|
GOBP PIGMENT GRANULE ORGANIZATION
|
37
|
6.18e-01
|
9.00e-01
|
0.09800
|
-8.28e-02
|
5.24e-02
|
3.83e-01
|
5.81e-01
|
GOBP SLEEP
|
22
|
7.49e-01
|
9.40e-01
|
0.09800
|
-4.63e-02
|
8.64e-02
|
7.07e-01
|
4.83e-01
|
GOBP REGULATION OF ACTIN FILAMENT BASED PROCESS
|
362
|
7.12e-03
|
1.77e-01
|
0.09800
|
-2.07e-02
|
9.58e-02
|
4.99e-01
|
1.75e-03
|
GOBP NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY
|
18
|
7.85e-01
|
9.52e-01
|
0.09790
|
-9.18e-02
|
3.40e-02
|
5.00e-01
|
8.03e-01
|
GOBP REGULATION OF LEUKOCYTE MIGRATION
|
218
|
6.23e-02
|
4.82e-01
|
0.09790
|
-7.64e-02
|
6.12e-02
|
5.19e-02
|
1.20e-01
|
GOBP REGULATION OF TESTOSTERONE BIOSYNTHETIC PROCESS
|
7
|
8.97e-01
|
9.78e-01
|
0.09780
|
-2.96e-02
|
-9.32e-02
|
8.92e-01
|
6.69e-01
|
GOBP BONE MORPHOGENESIS
|
97
|
2.79e-01
|
7.52e-01
|
0.09780
|
-4.05e-02
|
8.90e-02
|
4.91e-01
|
1.30e-01
|
GOBP ACIDIC AMINO ACID TRANSPORT
|
65
|
3.48e-01
|
7.96e-01
|
0.09770
|
7.24e-02
|
6.57e-02
|
3.13e-01
|
3.60e-01
|
GOBP AMINOACYL TRNA METABOLISM INVOLVED IN TRANSLATIONAL FIDELITY
|
13
|
8.47e-01
|
9.66e-01
|
0.09770
|
7.00e-02
|
-6.83e-02
|
6.62e-01
|
6.70e-01
|
GOMF AMINOACYL TRNA EDITING ACTIVITY
|
13
|
8.47e-01
|
9.66e-01
|
0.09770
|
7.00e-02
|
-6.83e-02
|
6.62e-01
|
6.70e-01
|
GOBP POSITIVE REGULATION OF TELOMERE MAINTENANCE
|
66
|
3.91e-01
|
8.22e-01
|
0.09770
|
7.67e-03
|
-9.74e-02
|
9.14e-01
|
1.71e-01
|
GOBP INDUCTION OF POSITIVE CHEMOTAXIS
|
13
|
8.27e-01
|
9.62e-01
|
0.09770
|
2.25e-03
|
9.77e-02
|
9.89e-01
|
5.42e-01
|
GOMF MONOATOMIC ANION CHANNEL ACTIVITY
|
87
|
3.09e-01
|
7.72e-01
|
0.09770
|
2.81e-02
|
-9.35e-02
|
6.50e-01
|
1.32e-01
|
GOBP CALCIUM ION IMPORT
|
46
|
4.81e-01
|
8.54e-01
|
0.09770
|
4.40e-02
|
8.72e-02
|
6.06e-01
|
3.06e-01
|
GOMF PROTEIN KINASE A REGULATORY SUBUNIT BINDING
|
24
|
7.21e-01
|
9.30e-01
|
0.09770
|
-9.45e-02
|
2.47e-02
|
4.23e-01
|
8.34e-01
|
GOBP CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC
|
111
|
2.43e-01
|
7.25e-01
|
0.09770
|
-7.66e-02
|
6.05e-02
|
1.63e-01
|
2.71e-01
|
GOBP POSITIVE REGULATION OF PROTEIN POLYMERIZATION
|
89
|
2.49e-01
|
7.27e-01
|
0.09770
|
3.49e-02
|
9.12e-02
|
5.69e-01
|
1.37e-01
|
GOBP REGULATION OF MONOATOMIC CATION TRANSMEMBRANE TRANSPORT
|
299
|
1.52e-02
|
2.62e-01
|
0.09770
|
-8.91e-03
|
9.72e-02
|
7.91e-01
|
3.82e-03
|
GOBP CELL SURFACE PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY
|
70
|
3.22e-01
|
7.79e-01
|
0.09760
|
-7.39e-02
|
-6.38e-02
|
2.85e-01
|
3.56e-01
|
GOBP PERIPHERAL NERVOUS SYSTEM DEVELOPMENT
|
80
|
3.20e-01
|
7.78e-01
|
0.09760
|
-5.73e-03
|
9.75e-02
|
9.29e-01
|
1.32e-01
|
GOBP REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION
|
12
|
8.56e-01
|
9.68e-01
|
0.09760
|
8.51e-02
|
-4.78e-02
|
6.10e-01
|
7.74e-01
|
GOCC SET1C COMPASS COMPLEX
|
14
|
8.04e-01
|
9.57e-01
|
0.09760
|
-9.26e-02
|
-3.08e-02
|
5.48e-01
|
8.42e-01
|
GOBP PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS
|
46
|
5.56e-01
|
8.81e-01
|
0.09750
|
5.68e-02
|
-7.92e-02
|
5.05e-01
|
3.53e-01
|
GOBP NEURON FATE COMMITMENT
|
73
|
3.77e-01
|
8.13e-01
|
0.09750
|
-9.24e-02
|
3.11e-02
|
1.72e-01
|
6.46e-01
|
GOBP REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY
|
14
|
8.10e-01
|
9.59e-01
|
0.09740
|
9.57e-02
|
1.82e-02
|
5.35e-01
|
9.06e-01
|
GOBP NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION
|
179
|
5.86e-02
|
4.71e-01
|
0.09740
|
4.94e-02
|
8.40e-02
|
2.55e-01
|
5.25e-02
|
GOBP REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION
|
343
|
4.21e-03
|
1.33e-01
|
0.09740
|
-6.92e-02
|
-6.86e-02
|
2.76e-02
|
2.91e-02
|
GOBP CEREBELLAR GRANULAR LAYER DEVELOPMENT
|
12
|
8.27e-01
|
9.62e-01
|
0.09740
|
-4.24e-02
|
-8.76e-02
|
7.99e-01
|
5.99e-01
|
GOBP CELLULAR RESPONSE TO INTERFERON BETA
|
26
|
6.58e-01
|
9.09e-01
|
0.09730
|
-7.45e-02
|
-6.26e-02
|
5.11e-01
|
5.81e-01
|
GOMF STRUCTURAL CONSTITUENT OF POSTSYNAPSE
|
18
|
7.50e-01
|
9.40e-01
|
0.09730
|
-5.12e-02
|
-8.28e-02
|
7.07e-01
|
5.43e-01
|
GOBP REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE
|
14
|
8.06e-01
|
9.57e-01
|
0.09720
|
-9.22e-02
|
-3.07e-02
|
5.50e-01
|
8.42e-01
|
GOMF GAMMA AMINOBUTYRIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY
|
8
|
8.86e-01
|
9.76e-01
|
0.09720
|
9.46e-02
|
2.25e-02
|
6.43e-01
|
9.12e-01
|
GOMF MAGNESIUM ION BINDING
|
211
|
6.04e-02
|
4.78e-01
|
0.09720
|
-9.32e-02
|
2.78e-02
|
1.97e-02
|
4.87e-01
|
GOBP CELLULAR RESPONSE TO ALKALOID
|
35
|
6.28e-01
|
9.02e-01
|
0.09720
|
-3.11e-02
|
9.21e-02
|
7.50e-01
|
3.46e-01
|
GOBP HORMONE BIOSYNTHETIC PROCESS
|
65
|
4.16e-01
|
8.30e-01
|
0.09720
|
2.42e-02
|
-9.41e-02
|
7.36e-01
|
1.89e-01
|
GOBP POSITIVE REGULATION OF NEUROBLAST PROLIFERATION
|
37
|
6.13e-01
|
8.98e-01
|
0.09720
|
9.15e-02
|
-3.29e-02
|
3.36e-01
|
7.29e-01
|
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION
|
458
|
3.32e-03
|
1.15e-01
|
0.09710
|
-7.93e-02
|
5.61e-02
|
3.61e-03
|
3.98e-02
|
GOCC MEMBRANE MICRODOMAIN
|
279
|
1.26e-02
|
2.43e-01
|
0.09710
|
4.97e-02
|
8.34e-02
|
1.53e-01
|
1.65e-02
|
GOMF N ACYLTRANSFERASE ACTIVITY
|
84
|
2.83e-01
|
7.56e-01
|
0.09710
|
-9.47e-02
|
-2.16e-02
|
1.34e-01
|
7.32e-01
|
GOMF MOLECULAR SEQUESTERING ACTIVITY
|
38
|
5.70e-01
|
8.86e-01
|
0.09710
|
-1.37e-02
|
-9.61e-02
|
8.84e-01
|
3.05e-01
|
GOMF HISTONE H2A UBIQUITIN LIGASE ACTIVITY
|
5
|
9.37e-01
|
9.88e-01
|
0.09710
|
8.83e-02
|
-4.04e-02
|
7.33e-01
|
8.76e-01
|
GOBP METHYLATION
|
261
|
1.63e-02
|
2.72e-01
|
0.09700
|
-7.99e-02
|
-5.50e-02
|
2.62e-02
|
1.26e-01
|
GOBP POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT
|
52
|
5.14e-01
|
8.68e-01
|
0.09700
|
-8.43e-02
|
4.79e-02
|
2.93e-01
|
5.50e-01
|
GOBP PROTEIN KINASE C SIGNALING
|
35
|
6.32e-01
|
9.03e-01
|
0.09690
|
-9.05e-02
|
3.47e-02
|
3.54e-01
|
7.22e-01
|
GOBP HAIR CYCLE PHASE
|
9
|
8.78e-01
|
9.75e-01
|
0.09690
|
9.68e-02
|
4.82e-03
|
6.15e-01
|
9.80e-01
|
GOBP NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY
|
154
|
1.44e-01
|
6.28e-01
|
0.09690
|
-5.58e-02
|
7.92e-02
|
2.32e-01
|
8.97e-02
|
GOMF CARBOXY LYASE ACTIVITY
|
33
|
5.90e-01
|
8.92e-01
|
0.09690
|
-6.08e-02
|
-7.54e-02
|
5.45e-01
|
4.53e-01
|
GOBP MUCOSA ASSOCIATED LYMPHOID TISSUE DEVELOPMENT
|
8
|
8.91e-01
|
9.76e-01
|
0.09690
|
9.67e-02
|
5.28e-03
|
6.36e-01
|
9.79e-01
|
GOBP DENDRITIC SPINE MORPHOGENESIS
|
51
|
5.08e-01
|
8.66e-01
|
0.09680
|
-2.82e-02
|
9.26e-02
|
7.27e-01
|
2.53e-01
|
GOBP POSITIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION
|
23
|
6.97e-01
|
9.21e-01
|
0.09680
|
-4.59e-02
|
-8.52e-02
|
7.03e-01
|
4.79e-01
|
GOBP REGULATION OF MRNA SPLICING VIA SPLICEOSOME
|
95
|
2.38e-01
|
7.25e-01
|
0.09680
|
-9.28e-02
|
-2.73e-02
|
1.18e-01
|
6.45e-01
|
GOBP RESPONSE TO OXYGEN RADICAL
|
27
|
6.68e-01
|
9.11e-01
|
0.09670
|
-2.08e-02
|
-9.45e-02
|
8.52e-01
|
3.96e-01
|
GOBP ASTROCYTE DEVELOPMENT
|
42
|
5.92e-01
|
8.93e-01
|
0.09670
|
-7.12e-02
|
6.55e-02
|
4.25e-01
|
4.63e-01
|
GOBP REGULATION OF ACTIVATION OF JANUS KINASE ACTIVITY
|
8
|
8.81e-01
|
9.75e-01
|
0.09670
|
-5.86e-02
|
-7.69e-02
|
7.74e-01
|
7.06e-01
|
GOBP APPENDAGE DEVELOPMENT
|
177
|
1.11e-01
|
5.90e-01
|
0.09660
|
-6.66e-02
|
7.01e-02
|
1.27e-01
|
1.08e-01
|
GOCC CLEAVAGE FURROW
|
51
|
5.30e-01
|
8.73e-01
|
0.09660
|
-7.01e-02
|
6.65e-02
|
3.86e-01
|
4.12e-01
|
GOMF PROTEIN KINASE ACTIVITY
|
550
|
1.23e-03
|
5.88e-02
|
0.09660
|
-6.53e-02
|
7.12e-02
|
8.83e-03
|
4.29e-03
|
GOBP MINERALOCORTICOID BIOSYNTHETIC PROCESS
|
12
|
8.52e-01
|
9.67e-01
|
0.09660
|
-9.38e-02
|
2.29e-02
|
5.74e-01
|
8.91e-01
|
GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION
|
66
|
4.27e-01
|
8.36e-01
|
0.09650
|
-8.85e-02
|
3.86e-02
|
2.14e-01
|
5.88e-01
|
GOBP GLUTAMINE METABOLIC PROCESS
|
25
|
7.20e-01
|
9.30e-01
|
0.09650
|
3.15e-02
|
-9.12e-02
|
7.85e-01
|
4.30e-01
|
GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE
|
32
|
6.10e-01
|
8.98e-01
|
0.09650
|
-8.77e-02
|
-4.04e-02
|
3.91e-01
|
6.92e-01
|
GOBP POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION
|
25
|
6.79e-01
|
9.14e-01
|
0.09650
|
-4.22e-02
|
-8.68e-02
|
7.15e-01
|
4.53e-01
|
GOBP DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE
|
46
|
5.40e-01
|
8.78e-01
|
0.09650
|
-9.40e-02
|
2.14e-02
|
2.70e-01
|
8.02e-01
|
GOBP ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS
|
305
|
8.88e-03
|
1.97e-01
|
0.09640
|
-5.16e-02
|
-8.15e-02
|
1.21e-01
|
1.44e-02
|
GOBP OLFACTORY LOBE DEVELOPMENT
|
36
|
5.66e-01
|
8.85e-01
|
0.09640
|
-7.35e-02
|
-6.24e-02
|
4.45e-01
|
5.17e-01
|
GOBP GLYCOPROTEIN METABOLIC PROCESS
|
357
|
9.55e-03
|
2.08e-01
|
0.09640
|
-9.27e-02
|
2.67e-02
|
2.63e-03
|
3.87e-01
|
GOBP DE NOVO NAD BIOSYNTHETIC PROCESS
|
8
|
8.87e-01
|
9.76e-01
|
0.09640
|
-2.49e-02
|
-9.31e-02
|
9.03e-01
|
6.48e-01
|
GOBP REGULATION OF ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME
|
50
|
4.87e-01
|
8.56e-01
|
0.09640
|
-9.60e-02
|
-8.31e-03
|
2.40e-01
|
9.19e-01
|
GOBP RESPONSE TO ORGANOPHOSPHORUS
|
121
|
1.87e-01
|
6.79e-01
|
0.09640
|
-9.62e-02
|
5.95e-03
|
6.76e-02
|
9.10e-01
|
GOBP REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY
|
15
|
8.30e-01
|
9.64e-01
|
0.09630
|
-6.84e-02
|
6.78e-02
|
6.46e-01
|
6.49e-01
|
GOBP POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION
|
19
|
7.77e-01
|
9.50e-01
|
0.09630
|
-2.35e-02
|
9.34e-02
|
8.59e-01
|
4.81e-01
|
GOBP STARTLE RESPONSE
|
26
|
7.19e-01
|
9.29e-01
|
0.09630
|
-4.40e-02
|
8.56e-02
|
6.98e-01
|
4.50e-01
|
GOBP PEPTIDYL SERINE MODIFICATION
|
291
|
2.82e-02
|
3.48e-01
|
0.09630
|
-7.35e-02
|
6.22e-02
|
3.09e-02
|
6.81e-02
|
GOBP AMYGDALA DEVELOPMENT
|
5
|
9.32e-01
|
9.86e-01
|
0.09620
|
9.62e-02
|
-9.09e-05
|
7.10e-01
|
1.00e+00
|
GOMF CALCIUM DEPENDENT PHOSPHOLIPID BINDING
|
53
|
5.11e-01
|
8.66e-01
|
0.09620
|
-8.59e-02
|
4.32e-02
|
2.79e-01
|
5.86e-01
|
GOBP POSITIVE REGULATION OF MICROTUBULE NUCLEATION
|
7
|
9.00e-01
|
9.79e-01
|
0.09620
|
-9.15e-02
|
-2.96e-02
|
6.75e-01
|
8.92e-01
|
GOBP REGULATION OF MUSCLE SYSTEM PROCESS
|
239
|
4.20e-02
|
4.23e-01
|
0.09620
|
-1.93e-02
|
9.42e-02
|
6.08e-01
|
1.21e-02
|
GOBP POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS
|
28
|
6.49e-01
|
9.07e-01
|
0.09610
|
-8.56e-02
|
-4.38e-02
|
4.33e-01
|
6.88e-01
|
GOMF METAL CATION PROTON ANTIPORTER ACTIVITY
|
23
|
7.28e-01
|
9.31e-01
|
0.09610
|
9.59e-02
|
-6.27e-03
|
4.26e-01
|
9.58e-01
|
GOBP REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT
|
431
|
2.09e-03
|
8.55e-02
|
0.09610
|
1.53e-02
|
9.49e-02
|
5.85e-01
|
7.28e-04
|
GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION
|
12
|
8.55e-01
|
9.68e-01
|
0.09610
|
-9.14e-02
|
2.97e-02
|
5.84e-01
|
8.59e-01
|
GOBP REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS
|
53
|
4.45e-01
|
8.40e-01
|
0.09610
|
3.97e-02
|
8.75e-02
|
6.17e-01
|
2.71e-01
|
GOBP ANDROGEN METABOLIC PROCESS
|
29
|
6.96e-01
|
9.21e-01
|
0.09600
|
5.00e-02
|
-8.20e-02
|
6.41e-01
|
4.45e-01
|
GOBP RESPONSE TO TRANSFORMING GROWTH FACTOR BETA
|
287
|
3.06e-02
|
3.61e-01
|
0.09590
|
-6.82e-02
|
6.75e-02
|
4.68e-02
|
4.92e-02
|
GOCC CALCINEURIN COMPLEX
|
6
|
9.13e-01
|
9.82e-01
|
0.09590
|
3.69e-02
|
8.86e-02
|
8.76e-01
|
7.07e-01
|
GOBP STRIATED MUSCLE ATROPHY
|
7
|
8.97e-01
|
9.78e-01
|
0.09590
|
8.22e-02
|
4.94e-02
|
7.06e-01
|
8.21e-01
|
GOBP ESTABLISHMENT OF SISTER CHROMATID COHESION
|
9
|
8.95e-01
|
9.77e-01
|
0.09590
|
-7.57e-02
|
5.89e-02
|
6.94e-01
|
7.60e-01
|
GOBP CEREBELLAR CORTEX DEVELOPMENT
|
49
|
4.82e-01
|
8.54e-01
|
0.09580
|
-2.77e-02
|
-9.18e-02
|
7.37e-01
|
2.66e-01
|
GOBP PROTEIN O LINKED GLYCOSYLATION
|
96
|
2.88e-01
|
7.60e-01
|
0.09580
|
-9.15e-02
|
2.85e-02
|
1.21e-01
|
6.29e-01
|
GOCC EXTRINSIC COMPONENT OF SYNAPTIC MEMBRANE
|
13
|
8.40e-01
|
9.65e-01
|
0.09580
|
-1.49e-02
|
9.46e-02
|
9.26e-01
|
5.55e-01
|
GOBP MICROTUBULE ORGANIZING CENTER LOCALIZATION
|
32
|
6.41e-01
|
9.07e-01
|
0.09580
|
9.57e-02
|
-1.46e-03
|
3.49e-01
|
9.89e-01
|
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS
|
62
|
3.98e-01
|
8.25e-01
|
0.09570
|
-9.13e-02
|
-2.87e-02
|
2.14e-01
|
6.95e-01
|
GOCC EXTERNAL SIDE OF PLASMA MEMBRANE
|
358
|
4.22e-03
|
1.33e-01
|
0.09570
|
7.87e-02
|
5.44e-02
|
1.05e-02
|
7.68e-02
|
GOBP GLYCOSYLCERAMIDE BIOSYNTHETIC PROCESS
|
8
|
8.87e-01
|
9.76e-01
|
0.09570
|
8.92e-02
|
3.46e-02
|
6.62e-01
|
8.66e-01
|
GOCC ASTROCYTE PROJECTION
|
19
|
7.50e-01
|
9.40e-01
|
0.09560
|
3.84e-02
|
8.76e-02
|
7.72e-01
|
5.09e-01
|
GOBP POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT
|
6
|
9.17e-01
|
9.83e-01
|
0.09560
|
1.73e-02
|
9.41e-02
|
9.41e-01
|
6.90e-01
|
GOBP NEGATIVE REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY
|
9
|
8.88e-01
|
9.76e-01
|
0.09560
|
9.37e-02
|
-1.92e-02
|
6.26e-01
|
9.20e-01
|
GOBP REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION
|
72
|
3.49e-01
|
7.96e-01
|
0.09560
|
2.14e-02
|
9.32e-02
|
7.54e-01
|
1.71e-01
|
GOBP MISMATCH REPAIR
|
34
|
6.15e-01
|
8.99e-01
|
0.09560
|
-1.15e-02
|
-9.49e-02
|
9.08e-01
|
3.38e-01
|
GOMF L ARGININE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
12
|
8.48e-01
|
9.66e-01
|
0.09560
|
-9.55e-02
|
5.01e-03
|
5.67e-01
|
9.76e-01
|
GOCC MITOCHONDRIAL MATRIX
|
468
|
9.84e-04
|
5.01e-02
|
0.09560
|
-3.75e-02
|
-8.79e-02
|
1.64e-01
|
1.12e-03
|
GOBP NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE
|
11
|
8.51e-01
|
9.67e-01
|
0.09550
|
-2.34e-02
|
-9.26e-02
|
8.93e-01
|
5.95e-01
|
GOBP REGULATION OF GLUCOCORTICOID BIOSYNTHETIC PROCESS
|
9
|
8.70e-01
|
9.73e-01
|
0.09550
|
5.88e-02
|
7.53e-02
|
7.60e-01
|
6.96e-01
|
GOBP PROTEIN EXIT FROM ENDOPLASMIC RETICULUM
|
48
|
4.94e-01
|
8.58e-01
|
0.09550
|
-2.43e-02
|
-9.24e-02
|
7.71e-01
|
2.68e-01
|
GOCC NUCLEAR ENVELOPE
|
465
|
1.57e-03
|
7.12e-02
|
0.09550
|
-9.51e-02
|
-8.36e-03
|
4.38e-04
|
7.57e-01
|
GOBP PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS
|
24
|
7.05e-01
|
9.24e-01
|
0.09550
|
-9.34e-02
|
-1.98e-02
|
4.28e-01
|
8.66e-01
|
GOBP NUCLEAR EXPORT
|
157
|
9.76e-02
|
5.62e-01
|
0.09550
|
-9.00e-02
|
-3.18e-02
|
5.16e-02
|
4.92e-01
|
GOCC SMOOTH ENDOPLASMIC RETICULUM
|
27
|
6.73e-01
|
9.13e-01
|
0.09550
|
-2.36e-02
|
-9.25e-02
|
8.32e-01
|
4.05e-01
|
GOBP REGULATION OF POSTSYNAPSE ORGANIZATION
|
96
|
3.07e-01
|
7.72e-01
|
0.09550
|
-8.01e-02
|
5.19e-02
|
1.75e-01
|
3.80e-01
|
GOBP REGULATION OF SODIUM DEPENDENT PHOSPHATE TRANSPORT
|
5
|
9.25e-01
|
9.84e-01
|
0.09540
|
-7.15e-02
|
-6.32e-02
|
7.82e-01
|
8.07e-01
|
GOBP OLIGODENDROCYTE DEVELOPMENT
|
44
|
5.85e-01
|
8.90e-01
|
0.09540
|
-7.37e-02
|
6.07e-02
|
3.98e-01
|
4.86e-01
|
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION
|
38
|
5.61e-01
|
8.84e-01
|
0.09540
|
-8.47e-02
|
-4.40e-02
|
3.66e-01
|
6.39e-01
|
GOBP POSITIVE REGULATION OF LIPID CATABOLIC PROCESS
|
26
|
6.92e-01
|
9.21e-01
|
0.09540
|
-9.50e-02
|
-9.15e-03
|
4.02e-01
|
9.36e-01
|
GOBP INTRACELLULAR TRANSPORT
|
1508
|
1.29e-08
|
1.10e-05
|
0.09540
|
-9.13e-02
|
2.78e-02
|
3.08e-09
|
7.14e-02
|
GOMF PROTEIN SERINE KINASE ACTIVITY
|
340
|
1.69e-02
|
2.76e-01
|
0.09540
|
-7.16e-02
|
6.30e-02
|
2.32e-02
|
4.58e-02
|
GOBP VACUOLE ORGANIZATION
|
219
|
4.47e-02
|
4.29e-01
|
0.09540
|
-9.43e-02
|
-1.41e-02
|
1.61e-02
|
7.20e-01
|
GOMF INSULIN LIKE GROWTH FACTOR I BINDING
|
13
|
8.38e-01
|
9.64e-01
|
0.09530
|
9.52e-02
|
-5.67e-03
|
5.52e-01
|
9.72e-01
|
GOBP REGULATION OF PHOSPHATASE ACTIVITY
|
59
|
4.02e-01
|
8.26e-01
|
0.09530
|
6.62e-02
|
6.86e-02
|
3.79e-01
|
3.62e-01
|
GOBP INTEGRIN ACTIVATION
|
26
|
7.29e-01
|
9.32e-01
|
0.09530
|
-6.54e-02
|
6.93e-02
|
5.64e-01
|
5.41e-01
|
GOBP REGULATION OF KETONE BIOSYNTHETIC PROCESS
|
21
|
7.31e-01
|
9.32e-01
|
0.09530
|
-8.84e-02
|
-3.54e-02
|
4.83e-01
|
7.79e-01
|
GOBP RESPONSE TO HUMAN CHORIONIC GONADOTROPIN
|
5
|
9.38e-01
|
9.88e-01
|
0.09520
|
-8.93e-02
|
3.30e-02
|
7.29e-01
|
8.98e-01
|
GOBP METANEPHRIC COLLECTING DUCT DEVELOPMENT
|
10
|
8.63e-01
|
9.69e-01
|
0.09520
|
9.06e-02
|
2.93e-02
|
6.20e-01
|
8.73e-01
|
GOCC ORGANELLE ENVELOPE LUMEN
|
86
|
2.83e-01
|
7.56e-01
|
0.09520
|
-2.76e-02
|
-9.11e-02
|
6.59e-01
|
1.44e-01
|
GOMF 5 3 EXONUCLEASE ACTIVITY
|
19
|
7.80e-01
|
9.51e-01
|
0.09510
|
1.91e-02
|
-9.32e-02
|
8.85e-01
|
4.82e-01
|
GOBP SERINE TRANSPORT
|
9
|
8.80e-01
|
9.75e-01
|
0.09510
|
-9.40e-02
|
-1.41e-02
|
6.25e-01
|
9.42e-01
|
GOMF SERINE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
9
|
8.80e-01
|
9.75e-01
|
0.09510
|
-9.40e-02
|
-1.41e-02
|
6.25e-01
|
9.42e-01
|
GOBP RNA SPLICING VIA TRANSESTERIFICATION REACTIONS
|
285
|
1.65e-02
|
2.73e-01
|
0.09510
|
-2.48e-02
|
-9.18e-02
|
4.72e-01
|
7.68e-03
|
GOBP POSITIVE REGULATION OF MUSCLE CONTRACTION
|
46
|
5.51e-01
|
8.80e-01
|
0.09500
|
-2.30e-02
|
9.22e-02
|
7.87e-01
|
2.79e-01
|
GOMF PROTEIN PHOSPHATASE ACTIVATOR ACTIVITY
|
15
|
8.18e-01
|
9.60e-01
|
0.09500
|
-9.46e-02
|
9.32e-03
|
5.26e-01
|
9.50e-01
|
GOBP RESPONSE TO DOPAMINE
|
70
|
4.16e-01
|
8.30e-01
|
0.09500
|
-3.54e-02
|
8.81e-02
|
6.08e-01
|
2.02e-01
|
GOBP NEUTRAL AMINO ACID TRANSPORT
|
54
|
4.44e-01
|
8.40e-01
|
0.09500
|
4.37e-02
|
8.43e-02
|
5.79e-01
|
2.84e-01
|
GOBP REGULATION OF PHOSPHOLIPID TRANSPORT
|
15
|
8.15e-01
|
9.59e-01
|
0.09500
|
-2.10e-03
|
9.49e-02
|
9.89e-01
|
5.24e-01
|
GOBP REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION
|
30
|
6.63e-01
|
9.10e-01
|
0.09490
|
9.49e-02
|
1.17e-04
|
3.68e-01
|
9.99e-01
|
GOBP POSITIVE REGULATION OF MUSCLE ADAPTATION
|
13
|
8.47e-01
|
9.66e-01
|
0.09490
|
-2.80e-02
|
9.07e-02
|
8.61e-01
|
5.71e-01
|
GOMF GLUCURONOSYL N ACETYLGALACTOSAMINYL PROTEOGLYCAN 4 BETA N ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY
|
6
|
9.15e-01
|
9.83e-01
|
0.09490
|
-8.95e-02
|
-3.16e-02
|
7.04e-01
|
8.93e-01
|
GOBP REGULATION OF PROTEIN BINDING
|
139
|
1.68e-01
|
6.54e-01
|
0.09490
|
-2.34e-02
|
9.19e-02
|
6.34e-01
|
6.13e-02
|
GOMF ATP HYDROLYSIS ACTIVITY
|
395
|
2.68e-03
|
1.01e-01
|
0.09490
|
-5.50e-02
|
-7.73e-02
|
6.04e-02
|
8.39e-03
|
GOMF MOLECULAR TRANSDUCER ACTIVITY
|
1363
|
7.83e-09
|
7.28e-06
|
0.09480
|
9.10e-02
|
2.66e-02
|
1.70e-08
|
9.91e-02
|
GOCC MEIOTIC COHESIN COMPLEX
|
6
|
9.15e-01
|
9.83e-01
|
0.09470
|
3.75e-02
|
8.70e-02
|
8.74e-01
|
7.12e-01
|
GOMF GLYCOSYLTRANSFERASE ACTIVITY
|
266
|
2.72e-02
|
3.43e-01
|
0.09470
|
-9.47e-02
|
-1.89e-03
|
7.84e-03
|
9.58e-01
|
GOMF INOSITOL 1 3 4 5 6 PENTAKISPHOSPHATE KINASE ACTIVITY
|
5
|
9.39e-01
|
9.89e-01
|
0.09470
|
-3.45e-02
|
8.82e-02
|
8.94e-01
|
7.33e-01
|
GOBP REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING
|
57
|
4.79e-01
|
8.54e-01
|
0.09470
|
2.07e-02
|
-9.24e-02
|
7.86e-01
|
2.28e-01
|
GOBP CELLULAR RESPONSE TO GLUCOSE STARVATION
|
49
|
4.84e-01
|
8.54e-01
|
0.09470
|
-8.66e-02
|
-3.81e-02
|
2.94e-01
|
6.44e-01
|
GOMF CCR CHEMOKINE RECEPTOR BINDING
|
39
|
6.20e-01
|
9.00e-01
|
0.09460
|
-4.35e-02
|
8.41e-02
|
6.38e-01
|
3.64e-01
|
GOMF DNA ENDONUCLEASE ACTIVITY
|
38
|
5.70e-01
|
8.86e-01
|
0.09460
|
-3.68e-02
|
-8.72e-02
|
6.95e-01
|
3.52e-01
|
GOBP REGULATION OF RNA SPLICING
|
163
|
9.07e-02
|
5.51e-01
|
0.09460
|
-8.68e-02
|
-3.76e-02
|
5.57e-02
|
4.08e-01
|
GOBP DETECTION OF LIGHT STIMULUS
|
61
|
4.82e-01
|
8.54e-01
|
0.09460
|
-6.48e-02
|
6.90e-02
|
3.82e-01
|
3.51e-01
|
GOBP POLYAMINE BIOSYNTHETIC PROCESS
|
12
|
8.66e-01
|
9.70e-01
|
0.09460
|
6.40e-02
|
-6.97e-02
|
7.01e-01
|
6.76e-01
|
GOBP CELLULAR RESPONSE TO GAMMA RADIATION
|
26
|
6.75e-01
|
9.13e-01
|
0.09460
|
7.95e-02
|
5.13e-02
|
4.83e-01
|
6.51e-01
|
GOBP PHOSPHOLIPID EFFLUX
|
14
|
8.13e-01
|
9.59e-01
|
0.09450
|
3.76e-02
|
8.67e-02
|
8.07e-01
|
5.74e-01
|
GOBP EMBRYONIC APPENDAGE MORPHOGENESIS
|
119
|
2.42e-01
|
7.25e-01
|
0.09450
|
-6.22e-02
|
7.12e-02
|
2.41e-01
|
1.80e-01
|
GOBP NEUTROPHIL EXTRAVASATION
|
11
|
8.58e-01
|
9.68e-01
|
0.09450
|
-9.40e-02
|
-9.72e-03
|
5.89e-01
|
9.55e-01
|
GOBP PRIMARY AMINO COMPOUND METABOLIC PROCESS
|
13
|
8.55e-01
|
9.68e-01
|
0.09450
|
7.96e-02
|
-5.10e-02
|
6.19e-01
|
7.50e-01
|
GOBP NEGATIVE REGULATION OF WOUND HEALING
|
72
|
3.73e-01
|
8.10e-01
|
0.09450
|
4.40e-03
|
9.44e-02
|
9.49e-01
|
1.66e-01
|
GOBP PEROXISOME ORGANIZATION
|
34
|
6.60e-01
|
9.09e-01
|
0.09450
|
4.31e-02
|
-8.41e-02
|
6.64e-01
|
3.96e-01
|
GOBP DORSAL ROOT GANGLION DEVELOPMENT
|
7
|
9.20e-01
|
9.84e-01
|
0.09440
|
-5.96e-02
|
7.32e-02
|
7.85e-01
|
7.37e-01
|
GOBP DNA METHYLATION
|
47
|
4.92e-01
|
8.58e-01
|
0.09440
|
-5.54e-02
|
-7.65e-02
|
5.11e-01
|
3.64e-01
|
GOBP CARDIAC MUSCLE CELL FATE COMMITMENT
|
11
|
8.77e-01
|
9.75e-01
|
0.09440
|
7.16e-02
|
-6.16e-02
|
6.81e-01
|
7.24e-01
|
GOBP POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY
|
18
|
7.79e-01
|
9.51e-01
|
0.09430
|
9.36e-02
|
1.10e-02
|
4.92e-01
|
9.36e-01
|
GOBP POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS
|
13
|
8.57e-01
|
9.68e-01
|
0.09430
|
6.18e-02
|
-7.11e-02
|
6.99e-01
|
6.57e-01
|
GOBP RESPONSE TO COLD
|
43
|
5.33e-01
|
8.76e-01
|
0.09420
|
3.70e-02
|
8.66e-02
|
6.75e-01
|
3.26e-01
|
GOBP REGULATION OF HORMONE METABOLIC PROCESS
|
39
|
6.16e-01
|
9.00e-01
|
0.09420
|
8.82e-02
|
-3.29e-02
|
3.40e-01
|
7.22e-01
|
GOBP NEGATIVE REGULATION OF MACROPHAGE MIGRATION
|
14
|
8.34e-01
|
9.64e-01
|
0.09420
|
-9.29e-02
|
1.54e-02
|
5.47e-01
|
9.21e-01
|
GOBP ANTEROGRADE AXONAL TRANSPORT
|
49
|
4.97e-01
|
8.60e-01
|
0.09420
|
-2.44e-02
|
-9.09e-02
|
7.68e-01
|
2.71e-01
|
GOBP REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION
|
93
|
3.33e-01
|
7.86e-01
|
0.09400
|
-5.98e-02
|
7.26e-02
|
3.19e-01
|
2.26e-01
|
GOBP DNA INTEGRITY CHECKPOINT SIGNALING
|
131
|
1.50e-01
|
6.36e-01
|
0.09400
|
-3.48e-02
|
-8.74e-02
|
4.92e-01
|
8.42e-02
|
GOBP EMBRYONIC RETINA MORPHOGENESIS IN CAMERA TYPE EYE
|
6
|
9.28e-01
|
9.85e-01
|
0.09400
|
2.71e-02
|
-9.00e-02
|
9.08e-01
|
7.03e-01
|
GOBP DNA CONFORMATION CHANGE
|
88
|
2.67e-01
|
7.43e-01
|
0.09400
|
-7.20e-02
|
-6.04e-02
|
2.43e-01
|
3.27e-01
|
GOBP DIGESTIVE TRACT MORPHOGENESIS
|
48
|
5.26e-01
|
8.71e-01
|
0.09400
|
-5.45e-04
|
9.40e-02
|
9.95e-01
|
2.60e-01
|
GOBP PROXIMAL DISTAL PATTERN FORMATION
|
34
|
6.01e-01
|
8.96e-01
|
0.09390
|
-5.83e-02
|
-7.37e-02
|
5.56e-01
|
4.57e-01
|
GOMF CYTOSKELETAL ANCHOR ACTIVITY
|
23
|
7.51e-01
|
9.40e-01
|
0.09390
|
-3.00e-02
|
8.90e-02
|
8.03e-01
|
4.60e-01
|
GOBP POSITIVE REGULATION OF INSULIN SECRETION
|
83
|
3.77e-01
|
8.13e-01
|
0.09390
|
-6.52e-02
|
6.76e-02
|
3.05e-01
|
2.87e-01
|
GOBP HAIR CELL DIFFERENTIATION
|
53
|
4.52e-01
|
8.45e-01
|
0.09390
|
7.27e-02
|
5.94e-02
|
3.60e-01
|
4.55e-01
|
GOMF GLYCINE BINDING
|
10
|
8.61e-01
|
9.69e-01
|
0.09390
|
-6.08e-02
|
-7.16e-02
|
7.39e-01
|
6.95e-01
|
GOBP VESICLE ORGANIZATION
|
350
|
1.28e-02
|
2.45e-01
|
0.09390
|
-9.11e-02
|
2.26e-02
|
3.41e-03
|
4.67e-01
|
GOBP NUCLEOBASE TRANSPORT
|
12
|
8.37e-01
|
9.64e-01
|
0.09390
|
-8.10e-02
|
-4.74e-02
|
6.27e-01
|
7.76e-01
|
GOBP REGULATION OF PROTEIN POLYMERIZATION
|
195
|
9.78e-02
|
5.63e-01
|
0.09380
|
-4.56e-02
|
8.20e-02
|
2.72e-01
|
4.83e-02
|
GOCC INTRACILIARY TRANSPORT PARTICLE
|
22
|
7.19e-01
|
9.29e-01
|
0.09380
|
-7.16e-02
|
-6.06e-02
|
5.61e-01
|
6.23e-01
|
GOBP REGULATION OF SIGNALING RECEPTOR ACTIVITY
|
102
|
2.96e-01
|
7.66e-01
|
0.09380
|
-8.09e-02
|
4.75e-02
|
1.58e-01
|
4.08e-01
|
GOBP MYELOID LEUKOCYTE ACTIVATION
|
235
|
5.79e-02
|
4.69e-01
|
0.09380
|
-3.57e-02
|
8.67e-02
|
3.46e-01
|
2.20e-02
|
GOBP PROTEIN LOCALIZATION TO PLASMA MEMBRANE
|
278
|
3.96e-02
|
4.08e-01
|
0.09380
|
-6.72e-02
|
6.54e-02
|
5.38e-02
|
6.06e-02
|
GOBP MYELOID CELL DEVELOPMENT
|
80
|
3.51e-01
|
7.96e-01
|
0.09370
|
-9.35e-02
|
7.11e-03
|
1.48e-01
|
9.12e-01
|
GOBP PURINE CONTAINING COMPOUND METABOLIC PROCESS
|
460
|
1.19e-03
|
5.78e-02
|
0.09360
|
-6.29e-02
|
-6.94e-02
|
2.08e-02
|
1.07e-02
|
GOBP AMINE BIOSYNTHETIC PROCESS
|
37
|
6.35e-01
|
9.05e-01
|
0.09360
|
3.19e-02
|
-8.80e-02
|
7.37e-01
|
3.54e-01
|
GOMF ADENYLYLTRANSFERASE ACTIVITY
|
29
|
6.71e-01
|
9.11e-01
|
0.09360
|
-9.27e-02
|
-1.34e-02
|
3.88e-01
|
9.00e-01
|
GOMF AMINOACYLASE ACTIVITY
|
6
|
9.32e-01
|
9.86e-01
|
0.09360
|
6.87e-02
|
-6.35e-02
|
7.71e-01
|
7.88e-01
|
GOBP DNA DEAMINATION
|
13
|
8.35e-01
|
9.64e-01
|
0.09360
|
-1.47e-02
|
-9.24e-02
|
9.27e-01
|
5.64e-01
|
GOCC CHROMOCENTER
|
13
|
8.31e-01
|
9.64e-01
|
0.09360
|
2.92e-02
|
8.89e-02
|
8.55e-01
|
5.79e-01
|
GOBP REGULATION OF GLIAL CELL DIFFERENTIATION
|
78
|
3.54e-01
|
7.97e-01
|
0.09360
|
-9.36e-02
|
-7.48e-04
|
1.53e-01
|
9.91e-01
|
GOCC ACETYLTRANSFERASE COMPLEX
|
91
|
3.01e-01
|
7.67e-01
|
0.09350
|
-9.35e-02
|
1.89e-03
|
1.23e-01
|
9.75e-01
|
GOBP NEGATIVE REGULATION OF AMINE TRANSPORT
|
28
|
6.92e-01
|
9.21e-01
|
0.09350
|
3.94e-03
|
-9.34e-02
|
9.71e-01
|
3.92e-01
|
GOMF TETRAPYRROLE BINDING
|
143
|
1.56e-01
|
6.43e-01
|
0.09350
|
9.32e-02
|
-7.22e-03
|
5.43e-02
|
8.82e-01
|
GOBP CIRCADIAN SLEEP WAKE CYCLE
|
21
|
7.74e-01
|
9.49e-01
|
0.09350
|
-3.33e-02
|
8.73e-02
|
7.91e-01
|
4.88e-01
|
GOBP POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS
|
67
|
4.52e-01
|
8.45e-01
|
0.09350
|
-8.07e-02
|
4.72e-02
|
2.53e-01
|
5.04e-01
|
GOBP RNA SPLICING
|
420
|
2.43e-03
|
9.50e-02
|
0.09340
|
-4.32e-02
|
-8.29e-02
|
1.29e-01
|
3.57e-03
|
GOMF NEUROTRANSMITTER TRANSMEMBRANE TRANSPORTER ACTIVITY
|
20
|
7.65e-01
|
9.45e-01
|
0.09340
|
3.50e-03
|
9.33e-02
|
9.78e-01
|
4.70e-01
|
GOBP PEPTIDE BIOSYNTHETIC PROCESS
|
805
|
2.92e-05
|
3.64e-03
|
0.09340
|
-5.19e-03
|
-9.33e-02
|
8.02e-01
|
6.83e-06
|
GOBP RESPONSE TO ANTIBIOTIC
|
36
|
6.45e-01
|
9.07e-01
|
0.09330
|
-3.28e-02
|
8.74e-02
|
7.34e-01
|
3.64e-01
|
GOBP POSITIVE REGULATION OF SPROUTING ANGIOGENESIS
|
28
|
7.08e-01
|
9.25e-01
|
0.09330
|
-8.89e-02
|
2.83e-02
|
4.15e-01
|
7.96e-01
|
GOBP CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS
|
146
|
1.76e-01
|
6.65e-01
|
0.09330
|
-4.12e-02
|
8.37e-02
|
3.90e-01
|
8.09e-02
|
GOBP POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY
|
44
|
5.97e-01
|
8.95e-01
|
0.09330
|
-7.73e-02
|
5.21e-02
|
3.75e-01
|
5.50e-01
|
GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I
|
11
|
8.79e-01
|
9.75e-01
|
0.09330
|
-7.86e-02
|
5.02e-02
|
6.52e-01
|
7.73e-01
|
GOBP CD4 POSITIVE ALPHA BETA T CELL ACTIVATION
|
112
|
2.63e-01
|
7.40e-01
|
0.09330
|
-4.03e-02
|
8.41e-02
|
4.61e-01
|
1.24e-01
|
GOBP TAURINE TRANSPORT
|
8
|
8.88e-01
|
9.76e-01
|
0.09320
|
6.69e-02
|
6.50e-02
|
7.43e-01
|
7.50e-01
|
GOBP CARDIAC SEPTUM MORPHOGENESIS
|
72
|
4.06e-01
|
8.26e-01
|
0.09320
|
-2.00e-02
|
9.11e-02
|
7.69e-01
|
1.82e-01
|
GOBP ERBB SIGNALING PATHWAY
|
123
|
2.36e-01
|
7.24e-01
|
0.09320
|
-7.93e-02
|
4.89e-02
|
1.29e-01
|
3.48e-01
|
GOBP PERICARDIUM DEVELOPMENT
|
19
|
8.02e-01
|
9.57e-01
|
0.09310
|
-7.05e-02
|
6.08e-02
|
5.95e-01
|
6.46e-01
|
GOBP AMIDE BIOSYNTHETIC PROCESS
|
937
|
3.08e-06
|
6.86e-04
|
0.09310
|
-2.88e-02
|
-8.85e-02
|
1.35e-01
|
4.35e-06
|
GOMF PEPTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
10
|
8.77e-01
|
9.75e-01
|
0.09310
|
9.31e-02
|
-1.00e-03
|
6.10e-01
|
9.96e-01
|
GOBP REGULATION OF DNA REPLICATION
|
121
|
1.73e-01
|
6.61e-01
|
0.09310
|
-7.97e-02
|
-4.80e-02
|
1.30e-01
|
3.61e-01
|
GOBP REGULATION OF ORGANIC ACID TRANSPORT
|
75
|
3.90e-01
|
8.21e-01
|
0.09300
|
-1.73e-02
|
9.14e-02
|
7.96e-01
|
1.71e-01
|
GOBP POSITIVE REGULATION OF AMIDE METABOLIC PROCESS
|
155
|
1.20e-01
|
6.01e-01
|
0.09300
|
-9.13e-02
|
-1.78e-02
|
4.99e-02
|
7.02e-01
|
GOBP REGULATORY NCRNA PROCESSING
|
84
|
3.72e-01
|
8.09e-01
|
0.09300
|
-8.21e-02
|
4.37e-02
|
1.94e-01
|
4.89e-01
|
GOBP ENDOCRINE SYSTEM DEVELOPMENT
|
137
|
2.02e-01
|
6.92e-01
|
0.09290
|
-7.93e-02
|
4.84e-02
|
1.09e-01
|
3.28e-01
|
GOBP INTRACELLULAR GLUCOSE HOMEOSTASIS
|
152
|
1.64e-01
|
6.48e-01
|
0.09290
|
-3.69e-02
|
8.53e-02
|
4.33e-01
|
6.94e-02
|
GOBP RETINA DEVELOPMENT IN CAMERA TYPE EYE
|
156
|
1.18e-01
|
6.00e-01
|
0.09290
|
-9.08e-02
|
-1.96e-02
|
5.04e-02
|
6.72e-01
|
GOBP TRIGLYCERIDE METABOLIC PROCESS
|
101
|
2.97e-01
|
7.66e-01
|
0.09290
|
-8.69e-02
|
3.28e-02
|
1.31e-01
|
5.69e-01
|
GOMF MDM2 MDM4 FAMILY PROTEIN BINDING
|
11
|
8.80e-01
|
9.75e-01
|
0.09290
|
-5.30e-02
|
7.62e-02
|
7.61e-01
|
6.62e-01
|
GOMF LYASE ACTIVITY
|
189
|
7.33e-02
|
5.13e-01
|
0.09280
|
-8.95e-02
|
-2.49e-02
|
3.39e-02
|
5.55e-01
|
GOBP VASCULAR TRANSPORT
|
84
|
3.69e-01
|
8.09e-01
|
0.09280
|
-3.83e-02
|
8.45e-02
|
5.44e-01
|
1.80e-01
|
GOBP AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS
|
67
|
4.21e-01
|
8.33e-01
|
0.09280
|
-9.27e-02
|
4.21e-03
|
1.90e-01
|
9.52e-01
|
GOBP PHOSPHATE ION TRANSMEMBRANE TRANSPORT
|
17
|
8.12e-01
|
9.59e-01
|
0.09270
|
-2.54e-02
|
8.92e-02
|
8.56e-01
|
5.24e-01
|
GOBP RNA METHYLATION
|
85
|
2.98e-01
|
7.67e-01
|
0.09270
|
-3.97e-02
|
-8.38e-02
|
5.27e-01
|
1.82e-01
|
GOBP NEURON RECOGNITION
|
45
|
5.96e-01
|
8.95e-01
|
0.09270
|
5.98e-02
|
-7.09e-02
|
4.88e-01
|
4.11e-01
|
GOBP REGULATION OF LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR
|
5
|
9.43e-01
|
9.89e-01
|
0.09270
|
8.23e-02
|
-4.27e-02
|
7.50e-01
|
8.69e-01
|
GOBP REGULATION OF INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY
|
10
|
8.85e-01
|
9.76e-01
|
0.09270
|
8.92e-02
|
-2.51e-02
|
6.25e-01
|
8.91e-01
|
GOBP OOGENESIS
|
108
|
2.48e-01
|
7.27e-01
|
0.09270
|
-3.68e-03
|
9.26e-02
|
9.47e-01
|
9.63e-02
|
GOBP NEGATIVE REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE
|
6
|
9.33e-01
|
9.87e-01
|
0.09270
|
6.58e-02
|
-6.53e-02
|
7.80e-01
|
7.82e-01
|
GOBP VESICLE TRANSPORT ALONG MICROTUBULE
|
45
|
5.62e-01
|
8.84e-01
|
0.09270
|
-9.24e-02
|
7.58e-03
|
2.84e-01
|
9.30e-01
|
GOBP POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION
|
107
|
2.77e-01
|
7.51e-01
|
0.09260
|
-8.70e-02
|
3.19e-02
|
1.20e-01
|
5.69e-01
|
GOBP LENS FIBER CELL DIFFERENTIATION
|
37
|
5.83e-01
|
8.90e-01
|
0.09260
|
5.63e-02
|
7.36e-02
|
5.53e-01
|
4.39e-01
|
GOBP POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION
|
65
|
4.33e-01
|
8.37e-01
|
0.09260
|
4.31e-03
|
-9.25e-02
|
9.52e-01
|
1.97e-01
|
GOCC 9PLUS0 NON MOTILE CILIUM
|
119
|
2.09e-01
|
6.98e-01
|
0.09260
|
4.89e-03
|
9.24e-02
|
9.27e-01
|
8.15e-02
|
GOCC UNIPLEX COMPLEX
|
6
|
9.16e-01
|
9.83e-01
|
0.09260
|
-7.26e-02
|
-5.74e-02
|
7.58e-01
|
8.08e-01
|
GOBP ENDOTHELIUM DEVELOPMENT
|
142
|
1.34e-01
|
6.16e-01
|
0.09250
|
3.97e-02
|
8.36e-02
|
4.14e-01
|
8.55e-02
|
GOBP MONOCARBOXYLIC ACID CATABOLIC PROCESS
|
128
|
1.71e-01
|
6.59e-01
|
0.09250
|
-8.88e-02
|
-2.60e-02
|
8.27e-02
|
6.12e-01
|
GOMF DNA NUCLEASE ACTIVITY
|
58
|
4.30e-01
|
8.37e-01
|
0.09250
|
-6.41e-02
|
-6.67e-02
|
3.99e-01
|
3.80e-01
|
GOBP NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION
|
19
|
7.72e-01
|
9.48e-01
|
0.09240
|
-9.06e-02
|
-1.84e-02
|
4.94e-01
|
8.89e-01
|
GOBP REGULATION OF PROTEIN SECRETION
|
261
|
4.73e-02
|
4.38e-01
|
0.09240
|
-8.45e-02
|
3.74e-02
|
1.87e-02
|
2.98e-01
|
GOBP TYPE B PANCREATIC CELL APOPTOTIC PROCESS
|
10
|
8.90e-01
|
9.76e-01
|
0.09240
|
-8.10e-02
|
4.45e-02
|
6.57e-01
|
8.08e-01
|
GOBP HYDROGEN PEROXIDE CATABOLIC PROCESS
|
30
|
7.07e-01
|
9.25e-01
|
0.09240
|
7.86e-02
|
-4.85e-02
|
4.56e-01
|
6.46e-01
|
GOBP B CELL DIFFERENTIATION
|
143
|
1.83e-01
|
6.73e-01
|
0.09230
|
-3.19e-02
|
8.66e-02
|
5.10e-01
|
7.38e-02
|
GOBP CHONDROCYTE DIFFERENTIATION
|
113
|
2.73e-01
|
7.47e-01
|
0.09230
|
-4.90e-02
|
7.82e-02
|
3.68e-01
|
1.51e-01
|
GOCC CELL SUBSTRATE JUNCTION
|
418
|
8.95e-03
|
1.97e-01
|
0.09230
|
-5.20e-02
|
7.63e-02
|
6.84e-02
|
7.48e-03
|
GOBP HETEROCHROMATIN ORGANIZATION
|
89
|
2.77e-01
|
7.51e-01
|
0.09230
|
-7.23e-02
|
-5.73e-02
|
2.38e-01
|
3.50e-01
|
GOMF SODIUM INDEPENDENT ORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
16
|
7.97e-01
|
9.55e-01
|
0.09220
|
8.27e-02
|
4.08e-02
|
5.67e-01
|
7.77e-01
|
GOBP POSITIVE REGULATION OF PROTEIN UBIQUITINATION
|
100
|
2.58e-01
|
7.35e-01
|
0.09220
|
9.01e-02
|
1.97e-02
|
1.19e-01
|
7.34e-01
|
GOBP REGULATION OF LIPID KINASE ACTIVITY
|
38
|
5.99e-01
|
8.95e-01
|
0.09220
|
1.66e-02
|
9.07e-02
|
8.60e-01
|
3.33e-01
|
GOBP ESTABLISHMENT OF MITOTIC SISTER CHROMATID COHESION
|
5
|
9.30e-01
|
9.86e-01
|
0.09220
|
-7.24e-02
|
-5.71e-02
|
7.79e-01
|
8.25e-01
|
GOBP NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS
|
567
|
3.35e-04
|
2.28e-02
|
0.09220
|
-6.09e-02
|
-6.91e-02
|
1.31e-02
|
4.88e-03
|
GOBP REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY
|
57
|
4.74e-01
|
8.54e-01
|
0.09210
|
-6.12e-03
|
-9.19e-02
|
9.36e-01
|
2.30e-01
|
GOBP PIGMENT CELL DIFFERENTIATION
|
35
|
6.22e-01
|
9.01e-01
|
0.09200
|
-8.94e-02
|
-2.17e-02
|
3.60e-01
|
8.24e-01
|
GOBP GROWTH PLATE CARTILAGE DEVELOPMENT
|
20
|
7.50e-01
|
9.40e-01
|
0.09200
|
5.84e-02
|
7.10e-02
|
6.51e-01
|
5.82e-01
|
GOBP MODULATION BY HOST OF VIRAL PROCESS
|
45
|
5.54e-01
|
8.81e-01
|
0.09200
|
-8.75e-03
|
-9.15e-02
|
9.19e-01
|
2.88e-01
|
GOBP REGULATION OF FILOPODIUM ASSEMBLY
|
47
|
5.18e-01
|
8.69e-01
|
0.09200
|
3.75e-02
|
8.39e-02
|
6.56e-01
|
3.19e-01
|
GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT TO PLASMA MEMBRANE
|
16
|
8.29e-01
|
9.62e-01
|
0.09190
|
3.64e-02
|
-8.44e-02
|
8.01e-01
|
5.59e-01
|
GOBP REGULATION OF CIRCADIAN RHYTHM
|
109
|
2.88e-01
|
7.59e-01
|
0.09190
|
-7.90e-02
|
4.68e-02
|
1.54e-01
|
3.98e-01
|
GOBP ANTEROGRADE AXONAL TRANSPORT OF MITOCHONDRION
|
6
|
9.24e-01
|
9.84e-01
|
0.09190
|
1.04e-02
|
9.13e-02
|
9.65e-01
|
6.99e-01
|
GOBP TROPHECTODERMAL CELL DIFFERENTIATION
|
19
|
7.75e-01
|
9.50e-01
|
0.09180
|
8.99e-02
|
1.85e-02
|
4.97e-01
|
8.89e-01
|
GOBP POSITIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT
|
149
|
1.26e-01
|
6.06e-01
|
0.09180
|
3.80e-02
|
8.35e-02
|
4.23e-01
|
7.84e-02
|
GOBP PHAGOCYTOSIS
|
228
|
7.42e-02
|
5.15e-01
|
0.09170
|
-8.13e-02
|
4.25e-02
|
3.45e-02
|
2.69e-01
|
GOBP REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION
|
7
|
9.24e-01
|
9.84e-01
|
0.09170
|
6.54e-02
|
-6.42e-02
|
7.64e-01
|
7.68e-01
|
GOMF IMMUNOGLOBULIN BINDING
|
20
|
7.92e-01
|
9.54e-01
|
0.09160
|
-8.45e-02
|
3.55e-02
|
5.13e-01
|
7.84e-01
|
GOBP CELLULAR RESPONSE TO EXTERNAL STIMULUS
|
328
|
2.47e-02
|
3.31e-01
|
0.09160
|
-7.99e-02
|
4.47e-02
|
1.28e-02
|
1.64e-01
|
GOBP NEUROTRANSMITTER METABOLIC PROCESS
|
25
|
7.53e-01
|
9.41e-01
|
0.09160
|
7.77e-02
|
-4.86e-02
|
5.01e-01
|
6.74e-01
|
GOBP KERATINOCYTE DIFFERENTIATION
|
172
|
1.12e-01
|
5.91e-01
|
0.09160
|
9.16e-02
|
1.85e-03
|
3.82e-02
|
9.67e-01
|
GOBP POLYAMINE METABOLIC PROCESS
|
15
|
8.28e-01
|
9.62e-01
|
0.09160
|
5.68e-03
|
-9.14e-02
|
9.70e-01
|
5.40e-01
|
GOBP SPINDLE ORGANIZATION
|
191
|
7.41e-02
|
5.14e-01
|
0.09160
|
-8.62e-02
|
-3.10e-02
|
4.00e-02
|
4.60e-01
|
GOBP GENITALIA DEVELOPMENT
|
46
|
5.20e-01
|
8.69e-01
|
0.09160
|
5.40e-02
|
7.39e-02
|
5.26e-01
|
3.86e-01
|
GOBP SYNAPTIC TRANSMISSION GLUTAMATERGIC
|
106
|
2.58e-01
|
7.35e-01
|
0.09150
|
9.15e-02
|
2.71e-03
|
1.04e-01
|
9.61e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN BINDING
|
76
|
3.70e-01
|
8.09e-01
|
0.09150
|
1.12e-02
|
9.08e-02
|
8.65e-01
|
1.71e-01
|
GOBP TUBULIN DEACETYLATION
|
19
|
7.72e-01
|
9.48e-01
|
0.09150
|
-8.73e-02
|
-2.75e-02
|
5.10e-01
|
8.36e-01
|
GOBP LONG TERM SYNAPTIC POTENTIATION
|
102
|
3.14e-01
|
7.76e-01
|
0.09150
|
-4.47e-02
|
7.98e-02
|
4.36e-01
|
1.64e-01
|
GOBP BODY FLUID SECRETION
|
87
|
3.43e-01
|
7.94e-01
|
0.09140
|
-9.07e-02
|
1.10e-02
|
1.43e-01
|
8.59e-01
|
GOBP CELLULAR RESPONSE TO LEUCINE STARVATION
|
12
|
8.60e-01
|
9.68e-01
|
0.09140
|
-9.13e-02
|
3.51e-03
|
5.84e-01
|
9.83e-01
|
GOBP RESPONSE TO ESTROGEN
|
66
|
4.14e-01
|
8.29e-01
|
0.09140
|
-2.15e-02
|
-8.88e-02
|
7.63e-01
|
2.12e-01
|
GOBP NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT
|
133
|
1.58e-01
|
6.46e-01
|
0.09140
|
4.13e-02
|
8.15e-02
|
4.11e-01
|
1.05e-01
|
GOBP MICROTUBULE ORGANIZING CENTER ORGANIZATION
|
150
|
1.22e-01
|
6.03e-01
|
0.09130
|
-7.51e-02
|
-5.21e-02
|
1.13e-01
|
2.71e-01
|
GOBP BODY MORPHOGENESIS
|
46
|
5.99e-01
|
8.95e-01
|
0.09130
|
-6.35e-02
|
6.57e-02
|
4.56e-01
|
4.41e-01
|
GOBP NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION
|
15
|
8.08e-01
|
9.59e-01
|
0.09130
|
-6.46e-02
|
-6.45e-02
|
6.65e-01
|
6.65e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION
|
28
|
7.27e-01
|
9.31e-01
|
0.09130
|
-4.48e-02
|
7.96e-02
|
6.82e-01
|
4.66e-01
|
GOBP CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS
|
25
|
7.25e-01
|
9.30e-01
|
0.09130
|
-4.99e-03
|
-9.12e-02
|
9.66e-01
|
4.30e-01
|
GOBP PLACENTA DEVELOPMENT
|
146
|
1.97e-01
|
6.88e-01
|
0.09130
|
-5.63e-02
|
7.18e-02
|
2.40e-01
|
1.34e-01
|
GOBP DENDRITE DEVELOPMENT
|
218
|
6.98e-02
|
5.03e-01
|
0.09130
|
-1.04e-02
|
9.07e-02
|
7.92e-01
|
2.10e-02
|
GOBP TRANSEPITHELIAL TRANSPORT
|
34
|
6.23e-01
|
9.01e-01
|
0.09120
|
7.96e-02
|
4.44e-02
|
4.22e-01
|
6.54e-01
|
GOBP NCRNA CATABOLIC PROCESS
|
54
|
4.88e-01
|
8.56e-01
|
0.09120
|
-8.89e-02
|
-2.03e-02
|
2.59e-01
|
7.96e-01
|
GOCC GOLGI MEMBRANE
|
641
|
6.69e-04
|
3.96e-02
|
0.09120
|
-8.66e-02
|
2.84e-02
|
1.82e-04
|
2.20e-01
|
GOMF NF KAPPAB BINDING
|
28
|
7.16e-01
|
9.28e-01
|
0.09110
|
2.14e-02
|
-8.86e-02
|
8.44e-01
|
4.17e-01
|
GOBP CARBOHYDRATE BIOSYNTHETIC PROCESS
|
205
|
5.72e-02
|
4.68e-01
|
0.09110
|
-7.40e-02
|
-5.32e-02
|
6.78e-02
|
1.89e-01
|
GOBP CYTOSOLIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY
|
137
|
1.51e-01
|
6.38e-01
|
0.09110
|
-8.07e-02
|
-4.22e-02
|
1.03e-01
|
3.93e-01
|
GOBP MRNA SPLICE SITE RECOGNITION
|
35
|
6.55e-01
|
9.09e-01
|
0.09110
|
1.56e-02
|
-8.97e-02
|
8.73e-01
|
3.58e-01
|
GOMF ICOSANOID TRANSMEMBRANE TRANSPORTER ACTIVITY
|
13
|
8.48e-01
|
9.66e-01
|
0.09100
|
3.67e-03
|
9.10e-02
|
9.82e-01
|
5.70e-01
|
GOBP INTERLEUKIN 5 PRODUCTION
|
19
|
7.71e-01
|
9.48e-01
|
0.09100
|
-8.34e-02
|
-3.64e-02
|
5.29e-01
|
7.84e-01
|
GOCC TERMINAL BOUTON
|
43
|
5.93e-01
|
8.93e-01
|
0.09100
|
-1.22e-02
|
9.02e-02
|
8.90e-01
|
3.06e-01
|
GOCC SPINDLE POLE
|
167
|
1.21e-01
|
6.02e-01
|
0.09100
|
-9.09e-02
|
-4.43e-03
|
4.28e-02
|
9.21e-01
|
GOBP REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS
|
52
|
4.95e-01
|
8.58e-01
|
0.09100
|
-8.57e-02
|
-3.05e-02
|
2.85e-01
|
7.03e-01
|
GOBP RETINAL METABOLIC PROCESS
|
18
|
7.76e-01
|
9.50e-01
|
0.09090
|
-6.85e-02
|
-5.97e-02
|
6.15e-01
|
6.61e-01
|
GOCC SARCOLEMMA
|
136
|
1.65e-01
|
6.50e-01
|
0.09090
|
2.27e-02
|
8.80e-02
|
6.47e-01
|
7.63e-02
|
GOBP PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE
|
220
|
5.84e-02
|
4.71e-01
|
0.09090
|
-8.98e-02
|
-1.42e-02
|
2.18e-02
|
7.17e-01
|
GOBP NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT
|
24
|
7.37e-01
|
9.35e-01
|
0.09090
|
-9.07e-02
|
-5.56e-03
|
4.42e-01
|
9.62e-01
|
GOBP POSITIVE REGULATION OF GLYCOLYTIC PROCESS
|
22
|
7.79e-01
|
9.51e-01
|
0.09080
|
-8.23e-02
|
3.85e-02
|
5.04e-01
|
7.55e-01
|
GOBP POSITIVE REGULATION OF CHOLESTEROL METABOLIC PROCESS
|
15
|
8.32e-01
|
9.64e-01
|
0.09070
|
-6.97e-03
|
9.05e-02
|
9.63e-01
|
5.44e-01
|
GOBP REGULATION OF MEMBRANE DEPOLARIZATION
|
45
|
5.33e-01
|
8.76e-01
|
0.09070
|
5.80e-02
|
6.98e-02
|
5.01e-01
|
4.18e-01
|
GOBP ALCOHOL METABOLIC PROCESS
|
355
|
7.71e-03
|
1.83e-01
|
0.09060
|
-7.40e-02
|
-5.23e-02
|
1.65e-02
|
9.07e-02
|
GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION
|
45
|
5.51e-01
|
8.80e-01
|
0.09060
|
2.47e-02
|
8.72e-02
|
7.74e-01
|
3.12e-01
|
GOBP REGULATION OF FAT CELL DIFFERENTIATION
|
140
|
1.47e-01
|
6.34e-01
|
0.09060
|
-7.94e-02
|
-4.36e-02
|
1.05e-01
|
3.73e-01
|
GOBP REGULATION OF PROTEIN COMPLEX STABILITY
|
14
|
8.25e-01
|
9.62e-01
|
0.09060
|
-7.92e-02
|
-4.38e-02
|
6.08e-01
|
7.76e-01
|
GOBP DENDRITIC SPINE MAINTENANCE
|
21
|
7.60e-01
|
9.44e-01
|
0.09060
|
-8.85e-02
|
-1.91e-02
|
4.83e-01
|
8.79e-01
|
GOBP B CELL HOMEOSTASIS
|
31
|
6.51e-01
|
9.07e-01
|
0.09050
|
5.31e-02
|
7.32e-02
|
6.09e-01
|
4.80e-01
|
GOBP REGULATION OF PHOSPHOLIPASE C ACTIVITY
|
39
|
6.15e-01
|
8.99e-01
|
0.09040
|
7.12e-04
|
9.04e-02
|
9.94e-01
|
3.29e-01
|
GOBP STRIATED MUSCLE CONTRACTION
|
175
|
9.28e-02
|
5.54e-01
|
0.09040
|
4.25e-02
|
7.98e-02
|
3.33e-01
|
6.85e-02
|
GOMF MHC CLASS II RECEPTOR ACTIVITY
|
9
|
8.97e-01
|
9.78e-01
|
0.09040
|
8.97e-02
|
-1.10e-02
|
6.41e-01
|
9.54e-01
|
GOBP CELLULAR RESPONSE TO SALT
|
190
|
1.21e-01
|
6.02e-01
|
0.09040
|
-8.05e-02
|
4.12e-02
|
5.58e-02
|
3.28e-01
|
GOMF PLATELET DERIVED GROWTH FACTOR BINDING
|
11
|
8.77e-01
|
9.75e-01
|
0.09030
|
1.45e-02
|
-8.92e-02
|
9.34e-01
|
6.09e-01
|
GOBP PROGESTERONE METABOLIC PROCESS
|
16
|
8.39e-01
|
9.65e-01
|
0.09030
|
5.71e-02
|
-7.00e-02
|
6.92e-01
|
6.28e-01
|
GOCC PHAGOCYTIC VESICLE MEMBRANE
|
72
|
3.89e-01
|
8.20e-01
|
0.09030
|
-2.36e-02
|
-8.72e-02
|
7.29e-01
|
2.01e-01
|
GOBP NEGATIVE REGULATION OF MACROPHAGE APOPTOTIC PROCESS
|
7
|
9.15e-01
|
9.83e-01
|
0.09030
|
-9.01e-02
|
-6.43e-03
|
6.80e-01
|
9.77e-01
|
GOBP PROTEIN LOCALIZATION TO POSTSYNAPSE
|
40
|
6.28e-01
|
9.02e-01
|
0.09030
|
-8.71e-02
|
2.38e-02
|
3.40e-01
|
7.94e-01
|
GOCC PLATELET ALPHA GRANULE MEMBRANE
|
16
|
8.17e-01
|
9.60e-01
|
0.09030
|
-9.01e-02
|
-6.30e-03
|
5.33e-01
|
9.65e-01
|
GOBP POSITIVE REGULATION OF NEURON DIFFERENTIATION
|
91
|
2.86e-01
|
7.58e-01
|
0.09020
|
-5.34e-02
|
-7.28e-02
|
3.79e-01
|
2.30e-01
|
GOBP REGULATION OF T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL
|
8
|
9.08e-01
|
9.81e-01
|
0.09020
|
1.04e-02
|
-8.96e-02
|
9.59e-01
|
6.61e-01
|
GOBP POSTSYNAPSE ORGANIZATION
|
178
|
1.42e-01
|
6.26e-01
|
0.09020
|
-7.75e-02
|
4.61e-02
|
7.44e-02
|
2.89e-01
|
GOBP MORPHOGENESIS OF AN EPITHELIAL FOLD
|
23
|
7.60e-01
|
9.44e-01
|
0.09010
|
1.23e-02
|
-8.93e-02
|
9.19e-01
|
4.58e-01
|
GOBP INTRACILIARY TRANSPORT
|
45
|
5.59e-01
|
8.82e-01
|
0.09010
|
-8.84e-02
|
-1.77e-02
|
3.05e-01
|
8.38e-01
|
GOBP NEGATIVE REGULATION OF CHOLESTEROL METABOLIC PROCESS
|
10
|
8.77e-01
|
9.75e-01
|
0.09010
|
-8.65e-02
|
-2.53e-02
|
6.36e-01
|
8.90e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN ACETYLATION
|
8
|
8.95e-01
|
9.78e-01
|
0.09010
|
5.50e-02
|
7.14e-02
|
7.88e-01
|
7.27e-01
|
GOBP FORELIMB MORPHOGENESIS
|
39
|
5.99e-01
|
8.95e-01
|
0.09010
|
-8.68e-02
|
-2.44e-02
|
3.48e-01
|
7.92e-01
|
GOMF DIPEPTIDYL PEPTIDASE ACTIVITY
|
12
|
8.72e-01
|
9.73e-01
|
0.09010
|
-8.55e-02
|
2.84e-02
|
6.08e-01
|
8.65e-01
|
GOMF CALCIUM ACTIVATED CATION CHANNEL ACTIVITY
|
26
|
6.99e-01
|
9.21e-01
|
0.09010
|
5.44e-02
|
7.18e-02
|
6.31e-01
|
5.26e-01
|
GOBP NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY
|
32
|
6.95e-01
|
9.21e-01
|
0.09010
|
-3.01e-02
|
8.49e-02
|
7.68e-01
|
4.06e-01
|
GOBP BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH SYMBIONT
|
110
|
2.31e-01
|
7.18e-01
|
0.09000
|
-3.37e-02
|
-8.35e-02
|
5.41e-01
|
1.30e-01
|
GOBP MITOTIC SPINDLE ORGANIZATION
|
125
|
1.84e-01
|
6.74e-01
|
0.09000
|
-7.88e-02
|
-4.35e-02
|
1.28e-01
|
4.01e-01
|
GOMF SULFURIC ESTER HYDROLASE ACTIVITY
|
11
|
8.64e-01
|
9.70e-01
|
0.09000
|
-3.16e-02
|
-8.43e-02
|
8.56e-01
|
6.28e-01
|
GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION
|
19
|
7.72e-01
|
9.48e-01
|
0.09000
|
-4.69e-02
|
-7.68e-02
|
7.24e-01
|
5.62e-01
|
GOCC PROTEIN PHOSPHATASE TYPE 2A COMPLEX
|
16
|
8.37e-01
|
9.64e-01
|
0.08990
|
-7.99e-02
|
4.12e-02
|
5.80e-01
|
7.75e-01
|
GOBP MITOTIC CELL CYCLE PHASE TRANSITION
|
452
|
2.24e-03
|
8.96e-02
|
0.08990
|
-6.64e-02
|
-6.06e-02
|
1.56e-02
|
2.72e-02
|
GOBP RNA 3 END PROCESSING
|
90
|
3.22e-01
|
7.79e-01
|
0.08990
|
-1.11e-02
|
-8.92e-02
|
8.55e-01
|
1.44e-01
|
GOMF TRANSLATION ELONGATION FACTOR ACTIVITY
|
19
|
7.74e-01
|
9.49e-01
|
0.08990
|
-7.99e-02
|
-4.11e-02
|
5.47e-01
|
7.56e-01
|
GOBP REGULATION OF HISTONE ACETYLATION
|
18
|
7.92e-01
|
9.54e-01
|
0.08990
|
-8.74e-02
|
-2.07e-02
|
5.21e-01
|
8.79e-01
|
GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION
|
18
|
7.84e-01
|
9.52e-01
|
0.08980
|
7.94e-02
|
4.20e-02
|
5.60e-01
|
7.58e-01
|
GOBP BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION
|
305
|
2.04e-02
|
3.04e-01
|
0.08980
|
-8.74e-02
|
-2.07e-02
|
8.68e-03
|
5.33e-01
|
GOBP POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT
|
32
|
6.80e-01
|
9.15e-01
|
0.08970
|
-6.22e-03
|
8.95e-02
|
9.51e-01
|
3.81e-01
|
GOBP TAXIS
|
441
|
5.79e-03
|
1.60e-01
|
0.08970
|
-9.85e-03
|
8.91e-02
|
7.23e-01
|
1.33e-03
|
GOBP LONG TERM MEMORY
|
36
|
6.73e-01
|
9.13e-01
|
0.08960
|
7.96e-02
|
-4.13e-02
|
4.09e-01
|
6.68e-01
|
GOBP POSITIVE REGULATION OF LIPID KINASE ACTIVITY
|
26
|
7.03e-01
|
9.23e-01
|
0.08960
|
4.92e-02
|
7.49e-02
|
6.64e-01
|
5.09e-01
|
GOBP BASE EXCISION REPAIR GAP FILLING
|
14
|
8.47e-01
|
9.66e-01
|
0.08960
|
-8.89e-02
|
1.10e-02
|
5.65e-01
|
9.43e-01
|
GOBP MITOCHONDRIAL FRAGMENTATION INVOLVED IN APOPTOTIC PROCESS
|
10
|
8.94e-01
|
9.77e-01
|
0.08960
|
-3.12e-02
|
8.40e-02
|
8.64e-01
|
6.46e-01
|
GOBP HEART PROCESS
|
245
|
3.63e-02
|
3.88e-01
|
0.08960
|
6.36e-02
|
6.31e-02
|
8.65e-02
|
8.90e-02
|
GOBP MAINTENANCE OF LOCATION IN CELL
|
225
|
7.50e-02
|
5.17e-01
|
0.08950
|
-1.76e-02
|
8.78e-02
|
6.50e-01
|
2.33e-02
|
GOMF COLLAGEN BINDING
|
68
|
4.82e-01
|
8.54e-01
|
0.08950
|
-5.66e-02
|
6.94e-02
|
4.20e-01
|
3.22e-01
|
GOBP EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT
|
45
|
6.17e-01
|
9.00e-01
|
0.08950
|
-6.92e-02
|
5.68e-02
|
4.22e-01
|
5.09e-01
|
GOBP NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT
|
21
|
7.97e-01
|
9.55e-01
|
0.08950
|
7.37e-02
|
-5.08e-02
|
5.59e-01
|
6.87e-01
|
GOBP REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE
|
31
|
6.75e-01
|
9.13e-01
|
0.08950
|
8.81e-02
|
1.59e-02
|
3.96e-01
|
8.78e-01
|
GOMF INOSITOL 1 4 5 TRISPHOSPHATE BINDING
|
11
|
8.78e-01
|
9.75e-01
|
0.08950
|
-9.77e-03
|
8.90e-02
|
9.55e-01
|
6.09e-01
|
GOBP AMINO ACID METABOLIC PROCESS
|
277
|
3.43e-02
|
3.78e-01
|
0.08950
|
-4.36e-03
|
-8.94e-02
|
9.01e-01
|
1.05e-02
|
GOBP PROTEIN AUTOUBIQUITINATION
|
67
|
4.88e-01
|
8.56e-01
|
0.08940
|
-6.96e-02
|
5.61e-02
|
3.24e-01
|
4.27e-01
|
GOBP NUCLEOLUS ORGANIZATION
|
16
|
8.06e-01
|
9.58e-01
|
0.08940
|
-4.57e-02
|
-7.68e-02
|
7.51e-01
|
5.95e-01
|
GOCC U2 TYPE CATALYTIC STEP 2 SPLICEOSOME
|
30
|
6.70e-01
|
9.11e-01
|
0.08940
|
-4.17e-02
|
-7.91e-02
|
6.93e-01
|
4.53e-01
|
GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS
|
17
|
7.94e-01
|
9.55e-01
|
0.08940
|
5.88e-02
|
6.73e-02
|
6.75e-01
|
6.31e-01
|
GOBP ORGANIC CATION TRANSPORT
|
62
|
4.60e-01
|
8.48e-01
|
0.08930
|
8.84e-02
|
1.28e-02
|
2.29e-01
|
8.61e-01
|
GOMF POLY PURINE TRACT BINDING
|
28
|
6.86e-01
|
9.19e-01
|
0.08920
|
-7.51e-02
|
-4.83e-02
|
4.92e-01
|
6.59e-01
|
GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION
|
13
|
8.55e-01
|
9.68e-01
|
0.08920
|
8.88e-04
|
-8.92e-02
|
9.96e-01
|
5.77e-01
|
GOBP POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS
|
85
|
4.03e-01
|
8.26e-01
|
0.08920
|
-7.39e-02
|
4.98e-02
|
2.39e-01
|
4.27e-01
|
GOBP PANCREAS DEVELOPMENT
|
78
|
4.37e-01
|
8.39e-01
|
0.08920
|
-6.88e-02
|
5.67e-02
|
2.93e-01
|
3.87e-01
|
GOBP TYPE II INTERFERON MEDIATED SIGNALING PATHWAY
|
26
|
7.57e-01
|
9.43e-01
|
0.08910
|
-5.05e-02
|
7.35e-02
|
6.56e-01
|
5.17e-01
|
GOMF TRANSMEMBRANE TRANSPORTER BINDING
|
125
|
2.40e-01
|
7.25e-01
|
0.08910
|
-1.84e-02
|
8.72e-02
|
7.22e-01
|
9.24e-02
|
GOBP RESPONSE TO CATECHOLAMINE
|
86
|
4.02e-01
|
8.26e-01
|
0.08910
|
-5.82e-02
|
6.75e-02
|
3.51e-01
|
2.80e-01
|
GOBP REGULATION OF CELL CYCLE CHECKPOINT
|
45
|
5.55e-01
|
8.81e-01
|
0.08900
|
-3.43e-02
|
-8.22e-02
|
6.91e-01
|
3.40e-01
|
GOBP CARDIAC CONDUCTION SYSTEM DEVELOPMENT
|
37
|
6.13e-01
|
8.98e-01
|
0.08900
|
-4.17e-02
|
-7.86e-02
|
6.61e-01
|
4.08e-01
|
GOMF MONOATOMIC ANION SODIUM SYMPORTER ACTIVITY
|
17
|
8.00e-01
|
9.56e-01
|
0.08900
|
3.76e-02
|
8.06e-02
|
7.89e-01
|
5.65e-01
|
GOBP CARDIAC PACEMAKER CELL DEVELOPMENT
|
9
|
8.90e-01
|
9.76e-01
|
0.08900
|
2.85e-02
|
8.43e-02
|
8.82e-01
|
6.62e-01
|
GOBP OOCYTE DIFFERENTIATION
|
64
|
4.56e-01
|
8.48e-01
|
0.08890
|
7.86e-03
|
8.86e-02
|
9.13e-01
|
2.20e-01
|
GOBP REGULATION OF INTRACELLULAR PROTEIN TRANSPORT
|
214
|
9.67e-02
|
5.61e-01
|
0.08890
|
-8.24e-02
|
3.35e-02
|
3.78e-02
|
3.98e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN UBIQUITINATION
|
69
|
4.19e-01
|
8.33e-01
|
0.08890
|
-1.86e-02
|
-8.70e-02
|
7.89e-01
|
2.12e-01
|
GOBP GLUCAN BIOSYNTHETIC PROCESS
|
44
|
5.58e-01
|
8.82e-01
|
0.08890
|
-4.34e-02
|
-7.76e-02
|
6.18e-01
|
3.73e-01
|
GOMF ALPHA ACTININ BINDING
|
28
|
6.92e-01
|
9.21e-01
|
0.08890
|
3.93e-02
|
7.97e-02
|
7.19e-01
|
4.65e-01
|
GOBP RESPONSE TO INTERLEUKIN 12
|
12
|
8.65e-01
|
9.70e-01
|
0.08890
|
1.77e-03
|
8.88e-02
|
9.92e-01
|
5.94e-01
|
GOBP REGULATION OF HEART RATE
|
99
|
2.68e-01
|
7.43e-01
|
0.08890
|
4.90e-02
|
7.41e-02
|
4.00e-01
|
2.02e-01
|
GOBP POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION
|
335
|
2.36e-02
|
3.25e-01
|
0.08880
|
-2.06e-02
|
8.64e-02
|
5.18e-01
|
6.54e-03
|
GOCC EXTERNAL SIDE OF APICAL PLASMA MEMBRANE
|
6
|
9.31e-01
|
9.86e-01
|
0.08880
|
-4.33e-03
|
8.87e-02
|
9.85e-01
|
7.07e-01
|
GOCC EXTRINSIC COMPONENT OF SYNAPTIC VESICLE MEMBRANE
|
10
|
8.87e-01
|
9.76e-01
|
0.08880
|
-8.88e-02
|
-9.91e-04
|
6.27e-01
|
9.96e-01
|
GOCC MITOTIC SPINDLE MIDZONE
|
13
|
8.43e-01
|
9.66e-01
|
0.08880
|
-3.71e-02
|
-8.07e-02
|
8.17e-01
|
6.14e-01
|
GOMF TRANSCRIPTION FACTOR BINDING
|
569
|
1.37e-03
|
6.43e-02
|
0.08880
|
-8.87e-02
|
3.40e-03
|
2.96e-04
|
8.90e-01
|
GOMF ERBB 3 CLASS RECEPTOR BINDING
|
5
|
9.35e-01
|
9.87e-01
|
0.08880
|
6.26e-02
|
6.30e-02
|
8.09e-01
|
8.07e-01
|
GOMF ALCOHOL BINDING
|
87
|
3.88e-01
|
8.20e-01
|
0.08880
|
-8.13e-02
|
3.57e-02
|
1.90e-01
|
5.65e-01
|
GOBP RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN
|
155
|
1.33e-01
|
6.13e-01
|
0.08880
|
-8.00e-02
|
-3.85e-02
|
8.56e-02
|
4.08e-01
|
GOBP DNA REPAIR DEPENDENT CHROMATIN REMODELING
|
19
|
7.77e-01
|
9.50e-01
|
0.08870
|
-4.80e-02
|
-7.46e-02
|
7.17e-01
|
5.73e-01
|
GOBP SYNAPTONEMAL COMPLEX ORGANIZATION
|
25
|
7.27e-01
|
9.30e-01
|
0.08870
|
2.58e-02
|
8.49e-02
|
8.23e-01
|
4.62e-01
|
GOMF ACYLTRANSFERASE ACTIVITY
|
670
|
7.86e-04
|
4.40e-02
|
0.08870
|
-8.28e-02
|
3.19e-02
|
2.59e-04
|
1.59e-01
|
GOCC MRNA CLEAVAGE FACTOR COMPLEX
|
19
|
7.75e-01
|
9.50e-01
|
0.08870
|
-6.28e-02
|
-6.26e-02
|
6.36e-01
|
6.37e-01
|
GOBP TETRAPYRROLE METABOLIC PROCESS
|
58
|
5.44e-01
|
8.78e-01
|
0.08870
|
6.70e-02
|
-5.81e-02
|
3.78e-01
|
4.44e-01
|
GOBP DEVELOPMENTAL PIGMENTATION
|
47
|
5.36e-01
|
8.77e-01
|
0.08870
|
-7.40e-02
|
-4.89e-02
|
3.80e-01
|
5.62e-01
|
GOCC VESICLE COAT
|
61
|
5.15e-01
|
8.68e-01
|
0.08860
|
-8.15e-02
|
3.47e-02
|
2.71e-01
|
6.39e-01
|
GOBP REGULATION OF URINE VOLUME
|
20
|
7.82e-01
|
9.52e-01
|
0.08860
|
-1.09e-02
|
-8.80e-02
|
9.33e-01
|
4.96e-01
|
GOBP MOTOR NEURON APOPTOTIC PROCESS
|
21
|
7.85e-01
|
9.52e-01
|
0.08860
|
-8.77e-02
|
1.20e-02
|
4.86e-01
|
9.24e-01
|
GOBP CELL FATE DETERMINATION
|
42
|
5.76e-01
|
8.89e-01
|
0.08850
|
-4.35e-02
|
-7.71e-02
|
6.26e-01
|
3.87e-01
|
GOBP WALKING BEHAVIOR
|
35
|
6.57e-01
|
9.09e-01
|
0.08850
|
-2.25e-03
|
-8.85e-02
|
9.82e-01
|
3.65e-01
|
GOBP RESPONSE TO PURINE CONTAINING COMPOUND
|
137
|
1.94e-01
|
6.86e-01
|
0.08850
|
-8.84e-02
|
-3.81e-03
|
7.39e-02
|
9.39e-01
|
GOCC CILIARY TRANSITION ZONE
|
71
|
4.02e-01
|
8.26e-01
|
0.08850
|
3.06e-02
|
8.31e-02
|
6.55e-01
|
2.26e-01
|
GOBP REGULATION OF COA TRANSFERASE ACTIVITY
|
10
|
8.84e-01
|
9.76e-01
|
0.08850
|
-8.74e-02
|
-1.40e-02
|
6.32e-01
|
9.39e-01
|
GOBP MESENCHYMAL STEM CELL DIFFERENTIATION
|
12
|
8.73e-01
|
9.73e-01
|
0.08840
|
-1.80e-02
|
8.66e-02
|
9.14e-01
|
6.04e-01
|
GOBP POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS
|
18
|
8.04e-01
|
9.57e-01
|
0.08840
|
-8.81e-02
|
-7.76e-03
|
5.18e-01
|
9.55e-01
|
GOBP REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY
|
381
|
2.00e-02
|
3.00e-01
|
0.08830
|
-6.04e-02
|
6.45e-02
|
4.31e-02
|
3.06e-02
|
GOBP RECOMBINATIONAL REPAIR
|
169
|
1.09e-01
|
5.84e-01
|
0.08820
|
-7.15e-02
|
-5.17e-02
|
1.09e-01
|
2.46e-01
|
GOBP CORTICOSPINAL TRACT MORPHOGENESIS
|
8
|
8.99e-01
|
9.79e-01
|
0.08820
|
-6.24e-02
|
-6.24e-02
|
7.60e-01
|
7.60e-01
|
GOBP ESTROUS CYCLE
|
16
|
8.46e-01
|
9.66e-01
|
0.08820
|
6.79e-02
|
-5.64e-02
|
6.38e-01
|
6.96e-01
|
GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS
|
135
|
2.32e-01
|
7.18e-01
|
0.08820
|
-3.06e-02
|
8.27e-02
|
5.39e-01
|
9.72e-02
|
GOMF CIS TRANS ISOMERASE ACTIVITY
|
38
|
6.71e-01
|
9.12e-01
|
0.08810
|
7.38e-02
|
-4.82e-02
|
4.31e-01
|
6.07e-01
|
GOBP PURINE CONTAINING COMPOUND CATABOLIC PROCESS
|
57
|
5.54e-01
|
8.81e-01
|
0.08810
|
6.24e-02
|
-6.22e-02
|
4.15e-01
|
4.17e-01
|
GOCC CONDENSED CHROMOSOME
|
265
|
3.13e-02
|
3.63e-01
|
0.08810
|
-5.81e-02
|
-6.62e-02
|
1.03e-01
|
6.37e-02
|
GOBP PROTEIN CONTAINING COMPLEX REMODELING
|
36
|
6.88e-01
|
9.19e-01
|
0.08810
|
6.97e-02
|
-5.38e-02
|
4.69e-01
|
5.77e-01
|
GOBP B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE
|
84
|
4.17e-01
|
8.31e-01
|
0.08800
|
-5.06e-02
|
7.20e-02
|
4.23e-01
|
2.54e-01
|
GOBP CARDIAC MUSCLE CELL PROLIFERATION
|
57
|
5.54e-01
|
8.81e-01
|
0.08800
|
-5.61e-02
|
6.77e-02
|
4.63e-01
|
3.76e-01
|
GOCC CORTICAL ACTIN CYTOSKELETON
|
71
|
4.10e-01
|
8.27e-01
|
0.08800
|
2.60e-02
|
8.41e-02
|
7.05e-01
|
2.21e-01
|
GOBP PROXIMAL DISTAL PATTERN FORMATION INVOLVED IN NEPHRON DEVELOPMENT
|
5
|
9.48e-01
|
9.90e-01
|
0.08800
|
-3.76e-02
|
7.95e-02
|
8.84e-01
|
7.58e-01
|
GOBP REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT
|
5
|
9.48e-01
|
9.90e-01
|
0.08800
|
4.12e-02
|
-7.77e-02
|
8.73e-01
|
7.64e-01
|
GOBP CHROMOSOME ORGANIZATION
|
605
|
4.38e-04
|
2.80e-02
|
0.08790
|
-5.30e-02
|
-7.02e-02
|
2.61e-02
|
3.18e-03
|
GOBP HEMATOPOIETIC STEM CELL DIFFERENTIATION
|
36
|
6.31e-01
|
9.03e-01
|
0.08790
|
-8.10e-02
|
-3.43e-02
|
4.01e-01
|
7.22e-01
|
GOBP STRIATUM DEVELOPMENT
|
20
|
7.91e-01
|
9.54e-01
|
0.08790
|
8.79e-02
|
-1.76e-03
|
4.96e-01
|
9.89e-01
|
GOBP SKELETAL MUSCLE TISSUE GROWTH
|
9
|
8.92e-01
|
9.76e-01
|
0.08790
|
3.13e-02
|
8.21e-02
|
8.71e-01
|
6.70e-01
|
GOBP REGULATION OF CHROMATIN BINDING
|
11
|
8.92e-01
|
9.76e-01
|
0.08780
|
-7.23e-02
|
5.00e-02
|
6.78e-01
|
7.74e-01
|
GOMF WATER TRANSMEMBRANE TRANSPORTER ACTIVITY
|
18
|
8.05e-01
|
9.57e-01
|
0.08780
|
-9.52e-03
|
-8.73e-02
|
9.44e-01
|
5.21e-01
|
GOBP ASTROCYTE DIFFERENTIATION
|
84
|
3.48e-01
|
7.96e-01
|
0.08780
|
-8.31e-02
|
-2.84e-02
|
1.88e-01
|
6.53e-01
|
GOBP NEGATIVE REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION
|
5
|
9.49e-01
|
9.90e-01
|
0.08780
|
4.95e-02
|
-7.25e-02
|
8.48e-01
|
7.79e-01
|
GOBP INTERMEDIATE FILAMENT BASED PROCESS
|
94
|
3.06e-01
|
7.70e-01
|
0.08780
|
3.03e-02
|
8.24e-02
|
6.12e-01
|
1.67e-01
|
GOBP MOTOR BEHAVIOR
|
22
|
7.96e-01
|
9.55e-01
|
0.08780
|
6.97e-02
|
-5.33e-02
|
5.71e-01
|
6.65e-01
|
GOBP REGULATION OF MEIOTIC CELL CYCLE
|
66
|
4.77e-01
|
8.54e-01
|
0.08770
|
8.64e-02
|
-1.50e-02
|
2.25e-01
|
8.33e-01
|
GOBP REGULATION OF HEART GROWTH
|
68
|
4.49e-01
|
8.43e-01
|
0.08770
|
2.58e-03
|
8.77e-02
|
9.71e-01
|
2.11e-01
|
GOMF CALCIUM ION BINDING
|
675
|
2.55e-04
|
1.80e-02
|
0.08770
|
3.09e-02
|
8.21e-02
|
1.71e-01
|
2.76e-04
|
GOBP REGULATION OF OXIDOREDUCTASE ACTIVITY
|
77
|
4.26e-01
|
8.36e-01
|
0.08770
|
-8.57e-02
|
1.85e-02
|
1.93e-01
|
7.79e-01
|
GOBP LUNG EPITHELIUM DEVELOPMENT
|
44
|
6.12e-01
|
8.98e-01
|
0.08760
|
-1.54e-02
|
8.62e-02
|
8.60e-01
|
3.22e-01
|
GOBP SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS
|
65
|
4.63e-01
|
8.48e-01
|
0.08760
|
-8.74e-02
|
-6.29e-03
|
2.23e-01
|
9.30e-01
|
GOBP REGULATION OF VASCULATURE DEVELOPMENT
|
337
|
1.65e-02
|
2.73e-01
|
0.08760
|
2.18e-02
|
8.48e-02
|
4.92e-01
|
7.43e-03
|
GOBP REGULATION OF CELLULAR RESPONSE TO STRESS
|
627
|
8.28e-04
|
4.55e-02
|
0.08750
|
-8.75e-02
|
5.71e-04
|
1.82e-04
|
9.81e-01
|
GOCC P BODY
|
98
|
3.31e-01
|
7.85e-01
|
0.08750
|
-1.02e-02
|
8.69e-02
|
8.61e-01
|
1.37e-01
|
GOMF CARBOHYDRATE BINDING
|
259
|
7.26e-02
|
5.13e-01
|
0.08750
|
-6.25e-02
|
6.13e-02
|
8.34e-02
|
8.95e-02
|
GOCC NUCLEAR PROTEIN CONTAINING COMPLEX
|
1136
|
1.20e-06
|
3.32e-04
|
0.08750
|
-8.10e-02
|
-3.31e-02
|
4.12e-06
|
5.95e-02
|
GOBP CARDIAC LEFT VENTRICLE MORPHOGENESIS
|
16
|
8.34e-01
|
9.64e-01
|
0.08750
|
-8.70e-02
|
9.35e-03
|
5.47e-01
|
9.48e-01
|
GOCC APICAL JUNCTION COMPLEX
|
139
|
1.73e-01
|
6.61e-01
|
0.08750
|
7.99e-02
|
3.55e-02
|
1.04e-01
|
4.69e-01
|
GOBP REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS
|
889
|
6.30e-05
|
6.58e-03
|
0.08750
|
-9.67e-03
|
8.69e-02
|
6.25e-01
|
1.09e-05
|
GOBP REGULATION OF TELOMERE CAPPING
|
26
|
7.53e-01
|
9.41e-01
|
0.08740
|
-8.44e-02
|
2.27e-02
|
4.56e-01
|
8.41e-01
|
GOBP REGULATION OF CORTISOL BIOSYNTHETIC PROCESS
|
7
|
9.31e-01
|
9.86e-01
|
0.08740
|
-6.71e-02
|
5.61e-02
|
7.59e-01
|
7.97e-01
|
GOBP HUMORAL IMMUNE RESPONSE
|
230
|
9.03e-02
|
5.51e-01
|
0.08740
|
7.94e-02
|
-3.66e-02
|
3.80e-02
|
3.39e-01
|
GOMF RNA POLYMERASE II GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY
|
36
|
6.87e-01
|
9.19e-01
|
0.08740
|
7.64e-02
|
-4.24e-02
|
4.27e-01
|
6.60e-01
|
GOBP REGULATION OF SYNAPTIC VESICLE PRIMING
|
7
|
9.13e-01
|
9.82e-01
|
0.08740
|
5.53e-02
|
6.77e-02
|
8.00e-01
|
7.56e-01
|
GOBP REGULATION OF MEIOTIC NUCLEAR DIVISION
|
33
|
7.14e-01
|
9.27e-01
|
0.08740
|
6.68e-02
|
-5.64e-02
|
5.07e-01
|
5.75e-01
|
GOCC SARCOPLASMIC RETICULUM MEMBRANE
|
42
|
5.95e-01
|
8.95e-01
|
0.08730
|
2.55e-02
|
8.35e-02
|
7.75e-01
|
3.49e-01
|
GOBP MONOATOMIC ION HOMEOSTASIS
|
581
|
1.99e-03
|
8.20e-02
|
0.08730
|
-1.96e-02
|
8.51e-02
|
4.19e-01
|
4.55e-04
|
GOBP NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION
|
59
|
5.35e-01
|
8.76e-01
|
0.08730
|
-8.11e-02
|
3.25e-02
|
2.82e-01
|
6.66e-01
|
GOBP UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS
|
9
|
9.02e-01
|
9.80e-01
|
0.08730
|
8.73e-02
|
-3.57e-03
|
6.50e-01
|
9.85e-01
|
GOBP POSITIVE REGULATION OF TRANSCRIPTION ELONGATION BY RNA POLYMERASE II
|
48
|
5.40e-01
|
8.78e-01
|
0.08730
|
-7.43e-02
|
-4.58e-02
|
3.73e-01
|
5.83e-01
|
GOBP MEMBRANE ORGANIZATION
|
773
|
1.79e-04
|
1.43e-02
|
0.08730
|
-8.73e-02
|
9.25e-04
|
3.65e-05
|
9.65e-01
|
GOBP CARDIOBLAST DIFFERENTIATION
|
17
|
8.27e-01
|
9.62e-01
|
0.08730
|
-1.34e-02
|
8.62e-02
|
9.24e-01
|
5.38e-01
|
GOBP NUCLEOBASE CONTAINING COMPOUND TRANSPORT
|
206
|
9.32e-02
|
5.55e-01
|
0.08730
|
-8.73e-02
|
-1.12e-03
|
3.08e-02
|
9.78e-01
|
GOBP REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY
|
21
|
7.95e-01
|
9.55e-01
|
0.08730
|
-2.19e-02
|
8.45e-02
|
8.62e-01
|
5.03e-01
|
GOMF GROWTH FACTOR RECEPTOR BINDING
|
135
|
1.80e-01
|
6.70e-01
|
0.08720
|
4.19e-02
|
7.65e-02
|
4.01e-01
|
1.25e-01
|
GOMF SPHINGOLIPID BINDING
|
28
|
7.50e-01
|
9.40e-01
|
0.08720
|
-4.88e-02
|
7.23e-02
|
6.55e-01
|
5.08e-01
|
GOBP NEGATIVE REGULATION OF MONOATOMIC ION TRANSPORT
|
125
|
2.77e-01
|
7.51e-01
|
0.08720
|
-4.65e-02
|
7.38e-02
|
3.69e-01
|
1.54e-01
|
GOBP POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE
|
27
|
7.59e-01
|
9.44e-01
|
0.08720
|
-6.90e-02
|
5.33e-02
|
5.35e-01
|
6.32e-01
|
GOBP REGULATION OF RESPONSE TO WOUNDING
|
166
|
1.77e-01
|
6.67e-01
|
0.08720
|
-3.74e-02
|
7.88e-02
|
4.06e-01
|
7.98e-02
|
GOCC CUL3 RING UBIQUITIN LIGASE COMPLEX
|
35
|
6.55e-01
|
9.09e-01
|
0.08720
|
-8.56e-02
|
-1.66e-02
|
3.81e-01
|
8.65e-01
|
GOBP DOPAMINE RECEPTOR SIGNALING PATHWAY
|
37
|
6.79e-01
|
9.14e-01
|
0.08720
|
-3.72e-02
|
7.89e-02
|
6.95e-01
|
4.06e-01
|
GOBP POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE
|
118
|
2.87e-01
|
7.59e-01
|
0.08720
|
-8.16e-02
|
3.08e-02
|
1.26e-01
|
5.64e-01
|
GOBP INTEGRATED STRESS RESPONSE SIGNALING
|
42
|
6.00e-01
|
8.95e-01
|
0.08720
|
-2.00e-02
|
-8.48e-02
|
8.22e-01
|
3.42e-01
|
GOMF RECEPTOR SERINE THREONINE KINASE BINDING
|
25
|
7.62e-01
|
9.45e-01
|
0.08710
|
-2.16e-02
|
8.44e-02
|
8.52e-01
|
4.65e-01
|
GOMF INSULIN LIKE GROWTH FACTOR RECEPTOR BINDING
|
16
|
8.13e-01
|
9.59e-01
|
0.08710
|
-5.93e-02
|
-6.37e-02
|
6.81e-01
|
6.59e-01
|
GOCC INTERCELLULAR BRIDGE
|
90
|
3.30e-01
|
7.85e-01
|
0.08700
|
-8.27e-02
|
-2.73e-02
|
1.75e-01
|
6.55e-01
|
GOBP GENERATION OF PRECURSOR METABOLITES AND ENERGY
|
468
|
2.83e-03
|
1.04e-01
|
0.08700
|
-7.31e-02
|
-4.72e-02
|
6.73e-03
|
7.99e-02
|
GOBP POSITIVE REGULATION OF CELL GROWTH
|
153
|
2.08e-01
|
6.97e-01
|
0.08700
|
-7.60e-02
|
4.24e-02
|
1.05e-01
|
3.65e-01
|
GOBP POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS
|
44
|
6.16e-01
|
8.99e-01
|
0.08700
|
-8.56e-02
|
1.57e-02
|
3.26e-01
|
8.57e-01
|
GOBP NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY
|
24
|
7.47e-01
|
9.39e-01
|
0.08700
|
-2.06e-02
|
-8.46e-02
|
8.61e-01
|
4.73e-01
|
GOBP PROTEIN LOCALIZATION TO CELL PERIPHERY
|
336
|
3.50e-02
|
3.81e-01
|
0.08700
|
-6.02e-02
|
6.29e-02
|
5.80e-02
|
4.76e-02
|
GOBP REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE
|
22
|
7.70e-01
|
9.47e-01
|
0.08700
|
1.25e-02
|
8.61e-02
|
9.19e-01
|
4.85e-01
|
GOBP REGULATION OF LAMELLIPODIUM ASSEMBLY
|
37
|
6.88e-01
|
9.19e-01
|
0.08700
|
-6.48e-02
|
5.80e-02
|
4.95e-01
|
5.41e-01
|
GOBP NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC
|
6
|
9.32e-01
|
9.86e-01
|
0.08690
|
8.48e-03
|
8.65e-02
|
9.71e-01
|
7.14e-01
|
GOBP REGULATION OF EXTENT OF CELL GROWTH
|
101
|
3.50e-01
|
7.96e-01
|
0.08690
|
-3.62e-02
|
7.90e-02
|
5.30e-01
|
1.70e-01
|
GOBP EMBRYONIC CAMERA TYPE EYE FORMATION
|
11
|
8.92e-01
|
9.76e-01
|
0.08690
|
7.87e-02
|
-3.70e-02
|
6.51e-01
|
8.32e-01
|
GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT CONFERRING COMPRESSION RESISTANCE
|
19
|
8.04e-01
|
9.57e-01
|
0.08690
|
8.69e-02
|
8.04e-04
|
5.12e-01
|
9.95e-01
|
GOBP MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION
|
129
|
2.58e-01
|
7.35e-01
|
0.08680
|
-8.15e-02
|
2.99e-02
|
1.10e-01
|
5.58e-01
|
GOBP KERATINOCYTE MIGRATION
|
20
|
7.85e-01
|
9.52e-01
|
0.08680
|
-8.39e-02
|
-2.20e-02
|
5.16e-01
|
8.65e-01
|
GOMF MUTLALPHA COMPLEX BINDING
|
7
|
9.31e-01
|
9.86e-01
|
0.08670
|
-4.37e-02
|
7.49e-02
|
8.41e-01
|
7.31e-01
|
GOBP APPENDAGE MORPHOGENESIS
|
142
|
2.41e-01
|
7.25e-01
|
0.08670
|
-6.76e-02
|
5.43e-02
|
1.64e-01
|
2.64e-01
|
GOBP NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS
|
193
|
1.28e-01
|
6.08e-01
|
0.08670
|
-8.37e-02
|
2.26e-02
|
4.49e-02
|
5.89e-01
|
GOBP PLATELET DEGRANULATION
|
7
|
9.16e-01
|
9.83e-01
|
0.08670
|
4.11e-02
|
7.63e-02
|
8.51e-01
|
7.27e-01
|
GOBP PEPTIDYL LYSINE MODIFICATION
|
204
|
1.13e-01
|
5.91e-01
|
0.08670
|
-8.43e-02
|
2.04e-02
|
3.80e-02
|
6.15e-01
|
GOBP SUPRAMOLECULAR FIBER ORGANIZATION
|
811
|
2.31e-04
|
1.67e-02
|
0.08670
|
-2.35e-02
|
8.34e-02
|
2.56e-01
|
5.36e-05
|
GOBP CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT
|
54
|
5.73e-01
|
8.88e-01
|
0.08670
|
-3.76e-02
|
7.81e-02
|
6.33e-01
|
3.21e-01
|
GOBP BONE GROWTH
|
32
|
6.73e-01
|
9.13e-01
|
0.08670
|
8.06e-02
|
3.17e-02
|
4.30e-01
|
7.56e-01
|
GOBP CELLULAR LIPID METABOLIC PROCESS
|
969
|
5.03e-05
|
5.54e-03
|
0.08670
|
-8.31e-02
|
2.45e-02
|
1.17e-05
|
1.97e-01
|
GOMF GLYCOLIPID BINDING
|
29
|
7.34e-01
|
9.34e-01
|
0.08660
|
-2.50e-02
|
8.30e-02
|
8.16e-01
|
4.39e-01
|
GOBP EPITHELIAL TO MESENCHYMAL TRANSITION
|
176
|
1.60e-01
|
6.48e-01
|
0.08660
|
-3.17e-02
|
8.06e-02
|
4.68e-01
|
6.51e-02
|
GOBP NEGATIVE REGULATION OF CELL ACTIVATION
|
215
|
1.10e-01
|
5.87e-01
|
0.08660
|
-3.66e-02
|
7.85e-02
|
3.55e-01
|
4.73e-02
|
GOMF PHOSPHATIDYLINOSITOL MONOPHOSPHATE PHOSPHATASE ACTIVITY
|
11
|
8.91e-01
|
9.76e-01
|
0.08660
|
-8.07e-02
|
3.12e-02
|
6.43e-01
|
8.58e-01
|
GOBP REGULATION OF MUSCLE HYPERTROPHY
|
69
|
4.79e-01
|
8.54e-01
|
0.08650
|
-2.31e-02
|
8.34e-02
|
7.40e-01
|
2.31e-01
|
GOBP NEGATIVE REGULATION OF AXON EXTENSION
|
43
|
5.84e-01
|
8.90e-01
|
0.08650
|
3.95e-02
|
7.70e-02
|
6.54e-01
|
3.83e-01
|
GOMF LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR BINDING
|
24
|
7.45e-01
|
9.38e-01
|
0.08640
|
-8.10e-02
|
-3.01e-02
|
4.92e-01
|
7.98e-01
|
GOBP CAMP METABOLIC PROCESS
|
23
|
7.55e-01
|
9.42e-01
|
0.08640
|
2.78e-02
|
8.19e-02
|
8.18e-01
|
4.97e-01
|
GOBP MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS
|
23
|
7.51e-01
|
9.40e-01
|
0.08640
|
-7.74e-02
|
-3.84e-02
|
5.20e-01
|
7.50e-01
|
GOBP NEURAL CREST FORMATION
|
15
|
8.34e-01
|
9.64e-01
|
0.08640
|
-8.29e-02
|
-2.42e-02
|
5.78e-01
|
8.71e-01
|
GOBP REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY
|
18
|
8.13e-01
|
9.59e-01
|
0.08630
|
8.62e-02
|
4.94e-03
|
5.27e-01
|
9.71e-01
|
GOBP REGULATION OF CELLULAR KETONE METABOLIC PROCESS
|
139
|
2.37e-01
|
7.24e-01
|
0.08630
|
-8.06e-02
|
3.09e-02
|
1.01e-01
|
5.29e-01
|
GOMF HISTONE H4K20 METHYLTRANSFERASE ACTIVITY
|
10
|
8.98e-01
|
9.78e-01
|
0.08630
|
-8.45e-02
|
1.75e-02
|
6.44e-01
|
9.24e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY
|
99
|
2.87e-01
|
7.59e-01
|
0.08630
|
-5.45e-02
|
-6.69e-02
|
3.49e-01
|
2.50e-01
|
GOBP REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL
|
38
|
6.69e-01
|
9.11e-01
|
0.08630
|
-8.30e-02
|
2.34e-02
|
3.76e-01
|
8.03e-01
|
GOBP REGULATION OF MUSCLE CONTRACTION
|
163
|
1.71e-01
|
6.58e-01
|
0.08630
|
-1.27e-02
|
8.53e-02
|
7.79e-01
|
6.02e-02
|
GOBP REGULATION OF CELLULAR CATABOLIC PROCESS
|
686
|
1.05e-03
|
5.27e-02
|
0.08620
|
-7.92e-02
|
3.41e-02
|
4.04e-04
|
1.28e-01
|
GOCC MITOCHONDRIAL ENVELOPE
|
748
|
1.47e-04
|
1.27e-02
|
0.08620
|
-3.00e-02
|
-8.08e-02
|
1.62e-01
|
1.68e-04
|
GOBP REGULATION OF TRANSCRIPTION ELONGATION BY RNA POLYMERASE II
|
85
|
3.79e-01
|
8.14e-01
|
0.08620
|
-8.61e-02
|
-4.67e-03
|
1.70e-01
|
9.41e-01
|
GOBP CEREBELLAR GRANULAR LAYER MORPHOGENESIS
|
8
|
9.22e-01
|
9.84e-01
|
0.08620
|
-4.03e-02
|
7.62e-02
|
8.44e-01
|
7.09e-01
|
GOMF ASPARTIC ENDOPEPTIDASE ACTIVITY INTRAMEMBRANE CLEAVING
|
8
|
9.22e-01
|
9.84e-01
|
0.08610
|
-7.50e-02
|
4.24e-02
|
7.13e-01
|
8.36e-01
|
GOBP PORE COMPLEX ASSEMBLY
|
19
|
8.28e-01
|
9.62e-01
|
0.08610
|
6.74e-02
|
-5.36e-02
|
6.11e-01
|
6.86e-01
|
GOCC DISTAL AXON
|
261
|
5.79e-02
|
4.69e-01
|
0.08610
|
-7.61e-03
|
8.58e-02
|
8.32e-01
|
1.71e-02
|
GOMF GUANYLATE KINASE ACTIVITY
|
7
|
9.24e-01
|
9.84e-01
|
0.08610
|
-8.61e-02
|
-5.06e-04
|
6.93e-01
|
9.98e-01
|
GOBP VENTRICULAR SEPTUM DEVELOPMENT
|
74
|
4.23e-01
|
8.35e-01
|
0.08610
|
1.17e-02
|
8.53e-02
|
8.61e-01
|
2.05e-01
|
GOCC ASTROCYTE END FOOT
|
9
|
8.95e-01
|
9.77e-01
|
0.08610
|
3.89e-02
|
7.68e-02
|
8.40e-01
|
6.90e-01
|
GOBP PROTEIN INSERTION INTO ER MEMBRANE
|
26
|
7.43e-01
|
9.38e-01
|
0.08610
|
-8.59e-02
|
-5.46e-03
|
4.48e-01
|
9.62e-01
|
GOBP NEGATIVE REGULATION OF CELL CYCLE
|
391
|
9.71e-03
|
2.09e-01
|
0.08600
|
-2.63e-02
|
-8.19e-02
|
3.71e-01
|
5.42e-03
|
GOBP POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS
|
17
|
8.45e-01
|
9.66e-01
|
0.08600
|
-6.69e-02
|
5.40e-02
|
6.33e-01
|
7.00e-01
|
GOCC IRON SULFUR CLUSTER ASSEMBLY COMPLEX
|
10
|
8.82e-01
|
9.75e-01
|
0.08600
|
-5.12e-02
|
-6.91e-02
|
7.79e-01
|
7.05e-01
|
GOBP NEGATIVE REGULATION OF MITOTIC CELL CYCLE
|
241
|
5.39e-02
|
4.58e-01
|
0.08600
|
-3.43e-02
|
-7.88e-02
|
3.58e-01
|
3.50e-02
|
GOBP CELLULAR RESPONSE TO ESTROGEN STIMULUS
|
18
|
8.10e-01
|
9.59e-01
|
0.08600
|
-1.48e-02
|
-8.47e-02
|
9.13e-01
|
5.34e-01
|
GOCC MICROTUBULE END
|
34
|
6.84e-01
|
9.17e-01
|
0.08600
|
-8.60e-02
|
1.84e-03
|
3.86e-01
|
9.85e-01
|
GOMF LIPASE ACTIVATOR ACTIVITY
|
17
|
8.45e-01
|
9.66e-01
|
0.08590
|
-6.85e-02
|
5.19e-02
|
6.25e-01
|
7.11e-01
|
GOCC RETROMER COMPLEX
|
11
|
8.96e-01
|
9.78e-01
|
0.08590
|
4.74e-02
|
-7.16e-02
|
7.85e-01
|
6.81e-01
|
GOBP PROTEIN K63 LINKED DEUBIQUITINATION
|
26
|
7.44e-01
|
9.38e-01
|
0.08590
|
5.38e-03
|
8.57e-02
|
9.62e-01
|
4.49e-01
|
GOMF NAD BINDING
|
55
|
5.46e-01
|
8.78e-01
|
0.08590
|
-8.56e-02
|
6.78e-03
|
2.72e-01
|
9.31e-01
|
GOCC RNAI EFFECTOR COMPLEX
|
357
|
2.36e-02
|
3.25e-01
|
0.08580
|
-1.77e-02
|
8.40e-02
|
5.66e-01
|
6.40e-03
|
GOCC CILIARY PLASM
|
158
|
2.10e-01
|
7.00e-01
|
0.08580
|
7.02e-02
|
-4.93e-02
|
1.28e-01
|
2.85e-01
|
GOCC MICROVILLUS
|
94
|
3.70e-01
|
8.09e-01
|
0.08580
|
-1.92e-02
|
8.36e-02
|
7.48e-01
|
1.61e-01
|
GOBP LIMBIC SYSTEM DEVELOPMENT
|
117
|
2.70e-01
|
7.45e-01
|
0.08580
|
-1.93e-03
|
-8.57e-02
|
9.71e-01
|
1.09e-01
|
GOBP IN UTERO EMBRYONIC DEVELOPMENT
|
382
|
2.18e-02
|
3.13e-01
|
0.08580
|
-7.85e-02
|
3.46e-02
|
8.46e-03
|
2.46e-01
|
GOBP BLOOD VESSEL REMODELING
|
45
|
5.99e-01
|
8.95e-01
|
0.08570
|
-8.55e-02
|
-6.87e-03
|
3.21e-01
|
9.36e-01
|
GOMF ORGANIC HYDROXY COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY
|
50
|
5.35e-01
|
8.76e-01
|
0.08570
|
6.32e-02
|
5.79e-02
|
4.39e-01
|
4.78e-01
|
GOBP CELLULAR RESPONSE TO CALCIUM ION
|
82
|
3.66e-01
|
8.06e-01
|
0.08570
|
-7.54e-02
|
-4.07e-02
|
2.38e-01
|
5.24e-01
|
GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE
|
79
|
3.88e-01
|
8.20e-01
|
0.08570
|
-8.06e-02
|
-2.89e-02
|
2.15e-01
|
6.56e-01
|
GOBP POSITIVE REGULATION OF T CELL MIGRATION
|
33
|
7.24e-01
|
9.30e-01
|
0.08570
|
-5.98e-02
|
6.13e-02
|
5.52e-01
|
5.42e-01
|
GOBP NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION
|
6
|
9.41e-01
|
9.89e-01
|
0.08560
|
-7.70e-02
|
3.76e-02
|
7.44e-01
|
8.73e-01
|
GOBP INORGANIC ION HOMEOSTASIS
|
515
|
4.23e-03
|
1.33e-01
|
0.08560
|
-9.37e-03
|
8.51e-02
|
7.16e-01
|
9.47e-04
|
GOBP REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION
|
20
|
7.90e-01
|
9.54e-01
|
0.08560
|
8.31e-02
|
2.03e-02
|
5.20e-01
|
8.75e-01
|
GOMF LIPID TRANSPORTER ACTIVITY
|
169
|
1.89e-01
|
6.81e-01
|
0.08560
|
-7.32e-02
|
4.42e-02
|
1.00e-01
|
3.21e-01
|
GOBP MYOTUBE DIFFERENTIATION INVOLVED IN SKELETAL MUSCLE REGENERATION
|
8
|
9.25e-01
|
9.84e-01
|
0.08550
|
6.55e-02
|
-5.50e-02
|
7.48e-01
|
7.88e-01
|
GOMF PROTEIN TYROSINE KINASE INHIBITOR ACTIVITY
|
6
|
9.34e-01
|
9.87e-01
|
0.08550
|
-8.50e-02
|
-9.12e-03
|
7.18e-01
|
9.69e-01
|
GOBP MESONEPHRIC TUBULE FORMATION
|
10
|
8.84e-01
|
9.76e-01
|
0.08550
|
-7.34e-02
|
-4.39e-02
|
6.88e-01
|
8.10e-01
|
GOBP CAMP MEDIATED SIGNALING
|
53
|
5.34e-01
|
8.76e-01
|
0.08550
|
8.19e-02
|
2.45e-02
|
3.03e-01
|
7.58e-01
|
GOMF LIGASE ACTIVITY
|
160
|
1.40e-01
|
6.24e-01
|
0.08540
|
-7.06e-02
|
-4.82e-02
|
1.23e-01
|
2.93e-01
|
GOMF PROTEIN PHOSPHATASE 2B BINDING
|
6
|
9.42e-01
|
9.89e-01
|
0.08540
|
-4.50e-02
|
7.26e-02
|
8.49e-01
|
7.58e-01
|
GOBP POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION
|
44
|
5.86e-01
|
8.90e-01
|
0.08540
|
7.66e-02
|
3.78e-02
|
3.79e-01
|
6.64e-01
|
GOBP GASTRULATION
|
188
|
1.62e-01
|
6.48e-01
|
0.08540
|
-6.14e-02
|
5.94e-02
|
1.47e-01
|
1.60e-01
|
GOCC GOLGI ASSOCIATED VESICLE
|
89
|
4.20e-01
|
8.33e-01
|
0.08540
|
-6.70e-02
|
5.29e-02
|
2.75e-01
|
3.88e-01
|
GOBP CELL DIFFERENTIATION IN SPINAL CORD
|
49
|
6.15e-01
|
8.99e-01
|
0.08530
|
7.42e-02
|
-4.22e-02
|
3.69e-01
|
6.09e-01
|
GOBP CYTIDINE METABOLIC PROCESS
|
12
|
8.90e-01
|
9.76e-01
|
0.08530
|
6.00e-02
|
-6.07e-02
|
7.19e-01
|
7.16e-01
|
GOMF CYTIDINE DEAMINASE ACTIVITY
|
12
|
8.90e-01
|
9.76e-01
|
0.08530
|
6.00e-02
|
-6.07e-02
|
7.19e-01
|
7.16e-01
|
GOBP REGULATION OF MITOCHONDRION ORGANIZATION
|
147
|
1.91e-01
|
6.85e-01
|
0.08530
|
-8.49e-02
|
-8.32e-03
|
7.56e-02
|
8.62e-01
|
GOBP MOLTING CYCLE
|
113
|
2.86e-01
|
7.58e-01
|
0.08530
|
2.26e-03
|
8.53e-02
|
9.67e-01
|
1.17e-01
|
GOCC CONDENSED NUCLEAR CHROMOSOME
|
74
|
4.07e-01
|
8.26e-01
|
0.08530
|
-7.47e-02
|
-4.11e-02
|
2.66e-01
|
5.41e-01
|
GOBP REGULATION OF LEUKOCYTE CHEMOTAXIS
|
120
|
3.01e-01
|
7.67e-01
|
0.08520
|
-3.54e-02
|
7.75e-02
|
5.03e-01
|
1.42e-01
|
GOBP REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS
|
74
|
4.05e-01
|
8.26e-01
|
0.08520
|
7.31e-02
|
4.39e-02
|
2.77e-01
|
5.14e-01
|
GOMF ENDONUCLEASE ACTIVITY
|
118
|
2.34e-01
|
7.22e-01
|
0.08520
|
-5.29e-02
|
-6.68e-02
|
3.21e-01
|
2.10e-01
|
GOBP BEHAVIORAL RESPONSE TO COCAINE
|
14
|
8.60e-01
|
9.69e-01
|
0.08520
|
1.02e-02
|
-8.46e-02
|
9.47e-01
|
5.84e-01
|
GOBP MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS
|
217
|
8.27e-02
|
5.35e-01
|
0.08520
|
-8.34e-02
|
-1.76e-02
|
3.42e-02
|
6.55e-01
|
GOBP LIVER MORPHOGENESIS
|
25
|
7.82e-01
|
9.52e-01
|
0.08520
|
-4.69e-02
|
7.11e-02
|
6.85e-01
|
5.38e-01
|
GOMF LIPID PHOSPHATASE ACTIVITY
|
19
|
8.13e-01
|
9.59e-01
|
0.08520
|
-8.51e-02
|
4.32e-03
|
5.21e-01
|
9.74e-01
|
GOBP REGULATION OF CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION
|
8
|
9.25e-01
|
9.84e-01
|
0.08520
|
-5.58e-02
|
6.44e-02
|
7.85e-01
|
7.52e-01
|
GOBP REGULATION OF CHEMOTAXIS
|
221
|
8.95e-02
|
5.51e-01
|
0.08520
|
-2.76e-04
|
8.52e-02
|
9.94e-01
|
2.91e-02
|
GOBP SENSORY PERCEPTION OF BITTER TASTE
|
44
|
6.25e-01
|
9.01e-01
|
0.08510
|
-8.45e-02
|
1.03e-02
|
3.32e-01
|
9.06e-01
|
GOCC SMOOTH ENDOPLASMIC RETICULUM MEMBRANE
|
7
|
9.32e-01
|
9.86e-01
|
0.08510
|
3.55e-02
|
-7.73e-02
|
8.71e-01
|
7.23e-01
|
GOBP NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE
|
30
|
6.96e-01
|
9.21e-01
|
0.08500
|
-3.87e-02
|
-7.57e-02
|
7.14e-01
|
4.73e-01
|
GOCC FLEMMING BODY
|
34
|
7.07e-01
|
9.25e-01
|
0.08500
|
-8.08e-02
|
2.66e-02
|
4.15e-01
|
7.88e-01
|
GOBP COP9 SIGNALOSOME ASSEMBLY
|
5
|
9.50e-01
|
9.90e-01
|
0.08500
|
-8.22e-02
|
2.15e-02
|
7.50e-01
|
9.34e-01
|
GOBP AMINO ACID SALVAGE
|
7
|
9.33e-01
|
9.86e-01
|
0.08500
|
3.53e-02
|
-7.73e-02
|
8.71e-01
|
7.23e-01
|
GOBP POSITIVE REGULATION OF T CELL PROLIFERATION
|
99
|
3.48e-01
|
7.96e-01
|
0.08490
|
8.45e-02
|
-8.94e-03
|
1.46e-01
|
8.78e-01
|
GOBP REGULATION OF CARBOHYDRATE METABOLIC PROCESS
|
180
|
1.43e-01
|
6.28e-01
|
0.08490
|
-8.49e-02
|
2.26e-03
|
4.95e-02
|
9.58e-01
|
GOCC CHITOSOME
|
19
|
8.21e-01
|
9.60e-01
|
0.08490
|
-1.88e-02
|
8.28e-02
|
8.87e-01
|
5.32e-01
|
GOBP PIGMENT BIOSYNTHETIC PROCESS
|
51
|
5.66e-01
|
8.85e-01
|
0.08480
|
-6.94e-03
|
-8.46e-02
|
9.32e-01
|
2.96e-01
|
GOBP SENSORY PERCEPTION OF SOUR TASTE
|
9
|
9.15e-01
|
9.83e-01
|
0.08480
|
7.65e-02
|
-3.66e-02
|
6.91e-01
|
8.49e-01
|
GOBP CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS
|
58
|
5.63e-01
|
8.84e-01
|
0.08480
|
3.52e-02
|
-7.71e-02
|
6.43e-01
|
3.10e-01
|
GOCC INCLUSION BODY
|
69
|
4.31e-01
|
8.37e-01
|
0.08470
|
-6.30e-02
|
-5.67e-02
|
3.66e-01
|
4.15e-01
|
GOMF HEXOSYLTRANSFERASE ACTIVITY
|
191
|
1.29e-01
|
6.09e-01
|
0.08470
|
-8.46e-02
|
3.64e-03
|
4.37e-02
|
9.31e-01
|
GOMF GROWTH FACTOR BINDING
|
130
|
2.06e-01
|
6.95e-01
|
0.08470
|
6.18e-02
|
5.79e-02
|
2.23e-01
|
2.54e-01
|
GOBP POSITIVE REGULATION OF FIBROBLAST MIGRATION
|
15
|
8.38e-01
|
9.64e-01
|
0.08470
|
-7.87e-02
|
-3.12e-02
|
5.98e-01
|
8.34e-01
|
GOBP RESPONSE TO INCREASED OXYGEN LEVELS
|
24
|
7.83e-01
|
9.52e-01
|
0.08470
|
-2.33e-02
|
8.14e-02
|
8.43e-01
|
4.90e-01
|
GOBP MAINTENANCE OF GASTROINTESTINAL EPITHELIUM
|
23
|
7.85e-01
|
9.52e-01
|
0.08470
|
-1.17e-02
|
8.38e-02
|
9.23e-01
|
4.86e-01
|
GOMF LIPID BINDING
|
815
|
5.07e-04
|
3.14e-02
|
0.08460
|
-4.85e-02
|
6.94e-02
|
1.85e-02
|
7.65e-04
|
GOBP ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS
|
47
|
6.08e-01
|
8.97e-01
|
0.08460
|
9.85e-03
|
-8.41e-02
|
9.07e-01
|
3.19e-01
|
GOBP MYELOID DENDRITIC CELL DIFFERENTIATION
|
20
|
7.91e-01
|
9.54e-01
|
0.08460
|
2.95e-02
|
7.93e-02
|
8.19e-01
|
5.39e-01
|
GOBP APOPTOTIC MITOCHONDRIAL CHANGES
|
105
|
2.79e-01
|
7.52e-01
|
0.08460
|
-5.55e-02
|
-6.38e-02
|
3.26e-01
|
2.58e-01
|
GOCC CELL CELL CONTACT ZONE
|
70
|
4.33e-01
|
8.37e-01
|
0.08460
|
7.46e-02
|
3.98e-02
|
2.80e-01
|
5.65e-01
|
GOBP VIRAL TRANSCRIPTION
|
50
|
6.05e-01
|
8.96e-01
|
0.08460
|
-7.99e-02
|
2.78e-02
|
3.28e-01
|
7.34e-01
|
GOBP BLASTOCYST FORMATION
|
45
|
6.39e-01
|
9.06e-01
|
0.08460
|
-7.84e-02
|
3.16e-02
|
3.63e-01
|
7.13e-01
|
GOBP AXIS SPECIFICATION
|
91
|
4.01e-01
|
8.26e-01
|
0.08450
|
-8.03e-02
|
2.65e-02
|
1.86e-01
|
6.62e-01
|
GOBP EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS
|
82
|
3.95e-01
|
8.24e-01
|
0.08450
|
1.67e-02
|
8.28e-02
|
7.93e-01
|
1.95e-01
|
GOBP POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY
|
98
|
3.20e-01
|
7.78e-01
|
0.08440
|
2.84e-02
|
7.95e-02
|
6.27e-01
|
1.74e-01
|
GOCC ALVEOLAR LAMELLAR BODY
|
7
|
9.24e-01
|
9.84e-01
|
0.08440
|
8.34e-02
|
1.32e-02
|
7.02e-01
|
9.52e-01
|
GOBP REGULATION OF MICROTUBULE BASED MOVEMENT
|
50
|
5.52e-01
|
8.80e-01
|
0.08440
|
-3.92e-02
|
-7.48e-02
|
6.32e-01
|
3.60e-01
|
GOBP DOPAMINE TRANSPORT
|
54
|
5.34e-01
|
8.76e-01
|
0.08440
|
2.83e-02
|
7.95e-02
|
7.19e-01
|
3.12e-01
|
GOBP ORGANIC ACID BIOSYNTHETIC PROCESS
|
320
|
2.20e-02
|
3.13e-01
|
0.08440
|
-6.59e-02
|
-5.26e-02
|
4.25e-02
|
1.06e-01
|
GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION
|
514
|
7.24e-03
|
1.78e-01
|
0.08430
|
-7.62e-02
|
3.61e-02
|
3.09e-03
|
1.62e-01
|
GOMF ADENYL NUCLEOTIDE BINDING
|
1567
|
2.66e-07
|
1.17e-04
|
0.08430
|
-8.31e-02
|
1.41e-02
|
3.89e-08
|
3.50e-01
|
GOCC STEREOCILIUM BUNDLE
|
61
|
5.28e-01
|
8.72e-01
|
0.08430
|
8.36e-02
|
-1.07e-02
|
2.58e-01
|
8.85e-01
|
GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE
|
122
|
2.40e-01
|
7.25e-01
|
0.08430
|
-7.78e-02
|
-3.25e-02
|
1.38e-01
|
5.35e-01
|
GOBP GLYCOSYL COMPOUND METABOLIC PROCESS
|
79
|
4.27e-01
|
8.36e-01
|
0.08430
|
-2.76e-04
|
-8.43e-02
|
9.97e-01
|
1.95e-01
|
GOBP ENDOTHELIN RECEPTOR SIGNALING PATHWAY
|
10
|
9.05e-01
|
9.80e-01
|
0.08430
|
-7.91e-02
|
2.92e-02
|
6.65e-01
|
8.73e-01
|
GOBP REGULATION OF INNATE IMMUNE RESPONSE
|
403
|
8.47e-03
|
1.94e-01
|
0.08430
|
-6.78e-02
|
-5.00e-02
|
1.94e-02
|
8.51e-02
|
GOCC NUCLEAR MEMBRANE
|
296
|
3.05e-02
|
3.61e-01
|
0.08420
|
-7.21e-02
|
-4.34e-02
|
3.27e-02
|
1.99e-01
|
GOMF CGMP BINDING
|
15
|
8.52e-01
|
9.67e-01
|
0.08420
|
8.41e-02
|
-3.06e-03
|
5.73e-01
|
9.84e-01
|
GOBP ORGANOPHOSPHATE METABOLIC PROCESS
|
915
|
4.98e-05
|
5.53e-03
|
0.08420
|
-8.25e-02
|
-1.67e-02
|
2.31e-05
|
3.92e-01
|
GOBP REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY
|
278
|
4.51e-02
|
4.30e-01
|
0.08410
|
-8.23e-02
|
-1.72e-02
|
1.81e-02
|
6.22e-01
|
GOBP INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION
|
35
|
6.57e-01
|
9.09e-01
|
0.08410
|
5.23e-02
|
6.58e-02
|
5.93e-01
|
5.00e-01
|
GOBP GLUTAMATE RECEPTOR SIGNALING PATHWAY
|
47
|
6.40e-01
|
9.06e-01
|
0.08400
|
-6.74e-02
|
5.02e-02
|
4.24e-01
|
5.52e-01
|
GOBP POSITIVE REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION
|
24
|
7.50e-01
|
9.40e-01
|
0.08400
|
5.09e-02
|
6.69e-02
|
6.66e-01
|
5.71e-01
|
GOMF SNAP RECEPTOR ACTIVITY
|
36
|
6.49e-01
|
9.07e-01
|
0.08400
|
-6.17e-02
|
-5.70e-02
|
5.22e-01
|
5.54e-01
|
GOBP SPINAL CORD MOTOR NEURON DIFFERENTIATION
|
28
|
7.54e-01
|
9.41e-01
|
0.08400
|
-2.08e-02
|
8.14e-02
|
8.49e-01
|
4.56e-01
|
GOBP PHOSPHATE ION HOMEOSTASIS
|
20
|
7.88e-01
|
9.54e-01
|
0.08400
|
-4.48e-02
|
-7.10e-02
|
7.29e-01
|
5.83e-01
|
GOBP MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER
|
13
|
8.71e-01
|
9.73e-01
|
0.08390
|
2.32e-03
|
-8.39e-02
|
9.88e-01
|
6.00e-01
|
GOMF GATED CHANNEL ACTIVITY
|
310
|
2.57e-02
|
3.33e-01
|
0.08390
|
5.07e-02
|
6.69e-02
|
1.25e-01
|
4.27e-02
|
GOBP REGULATION OF PROTEIN IMPORT INTO NUCLEUS
|
57
|
5.84e-01
|
8.90e-01
|
0.08390
|
-6.55e-02
|
5.24e-02
|
3.92e-01
|
4.94e-01
|
GOBP RESPONSE TO ETHER
|
11
|
8.94e-01
|
9.77e-01
|
0.08390
|
-1.72e-02
|
8.21e-02
|
9.21e-01
|
6.37e-01
|
GOMF NUCLEAR THYROID HORMONE RECEPTOR BINDING
|
28
|
7.22e-01
|
9.30e-01
|
0.08390
|
-3.32e-02
|
-7.70e-02
|
7.61e-01
|
4.80e-01
|
GOCC CYTOSOLIC REGION
|
19
|
8.33e-01
|
9.64e-01
|
0.08390
|
-7.35e-02
|
4.05e-02
|
5.79e-01
|
7.60e-01
|
GOBP RESPONSE TO VIRUS
|
417
|
7.68e-03
|
1.83e-01
|
0.08390
|
-4.63e-02
|
-6.99e-02
|
1.05e-01
|
1.43e-02
|
GOBP PHOSPHATIDYLCHOLINE CATABOLIC PROCESS
|
16
|
8.60e-01
|
9.68e-01
|
0.08390
|
-5.28e-02
|
6.52e-02
|
7.15e-01
|
6.52e-01
|
GOBP RESPONSE TO WATER
|
13
|
8.56e-01
|
9.68e-01
|
0.08390
|
5.04e-02
|
6.70e-02
|
7.53e-01
|
6.76e-01
|
GOBP VIRAL GENOME REPLICATION
|
123
|
2.32e-01
|
7.18e-01
|
0.08380
|
-6.26e-02
|
-5.57e-02
|
2.31e-01
|
2.86e-01
|
GOBP SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING
|
13
|
8.84e-01
|
9.76e-01
|
0.08370
|
7.08e-02
|
-4.47e-02
|
6.58e-01
|
7.80e-01
|
GOMF KINASE BINDING
|
739
|
1.06e-03
|
5.34e-02
|
0.08370
|
-3.94e-02
|
7.38e-02
|
6.82e-02
|
6.35e-04
|
GOBP LUNG CELL DIFFERENTIATION
|
28
|
7.20e-01
|
9.29e-01
|
0.08360
|
7.29e-02
|
4.10e-02
|
5.04e-01
|
7.07e-01
|
GOBP CONNECTIVE TISSUE DEVELOPMENT
|
277
|
7.71e-02
|
5.23e-01
|
0.08360
|
-5.51e-02
|
6.29e-02
|
1.14e-01
|
7.16e-02
|
GOBP RESPONSE TO L ASCORBIC ACID
|
6
|
9.44e-01
|
9.90e-01
|
0.08360
|
-7.27e-02
|
4.13e-02
|
7.58e-01
|
8.61e-01
|
GOBP SECOND MESSENGER MEDIATED SIGNALING
|
297
|
3.48e-02
|
3.81e-01
|
0.08360
|
2.82e-02
|
7.87e-02
|
4.03e-01
|
1.96e-02
|
GOBP REGULATION OF CHROMOSOME ORGANIZATION
|
239
|
6.00e-02
|
4.78e-01
|
0.08360
|
-5.32e-02
|
-6.45e-02
|
1.57e-01
|
8.58e-02
|
GOBP ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS
|
1760
|
4.17e-09
|
4.46e-06
|
0.08360
|
-5.43e-02
|
-6.36e-02
|
1.54e-04
|
9.39e-06
|
GOBP POSITIVE REGULATION OF CIRCADIAN RHYTHM
|
18
|
8.45e-01
|
9.66e-01
|
0.08350
|
-5.79e-02
|
6.02e-02
|
6.70e-01
|
6.58e-01
|
GOMF PROTEIN TYROSINE PHOSPHATASE ACTIVITY
|
95
|
4.01e-01
|
8.26e-01
|
0.08350
|
-3.35e-02
|
7.64e-02
|
5.73e-01
|
1.98e-01
|
GOBP NON MOTILE CILIUM ASSEMBLY
|
63
|
5.55e-01
|
8.81e-01
|
0.08340
|
6.69e-02
|
-4.99e-02
|
3.59e-01
|
4.94e-01
|
GOBP DEPHOSPHORYLATION
|
287
|
6.95e-02
|
5.02e-01
|
0.08330
|
-4.48e-02
|
7.02e-02
|
1.91e-01
|
4.06e-02
|
GOBP REGULATION OF NEUROTRANSMITTER TRANSPORT
|
92
|
3.47e-01
|
7.96e-01
|
0.08320
|
3.61e-02
|
7.50e-02
|
5.50e-01
|
2.14e-01
|
GOBP REGULATION OF CATABOLIC PROCESS
|
1028
|
6.67e-05
|
6.83e-03
|
0.08320
|
-7.94e-02
|
2.49e-02
|
1.67e-05
|
1.77e-01
|
GOBP SYNAPSE MATURATION
|
33
|
6.89e-01
|
9.19e-01
|
0.08310
|
7.87e-02
|
2.67e-02
|
4.34e-01
|
7.90e-01
|
GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION
|
34
|
7.29e-01
|
9.32e-01
|
0.08310
|
-6.75e-02
|
4.85e-02
|
4.96e-01
|
6.24e-01
|
GOCC BASEMENT MEMBRANE
|
85
|
3.90e-01
|
8.21e-01
|
0.08310
|
8.06e-02
|
2.03e-02
|
1.99e-01
|
7.46e-01
|
GOCC CELL CORTEX
|
297
|
4.72e-02
|
4.38e-01
|
0.08310
|
-3.00e-03
|
8.30e-02
|
9.29e-01
|
1.38e-02
|
GOBP NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT
|
139
|
2.64e-01
|
7.41e-01
|
0.08300
|
-2.98e-02
|
7.74e-02
|
5.44e-01
|
1.15e-01
|
GOMF IONOTROPIC GLUTAMATE RECEPTOR ACTIVITY
|
18
|
8.17e-01
|
9.60e-01
|
0.08300
|
2.71e-02
|
7.84e-02
|
8.42e-01
|
5.65e-01
|
GOBP RESPIRATORY SYSTEM DEVELOPMENT
|
207
|
1.40e-01
|
6.23e-01
|
0.08300
|
-3.07e-02
|
7.71e-02
|
4.47e-01
|
5.59e-02
|
GOBP REGULATION OF CELL JUNCTION ASSEMBLY
|
199
|
1.50e-01
|
6.38e-01
|
0.08290
|
-3.01e-02
|
7.72e-02
|
4.63e-01
|
6.03e-02
|
GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS ANTIGEN
|
45
|
6.09e-01
|
8.97e-01
|
0.08290
|
-8.05e-02
|
-2.00e-02
|
3.50e-01
|
8.17e-01
|
GOBP ORGANOPHOSPHATE ESTER TRANSPORT
|
147
|
2.18e-01
|
7.07e-01
|
0.08280
|
-8.28e-02
|
3.95e-04
|
8.29e-02
|
9.93e-01
|
GOBP RESPONSE TO HEAT
|
98
|
4.08e-01
|
8.27e-01
|
0.08280
|
6.21e-02
|
-5.48e-02
|
2.88e-01
|
3.49e-01
|
GOBP REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT
|
106
|
3.53e-01
|
7.97e-01
|
0.08270
|
-8.06e-02
|
1.86e-02
|
1.51e-01
|
7.41e-01
|
GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION
|
29
|
7.61e-01
|
9.45e-01
|
0.08270
|
-7.41e-02
|
3.68e-02
|
4.90e-01
|
7.32e-01
|
GOBP ACYLGLYCEROL HOMEOSTASIS
|
42
|
6.70e-01
|
9.11e-01
|
0.08270
|
-7.69e-02
|
3.04e-02
|
3.88e-01
|
7.33e-01
|
GOBP MYELOID CELL HOMEOSTASIS
|
165
|
1.82e-01
|
6.72e-01
|
0.08270
|
-8.27e-02
|
7.11e-04
|
6.67e-02
|
9.87e-01
|
GOBP HOMEOSTASIS OF NUMBER OF CELLS
|
298
|
5.85e-02
|
4.71e-01
|
0.08270
|
-7.85e-02
|
2.61e-02
|
1.98e-02
|
4.38e-01
|
GOMF GAMMA CATENIN BINDING
|
12
|
8.76e-01
|
9.75e-01
|
0.08270
|
7.95e-02
|
2.26e-02
|
6.33e-01
|
8.92e-01
|
GOBP ASTROCYTE CELL MIGRATION
|
9
|
9.11e-01
|
9.82e-01
|
0.08270
|
6.87e-04
|
-8.27e-02
|
9.97e-01
|
6.68e-01
|
GOBP POSITIVE REGULATION OF FATTY ACID OXIDATION
|
14
|
8.58e-01
|
9.68e-01
|
0.08270
|
8.06e-02
|
1.85e-02
|
6.02e-01
|
9.04e-01
|
GOBP NEUROPEPTIDE SIGNALING PATHWAY
|
101
|
3.53e-01
|
7.97e-01
|
0.08270
|
9.60e-04
|
-8.26e-02
|
9.87e-01
|
1.51e-01
|
GOBP CELLULAR RESPONSE TO OXIDATIVE STRESS
|
247
|
6.52e-02
|
4.93e-01
|
0.08260
|
-7.80e-02
|
-2.72e-02
|
3.47e-02
|
4.61e-01
|
GOBP POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY
|
231
|
1.20e-01
|
6.00e-01
|
0.08260
|
-7.07e-02
|
4.27e-02
|
6.40e-02
|
2.63e-01
|
GOMF ENDODEOXYRIBONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS
|
11
|
8.96e-01
|
9.78e-01
|
0.08260
|
1.24e-02
|
-8.17e-02
|
9.43e-01
|
6.39e-01
|
GOBP PIGMENT CATABOLIC PROCESS
|
11
|
8.80e-01
|
9.75e-01
|
0.08260
|
5.99e-02
|
5.68e-02
|
7.31e-01
|
7.44e-01
|
GOBP NEGATIVE REGULATION OF WNT SIGNALING PATHWAY
|
167
|
1.69e-01
|
6.55e-01
|
0.08250
|
1.23e-02
|
8.16e-02
|
7.84e-01
|
6.89e-02
|
GOCC UBIQUITIN LIGASE COMPLEX
|
299
|
4.63e-02
|
4.35e-01
|
0.08250
|
-8.25e-02
|
-1.87e-03
|
1.41e-02
|
9.56e-01
|
GOMF AMINE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
6
|
9.40e-01
|
9.89e-01
|
0.08250
|
-8.24e-02
|
3.38e-03
|
7.27e-01
|
9.89e-01
|
GOMF NADPLUS PROTEIN CYSTEINE ADP RIBOSYLTRANSFERASE ACTIVITY
|
6
|
9.47e-01
|
9.90e-01
|
0.08250
|
-6.60e-02
|
4.95e-02
|
7.80e-01
|
8.34e-01
|
GOCC GOLGI APPARATUS
|
1531
|
1.41e-06
|
3.70e-04
|
0.08250
|
-7.59e-02
|
3.22e-02
|
6.90e-07
|
3.53e-02
|
GOCC SAGA TYPE COMPLEX
|
35
|
7.11e-01
|
9.26e-01
|
0.08240
|
-8.02e-02
|
1.87e-02
|
4.11e-01
|
8.48e-01
|
GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION
|
312
|
6.13e-02
|
4.80e-01
|
0.08240
|
-5.98e-02
|
5.66e-02
|
6.93e-02
|
8.54e-02
|
GOBP REGULATION OF ORGANELLE ASSEMBLY
|
231
|
7.20e-02
|
5.12e-01
|
0.08240
|
-6.68e-02
|
-4.81e-02
|
8.00e-02
|
2.08e-01
|
GOBP VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION
|
14
|
8.78e-01
|
9.75e-01
|
0.08230
|
7.40e-02
|
-3.62e-02
|
6.32e-01
|
8.15e-01
|
GOBP DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM
|
79
|
4.87e-01
|
8.56e-01
|
0.08230
|
-4.87e-02
|
6.64e-02
|
4.54e-01
|
3.08e-01
|
GOBP GLYCOSYL COMPOUND CATABOLIC PROCESS
|
34
|
6.75e-01
|
9.13e-01
|
0.08230
|
-5.54e-02
|
-6.09e-02
|
5.76e-01
|
5.39e-01
|
GOBP POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION
|
40
|
6.93e-01
|
9.21e-01
|
0.08230
|
-4.54e-02
|
6.87e-02
|
6.20e-01
|
4.52e-01
|
GOBP BONE TRABECULA FORMATION
|
10
|
9.13e-01
|
9.82e-01
|
0.08230
|
-5.81e-02
|
5.83e-02
|
7.50e-01
|
7.49e-01
|
GOMF HISTONE UBIQUITIN LIGASE ACTIVITY
|
9
|
9.15e-01
|
9.83e-01
|
0.08230
|
8.10e-02
|
-1.47e-02
|
6.74e-01
|
9.39e-01
|
GOBP PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS
|
123
|
3.26e-01
|
7.82e-01
|
0.08230
|
-6.88e-02
|
4.53e-02
|
1.88e-01
|
3.86e-01
|
GOBP REGULATION OF RNA EXPORT FROM NUCLEUS
|
13
|
8.83e-01
|
9.76e-01
|
0.08230
|
-2.69e-02
|
7.78e-02
|
8.66e-01
|
6.27e-01
|
GOBP RESPONSE TO ENDOPLASMIC RETICULUM STRESS
|
257
|
7.88e-02
|
5.27e-01
|
0.08230
|
-8.17e-02
|
1.03e-02
|
2.42e-02
|
7.75e-01
|
GOCC TERTIARY GRANULE
|
157
|
2.11e-01
|
7.00e-01
|
0.08230
|
-8.15e-02
|
1.12e-02
|
7.79e-02
|
8.09e-01
|
GOCC MICROBODY LUMEN
|
51
|
6.26e-01
|
9.01e-01
|
0.08230
|
7.02e-02
|
-4.30e-02
|
3.86e-01
|
5.95e-01
|
GOMF HYDROLASE ACTIVITY ACTING ON GLYCOSYL BONDS
|
125
|
2.87e-01
|
7.59e-01
|
0.08230
|
-8.18e-02
|
8.94e-03
|
1.14e-01
|
8.63e-01
|
GOBP GLANDULAR EPITHELIAL CELL DEVELOPMENT
|
36
|
7.06e-01
|
9.24e-01
|
0.08230
|
-7.95e-02
|
2.11e-02
|
4.09e-01
|
8.27e-01
|
GOCC BLOOD MICROPARTICLE
|
111
|
3.48e-01
|
7.96e-01
|
0.08230
|
7.82e-02
|
-2.56e-02
|
1.55e-01
|
6.42e-01
|
GOCC ENDOSOME MEMBRANE
|
526
|
8.58e-03
|
1.95e-01
|
0.08210
|
-7.33e-02
|
3.71e-02
|
4.04e-03
|
1.45e-01
|
GOBP POSITIVE REGULATION OF HEMOPOIESIS
|
181
|
1.93e-01
|
6.85e-01
|
0.08210
|
-4.22e-02
|
7.05e-02
|
3.28e-01
|
1.02e-01
|
GOBP LYMPHOCYTE CHEMOTAXIS
|
58
|
5.47e-01
|
8.78e-01
|
0.08210
|
5.61e-03
|
8.19e-02
|
9.41e-01
|
2.81e-01
|
GOBP PROTEIN STABILIZATION
|
201
|
1.16e-01
|
5.95e-01
|
0.08210
|
-1.91e-02
|
-7.98e-02
|
6.41e-01
|
5.10e-02
|
GOBP NUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS
|
12
|
8.98e-01
|
9.78e-01
|
0.08210
|
5.68e-02
|
-5.93e-02
|
7.34e-01
|
7.22e-01
|
GOBP SUBSTRATE DEPENDENT CELL MIGRATION
|
25
|
7.53e-01
|
9.41e-01
|
0.08210
|
6.99e-02
|
4.30e-02
|
5.45e-01
|
7.10e-01
|
GOMF HYDRO LYASE ACTIVITY
|
56
|
5.29e-01
|
8.72e-01
|
0.08210
|
-6.75e-02
|
-4.68e-02
|
3.83e-01
|
5.45e-01
|
GOBP RENAL SODIUM EXCRETION
|
11
|
9.04e-01
|
9.80e-01
|
0.08200
|
4.29e-02
|
-6.99e-02
|
8.06e-01
|
6.88e-01
|
GOMF CALMODULIN BINDING
|
197
|
1.32e-01
|
6.13e-01
|
0.08200
|
4.15e-03
|
8.19e-02
|
9.20e-01
|
4.74e-02
|
GOBP PROTEIN LOCALIZATION TO PHOTORECEPTOR OUTER SEGMENT
|
7
|
9.35e-01
|
9.87e-01
|
0.08200
|
7.97e-02
|
-1.95e-02
|
7.15e-01
|
9.29e-01
|
GOBP CELLULAR RESPONSE TO HYDROPEROXIDE
|
8
|
9.27e-01
|
9.85e-01
|
0.08200
|
7.78e-02
|
-2.59e-02
|
7.03e-01
|
8.99e-01
|
GOCC NUCLEOLUS
|
1322
|
3.68e-06
|
8.02e-04
|
0.08200
|
5.49e-03
|
-8.18e-02
|
7.38e-01
|
5.88e-07
|
GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE
|
307
|
4.20e-02
|
4.23e-01
|
0.08200
|
-8.16e-02
|
-8.13e-03
|
1.40e-02
|
8.07e-01
|
GOBP LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE
|
34
|
7.35e-01
|
9.34e-01
|
0.08190
|
-4.56e-02
|
6.80e-02
|
6.45e-01
|
4.92e-01
|
GOBP MICROTUBULE BUNDLE FORMATION
|
121
|
2.52e-01
|
7.31e-01
|
0.08190
|
6.04e-02
|
5.54e-02
|
2.51e-01
|
2.93e-01
|
GOBP ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS
|
242
|
6.45e-02
|
4.90e-01
|
0.08190
|
-5.80e-02
|
-5.79e-02
|
1.20e-01
|
1.21e-01
|
GOBP POSITIVE REGULATION OF COLLATERAL SPROUTING
|
10
|
9.14e-01
|
9.82e-01
|
0.08170
|
-4.51e-02
|
6.82e-02
|
8.05e-01
|
7.09e-01
|
GOBP REGULATION OF VIRAL PROCESS
|
163
|
1.82e-01
|
6.72e-01
|
0.08170
|
-8.08e-02
|
-1.24e-02
|
7.51e-02
|
7.85e-01
|
GOBP BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE
|
151
|
2.62e-01
|
7.39e-01
|
0.08170
|
-6.08e-02
|
5.46e-02
|
1.97e-01
|
2.47e-01
|
GOBP REGULATION OF ACTIN FILAMENT LENGTH
|
149
|
2.14e-01
|
7.03e-01
|
0.08170
|
8.82e-03
|
8.12e-02
|
8.53e-01
|
8.69e-02
|
GOBP PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM
|
68
|
5.01e-01
|
8.62e-01
|
0.08170
|
-1.04e-03
|
-8.17e-02
|
9.88e-01
|
2.44e-01
|
GOBP POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION
|
100
|
4.02e-01
|
8.26e-01
|
0.08170
|
-3.72e-02
|
7.27e-02
|
5.20e-01
|
2.09e-01
|
GOBP CARBOHYDRATE DERIVATIVE METABOLIC PROCESS
|
982
|
3.62e-05
|
4.29e-03
|
0.08170
|
-7.74e-02
|
-2.61e-02
|
4.01e-05
|
1.67e-01
|
GOCC CONTRACTILE FIBER
|
238
|
7.49e-02
|
5.17e-01
|
0.08160
|
3.10e-02
|
7.55e-02
|
4.10e-01
|
4.48e-02
|
GOBP POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY
|
10
|
8.93e-01
|
9.77e-01
|
0.08160
|
-4.61e-02
|
-6.74e-02
|
8.01e-01
|
7.12e-01
|
GOBP RIBONUCLEOSIDE METABOLIC PROCESS
|
34
|
7.21e-01
|
9.30e-01
|
0.08160
|
7.98e-02
|
-1.71e-02
|
4.21e-01
|
8.63e-01
|
GOBP SOMATOTROPIN SECRETING CELL DIFFERENTIATION
|
5
|
9.54e-01
|
9.90e-01
|
0.08160
|
2.78e-02
|
-7.67e-02
|
9.14e-01
|
7.67e-01
|
GOCC INO80 COMPLEX
|
15
|
8.64e-01
|
9.70e-01
|
0.08160
|
-8.07e-02
|
1.21e-02
|
5.89e-01
|
9.35e-01
|
GOBP GLYCEROL ETHER METABOLIC PROCESS
|
21
|
7.96e-01
|
9.55e-01
|
0.08150
|
-7.72e-02
|
-2.62e-02
|
5.40e-01
|
8.35e-01
|
GOCC ENDOSOME
|
989
|
1.71e-04
|
1.38e-02
|
0.08150
|
-7.39e-02
|
3.45e-02
|
8.38e-05
|
6.64e-02
|
GOBP ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE
|
24
|
7.65e-01
|
9.45e-01
|
0.08150
|
4.01e-02
|
7.10e-02
|
7.34e-01
|
5.47e-01
|
GOBP PROTEIN LOCALIZATION TO CELL SURFACE
|
65
|
5.35e-01
|
8.76e-01
|
0.08150
|
-8.00e-02
|
1.59e-02
|
2.65e-01
|
8.25e-01
|
GOBP MYOTUBE CELL DEVELOPMENT
|
40
|
6.74e-01
|
9.13e-01
|
0.08150
|
8.11e-02
|
-8.02e-03
|
3.75e-01
|
9.30e-01
|
GOCC TRANSCRIPTION ELONGATION FACTOR COMPLEX
|
47
|
5.90e-01
|
8.92e-01
|
0.08150
|
4.61e-02
|
6.72e-02
|
5.85e-01
|
4.25e-01
|
GOBP MYOBLAST DIFFERENTIATION
|
109
|
3.36e-01
|
7.88e-01
|
0.08140
|
-8.14e-02
|
8.56e-04
|
1.42e-01
|
9.88e-01
|
GOBP REGULATION OF AXONOGENESIS
|
145
|
2.71e-01
|
7.47e-01
|
0.08140
|
-3.94e-02
|
7.12e-02
|
4.12e-01
|
1.39e-01
|
GOBP CELLULAR RESPONSE TO INTERLEUKIN 1
|
105
|
3.54e-01
|
7.97e-01
|
0.08140
|
-5.10e-03
|
8.12e-02
|
9.28e-01
|
1.51e-01
|
GOBP RESPIRATORY BURST
|
32
|
7.20e-01
|
9.29e-01
|
0.08140
|
-8.10e-02
|
-7.59e-03
|
4.28e-01
|
9.41e-01
|
GOBP RESPONSE TO INTERLEUKIN 1
|
132
|
2.79e-01
|
7.52e-01
|
0.08130
|
-1.20e-02
|
8.05e-02
|
8.12e-01
|
1.10e-01
|
GOBP TANGENTIAL MIGRATION FROM THE SUBVENTRICULAR ZONE TO THE OLFACTORY BULB
|
7
|
9.37e-01
|
9.88e-01
|
0.08130
|
-7.63e-02
|
2.81e-02
|
7.27e-01
|
8.98e-01
|
GOBP PRIMARY ALCOHOL METABOLIC PROCESS
|
101
|
3.22e-01
|
7.79e-01
|
0.08120
|
-5.73e-02
|
-5.76e-02
|
3.19e-01
|
3.18e-01
|
GOBP GLUTAMATERGIC NEURON DIFFERENTIATION
|
15
|
8.45e-01
|
9.66e-01
|
0.08120
|
-6.39e-02
|
-5.00e-02
|
6.68e-01
|
7.37e-01
|
GOMF BITTER TASTE RECEPTOR ACTIVITY
|
24
|
7.65e-01
|
9.45e-01
|
0.08120
|
-6.47e-02
|
-4.91e-02
|
5.83e-01
|
6.77e-01
|
GOBP EXPORT ACROSS PLASMA MEMBRANE
|
78
|
4.33e-01
|
8.37e-01
|
0.08120
|
2.64e-02
|
7.68e-02
|
6.87e-01
|
2.41e-01
|
GOBP FOREBRAIN GENERATION OF NEURONS
|
51
|
6.39e-01
|
9.06e-01
|
0.08120
|
5.85e-02
|
-5.63e-02
|
4.70e-01
|
4.87e-01
|
GOBP SPROUTING ANGIOGENESIS
|
183
|
1.62e-01
|
6.48e-01
|
0.08120
|
-6.51e-06
|
8.12e-02
|
1.00e+00
|
5.83e-02
|
GOBP REGULATION OF STRIATED MUSCLE TISSUE DEVELOPMENT
|
18
|
8.53e-01
|
9.68e-01
|
0.08120
|
-5.35e-02
|
6.10e-02
|
6.94e-01
|
6.54e-01
|
GOMF SPHINGOLIPID TRANSPORTER ACTIVITY
|
18
|
8.41e-01
|
9.66e-01
|
0.08110
|
-8.01e-02
|
1.27e-02
|
5.56e-01
|
9.26e-01
|
GOBP ENDOTHELIAL CELL PROLIFERATION
|
197
|
1.12e-01
|
5.91e-01
|
0.08110
|
5.99e-02
|
5.47e-02
|
1.47e-01
|
1.85e-01
|
GOCC OUTER MEMBRANE
|
230
|
8.40e-02
|
5.37e-01
|
0.08110
|
-7.47e-02
|
-3.16e-02
|
5.10e-02
|
4.09e-01
|
GOBP PHENOL CONTAINING COMPOUND METABOLIC PROCESS
|
105
|
3.75e-01
|
8.11e-01
|
0.08110
|
7.82e-02
|
-2.14e-02
|
1.66e-01
|
7.05e-01
|
GOBP POLYOL BIOSYNTHETIC PROCESS
|
62
|
5.03e-01
|
8.64e-01
|
0.08110
|
-4.40e-02
|
-6.81e-02
|
5.49e-01
|
3.54e-01
|
GOMF EXOGENOUS PROTEIN BINDING
|
79
|
4.17e-01
|
8.31e-01
|
0.08100
|
-4.53e-02
|
-6.72e-02
|
4.87e-01
|
3.02e-01
|
GOBP CELLULAR RESPONSE TO CAMP
|
49
|
5.83e-01
|
8.90e-01
|
0.08100
|
-6.97e-02
|
-4.13e-02
|
3.99e-01
|
6.17e-01
|
GOBP NEUROBLAST DIVISION
|
13
|
8.71e-01
|
9.73e-01
|
0.08100
|
7.79e-02
|
2.22e-02
|
6.27e-01
|
8.90e-01
|
GOBP OUTFLOW TRACT MORPHOGENESIS
|
82
|
4.41e-01
|
8.40e-01
|
0.08090
|
-8.09e-02
|
-1.69e-03
|
2.05e-01
|
9.79e-01
|
GOBP AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS
|
93
|
3.79e-01
|
8.14e-01
|
0.08090
|
-7.90e-02
|
-1.77e-02
|
1.88e-01
|
7.68e-01
|
GOCC SECRETORY GRANULE
|
854
|
2.21e-04
|
1.62e-02
|
0.08090
|
-8.03e-02
|
-9.66e-03
|
6.70e-05
|
6.32e-01
|
GOBP RESPONSE TO MUSCLE STRETCH
|
24
|
7.65e-01
|
9.45e-01
|
0.08090
|
6.03e-02
|
5.38e-02
|
6.09e-01
|
6.48e-01
|
GOMF ANTIGEN BINDING
|
66
|
5.07e-01
|
8.65e-01
|
0.08090
|
7.99e-02
|
1.26e-02
|
2.62e-01
|
8.59e-01
|
GOBP NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE
|
36
|
6.70e-01
|
9.11e-01
|
0.08080
|
6.16e-02
|
5.24e-02
|
5.23e-01
|
5.86e-01
|
GOBP TEMPERATURE HOMEOSTASIS
|
181
|
1.97e-01
|
6.88e-01
|
0.08080
|
-7.38e-02
|
3.31e-02
|
8.69e-02
|
4.43e-01
|
GOBP POSITIVE REGULATION OF MAP KINASE ACTIVITY
|
86
|
4.47e-01
|
8.41e-01
|
0.08080
|
-7.85e-02
|
1.93e-02
|
2.08e-01
|
7.58e-01
|
GOBP POSTSYNAPTIC SPECIALIZATION ASSEMBLY
|
26
|
7.50e-01
|
9.40e-01
|
0.08080
|
-4.57e-02
|
-6.67e-02
|
6.87e-01
|
5.56e-01
|
GOBP EPITHELIAL TUBE FORMATION
|
136
|
2.81e-01
|
7.54e-01
|
0.08080
|
-1.87e-02
|
7.86e-02
|
7.06e-01
|
1.14e-01
|
GOBP PROTEIN AUTOPHOSPHORYLATION
|
188
|
1.50e-01
|
6.36e-01
|
0.08070
|
-8.03e-02
|
-8.85e-03
|
5.77e-02
|
8.34e-01
|
GOCC FICOLIN 1 RICH GRANULE
|
180
|
1.73e-01
|
6.61e-01
|
0.08070
|
-8.06e-02
|
2.70e-03
|
6.20e-02
|
9.50e-01
|
GOBP SYNAPTIC TRANSMISSION GABAERGIC
|
56
|
6.15e-01
|
8.99e-01
|
0.08070
|
5.74e-02
|
-5.66e-02
|
4.57e-01
|
4.63e-01
|
GOBP RESPONSE TO CAMP
|
82
|
4.09e-01
|
8.27e-01
|
0.08070
|
-7.00e-02
|
-4.02e-02
|
2.73e-01
|
5.29e-01
|
GOBP POSITIVE REGULATION OF PROTEIN MATURATION
|
27
|
7.56e-01
|
9.43e-01
|
0.08070
|
-7.92e-02
|
-1.54e-02
|
4.76e-01
|
8.90e-01
|
GOBP HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS
|
52
|
5.75e-01
|
8.89e-01
|
0.08060
|
7.60e-02
|
2.69e-02
|
3.43e-01
|
7.37e-01
|
GOBP RETROGRADE TRANS SYNAPTIC SIGNALING BY LIPID
|
5
|
9.50e-01
|
9.90e-01
|
0.08060
|
-1.27e-02
|
-7.96e-02
|
9.61e-01
|
7.58e-01
|
GOMF PURINE NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
24
|
8.03e-01
|
9.57e-01
|
0.08060
|
-7.65e-02
|
2.55e-02
|
5.17e-01
|
8.29e-01
|
GOBP REGULATION OF LIPID BIOSYNTHETIC PROCESS
|
179
|
1.70e-01
|
6.57e-01
|
0.08050
|
-8.05e-02
|
-3.44e-03
|
6.33e-02
|
9.37e-01
|
GOBP MONOAMINE TRANSPORT
|
85
|
3.92e-01
|
8.22e-01
|
0.08050
|
5.59e-02
|
5.80e-02
|
3.73e-01
|
3.56e-01
|
GOBP PROTEIN DEUBIQUITINATION INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS
|
5
|
9.56e-01
|
9.90e-01
|
0.08050
|
7.28e-02
|
-3.45e-02
|
7.78e-01
|
8.94e-01
|
GOBP CELLULAR RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR STIMULUS
|
13
|
8.71e-01
|
9.73e-01
|
0.08050
|
-7.57e-02
|
-2.75e-02
|
6.37e-01
|
8.64e-01
|
GOBP AMIDE METABOLIC PROCESS
|
1222
|
4.09e-06
|
8.51e-04
|
0.08050
|
-3.28e-02
|
-7.35e-02
|
5.38e-02
|
1.52e-05
|
GOBP LYMPHOCYTE HOMEOSTASIS
|
72
|
5.27e-01
|
8.72e-01
|
0.08040
|
-3.48e-02
|
7.25e-02
|
6.10e-01
|
2.87e-01
|
GOBP MONOATOMIC CATION TRANSMEMBRANE TRANSPORT
|
814
|
3.44e-04
|
2.33e-02
|
0.08030
|
1.22e-02
|
7.94e-02
|
5.55e-01
|
1.18e-04
|
GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION
|
49
|
6.07e-01
|
8.97e-01
|
0.08020
|
1.46e-02
|
7.89e-02
|
8.60e-01
|
3.39e-01
|
GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION
|
357
|
3.93e-02
|
4.06e-01
|
0.08020
|
-7.76e-02
|
2.04e-02
|
1.18e-02
|
5.07e-01
|
GOBP NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH
|
12
|
8.90e-01
|
9.76e-01
|
0.08020
|
-8.01e-02
|
3.10e-03
|
6.31e-01
|
9.85e-01
|
GOBP SPINAL CORD PATTERNING
|
21
|
8.03e-01
|
9.57e-01
|
0.08020
|
2.43e-02
|
7.64e-02
|
8.47e-01
|
5.44e-01
|
GOMF XENOBIOTIC TRANSMEMBRANE TRANSPORTER ACTIVITY
|
37
|
6.84e-01
|
9.17e-01
|
0.08020
|
-1.66e-02
|
-7.84e-02
|
8.61e-01
|
4.09e-01
|
GOMF MINUS END DIRECTED MICROTUBULE MOTOR ACTIVITY
|
17
|
8.58e-01
|
9.68e-01
|
0.08010
|
2.80e-02
|
-7.50e-02
|
8.42e-01
|
5.92e-01
|
GOMF TYPE 5 METABOTROPIC GLUTAMATE RECEPTOR BINDING
|
6
|
9.37e-01
|
9.87e-01
|
0.08010
|
-5.92e-02
|
-5.39e-02
|
8.02e-01
|
8.19e-01
|
GOBP ECTOPIC GERM CELL PROGRAMMED CELL DEATH
|
17
|
8.47e-01
|
9.66e-01
|
0.08000
|
-9.63e-05
|
8.00e-02
|
9.99e-01
|
5.68e-01
|
GOBP POSITIVE REGULATION OF FATTY ACID BETA OXIDATION
|
10
|
9.15e-01
|
9.83e-01
|
0.08000
|
-3.27e-02
|
7.30e-02
|
8.58e-01
|
6.89e-01
|
GOBP GLIAL CELL APOPTOTIC PROCESS
|
15
|
8.70e-01
|
9.73e-01
|
0.08000
|
-7.87e-02
|
1.47e-02
|
5.98e-01
|
9.21e-01
|
GOBP GERM CELL PROLIFERATION
|
10
|
9.12e-01
|
9.82e-01
|
0.08000
|
-7.82e-02
|
1.72e-02
|
6.69e-01
|
9.25e-01
|
GOBP ADULT FEEDING BEHAVIOR
|
9
|
9.18e-01
|
9.83e-01
|
0.08000
|
-7.97e-02
|
7.21e-03
|
6.79e-01
|
9.70e-01
|
GOCC ATAC COMPLEX
|
13
|
8.91e-01
|
9.76e-01
|
0.08000
|
-3.33e-02
|
7.28e-02
|
8.35e-01
|
6.50e-01
|
GOBP IMMATURE T CELL PROLIFERATION
|
12
|
8.77e-01
|
9.75e-01
|
0.08000
|
5.00e-02
|
6.25e-02
|
7.64e-01
|
7.08e-01
|
GOBP REGULATION OF DNA METABOLIC PROCESS
|
506
|
5.12e-03
|
1.48e-01
|
0.08000
|
-7.21e-02
|
-3.48e-02
|
5.52e-03
|
1.81e-01
|
GOBP REGULATION OF CANONICAL WNT SIGNALING PATHWAY
|
249
|
9.76e-02
|
5.62e-01
|
0.08000
|
-9.98e-03
|
7.94e-02
|
7.86e-01
|
3.10e-02
|
GOBP REGULATION OF COMPLEMENT DEPENDENT CYTOTOXICITY
|
11
|
8.89e-01
|
9.76e-01
|
0.08000
|
-3.76e-02
|
-7.06e-02
|
8.29e-01
|
6.85e-01
|
GOCC RUFFLE MEMBRANE
|
99
|
4.15e-01
|
8.30e-01
|
0.08000
|
-2.99e-02
|
7.42e-02
|
6.07e-01
|
2.02e-01
|
GOBP CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES
|
269
|
5.52e-02
|
4.63e-01
|
0.07990
|
5.80e-02
|
5.50e-02
|
1.02e-01
|
1.20e-01
|
GOBP NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS
|
1210
|
2.77e-05
|
3.54e-03
|
0.07990
|
-7.76e-02
|
1.92e-02
|
5.51e-06
|
2.60e-01
|
GOBP POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS
|
20
|
8.35e-01
|
9.64e-01
|
0.07990
|
-2.33e-02
|
7.64e-02
|
8.57e-01
|
5.54e-01
|
GOCC EXTRINSIC COMPONENT OF CYTOPLASMIC SIDE OF PLASMA MEMBRANE
|
69
|
5.41e-01
|
8.78e-01
|
0.07990
|
-2.81e-02
|
7.48e-02
|
6.86e-01
|
2.83e-01
|
GOBP AMINO ACID CATABOLIC PROCESS
|
108
|
3.44e-01
|
7.95e-01
|
0.07980
|
-7.74e-03
|
-7.95e-02
|
8.89e-01
|
1.54e-01
|
GOBP ALCOHOL CATABOLIC PROCESS
|
33
|
7.41e-01
|
9.36e-01
|
0.07980
|
7.72e-02
|
-2.04e-02
|
4.43e-01
|
8.39e-01
|
GOBP AZOLE TRANSMEMBRANE TRANSPORT
|
13
|
8.71e-01
|
9.73e-01
|
0.07980
|
-3.47e-02
|
-7.19e-02
|
8.28e-01
|
6.54e-01
|
GOMF PEPTIDASE ACTIVATOR ACTIVITY
|
51
|
6.06e-01
|
8.97e-01
|
0.07980
|
-5.28e-03
|
-7.96e-02
|
9.48e-01
|
3.25e-01
|
GOBP NEGATIVE REGULATION OF DNA REPLICATION
|
24
|
8.01e-01
|
9.57e-01
|
0.07980
|
-7.84e-02
|
1.46e-02
|
5.06e-01
|
9.02e-01
|
GOBP CELLULAR RESPONSE TO HYDROGEN PEROXIDE
|
65
|
5.68e-01
|
8.86e-01
|
0.07980
|
-7.08e-02
|
3.67e-02
|
3.23e-01
|
6.09e-01
|
GOBP RECEPTOR RECYCLING
|
46
|
6.24e-01
|
9.01e-01
|
0.07980
|
-7.69e-02
|
-2.11e-02
|
3.67e-01
|
8.05e-01
|
GOBP REGULATION OF CELL CYCLE PHASE TRANSITION
|
438
|
9.55e-03
|
2.08e-01
|
0.07980
|
-6.16e-02
|
-5.07e-02
|
2.71e-02
|
6.91e-02
|
GOBP REGULATION OF CELL ADHESION
|
772
|
6.14e-04
|
3.72e-02
|
0.07970
|
8.42e-03
|
7.93e-02
|
6.90e-01
|
1.78e-04
|
GOBP POLYOL METABOLIC PROCESS
|
103
|
3.57e-01
|
7.99e-01
|
0.07970
|
-7.87e-02
|
-1.28e-02
|
1.68e-01
|
8.22e-01
|
GOBP POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION
|
60
|
5.79e-01
|
8.90e-01
|
0.07970
|
-7.73e-02
|
1.93e-02
|
3.00e-01
|
7.96e-01
|
GOBP RETROGRADE TRANSPORT VESICLE RECYCLING WITHIN GOLGI
|
9
|
9.09e-01
|
9.81e-01
|
0.07970
|
-7.02e-02
|
-3.78e-02
|
7.15e-01
|
8.44e-01
|
GOCC ENVELOPE
|
1185
|
5.26e-06
|
9.45e-04
|
0.07970
|
-5.88e-02
|
-5.38e-02
|
6.51e-04
|
1.80e-03
|
GOBP CELLULAR RESPONSE TO STRESS
|
1866
|
2.94e-08
|
2.31e-05
|
0.07970
|
-7.79e-02
|
-1.67e-02
|
2.43e-08
|
2.31e-01
|
GOBP NEGATIVE REGULATION OF DNA TEMPLATED DNA REPLICATION
|
9
|
9.13e-01
|
9.82e-01
|
0.07970
|
-7.76e-02
|
-1.79e-02
|
6.87e-01
|
9.26e-01
|
GOBP POSITIVE REGULATION OF LIPID METABOLIC PROCESS
|
139
|
3.08e-01
|
7.72e-01
|
0.07970
|
-6.27e-02
|
4.91e-02
|
2.02e-01
|
3.17e-01
|
GOBP GLUTAMATE METABOLIC PROCESS
|
32
|
7.19e-01
|
9.29e-01
|
0.07960
|
-7.59e-02
|
-2.41e-02
|
4.57e-01
|
8.13e-01
|
GOBP POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS
|
198
|
1.40e-01
|
6.23e-01
|
0.07960
|
-7.86e-02
|
-1.29e-02
|
5.66e-02
|
7.53e-01
|
GOCC CHYLOMICRON
|
12
|
8.90e-01
|
9.76e-01
|
0.07960
|
-3.00e-03
|
-7.95e-02
|
9.86e-01
|
6.33e-01
|
GOMF ACID AMINO ACID LIGASE ACTIVITY
|
23
|
7.81e-01
|
9.52e-01
|
0.07960
|
-6.38e-02
|
-4.76e-02
|
5.96e-01
|
6.93e-01
|
GOCC PORE COMPLEX
|
24
|
8.14e-01
|
9.59e-01
|
0.07960
|
4.15e-02
|
-6.79e-02
|
7.25e-01
|
5.65e-01
|
GOBP POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION
|
12
|
8.94e-01
|
9.77e-01
|
0.07950
|
-9.18e-03
|
7.90e-02
|
9.56e-01
|
6.36e-01
|
GOBP CARDIAC CELL DEVELOPMENT
|
92
|
4.01e-01
|
8.26e-01
|
0.07950
|
1.19e-02
|
7.86e-02
|
8.44e-01
|
1.92e-01
|
GOBP SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT
|
22
|
8.23e-01
|
9.61e-01
|
0.07950
|
7.47e-02
|
-2.72e-02
|
5.44e-01
|
8.25e-01
|
GOBP NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS
|
8
|
9.31e-01
|
9.86e-01
|
0.07950
|
7.63e-02
|
-2.25e-02
|
7.09e-01
|
9.12e-01
|
GOCC PROTEIN KINASE COMPLEX
|
135
|
2.51e-01
|
7.29e-01
|
0.07950
|
-7.59e-02
|
-2.38e-02
|
1.28e-01
|
6.33e-01
|
GOBP ASSOCIATIVE LEARNING
|
84
|
4.11e-01
|
8.28e-01
|
0.07950
|
3.89e-02
|
6.94e-02
|
5.38e-01
|
2.72e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY
|
76
|
4.97e-01
|
8.60e-01
|
0.07950
|
-1.33e-02
|
7.84e-02
|
8.42e-01
|
2.37e-01
|
GOBP ACTIN MEDIATED CELL CONTRACTION
|
101
|
3.47e-01
|
7.96e-01
|
0.07950
|
7.16e-02
|
3.45e-02
|
2.14e-01
|
5.49e-01
|
GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY
|
1139
|
1.49e-05
|
2.12e-03
|
0.07940
|
7.55e-02
|
2.46e-02
|
1.71e-05
|
1.62e-01
|
GOBP POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION
|
52
|
5.94e-01
|
8.94e-01
|
0.07940
|
1.54e-02
|
7.79e-02
|
8.48e-01
|
3.31e-01
|
GOBP RIBONUCLEOPROTEIN COMPLEX LOCALIZATION
|
9
|
9.27e-01
|
9.85e-01
|
0.07940
|
-6.00e-02
|
5.20e-02
|
7.55e-01
|
7.87e-01
|
GOBP PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT
|
17
|
8.56e-01
|
9.68e-01
|
0.07940
|
-7.79e-02
|
1.56e-02
|
5.78e-01
|
9.12e-01
|
GOBP ENTRY INTO HOST
|
159
|
2.26e-01
|
7.14e-01
|
0.07940
|
-7.91e-02
|
6.09e-03
|
8.51e-02
|
8.94e-01
|
GOBP IMMUNOGLOBULIN PRODUCTION
|
103
|
3.75e-01
|
8.11e-01
|
0.07940
|
-7.94e-02
|
6.91e-04
|
1.64e-01
|
9.90e-01
|
GOBP CHROMOSOME SEGREGATION
|
405
|
1.66e-02
|
2.74e-01
|
0.07930
|
-7.45e-02
|
-2.69e-02
|
1.00e-02
|
3.52e-01
|
GOBP POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE
|
19
|
8.17e-01
|
9.60e-01
|
0.07920
|
4.76e-02
|
6.33e-02
|
7.19e-01
|
6.33e-01
|
GOBP PEPTIDYL AMINO ACID MODIFICATION
|
889
|
7.48e-04
|
4.27e-02
|
0.07920
|
-6.25e-02
|
4.87e-02
|
1.57e-03
|
1.37e-02
|
GOBP POSITIVE REGULATION OF WOUND HEALING
|
61
|
5.22e-01
|
8.70e-01
|
0.07920
|
-6.12e-02
|
-5.03e-02
|
4.08e-01
|
4.97e-01
|
GOMF NEUTRAL L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY
|
44
|
6.39e-01
|
9.06e-01
|
0.07920
|
2.27e-02
|
7.59e-02
|
7.95e-01
|
3.84e-01
|
GOBP REGULATION OF OSTEOCLAST DIFFERENTIATION
|
68
|
5.42e-01
|
8.78e-01
|
0.07920
|
-7.71e-02
|
1.82e-02
|
2.72e-01
|
7.95e-01
|
GOBP MITOTIC NUCLEAR DIVISION
|
270
|
5.80e-02
|
4.69e-01
|
0.07920
|
-6.18e-02
|
-4.95e-02
|
8.03e-02
|
1.62e-01
|
GOBP RESPONSE TO ALKALOID
|
90
|
4.45e-01
|
8.40e-01
|
0.07920
|
-1.75e-02
|
7.72e-02
|
7.74e-01
|
2.05e-01
|
GOBP MUSCLE ATROPHY
|
10
|
9.09e-01
|
9.81e-01
|
0.07920
|
7.92e-02
|
1.21e-03
|
6.65e-01
|
9.95e-01
|
GOMF MOLECULAR ADAPTOR ACTIVITY
|
547
|
9.90e-03
|
2.11e-01
|
0.07920
|
-7.16e-02
|
3.38e-02
|
4.17e-03
|
1.77e-01
|
GOBP REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION
|
57
|
5.62e-01
|
8.84e-01
|
0.07910
|
2.22e-02
|
7.59e-02
|
7.71e-01
|
3.21e-01
|
GOBP CELLULAR HOMEOSTASIS
|
781
|
1.64e-03
|
7.35e-02
|
0.07910
|
-4.04e-02
|
6.80e-02
|
5.49e-02
|
1.22e-03
|
GOBP REGULATION OF MACROPHAGE ACTIVATION
|
60
|
5.87e-01
|
8.91e-01
|
0.07910
|
7.60e-02
|
-2.18e-02
|
3.09e-01
|
7.70e-01
|
GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY
|
107
|
4.08e-01
|
8.27e-01
|
0.07900
|
-6.46e-02
|
4.55e-02
|
2.48e-01
|
4.17e-01
|
GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION
|
57
|
6.01e-01
|
8.96e-01
|
0.07900
|
-1.95e-02
|
7.66e-02
|
7.99e-01
|
3.17e-01
|
GOBP POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT
|
204
|
1.32e-01
|
6.13e-01
|
0.07900
|
1.81e-02
|
7.69e-02
|
6.55e-01
|
5.84e-02
|
GOBP MAINTENANCE OF LOCATION
|
335
|
6.39e-02
|
4.87e-01
|
0.07890
|
-5.41e-02
|
5.75e-02
|
8.87e-02
|
7.07e-02
|
GOBP RESPONSE TO LEUKEMIA INHIBITORY FACTOR
|
101
|
3.49e-01
|
7.96e-01
|
0.07890
|
-3.98e-02
|
-6.81e-02
|
4.89e-01
|
2.37e-01
|
GOBP PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS
|
7
|
9.30e-01
|
9.86e-01
|
0.07890
|
3.35e-02
|
7.14e-02
|
8.78e-01
|
7.44e-01
|
GOBP PRIMITIVE STREAK FORMATION
|
10
|
9.13e-01
|
9.82e-01
|
0.07890
|
7.81e-02
|
-1.14e-02
|
6.69e-01
|
9.50e-01
|
GOBP CANONICAL WNT SIGNALING PATHWAY
|
302
|
5.50e-02
|
4.63e-01
|
0.07880
|
9.57e-03
|
7.83e-02
|
7.75e-01
|
1.93e-02
|
GOMF PHOSPHATASE BINDING
|
184
|
2.11e-01
|
7.00e-01
|
0.07880
|
-3.53e-02
|
7.04e-02
|
4.08e-01
|
9.95e-02
|
GOBP TISSUE HOMEOSTASIS
|
264
|
8.36e-02
|
5.37e-01
|
0.07880
|
2.33e-03
|
7.87e-02
|
9.48e-01
|
2.76e-02
|
GOCC AXONEMAL MICROTUBULE
|
38
|
7.11e-01
|
9.27e-01
|
0.07880
|
1.58e-02
|
-7.71e-02
|
8.66e-01
|
4.11e-01
|
GOMF MICROTUBULE PLUS END BINDING
|
21
|
8.14e-01
|
9.59e-01
|
0.07870
|
-7.77e-02
|
-1.29e-02
|
5.38e-01
|
9.18e-01
|
GOBP REGULATION OF MONOATOMIC ANION TRANSMEMBRANE TRANSPORT
|
8
|
9.35e-01
|
9.87e-01
|
0.07870
|
4.48e-02
|
-6.47e-02
|
8.26e-01
|
7.51e-01
|
GOCC MITOCHONDRION
|
1572
|
2.10e-07
|
1.02e-04
|
0.07870
|
-4.78e-02
|
-6.25e-02
|
1.57e-03
|
3.50e-05
|
GOBP NEGATIVE REGULATION OF CELL CYCLE PROCESS
|
307
|
4.42e-02
|
4.29e-01
|
0.07870
|
-3.37e-02
|
-7.11e-02
|
3.10e-01
|
3.22e-02
|
GOCC CHROMOSOME CENTROMERIC REGION
|
242
|
8.00e-02
|
5.28e-01
|
0.07870
|
-5.28e-02
|
-5.83e-02
|
1.57e-01
|
1.18e-01
|
GOBP NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE
|
18
|
8.29e-01
|
9.63e-01
|
0.07860
|
-4.01e-02
|
-6.76e-02
|
7.68e-01
|
6.19e-01
|
GOBP REGULATION OF RESPONSE TO CYTOKINE STIMULUS
|
175
|
2.14e-01
|
7.03e-01
|
0.07860
|
1.80e-02
|
-7.65e-02
|
6.81e-01
|
8.09e-02
|
GOBP MITOTIC CELL CYCLE PROCESS
|
748
|
6.71e-04
|
3.96e-02
|
0.07860
|
-7.40e-02
|
-2.62e-02
|
5.66e-04
|
2.22e-01
|
GOBP VASCULAR PROCESS IN CIRCULATORY SYSTEM
|
260
|
9.69e-02
|
5.61e-01
|
0.07850
|
-1.07e-02
|
7.78e-02
|
7.67e-01
|
3.08e-02
|
GOBP POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION
|
17
|
8.41e-01
|
9.66e-01
|
0.07850
|
3.13e-02
|
7.20e-02
|
8.23e-01
|
6.07e-01
|
GOBP FOREBRAIN NEURON DEVELOPMENT
|
23
|
7.87e-01
|
9.53e-01
|
0.07850
|
-6.60e-02
|
-4.25e-02
|
5.84e-01
|
7.24e-01
|
GOBP VIRAL GENE EXPRESSION
|
99
|
3.77e-01
|
8.13e-01
|
0.07850
|
-7.63e-02
|
-1.84e-02
|
1.89e-01
|
7.52e-01
|
GOCC DESMOSOME
|
25
|
8.12e-01
|
9.59e-01
|
0.07850
|
6.60e-02
|
-4.24e-02
|
5.68e-01
|
7.13e-01
|
GOMF PDZ DOMAIN BINDING
|
84
|
4.98e-01
|
8.61e-01
|
0.07850
|
-4.32e-02
|
6.56e-02
|
4.94e-01
|
2.99e-01
|
GOBP REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION
|
109
|
3.59e-01
|
8.01e-01
|
0.07850
|
2.16e-03
|
7.85e-02
|
9.69e-01
|
1.57e-01
|
GOBP NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC
|
107
|
3.44e-01
|
7.95e-01
|
0.07850
|
-7.51e-02
|
-2.30e-02
|
1.80e-01
|
6.82e-01
|
GOBP REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY
|
233
|
1.31e-01
|
6.11e-01
|
0.07850
|
-1.98e-02
|
7.59e-02
|
6.03e-01
|
4.58e-02
|
GOBP EPIDERMAL CELL DIFFERENTIATION
|
240
|
9.16e-02
|
5.51e-01
|
0.07850
|
7.42e-02
|
2.56e-02
|
4.78e-02
|
4.94e-01
|
GOBP LOCALIZATION WITHIN MEMBRANE
|
653
|
5.36e-03
|
1.52e-01
|
0.07850
|
-5.99e-02
|
5.07e-02
|
9.04e-03
|
2.71e-02
|
GOBP POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION
|
62
|
5.56e-01
|
8.81e-01
|
0.07840
|
7.83e-02
|
4.87e-03
|
2.86e-01
|
9.47e-01
|
GOMF ATP DEPENDENT ACTIVITY
|
550
|
3.79e-03
|
1.25e-01
|
0.07840
|
-6.60e-02
|
-4.24e-02
|
8.10e-03
|
8.93e-02
|
GOMF HYALURONONGLUCOSAMINIDASE ACTIVITY
|
8
|
9.20e-01
|
9.84e-01
|
0.07840
|
-5.97e-02
|
-5.09e-02
|
7.70e-01
|
8.03e-01
|
GOBP EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS
|
93
|
4.28e-01
|
8.36e-01
|
0.07840
|
-7.81e-02
|
7.19e-03
|
1.93e-01
|
9.05e-01
|
GOBP GLYCOSIDE METABOLIC PROCESS
|
20
|
8.48e-01
|
9.66e-01
|
0.07840
|
5.11e-02
|
-5.95e-02
|
6.93e-01
|
6.45e-01
|
GOBP FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE
|
12
|
8.91e-01
|
9.76e-01
|
0.07840
|
-7.79e-02
|
-9.37e-03
|
6.41e-01
|
9.55e-01
|
GOCC PLASMA MEMBRANE RAFT
|
112
|
3.12e-01
|
7.76e-01
|
0.07840
|
4.76e-02
|
6.23e-02
|
3.84e-01
|
2.55e-01
|
GOCC BASAL PART OF CELL
|
291
|
9.23e-02
|
5.54e-01
|
0.07840
|
-4.42e-02
|
6.48e-02
|
1.95e-01
|
5.74e-02
|
GOBP REGULATION OF PROTEIN MATURATION
|
67
|
4.98e-01
|
8.61e-01
|
0.07840
|
-4.61e-02
|
-6.34e-02
|
5.14e-01
|
3.70e-01
|
GOBP CELL CYCLE PHASE TRANSITION
|
550
|
3.72e-03
|
1.24e-01
|
0.07840
|
-6.29e-02
|
-4.68e-02
|
1.17e-02
|
6.06e-02
|
GOBP GLIAL CELL ACTIVATION
|
57
|
5.86e-01
|
8.90e-01
|
0.07830
|
-7.83e-02
|
-2.23e-03
|
3.07e-01
|
9.77e-01
|
GOMF POTASSIUM ION LEAK CHANNEL ACTIVITY
|
16
|
8.46e-01
|
9.66e-01
|
0.07830
|
5.92e-02
|
5.13e-02
|
6.82e-01
|
7.22e-01
|
GOCC CATALYTIC COMPLEX
|
1609
|
2.96e-07
|
1.17e-04
|
0.07830
|
-7.33e-02
|
-2.74e-02
|
9.28e-07
|
6.65e-02
|
GOBP POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS
|
109
|
4.10e-01
|
8.27e-01
|
0.07830
|
-5.91e-02
|
5.14e-02
|
2.87e-01
|
3.54e-01
|
GOBP GLIOGENESIS
|
328
|
6.70e-02
|
4.98e-01
|
0.07830
|
-6.83e-02
|
3.82e-02
|
3.34e-02
|
2.34e-01
|
GOBP NEGATIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT
|
6
|
9.50e-01
|
9.90e-01
|
0.07830
|
3.20e-02
|
-7.14e-02
|
8.92e-01
|
7.62e-01
|
GOBP TYROSINE PHOSPHORYLATION OF STAT PROTEIN
|
81
|
4.31e-01
|
8.37e-01
|
0.07830
|
-5.20e-02
|
-5.85e-02
|
4.19e-01
|
3.63e-01
|
GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION
|
12
|
9.06e-01
|
9.81e-01
|
0.07830
|
-5.42e-02
|
5.64e-02
|
7.45e-01
|
7.35e-01
|
GOBP RESPONSE TO DEXAMETHASONE
|
38
|
7.26e-01
|
9.30e-01
|
0.07820
|
7.08e-02
|
-3.34e-02
|
4.50e-01
|
7.22e-01
|
GOBP RIG I SIGNALING PATHWAY
|
27
|
7.80e-01
|
9.51e-01
|
0.07820
|
-7.82e-02
|
2.86e-03
|
4.82e-01
|
9.79e-01
|
GOBP PROTEIN UFMYLATION
|
6
|
9.41e-01
|
9.89e-01
|
0.07820
|
3.19e-02
|
7.15e-02
|
8.92e-01
|
7.62e-01
|
GOBP COMMISSURAL NEURON AXON GUIDANCE
|
12
|
8.82e-01
|
9.75e-01
|
0.07820
|
-5.49e-02
|
-5.57e-02
|
7.42e-01
|
7.38e-01
|
GOBP REGULATION OF MEMBRANE REPOLARIZATION
|
36
|
6.96e-01
|
9.21e-01
|
0.07820
|
2.82e-02
|
7.30e-02
|
7.70e-01
|
4.49e-01
|
GOBP REGULATION OF TRANSPORTER ACTIVITY
|
253
|
1.03e-01
|
5.74e-01
|
0.07820
|
-7.20e-03
|
7.79e-02
|
8.44e-01
|
3.29e-02
|
GOBP NEUROINFLAMMATORY RESPONSE
|
82
|
4.28e-01
|
8.36e-01
|
0.07820
|
-6.35e-02
|
-4.56e-02
|
3.20e-01
|
4.75e-01
|
GOBP PEPTIDE METABOLIC PROCESS
|
929
|
1.71e-04
|
1.38e-02
|
0.07810
|
-1.60e-02
|
-7.65e-02
|
4.09e-01
|
7.73e-05
|
GOBP REGULATION OF EPIDERMIS DEVELOPMENT
|
66
|
5.63e-01
|
8.84e-01
|
0.07810
|
-7.55e-02
|
2.00e-02
|
2.89e-01
|
7.79e-01
|
GOBP REGULATION OF MORPHOGENESIS OF AN EPITHELIUM
|
62
|
5.26e-01
|
8.71e-01
|
0.07810
|
5.90e-02
|
5.11e-02
|
4.21e-01
|
4.86e-01
|
GOBP PROTEIN LOCALIZATION TO SYNAPSE
|
73
|
5.37e-01
|
8.78e-01
|
0.07800
|
-7.33e-02
|
2.68e-02
|
2.79e-01
|
6.92e-01
|
GOCC PROTEIN PHOSPHATASE TYPE 1 COMPLEX
|
18
|
8.32e-01
|
9.64e-01
|
0.07800
|
6.66e-02
|
4.06e-02
|
6.25e-01
|
7.66e-01
|
GOMF HYDROLASE ACTIVITY HYDROLYZING N GLYCOSYL COMPOUNDS
|
37
|
6.97e-01
|
9.21e-01
|
0.07800
|
7.59e-02
|
1.81e-02
|
4.25e-01
|
8.49e-01
|
GOBP PROTEIN LOCALIZATION TO EXTRACELLULAR REGION
|
364
|
4.99e-02
|
4.43e-01
|
0.07800
|
-7.01e-02
|
3.42e-02
|
2.16e-02
|
2.63e-01
|
GOBP RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE
|
18
|
8.57e-01
|
9.68e-01
|
0.07800
|
2.42e-02
|
-7.41e-02
|
8.59e-01
|
5.86e-01
|
GOBP ZYMOGEN ACTIVATION
|
57
|
5.55e-01
|
8.81e-01
|
0.07800
|
-4.82e-02
|
-6.13e-02
|
5.29e-01
|
4.23e-01
|
GOBP REGULATION OF PROTEIN DEACETYLATION
|
31
|
7.25e-01
|
9.30e-01
|
0.07800
|
-5.78e-02
|
-5.23e-02
|
5.77e-01
|
6.14e-01
|
GOBP ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS
|
1213
|
4.12e-05
|
4.68e-03
|
0.07800
|
-1.58e-02
|
7.63e-02
|
3.53e-01
|
7.57e-06
|
GOBP RECEPTOR METABOLIC PROCESS
|
71
|
5.18e-01
|
8.69e-01
|
0.07800
|
-7.79e-02
|
-2.00e-03
|
2.56e-01
|
9.77e-01
|
GOBP MOTOR NEURON AXON GUIDANCE
|
23
|
8.28e-01
|
9.62e-01
|
0.07790
|
-6.47e-02
|
4.35e-02
|
5.91e-01
|
7.18e-01
|
GOBP REGULATION OF CELL CYCLE PROCESS
|
712
|
9.58e-04
|
5.00e-02
|
0.07790
|
-7.08e-02
|
-3.24e-02
|
1.28e-03
|
1.41e-01
|
GOBP ACTIN FILAMENT BASED TRANSPORT
|
21
|
8.19e-01
|
9.60e-01
|
0.07790
|
1.03e-02
|
7.72e-02
|
9.35e-01
|
5.40e-01
|
GOCC M BAND
|
21
|
8.08e-01
|
9.59e-01
|
0.07780
|
3.61e-02
|
6.89e-02
|
7.74e-01
|
5.84e-01
|
GOMF PEPTIDE HORMONE BINDING
|
48
|
6.78e-01
|
9.14e-01
|
0.07780
|
5.57e-02
|
-5.44e-02
|
5.05e-01
|
5.15e-01
|
GOBP REGULATION OF MUSCLE TISSUE DEVELOPMENT
|
45
|
6.83e-01
|
9.17e-01
|
0.07780
|
7.28e-02
|
-2.75e-02
|
3.98e-01
|
7.49e-01
|
GOBP MYELOID LEUKOCYTE DIFFERENTIATION
|
227
|
1.62e-01
|
6.48e-01
|
0.07780
|
-5.82e-02
|
5.16e-02
|
1.31e-01
|
1.80e-01
|
GOMF NEUROPEPTIDE RECEPTOR ACTIVITY
|
43
|
6.77e-01
|
9.14e-01
|
0.07780
|
4.49e-03
|
-7.77e-02
|
9.59e-01
|
3.78e-01
|
GOBP REGULATION OF RESPIRATORY BURST
|
15
|
8.75e-01
|
9.75e-01
|
0.07780
|
-7.69e-02
|
1.14e-02
|
6.06e-01
|
9.39e-01
|
GOBP STEROID BIOSYNTHETIC PROCESS
|
177
|
1.64e-01
|
6.48e-01
|
0.07780
|
-5.92e-02
|
-5.04e-02
|
1.74e-01
|
2.48e-01
|
GOBP NUCLEAR CHROMOSOME SEGREGATION
|
306
|
4.70e-02
|
4.37e-01
|
0.07770
|
-6.82e-02
|
-3.74e-02
|
4.03e-02
|
2.61e-01
|
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL
|
42
|
6.66e-01
|
9.11e-01
|
0.07770
|
-7.54e-02
|
-1.88e-02
|
3.98e-01
|
8.33e-01
|
GOBP REGULATED EXOCYTOSIS
|
213
|
1.81e-01
|
6.71e-01
|
0.07770
|
-4.89e-02
|
6.04e-02
|
2.19e-01
|
1.29e-01
|
GOBP SOMATIC STEM CELL POPULATION MAINTENANCE
|
65
|
5.23e-01
|
8.70e-01
|
0.07750
|
-7.01e-02
|
-3.30e-02
|
3.28e-01
|
6.45e-01
|
GOBP REGULATION OF DENDRITIC CELL DIFFERENTIATION
|
13
|
8.77e-01
|
9.75e-01
|
0.07750
|
-3.89e-02
|
-6.71e-02
|
8.08e-01
|
6.75e-01
|
GOBP REGULATION OF PEPTIDYL LYSINE ACETYLATION
|
28
|
7.91e-01
|
9.54e-01
|
0.07750
|
-7.24e-02
|
2.75e-02
|
5.07e-01
|
8.01e-01
|
GOBP NEGATIVE REGULATION OF NOREPINEPHRINE SECRETION
|
5
|
9.54e-01
|
9.90e-01
|
0.07750
|
8.64e-03
|
7.70e-02
|
9.73e-01
|
7.66e-01
|
GOBP REGULATION OF CELL DIVISION
|
177
|
2.29e-01
|
7.18e-01
|
0.07750
|
-7.21e-02
|
2.83e-02
|
9.79e-02
|
5.16e-01
|
GOBP BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS
|
36
|
7.37e-01
|
9.35e-01
|
0.07750
|
-7.36e-02
|
2.43e-02
|
4.45e-01
|
8.01e-01
|
GOBP HISTONE MRNA CATABOLIC PROCESS
|
15
|
8.58e-01
|
9.68e-01
|
0.07750
|
-6.06e-02
|
-4.83e-02
|
6.85e-01
|
7.46e-01
|
GOMF UDP GLYCOSYLTRANSFERASE ACTIVITY
|
140
|
3.13e-01
|
7.76e-01
|
0.07740
|
-7.14e-02
|
3.00e-02
|
1.45e-01
|
5.41e-01
|
GOBP REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE
|
184
|
1.78e-01
|
6.67e-01
|
0.07740
|
-7.65e-02
|
-1.20e-02
|
7.35e-02
|
7.79e-01
|
GOBP POSITIVE REGULATION OF PROTEIN ACETYLATION
|
24
|
7.98e-01
|
9.56e-01
|
0.07740
|
-1.09e-02
|
-7.67e-02
|
9.26e-01
|
5.16e-01
|
GOMF CYTOSKELETAL PROTEIN BINDING
|
945
|
6.18e-04
|
3.72e-02
|
0.07740
|
-3.83e-02
|
6.72e-02
|
4.61e-02
|
4.60e-04
|
GOMF DNA BINDING TRANSCRIPTION FACTOR BINDING
|
450
|
1.76e-02
|
2.83e-01
|
0.07740
|
-7.74e-02
|
-1.83e-03
|
4.90e-03
|
9.47e-01
|
GOCC NEUROMUSCULAR JUNCTION
|
73
|
5.41e-01
|
8.78e-01
|
0.07740
|
-2.45e-02
|
7.34e-02
|
7.18e-01
|
2.78e-01
|
GOCC PLATELET ALPHA GRANULE
|
82
|
4.93e-01
|
8.58e-01
|
0.07740
|
-1.60e-02
|
7.57e-02
|
8.02e-01
|
2.36e-01
|
GOBP ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS
|
52
|
6.13e-01
|
8.98e-01
|
0.07740
|
7.64e-02
|
1.21e-02
|
3.41e-01
|
8.80e-01
|
GOBP EMBRYONIC FORELIMB MORPHOGENESIS
|
33
|
7.27e-01
|
9.31e-01
|
0.07730
|
-7.43e-02
|
-2.15e-02
|
4.60e-01
|
8.30e-01
|
GOBP C21 STEROID HORMONE BIOSYNTHETIC PROCESS
|
20
|
8.16e-01
|
9.59e-01
|
0.07730
|
-5.14e-02
|
-5.78e-02
|
6.91e-01
|
6.55e-01
|
GOBP PROTEIN DEPHOSPHORYLATION
|
194
|
2.02e-01
|
6.92e-01
|
0.07730
|
-2.92e-02
|
7.16e-02
|
4.83e-01
|
8.57e-02
|
GOBP REGULATION OF SODIUM ION TRANSPORT
|
79
|
5.00e-01
|
8.62e-01
|
0.07730
|
-9.90e-03
|
7.66e-02
|
8.79e-01
|
2.39e-01
|
GOBP REGULATION OF GLUCOSE METABOLIC PROCESS
|
98
|
4.49e-01
|
8.43e-01
|
0.07730
|
-6.89e-02
|
3.49e-02
|
2.38e-01
|
5.50e-01
|
GOBP REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III
|
28
|
7.74e-01
|
9.49e-01
|
0.07730
|
-7.72e-02
|
-2.75e-03
|
4.79e-01
|
9.80e-01
|
GOBP OSSIFICATION
|
424
|
3.27e-02
|
3.69e-01
|
0.07730
|
-6.96e-02
|
3.35e-02
|
1.39e-02
|
2.37e-01
|
GOBP MODIFIED AMINO ACID TRANSPORT
|
47
|
6.37e-01
|
9.06e-01
|
0.07720
|
7.46e-02
|
2.00e-02
|
3.76e-01
|
8.13e-01
|
GOBP ADAPTIVE IMMUNE RESPONSE
|
444
|
1.21e-02
|
2.36e-01
|
0.07720
|
6.12e-02
|
4.71e-02
|
2.71e-02
|
8.87e-02
|
GOBP NEGATIVE REGULATION OF TOR SIGNALING
|
71
|
4.89e-01
|
8.57e-01
|
0.07720
|
-6.36e-02
|
-4.38e-02
|
3.54e-01
|
5.23e-01
|
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION
|
1617
|
2.40e-06
|
5.70e-04
|
0.07710
|
-7.56e-02
|
1.53e-02
|
3.97e-07
|
3.04e-01
|
GOBP REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY
|
31
|
7.77e-01
|
9.50e-01
|
0.07710
|
3.68e-02
|
-6.78e-02
|
7.23e-01
|
5.13e-01
|
GOBP REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL
|
12
|
8.88e-01
|
9.76e-01
|
0.07710
|
-3.44e-02
|
-6.90e-02
|
8.37e-01
|
6.79e-01
|
GOBP POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL
|
13
|
8.77e-01
|
9.75e-01
|
0.07700
|
-5.71e-02
|
-5.17e-02
|
7.22e-01
|
7.47e-01
|
GOBP NEGATIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION
|
86
|
4.21e-01
|
8.33e-01
|
0.07700
|
-5.69e-02
|
-5.18e-02
|
3.61e-01
|
4.06e-01
|
GOBP POSITIVE REGULATION OF PHOSPHORYLATION
|
634
|
7.17e-03
|
1.77e-01
|
0.07690
|
-4.17e-02
|
6.47e-02
|
7.34e-02
|
5.43e-03
|
GOBP NEURON PROJECTION ORGANIZATION
|
84
|
5.16e-01
|
8.68e-01
|
0.07690
|
-5.40e-02
|
5.48e-02
|
3.92e-01
|
3.86e-01
|
GOBP NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY
|
27
|
8.03e-01
|
9.57e-01
|
0.07690
|
-3.45e-02
|
6.87e-02
|
7.56e-01
|
5.36e-01
|
GOBP NON MEMBRANE BOUNDED ORGANELLE ASSEMBLY
|
386
|
2.30e-02
|
3.21e-01
|
0.07690
|
-6.61e-02
|
-3.92e-02
|
2.57e-02
|
1.86e-01
|
GOBP AMEBOIDAL TYPE CELL MIGRATION
|
478
|
1.46e-02
|
2.59e-01
|
0.07690
|
1.66e-03
|
7.68e-02
|
9.51e-01
|
4.00e-03
|
GOBP POSITIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE
|
15
|
8.88e-01
|
9.76e-01
|
0.07680
|
4.87e-02
|
-5.94e-02
|
7.44e-01
|
6.90e-01
|
GOBP REGULATION OF TRANSMEMBRANE TRANSPORT
|
561
|
6.54e-03
|
1.68e-01
|
0.07680
|
7.82e-03
|
7.64e-02
|
7.51e-01
|
1.97e-03
|
GOBP RESPONSE TO HYPEROXIA
|
18
|
8.41e-01
|
9.66e-01
|
0.07680
|
7.26e-02
|
2.51e-02
|
5.94e-01
|
8.54e-01
|
GOBP POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS
|
351
|
3.12e-02
|
3.63e-01
|
0.07670
|
-5.84e-02
|
-4.98e-02
|
6.00e-02
|
1.09e-01
|
GOBP PIGMENT METABOLIC PROCESS
|
74
|
5.45e-01
|
8.78e-01
|
0.07670
|
7.14e-02
|
-2.81e-02
|
2.88e-01
|
6.76e-01
|
GOBP POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION
|
28
|
7.94e-01
|
9.55e-01
|
0.07670
|
2.76e-02
|
-7.16e-02
|
8.00e-01
|
5.12e-01
|
GOBP POSITIVE REGULATION OF LIPID STORAGE
|
27
|
8.01e-01
|
9.57e-01
|
0.07670
|
-2.71e-02
|
7.17e-02
|
8.07e-01
|
5.19e-01
|
GOBP TRANSMISSION OF NERVE IMPULSE
|
68
|
5.07e-01
|
8.65e-01
|
0.07670
|
-5.84e-02
|
-4.97e-02
|
4.05e-01
|
4.78e-01
|
GOCC CELL BODY
|
529
|
6.41e-03
|
1.66e-01
|
0.07660
|
3.29e-02
|
6.92e-02
|
1.96e-01
|
6.44e-03
|
GOCC VESICLE MEMBRANE
|
1175
|
1.04e-04
|
9.39e-03
|
0.07660
|
-7.20e-02
|
2.62e-02
|
3.18e-05
|
1.30e-01
|
GOBP POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT
|
151
|
2.46e-01
|
7.26e-01
|
0.07660
|
1.48e-02
|
7.51e-02
|
7.53e-01
|
1.11e-01
|
GOMF G PROTEIN BETA SUBUNIT BINDING
|
21
|
8.43e-01
|
9.66e-01
|
0.07650
|
3.03e-02
|
-7.03e-02
|
8.10e-01
|
5.77e-01
|
GOBP REPLICATIVE SENESCENCE
|
17
|
8.71e-01
|
9.73e-01
|
0.07650
|
7.02e-02
|
-3.04e-02
|
6.16e-01
|
8.28e-01
|
GOMF PROTEIN CONTAINING COMPLEX BINDING
|
1670
|
5.40e-06
|
9.52e-04
|
0.07650
|
-6.01e-02
|
4.73e-02
|
4.30e-05
|
1.29e-03
|
GOMF MHC CLASS II PROTEIN COMPLEX BINDING
|
25
|
8.11e-01
|
9.59e-01
|
0.07640
|
7.41e-02
|
-1.89e-02
|
5.22e-01
|
8.70e-01
|
GOBP NEURAL NUCLEUS DEVELOPMENT
|
61
|
5.89e-01
|
8.92e-01
|
0.07640
|
-7.61e-02
|
6.49e-03
|
3.04e-01
|
9.30e-01
|
GOBP NEGATIVE REGULATION OF CATABOLIC PROCESS
|
323
|
6.10e-02
|
4.78e-01
|
0.07640
|
-7.63e-02
|
3.17e-03
|
1.84e-02
|
9.22e-01
|
GOBP OLEFINIC COMPOUND METABOLIC PROCESS
|
156
|
2.32e-01
|
7.18e-01
|
0.07640
|
-2.08e-02
|
-7.35e-02
|
6.54e-01
|
1.13e-01
|
GOBP POSITIVE REGULATION OF TRANSLATION
|
127
|
3.05e-01
|
7.69e-01
|
0.07630
|
-7.36e-02
|
-2.01e-02
|
1.52e-01
|
6.96e-01
|
GOBP ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION
|
20
|
8.48e-01
|
9.66e-01
|
0.07630
|
2.21e-02
|
-7.30e-02
|
8.64e-01
|
5.72e-01
|
GOBP COPULATION
|
19
|
8.57e-01
|
9.68e-01
|
0.07630
|
-2.78e-02
|
7.10e-02
|
8.34e-01
|
5.92e-01
|
GOMF EXOPEPTIDASE ACTIVITY
|
100
|
4.57e-01
|
8.48e-01
|
0.07620
|
-6.32e-02
|
4.26e-02
|
2.74e-01
|
4.62e-01
|
GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS
|
31
|
7.36e-01
|
9.35e-01
|
0.07620
|
-5.87e-02
|
-4.86e-02
|
5.71e-01
|
6.40e-01
|
GOBP MUSCLE CELL MIGRATION
|
100
|
4.05e-01
|
8.26e-01
|
0.07620
|
8.21e-03
|
7.58e-02
|
8.87e-01
|
1.90e-01
|
GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION
|
93
|
4.03e-01
|
8.26e-01
|
0.07620
|
-6.35e-02
|
-4.21e-02
|
2.90e-01
|
4.83e-01
|
GOBP PROGRAMMED NECROTIC CELL DEATH
|
56
|
6.42e-01
|
9.07e-01
|
0.07620
|
-3.62e-02
|
6.70e-02
|
6.39e-01
|
3.86e-01
|
GOCC MISMATCH REPAIR COMPLEX
|
10
|
9.15e-01
|
9.83e-01
|
0.07610
|
-7.60e-02
|
-2.82e-03
|
6.77e-01
|
9.88e-01
|
GOCC RECYCLING ENDOSOME MEMBRANE
|
99
|
4.38e-01
|
8.40e-01
|
0.07600
|
-7.44e-02
|
1.56e-02
|
2.01e-01
|
7.88e-01
|
GOBP DOPAMINE BIOSYNTHETIC PROCESS
|
12
|
8.95e-01
|
9.77e-01
|
0.07600
|
7.38e-02
|
1.81e-02
|
6.58e-01
|
9.14e-01
|
GOBP REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE
|
12
|
8.98e-01
|
9.78e-01
|
0.07590
|
-7.57e-02
|
-5.83e-03
|
6.50e-01
|
9.72e-01
|
GOBP GERM CELL DEVELOPMENT
|
344
|
5.70e-02
|
4.68e-01
|
0.07590
|
-1.13e-02
|
7.51e-02
|
7.19e-01
|
1.67e-02
|
GOBP ACTIN NUCLEATION
|
55
|
6.31e-01
|
9.03e-01
|
0.07590
|
-7.46e-02
|
1.39e-02
|
3.38e-01
|
8.58e-01
|
GOBP POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION
|
67
|
5.43e-01
|
8.78e-01
|
0.07590
|
1.36e-02
|
7.47e-02
|
8.48e-01
|
2.91e-01
|
GOBP DNA DAMAGE RESPONSE
|
833
|
4.31e-04
|
2.78e-02
|
0.07580
|
-6.58e-02
|
-3.77e-02
|
1.26e-03
|
6.44e-02
|
GOBP TRANSCRIPTION BY RNA POLYMERASE III
|
59
|
5.69e-01
|
8.86e-01
|
0.07580
|
-6.85e-02
|
-3.24e-02
|
3.62e-01
|
6.67e-01
|
GOBP REGULATION OF PRESYNAPTIC MEMBRANE POTENTIAL
|
28
|
8.00e-01
|
9.56e-01
|
0.07580
|
7.00e-02
|
-2.91e-02
|
5.21e-01
|
7.90e-01
|
GOMF PROTEIN TYROSINE KINASE BINDING
|
118
|
3.26e-01
|
7.82e-01
|
0.07580
|
3.20e-02
|
6.87e-02
|
5.48e-01
|
1.97e-01
|
GOMF POLYOL TRANSMEMBRANE TRANSPORTER ACTIVITY
|
11
|
9.01e-01
|
9.80e-01
|
0.07580
|
2.61e-02
|
7.12e-02
|
8.81e-01
|
6.83e-01
|
GOBP POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS
|
13
|
8.88e-01
|
9.76e-01
|
0.07580
|
-1.37e-02
|
-7.46e-02
|
9.32e-01
|
6.42e-01
|
GOBP REGULATION OF LEUKOCYTE MEDIATED IMMUNITY
|
236
|
1.63e-01
|
6.48e-01
|
0.07580
|
-6.27e-02
|
4.25e-02
|
9.70e-02
|
2.60e-01
|
GOMF ALDEHYDE DEHYDROGENASE NAD P PLUS ACTIVITY
|
17
|
8.55e-01
|
9.68e-01
|
0.07580
|
-1.72e-02
|
-7.38e-02
|
9.02e-01
|
5.98e-01
|
GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS
|
14
|
8.72e-01
|
9.73e-01
|
0.07580
|
6.00e-02
|
4.63e-02
|
6.98e-01
|
7.64e-01
|
GOBP CELLULAR RESPONSE TO FATTY ACID
|
33
|
7.24e-01
|
9.30e-01
|
0.07580
|
-5.15e-02
|
-5.55e-02
|
6.08e-01
|
5.81e-01
|
GOBP POSITIVE REGULATION OF CELLULAR RESPIRATION
|
13
|
9.00e-01
|
9.79e-01
|
0.07580
|
7.25e-02
|
-2.21e-02
|
6.51e-01
|
8.90e-01
|
GOBP ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY
|
55
|
6.33e-01
|
9.03e-01
|
0.07570
|
-7.44e-02
|
1.41e-02
|
3.40e-01
|
8.57e-01
|
GOBP MEMBRANE DOCKING
|
91
|
4.17e-01
|
8.31e-01
|
0.07570
|
6.50e-02
|
3.88e-02
|
2.84e-01
|
5.22e-01
|
GOBP PROTEIN LOCALIZATION TO CONDENSED CHROMOSOME
|
15
|
8.83e-01
|
9.76e-01
|
0.07570
|
-1.66e-02
|
7.39e-02
|
9.12e-01
|
6.20e-01
|
GOBP INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY
|
88
|
4.48e-01
|
8.41e-01
|
0.07570
|
-7.39e-02
|
-1.65e-02
|
2.31e-01
|
7.88e-01
|
GOBP MESODERMAL CELL MIGRATION
|
5
|
9.55e-01
|
9.90e-01
|
0.07570
|
-1.68e-02
|
-7.38e-02
|
9.48e-01
|
7.75e-01
|
GOBP DNA TEMPLATED TRANSCRIPTION TERMINATION
|
24
|
8.22e-01
|
9.61e-01
|
0.07570
|
1.96e-02
|
-7.31e-02
|
8.68e-01
|
5.35e-01
|
GOBP FOLIC ACID METABOLIC PROCESS
|
15
|
8.72e-01
|
9.73e-01
|
0.07570
|
-1.59e-02
|
-7.40e-02
|
9.15e-01
|
6.20e-01
|
GOBP REGULATION OF FIBROBLAST MIGRATION
|
38
|
7.44e-01
|
9.38e-01
|
0.07570
|
-3.87e-02
|
6.50e-02
|
6.79e-01
|
4.88e-01
|
GOBP SOMITE DEVELOPMENT
|
82
|
5.34e-01
|
8.76e-01
|
0.07560
|
-4.72e-02
|
5.91e-02
|
4.60e-01
|
3.55e-01
|
GOBP NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS
|
1429
|
1.36e-05
|
2.02e-03
|
0.07560
|
-7.47e-02
|
1.16e-02
|
2.24e-06
|
4.64e-01
|
GOBP REGULATION OF SISTER CHROMATID SEGREGATION
|
104
|
3.66e-01
|
8.07e-01
|
0.07560
|
-6.04e-02
|
-4.54e-02
|
2.87e-01
|
4.24e-01
|
GOBP REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT
|
16
|
8.81e-01
|
9.75e-01
|
0.07560
|
-3.09e-02
|
6.89e-02
|
8.31e-01
|
6.33e-01
|
GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND
|
44
|
6.63e-01
|
9.10e-01
|
0.07560
|
-7.10e-02
|
-2.60e-02
|
4.15e-01
|
7.66e-01
|
GOBP TRANSITION METAL ION TRANSPORT
|
93
|
4.65e-01
|
8.49e-01
|
0.07550
|
-7.40e-02
|
1.53e-02
|
2.18e-01
|
7.99e-01
|
GOBP NEUROTRANSMITTER TRANSPORT
|
198
|
1.52e-01
|
6.39e-01
|
0.07550
|
3.86e-02
|
6.49e-02
|
3.49e-01
|
1.15e-01
|
GOMF MONOATOMIC CATION CHANNEL ACTIVITY
|
324
|
4.51e-02
|
4.30e-01
|
0.07550
|
5.87e-02
|
4.75e-02
|
6.91e-02
|
1.42e-01
|
GOBP SMAD PROTEIN SIGNAL TRANSDUCTION
|
83
|
5.03e-01
|
8.64e-01
|
0.07540
|
-1.29e-02
|
7.43e-02
|
8.38e-01
|
2.42e-01
|
GOBP POSITIVE REGULATION OF MACROAUTOPHAGY
|
71
|
5.63e-01
|
8.84e-01
|
0.07540
|
-2.05e-02
|
7.26e-02
|
7.65e-01
|
2.90e-01
|
GOBP ORGANIC ACID TRANSMEMBRANE TRANSPORT
|
146
|
3.31e-01
|
7.85e-01
|
0.07540
|
-4.83e-02
|
5.79e-02
|
3.13e-01
|
2.27e-01
|
GOBP CELLULAR RESPONSE TO ABIOTIC STIMULUS
|
318
|
8.69e-02
|
5.46e-01
|
0.07540
|
-6.69e-02
|
3.48e-02
|
4.02e-02
|
2.87e-01
|
GOBP RESPONSE TO EXTRACELLULAR STIMULUS
|
500
|
2.25e-02
|
3.17e-01
|
0.07540
|
-6.60e-02
|
3.65e-02
|
1.15e-02
|
1.63e-01
|
GOBP LONG CHAIN FATTY ACID METABOLIC PROCESS
|
103
|
4.56e-01
|
8.48e-01
|
0.07540
|
-4.44e-02
|
6.09e-02
|
4.36e-01
|
2.85e-01
|
GOBP POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY
|
48
|
6.33e-01
|
9.03e-01
|
0.07540
|
3.69e-02
|
6.57e-02
|
6.59e-01
|
4.31e-01
|
GOBP POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION
|
74
|
4.94e-01
|
8.58e-01
|
0.07530
|
3.81e-02
|
6.49e-02
|
5.70e-01
|
3.34e-01
|
GOBP HYPEROSMOTIC SALINITY RESPONSE
|
10
|
9.16e-01
|
9.83e-01
|
0.07520
|
4.02e-03
|
7.51e-02
|
9.82e-01
|
6.81e-01
|
GOBP POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION
|
48
|
6.84e-01
|
9.17e-01
|
0.07520
|
-2.59e-02
|
7.06e-02
|
7.56e-01
|
3.97e-01
|
GOBP PHOTORECEPTOR CELL DEVELOPMENT
|
49
|
6.72e-01
|
9.13e-01
|
0.07520
|
1.79e-02
|
-7.31e-02
|
8.29e-01
|
3.76e-01
|
GOBP TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION
|
183
|
2.53e-01
|
7.32e-01
|
0.07520
|
-5.35e-02
|
5.28e-02
|
2.12e-01
|
2.18e-01
|
GOBP REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION
|
45
|
6.83e-01
|
9.17e-01
|
0.07510
|
-3.82e-03
|
7.51e-02
|
9.65e-01
|
3.84e-01
|
GOCC SPINDLE
|
405
|
3.08e-02
|
3.61e-01
|
0.07510
|
-7.48e-02
|
-6.12e-03
|
9.75e-03
|
8.33e-01
|
GOBP LEUKOCYTE APOPTOTIC PROCESS
|
118
|
3.42e-01
|
7.93e-01
|
0.07500
|
2.17e-02
|
7.18e-02
|
6.84e-01
|
1.78e-01
|
GOBP NEGATIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS
|
6
|
9.46e-01
|
9.90e-01
|
0.07500
|
-7.00e-02
|
-2.68e-02
|
7.66e-01
|
9.09e-01
|
GOBP IRON ION TRANSPORT
|
53
|
6.58e-01
|
9.09e-01
|
0.07500
|
-2.41e-02
|
7.10e-02
|
7.62e-01
|
3.71e-01
|
GOBP RESPONSE TO POTASSIUM ION
|
17
|
8.52e-01
|
9.67e-01
|
0.07500
|
6.62e-02
|
3.52e-02
|
6.37e-01
|
8.01e-01
|
GOBP POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY
|
142
|
2.90e-01
|
7.61e-01
|
0.07500
|
-7.45e-02
|
-7.78e-03
|
1.25e-01
|
8.73e-01
|
GOBP NEURON FATE SPECIFICATION
|
34
|
7.31e-01
|
9.32e-01
|
0.07490
|
-7.01e-02
|
-2.66e-02
|
4.80e-01
|
7.89e-01
|
GOMF DEUBIQUITINASE ACTIVITY
|
87
|
4.52e-01
|
8.45e-01
|
0.07490
|
-7.10e-02
|
-2.40e-02
|
2.53e-01
|
6.99e-01
|
GOBP EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING
|
658
|
7.23e-03
|
1.78e-01
|
0.07490
|
-6.74e-02
|
3.27e-02
|
3.20e-03
|
1.53e-01
|
GOBP POSITIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS
|
112
|
3.67e-01
|
8.07e-01
|
0.07490
|
-7.28e-02
|
-1.74e-02
|
1.83e-01
|
7.50e-01
|
GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY
|
18
|
8.43e-01
|
9.66e-01
|
0.07490
|
-6.00e-02
|
-4.47e-02
|
6.59e-01
|
7.43e-01
|
GOBP REGULATION OF CYTOSKELETON ORGANIZATION
|
493
|
2.65e-02
|
3.40e-01
|
0.07480
|
-4.46e-02
|
6.01e-02
|
9.01e-02
|
2.23e-02
|
GOMF REGULATORY RNA BINDING
|
49
|
6.51e-01
|
9.07e-01
|
0.07480
|
-7.41e-02
|
-1.00e-02
|
3.69e-01
|
9.03e-01
|
GOBP REGULATION OF TRANSPORT
|
1704
|
7.55e-06
|
1.23e-03
|
0.07480
|
-4.89e-02
|
5.66e-02
|
7.84e-04
|
1.01e-04
|
GOBP RESPONSE TO PEPTIDE HORMONE
|
415
|
3.51e-02
|
3.82e-01
|
0.07480
|
-7.40e-02
|
1.06e-02
|
9.66e-03
|
7.10e-01
|
GOBP ENDOTHELIAL CELL APOPTOTIC PROCESS
|
67
|
5.57e-01
|
8.82e-01
|
0.07480
|
8.76e-03
|
7.43e-02
|
9.01e-01
|
2.93e-01
|
GOBP REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY
|
34
|
7.38e-01
|
9.35e-01
|
0.07480
|
1.57e-02
|
7.31e-02
|
8.74e-01
|
4.61e-01
|
GOCC ACTIN CYTOSKELETON
|
485
|
1.52e-02
|
2.62e-01
|
0.07470
|
1.20e-02
|
7.38e-02
|
6.52e-01
|
5.39e-03
|
GOBP PROTEIN FOLDING
|
207
|
1.80e-01
|
6.70e-01
|
0.07470
|
5.10e-03
|
-7.46e-02
|
8.99e-01
|
6.44e-02
|
GOBP EMBRYONIC PATTERN SPECIFICATION
|
68
|
5.79e-01
|
8.90e-01
|
0.07470
|
-7.29e-02
|
1.63e-02
|
2.99e-01
|
8.16e-01
|
GOBP REGULATION OF MICROTUBULE BASED PROCESS
|
248
|
9.98e-02
|
5.68e-01
|
0.07470
|
-6.36e-02
|
-3.91e-02
|
8.44e-02
|
2.89e-01
|
GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE
|
40
|
7.30e-01
|
9.32e-01
|
0.07460
|
-7.12e-02
|
2.24e-02
|
4.36e-01
|
8.06e-01
|
GOMF PHOSPHATASE REGULATOR ACTIVITY
|
98
|
4.24e-01
|
8.35e-01
|
0.07460
|
1.16e-02
|
7.37e-02
|
8.43e-01
|
2.07e-01
|
GOBP REGULATION OF POLYSACCHARIDE BIOSYNTHETIC PROCESS
|
38
|
7.21e-01
|
9.30e-01
|
0.07460
|
-4.70e-03
|
-7.45e-02
|
9.60e-01
|
4.27e-01
|
GOBP POSITIVE REGULATION OF PLATELET AGGREGATION
|
11
|
9.01e-01
|
9.79e-01
|
0.07460
|
4.83e-02
|
5.69e-02
|
7.82e-01
|
7.44e-01
|
GOBP DNA MODIFICATION
|
99
|
4.09e-01
|
8.27e-01
|
0.07460
|
-2.24e-02
|
-7.12e-02
|
7.00e-01
|
2.21e-01
|
GOBP NEGATIVE REGULATION OF CELL ADHESION
|
298
|
8.88e-02
|
5.50e-01
|
0.07460
|
-8.73e-03
|
7.41e-02
|
7.96e-01
|
2.78e-02
|
GOBP POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY
|
45
|
7.05e-01
|
9.24e-01
|
0.07460
|
-2.64e-02
|
6.98e-02
|
7.60e-01
|
4.18e-01
|
GOMF METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
426
|
2.35e-02
|
3.25e-01
|
0.07460
|
1.93e-02
|
7.21e-02
|
4.95e-01
|
1.07e-02
|
GOMF CATALYTIC ACTIVITY ACTING ON A RRNA
|
23
|
8.04e-01
|
9.57e-01
|
0.07460
|
5.05e-02
|
5.49e-02
|
6.75e-01
|
6.49e-01
|
GOBP BILE ACID AND BILE SALT TRANSPORT
|
28
|
7.67e-01
|
9.46e-01
|
0.07460
|
5.15e-02
|
5.40e-02
|
6.37e-01
|
6.21e-01
|
GOCC EARLY ENDOSOME
|
414
|
4.68e-02
|
4.37e-01
|
0.07460
|
-6.32e-02
|
3.96e-02
|
2.74e-02
|
1.67e-01
|
GOBP SOMITOGENESIS
|
64
|
6.22e-01
|
9.01e-01
|
0.07450
|
-5.00e-02
|
5.52e-02
|
4.89e-01
|
4.45e-01
|
GOBP RESPONSE TO WOUNDING
|
538
|
1.88e-02
|
2.92e-01
|
0.07450
|
-3.62e-02
|
6.51e-02
|
1.50e-01
|
9.82e-03
|
GOMF CYCLOSPORIN A BINDING
|
17
|
8.77e-01
|
9.75e-01
|
0.07440
|
2.79e-02
|
-6.89e-02
|
8.42e-01
|
6.23e-01
|
GOBP POSITIVE REGULATION OF TRANSPORT
|
856
|
2.22e-03
|
8.91e-02
|
0.07430
|
-4.53e-02
|
5.89e-02
|
2.44e-02
|
3.41e-03
|
GOBP ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT
|
27
|
8.19e-01
|
9.60e-01
|
0.07430
|
4.88e-02
|
-5.61e-02
|
6.61e-01
|
6.14e-01
|
GOBP REGULATION PROTEIN CATABOLIC PROCESS AT SYNAPSE
|
6
|
9.55e-01
|
9.90e-01
|
0.07430
|
-6.89e-02
|
2.78e-02
|
7.70e-01
|
9.06e-01
|
GOBP VASCULOGENESIS
|
81
|
5.26e-01
|
8.71e-01
|
0.07430
|
-1.69e-02
|
7.24e-02
|
7.93e-01
|
2.60e-01
|
GOBP SODIUM ION TRANSMEMBRANE TRANSPORT
|
169
|
2.57e-01
|
7.35e-01
|
0.07430
|
-1.08e-02
|
7.35e-02
|
8.09e-01
|
9.92e-02
|
GOBP PROSTANOID METABOLIC PROCESS
|
50
|
6.66e-01
|
9.11e-01
|
0.07420
|
8.66e-03
|
-7.37e-02
|
9.16e-01
|
3.67e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS
|
6
|
9.52e-01
|
9.90e-01
|
0.07420
|
7.41e-02
|
-4.12e-03
|
7.53e-01
|
9.86e-01
|
GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II
|
890
|
1.18e-03
|
5.76e-02
|
0.07420
|
-7.19e-02
|
1.82e-02
|
2.71e-04
|
3.58e-01
|
GOBP RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION
|
13
|
8.86e-01
|
9.76e-01
|
0.07410
|
6.11e-02
|
4.19e-02
|
7.03e-01
|
7.94e-01
|
GOCC EXTERNAL ENCAPSULATING STRUCTURE
|
537
|
1.05e-02
|
2.19e-01
|
0.07400
|
7.29e-02
|
1.29e-02
|
3.84e-03
|
6.09e-01
|
GOBP CELLULAR RESPONSE TO RADIATION
|
170
|
2.23e-01
|
7.12e-01
|
0.07400
|
-7.09e-02
|
-2.13e-02
|
1.11e-01
|
6.33e-01
|
GOBP REGULATION OF PROTEIN STABILITY
|
304
|
6.07e-02
|
4.78e-01
|
0.07400
|
-5.01e-02
|
-5.45e-02
|
1.33e-01
|
1.02e-01
|
GOBP DEOXYRIBONUCLEOTIDE METABOLIC PROCESS
|
42
|
7.17e-01
|
9.28e-01
|
0.07400
|
-7.24e-02
|
1.52e-02
|
4.17e-01
|
8.64e-01
|
GOBP RESPONSE TO CALCIUM ION
|
138
|
2.83e-01
|
7.56e-01
|
0.07400
|
-3.78e-02
|
-6.36e-02
|
4.44e-01
|
1.97e-01
|
GOBP REGULATION OF STEM CELL PROLIFERATION
|
91
|
4.64e-01
|
8.48e-01
|
0.07390
|
6.12e-03
|
7.37e-02
|
9.20e-01
|
2.25e-01
|
GOBP BEHAVIORAL RESPONSE TO NICOTINE
|
9
|
9.35e-01
|
9.87e-01
|
0.07380
|
-3.32e-02
|
6.59e-02
|
8.63e-01
|
7.32e-01
|
GOMF AMINOACYLTRANSFERASE ACTIVITY
|
456
|
3.67e-02
|
3.91e-01
|
0.07380
|
-6.29e-02
|
3.87e-02
|
2.14e-02
|
1.56e-01
|
GOBP CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT
|
24
|
8.34e-01
|
9.64e-01
|
0.07380
|
6.83e-02
|
-2.79e-02
|
5.62e-01
|
8.13e-01
|
GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION
|
26
|
7.94e-01
|
9.55e-01
|
0.07380
|
2.20e-02
|
7.05e-02
|
8.46e-01
|
5.34e-01
|
GOBP T HELPER 1 TYPE IMMUNE RESPONSE
|
48
|
6.75e-01
|
9.13e-01
|
0.07380
|
-7.38e-02
|
2.64e-03
|
3.77e-01
|
9.75e-01
|
GOCC CCR4 NOT CORE COMPLEX
|
6
|
9.56e-01
|
9.90e-01
|
0.07380
|
-6.79e-02
|
2.88e-02
|
7.73e-01
|
9.03e-01
|
GOBP N TERMINAL PEPTIDYL METHIONINE ACETYLATION
|
6
|
9.47e-01
|
9.90e-01
|
0.07370
|
-6.75e-02
|
-2.97e-02
|
7.75e-01
|
9.00e-01
|
GOBP TUBE FORMATION
|
149
|
2.99e-01
|
7.67e-01
|
0.07370
|
-3.46e-03
|
7.36e-02
|
9.42e-01
|
1.21e-01
|
GOBP RESPONSE TO INTERFERON BETA
|
33
|
7.39e-01
|
9.35e-01
|
0.07370
|
-6.17e-02
|
-4.02e-02
|
5.40e-01
|
6.89e-01
|
GOBP POSITIVE REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE
|
16
|
8.90e-01
|
9.76e-01
|
0.07360
|
-5.97e-02
|
4.31e-02
|
6.79e-01
|
7.65e-01
|
GOBP HYPEROSMOTIC RESPONSE
|
25
|
8.34e-01
|
9.64e-01
|
0.07360
|
-5.80e-02
|
4.54e-02
|
6.16e-01
|
6.94e-01
|
GOBP NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT
|
138
|
3.14e-01
|
7.76e-01
|
0.07360
|
7.83e-03
|
7.31e-02
|
8.74e-01
|
1.38e-01
|
GOBP CHEMICAL HOMEOSTASIS
|
995
|
9.26e-04
|
4.91e-02
|
0.07360
|
-3.83e-02
|
6.28e-02
|
4.08e-02
|
8.01e-04
|
GOBP REGULATION OF LIPASE ACTIVITY
|
76
|
5.78e-01
|
8.89e-01
|
0.07350
|
4.99e-02
|
-5.40e-02
|
4.52e-01
|
4.15e-01
|
GOBP MICROTUBULE BASED PROTEIN TRANSPORT
|
14
|
8.81e-01
|
9.75e-01
|
0.07350
|
3.71e-02
|
6.35e-02
|
8.10e-01
|
6.81e-01
|
GOBP REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS
|
18
|
8.67e-01
|
9.71e-01
|
0.07350
|
1.20e-02
|
-7.25e-02
|
9.30e-01
|
5.94e-01
|
GOCC CELL CELL JUNCTION
|
484
|
1.27e-02
|
2.45e-01
|
0.07350
|
5.45e-02
|
4.93e-02
|
4.01e-02
|
6.30e-02
|
GOBP ENDOCRINE PANCREAS DEVELOPMENT
|
46
|
7.15e-01
|
9.27e-01
|
0.07350
|
-6.18e-02
|
3.99e-02
|
4.69e-01
|
6.40e-01
|
GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR
|
70
|
5.81e-01
|
8.90e-01
|
0.07350
|
1.65e-02
|
-7.16e-02
|
8.11e-01
|
3.00e-01
|
GOBP REGULATION OF GLYCOGEN METABOLIC PROCESS
|
36
|
7.21e-01
|
9.30e-01
|
0.07350
|
-3.71e-02
|
-6.34e-02
|
7.00e-01
|
5.10e-01
|
GOCC METHYLTRANSFERASE COMPLEX
|
88
|
4.49e-01
|
8.42e-01
|
0.07350
|
-6.06e-02
|
-4.15e-02
|
3.25e-01
|
5.01e-01
|
GOMF PROTEIN MACROMOLECULE ADAPTOR ACTIVITY
|
400
|
5.19e-02
|
4.49e-01
|
0.07350
|
-6.83e-02
|
2.70e-02
|
1.91e-02
|
3.53e-01
|
GOBP SULFUR COMPOUND TRANSPORT
|
53
|
6.19e-01
|
9.00e-01
|
0.07340
|
3.77e-02
|
6.30e-02
|
6.35e-01
|
4.27e-01
|
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS
|
17
|
8.81e-01
|
9.75e-01
|
0.07340
|
-6.75e-02
|
2.89e-02
|
6.30e-01
|
8.37e-01
|
GOBP REGULATION OF SMOOTH MUSCLE CONTRACTION
|
61
|
6.44e-01
|
9.07e-01
|
0.07340
|
-5.60e-02
|
4.75e-02
|
4.49e-01
|
5.21e-01
|
GOBP PHAGOCYTOSIS RECOGNITION
|
27
|
7.83e-01
|
9.52e-01
|
0.07340
|
3.62e-02
|
6.39e-02
|
7.45e-01
|
5.66e-01
|
GOBP PROTEIN CATABOLIC PROCESS
|
930
|
1.12e-03
|
5.49e-02
|
0.07340
|
-7.00e-02
|
2.20e-02
|
2.96e-04
|
2.54e-01
|
GOBP POSITIVE REGULATION OF DEPHOSPHORYLATION
|
51
|
6.89e-01
|
9.19e-01
|
0.07340
|
-6.23e-02
|
3.88e-02
|
4.41e-01
|
6.32e-01
|
GOMF NUCLEAR EXPORT SIGNAL RECEPTOR ACTIVITY
|
12
|
9.13e-01
|
9.82e-01
|
0.07340
|
-6.95e-02
|
2.34e-02
|
6.77e-01
|
8.88e-01
|
GOBP SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS
|
47
|
6.99e-01
|
9.21e-01
|
0.07340
|
-2.17e-02
|
7.01e-02
|
7.97e-01
|
4.06e-01
|
GOBP REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY
|
58
|
6.55e-01
|
9.09e-01
|
0.07340
|
-6.25e-02
|
3.85e-02
|
4.11e-01
|
6.12e-01
|
GOBP DNA METABOLIC PROCESS
|
983
|
1.85e-04
|
1.46e-02
|
0.07340
|
-5.82e-02
|
-4.47e-02
|
2.01e-03
|
1.78e-02
|
GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR BINDING
|
12
|
9.16e-01
|
9.83e-01
|
0.07330
|
3.90e-02
|
-6.21e-02
|
8.15e-01
|
7.10e-01
|
GOBP POSITIVE REGULATION OF CILIUM ASSEMBLY
|
28
|
7.94e-01
|
9.55e-01
|
0.07330
|
-2.46e-03
|
-7.33e-02
|
9.82e-01
|
5.02e-01
|
GOCC RIBONUCLEOPROTEIN COMPLEX
|
1035
|
2.20e-04
|
1.62e-02
|
0.07330
|
-1.33e-02
|
-7.21e-02
|
4.70e-01
|
8.77e-05
|
GOBP REGULATION OF CATECHOLAMINE METABOLIC PROCESS
|
18
|
8.69e-01
|
9.73e-01
|
0.07330
|
-1.52e-02
|
7.17e-02
|
9.11e-01
|
5.98e-01
|
GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS BY CYTOCHROME C
|
6
|
9.47e-01
|
9.90e-01
|
0.07330
|
4.31e-02
|
5.93e-02
|
8.55e-01
|
8.01e-01
|
GOCC ACROSOMAL MEMBRANE
|
32
|
7.83e-01
|
9.52e-01
|
0.07330
|
-1.91e-02
|
7.07e-02
|
8.52e-01
|
4.89e-01
|
GOMF UBIQUITIN LIKE PROTEIN LIGASE ACTIVITY
|
337
|
9.10e-02
|
5.51e-01
|
0.07330
|
-5.88e-02
|
4.37e-02
|
6.37e-02
|
1.68e-01
|
GOBP POSITIVE REGULATION OF MEMBRANE PERMEABILITY
|
49
|
6.62e-01
|
9.10e-01
|
0.07330
|
9.86e-03
|
7.26e-02
|
9.05e-01
|
3.79e-01
|
GOCC SARCOPLASMIC RETICULUM
|
72
|
5.35e-01
|
8.76e-01
|
0.07320
|
6.99e-02
|
2.19e-02
|
3.05e-01
|
7.48e-01
|
GOBP REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION
|
368
|
6.87e-02
|
5.00e-01
|
0.07320
|
-3.10e-02
|
6.63e-02
|
3.06e-01
|
2.89e-02
|
GOBP VIRAL PROCESS
|
413
|
2.97e-02
|
3.59e-01
|
0.07320
|
-7.04e-02
|
-2.01e-02
|
1.41e-02
|
4.83e-01
|
GOBP MITOCHONDRIAL RESPIRASOME ASSEMBLY
|
10
|
9.19e-01
|
9.84e-01
|
0.07320
|
1.31e-02
|
7.20e-02
|
9.43e-01
|
6.93e-01
|
GOBP REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION
|
144
|
2.75e-01
|
7.49e-01
|
0.07320
|
6.28e-02
|
3.76e-02
|
1.93e-01
|
4.36e-01
|
GOCC TRANSFERASE COMPLEX
|
790
|
1.51e-03
|
6.87e-02
|
0.07310
|
-7.17e-02
|
-1.45e-02
|
6.09e-04
|
4.90e-01
|
GOBP ERBB3 SIGNALING PATHWAY
|
5
|
9.61e-01
|
9.91e-01
|
0.07310
|
-9.93e-03
|
7.24e-02
|
9.69e-01
|
7.79e-01
|
GOBP REGULATION OF ALDOSTERONE METABOLIC PROCESS
|
8
|
9.41e-01
|
9.89e-01
|
0.07310
|
-2.11e-02
|
7.00e-02
|
9.18e-01
|
7.32e-01
|
GOCC CHROMOSOME TELOMERIC REGION
|
165
|
2.83e-01
|
7.56e-01
|
0.07310
|
1.63e-02
|
-7.13e-02
|
7.17e-01
|
1.14e-01
|
GOMF ALKALINE PHOSPHATASE ACTIVITY
|
6
|
9.58e-01
|
9.90e-01
|
0.07310
|
-4.68e-02
|
5.61e-02
|
8.43e-01
|
8.12e-01
|
GOBP GLAND MORPHOGENESIS
|
120
|
4.12e-01
|
8.28e-01
|
0.07300
|
-2.80e-02
|
6.75e-02
|
5.97e-01
|
2.02e-01
|
GOBP ALPHA AMINO ACID METABOLIC PROCESS
|
196
|
2.03e-01
|
6.93e-01
|
0.07300
|
-3.37e-03
|
-7.30e-02
|
9.35e-01
|
7.82e-02
|
GOBP NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS
|
28
|
8.13e-01
|
9.59e-01
|
0.07300
|
6.66e-02
|
-2.99e-02
|
5.42e-01
|
7.84e-01
|
GOMF SECONDARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
274
|
1.18e-01
|
6.00e-01
|
0.07300
|
-8.31e-03
|
7.25e-02
|
8.13e-01
|
3.88e-02
|
GOBP REGULATION OF CELL CYCLE
|
1068
|
1.16e-04
|
1.04e-02
|
0.07300
|
-6.47e-02
|
-3.38e-02
|
3.55e-04
|
6.20e-02
|
GOMF VOLUME SENSITIVE ANION CHANNEL ACTIVITY
|
9
|
9.35e-01
|
9.87e-01
|
0.07300
|
2.65e-02
|
-6.80e-02
|
8.91e-01
|
7.24e-01
|
GOBP REGULATION OF NEURON DIFFERENTIATION
|
192
|
1.80e-01
|
6.70e-01
|
0.07300
|
-6.03e-02
|
-4.11e-02
|
1.50e-01
|
3.26e-01
|
GOBP REGULATION OF GASTRULATION
|
16
|
8.76e-01
|
9.75e-01
|
0.07300
|
-7.25e-02
|
-7.92e-03
|
6.15e-01
|
9.56e-01
|
GOBP POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION
|
160
|
2.74e-01
|
7.48e-01
|
0.07290
|
2.80e-03
|
7.28e-02
|
9.51e-01
|
1.12e-01
|
GOBP NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS
|
89
|
4.84e-01
|
8.54e-01
|
0.07280
|
-4.31e-03
|
-7.27e-02
|
9.44e-01
|
2.36e-01
|
GOBP NEURON PROJECTION EXTENSION
|
168
|
2.52e-01
|
7.30e-01
|
0.07280
|
7.69e-03
|
7.24e-02
|
8.64e-01
|
1.05e-01
|
GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE
|
192
|
2.42e-01
|
7.25e-01
|
0.07280
|
-6.86e-02
|
2.45e-02
|
1.01e-01
|
5.58e-01
|
GOBP RESPONSE TO PEPTIDE
|
501
|
2.07e-02
|
3.05e-01
|
0.07280
|
-7.26e-02
|
5.55e-03
|
5.40e-03
|
8.32e-01
|
GOBP REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY
|
31
|
7.57e-01
|
9.43e-01
|
0.07280
|
-5.77e-02
|
-4.44e-02
|
5.78e-01
|
6.69e-01
|
GOBP CONVERGENT EXTENSION
|
15
|
8.82e-01
|
9.75e-01
|
0.07280
|
1.11e-02
|
7.19e-02
|
9.40e-01
|
6.30e-01
|
GOMF MHC PROTEIN BINDING
|
32
|
7.84e-01
|
9.52e-01
|
0.07280
|
7.08e-02
|
-1.67e-02
|
4.88e-01
|
8.70e-01
|
GOBP FAS SIGNALING PATHWAY
|
8
|
9.45e-01
|
9.90e-01
|
0.07270
|
-4.44e-02
|
5.76e-02
|
8.28e-01
|
7.78e-01
|
GOBP ALPHA AMINO ACID CATABOLIC PROCESS
|
88
|
5.18e-01
|
8.69e-01
|
0.07270
|
2.09e-02
|
-6.96e-02
|
7.34e-01
|
2.59e-01
|
GOMF SULFOTRANSFERASE ACTIVITY
|
49
|
7.04e-01
|
9.23e-01
|
0.07270
|
-3.73e-02
|
6.24e-02
|
6.52e-01
|
4.50e-01
|
GOMF LYSOPHOSPHATIDIC ACID PHOSPHATASE ACTIVITY
|
6
|
9.54e-01
|
9.90e-01
|
0.07270
|
7.26e-02
|
-3.92e-03
|
7.58e-01
|
9.87e-01
|
GOBP PEROXISOME FISSION
|
9
|
9.37e-01
|
9.88e-01
|
0.07270
|
3.54e-02
|
-6.35e-02
|
8.54e-01
|
7.42e-01
|
GOBP REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION
|
12
|
9.04e-01
|
9.80e-01
|
0.07270
|
-7.15e-02
|
-1.27e-02
|
6.68e-01
|
9.39e-01
|
GOMF SPHINGOLIPID TRANSFER ACTIVITY
|
9
|
9.38e-01
|
9.88e-01
|
0.07260
|
-5.63e-02
|
4.59e-02
|
7.70e-01
|
8.11e-01
|
GOBP FIBRINOLYSIS
|
27
|
8.18e-01
|
9.60e-01
|
0.07260
|
6.89e-02
|
-2.31e-02
|
5.36e-01
|
8.35e-01
|
GOBP CELLULAR CATABOLIC PROCESS
|
1534
|
2.75e-05
|
3.54e-03
|
0.07260
|
-6.74e-02
|
2.69e-02
|
1.02e-05
|
7.84e-02
|
GOBP MYOTUBE DIFFERENTIATION
|
126
|
3.76e-01
|
8.12e-01
|
0.07260
|
-8.29e-03
|
7.21e-02
|
8.72e-01
|
1.62e-01
|
GOBP MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION
|
35
|
7.31e-01
|
9.32e-01
|
0.07260
|
4.36e-02
|
5.80e-02
|
6.55e-01
|
5.52e-01
|
GOBP OSTEOCLAST FUSION
|
6
|
9.57e-01
|
9.90e-01
|
0.07260
|
-2.61e-02
|
6.77e-02
|
9.12e-01
|
7.74e-01
|
GOBP MITOCHONDRIAL DNA REPAIR
|
5
|
9.58e-01
|
9.90e-01
|
0.07250
|
-7.01e-02
|
-1.86e-02
|
7.86e-01
|
9.43e-01
|
GOMF CAMP RESPONSE ELEMENT BINDING
|
12
|
9.11e-01
|
9.82e-01
|
0.07250
|
-8.90e-03
|
7.19e-02
|
9.57e-01
|
6.66e-01
|
GOBP POSITIVE REGULATION OF COAGULATION
|
30
|
7.85e-01
|
9.52e-01
|
0.07250
|
-2.51e-03
|
-7.24e-02
|
9.81e-01
|
4.92e-01
|
GOMF UBIQUINOL CYTOCHROME C REDUCTASE ACTIVITY
|
5
|
9.65e-01
|
9.92e-01
|
0.07250
|
-5.50e-02
|
4.71e-02
|
8.31e-01
|
8.55e-01
|
GOBP CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE
|
291
|
1.28e-01
|
6.09e-01
|
0.07240
|
-3.63e-02
|
6.27e-02
|
2.87e-01
|
6.59e-02
|
GOBP INTRACELLULAR PROTEIN TRANSPORT
|
835
|
1.85e-03
|
7.97e-02
|
0.07240
|
-7.22e-02
|
5.66e-03
|
3.93e-04
|
7.81e-01
|
GOBP REGULATION OF MITOTIC CELL CYCLE
|
508
|
1.36e-02
|
2.52e-01
|
0.07240
|
-6.70e-02
|
-2.75e-02
|
9.73e-03
|
2.89e-01
|
GOMF RACEMASE AND EPIMERASE ACTIVITY
|
17
|
8.63e-01
|
9.69e-01
|
0.07240
|
6.60e-02
|
2.98e-02
|
6.38e-01
|
8.32e-01
|
GOBP T CELL DIFFERENTIATION
|
301
|
1.24e-01
|
6.06e-01
|
0.07240
|
-4.50e-02
|
5.67e-02
|
1.79e-01
|
9.04e-02
|
GOBP EGG ACTIVATION
|
11
|
9.21e-01
|
9.84e-01
|
0.07240
|
-1.87e-02
|
6.99e-02
|
9.15e-01
|
6.88e-01
|
GOCC MONOATOMIC ION CHANNEL COMPLEX
|
286
|
9.65e-02
|
5.61e-01
|
0.07240
|
7.14e-02
|
1.20e-02
|
3.78e-02
|
7.28e-01
|
GOBP REGULATION OF RESPONSE TO BIOTIC STIMULUS
|
488
|
1.42e-02
|
2.57e-01
|
0.07230
|
-5.23e-02
|
-5.00e-02
|
4.80e-02
|
5.87e-02
|
GOBP B CELL ACTIVATION
|
261
|
1.32e-01
|
6.13e-01
|
0.07220
|
-3.66e-03
|
7.21e-02
|
9.19e-01
|
4.49e-02
|
GOBP REGULATION OF NEURON PROJECTION DEVELOPMENT
|
431
|
4.53e-02
|
4.31e-01
|
0.07220
|
-2.40e-02
|
6.80e-02
|
3.92e-01
|
1.54e-02
|
GOBP POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY
|
272
|
1.51e-01
|
6.38e-01
|
0.07200
|
-3.85e-02
|
6.08e-02
|
2.74e-01
|
8.41e-02
|
GOBP MYELIN MAINTENANCE
|
17
|
8.80e-01
|
9.75e-01
|
0.07200
|
-1.42e-02
|
7.06e-02
|
9.20e-01
|
6.14e-01
|
GOBP APICAL JUNCTION ASSEMBLY
|
73
|
5.26e-01
|
8.71e-01
|
0.07200
|
4.65e-02
|
5.49e-02
|
4.92e-01
|
4.17e-01
|
GOBP G2 MI TRANSITION OF MEIOTIC CELL CYCLE
|
6
|
9.59e-01
|
9.91e-01
|
0.07200
|
4.68e-02
|
-5.46e-02
|
8.43e-01
|
8.17e-01
|
GOMF ATPASE REGULATOR ACTIVITY
|
47
|
6.65e-01
|
9.10e-01
|
0.07190
|
-6.28e-02
|
-3.51e-02
|
4.56e-01
|
6.77e-01
|
GOBP SMALL MOLECULE METABOLIC PROCESS
|
1777
|
7.14e-07
|
2.36e-04
|
0.07190
|
-6.38e-02
|
-3.32e-02
|
7.83e-06
|
2.02e-02
|
GOBP CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION
|
19
|
8.55e-01
|
9.68e-01
|
0.07190
|
-7.06e-02
|
-1.37e-02
|
5.94e-01
|
9.18e-01
|
GOBP RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR
|
17
|
8.61e-01
|
9.69e-01
|
0.07190
|
-4.30e-02
|
-5.76e-02
|
7.59e-01
|
6.81e-01
|
GOBP REGULATION OF PHOSPHOLIPID TRANSLOCATION
|
6
|
9.54e-01
|
9.90e-01
|
0.07190
|
7.19e-02
|
-7.58e-04
|
7.60e-01
|
9.97e-01
|
GOBP NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION
|
67
|
5.55e-01
|
8.81e-01
|
0.07190
|
-5.54e-02
|
-4.58e-02
|
4.33e-01
|
5.17e-01
|
GOBP MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON
|
11
|
9.16e-01
|
9.83e-01
|
0.07190
|
-5.35e-03
|
-7.17e-02
|
9.75e-01
|
6.81e-01
|
GOBP REGULATION OF MACROPHAGE APOPTOTIC PROCESS
|
11
|
9.18e-01
|
9.83e-01
|
0.07190
|
2.03e-03
|
-7.18e-02
|
9.91e-01
|
6.80e-01
|
GOMF MITOCHONDRIAL RIBOSOME BINDING
|
9
|
9.25e-01
|
9.84e-01
|
0.07180
|
6.37e-02
|
3.32e-02
|
7.41e-01
|
8.63e-01
|
GOBP REGULATION OF GERMINAL CENTER FORMATION
|
8
|
9.34e-01
|
9.87e-01
|
0.07180
|
6.48e-02
|
3.09e-02
|
7.51e-01
|
8.80e-01
|
GOBP CARDIAC CHAMBER DEVELOPMENT
|
168
|
2.58e-01
|
7.35e-01
|
0.07180
|
1.11e-02
|
7.09e-02
|
8.03e-01
|
1.13e-01
|
GOCC COLLAGEN CONTAINING EXTRACELLULAR MATRIX
|
406
|
5.11e-02
|
4.47e-01
|
0.07170
|
7.03e-02
|
-1.42e-02
|
1.51e-02
|
6.23e-01
|
GOBP NUCLEAR TRANSPORT
|
314
|
9.60e-02
|
5.61e-01
|
0.07170
|
-7.10e-02
|
9.88e-03
|
3.04e-02
|
7.63e-01
|
GOCC ORGANELLE SUBCOMPARTMENT
|
1416
|
1.43e-05
|
2.05e-03
|
0.07170
|
-6.77e-02
|
-2.36e-02
|
1.95e-05
|
1.37e-01
|
GOBP POSITIVE REGULATION OF T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL
|
5
|
9.63e-01
|
9.92e-01
|
0.07170
|
-1.30e-02
|
7.05e-02
|
9.60e-01
|
7.85e-01
|
GOBP REGULATION OF BRANCHING MORPHOGENESIS OF A NERVE
|
5
|
9.58e-01
|
9.90e-01
|
0.07170
|
-3.51e-02
|
-6.25e-02
|
8.92e-01
|
8.09e-01
|
GOBP ENDOTHELIAL CELL MIGRATION
|
270
|
9.64e-02
|
5.61e-01
|
0.07170
|
4.92e-02
|
5.21e-02
|
1.64e-01
|
1.40e-01
|
GOBP NEGATIVE REGULATION OF LYASE ACTIVITY
|
18
|
8.65e-01
|
9.70e-01
|
0.07170
|
-9.74e-03
|
-7.10e-02
|
9.43e-01
|
6.02e-01
|
GOCC NUCLEAR PERIPHERY
|
142
|
3.72e-01
|
8.09e-01
|
0.07170
|
-6.24e-02
|
3.53e-02
|
1.99e-01
|
4.68e-01
|
GOBP CELLULAR RESPONSE TO NITROGEN COMPOUND
|
660
|
1.09e-02
|
2.23e-01
|
0.07160
|
-6.45e-02
|
3.10e-02
|
4.70e-03
|
1.74e-01
|
GOMF G PROTEIN COUPLED RECEPTOR BINDING
|
273
|
1.20e-01
|
6.00e-01
|
0.07160
|
2.93e-03
|
7.15e-02
|
9.34e-01
|
4.20e-02
|
GOBP T CELL ACTIVATION
|
539
|
1.96e-02
|
3.00e-01
|
0.07160
|
-1.23e-02
|
7.05e-02
|
6.24e-01
|
5.12e-03
|
GOBP VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT
|
58
|
6.05e-01
|
8.96e-01
|
0.07150
|
5.77e-02
|
4.23e-02
|
4.47e-01
|
5.77e-01
|
GOMF GAP JUNCTION CHANNEL ACTIVITY INVOLVED IN CELL COMMUNICATION BY ELECTRICAL COUPLING
|
8
|
9.34e-01
|
9.87e-01
|
0.07150
|
6.29e-02
|
3.39e-02
|
7.58e-01
|
8.68e-01
|
GOBP NEGATIVE REGULATION OF CELL CELL ADHESION
|
196
|
2.46e-01
|
7.26e-01
|
0.07150
|
-2.20e-02
|
6.80e-02
|
5.96e-01
|
1.01e-01
|
GOBP REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE
|
21
|
8.33e-01
|
9.64e-01
|
0.07150
|
-4.85e-02
|
-5.25e-02
|
7.00e-01
|
6.77e-01
|
GOBP SYNAPTIC VESICLE LUMEN ACIDIFICATION
|
14
|
8.86e-01
|
9.76e-01
|
0.07150
|
-4.39e-02
|
-5.64e-02
|
7.76e-01
|
7.15e-01
|
GOBP REGULATION OF T HELPER CELL DIFFERENTIATION
|
42
|
6.98e-01
|
9.21e-01
|
0.07140
|
6.14e-02
|
3.65e-02
|
4.91e-01
|
6.83e-01
|
GOBP EXTRINSIC APOPTOTIC SIGNALING PATHWAY
|
221
|
1.99e-01
|
6.89e-01
|
0.07140
|
-1.48e-02
|
6.98e-02
|
7.05e-01
|
7.36e-02
|
GOCC TRANS GOLGI NETWORK MEMBRANE
|
100
|
4.96e-01
|
8.59e-01
|
0.07140
|
-6.50e-02
|
2.94e-02
|
2.61e-01
|
6.12e-01
|
GOBP REGULATION OF NERVOUS SYSTEM DEVELOPMENT
|
445
|
4.69e-02
|
4.37e-01
|
0.07130
|
-3.07e-02
|
6.44e-02
|
2.68e-01
|
1.98e-02
|
GOBP COLLATERAL SPROUTING
|
26
|
8.37e-01
|
9.64e-01
|
0.07130
|
-5.87e-02
|
4.05e-02
|
6.05e-01
|
7.21e-01
|
GOBP MRNA TRANSPORT
|
113
|
3.93e-01
|
8.22e-01
|
0.07130
|
-6.73e-02
|
-2.35e-02
|
2.17e-01
|
6.67e-01
|
GOBP REGULATION OF TELOMERE MAINTENANCE
|
98
|
4.59e-01
|
8.48e-01
|
0.07120
|
-9.70e-03
|
-7.06e-02
|
8.68e-01
|
2.27e-01
|
GOBP TISSUE REMODELING
|
178
|
2.76e-01
|
7.50e-01
|
0.07120
|
-1.74e-02
|
6.91e-02
|
6.89e-01
|
1.12e-01
|
GOMF STRUCTURAL CONSTITUENT OF CHROMATIN
|
78
|
5.12e-01
|
8.67e-01
|
0.07120
|
-5.68e-02
|
-4.30e-02
|
3.86e-01
|
5.12e-01
|
GOBP MUSCLE HYPERTROPHY
|
103
|
4.80e-01
|
8.54e-01
|
0.07120
|
-2.23e-02
|
6.76e-02
|
6.96e-01
|
2.36e-01
|
GOMF CYSTEINE TYPE PEPTIDASE ACTIVITY
|
155
|
2.65e-01
|
7.41e-01
|
0.07120
|
-5.44e-02
|
-4.58e-02
|
2.42e-01
|
3.25e-01
|
GOBP POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY
|
126
|
3.81e-01
|
8.16e-01
|
0.07120
|
-7.12e-02
|
1.73e-04
|
1.68e-01
|
9.97e-01
|
GOBP POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS
|
776
|
5.89e-03
|
1.61e-01
|
0.07110
|
-3.83e-02
|
6.00e-02
|
6.96e-02
|
4.49e-03
|
GOBP POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS
|
68
|
6.32e-01
|
9.03e-01
|
0.07110
|
5.45e-02
|
-4.56e-02
|
4.37e-01
|
5.15e-01
|
GOBP REGULATION OF SMOOTHENED SIGNALING PATHWAY
|
84
|
5.51e-01
|
8.80e-01
|
0.07100
|
-2.27e-02
|
6.73e-02
|
7.19e-01
|
2.86e-01
|
GOMF MYOSIN V BINDING
|
16
|
8.82e-01
|
9.75e-01
|
0.07100
|
-7.06e-02
|
-7.56e-03
|
6.25e-01
|
9.58e-01
|
GOBP POSITIVE REGULATION OF SYNAPTIC VESICLE RECYCLING
|
8
|
9.36e-01
|
9.87e-01
|
0.07100
|
-6.60e-02
|
-2.63e-02
|
7.47e-01
|
8.98e-01
|
GOBP REGULATION OF NEUROGENESIS
|
373
|
8.34e-02
|
5.37e-01
|
0.07100
|
-4.31e-02
|
5.64e-02
|
1.53e-01
|
6.14e-02
|
GOBP PITUITARY GLAND DEVELOPMENT
|
40
|
7.46e-01
|
9.38e-01
|
0.07100
|
-6.98e-02
|
1.28e-02
|
4.45e-01
|
8.89e-01
|
GOBP PHOSPHORYLATION
|
1523
|
6.89e-05
|
6.94e-03
|
0.07100
|
-5.47e-02
|
4.53e-02
|
3.64e-04
|
3.14e-03
|
GOMF ENDOPEPTIDASE REGULATOR ACTIVITY
|
173
|
3.13e-01
|
7.76e-01
|
0.07100
|
5.51e-02
|
-4.48e-02
|
2.12e-01
|
3.09e-01
|
GOBP NEGATIVE REGULATION OF MUSCLE CONTRACTION
|
23
|
8.48e-01
|
9.66e-01
|
0.07100
|
-1.93e-02
|
6.83e-02
|
8.73e-01
|
5.71e-01
|
GOMF CADHERIN BINDING
|
329
|
9.41e-02
|
5.57e-01
|
0.07090
|
-6.95e-02
|
1.44e-02
|
3.03e-02
|
6.53e-01
|
GOBP REGULATION OF SOMATIC STEM CELL POPULATION MAINTENANCE
|
12
|
9.19e-01
|
9.84e-01
|
0.07090
|
-6.66e-02
|
2.45e-02
|
6.90e-01
|
8.83e-01
|
GOBP NEGATIVE REGULATION OF RESPONSE TO WOUNDING
|
94
|
5.02e-01
|
8.63e-01
|
0.07090
|
-1.14e-02
|
7.00e-02
|
8.48e-01
|
2.41e-01
|
GOMF ENZYME SUBSTRATE ADAPTOR ACTIVITY
|
61
|
6.38e-01
|
9.06e-01
|
0.07090
|
-7.02e-02
|
1.01e-02
|
3.43e-01
|
8.91e-01
|
GOCC B WICH COMPLEX
|
7
|
9.43e-01
|
9.89e-01
|
0.07090
|
-6.25e-02
|
-3.35e-02
|
7.75e-01
|
8.78e-01
|
GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION
|
27
|
8.21e-01
|
9.60e-01
|
0.07090
|
-1.30e-02
|
6.97e-02
|
9.07e-01
|
5.31e-01
|
GOBP CELLULAR KETONE METABOLIC PROCESS
|
220
|
1.76e-01
|
6.65e-01
|
0.07080
|
-6.96e-02
|
-1.33e-02
|
7.53e-02
|
7.34e-01
|
GOBP ESTABLISHMENT OF ORGANELLE LOCALIZATION
|
454
|
4.85e-02
|
4.41e-01
|
0.07080
|
-6.00e-02
|
3.77e-02
|
2.85e-02
|
1.68e-01
|
GOBP SENSORY PERCEPTION OF MECHANICAL STIMULUS
|
178
|
2.28e-01
|
7.15e-01
|
0.07080
|
6.35e-02
|
3.14e-02
|
1.44e-01
|
4.70e-01
|
GOBP NEGATIVE REGULATION OF EPINEPHRINE SECRETION
|
5
|
9.64e-01
|
9.92e-01
|
0.07080
|
-1.14e-02
|
6.99e-02
|
9.65e-01
|
7.87e-01
|
GOCC ENDOPEPTIDASE COMPLEX
|
83
|
5.50e-01
|
8.80e-01
|
0.07080
|
1.57e-02
|
-6.90e-02
|
8.04e-01
|
2.77e-01
|
GOMF SODIUM CHANNEL REGULATOR ACTIVITY
|
37
|
7.77e-01
|
9.50e-01
|
0.07080
|
-3.45e-02
|
6.18e-02
|
7.17e-01
|
5.15e-01
|
GOBP POSITIVE REGULATION OF DNA REPLICATION
|
37
|
7.79e-01
|
9.51e-01
|
0.07080
|
3.94e-02
|
-5.88e-02
|
6.79e-01
|
5.36e-01
|
GOBP RESPONSE TO ESTRADIOL
|
111
|
3.91e-01
|
8.21e-01
|
0.07070
|
-4.37e-02
|
-5.56e-02
|
4.26e-01
|
3.12e-01
|
GOBP CELL DIVISION
|
614
|
8.79e-03
|
1.97e-01
|
0.07070
|
-6.97e-02
|
-1.22e-02
|
3.20e-03
|
6.05e-01
|
GOBP REGULATION OF PROTEIN DEPHOSPHORYLATION
|
75
|
5.71e-01
|
8.87e-01
|
0.07070
|
-3.99e-03
|
7.06e-02
|
9.52e-01
|
2.91e-01
|
GOBP ENDODERMAL CELL DIFFERENTIATION
|
48
|
6.89e-01
|
9.19e-01
|
0.07060
|
7.02e-03
|
7.03e-02
|
9.33e-01
|
4.00e-01
|
GOBP CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS
|
302
|
1.22e-01
|
6.03e-01
|
0.07060
|
-6.73e-02
|
2.13e-02
|
4.43e-02
|
5.25e-01
|
GOMF ENZYME ACTIVATOR ACTIVITY
|
544
|
2.91e-02
|
3.54e-01
|
0.07060
|
-5.18e-02
|
4.80e-02
|
3.90e-02
|
5.56e-02
|
GOBP VIRAL LIFE CYCLE
|
308
|
8.07e-02
|
5.30e-01
|
0.07060
|
-6.38e-02
|
-3.02e-02
|
5.43e-02
|
3.62e-01
|
GOBP REGULATION OF MELANOCYTE DIFFERENTIATION
|
6
|
9.50e-01
|
9.90e-01
|
0.07050
|
-4.87e-02
|
-5.10e-02
|
8.36e-01
|
8.29e-01
|
GOMF PROTEIN PHOSPHATASE BINDING
|
139
|
3.97e-01
|
8.25e-01
|
0.07050
|
-4.30e-02
|
5.59e-02
|
3.82e-01
|
2.55e-01
|
GOBP STEM CELL DEVELOPMENT
|
87
|
5.52e-01
|
8.80e-01
|
0.07040
|
-2.95e-02
|
6.40e-02
|
6.35e-01
|
3.02e-01
|
GOBP POSITIVE REGULATION OF VACUOLE ORGANIZATION
|
23
|
8.59e-01
|
9.68e-01
|
0.07040
|
-4.77e-02
|
5.18e-02
|
6.92e-01
|
6.67e-01
|
GOMF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY
|
70
|
6.30e-01
|
9.02e-01
|
0.07040
|
-4.68e-02
|
5.25e-02
|
4.98e-01
|
4.47e-01
|
GOBP NUCLEAR RNA SURVEILLANCE
|
14
|
9.05e-01
|
9.80e-01
|
0.07040
|
1.64e-02
|
-6.84e-02
|
9.15e-01
|
6.58e-01
|
GOMF PHOSPHORIC ESTER HYDROLASE ACTIVITY
|
343
|
9.13e-02
|
5.51e-01
|
0.07040
|
-1.77e-02
|
6.81e-02
|
5.73e-01
|
3.02e-02
|
GOBP CELLULAR RESPONSE TO COLD
|
13
|
9.06e-01
|
9.81e-01
|
0.07030
|
7.03e-02
|
1.54e-03
|
6.61e-01
|
9.92e-01
|
GOCC MICROBODY
|
143
|
3.40e-01
|
7.91e-01
|
0.07030
|
-2.91e-03
|
-7.02e-02
|
9.52e-01
|
1.47e-01
|
GOBP POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS
|
696
|
1.08e-02
|
2.23e-01
|
0.07030
|
-3.57e-02
|
6.05e-02
|
1.08e-01
|
6.53e-03
|
GOBP POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY
|
102
|
4.90e-01
|
8.57e-01
|
0.07020
|
-6.75e-02
|
1.94e-02
|
2.39e-01
|
7.35e-01
|
GOBP POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY
|
36
|
7.80e-01
|
9.52e-01
|
0.07020
|
-6.58e-02
|
2.45e-02
|
4.95e-01
|
7.99e-01
|
GOMF CYTOKINE ACTIVITY
|
226
|
1.80e-01
|
6.70e-01
|
0.07020
|
6.99e-02
|
6.20e-03
|
7.01e-02
|
8.72e-01
|
GOMF CHLORIDE CHANNEL INHIBITOR ACTIVITY
|
6
|
9.54e-01
|
9.90e-01
|
0.07020
|
-6.93e-02
|
-1.11e-02
|
7.69e-01
|
9.63e-01
|
GOCC CELL PROJECTION MEMBRANE
|
338
|
1.10e-01
|
5.87e-01
|
0.07020
|
-4.24e-02
|
5.59e-02
|
1.80e-01
|
7.75e-02
|
GOBP MONOATOMIC CATION TRANSPORT
|
996
|
5.23e-04
|
3.21e-02
|
0.07010
|
1.87e-02
|
6.76e-02
|
3.18e-01
|
3.08e-04
|
GOBP LIPID OXIDATION
|
112
|
4.55e-01
|
8.46e-01
|
0.07000
|
-6.83e-02
|
1.53e-02
|
2.12e-01
|
7.79e-01
|
GOCC LYSOSOMAL LUMEN
|
91
|
5.20e-01
|
8.69e-01
|
0.07000
|
-9.73e-03
|
6.93e-02
|
8.73e-01
|
2.53e-01
|
GOMF CULLIN FAMILY PROTEIN BINDING
|
24
|
8.53e-01
|
9.67e-01
|
0.07000
|
-3.62e-02
|
5.99e-02
|
7.59e-01
|
6.12e-01
|
GOBP HEART MORPHOGENESIS
|
262
|
1.68e-01
|
6.54e-01
|
0.06990
|
-2.30e-02
|
6.60e-02
|
5.21e-01
|
6.57e-02
|
GOBP TISSUE MIGRATION
|
364
|
6.05e-02
|
4.78e-01
|
0.06990
|
1.58e-02
|
6.81e-02
|
6.05e-01
|
2.56e-02
|
GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX PROTON TRANSPORTING DOMAIN
|
23
|
8.57e-01
|
9.68e-01
|
0.06990
|
-6.28e-02
|
3.07e-02
|
6.02e-01
|
7.99e-01
|
GOBP REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY
|
10
|
9.28e-01
|
9.85e-01
|
0.06990
|
-3.39e-03
|
-6.98e-02
|
9.85e-01
|
7.02e-01
|
GOBP REGULATION OF CELL SIZE
|
176
|
3.15e-01
|
7.76e-01
|
0.06990
|
-3.71e-02
|
5.92e-02
|
3.96e-01
|
1.75e-01
|
GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION
|
9
|
9.30e-01
|
9.86e-01
|
0.06990
|
-6.48e-02
|
-2.63e-02
|
7.37e-01
|
8.91e-01
|
GOCC PLASMA MEMBRANE PROTEIN COMPLEX
|
564
|
1.09e-02
|
2.23e-01
|
0.06980
|
3.60e-02
|
5.98e-02
|
1.44e-01
|
1.51e-02
|
GOBP RESPONSE TO CORTICOSTEROID
|
143
|
3.59e-01
|
8.01e-01
|
0.06980
|
8.16e-03
|
-6.94e-02
|
8.66e-01
|
1.52e-01
|
GOBP POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION
|
41
|
7.60e-01
|
9.44e-01
|
0.06980
|
-3.13e-02
|
6.24e-02
|
7.29e-01
|
4.89e-01
|
GOBP REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY
|
22
|
8.33e-01
|
9.64e-01
|
0.06980
|
4.43e-02
|
5.40e-02
|
7.19e-01
|
6.61e-01
|
GOCC NEURON PROJECTION MEMBRANE
|
56
|
6.29e-01
|
9.02e-01
|
0.06980
|
4.33e-02
|
5.47e-02
|
5.75e-01
|
4.79e-01
|
GOBP NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY
|
13
|
9.03e-01
|
9.80e-01
|
0.06980
|
-1.95e-02
|
-6.70e-02
|
9.03e-01
|
6.76e-01
|
GOBP CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT
|
201
|
2.74e-01
|
7.48e-01
|
0.06970
|
-4.61e-02
|
5.23e-02
|
2.60e-01
|
2.01e-01
|
GOBP FIBROBLAST APOPTOTIC PROCESS
|
25
|
8.28e-01
|
9.62e-01
|
0.06970
|
-6.16e-03
|
-6.94e-02
|
9.57e-01
|
5.48e-01
|
GOMF GLYCOSAMINOGLYCAN BINDING
|
233
|
1.64e-01
|
6.49e-01
|
0.06960
|
6.73e-02
|
1.80e-02
|
7.69e-02
|
6.36e-01
|
GOMF PLUS END DIRECTED MICROTUBULE MOTOR ACTIVITY
|
16
|
8.79e-01
|
9.75e-01
|
0.06960
|
-6.30e-02
|
-2.96e-02
|
6.62e-01
|
8.38e-01
|
GOBP POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE
|
133
|
3.36e-01
|
7.88e-01
|
0.06960
|
-5.25e-02
|
-4.57e-02
|
2.96e-01
|
3.63e-01
|
GOCC NUCLEAR SPECK
|
395
|
4.84e-02
|
4.41e-01
|
0.06960
|
-6.74e-02
|
-1.72e-02
|
2.14e-02
|
5.56e-01
|
GOBP HEART GROWTH
|
94
|
5.33e-01
|
8.76e-01
|
0.06960
|
-2.74e-02
|
6.40e-02
|
6.46e-01
|
2.84e-01
|
GOBP POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS
|
80
|
5.85e-01
|
8.90e-01
|
0.06960
|
-6.40e-02
|
2.74e-02
|
3.23e-01
|
6.71e-01
|
GOCC CHROMOSOMAL REGION
|
380
|
4.66e-02
|
4.37e-01
|
0.06950
|
-4.09e-02
|
-5.63e-02
|
1.71e-01
|
5.97e-02
|
GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX
|
46
|
6.86e-01
|
9.18e-01
|
0.06950
|
-5.61e-02
|
-4.10e-02
|
5.10e-01
|
6.30e-01
|
GOCC LEADING EDGE MEMBRANE
|
174
|
2.72e-01
|
7.47e-01
|
0.06950
|
7.49e-03
|
6.91e-02
|
8.65e-01
|
1.16e-01
|
GOBP POSITIVE REGULATION OF GLUCOSE IMPORT
|
35
|
7.57e-01
|
9.43e-01
|
0.06950
|
2.49e-02
|
6.49e-02
|
7.99e-01
|
5.06e-01
|
GOBP PHOSPHATIDYLINOSITOL PHOSPHATE BIOSYNTHETIC PROCESS
|
63
|
6.59e-01
|
9.09e-01
|
0.06950
|
-3.10e-02
|
6.22e-02
|
6.70e-01
|
3.93e-01
|
GOBP DNA SYNTHESIS INVOLVED IN DNA REPAIR
|
39
|
7.43e-01
|
9.38e-01
|
0.06950
|
-6.86e-02
|
-1.08e-02
|
4.58e-01
|
9.07e-01
|
GOBP EXTERNAL ENCAPSULATING STRUCTURE ORGANIZATION
|
311
|
9.67e-02
|
5.61e-01
|
0.06950
|
1.10e-02
|
6.86e-02
|
7.40e-01
|
3.75e-02
|
GOBP CELL CELL SIGNALING BY WNT
|
441
|
4.91e-02
|
4.42e-01
|
0.06940
|
-1.43e-02
|
6.79e-02
|
6.07e-01
|
1.45e-02
|
GOBP PROTEIN EXPORT FROM NUCLEUS
|
59
|
6.47e-01
|
9.07e-01
|
0.06940
|
-6.93e-02
|
-2.94e-03
|
3.57e-01
|
9.69e-01
|
GOBP REGULATION OF GLUCOSE IMPORT
|
58
|
6.48e-01
|
9.07e-01
|
0.06940
|
6.40e-03
|
6.91e-02
|
9.33e-01
|
3.63e-01
|
GOBP SMOOTH MUSCLE CELL PROLIFERATION
|
160
|
3.56e-01
|
7.97e-01
|
0.06940
|
-3.83e-02
|
5.78e-02
|
4.03e-01
|
2.07e-01
|
GOBP CELL CELL ADHESION
|
919
|
1.08e-03
|
5.38e-02
|
0.06930
|
1.77e-02
|
6.70e-02
|
3.63e-01
|
5.71e-04
|
GOBP REGULATION OF TUBE SIZE
|
141
|
3.17e-01
|
7.77e-01
|
0.06930
|
4.70e-02
|
5.10e-02
|
3.36e-01
|
2.96e-01
|
GOBP PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM EXIT SITE
|
6
|
9.61e-01
|
9.91e-01
|
0.06930
|
-6.15e-02
|
3.20e-02
|
7.94e-01
|
8.92e-01
|
GOCC SARCOPLASM
|
90
|
4.86e-01
|
8.56e-01
|
0.06930
|
6.04e-02
|
3.40e-02
|
3.22e-01
|
5.78e-01
|
GOBP PROTEIN N LINKED GLYCOSYLATION
|
68
|
6.06e-01
|
8.97e-01
|
0.06920
|
-6.91e-02
|
-3.77e-03
|
3.24e-01
|
9.57e-01
|
GOBP EMBRYO DEVELOPMENT
|
1092
|
1.20e-03
|
5.80e-02
|
0.06920
|
-5.76e-02
|
3.84e-02
|
1.31e-03
|
3.22e-02
|
GOMF PURINE NUCLEOTIDE BINDING
|
1888
|
5.16e-06
|
9.42e-04
|
0.06920
|
-6.86e-02
|
9.44e-03
|
8.06e-07
|
4.97e-01
|
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION
|
107
|
4.59e-01
|
8.48e-01
|
0.06920
|
1.71e-03
|
6.91e-02
|
9.76e-01
|
2.17e-01
|
GOBP INTERLEUKIN 12 PRODUCTION
|
62
|
6.65e-01
|
9.10e-01
|
0.06910
|
-6.27e-02
|
2.91e-02
|
3.93e-01
|
6.91e-01
|
GOBP ADHERENS JUNCTION ORGANIZATION
|
57
|
6.87e-01
|
9.19e-01
|
0.06910
|
-2.97e-02
|
6.24e-02
|
6.98e-01
|
4.15e-01
|
GOBP REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS
|
140
|
4.11e-01
|
8.27e-01
|
0.06910
|
-5.00e-02
|
4.78e-02
|
3.07e-01
|
3.29e-01
|
GOMF MICROTUBULE BINDING
|
261
|
1.78e-01
|
6.67e-01
|
0.06910
|
-6.48e-02
|
2.40e-02
|
7.15e-02
|
5.04e-01
|
GOBP REGULATION OF SYSTEM PROCESS
|
539
|
3.21e-02
|
3.67e-01
|
0.06910
|
-3.22e-02
|
6.11e-02
|
2.00e-01
|
1.52e-02
|
GOBP LACTATION
|
37
|
7.74e-01
|
9.49e-01
|
0.06910
|
6.79e-02
|
-1.28e-02
|
4.75e-01
|
8.93e-01
|
GOCC CHROMOSOME PASSENGER COMPLEX
|
6
|
9.52e-01
|
9.90e-01
|
0.06900
|
-5.28e-02
|
-4.44e-02
|
8.23e-01
|
8.50e-01
|
GOBP REGULATION OF CELL DEVELOPMENT
|
814
|
6.69e-03
|
1.70e-01
|
0.06900
|
-4.33e-02
|
5.37e-02
|
3.57e-02
|
9.21e-03
|
GOBP REGULATION OF CELLULAR COMPONENT SIZE
|
350
|
9.22e-02
|
5.54e-01
|
0.06900
|
-1.28e-02
|
6.78e-02
|
6.82e-01
|
2.94e-02
|
GOBP TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY
|
391
|
8.58e-02
|
5.44e-01
|
0.06890
|
-4.14e-02
|
5.52e-02
|
1.60e-01
|
6.12e-02
|
GOMF PROTEIN SELF ASSOCIATION
|
70
|
6.37e-01
|
9.06e-01
|
0.06890
|
-3.55e-02
|
5.91e-02
|
6.08e-01
|
3.93e-01
|
GOBP CELL CYCLE
|
1732
|
9.19e-06
|
1.47e-03
|
0.06890
|
-6.89e-02
|
-1.47e-03
|
1.87e-06
|
9.19e-01
|
GOBP NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION
|
162
|
3.60e-01
|
8.01e-01
|
0.06890
|
-4.38e-02
|
5.31e-02
|
3.36e-01
|
2.43e-01
|
GOBP PROTEIN PROCESSING INVOLVED IN PROTEIN TARGETING TO MITOCHONDRION
|
7
|
9.46e-01
|
9.90e-01
|
0.06880
|
-3.23e-02
|
-6.08e-02
|
8.82e-01
|
7.81e-01
|
GOBP REGULATION OF MUSCLE ADAPTATION
|
92
|
5.46e-01
|
8.78e-01
|
0.06880
|
-2.51e-02
|
6.40e-02
|
6.77e-01
|
2.88e-01
|
GOBP FAT SOLUBLE VITAMIN METABOLIC PROCESS
|
45
|
7.08e-01
|
9.25e-01
|
0.06880
|
6.59e-02
|
1.98e-02
|
4.45e-01
|
8.18e-01
|
GOBP REGULATION OF AUTOPHAGOSOME ASSEMBLY
|
42
|
7.32e-01
|
9.33e-01
|
0.06880
|
6.82e-02
|
9.13e-03
|
4.45e-01
|
9.18e-01
|
GOBP NATURAL KILLER CELL ACTIVATION
|
92
|
5.04e-01
|
8.64e-01
|
0.06870
|
6.77e-02
|
1.19e-02
|
2.62e-01
|
8.43e-01
|
GOBP REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION
|
41
|
7.25e-01
|
9.30e-01
|
0.06870
|
-6.18e-02
|
-2.99e-02
|
4.93e-01
|
7.41e-01
|
GOCC TRANSFERASE COMPLEX TRANSFERRING PHOSPHORUS CONTAINING GROUPS
|
271
|
1.53e-01
|
6.41e-01
|
0.06860
|
-6.83e-02
|
6.01e-03
|
5.28e-02
|
8.65e-01
|
GOBP CELLULAR RESPONSE TO NUTRIENT
|
45
|
7.49e-01
|
9.40e-01
|
0.06860
|
-5.98e-02
|
3.35e-02
|
4.87e-01
|
6.97e-01
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS DISULFIDE AS ACCEPTOR
|
8
|
9.38e-01
|
9.88e-01
|
0.06860
|
4.73e-02
|
4.97e-02
|
8.17e-01
|
8.08e-01
|
GOCC NEURON PROJECTION CYTOPLASM
|
82
|
5.84e-01
|
8.90e-01
|
0.06860
|
-2.48e-02
|
6.39e-02
|
6.97e-01
|
3.17e-01
|
GOBP POSITIVE REGULATION OF TYPE II INTERFERON PRODUCTION
|
74
|
5.78e-01
|
8.89e-01
|
0.06860
|
6.77e-02
|
1.11e-02
|
3.14e-01
|
8.68e-01
|
GOMF ORGANIC ACID BINDING
|
211
|
2.08e-01
|
6.97e-01
|
0.06860
|
6.71e-02
|
1.43e-02
|
9.32e-02
|
7.21e-01
|
GOBP MESODERMAL CELL FATE COMMITMENT
|
17
|
8.77e-01
|
9.75e-01
|
0.06860
|
-6.38e-02
|
-2.50e-02
|
6.49e-01
|
8.59e-01
|
GOCC MITOTIC SPINDLE
|
175
|
2.58e-01
|
7.35e-01
|
0.06850
|
-6.23e-02
|
-2.85e-02
|
1.55e-01
|
5.16e-01
|
GOBP NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS
|
43
|
7.09e-01
|
9.26e-01
|
0.06850
|
-5.09e-02
|
-4.59e-02
|
5.64e-01
|
6.02e-01
|
GOBP CYTOSKELETON ORGANIZATION
|
1442
|
1.91e-04
|
1.48e-02
|
0.06850
|
-3.73e-02
|
5.74e-02
|
1.77e-02
|
2.59e-04
|
GOBP TRICARBOXYLIC ACID METABOLIC PROCESS
|
14
|
9.12e-01
|
9.82e-01
|
0.06850
|
-6.38e-02
|
2.49e-02
|
6.79e-01
|
8.72e-01
|
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION
|
44
|
7.18e-01
|
9.29e-01
|
0.06850
|
6.64e-02
|
1.65e-02
|
4.46e-01
|
8.50e-01
|
GOBP ACTIN FILAMENT BASED MOVEMENT
|
128
|
3.62e-01
|
8.03e-01
|
0.06840
|
4.79e-02
|
4.89e-02
|
3.50e-01
|
3.40e-01
|
GOBP COCHLEA DEVELOPMENT
|
46
|
6.96e-01
|
9.21e-01
|
0.06840
|
5.85e-02
|
3.54e-02
|
4.92e-01
|
6.78e-01
|
GOBP REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS
|
17
|
8.81e-01
|
9.75e-01
|
0.06830
|
-1.49e-02
|
-6.67e-02
|
9.15e-01
|
6.34e-01
|
GOCC PEPTIDASE COMPLEX
|
116
|
4.28e-01
|
8.36e-01
|
0.06830
|
-1.02e-02
|
-6.75e-02
|
8.50e-01
|
2.09e-01
|
GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION
|
121
|
4.73e-01
|
8.53e-01
|
0.06820
|
-4.90e-02
|
4.75e-02
|
3.52e-01
|
3.67e-01
|
GOBP POSITIVE REGULATION OF RESPONSE TO WOUNDING
|
73
|
5.99e-01
|
8.95e-01
|
0.06810
|
-6.81e-02
|
1.10e-03
|
3.14e-01
|
9.87e-01
|
GOBP POSITIVE REGULATION OF CATABOLIC PROCESS
|
575
|
2.68e-02
|
3.41e-01
|
0.06810
|
-6.30e-02
|
2.59e-02
|
9.80e-03
|
2.89e-01
|
GOBP CELLULAR PIGMENTATION
|
60
|
6.39e-01
|
9.06e-01
|
0.06810
|
-6.57e-02
|
-1.79e-02
|
3.78e-01
|
8.11e-01
|
GOBP CELL RECOGNITION
|
152
|
3.83e-01
|
8.16e-01
|
0.06810
|
6.05e-02
|
-3.12e-02
|
1.98e-01
|
5.06e-01
|
GOMF PEPTIDASE REGULATOR ACTIVITY
|
215
|
2.61e-01
|
7.38e-01
|
0.06810
|
5.89e-02
|
-3.41e-02
|
1.36e-01
|
3.89e-01
|
GOMF TRANSLATION REPRESSOR ACTIVITY
|
275
|
1.23e-01
|
6.06e-01
|
0.06800
|
6.17e-02
|
2.88e-02
|
7.84e-02
|
4.11e-01
|
GOBP REGULATION OF GLUCONEOGENESIS
|
50
|
6.77e-01
|
9.14e-01
|
0.06800
|
-5.79e-02
|
-3.57e-02
|
4.79e-01
|
6.62e-01
|
GOBP STEROID HORMONE MEDIATED SIGNALING PATHWAY
|
129
|
4.20e-01
|
8.33e-01
|
0.06800
|
-6.71e-02
|
1.15e-02
|
1.88e-01
|
8.22e-01
|
GOBP CELLULAR COMPONENT MORPHOGENESIS
|
753
|
8.79e-03
|
1.97e-01
|
0.06800
|
-2.27e-02
|
6.41e-02
|
2.89e-01
|
2.74e-03
|
GOBP POSITIVE REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY
|
18
|
8.83e-01
|
9.76e-01
|
0.06800
|
5.29e-03
|
-6.78e-02
|
9.69e-01
|
6.19e-01
|
GOBP NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS
|
31
|
7.99e-01
|
9.56e-01
|
0.06800
|
-6.76e-02
|
-7.80e-03
|
5.15e-01
|
9.40e-01
|
GOBP CELL CYCLE G1 S PHASE TRANSITION
|
264
|
1.58e-01
|
6.46e-01
|
0.06800
|
-6.79e-02
|
-2.01e-03
|
5.74e-02
|
9.55e-01
|
GOBP MONOATOMIC ION TRANSMEMBRANE TRANSPORT
|
975
|
1.08e-03
|
5.38e-02
|
0.06800
|
1.19e-02
|
6.69e-02
|
5.28e-01
|
4.04e-04
|
GOBP NEGATIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION
|
8
|
9.43e-01
|
9.89e-01
|
0.06790
|
-1.39e-02
|
-6.65e-02
|
9.46e-01
|
7.45e-01
|
GOBP RRNA MODIFICATION
|
31
|
7.99e-01
|
9.56e-01
|
0.06790
|
-9.69e-03
|
-6.72e-02
|
9.26e-01
|
5.17e-01
|
GOBP ENDOTHELIAL CELL DEVELOPMENT
|
65
|
6.59e-01
|
9.09e-01
|
0.06790
|
-2.49e-02
|
6.31e-02
|
7.28e-01
|
3.79e-01
|
GOBP NEGATIVE REGULATION OF MEMBRANE POTENTIAL
|
12
|
9.15e-01
|
9.83e-01
|
0.06780
|
1.70e-02
|
6.57e-02
|
9.19e-01
|
6.94e-01
|
GOBP PHAGOCYTOSIS ENGULFMENT
|
46
|
7.53e-01
|
9.41e-01
|
0.06780
|
-4.30e-02
|
5.24e-02
|
6.14e-01
|
5.39e-01
|
GOBP CELLULAR RESPONSE TO DECREASED OXYGEN LEVELS
|
145
|
3.26e-01
|
7.82e-01
|
0.06780
|
-3.78e-02
|
-5.63e-02
|
4.33e-01
|
2.42e-01
|
GOBP CARDIAC CELL FATE COMMITMENT
|
16
|
9.01e-01
|
9.79e-01
|
0.06780
|
1.98e-02
|
-6.48e-02
|
8.91e-01
|
6.53e-01
|
GOBP REGULATION OF CELL MATRIX ADHESION
|
121
|
4.58e-01
|
8.48e-01
|
0.06780
|
-2.10e-02
|
6.44e-02
|
6.90e-01
|
2.21e-01
|
GOBP REGULATION OF INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION
|
9
|
9.46e-01
|
9.90e-01
|
0.06770
|
3.66e-02
|
-5.70e-02
|
8.49e-01
|
7.67e-01
|
GOBP CALCIUM IMPORT INTO THE MITOCHONDRION
|
12
|
9.23e-01
|
9.84e-01
|
0.06770
|
-6.67e-02
|
1.17e-02
|
6.89e-01
|
9.44e-01
|
GOBP POST TRANSLATIONAL PROTEIN MODIFICATION
|
993
|
1.41e-03
|
6.51e-02
|
0.06770
|
-6.77e-02
|
2.12e-03
|
3.07e-04
|
9.10e-01
|
GOBP MESENCHYME DEVELOPMENT
|
311
|
1.14e-01
|
5.91e-01
|
0.06770
|
4.88e-03
|
6.75e-02
|
8.82e-01
|
4.06e-02
|
GOBP SYNAPSE ASSEMBLY
|
184
|
2.40e-01
|
7.25e-01
|
0.06770
|
4.78e-02
|
4.79e-02
|
2.63e-01
|
2.63e-01
|
GOBP REGULATION OF PHOSPHOLIPASE ACTIVITY
|
57
|
6.45e-01
|
9.07e-01
|
0.06770
|
3.53e-02
|
5.77e-02
|
6.45e-01
|
4.51e-01
|
GOBP REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY
|
403
|
8.66e-02
|
5.46e-01
|
0.06760
|
-5.62e-02
|
3.76e-02
|
5.28e-02
|
1.95e-01
|
GOBP POSITIVE REGULATION OF PEPTIDASE ACTIVITY
|
167
|
2.88e-01
|
7.59e-01
|
0.06760
|
-6.33e-02
|
-2.37e-02
|
1.58e-01
|
5.97e-01
|
GOBP CELL ADHESION
|
1464
|
3.19e-05
|
3.93e-03
|
0.06760
|
2.67e-02
|
6.21e-02
|
8.72e-02
|
6.94e-05
|
GOBP ACTIVATION OF PROTEIN KINASE ACTIVITY
|
86
|
5.75e-01
|
8.88e-01
|
0.06760
|
-2.08e-02
|
6.43e-02
|
7.39e-01
|
3.02e-01
|
GOBP RESPONSE TO INTERLEUKIN 4
|
33
|
8.03e-01
|
9.57e-01
|
0.06760
|
-6.64e-02
|
1.27e-02
|
5.09e-01
|
8.99e-01
|
GOBP NUCLEOBASE METABOLIC PROCESS
|
38
|
7.50e-01
|
9.40e-01
|
0.06760
|
2.78e-02
|
6.16e-02
|
7.67e-01
|
5.11e-01
|
GOBP PROTEIN LOCALIZATION TO CILIUM
|
70
|
6.50e-01
|
9.07e-01
|
0.06760
|
5.62e-02
|
-3.74e-02
|
4.16e-01
|
5.88e-01
|
GOBP REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY
|
9
|
9.46e-01
|
9.90e-01
|
0.06760
|
5.86e-02
|
-3.36e-02
|
7.61e-01
|
8.61e-01
|
GOBP VESICLE CYTOSKELETAL TRAFFICKING
|
68
|
6.61e-01
|
9.09e-01
|
0.06750
|
-5.19e-02
|
4.32e-02
|
4.59e-01
|
5.38e-01
|
GOBP ASTROCYTE ACTIVATION
|
25
|
8.32e-01
|
9.64e-01
|
0.06750
|
1.82e-02
|
6.50e-02
|
8.75e-01
|
5.74e-01
|
GOBP REGULATION OF MESONEPHROS DEVELOPMENT
|
5
|
9.63e-01
|
9.91e-01
|
0.06750
|
-5.94e-02
|
-3.20e-02
|
8.18e-01
|
9.01e-01
|
GOMF PROTEIN PHOSPHATASE 2A BINDING
|
27
|
8.14e-01
|
9.59e-01
|
0.06750
|
5.96e-02
|
3.16e-02
|
5.92e-01
|
7.76e-01
|
GOBP REGULATION OF WOUND HEALING
|
129
|
4.43e-01
|
8.40e-01
|
0.06740
|
-2.44e-02
|
6.29e-02
|
6.33e-01
|
2.17e-01
|
GOMF RNA METHYLTRANSFERASE ACTIVITY
|
61
|
6.27e-01
|
9.02e-01
|
0.06740
|
-5.71e-02
|
-3.59e-02
|
4.41e-01
|
6.27e-01
|
GOMF EPIDERMAL GROWTH FACTOR RECEPTOR BINDING
|
34
|
8.13e-01
|
9.59e-01
|
0.06740
|
-4.69e-02
|
4.85e-02
|
6.36e-01
|
6.25e-01
|
GOBP EPITHELIAL STRUCTURE MAINTENANCE
|
33
|
7.90e-01
|
9.54e-01
|
0.06740
|
9.50e-03
|
6.67e-02
|
9.25e-01
|
5.07e-01
|
GOBP TYPE B PANCREATIC CELL DIFFERENTIATION
|
30
|
8.20e-01
|
9.60e-01
|
0.06740
|
-6.63e-02
|
1.21e-02
|
5.30e-01
|
9.09e-01
|
GOBP PROTEIN LOCALIZATION TO PERINUCLEAR REGION OF CYTOPLASM
|
9
|
9.43e-01
|
9.89e-01
|
0.06740
|
6.56e-02
|
-1.53e-02
|
7.33e-01
|
9.37e-01
|
GOMF 5S RRNA BINDING
|
9
|
9.45e-01
|
9.90e-01
|
0.06740
|
-2.97e-02
|
6.05e-02
|
8.78e-01
|
7.53e-01
|
GOBP REGULATION OF ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION
|
6
|
9.55e-01
|
9.90e-01
|
0.06730
|
3.36e-02
|
5.84e-02
|
8.87e-01
|
8.04e-01
|
GOBP NEURON MIGRATION
|
166
|
3.65e-01
|
8.06e-01
|
0.06730
|
3.94e-02
|
-5.47e-02
|
3.82e-01
|
2.24e-01
|
GOBP POSITIVE REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS
|
14
|
9.13e-01
|
9.82e-01
|
0.06730
|
1.50e-02
|
-6.57e-02
|
9.23e-01
|
6.71e-01
|
GOBP EYE PHOTORECEPTOR CELL DIFFERENTIATION
|
47
|
7.53e-01
|
9.41e-01
|
0.06720
|
4.74e-02
|
-4.76e-02
|
5.74e-01
|
5.72e-01
|
GOBP NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS
|
35
|
7.76e-01
|
9.50e-01
|
0.06720
|
1.57e-02
|
6.54e-02
|
8.73e-01
|
5.03e-01
|
GOBP CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE
|
52
|
6.71e-01
|
9.12e-01
|
0.06720
|
4.35e-02
|
5.12e-02
|
5.87e-01
|
5.23e-01
|
GOCC NUCLEAR INNER MEMBRANE
|
54
|
6.84e-01
|
9.17e-01
|
0.06720
|
-7.17e-03
|
-6.68e-02
|
9.27e-01
|
3.96e-01
|
GOBP HOMEOSTATIC PROCESS
|
1658
|
9.49e-05
|
9.04e-03
|
0.06710
|
-4.34e-02
|
5.12e-02
|
3.24e-03
|
5.15e-04
|
GOBP REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY
|
117
|
4.45e-01
|
8.40e-01
|
0.06710
|
4.12e-03
|
6.70e-02
|
9.39e-01
|
2.11e-01
|
GOBP REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC
|
75
|
5.87e-01
|
8.91e-01
|
0.06710
|
6.60e-02
|
1.17e-02
|
3.23e-01
|
8.61e-01
|
GOBP NEGATIVE REGULATION OF LOCOMOTION
|
395
|
5.51e-02
|
4.63e-01
|
0.06700
|
2.86e-02
|
6.06e-02
|
3.29e-01
|
3.87e-02
|
GOBP REGULATION OF EPITHELIAL CELL DIFFERENTIATION
|
169
|
3.63e-01
|
8.04e-01
|
0.06700
|
-5.42e-02
|
3.94e-02
|
2.24e-01
|
3.77e-01
|
GOMF L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY
|
62
|
6.23e-01
|
9.01e-01
|
0.06700
|
4.79e-02
|
4.68e-02
|
5.14e-01
|
5.24e-01
|
GOCC CORTICAL CYTOSKELETON
|
101
|
4.67e-01
|
8.51e-01
|
0.06690
|
3.71e-02
|
5.57e-02
|
5.19e-01
|
3.33e-01
|
GOCC NUCLEAR OUTER MEMBRANE ENDOPLASMIC RETICULUM MEMBRANE NETWORK
|
1145
|
2.93e-04
|
2.02e-02
|
0.06690
|
-5.94e-02
|
-3.08e-02
|
6.92e-04
|
7.92e-02
|
GOCC SEX CHROMOSOME
|
33
|
8.19e-01
|
9.60e-01
|
0.06690
|
-3.63e-02
|
5.62e-02
|
7.18e-01
|
5.76e-01
|
GOBP REGULATION OF HEPATOCYTE PROLIFERATION
|
16
|
8.97e-01
|
9.78e-01
|
0.06690
|
6.69e-02
|
2.27e-05
|
6.43e-01
|
1.00e+00
|
GOBP REGULATION OF HEXOKINASE ACTIVITY
|
7
|
9.59e-01
|
9.90e-01
|
0.06690
|
4.10e-02
|
-5.28e-02
|
8.51e-01
|
8.09e-01
|
GOBP INFLAMMATORY RESPONSE
|
845
|
6.89e-03
|
1.74e-01
|
0.06690
|
-5.91e-02
|
3.13e-02
|
3.54e-03
|
1.22e-01
|
GOBP POSITIVE REGULATION OF HYDROLASE ACTIVITY
|
475
|
6.09e-02
|
4.78e-01
|
0.06680
|
-3.89e-02
|
5.44e-02
|
1.47e-01
|
4.23e-02
|
GOBP TRIGLYCERIDE CATABOLIC PROCESS
|
27
|
8.51e-01
|
9.67e-01
|
0.06680
|
-4.77e-02
|
4.69e-02
|
6.68e-01
|
6.73e-01
|
GOBP REGULATION OF CELL PROJECTION ORGANIZATION
|
657
|
1.98e-02
|
3.00e-01
|
0.06680
|
-2.91e-02
|
6.02e-02
|
2.03e-01
|
8.53e-03
|
GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT
|
51
|
6.81e-01
|
9.15e-01
|
0.06680
|
-3.81e-02
|
-5.49e-02
|
6.38e-01
|
4.98e-01
|
GOBP MANCHETTE ASSEMBLY
|
6
|
9.65e-01
|
9.92e-01
|
0.06680
|
-4.98e-02
|
4.45e-02
|
8.33e-01
|
8.50e-01
|
GOBP SKIN DEVELOPMENT
|
309
|
9.87e-02
|
5.66e-01
|
0.06680
|
4.38e-02
|
5.04e-02
|
1.85e-01
|
1.28e-01
|
GOBP VENTRAL SPINAL CORD DEVELOPMENT
|
45
|
7.11e-01
|
9.26e-01
|
0.06680
|
4.77e-02
|
4.67e-02
|
5.80e-01
|
5.87e-01
|
GOBP STEROL TRANSPORT
|
141
|
3.89e-01
|
8.20e-01
|
0.06680
|
-6.67e-02
|
1.90e-03
|
1.71e-01
|
9.69e-01
|
GOBP VESICLE MEDIATED TRANSPORT IN SYNAPSE
|
208
|
2.90e-01
|
7.61e-01
|
0.06680
|
-3.91e-02
|
5.41e-02
|
3.32e-01
|
1.78e-01
|
GOBP REGULATION OF MRNA PROCESSING
|
116
|
4.19e-01
|
8.33e-01
|
0.06670
|
-5.59e-02
|
-3.64e-02
|
2.98e-01
|
4.98e-01
|
GOBP BRANCH ELONGATION OF AN EPITHELIUM
|
19
|
8.77e-01
|
9.75e-01
|
0.06670
|
-6.65e-02
|
-5.80e-03
|
6.16e-01
|
9.65e-01
|
GOBP SPERMATID DIFFERENTIATION
|
201
|
2.33e-01
|
7.20e-01
|
0.06670
|
2.31e-02
|
6.26e-02
|
5.73e-01
|
1.26e-01
|
GOBP ECTODERMAL CELL DIFFERENTIATION
|
6
|
9.58e-01
|
9.90e-01
|
0.06670
|
6.45e-02
|
1.72e-02
|
7.84e-01
|
9.42e-01
|
GOBP REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS
|
81
|
6.18e-01
|
9.00e-01
|
0.06670
|
-5.12e-02
|
4.28e-02
|
4.26e-01
|
5.06e-01
|
GOBP MESENCHYMAL CELL DIFFERENTIATION
|
256
|
2.06e-01
|
6.95e-01
|
0.06670
|
-2.31e-02
|
6.26e-02
|
5.25e-01
|
8.48e-02
|
GOBP POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY
|
12
|
9.24e-01
|
9.84e-01
|
0.06660
|
-6.46e-03
|
6.63e-02
|
9.69e-01
|
6.91e-01
|
GOBP POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION
|
180
|
2.81e-01
|
7.54e-01
|
0.06660
|
1.48e-02
|
6.50e-02
|
7.33e-01
|
1.33e-01
|
GOMF FATZ BINDING
|
5
|
9.71e-01
|
9.93e-01
|
0.06660
|
-3.76e-02
|
5.50e-02
|
8.84e-01
|
8.31e-01
|
GOBP SMOOTH MUSCLE CELL MIGRATION
|
86
|
5.58e-01
|
8.82e-01
|
0.06660
|
2.87e-03
|
6.65e-02
|
9.63e-01
|
2.86e-01
|
GOBP TRANS SYNAPTIC SIGNALING BY LIPID
|
7
|
9.52e-01
|
9.90e-01
|
0.06650
|
-6.55e-02
|
-1.18e-02
|
7.64e-01
|
9.57e-01
|
GOMF RNA POLYMERASE ACTIVITY
|
31
|
8.03e-01
|
9.57e-01
|
0.06650
|
-1.40e-02
|
-6.51e-02
|
8.93e-01
|
5.31e-01
|
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR
|
43
|
7.70e-01
|
9.47e-01
|
0.06650
|
6.02e-02
|
-2.83e-02
|
4.95e-01
|
7.48e-01
|
GOCC CHROMOSOME
|
1814
|
4.56e-06
|
8.51e-04
|
0.06650
|
-5.95e-02
|
-2.98e-02
|
2.64e-05
|
3.52e-02
|
GOBP ENDODERM FORMATION
|
57
|
6.53e-01
|
9.08e-01
|
0.06650
|
3.92e-02
|
5.37e-02
|
6.09e-01
|
4.83e-01
|
GOBP RESPONSE TO VITAMIN E
|
8
|
9.51e-01
|
9.90e-01
|
0.06650
|
-1.85e-02
|
6.39e-02
|
9.28e-01
|
7.54e-01
|
GOBP PROTEIN K48 LINKED DEUBIQUITINATION
|
24
|
8.35e-01
|
9.64e-01
|
0.06650
|
-4.88e-02
|
-4.51e-02
|
6.79e-01
|
7.02e-01
|
GOBP L ASPARTATE IMPORT ACROSS PLASMA MEMBRANE
|
6
|
9.65e-01
|
9.92e-01
|
0.06650
|
4.22e-02
|
-5.14e-02
|
8.58e-01
|
8.28e-01
|
GOBP REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY
|
13
|
9.20e-01
|
9.84e-01
|
0.06650
|
-6.54e-02
|
1.20e-02
|
6.83e-01
|
9.40e-01
|
GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN
|
15
|
8.96e-01
|
9.78e-01
|
0.06640
|
5.98e-02
|
2.89e-02
|
6.88e-01
|
8.47e-01
|
GOCC CYTOPLASMIC SIDE OF PLASMA MEMBRANE
|
164
|
3.40e-01
|
7.91e-01
|
0.06630
|
-2.82e-03
|
6.63e-02
|
9.50e-01
|
1.43e-01
|
GOBP CELL FATE COMMITMENT INVOLVED IN PATTERN SPECIFICATION
|
11
|
9.21e-01
|
9.84e-01
|
0.06630
|
3.90e-02
|
5.36e-02
|
8.23e-01
|
7.58e-01
|
GOBP POSITIVE REGULATION OF ORGANELLE ASSEMBLY
|
82
|
5.43e-01
|
8.78e-01
|
0.06630
|
-4.10e-02
|
-5.20e-02
|
5.21e-01
|
4.15e-01
|
GOCC TRANSCRIPTION REGULATOR COMPLEX
|
481
|
3.49e-02
|
3.81e-01
|
0.06620
|
-6.33e-02
|
-1.94e-02
|
1.73e-02
|
4.67e-01
|
GOBP REGULATION OF MESENCHYMAL STEM CELL DIFFERENTIATION
|
8
|
9.52e-01
|
9.90e-01
|
0.06620
|
-2.27e-02
|
6.22e-02
|
9.11e-01
|
7.61e-01
|
GOBP POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY
|
140
|
4.42e-01
|
8.40e-01
|
0.06620
|
-4.96e-02
|
4.38e-02
|
3.11e-01
|
3.71e-01
|
GOBP NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION
|
89
|
5.86e-01
|
8.90e-01
|
0.06610
|
-5.97e-02
|
2.83e-02
|
3.30e-01
|
6.44e-01
|
GOBP ECTODERM DEVELOPMENT
|
21
|
8.81e-01
|
9.75e-01
|
0.06610
|
-2.68e-02
|
6.04e-02
|
8.32e-01
|
6.32e-01
|
GOBP REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS
|
32
|
8.03e-01
|
9.57e-01
|
0.06600
|
9.80e-03
|
6.53e-02
|
9.24e-01
|
5.23e-01
|
GOBP POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS
|
33
|
7.83e-01
|
9.52e-01
|
0.06600
|
-5.29e-02
|
-3.96e-02
|
5.99e-01
|
6.94e-01
|
GOBP CELLULAR RESPONSE TO PEPTIDE
|
366
|
1.08e-01
|
5.82e-01
|
0.06600
|
-6.31e-02
|
1.94e-02
|
3.81e-02
|
5.24e-01
|
GOMF SECONDARY ACTIVE MONOCARBOXYLATE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
17
|
9.02e-01
|
9.80e-01
|
0.06600
|
2.60e-02
|
-6.07e-02
|
8.53e-01
|
6.65e-01
|
GOMF RNA POLYMERASE II SPECIFIC DNA BINDING TRANSCRIPTION FACTOR BINDING
|
330
|
1.11e-01
|
5.87e-01
|
0.06590
|
-6.56e-02
|
-6.40e-03
|
4.04e-02
|
8.42e-01
|
GOBP PROTEIN LOCALIZATION TO EARLY ENDOSOME
|
11
|
9.24e-01
|
9.84e-01
|
0.06590
|
-2.82e-02
|
-5.96e-02
|
8.71e-01
|
7.32e-01
|
GOBP UBIQUITIN DEPENDENT ERAD PATHWAY
|
82
|
5.51e-01
|
8.80e-01
|
0.06590
|
-5.71e-02
|
-3.29e-02
|
3.71e-01
|
6.07e-01
|
GOBP POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT
|
50
|
7.01e-01
|
9.22e-01
|
0.06590
|
-2.25e-02
|
-6.19e-02
|
7.83e-01
|
4.49e-01
|
GOCC BRUSH BORDER
|
103
|
4.70e-01
|
8.51e-01
|
0.06570
|
4.13e-02
|
5.12e-02
|
4.69e-01
|
3.70e-01
|
GOBP MUSCLE CELL PROLIFERATION
|
230
|
2.68e-01
|
7.43e-01
|
0.06570
|
-4.79e-02
|
4.50e-02
|
2.11e-01
|
2.39e-01
|
GOBP EMBRYONIC EYE MORPHOGENESIS
|
35
|
7.83e-01
|
9.52e-01
|
0.06570
|
1.90e-02
|
6.29e-02
|
8.46e-01
|
5.19e-01
|
GOCC BARR BODY
|
7
|
9.55e-01
|
9.90e-01
|
0.06570
|
7.66e-04
|
6.57e-02
|
9.97e-01
|
7.63e-01
|
GOBP FRUCTOSE 1 6 BISPHOSPHATE METABOLIC PROCESS
|
9
|
9.48e-01
|
9.90e-01
|
0.06570
|
-5.72e-02
|
3.23e-02
|
7.66e-01
|
8.67e-01
|
GOMF LIPOPEPTIDE BINDING
|
10
|
9.31e-01
|
9.86e-01
|
0.06570
|
2.74e-02
|
5.97e-02
|
8.81e-01
|
7.44e-01
|
GOBP REGULATION OF BMP SIGNALING PATHWAY
|
115
|
4.74e-01
|
8.54e-01
|
0.06570
|
-6.57e-02
|
1.85e-03
|
2.24e-01
|
9.73e-01
|
GOBP BILE ACID BIOSYNTHETIC PROCESS
|
36
|
7.71e-01
|
9.48e-01
|
0.06570
|
3.30e-02
|
5.68e-02
|
7.32e-01
|
5.56e-01
|
GOBP POSTSYNAPSE ASSEMBLY
|
35
|
7.76e-01
|
9.50e-01
|
0.06560
|
-3.45e-02
|
-5.58e-02
|
7.24e-01
|
5.68e-01
|
GOCC AGGRESOME
|
33
|
8.21e-01
|
9.60e-01
|
0.06560
|
-2.52e-02
|
6.06e-02
|
8.02e-01
|
5.47e-01
|
GOMF HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDES
|
756
|
4.83e-03
|
1.44e-01
|
0.06560
|
-3.86e-02
|
-5.31e-02
|
7.12e-02
|
1.30e-02
|
GOBP METANEPHRIC GLOMERULUS DEVELOPMENT
|
16
|
9.05e-01
|
9.80e-01
|
0.06560
|
1.16e-02
|
-6.45e-02
|
9.36e-01
|
6.55e-01
|
GOMF TAU PROTEIN KINASE ACTIVITY
|
22
|
8.52e-01
|
9.67e-01
|
0.06550
|
-5.37e-02
|
-3.76e-02
|
6.63e-01
|
7.60e-01
|
GOCC RNA POLYMERASE II CORE COMPLEX
|
13
|
9.28e-01
|
9.85e-01
|
0.06550
|
-4.34e-02
|
4.91e-02
|
7.86e-01
|
7.59e-01
|
GOMF MHC CLASS I PROTEIN COMPLEX BINDING
|
6
|
9.57e-01
|
9.90e-01
|
0.06550
|
4.06e-02
|
5.15e-02
|
8.63e-01
|
8.27e-01
|
GOCC PROTEASOME COMPLEX
|
59
|
7.00e-01
|
9.22e-01
|
0.06550
|
6.22e-02
|
-2.05e-02
|
4.09e-01
|
7.85e-01
|
GOBP HAIR FOLLICLE MATURATION
|
15
|
9.15e-01
|
9.83e-01
|
0.06540
|
-2.75e-02
|
5.94e-02
|
8.54e-01
|
6.91e-01
|
GOBP REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS
|
139
|
4.28e-01
|
8.36e-01
|
0.06540
|
-6.36e-02
|
1.55e-02
|
1.96e-01
|
7.52e-01
|
GOBP REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION
|
155
|
3.55e-01
|
7.97e-01
|
0.06540
|
-6.48e-02
|
-8.88e-03
|
1.64e-01
|
8.49e-01
|
GOBP CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION
|
543
|
4.75e-02
|
4.38e-01
|
0.06540
|
-3.95e-02
|
5.21e-02
|
1.15e-01
|
3.78e-02
|
GOBP HYALURONAN CATABOLIC PROCESS
|
16
|
8.92e-01
|
9.76e-01
|
0.06540
|
-5.90e-02
|
-2.82e-02
|
6.83e-01
|
8.45e-01
|
GOBP AMINO SUGAR BIOSYNTHETIC PROCESS
|
11
|
9.39e-01
|
9.88e-01
|
0.06540
|
3.70e-02
|
-5.39e-02
|
8.32e-01
|
7.57e-01
|
GOBP PROTEIN LOCALIZATION TO MITOCHONDRION
|
126
|
4.22e-01
|
8.34e-01
|
0.06540
|
-6.32e-02
|
-1.65e-02
|
2.20e-01
|
7.50e-01
|
GOBP MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS
|
45
|
7.26e-01
|
9.30e-01
|
0.06530
|
-5.83e-02
|
-2.95e-02
|
4.99e-01
|
7.32e-01
|
GOBP POLYSACCHARIDE CATABOLIC PROCESS
|
21
|
8.62e-01
|
9.69e-01
|
0.06530
|
-5.94e-02
|
-2.72e-02
|
6.37e-01
|
8.29e-01
|
GOMF URATE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
9
|
9.37e-01
|
9.88e-01
|
0.06530
|
4.17e-02
|
5.03e-02
|
8.29e-01
|
7.94e-01
|
GOBP POSITIVE REGULATION OF CELL CYCLE
|
319
|
1.22e-01
|
6.03e-01
|
0.06530
|
-6.48e-02
|
-8.40e-03
|
4.67e-02
|
7.96e-01
|
GOBP MODULATION BY HOST OF SYMBIONT PROCESS
|
81
|
5.63e-01
|
8.84e-01
|
0.06530
|
-2.95e-02
|
-5.83e-02
|
6.47e-01
|
3.65e-01
|
GOMF CELL ADHESION MEDIATOR ACTIVITY
|
64
|
6.95e-01
|
9.21e-01
|
0.06530
|
4.82e-02
|
-4.40e-02
|
5.04e-01
|
5.43e-01
|
GOBP REGENERATION
|
181
|
3.15e-01
|
7.76e-01
|
0.06530
|
-6.52e-02
|
2.41e-03
|
1.30e-01
|
9.55e-01
|
GOBP POSITIVE REGULATION OF CHEMOTAXIS
|
140
|
4.46e-01
|
8.41e-01
|
0.06530
|
-3.30e-02
|
5.63e-02
|
5.00e-01
|
2.50e-01
|
GOBP STRIATED MUSCLE CELL PROLIFERATION
|
80
|
6.30e-01
|
9.03e-01
|
0.06530
|
-5.60e-02
|
3.35e-02
|
3.86e-01
|
6.05e-01
|
GOBP REGULATION OF DIGESTIVE SYSTEM PROCESS
|
37
|
7.90e-01
|
9.54e-01
|
0.06520
|
-6.51e-02
|
4.72e-03
|
4.93e-01
|
9.60e-01
|
GOBP T CELL EXTRAVASATION
|
10
|
9.43e-01
|
9.89e-01
|
0.06520
|
-3.06e-02
|
5.76e-02
|
8.67e-01
|
7.52e-01
|
GOBP NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY
|
66
|
6.35e-01
|
9.05e-01
|
0.06520
|
-6.25e-02
|
-1.85e-02
|
3.80e-01
|
7.95e-01
|
GOMF NUCLEOBASE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY
|
50
|
7.15e-01
|
9.27e-01
|
0.06520
|
-6.43e-02
|
-1.04e-02
|
4.31e-01
|
8.98e-01
|
GOBP POSITIVE REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE
|
6
|
9.58e-01
|
9.90e-01
|
0.06510
|
5.29e-02
|
3.80e-02
|
8.22e-01
|
8.72e-01
|
GOBP POSITIVE REGULATION OF HIPPO SIGNALING
|
10
|
9.32e-01
|
9.86e-01
|
0.06510
|
2.86e-02
|
5.85e-02
|
8.75e-01
|
7.49e-01
|
GOBP REGULATION OF WNT SIGNALING PATHWAY
|
325
|
1.27e-01
|
6.07e-01
|
0.06510
|
-9.07e-04
|
6.51e-02
|
9.78e-01
|
4.36e-02
|
GOBP NEURAL TUBE FORMATION
|
103
|
5.26e-01
|
8.71e-01
|
0.06510
|
-7.59e-03
|
6.46e-02
|
8.94e-01
|
2.57e-01
|
GOBP MEMBRANE BIOGENESIS
|
59
|
7.11e-01
|
9.26e-01
|
0.06510
|
-3.02e-02
|
5.77e-02
|
6.89e-01
|
4.44e-01
|
GOBP POSITIVE REGULATION OF PROTEIN SECRETION
|
142
|
4.48e-01
|
8.42e-01
|
0.06510
|
-4.08e-02
|
5.07e-02
|
4.02e-01
|
2.97e-01
|
GOBP RESPONSE TO FOOD
|
35
|
8.14e-01
|
9.59e-01
|
0.06500
|
-6.02e-02
|
2.47e-02
|
5.38e-01
|
8.01e-01
|
GOBP MITOTIC CELL CYCLE
|
899
|
2.69e-03
|
1.01e-01
|
0.06500
|
-6.22e-02
|
-1.89e-02
|
1.56e-03
|
3.37e-01
|
GOMF AMIDE BINDING
|
380
|
7.50e-02
|
5.17e-01
|
0.06500
|
-2.25e-02
|
-6.10e-02
|
4.51e-01
|
4.13e-02
|
GOBP REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT
|
1423
|
4.31e-04
|
2.78e-02
|
0.06500
|
-2.81e-02
|
5.86e-02
|
7.62e-02
|
2.13e-04
|
GOMF MONOATOMIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
574
|
2.15e-02
|
3.10e-01
|
0.06500
|
1.96e-02
|
6.20e-02
|
4.23e-01
|
1.12e-02
|
GOMF ANTIPORTER ACTIVITY
|
127
|
4.78e-01
|
8.54e-01
|
0.06500
|
-5.95e-02
|
2.62e-02
|
2.47e-01
|
6.11e-01
|
GOBP MULTICELLULAR ORGANISM GROWTH
|
144
|
4.44e-01
|
8.40e-01
|
0.06490
|
-5.17e-02
|
3.93e-02
|
2.84e-01
|
4.15e-01
|
GOBP NEGATIVE REGULATION OF LEUKOCYTE MIGRATION
|
53
|
7.33e-01
|
9.33e-01
|
0.06490
|
5.99e-02
|
-2.51e-02
|
4.51e-01
|
7.52e-01
|
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE
|
20
|
8.93e-01
|
9.77e-01
|
0.06490
|
4.93e-02
|
-4.22e-02
|
7.03e-01
|
7.44e-01
|
GOBP WOUND HEALING
|
407
|
9.94e-02
|
5.68e-01
|
0.06490
|
-2.92e-02
|
5.79e-02
|
3.12e-01
|
4.51e-02
|
GOBP G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY
|
14
|
9.21e-01
|
9.84e-01
|
0.06480
|
2.14e-02
|
-6.12e-02
|
8.90e-01
|
6.92e-01
|
GOMF PHOSPHOLIPID TRANSPORTER ACTIVITY
|
63
|
7.02e-01
|
9.22e-01
|
0.06480
|
-3.97e-02
|
5.12e-02
|
5.86e-01
|
4.82e-01
|
GOBP ENERGY RESERVE METABOLIC PROCESS
|
84
|
5.78e-01
|
8.89e-01
|
0.06470
|
-6.43e-02
|
-7.06e-03
|
3.08e-01
|
9.11e-01
|
GOBP VITAMIN A METABOLIC PROCESS
|
8
|
9.48e-01
|
9.90e-01
|
0.06470
|
6.39e-02
|
1.01e-02
|
7.54e-01
|
9.61e-01
|
GOBP RESPONSE TO OXIDATIVE STRESS
|
383
|
7.80e-02
|
5.25e-01
|
0.06470
|
-6.23e-02
|
-1.75e-02
|
3.63e-02
|
5.56e-01
|
GOBP LEARNING
|
145
|
3.76e-01
|
8.11e-01
|
0.06470
|
1.84e-02
|
6.21e-02
|
7.03e-01
|
1.97e-01
|
GOBP HORMONE METABOLIC PROCESS
|
231
|
2.72e-01
|
7.47e-01
|
0.06470
|
5.54e-02
|
-3.34e-02
|
1.47e-01
|
3.81e-01
|
GOBP HEMOSTASIS
|
220
|
2.43e-01
|
7.25e-01
|
0.06470
|
5.60e-03
|
6.45e-02
|
8.86e-01
|
9.95e-02
|
GOBP MYELOID LEUKOCYTE CYTOKINE PRODUCTION
|
50
|
7.38e-01
|
9.35e-01
|
0.06470
|
-6.36e-02
|
1.15e-02
|
4.36e-01
|
8.88e-01
|
GOCC SECRETORY VESICLE
|
1017
|
2.17e-03
|
8.81e-02
|
0.06470
|
-6.46e-02
|
1.92e-03
|
4.88e-04
|
9.17e-01
|
GOMF TFIID CLASS TRANSCRIPTION FACTOR COMPLEX BINDING
|
10
|
9.41e-01
|
9.89e-01
|
0.06470
|
1.37e-02
|
-6.32e-02
|
9.40e-01
|
7.29e-01
|
GOBP RETINAL ROD CELL DIFFERENTIATION
|
14
|
9.22e-01
|
9.84e-01
|
0.06470
|
5.89e-02
|
-2.66e-02
|
7.03e-01
|
8.63e-01
|
GOBP AXONAL FASCICULATION
|
21
|
8.86e-01
|
9.76e-01
|
0.06460
|
2.74e-02
|
-5.86e-02
|
8.28e-01
|
6.42e-01
|
GOBP PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS
|
21
|
8.64e-01
|
9.70e-01
|
0.06460
|
-2.98e-02
|
-5.73e-02
|
8.13e-01
|
6.49e-01
|
GOBP MAINTENANCE OF APICAL BASAL CELL POLARITY
|
10
|
9.46e-01
|
9.90e-01
|
0.06460
|
5.05e-02
|
-4.03e-02
|
7.82e-01
|
8.26e-01
|
GOBP EPITHELIAL CELL APOPTOTIC PROCESS
|
143
|
4.43e-01
|
8.40e-01
|
0.06460
|
-5.78e-02
|
2.88e-02
|
2.33e-01
|
5.52e-01
|
GOBP METENCEPHALON DEVELOPMENT
|
105
|
4.80e-01
|
8.54e-01
|
0.06460
|
-3.42e-02
|
-5.48e-02
|
5.45e-01
|
3.32e-01
|
GOMF MYOSIN PHOSPHATASE ACTIVITY
|
72
|
6.08e-01
|
8.97e-01
|
0.06450
|
2.79e-02
|
5.82e-02
|
6.83e-01
|
3.93e-01
|
GOBP MRNA TRANSCRIPTION
|
47
|
7.68e-01
|
9.46e-01
|
0.06450
|
-3.47e-02
|
5.44e-02
|
6.81e-01
|
5.19e-01
|
GOBP ORGANELLE FUSION
|
156
|
3.45e-01
|
7.96e-01
|
0.06450
|
-5.96e-02
|
-2.47e-02
|
1.99e-01
|
5.95e-01
|
GOBP POSITIVE REGULATION OF GROWTH
|
240
|
2.51e-01
|
7.29e-01
|
0.06450
|
-6.04e-02
|
2.26e-02
|
1.07e-01
|
5.46e-01
|
GOMF LAMININ BINDING
|
28
|
8.25e-01
|
9.62e-01
|
0.06450
|
-2.63e-02
|
-5.88e-02
|
8.10e-01
|
5.90e-01
|
GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND
|
15
|
9.15e-01
|
9.83e-01
|
0.06440
|
1.83e-02
|
-6.18e-02
|
9.02e-01
|
6.79e-01
|
GOBP REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL
|
141
|
4.57e-01
|
8.48e-01
|
0.06440
|
-5.13e-02
|
3.89e-02
|
2.93e-01
|
4.25e-01
|
GOBP ORGANIC ACID METABOLIC PROCESS
|
933
|
1.80e-03
|
7.83e-02
|
0.06440
|
-4.84e-02
|
-4.26e-02
|
1.23e-02
|
2.76e-02
|
GOBP NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT
|
33
|
8.23e-01
|
9.61e-01
|
0.06440
|
6.18e-02
|
-1.82e-02
|
5.39e-01
|
8.57e-01
|
GOBP POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS
|
12
|
9.35e-01
|
9.87e-01
|
0.06440
|
-4.93e-02
|
4.14e-02
|
7.67e-01
|
8.04e-01
|
GOBP REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY
|
86
|
5.77e-01
|
8.89e-01
|
0.06440
|
-6.41e-02
|
-5.26e-03
|
3.04e-01
|
9.33e-01
|
GOBP POTASSIUM ION TRANSPORT
|
234
|
2.08e-01
|
6.97e-01
|
0.06430
|
6.07e-02
|
2.13e-02
|
1.10e-01
|
5.75e-01
|
GOBP REGULATION OF RETINAL GANGLION CELL AXON GUIDANCE
|
6
|
9.64e-01
|
9.92e-01
|
0.06430
|
-6.41e-02
|
5.51e-03
|
7.86e-01
|
9.81e-01
|
GOMF ORGANIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY
|
158
|
4.13e-01
|
8.29e-01
|
0.06430
|
-3.22e-02
|
5.57e-02
|
4.85e-01
|
2.27e-01
|
GOBP STRESS INDUCED PREMATURE SENESCENCE
|
8
|
9.45e-01
|
9.90e-01
|
0.06430
|
-5.20e-02
|
-3.79e-02
|
7.99e-01
|
8.53e-01
|
GOCC MEIOTIC SPINDLE
|
15
|
9.08e-01
|
9.81e-01
|
0.06430
|
6.40e-02
|
5.94e-03
|
6.68e-01
|
9.68e-01
|
GOBP GLANDULAR EPITHELIAL CELL DIFFERENTIATION
|
72
|
6.21e-01
|
9.00e-01
|
0.06430
|
1.53e-02
|
6.24e-02
|
8.23e-01
|
3.60e-01
|
GOBP UNSATURATED FATTY ACID METABOLIC PROCESS
|
109
|
5.41e-01
|
8.78e-01
|
0.06430
|
2.93e-02
|
-5.72e-02
|
5.97e-01
|
3.02e-01
|
GOBP MUSCLE ADAPTATION
|
117
|
5.16e-01
|
8.69e-01
|
0.06430
|
-2.86e-02
|
5.76e-02
|
5.94e-01
|
2.82e-01
|
GOBP BLOOD VESSEL MORPHOGENESIS
|
679
|
1.52e-02
|
2.62e-01
|
0.06430
|
3.30e-03
|
6.42e-02
|
8.84e-01
|
4.35e-03
|
GOCC CLUSTER OF ACTIN BASED CELL PROJECTIONS
|
158
|
3.46e-01
|
7.96e-01
|
0.06430
|
6.06e-02
|
2.13e-02
|
1.89e-01
|
6.43e-01
|
GOCC CENTRIOLAR SATELLITE
|
107
|
5.25e-01
|
8.71e-01
|
0.06420
|
1.02e-02
|
-6.34e-02
|
8.55e-01
|
2.57e-01
|
GOMF INSULIN LIKE GROWTH FACTOR BINDING
|
19
|
8.81e-01
|
9.75e-01
|
0.06420
|
6.17e-02
|
1.78e-02
|
6.42e-01
|
8.93e-01
|
GOCC PROTEIN DNA COMPLEX
|
1327
|
2.63e-04
|
1.84e-02
|
0.06420
|
-6.24e-02
|
-1.48e-02
|
1.33e-04
|
3.67e-01
|
GOBP ICOSANOID BIOSYNTHETIC PROCESS
|
56
|
6.76e-01
|
9.13e-01
|
0.06420
|
-4.92e-02
|
-4.11e-02
|
5.24e-01
|
5.94e-01
|
GOBP REGULATION OF PEPTIDE TRANSPORT
|
195
|
3.27e-01
|
7.83e-01
|
0.06410
|
-6.04e-02
|
2.15e-02
|
1.46e-01
|
6.04e-01
|
GOBP CELL MIGRATION INVOLVED IN GASTRULATION
|
13
|
9.21e-01
|
9.84e-01
|
0.06410
|
6.39e-02
|
5.13e-03
|
6.90e-01
|
9.74e-01
|
GOBP REGULATORY NCRNA MEDIATED GENE SILENCING
|
606
|
1.88e-02
|
2.92e-01
|
0.06410
|
2.26e-02
|
6.00e-02
|
3.43e-01
|
1.17e-02
|
GOMF UBIQUITIN LIKE PROTEIN LIGASE BINDING
|
309
|
1.35e-01
|
6.16e-01
|
0.06410
|
-6.24e-02
|
-1.44e-02
|
5.92e-02
|
6.63e-01
|
GOBP POSITIVE REGULATION OF INFLAMMATORY RESPONSE
|
148
|
4.39e-01
|
8.40e-01
|
0.06400
|
5.63e-02
|
-3.06e-02
|
2.37e-01
|
5.21e-01
|
GOBP REGULATION OF IMMUNOGLOBULIN PRODUCTION
|
71
|
6.37e-01
|
9.06e-01
|
0.06400
|
-6.38e-02
|
-5.61e-03
|
3.53e-01
|
9.35e-01
|
GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC
|
32
|
8.29e-01
|
9.62e-01
|
0.06390
|
-6.22e-02
|
1.45e-02
|
5.42e-01
|
8.87e-01
|
GOBP POSITIVE REGULATION OF CELLULAR CATABOLIC PROCESS
|
382
|
1.25e-01
|
6.06e-01
|
0.06390
|
-5.44e-02
|
3.34e-02
|
6.77e-02
|
2.62e-01
|
GOBP POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE
|
11
|
9.28e-01
|
9.85e-01
|
0.06390
|
-5.65e-02
|
-2.99e-02
|
7.46e-01
|
8.64e-01
|
GOBP ENDOCHONDRAL BONE MORPHOGENESIS
|
58
|
6.69e-01
|
9.11e-01
|
0.06390
|
4.40e-02
|
4.63e-02
|
5.62e-01
|
5.42e-01
|
GOBP POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION
|
124
|
5.06e-01
|
8.65e-01
|
0.06390
|
-3.50e-02
|
5.34e-02
|
5.01e-01
|
3.04e-01
|
GOBP REGULATION OF LIPID STORAGE
|
54
|
6.88e-01
|
9.19e-01
|
0.06380
|
-4.63e-02
|
-4.39e-02
|
5.56e-01
|
5.77e-01
|
GOBP POSITIVE REGULATION OF NEURON MIGRATION
|
17
|
9.02e-01
|
9.80e-01
|
0.06380
|
-6.67e-03
|
6.35e-02
|
9.62e-01
|
6.51e-01
|
GOBP INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS
|
62
|
6.67e-01
|
9.11e-01
|
0.06380
|
1.55e-02
|
6.19e-02
|
8.33e-01
|
3.99e-01
|
GOBP RESPONSE TO AMINO ACID STARVATION
|
53
|
6.94e-01
|
9.21e-01
|
0.06380
|
-3.83e-02
|
-5.10e-02
|
6.30e-01
|
5.21e-01
|
GOBP RENAL SODIUM ION ABSORPTION
|
12
|
9.22e-01
|
9.84e-01
|
0.06380
|
-5.67e-02
|
-2.91e-02
|
7.34e-01
|
8.61e-01
|
GOBP NEGATIVE REGULATION OF GLUCONEOGENESIS
|
17
|
9.10e-01
|
9.82e-01
|
0.06380
|
-5.53e-02
|
3.18e-02
|
6.93e-01
|
8.20e-01
|
GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION
|
102
|
5.27e-01
|
8.72e-01
|
0.06370
|
-6.35e-02
|
-5.47e-03
|
2.68e-01
|
9.24e-01
|
GOBP POSITIVE REGULATION OF CELL ADHESION
|
466
|
6.03e-02
|
4.78e-01
|
0.06370
|
-8.85e-04
|
6.37e-02
|
9.74e-01
|
1.84e-02
|
GOBP REGULATION OF T CELL ACTIVATION
|
366
|
1.05e-01
|
5.75e-01
|
0.06370
|
4.20e-03
|
6.36e-02
|
8.90e-01
|
3.68e-02
|
GOBP PROTEIN PHOSPHORYLATION
|
1272
|
1.45e-03
|
6.67e-02
|
0.06370
|
-3.91e-02
|
5.02e-02
|
1.89e-02
|
2.59e-03
|
GOBP REGULATION OF HEMATOPOIETIC STEM CELL PROLIFERATION
|
15
|
9.21e-01
|
9.84e-01
|
0.06370
|
5.45e-02
|
-3.30e-02
|
7.15e-01
|
8.25e-01
|
GOBP REGULATION OF APOPTOTIC CELL CLEARANCE
|
10
|
9.33e-01
|
9.87e-01
|
0.06370
|
-4.65e-02
|
-4.35e-02
|
7.99e-01
|
8.12e-01
|
GOBP POSITIVE REGULATION OF PHOSPHOLIPASE A2 ACTIVITY
|
5
|
9.73e-01
|
9.93e-01
|
0.06360
|
-3.70e-02
|
5.18e-02
|
8.86e-01
|
8.41e-01
|
GOBP BLASTOCYST GROWTH
|
21
|
8.92e-01
|
9.76e-01
|
0.06360
|
-3.66e-02
|
5.20e-02
|
7.71e-01
|
6.80e-01
|
GOBP CELLULAR RESPONSE TO OXYGEN LEVELS
|
159
|
3.37e-01
|
7.89e-01
|
0.06360
|
-4.85e-02
|
-4.11e-02
|
2.91e-01
|
3.71e-01
|
GOBP ANTIGEN PROCESSING AND PRESENTATION
|
110
|
4.72e-01
|
8.52e-01
|
0.06350
|
-3.83e-02
|
-5.06e-02
|
4.87e-01
|
3.59e-01
|
GOMF OXIDOREDUCTASE ACTIVITY
|
687
|
1.04e-02
|
2.18e-01
|
0.06350
|
-3.98e-02
|
-4.95e-02
|
7.57e-02
|
2.69e-02
|
GOBP HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION
|
132
|
4.84e-01
|
8.54e-01
|
0.06350
|
-5.66e-02
|
2.88e-02
|
2.62e-01
|
5.68e-01
|
GOBP REGULATION OF COLLATERAL SPROUTING
|
20
|
8.74e-01
|
9.74e-01
|
0.06350
|
-5.67e-02
|
-2.84e-02
|
6.60e-01
|
8.26e-01
|
GOBP PROTEIN INSERTION INTO MEMBRANE
|
71
|
6.73e-01
|
9.13e-01
|
0.06340
|
2.44e-02
|
-5.86e-02
|
7.22e-01
|
3.94e-01
|
GOBP PRIMARY ALCOHOL BIOSYNTHETIC PROCESS
|
14
|
9.23e-01
|
9.84e-01
|
0.06340
|
-6.06e-02
|
1.89e-02
|
6.95e-01
|
9.03e-01
|
GOBP LOCOMOTION
|
1258
|
7.46e-04
|
4.27e-02
|
0.06340
|
-2.14e-03
|
6.34e-02
|
8.98e-01
|
1.57e-04
|
GOCC HIPPOCAMPAL MOSSY FIBER TO CA3 SYNAPSE
|
42
|
7.91e-01
|
9.54e-01
|
0.06340
|
-2.37e-02
|
5.88e-02
|
7.91e-01
|
5.10e-01
|
GOBP REGULATION OF PROTEIN CATABOLIC PROCESS
|
340
|
1.14e-01
|
5.91e-01
|
0.06340
|
-6.11e-02
|
-1.68e-02
|
5.27e-02
|
5.94e-01
|
GOBP RESPONSE TO TUMOR CELL
|
42
|
7.52e-01
|
9.41e-01
|
0.06340
|
5.33e-02
|
3.43e-02
|
5.50e-01
|
7.01e-01
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H
|
75
|
6.02e-01
|
8.96e-01
|
0.06340
|
-5.31e-02
|
-3.46e-02
|
4.26e-01
|
6.05e-01
|
GOBP INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS
|
29
|
8.52e-01
|
9.67e-01
|
0.06340
|
-2.83e-02
|
5.67e-02
|
7.92e-01
|
5.97e-01
|
GOBP REGULATION OF ENDOTHELIAL CELL MIGRATION
|
220
|
2.47e-01
|
7.26e-01
|
0.06340
|
6.19e-02
|
1.35e-02
|
1.14e-01
|
7.29e-01
|
GOBP POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL
|
122
|
4.42e-01
|
8.40e-01
|
0.06320
|
3.26e-02
|
5.42e-02
|
5.33e-01
|
3.02e-01
|
GOBP NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS
|
26
|
8.55e-01
|
9.68e-01
|
0.06320
|
2.60e-03
|
-6.32e-02
|
9.82e-01
|
5.77e-01
|
GOCC CCR4 NOT COMPLEX
|
14
|
9.09e-01
|
9.82e-01
|
0.06320
|
4.59e-02
|
4.34e-02
|
7.66e-01
|
7.79e-01
|
GOCC TRANSCRIPTION PREINITIATION COMPLEX
|
13
|
9.28e-01
|
9.85e-01
|
0.06320
|
1.51e-02
|
-6.13e-02
|
9.25e-01
|
7.02e-01
|
GOBP REGULATION OF NEUROTRANSMITTER SECRETION
|
76
|
5.99e-01
|
8.95e-01
|
0.06320
|
5.06e-02
|
3.78e-02
|
4.46e-01
|
5.69e-01
|
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DEVELOPMENT
|
12
|
9.24e-01
|
9.84e-01
|
0.06310
|
-2.47e-02
|
-5.81e-02
|
8.82e-01
|
7.28e-01
|
GOMF EPHRIN RECEPTOR ACTIVITY
|
18
|
9.00e-01
|
9.79e-01
|
0.06310
|
9.70e-03
|
-6.24e-02
|
9.43e-01
|
6.47e-01
|
GOBP AMINO ACID TRANSPORT
|
142
|
4.57e-01
|
8.48e-01
|
0.06310
|
-2.33e-02
|
5.86e-02
|
6.32e-01
|
2.28e-01
|
GOBP CELL ACTIVATION
|
1060
|
3.04e-03
|
1.07e-01
|
0.06310
|
-1.39e-02
|
6.15e-02
|
4.45e-01
|
7.09e-04
|
GOBP REGULATION OF MYELOID CELL APOPTOTIC PROCESS
|
31
|
8.29e-01
|
9.62e-01
|
0.06310
|
6.31e-02
|
2.00e-04
|
5.43e-01
|
9.98e-01
|
GOMF UBIQUITIN LIKE PROTEIN PEPTIDASE ACTIVITY
|
99
|
5.16e-01
|
8.69e-01
|
0.06310
|
-5.34e-02
|
-3.36e-02
|
3.59e-01
|
5.64e-01
|
GOBP ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY
|
978
|
5.38e-03
|
1.52e-01
|
0.06310
|
-2.11e-02
|
5.94e-02
|
2.64e-01
|
1.65e-03
|
GOCC PHOTORECEPTOR OUTER SEGMENT
|
85
|
6.02e-01
|
8.96e-01
|
0.06310
|
-2.81e-03
|
6.30e-02
|
9.64e-01
|
3.15e-01
|
GOBP POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION
|
979
|
6.96e-03
|
1.74e-01
|
0.06300
|
-4.69e-02
|
4.20e-02
|
1.30e-02
|
2.61e-02
|
GOMF NEUROTRANSMITTER RECEPTOR ACTIVITY
|
93
|
5.90e-01
|
8.92e-01
|
0.06290
|
-1.50e-02
|
6.11e-02
|
8.02e-01
|
3.08e-01
|
GOMF HISTONE H3K9 METHYLTRANSFERASE ACTIVITY
|
12
|
9.26e-01
|
9.85e-01
|
0.06290
|
-6.09e-02
|
-1.59e-02
|
7.15e-01
|
9.24e-01
|
GOBP POLYSACCHARIDE METABOLIC PROCESS
|
96
|
5.97e-01
|
8.95e-01
|
0.06290
|
-5.47e-02
|
3.12e-02
|
3.55e-01
|
5.98e-01
|
GOBP FORMATION OF PRIMARY GERM LAYER
|
126
|
4.77e-01
|
8.54e-01
|
0.06290
|
-5.18e-03
|
6.27e-02
|
9.20e-01
|
2.24e-01
|
GOBP MESONEPHRIC DUCT DEVELOPMENT
|
8
|
9.56e-01
|
9.90e-01
|
0.06290
|
-6.08e-02
|
1.61e-02
|
7.66e-01
|
9.37e-01
|
GOBP REGULATION OF LIPID METABOLIC PROCESS
|
328
|
1.81e-01
|
6.71e-01
|
0.06290
|
-4.18e-02
|
4.70e-02
|
1.93e-01
|
1.44e-01
|
GOMF ZINC ION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
24
|
8.79e-01
|
9.75e-01
|
0.06290
|
-3.32e-02
|
5.34e-02
|
7.78e-01
|
6.51e-01
|
GOBP REGULATION OF MESODERMAL CELL FATE SPECIFICATION
|
5
|
9.68e-01
|
9.92e-01
|
0.06280
|
-5.61e-02
|
-2.84e-02
|
8.28e-01
|
9.12e-01
|
GOCC SPINDLE MICROTUBULE
|
76
|
6.03e-01
|
8.96e-01
|
0.06280
|
-3.54e-02
|
-5.19e-02
|
5.94e-01
|
4.34e-01
|
GOBP ESTABLISHMENT OF RNA LOCALIZATION
|
147
|
3.99e-01
|
8.25e-01
|
0.06280
|
-6.16e-02
|
-1.25e-02
|
1.98e-01
|
7.94e-01
|
GOBP REGULATION OF ANATOMICAL STRUCTURE SIZE
|
485
|
5.52e-02
|
4.63e-01
|
0.06280
|
4.73e-03
|
6.26e-02
|
8.58e-01
|
1.82e-02
|
GOBP RESPONSE TO OXYGEN LEVELS
|
320
|
1.50e-01
|
6.37e-01
|
0.06280
|
-6.28e-02
|
-7.76e-04
|
5.36e-02
|
9.81e-01
|
GOMF EXCITATORY EXTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY
|
36
|
8.25e-01
|
9.62e-01
|
0.06270
|
-3.26e-02
|
5.36e-02
|
7.35e-01
|
5.78e-01
|
GOMF PASSIVE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
484
|
4.66e-02
|
4.37e-01
|
0.06270
|
5.84e-02
|
2.28e-02
|
2.78e-02
|
3.89e-01
|
GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS
|
67
|
6.98e-01
|
9.21e-01
|
0.06270
|
-5.54e-02
|
2.94e-02
|
4.33e-01
|
6.77e-01
|
GOBP AXONEMAL DYNEIN COMPLEX ASSEMBLY
|
39
|
8.05e-01
|
9.57e-01
|
0.06270
|
-1.86e-02
|
5.98e-02
|
8.41e-01
|
5.18e-01
|
GOBP EXOCYTOSIS
|
328
|
1.77e-01
|
6.67e-01
|
0.06260
|
-3.02e-02
|
5.49e-02
|
3.46e-01
|
8.76e-02
|
GOBP THALAMUS DEVELOPMENT
|
11
|
9.30e-01
|
9.86e-01
|
0.06260
|
-3.32e-02
|
-5.31e-02
|
8.49e-01
|
7.60e-01
|
GOBP AMINOGLYCAN CATABOLIC PROCESS
|
33
|
8.10e-01
|
9.59e-01
|
0.06260
|
2.03e-02
|
5.93e-02
|
8.40e-01
|
5.56e-01
|
GOBP POSITIVE REGULATION OF NEURON PROJECTION ARBORIZATION
|
8
|
9.59e-01
|
9.90e-01
|
0.06260
|
-3.87e-02
|
4.92e-02
|
8.50e-01
|
8.09e-01
|
GOMF METALLOENDOPEPTIDASE ACTIVITY
|
106
|
5.70e-01
|
8.86e-01
|
0.06260
|
3.26e-02
|
-5.35e-02
|
5.62e-01
|
3.42e-01
|
GOCC PRERIBOSOME LARGE SUBUNIT PRECURSOR
|
18
|
8.92e-01
|
9.76e-01
|
0.06260
|
-1.89e-02
|
-5.97e-02
|
8.90e-01
|
6.61e-01
|
GOBP REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE
|
35
|
7.99e-01
|
9.56e-01
|
0.06260
|
2.11e-02
|
5.89e-02
|
8.29e-01
|
5.46e-01
|
GOBP GLIAL CELL DIFFERENTIATION
|
246
|
2.73e-01
|
7.47e-01
|
0.06260
|
-5.45e-02
|
3.07e-02
|
1.41e-01
|
4.07e-01
|
GOBP VOCALIZATION BEHAVIOR
|
15
|
9.23e-01
|
9.84e-01
|
0.06250
|
3.10e-02
|
-5.43e-02
|
8.36e-01
|
7.16e-01
|
GOCC ANCHORING JUNCTION
|
862
|
5.52e-03
|
1.54e-01
|
0.06240
|
1.54e-02
|
6.05e-02
|
4.42e-01
|
2.57e-03
|
GOBP SMOOTH MUSCLE CELL DIFFERENTIATION
|
72
|
6.40e-01
|
9.06e-01
|
0.06240
|
-6.10e-02
|
-1.31e-02
|
3.71e-01
|
8.47e-01
|
GOBP REGULATION OF PROTEIN LOCALIZATION TO CILIUM
|
11
|
9.43e-01
|
9.89e-01
|
0.06240
|
5.64e-02
|
-2.67e-02
|
7.46e-01
|
8.78e-01
|
GOCC NUCLEOSOME
|
114
|
4.96e-01
|
8.59e-01
|
0.06240
|
-6.14e-02
|
-1.13e-02
|
2.58e-01
|
8.35e-01
|
GOBP NEGATIVE REGULATION OF PROTEOLYSIS
|
211
|
2.53e-01
|
7.32e-01
|
0.06240
|
-5.26e-02
|
-3.35e-02
|
1.87e-01
|
4.01e-01
|
GOBP POSITIVE REGULATION OF SIGNALING
|
1725
|
2.52e-04
|
1.79e-02
|
0.06240
|
-4.41e-02
|
4.41e-02
|
2.31e-03
|
2.30e-03
|
GOBP EMBRYONIC SKELETAL SYSTEM DEVELOPMENT
|
126
|
4.87e-01
|
8.56e-01
|
0.06240
|
-6.19e-02
|
7.91e-03
|
2.30e-01
|
8.78e-01
|
GOBP RETINAL CONE CELL DEVELOPMENT
|
11
|
9.44e-01
|
9.90e-01
|
0.06240
|
4.07e-02
|
-4.73e-02
|
8.15e-01
|
7.86e-01
|
GOBP NORADRENERGIC NEURON DIFFERENTIATION
|
10
|
9.49e-01
|
9.90e-01
|
0.06240
|
-4.49e-02
|
4.33e-02
|
8.06e-01
|
8.13e-01
|
GOBP REGULATION OF DNA DAMAGE CHECKPOINT
|
23
|
8.65e-01
|
9.70e-01
|
0.06230
|
-1.68e-02
|
-6.00e-02
|
8.89e-01
|
6.18e-01
|
GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY
|
26
|
8.46e-01
|
9.66e-01
|
0.06230
|
5.67e-02
|
2.59e-02
|
6.17e-01
|
8.19e-01
|
GOMF MONOCARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY
|
58
|
7.10e-01
|
9.26e-01
|
0.06230
|
-6.23e-02
|
-9.91e-04
|
4.12e-01
|
9.90e-01
|
GOBP NEGATIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION
|
36
|
7.90e-01
|
9.54e-01
|
0.06230
|
-5.23e-02
|
-3.38e-02
|
5.87e-01
|
7.25e-01
|
GOBP CARDIAC VENTRICLE DEVELOPMENT
|
127
|
4.36e-01
|
8.39e-01
|
0.06230
|
3.48e-02
|
5.17e-02
|
4.98e-01
|
3.15e-01
|
GOBP CELL CYCLE PROCESS
|
1243
|
9.74e-04
|
5.01e-02
|
0.06220
|
-6.22e-02
|
-7.59e-04
|
2.23e-04
|
9.64e-01
|
GOBP PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION
|
32
|
8.46e-01
|
9.66e-01
|
0.06220
|
-3.20e-02
|
5.33e-02
|
7.54e-01
|
6.02e-01
|
GOBP GLUCAN METABOLIC PROCESS
|
73
|
6.31e-01
|
9.03e-01
|
0.06220
|
-5.87e-02
|
-2.03e-02
|
3.86e-01
|
7.64e-01
|
GOBP REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM
|
24
|
8.84e-01
|
9.76e-01
|
0.06210
|
-4.39e-02
|
4.40e-02
|
7.10e-01
|
7.09e-01
|
GOBP ORGANELLE LOCALIZATION
|
588
|
5.19e-02
|
4.49e-01
|
0.06210
|
-4.64e-02
|
4.14e-02
|
5.47e-02
|
8.66e-02
|
GOBP NEUROBLAST PROLIFERATION
|
80
|
6.42e-01
|
9.07e-01
|
0.06210
|
6.05e-02
|
-1.40e-02
|
3.49e-01
|
8.28e-01
|
GOBP NEURON CELLULAR HOMEOSTASIS
|
59
|
7.38e-01
|
9.35e-01
|
0.06210
|
4.00e-02
|
-4.75e-02
|
5.95e-01
|
5.28e-01
|
GOBP TUBE MORPHOGENESIS
|
915
|
5.58e-03
|
1.55e-01
|
0.06210
|
2.29e-03
|
6.20e-02
|
9.06e-01
|
1.47e-03
|
GOBP REGULATION OF MEMBRANE REPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL
|
6
|
9.70e-01
|
9.93e-01
|
0.06210
|
-4.37e-02
|
4.40e-02
|
8.53e-01
|
8.52e-01
|
GOBP AXON EXTENSION
|
111
|
5.56e-01
|
8.81e-01
|
0.06200
|
-2.65e-02
|
5.61e-02
|
6.30e-01
|
3.07e-01
|
GOBP NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS
|
1190
|
3.00e-03
|
1.06e-01
|
0.06200
|
-3.95e-02
|
4.78e-02
|
2.16e-02
|
5.50e-03
|
GOBP BLASTOCYST DEVELOPMENT
|
113
|
5.61e-01
|
8.83e-01
|
0.06200
|
-4.61e-02
|
4.14e-02
|
3.97e-01
|
4.47e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS
|
102
|
5.54e-01
|
8.81e-01
|
0.06200
|
-6.20e-02
|
1.73e-03
|
2.79e-01
|
9.76e-01
|
GOBP REGULATION OF PROTEIN DEPOLYMERIZATION
|
82
|
5.98e-01
|
8.95e-01
|
0.06200
|
2.05e-02
|
5.85e-02
|
7.48e-01
|
3.60e-01
|
GOBP PALLIUM DEVELOPMENT
|
181
|
3.46e-01
|
7.96e-01
|
0.06200
|
-3.02e-03
|
-6.19e-02
|
9.44e-01
|
1.51e-01
|
GOBP TRANSPORT ALONG MICROTUBULE
|
164
|
4.29e-01
|
8.36e-01
|
0.06200
|
-5.15e-02
|
3.45e-02
|
2.55e-01
|
4.45e-01
|
GOBP SKELETAL MUSCLE ORGAN DEVELOPMENT
|
169
|
4.20e-01
|
8.33e-01
|
0.06200
|
5.01e-02
|
-3.65e-02
|
2.61e-01
|
4.13e-01
|
GOBP PROTEIN LOCALIZATION TO CILIARY MEMBRANE
|
11
|
9.45e-01
|
9.90e-01
|
0.06200
|
4.44e-02
|
-4.32e-02
|
7.99e-01
|
8.04e-01
|
GOBP SECRETION OF LYSOSOMAL ENZYMES
|
7
|
9.55e-01
|
9.90e-01
|
0.06190
|
-4.76e-02
|
-3.97e-02
|
8.27e-01
|
8.56e-01
|
GOBP REGULATION OF RESPONSE TO STRESS
|
1432
|
4.81e-04
|
3.03e-02
|
0.06190
|
-6.16e-02
|
5.81e-03
|
9.33e-05
|
7.13e-01
|
GOBP SKELETAL SYSTEM DEVELOPMENT
|
508
|
7.85e-02
|
5.26e-01
|
0.06190
|
-4.25e-02
|
4.50e-02
|
1.01e-01
|
8.25e-02
|
GOMF STRUCTURAL CONSTITUENT OF CYTOSKELETON
|
104
|
5.09e-01
|
8.66e-01
|
0.06190
|
4.60e-02
|
4.14e-02
|
4.18e-01
|
4.66e-01
|
GOBP POSITIVE REGULATION OF HEART GROWTH
|
38
|
8.03e-01
|
9.57e-01
|
0.06190
|
6.18e-02
|
-1.57e-03
|
5.09e-01
|
9.87e-01
|
GOBP MONONUCLEAR CELL DIFFERENTIATION
|
463
|
9.09e-02
|
5.51e-01
|
0.06190
|
-2.58e-02
|
5.62e-02
|
3.41e-01
|
3.82e-02
|
GOBP GLUTAMINE TRANSPORT
|
9
|
9.43e-01
|
9.89e-01
|
0.06190
|
-3.92e-02
|
-4.79e-02
|
8.39e-01
|
8.04e-01
|
GOBP NUCLEOSIDE METABOLIC PROCESS
|
53
|
7.18e-01
|
9.29e-01
|
0.06180
|
-2.15e-02
|
-5.80e-02
|
7.87e-01
|
4.65e-01
|
GOBP MONOATOMIC ION TRANSPORT
|
1195
|
9.79e-04
|
5.01e-02
|
0.06180
|
1.41e-02
|
6.02e-02
|
4.13e-01
|
4.55e-04
|
GOMF CHANNEL INHIBITOR ACTIVITY
|
35
|
8.10e-01
|
9.59e-01
|
0.06180
|
9.10e-03
|
6.11e-02
|
9.26e-01
|
5.31e-01
|
GOBP MITOTIC DNA INTEGRITY CHECKPOINT SIGNALING
|
84
|
5.80e-01
|
8.90e-01
|
0.06180
|
-4.68e-02
|
-4.03e-02
|
4.59e-01
|
5.23e-01
|
GOBP REGULATION OF DEPHOSPHORYLATION
|
101
|
5.88e-01
|
8.91e-01
|
0.06170
|
-2.52e-02
|
5.64e-02
|
6.62e-01
|
3.28e-01
|
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME
|
27
|
8.41e-01
|
9.66e-01
|
0.06170
|
-5.38e-02
|
-3.03e-02
|
6.28e-01
|
7.85e-01
|
GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX
|
14
|
9.23e-01
|
9.84e-01
|
0.06170
|
6.17e-02
|
-1.60e-03
|
6.89e-01
|
9.92e-01
|
GOBP REGULATION OF ORGAN GROWTH
|
93
|
5.83e-01
|
8.90e-01
|
0.06170
|
1.77e-03
|
6.17e-02
|
9.76e-01
|
3.04e-01
|
GOBP POSITIVE REGULATION OF KINASE ACTIVITY
|
326
|
1.84e-01
|
6.73e-01
|
0.06160
|
-2.41e-02
|
5.67e-02
|
4.55e-01
|
7.83e-02
|
GOBP MYELOID CELL DIFFERENTIATION
|
413
|
1.26e-01
|
6.06e-01
|
0.06160
|
-5.04e-02
|
3.55e-02
|
7.90e-02
|
2.16e-01
|
GOMF RIBOSOMAL LARGE SUBUNIT BINDING
|
14
|
9.29e-01
|
9.86e-01
|
0.06160
|
2.55e-02
|
-5.61e-02
|
8.69e-01
|
7.16e-01
|
GOBP ORGAN INDUCTION
|
22
|
8.92e-01
|
9.76e-01
|
0.06150
|
-2.92e-02
|
5.42e-02
|
8.13e-01
|
6.60e-01
|
GOBP REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION
|
98
|
5.80e-01
|
8.90e-01
|
0.06150
|
6.10e-02
|
-8.22e-03
|
2.97e-01
|
8.88e-01
|
GOMF CALCIUM CHANNEL REGULATOR ACTIVITY
|
46
|
7.91e-01
|
9.54e-01
|
0.06150
|
-3.51e-02
|
5.05e-02
|
6.81e-01
|
5.53e-01
|
GOBP MESENCHYMAL CELL MIGRATION
|
61
|
7.30e-01
|
9.32e-01
|
0.06150
|
-2.95e-02
|
5.39e-02
|
6.90e-01
|
4.66e-01
|
GOBP POSITIVE REGULATION OF HEAT GENERATION
|
9
|
9.49e-01
|
9.90e-01
|
0.06150
|
6.13e-02
|
3.65e-03
|
7.50e-01
|
9.85e-01
|
GOBP REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION
|
222
|
3.03e-01
|
7.68e-01
|
0.06140
|
-1.40e-02
|
5.98e-02
|
7.19e-01
|
1.25e-01
|
GOBP REGULATION OF VESICLE FUSION
|
24
|
8.85e-01
|
9.76e-01
|
0.06140
|
-3.57e-02
|
4.99e-02
|
7.62e-01
|
6.72e-01
|
GOBP SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE
|
182
|
3.55e-01
|
7.97e-01
|
0.06140
|
-1.17e-04
|
-6.14e-02
|
9.98e-01
|
1.53e-01
|
GOBP ACUTE INFLAMMATORY RESPONSE
|
101
|
5.26e-01
|
8.71e-01
|
0.06140
|
-3.48e-02
|
-5.05e-02
|
5.45e-01
|
3.80e-01
|
GOMF MICROTUBULE MOTOR ACTIVITY
|
67
|
6.55e-01
|
9.09e-01
|
0.06140
|
-3.08e-02
|
-5.31e-02
|
6.63e-01
|
4.52e-01
|
GOBP MULTICELLULAR ORGANISM REPRODUCTION
|
872
|
1.46e-02
|
2.59e-01
|
0.06130
|
-4.69e-02
|
3.95e-02
|
1.87e-02
|
4.75e-02
|
GOBP REGULATION OF SMALL MOLECULE METABOLIC PROCESS
|
324
|
1.84e-01
|
6.73e-01
|
0.06130
|
-5.82e-02
|
1.94e-02
|
7.18e-02
|
5.48e-01
|
GOMF PROTEOGLYCAN BINDING
|
36
|
7.99e-01
|
9.56e-01
|
0.06130
|
5.63e-02
|
2.44e-02
|
5.59e-01
|
8.00e-01
|
GOCC NUCLEAR BODY
|
812
|
9.94e-03
|
2.12e-01
|
0.06130
|
-6.07e-02
|
-8.05e-03
|
3.26e-03
|
6.96e-01
|
GOBP REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY
|
285
|
2.43e-01
|
7.25e-01
|
0.06130
|
-4.61e-02
|
4.03e-02
|
1.80e-01
|
2.41e-01
|
GOBP LYMPHOCYTE ACTIVATION
|
755
|
1.77e-02
|
2.83e-01
|
0.06130
|
-8.01e-03
|
6.07e-02
|
7.08e-01
|
4.50e-03
|
GOMF RNA POLYMERASE III ACTIVITY
|
10
|
9.43e-01
|
9.89e-01
|
0.06120
|
-7.37e-03
|
-6.08e-02
|
9.68e-01
|
7.39e-01
|
GOMF E BOX BINDING
|
58
|
7.33e-01
|
9.33e-01
|
0.06120
|
5.93e-02
|
-1.52e-02
|
4.35e-01
|
8.41e-01
|
GOBP L SERINE TRANSPORT
|
7
|
9.61e-01
|
9.91e-01
|
0.06120
|
3.32e-03
|
-6.11e-02
|
9.88e-01
|
7.80e-01
|
GOMF L SERINE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
7
|
9.61e-01
|
9.91e-01
|
0.06120
|
3.32e-03
|
-6.11e-02
|
9.88e-01
|
7.80e-01
|
GOBP C4 DICARBOXYLATE TRANSPORT
|
27
|
8.50e-01
|
9.67e-01
|
0.06110
|
1.52e-02
|
5.92e-02
|
8.92e-01
|
5.94e-01
|
GOCC CLATHRIN COATED VESICLE
|
202
|
3.54e-01
|
7.97e-01
|
0.06110
|
-2.45e-02
|
5.60e-02
|
5.49e-01
|
1.70e-01
|
GOBP REGULATION OF RESPONSE TO TYPE II INTERFERON
|
14
|
9.24e-01
|
9.84e-01
|
0.06110
|
6.10e-02
|
-1.56e-03
|
6.92e-01
|
9.92e-01
|
GOBP REGULATION OF CARDIAC CONDUCTION
|
26
|
8.65e-01
|
9.70e-01
|
0.06110
|
6.10e-02
|
-3.40e-03
|
5.91e-01
|
9.76e-01
|
GOBP PROTEIN CONTAINING COMPLEX LOCALIZATION
|
178
|
3.80e-01
|
8.15e-01
|
0.06100
|
-6.05e-02
|
8.27e-03
|
1.64e-01
|
8.49e-01
|
GOMF TRANSLATION REGULATOR ACTIVITY
|
367
|
1.51e-01
|
6.38e-01
|
0.06100
|
5.76e-02
|
-2.01e-02
|
5.80e-02
|
5.08e-01
|
GOBP DEVELOPMENTAL GROWTH
|
632
|
4.68e-02
|
4.37e-01
|
0.06100
|
-4.04e-02
|
4.58e-02
|
8.33e-02
|
4.95e-02
|
GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION
|
37
|
8.32e-01
|
9.64e-01
|
0.06100
|
-4.58e-02
|
4.03e-02
|
6.30e-01
|
6.71e-01
|
GOCC OXIDOREDUCTASE COMPLEX
|
108
|
5.07e-01
|
8.65e-01
|
0.06100
|
-4.84e-02
|
-3.70e-02
|
3.85e-01
|
5.06e-01
|
GOBP REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA
|
10
|
9.48e-01
|
9.90e-01
|
0.06090
|
-5.86e-02
|
1.67e-02
|
7.48e-01
|
9.27e-01
|
GOBP HEART DEVELOPMENT
|
597
|
5.23e-02
|
4.50e-01
|
0.06090
|
-2.88e-02
|
5.37e-02
|
2.29e-01
|
2.51e-02
|
GOMF HEPARIN BINDING
|
169
|
3.58e-01
|
7.99e-01
|
0.06090
|
2.36e-02
|
5.61e-02
|
5.97e-01
|
2.08e-01
|
GOBP CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM
|
450
|
1.01e-01
|
5.70e-01
|
0.06080
|
-2.05e-02
|
5.73e-02
|
4.57e-01
|
3.72e-02
|
GOMF STRUCTURAL MOLECULE ACTIVITY
|
751
|
2.18e-02
|
3.13e-01
|
0.06080
|
5.86e-02
|
-1.64e-02
|
6.31e-03
|
4.43e-01
|
GOBP CELLULAR RESPONSE TO VIRUS
|
80
|
6.37e-01
|
9.06e-01
|
0.06080
|
-1.54e-03
|
-6.08e-02
|
9.81e-01
|
3.47e-01
|
GOBP CELL VOLUME HOMEOSTASIS
|
34
|
8.22e-01
|
9.61e-01
|
0.06080
|
-6.05e-02
|
-6.14e-03
|
5.42e-01
|
9.51e-01
|
GOBP STRIATED MUSCLE ADAPTATION
|
55
|
7.60e-01
|
9.44e-01
|
0.06080
|
-3.26e-02
|
5.13e-02
|
6.76e-01
|
5.11e-01
|
GOCC NEURON PROJECTION TERMINUS
|
123
|
5.03e-01
|
8.63e-01
|
0.06070
|
6.07e-02
|
4.73e-04
|
2.45e-01
|
9.93e-01
|
GOBP POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS
|
1245
|
2.84e-03
|
1.04e-01
|
0.06070
|
-5.08e-02
|
3.32e-02
|
2.55e-03
|
4.84e-02
|
GOMF SYNTAXIN BINDING
|
64
|
7.30e-01
|
9.32e-01
|
0.06070
|
-4.24e-02
|
4.34e-02
|
5.57e-01
|
5.48e-01
|
GOBP ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS
|
22
|
8.76e-01
|
9.75e-01
|
0.06070
|
-5.76e-02
|
-1.91e-02
|
6.40e-01
|
8.77e-01
|
GOMF PROTEIN TYROSINE KINASE ACTIVITY
|
140
|
5.01e-01
|
8.62e-01
|
0.06070
|
-3.42e-02
|
5.01e-02
|
4.84e-01
|
3.06e-01
|
GOBP BIOLOGICAL PHASE
|
11
|
9.47e-01
|
9.90e-01
|
0.06060
|
-4.06e-02
|
4.51e-02
|
8.16e-01
|
7.96e-01
|
GOBP ENDODERM DEVELOPMENT
|
81
|
6.32e-01
|
9.03e-01
|
0.06060
|
4.30e-03
|
6.04e-02
|
9.47e-01
|
3.47e-01
|
GOCC SPINDLE POLE CENTROSOME
|
13
|
9.34e-01
|
9.87e-01
|
0.06060
|
-5.87e-02
|
1.52e-02
|
7.14e-01
|
9.25e-01
|
GOBP NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT
|
11
|
9.46e-01
|
9.90e-01
|
0.06050
|
-2.95e-02
|
5.29e-02
|
8.65e-01
|
7.61e-01
|
GOBP REGULATION OF HYALURONAN BIOSYNTHETIC PROCESS
|
8
|
9.51e-01
|
9.90e-01
|
0.06050
|
4.47e-02
|
4.07e-02
|
8.27e-01
|
8.42e-01
|
GOBP ACTIVATED T CELL PROLIFERATION
|
46
|
7.58e-01
|
9.44e-01
|
0.06040
|
5.59e-02
|
2.30e-02
|
5.12e-01
|
7.88e-01
|
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE
|
87
|
6.40e-01
|
9.06e-01
|
0.06040
|
1.90e-02
|
-5.74e-02
|
7.60e-01
|
3.55e-01
|
GOBP LEUKOCYTE DIFFERENTIATION
|
596
|
5.70e-02
|
4.68e-01
|
0.06040
|
-3.27e-02
|
5.08e-02
|
1.73e-01
|
3.42e-02
|
GOMF PEPTIDYL PROLINE DIOXYGENASE ACTIVITY
|
12
|
9.41e-01
|
9.89e-01
|
0.06040
|
-2.17e-02
|
5.64e-02
|
8.97e-01
|
7.35e-01
|
GOBP REGULATION OF INSULIN RECEPTOR SIGNALING PATHWAY
|
69
|
6.52e-01
|
9.08e-01
|
0.06040
|
-4.36e-02
|
-4.18e-02
|
5.31e-01
|
5.49e-01
|
GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION
|
61
|
7.20e-01
|
9.30e-01
|
0.06030
|
-6.00e-02
|
6.61e-03
|
4.18e-01
|
9.29e-01
|
GOBP ORGAN GROWTH
|
168
|
4.18e-01
|
8.32e-01
|
0.06030
|
-1.39e-02
|
5.87e-02
|
7.56e-01
|
1.89e-01
|
GOBP HIPPOCAMPUS DEVELOPMENT
|
90
|
5.87e-01
|
8.91e-01
|
0.06030
|
-2.03e-02
|
-5.68e-02
|
7.39e-01
|
3.52e-01
|
GOBP LIPID LOCALIZATION
|
496
|
8.12e-02
|
5.32e-01
|
0.06020
|
-5.81e-02
|
1.59e-02
|
2.68e-02
|
5.45e-01
|
GOBP LIPID METABOLIC PROCESS
|
1348
|
1.24e-03
|
5.90e-02
|
0.06020
|
-5.93e-02
|
1.06e-02
|
2.60e-04
|
5.14e-01
|
GOBP AMINE TRANSPORT
|
105
|
5.35e-01
|
8.76e-01
|
0.06020
|
5.54e-02
|
2.34e-02
|
3.27e-01
|
6.78e-01
|
GOBP MIDGUT DEVELOPMENT
|
10
|
9.53e-01
|
9.90e-01
|
0.06010
|
4.00e-02
|
-4.49e-02
|
8.27e-01
|
8.06e-01
|
GOBP CELL CELL JUNCTION ASSEMBLY
|
152
|
4.49e-01
|
8.43e-01
|
0.06010
|
5.94e-02
|
-9.30e-03
|
2.06e-01
|
8.43e-01
|
GOBP SKELETAL SYSTEM MORPHOGENESIS
|
225
|
3.40e-01
|
7.91e-01
|
0.06010
|
-4.57e-02
|
3.90e-02
|
2.37e-01
|
3.14e-01
|
GOBP RESPONSE TO RETINOIC ACID
|
105
|
6.03e-01
|
8.96e-01
|
0.06010
|
-4.02e-02
|
4.47e-02
|
4.77e-01
|
4.29e-01
|
GOBP MUSCLE CONTRACTION
|
338
|
1.60e-01
|
6.48e-01
|
0.06000
|
1.21e-03
|
6.00e-02
|
9.69e-01
|
5.79e-02
|
GOBP CARTILAGE CONDENSATION
|
19
|
8.95e-01
|
9.78e-01
|
0.06000
|
1.60e-02
|
5.78e-02
|
9.04e-01
|
6.62e-01
|
GOMF MODIFIED AMINO ACID BINDING
|
79
|
6.17e-01
|
9.00e-01
|
0.06000
|
-4.65e-02
|
-3.79e-02
|
4.75e-01
|
5.60e-01
|
GOMF TRNA BINDING
|
73
|
6.41e-01
|
9.06e-01
|
0.06000
|
-4.84e-02
|
-3.55e-02
|
4.75e-01
|
6.00e-01
|
GOBP TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY
|
617
|
4.21e-02
|
4.23e-01
|
0.06000
|
-9.12e-03
|
5.93e-02
|
6.99e-01
|
1.19e-02
|
GOMF MIRNA BINDING
|
39
|
8.05e-01
|
9.57e-01
|
0.06000
|
-5.99e-02
|
-3.71e-03
|
5.18e-01
|
9.68e-01
|
GOBP EAR MORPHOGENESIS
|
124
|
5.51e-01
|
8.80e-01
|
0.06000
|
-3.59e-02
|
4.80e-02
|
4.90e-01
|
3.56e-01
|
GOCC PRESYNAPTIC ACTIVE ZONE
|
74
|
6.37e-01
|
9.06e-01
|
0.05990
|
3.63e-02
|
4.77e-02
|
5.89e-01
|
4.78e-01
|
GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION
|
22
|
8.74e-01
|
9.74e-01
|
0.05990
|
4.51e-02
|
3.95e-02
|
7.14e-01
|
7.48e-01
|
GOBP MICROTUBULE DEPOLYMERIZATION
|
42
|
7.88e-01
|
9.53e-01
|
0.05990
|
-1.06e-02
|
-5.90e-02
|
9.06e-01
|
5.08e-01
|
GOMF CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY
|
34
|
8.28e-01
|
9.62e-01
|
0.05990
|
5.97e-02
|
4.23e-03
|
5.47e-01
|
9.66e-01
|
GOBP N ACETYLGLUCOSAMINE METABOLIC PROCESS
|
16
|
9.08e-01
|
9.81e-01
|
0.05980
|
-4.93e-02
|
-3.39e-02
|
7.33e-01
|
8.14e-01
|
GOBP FATTY ACID METABOLIC PROCESS
|
387
|
1.29e-01
|
6.09e-01
|
0.05970
|
-5.97e-02
|
1.92e-03
|
4.38e-02
|
9.48e-01
|
GOMF G QUADRUPLEX DNA BINDING
|
11
|
9.44e-01
|
9.90e-01
|
0.05970
|
9.20e-03
|
-5.89e-02
|
9.58e-01
|
7.35e-01
|
GOBP CO TRANSCRIPTIONAL MRNA 3 END PROCESSING CLEAVAGE AND POLYADENYLATION PATHWAY
|
5
|
9.72e-01
|
9.93e-01
|
0.05960
|
1.71e-02
|
5.71e-02
|
9.47e-01
|
8.25e-01
|
GOBP MORPHOGENESIS OF EMBRYONIC EPITHELIUM
|
150
|
4.81e-01
|
8.54e-01
|
0.05960
|
-2.44e-02
|
5.44e-02
|
6.06e-01
|
2.50e-01
|
GOMF DOUBLE STRANDED RNA BINDING
|
71
|
6.60e-01
|
9.09e-01
|
0.05960
|
-5.49e-02
|
-2.32e-02
|
4.24e-01
|
7.35e-01
|
GOBP REGULATION OF PHOSPHORYLATION
|
1009
|
1.03e-02
|
2.18e-01
|
0.05960
|
-4.11e-02
|
4.31e-02
|
2.73e-02
|
2.04e-02
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON METAL IONS
|
16
|
9.26e-01
|
9.85e-01
|
0.05950
|
3.33e-02
|
-4.94e-02
|
8.18e-01
|
7.32e-01
|
GOBP KIDNEY MORPHOGENESIS
|
94
|
5.88e-01
|
8.91e-01
|
0.05950
|
1.33e-02
|
5.80e-02
|
8.24e-01
|
3.31e-01
|
GOBP NEGATIVE REGULATION OF INTERFERON ALPHA PRODUCTION
|
6
|
9.72e-01
|
9.93e-01
|
0.05950
|
-4.50e-02
|
3.89e-02
|
8.49e-01
|
8.69e-01
|
GOBP MACROMOLECULE CATABOLIC PROCESS
|
1346
|
1.62e-03
|
7.31e-02
|
0.05950
|
-5.78e-02
|
1.43e-02
|
3.76e-04
|
3.79e-01
|
GOBP NEGATIVE REGULATION OF WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT
|
7
|
9.66e-01
|
9.92e-01
|
0.05950
|
1.98e-02
|
-5.61e-02
|
9.28e-01
|
7.97e-01
|
GOBP INTERFERON MEDIATED SIGNALING PATHWAY
|
101
|
5.84e-01
|
8.90e-01
|
0.05940
|
-5.94e-02
|
1.53e-03
|
3.02e-01
|
9.79e-01
|
GOMF SALT TRANSMEMBRANE TRANSPORTER ACTIVITY
|
560
|
4.86e-02
|
4.41e-01
|
0.05940
|
8.21e-03
|
5.88e-02
|
7.40e-01
|
1.74e-02
|
GOBP REGULATION OF B CELL DIFFERENTIATION
|
31
|
8.48e-01
|
9.66e-01
|
0.05940
|
-5.93e-02
|
1.95e-03
|
5.68e-01
|
9.85e-01
|
GOBP APOPTOTIC CELL CLEARANCE
|
47
|
7.96e-01
|
9.55e-01
|
0.05930
|
-2.47e-02
|
5.39e-02
|
7.70e-01
|
5.22e-01
|
GOMF DIPEPTIDASE ACTIVITY
|
16
|
9.26e-01
|
9.84e-01
|
0.05930
|
-2.66e-02
|
5.30e-02
|
8.54e-01
|
7.14e-01
|
GOBP EXPORT FROM CELL
|
867
|
2.01e-02
|
3.01e-01
|
0.05920
|
-4.15e-02
|
4.22e-02
|
3.79e-02
|
3.49e-02
|
GOCC CILIARY BASAL BODY
|
158
|
4.79e-01
|
8.54e-01
|
0.05920
|
-4.40e-02
|
3.97e-02
|
3.40e-01
|
3.90e-01
|
GOMF ATPASE BINDING
|
82
|
6.68e-01
|
9.11e-01
|
0.05920
|
1.93e-02
|
-5.60e-02
|
7.62e-01
|
3.81e-01
|
GOCC GLUTAMATERGIC SYNAPSE
|
387
|
1.62e-01
|
6.48e-01
|
0.05920
|
-2.89e-02
|
5.17e-02
|
3.29e-01
|
8.10e-02
|
GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5
|
12
|
9.31e-01
|
9.86e-01
|
0.05920
|
-3.56e-02
|
-4.73e-02
|
8.31e-01
|
7.77e-01
|
GOBP INNER EAR MORPHOGENESIS
|
104
|
5.99e-01
|
8.95e-01
|
0.05920
|
-1.86e-02
|
5.62e-02
|
7.44e-01
|
3.22e-01
|
GOCC EUCHROMATIN
|
56
|
7.41e-01
|
9.37e-01
|
0.05920
|
1.16e-03
|
5.92e-02
|
9.88e-01
|
4.44e-01
|
GOBP REGULATION OF SECRETION
|
600
|
6.39e-02
|
4.87e-01
|
0.05910
|
-4.83e-02
|
3.41e-02
|
4.34e-02
|
1.53e-01
|
GOBP CIRCULATORY SYSTEM PROCESS
|
576
|
5.45e-02
|
4.61e-01
|
0.05910
|
-5.66e-03
|
5.88e-02
|
8.17e-01
|
1.59e-02
|
GOBP LIPID CATABOLIC PROCESS
|
328
|
1.95e-01
|
6.86e-01
|
0.05910
|
-5.79e-02
|
1.14e-02
|
7.12e-02
|
7.23e-01
|
GOBP NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION
|
127
|
5.40e-01
|
8.78e-01
|
0.05900
|
-5.50e-02
|
2.14e-02
|
2.84e-01
|
6.77e-01
|
GOBP NEGATIVE REGULATION OF BINDING
|
118
|
5.22e-01
|
8.70e-01
|
0.05900
|
1.08e-02
|
5.80e-02
|
8.40e-01
|
2.76e-01
|
GOBP MEMBRANE FUSION
|
174
|
3.62e-01
|
8.03e-01
|
0.05900
|
-4.99e-02
|
-3.16e-02
|
2.56e-01
|
4.73e-01
|
GOBP RESPONSE TO UV B
|
21
|
9.07e-01
|
9.81e-01
|
0.05890
|
-4.75e-02
|
3.48e-02
|
7.06e-01
|
7.82e-01
|
GOBP REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS
|
101
|
5.53e-01
|
8.80e-01
|
0.05890
|
-4.77e-02
|
-3.47e-02
|
4.08e-01
|
5.47e-01
|
GOBP NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS
|
83
|
6.81e-01
|
9.16e-01
|
0.05890
|
4.27e-02
|
-4.06e-02
|
5.01e-01
|
5.23e-01
|
GOBP ORGANIC HYDROXY COMPOUND METABOLIC PROCESS
|
541
|
4.44e-02
|
4.29e-01
|
0.05890
|
-4.58e-02
|
-3.71e-02
|
6.86e-02
|
1.40e-01
|
GOBP NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION
|
43
|
7.89e-01
|
9.54e-01
|
0.05890
|
1.20e-02
|
5.76e-02
|
8.92e-01
|
5.13e-01
|
GOBP REGULATION OF CELLULAR COMPONENT BIOGENESIS
|
953
|
1.41e-02
|
2.57e-01
|
0.05890
|
-4.82e-02
|
3.38e-02
|
1.18e-02
|
7.68e-02
|
GOBP ERK1 AND ERK2 CASCADE
|
333
|
1.56e-01
|
6.43e-01
|
0.05890
|
1.94e-02
|
5.56e-02
|
5.43e-01
|
8.13e-02
|
GOBP MAINTENANCE OF ORGANELLE LOCATION
|
13
|
9.32e-01
|
9.86e-01
|
0.05880
|
5.84e-02
|
7.04e-03
|
7.15e-01
|
9.65e-01
|
GOBP NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION
|
144
|
5.01e-01
|
8.62e-01
|
0.05880
|
-2.13e-02
|
5.48e-02
|
6.59e-01
|
2.56e-01
|
GOBP CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS
|
41
|
8.10e-01
|
9.59e-01
|
0.05880
|
5.22e-03
|
-5.86e-02
|
9.54e-01
|
5.16e-01
|
GOBP CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE
|
63
|
7.42e-01
|
9.37e-01
|
0.05880
|
5.26e-02
|
-2.64e-02
|
4.71e-01
|
7.17e-01
|
GOBP CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT
|
85
|
6.13e-01
|
8.98e-01
|
0.05880
|
-2.69e-02
|
-5.23e-02
|
6.68e-01
|
4.05e-01
|
GOBP CIRCULATORY SYSTEM DEVELOPMENT
|
1174
|
3.55e-03
|
1.21e-01
|
0.05880
|
-8.48e-03
|
5.82e-02
|
6.24e-01
|
7.85e-04
|
GOBP VIRAL RNA GENOME REPLICATION
|
29
|
8.75e-01
|
9.75e-01
|
0.05870
|
-4.28e-02
|
4.02e-02
|
6.90e-01
|
7.08e-01
|
GOCC CDC73 PAF1 COMPLEX
|
7
|
9.62e-01
|
9.91e-01
|
0.05870
|
1.31e-02
|
5.72e-02
|
9.52e-01
|
7.93e-01
|
GOCC MEDIATOR COMPLEX
|
34
|
8.20e-01
|
9.60e-01
|
0.05870
|
-3.64e-02
|
-4.61e-02
|
7.13e-01
|
6.42e-01
|
GOBP CELLULAR RESPONSE TO UV
|
87
|
6.02e-01
|
8.96e-01
|
0.05870
|
-3.54e-02
|
-4.68e-02
|
5.68e-01
|
4.50e-01
|
GOBP ORGANIC ACID CATABOLIC PROCESS
|
245
|
2.44e-01
|
7.25e-01
|
0.05870
|
-4.89e-02
|
-3.25e-02
|
1.88e-01
|
3.81e-01
|
GOCC DYNEIN COMPLEX
|
53
|
7.79e-01
|
9.51e-01
|
0.05870
|
-2.64e-02
|
5.24e-02
|
7.40e-01
|
5.09e-01
|
GOBP REGULATION OF LYMPHOCYTE DIFFERENTIATION
|
206
|
3.90e-01
|
8.21e-01
|
0.05870
|
-3.85e-02
|
4.42e-02
|
3.41e-01
|
2.74e-01
|
GOBP NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR
|
14
|
9.24e-01
|
9.84e-01
|
0.05860
|
1.86e-02
|
5.56e-02
|
9.04e-01
|
7.19e-01
|
GOBP LEUKOCYTE CELL CELL ADHESION
|
400
|
1.45e-01
|
6.29e-01
|
0.05860
|
-1.49e-02
|
5.67e-02
|
6.09e-01
|
5.17e-02
|
GOCC MICROTUBULE ORGANIZING CENTER
|
808
|
2.22e-02
|
3.16e-01
|
0.05860
|
-5.63e-02
|
1.62e-02
|
6.50e-03
|
4.34e-01
|
GOBP REGULATION OF DENDRITE EXTENSION
|
26
|
8.70e-01
|
9.73e-01
|
0.05850
|
5.82e-02
|
6.39e-03
|
6.08e-01
|
9.55e-01
|
GOMF ABC TYPE TRANSPORTER ACTIVITY
|
46
|
7.70e-01
|
9.47e-01
|
0.05850
|
-5.26e-02
|
-2.57e-02
|
5.37e-01
|
7.63e-01
|
GOBP PROTEIN CONTAINING COMPLEX DISASSEMBLY
|
241
|
2.91e-01
|
7.61e-01
|
0.05850
|
-5.85e-02
|
1.13e-03
|
1.18e-01
|
9.76e-01
|
GOCC SOMATODENDRITIC COMPARTMENT
|
799
|
1.66e-02
|
2.73e-01
|
0.05840
|
5.92e-03
|
5.81e-02
|
7.76e-01
|
5.20e-03
|
GOCC MICROTUBULE ASSOCIATED COMPLEX
|
149
|
4.38e-01
|
8.40e-01
|
0.05840
|
-5.54e-02
|
-1.87e-02
|
2.43e-01
|
6.93e-01
|
GOBP LEUKOCYTE HOMEOSTASIS
|
103
|
5.94e-01
|
8.94e-01
|
0.05840
|
-5.14e-03
|
5.82e-02
|
9.28e-01
|
3.07e-01
|
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE
|
437
|
9.89e-02
|
5.66e-01
|
0.05840
|
-5.76e-02
|
-9.91e-03
|
3.91e-02
|
7.22e-01
|
GOBP NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS
|
371
|
1.64e-01
|
6.49e-01
|
0.05840
|
-5.73e-02
|
1.11e-02
|
5.80e-02
|
7.13e-01
|
GOBP ANIMAL ORGAN MORPHOGENESIS
|
1012
|
1.12e-02
|
2.25e-01
|
0.05840
|
-2.82e-02
|
5.11e-02
|
1.29e-01
|
5.96e-03
|
GOMF L ASCORBIC ACID BINDING
|
20
|
9.13e-01
|
9.82e-01
|
0.05840
|
3.60e-02
|
-4.59e-02
|
7.80e-01
|
7.22e-01
|
GOBP C21 STEROID HORMONE METABOLIC PROCESS
|
36
|
8.37e-01
|
9.64e-01
|
0.05840
|
5.74e-02
|
-1.03e-02
|
5.51e-01
|
9.15e-01
|
GOBP REGULATION OF DNA DIRECTED DNA POLYMERASE ACTIVITY
|
9
|
9.60e-01
|
9.91e-01
|
0.05840
|
4.57e-02
|
-3.63e-02
|
8.12e-01
|
8.50e-01
|
GOBP SMALL MOLECULE CATABOLIC PROCESS
|
364
|
1.34e-01
|
6.16e-01
|
0.05830
|
-5.42e-02
|
-2.16e-02
|
7.56e-02
|
4.80e-01
|
GOCC GAMMA SECRETASE COMPLEX
|
7
|
9.64e-01
|
9.92e-01
|
0.05830
|
-5.82e-02
|
-4.53e-03
|
7.90e-01
|
9.83e-01
|
GOBP NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY
|
27
|
8.83e-01
|
9.76e-01
|
0.05830
|
3.06e-02
|
-4.96e-02
|
7.83e-01
|
6.55e-01
|
GOBP PROSTATE GLAND DEVELOPMENT
|
49
|
7.94e-01
|
9.55e-01
|
0.05830
|
-2.28e-02
|
5.37e-02
|
7.82e-01
|
5.16e-01
|
GOBP CELL JUNCTION ORGANIZATION
|
713
|
2.52e-02
|
3.31e-01
|
0.05830
|
7.79e-03
|
5.77e-02
|
7.23e-01
|
8.62e-03
|
GOMF SODIUM CHANNEL INHIBITOR ACTIVITY
|
8
|
9.57e-01
|
9.90e-01
|
0.05830
|
1.51e-02
|
5.63e-02
|
9.41e-01
|
7.83e-01
|
GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY
|
186
|
3.79e-01
|
8.14e-01
|
0.05820
|
-5.81e-02
|
-4.63e-03
|
1.72e-01
|
9.13e-01
|
GOBP NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS
|
941
|
1.68e-02
|
2.75e-01
|
0.05820
|
-4.19e-02
|
4.04e-02
|
2.93e-02
|
3.57e-02
|
GOMF INTRAMOLECULAR TRANSFERASE ACTIVITY PHOSPHOTRANSFERASES
|
10
|
9.55e-01
|
9.90e-01
|
0.05820
|
2.84e-02
|
-5.08e-02
|
8.76e-01
|
7.81e-01
|
GOBP SYNAPTIC VESICLE EXOCYTOSIS
|
91
|
6.31e-01
|
9.03e-01
|
0.05820
|
-3.83e-03
|
5.81e-02
|
9.50e-01
|
3.38e-01
|
GOBP INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY
|
6
|
9.73e-01
|
9.93e-01
|
0.05820
|
-5.06e-02
|
2.88e-02
|
8.30e-01
|
9.03e-01
|
GOBP RHYTHMIC PROCESS
|
286
|
2.47e-01
|
7.26e-01
|
0.05820
|
-5.74e-02
|
9.25e-03
|
9.46e-02
|
7.88e-01
|
GOBP NEGATIVE REGULATION OF CELL DEVELOPMENT
|
274
|
2.42e-01
|
7.25e-01
|
0.05810
|
-5.80e-02
|
-4.27e-03
|
9.85e-02
|
9.03e-01
|
GOBP SUBSTRATE INDEPENDENT TELENCEPHALIC TANGENTIAL MIGRATION
|
10
|
9.53e-01
|
9.90e-01
|
0.05810
|
1.48e-02
|
-5.62e-02
|
9.35e-01
|
7.58e-01
|
GOBP EPIDERMIS DEVELOPMENT
|
373
|
1.22e-01
|
6.03e-01
|
0.05810
|
4.62e-02
|
3.52e-02
|
1.25e-01
|
2.43e-01
|
GOBP PHARYNGEAL SYSTEM DEVELOPMENT
|
30
|
8.52e-01
|
9.67e-01
|
0.05810
|
1.05e-02
|
5.71e-02
|
9.21e-01
|
5.88e-01
|
GOCC INTRACELLULAR PROTEIN CONTAINING COMPLEX
|
852
|
1.15e-02
|
2.29e-01
|
0.05800
|
-5.56e-02
|
-1.64e-02
|
5.82e-03
|
4.17e-01
|
GOBP REGULATION OF MYOBLAST FUSION
|
21
|
9.07e-01
|
9.81e-01
|
0.05800
|
-2.21e-02
|
5.36e-02
|
8.61e-01
|
6.71e-01
|
GOMF CYTIDYLYLTRANSFERASE ACTIVITY
|
9
|
9.60e-01
|
9.91e-01
|
0.05790
|
-4.14e-02
|
4.05e-02
|
8.30e-01
|
8.33e-01
|
GOBP PROTEIN UNFOLDING
|
5
|
9.73e-01
|
9.93e-01
|
0.05780
|
5.44e-02
|
1.96e-02
|
8.33e-01
|
9.40e-01
|
GOBP VERY LONG CHAIN FATTY ACID CATABOLIC PROCESS
|
6
|
9.71e-01
|
9.93e-01
|
0.05780
|
-1.18e-02
|
5.66e-02
|
9.60e-01
|
8.10e-01
|
GOBP MEMORY
|
120
|
5.24e-01
|
8.70e-01
|
0.05780
|
1.68e-02
|
5.53e-02
|
7.51e-01
|
2.96e-01
|
GOCC PROTEASOME REGULATORY PARTICLE LID SUBCOMPLEX
|
7
|
9.61e-01
|
9.91e-01
|
0.05770
|
-3.37e-02
|
-4.69e-02
|
8.77e-01
|
8.30e-01
|
GOBP CELL PART MORPHOGENESIS
|
644
|
5.76e-02
|
4.68e-01
|
0.05770
|
-2.64e-02
|
5.13e-02
|
2.53e-01
|
2.64e-02
|
GOBP REGULATION OF HEART RATE BY CARDIAC CONDUCTION
|
37
|
8.22e-01
|
9.61e-01
|
0.05770
|
1.12e-02
|
5.66e-02
|
9.06e-01
|
5.52e-01
|
GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE
|
35
|
8.52e-01
|
9.67e-01
|
0.05760
|
2.39e-02
|
-5.24e-02
|
8.06e-01
|
5.92e-01
|
GOBP NEGATIVE REGULATION OF CATECHOLAMINE SECRETION
|
13
|
9.43e-01
|
9.89e-01
|
0.05760
|
-3.02e-02
|
4.90e-02
|
8.50e-01
|
7.60e-01
|
GOBP REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS
|
91
|
6.67e-01
|
9.11e-01
|
0.05760
|
-4.75e-02
|
3.25e-02
|
4.34e-01
|
5.92e-01
|
GOBP REGULATION OF LEUKOCYTE DIFFERENTIATION
|
314
|
2.46e-01
|
7.26e-01
|
0.05750
|
-5.09e-02
|
2.69e-02
|
1.21e-01
|
4.13e-01
|
GOMF POTASSIUM CHANNEL REGULATOR ACTIVITY
|
46
|
7.92e-01
|
9.54e-01
|
0.05750
|
5.74e-02
|
2.43e-03
|
5.00e-01
|
9.77e-01
|
GOCC POSTSYNAPTIC SPECIALIZATION MEMBRANE
|
117
|
5.25e-01
|
8.71e-01
|
0.05750
|
-5.01e-02
|
-2.81e-02
|
3.49e-01
|
5.99e-01
|
GOBP T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE
|
82
|
6.78e-01
|
9.14e-01
|
0.05740
|
-1.27e-02
|
5.60e-02
|
8.42e-01
|
3.80e-01
|
GOBP L ASPARTATE TRANSMEMBRANE TRANSPORT
|
11
|
9.51e-01
|
9.90e-01
|
0.05740
|
2.65e-02
|
-5.10e-02
|
8.79e-01
|
7.70e-01
|
GOBP RESPONSE TO KETONE
|
197
|
4.10e-01
|
8.27e-01
|
0.05740
|
5.24e-02
|
-2.35e-02
|
2.05e-01
|
5.69e-01
|
GOBP MORPHOGENESIS OF AN EPITHELIUM
|
505
|
1.11e-01
|
5.87e-01
|
0.05730
|
-3.03e-02
|
4.87e-02
|
2.44e-01
|
6.12e-02
|
GOBP POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION
|
158
|
4.77e-01
|
8.54e-01
|
0.05730
|
5.57e-02
|
-1.35e-02
|
2.27e-01
|
7.70e-01
|
GOBP ISOPRENOID METABOLIC PROCESS
|
130
|
5.00e-01
|
8.62e-01
|
0.05730
|
-1.80e-02
|
-5.44e-02
|
7.23e-01
|
2.84e-01
|
GOBP PROTEIN LOCALIZATION TO NUCLEOLUS
|
18
|
9.23e-01
|
9.84e-01
|
0.05730
|
2.88e-02
|
-4.96e-02
|
8.32e-01
|
7.16e-01
|
GOBP REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION
|
1711
|
9.75e-04
|
5.01e-02
|
0.05730
|
-3.86e-02
|
4.23e-02
|
7.89e-03
|
3.60e-03
|
GOBP UROGENITAL SYSTEM DEVELOPMENT
|
66
|
6.97e-01
|
9.21e-01
|
0.05730
|
-5.08e-02
|
-2.65e-02
|
4.76e-01
|
7.10e-01
|
GOBP CELLULAR COMPONENT DISASSEMBLY
|
479
|
1.09e-01
|
5.84e-01
|
0.05720
|
-5.60e-02
|
1.20e-02
|
3.59e-02
|
6.52e-01
|
GOBP POSITIVE REGULATION OF URINE VOLUME
|
13
|
9.31e-01
|
9.86e-01
|
0.05720
|
-3.19e-02
|
-4.75e-02
|
8.42e-01
|
7.67e-01
|
GOBP SECRETION
|
923
|
1.99e-02
|
3.00e-01
|
0.05720
|
-4.80e-02
|
3.10e-02
|
1.33e-02
|
1.10e-01
|
GOBP POSITIVE REGULATION OF MOLECULAR FUNCTION
|
1210
|
6.68e-03
|
1.70e-01
|
0.05720
|
-3.66e-02
|
4.39e-02
|
3.20e-02
|
1.02e-02
|
GOBP TYPE II INTERFERON PRODUCTION
|
112
|
5.42e-01
|
8.78e-01
|
0.05710
|
4.92e-02
|
2.91e-02
|
3.68e-01
|
5.95e-01
|
GOBP REGULATION OF CHOLESTEROL METABOLIC PROCESS
|
40
|
8.10e-01
|
9.59e-01
|
0.05710
|
-1.48e-02
|
-5.52e-02
|
8.71e-01
|
5.46e-01
|
GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT
|
36
|
8.34e-01
|
9.64e-01
|
0.05710
|
-5.69e-02
|
-4.67e-03
|
5.54e-01
|
9.61e-01
|
GOMF SULFUR COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY
|
56
|
7.42e-01
|
9.37e-01
|
0.05710
|
1.97e-02
|
5.36e-02
|
7.99e-01
|
4.88e-01
|
GOCC GABA ERGIC SYNAPSE
|
73
|
7.15e-01
|
9.27e-01
|
0.05710
|
-1.79e-02
|
5.42e-02
|
7.91e-01
|
4.23e-01
|
GOBP REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS
|
135
|
5.19e-01
|
8.69e-01
|
0.05710
|
-5.70e-02
|
3.83e-03
|
2.53e-01
|
9.39e-01
|
GOCC CILIARY BASE
|
44
|
8.02e-01
|
9.57e-01
|
0.05710
|
2.88e-03
|
5.70e-02
|
9.74e-01
|
5.13e-01
|
GOBP POSTSYNAPTIC CYTOSKELETON ORGANIZATION
|
17
|
9.14e-01
|
9.82e-01
|
0.05710
|
5.44e-02
|
1.72e-02
|
6.98e-01
|
9.02e-01
|
GOBP REGULATION OF IMMUNE EFFECTOR PROCESS
|
370
|
1.85e-01
|
6.77e-01
|
0.05710
|
-5.48e-02
|
1.60e-02
|
7.04e-02
|
5.97e-01
|
GOCC AXON
|
619
|
3.59e-02
|
3.87e-01
|
0.05710
|
3.43e-02
|
4.56e-02
|
1.45e-01
|
5.28e-02
|
GOBP OUTER DYNEIN ARM ASSEMBLY
|
23
|
9.01e-01
|
9.79e-01
|
0.05700
|
5.29e-02
|
-2.13e-02
|
6.60e-01
|
8.60e-01
|
GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS
|
127
|
5.05e-01
|
8.65e-01
|
0.05700
|
-2.39e-02
|
-5.18e-02
|
6.42e-01
|
3.13e-01
|
GOBP LIVER REGENERATION
|
28
|
8.85e-01
|
9.76e-01
|
0.05700
|
-3.33e-02
|
4.63e-02
|
7.61e-01
|
6.71e-01
|
GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE
|
37
|
8.21e-01
|
9.60e-01
|
0.05700
|
1.96e-02
|
5.36e-02
|
8.37e-01
|
5.73e-01
|
GOCC PROTEASOME REGULATORY PARTICLE
|
19
|
9.21e-01
|
9.84e-01
|
0.05700
|
3.87e-02
|
-4.19e-02
|
7.70e-01
|
7.52e-01
|
GOBP CELL MOTILITY
|
1713
|
3.49e-04
|
2.35e-02
|
0.05700
|
4.32e-03
|
5.68e-02
|
7.66e-01
|
9.10e-05
|
GOBP DORSAL VENTRAL NEURAL TUBE PATTERNING
|
24
|
8.83e-01
|
9.76e-01
|
0.05700
|
5.54e-02
|
1.32e-02
|
6.38e-01
|
9.11e-01
|
GOBP RESPONSE TO NITROGEN COMPOUND
|
1079
|
7.84e-03
|
1.84e-01
|
0.05690
|
-5.60e-02
|
1.02e-02
|
1.88e-03
|
5.70e-01
|
GOBP REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION
|
89
|
6.46e-01
|
9.07e-01
|
0.05690
|
-5.69e-02
|
3.64e-04
|
3.53e-01
|
9.95e-01
|
GOBP REGULATION OF ACTIN NUCLEATION
|
38
|
8.46e-01
|
9.66e-01
|
0.05690
|
-4.90e-02
|
2.90e-02
|
6.01e-01
|
7.57e-01
|
GOBP AMINO ACID IMPORT ACROSS PLASMA MEMBRANE
|
44
|
7.85e-01
|
9.52e-01
|
0.05690
|
3.75e-02
|
4.28e-02
|
6.67e-01
|
6.23e-01
|
GOBP APOPTOTIC SIGNALING PATHWAY
|
599
|
7.73e-02
|
5.24e-01
|
0.05690
|
-4.83e-02
|
3.01e-02
|
4.34e-02
|
2.09e-01
|
GOBP PARANODAL JUNCTION ASSEMBLY
|
6
|
9.69e-01
|
9.93e-01
|
0.05680
|
-5.28e-02
|
-2.08e-02
|
8.23e-01
|
9.30e-01
|
GOCC DENDRITIC TREE
|
589
|
6.10e-02
|
4.78e-01
|
0.05680
|
-1.41e-03
|
5.68e-02
|
9.53e-01
|
1.86e-02
|
GOBP REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL
|
72
|
7.22e-01
|
9.30e-01
|
0.05680
|
-1.80e-02
|
5.38e-02
|
7.92e-01
|
4.30e-01
|
GOBP ENDODERMAL CELL FATE COMMITMENT
|
15
|
9.25e-01
|
9.84e-01
|
0.05680
|
1.32e-02
|
5.52e-02
|
9.29e-01
|
7.11e-01
|
GOBP PURINE NUCLEOSIDE METABOLIC PROCESS
|
25
|
8.93e-01
|
9.77e-01
|
0.05670
|
5.32e-02
|
-1.97e-02
|
6.45e-01
|
8.65e-01
|
GOBP REGULATION OF ANOIKIS
|
23
|
8.85e-01
|
9.76e-01
|
0.05660
|
-2.24e-02
|
-5.20e-02
|
8.52e-01
|
6.66e-01
|
GOBP FEMALE SEX DIFFERENTIATION
|
117
|
5.39e-01
|
8.78e-01
|
0.05660
|
-2.25e-02
|
-5.19e-02
|
6.75e-01
|
3.32e-01
|
GOBP PHAGOSOME MATURATION
|
28
|
8.66e-01
|
9.70e-01
|
0.05660
|
5.50e-02
|
1.34e-02
|
6.15e-01
|
9.02e-01
|
GOBP CELL PROLIFERATION IN HINDBRAIN
|
16
|
9.34e-01
|
9.87e-01
|
0.05660
|
-3.94e-02
|
4.06e-02
|
7.85e-01
|
7.79e-01
|
GOMF CDP ALCOHOL PHOSPHATIDYLTRANSFERASE ACTIVITY
|
8
|
9.58e-01
|
9.90e-01
|
0.05650
|
-4.69e-02
|
-3.15e-02
|
8.18e-01
|
8.77e-01
|
GOBP ROOF OF MOUTH DEVELOPMENT
|
90
|
6.49e-01
|
9.07e-01
|
0.05640
|
-1.57e-03
|
5.64e-02
|
9.80e-01
|
3.55e-01
|
GOBP REGULATION OF ORGANELLE ORGANIZATION
|
1150
|
5.98e-03
|
1.62e-01
|
0.05640
|
-5.60e-02
|
7.41e-03
|
1.38e-03
|
6.72e-01
|
GOBP DORSAL VENTRAL PATTERN FORMATION
|
97
|
5.95e-01
|
8.95e-01
|
0.05640
|
-2.96e-02
|
-4.80e-02
|
6.14e-01
|
4.14e-01
|
GOBP NEGATIVE REGULATION OF RESPONSE TO STIMULUS
|
1673
|
1.38e-03
|
6.43e-02
|
0.05640
|
-3.83e-02
|
4.14e-02
|
9.07e-03
|
4.80e-03
|
GOCC CLATHRIN COATED VESICLE MEMBRANE
|
127
|
5.22e-01
|
8.70e-01
|
0.05640
|
1.50e-02
|
5.44e-02
|
7.70e-01
|
2.90e-01
|
GOMF MONOCARBOXYLIC ACID BINDING
|
87
|
6.26e-01
|
9.01e-01
|
0.05640
|
4.48e-02
|
3.42e-02
|
4.70e-01
|
5.81e-01
|
GOBP REGULATION OF MONOCYTE EXTRAVASATION
|
7
|
9.70e-01
|
9.93e-01
|
0.05640
|
-5.19e-02
|
2.19e-02
|
8.12e-01
|
9.20e-01
|
GOMF TUBULIN BINDING
|
357
|
1.99e-01
|
6.89e-01
|
0.05640
|
-5.51e-02
|
1.17e-02
|
7.35e-02
|
7.03e-01
|
GOBP REGULATION OF LOCOMOTION
|
1080
|
7.65e-03
|
1.83e-01
|
0.05640
|
-4.33e-03
|
5.62e-02
|
8.10e-01
|
1.81e-03
|
GOBP TERPENOID METABOLIC PROCESS
|
96
|
6.51e-01
|
9.07e-01
|
0.05630
|
1.69e-02
|
-5.37e-02
|
7.75e-01
|
3.63e-01
|
GOMF PEPTIDE BINDING
|
301
|
2.39e-01
|
7.25e-01
|
0.05630
|
-8.97e-05
|
-5.63e-02
|
9.98e-01
|
9.30e-02
|
GOBP REGULATION OF CELL CELL ADHESION
|
476
|
9.33e-02
|
5.55e-01
|
0.05630
|
1.35e-02
|
5.46e-02
|
6.15e-01
|
4.11e-02
|
GOBP NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION
|
153
|
5.19e-01
|
8.69e-01
|
0.05630
|
-2.83e-02
|
4.86e-02
|
5.45e-01
|
2.99e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS
|
419
|
1.43e-01
|
6.28e-01
|
0.05630
|
-5.61e-02
|
4.30e-03
|
4.88e-02
|
8.80e-01
|
GOBP NEGATIVE REGULATION OF SODIUM ION TRANSPORT
|
17
|
9.25e-01
|
9.84e-01
|
0.05630
|
-5.53e-02
|
1.05e-02
|
6.93e-01
|
9.40e-01
|
GOMF AMYLOID BETA BINDING
|
82
|
6.89e-01
|
9.19e-01
|
0.05630
|
-5.48e-02
|
1.29e-02
|
3.91e-01
|
8.40e-01
|
GOBP SYNAPTIC TRANSMISSION DOPAMINERGIC
|
28
|
8.63e-01
|
9.69e-01
|
0.05620
|
-2.55e-02
|
-5.01e-02
|
8.15e-01
|
6.46e-01
|
GOMF PHOSPHATASE ACTIVATOR ACTIVITY
|
18
|
9.25e-01
|
9.84e-01
|
0.05620
|
-5.02e-02
|
2.52e-02
|
7.12e-01
|
8.53e-01
|
GOBP DNA BIOSYNTHETIC PROCESS
|
188
|
3.85e-01
|
8.18e-01
|
0.05610
|
-5.36e-02
|
-1.67e-02
|
2.05e-01
|
6.94e-01
|
GOBP ESTABLISHMENT OF ENDOTHELIAL BARRIER
|
51
|
8.05e-01
|
9.57e-01
|
0.05600
|
-4.71e-02
|
3.03e-02
|
5.60e-01
|
7.08e-01
|
GOBP PROTEIN POLYUFMYLATION
|
5
|
9.78e-01
|
9.95e-01
|
0.05600
|
5.32e-02
|
-1.77e-02
|
8.37e-01
|
9.45e-01
|
GOBP REGULATION OF HORMONE SECRETION
|
248
|
3.14e-01
|
7.76e-01
|
0.05600
|
-5.60e-02
|
2.69e-03
|
1.29e-01
|
9.42e-01
|
GOBP REGULATION OF SPROUTING ANGIOGENESIS
|
62
|
7.53e-01
|
9.41e-01
|
0.05600
|
-9.61e-03
|
5.52e-02
|
8.96e-01
|
4.52e-01
|
GOBP POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION
|
170
|
4.86e-01
|
8.56e-01
|
0.05600
|
-2.79e-02
|
4.85e-02
|
5.30e-01
|
2.75e-01
|
GOBP MUSCLE CELL CELLULAR HOMEOSTASIS
|
21
|
9.14e-01
|
9.82e-01
|
0.05600
|
-2.66e-02
|
4.93e-02
|
8.33e-01
|
6.96e-01
|
GOMF STEROID BINDING
|
98
|
6.15e-01
|
8.99e-01
|
0.05600
|
-5.50e-02
|
-1.07e-02
|
3.47e-01
|
8.55e-01
|
GOBP PEPTIDYL TYROSINE MODIFICATION
|
269
|
2.96e-01
|
7.65e-01
|
0.05600
|
-9.00e-03
|
5.52e-02
|
7.99e-01
|
1.19e-01
|
GOBP RESPONSE TO GROWTH FACTOR
|
730
|
4.24e-02
|
4.24e-01
|
0.05590
|
-1.41e-02
|
5.41e-02
|
5.16e-01
|
1.28e-02
|
GOBP POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS
|
26
|
8.97e-01
|
9.78e-01
|
0.05590
|
-4.33e-02
|
3.54e-02
|
7.03e-01
|
7.54e-01
|
GOBP REGULATION OF B CELL ACTIVATION
|
123
|
5.51e-01
|
8.80e-01
|
0.05590
|
5.93e-03
|
5.56e-02
|
9.10e-01
|
2.87e-01
|
GOCC FIBRINOGEN COMPLEX
|
8
|
9.65e-01
|
9.92e-01
|
0.05590
|
1.27e-02
|
-5.44e-02
|
9.50e-01
|
7.90e-01
|
GOCC CELL SURFACE
|
842
|
1.37e-02
|
2.54e-01
|
0.05570
|
3.97e-02
|
3.92e-02
|
5.07e-02
|
5.36e-02
|
GOBP POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS
|
1618
|
1.65e-03
|
7.39e-02
|
0.05570
|
-2.40e-02
|
5.02e-02
|
1.08e-01
|
7.57e-04
|
GOBP DEVELOPMENT OF SECONDARY FEMALE SEXUAL CHARACTERISTICS
|
6
|
9.75e-01
|
9.95e-01
|
0.05560
|
-3.45e-02
|
4.36e-02
|
8.84e-01
|
8.53e-01
|
GOBP CELL CELL JUNCTION ORGANIZATION
|
207
|
3.57e-01
|
7.99e-01
|
0.05560
|
1.57e-02
|
5.34e-02
|
6.97e-01
|
1.86e-01
|
GOBP PROTEIN LOCALIZATION TO ORGANELLE
|
915
|
1.37e-02
|
2.54e-01
|
0.05560
|
-5.49e-02
|
-8.74e-03
|
4.83e-03
|
6.54e-01
|
GOBP NEUROTRANSMITTER SECRETION
|
138
|
4.88e-01
|
8.56e-01
|
0.05560
|
3.08e-02
|
4.63e-02
|
5.32e-01
|
3.47e-01
|
GOBP NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION
|
93
|
6.48e-01
|
9.07e-01
|
0.05560
|
1.15e-03
|
-5.56e-02
|
9.85e-01
|
3.54e-01
|
GOBP REGULATION OF STEROID BIOSYNTHETIC PROCESS
|
79
|
6.94e-01
|
9.21e-01
|
0.05550
|
-5.55e-02
|
2.69e-03
|
3.94e-01
|
9.67e-01
|
GOBP REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY
|
24
|
9.01e-01
|
9.79e-01
|
0.05550
|
-1.70e-02
|
5.29e-02
|
8.85e-01
|
6.54e-01
|
GOCC PARALLEL FIBER TO PURKINJE CELL SYNAPSE
|
17
|
9.16e-01
|
9.83e-01
|
0.05550
|
-2.77e-02
|
-4.81e-02
|
8.43e-01
|
7.31e-01
|
GOBP B CELL APOPTOTIC PROCESS
|
26
|
8.97e-01
|
9.78e-01
|
0.05550
|
-4.75e-02
|
2.87e-02
|
6.75e-01
|
8.00e-01
|
GOCC MITOTIC SPINDLE POLE
|
35
|
8.38e-01
|
9.64e-01
|
0.05550
|
-1.88e-02
|
-5.22e-02
|
8.47e-01
|
5.93e-01
|
GOBP SEGMENT SPECIFICATION
|
16
|
9.23e-01
|
9.84e-01
|
0.05550
|
-1.55e-02
|
-5.33e-02
|
9.14e-01
|
7.12e-01
|
GOBP MEIOTIC SISTER CHROMATID COHESION
|
13
|
9.47e-01
|
9.90e-01
|
0.05550
|
-4.81e-02
|
2.77e-02
|
7.64e-01
|
8.63e-01
|
GOBP NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS
|
10
|
9.52e-01
|
9.90e-01
|
0.05540
|
1.27e-02
|
5.40e-02
|
9.45e-01
|
7.68e-01
|
GOBP FEMALE GAMETE GENERATION
|
158
|
4.80e-01
|
8.54e-01
|
0.05540
|
4.00e-05
|
5.54e-02
|
9.99e-01
|
2.29e-01
|
GOBP HORMONE MEDIATED SIGNALING PATHWAY
|
182
|
4.75e-01
|
8.54e-01
|
0.05540
|
-4.40e-02
|
3.36e-02
|
3.05e-01
|
4.34e-01
|
GOBP PHOTORECEPTOR CELL DIFFERENTIATION
|
63
|
7.29e-01
|
9.32e-01
|
0.05540
|
-1.85e-02
|
-5.22e-02
|
8.00e-01
|
4.73e-01
|
GOBP REGULATION OF NATURAL KILLER CELL ACTIVATION
|
41
|
8.11e-01
|
9.59e-01
|
0.05540
|
-5.00e-02
|
-2.38e-02
|
5.80e-01
|
7.92e-01
|
GOCC PHAGOCYTIC VESICLE
|
131
|
5.69e-01
|
8.86e-01
|
0.05540
|
-5.26e-02
|
1.73e-02
|
2.98e-01
|
7.33e-01
|
GOBP ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY
|
79
|
7.24e-01
|
9.30e-01
|
0.05540
|
-3.84e-02
|
3.99e-02
|
5.55e-01
|
5.40e-01
|
GOBP MRNA METABOLIC PROCESS
|
742
|
2.46e-02
|
3.31e-01
|
0.05540
|
-2.91e-02
|
-4.71e-02
|
1.76e-01
|
2.91e-02
|
GOBP NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS
|
20
|
9.12e-01
|
9.82e-01
|
0.05530
|
1.84e-03
|
-5.53e-02
|
9.89e-01
|
6.69e-01
|
GOBP CLUSTERING OF VOLTAGE GATED SODIUM CHANNELS
|
6
|
9.74e-01
|
9.94e-01
|
0.05530
|
-1.04e-02
|
5.43e-02
|
9.65e-01
|
8.18e-01
|
GOBP RESPONSE TO CARBOHYDRATE
|
224
|
4.02e-01
|
8.26e-01
|
0.05520
|
-3.25e-02
|
4.46e-02
|
4.01e-01
|
2.50e-01
|
GOBP DNA DEALKYLATION
|
37
|
8.34e-01
|
9.64e-01
|
0.05520
|
-5.34e-02
|
-1.40e-02
|
5.74e-01
|
8.83e-01
|
GOBP REGULATION OF EPITHELIAL CELL MIGRATION
|
282
|
2.45e-01
|
7.26e-01
|
0.05520
|
2.25e-02
|
5.04e-02
|
5.16e-01
|
1.45e-01
|
GOBP DNA RECOMBINATION
|
318
|
1.98e-01
|
6.88e-01
|
0.05520
|
-3.23e-02
|
-4.47e-02
|
3.22e-01
|
1.70e-01
|
GOBP V D J RECOMBINATION
|
19
|
9.08e-01
|
9.81e-01
|
0.05520
|
-2.33e-02
|
-5.00e-02
|
8.60e-01
|
7.06e-01
|
GOBP NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION
|
55
|
7.92e-01
|
9.54e-01
|
0.05520
|
-5.10e-02
|
2.10e-02
|
5.13e-01
|
7.88e-01
|
GOBP PURINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS
|
6
|
9.70e-01
|
9.93e-01
|
0.05510
|
-2.75e-02
|
-4.78e-02
|
9.07e-01
|
8.39e-01
|
GOBP REGULATION OF PROTEIN MODIFICATION PROCESS
|
1249
|
8.25e-03
|
1.90e-01
|
0.05510
|
-4.08e-02
|
3.70e-02
|
1.52e-02
|
2.76e-02
|
GOBP REGULATION OF CELL PROJECTION ASSEMBLY
|
217
|
4.08e-01
|
8.27e-01
|
0.05510
|
-4.91e-02
|
2.49e-02
|
2.12e-01
|
5.27e-01
|
GOMF INTRAMEMBRANE LIPID TRANSPORTER ACTIVITY
|
41
|
8.31e-01
|
9.64e-01
|
0.05500
|
-5.48e-02
|
4.43e-03
|
5.43e-01
|
9.61e-01
|
GOBP POSITIVE REGULATION OF DEVELOPMENTAL PROCESS
|
1310
|
6.01e-03
|
1.62e-01
|
0.05490
|
-2.45e-02
|
4.92e-02
|
1.36e-01
|
2.80e-03
|
GOMF CO SMAD BINDING
|
9
|
9.59e-01
|
9.90e-01
|
0.05490
|
-5.47e-02
|
-4.34e-03
|
7.76e-01
|
9.82e-01
|
GOBP CARDIAC PACEMAKER CELL DIFFERENTIATION
|
11
|
9.57e-01
|
9.90e-01
|
0.05480
|
-4.37e-02
|
3.32e-02
|
8.02e-01
|
8.49e-01
|
GOBP REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR
|
104
|
6.60e-01
|
9.09e-01
|
0.05480
|
4.02e-02
|
-3.72e-02
|
4.78e-01
|
5.12e-01
|
GOBP CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT
|
22
|
9.02e-01
|
9.80e-01
|
0.05470
|
5.43e-02
|
6.79e-03
|
6.59e-01
|
9.56e-01
|
GOBP CELL MORPHOGENESIS
|
914
|
2.68e-02
|
3.41e-01
|
0.05470
|
-2.34e-02
|
4.95e-02
|
2.31e-01
|
1.12e-02
|
GOBP NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION
|
72
|
7.12e-01
|
9.27e-01
|
0.05460
|
5.38e-02
|
9.50e-03
|
4.30e-01
|
8.89e-01
|
GOMF BHLH TRANSCRIPTION FACTOR BINDING
|
31
|
8.84e-01
|
9.76e-01
|
0.05460
|
-3.61e-02
|
4.09e-02
|
7.28e-01
|
6.93e-01
|
GOBP EMBRYO IMPLANTATION
|
57
|
7.90e-01
|
9.54e-01
|
0.05450
|
2.03e-02
|
-5.06e-02
|
7.91e-01
|
5.09e-01
|
GOMF CYCLIC NUCLEOTIDE BINDING
|
37
|
8.38e-01
|
9.64e-01
|
0.05450
|
5.29e-02
|
1.31e-02
|
5.77e-01
|
8.90e-01
|
GOBP METANEPHROS DEVELOPMENT
|
91
|
6.65e-01
|
9.10e-01
|
0.05450
|
-5.45e-02
|
7.21e-04
|
3.69e-01
|
9.91e-01
|
GOBP DETECTION OF MECHANICAL STIMULUS
|
53
|
7.66e-01
|
9.46e-01
|
0.05450
|
3.23e-02
|
4.39e-02
|
6.84e-01
|
5.80e-01
|
GOMF FATTY ACID BINDING
|
49
|
8.23e-01
|
9.61e-01
|
0.05440
|
4.15e-02
|
-3.52e-02
|
6.15e-01
|
6.70e-01
|
GOMF QUATERNARY AMMONIUM GROUP BINDING
|
51
|
7.79e-01
|
9.51e-01
|
0.05440
|
-4.96e-02
|
-2.22e-02
|
5.40e-01
|
7.84e-01
|
GOBP IMPORT INTO NUCLEUS
|
163
|
5.13e-01
|
8.67e-01
|
0.05430
|
-5.05e-02
|
1.99e-02
|
2.66e-01
|
6.60e-01
|
GOBP REGULATION OF PHOSPHORUS METABOLIC PROCESS
|
1134
|
1.40e-02
|
2.56e-01
|
0.05430
|
-3.27e-02
|
4.34e-02
|
6.32e-02
|
1.37e-02
|
GOBP XENOBIOTIC TRANSPORT
|
59
|
7.93e-01
|
9.55e-01
|
0.05430
|
3.79e-02
|
-3.88e-02
|
6.14e-01
|
6.06e-01
|
GOBP NEUROTROPHIN SIGNALING PATHWAY
|
38
|
8.49e-01
|
9.66e-01
|
0.05430
|
5.36e-02
|
-8.47e-03
|
5.68e-01
|
9.28e-01
|
GOBP PHOSPHOLIPID TRANSLOCATION
|
50
|
8.05e-01
|
9.57e-01
|
0.05420
|
-5.38e-02
|
6.43e-03
|
5.10e-01
|
9.37e-01
|
GOMF RNA ENDONUCLEASE ACTIVITY
|
71
|
7.05e-01
|
9.24e-01
|
0.05410
|
-4.65e-02
|
-2.77e-02
|
4.98e-01
|
6.87e-01
|
GOBP PLASMA LIPOPROTEIN PARTICLE CLEARANCE
|
54
|
8.09e-01
|
9.59e-01
|
0.05410
|
-3.21e-02
|
4.36e-02
|
6.84e-01
|
5.80e-01
|
GOBP REGULATION OF DEVELOPMENTAL GROWTH
|
311
|
3.00e-01
|
7.67e-01
|
0.05410
|
-3.36e-02
|
4.24e-02
|
3.08e-01
|
1.99e-01
|
GOBP HORMONE TRANSPORT
|
311
|
2.65e-01
|
7.41e-01
|
0.05410
|
-5.37e-02
|
5.95e-03
|
1.03e-01
|
8.57e-01
|
GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY
|
151
|
4.79e-01
|
8.54e-01
|
0.05410
|
2.70e-02
|
4.68e-02
|
5.67e-01
|
3.21e-01
|
GOMF GROWTH FACTOR ACTIVITY
|
152
|
5.20e-01
|
8.69e-01
|
0.05400
|
-5.60e-03
|
5.37e-02
|
9.05e-01
|
2.53e-01
|
GOBP ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE
|
74
|
6.96e-01
|
9.21e-01
|
0.05400
|
-4.61e-02
|
-2.81e-02
|
4.93e-01
|
6.76e-01
|
GOBP PROTEIN TETRAMERIZATION
|
88
|
6.89e-01
|
9.19e-01
|
0.05400
|
-5.32e-02
|
8.88e-03
|
3.88e-01
|
8.86e-01
|
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR
|
82
|
6.68e-01
|
9.11e-01
|
0.05390
|
3.30e-02
|
4.26e-02
|
6.05e-01
|
5.05e-01
|
GOBP MONOCARBOXYLIC ACID METABOLIC PROCESS
|
609
|
6.00e-02
|
4.78e-01
|
0.05390
|
-5.08e-02
|
-1.79e-02
|
3.23e-02
|
4.50e-01
|
GOBP ENDODERMAL CELL FATE SPECIFICATION
|
8
|
9.62e-01
|
9.91e-01
|
0.05390
|
-4.72e-02
|
-2.59e-02
|
8.17e-01
|
8.99e-01
|
GOBP REGULATION OF CELL SHAPE
|
134
|
5.97e-01
|
8.95e-01
|
0.05380
|
-3.73e-02
|
3.89e-02
|
4.56e-01
|
4.37e-01
|
GOBP TISSUE MORPHOGENESIS
|
620
|
7.88e-02
|
5.27e-01
|
0.05380
|
-9.70e-03
|
5.29e-02
|
6.80e-01
|
2.44e-02
|
GOBP REGULATION OF CELL CYCLE G1 S PHASE TRANSITION
|
198
|
4.46e-01
|
8.40e-01
|
0.05380
|
-5.17e-02
|
1.50e-02
|
2.10e-01
|
7.16e-01
|
GOBP REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY
|
68
|
7.69e-01
|
9.47e-01
|
0.05380
|
-4.15e-02
|
3.42e-02
|
5.54e-01
|
6.26e-01
|
GOMF MONOATOMIC ION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
686
|
4.46e-02
|
4.29e-01
|
0.05370
|
1.54e-02
|
5.14e-02
|
4.92e-01
|
2.17e-02
|
GOBP SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS
|
77
|
6.88e-01
|
9.19e-01
|
0.05370
|
-4.49e-02
|
-2.95e-02
|
4.96e-01
|
6.55e-01
|
GOBP AXON DEVELOPMENT
|
481
|
1.58e-01
|
6.46e-01
|
0.05360
|
-2.58e-02
|
4.70e-02
|
3.32e-01
|
7.77e-02
|
GOBP RESPONSE TO REACTIVE OXYGEN SPECIES
|
195
|
4.64e-01
|
8.48e-01
|
0.05350
|
-4.90e-02
|
2.15e-02
|
2.38e-01
|
6.05e-01
|
GOBP NEGATIVE REGULATION OF KINASE ACTIVITY
|
190
|
4.61e-01
|
8.48e-01
|
0.05350
|
-5.19e-02
|
1.28e-02
|
2.17e-01
|
7.61e-01
|
GOBP INNATE IMMUNE RESPONSE
|
897
|
1.63e-02
|
2.72e-01
|
0.05350
|
-4.76e-02
|
-2.45e-02
|
1.57e-02
|
2.14e-01
|
GOMF PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY
|
90
|
6.48e-01
|
9.07e-01
|
0.05340
|
2.99e-02
|
4.43e-02
|
6.24e-01
|
4.67e-01
|
GOBP PEPTIDE TRANSPORT
|
254
|
3.70e-01
|
8.09e-01
|
0.05340
|
-4.89e-02
|
2.15e-02
|
1.79e-01
|
5.55e-01
|
GOMF LIM DOMAIN BINDING
|
5
|
9.78e-01
|
9.95e-01
|
0.05340
|
1.87e-03
|
5.34e-02
|
9.94e-01
|
8.36e-01
|
GOBP ALPHA BETA T CELL ACTIVATION
|
168
|
4.54e-01
|
8.46e-01
|
0.05340
|
2.22e-02
|
4.86e-02
|
6.19e-01
|
2.78e-01
|
GOBP PROTEIN POLYUBIQUITINATION
|
219
|
4.20e-01
|
8.33e-01
|
0.05340
|
-5.02e-02
|
1.81e-02
|
2.00e-01
|
6.45e-01
|
GOBP POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS
|
27
|
9.01e-01
|
9.79e-01
|
0.05340
|
-2.78e-02
|
4.56e-02
|
8.03e-01
|
6.82e-01
|
GOBP MUSCLE SYSTEM PROCESS
|
438
|
1.68e-01
|
6.54e-01
|
0.05340
|
-9.65e-03
|
5.25e-02
|
7.29e-01
|
5.96e-02
|
GOBP REGULATION OF PROTEIN KINASE C SIGNALING
|
18
|
9.17e-01
|
9.83e-01
|
0.05340
|
4.46e-02
|
2.93e-02
|
7.43e-01
|
8.30e-01
|
GOBP ORGANONITROGEN COMPOUND CATABOLIC PROCESS
|
1268
|
8.81e-03
|
1.97e-01
|
0.05330
|
-4.93e-02
|
2.05e-02
|
3.19e-03
|
2.20e-01
|
GOBP NEGATIVE REGULATION OF STEROID METABOLIC PROCESS
|
32
|
8.57e-01
|
9.68e-01
|
0.05330
|
3.44e-02
|
4.07e-02
|
7.36e-01
|
6.90e-01
|
GOMF DNA BINDING TRANSCRIPTION REPRESSOR ACTIVITY
|
319
|
3.02e-01
|
7.68e-01
|
0.05330
|
-4.08e-02
|
3.43e-02
|
2.11e-01
|
2.92e-01
|
GOBP CARDIAC CHAMBER MORPHOGENESIS
|
127
|
5.71e-01
|
8.87e-01
|
0.05330
|
6.23e-03
|
5.29e-02
|
9.04e-01
|
3.03e-01
|
GOBP CELL JUNCTION ASSEMBLY
|
422
|
1.38e-01
|
6.21e-01
|
0.05320
|
2.93e-02
|
4.44e-02
|
3.01e-01
|
1.18e-01
|
GOBP REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT
|
19
|
9.13e-01
|
9.82e-01
|
0.05320
|
-2.80e-02
|
-4.52e-02
|
8.33e-01
|
7.33e-01
|
GOBP POSITIVE REGULATION OF JNK CASCADE
|
83
|
6.98e-01
|
9.21e-01
|
0.05320
|
2.73e-03
|
5.31e-02
|
9.66e-01
|
4.03e-01
|
GOMF PROTEIN HOMODIMERIZATION ACTIVITY
|
682
|
7.24e-02
|
5.13e-01
|
0.05310
|
-5.01e-02
|
1.76e-02
|
2.56e-02
|
4.34e-01
|
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE
|
101
|
6.84e-01
|
9.17e-01
|
0.05310
|
-3.47e-02
|
4.02e-02
|
5.47e-01
|
4.85e-01
|
GOMF DYNEIN COMPLEX BINDING
|
23
|
9.03e-01
|
9.80e-01
|
0.05310
|
5.25e-02
|
8.01e-03
|
6.63e-01
|
9.47e-01
|
GOBP CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND
|
524
|
1.09e-01
|
5.84e-01
|
0.05310
|
-5.31e-02
|
-2.15e-03
|
3.77e-02
|
9.33e-01
|
GOMF NUCLEOBASE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
10
|
9.53e-01
|
9.90e-01
|
0.05300
|
-3.74e-02
|
-3.75e-02
|
8.38e-01
|
8.37e-01
|
GOBP NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION
|
899
|
2.09e-02
|
3.05e-01
|
0.05290
|
1.17e-02
|
5.16e-02
|
5.53e-01
|
8.63e-03
|
GOCC NEUROFILAMENT
|
9
|
9.58e-01
|
9.90e-01
|
0.05290
|
-3.44e-02
|
-4.02e-02
|
8.58e-01
|
8.34e-01
|
GOBP REGULATION OF BODY FLUID LEVELS
|
351
|
2.59e-01
|
7.37e-01
|
0.05290
|
-1.94e-02
|
4.92e-02
|
5.32e-01
|
1.13e-01
|
GOBP REGULATION OF HYDROLASE ACTIVITY
|
731
|
5.68e-02
|
4.68e-01
|
0.05290
|
-1.05e-02
|
5.18e-02
|
6.28e-01
|
1.70e-02
|
GOBP STABILIZATION OF MEMBRANE POTENTIAL
|
17
|
9.37e-01
|
9.88e-01
|
0.05290
|
4.57e-02
|
-2.67e-02
|
7.44e-01
|
8.49e-01
|
GOBP GAMETE GENERATION
|
721
|
7.34e-02
|
5.13e-01
|
0.05290
|
-3.46e-02
|
3.99e-02
|
1.13e-01
|
6.77e-02
|
GOMF NUCLEAR RECEPTOR ACTIVITY
|
51
|
8.24e-01
|
9.61e-01
|
0.05290
|
2.65e-02
|
-4.57e-02
|
7.43e-01
|
5.72e-01
|
GOBP ANATOMICAL STRUCTURE MATURATION
|
253
|
3.15e-01
|
7.76e-01
|
0.05280
|
-4.89e-02
|
-2.01e-02
|
1.81e-01
|
5.83e-01
|
GOBP NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT
|
147
|
5.79e-01
|
8.89e-01
|
0.05280
|
-4.11e-02
|
3.31e-02
|
3.89e-01
|
4.88e-01
|
GOBP REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT
|
112
|
6.59e-01
|
9.09e-01
|
0.05280
|
3.20e-02
|
-4.19e-02
|
5.58e-01
|
4.43e-01
|
GOMF ENZYME REGULATOR ACTIVITY
|
1203
|
1.35e-02
|
2.52e-01
|
0.05280
|
-2.72e-02
|
4.52e-02
|
1.12e-01
|
8.27e-03
|
GOBP REGULATION OF ACTION POTENTIAL
|
55
|
8.09e-01
|
9.59e-01
|
0.05270
|
4.82e-02
|
-2.14e-02
|
5.36e-01
|
7.84e-01
|
GOBP POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION
|
81
|
6.99e-01
|
9.21e-01
|
0.05270
|
1.11e-02
|
5.15e-02
|
8.62e-01
|
4.23e-01
|
GOBP PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS
|
715
|
7.29e-02
|
5.13e-01
|
0.05270
|
-4.56e-02
|
2.65e-02
|
3.78e-02
|
2.28e-01
|
GOCC NEUROFIBRILLARY TANGLE
|
5
|
9.78e-01
|
9.95e-01
|
0.05270
|
-1.31e-02
|
-5.10e-02
|
9.60e-01
|
8.43e-01
|
GOBP PEPTIDE CROSS LINKING
|
27
|
8.82e-01
|
9.75e-01
|
0.05270
|
2.60e-02
|
4.58e-02
|
8.15e-01
|
6.80e-01
|
GOBP HEART FIELD SPECIFICATION
|
17
|
9.26e-01
|
9.85e-01
|
0.05270
|
5.06e-02
|
1.46e-02
|
7.18e-01
|
9.17e-01
|
GOCC OUTER DYNEIN ARM
|
11
|
9.49e-01
|
9.90e-01
|
0.05270
|
3.86e-02
|
3.58e-02
|
8.25e-01
|
8.37e-01
|
GOMF CELL ADHESION MOLECULE BINDING
|
541
|
1.36e-01
|
6.18e-01
|
0.05260
|
-2.62e-02
|
4.57e-02
|
2.98e-01
|
6.91e-02
|
GOMF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY
|
166
|
5.33e-01
|
8.76e-01
|
0.05260
|
-2.24e-02
|
4.76e-02
|
6.18e-01
|
2.90e-01
|
GOBP PROTEASOMAL PROTEIN CATABOLIC PROCESS
|
509
|
1.23e-01
|
6.04e-01
|
0.05250
|
-5.25e-02
|
-7.89e-04
|
4.24e-02
|
9.76e-01
|
GOBP REGULATION OF SALIVA SECRETION
|
7
|
9.74e-01
|
9.94e-01
|
0.05250
|
-4.57e-02
|
2.60e-02
|
8.34e-01
|
9.05e-01
|
GOBP POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION
|
74
|
7.08e-01
|
9.25e-01
|
0.05250
|
-4.06e-02
|
-3.33e-02
|
5.46e-01
|
6.21e-01
|
GOBP METHYLGUANOSINE CAP DECAPPING
|
16
|
9.42e-01
|
9.89e-01
|
0.05250
|
-4.49e-02
|
2.71e-02
|
7.56e-01
|
8.51e-01
|
GOBP NERVOUS SYSTEM PROCESS
|
1386
|
4.01e-03
|
1.31e-01
|
0.05250
|
5.24e-02
|
3.10e-03
|
1.08e-03
|
8.47e-01
|
GOBP DEVELOPMENTAL CELL GROWTH
|
226
|
3.91e-01
|
8.21e-01
|
0.05250
|
4.87e-04
|
5.25e-02
|
9.90e-01
|
1.74e-01
|
GOBP WATER TRANSPORT
|
28
|
8.79e-01
|
9.75e-01
|
0.05250
|
-4.55e-02
|
-2.61e-02
|
6.77e-01
|
8.11e-01
|
GOBP PURINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT
|
35
|
8.63e-01
|
9.69e-01
|
0.05240
|
-5.24e-02
|
-2.14e-03
|
5.92e-01
|
9.83e-01
|
GOBP NEGATIVE REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS
|
5
|
9.82e-01
|
9.96e-01
|
0.05240
|
-3.37e-02
|
4.02e-02
|
8.96e-01
|
8.76e-01
|
GOBP POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE
|
218
|
3.84e-01
|
8.17e-01
|
0.05240
|
1.33e-02
|
5.07e-02
|
7.35e-01
|
1.97e-01
|
GOMF ORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
232
|
4.30e-01
|
8.37e-01
|
0.05240
|
-3.83e-02
|
3.58e-02
|
3.15e-01
|
3.48e-01
|
GOBP NEUROENDOCRINE CELL DIFFERENTIATION
|
16
|
9.29e-01
|
9.86e-01
|
0.05240
|
-4.61e-02
|
-2.48e-02
|
7.49e-01
|
8.64e-01
|
GOBP REGULATION OF KERATINOCYTE PROLIFERATION
|
47
|
8.16e-01
|
9.59e-01
|
0.05240
|
8.56e-03
|
5.17e-02
|
9.19e-01
|
5.40e-01
|
GOBP DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN
|
26
|
8.86e-01
|
9.76e-01
|
0.05240
|
3.94e-02
|
3.44e-02
|
7.28e-01
|
7.61e-01
|
GOBP REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS
|
169
|
5.36e-01
|
8.77e-01
|
0.05230
|
-4.44e-02
|
2.77e-02
|
3.19e-01
|
5.35e-01
|
GOBP L AMINO ACID TRANSPORT
|
84
|
6.80e-01
|
9.15e-01
|
0.05230
|
2.68e-02
|
4.49e-02
|
6.71e-01
|
4.76e-01
|
GOMF PROTEIN PHOSPHATASE 1 BINDING
|
24
|
9.16e-01
|
9.83e-01
|
0.05230
|
-3.72e-02
|
3.68e-02
|
7.52e-01
|
7.55e-01
|
GOCC PRESYNAPTIC CYTOSOL
|
12
|
9.46e-01
|
9.90e-01
|
0.05230
|
-2.57e-02
|
-4.55e-02
|
8.78e-01
|
7.85e-01
|
GOBP RETINA LAYER FORMATION
|
23
|
8.99e-01
|
9.78e-01
|
0.05220
|
-3.68e-02
|
-3.70e-02
|
7.60e-01
|
7.58e-01
|
GOBP HINDBRAIN DEVELOPMENT
|
147
|
5.33e-01
|
8.76e-01
|
0.05220
|
-8.63e-03
|
-5.15e-02
|
8.57e-01
|
2.82e-01
|
GOBP CARDIAC MUSCLE CELL DIFFERENTIATION
|
128
|
5.94e-01
|
8.94e-01
|
0.05210
|
-2.25e-03
|
5.21e-02
|
9.65e-01
|
3.09e-01
|
GOBP REGULATION OF COAGULATION
|
73
|
7.14e-01
|
9.27e-01
|
0.05210
|
3.71e-02
|
3.66e-02
|
5.84e-01
|
5.89e-01
|
GOCC COATED VESICLE
|
297
|
2.97e-01
|
7.66e-01
|
0.05210
|
-5.21e-02
|
-5.44e-04
|
1.22e-01
|
9.87e-01
|
GOBP REGULATION OF LIPID LOCALIZATION
|
183
|
4.89e-01
|
8.56e-01
|
0.05200
|
-5.12e-02
|
9.31e-03
|
2.32e-01
|
8.28e-01
|
GOBP CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION
|
89
|
7.25e-01
|
9.30e-01
|
0.05200
|
-3.30e-02
|
4.02e-02
|
5.91e-01
|
5.12e-01
|
GOBP NEGATIVE REGULATION OF SIGNALING
|
1396
|
8.75e-03
|
1.97e-01
|
0.05200
|
-3.43e-02
|
3.91e-02
|
3.19e-02
|
1.43e-02
|
GOBP REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION
|
106
|
6.16e-01
|
8.99e-01
|
0.05200
|
-3.20e-02
|
-4.10e-02
|
5.70e-01
|
4.66e-01
|
GOBP NEGATIVE REGULATION OF CELL GROWTH
|
177
|
5.29e-01
|
8.73e-01
|
0.05200
|
-3.40e-02
|
3.94e-02
|
4.36e-01
|
3.66e-01
|
GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN CYCLIC AMIDINES
|
36
|
8.57e-01
|
9.68e-01
|
0.05200
|
-5.10e-02
|
-1.01e-02
|
5.97e-01
|
9.16e-01
|
GOBP P BODY ASSEMBLY
|
20
|
9.25e-01
|
9.84e-01
|
0.05190
|
5.09e-02
|
-1.04e-02
|
6.94e-01
|
9.36e-01
|
GOBP POSITIVE REGULATION OF ORGAN GROWTH
|
47
|
8.42e-01
|
9.66e-01
|
0.05190
|
4.42e-02
|
-2.71e-02
|
6.00e-01
|
7.48e-01
|
GOBP POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS
|
34
|
8.72e-01
|
9.73e-01
|
0.05190
|
5.17e-02
|
-3.88e-03
|
6.02e-01
|
9.69e-01
|
GOBP RESPONSE TO BILE ACID
|
7
|
9.69e-01
|
9.93e-01
|
0.05180
|
2.69e-02
|
4.43e-02
|
9.02e-01
|
8.39e-01
|
GOBP REGULATION OF SISTER CHROMATID COHESION
|
15
|
9.43e-01
|
9.89e-01
|
0.05180
|
-7.88e-03
|
5.12e-02
|
9.58e-01
|
7.32e-01
|
GOBP CHRONIC INFLAMMATORY RESPONSE
|
18
|
9.22e-01
|
9.84e-01
|
0.05180
|
4.35e-02
|
2.81e-02
|
7.49e-01
|
8.37e-01
|
GOCC ENDOCYTIC VESICLE MEMBRANE
|
187
|
5.15e-01
|
8.68e-01
|
0.05170
|
3.81e-02
|
-3.50e-02
|
3.69e-01
|
4.09e-01
|
GOCC SIDE OF MEMBRANE
|
674
|
5.32e-02
|
4.56e-01
|
0.05170
|
4.51e-02
|
2.52e-02
|
4.56e-02
|
2.64e-01
|
GOBP INTRACELLULAR PH ELEVATION
|
7
|
9.75e-01
|
9.95e-01
|
0.05170
|
-3.66e-02
|
3.65e-02
|
8.67e-01
|
8.67e-01
|
GOMF PROTEIN SEQUESTERING ACTIVITY
|
23
|
9.07e-01
|
9.81e-01
|
0.05170
|
-8.84e-03
|
-5.09e-02
|
9.41e-01
|
6.73e-01
|
GOBP NEPHRON EPITHELIUM DEVELOPMENT
|
115
|
6.32e-01
|
9.03e-01
|
0.05170
|
-2.46e-03
|
5.16e-02
|
9.64e-01
|
3.39e-01
|
GOBP REGULATION OF GTP BINDING
|
11
|
9.61e-01
|
9.91e-01
|
0.05160
|
4.31e-02
|
-2.84e-02
|
8.04e-01
|
8.71e-01
|
GOBP EPITHELIAL TUBE MORPHOGENESIS
|
326
|
3.10e-01
|
7.73e-01
|
0.05160
|
-2.37e-02
|
4.58e-02
|
4.62e-01
|
1.55e-01
|
GOBP POSITIVE REGULATION OF MELANOCYTE DIFFERENTIATION
|
5
|
9.79e-01
|
9.95e-01
|
0.05160
|
-8.34e-03
|
-5.09e-02
|
9.74e-01
|
8.44e-01
|
GOBP RESPONSE TO AMYLOID BETA
|
54
|
8.25e-01
|
9.62e-01
|
0.05150
|
3.22e-02
|
-4.02e-02
|
6.82e-01
|
6.09e-01
|
GOBP HEMOPOIESIS
|
913
|
4.17e-02
|
4.21e-01
|
0.05150
|
-2.45e-02
|
4.53e-02
|
2.09e-01
|
2.02e-02
|
GOMF BILE ACID TRANSMEMBRANE TRANSPORTER ACTIVITY
|
18
|
9.35e-01
|
9.87e-01
|
0.05150
|
-1.75e-02
|
4.85e-02
|
8.98e-01
|
7.22e-01
|
GOBP OSTEOBLAST PROLIFERATION
|
36
|
8.50e-01
|
9.67e-01
|
0.05150
|
-3.30e-02
|
-3.96e-02
|
7.32e-01
|
6.81e-01
|
GOBP POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN
|
11
|
9.53e-01
|
9.90e-01
|
0.05150
|
-4.84e-02
|
-1.75e-02
|
7.81e-01
|
9.20e-01
|
GOCC CYTOPLASMIC SIDE OF LYSOSOMAL MEMBRANE
|
13
|
9.55e-01
|
9.90e-01
|
0.05150
|
3.31e-02
|
-3.94e-02
|
8.36e-01
|
8.06e-01
|
GOBP MEDIUM CHAIN FATTY ACID METABOLIC PROCESS
|
15
|
9.46e-01
|
9.90e-01
|
0.05140
|
1.97e-02
|
-4.75e-02
|
8.95e-01
|
7.50e-01
|
GOBP REPLACEMENT OSSIFICATION
|
29
|
8.90e-01
|
9.76e-01
|
0.05140
|
-5.43e-04
|
5.14e-02
|
9.96e-01
|
6.32e-01
|
GOBP FATTY ACID TRANSPORT
|
115
|
6.13e-01
|
8.98e-01
|
0.05140
|
1.38e-02
|
4.96e-02
|
7.98e-01
|
3.59e-01
|
GOBP POSITIVE REGULATION OF CELL DIFFERENTIATION
|
854
|
5.47e-02
|
4.62e-01
|
0.05140
|
-3.48e-02
|
3.79e-02
|
8.46e-02
|
6.01e-02
|
GOBP REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY
|
51
|
8.35e-01
|
9.64e-01
|
0.05140
|
3.85e-02
|
-3.41e-02
|
6.34e-01
|
6.74e-01
|
GOBP POSITIVE REGULATION OF CATALYTIC ACTIVITY
|
889
|
4.85e-02
|
4.41e-01
|
0.05140
|
-3.24e-02
|
3.99e-02
|
1.01e-01
|
4.35e-02
|
GOBP POSITIVE REGULATION OF B CELL ACTIVATION
|
79
|
7.35e-01
|
9.34e-01
|
0.05140
|
-6.21e-03
|
5.10e-02
|
9.24e-01
|
4.33e-01
|
GOBP PEPTIDYL THREONINE DEPHOSPHORYLATION
|
18
|
9.32e-01
|
9.86e-01
|
0.05140
|
5.09e-02
|
-6.75e-03
|
7.08e-01
|
9.60e-01
|
GOBP REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION
|
122
|
6.40e-01
|
9.06e-01
|
0.05130
|
-4.78e-02
|
1.88e-02
|
3.62e-01
|
7.20e-01
|
GOBP MORPHOGENESIS OF A BRANCHING STRUCTURE
|
195
|
5.01e-01
|
8.62e-01
|
0.05130
|
-2.68e-02
|
4.38e-02
|
5.19e-01
|
2.91e-01
|
GOBP BILE ACID METABOLIC PROCESS
|
49
|
8.40e-01
|
9.65e-01
|
0.05130
|
4.40e-02
|
-2.64e-02
|
5.94e-01
|
7.49e-01
|
GOBP REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR
|
37
|
8.56e-01
|
9.68e-01
|
0.05130
|
5.01e-02
|
1.11e-02
|
5.98e-01
|
9.07e-01
|
GOCC CULLIN RING UBIQUITIN LIGASE COMPLEX
|
174
|
5.41e-01
|
8.78e-01
|
0.05120
|
-4.38e-02
|
2.64e-02
|
3.19e-01
|
5.49e-01
|
GOBP WATER SOLUBLE VITAMIN METABOLIC PROCESS
|
58
|
8.07e-01
|
9.59e-01
|
0.05110
|
1.52e-02
|
-4.88e-02
|
8.42e-01
|
5.21e-01
|
GOBP NEGATIVE REGULATION OF IMMUNE RESPONSE
|
198
|
4.28e-01
|
8.36e-01
|
0.05100
|
-4.67e-02
|
-2.06e-02
|
2.57e-01
|
6.18e-01
|
GOBP CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND
|
14
|
9.41e-01
|
9.89e-01
|
0.05100
|
-2.29e-02
|
-4.56e-02
|
8.82e-01
|
7.68e-01
|
GOBP POSITIVE REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE
|
11
|
9.58e-01
|
9.90e-01
|
0.05100
|
-2.77e-03
|
5.09e-02
|
9.87e-01
|
7.70e-01
|
GOBP NEGATIVE REGULATION OF PHOSPHORYLATION
|
321
|
3.05e-01
|
7.69e-01
|
0.05100
|
-4.98e-02
|
1.09e-02
|
1.25e-01
|
7.38e-01
|
GOBP GLAND DEVELOPMENT
|
429
|
2.28e-01
|
7.15e-01
|
0.05090
|
-2.65e-02
|
4.35e-02
|
3.47e-01
|
1.23e-01
|
GOBP BLOOD VESSEL ENDOTHELIAL CELL MIGRATION
|
170
|
4.75e-01
|
8.54e-01
|
0.05090
|
3.29e-02
|
3.88e-02
|
4.59e-01
|
3.83e-01
|
GOBP MUSCLE CELL DEVELOPMENT
|
191
|
4.40e-01
|
8.40e-01
|
0.05090
|
2.40e-02
|
4.49e-02
|
5.67e-01
|
2.85e-01
|
GOBP PLATELET ACTIVATING FACTOR METABOLIC PROCESS
|
8
|
9.66e-01
|
9.92e-01
|
0.05090
|
2.46e-02
|
4.45e-02
|
9.04e-01
|
8.27e-01
|
GOBP SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND
|
65
|
7.52e-01
|
9.40e-01
|
0.05080
|
-3.37e-02
|
-3.80e-02
|
6.38e-01
|
5.96e-01
|
GOBP REGULATION OF SKELETAL MUSCLE CONTRACTION BY CALCIUM ION SIGNALING
|
6
|
9.76e-01
|
9.95e-01
|
0.05080
|
8.32e-03
|
5.01e-02
|
9.72e-01
|
8.32e-01
|
GOMF PHOSPHATASE ACTIVITY
|
256
|
4.00e-01
|
8.26e-01
|
0.05080
|
-1.75e-02
|
4.77e-02
|
6.29e-01
|
1.89e-01
|
GOBP NOTCH RECEPTOR PROCESSING
|
9
|
9.67e-01
|
9.92e-01
|
0.05080
|
1.12e-02
|
-4.95e-02
|
9.54e-01
|
7.97e-01
|
GOBP GROOMING BEHAVIOR
|
17
|
9.42e-01
|
9.89e-01
|
0.05070
|
-4.56e-02
|
2.21e-02
|
7.45e-01
|
8.75e-01
|
GOBP POSITIVE REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT
|
8
|
9.68e-01
|
9.92e-01
|
0.05070
|
9.38e-03
|
4.98e-02
|
9.63e-01
|
8.07e-01
|
GOBP NEGATIVE REGULATION OF GROWTH
|
233
|
4.41e-01
|
8.40e-01
|
0.05070
|
-2.12e-02
|
4.60e-02
|
5.77e-01
|
2.26e-01
|
GOBP RESPONSE TO SALT
|
349
|
2.97e-01
|
7.66e-01
|
0.05070
|
-4.55e-02
|
2.22e-02
|
1.44e-01
|
4.76e-01
|
GOBP NEGATIVE REGULATION OF MOLECULAR FUNCTION
|
750
|
8.29e-02
|
5.35e-01
|
0.05060
|
-3.91e-02
|
3.22e-02
|
6.87e-02
|
1.33e-01
|
GOBP MULTICELLULAR ORGANISMAL LEVEL HOMEOSTASIS
|
780
|
7.62e-02
|
5.19e-01
|
0.05060
|
-3.52e-02
|
3.63e-02
|
9.40e-02
|
8.49e-02
|
GOBP POSITIVE REGULATION OF LOCOMOTION
|
588
|
1.36e-01
|
6.17e-01
|
0.05050
|
-2.43e-02
|
4.43e-02
|
3.14e-01
|
6.64e-02
|
GOMF MRNA 3 UTR BINDING
|
230
|
4.61e-01
|
8.48e-01
|
0.05040
|
3.48e-02
|
-3.65e-02
|
3.64e-01
|
3.40e-01
|
GOCC CILIARY TIP
|
45
|
8.26e-01
|
9.62e-01
|
0.05040
|
-2.47e-02
|
-4.39e-02
|
7.74e-01
|
6.10e-01
|
GOBP PHOSPHOLIPID TRANSPORT
|
101
|
6.89e-01
|
9.19e-01
|
0.05040
|
-4.97e-02
|
8.66e-03
|
3.89e-01
|
8.80e-01
|
GOMF CHANNEL REGULATOR ACTIVITY
|
135
|
6.26e-01
|
9.01e-01
|
0.05040
|
-2.23e-02
|
4.52e-02
|
6.55e-01
|
3.65e-01
|
GOBP PROTEIN LIPID COMPLEX ORGANIZATION
|
54
|
8.30e-01
|
9.64e-01
|
0.05030
|
-4.34e-02
|
2.55e-02
|
5.81e-01
|
7.46e-01
|
GOCC RNA POLYMERASE II TRANSCRIPTION REGULATOR COMPLEX
|
233
|
4.18e-01
|
8.32e-01
|
0.05030
|
-5.02e-02
|
3.73e-03
|
1.87e-01
|
9.22e-01
|
GOMF ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
423
|
2.45e-01
|
7.26e-01
|
0.05030
|
-3.78e-02
|
3.32e-02
|
1.83e-01
|
2.41e-01
|
GOBP REGULATION OF NEURON APOPTOTIC PROCESS
|
223
|
4.06e-01
|
8.26e-01
|
0.05030
|
-4.87e-02
|
-1.28e-02
|
2.11e-01
|
7.42e-01
|
GOBP REGULATION OF AMIDE METABOLIC PROCESS
|
570
|
9.16e-02
|
5.51e-01
|
0.05030
|
-3.88e-02
|
-3.20e-02
|
1.14e-01
|
1.91e-01
|
GOMF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY
|
51
|
8.11e-01
|
9.59e-01
|
0.05030
|
4.76e-02
|
1.61e-02
|
5.56e-01
|
8.43e-01
|
GOBP POSITIVE REGULATION OF MAPK CASCADE
|
463
|
2.15e-01
|
7.04e-01
|
0.05030
|
-3.09e-02
|
3.96e-02
|
2.54e-01
|
1.44e-01
|
GOBP REGULATION OF LYMPHOCYTE ACTIVATION
|
487
|
1.69e-01
|
6.55e-01
|
0.05020
|
-5.77e-03
|
4.99e-02
|
8.28e-01
|
5.93e-02
|
GOBP REGULATION OF DEFENSE RESPONSE
|
781
|
4.76e-02
|
4.38e-01
|
0.05020
|
-4.90e-02
|
-1.11e-02
|
1.99e-02
|
5.96e-01
|
GOBP POSITIVE REGULATION OF BLOOD PRESSURE
|
32
|
8.79e-01
|
9.75e-01
|
0.05020
|
-1.15e-02
|
-4.89e-02
|
9.10e-01
|
6.32e-01
|
GOBP HEMATOPOIETIC OR LYMPHOID ORGAN DEVELOPMENT
|
98
|
6.70e-01
|
9.11e-01
|
0.05020
|
1.56e-02
|
4.77e-02
|
7.90e-01
|
4.14e-01
|
GOBP PEPTIDYL TYROSINE DEPHOSPHORYLATION INVOLVED IN INACTIVATION OF PROTEIN KINASE ACTIVITY
|
8
|
9.70e-01
|
9.93e-01
|
0.05020
|
1.33e-03
|
5.02e-02
|
9.95e-01
|
8.06e-01
|
GOBP POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY
|
11
|
9.61e-01
|
9.91e-01
|
0.05020
|
-1.02e-02
|
4.91e-02
|
9.53e-01
|
7.78e-01
|
GOBP NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY
|
94
|
6.99e-01
|
9.21e-01
|
0.05020
|
6.80e-05
|
5.02e-02
|
9.99e-01
|
4.01e-01
|
GOBP RESPONSE TO VITAMIN
|
81
|
7.13e-01
|
9.27e-01
|
0.05020
|
2.14e-02
|
4.54e-02
|
7.39e-01
|
4.80e-01
|
GOMF MAP KINASE KINASE KINASE ACTIVITY
|
24
|
9.11e-01
|
9.82e-01
|
0.05020
|
-5.01e-02
|
-2.29e-03
|
6.71e-01
|
9.85e-01
|
GOBP RESPONSE TO TEMPERATURE STIMULUS
|
164
|
5.21e-01
|
8.69e-01
|
0.05010
|
4.91e-02
|
1.00e-02
|
2.78e-01
|
8.25e-01
|
GOBP KERATINOCYTE PROLIFERATION
|
59
|
8.19e-01
|
9.60e-01
|
0.05010
|
-2.93e-02
|
4.07e-02
|
6.97e-01
|
5.89e-01
|
GOBP PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS
|
42
|
8.58e-01
|
9.68e-01
|
0.05010
|
-9.77e-03
|
4.92e-02
|
9.13e-01
|
5.81e-01
|
GOBP POSITIVE REGULATION OF RECEPTOR RECYCLING
|
14
|
9.51e-01
|
9.90e-01
|
0.05010
|
-4.87e-02
|
1.16e-02
|
7.52e-01
|
9.40e-01
|
GOBP RESPONSE TO FATTY ACID
|
55
|
7.92e-01
|
9.54e-01
|
0.05010
|
-2.81e-02
|
-4.15e-02
|
7.19e-01
|
5.95e-01
|
GOBP DEFENSE RESPONSE TO OTHER ORGANISM
|
1132
|
1.08e-02
|
2.22e-01
|
0.05000
|
-4.28e-02
|
-2.59e-02
|
1.52e-02
|
1.41e-01
|
GOCC MICROTUBULE CYTOSKELETON
|
1299
|
1.46e-02
|
2.59e-01
|
0.04990
|
-4.58e-02
|
1.98e-02
|
5.50e-03
|
2.31e-01
|
GOBP CILIUM MOVEMENT
|
194
|
5.13e-01
|
8.67e-01
|
0.04990
|
4.63e-02
|
-1.84e-02
|
2.66e-01
|
6.58e-01
|
GOBP INTERLEUKIN 17 PRODUCTION
|
46
|
8.56e-01
|
9.68e-01
|
0.04990
|
2.51e-02
|
-4.31e-02
|
7.68e-01
|
6.13e-01
|
GOBP NEGATIVE REGULATION OF CHOLESTEROL EFFLUX
|
22
|
9.29e-01
|
9.86e-01
|
0.04990
|
2.67e-02
|
-4.21e-02
|
8.29e-01
|
7.32e-01
|
GOBP REGULATION OF INTEGRIN ACTIVATION
|
17
|
9.45e-01
|
9.90e-01
|
0.04980
|
-3.82e-02
|
3.19e-02
|
7.85e-01
|
8.20e-01
|
GOBP REGULATION OF POLYSACCHARIDE METABOLIC PROCESS
|
44
|
8.34e-01
|
9.64e-01
|
0.04970
|
-2.22e-02
|
-4.45e-02
|
7.99e-01
|
6.09e-01
|
GOBP REGULATION OF CHLORIDE TRANSPORT
|
6
|
9.77e-01
|
9.95e-01
|
0.04970
|
-4.95e-02
|
-4.45e-03
|
8.34e-01
|
9.85e-01
|
GOBP CHOLESTEROL EFFLUX
|
73
|
7.37e-01
|
9.35e-01
|
0.04970
|
-2.79e-02
|
-4.12e-02
|
6.80e-01
|
5.43e-01
|
GOBP POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEPARATION
|
18
|
9.28e-01
|
9.85e-01
|
0.04970
|
-2.56e-02
|
-4.26e-02
|
8.51e-01
|
7.54e-01
|
GOMF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
150
|
5.42e-01
|
8.78e-01
|
0.04970
|
2.08e-02
|
4.51e-02
|
6.60e-01
|
3.40e-01
|
GOMF NUCLEAR ESTROGEN RECEPTOR BINDING
|
39
|
8.49e-01
|
9.66e-01
|
0.04970
|
3.37e-02
|
3.65e-02
|
7.15e-01
|
6.93e-01
|
GOBP PROSTAGLANDIN SECRETION
|
17
|
9.39e-01
|
9.88e-01
|
0.04970
|
1.71e-03
|
-4.96e-02
|
9.90e-01
|
7.23e-01
|
GOMF NON MEMBRANE SPANNING PROTEIN TYROSINE KINASE ACTIVITY
|
43
|
8.63e-01
|
9.69e-01
|
0.04970
|
-1.96e-02
|
4.57e-02
|
8.24e-01
|
6.04e-01
|
GOBP AXON GUIDANCE
|
223
|
4.73e-01
|
8.53e-01
|
0.04970
|
-2.19e-02
|
4.46e-02
|
5.74e-01
|
2.51e-01
|
GOBP REGULATION OF SKELETAL MUSCLE SATELLITE CELL PROLIFERATION
|
12
|
9.61e-01
|
9.91e-01
|
0.04970
|
3.32e-02
|
-3.70e-02
|
8.42e-01
|
8.24e-01
|
GOBP REGULATION OF TRANS SYNAPTIC SIGNALING
|
469
|
2.17e-01
|
7.07e-01
|
0.04970
|
-2.87e-02
|
4.05e-02
|
2.87e-01
|
1.33e-01
|
GOBP POSITIVE REGULATION OF PEPTIDE SECRETION
|
110
|
6.64e-01
|
9.10e-01
|
0.04960
|
-4.44e-04
|
4.96e-02
|
9.94e-01
|
3.68e-01
|
GOCC PROTEASOME REGULATORY PARTICLE BASE SUBCOMPLEX
|
9
|
9.71e-01
|
9.93e-01
|
0.04960
|
3.75e-02
|
-3.25e-02
|
8.45e-01
|
8.66e-01
|
GOCC ACTIN BASED CELL PROJECTION
|
218
|
4.15e-01
|
8.30e-01
|
0.04960
|
1.97e-02
|
4.56e-02
|
6.16e-01
|
2.46e-01
|
GOBP CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION
|
175
|
5.06e-01
|
8.65e-01
|
0.04960
|
-9.86e-03
|
-4.86e-02
|
8.22e-01
|
2.67e-01
|
GOBP ANATOMICAL STRUCTURE ARRANGEMENT
|
15
|
9.50e-01
|
9.90e-01
|
0.04960
|
4.47e-02
|
-2.15e-02
|
7.64e-01
|
8.85e-01
|
GOBP RESPONSE TO UV
|
147
|
5.43e-01
|
8.78e-01
|
0.04950
|
-3.44e-02
|
-3.56e-02
|
4.71e-01
|
4.57e-01
|
GOBP REGULATION OF DNA RECOMBINATION
|
128
|
5.94e-01
|
8.94e-01
|
0.04950
|
-4.43e-02
|
-2.20e-02
|
3.87e-01
|
6.67e-01
|
GOBP METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT
|
25
|
9.08e-01
|
9.81e-01
|
0.04940
|
-4.89e-02
|
-7.25e-03
|
6.72e-01
|
9.50e-01
|
GOBP PIGMENTATION
|
108
|
6.64e-01
|
9.10e-01
|
0.04940
|
-5.28e-03
|
-4.91e-02
|
9.24e-01
|
3.78e-01
|
GOCC EXOCYTIC VESICLE
|
221
|
4.41e-01
|
8.40e-01
|
0.04940
|
1.16e-03
|
4.94e-02
|
9.76e-01
|
2.06e-01
|
GOMF RDNA BINDING
|
10
|
9.62e-01
|
9.91e-01
|
0.04940
|
-4.81e-02
|
-1.15e-02
|
7.92e-01
|
9.50e-01
|
GOBP STRIATED MUSCLE CELL DIFFERENTIATION
|
297
|
3.51e-01
|
7.96e-01
|
0.04940
|
-7.72e-03
|
4.88e-02
|
8.19e-01
|
1.48e-01
|
GOBP NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE
|
71
|
7.81e-01
|
9.52e-01
|
0.04940
|
-1.30e-02
|
4.77e-02
|
8.50e-01
|
4.87e-01
|
GOBP ANTERIOR POSTERIOR PATTERN SPECIFICATION
|
209
|
5.06e-01
|
8.65e-01
|
0.04940
|
-2.84e-02
|
4.04e-02
|
4.80e-01
|
3.14e-01
|
GOMF PROSTANOID RECEPTOR ACTIVITY
|
11
|
9.64e-01
|
9.92e-01
|
0.04930
|
4.27e-02
|
-2.48e-02
|
8.06e-01
|
8.87e-01
|
GOBP NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION
|
150
|
6.01e-01
|
8.96e-01
|
0.04930
|
-1.61e-02
|
4.66e-02
|
7.34e-01
|
3.25e-01
|
GOBP CELLULAR RESPONSE TO IONIZING RADIATION
|
68
|
7.62e-01
|
9.45e-01
|
0.04930
|
-1.87e-02
|
-4.56e-02
|
7.89e-01
|
5.16e-01
|
GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION
|
20
|
9.26e-01
|
9.84e-01
|
0.04930
|
-9.13e-03
|
-4.84e-02
|
9.44e-01
|
7.08e-01
|
GOBP EMBRYONIC PLACENTA DEVELOPMENT
|
86
|
7.55e-01
|
9.42e-01
|
0.04920
|
-4.09e-02
|
2.75e-02
|
5.12e-01
|
6.60e-01
|
GOBP CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS
|
31
|
9.04e-01
|
9.80e-01
|
0.04920
|
-3.13e-02
|
3.80e-02
|
7.63e-01
|
7.14e-01
|
GOBP POSITIVE REGULATION OF CELL POPULATION PROLIFERATION
|
1213
|
2.07e-02
|
3.05e-01
|
0.04920
|
-1.82e-02
|
4.58e-02
|
2.85e-01
|
7.30e-03
|
GOBP MALE GAMETE GENERATION
|
568
|
1.64e-01
|
6.48e-01
|
0.04920
|
-2.83e-02
|
4.03e-02
|
2.49e-01
|
1.01e-01
|
GOCC EXTRINSIC COMPONENT OF MEMBRANE
|
198
|
4.96e-01
|
8.59e-01
|
0.04920
|
-4.88e-02
|
6.34e-03
|
2.36e-01
|
8.78e-01
|
GOBP POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION
|
22
|
9.16e-01
|
9.83e-01
|
0.04920
|
-1.71e-02
|
-4.61e-02
|
8.89e-01
|
7.08e-01
|
GOBP REGULATION OF CHOLESTEROL EFFLUX
|
54
|
8.14e-01
|
9.59e-01
|
0.04920
|
8.26e-03
|
4.85e-02
|
9.16e-01
|
5.38e-01
|
GOBP GROWTH
|
886
|
6.40e-02
|
4.87e-01
|
0.04910
|
-3.49e-02
|
3.46e-02
|
7.80e-02
|
8.04e-02
|
GOBP REGULATION OF T CELL MEDIATED IMMUNITY
|
94
|
7.14e-01
|
9.27e-01
|
0.04910
|
4.31e-03
|
-4.90e-02
|
9.42e-01
|
4.12e-01
|
GOBP RESPONSE TO TYPE I INTERFERON
|
84
|
7.59e-01
|
9.44e-01
|
0.04910
|
-4.27e-02
|
2.43e-02
|
4.99e-01
|
7.00e-01
|
GOBP TUBE DEVELOPMENT
|
1121
|
2.03e-02
|
3.03e-01
|
0.04910
|
-6.29e-04
|
4.91e-02
|
9.72e-01
|
5.52e-03
|
GOCC GOLGI LUMEN
|
93
|
6.86e-01
|
9.18e-01
|
0.04910
|
4.14e-02
|
2.64e-02
|
4.90e-01
|
6.60e-01
|
GOCC RECYCLING ENDOSOME
|
194
|
5.28e-01
|
8.72e-01
|
0.04910
|
-4.44e-02
|
2.10e-02
|
2.86e-01
|
6.15e-01
|
GOBP SKELETAL MUSCLE CELL DIFFERENTIATION
|
71
|
7.81e-01
|
9.52e-01
|
0.04910
|
4.81e-02
|
-9.92e-03
|
4.84e-01
|
8.85e-01
|
GOBP RESPONSE TO LIGHT STIMULUS
|
301
|
3.85e-01
|
8.17e-01
|
0.04900
|
-3.71e-02
|
3.20e-02
|
2.68e-01
|
3.39e-01
|
GOBP FOREBRAIN MORPHOGENESIS
|
13
|
9.55e-01
|
9.90e-01
|
0.04890
|
-4.85e-02
|
6.74e-03
|
7.62e-01
|
9.66e-01
|
GOBP SYNAPTIC SIGNALING
|
747
|
9.29e-02
|
5.54e-01
|
0.04890
|
-2.15e-02
|
4.39e-02
|
3.17e-01
|
4.10e-02
|
GOBP POSITIVE REGULATION OF PROTEOLYSIS
|
340
|
2.79e-01
|
7.52e-01
|
0.04890
|
-4.78e-02
|
-1.02e-02
|
1.30e-01
|
7.47e-01
|
GOMF HMG BOX DOMAIN BINDING
|
13
|
9.58e-01
|
9.90e-01
|
0.04880
|
-1.81e-02
|
4.53e-02
|
9.10e-01
|
7.77e-01
|
GOBP REGULATION OF OSTEOBLAST DIFFERENTIATION
|
144
|
6.29e-01
|
9.02e-01
|
0.04880
|
-2.45e-02
|
4.22e-02
|
6.11e-01
|
3.82e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS
|
37
|
8.62e-01
|
9.69e-01
|
0.04880
|
2.78e-02
|
4.01e-02
|
7.70e-01
|
6.73e-01
|
GOBP NEGATIVE REGULATION OF MYELINATION
|
9
|
9.66e-01
|
9.92e-01
|
0.04870
|
-1.36e-02
|
-4.68e-02
|
9.44e-01
|
8.08e-01
|
GOBP MUSCLE ORGAN DEVELOPMENT
|
342
|
2.60e-01
|
7.37e-01
|
0.04870
|
2.62e-02
|
4.10e-02
|
4.05e-01
|
1.92e-01
|
GOMF CARBOXYLIC ESTER HYDROLASE ACTIVITY
|
150
|
6.11e-01
|
8.98e-01
|
0.04870
|
-4.51e-02
|
1.84e-02
|
3.40e-01
|
6.98e-01
|
GOBP PROTEIN CONTAINING COMPLEX ASSEMBLY
|
1520
|
3.43e-03
|
1.18e-01
|
0.04860
|
-4.01e-02
|
-2.76e-02
|
9.06e-03
|
7.22e-02
|
GOBP ZINC ION TRANSPORT
|
28
|
9.11e-01
|
9.82e-01
|
0.04860
|
-4.61e-02
|
1.54e-02
|
6.73e-01
|
8.87e-01
|
GOCC FICOLIN 1 RICH GRANULE LUMEN
|
121
|
6.44e-01
|
9.07e-01
|
0.04860
|
-4.84e-02
|
-3.43e-03
|
3.57e-01
|
9.48e-01
|
GOMF KINASE REGULATOR ACTIVITY
|
246
|
3.94e-01
|
8.23e-01
|
0.04850
|
-4.64e-02
|
-1.44e-02
|
2.10e-01
|
6.98e-01
|
GOCC EXTRINSIC COMPONENT OF PRESYNAPTIC MEMBRANE
|
6
|
9.81e-01
|
9.96e-01
|
0.04840
|
-3.89e-02
|
2.89e-02
|
8.69e-01
|
9.02e-01
|
GOBP TYROSINE METABOLIC PROCESS
|
17
|
9.45e-01
|
9.90e-01
|
0.04840
|
-4.62e-02
|
1.45e-02
|
7.42e-01
|
9.18e-01
|
GOBP PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION
|
774
|
7.01e-02
|
5.04e-01
|
0.04840
|
-4.84e-02
|
3.35e-04
|
2.20e-02
|
9.87e-01
|
GOCC MITOCHONDRIAL TRICARBOXYLIC ACID CYCLE ENZYME COMPLEX
|
9
|
9.69e-01
|
9.93e-01
|
0.04830
|
4.79e-02
|
-6.37e-03
|
8.03e-01
|
9.74e-01
|
GOCC BASOLATERAL PLASMA MEMBRANE
|
240
|
4.74e-01
|
8.54e-01
|
0.04830
|
-3.83e-02
|
2.95e-02
|
3.06e-01
|
4.32e-01
|
GOCC MICROTUBULE
|
441
|
2.28e-01
|
7.16e-01
|
0.04830
|
-4.77e-02
|
7.96e-03
|
8.60e-02
|
7.74e-01
|
GOMF DEATH DOMAIN BINDING
|
11
|
9.64e-01
|
9.92e-01
|
0.04830
|
-1.44e-02
|
4.61e-02
|
9.34e-01
|
7.91e-01
|
GOBP ANTIBACTERIAL HUMORAL RESPONSE
|
57
|
8.03e-01
|
9.57e-01
|
0.04820
|
-1.98e-02
|
-4.39e-02
|
7.96e-01
|
5.66e-01
|
GOBP NEGATIVE REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION
|
14
|
9.52e-01
|
9.90e-01
|
0.04820
|
4.82e-02
|
2.14e-04
|
7.55e-01
|
9.99e-01
|
GOBP PYRIMIDINE NUCLEOSIDE TRANSPORT
|
6
|
9.81e-01
|
9.96e-01
|
0.04810
|
2.19e-02
|
-4.29e-02
|
9.26e-01
|
8.56e-01
|
GOBP DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS
|
102
|
6.70e-01
|
9.11e-01
|
0.04810
|
-3.77e-02
|
-2.99e-02
|
5.10e-01
|
6.02e-01
|
GOBP DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS
|
231
|
4.40e-01
|
8.40e-01
|
0.04810
|
4.15e-03
|
4.79e-02
|
9.14e-01
|
2.09e-01
|
GOMF OMEGA PEPTIDASE ACTIVITY
|
14
|
9.48e-01
|
9.90e-01
|
0.04810
|
-4.35e-02
|
-2.04e-02
|
7.78e-01
|
8.95e-01
|
GOBP NEGATIVE REGULATION OF TRANSPORT
|
449
|
2.30e-01
|
7.18e-01
|
0.04810
|
-4.70e-02
|
1.01e-02
|
8.77e-02
|
7.12e-01
|
GOBP POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY
|
121
|
6.69e-01
|
9.11e-01
|
0.04810
|
4.69e-02
|
-1.04e-02
|
3.73e-01
|
8.44e-01
|
GOCC ENDOCYTIC VESICLE
|
326
|
3.33e-01
|
7.86e-01
|
0.04810
|
-5.23e-03
|
4.78e-02
|
8.71e-01
|
1.38e-01
|
GOBP CELL CELL SIGNALING
|
1628
|
7.28e-03
|
1.78e-01
|
0.04800
|
-1.47e-02
|
4.57e-02
|
3.23e-01
|
2.10e-03
|
GOBP PROSTAGLANDIN TRANSPORT
|
28
|
8.98e-01
|
9.78e-01
|
0.04800
|
2.06e-02
|
4.33e-02
|
8.50e-01
|
6.91e-01
|
GOMF HISTAMINE RECEPTOR ACTIVITY
|
6
|
9.78e-01
|
9.95e-01
|
0.04800
|
1.32e-02
|
4.61e-02
|
9.56e-01
|
8.45e-01
|
GOBP CELL FATE SPECIFICATION
|
107
|
7.14e-01
|
9.27e-01
|
0.04800
|
-2.16e-02
|
4.28e-02
|
6.99e-01
|
4.44e-01
|
GOBP CELLULAR RESPONSE TO ACID CHEMICAL
|
85
|
7.23e-01
|
9.30e-01
|
0.04800
|
2.13e-02
|
4.30e-02
|
7.34e-01
|
4.93e-01
|
GOMF BICARBONATE MONOATOMIC ANION ANTIPORTER ACTIVITY
|
12
|
9.54e-01
|
9.90e-01
|
0.04800
|
3.70e-02
|
3.05e-02
|
8.24e-01
|
8.55e-01
|
GOBP NEURAL CREST CELL DIFFERENTIATION
|
93
|
7.52e-01
|
9.40e-01
|
0.04800
|
-3.70e-02
|
3.05e-02
|
5.37e-01
|
6.11e-01
|
GOBP REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION
|
52
|
8.23e-01
|
9.61e-01
|
0.04790
|
1.64e-02
|
4.50e-02
|
8.38e-01
|
5.75e-01
|
GOCC COSTAMERE
|
16
|
9.52e-01
|
9.90e-01
|
0.04780
|
-3.59e-02
|
3.15e-02
|
8.04e-01
|
8.27e-01
|
GOBP IMMUNOLOGICAL MEMORY PROCESS
|
17
|
9.46e-01
|
9.90e-01
|
0.04780
|
-1.32e-02
|
4.59e-02
|
9.25e-01
|
7.43e-01
|
GOBP CELL CELL ADHESION MEDIATED BY CADHERIN
|
47
|
8.66e-01
|
9.70e-01
|
0.04770
|
2.70e-02
|
-3.94e-02
|
7.49e-01
|
6.40e-01
|
GOCC REPLISOME
|
13
|
9.53e-01
|
9.90e-01
|
0.04770
|
4.57e-02
|
1.38e-02
|
7.76e-01
|
9.32e-01
|
GOBP REGULATION OF OSTEOBLAST PROLIFERATION
|
30
|
9.01e-01
|
9.79e-01
|
0.04770
|
-4.77e-02
|
-1.18e-03
|
6.51e-01
|
9.91e-01
|
GOBP RESPONSE TO IONIZING RADIATION
|
136
|
5.97e-01
|
8.95e-01
|
0.04760
|
-2.40e-02
|
-4.11e-02
|
6.28e-01
|
4.08e-01
|
GOBP NEGATIVE REGULATION OF CELL DIFFERENTIATION
|
683
|
1.25e-01
|
6.06e-01
|
0.04760
|
-4.36e-02
|
1.89e-02
|
5.20e-02
|
3.99e-01
|
GOMF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BINDING
|
11
|
9.59e-01
|
9.90e-01
|
0.04760
|
-3.64e-02
|
-3.07e-02
|
8.35e-01
|
8.60e-01
|
GOBP POSITIVE REGULATION OF GENE EXPRESSION
|
1129
|
3.33e-02
|
3.71e-01
|
0.04750
|
-4.48e-02
|
1.59e-02
|
1.11e-02
|
3.67e-01
|
GOMF PROTEASE BINDING
|
140
|
5.93e-01
|
8.94e-01
|
0.04750
|
-4.30e-02
|
-2.02e-02
|
3.80e-01
|
6.79e-01
|
GOBP NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS
|
110
|
7.19e-01
|
9.29e-01
|
0.04740
|
-3.12e-02
|
3.57e-02
|
5.71e-01
|
5.18e-01
|
GOBP RESPONSE TO MOLECULE OF BACTERIAL ORIGIN
|
350
|
2.72e-01
|
7.47e-01
|
0.04740
|
-2.41e-02
|
-4.08e-02
|
4.38e-01
|
1.90e-01
|
GOBP REGULATION OF ALPHA BETA T CELL ACTIVATION
|
108
|
6.64e-01
|
9.10e-01
|
0.04740
|
2.75e-02
|
3.86e-02
|
6.22e-01
|
4.89e-01
|
GOBP POSITIVE REGULATION OF DEFENSE RESPONSE
|
460
|
1.79e-01
|
6.69e-01
|
0.04730
|
-3.29e-02
|
-3.40e-02
|
2.26e-01
|
2.12e-01
|
GOBP ANIMAL ORGAN REGENERATION
|
60
|
8.35e-01
|
9.64e-01
|
0.04730
|
2.73e-02
|
-3.86e-02
|
7.15e-01
|
6.05e-01
|
GOBP RESPONSE TO ENDOGENOUS STIMULUS
|
1695
|
9.39e-03
|
2.06e-01
|
0.04720
|
-3.38e-02
|
3.30e-02
|
2.05e-02
|
2.39e-02
|
GOBP NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS
|
121
|
6.83e-01
|
9.17e-01
|
0.04720
|
-4.53e-02
|
1.32e-02
|
3.89e-01
|
8.03e-01
|
GOBP NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY
|
231
|
4.27e-01
|
8.36e-01
|
0.04710
|
-4.09e-02
|
-2.33e-02
|
2.84e-01
|
5.42e-01
|
GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS
|
43
|
8.76e-01
|
9.75e-01
|
0.04700
|
-4.38e-02
|
1.70e-02
|
6.19e-01
|
8.47e-01
|
GOBP GLYCOSYLCERAMIDE METABOLIC PROCESS
|
16
|
9.42e-01
|
9.89e-01
|
0.04700
|
-3.74e-02
|
-2.84e-02
|
7.96e-01
|
8.44e-01
|
GOBP ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME
|
66
|
8.12e-01
|
9.59e-01
|
0.04690
|
-4.56e-02
|
1.12e-02
|
5.22e-01
|
8.75e-01
|
GOBP REGULATION OF CD4 POSITIVE CD25 POSITIVE ALPHA BETA REGULATORY T CELL DIFFERENTIATION
|
5
|
9.82e-01
|
9.96e-01
|
0.04690
|
-2.06e-02
|
-4.21e-02
|
9.37e-01
|
8.70e-01
|
GOBP MESONEPHRIC TUBULE MORPHOGENESIS
|
64
|
7.88e-01
|
9.53e-01
|
0.04690
|
3.67e-02
|
2.91e-02
|
6.11e-01
|
6.87e-01
|
GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY
|
51
|
8.34e-01
|
9.64e-01
|
0.04690
|
1.41e-02
|
4.47e-02
|
8.62e-01
|
5.81e-01
|
GOMF SERINE HYDROLASE ACTIVITY
|
189
|
5.06e-01
|
8.65e-01
|
0.04680
|
-4.30e-02
|
-1.85e-02
|
3.08e-01
|
6.61e-01
|
GOBP BIOLOGICAL PROCESS INVOLVED IN INTERSPECIES INTERACTION BETWEEN ORGANISMS
|
1608
|
4.02e-03
|
1.31e-01
|
0.04680
|
-3.92e-02
|
-2.55e-02
|
8.75e-03
|
8.78e-02
|
GOBP POSITIVE REGULATION OF PHOSPHATASE ACTIVITY
|
27
|
9.22e-01
|
9.84e-01
|
0.04680
|
2.13e-02
|
-4.16e-02
|
8.48e-01
|
7.08e-01
|
GOBP CELLULAR RESPONSE TO RETINOIC ACID
|
67
|
8.23e-01
|
9.61e-01
|
0.04670
|
-3.56e-02
|
3.01e-02
|
6.14e-01
|
6.70e-01
|
GOBP CELLULAR RESPONSE TO INORGANIC SUBSTANCE
|
217
|
4.64e-01
|
8.48e-01
|
0.04660
|
-4.34e-02
|
-1.71e-02
|
2.71e-01
|
6.65e-01
|
GOBP POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE
|
124
|
6.98e-01
|
9.21e-01
|
0.04660
|
2.79e-02
|
-3.73e-02
|
5.92e-01
|
4.73e-01
|
GOBP ER OVERLOAD RESPONSE
|
11
|
9.67e-01
|
9.92e-01
|
0.04660
|
-1.60e-02
|
4.37e-02
|
9.27e-01
|
8.02e-01
|
GOBP POSITIVE REGULATION OF SECRETION
|
304
|
4.15e-01
|
8.30e-01
|
0.04660
|
-3.91e-02
|
2.52e-02
|
2.40e-01
|
4.50e-01
|
GOBP FOREBRAIN CELL MIGRATION
|
63
|
8.32e-01
|
9.64e-01
|
0.04660
|
-3.92e-02
|
2.51e-02
|
5.90e-01
|
7.30e-01
|
GOBP REGULATION OF HEMOPOIESIS
|
405
|
3.15e-01
|
7.76e-01
|
0.04650
|
-3.64e-02
|
2.90e-02
|
2.09e-01
|
3.17e-01
|
GOBP CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND
|
1241
|
3.10e-02
|
3.62e-01
|
0.04650
|
-4.15e-02
|
2.09e-02
|
1.39e-02
|
2.16e-01
|
GOMF TAU PROTEIN BINDING
|
42
|
8.59e-01
|
9.68e-01
|
0.04640
|
-2.25e-02
|
-4.06e-02
|
8.01e-01
|
6.49e-01
|
GOBP CARDIOCYTE DIFFERENTIATION
|
162
|
6.17e-01
|
9.00e-01
|
0.04640
|
-1.70e-02
|
4.32e-02
|
7.09e-01
|
3.43e-01
|
GOCC ATG12 ATG5 ATG16 COMPLEX
|
5
|
9.83e-01
|
9.96e-01
|
0.04630
|
-1.19e-02
|
-4.48e-02
|
9.63e-01
|
8.62e-01
|
GOBP REGULATION OF MUSCLE CELL DIFFERENTIATION
|
154
|
6.44e-01
|
9.07e-01
|
0.04630
|
-3.11e-02
|
3.43e-02
|
5.05e-01
|
4.62e-01
|
GOBP LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE
|
202
|
5.63e-01
|
8.85e-01
|
0.04630
|
-3.10e-02
|
3.44e-02
|
4.48e-01
|
4.00e-01
|
GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY
|
58
|
8.12e-01
|
9.59e-01
|
0.04630
|
-3.97e-02
|
-2.38e-02
|
6.01e-01
|
7.54e-01
|
GOCC ENDOPLASMIC RETICULUM TUBULAR NETWORK
|
26
|
9.10e-01
|
9.82e-01
|
0.04620
|
3.46e-02
|
3.07e-02
|
7.60e-01
|
7.87e-01
|
GOBP MICROTUBULE BASED TRANSPORT
|
204
|
5.58e-01
|
8.82e-01
|
0.04620
|
-3.79e-02
|
2.65e-02
|
3.51e-01
|
5.14e-01
|
GOBP POSITIVE REGULATION OF HORMONE SECRETION
|
139
|
6.70e-01
|
9.11e-01
|
0.04620
|
-2.47e-02
|
3.90e-02
|
6.15e-01
|
4.27e-01
|
GOBP RESPONSE TO STEROID HORMONE
|
315
|
3.51e-01
|
7.96e-01
|
0.04620
|
-7.25e-03
|
-4.56e-02
|
8.25e-01
|
1.64e-01
|
GOBP NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH
|
108
|
7.31e-01
|
9.32e-01
|
0.04620
|
-2.22e-02
|
4.05e-02
|
6.90e-01
|
4.68e-01
|
GOBP RETINAL BIPOLAR NEURON DIFFERENTIATION
|
7
|
9.80e-01
|
9.96e-01
|
0.04620
|
3.51e-02
|
-3.00e-02
|
8.72e-01
|
8.91e-01
|
GOBP EMBRYONIC MORPHOGENESIS
|
604
|
1.88e-01
|
6.79e-01
|
0.04620
|
-3.28e-02
|
3.24e-02
|
1.68e-01
|
1.74e-01
|
GOBP TELOMERE CAPPING
|
39
|
8.76e-01
|
9.75e-01
|
0.04610
|
-4.52e-02
|
-9.39e-03
|
6.26e-01
|
9.19e-01
|
GOCC ADHERENS JUNCTION
|
178
|
5.54e-01
|
8.81e-01
|
0.04610
|
6.33e-03
|
4.57e-02
|
8.84e-01
|
2.93e-01
|
GOBP REGULATION OF CELL DIFFERENTIATION
|
1554
|
1.64e-02
|
2.73e-01
|
0.04610
|
-3.10e-02
|
3.41e-02
|
4.14e-02
|
2.47e-02
|
GOBP GLIAL CELL FATE COMMITMENT
|
13
|
9.60e-01
|
9.91e-01
|
0.04600
|
4.56e-02
|
-6.06e-03
|
7.76e-01
|
9.70e-01
|
GOMF GLUTAMATE RECEPTOR ACTIVITY
|
26
|
9.12e-01
|
9.82e-01
|
0.04600
|
4.01e-02
|
2.25e-02
|
7.23e-01
|
8.43e-01
|
GOMF GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE NADPLUS NON PHOSPHORYLATING ACTIVITY
|
7
|
9.77e-01
|
9.95e-01
|
0.04600
|
-4.54e-02
|
-7.19e-03
|
8.35e-01
|
9.74e-01
|
GOCC RNA POLYMERASE II HOLOENZYME
|
67
|
7.86e-01
|
9.53e-01
|
0.04600
|
-3.55e-02
|
-2.92e-02
|
6.15e-01
|
6.80e-01
|
GOCC CIA COMPLEX
|
5
|
9.82e-01
|
9.96e-01
|
0.04590
|
2.33e-02
|
3.96e-02
|
9.28e-01
|
8.78e-01
|
GOBP RESPONSE TO MONOSACCHARIDE
|
200
|
5.70e-01
|
8.86e-01
|
0.04590
|
-3.71e-02
|
2.69e-02
|
3.65e-01
|
5.12e-01
|
GOBP VASCULATURE DEVELOPMENT
|
794
|
9.27e-02
|
5.54e-01
|
0.04590
|
-5.59e-03
|
4.55e-02
|
7.89e-01
|
2.92e-02
|
GOMF METALLOENDOPEPTIDASE INHIBITOR ACTIVITY
|
15
|
9.51e-01
|
9.90e-01
|
0.04580
|
-4.48e-02
|
-9.59e-03
|
7.64e-01
|
9.49e-01
|
GOBP STRIATED MUSCLE TISSUE DEVELOPMENT
|
259
|
4.70e-01
|
8.51e-01
|
0.04580
|
-1.53e-02
|
4.32e-02
|
6.73e-01
|
2.31e-01
|
GOBP CIRCADIAN RHYTHM
|
195
|
5.39e-01
|
8.78e-01
|
0.04580
|
-4.58e-02
|
-1.38e-04
|
2.70e-01
|
9.97e-01
|
GOBP SYNAPSE ORGANIZATION
|
447
|
2.40e-01
|
7.25e-01
|
0.04580
|
4.16e-03
|
4.56e-02
|
8.80e-01
|
9.84e-02
|
GOMF RNA POLYMERASE II GENERAL TRANSCRIPTION INITIATION FACTOR BINDING
|
23
|
9.21e-01
|
9.84e-01
|
0.04570
|
-3.54e-02
|
-2.90e-02
|
7.69e-01
|
8.10e-01
|
GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX
|
28
|
9.24e-01
|
9.84e-01
|
0.04570
|
-2.53e-02
|
3.81e-02
|
8.17e-01
|
7.27e-01
|
GOMF ENDOPEPTIDASE ACTIVITY
|
375
|
2.72e-01
|
7.47e-01
|
0.04570
|
-3.73e-02
|
-2.64e-02
|
2.15e-01
|
3.80e-01
|
GOBP FATTY ACID HOMEOSTASIS
|
16
|
9.54e-01
|
9.90e-01
|
0.04560
|
1.54e-02
|
-4.30e-02
|
9.15e-01
|
7.66e-01
|
GOBP POSITIVE REGULATION OF RNA METABOLIC PROCESS
|
1806
|
5.93e-03
|
1.61e-01
|
0.04560
|
-4.54e-02
|
4.51e-03
|
1.37e-03
|
7.50e-01
|
GOBP DISRUPTION OF ANATOMICAL STRUCTURE IN ANOTHER ORGANISM
|
91
|
7.49e-01
|
9.40e-01
|
0.04560
|
-4.56e-02
|
-9.96e-04
|
4.52e-01
|
9.87e-01
|
GOBP NEURON APOPTOTIC PROCESS
|
264
|
4.33e-01
|
8.37e-01
|
0.04560
|
-4.55e-02
|
-2.92e-03
|
2.03e-01
|
9.35e-01
|
GOBP PROTEOLYSIS
|
1547
|
1.16e-02
|
2.31e-01
|
0.04550
|
-4.54e-02
|
3.71e-03
|
2.86e-03
|
8.07e-01
|
GOMF SPHINGOSINE 1 PHOSPHATE RECEPTOR ACTIVITY
|
8
|
9.77e-01
|
9.95e-01
|
0.04550
|
-4.36e-02
|
1.32e-02
|
8.31e-01
|
9.48e-01
|
GOCC AMPA GLUTAMATE RECEPTOR COMPLEX
|
22
|
9.33e-01
|
9.87e-01
|
0.04550
|
-4.55e-02
|
4.05e-04
|
7.12e-01
|
9.97e-01
|
GOCC CHLORIDE CHANNEL COMPLEX
|
50
|
8.44e-01
|
9.66e-01
|
0.04550
|
-1.66e-02
|
-4.24e-02
|
8.39e-01
|
6.04e-01
|
GOBP POSITIVE REGULATION OF PROTEIN K63 LINKED UBIQUITINATION
|
7
|
9.76e-01
|
9.95e-01
|
0.04550
|
3.53e-02
|
2.87e-02
|
8.72e-01
|
8.95e-01
|
GOMF METAL CATION MONOATOMIC CATION ANTIPORTER ACTIVITY
|
39
|
8.80e-01
|
9.75e-01
|
0.04550
|
8.80e-03
|
4.46e-02
|
9.24e-01
|
6.30e-01
|
GOBP EPITHELIAL CELL DIFFERENTIATION
|
719
|
8.69e-02
|
5.46e-01
|
0.04540
|
3.30e-02
|
3.12e-02
|
1.32e-01
|
1.54e-01
|
GOBP REGULATION OF SKELETAL MUSCLE CELL PROLIFERATION
|
15
|
9.49e-01
|
9.90e-01
|
0.04540
|
3.39e-02
|
3.02e-02
|
8.20e-01
|
8.40e-01
|
GOBP PYRIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS
|
28
|
9.24e-01
|
9.84e-01
|
0.04530
|
-4.07e-02
|
2.00e-02
|
7.10e-01
|
8.55e-01
|
GOBP POSITIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION
|
146
|
6.37e-01
|
9.06e-01
|
0.04530
|
-5.34e-04
|
4.53e-02
|
9.91e-01
|
3.45e-01
|
GOMF CELL ADHESIVE PROTEIN BINDING INVOLVED IN BUNDLE OF HIS CELL PURKINJE MYOCYTE COMMUNICATION
|
5
|
9.86e-01
|
9.98e-01
|
0.04520
|
3.03e-02
|
-3.36e-02
|
9.07e-01
|
8.96e-01
|
GOMF NUCLEAR VITAMIN D RECEPTOR BINDING
|
13
|
9.60e-01
|
9.91e-01
|
0.04520
|
2.66e-04
|
-4.52e-02
|
9.99e-01
|
7.78e-01
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PEROXIDE AS ACCEPTOR
|
54
|
8.40e-01
|
9.65e-01
|
0.04520
|
7.75e-03
|
4.46e-02
|
9.22e-01
|
5.71e-01
|
GOBP INORGANIC ANION TRANSPORT
|
162
|
6.44e-01
|
9.07e-01
|
0.04520
|
-2.88e-02
|
3.48e-02
|
5.27e-01
|
4.44e-01
|
GOBP POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION
|
263
|
4.28e-01
|
8.36e-01
|
0.04520
|
9.73e-03
|
4.41e-02
|
7.86e-01
|
2.18e-01
|
GOBP MIRNA MEDIATED GENE SILENCING BY INHIBITION OF TRANSLATION
|
91
|
7.45e-01
|
9.38e-01
|
0.04510
|
4.42e-02
|
9.07e-03
|
4.66e-01
|
8.81e-01
|
GOBP POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION
|
52
|
8.39e-01
|
9.65e-01
|
0.04510
|
-1.87e-02
|
-4.10e-02
|
8.15e-01
|
6.09e-01
|
GOBP CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS
|
29
|
9.22e-01
|
9.84e-01
|
0.04510
|
1.87e-02
|
-4.10e-02
|
8.61e-01
|
7.02e-01
|
GOBP RNA LOCALIZATION
|
183
|
5.38e-01
|
8.78e-01
|
0.04510
|
-3.87e-02
|
-2.31e-02
|
3.67e-01
|
5.90e-01
|
GOBP POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS
|
480
|
2.64e-01
|
7.40e-01
|
0.04510
|
-1.61e-02
|
4.21e-02
|
5.46e-01
|
1.14e-01
|
GOBP REGULATION OF RECEPTOR RECYCLING
|
25
|
9.32e-01
|
9.86e-01
|
0.04500
|
1.67e-02
|
-4.17e-02
|
8.85e-01
|
7.18e-01
|
GOMF DICARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY
|
31
|
9.00e-01
|
9.79e-01
|
0.04480
|
2.51e-02
|
3.72e-02
|
8.09e-01
|
7.20e-01
|
GOCC RNA POLYMERASE COMPLEX
|
97
|
7.21e-01
|
9.30e-01
|
0.04480
|
-2.40e-02
|
-3.78e-02
|
6.82e-01
|
5.20e-01
|
GOBP REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL
|
18
|
9.41e-01
|
9.89e-01
|
0.04470
|
-3.18e-02
|
-3.14e-02
|
8.15e-01
|
8.17e-01
|
GOBP CYTOKINE PRODUCTION
|
837
|
1.16e-01
|
5.94e-01
|
0.04470
|
-3.51e-02
|
2.77e-02
|
8.49e-02
|
1.74e-01
|
GOBP REGULATION OF CELL GROWTH
|
399
|
3.52e-01
|
7.96e-01
|
0.04460
|
-2.99e-02
|
3.31e-02
|
3.05e-01
|
2.56e-01
|
GOBP ONE CARBON METABOLIC PROCESS
|
37
|
8.93e-01
|
9.76e-01
|
0.04460
|
-2.90e-03
|
-4.45e-02
|
9.76e-01
|
6.39e-01
|
GOCC PLASMA MEMBRANE REGION
|
1247
|
3.78e-02
|
3.96e-01
|
0.04460
|
-1.61e-02
|
4.16e-02
|
3.40e-01
|
1.34e-02
|
GOMF COA HYDROLASE ACTIVITY
|
21
|
9.31e-01
|
9.86e-01
|
0.04460
|
-2.84e-02
|
-3.44e-02
|
8.22e-01
|
7.85e-01
|
GOBP CELL PROJECTION ASSEMBLY
|
586
|
1.77e-01
|
6.67e-01
|
0.04460
|
4.84e-04
|
4.46e-02
|
9.84e-01
|
6.51e-02
|
GOMF HORMONE ACTIVITY
|
122
|
6.97e-01
|
9.21e-01
|
0.04460
|
-4.45e-02
|
3.33e-03
|
3.96e-01
|
9.49e-01
|
GOBP NEGATIVE REGULATION OF TRANSFERASE ACTIVITY
|
223
|
4.89e-01
|
8.57e-01
|
0.04460
|
-4.24e-02
|
-1.37e-02
|
2.75e-01
|
7.24e-01
|
GOBP BASE CONVERSION OR SUBSTITUTION EDITING
|
19
|
9.43e-01
|
9.89e-01
|
0.04460
|
4.84e-03
|
4.43e-02
|
9.71e-01
|
7.38e-01
|
GOBP REGULATION OF AMINO ACID TRANSMEMBRANE TRANSPORT
|
14
|
9.57e-01
|
9.90e-01
|
0.04450
|
5.72e-03
|
4.42e-02
|
9.70e-01
|
7.75e-01
|
GOBP RESPONSE TO TYPE II INTERFERON
|
135
|
6.39e-01
|
9.06e-01
|
0.04450
|
-3.80e-02
|
-2.31e-02
|
4.45e-01
|
6.43e-01
|
GOMF PEPTIDASE ACTIVATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS
|
23
|
9.34e-01
|
9.87e-01
|
0.04450
|
4.44e-02
|
-1.63e-03
|
7.12e-01
|
9.89e-01
|
GOBP OSTEOBLAST DIFFERENTIATION
|
249
|
4.87e-01
|
8.56e-01
|
0.04450
|
-4.41e-02
|
5.56e-03
|
2.31e-01
|
8.80e-01
|
GOBP PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY
|
29
|
9.17e-01
|
9.83e-01
|
0.04450
|
4.83e-04
|
-4.45e-02
|
9.96e-01
|
6.79e-01
|
GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS
|
155
|
6.39e-01
|
9.06e-01
|
0.04440
|
-4.41e-02
|
5.47e-03
|
3.44e-01
|
9.06e-01
|
GOBP CELLULAR RESPONSE TO AMYLOID BETA
|
44
|
8.89e-01
|
9.76e-01
|
0.04440
|
3.87e-02
|
-2.18e-02
|
6.57e-01
|
8.02e-01
|
GOBP POSITIVE REGULATION OF CELL CYCLE PROCESS
|
251
|
4.48e-01
|
8.42e-01
|
0.04440
|
-4.16e-02
|
-1.54e-02
|
2.56e-01
|
6.74e-01
|
GOBP STEROID METABOLIC PROCESS
|
312
|
3.65e-01
|
8.05e-01
|
0.04430
|
-1.98e-02
|
-3.97e-02
|
5.48e-01
|
2.28e-01
|
GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION
|
43
|
8.92e-01
|
9.76e-01
|
0.04430
|
-2.49e-02
|
3.67e-02
|
7.78e-01
|
6.77e-01
|
GOBP REGULATION OF FIBROBLAST APOPTOTIC PROCESS
|
19
|
9.51e-01
|
9.90e-01
|
0.04420
|
2.77e-02
|
-3.45e-02
|
8.34e-01
|
7.95e-01
|
GOBP BIOGENIC AMINE METABOLIC PROCESS
|
87
|
7.95e-01
|
9.55e-01
|
0.04420
|
2.43e-02
|
-3.70e-02
|
6.95e-01
|
5.51e-01
|
GOBP NEPHRON MORPHOGENESIS
|
77
|
8.06e-01
|
9.57e-01
|
0.04420
|
-1.00e-02
|
4.31e-02
|
8.79e-01
|
5.13e-01
|
GOMF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY
|
26
|
9.30e-01
|
9.86e-01
|
0.04420
|
-1.10e-02
|
4.28e-02
|
9.23e-01
|
7.06e-01
|
GOCC NON MOTILE CILIUM
|
153
|
6.33e-01
|
9.03e-01
|
0.04420
|
2.56e-03
|
4.41e-02
|
9.56e-01
|
3.46e-01
|
GOCC SPERM PRINCIPAL PIECE
|
32
|
9.17e-01
|
9.83e-01
|
0.04420
|
1.75e-02
|
-4.05e-02
|
8.64e-01
|
6.91e-01
|
GOCC SUPRAMOLECULAR POLYMER
|
981
|
4.85e-02
|
4.41e-01
|
0.04420
|
1.73e-02
|
4.06e-02
|
3.58e-01
|
3.12e-02
|
GOBP POSITIVE REGULATION OF TRANSFERASE ACTIVITY
|
399
|
3.45e-01
|
7.96e-01
|
0.04410
|
-1.64e-02
|
4.09e-02
|
5.74e-01
|
1.60e-01
|
GOMF DNA BINDING TRANSCRIPTION ACTIVATOR ACTIVITY
|
452
|
2.43e-01
|
7.25e-01
|
0.04410
|
-1.53e-02
|
-4.14e-02
|
5.78e-01
|
1.32e-01
|
GOBP RETINAL GANGLION CELL AXON GUIDANCE
|
22
|
9.44e-01
|
9.90e-01
|
0.04410
|
2.97e-02
|
-3.25e-02
|
8.09e-01
|
7.92e-01
|
GOBP SODIUM ION TRANSPORT
|
234
|
5.24e-01
|
8.70e-01
|
0.04410
|
-1.03e-02
|
4.28e-02
|
7.86e-01
|
2.59e-01
|
GOCC FILOPODIUM
|
103
|
7.20e-01
|
9.30e-01
|
0.04410
|
1.65e-02
|
4.08e-02
|
7.72e-01
|
4.74e-01
|
GOBP POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION
|
71
|
8.25e-01
|
9.62e-01
|
0.04400
|
-4.14e-02
|
1.49e-02
|
5.46e-01
|
8.28e-01
|
GOBP HOMOLOGOUS CHROMOSOME SEGREGATION
|
63
|
8.15e-01
|
9.59e-01
|
0.04400
|
3.80e-02
|
2.22e-02
|
6.02e-01
|
7.60e-01
|
GOBP POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION
|
165
|
6.09e-01
|
8.97e-01
|
0.04400
|
4.94e-03
|
4.37e-02
|
9.13e-01
|
3.33e-01
|
GOBP NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS
|
27
|
9.16e-01
|
9.83e-01
|
0.04400
|
3.68e-02
|
2.41e-02
|
7.41e-01
|
8.28e-01
|
GOBP REGULATION OF PROTEIN UBIQUITINATION
|
180
|
6.10e-01
|
8.98e-01
|
0.04390
|
4.26e-02
|
-1.08e-02
|
3.24e-01
|
8.03e-01
|
GOBP RETINA MORPHOGENESIS IN CAMERA TYPE EYE
|
63
|
8.25e-01
|
9.62e-01
|
0.04390
|
-4.31e-02
|
-8.36e-03
|
5.54e-01
|
9.09e-01
|
GOBP REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS
|
341
|
4.21e-01
|
8.33e-01
|
0.04390
|
-3.26e-02
|
2.93e-02
|
3.00e-01
|
3.52e-01
|
GOBP CELL GROWTH
|
476
|
2.91e-01
|
7.61e-01
|
0.04380
|
-1.86e-02
|
3.97e-02
|
4.86e-01
|
1.38e-01
|
GOMF HYDROLASE ACTIVITY ACTING ON ESTER BONDS
|
718
|
1.39e-01
|
6.23e-01
|
0.04380
|
-4.35e-02
|
5.06e-03
|
4.72e-02
|
8.17e-01
|
GOBP EMBRYONIC ORGAN MORPHOGENESIS
|
292
|
4.77e-01
|
8.54e-01
|
0.04380
|
-2.84e-02
|
3.33e-02
|
4.04e-01
|
3.28e-01
|
GOCC TRANSCRIPTION FACTOR TFIID COMPLEX
|
30
|
9.17e-01
|
9.83e-01
|
0.04370
|
-9.40e-05
|
-4.37e-02
|
9.99e-01
|
6.79e-01
|
GOMF LIGASE ACTIVITY FORMING CARBON NITROGEN BONDS
|
49
|
8.82e-01
|
9.75e-01
|
0.04370
|
-3.39e-02
|
2.76e-02
|
6.81e-01
|
7.38e-01
|
GOBP PROTEIN PROCESSING
|
232
|
5.11e-01
|
8.66e-01
|
0.04370
|
-4.37e-02
|
-1.35e-03
|
2.52e-01
|
9.72e-01
|
GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS
|
37
|
9.10e-01
|
9.82e-01
|
0.04360
|
-3.00e-02
|
3.17e-02
|
7.52e-01
|
7.39e-01
|
GOBP IMMUNE RESPONSE REGULATING SIGNALING PATHWAY
|
456
|
2.66e-01
|
7.42e-01
|
0.04360
|
4.52e-03
|
4.34e-02
|
8.68e-01
|
1.12e-01
|
GOBP REGULATION OF PROTEOLYSIS
|
586
|
1.67e-01
|
6.52e-01
|
0.04350
|
-4.00e-02
|
-1.73e-02
|
9.84e-02
|
4.75e-01
|
GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION
|
12
|
9.67e-01
|
9.92e-01
|
0.04350
|
-4.34e-02
|
3.36e-03
|
7.95e-01
|
9.84e-01
|
GOBP REGULATION OF PROTEIN TARGETING
|
75
|
8.20e-01
|
9.60e-01
|
0.04350
|
-4.07e-02
|
1.53e-02
|
5.42e-01
|
8.19e-01
|
GOBP STEROL HOMEOSTASIS
|
99
|
7.50e-01
|
9.40e-01
|
0.04340
|
2.86e-03
|
4.33e-02
|
9.61e-01
|
4.56e-01
|
GOBP SEXUAL REPRODUCTION
|
984
|
6.67e-02
|
4.98e-01
|
0.04340
|
-4.34e-02
|
-7.51e-04
|
2.12e-02
|
9.68e-01
|
GOBP DEFENSE RESPONSE
|
1720
|
1.60e-02
|
2.68e-01
|
0.04340
|
-3.95e-02
|
1.80e-02
|
6.43e-03
|
2.15e-01
|
GOBP BIOLOGICAL PROCESS INVOLVED IN INTRASPECIES INTERACTION BETWEEN ORGANISMS
|
48
|
8.59e-01
|
9.68e-01
|
0.04340
|
3.72e-02
|
2.24e-02
|
6.56e-01
|
7.88e-01
|
GOBP MYELOID CELL APOPTOTIC PROCESS
|
38
|
9.07e-01
|
9.81e-01
|
0.04340
|
2.06e-02
|
-3.81e-02
|
8.26e-01
|
6.84e-01
|
GOBP ICOSANOID METABOLIC PROCESS
|
117
|
6.97e-01
|
9.21e-01
|
0.04340
|
-1.57e-02
|
-4.04e-02
|
7.69e-01
|
4.50e-01
|
GOBP NEPHRON DEVELOPMENT
|
152
|
6.25e-01
|
9.01e-01
|
0.04340
|
1.70e-02
|
3.99e-02
|
7.18e-01
|
3.96e-01
|
GOBP REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION
|
29
|
9.17e-01
|
9.83e-01
|
0.04330
|
-4.25e-02
|
-8.22e-03
|
6.92e-01
|
9.39e-01
|
GOBP DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION
|
20
|
9.38e-01
|
9.88e-01
|
0.04330
|
2.60e-02
|
3.46e-02
|
8.41e-01
|
7.89e-01
|
GOBP CELL CELL RECOGNITION
|
72
|
8.32e-01
|
9.64e-01
|
0.04330
|
2.08e-02
|
-3.80e-02
|
7.60e-01
|
5.77e-01
|
GOBP UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE C END DEGRON RULE PATHWAY
|
12
|
9.68e-01
|
9.93e-01
|
0.04330
|
1.10e-02
|
-4.19e-02
|
9.48e-01
|
8.02e-01
|
GOBP POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT
|
18
|
9.54e-01
|
9.90e-01
|
0.04320
|
1.40e-02
|
-4.09e-02
|
9.18e-01
|
7.64e-01
|
GOBP ORGANOPHOSPHATE CATABOLIC PROCESS
|
142
|
6.97e-01
|
9.21e-01
|
0.04320
|
-2.05e-02
|
3.80e-02
|
6.73e-01
|
4.34e-01
|
GOCC EXCITATORY SYNAPSE
|
57
|
8.46e-01
|
9.66e-01
|
0.04320
|
-6.44e-03
|
-4.27e-02
|
9.33e-01
|
5.77e-01
|
GOBP COLLAGEN FIBRIL ORGANIZATION
|
63
|
8.34e-01
|
9.64e-01
|
0.04320
|
4.31e-02
|
3.43e-03
|
5.54e-01
|
9.62e-01
|
GOBP AMYLOID FIBRIL FORMATION
|
38
|
9.05e-01
|
9.80e-01
|
0.04320
|
-4.09e-02
|
1.40e-02
|
6.63e-01
|
8.81e-01
|
GOBP SENSORY SYSTEM DEVELOPMENT
|
392
|
3.79e-01
|
8.14e-01
|
0.04320
|
-2.41e-02
|
3.58e-02
|
4.13e-01
|
2.23e-01
|
GOBP ORGANELLE MEMBRANE FUSION
|
118
|
6.89e-01
|
9.19e-01
|
0.04320
|
-3.05e-02
|
-3.05e-02
|
5.67e-01
|
5.67e-01
|
GOBP MUSCLE STRUCTURE DEVELOPMENT
|
676
|
1.91e-01
|
6.85e-01
|
0.04320
|
-2.25e-02
|
3.69e-02
|
3.20e-01
|
1.02e-01
|
GOBP PROTEIN LOCALIZATION TO NUCLEUS
|
305
|
4.48e-01
|
8.41e-01
|
0.04310
|
-4.19e-02
|
1.02e-02
|
2.08e-01
|
7.60e-01
|
GOBP REGULATION OF APOPTOTIC SIGNALING PATHWAY
|
380
|
3.66e-01
|
8.07e-01
|
0.04300
|
-4.22e-02
|
8.22e-03
|
1.58e-01
|
7.83e-01
|
GOBP REGULATION OF TELOMERASE ACTIVITY
|
48
|
8.87e-01
|
9.76e-01
|
0.04300
|
-3.56e-02
|
2.41e-02
|
6.70e-01
|
7.72e-01
|
GOBP ICOSANOID SECRETION
|
46
|
8.92e-01
|
9.76e-01
|
0.04300
|
2.48e-02
|
-3.51e-02
|
7.71e-01
|
6.80e-01
|
GOBP REGULATION OF SMOOTH MUSCLE CELL CHEMOTAXIS
|
7
|
9.81e-01
|
9.96e-01
|
0.04300
|
4.29e-02
|
-6.23e-04
|
8.44e-01
|
9.98e-01
|
GOBP DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM
|
106
|
7.45e-01
|
9.38e-01
|
0.04290
|
-1.19e-03
|
4.29e-02
|
9.83e-01
|
4.45e-01
|
GOBP REGULATION OF BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS
|
5
|
9.86e-01
|
9.98e-01
|
0.04290
|
-4.29e-02
|
-1.98e-03
|
8.68e-01
|
9.94e-01
|
GOBP RENAL SYSTEM DEVELOPMENT
|
316
|
4.23e-01
|
8.34e-01
|
0.04290
|
-2.23e-03
|
4.28e-02
|
9.46e-01
|
1.90e-01
|
GOBP PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX
|
19
|
9.42e-01
|
9.89e-01
|
0.04290
|
-2.99e-02
|
-3.07e-02
|
8.21e-01
|
8.17e-01
|
GOBP CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS
|
89
|
7.58e-01
|
9.44e-01
|
0.04290
|
2.73e-02
|
3.31e-02
|
6.57e-01
|
5.90e-01
|
GOCC MALE GERM CELL NUCLEUS
|
52
|
8.80e-01
|
9.75e-01
|
0.04280
|
2.98e-02
|
-3.08e-02
|
7.10e-01
|
7.01e-01
|
GOBP SIGNAL RELEASE
|
466
|
3.25e-01
|
7.81e-01
|
0.04280
|
-2.66e-02
|
3.35e-02
|
3.24e-01
|
2.15e-01
|
GOMF HISTONE DEACETYLASE BINDING
|
108
|
7.35e-01
|
9.34e-01
|
0.04280
|
-4.25e-02
|
-4.96e-03
|
4.45e-01
|
9.29e-01
|
GOCC APICAL PART OF CELL
|
449
|
2.54e-01
|
7.32e-01
|
0.04280
|
2.89e-02
|
3.15e-02
|
2.93e-01
|
2.53e-01
|
GOMF SIGNALING RECEPTOR REGULATOR ACTIVITY
|
513
|
2.27e-01
|
7.15e-01
|
0.04270
|
4.11e-02
|
1.17e-02
|
1.11e-01
|
6.50e-01
|
GOBP MICROTUBULE CYTOSKELETON ORGANIZATION
|
624
|
1.62e-01
|
6.48e-01
|
0.04270
|
-3.99e-02
|
-1.52e-02
|
8.88e-02
|
5.17e-01
|
GOBP GLUTATHIONE METABOLIC PROCESS
|
48
|
8.86e-01
|
9.76e-01
|
0.04270
|
3.89e-02
|
-1.75e-02
|
6.41e-01
|
8.34e-01
|
GOBP PROTEIN TARGETING
|
314
|
4.09e-01
|
8.27e-01
|
0.04260
|
-4.17e-02
|
-8.63e-03
|
2.04e-01
|
7.93e-01
|
GOBP CANONICAL WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT
|
6
|
9.82e-01
|
9.96e-01
|
0.04240
|
-3.17e-02
|
-2.82e-02
|
8.93e-01
|
9.05e-01
|
GOBP MAPK CASCADE
|
740
|
1.64e-01
|
6.49e-01
|
0.04240
|
-1.48e-02
|
3.98e-02
|
4.94e-01
|
6.53e-02
|
GOBP EMBRYONIC ORGAN DEVELOPMENT
|
446
|
3.47e-01
|
7.96e-01
|
0.04240
|
-2.43e-02
|
3.47e-02
|
3.78e-01
|
2.09e-01
|
GOBP ENDOPLASMIC RETICULUM MEMBRANE ORGANIZATION
|
12
|
9.68e-01
|
9.92e-01
|
0.04240
|
8.79e-04
|
-4.23e-02
|
9.96e-01
|
8.00e-01
|
GOBP MITOTIC INTRA S DNA DAMAGE CHECKPOINT SIGNALING
|
17
|
9.59e-01
|
9.91e-01
|
0.04230
|
1.98e-02
|
-3.74e-02
|
8.87e-01
|
7.89e-01
|
GOBP PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION
|
284
|
4.88e-01
|
8.56e-01
|
0.04230
|
-1.13e-02
|
4.08e-02
|
7.43e-01
|
2.37e-01
|
GOCC ENZYME ACTIVATOR COMPLEX
|
16
|
9.55e-01
|
9.90e-01
|
0.04230
|
4.15e-02
|
8.45e-03
|
7.74e-01
|
9.53e-01
|
GOCC CYTOPLASMIC SIDE OF MEMBRANE
|
200
|
5.97e-01
|
8.95e-01
|
0.04230
|
-7.94e-03
|
4.16e-02
|
8.47e-01
|
3.11e-01
|
GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS
|
37
|
8.98e-01
|
9.78e-01
|
0.04230
|
-4.07e-02
|
-1.15e-02
|
6.68e-01
|
9.04e-01
|
GOBP REGULATION OF KINASE ACTIVITY
|
563
|
2.66e-01
|
7.42e-01
|
0.04230
|
-3.44e-02
|
2.46e-02
|
1.63e-01
|
3.18e-01
|
GOBP RESPONSE TO SALT STRESS
|
24
|
9.43e-01
|
9.89e-01
|
0.04230
|
-3.75e-02
|
1.95e-02
|
7.51e-01
|
8.69e-01
|
GOBP POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY
|
192
|
6.35e-01
|
9.05e-01
|
0.04220
|
-2.80e-02
|
3.16e-02
|
5.03e-01
|
4.51e-01
|
GOCC RIBONUCLEOPROTEIN GRANULE
|
259
|
5.41e-01
|
8.78e-01
|
0.04220
|
-2.49e-02
|
3.41e-02
|
4.90e-01
|
3.45e-01
|
GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT
|
29
|
9.32e-01
|
9.86e-01
|
0.04220
|
-3.73e-02
|
1.96e-02
|
7.28e-01
|
8.55e-01
|
GOBP EXPLORATION BEHAVIOR
|
28
|
9.36e-01
|
9.87e-01
|
0.04210
|
2.62e-02
|
-3.30e-02
|
8.10e-01
|
7.63e-01
|
GOBP NEGATIVE REGULATION OF ORGANELLE ORGANIZATION
|
337
|
3.83e-01
|
8.17e-01
|
0.04210
|
-4.01e-02
|
-1.28e-02
|
2.06e-01
|
6.87e-01
|
GOBP POSITIVE REGULATION OF CELL CELL ADHESION
|
310
|
4.10e-01
|
8.27e-01
|
0.04210
|
1.54e-02
|
3.92e-02
|
6.41e-01
|
2.36e-01
|
GOBP RIBONUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS
|
8
|
9.80e-01
|
9.96e-01
|
0.04210
|
1.40e-02
|
-3.96e-02
|
9.45e-01
|
8.46e-01
|
GOBP ANTIMICROBIAL HUMORAL RESPONSE
|
114
|
7.31e-01
|
9.32e-01
|
0.04200
|
-4.54e-03
|
-4.18e-02
|
9.33e-01
|
4.41e-01
|
GOMF MOLECULAR FUNCTION ACTIVATOR ACTIVITY
|
1043
|
8.00e-02
|
5.28e-01
|
0.04200
|
-9.46e-03
|
4.09e-02
|
6.05e-01
|
2.55e-02
|
GOBP FEMALE MEIOTIC NUCLEAR DIVISION
|
38
|
9.09e-01
|
9.82e-01
|
0.04200
|
1.24e-02
|
-4.01e-02
|
8.95e-01
|
6.69e-01
|
GOBP IMMUNE EFFECTOR PROCESS
|
605
|
2.42e-01
|
7.25e-01
|
0.04200
|
-3.68e-02
|
2.03e-02
|
1.23e-01
|
3.94e-01
|
GOBP DICARBOXYLIC ACID TRANSPORT
|
98
|
7.52e-01
|
9.41e-01
|
0.04190
|
3.80e-02
|
1.76e-02
|
5.15e-01
|
7.63e-01
|
GOBP POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION
|
16
|
9.53e-01
|
9.90e-01
|
0.04190
|
-2.68e-02
|
-3.22e-02
|
8.53e-01
|
8.23e-01
|
GOBP POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION
|
113
|
7.14e-01
|
9.27e-01
|
0.04190
|
-3.14e-02
|
-2.77e-02
|
5.64e-01
|
6.11e-01
|
GOBP CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY
|
155
|
6.65e-01
|
9.10e-01
|
0.04180
|
4.18e-02
|
-3.63e-04
|
3.69e-01
|
9.94e-01
|
GOBP PROTEIN TARGETING TO MITOCHONDRION
|
101
|
7.44e-01
|
9.38e-01
|
0.04170
|
-3.47e-02
|
-2.31e-02
|
5.47e-01
|
6.89e-01
|
GOBP SPINAL CORD DEVELOPMENT
|
99
|
7.51e-01
|
9.40e-01
|
0.04150
|
2.20e-02
|
3.53e-02
|
7.06e-01
|
5.44e-01
|
GOBP CELLULAR RESPONSE TO CAFFEINE
|
11
|
9.70e-01
|
9.93e-01
|
0.04150
|
-1.13e-02
|
-3.99e-02
|
9.48e-01
|
8.19e-01
|
GOBP RESPONSE TO HYDROGEN PEROXIDE
|
96
|
7.81e-01
|
9.52e-01
|
0.04140
|
-4.14e-02
|
2.20e-03
|
4.83e-01
|
9.70e-01
|
GOBP DETOXIFICATION
|
152
|
6.50e-01
|
9.07e-01
|
0.04140
|
3.73e-02
|
1.79e-02
|
4.27e-01
|
7.03e-01
|
GOBP CEREBRAL CORTEX DEVELOPMENT
|
119
|
7.29e-01
|
9.32e-01
|
0.04140
|
-4.19e-03
|
-4.12e-02
|
9.37e-01
|
4.38e-01
|
GOMF PROTEIN HETERODIMERIZATION ACTIVITY
|
302
|
4.95e-01
|
8.58e-01
|
0.04130
|
-1.70e-02
|
3.77e-02
|
6.12e-01
|
2.60e-01
|
GOBP RESPONSE TO MECHANICAL STIMULUS
|
209
|
5.55e-01
|
8.81e-01
|
0.04130
|
3.72e-02
|
1.79e-02
|
3.54e-01
|
6.55e-01
|
GOBP NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION
|
161
|
6.29e-01
|
9.02e-01
|
0.04130
|
3.22e-02
|
2.58e-02
|
4.80e-01
|
5.72e-01
|
GOBP REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS
|
182
|
5.92e-01
|
8.93e-01
|
0.04130
|
-2.84e-02
|
-2.99e-02
|
5.09e-01
|
4.86e-01
|
GOBP CALCIUM ION TRANSPORT INTO CYTOSOL
|
28
|
9.36e-01
|
9.87e-01
|
0.04120
|
1.48e-02
|
-3.85e-02
|
8.92e-01
|
7.25e-01
|
GOBP POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION
|
1067
|
9.84e-02
|
5.65e-01
|
0.04120
|
-2.48e-02
|
3.29e-02
|
1.71e-01
|
6.94e-02
|
GOBP SENSORY ORGAN MORPHOGENESIS
|
272
|
5.39e-01
|
8.78e-01
|
0.04120
|
-2.20e-02
|
3.49e-02
|
5.33e-01
|
3.22e-01
|
GOBP ORGANIC ACID TRANSPORT
|
341
|
4.40e-01
|
8.40e-01
|
0.04120
|
-9.04e-03
|
4.02e-02
|
7.74e-01
|
2.02e-01
|
GOBP MIRNA MEDIATED GENE SILENCING BY MRNA DESTABILIZATION
|
62
|
8.37e-01
|
9.64e-01
|
0.04110
|
-2.48e-02
|
-3.28e-02
|
7.36e-01
|
6.55e-01
|
GOBP POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY
|
104
|
7.58e-01
|
9.44e-01
|
0.04110
|
7.15e-03
|
4.05e-02
|
9.00e-01
|
4.76e-01
|
GOBP CELLULAR OXIDANT DETOXIFICATION
|
94
|
8.04e-01
|
9.57e-01
|
0.04110
|
-1.75e-02
|
3.72e-02
|
7.70e-01
|
5.33e-01
|
GOBP EXIT FROM MITOSIS
|
32
|
9.29e-01
|
9.86e-01
|
0.04110
|
3.66e-02
|
-1.87e-02
|
7.20e-01
|
8.55e-01
|
GOBP LABYRINTHINE LAYER DEVELOPMENT
|
43
|
9.04e-01
|
9.80e-01
|
0.04110
|
3.80e-02
|
-1.57e-02
|
6.66e-01
|
8.59e-01
|
GOBP REGULATION OF CEREBELLAR GRANULE CELL PRECURSOR PROLIFERATION
|
11
|
9.70e-01
|
9.93e-01
|
0.04100
|
3.82e-02
|
1.48e-02
|
8.26e-01
|
9.32e-01
|
GOCC COATED VESICLE MEMBRANE
|
192
|
5.85e-01
|
8.90e-01
|
0.04100
|
-1.98e-02
|
-3.59e-02
|
6.36e-01
|
3.91e-01
|
GOBP REGULATION OF ENDODEOXYRIBONUCLEASE ACTIVITY
|
8
|
9.82e-01
|
9.96e-01
|
0.04090
|
3.76e-02
|
-1.61e-02
|
8.54e-01
|
9.37e-01
|
GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION
|
31
|
9.30e-01
|
9.86e-01
|
0.04090
|
1.47e-02
|
-3.81e-02
|
8.87e-01
|
7.13e-01
|
GOMF INORGANIC MOLECULAR ENTITY TRANSMEMBRANE TRANSPORTER ACTIVITY
|
652
|
1.96e-01
|
6.88e-01
|
0.04080
|
2.60e-03
|
4.08e-02
|
9.10e-01
|
7.58e-02
|
GOBP REGULATION OF SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING
|
11
|
9.74e-01
|
9.94e-01
|
0.04080
|
7.68e-03
|
-4.01e-02
|
9.65e-01
|
8.18e-01
|
GOBP REGULATION OF HEAT GENERATION
|
12
|
9.71e-01
|
9.93e-01
|
0.04080
|
4.06e-02
|
-3.91e-03
|
8.08e-01
|
9.81e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS
|
952
|
9.15e-02
|
5.51e-01
|
0.04080
|
-4.03e-02
|
-6.40e-03
|
3.53e-02
|
7.38e-01
|
GOBP POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION
|
314
|
4.59e-01
|
8.48e-01
|
0.04080
|
-8.77e-04
|
4.08e-02
|
9.79e-01
|
2.14e-01
|
GOBP EPITHELIUM DEVELOPMENT
|
1203
|
4.61e-02
|
4.34e-01
|
0.04070
|
1.25e-02
|
3.88e-02
|
4.65e-01
|
2.35e-02
|
GOBP POSITIVE REGULATION OF STEROL TRANSPORT
|
38
|
9.02e-01
|
9.80e-01
|
0.04070
|
1.29e-02
|
3.87e-02
|
8.91e-01
|
6.80e-01
|
GOBP STEM CELL DIFFERENTIATION
|
240
|
5.76e-01
|
8.89e-01
|
0.04070
|
-3.81e-02
|
1.43e-02
|
3.09e-01
|
7.03e-01
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN
|
171
|
6.69e-01
|
9.11e-01
|
0.04070
|
3.93e-02
|
-1.07e-02
|
3.76e-01
|
8.09e-01
|
GOBP DEVELOPMENTAL MATURATION
|
318
|
4.28e-01
|
8.36e-01
|
0.04070
|
-3.84e-02
|
-1.34e-02
|
2.39e-01
|
6.80e-01
|
GOBP REGULATION OF GROWTH
|
589
|
2.81e-01
|
7.53e-01
|
0.04070
|
-3.06e-02
|
2.68e-02
|
2.05e-01
|
2.66e-01
|
GOBP KIDNEY EPITHELIUM DEVELOPMENT
|
145
|
7.22e-01
|
9.30e-01
|
0.04070
|
-1.95e-02
|
3.56e-02
|
6.84e-01
|
4.59e-01
|
GOBP ACTIVATION OF JANUS KINASE ACTIVITY
|
13
|
9.64e-01
|
9.92e-01
|
0.04060
|
-3.12e-02
|
-2.60e-02
|
8.45e-01
|
8.71e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE
|
11
|
9.75e-01
|
9.95e-01
|
0.04060
|
3.64e-02
|
-1.80e-02
|
8.34e-01
|
9.18e-01
|
GOBP ATRIAL CARDIAC MUSCLE TISSUE DEVELOPMENT
|
21
|
9.49e-01
|
9.90e-01
|
0.04060
|
-1.06e-03
|
4.06e-02
|
9.93e-01
|
7.47e-01
|
GOBP NEGATIVE REGULATION OF COAGULATION
|
52
|
8.64e-01
|
9.70e-01
|
0.04060
|
2.59e-02
|
3.12e-02
|
7.46e-01
|
6.97e-01
|
GOBP CONVERGENT EXTENSION INVOLVED IN AXIS ELONGATION
|
6
|
9.83e-01
|
9.97e-01
|
0.04060
|
-2.48e-02
|
-3.21e-02
|
9.16e-01
|
8.92e-01
|
GOBP CERAMIDE TRANSPORT
|
17
|
9.60e-01
|
9.91e-01
|
0.04050
|
3.97e-02
|
-8.31e-03
|
7.77e-01
|
9.53e-01
|
GOBP ORGANELLE FISSION
|
479
|
2.69e-01
|
7.44e-01
|
0.04050
|
-2.79e-02
|
-2.94e-02
|
2.96e-01
|
2.70e-01
|
GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION
|
166
|
6.81e-01
|
9.16e-01
|
0.04050
|
-1.18e-02
|
3.87e-02
|
7.93e-01
|
3.89e-01
|
GOMF PROTEIN LIPID COMPLEX BINDING
|
31
|
9.24e-01
|
9.84e-01
|
0.04050
|
3.62e-03
|
4.03e-02
|
9.72e-01
|
6.98e-01
|
GOCC ACROSOMAL VESICLE
|
138
|
6.82e-01
|
9.16e-01
|
0.04050
|
-3.10e-02
|
-2.60e-02
|
5.29e-01
|
5.98e-01
|
GOBP RESPONSE TO FUNGICIDE
|
7
|
9.81e-01
|
9.96e-01
|
0.04040
|
1.52e-02
|
3.74e-02
|
9.44e-01
|
8.64e-01
|
GOMF SIGNALING RECEPTOR BINDING
|
1401
|
3.14e-02
|
3.63e-01
|
0.04030
|
1.13e-02
|
3.87e-02
|
4.79e-01
|
1.51e-02
|
GOBP REGULATION OF CELL ACTIVATION
|
626
|
2.20e-01
|
7.09e-01
|
0.04030
|
1.22e-03
|
4.03e-02
|
9.58e-01
|
8.54e-02
|
GOBP REGULATION OF ACUTE INFLAMMATORY RESPONSE
|
46
|
8.91e-01
|
9.76e-01
|
0.04030
|
-3.37e-03
|
-4.01e-02
|
9.68e-01
|
6.38e-01
|
GOBP PROTEIN K63 LINKED UBIQUITINATION
|
56
|
8.84e-01
|
9.76e-01
|
0.04020
|
-2.12e-02
|
3.42e-02
|
7.83e-01
|
6.58e-01
|
GOBP MAMMARY GLAND DEVELOPMENT
|
126
|
7.52e-01
|
9.41e-01
|
0.04020
|
-1.38e-02
|
3.78e-02
|
7.89e-01
|
4.64e-01
|
GOBP RESPONSE TO PARATHYROID HORMONE
|
10
|
9.76e-01
|
9.95e-01
|
0.04020
|
-3.46e-03
|
4.00e-02
|
9.85e-01
|
8.27e-01
|
GOBP POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS
|
256
|
5.21e-01
|
8.69e-01
|
0.04010
|
-3.92e-02
|
-8.73e-03
|
2.80e-01
|
8.10e-01
|
GOBP REGULATION OF BINDING
|
252
|
5.75e-01
|
8.88e-01
|
0.04010
|
-3.65e-02
|
1.67e-02
|
3.19e-01
|
6.49e-01
|
GOBP NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION
|
24
|
9.44e-01
|
9.89e-01
|
0.04010
|
4.00e-02
|
-1.82e-03
|
7.34e-01
|
9.88e-01
|
GOBP CATECHOL CONTAINING COMPOUND METABOLIC PROCESS
|
50
|
8.87e-01
|
9.76e-01
|
0.04010
|
3.99e-02
|
-3.15e-03
|
6.25e-01
|
9.69e-01
|
GOBP POSITIVE REGULATION OF LIPASE ACTIVITY
|
59
|
8.77e-01
|
9.75e-01
|
0.04000
|
3.72e-02
|
-1.47e-02
|
6.21e-01
|
8.45e-01
|
GOBP MICROTUBULE BASED PROCESS
|
897
|
1.04e-01
|
5.75e-01
|
0.04000
|
-3.74e-02
|
-1.41e-02
|
5.72e-02
|
4.75e-01
|
GOBP RESPONSE TO BMP
|
170
|
6.97e-01
|
9.21e-01
|
0.04000
|
-3.12e-02
|
2.49e-02
|
4.83e-01
|
5.75e-01
|
GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS
|
23
|
9.41e-01
|
9.89e-01
|
0.03990
|
-3.58e-02
|
-1.76e-02
|
7.66e-01
|
8.84e-01
|
GOMF NARROW PORE CHANNEL ACTIVITY
|
19
|
9.60e-01
|
9.91e-01
|
0.03990
|
2.29e-02
|
-3.27e-02
|
8.63e-01
|
8.05e-01
|
GOCC DYNEIN AXONEMAL PARTICLE
|
20
|
9.48e-01
|
9.90e-01
|
0.03990
|
3.27e-02
|
2.28e-02
|
8.00e-01
|
8.60e-01
|
GOBP CELL FATE COMMITMENT
|
279
|
5.36e-01
|
8.77e-01
|
0.03990
|
-1.08e-02
|
3.84e-02
|
7.56e-01
|
2.70e-01
|
GOBP PEPTIDYL PROLINE MODIFICATION
|
32
|
9.26e-01
|
9.84e-01
|
0.03970
|
-1.07e-03
|
-3.97e-02
|
9.92e-01
|
6.98e-01
|
GOBP NEGATIVE REGULATION OF CELL SIZE
|
9
|
9.80e-01
|
9.96e-01
|
0.03970
|
3.89e-02
|
-7.85e-03
|
8.40e-01
|
9.67e-01
|
GOCC NEURON PROJECTION
|
1248
|
4.91e-02
|
4.42e-01
|
0.03960
|
1.20e-02
|
3.78e-02
|
4.75e-01
|
2.48e-02
|
GOBP REGULATION OF RESPONSE TO EXTERNAL STIMULUS
|
1082
|
1.09e-01
|
5.84e-01
|
0.03960
|
-3.51e-02
|
1.85e-02
|
5.15e-02
|
3.05e-01
|
GOBP REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE
|
183
|
6.22e-01
|
9.01e-01
|
0.03960
|
-3.55e-02
|
-1.76e-02
|
4.08e-01
|
6.81e-01
|
GOBP PROTEIN HYDROXYLATION
|
23
|
9.42e-01
|
9.89e-01
|
0.03960
|
1.61e-02
|
3.62e-02
|
8.94e-01
|
7.64e-01
|
GOCC DENDRITIC SHAFT
|
40
|
9.00e-01
|
9.79e-01
|
0.03960
|
3.35e-02
|
2.10e-02
|
7.14e-01
|
8.18e-01
|
GOBP PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE
|
35
|
9.21e-01
|
9.84e-01
|
0.03950
|
2.39e-03
|
-3.95e-02
|
9.80e-01
|
6.86e-01
|
GOBP RESPONSE TO CADMIUM ION
|
56
|
8.89e-01
|
9.76e-01
|
0.03950
|
2.49e-02
|
-3.07e-02
|
7.47e-01
|
6.91e-01
|
GOCC COHESIN COMPLEX
|
8
|
9.83e-01
|
9.97e-01
|
0.03950
|
-2.92e-02
|
2.66e-02
|
8.86e-01
|
8.96e-01
|
GOBP REGULATION OF GLUCOCORTICOID METABOLIC PROCESS
|
11
|
9.73e-01
|
9.93e-01
|
0.03950
|
-3.88e-02
|
-7.00e-03
|
8.24e-01
|
9.68e-01
|
GOBP REGULATION OF MACROPHAGE PROLIFERATION
|
7
|
9.84e-01
|
9.97e-01
|
0.03940
|
-7.81e-03
|
3.86e-02
|
9.71e-01
|
8.59e-01
|
GOCC NEURON SPINE
|
168
|
6.57e-01
|
9.09e-01
|
0.03940
|
1.14e-02
|
3.77e-02
|
7.98e-01
|
3.99e-01
|
GOBP POSITIVE REGULATION OF PROGRAMMED CELL DEATH
|
545
|
3.22e-01
|
7.79e-01
|
0.03940
|
-3.52e-02
|
1.77e-02
|
1.60e-01
|
4.81e-01
|
GOBP NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS
|
461
|
3.51e-01
|
7.96e-01
|
0.03940
|
-3.93e-02
|
2.78e-03
|
1.49e-01
|
9.18e-01
|
GOCC H4 H2A HISTONE ACETYLTRANSFERASE COMPLEX
|
25
|
9.47e-01
|
9.90e-01
|
0.03940
|
1.14e-02
|
-3.77e-02
|
9.21e-01
|
7.44e-01
|
GOBP APOPTOTIC DNA FRAGMENTATION
|
19
|
9.59e-01
|
9.90e-01
|
0.03930
|
-3.80e-02
|
1.01e-02
|
7.74e-01
|
9.39e-01
|
GOBP POSITIVE REGULATION OF HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE
|
7
|
9.86e-01
|
9.97e-01
|
0.03930
|
2.55e-02
|
-2.98e-02
|
9.07e-01
|
8.91e-01
|
GOBP REELIN MEDIATED SIGNALING PATHWAY
|
7
|
9.83e-01
|
9.96e-01
|
0.03920
|
3.71e-02
|
1.29e-02
|
8.65e-01
|
9.53e-01
|
GOBP POSITIVE REGULATION OF TELOMERE CAPPING
|
17
|
9.64e-01
|
9.92e-01
|
0.03920
|
-3.75e-02
|
1.14e-02
|
7.89e-01
|
9.35e-01
|
GOBP DOPAMINE SECRETION
|
40
|
9.09e-01
|
9.81e-01
|
0.03920
|
4.14e-03
|
3.90e-02
|
9.64e-01
|
6.70e-01
|
GOBP POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL
|
41
|
9.05e-01
|
9.80e-01
|
0.03920
|
7.28e-03
|
3.85e-02
|
9.36e-01
|
6.69e-01
|
GOBP ENTEROENDOCRINE CELL DIFFERENTIATION
|
36
|
9.24e-01
|
9.84e-01
|
0.03920
|
-3.78e-02
|
1.02e-02
|
6.94e-01
|
9.16e-01
|
GOBP POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS
|
132
|
7.60e-01
|
9.44e-01
|
0.03920
|
-3.41e-02
|
1.94e-02
|
4.99e-01
|
7.01e-01
|
GOCC NEUROTRANSMITTER RECEPTOR COMPLEX
|
42
|
8.98e-01
|
9.78e-01
|
0.03910
|
1.99e-02
|
3.37e-02
|
8.24e-01
|
7.05e-01
|
GOBP DEMETHYLATION
|
51
|
8.83e-01
|
9.76e-01
|
0.03910
|
3.82e-02
|
8.46e-03
|
6.37e-01
|
9.17e-01
|
GOMF TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY
|
81
|
8.34e-01
|
9.64e-01
|
0.03910
|
-5.61e-03
|
3.87e-02
|
9.30e-01
|
5.47e-01
|
GOBP CRANIAL NERVE STRUCTURAL ORGANIZATION
|
9
|
9.79e-01
|
9.95e-01
|
0.03910
|
-3.91e-02
|
-1.23e-03
|
8.39e-01
|
9.95e-01
|
GOBP REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION
|
17
|
9.57e-01
|
9.90e-01
|
0.03900
|
-2.72e-02
|
-2.80e-02
|
8.46e-01
|
8.42e-01
|
GOBP RESPONSE TO XENOBIOTIC STIMULUS
|
422
|
3.46e-01
|
7.96e-01
|
0.03900
|
3.34e-02
|
2.01e-02
|
2.39e-01
|
4.80e-01
|
GOBP NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION
|
90
|
8.32e-01
|
9.64e-01
|
0.03900
|
2.20e-02
|
-3.22e-02
|
7.19e-01
|
5.97e-01
|
GOBP FOREBRAIN NEURON FATE COMMITMENT
|
7
|
9.84e-01
|
9.97e-01
|
0.03890
|
-1.06e-03
|
-3.89e-02
|
9.96e-01
|
8.59e-01
|
GOBP AUTONOMIC NERVOUS SYSTEM DEVELOPMENT
|
45
|
9.03e-01
|
9.80e-01
|
0.03890
|
-3.88e-02
|
1.14e-03
|
6.52e-01
|
9.89e-01
|
GOBP TROPHOBLAST GIANT CELL DIFFERENTIATION
|
12
|
9.70e-01
|
9.93e-01
|
0.03880
|
-3.44e-02
|
-1.81e-02
|
8.37e-01
|
9.14e-01
|
GOBP NEGATIVE REGULATION OF MAP KINASE ACTIVITY
|
50
|
8.99e-01
|
9.79e-01
|
0.03880
|
-1.17e-02
|
3.70e-02
|
8.86e-01
|
6.51e-01
|
GOBP MESODERMAL CELL DIFFERENTIATION
|
34
|
9.33e-01
|
9.87e-01
|
0.03870
|
-3.33e-02
|
1.98e-02
|
7.37e-01
|
8.42e-01
|
GOBP HEPATICOBILIARY SYSTEM DEVELOPMENT
|
140
|
7.44e-01
|
9.38e-01
|
0.03860
|
-1.07e-02
|
3.71e-02
|
8.27e-01
|
4.48e-01
|
GOBP CENTRAL NERVOUS SYSTEM DEVELOPMENT
|
967
|
1.39e-01
|
6.23e-01
|
0.03860
|
-3.73e-02
|
1.02e-02
|
4.98e-02
|
5.90e-01
|
GOBP POSITIVE REGULATION OF DEVELOPMENTAL GROWTH
|
157
|
7.28e-01
|
9.32e-01
|
0.03860
|
-3.34e-02
|
1.94e-02
|
4.70e-01
|
6.75e-01
|
GOBP RESPONSE TO ETHANOL
|
117
|
7.77e-01
|
9.50e-01
|
0.03860
|
3.79e-02
|
-7.65e-03
|
4.79e-01
|
8.86e-01
|
GOBP CARDIAC VENTRICLE MORPHOGENESIS
|
72
|
8.45e-01
|
9.66e-01
|
0.03860
|
5.82e-03
|
3.82e-02
|
9.32e-01
|
5.75e-01
|
GOCC SYNAPTIC VESICLE MEMBRANE
|
122
|
7.65e-01
|
9.45e-01
|
0.03850
|
-3.81e-03
|
3.84e-02
|
9.42e-01
|
4.64e-01
|
GOBP REGULATION OF PEPTIDASE ACTIVITY
|
298
|
5.04e-01
|
8.65e-01
|
0.03850
|
-3.82e-02
|
-4.90e-03
|
2.56e-01
|
8.84e-01
|
GOBP REGULATION OF OSTEOCLAST DEVELOPMENT
|
11
|
9.77e-01
|
9.95e-01
|
0.03850
|
-1.22e-02
|
3.65e-02
|
9.44e-01
|
8.34e-01
|
GOBP CELLULAR RESPONSE TO MECHANICAL STIMULUS
|
69
|
8.56e-01
|
9.68e-01
|
0.03840
|
9.44e-04
|
3.84e-02
|
9.89e-01
|
5.81e-01
|
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION
|
126
|
7.33e-01
|
9.33e-01
|
0.03840
|
3.36e-02
|
1.87e-02
|
5.15e-01
|
7.17e-01
|
GOBP CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS
|
120
|
7.89e-01
|
9.54e-01
|
0.03840
|
2.44e-02
|
-2.97e-02
|
6.44e-01
|
5.74e-01
|
GOBP REGULATION OF ALPHA BETA T CELL DIFFERENTIATION
|
70
|
8.55e-01
|
9.68e-01
|
0.03840
|
-6.53e-04
|
3.84e-02
|
9.92e-01
|
5.78e-01
|
GOMF POTASSIUM PROTON ANTIPORTER ACTIVITY
|
12
|
9.70e-01
|
9.93e-01
|
0.03830
|
2.41e-02
|
2.98e-02
|
8.85e-01
|
8.58e-01
|
GOBP REGULATION OF POTASSIUM ION TRANSPORT
|
99
|
8.10e-01
|
9.59e-01
|
0.03820
|
3.77e-02
|
-6.17e-03
|
5.16e-01
|
9.15e-01
|
GOMF TRANSCRIPTION REGULATOR ACTIVITY
|
1822
|
2.99e-02
|
3.61e-01
|
0.03820
|
-3.72e-02
|
8.74e-03
|
8.49e-03
|
5.36e-01
|
GOMF CYTOKINE RECEPTOR BINDING
|
254
|
5.48e-01
|
8.79e-01
|
0.03820
|
3.56e-02
|
1.37e-02
|
3.28e-01
|
7.06e-01
|
GOBP CELLULAR RESPONSE TO KETONE
|
96
|
8.21e-01
|
9.61e-01
|
0.03810
|
1.12e-02
|
-3.64e-02
|
8.49e-01
|
5.38e-01
|
GOBP REGULATION OF INFLAMMATORY RESPONSE
|
407
|
4.46e-01
|
8.40e-01
|
0.03800
|
-3.54e-02
|
1.40e-02
|
2.21e-01
|
6.28e-01
|
GOMF CYCLIN BINDING
|
34
|
9.32e-01
|
9.86e-01
|
0.03800
|
9.95e-03
|
-3.67e-02
|
9.20e-01
|
7.11e-01
|
GOBP LEUKOCYTE MEDIATED IMMUNITY
|
377
|
4.88e-01
|
8.56e-01
|
0.03800
|
-2.81e-02
|
2.56e-02
|
3.49e-01
|
3.93e-01
|
GOBP SNO S RNA PROCESSING
|
12
|
9.74e-01
|
9.94e-01
|
0.03790
|
-3.79e-02
|
1.94e-03
|
8.20e-01
|
9.91e-01
|
GOBP PHOTORECEPTOR CELL MAINTENANCE
|
43
|
9.00e-01
|
9.79e-01
|
0.03790
|
2.68e-02
|
2.69e-02
|
7.61e-01
|
7.60e-01
|
GOMF PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY
|
31
|
9.41e-01
|
9.89e-01
|
0.03790
|
-1.79e-02
|
3.35e-02
|
8.63e-01
|
7.47e-01
|
GOBP REACTIVE OXYGEN SPECIES METABOLIC PROCESS
|
216
|
6.60e-01
|
9.09e-01
|
0.03790
|
-2.19e-02
|
3.10e-02
|
5.79e-01
|
4.33e-01
|
GOMF PEPTIDASE ACTIVITY
|
559
|
2.75e-01
|
7.49e-01
|
0.03770
|
-3.41e-02
|
-1.62e-02
|
1.68e-01
|
5.13e-01
|
GOBP ORGANIC ANION TRANSPORT
|
429
|
4.44e-01
|
8.40e-01
|
0.03770
|
-1.96e-02
|
3.22e-02
|
4.86e-01
|
2.53e-01
|
GOBP CELLULAR RESPONSE TO TYPE II INTERFERON
|
113
|
7.62e-01
|
9.45e-01
|
0.03770
|
-2.73e-02
|
-2.59e-02
|
6.16e-01
|
6.34e-01
|
GOCC POSTSYNAPSE
|
615
|
2.91e-01
|
7.61e-01
|
0.03760
|
-6.22e-03
|
3.71e-02
|
7.92e-01
|
1.16e-01
|
GOBP PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS
|
31
|
9.34e-01
|
9.87e-01
|
0.03760
|
-3.75e-02
|
-2.89e-03
|
7.18e-01
|
9.78e-01
|
GOBP PEPTIDYL LYSINE TRIMETHYLATION
|
9
|
9.82e-01
|
9.96e-01
|
0.03750
|
8.97e-03
|
-3.64e-02
|
9.63e-01
|
8.50e-01
|
GOMF ISOMERASE ACTIVITY
|
155
|
6.94e-01
|
9.21e-01
|
0.03750
|
-3.16e-02
|
-2.01e-02
|
4.97e-01
|
6.65e-01
|
GOCC CENTROSOME
|
608
|
2.77e-01
|
7.51e-01
|
0.03750
|
-3.74e-02
|
-2.18e-03
|
1.15e-01
|
9.27e-01
|
GOBP INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY
|
50
|
8.89e-01
|
9.76e-01
|
0.03750
|
1.84e-02
|
3.26e-02
|
8.22e-01
|
6.90e-01
|
GOMF UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME ACTIVITY
|
36
|
9.33e-01
|
9.87e-01
|
0.03740
|
-3.29e-02
|
1.78e-02
|
7.32e-01
|
8.53e-01
|
GOBP BASE EXCISION REPAIR
|
42
|
9.24e-01
|
9.84e-01
|
0.03730
|
3.06e-02
|
-2.14e-02
|
7.32e-01
|
8.10e-01
|
GOBP SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION
|
22
|
9.58e-01
|
9.90e-01
|
0.03730
|
-1.54e-02
|
3.40e-02
|
9.00e-01
|
7.82e-01
|
GOBP EMBRYONIC HEART TUBE MORPHOGENESIS
|
70
|
8.78e-01
|
9.75e-01
|
0.03720
|
-2.26e-02
|
2.96e-02
|
7.44e-01
|
6.69e-01
|
GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER
|
54
|
8.87e-01
|
9.76e-01
|
0.03720
|
3.60e-02
|
9.32e-03
|
6.47e-01
|
9.06e-01
|
GOMF DEAMINASE ACTIVITY
|
33
|
9.33e-01
|
9.86e-01
|
0.03720
|
8.77e-04
|
3.72e-02
|
9.93e-01
|
7.12e-01
|
GOBP NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT
|
14
|
9.70e-01
|
9.93e-01
|
0.03720
|
-5.20e-03
|
-3.68e-02
|
9.73e-01
|
8.12e-01
|
GOBP RESPONSE TO ORGANIC CYCLIC COMPOUND
|
870
|
1.45e-01
|
6.29e-01
|
0.03700
|
-3.10e-02
|
-2.03e-02
|
1.21e-01
|
3.10e-01
|
GOBP POSITIVE REGULATION OF DNA METABOLIC PROCESS
|
286
|
5.20e-01
|
8.69e-01
|
0.03700
|
-3.04e-02
|
-2.10e-02
|
3.76e-01
|
5.42e-01
|
GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC
|
20
|
9.64e-01
|
9.92e-01
|
0.03700
|
-2.23e-02
|
2.95e-02
|
8.63e-01
|
8.19e-01
|
GOBP NEGATIVE REGULATION OF GENE EXPRESSION
|
1472
|
8.04e-02
|
5.29e-01
|
0.03700
|
-2.93e-02
|
2.26e-02
|
6.04e-02
|
1.47e-01
|
GOBP POSITIVE REGULATION OF LIPID LOCALIZATION
|
111
|
8.14e-01
|
9.59e-01
|
0.03690
|
-1.77e-02
|
3.24e-02
|
7.48e-01
|
5.56e-01
|
GOBP AMINO ACID TRANSMEMBRANE TRANSPORT
|
93
|
8.44e-01
|
9.66e-01
|
0.03690
|
-2.12e-02
|
3.02e-02
|
7.24e-01
|
6.15e-01
|
GOBP RESPONSE TO HORMONE
|
838
|
1.63e-01
|
6.48e-01
|
0.03690
|
-3.37e-02
|
-1.48e-02
|
9.72e-02
|
4.65e-01
|
GOBP CELL AGGREGATION
|
23
|
9.57e-01
|
9.90e-01
|
0.03680
|
-3.46e-02
|
1.26e-02
|
7.74e-01
|
9.17e-01
|
GOBP GLUCOSE IMPORT
|
75
|
8.72e-01
|
9.73e-01
|
0.03680
|
-2.15e-02
|
2.99e-02
|
7.47e-01
|
6.55e-01
|
GOBP PHASIC SMOOTH MUSCLE CONTRACTION
|
24
|
9.57e-01
|
9.90e-01
|
0.03680
|
-2.30e-02
|
2.87e-02
|
8.46e-01
|
8.07e-01
|
GOCC MICROBODY MEMBRANE
|
62
|
8.82e-01
|
9.75e-01
|
0.03680
|
-3.67e-02
|
2.03e-03
|
6.17e-01
|
9.78e-01
|
GOBP NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION
|
75
|
8.72e-01
|
9.73e-01
|
0.03670
|
-1.83e-02
|
3.18e-02
|
7.84e-01
|
6.34e-01
|
GOBP NEGATIVE REGULATION OF VIRAL PROCESS
|
90
|
8.17e-01
|
9.60e-01
|
0.03670
|
-3.24e-02
|
-1.71e-02
|
5.95e-01
|
7.79e-01
|
GOBP SENSORY PERCEPTION OF PAIN
|
76
|
8.72e-01
|
9.73e-01
|
0.03660
|
2.87e-02
|
-2.27e-02
|
6.65e-01
|
7.32e-01
|
GOBP RESPONSE TO INTERLEUKIN 7
|
12
|
9.77e-01
|
9.95e-01
|
0.03660
|
4.76e-03
|
-3.63e-02
|
9.77e-01
|
8.28e-01
|
GOBP HYALURONAN METABOLIC PROCESS
|
33
|
9.35e-01
|
9.87e-01
|
0.03660
|
-1.39e-03
|
-3.66e-02
|
9.89e-01
|
7.16e-01
|
GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS
|
15
|
9.73e-01
|
9.93e-01
|
0.03660
|
-3.12e-02
|
1.90e-02
|
8.34e-01
|
8.98e-01
|
GOBP RESPONSE TO TOXIC SUBSTANCE
|
248
|
5.73e-01
|
8.88e-01
|
0.03650
|
2.81e-02
|
2.34e-02
|
4.47e-01
|
5.26e-01
|
GOBP POSITIVE REGULATION OF REPRODUCTIVE PROCESS
|
83
|
8.59e-01
|
9.68e-01
|
0.03650
|
-1.51e-02
|
3.33e-02
|
8.13e-01
|
6.00e-01
|
GOBP POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS
|
141
|
7.72e-01
|
9.48e-01
|
0.03650
|
-3.35e-02
|
1.45e-02
|
4.92e-01
|
7.67e-01
|
GOCC SYNAPTONEMAL STRUCTURE
|
35
|
9.26e-01
|
9.85e-01
|
0.03650
|
-3.39e-02
|
-1.35e-02
|
7.29e-01
|
8.90e-01
|
GOMF HISTONE ACETYLTRANSFERASE BINDING
|
23
|
9.49e-01
|
9.90e-01
|
0.03650
|
2.47e-02
|
2.68e-02
|
8.38e-01
|
8.24e-01
|
GOBP QUINONE METABOLIC PROCESS
|
39
|
9.26e-01
|
9.85e-01
|
0.03640
|
3.50e-03
|
-3.63e-02
|
9.70e-01
|
6.95e-01
|
GOCC GERM CELL NUCLEUS
|
68
|
8.77e-01
|
9.75e-01
|
0.03640
|
5.45e-03
|
-3.60e-02
|
9.38e-01
|
6.08e-01
|
GOBP REGULATION OF MICROTUBULE DEPOLYMERIZATION
|
26
|
9.51e-01
|
9.90e-01
|
0.03620
|
-4.72e-03
|
3.59e-02
|
9.67e-01
|
7.51e-01
|
GOBP EAR DEVELOPMENT
|
218
|
6.36e-01
|
9.06e-01
|
0.03620
|
8.09e-03
|
3.53e-02
|
8.37e-01
|
3.70e-01
|
GOBP ALPHA BETA T CELL DIFFERENTIATION
|
119
|
7.94e-01
|
9.55e-01
|
0.03610
|
-3.35e-03
|
3.60e-02
|
9.50e-01
|
4.98e-01
|
GOBP NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION
|
140
|
7.75e-01
|
9.50e-01
|
0.03610
|
-3.40e-02
|
1.24e-02
|
4.88e-01
|
8.00e-01
|
GOBP ACTIVATION OF PROTEIN KINASE B ACTIVITY
|
25
|
9.52e-01
|
9.90e-01
|
0.03610
|
3.61e-02
|
-1.08e-03
|
7.55e-01
|
9.93e-01
|
GOBP CARNITINE METABOLIC PROCESS
|
11
|
9.81e-01
|
9.96e-01
|
0.03610
|
-2.59e-02
|
2.51e-02
|
8.82e-01
|
8.85e-01
|
GOBP NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS
|
48
|
9.17e-01
|
9.83e-01
|
0.03600
|
-1.35e-02
|
3.34e-02
|
8.71e-01
|
6.89e-01
|
GOBP REGULATION OF VACUOLE ORGANIZATION
|
53
|
8.97e-01
|
9.78e-01
|
0.03600
|
-7.02e-03
|
-3.53e-02
|
9.30e-01
|
6.57e-01
|
GOMF PROTEIN DIMERIZATION ACTIVITY
|
1019
|
1.86e-01
|
6.77e-01
|
0.03590
|
-2.69e-02
|
2.38e-02
|
1.46e-01
|
1.98e-01
|
GOBP PROTEIN MATURATION
|
513
|
3.52e-01
|
7.96e-01
|
0.03590
|
-9.43e-03
|
-3.47e-02
|
7.15e-01
|
1.79e-01
|
GOBP REGULATION OF LIPID TRANSPORT
|
153
|
7.49e-01
|
9.40e-01
|
0.03590
|
-3.56e-02
|
4.76e-03
|
4.47e-01
|
9.19e-01
|
GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION
|
483
|
4.41e-01
|
8.40e-01
|
0.03590
|
-2.17e-02
|
2.86e-02
|
4.15e-01
|
2.81e-01
|
GOBP REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION
|
40
|
9.19e-01
|
9.84e-01
|
0.03590
|
-3.36e-02
|
-1.27e-02
|
7.13e-01
|
8.90e-01
|
GOBP CELLULAR RESPONSE TO SALT STRESS
|
14
|
9.71e-01
|
9.93e-01
|
0.03590
|
3.31e-02
|
1.39e-02
|
8.30e-01
|
9.28e-01
|
GOBP HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES
|
51
|
9.12e-01
|
9.82e-01
|
0.03580
|
1.08e-02
|
-3.42e-02
|
8.94e-01
|
6.73e-01
|
GOBP RENAL TUBULE DEVELOPMENT
|
99
|
8.36e-01
|
9.64e-01
|
0.03580
|
-1.10e-02
|
3.41e-02
|
8.50e-01
|
5.58e-01
|
GOBP POSITIVE REGULATION OF BINDING
|
121
|
7.91e-01
|
9.54e-01
|
0.03570
|
-3.42e-04
|
-3.57e-02
|
9.95e-01
|
4.97e-01
|
GOBP NEGATIVE REGULATION OF TYPE II INTERFERON PRODUCTION
|
40
|
9.20e-01
|
9.84e-01
|
0.03570
|
-3.38e-02
|
-1.16e-02
|
7.11e-01
|
8.99e-01
|
GOBP RESPONSE TO ABIOTIC STIMULUS
|
1075
|
1.71e-01
|
6.58e-01
|
0.03570
|
-3.04e-02
|
1.87e-02
|
9.26e-02
|
2.99e-01
|
GOBP T CELL MEDIATED IMMUNITY
|
122
|
8.15e-01
|
9.59e-01
|
0.03550
|
2.30e-02
|
-2.71e-02
|
6.61e-01
|
6.06e-01
|
GOBP DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION
|
915
|
2.28e-01
|
7.16e-01
|
0.03550
|
-2.43e-02
|
2.59e-02
|
2.13e-01
|
1.85e-01
|
GOBP REGULATION OF DNA BIOSYNTHETIC PROCESS
|
117
|
7.85e-01
|
9.52e-01
|
0.03540
|
-3.26e-02
|
-1.39e-02
|
5.43e-01
|
7.95e-01
|
GOBP CELL PROJECTION ORGANIZATION
|
1543
|
8.33e-02
|
5.37e-01
|
0.03540
|
-1.44e-02
|
3.23e-02
|
3.46e-01
|
3.40e-02
|
GOBP NEURAL RETINA DEVELOPMENT
|
78
|
8.47e-01
|
9.66e-01
|
0.03530
|
-2.42e-02
|
-2.58e-02
|
7.12e-01
|
6.94e-01
|
GOBP AUTOPHAGOSOME ORGANIZATION
|
115
|
7.84e-01
|
9.52e-01
|
0.03530
|
-2.66e-02
|
-2.32e-02
|
6.22e-01
|
6.67e-01
|
GOBP REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS
|
38
|
9.38e-01
|
9.88e-01
|
0.03530
|
-3.00e-02
|
1.86e-02
|
7.49e-01
|
8.43e-01
|
GOBP POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN
|
65
|
8.72e-01
|
9.73e-01
|
0.03520
|
-2.18e-02
|
-2.76e-02
|
7.61e-01
|
7.00e-01
|
GOBP MEIOTIC CHROMOSOME SEGREGATION
|
89
|
8.62e-01
|
9.69e-01
|
0.03520
|
2.94e-02
|
-1.93e-02
|
6.31e-01
|
7.53e-01
|
GOBP AMIDE TRANSPORT
|
344
|
5.51e-01
|
8.80e-01
|
0.03520
|
-3.37e-02
|
9.89e-03
|
2.82e-01
|
7.53e-01
|
GOBP SNRNA TRANSCRIPTION BY RNA POLYMERASE III
|
8
|
9.85e-01
|
9.97e-01
|
0.03510
|
-3.94e-03
|
-3.49e-02
|
9.85e-01
|
8.64e-01
|
GOBP RESPONSE TO GONADOTROPIN
|
27
|
9.48e-01
|
9.90e-01
|
0.03510
|
-3.36e-02
|
-1.00e-02
|
7.63e-01
|
9.28e-01
|
GOBP REGULATION OF CATALYTIC ACTIVITY
|
1418
|
1.13e-01
|
5.91e-01
|
0.03500
|
-2.54e-02
|
2.42e-02
|
1.09e-01
|
1.27e-01
|
GOBP CATECHOLAMINE SECRETION
|
59
|
8.92e-01
|
9.76e-01
|
0.03500
|
5.87e-03
|
3.45e-02
|
9.38e-01
|
6.47e-01
|
GOBP REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE
|
48
|
9.25e-01
|
9.84e-01
|
0.03500
|
-2.33e-02
|
2.61e-02
|
7.80e-01
|
7.54e-01
|
GOMF AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY
|
80
|
8.73e-01
|
9.73e-01
|
0.03490
|
-1.21e-02
|
3.27e-02
|
8.52e-01
|
6.13e-01
|
GOBP REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION
|
129
|
7.72e-01
|
9.48e-01
|
0.03480
|
-1.47e-02
|
-3.15e-02
|
7.73e-01
|
5.36e-01
|
GOBP REGULATION OF MYELOID CELL DIFFERENTIATION
|
206
|
7.10e-01
|
9.26e-01
|
0.03480
|
-1.38e-02
|
3.19e-02
|
7.34e-01
|
4.29e-01
|
GOBP DETECTION OF ABIOTIC STIMULUS
|
133
|
7.97e-01
|
9.55e-01
|
0.03480
|
-9.74e-03
|
3.34e-02
|
8.46e-01
|
5.06e-01
|
GOBP LYMPHANGIOGENESIS
|
18
|
9.71e-01
|
9.93e-01
|
0.03480
|
-2.62e-02
|
2.28e-02
|
8.47e-01
|
8.67e-01
|
GOBP NEGATIVE REGULATION OF CYCLASE ACTIVITY
|
15
|
9.74e-01
|
9.94e-01
|
0.03470
|
-6.98e-03
|
3.40e-02
|
9.63e-01
|
8.20e-01
|
GOBP ACTION POTENTIAL
|
139
|
7.84e-01
|
9.52e-01
|
0.03470
|
3.42e-02
|
-5.71e-03
|
4.86e-01
|
9.07e-01
|
GOBP RNA STABILIZATION
|
66
|
8.96e-01
|
9.78e-01
|
0.03470
|
-3.16e-02
|
1.42e-02
|
6.57e-01
|
8.41e-01
|
GOBP GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS
|
23
|
9.56e-01
|
9.90e-01
|
0.03470
|
3.31e-02
|
1.04e-02
|
7.84e-01
|
9.32e-01
|
GOBP B CELL MEDIATED IMMUNITY
|
128
|
7.96e-01
|
9.55e-01
|
0.03450
|
1.42e-03
|
-3.45e-02
|
9.78e-01
|
5.00e-01
|
GOBP DIENCEPHALON DEVELOPMENT
|
73
|
8.83e-01
|
9.76e-01
|
0.03450
|
8.47e-03
|
-3.35e-02
|
9.00e-01
|
6.21e-01
|
GOBP INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY
|
31
|
9.40e-01
|
9.89e-01
|
0.03450
|
-1.59e-02
|
-3.06e-02
|
8.78e-01
|
7.68e-01
|
GOBP MITOCHONDRIAL TRANSPORT
|
181
|
6.98e-01
|
9.21e-01
|
0.03450
|
-2.97e-02
|
-1.75e-02
|
4.90e-01
|
6.85e-01
|
GOBP CELLULAR RESPONSE TO TOXIC SUBSTANCE
|
123
|
8.17e-01
|
9.60e-01
|
0.03440
|
-3.20e-02
|
1.27e-02
|
5.40e-01
|
8.08e-01
|
GOBP VITAMIN METABOLIC PROCESS
|
107
|
8.45e-01
|
9.66e-01
|
0.03440
|
2.61e-02
|
-2.24e-02
|
6.40e-01
|
6.90e-01
|
GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY
|
60
|
8.91e-01
|
9.76e-01
|
0.03430
|
-3.21e-02
|
-1.21e-02
|
6.67e-01
|
8.71e-01
|
GOBP SPERM MOTILITY
|
127
|
7.77e-01
|
9.50e-01
|
0.03430
|
1.97e-02
|
2.81e-02
|
7.01e-01
|
5.85e-01
|
GOBP PROTEIN K48 LINKED UBIQUITINATION
|
64
|
8.85e-01
|
9.76e-01
|
0.03420
|
3.23e-02
|
1.13e-02
|
6.55e-01
|
8.76e-01
|
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION
|
84
|
8.49e-01
|
9.66e-01
|
0.03420
|
2.99e-02
|
1.65e-02
|
6.35e-01
|
7.93e-01
|
GOCC SYNAPSE
|
1377
|
1.00e-01
|
5.68e-01
|
0.03420
|
5.61e-04
|
3.42e-02
|
9.72e-01
|
3.35e-02
|
GOBP PURKINJE MYOCYTE TO VENTRICULAR CARDIAC MUSCLE CELL COMMUNICATION
|
6
|
9.89e-01
|
9.98e-01
|
0.03410
|
3.27e-03
|
3.39e-02
|
9.89e-01
|
8.86e-01
|
GOMF MHC PROTEIN COMPLEX BINDING
|
34
|
9.35e-01
|
9.87e-01
|
0.03410
|
2.66e-02
|
2.13e-02
|
7.89e-01
|
8.30e-01
|
GOBP NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY
|
80
|
8.56e-01
|
9.68e-01
|
0.03410
|
1.69e-02
|
2.96e-02
|
7.94e-01
|
6.48e-01
|
GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II
|
1191
|
1.45e-01
|
6.29e-01
|
0.03400
|
-3.38e-02
|
3.59e-03
|
4.94e-02
|
8.35e-01
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON DIPHENOLS AND RELATED SUBSTANCES AS DONORS
|
8
|
9.84e-01
|
9.97e-01
|
0.03400
|
-2.33e-02
|
-2.47e-02
|
9.09e-01
|
9.04e-01
|
GOBP REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION
|
262
|
6.53e-01
|
9.08e-01
|
0.03400
|
-3.28e-02
|
8.92e-03
|
3.61e-01
|
8.04e-01
|
GOMF ZINC ION BINDING
|
775
|
3.07e-01
|
7.71e-01
|
0.03390
|
-3.01e-02
|
1.56e-02
|
1.54e-01
|
4.61e-01
|
GOBP CAMERA TYPE EYE MORPHOGENESIS
|
130
|
8.08e-01
|
9.59e-01
|
0.03390
|
-3.29e-02
|
7.99e-03
|
5.17e-01
|
8.75e-01
|
GOBP POSITIVE REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS
|
10
|
9.85e-01
|
9.97e-01
|
0.03390
|
-1.72e-02
|
2.92e-02
|
9.25e-01
|
8.73e-01
|
GOCC CYTOPLASMIC MICROTUBULE
|
96
|
8.42e-01
|
9.66e-01
|
0.03380
|
3.36e-02
|
4.02e-03
|
5.69e-01
|
9.46e-01
|
GOMF ACTININ BINDING
|
35
|
9.45e-01
|
9.90e-01
|
0.03380
|
-1.00e-02
|
3.23e-02
|
9.18e-01
|
7.41e-01
|
GOBP LYMPH VESSEL MORPHOGENESIS
|
23
|
9.65e-01
|
9.92e-01
|
0.03370
|
-1.57e-02
|
2.99e-02
|
8.97e-01
|
8.04e-01
|
GOBP SENSORY ORGAN DEVELOPMENT
|
576
|
4.06e-01
|
8.26e-01
|
0.03370
|
-1.03e-02
|
3.21e-02
|
6.72e-01
|
1.88e-01
|
GOBP REGULATION OF DNA METHYLATION
|
20
|
9.69e-01
|
9.93e-01
|
0.03370
|
-3.04e-02
|
1.46e-02
|
8.14e-01
|
9.10e-01
|
GOCC FIBRILLAR CENTER
|
144
|
7.94e-01
|
9.55e-01
|
0.03360
|
-9.62e-03
|
3.22e-02
|
8.42e-01
|
5.04e-01
|
GOBP NEGATIVE REGULATION OF TISSUE REMODELING
|
21
|
9.68e-01
|
9.92e-01
|
0.03360
|
-3.04e-02
|
1.45e-02
|
8.10e-01
|
9.08e-01
|
GOBP CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION
|
29
|
9.57e-01
|
9.90e-01
|
0.03340
|
-2.94e-02
|
1.60e-02
|
7.84e-01
|
8.82e-01
|
GOBP NEURON DEVELOPMENT
|
1090
|
2.13e-01
|
7.01e-01
|
0.03340
|
-2.53e-02
|
2.18e-02
|
1.59e-01
|
2.24e-01
|
GOCC MRNA EDITING COMPLEX
|
15
|
9.78e-01
|
9.95e-01
|
0.03340
|
1.81e-02
|
-2.81e-02
|
9.04e-01
|
8.51e-01
|
GOBP CELLULAR RESPONSE TO STEROID HORMONE STIMULUS
|
197
|
7.00e-01
|
9.22e-01
|
0.03330
|
-1.20e-02
|
-3.11e-02
|
7.72e-01
|
4.51e-01
|
GOCC POSTSYNAPTIC DENSITY MEMBRANE
|
94
|
8.37e-01
|
9.64e-01
|
0.03330
|
-2.43e-02
|
-2.28e-02
|
6.84e-01
|
7.02e-01
|
GOBP CELL MATURATION
|
191
|
6.99e-01
|
9.21e-01
|
0.03330
|
-2.25e-02
|
-2.46e-02
|
5.92e-01
|
5.58e-01
|
GOBP GLYCOSAMINOGLYCAN CATABOLIC PROCESS
|
27
|
9.57e-01
|
9.90e-01
|
0.03330
|
-6.17e-03
|
3.27e-02
|
9.56e-01
|
7.69e-01
|
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE
|
256
|
6.20e-01
|
9.00e-01
|
0.03330
|
-2.40e-02
|
-2.30e-02
|
5.08e-01
|
5.26e-01
|
GOBP REGULATION OF APPETITE
|
19
|
9.71e-01
|
9.93e-01
|
0.03320
|
-3.11e-02
|
1.17e-02
|
8.15e-01
|
9.29e-01
|
GOBP MULTI MULTICELLULAR ORGANISM PROCESS
|
200
|
7.37e-01
|
9.35e-01
|
0.03320
|
-3.11e-02
|
1.15e-02
|
4.48e-01
|
7.79e-01
|
GOBP NEGATIVE REGULATION OF T CELL PROLIFERATION
|
67
|
8.97e-01
|
9.78e-01
|
0.03310
|
-3.30e-02
|
3.14e-03
|
6.41e-01
|
9.65e-01
|
GOMF GLUTATHIONE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
5
|
9.91e-01
|
9.99e-01
|
0.03300
|
2.90e-02
|
1.59e-02
|
9.11e-01
|
9.51e-01
|
GOMF KINASE ACTIVATOR ACTIVITY
|
127
|
8.32e-01
|
9.64e-01
|
0.03300
|
-2.38e-02
|
2.29e-02
|
6.43e-01
|
6.56e-01
|
GOBP NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY
|
169
|
7.32e-01
|
9.33e-01
|
0.03300
|
-2.20e-02
|
-2.46e-02
|
6.21e-01
|
5.81e-01
|
GOBP MEIOTIC CELL CYCLE
|
274
|
6.34e-01
|
9.05e-01
|
0.03300
|
-3.30e-02
|
-1.87e-03
|
3.48e-01
|
9.58e-01
|
GOBP REGULATION OF MITOTIC NUCLEAR DIVISION
|
118
|
8.15e-01
|
9.59e-01
|
0.03300
|
-3.23e-02
|
-6.86e-03
|
5.45e-01
|
8.98e-01
|
GOBP NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS
|
158
|
7.60e-01
|
9.44e-01
|
0.03300
|
-3.20e-02
|
-8.07e-03
|
4.88e-01
|
8.61e-01
|
GOBP BLOOD VESSEL ENDOTHELIAL CELL DIFFERENTIATION
|
14
|
9.78e-01
|
9.95e-01
|
0.03300
|
3.29e-02
|
-2.89e-03
|
8.31e-01
|
9.85e-01
|
GOBP POLYSACCHARIDE BIOSYNTHETIC PROCESS
|
64
|
8.94e-01
|
9.77e-01
|
0.03290
|
-3.19e-02
|
-8.42e-03
|
6.59e-01
|
9.07e-01
|
GOBP TRANSMEMBRANE TRANSPORT
|
1481
|
9.66e-02
|
5.61e-01
|
0.03290
|
3.33e-03
|
3.28e-02
|
8.30e-01
|
3.49e-02
|
GOBP CYTOKINE MEDIATED SIGNALING PATHWAY
|
485
|
4.41e-01
|
8.40e-01
|
0.03290
|
6.78e-03
|
3.22e-02
|
7.98e-01
|
2.25e-01
|
GOBP NEGATIVE REGULATION OF BONE REMODELING
|
18
|
9.68e-01
|
9.92e-01
|
0.03290
|
-2.64e-02
|
-1.96e-02
|
8.46e-01
|
8.85e-01
|
GOBP NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION
|
557
|
4.23e-01
|
8.34e-01
|
0.03280
|
-3.25e-02
|
4.74e-03
|
1.90e-01
|
8.48e-01
|
GOBP MUSCLE CELL DIFFERENTIATION
|
406
|
5.24e-01
|
8.70e-01
|
0.03280
|
-1.10e-03
|
3.28e-02
|
9.70e-01
|
2.57e-01
|
GOBP PROTEIN HOMOOLIGOMERIZATION
|
188
|
7.56e-01
|
9.42e-01
|
0.03280
|
-1.17e-02
|
3.06e-02
|
7.82e-01
|
4.69e-01
|
GOBP SENSORY PERCEPTION OF LIGHT STIMULUS
|
207
|
7.02e-01
|
9.23e-01
|
0.03270
|
-3.16e-02
|
-8.35e-03
|
4.33e-01
|
8.36e-01
|
GOBP ORGANELLE ASSEMBLY
|
957
|
2.00e-01
|
6.90e-01
|
0.03260
|
-3.00e-02
|
-1.26e-02
|
1.15e-01
|
5.08e-01
|
GOBP EMBRYONIC DIGESTIVE TRACT DEVELOPMENT
|
33
|
9.54e-01
|
9.90e-01
|
0.03260
|
-2.38e-02
|
2.22e-02
|
8.13e-01
|
8.25e-01
|
GOBP REGULATION OF PROGRAMMED CELL DEATH
|
1460
|
1.33e-01
|
6.14e-01
|
0.03260
|
-3.03e-02
|
1.20e-02
|
5.28e-02
|
4.44e-01
|
GOBP SYNAPTIC VESICLE MATURATION
|
23
|
9.61e-01
|
9.91e-01
|
0.03250
|
3.05e-02
|
1.11e-02
|
8.00e-01
|
9.27e-01
|
GOBP SKELETAL MUSCLE CELL PROLIFERATION
|
24
|
9.58e-01
|
9.90e-01
|
0.03250
|
-2.46e-02
|
-2.11e-02
|
8.34e-01
|
8.58e-01
|
GOCC 9PLUS2 MOTILE CILIUM
|
166
|
7.46e-01
|
9.38e-01
|
0.03240
|
2.69e-02
|
1.82e-02
|
5.50e-01
|
6.86e-01
|
GOBP T CELL PROLIFERATION
|
202
|
7.25e-01
|
9.30e-01
|
0.03240
|
3.76e-04
|
3.24e-02
|
9.93e-01
|
4.27e-01
|
GOBP RESPONSE TO LIPID
|
889
|
2.28e-01
|
7.15e-01
|
0.03230
|
-1.39e-02
|
-2.91e-02
|
4.83e-01
|
1.41e-01
|
GOBP MALE GENITALIA DEVELOPMENT
|
23
|
9.61e-01
|
9.91e-01
|
0.03220
|
2.75e-02
|
1.68e-02
|
8.20e-01
|
8.89e-01
|
GOBP PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS
|
16
|
9.73e-01
|
9.93e-01
|
0.03220
|
-1.38e-02
|
-2.90e-02
|
9.24e-01
|
8.41e-01
|
GOBP REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS
|
113
|
8.54e-01
|
9.68e-01
|
0.03210
|
-2.80e-02
|
1.56e-02
|
6.07e-01
|
7.74e-01
|
GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT
|
13
|
9.82e-01
|
9.96e-01
|
0.03200
|
-2.50e-02
|
2.00e-02
|
8.76e-01
|
9.01e-01
|
GOMF PHOSPHATIDYLSERINE BINDING
|
60
|
9.21e-01
|
9.84e-01
|
0.03200
|
2.54e-02
|
-1.94e-02
|
7.33e-01
|
7.95e-01
|
GOBP MITOCHONDRIAL PROTEIN PROCESSING
|
13
|
9.78e-01
|
9.95e-01
|
0.03200
|
-2.64e-02
|
-1.80e-02
|
8.69e-01
|
9.11e-01
|
GOBP MESODERM DEVELOPMENT
|
124
|
8.32e-01
|
9.64e-01
|
0.03190
|
-5.37e-03
|
3.15e-02
|
9.18e-01
|
5.45e-01
|
GOMF PEPTIDOGLYCAN MURALYTIC ACTIVITY
|
13
|
9.79e-01
|
9.95e-01
|
0.03190
|
-1.02e-02
|
-3.02e-02
|
9.49e-01
|
8.50e-01
|
GOBP IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE
|
56
|
9.25e-01
|
9.84e-01
|
0.03190
|
-2.87e-02
|
1.40e-02
|
7.11e-01
|
8.56e-01
|
GOBP RESPONSE TO OXYGEN CONTAINING COMPOUND
|
1733
|
1.08e-01
|
5.81e-01
|
0.03190
|
-2.84e-02
|
1.44e-02
|
4.90e-02
|
3.19e-01
|
GOBP RRNA METHYLATION
|
23
|
9.62e-01
|
9.91e-01
|
0.03180
|
2.89e-02
|
1.33e-02
|
8.10e-01
|
9.12e-01
|
GOMF CARBON OXYGEN LYASE ACTIVITY
|
73
|
8.87e-01
|
9.76e-01
|
0.03180
|
-1.05e-02
|
-3.00e-02
|
8.77e-01
|
6.58e-01
|
GOBP POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION
|
210
|
7.50e-01
|
9.40e-01
|
0.03180
|
-2.81e-02
|
1.48e-02
|
4.83e-01
|
7.12e-01
|
GOBP ENTERIC NERVOUS SYSTEM DEVELOPMENT
|
12
|
9.84e-01
|
9.97e-01
|
0.03170
|
-2.37e-02
|
2.11e-02
|
8.87e-01
|
8.99e-01
|
GOMF RRNA ADENINE METHYLTRANSFERASE ACTIVITY
|
8
|
9.88e-01
|
9.98e-01
|
0.03170
|
2.48e-03
|
3.16e-02
|
9.90e-01
|
8.77e-01
|
GOBP OXALATE TRANSPORT
|
12
|
9.80e-01
|
9.96e-01
|
0.03170
|
1.81e-02
|
2.60e-02
|
9.13e-01
|
8.76e-01
|
GOBP POSTREPLICATION REPAIR
|
33
|
9.53e-01
|
9.90e-01
|
0.03160
|
-3.13e-02
|
4.74e-03
|
7.56e-01
|
9.62e-01
|
GOMF PHOSPHATIDYLINOSITOL 4 PHOSPHATE BINDING
|
29
|
9.53e-01
|
9.90e-01
|
0.03160
|
1.39e-02
|
2.84e-02
|
8.97e-01
|
7.92e-01
|
GOBP CELLULAR RESPONSE TO HORMONE STIMULUS
|
586
|
4.09e-01
|
8.27e-01
|
0.03160
|
-3.13e-02
|
-4.29e-03
|
1.96e-01
|
8.59e-01
|
GOCC EXTRINSIC COMPONENT OF PLASMA MEMBRANE
|
122
|
8.50e-01
|
9.67e-01
|
0.03150
|
-2.59e-02
|
1.79e-02
|
6.21e-01
|
7.33e-01
|
GOBP PROTEIN DEPOLYMERIZATION
|
112
|
8.42e-01
|
9.66e-01
|
0.03140
|
3.71e-03
|
3.12e-02
|
9.46e-01
|
5.68e-01
|
GOBP EMBRYONIC HEART TUBE DEVELOPMENT
|
83
|
8.96e-01
|
9.78e-01
|
0.03140
|
-1.74e-02
|
2.61e-02
|
7.84e-01
|
6.81e-01
|
GOBP SMOOTHENED SIGNALING PATHWAY
|
140
|
8.01e-01
|
9.57e-01
|
0.03140
|
9.32e-03
|
2.99e-02
|
8.49e-01
|
5.41e-01
|
GOBP NEGATIVE REGULATION OF PEPTIDASE ACTIVITY
|
125
|
8.19e-01
|
9.60e-01
|
0.03130
|
-2.97e-02
|
-1.01e-02
|
5.67e-01
|
8.46e-01
|
GOBP REGULATION OF EMBRYONIC DEVELOPMENT
|
89
|
8.72e-01
|
9.73e-01
|
0.03130
|
-3.10e-02
|
-4.26e-03
|
6.13e-01
|
9.45e-01
|
GOMF NEUROPEPTIDE BINDING
|
30
|
9.56e-01
|
9.90e-01
|
0.03130
|
-3.12e-02
|
-2.32e-03
|
7.68e-01
|
9.82e-01
|
GOBP RESPONSE TO TUMOR NECROSIS FACTOR
|
246
|
6.69e-01
|
9.11e-01
|
0.03110
|
-2.26e-02
|
-2.14e-02
|
5.41e-01
|
5.64e-01
|
GOBP SISTER CHROMATID COHESION
|
53
|
9.17e-01
|
9.83e-01
|
0.03110
|
-2.56e-02
|
-1.78e-02
|
7.48e-01
|
8.23e-01
|
GOBP PROTEIN COMPLEX OLIGOMERIZATION
|
249
|
7.27e-01
|
9.31e-01
|
0.03110
|
-2.23e-02
|
2.16e-02
|
5.44e-01
|
5.56e-01
|
GOBP POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION
|
61
|
9.06e-01
|
9.81e-01
|
0.03100
|
-2.54e-02
|
-1.77e-02
|
7.31e-01
|
8.11e-01
|
GOBP INTRACELLULAR RECEPTOR SIGNALING PATHWAY
|
334
|
6.01e-01
|
8.96e-01
|
0.03100
|
-3.01e-02
|
-7.41e-03
|
3.44e-01
|
8.16e-01
|
GOBP T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE
|
117
|
8.50e-01
|
9.67e-01
|
0.03100
|
-5.44e-03
|
3.05e-02
|
9.19e-01
|
5.69e-01
|
GOBP POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS
|
592
|
4.27e-01
|
8.36e-01
|
0.03100
|
-3.09e-02
|
-1.74e-03
|
1.99e-01
|
9.42e-01
|
GOBP LACTATE TRANSMEMBRANE TRANSPORT
|
7
|
9.91e-01
|
9.99e-01
|
0.03090
|
-2.53e-02
|
1.78e-02
|
9.08e-01
|
9.35e-01
|
GOBP SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR
|
168
|
8.08e-01
|
9.59e-01
|
0.03090
|
2.26e-02
|
-2.10e-02
|
6.13e-01
|
6.38e-01
|
GOBP NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION
|
690
|
4.22e-01
|
8.34e-01
|
0.03080
|
-2.64e-02
|
1.60e-02
|
2.38e-01
|
4.75e-01
|
GOBP VENTRAL MIDLINE DEVELOPMENT
|
6
|
9.92e-01
|
9.99e-01
|
0.03080
|
1.52e-02
|
-2.68e-02
|
9.49e-01
|
9.10e-01
|
GOMF ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY
|
34
|
9.58e-01
|
9.90e-01
|
0.03070
|
-2.11e-02
|
2.24e-02
|
8.31e-01
|
8.21e-01
|
GOBP HOMOLOGOUS RECOMBINATION
|
65
|
9.19e-01
|
9.84e-01
|
0.03060
|
2.81e-02
|
-1.21e-02
|
6.96e-01
|
8.66e-01
|
GOBP RESPONSE TO FOLLICLE STIMULATING HORMONE
|
15
|
9.78e-01
|
9.95e-01
|
0.03050
|
-3.02e-02
|
-4.91e-03
|
8.40e-01
|
9.74e-01
|
GOBP EXTRACELLULAR EXOSOME ASSEMBLY
|
7
|
9.91e-01
|
9.99e-01
|
0.03050
|
1.90e-02
|
-2.39e-02
|
9.30e-01
|
9.13e-01
|
GOBP RESPONSE TO RADIATION
|
409
|
5.63e-01
|
8.84e-01
|
0.03040
|
-3.04e-02
|
-1.67e-03
|
2.91e-01
|
9.54e-01
|
GOCC CAJAL BODY
|
76
|
8.92e-01
|
9.76e-01
|
0.03040
|
2.91e-02
|
8.95e-03
|
6.61e-01
|
8.93e-01
|
GOBP MAMMARY GLAND MORPHOGENESIS
|
42
|
9.48e-01
|
9.90e-01
|
0.03040
|
-2.73e-02
|
1.33e-02
|
7.59e-01
|
8.82e-01
|
GOBP REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION
|
53
|
9.24e-01
|
9.84e-01
|
0.03030
|
2.91e-02
|
8.53e-03
|
7.14e-01
|
9.14e-01
|
GOCC PRESYNAPSE
|
539
|
4.69e-01
|
8.51e-01
|
0.03030
|
3.80e-03
|
3.01e-02
|
8.80e-01
|
2.32e-01
|
GOBP REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS
|
28
|
9.58e-01
|
9.90e-01
|
0.03030
|
2.59e-02
|
1.56e-02
|
8.12e-01
|
8.86e-01
|
GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION
|
50
|
9.39e-01
|
9.88e-01
|
0.03010
|
-2.82e-02
|
1.04e-02
|
7.30e-01
|
8.99e-01
|
GOBP POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION
|
167
|
8.17e-01
|
9.60e-01
|
0.03010
|
-1.77e-02
|
2.43e-02
|
6.93e-01
|
5.88e-01
|
GOBP REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS
|
72
|
9.09e-01
|
9.81e-01
|
0.03010
|
-3.67e-03
|
2.98e-02
|
9.57e-01
|
6.61e-01
|
GOBP INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS
|
74
|
9.01e-01
|
9.79e-01
|
0.03010
|
2.98e-02
|
4.01e-03
|
6.58e-01
|
9.52e-01
|
GOBP NEGATIVE REGULATION OF LIPID METABOLIC PROCESS
|
107
|
8.50e-01
|
9.67e-01
|
0.03000
|
2.45e-02
|
1.74e-02
|
6.62e-01
|
7.56e-01
|
GOBP REGULATION OF ANIMAL ORGAN FORMATION
|
27
|
9.64e-01
|
9.92e-01
|
0.02990
|
1.31e-03
|
2.99e-02
|
9.91e-01
|
7.88e-01
|
GOBP NEUROGENESIS
|
1647
|
1.63e-01
|
6.48e-01
|
0.02980
|
-2.36e-02
|
1.82e-02
|
1.11e-01
|
2.19e-01
|
GOBP POST EMBRYONIC ANIMAL ORGAN MORPHOGENESIS
|
11
|
9.85e-01
|
9.97e-01
|
0.02980
|
2.91e-02
|
6.21e-03
|
8.67e-01
|
9.72e-01
|
GOBP REGULATION OF MEMBRANE POTENTIAL
|
423
|
5.47e-01
|
8.78e-01
|
0.02970
|
1.07e-02
|
2.77e-02
|
7.06e-01
|
3.28e-01
|
GOBP AMINO SUGAR METABOLIC PROCESS
|
40
|
9.52e-01
|
9.90e-01
|
0.02950
|
9.05e-03
|
-2.81e-02
|
9.21e-01
|
7.59e-01
|
GOBP REGULATION OF B CELL APOPTOTIC PROCESS
|
20
|
9.76e-01
|
9.95e-01
|
0.02950
|
-9.97e-03
|
2.78e-02
|
9.38e-01
|
8.30e-01
|
GOBP ENDOPLASMIC RETICULUM ORGANIZATION
|
94
|
8.70e-01
|
9.73e-01
|
0.02950
|
-2.27e-02
|
-1.89e-02
|
7.04e-01
|
7.52e-01
|
GOBP NEGATIVE REGULATION OF MRNA PROCESSING
|
22
|
9.68e-01
|
9.92e-01
|
0.02950
|
-1.84e-02
|
-2.30e-02
|
8.81e-01
|
8.52e-01
|
GOBP REGULATION OF TRANSFERASE ACTIVITY
|
671
|
4.42e-01
|
8.40e-01
|
0.02940
|
-2.88e-02
|
6.14e-03
|
2.03e-01
|
7.86e-01
|
GOBP CELLULAR HYPEROSMOTIC RESPONSE
|
19
|
9.74e-01
|
9.94e-01
|
0.02930
|
-6.59e-03
|
-2.85e-02
|
9.60e-01
|
8.30e-01
|
GOBP POSITIVE REGULATION OF CELL PROLIFERATION IN BONE MARROW
|
6
|
9.92e-01
|
9.99e-01
|
0.02930
|
-2.92e-02
|
-2.27e-03
|
9.01e-01
|
9.92e-01
|
GOCC TRANSPORTER COMPLEX
|
392
|
6.20e-01
|
9.00e-01
|
0.02930
|
2.86e-02
|
-5.95e-03
|
3.30e-01
|
8.40e-01
|
GOBP DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS
|
28
|
9.67e-01
|
9.92e-01
|
0.02920
|
9.29e-03
|
-2.77e-02
|
9.32e-01
|
8.00e-01
|
GOMF LIPOPROTEIN LIPASE ACTIVITY
|
9
|
9.88e-01
|
9.98e-01
|
0.02920
|
-2.87e-02
|
-5.46e-03
|
8.82e-01
|
9.77e-01
|
GOBP APOPTOTIC PROCESS
|
1847
|
1.36e-01
|
6.18e-01
|
0.02920
|
-2.67e-02
|
1.17e-02
|
5.73e-02
|
4.03e-01
|
GOCC PRESYNAPTIC ACTIVE ZONE MEMBRANE
|
29
|
9.67e-01
|
9.92e-01
|
0.02910
|
-2.55e-02
|
1.41e-02
|
8.12e-01
|
8.95e-01
|
GOBP CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER
|
32
|
9.55e-01
|
9.90e-01
|
0.02910
|
2.45e-02
|
1.57e-02
|
8.10e-01
|
8.78e-01
|
GOBP REGULATION OF FEVER GENERATION
|
9
|
9.89e-01
|
9.98e-01
|
0.02900
|
-7.47e-03
|
2.81e-02
|
9.69e-01
|
8.84e-01
|
GOMF C4 DICARBOXYLATE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
15
|
9.82e-01
|
9.96e-01
|
0.02900
|
-2.85e-02
|
5.55e-03
|
8.49e-01
|
9.70e-01
|
GOBP EMBRYONIC HEMOPOIESIS
|
23
|
9.69e-01
|
9.93e-01
|
0.02900
|
-1.07e-02
|
-2.69e-02
|
9.29e-01
|
8.23e-01
|
GOCC CENTRIOLE
|
151
|
8.45e-01
|
9.66e-01
|
0.02900
|
-2.20e-02
|
1.89e-02
|
6.41e-01
|
6.89e-01
|
GOBP PHOSPHATE ION TRANSPORT
|
28
|
9.61e-01
|
9.91e-01
|
0.02890
|
2.32e-02
|
1.73e-02
|
8.32e-01
|
8.74e-01
|
GOMF ANTIOXIDANT ACTIVITY
|
80
|
9.15e-01
|
9.83e-01
|
0.02880
|
-1.78e-02
|
2.27e-02
|
7.83e-01
|
7.26e-01
|
GOMF SEQUENCE SPECIFIC DNA BINDING
|
1563
|
1.36e-01
|
6.18e-01
|
0.02880
|
-2.67e-02
|
-1.08e-02
|
7.78e-02
|
4.74e-01
|
GOBP MRNA CATABOLIC PROCESS
|
295
|
6.74e-01
|
9.13e-01
|
0.02880
|
-2.72e-02
|
-9.43e-03
|
4.21e-01
|
7.80e-01
|
GOBP SODIUM ION HOMEOSTASIS
|
46
|
9.42e-01
|
9.89e-01
|
0.02880
|
2.86e-02
|
3.33e-03
|
7.37e-01
|
9.69e-01
|
GOBP REGULATION OF CHOLESTEROL STORAGE
|
19
|
9.74e-01
|
9.94e-01
|
0.02880
|
-1.34e-02
|
-2.55e-02
|
9.20e-01
|
8.48e-01
|
GOBP REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY
|
28
|
9.66e-01
|
9.92e-01
|
0.02880
|
-2.87e-02
|
1.16e-03
|
7.92e-01
|
9.92e-01
|
GOBP HEAD DEVELOPMENT
|
721
|
4.44e-01
|
8.40e-01
|
0.02870
|
-2.72e-02
|
9.41e-03
|
2.14e-01
|
6.67e-01
|
GOCC CYTOPLASMIC REGION
|
277
|
6.99e-01
|
9.21e-01
|
0.02870
|
2.81e-02
|
5.58e-03
|
4.21e-01
|
8.73e-01
|
GOBP NEGATIVE REGULATION OF GLUCOSE IMPORT
|
16
|
9.81e-01
|
9.96e-01
|
0.02870
|
2.86e-02
|
-1.81e-03
|
8.43e-01
|
9.90e-01
|
GOBP REGULATION OF PROTEIN LIPIDATION
|
11
|
9.87e-01
|
9.98e-01
|
0.02860
|
2.86e-02
|
-1.17e-03
|
8.70e-01
|
9.95e-01
|
GOCC NEURON TO NEURON SYNAPSE
|
345
|
6.40e-01
|
9.06e-01
|
0.02860
|
6.67e-03
|
2.78e-02
|
8.32e-01
|
3.74e-01
|
GOCC SUPRAMOLECULAR COMPLEX
|
1326
|
2.03e-01
|
6.93e-01
|
0.02860
|
3.21e-03
|
2.84e-02
|
8.44e-01
|
8.24e-02
|
GOBP NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION
|
14
|
9.85e-01
|
9.97e-01
|
0.02850
|
1.94e-02
|
-2.10e-02
|
9.00e-01
|
8.92e-01
|
GOBP RNA CATABOLIC PROCESS
|
349
|
6.39e-01
|
9.06e-01
|
0.02850
|
-2.77e-02
|
-6.64e-03
|
3.74e-01
|
8.31e-01
|
GOBP POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION
|
97
|
8.98e-01
|
9.78e-01
|
0.02840
|
1.30e-02
|
-2.53e-02
|
8.25e-01
|
6.67e-01
|
GOBP MONOCARBOXYLIC ACID TRANSPORT
|
174
|
7.89e-01
|
9.54e-01
|
0.02840
|
1.80e-02
|
2.20e-02
|
6.82e-01
|
6.17e-01
|
GOBP POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY
|
40
|
9.57e-01
|
9.90e-01
|
0.02820
|
-1.32e-02
|
2.49e-02
|
8.85e-01
|
7.85e-01
|
GOBP EXTRACELLULAR MATRIX DISASSEMBLY
|
60
|
9.30e-01
|
9.86e-01
|
0.02810
|
7.46e-04
|
2.81e-02
|
9.92e-01
|
7.06e-01
|
GOBP NEGATIVE REGULATION OF PROGRAMMED CELL DEATH
|
877
|
3.91e-01
|
8.21e-01
|
0.02810
|
-2.67e-02
|
8.65e-03
|
1.79e-01
|
6.64e-01
|
GOBP CD40 SIGNALING PATHWAY
|
15
|
9.83e-01
|
9.97e-01
|
0.02800
|
2.71e-02
|
-6.89e-03
|
8.56e-01
|
9.63e-01
|
GOBP STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE
|
226
|
7.73e-01
|
9.49e-01
|
0.02800
|
-2.77e-02
|
4.11e-03
|
4.74e-01
|
9.15e-01
|
GOBP POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT
|
42
|
9.48e-01
|
9.90e-01
|
0.02800
|
-2.64e-02
|
-9.04e-03
|
7.67e-01
|
9.19e-01
|
GOBP NATURAL KILLER CELL MEDIATED IMMUNITY
|
77
|
9.20e-01
|
9.84e-01
|
0.02790
|
2.58e-02
|
-1.05e-02
|
6.95e-01
|
8.74e-01
|
GOBP REGULATION OF MEMBRANE LIPID DISTRIBUTION
|
60
|
9.27e-01
|
9.85e-01
|
0.02770
|
-2.54e-02
|
-1.11e-02
|
7.33e-01
|
8.82e-01
|
GOBP EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS
|
26
|
9.73e-01
|
9.93e-01
|
0.02770
|
-2.46e-02
|
1.27e-02
|
8.28e-01
|
9.11e-01
|
GOBP SPECIFICATION OF ANIMAL ORGAN IDENTITY
|
35
|
9.63e-01
|
9.92e-01
|
0.02770
|
2.61e-02
|
-9.33e-03
|
7.90e-01
|
9.24e-01
|
GOBP REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT
|
76
|
9.10e-01
|
9.82e-01
|
0.02760
|
-2.62e-02
|
-8.76e-03
|
6.93e-01
|
8.95e-01
|
GOBP RESPONSE TO ACID CHEMICAL
|
131
|
8.48e-01
|
9.66e-01
|
0.02760
|
2.52e-02
|
1.14e-02
|
6.19e-01
|
8.22e-01
|
GOMF TRIGLYCERIDE LIPASE ACTIVITY
|
24
|
9.76e-01
|
9.95e-01
|
0.02760
|
-1.49e-02
|
2.32e-02
|
8.99e-01
|
8.44e-01
|
GOBP CYCLIC NUCLEOTIDE METABOLIC PROCESS
|
40
|
9.58e-01
|
9.90e-01
|
0.02750
|
-9.06e-03
|
2.60e-02
|
9.21e-01
|
7.76e-01
|
GOBP POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION
|
21
|
9.78e-01
|
9.95e-01
|
0.02750
|
-2.54e-02
|
1.06e-02
|
8.41e-01
|
9.33e-01
|
GOBP CELL KILLING
|
210
|
8.07e-01
|
9.59e-01
|
0.02740
|
-1.29e-02
|
2.42e-02
|
7.47e-01
|
5.46e-01
|
GOBP MELANIN METABOLIC PROCESS
|
24
|
9.71e-01
|
9.93e-01
|
0.02740
|
1.11e-02
|
2.50e-02
|
9.25e-01
|
8.32e-01
|
GOMF U2 SNRNA BINDING
|
6
|
9.93e-01
|
9.99e-01
|
0.02720
|
-6.53e-03
|
-2.65e-02
|
9.78e-01
|
9.11e-01
|
GOBP REGULATION OF JNK CASCADE
|
128
|
8.60e-01
|
9.68e-01
|
0.02710
|
2.59e-02
|
7.87e-03
|
6.13e-01
|
8.78e-01
|
GOBP OOCYTE MATURATION
|
33
|
9.60e-01
|
9.91e-01
|
0.02700
|
-1.34e-02
|
-2.34e-02
|
8.94e-01
|
8.16e-01
|
GOBP SPECIFICATION OF SYMMETRY
|
136
|
8.45e-01
|
9.66e-01
|
0.02700
|
1.76e-02
|
2.05e-02
|
7.23e-01
|
6.80e-01
|
GOBP POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY
|
36
|
9.58e-01
|
9.90e-01
|
0.02690
|
2.45e-02
|
1.13e-02
|
8.00e-01
|
9.07e-01
|
GOBP NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS
|
44
|
9.54e-01
|
9.90e-01
|
0.02680
|
-1.59e-03
|
2.68e-02
|
9.85e-01
|
7.59e-01
|
GOBP GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS
|
75
|
9.13e-01
|
9.82e-01
|
0.02680
|
-1.47e-02
|
-2.24e-02
|
8.26e-01
|
7.37e-01
|
GOBP T CELL CHEMOTAXIS
|
25
|
9.76e-01
|
9.95e-01
|
0.02680
|
2.42e-02
|
-1.13e-02
|
8.34e-01
|
9.22e-01
|
GOBP NEGATIVE REGULATION OF CELLULAR EXTRAVASATION
|
9
|
9.91e-01
|
9.99e-01
|
0.02650
|
9.73e-03
|
-2.47e-02
|
9.60e-01
|
8.98e-01
|
GOMF SOLUTE POTASSIUM ANTIPORTER ACTIVITY
|
17
|
9.82e-01
|
9.96e-01
|
0.02650
|
-2.65e-02
|
-9.90e-04
|
8.50e-01
|
9.94e-01
|
GOMF AMIDE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
44
|
9.57e-01
|
9.90e-01
|
0.02640
|
2.56e-02
|
-6.59e-03
|
7.69e-01
|
9.40e-01
|
GOBP REGULATION OF BEHAVIOR
|
73
|
9.30e-01
|
9.86e-01
|
0.02640
|
7.17e-03
|
-2.54e-02
|
9.16e-01
|
7.07e-01
|
GOBP REGULATION OF L GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE
|
8
|
9.91e-01
|
9.99e-01
|
0.02640
|
2.50e-02
|
8.51e-03
|
9.03e-01
|
9.67e-01
|
GOBP EYE MORPHOGENESIS
|
159
|
8.41e-01
|
9.66e-01
|
0.02640
|
4.35e-03
|
2.60e-02
|
9.25e-01
|
5.72e-01
|
GOBP EPHRIN RECEPTOR SIGNALING PATHWAY
|
49
|
9.45e-01
|
9.90e-01
|
0.02640
|
2.42e-02
|
1.05e-02
|
7.70e-01
|
8.98e-01
|
GOMF EXTRACELLULAR MATRIX BINDING
|
54
|
9.49e-01
|
9.90e-01
|
0.02630
|
-2.50e-02
|
8.16e-03
|
7.51e-01
|
9.17e-01
|
GOBP ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY
|
152
|
8.46e-01
|
9.66e-01
|
0.02630
|
2.57e-02
|
5.67e-03
|
5.85e-01
|
9.04e-01
|
GOCC AXON CYTOPLASM
|
60
|
9.34e-01
|
9.87e-01
|
0.02630
|
9.13e-03
|
2.46e-02
|
9.03e-01
|
7.41e-01
|
GOBP REPRODUCTION
|
1411
|
2.52e-01
|
7.31e-01
|
0.02620
|
-2.62e-02
|
-1.59e-04
|
9.97e-02
|
9.92e-01
|
GOBP RESPONSE TO BACTERIUM
|
657
|
4.86e-01
|
8.56e-01
|
0.02610
|
-1.06e-02
|
-2.39e-02
|
6.43e-01
|
2.97e-01
|
GOBP REGULATION OF ACTIN FILAMENT BASED MOVEMENT
|
39
|
9.65e-01
|
9.92e-01
|
0.02600
|
1.95e-02
|
-1.72e-02
|
8.33e-01
|
8.53e-01
|
GOMF METALLOPEPTIDASE ACTIVITY
|
179
|
8.17e-01
|
9.60e-01
|
0.02590
|
-1.65e-02
|
-1.99e-02
|
7.03e-01
|
6.47e-01
|
GOBP BEHAVIOR
|
629
|
5.73e-01
|
8.88e-01
|
0.02580
|
-2.26e-02
|
1.24e-02
|
3.32e-01
|
5.94e-01
|
GOBP REGULATION OF PROTEIN ACETYLATION
|
38
|
9.60e-01
|
9.91e-01
|
0.02580
|
-2.52e-02
|
-5.46e-03
|
7.88e-01
|
9.54e-01
|
GOBP ADENYLATE CYCLASE MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY
|
240
|
7.70e-01
|
9.48e-01
|
0.02580
|
2.40e-02
|
9.51e-03
|
5.22e-01
|
8.00e-01
|
GOBP NEGATIVE REGULATION OF OSTEOBLAST PROLIFERATION
|
15
|
9.87e-01
|
9.98e-01
|
0.02570
|
-2.12e-02
|
1.46e-02
|
8.87e-01
|
9.22e-01
|
GOBP GENERATION OF NEURONS
|
1420
|
3.05e-01
|
7.70e-01
|
0.02570
|
-2.11e-02
|
1.46e-02
|
1.82e-01
|
3.55e-01
|
GOBP EPITHELIAL CELL PROLIFERATION
|
468
|
6.42e-01
|
9.07e-01
|
0.02570
|
-4.17e-03
|
2.54e-02
|
8.77e-01
|
3.47e-01
|
GOBP REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY
|
93
|
9.22e-01
|
9.84e-01
|
0.02560
|
1.96e-02
|
-1.65e-02
|
7.44e-01
|
7.83e-01
|
GOCC RNA POLYMERASE III COMPLEX
|
18
|
9.81e-01
|
9.96e-01
|
0.02550
|
2.16e-02
|
1.35e-02
|
8.74e-01
|
9.21e-01
|
GOBP JNK CASCADE
|
155
|
8.44e-01
|
9.66e-01
|
0.02540
|
2.02e-02
|
1.55e-02
|
6.64e-01
|
7.40e-01
|
GOBP MEGAKARYOCYTE DIFFERENTIATION
|
61
|
9.39e-01
|
9.89e-01
|
0.02540
|
2.50e-02
|
4.76e-03
|
7.36e-01
|
9.49e-01
|
GOBP REGULATION OF MRNA METABOLIC PROCESS
|
339
|
7.36e-01
|
9.34e-01
|
0.02540
|
-2.44e-02
|
6.92e-03
|
4.39e-01
|
8.27e-01
|
GOBP ORGANIC HYDROXY COMPOUND TRANSPORT
|
301
|
7.73e-01
|
9.49e-01
|
0.02540
|
-1.48e-02
|
2.06e-02
|
6.59e-01
|
5.38e-01
|
GOBP VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION
|
13
|
9.87e-01
|
9.98e-01
|
0.02520
|
-5.37e-03
|
-2.47e-02
|
9.73e-01
|
8.78e-01
|
GOBP L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT
|
65
|
9.37e-01
|
9.88e-01
|
0.02510
|
5.75e-03
|
2.44e-02
|
9.36e-01
|
7.34e-01
|
GOBP REGULATION OF NUCLEAR DIVISION
|
146
|
8.58e-01
|
9.68e-01
|
0.02510
|
-2.14e-02
|
-1.31e-02
|
6.55e-01
|
7.85e-01
|
GOBP REGULATION OF REPRODUCTIVE PROCESS
|
200
|
8.26e-01
|
9.62e-01
|
0.02500
|
2.49e-02
|
1.55e-03
|
5.43e-01
|
9.70e-01
|
GOCC SYNAPTIC MEMBRANE
|
368
|
7.33e-01
|
9.33e-01
|
0.02480
|
-9.06e-03
|
2.31e-02
|
7.65e-01
|
4.47e-01
|
GOCC POSTSYNAPTIC SPECIALIZATION
|
331
|
7.65e-01
|
9.45e-01
|
0.02480
|
-1.71e-02
|
1.79e-02
|
5.93e-01
|
5.75e-01
|
GOBP REGULATION OF MEMBRANE PERMEABILITY
|
72
|
9.42e-01
|
9.89e-01
|
0.02480
|
-1.35e-02
|
2.08e-02
|
8.43e-01
|
7.61e-01
|
GOBP REGULATION OF IMMUNE SYSTEM PROCESS
|
1453
|
3.18e-01
|
7.77e-01
|
0.02460
|
-9.52e-03
|
2.27e-02
|
5.44e-01
|
1.47e-01
|
GOBP NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS
|
18
|
9.84e-01
|
9.97e-01
|
0.02460
|
2.45e-02
|
-1.78e-03
|
8.57e-01
|
9.90e-01
|
GOBP REGULATION OF ISOTYPE SWITCHING
|
37
|
9.66e-01
|
9.92e-01
|
0.02460
|
3.50e-03
|
2.43e-02
|
9.71e-01
|
7.98e-01
|
GOCC COPII VESICLE COAT
|
16
|
9.84e-01
|
9.97e-01
|
0.02460
|
-1.05e-02
|
-2.22e-02
|
9.42e-01
|
8.78e-01
|
GOBP NEGATIVE REGULATION OF DNA BINDING
|
33
|
9.68e-01
|
9.92e-01
|
0.02450
|
9.09e-03
|
2.28e-02
|
9.28e-01
|
8.21e-01
|
GOCC PRESYNAPTIC MEMBRANE
|
158
|
8.60e-01
|
9.69e-01
|
0.02450
|
2.40e-02
|
5.11e-03
|
6.03e-01
|
9.12e-01
|
GOMF GDP PHOSPHATASE ACTIVITY
|
10
|
9.90e-01
|
9.99e-01
|
0.02450
|
-1.55e-02
|
-1.90e-02
|
9.32e-01
|
9.17e-01
|
GOBP MALE SEX DIFFERENTIATION
|
163
|
8.57e-01
|
9.68e-01
|
0.02450
|
4.93e-03
|
2.40e-02
|
9.13e-01
|
5.98e-01
|
GOBP REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
55
|
9.50e-01
|
9.90e-01
|
0.02450
|
2.43e-02
|
2.88e-03
|
7.55e-01
|
9.71e-01
|
GOCC EARLY ENDOSOME MEMBRANE
|
183
|
8.46e-01
|
9.66e-01
|
0.02440
|
1.51e-03
|
2.44e-02
|
9.72e-01
|
5.69e-01
|
GOBP NEGATIVE REGULATION OF HYDROLASE ACTIVITY
|
202
|
8.16e-01
|
9.60e-01
|
0.02440
|
1.66e-02
|
1.79e-02
|
6.85e-01
|
6.61e-01
|
GOBP FOREBRAIN DEVELOPMENT
|
390
|
7.35e-01
|
9.34e-01
|
0.02440
|
2.06e-02
|
-1.29e-02
|
4.84e-01
|
6.61e-01
|
GOBP DNA INTEGRATION
|
8
|
9.92e-01
|
9.99e-01
|
0.02440
|
2.19e-02
|
1.06e-02
|
9.14e-01
|
9.59e-01
|
GOBP NEGATIVE REGULATION OF ANOIKIS
|
18
|
9.82e-01
|
9.96e-01
|
0.02430
|
2.19e-02
|
1.06e-02
|
8.72e-01
|
9.38e-01
|
GOBP NEURAL TUBE DEVELOPMENT
|
160
|
8.65e-01
|
9.70e-01
|
0.02420
|
3.08e-03
|
2.40e-02
|
9.46e-01
|
6.01e-01
|
GOBP RESPONSE TO PROGESTERONE
|
40
|
9.66e-01
|
9.92e-01
|
0.02400
|
-2.39e-02
|
2.64e-03
|
7.94e-01
|
9.77e-01
|
GOBP FOREBRAIN NEURON DIFFERENTIATION
|
42
|
9.62e-01
|
9.91e-01
|
0.02400
|
-5.25e-03
|
-2.34e-02
|
9.53e-01
|
7.93e-01
|
GOBP REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT
|
83
|
9.31e-01
|
9.86e-01
|
0.02400
|
2.39e-02
|
-1.59e-03
|
7.07e-01
|
9.80e-01
|
GOMF BETA TUBULIN BINDING
|
35
|
9.67e-01
|
9.92e-01
|
0.02390
|
-1.37e-02
|
-1.96e-02
|
8.88e-01
|
8.41e-01
|
GOBP LIPID HOMEOSTASIS
|
170
|
8.66e-01
|
9.70e-01
|
0.02390
|
-1.43e-03
|
2.38e-02
|
9.74e-01
|
5.92e-01
|
GOBP NEGATIVE REGULATION OF AMIDE METABOLIC PROCESS
|
329
|
7.67e-01
|
9.46e-01
|
0.02390
|
5.64e-03
|
-2.32e-02
|
8.60e-01
|
4.69e-01
|
GOMF TRANSMITTER GATED CHANNEL ACTIVITY
|
57
|
9.54e-01
|
9.90e-01
|
0.02380
|
2.36e-02
|
-2.90e-03
|
7.58e-01
|
9.70e-01
|
GOBP MEIOSIS I CELL CYCLE PROCESS
|
131
|
8.84e-01
|
9.76e-01
|
0.02370
|
2.04e-02
|
1.20e-02
|
6.87e-01
|
8.12e-01
|
GOMF CIS REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING
|
1140
|
3.68e-01
|
8.08e-01
|
0.02360
|
-2.16e-02
|
-9.60e-03
|
2.19e-01
|
5.85e-01
|
GOMF PHOSPHOLIPASE A2 ACTIVITY
|
34
|
9.70e-01
|
9.93e-01
|
0.02350
|
-2.27e-02
|
-6.17e-03
|
8.19e-01
|
9.50e-01
|
GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY
|
62
|
9.49e-01
|
9.90e-01
|
0.02340
|
2.34e-02
|
9.33e-04
|
7.50e-01
|
9.90e-01
|
GOMF DEOXYNUCLEOSIDE KINASE ACTIVITY
|
5
|
9.96e-01
|
1.00e+00
|
0.02340
|
3.24e-03
|
-2.31e-02
|
9.90e-01
|
9.29e-01
|
GOBP REGULATION OF LIPOPROTEIN METABOLIC PROCESS
|
17
|
9.85e-01
|
9.97e-01
|
0.02330
|
1.09e-02
|
2.06e-02
|
9.38e-01
|
8.83e-01
|
GOBP CELLULAR RESPONSE TO HEAT
|
62
|
9.56e-01
|
9.90e-01
|
0.02330
|
-1.96e-02
|
1.27e-02
|
7.90e-01
|
8.63e-01
|
GOBP BRAIN MORPHOGENESIS
|
37
|
9.68e-01
|
9.92e-01
|
0.02320
|
-2.15e-02
|
-8.69e-03
|
8.21e-01
|
9.27e-01
|
GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS
|
46
|
9.65e-01
|
9.92e-01
|
0.02320
|
2.25e-02
|
-5.46e-03
|
7.91e-01
|
9.49e-01
|
GOBP POSITIVE REGULATION OF CELL ACTIVATION
|
376
|
7.18e-01
|
9.29e-01
|
0.02310
|
2.05e-02
|
1.08e-02
|
4.96e-01
|
7.18e-01
|
GOBP REGULATION OF STEM CELL DIFFERENTIATION
|
78
|
9.44e-01
|
9.90e-01
|
0.02310
|
-9.11e-03
|
2.12e-02
|
8.89e-01
|
7.46e-01
|
GOCC POLYMERIC CYTOSKELETAL FIBER
|
737
|
5.51e-01
|
8.80e-01
|
0.02300
|
3.35e-03
|
2.28e-02
|
8.77e-01
|
2.92e-01
|
GOBP NEGATIVE REGULATION OF AMINE METABOLIC PROCESS
|
6
|
9.95e-01
|
1.00e+00
|
0.02300
|
-2.28e-02
|
-3.32e-03
|
9.23e-01
|
9.89e-01
|
GOBP REGULATION OF BLOOD PRESSURE
|
175
|
8.61e-01
|
9.69e-01
|
0.02300
|
-2.16e-02
|
-7.83e-03
|
6.22e-01
|
8.58e-01
|
GOBP POSITIVE REGULATION OF CHOLESTEROL EFFLUX
|
27
|
9.77e-01
|
9.95e-01
|
0.02290
|
-7.08e-03
|
-2.18e-02
|
9.49e-01
|
8.45e-01
|
GOBP REPRODUCTIVE SYSTEM DEVELOPMENT
|
289
|
8.09e-01
|
9.59e-01
|
0.02260
|
-3.76e-03
|
2.23e-02
|
9.12e-01
|
5.15e-01
|
GOBP REGULATION OF EPITHELIAL CELL PROLIFERATION
|
395
|
7.17e-01
|
9.28e-01
|
0.02250
|
1.30e-02
|
1.83e-02
|
6.57e-01
|
5.32e-01
|
GOBP TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY
|
105
|
9.14e-01
|
9.83e-01
|
0.02240
|
-1.68e-02
|
-1.48e-02
|
7.66e-01
|
7.93e-01
|
GOBP DEFENSE RESPONSE TO BACTERIUM
|
292
|
7.99e-01
|
9.56e-01
|
0.02200
|
-2.14e-02
|
-5.21e-03
|
5.29e-01
|
8.78e-01
|
GOBP NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT
|
56
|
9.61e-01
|
9.91e-01
|
0.02190
|
1.74e-03
|
-2.18e-02
|
9.82e-01
|
7.78e-01
|
GOBP HORMONE CATABOLIC PROCESS
|
11
|
9.93e-01
|
9.99e-01
|
0.02180
|
-2.09e-02
|
6.09e-03
|
9.04e-01
|
9.72e-01
|
GOBP AXONAL TRANSPORT
|
62
|
9.53e-01
|
9.90e-01
|
0.02180
|
2.05e-02
|
7.45e-03
|
7.80e-01
|
9.19e-01
|
GOBP OVARIAN FOLLICLE DEVELOPMENT
|
54
|
9.66e-01
|
9.92e-01
|
0.02170
|
-1.85e-02
|
1.13e-02
|
8.14e-01
|
8.86e-01
|
GOBP REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS
|
38
|
9.70e-01
|
9.93e-01
|
0.02160
|
1.34e-02
|
1.70e-02
|
8.87e-01
|
8.56e-01
|
GOBP CHLORIDE TRANSPORT
|
116
|
9.14e-01
|
9.82e-01
|
0.02160
|
1.06e-02
|
1.88e-02
|
8.44e-01
|
7.26e-01
|
GOBP REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY
|
35
|
9.78e-01
|
9.95e-01
|
0.02160
|
-1.97e-02
|
8.89e-03
|
8.41e-01
|
9.28e-01
|
GOBP FEEDING BEHAVIOR
|
102
|
9.32e-01
|
9.86e-01
|
0.02160
|
1.15e-03
|
-2.15e-02
|
9.84e-01
|
7.07e-01
|
GOBP ACUTE PHASE RESPONSE
|
46
|
9.66e-01
|
9.92e-01
|
0.02150
|
-6.03e-03
|
-2.07e-02
|
9.44e-01
|
8.08e-01
|
GOBP ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS
|
295
|
8.34e-01
|
9.64e-01
|
0.02150
|
1.20e-02
|
-1.78e-02
|
7.24e-01
|
5.98e-01
|
GOBP ENERGY HOMEOSTASIS
|
76
|
9.51e-01
|
9.90e-01
|
0.02140
|
-4.83e-03
|
2.08e-02
|
9.42e-01
|
7.54e-01
|
GOBP INORGANIC ANION TRANSMEMBRANE TRANSPORT
|
125
|
9.19e-01
|
9.84e-01
|
0.02120
|
-1.26e-03
|
2.12e-02
|
9.81e-01
|
6.82e-01
|
GOCC ENDOPLASMIC RETICULUM QUALITY CONTROL COMPARTMENT
|
15
|
9.89e-01
|
9.98e-01
|
0.02120
|
1.66e-02
|
1.31e-02
|
9.11e-01
|
9.30e-01
|
GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY
|
69
|
9.59e-01
|
9.90e-01
|
0.02110
|
1.02e-02
|
-1.85e-02
|
8.84e-01
|
7.90e-01
|
GOBP REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS
|
46
|
9.71e-01
|
9.93e-01
|
0.02110
|
-3.76e-03
|
2.07e-02
|
9.65e-01
|
8.08e-01
|
GOBP PROTEIN TARGETING TO MEMBRANE
|
118
|
9.33e-01
|
9.87e-01
|
0.02090
|
-1.56e-02
|
1.40e-02
|
7.70e-01
|
7.93e-01
|
GOBP RIBONUCLEOTIDE CATABOLIC PROCESS
|
48
|
9.72e-01
|
9.93e-01
|
0.02090
|
1.31e-02
|
-1.63e-02
|
8.75e-01
|
8.45e-01
|
GOBP NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION
|
14
|
9.91e-01
|
9.99e-01
|
0.02040
|
-1.30e-04
|
-2.04e-02
|
9.99e-01
|
8.95e-01
|
GOMF CARBOXYPEPTIDASE ACTIVITY
|
45
|
9.70e-01
|
9.93e-01
|
0.02040
|
1.95e-02
|
6.00e-03
|
8.21e-01
|
9.45e-01
|
GOBP AXO DENDRITIC TRANSPORT
|
74
|
9.56e-01
|
9.90e-01
|
0.02030
|
2.94e-03
|
-2.01e-02
|
9.65e-01
|
7.65e-01
|
GOCC CILIUM
|
704
|
6.78e-01
|
9.14e-01
|
0.02030
|
-1.85e-02
|
8.40e-03
|
4.03e-01
|
7.04e-01
|
GOMF CALCIUM DEPENDENT PROTEIN BINDING
|
77
|
9.48e-01
|
9.90e-01
|
0.02030
|
1.10e-02
|
1.71e-02
|
8.68e-01
|
7.96e-01
|
GOBP NUCLEAR MRNA SURVEILLANCE
|
10
|
9.95e-01
|
1.00e+00
|
0.01990
|
-1.77e-02
|
9.19e-03
|
9.23e-01
|
9.60e-01
|
GOBP RESPONSE TO NUTRIENT
|
146
|
9.15e-01
|
9.83e-01
|
0.01990
|
-1.37e-03
|
-1.99e-02
|
9.77e-01
|
6.79e-01
|
GOMF NUCLEAR RECEPTOR BINDING
|
132
|
9.27e-01
|
9.85e-01
|
0.01990
|
-2.91e-03
|
1.97e-02
|
9.54e-01
|
6.96e-01
|
GOBP NEGATIVE REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY
|
6
|
9.97e-01
|
1.00e+00
|
0.01990
|
-1.85e-02
|
7.26e-03
|
9.37e-01
|
9.75e-01
|
GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY
|
18
|
9.89e-01
|
9.98e-01
|
0.01980
|
1.92e-02
|
4.87e-03
|
8.88e-01
|
9.71e-01
|
GOBP NEGATIVE REGULATION OF CATALYTIC ACTIVITY
|
460
|
7.50e-01
|
9.40e-01
|
0.01980
|
-1.88e-02
|
-6.12e-03
|
4.89e-01
|
8.22e-01
|
GOBP PATTERN SPECIFICATION PROCESS
|
456
|
7.81e-01
|
9.52e-01
|
0.01980
|
-1.88e-02
|
5.95e-03
|
4.90e-01
|
8.28e-01
|
GOBP POSITIVE REGULATION OF CHROMATIN BINDING
|
9
|
9.95e-01
|
1.00e+00
|
0.01970
|
6.92e-03
|
-1.85e-02
|
9.71e-01
|
9.24e-01
|
GOBP REGULATION OF B CELL MEDIATED IMMUNITY
|
59
|
9.63e-01
|
9.91e-01
|
0.01970
|
1.79e-02
|
8.23e-03
|
8.12e-01
|
9.13e-01
|
GOBP RESPONSE TO ELECTRICAL STIMULUS
|
44
|
9.76e-01
|
9.95e-01
|
0.01960
|
-6.22e-03
|
1.86e-02
|
9.43e-01
|
8.31e-01
|
GOBP NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS
|
500
|
7.59e-01
|
9.44e-01
|
0.01960
|
-1.94e-02
|
2.78e-03
|
4.58e-01
|
9.15e-01
|
GOBP PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES
|
19
|
9.88e-01
|
9.98e-01
|
0.01950
|
-6.71e-03
|
-1.84e-02
|
9.60e-01
|
8.90e-01
|
GOBP COGNITION
|
303
|
8.47e-01
|
9.66e-01
|
0.01940
|
-2.68e-03
|
1.92e-02
|
9.36e-01
|
5.65e-01
|
GOMF CYTOSKELETAL MOTOR ACTIVITY
|
111
|
9.43e-01
|
9.89e-01
|
0.01930
|
1.84e-02
|
-5.85e-03
|
7.37e-01
|
9.15e-01
|
GOBP NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY
|
36
|
9.81e-01
|
9.96e-01
|
0.01930
|
-5.76e-03
|
1.85e-02
|
9.52e-01
|
8.48e-01
|
GOMF HISTONE H4K20 MONOMETHYLTRANSFERASE ACTIVITY
|
6
|
9.97e-01
|
1.00e+00
|
0.01920
|
3.23e-03
|
-1.89e-02
|
9.89e-01
|
9.36e-01
|
GOMF L GLUTAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
8
|
9.95e-01
|
1.00e+00
|
0.01920
|
4.78e-03
|
1.86e-02
|
9.81e-01
|
9.28e-01
|
GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION
|
33
|
9.84e-01
|
9.97e-01
|
0.01920
|
-1.53e-02
|
1.15e-02
|
8.79e-01
|
9.09e-01
|
GOBP CELLULAR RESPONSE TO LIPID
|
588
|
7.02e-01
|
9.22e-01
|
0.01910
|
-1.59e-02
|
-1.07e-02
|
5.11e-01
|
6.58e-01
|
GOMF INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
145
|
9.32e-01
|
9.86e-01
|
0.01910
|
-1.11e-02
|
1.56e-02
|
8.18e-01
|
7.46e-01
|
GOBP PROTON TRANSMEMBRANE TRANSPORT
|
141
|
9.22e-01
|
9.84e-01
|
0.01910
|
3.93e-03
|
1.86e-02
|
9.36e-01
|
7.02e-01
|
GOBP NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY
|
56
|
9.71e-01
|
9.93e-01
|
0.01900
|
2.46e-03
|
-1.89e-02
|
9.75e-01
|
8.07e-01
|
GOBP NEGATIVE REGULATION OF MRNA METABOLIC PROCESS
|
90
|
9.56e-01
|
9.90e-01
|
0.01900
|
-1.73e-02
|
7.74e-03
|
7.77e-01
|
8.99e-01
|
GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS
|
118
|
9.42e-01
|
9.89e-01
|
0.01890
|
1.81e-02
|
-5.67e-03
|
7.34e-01
|
9.15e-01
|
GOBP POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS
|
1006
|
5.72e-01
|
8.87e-01
|
0.01890
|
5.61e-03
|
1.81e-02
|
7.63e-01
|
3.32e-01
|
GOBP PROTEASOME ASSEMBLY
|
11
|
9.95e-01
|
1.00e+00
|
0.01870
|
-1.52e-02
|
1.08e-02
|
9.30e-01
|
9.50e-01
|
GOBP RESPONSE TO METAL ION
|
343
|
8.54e-01
|
9.68e-01
|
0.01870
|
-1.36e-02
|
1.27e-02
|
6.64e-01
|
6.85e-01
|
GOBP MESONEPHROS DEVELOPMENT
|
99
|
9.53e-01
|
9.90e-01
|
0.01850
|
-4.03e-03
|
1.80e-02
|
9.45e-01
|
7.57e-01
|
GOBP PURINE DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS
|
10
|
9.95e-01
|
1.00e+00
|
0.01840
|
1.71e-02
|
-6.95e-03
|
9.25e-01
|
9.70e-01
|
GOBP REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS
|
219
|
8.89e-01
|
9.76e-01
|
0.01840
|
-1.79e-02
|
-4.09e-03
|
6.47e-01
|
9.17e-01
|
GOBP REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS
|
44
|
9.79e-01
|
9.95e-01
|
0.01840
|
5.01e-03
|
-1.77e-02
|
9.54e-01
|
8.39e-01
|
GOMF GLUTATHIONE TRANSFERASE ACTIVITY
|
24
|
9.86e-01
|
9.98e-01
|
0.01830
|
1.47e-02
|
1.09e-02
|
9.01e-01
|
9.26e-01
|
GOBP REGULATION OF LEUKOCYTE PROLIFERATION
|
254
|
8.83e-01
|
9.76e-01
|
0.01830
|
1.82e-02
|
-2.24e-03
|
6.18e-01
|
9.51e-01
|
GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY
|
42
|
9.79e-01
|
9.95e-01
|
0.01830
|
7.70e-04
|
-1.83e-02
|
9.93e-01
|
8.38e-01
|
GOCC TRANSPORT VESICLE
|
408
|
8.38e-01
|
9.64e-01
|
0.01810
|
1.46e-02
|
-1.08e-02
|
6.14e-01
|
7.09e-01
|
GOBP EXTRACELLULAR TRANSPORT
|
45
|
9.79e-01
|
9.95e-01
|
0.01810
|
-3.14e-03
|
1.78e-02
|
9.71e-01
|
8.36e-01
|
GOMF ADENYLATE CYCLASE REGULATOR ACTIVITY
|
8
|
9.96e-01
|
1.00e+00
|
0.01810
|
3.28e-03
|
1.78e-02
|
9.87e-01
|
9.31e-01
|
GOBP DENDRITIC CELL DIFFERENTIATION
|
44
|
9.76e-01
|
9.95e-01
|
0.01800
|
9.98e-03
|
1.50e-02
|
9.09e-01
|
8.64e-01
|
GOBP GLUTATHIONE TRANSMEMBRANE TRANSPORT
|
7
|
9.97e-01
|
1.00e+00
|
0.01790
|
1.18e-02
|
-1.35e-02
|
9.57e-01
|
9.51e-01
|
GOBP NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION
|
18
|
9.92e-01
|
9.99e-01
|
0.01780
|
-1.45e-02
|
1.04e-02
|
9.15e-01
|
9.39e-01
|
GOBP LACTATE METABOLIC PROCESS
|
18
|
9.90e-01
|
9.99e-01
|
0.01780
|
1.46e-02
|
1.02e-02
|
9.15e-01
|
9.41e-01
|
GOBP AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS
|
16
|
9.93e-01
|
9.99e-01
|
0.01750
|
-1.63e-02
|
6.53e-03
|
9.10e-01
|
9.64e-01
|
GOCC SNARE COMPLEX
|
47
|
9.76e-01
|
9.95e-01
|
0.01750
|
-1.58e-02
|
-7.48e-03
|
8.51e-01
|
9.29e-01
|
GOMF ICOSANOID RECEPTOR ACTIVITY
|
14
|
9.93e-01
|
9.99e-01
|
0.01750
|
4.66e-03
|
1.68e-02
|
9.76e-01
|
9.13e-01
|
GOMF SINGLE STRANDED DNA 5 3 DNA EXONUCLEASE ACTIVITY
|
5
|
9.98e-01
|
1.00e+00
|
0.01750
|
-8.91e-04
|
-1.75e-02
|
9.97e-01
|
9.46e-01
|
GOBP NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION
|
60
|
9.72e-01
|
9.93e-01
|
0.01750
|
-2.00e-03
|
-1.73e-02
|
9.79e-01
|
8.16e-01
|
GOBP MONOATOMIC ANION TRANSPORT
|
161
|
9.22e-01
|
9.84e-01
|
0.01740
|
-8.01e-03
|
-1.55e-02
|
8.61e-01
|
7.34e-01
|
GOCC TRANSPORT VESICLE MEMBRANE
|
224
|
8.96e-01
|
9.78e-01
|
0.01740
|
-1.66e-02
|
-5.19e-03
|
6.68e-01
|
8.93e-01
|
GOBP NEGATIVE REGULATION OF RNA CATABOLIC PROCESS
|
78
|
9.68e-01
|
9.93e-01
|
0.01730
|
-1.57e-02
|
7.31e-03
|
8.11e-01
|
9.11e-01
|
GOBP REGULATION OF STEROID METABOLIC PROCESS
|
101
|
9.51e-01
|
9.90e-01
|
0.01720
|
9.66e-03
|
1.42e-02
|
8.67e-01
|
8.05e-01
|
GOBP IMMUNOLOGICAL MEMORY FORMATION PROCESS
|
14
|
9.94e-01
|
1.00e+00
|
0.01710
|
5.20e-05
|
-1.71e-02
|
1.00e+00
|
9.12e-01
|
GOBP MICROTUBULE BASED MOVEMENT
|
401
|
8.22e-01
|
9.61e-01
|
0.01710
|
-1.30e-02
|
-1.11e-02
|
6.54e-01
|
7.04e-01
|
GOBP ACTIVATION OF IMMUNE RESPONSE
|
496
|
7.97e-01
|
9.55e-01
|
0.01690
|
1.61e-02
|
5.31e-03
|
5.39e-01
|
8.39e-01
|
GOMF TRANSPORTER ACTIVITY
|
1173
|
6.35e-01
|
9.05e-01
|
0.01690
|
-4.47e-03
|
1.63e-02
|
7.96e-01
|
3.46e-01
|
GOBP RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES
|
15
|
9.94e-01
|
1.00e+00
|
0.01690
|
1.57e-02
|
-6.06e-03
|
9.16e-01
|
9.68e-01
|
GOBP REGULATION OF HORMONE LEVELS
|
520
|
7.88e-01
|
9.54e-01
|
0.01690
|
-1.55e-02
|
-6.51e-03
|
5.44e-01
|
8.00e-01
|
GOBP REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE
|
11
|
9.95e-01
|
1.00e+00
|
0.01680
|
-2.65e-03
|
-1.66e-02
|
9.88e-01
|
9.24e-01
|
GOBP REGULATION OF MRNA CATABOLIC PROCESS
|
240
|
9.10e-01
|
9.82e-01
|
0.01670
|
-5.21e-03
|
1.59e-02
|
8.89e-01
|
6.71e-01
|
GOMF MIRNA INHIBITOR ACTIVITY VIA BASE PAIRING
|
8
|
9.97e-01
|
1.00e+00
|
0.01670
|
-1.57e-02
|
5.49e-03
|
9.39e-01
|
9.79e-01
|
GOMF GUANYL NUCLEOTIDE BINDING
|
369
|
8.61e-01
|
9.69e-01
|
0.01660
|
9.67e-04
|
-1.65e-02
|
9.75e-01
|
5.85e-01
|
GOBP ACTIN MYOSIN FILAMENT SLIDING
|
16
|
9.94e-01
|
1.00e+00
|
0.01630
|
1.51e-02
|
-6.07e-03
|
9.17e-01
|
9.66e-01
|
GOBP SPERM CAPACITATION
|
30
|
9.87e-01
|
9.98e-01
|
0.01610
|
4.22e-03
|
1.56e-02
|
9.68e-01
|
8.83e-01
|
GOMF MRNA BINDING
|
544
|
8.29e-01
|
9.62e-01
|
0.01610
|
7.98e-03
|
-1.40e-02
|
7.50e-01
|
5.76e-01
|
GOBP POSITIVE REGULATION OF IMMUNE RESPONSE
|
692
|
7.43e-01
|
9.38e-01
|
0.01610
|
1.09e-02
|
1.19e-02
|
6.25e-01
|
5.95e-01
|
GOBP RETICULOPHAGY
|
18
|
9.92e-01
|
9.99e-01
|
0.01600
|
9.20e-03
|
1.31e-02
|
9.46e-01
|
9.23e-01
|
GOCC MEMBRANE PROTEIN COMPLEX
|
1148
|
6.37e-01
|
9.06e-01
|
0.01600
|
-1.54e-02
|
-4.41e-03
|
3.80e-01
|
8.01e-01
|
GOBP AXIS ELONGATION
|
28
|
9.90e-01
|
9.99e-01
|
0.01590
|
1.34e-02
|
-8.59e-03
|
9.02e-01
|
9.37e-01
|
GOBP POST TRANSCRIPTIONAL REGULATION OF GENE EXPRESSION
|
967
|
7.08e-01
|
9.25e-01
|
0.01580
|
-7.89e-04
|
1.57e-02
|
9.67e-01
|
4.07e-01
|
GOBP POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM
|
12
|
9.95e-01
|
1.00e+00
|
0.01570
|
2.92e-03
|
1.54e-02
|
9.86e-01
|
9.26e-01
|
GOBP RESPONSE TO INORGANIC SUBSTANCE
|
507
|
8.47e-01
|
9.66e-01
|
0.01570
|
-1.37e-02
|
7.74e-03
|
5.98e-01
|
7.66e-01
|
GOBP RESPONSE TO LUTEINIZING HORMONE
|
7
|
9.98e-01
|
1.00e+00
|
0.01560
|
-1.21e-02
|
9.91e-03
|
9.56e-01
|
9.64e-01
|
GOBP NEURAL PRECURSOR CELL PROLIFERATION
|
163
|
9.49e-01
|
9.90e-01
|
0.01560
|
1.17e-02
|
-1.03e-02
|
7.97e-01
|
8.20e-01
|
GOMF SULFUR COMPOUND BINDING
|
262
|
9.11e-01
|
9.82e-01
|
0.01550
|
-1.58e-03
|
1.55e-02
|
9.65e-01
|
6.67e-01
|
GOCC FHF COMPLEX
|
5
|
9.98e-01
|
1.00e+00
|
0.01530
|
1.53e-02
|
-9.82e-04
|
9.53e-01
|
9.97e-01
|
GOBP DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS
|
217
|
9.34e-01
|
9.87e-01
|
0.01530
|
-1.28e-02
|
8.33e-03
|
7.45e-01
|
8.33e-01
|
GOBP TELENCEPHALON DEVELOPMENT
|
266
|
9.15e-01
|
9.83e-01
|
0.01520
|
1.50e-02
|
-2.85e-03
|
6.75e-01
|
9.36e-01
|
GOBP POSITIVE REGULATION OF ORGANELLE ORGANIZATION
|
496
|
8.52e-01
|
9.67e-01
|
0.01510
|
3.21e-03
|
-1.48e-02
|
9.03e-01
|
5.73e-01
|
GOBP HEART FORMATION
|
33
|
9.89e-01
|
9.98e-01
|
0.01510
|
7.53e-04
|
-1.50e-02
|
9.94e-01
|
8.81e-01
|
GOBP NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT
|
41
|
9.87e-01
|
9.98e-01
|
0.01500
|
5.90e-03
|
-1.38e-02
|
9.48e-01
|
8.79e-01
|
GOMF FERROUS IRON BINDING
|
24
|
9.93e-01
|
9.99e-01
|
0.01480
|
-1.28e-02
|
7.53e-03
|
9.14e-01
|
9.49e-01
|
GOBP ADULT LOCOMOTORY BEHAVIOR
|
80
|
9.71e-01
|
9.93e-01
|
0.01470
|
1.07e-02
|
1.01e-02
|
8.69e-01
|
8.76e-01
|
GOBP PROSTATE GLAND MORPHOGENESIS
|
27
|
9.91e-01
|
9.99e-01
|
0.01420
|
-5.38e-03
|
-1.31e-02
|
9.61e-01
|
9.06e-01
|
GOBP NEGATIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS
|
59
|
9.83e-01
|
9.96e-01
|
0.01420
|
-1.41e-02
|
1.47e-03
|
8.51e-01
|
9.84e-01
|
GOMF POLYPEPTIDE N ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY
|
19
|
9.94e-01
|
1.00e+00
|
0.01420
|
7.74e-03
|
1.18e-02
|
9.53e-01
|
9.29e-01
|
GOBP EPITHELIAL CELL DEVELOPMENT
|
208
|
9.36e-01
|
9.87e-01
|
0.01390
|
6.01e-03
|
1.26e-02
|
8.81e-01
|
7.55e-01
|
GOMF 3 5 CYCLIC GMP PHOSPHODIESTERASE ACTIVITY
|
16
|
9.95e-01
|
1.00e+00
|
0.01380
|
4.25e-03
|
1.32e-02
|
9.77e-01
|
9.27e-01
|
GOCC POLAR MICROTUBULE
|
5
|
9.99e-01
|
1.00e+00
|
0.01370
|
-1.16e-03
|
1.37e-02
|
9.96e-01
|
9.58e-01
|
GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING
|
28
|
9.91e-01
|
9.99e-01
|
0.01370
|
9.93e-03
|
9.41e-03
|
9.28e-01
|
9.31e-01
|
GOBP REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY
|
5
|
9.99e-01
|
1.00e+00
|
0.01360
|
-6.67e-03
|
1.18e-02
|
9.79e-01
|
9.63e-01
|
GOBP REGULATION OF IMMUNE RESPONSE
|
865
|
8.08e-01
|
9.59e-01
|
0.01350
|
-4.31e-03
|
1.28e-02
|
8.29e-01
|
5.23e-01
|
GOBP RENAL SYSTEM PROCESS
|
117
|
9.65e-01
|
9.92e-01
|
0.01350
|
1.18e-02
|
6.55e-03
|
8.26e-01
|
9.03e-01
|
GOBP EMBRYONIC CAMERA TYPE EYE DEVELOPMENT
|
37
|
9.90e-01
|
9.99e-01
|
0.01330
|
1.23e-03
|
-1.32e-02
|
9.90e-01
|
8.89e-01
|
GOCC PHOSPHATASE COMPLEX
|
51
|
9.85e-01
|
9.97e-01
|
0.01310
|
7.28e-03
|
1.09e-02
|
9.28e-01
|
8.93e-01
|
GOBP REGULATION OF ADAPTIVE IMMUNE RESPONSE
|
199
|
9.54e-01
|
9.90e-01
|
0.01310
|
5.97e-03
|
-1.17e-02
|
8.85e-01
|
7.76e-01
|
GOBP NEURONAL STEM CELL POPULATION MAINTENANCE
|
23
|
9.93e-01
|
9.99e-01
|
0.01310
|
1.17e-02
|
5.90e-03
|
9.22e-01
|
9.61e-01
|
GOMF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY
|
1362
|
7.01e-01
|
9.22e-01
|
0.01310
|
-1.26e-02
|
-3.59e-03
|
4.35e-01
|
8.24e-01
|
GOMF GDP BINDING
|
69
|
9.82e-01
|
9.96e-01
|
0.01310
|
-1.31e-02
|
-3.99e-04
|
8.51e-01
|
9.95e-01
|
GOCC MOTILE CILIUM
|
248
|
9.41e-01
|
9.89e-01
|
0.01300
|
2.62e-03
|
-1.28e-02
|
9.43e-01
|
7.29e-01
|
GOBP FORMATION OF ANATOMICAL BOUNDARY
|
7
|
9.98e-01
|
1.00e+00
|
0.01300
|
3.36e-03
|
1.25e-02
|
9.88e-01
|
9.54e-01
|
GOBP NEURON PROJECTION ARBORIZATION
|
31
|
9.93e-01
|
9.99e-01
|
0.01280
|
-6.48e-03
|
1.11e-02
|
9.50e-01
|
9.15e-01
|
GOMF ORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
36
|
9.92e-01
|
9.99e-01
|
0.01280
|
1.15e-02
|
-5.58e-03
|
9.05e-01
|
9.54e-01
|
GOBP MUSCLE TISSUE DEVELOPMENT
|
421
|
9.04e-01
|
9.80e-01
|
0.01280
|
-9.22e-04
|
1.27e-02
|
9.74e-01
|
6.54e-01
|
GOBP SEX DIFFERENTIATION
|
266
|
9.43e-01
|
9.89e-01
|
0.01270
|
-1.15e-02
|
5.56e-03
|
7.48e-01
|
8.76e-01
|
GOBP REGULATION OF NEURON MIGRATION
|
44
|
9.89e-01
|
9.98e-01
|
0.01250
|
1.89e-03
|
1.24e-02
|
9.83e-01
|
8.87e-01
|
GOBP DIGESTIVE SYSTEM DEVELOPMENT
|
142
|
9.66e-01
|
9.92e-01
|
0.01220
|
4.81e-03
|
1.12e-02
|
9.21e-01
|
8.17e-01
|
GOBP AMINO SUGAR CATABOLIC PROCESS
|
14
|
9.96e-01
|
1.00e+00
|
0.01220
|
-7.76e-03
|
-9.36e-03
|
9.60e-01
|
9.52e-01
|
GOBP REGULATION OF KIDNEY DEVELOPMENT
|
32
|
9.93e-01
|
9.99e-01
|
0.01210
|
-1.20e-02
|
1.42e-03
|
9.06e-01
|
9.89e-01
|
GOBP REGULATION OF CELL KILLING
|
111
|
9.73e-01
|
9.93e-01
|
0.01210
|
1.01e-02
|
6.55e-03
|
8.54e-01
|
9.05e-01
|
GOMF EXTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY
|
69
|
9.86e-01
|
9.98e-01
|
0.01200
|
-4.68e-03
|
1.10e-02
|
9.46e-01
|
8.74e-01
|
GOBP REGULATION OF MITOCHONDRIAL MRNA STABILITY
|
7
|
9.99e-01
|
1.00e+00
|
0.01180
|
4.90e-03
|
-1.07e-02
|
9.82e-01
|
9.61e-01
|
GOBP POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION
|
24
|
9.95e-01
|
1.00e+00
|
0.01160
|
-4.50e-03
|
-1.07e-02
|
9.70e-01
|
9.28e-01
|
GOBP CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS
|
170
|
9.64e-01
|
9.92e-01
|
0.01150
|
3.87e-03
|
1.08e-02
|
9.31e-01
|
8.08e-01
|
GOBP ICOSANOID TRANSPORT
|
63
|
9.89e-01
|
9.98e-01
|
0.01150
|
-7.21e-03
|
8.90e-03
|
9.21e-01
|
9.03e-01
|
GOBP LEUKOCYTE PROLIFERATION
|
331
|
9.31e-01
|
9.86e-01
|
0.01150
|
5.51e-03
|
1.00e-02
|
8.63e-01
|
7.54e-01
|
GOBP REGULATION OF BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS
|
19
|
9.97e-01
|
1.00e+00
|
0.01140
|
-9.45e-03
|
6.33e-03
|
9.43e-01
|
9.62e-01
|
GOBP HETEROCYCLE CATABOLIC PROCESS
|
517
|
9.12e-01
|
9.82e-01
|
0.01110
|
-1.10e-02
|
1.79e-03
|
6.69e-01
|
9.44e-01
|
GOBP REGULATION OF GLYCOPROTEIN METABOLIC PROCESS
|
58
|
9.88e-01
|
9.98e-01
|
0.01110
|
5.15e-03
|
9.88e-03
|
9.46e-01
|
8.96e-01
|
GOBP RESPONSE TO CYTOKINE
|
903
|
8.66e-01
|
9.70e-01
|
0.01110
|
-8.12e-03
|
7.62e-03
|
6.79e-01
|
6.98e-01
|
GOMF TRANSITION METAL ION BINDING
|
1037
|
8.51e-01
|
9.67e-01
|
0.01100
|
-6.97e-03
|
8.54e-03
|
7.04e-01
|
6.42e-01
|
GOMF MOLECULAR FUNCTION INHIBITOR ACTIVITY
|
468
|
9.19e-01
|
9.84e-01
|
0.01090
|
-1.09e-02
|
-6.62e-04
|
6.85e-01
|
9.80e-01
|
GOBP ANIMAL ORGAN FORMATION
|
66
|
9.87e-01
|
9.98e-01
|
0.01090
|
9.14e-03
|
5.99e-03
|
8.98e-01
|
9.33e-01
|
GOMF ENZYME INHIBITOR ACTIVITY
|
370
|
9.40e-01
|
9.89e-01
|
0.01080
|
1.06e-02
|
-2.28e-03
|
7.27e-01
|
9.40e-01
|
GOBP REGULATION OF GLIAL CELL MIGRATION
|
19
|
9.97e-01
|
1.00e+00
|
0.01080
|
-4.06e-03
|
1.00e-02
|
9.76e-01
|
9.40e-01
|
GOBP CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS
|
39
|
9.94e-01
|
1.00e+00
|
0.01080
|
7.37e-03
|
-7.88e-03
|
9.37e-01
|
9.32e-01
|
GOBP MELANOCYTE DIFFERENTIATION
|
24
|
9.96e-01
|
1.00e+00
|
0.01060
|
6.13e-03
|
-8.71e-03
|
9.59e-01
|
9.41e-01
|
GOBP ENDOSOMAL LUMEN ACIDIFICATION
|
12
|
9.98e-01
|
1.00e+00
|
0.01060
|
8.02e-03
|
6.96e-03
|
9.62e-01
|
9.67e-01
|
GOCC ENDOPLASMIC RETICULUM LUMEN
|
295
|
9.50e-01
|
9.90e-01
|
0.01050
|
1.70e-03
|
1.04e-02
|
9.60e-01
|
7.59e-01
|
GOBP CELLULAR RESPONSE TO BIOTIC STIMULUS
|
251
|
9.56e-01
|
9.90e-01
|
0.01040
|
5.57e-03
|
8.78e-03
|
8.79e-01
|
8.11e-01
|
GOBP POSITIVE REGULATION OF DNA RECOMBINATION
|
67
|
9.90e-01
|
9.99e-01
|
0.01040
|
-7.86e-03
|
6.77e-03
|
9.11e-01
|
9.24e-01
|
GOBP POSITIVE REGULATION OF MRNA METABOLIC PROCESS
|
190
|
9.69e-01
|
9.93e-01
|
0.01030
|
-1.02e-02
|
-1.18e-03
|
8.09e-01
|
9.78e-01
|
GOBP LYMPHOCYTE MEDIATED IMMUNITY
|
279
|
9.61e-01
|
9.91e-01
|
0.01010
|
9.46e-03
|
-3.53e-03
|
7.86e-01
|
9.19e-01
|
GOBP CILIUM ORGANIZATION
|
409
|
9.43e-01
|
9.89e-01
|
0.01000
|
9.81e-03
|
-1.96e-03
|
7.33e-01
|
9.46e-01
|
GOBP RNA DESTABILIZATION
|
163
|
9.79e-01
|
9.95e-01
|
0.00994
|
-8.53e-03
|
5.09e-03
|
8.51e-01
|
9.11e-01
|
GOMF TRANSFERASE ACTIVITY TRANSFERRING ALKYL OR ARYL OTHER THAN METHYL GROUPS
|
55
|
9.93e-01
|
9.99e-01
|
0.00985
|
4.12e-03
|
-8.95e-03
|
9.58e-01
|
9.09e-01
|
GOBP POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM
|
33
|
9.96e-01
|
1.00e+00
|
0.00944
|
-2.46e-03
|
9.11e-03
|
9.81e-01
|
9.28e-01
|
GOBP LOCOMOTORY BEHAVIOR
|
198
|
9.72e-01
|
9.93e-01
|
0.00934
|
8.16e-03
|
4.54e-03
|
8.43e-01
|
9.12e-01
|
GOBP PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS
|
21
|
9.97e-01
|
1.00e+00
|
0.00919
|
9.19e-03
|
-3.60e-04
|
9.42e-01
|
9.98e-01
|
GOCC TRANSCRIPTION FACTOR TFTC COMPLEX
|
17
|
9.98e-01
|
1.00e+00
|
0.00913
|
-8.90e-03
|
-2.04e-03
|
9.49e-01
|
9.88e-01
|
GOBP NEGATIVE REGULATION OF INTERLEUKIN 13 PRODUCTION
|
7
|
9.99e-01
|
1.00e+00
|
0.00885
|
-8.73e-03
|
-1.47e-03
|
9.68e-01
|
9.95e-01
|
GOBP RECEPTOR SIGNALING PATHWAY VIA STAT
|
180
|
9.80e-01
|
9.96e-01
|
0.00861
|
-4.92e-04
|
-8.59e-03
|
9.91e-01
|
8.42e-01
|
GOBP EATING BEHAVIOR
|
37
|
9.95e-01
|
1.00e+00
|
0.00857
|
-4.11e-03
|
-7.52e-03
|
9.66e-01
|
9.37e-01
|
GOBP IMMUNE SYSTEM DEVELOPMENT
|
198
|
9.78e-01
|
9.95e-01
|
0.00847
|
-2.24e-03
|
-8.16e-03
|
9.57e-01
|
8.43e-01
|
GOBP POSITIVE REGULATION OF LIPID TRANSPORT
|
86
|
9.92e-01
|
9.99e-01
|
0.00837
|
-7.81e-03
|
3.01e-03
|
9.00e-01
|
9.61e-01
|
GOBP DENDRITE EXTENSION
|
35
|
9.96e-01
|
1.00e+00
|
0.00835
|
8.29e-03
|
-1.00e-03
|
9.32e-01
|
9.92e-01
|
GOBP PROTEIN LOCALIZATION TO CHROMOSOME
|
113
|
9.87e-01
|
9.98e-01
|
0.00834
|
5.30e-03
|
6.44e-03
|
9.22e-01
|
9.06e-01
|
GOBP CORONARY VASCULATURE MORPHOGENESIS
|
19
|
9.98e-01
|
1.00e+00
|
0.00832
|
-7.56e-03
|
-3.47e-03
|
9.55e-01
|
9.79e-01
|
GOBP POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY
|
144
|
9.87e-01
|
9.98e-01
|
0.00819
|
-6.05e-03
|
5.52e-03
|
9.00e-01
|
9.09e-01
|
GOBP LEUKOCYTE MEDIATED CYTOTOXICITY
|
132
|
9.87e-01
|
9.98e-01
|
0.00817
|
-1.86e-04
|
8.17e-03
|
9.97e-01
|
8.71e-01
|
GOBP OUTFLOW TRACT SEPTUM MORPHOGENESIS
|
26
|
9.98e-01
|
1.00e+00
|
0.00723
|
6.94e-03
|
-2.03e-03
|
9.51e-01
|
9.86e-01
|
GOBP ASPARTATE TRANSMEMBRANE TRANSPORT
|
19
|
9.99e-01
|
1.00e+00
|
0.00690
|
-3.38e-03
|
6.02e-03
|
9.80e-01
|
9.64e-01
|
GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY
|
8
|
9.99e-01
|
1.00e+00
|
0.00673
|
-6.64e-03
|
1.13e-03
|
9.74e-01
|
9.96e-01
|
GOBP CALCIUM ION REGULATED EXOCYTOSIS
|
63
|
9.96e-01
|
1.00e+00
|
0.00643
|
6.43e-03
|
-1.16e-05
|
9.30e-01
|
1.00e+00
|
GOMF STRUCTURAL CONSTITUENT OF SYNAPSE
|
24
|
9.98e-01
|
1.00e+00
|
0.00639
|
5.67e-03
|
2.93e-03
|
9.62e-01
|
9.80e-01
|
GOBP RESPONSE TO ALCOHOL
|
246
|
9.88e-01
|
9.98e-01
|
0.00611
|
-3.81e-03
|
4.77e-03
|
9.18e-01
|
8.97e-01
|
GOBP POSITIVE REGULATION OF CATECHOLAMINE SECRETION
|
12
|
9.99e-01
|
1.00e+00
|
0.00607
|
6.02e-03
|
7.88e-04
|
9.71e-01
|
9.96e-01
|
GOBP VITAMIN K METABOLIC PROCESS
|
10
|
9.99e-01
|
1.00e+00
|
0.00604
|
-5.43e-03
|
-2.65e-03
|
9.76e-01
|
9.88e-01
|
GOBP REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY
|
178
|
9.91e-01
|
9.99e-01
|
0.00597
|
5.22e-03
|
-2.90e-03
|
9.04e-01
|
9.47e-01
|
GOBP MULTICELLULAR ORGANISMAL LEVEL CHEMICAL HOMEOSTASIS
|
73
|
9.96e-01
|
1.00e+00
|
0.00581
|
4.59e-03
|
3.56e-03
|
9.46e-01
|
9.58e-01
|
GOBP MEIOTIC CELL CYCLE PROCESS
|
208
|
9.90e-01
|
9.99e-01
|
0.00575
|
7.99e-04
|
-5.69e-03
|
9.84e-01
|
8.87e-01
|
GOBP REGULATION OF STEROL TRANSPORT
|
80
|
9.97e-01
|
1.00e+00
|
0.00536
|
3.30e-03
|
-4.22e-03
|
9.59e-01
|
9.48e-01
|
GOBP MULTICELLULAR ORGANISMAL LEVEL WATER HOMEOSTASIS
|
33
|
9.98e-01
|
1.00e+00
|
0.00524
|
-3.08e-03
|
-4.23e-03
|
9.76e-01
|
9.66e-01
|
GOBP MITOCHONDRIAL TRANSLATIONAL ELONGATION
|
5
|
1.00e+00
|
1.00e+00
|
0.00516
|
4.71e-03
|
-2.11e-03
|
9.85e-01
|
9.93e-01
|
GOBP ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS
|
559
|
9.80e-01
|
9.96e-01
|
0.00499
|
-7.02e-04
|
4.94e-03
|
9.77e-01
|
8.42e-01
|
GOMF GTPASE ACTIVITY
|
303
|
9.89e-01
|
9.98e-01
|
0.00489
|
-2.25e-04
|
4.89e-03
|
9.95e-01
|
8.84e-01
|
GOBP POSITIVE REGULATION OF TELOMERASE ACTIVITY
|
33
|
9.99e-01
|
1.00e+00
|
0.00455
|
-3.17e-03
|
3.26e-03
|
9.75e-01
|
9.74e-01
|
GOBP ADULT BEHAVIOR
|
141
|
9.96e-01
|
1.00e+00
|
0.00430
|
-3.25e-03
|
-2.81e-03
|
9.47e-01
|
9.54e-01
|
GOCC ASYMMETRIC GLUTAMATERGIC EXCITATORY SYNAPSE
|
13
|
1.00e+00
|
1.00e+00
|
0.00426
|
-1.97e-03
|
-3.78e-03
|
9.90e-01
|
9.81e-01
|
GOCC POSTSYNAPTIC MEMBRANE
|
256
|
9.92e-01
|
9.99e-01
|
0.00424
|
-2.63e-03
|
-3.33e-03
|
9.42e-01
|
9.27e-01
|
GOBP RESPONSE TO VITAMIN D
|
36
|
9.99e-01
|
1.00e+00
|
0.00401
|
1.91e-03
|
3.53e-03
|
9.84e-01
|
9.71e-01
|
GOMF PROTON TRANSMEMBRANE TRANSPORTER ACTIVITY
|
129
|
9.97e-01
|
1.00e+00
|
0.00400
|
-3.29e-03
|
-2.27e-03
|
9.49e-01
|
9.64e-01
|
GOBP NEGATIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY
|
12
|
1.00e+00
|
1.00e+00
|
0.00363
|
2.92e-03
|
2.14e-03
|
9.86e-01
|
9.90e-01
|
GOMF MONOATOMIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
131
|
9.97e-01
|
1.00e+00
|
0.00354
|
3.07e-03
|
1.76e-03
|
9.52e-01
|
9.72e-01
|
GOBP NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS
|
64
|
9.99e-01
|
1.00e+00
|
0.00329
|
6.91e-04
|
-3.22e-03
|
9.92e-01
|
9.64e-01
|
GOCC BRUSH BORDER MEMBRANE
|
57
|
9.99e-01
|
1.00e+00
|
0.00310
|
-1.89e-03
|
-2.46e-03
|
9.80e-01
|
9.74e-01
|
GOCC DENDRITE MEMBRANE
|
36
|
1.00e+00
|
1.00e+00
|
0.00176
|
1.73e-03
|
3.19e-04
|
9.86e-01
|
9.97e-01
|
GOBP NEGATIVE REGULATION OF MAPK CASCADE
|
164
|
1.00e+00
|
1.00e+00
|
0.00122
|
-7.69e-04
|
9.46e-04
|
9.86e-01
|
9.83e-01
|